As filed with the Securities and
Exchange Commission on
November 12
,
2008
Registration
No. 333-144865
UNITED
STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON
D.C. 20549
FORM
S-1/A
REGISTRATION
STATEMENT
UNDER
THE
SECURITIES ACT OF 1933
eMagin
Corporation
(Name of
small business issuer in its charter)
Delaware
|
|
3679
|
|
56-1764501
|
(State
or other Jurisdiction of
|
|
(Primary
Standard Industrial
|
|
(I.R.S.
Employer
|
Incorporation
or Organization)
|
|
Classification
Code Number)
|
|
Identification
No.)
|
10500
N.E. 8
th
Street,
Suite 1400,
Bellevue,
WA 98004
(425)-749-3600
(Address
and telephone number of principal executive offices and principal place of
business)
Andrew G.
Sculley, Chief Executive Officer
eMagin
Corporation
10500
N.E. 8
th
Street,
Suite 1400,
Bellevue,
WA 98004
(425)-749-3600
(Name,
address and telephone number of agent for service)
Copies
to:
Richard A. Friedman,
Esq.
Sichenzia
Ross Friedman Ference LLP
61 Broadway, 32nd
Flr.
New
York, New York 10006
(212)
930-9700
(212)
930-9725 (fax)
APPROXIMATE
DATE OF PROPOSED SALE TO THE PUBLIC:
From time
to time after this Registration Statement becomes effective.
If any
securities being registered on this Form are to be offered on a delayed or
continuous basis pursuant to Rule 415 under the Securities Act of 1933, other
than securities offered only in connection with dividend or interest
reinvestment plans, check the following box:
x
If this
Form is filed to register additional securities for an offering pursuant to Rule
462(b) under the Securities Act, check the following box and list the Securities
Act registration statement number of the earlier effective registration
statement for the same offering.
o
If this
Form is a post-effective amendment filed pursuant to Rule 462(c) under the
Securities Act, check the following box and list the Securities Act registration
statement number of the earlier effective registration statement for the same
offering.
o
If this
Form is a post-effective amendment filed pursuant to Rule 462(d) under the
Securities Act, check the following box and list the Securities Act registration
statement number of the earlier effective registration statement for the same
offering.
o
If
delivery of the prospectus is expected to be made pursuant to Rule 434, please
check the following box.
o
Title of each class
of
securities to be
registered
|
|
Amount
to be
registered
|
|
|
Proposed
maximum
offering
price
per
share
|
|
|
Proposed
maximum
aggregate
offering
price
(1)
|
|
|
Amount
of
registration
fee
(2)
|
|
Common
Stock, $0.001 par value per share
|
|
|
2,450,000
|
|
|
$
|
0.38
|
|
|
$
|
931,000
|
|
|
$
|
36.59
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
|
Estimated
solely for purposes of calculating the registration fee in accordance with
Rule 457(c) and Rule 457(g) under the Securities Act of 1933, using the
average of the sale prices as reported on the OTCBB on October 14, 2008
which was $0.38 per share.
|
(2)
|
|
The
registrant previously paid a filing fee in the amount of
$113.00.
|
The
registrant hereby amends this registration statement on such date or dates as
may be necessary to delay its effective date until the registrant shall file a
further amendment which specifically states that this registration shall
thereafter become effective in accordance with Section 8(a) of the
Securities Act of 1933 or until the registration statement shall become
effective on such date as the Securities and Exchange Commission, acting
pursuant to said Section 8(a), may determine.
eMagin
Corporation
2,450,000
SHARES OF
COMMON
STOCK
This
prospectus relates to the resale by the selling stockholders of up to 2,450,000
shares of our common stock, consisting of up to (i) 1,000,000 shares issuable
upon the exercise of common stock purchase warrants, (ii) 729,524 shares of
common stock issuable upon conversion of the remaining $250,000 Stillwater Note
(Original Stillwater Note (as described herein) of $500,000 less $250,000
partial Note conversion (as described in iii)) and accrued interest of
$5,333 at a conversion price of $0.35 per share, and (iii) 720,476 shares
of common stock issued (but not registered) to the selling stockholder due
to the selling stockholder’s election to partially convert the Stillwater Note
pursuant to its terms. With respect to the aforementioned subpart (iii) above,
on July, 23 2007, Stillwater elected to convert $252,166.50 of the Stillwater
Note representing $250,000 of the principal amount of the Note due on July
23, 2007 and $2,166.50 of accrued and unpaid interest into shares of common
stock. Stillwater received 720,476 shares of the common stock at the conversion
price of $0.35. The selling stockholders may sell common stock from time to time
in the principal market on which the stock is traded at the prevailing market
price or in negotiated transactions. We will pay the expenses of registering
these shares.
Our
common stock is listed on the Over-The-Counter Bulletin Board under the symbol
“EMAN”. The last reported sales price per share of our common stock as reported
by the Over-The-Counter Bulletin Board on October 14, 2008 was
$0.50.
Investing
in these securities involves significant risks. See “Risk Factors” beginning on
page 10.
Neither
the Securities and Exchange Commission nor any state securities commission has
approved or disapproved of these securities or determined if this Prospectus is
truthful or complete. Any representation to the contrary is a criminal offense.
You should read this prospectus carefully before you invest.
The date
of this prospectus
is November ,
2008.
The
information in this Prospectus is not complete and may be changed. This
Prospectus is included in the Registration Statement that was filed by eMagin
Corporation with the Securities and Exchange Commission. The selling
stockholders may not sell these securities until the registration statement
becomes effective. This Prospectus is not an offer to sell these securities and
is not soliciting an offer to buy these securities in any state where the sale
is not permitted.
|
|
Page
|
|
|
|
Prospectus
Summary
|
|
4
|
Risk
Factors
|
|
10
|
Forward
Looking Statements
|
|
15
|
Use
of Proceeds
|
|
15
|
Market
For Equity and Related Stockholder Matters
|
|
15
|
Selected
Financial Data
|
|
16
|
Management’s
Discussion and Analysis of Financial Condition and Results of
Operations
|
|
17
|
Business
|
|
25
|
Description
of Property
|
|
39
|
Legal
Proceedings
|
|
39
|
Management
|
|
40
|
Executive
Compensation
|
|
43
|
Indemnification
for Securities Act Liabilities
|
|
55
|
Plan
of Distribution
|
|
55
|
Description
of Securities
|
|
57
|
Selling
Stockholders
|
|
57
|
Transactions
With Related Persons, Promoters and Certain Control
Persons
|
|
62
|
Legal
Matters
|
|
65
|
Experts
|
|
65
|
Available
Information
|
|
65
|
Index
to Financial Statements
|
|
66
|
The
following summary highlights selected information contained in this prospectus.
This summary does not contain all the information you should consider before
investing in the securities. Before making an investment decision, you should
read the entire prospectus carefully, including the “risk factors” section, the
financial statements and the notes to the financial statements.
We
design, develop, manufacture, and market virtual imaging products which utilize
OLEDs, or organic light emitting diodes, OLED-on-silicon microdisplays and
related information technology solutions. We integrate OLED technology with
silicon chips to produce high-resolution microdisplays smaller than one-inch
diagonally which, when viewed through a magnifier, create virtual images that
appear comparable in size to that of a computer monitor or a large-screen
television. Our products enable our original equipment manufacturer, or OEM,
customers to develop and market improved or new electronic products. We believe
that virtual imaging will become an important way for increasingly mobile people
to have quick access to high resolution data, work, and experience new more
immersive forms of communications and entertainment.
Our first
commercial product, the SVGA+ (Super Video Graphics Array of 800x600 picture
elements plus 52 added columns of data) OLED microdisplay was initially offered
for sampling in 2001, and our first SVGA-3D (Super Video Graphics Array plus
built-in stereovision capability) OLED microdisplay was shipped in early 2002.
These products are being applied or considered for near-eye and headset
applications in products such as entertainment and gaming headsets, handheld
Internet and telecommunication appliances, viewfinders, and wearable computers
to be manufactured by OEM customers for military, medical, industrial, and
consumer applications. We market our products globally.
In 2006
we introduced our OLED-XL technology, which provides longer luminance half life
and enhanced efficiency of eMagin's SVGA+ and SVGA-3D product lines. We are in
the process of completing development of 2 additional OLED microdisplays, namely
the SVGA 3DS (SVGA 3D shrink, a smaller format SVGA display with a new cell
architecture with embedded features) and an SXGA (1280 x 1024 picture
elements).
In
January 2005 we announced the world's first personal display system to combine
OLED technology with head-tracking and 3D stereovision, the Z800 3DVisor(tm),
which was first shipped in mid-2005. This product was recognized as a Digital
Living Class of 2005 Innovators, and received the Consumer Electronics
Association’s coveted Consumer Electronics Show (CES) 2006 Best of Innovation
Awards for the entire display category as well as a Design and Innovations Award
for the electronic gaming category. In February 2007 the Z800 3DVisor, as
integrated in Chatten Associates’ head-aimed remote viewer, was recognized as
one of Advanced Imaging's Solutions of the Year.
We
believe that our OLED-on-silicon microdisplays offer a number of advantages over
current liquid crystal microdisplays, including greatly increased system level
power efficiency, less weight and wider viewing angles. Using our active matrix
OLED technology, many computer and video electronic system functions can be
built directly into the OLED-on-silicon microdisplay, resulting in compact
systems with expected lower overall system costs relative to alternative
microdisplay technologies. We have developed our own technology to create high
performance OLED-on-silicon microdisplays and related optical systems and we
have licensed certain fundamental OLED and display technology from Eastman
Kodak.
As the
first to exploit OLED technology for microdisplays, and with the support of our
partners and the development of our intellectual property, we believe that we
enjoy a significant advantage in the commercialization of this display
technology for virtual imaging. We believe we are the only company to sell
full-color active matrix small molecule OLED-on-silicon
microdisplays.
eMagin
Corporation was created through the merger of Fashion Dynamics Corporation
("FDC"), which was organized on January 23, 1996 under the laws of the State of
Nevada and FED Corporation ("FED"), a developer and manufacturer of optical
systems and microdisplays for use in the electronics industry. FDC had no active
business operations other than to acquire an interest in a business. On March
16, 2000, FDC acquired FED. The merged company changed its name to eMagin
Corporation. Following the merger, the business conducted by eMagin is the
business conducted by FED prior to the merger.
Our
website is located at
www.emagin.com
and
our e-commerce site is
www.3dvisor.com
. The
contents of our website are not part of this Prospectus.
Common
stock offered by selling stockholders
|
|
Up
to 2,450,000 shares, consisting of the following:
|
|
|
|
|
|
·
729,524
shares of common stock issuable upon conversion of the remaining
Stillwater Note of $250,000 and accrued interest of $5,333 at a
conversion price of $0.35 per share and 720,476 shares of common stock
issued (but not registered) to Stillwater due to Stillwater's
election to partially convert the Stillwater Note pursuant to its
terms.*
|
|
|
|
|
|
·
up to
1,000,000 shares of common stock issuable upon the exercise of common
stock purchase warrants at an exercise price of $0.48 per
share.
|
|
|
|
Common
Stock to be outstanding after the offering
|
|
16,748,363
shares**
|
|
|
|
Use
of proceeds
|
|
We
will not receive any proceeds from the sale of the common stock; however
we will receive proceeds from the exercise of our
warrants.
|
|
|
|
Over-The-Counter
Bulletin Board Symbol
|
|
EMAN
|
|
* On
July, 23 2007, Stillwater elected to convert $252,166.50 of the Stillwater
Note representing $250,000 of the principal amount of the Note due on
July 23, 2007 and $2,166.50 of accrued and unpaid interest into
shares of common stock. Stillwater received 720,476 shares of the common
stock at the conversion price of $0.35.
|
|
**The
information above regarding the common stock to be outstanding after the
offering is based on 15,018,839 shares of the Company’s common stock
outstanding as of October 14,
2008.
|
Recent
Developments
Amendment
of Stillwater Note Purchase Agreement (the “Stillwater Note”) - April
2007
As previously reported in the Form 8-K
dated July 25, 2006, on
July
21, 2006, eMagin Corporation (the
“Company”) entered into a Note Purchase Agreement (the “Stillwater Agreement”)
with Stillwater LLC (“Stillwater”) which provides for the purchase and sale of a
6% senior secured convertible note in the principal amount of up to $500,000,
together with a warrant (the “Stillwater Warrant”) to purchase 70% of the number
of shares issuable upon conversion of the Stillwater Note, at the sole
discretion of the Company by delivery of a notice to Stillwater on December 14,
2006. Interest payments from the Stillwater Note are to be made in
cash, unless Stillwater elects to convert any portion of the principal of the
Stillwater Note plus any accrued and unpaid interest for such principal
amount.
As
previously reported in the Form 8-K dated April 13, 2007, by way of amendment to
the Stillwater Agreement, dated March 28, 2007 (the “Amendment”), the Company
and Stillwater agreed to certain amendments to the Stillwater Agreement. Based
upon the provisions of the Stillwater Agreement, Stillwater was bound to
purchase the Stillwater Note and the Stillwater Warrant so long as the
conditions to closing as set forth in the Stillwater Agreement were satisfied by
the Company. However, prior to Stillwater’s obligation to purchase
the Stillwater Note and Stillwater Warrant, the Company received notice from the
American Stock Exchange (“AMEX”) that it was no longer in compliance with their
listing requirements, and the Company was subsequently de-listed in March of
2007. Since compliance with the AMEX listing requirements was a condition of
closing in the Stillwater Agreement, Stillwater was no longer obligated to
purchase the Stillwater Note and Stillwater Warrant. Therefore, among
other things, pursuant to the Amendment, the parties agreed to a new
conversion price for the Stillwater Note of $0.35 per share, a new exercise
price for the Stillwater Warrant of $0.48 per share , a new closing date,
and amended certain closing conditions, including the following: on the closing
date, (i) trading in securities on the New York Stock Exchange, Inc., the AMEX,
Nasdaq, the Nasdaq Capital Market, the Over-The-Counter Bulletin Board, the Pink
Sheets, LLC or any similar organization shall not have been suspended or
materially limited, (ii) a general moratorium on commercial banking activities
in the State of New York shall not have been declared by either federal or state
authorities, and (iii) the Company has obtained waivers from all the note
holders of the other notes or has executed an additional Allonge with the
majority holders to amend Section 3.2 of the Note and other notes to provide
that the Company maintain cash and cash equivalents balances of at least equal
to $200,000 from April 1, 2007 through and including May 15, 2007 and
that subsequent to May 15, 2007 the Company maintain cash and cash
equivalents balances of at least equal to $600,000.
If all of
the Stillwater Warrants are exercised for cash, the Company would receive
$480,000, which would be used for working capital and other corporate purposes.
There cannot be any assurances that any of the Stillwater Warrants will be
exercised. The closing for the sale of the Stillwater Note and Stillwater
Warrant was completed on April 9, 2007 and the Company issued Stillwater the
Stillwater Note in a 6% Senior Secured Convertible Note in the principal amount
of $500,000 and the Stillwater Warrant to purchase 1,000,000 shares of the
Company’s common stock at an exercise price of $0.48 in accordance with the
terms of the Stillwater Agreement and Amendment. Interest payments from the
Stillwater Note are to be made in cash, unless Stillwater elects to convert any
portion of the principal of the Stillwater Note plus any accrued and unpaid
interest for such principal amount. The principal of the Stillwater
Note was due in installments as follows:
Principal
Amount
|
|
Due
Date*
|
$
|
250,000
|
|
July
23, 2007**
|
|
|
|
|
$
|
250,000
|
|
January
21, 2008
|
* If the
due date falls on a non-business day, the payment date will be the next business
day.
**On July, 23 2007, Stillwater
elected to convert $252,166.50 of the Note representing $250,000 of the
principal amount of the Note due on July 23, 2007 and $2,166.50 of accrued
and unpaid interest into shares of common stock. Stillwater
received
720,476 shares of the common stock at
the conversion price of $0.35.
This
prospectus covers the resale by Stillwater of the above-referenced common stock
underlying the Stillwater Note and the Stillwater Warrant.
Amendment
Agreements - July 2007
As
previously reported in the Form 8-K of the Company dated as of July 25, 2006,
the Company entered into several Note Purchase Agreements (the “Original
Purchase Agreements”), including the Stillwater Agreement, to sell to certain
qualified institutional buyers and accredited investors $5,990,000 in principal
amount 6% Senior Secured Convertible Notes Due July 21, 2007 and January 21,
2008 (the “Notes”), together with warrants (the “Warrants”) to purchase
1,612,700 shares of the Company’s common stock, par value $0.001 per share at
$3.60 per share.
As previously reported in the Form 8-K
of the Company dated as of July 25, 2007, by way of Amendment Agreements dated
July 23, 2007 (the “Amendment Agreements”) between the Company and each of the
holders of the Notes,
including Stillwate
r
(each a “Holder” and collectively, the
“Holders”), the Company agreed to issue each Holder an amended and restated
Note
f
or the outstanding
Notes
(the “Amended
Notes”) in the principal amount equal to the principal amount outstanding as of
July 23, 2007 and an amended restated Warrant (the “Amended
Warrants”). The changes to the Amended Notes and Amended
Warrants include the following:
·
|
The
maturity date for the Amended Notes (totaling after conversions an
aggregate of $6,020,000) was extended to December 21,
2008;
|
·
|
Liquidated
damages of 1% per month related to the Company’s delisting from the
American Stock Exchange will no longer accrue and the deferred interest
balance of approximately $230,000 has been forgiven;
|
·
|
The
Company no longer has to maintain a minimum cash or cash equivalents
balances of $600,000;
|
·
|
The
Amended Notes may not be prepaid without the consent of the
Holders;
|
·
|
As
of July 23, 2007 the interest rate was raised from 6% per annum to 8% per
annum;
|
·
|
The
Amended Notes are convertible into (i) 8,407,612 shares of the Company’s
common stock. The conversion price for the Amended Notes was
revised from $2.60 to $.75 per share except for the Stillwater Note which
remained $.35 per share for $250,000 of principal (which represents the
remaining portion of the original principal balance of $500,000 after
Stillwater’s partial conversion);
|
·
|
In
addition to the right to convert the Amended Notes in the Company’s common
stock, up to $3,010,000 of the Amended Notes can be converted into (ii)
3,010 shares of the Company’s newly formed Series A Senior Secured
Convertible Preferred Stock (the “Preferred”) at a stated value of $1,000
per share. The Preferred is convertible into common stock at
$.75 per share, subject to adjustment as provided for in the Certificate
of Designations (discussed below);
|
·
|
Except
for the Stillwater Warrant whose exercise price was unchanged, the
Amendment Agreements adjusted the exercise price of the Amended Warrants
from $3.60 to $1.03 per share for 1,553,468 shares of common stock and
requires the issuance of Warrants exercisable for an additional 3,831,859
shares of common stock at $1.03 per share with an
expiration date of July 21, 2011;
|
·
|
The
Amended Notes eliminate the requirement that the Company comply with
certain covenants of management contained in the Notes. Specifically,
among other things, the requirements to defer management compensation and
to maintain a management committee were removed; and
|
·
|
The
Amended Notes and/or the Preferred are subject to certain anti-dilution
adjustment rights in the event the Company issues shares of its common
stock or securities convertible into its common stock at a price per share
that is less than the Conversion Price, in which case the Conversion Price
shall be adjusted to such lower price. The Amended Warrants are
subject to certain anti-dilution adjustment rights in the event the
Company issues shares of its common stock or securities convertible into
its common stock at a price per share that is less than the Strike Price,
in which case the Strike Price shall be adjusted to the lower of (1) 138%
of the price at which such common stock is issued or issuable and (2) the
exercise price of warrants, issued in such
transaction.
|
·
|
the
consolidation or merger of the Company or any of its
subsidiaries;
|
·
|
the
acquisition by a person or group of entities acting in concert of 50% or
more of the combined voting power of the outstanding securities
of the Company; and
|
·
|
the
occurrence of any transaction or event in which all or substantially all
of the shares of the Company’s common stock is exchanged for converted
into acquired for or constitutes the right to receive consideration which
is not all or substantially all common stock which is listed on a national
securities exchange or approved for quotation on Nasdaq or any similar
United States system of automated dissemination of transaction reporting
securities prices.
|
Pursuant
to the Amendment Agreements, the Company filed a Certificate of Designations of
Series A Senior Secured Convertible Preferred Stock (the “Certificate of
Designations”). The Certificate of Designations designates 3,198 shares of the
Company’s preferred stock as Series A Senior Secured Convertible Preferred Stock
(the “Preferred Stock”). Each share of the Preferred Stock has a
stated value of $1,000. The Preferred Stock is entitled to cumulative
dividends which accrue at a rate of 8% per annum, payable on December 21, 2008.
Each share of Preferred Stock has voting rights equal to (1) in any case in
which the Preferred Stock votes together with the Company’s common stock or any
other class or series of stock of the Company, the number of shares of common
stock issuable upon conversion of such shares of Preferred Stock at such time
(determined without regard to the shares of common stock so issuable upon such
conversion in respect of accrued and unpaid dividends on such share of Preferred
Stock) and (2) in any case not covered by the immediately preceding clause one
vote per share of Preferred Stock. The Certificate of Designations
prohibits the Company from entering into a Fundamental Change without consent of
the Holders and contains antidilution adjustments rights that are comparable to
the antidilution adjustments contained in the Amended Notes.
Pursuant
to the Amendment Agreements, the Company was required to file a registration
statement with the Securities and Exchange Commission by August 31, 2007
covering the resale of 100% of the sum of (a) the number of shares issuable upon
conversion of the Amended Notes and Preferred Stock, and (b) the number of
shares issuable upon exercise of the Warrants.
Pursuant
to the Amendment Agreement, the Company and the Collateral Agent, on behalf of
the note holders, executed Amendment No. 1 to the Pledge and Security Agreement;
Amendment No. 1 to Patent and Trademark Security Agreement; and Amendment No. 1
to Lockbox Agreement. The Pledge and Security Agreement, Trademark
Security Agreement and Lockbox Agreement were previously entered into on July
21, 2006 (collectively, the “Ancillary Agreements”). The Ancillary
Agreements were amended to cover obligations that may become payable to holders
of Preferred Stock, to delete certain definitions used in the Ancillary
Agreements and substitute definitions of terms used in the Ancillary
Agreements.
The
summary of amendment terms contained herein does not include all information
included in the Amendment Agreement, the Amended Notes, the Amended Warrants,
the Certificate of Designations or the Ancillary Agreements and, consequently,
is qualified in its entirety by reference to the entire text of the Amendment
Agreements and the forms of the Amended Notes, Amended Warrants, Certificate of
Designations, Amendment No. 1 to Pledge and Security Agreement, Amendment No. 1
to Patent and Trademark Security Agreement and Amendment No. 1 to Lockbox
Agreement.
Securities
Purchase Agreement – April 2008
As
previously reported on a Form 8-K that was filed with the Securities and
Exchange Commission on April 4, 2008, the Company entered into a Securities
Purchase Agreement on April 2, 2008, (the “Purchase Agreement”) pursuant
to which it sold to certain qualified institutional buyers and accredited
investors (the “Investors”) an aggregate of 1,586,539 shares of the Company’s
common stock, par value $0.001 per share (the “Shares”), and warrants to
purchase an additional 793,273 shares of common stock, for an aggregate purchase
price of $1,650,000. The purchase price of the common stock was $1.04 per share
and the strike price of the corresponding warrant was $1.30 per share. The
warrants expire April 2, 2013.
The
Company entered into a Registration Rights Agreement with the Investors to
register the resale of the Shares sold in the offering and the shares of common
stock issuable upon exercise of the warrants. Subject to the terms of
the Registration Rights Agreement, the Company is required to file a
registration statement on Form S-1 with the Securities and Exchange Commission
(the “SEC”) within 45 days of the closing, to use its best efforts to cause the
registration statement to be declared effective under the Securities Act of 1933
(the “Act”) as promptly as possible after the filing thereof, but in no event
later than 90 days after the filing date and no later than 120 days after the
filing date in the event of SEC review of the registration statement. The
Company filed the registration statement within the 45 day period however the
Company was notified that the registration statement was under review by the
SEC. The Company failed to file the amended registration statement by
August 2, 2008 which was the 120th day from the signing of the Purchase
Agreement and therefore the registration statement is not
effective.
As the
registration statement was not effective within the grace periods (“Event
Date”), the Company must pay partial liquidated damages (“damages”) in cash to
each investor equal to 2% of the aggregate purchase price paid by each investor
under the Purchase Agreement on the Event Date and each monthly anniversary of
the Event Date (or on a pro-rata basis for any portion of a month) until the
registration statement is effective. The Company is not liable for
any damages with respect to the warrants or warrant shares. The
maximum damages payable to each investor is 36% of the aggregate purchase
price. If the Company fails to pay the damages to the investors
within 7 days after the date payable, the Company must pay interest at a rate of
15% per annum to each investor which accrues daily from the date payable until
damages are paid in full. The Company estimated $399 thousand to be
the maximum potential damages that the Company may be required to pay the
investors if the registration statement is not effective within three years of
the signing of the agreement. The Company estimated $66 thousand to be a
reasonable estimate of the potential damages that may be due to the investors
based on the anticipated filing date.
The
Company claims an exemption from the registration requirements of the Act for
the private placement of these securities pursuant to Section 4(2) of the Act
and/or Regulation D promulgated thereunder since, among other things, the
transaction did not involve a public offering, the investors were accredited
investors and/or qualified institutional buyers, the investors had access to
information about the company and their investment, the investors took the
securities for investment and not resale, and the Company took appropriate
measures to restrict the transfer of the securities.
Moriah
Capital Loan Agreement and Amendments
As
previously reported on a Form 8-K that was filed with the Securities and
Exchange Commission on August 10, 2007, the Company and Moriah Capital LP
(“Moriah”) entered into a Loan and Security Agreement, dated as of August
7, 2007 (the “Loan and Security Agreement”), which was amended as of January 30,
2008 by Amendment No. 1 and on March 18, 2008 by Amendment No. 2 (collectively,
the “Original Agreement”).
As
previously reported on a Form 8-K that was filed with the Securities and
Exchange Commission on August 26, 2008, the Company and Moriah entered into
Amendment No. 3 to the Loan and Security Agreement dated August 20, 2008 (the
“Amendment No. 3”). Pursuant to Amendment No. 3, the Company issued Moriah an
Amended and Restated Convertible Revolving Loan Note (the “Amended
Note”). The maturity date of the Amended Note has been extended
to August 7, 2009 and the maximum amount that the Company can borrow pursuant to
the Amended Note was increased to $3,000,000. The maturity date of the original
revolving loan note had previously been extended to August 20,
2008.
Pursuant
to Amendment No. 3, the Company issued Moriah a warrant, which terminates on
August 7, 2013, to purchase up to 370,000 shares of the Company’s common stock
at an exercise price of $1.30 per share. In connection with Amendment No. 3, the
Company will pay Moriah $85,000 in fees. As previously reported,
pursuant to Original Agreement, the Company issued Moriah warrants to purchase
up to 1,000,000 shares of the Company’s common stock at an exercise price of
$1.50 per share.
Pursuant
to Amendment No. 3, the Company and Moriah entered into an Amended and
Restated Securities Issuance agreement (the “Amended and Restated Securities
Issuance Agreement”). In connection with a Securities Issuance Agreement, dated
as of August 7, 2007 (the “Original Securities Issuance Agreement”), the Company
issued Moriah 162,500 shares of the Company’s common stock (the “2007
Shares”). Pursuant to the Amended and Restated Securities Issuance
Agreement, Moriah agreed to waive the Company’s obligation to buy back the
2007 Shares with respect to 125,000 of such shares and to defer the Company’s
obligation to buy back 37,500 of such 2007 Shares (collectively, the
“Put Waiver”). Pursuant to the Amended and Restated Securities Agreement, the
Company is issuing Moriah 485,000 shares of its Common Stock (of which 125,000
shares were issued in consideration for the Put Waiver from Moriah and 360,000
shares were issued in lieu of the issuance to Moriah of the Contingent
Issued Shares (as described in the Original Securities Issuance Agreement)).
Additionally, pursuant to the Amended and Restated Securities Issuance
Agreement, the Company has also granted Moriah a put option pursuant to which
Moriah can sell to the Company 162,500 shares of its common stock issued
under the Amended and Restated Securities Agreement for $195,000, pro-rated for
any portion thereof (the “2007 Put Price”). The 2007 Put Option shall
automatically be deemed exercised by Moriah unless Moriah delivers written
notice to the Company at any time between July 1, 2009 and August 1, 2009 that
it does not wish to exercise the 2007 Put Option. The Company also granted
Moriah a second put option pursuant to which Moriah can sell 360,000 of the
shares issued to Moriah pursuant to the Amended and Restated Securities Purchase
Agreement to the Company for $234,000 (the “2008 Put Option”). The
2008 Put Option shall automatically be deemed exercised by Moriah unless Moriah
delivers written notice to the Company at any time between July 1, 2009 and
August 1, 2009 that Moriah does not wish to exercise the 2008 Put option in
whole or in part.
Pursuant
to Amendment No. 3, the Company and Moriah entered into an Amendment to
Registration Rights Agreement (the “Amended Registration Rights
Agreement”). Pursuant to the Amended Registration Rights
Agreement, the Company agreed to use its best efforts to file a registration
statement to register the 485,000 shares of the Company’s common stock
issued pursuant to the Amended and Restated Securities Issuance Agreement and
the shares of common stock issuable upon exercise of the Warrant, provided that
the Company is permitted under applicable securities rules and regulations and
after the certain other registration statements that the Company was obligated
to file on behalf of selling shareholders have been declared
effective.
On August
19, 2008, the Holders of the Amended Notes and the Investors in
the Purchase Agreement consented to the Company’s execution of the Amended
Note, Amendment No. 3, Amended and Restated Securities Issuance Agreement, and
the Amended Registration Rights Agreement. In consideration for the
consent, a total of 144,000 shares of common stock were issued to the Holders
and Investors based on individual participation in the Amended Notes and
Securities Purchase Agreement on September 4, 2008.
The
Company claims an exemption from the registration requirements of the
Securities Act of 1933, amended (the "Act") for the private placement
of the above-referenced securities pursuant to Section 4(2) of the Act
since, among other things, these transactions did not involve a public offering
and the Company took appropriate measures to restrict the transfer of the
securities.
The
foregoing description of Amendment No. 3 to the Loan and Security
Agreement, the Amended and Restated Revolving Loan Note, the Amended and
Restated Securities Issuance Agreement, and the Amendment to the Registration
Rights Agreement does not purport to be complete and is qualified in its
entirety by reference to the entire text of the agreements.
The
following summary consolidated financial data should be read in conjunction with
our consolidated financial statements and related notes and “Management’s
Discussion and Analysis of Financial Condition and Results of Operations”. The
statements of operations data for the years ended December 31, 2007, 2006, and
2005 and the balance sheet data at December 31, 2007 and 2006 are derived
from our audited financial statements which are included in our Form 10-K filed
with the Securities and Exchange Commission on April 14, 2008 and included
elsewhere herein. The statements of operations data for the years ended December
31, 2004 and 2003 and the balance sheet data at December 31, 2005, 2004, and
2003 are derived from our audited financial statements which are not included
herein. The statements of operations data for the six months ended June 30, 2008
and 2007 and the balance sheet data at June 30, 2008 and 2007 are derived
from our unaudited condensed consolidated interim financial statements filed
with the Securities and Exchange Commission on August 14, 2008. The historical
results are not necessarily indicative of results to be expected for future
periods. The following information is presented in thousands, except per
share data.
Consolidated
Statements of Operations Data:
|
|
Year
Ended December 31,
|
|
|
Six
Months Ended June 30,
(unaudited)
|
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
2004
|
|
|
2003
|
|
|
2008
|
|
|
2007
|
|
|
|
(In
thousands, except per share data)
|
|
Revenue
|
|
$
|
17,554
|
|
|
$
|
8,169
|
|
|
$
|
3,745
|
|
|
$
|
3,593
|
|
|
$
|
2,578
|
|
|
$
|
8,284
|
|
|
$
|
7,841
|
|
Cost
of goods sold
|
|
|
12,628
|
|
|
|
11,359
|
|
|
|
10,219
|
|
|
|
5,966
|
|
|
|
5,141
|
|
|
|
5,309
|
|
|
|
6,061
|
|
Gross
profit (loss)
|
|
|
4,926
|
|
|
|
(3,190
|
)
|
|
|
(6,474
|
)
|
|
|
(2,373
|
)
|
|
|
(2,563
|
)
|
|
|
2,975
|
|
|
|
1,780
|
|
Operating
expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Research
and development
|
|
|
2,949
|
|
|
|
4,406
|
|
|
|
4,020
|
|
|
|
898
|
|
|
|
19
|
|
|
|
1,308
|
|
|
|
1,740
|
|
Selling,
general and administrative
|
|
|
6,591
|
|
|
|
8,860
|
|
|
|
6,316
|
|
|
|
4,428
|
|
|
|
5,712
|
|
|
|
3,504
|
|
|
|
3,764
|
|
Total
operating expenses
|
|
|
9,540
|
|
|
|
13,266
|
|
|
|
10,336
|
|
|
|
5,326
|
|
|
|
5,731
|
|
|
|
4,812
|
|
|
|
5,504
|
|
Loss
from operations
|
|
|
(4,614
|
)
|
|
|
(16,456
|
)
|
|
|
(16,810
|
)
|
|
|
(7,699
|
)
|
|
|
(8,294
|
)
|
|
|
(1,837
|
)
|
|
|
(3,724
|
)
|
Other
income (expense), net
|
|
|
(13,874
|
)
|
|
|
1,190
|
|
|
|
282
|
|
|
|
(5,012
|
)
|
|
|
3,571
|
|
|
|
(959
|
)
|
|
|
(941
|
)
|
Net
loss
|
|
$
|
(18,488
|
)
|
|
|
(15,266
|
)
|
|
$
|
(16,528
|
)
|
|
$
|
(12,711
|
)
|
|
$
|
(4,723
|
)
|
|
$
|
(2,796
|
)
|
|
$
|
(4,665
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
and diluted loss per share
|
|
$
|
(1.59
|
)
|
|
|
(1.52
|
)
|
|
$
|
(1.94
|
)
|
|
$
|
(1.98
|
)
|
|
$
|
(1.31
|
)
|
|
$
|
(0.
21
|
)
|
|
$
|
(0.42
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares
used in calculation of loss per share:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
and diluted
|
|
|
11,633
|
|
|
|
10,058
|
|
|
|
8,541
|
|
|
|
6,428
|
|
|
|
3,599
|
|
|
|
13,471
|
|
|
|
10,984
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Consolidated
Balance Sheet Data:
|
|
December
31,
|
|
June
30,
(unaudited)
|
|
|
2007
|
|
|
2006
|
|
2005
|
|
2004
|
|
2003
|
|
2008
|
|
2007
|
|
|
(In
thousands)
|
|
Cash
and cash equivalents
|
|
$
|
713
|
|
|
|
1,415
|
|
|
$
|
6,727
|
|
|
$
|
13,457
|
|
|
$
|
1,054
|
|
|
$
|
1,038
|
|
|
$
|
690
|
|
Working
(deficit) capital
|
|
|
(4,708
|
)
|
|
|
(305
|
)
|
|
|
8,868
|
|
|
|
14,925
|
|
|
|
106
|
|
|
|
(4,429
|
)
|
|
|
(5,008
|
)
|
Total
assets
|
|
|
6,648
|
|
|
|
7,005
|
|
|
|
14,142
|
|
|
|
18,436
|
|
|
|
3,749
|
|
|
|
8,026
|
|
|
|
5,544
|
|
Long-term
obligations
|
|
|
60
|
|
|
|
2,229
|
|
|
|
56
|
|
|
|
22
|
|
|
|
6,161
|
|
|
|
41
|
|
|
|
78
|
|
Total
shareholders’ (deficit) equity
|
|
$
|
(3,975
|
)
|
|
|
(1,164
|
)
|
|
$
|
10,401
|
|
|
$
|
16,447
|
|
|
$
|
(4,767
|
)
|
|
$
|
(3,653
|
)
|
|
$
|
(4,169
|
)
|
You
should carefully consider the following risk factors and the other information
included herein as well as the information included in other reports and filings
made with the SEC before investing in our common stock. If any of the following
risks actually occurs, our business, financial condition or results of
operations could be harmed. The trading price of our common stock could decline
due to any of these risks, and you may lose part or all of your
investment.
RISKS
RELATED TO OUR FINANCIAL RESULTS
We
have a history of losses since our inception and may incur losses for the
foreseeable future
Our
accumulated losses are $202 million as of June 30, 2008. We have not
yet achieved profitability and we cannot give assurance that we will achieve
profitability within the foreseeable future as we fund operating and capital
expenditures in areas such as market development, sales and marketing,
manufacturing equipment, acquisitions, and research and development. We cannot
assure investors that we will ever achieve or sustain profitability or that our
operating losses will not increase in the future.
We
may not be able to execute our business plan and may not generate cash from
operations.
As we
have reported, our business has experienced and is currently experiencing
revenue growth during the six months ended June 30, 2008. We anticipate that our
cash requirements to fund operating or investing activities over the next twelve
months may be greater than our current cash on hand and borrowing availability
under our revolving credit facility. In the event that cash flow from
operations is less than anticipated and we are unable to secure additional
funding to cover our expenses, in order to preserve cash, we would be required
to reduce expenditures and effect reductions in our corporate infrastructure,
either of which could have a material adverse effect on our ability to continue
our current level of operations. No assurance can be given that additional
financing will be available, or if available, will be on acceptable
terms.
We
may be subject to fines, sanctions, and/or penalties of an indeterminable nature
as a result of potential violations of federal securities laws.
In July
2006, we entered into a Note Purchase Agreement with Stillwater LLC, which
provided for the purchase and sale of a 6% senior secured convertible note in
principal amount of up to $500,000 (the “Stillwater Note”) and a warrant to
purchase 70% percent of the number of shares issuable upon conversion of the
Stillwater Note, at our sole discretion by delivery of a notice to Stillwater on
December 14, 2006. We then filed a registration statement on Form
S-3 up to 41,088,445 shares of common stock issuable upon conversion of our
6% senior secured convertible notes or exercise of warrants, which following the
effectuation by the Company of a one-for-ten reverse stock split on
November 3, 2006, amounted to 4,108,845 shares. In July 2007, we
amended the agreements with Stillwater. Amending the Stillwater
agreements without first withdrawing the Registration Statement on Form S-3 may
be inconsistent with Section 5 of the Securities Act of 1933, as amended, and we
may be subject to fines, sanctions and/or penalties of an indeterminable nature
as a result of potential violations of federal securities laws. If we
are assessed fines and penalties our business will be materially
affected.
The
issuance of shares of common stock in connection with the conversion of the
Notes may have not have been in compliance with certain state and federal
securities laws and any damages that we may have to pay as a result of such
issuance could have a material adverse effect on our revenues, profits, results
of operations, financial condition and future prospects.
Our
independent registered public accounting firm has expressed substantial doubt
about our ability to continue as a going concern, which may hinder our ability
to obtain future financing.
Our
unaudited condensed consolidated financial statements as of June 30, 2008 have
been prepared under the assumption that we will continue as a going concern. Our
independent registered public accounting firm issued a report dated April 9,
2008 in connection with the audit of the 2007 financial statements that included
an explanatory paragraph expressing substantial doubt as to our ability to
continue as a going concern without obtaining additional capital or financing
becoming available. Our ability to continue as a going concern ultimately
depends on our ability to generate a profit which is likely dependent
upon our ability to obtain additional equity or debt financing, attain
further operating efficiencies and, ultimately, to achieve profitable
operations. The financial statements do not include any adjustments that might
result from the outcome of this uncertainty.
RISKS
RELATED TO MANUFACTURING
The manufacture of
OLED
-on-silicon is new and
OLED
microdisplays have
not been produced in significant quantities.
If we are
unable to produce our products in sufficient quantity, we will be unable to
maintain and attract new customers. In addition, we cannot assure you that once
we commence volume production we will attain yields at high throughput that will
result in profitable gross margins or that we will not experience manufacturing
problems which could result in delays in delivery of orders or product
introductions.
We
are dependent on a single manufacturing line.
We
currently manufacture our products on a single manufacturing line. If we
experience any significant disruption in the operation of our manufacturing
facility or a serious failure of a critical piece of equipment, we may be unable
to supply microdisplays to our customers. For this reason, some OEMs may also be
reluctant to commit a broad line of products to our microdisplays without a
second production facility in place. However, we try to maintain product
inventory to fill the requirements under such circumstances. Interruptions in
our manufacturing could be caused by manufacturing equipment problems, the
introduction of new equipment into the manufacturing process or delays in the
delivery of new manufacturing equipment. Lead-time for delivery of manufacturing
equipment can be extensive. No assurance can be given that we will not lose
potential sales or be unable to meet production orders due to production
interruptions in our manufacturing line. In order to meet the requirements of
certain OEMs for multiple manufacturing sites, we will have to expend capital to
secure additional sites and may not be able to manage multiple sites
successfully.
We
could experience manufacturing interruptions, delays, or inefficiencies if we
are unable to timely and reliably procure components from single-sourced
suppliers.
We
maintain several single-source supplier relationships, either because
alternative sources are not available or because the relationship is
advantageous due to performance, quality, support, delivery, capacity, or price
considerations. If the supply of a critical single-source material or
component is delayed or curtailed, we may not be able to ship the related
product in desired quantities and in a timely manner. Even where
alternative sources of supply are available, qualification of the alternative
suppliers and establishment of reliable supplies could result in delays and a
possible loss of sales, which could harm operating results.
We
expect to depend on semiconductor contract manufacturers to supply our silicon
integrated circuits and other suppliers of key components, materials and
services.
We do not
manufacture the silicon integrated circuits on which we incorporate our OLED
technology. Instead, we expect to provide the design layouts to semiconductor
contract manufacturers who will manufacture the integrated circuits on silicon
wafers. We also expect to depend on suppliers of a variety of other components
and services, including circuit boards, graphic integrated circuits, passive
components, materials and chemicals, and equipment support. Our inability to
obtain sufficient quantities of high quality silicon integrated circuits or
other necessary components, materials or services on a timely basis could result
in manufacturing delays, increased costs and ultimately in reduced or delayed
sales or lost orders which could materially and adversely affect our operating
results.
RISKS
RELATED TO OUR INTELLECTUAL PROPERTY
We
rely on our license agreement with Eastman Kodak for the development of our
products.
We rely
on our license agreement with Eastman Kodak for the development of our products,
and the termination of this license, Eastman Kodak's licensing of its OLED
technology to others for microdisplay applications, or the sublicensing by
Eastman Kodak of our OLED technology to third parties, could have a material
adverse impact on our business.
Our
principal products under development utilize OLED technology that we license
from Eastman Kodak. We rely upon Eastman Kodak to protect and enforce key
patents held by Eastman Kodak, relating to OLED display technology. Eastman
Kodak's patents expire at various times in the future. Our license with Eastman
Kodak could terminate if we fail to perform any material term or covenant under
the license agreement. Since our license from Eastman Kodak is non-exclusive,
Eastman Kodak could also elect to become a competitor itself or to license OLED
technology for microdisplay applications to others who have the potential to
compete with us. The occurrence of any of these events could have a material
adverse impact on our business.
We
may not be successful in protecting our intellectual property and proprietary
rights.
We rely
on a combination of patents, trade secret protection, licensing agreements and
other arrangements to establish and protect our proprietary technologies. If we
fail to successfully enforce our intellectual property rights, our competitive
position could suffer, which could harm our operating results. Patents may not
be issued for our current patent applications, third parties may challenge,
invalidate or circumvent any patent issued to us, unauthorized parties could
obtain and use information that we regard as proprietary despite our efforts to
protect our proprietary rights, rights granted under patents issued to us may
not afford us any competitive advantage, others may independently develop
similar technology or design around our patents, our technology may be available
to licensees of Eastman Kodak, and protection of our intellectual property
rights may be limited in certain foreign countries. On April 30, 2007, the
U.S. Supreme Court, in
KSR
International Co. vs. Teleflex, Inc.
, mandated a more expansive and
flexible approach towards a determination as to whether a patent is obvious and
invalid, which may make it more difficult for patent holders to secure or
maintain existing patents. Any future infringement or other claims or
prosecutions related to our intellectual property could have a material adverse
effect on our business. Any such claims, with or without merit, could be time
consuming to defend, result in costly litigation, divert management's attention
and resources, or require us to enter into royalty or licensing agreements. Such
royalty or licensing agreements, if required, may not be available on terms
acceptable to us, if at all. Protection of intellectual property has
historically been a large yearly expense for eMagin. We have not been in a
financial position to properly protect all of our intellectual property, and may
not be in a position to properly protect our position or stay ahead of
competition in new research and the protecting of the resulting intellectual
property.
RISKS
RELATED TO THE MICRODISPLAY INDUSTRY
The
commercial success of the microdisplay industry depends on the widespread market
acceptance of microdisplay systems products.
The
market for microdisplays is emerging. Our success will depend on consumer
acceptance of microdisplays as well as the success of the commercialization of
the microdisplay market. As an OEM supplier, our customer's products must also
be well accepted. At present, it is difficult to assess or predict with any
assurance the potential size, timing and viability of market opportunities for
our technology in this market. The viewfinder microdisplay market sector is well
established with entrenched competitors with whom we must compete.
The
microdisplay systems business is intensely competitive.
We do
business in intensely competitive markets that are characterized by rapid
technological change, changes in market requirements and competition from both
other suppliers and our potential OEM customers. Such markets are typically
characterized by price erosion. This intense competition could result in pricing
pressures, lower sales, reduced margins, and lower market share. Our ability to
compete successfully will depend on a number of factors, both within and outside
our control. We expect these factors to include the following:
·
|
our
success in designing, manufacturing and delivering expected new products,
including those implementing new technologies on a timely
basis;
|
·
|
our
ability to address the needs of our customers and the quality of our
customer services;
|
·
|
the
quality, performance, reliability, features, ease of use and pricing of
our products;
|
·
|
successful
expansion of our manufacturing
capabilities;
|
·
|
our
efficiency of production, and ability to manufacture and ship products on
time;
|
·
|
the
rate at which original equipment manufacturing customers incorporate our
product solutions into their own
products;
|
·
|
the
market acceptance of our customers' products;
and
|
·
|
product
or technology introductions by our
competitors.
|
Our
competitive position could be damaged if one or more potential OEM customers
decide to manufacture their own microdisplays, using OLED or alternate
technologies. In addition, our customers may be reluctant to rely on a
relatively small company such as eMagin for a critical component. We cannot
assure you that we will be able to compete successfully against current and
future competition, and the failure to do so would have a materially adverse
effect upon our business, operating results and financial
condition.
The display industry may be
cyclical
.
Our
business strategy is dependent on OEM manufacturers building and selling
products that incorporate our OLED displays as components into those products.
Industry-wide fluctuations and downturns in the demand for flat panel displays
could cause significant harm to our business. The OLED microdisplay sector may
experience overcapacity, if and when all of the facilities presently in the
planning stage come on line, leading to a difficult market in which to sell our
products.
Competing
products may get to market sooner than ours.
Our
competitors are investing substantial resources in the development and
manufacture of microdisplay systems using alternative technologies such as
reflective liquid crystal displays (LCDs), LCD-on-Silicon ("LCOS")
microdisplays, active matrix electroluminescence and scanning image systems, and
transmissive active matrix LCDs. Our competitive position could be damaged if
one or more of our competitors’ products get to the market sooner than our
products. We cannot assure you that our product will get to market ahead of our
competitors or that we will be able to compete successfully against current and
future competition. The failure to do so would have a materially
adverse effect upon our business, operating results and financial
condition.
Our
competitors have many advantages over us.
As the
microdisplay market develops, we expect to experience intense competition from
numerous domestic and foreign companies including well-established corporations
possessing worldwide manufacturing and production facilities, greater name
recognition, larger retail bases and significantly greater financial, technical,
and marketing resources than us, as well as from emerging companies attempting
to obtain a share of the various markets in which our microdisplay products have
the potential to compete. We cannot assure you that we will be able to compete
successfully against current and future competition, and the failure to do so
would have a materially adverse effect upon our business, operating results and
financial condition.
Our
products are subject to lengthy OEM development periods.
We plan
to sell most of our microdisplays to OEMs who will incorporate them into
products they sell. OEMs determine during their product development phase
whether they will incorporate our products. The time elapsed between initial
sampling of our products by OEMs, the custom design of our products to meet
specific OEM product requirements, and the ultimate incorporation of our
products into OEM consumer products is significant often with a duration of
between one and three years. If our products fail to meet our OEM customers'
cost, performance or technical requirements or if unexpected technical
challenges arise in the integration of our products into OEM consumer products,
our operating results could be significantly and adversely affected. Long delays
in achieving customer qualification and incorporation of our products could
adversely affect our business.
Our
products will likely experience rapidly declining unit prices.
In the
markets in which we expect to compete, prices of established products tend to
decline significantly over time. In order to maintain our profit margins over
the long term, we believe that we will need to continuously develop product
enhancements and new technologies that will either slow price declines of our
products or reduce the cost of producing and delivering our products. While we
anticipate many opportunities to reduce production costs over time, there can be
no assurance that these cost reduction plans will be successful, that we will
have the resources to fund the expenditures necessary to implement certain
cost-saving measures, or that our costs can be reduced as quickly as any
reduction in unit prices. We may also attempt to offset the anticipated decrease
in our average selling price by introducing new products, increasing our sales
volumes or adjusting our product mix. If we fail to do so, our results of
operations would be materially and adversely affected.
RISKS
RELATED TO OUR BUSINESS
Our
success depends on attracting and retaining highly skilled and qualified
technical and consulting personnel.
We must
hire highly skilled technical personnel as employees and as independent
contractors in order to develop our products. The competition for skilled
technical employees is intense and we may not be able to retain or recruit such
personnel. We must compete with companies that possess greater financial and
other resources than we do, and that may be more attractive to potential
employees and contractors. To be competitive, we may have to increase the
compensation, bonuses, stock options and other fringe benefits offered to
employees in order to attract and retain such personnel. The costs of attracting
and retaining new personnel may have a materially adverse affect on our business
and our operating results. In addition, difficulties in hiring and retaining
technical personnel could delay the implementation of our business
plan.
Our
success depends in a large part on the continuing service of key
personnel.
Changes
in management could have an adverse effect on our business. We are dependent
upon the active participation of several key management personnel and will also
need to recruit additional management in order to expand according to our
business plan. The failure to attract and retain additional management or
personnel could have a material adverse effect on our operating results and
financial performance.
The
ineffectiveness of our internal control over financial reporting could result in
a loss of investor confidence in our financial reports and have an adverse
effect on our stock price.
Pursuant
to Section 404 of the Sarbanes-Oxley Act of 2002 (“Section 404”), and the rules
and regulations promulgated by the SEC to implement Section 404, we are required
to include in our Form 10-K an annual report by our management regarding the
effectiveness of our internal control over financial reporting. The
report includes, among other things, an assessment of the effectiveness of our
internal control over financial reporting as of the end of our fiscal
year. This assessment must include disclosure of any material
weaknesses in our internal control over financial reporting identified by
management.
As of
June 30, 2008, our internal control over financial reporting was ineffective due
to the presence of material weaknesses, as more fully described in Item 9A of
the December 31, 2007 Form 10-K filed with the SEC on April 14,
2008. This could result in a loss of investor confidence in the
accuracy and completeness of our financial reports, which may have an adverse
effect on our stock price.
Our
business depends on new products and technologies.
The
market for our products is characterized by rapid changes in product, design and
manufacturing process technologies. Our success depends to a large extent on our
ability to develop and manufacture new products and technologies to match the
varying requirements of different customers in order to establish a competitive
position and become profitable. Furthermore, we must adopt our products and
processes to technological changes and emerging industry standards and practices
on a cost-effective and timely basis. Our failure to accomplish any of the above
could harm our business and operating results.
We
generally do not have long-term contracts with our customers.
Our
business has primarily operated on the basis of short-term purchase
orders. We are now receiving longer term purchase agreements, such as
those which comprise our approximately $4.6 million backlog as of September 30,
2008, and procurement contracts, but we cannot guarantee that we will continue
to do so. Our current purchase agreements can be cancelled or revised without
penalty, depending on the circumstances. We plan production on the basis of
internally generated forecasts of demand, which makes it difficult to accurately
forecast revenues. If we fail to accurately forecast operating results, our
business may suffer and the value of your investment in eMagin may
decline.
Our
business strategy may fail if we cannot continue to form strategic relationships
with companies that manufacture and use products that could incorporate our
OLED-on-silicon technology.
Our
prospects will be significantly affected by our ability to develop strategic
alliances with OEMs for incorporation of our OLED-on-silicon technology into
their products. While we intend to continue to establish strategic relationships
with manufacturers of electronic consumer products, personal computers,
chipmakers, lens makers, equipment makers, material suppliers and/or systems
assemblers, there is no assurance that we will be able to continue to establish
and maintain strategic relationships on commercially acceptable terms, or that
the alliances we do enter in to will realize their objectives. Failure to do so
would have a material adverse effect on our business.
Our
business depends to some extent on international transactions.
We
purchase needed materials from companies located abroad and may be adversely
affected by political and currency risk, as well as the additional costs of
doing business with foreign entities. Some customers in other countries have
longer receivable periods or warranty periods. In addition, many of the foreign
OEMs that are the most likely long-term purchasers of our microdisplays expose
us to additional political and currency risk. We may find it necessary to locate
manufacturing facilities abroad to be closer to our customers which could expose
us to various risks, including management of a multi-national organization, the
complexities of complying with foreign laws and customs, political instability
and the complexities of taxation in multiple jurisdictions.
Our
business may expose us to product liability claims.
Our
business may expose us to potential product liability claims. Although no such
claims have been brought against us to date, and to our knowledge no such claim
is threatened or likely, we may face liability to product users for damages
resulting from the faulty design or manufacture of our products. While we plan
to maintain product liability insurance coverage, there can be no assurance that
product liability claims will not exceed coverage limits, fall outside the scope
of such coverage, or that such insurance will continue to be available at
commercially reasonable rates, if at all.
Our
business is subject to environmental regulations and possible liability arising
from potential employee claims of exposure to harmful substances used in the
development and manufacture of our products.
We are
subject to various governmental regulations related to toxic, volatile,
experimental and other hazardous chemicals used in our design and manufacturing
process. Our failure to comply with these regulations could result in the
imposition of fines or in the suspension or cessation of our operations.
Compliance with these regulations could require us to acquire costly equipment
or to incur other significant expenses. We develop, evaluate and utilize new
chemical compounds in the manufacture of our products. While we attempt to
ensure that our employees are protected from exposure to hazardous materials, we
cannot assure you that potentially harmful exposure will not occur or that we
will not be liable to employees as a result.
RISKS
RELATED TO OUR STOCK
The
substantial number of shares that are or will be eligible for sale could cause
our common stock price to decline even if eMagin is successful.
Sales of
significant amounts of common stock in the public market, or the perception that
such sales may occur, could materially affect the market price of our common
stock. These sales might also make it more difficult for us to sell equity or
equity-related securities in the future at a time and price that we deem
appropriate. As of October 14, 2008, we have outstanding (i) options to purchase
1,564,223 shares, (ii) warrants to purchase 10,403,772 shares of common stock,
and (iii) notes convertible into 8,330,689 shares of common
stock.
We
have a staggered board of directors and other anti-takeover provisions, which
could inhibit potential investors or delay or prevent a change of control that
may favor you.
Our Board
of Directors is divided into three classes and our Board members are elected for
terms that are staggered. This could discourage the efforts by others to obtain
control of eMagin. Some of the provisions of our certificate of incorporation,
our bylaws and Delaware law could, together or separately, discourage potential
acquisition proposals or delay or prevent a change in control. In particular,
our board of directors is authorized to issue up to 10,000,000 shares of
preferred stock (less any outstanding shares of preferred stock) with rights and
privileges that might be senior to our common stock, without the consent of the
holders of the common stock.
We and
our representatives may from time to time make written or oral statements that
are “forward-looking,” including statements contained in this prospectus and
other filings with the Securities and Exchange Commission, reports to our
stockholders and news releases. All statements that express expectations,
estimates, forecasts or projections are forward-looking statements. In addition,
other written or oral statements which constitute forward-looking statements may
be made by us or on our behalf. Words such as “expects,” “anticipates,”
“intends,” “plans,” “believes,” “seeks,” “estimates,” “projects,” “forecasts,”
“may,” “should,” variations of such words and similar expressions are intended
to identify forward-looking statements. These statements are not guarantees of
future performance and involve risks, uncertainties, and assumptions which are
difficult to predict. Therefore, actual outcomes and results may differ
materially from what is expressed or forecasted in or suggested by such
forward-looking statements. Among the important factors on which such statements
are based are assumptions concerning our ability to obtain additional funding,
our ability to compete against our competitors, our ability to integrate our
acquisitions and our ability to attract and retain key employees.
USE
OF PROCEEDS
This
prospectus relates to shares of our common stock that may be offered and sold
from time to time by the selling stockholders. We will not receive any proceeds
from the sale of shares of common stock in this offering. However, we will
receive the sale price of any common stock we sell to the selling stockholders
upon exercise of the warrants owned by the selling stockholders. We expect to
use the proceeds received from the exercise of the warrants, if any, for general
working capital purposes. We have not declared or paid any dividends and do not
currently expect to do so in the near future.
MARKET FOR COMMON EQUITY AND RELATED
STOCKHOLDER MATTERS
Our
common stock is quoted on the OTC Bulletin Board under the symbol “EMAN.OB.” The
following table sets forth the high and low sales prices as reported by the OTC
Bulletin Board Market for the periods indicated.
|
High
|
|
Low
|
|
Fiscal
2006
|
|
|
|
|
First
Quarter
|
|
$
|
7.10
|
|
|
$
|
4.60
|
|
Second
Quarter
|
|
$
|
5.70
|
|
|
$
|
2.50
|
|
Third
Quarter
|
|
$
|
3.80
|
|
|
$
|
1.80
|
|
Fourth
Quarter
|
|
$
|
2.50
|
|
|
$
|
1.01
|
|
Fiscal
2007
|
|
|
|
|
|
|
|
|
First
Quarter`
|
|
$
|
1.08
|
|
|
$
|
0.26
|
|
Second
Quarter
|
|
$
|
0.85
|
|
|
$
|
0.42
|
|
Third
Quarter
|
|
$
|
1.64
|
|
|
$
|
0.65
|
|
Fourth
Quarter
|
|
$
|
1.75
|
|
|
$
|
0.85
|
|
Fiscal
2008
|
|
|
|
|
|
|
|
|
First
Quarter
|
|
$
|
1.47
|
|
|
$
|
0.88
|
|
Second
Quarter
|
|
$
|
1.05
|
|
|
$
|
0.63
|
|
Third
Quarter
|
|
$
|
0.83
|
|
|
$
|
0.52
|
|
Fourth
Quarter (as of October 14, 2008)
|
|
$
|
0.60
|
|
|
$
|
0.21
|
|
As of
October 14, 2008, there were 511 holders of record of our common stock. Because
brokers and other institutions hold many of the shares on behalf of
shareholders, we are unable to determine the actual number of shareholders
represented by these record holders.
Dividends
We have
never declared or paid cash dividends on our common stock. We currently
anticipate that we will retain all future earnings to fund the operation of our
business and do not anticipate paying dividends on our common stock in the
foreseeable future.
The
following table summarizes our consolidated financial data for the periods
presented. We prepared this information using our consolidated financial
statements for each of the periods presented. The following selected
consolidated financial data should be read in conjunction with our consolidated
financial statements and related notes and “Management’s Discussion and Analysis
of Financial Condition and Results of Operations”. The historical results are
not necessarily indicative of results to be expected for future
periods.
Consolidated
Statements of Operations Data:
|
|
Year
Ended December 31,
|
|
|
Six
Months Ended June 30,
(unaudited)
|
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
2004
|
|
|
2003
|
|
|
2008
|
|
|
2007
|
|
|
|
(In
thousands, except per share data)
|
|
Revenue
|
|
$
|
17,554
|
|
|
$
|
8,169
|
|
|
$
|
3,745
|
|
|
$
|
3,593
|
|
|
$
|
2,578
|
|
|
$
|
8,284
|
|
|
$
|
7,841
|
|
Cost
of goods sold
|
|
|
12,628
|
|
|
|
11,359
|
|
|
|
10,219
|
|
|
|
5,966
|
|
|
|
5,141
|
|
|
|
5,309
|
|
|
|
6,061
|
|
Gross
profit (loss)
|
|
|
4,926
|
|
|
|
(3,190
|
)
|
|
|
(6,474
|
)
|
|
|
(2,373
|
)
|
|
|
(2,563
|
)
|
|
|
2,975
|
|
|
|
1,780
|
|
Operating
expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Research
and development
|
|
|
2,949
|
|
|
|
4,406
|
|
|
|
4,020
|
|
|
|
898
|
|
|
|
19
|
|
|
|
1,308
|
|
|
|
1,740
|
|
Selling,
general and administrative
|
|
|
6,591
|
|
|
|
8,860
|
|
|
|
6,316
|
|
|
|
4,428
|
|
|
|
5,712
|
|
|
|
3,504
|
|
|
|
3,764
|
|
Total
operating expenses
|
|
|
9,540
|
|
|
|
13,266
|
|
|
|
10,336
|
|
|
|
5,326
|
|
|
|
5,731
|
|
|
|
4,812
|
|
|
|
5,504
|
|
Loss
from operations
|
|
|
(4,614
|
)
|
|
|
(16,456
|
)
|
|
|
(16,810
|
)
|
|
|
(7,699
|
)
|
|
|
(8,294
|
)
|
|
|
(1,837
|
)
|
|
|
(3,724
|
)
|
Other
income (expense), net
|
|
|
(13,874
|
)
|
|
|
1,190
|
|
|
|
282
|
|
|
|
(5,012
|
)
|
|
|
3,571
|
|
|
|
(959
|
)
|
|
|
(941
|
)
|
Net
loss
|
|
$
|
(18,488
|
)
|
|
|
(15,266
|
)
|
|
$
|
(16,528
|
)
|
|
$
|
(12,711
|
)
|
|
$
|
(4,723
|
)
|
|
$
|
(2,796
|
)
|
|
$
|
(4,665
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
and diluted loss per share
|
|
$
|
(1.59
|
)
|
|
|
(1.52
|
)
|
|
$
|
(1.94
|
)
|
|
$
|
(1.98
|
)
|
|
$
|
(1.31
|
)
|
|
$
|
(0.
21
|
)
|
|
$
|
(0.42
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares
used in calculation of loss per share:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
and diluted
|
|
|
11,633
|
|
|
|
10,058
|
|
|
|
8,541
|
|
|
|
6,428
|
|
|
|
3,599
|
|
|
|
13,471
|
|
|
|
10,984
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Consolidated
Balance Sheet Data:
|
|
December
31,
|
|
June
30,
(unaudited)
|
|
|
2007
|
|
|
2006
|
|
2005
|
|
2004
|
|
2003
|
|
2008
|
|
2007
|
|
|
(In
thousands)
|
|
Cash
and cash equivalents
|
|
$
|
713
|
|
|
|
1,415
|
|
|
$
|
6,727
|
|
|
$
|
13,457
|
|
|
$
|
1,054
|
|
|
$
|
1,038
|
|
|
$
|
690
|
|
Working
(deficit) capital
|
|
|
(4,708
|
)
|
|
|
(305
|
)
|
|
|
8,868
|
|
|
|
14,925
|
|
|
|
106
|
|
|
|
(4,429
|
)
|
|
|
(5,008
|
)
|
Total
assets
|
|
|
6,648
|
|
|
|
7,005
|
|
|
|
14,142
|
|
|
|
18,436
|
|
|
|
3,749
|
|
|
|
8,026
|
|
|
|
5,544
|
|
Long-term
obligations
|
|
|
60
|
|
|
|
2,229
|
|
|
|
56
|
|
|
|
22
|
|
|
|
6,161
|
|
|
|
41
|
|
|
|
78
|
|
Total
shareholders’ (deficit) equity
|
|
$
|
(3,975
|
)
|
|
|
(1,164
|
)
|
|
$
|
10,401
|
|
|
$
|
16,447
|
|
|
$
|
(4,767
|
)
|
|
$
|
(3,653
|
)
|
|
$
|
(4,169
|
)
|
Introduction
The
following discussion should be read in conjunction with the Financial Statements
and Notes thereto. Our fiscal year ends December 31. This document contains
certain forward-looking statements including, among others, anticipated trends
in our financial condition and results of operations and our business strategy.
(See Part I, Item 1A, "Risk Factors "). These forward-looking statements are
based largely on our current expectations and are subject to a number of risks
and uncertainties. Actual results could differ materially from these
forward-looking statements. Important factors to consider in evaluating such
forward-looking statements include (i) changes in external factors or in our
internal budgeting process which might impact trends in our results of
operations; (ii) unanticipated working capital or other cash requirements; (iii)
changes in our business strategy or an inability to execute our strategy due to
unanticipated changes in the industries in which we operate; and (iv) various
competitive market factors that may prevent us from competing successfully in
the marketplace.
Overview
We design
and manufacture miniature displays, which we refer to as
OLED-on-silicon-microdisplays, and microdisplay modules for virtual imaging,
primarily for incorporation into the products of other manufacturers.
Microdisplays are typically smaller than many postage stamps, but when viewed
through a magnifier they can contain all of the information appearing on a
high-resolution personal computer screen. Our microdisplays use organic light
emitting diodes, or OLEDs, which emit light themselves when a current is passed
through the device. Our technology permits OLEDs to be coated onto silicon chips
to produce high resolution OLED-on-silicon microdisplays.
We
believe that our OLED-on-silicon microdisplays offer a number of advantages in
near to the eye applications over other current microdisplay technologies,
including lower power requirements, less weight, fast video speed without
flicker, and wider viewing angles. In addition, many computer and video
electronic system functions can be built directly into the OLED-on-silicon
microdisplay, resulting in compact systems with lower expected overall system
costs relative to alternate microdisplay technologies.
Since our
inception in 1996 through 2004, we derived the majority of our revenues from
fees paid to us under research and development contracts, primarily with the
U.S. federal government. We have devoted significant resources to the
development and commercial launch of our products. We commenced limited initial
sales of our SVGA+ microdisplay in May 2001 and commenced shipping samples of
our SVGA-3D microdisplay in February 2002. As of September 30, 2008,
we have a backlog of approximately $4.6 million in products ordered for delivery
through December 31, 2009. These products are being applied or considered for
near-eye and headset applications in products such as entertainment and gaming
headsets, handheld Internet and telecommunication appliances, viewfinders, and
wearable computers to be manufactured by original equipment manufacturer (OEM)
customers. We have also shipped a limited number of our Z800 3DVisor personal
display systems. In addition to marketing OLED-on-silicon microdisplays as
components, we also offer microdisplays as an integrated package, which we call
Microviewer that includes a compact lens for viewing the microdisplay and
electronic interfaces to convert the signal from our customer's product into a
viewable image on the microdisplay. We are also developing head-wearable
displays, including our Z800 3DVisor that incorporate our
Microviewer.
We
license our core OLED technology from Eastman Kodak and we have developed our
own technology to create high performance OLED-on-silicon microdisplays and
related optical systems. We believe our technology licensing agreement with
Eastman Kodak, coupled with our own intellectual property portfolio, gives us a
leadership position in OLED and OLED-on-silicon microdisplay technology. We
believe that we are the only company to demonstrate publicly and market
full-color small molecule OLED-on-silicon microdisplays.
Company
History
Historically,
we have been a developmental stage company. As of January 1, 2003, we were no
longer classified as a development stage company. We have transitioned to
manufacturing our product and intend to significantly increase our marketing,
sales, and research and development efforts, and expand our operating
infrastructure. Currently, most of our operating expenses are fixed. If we are
unable to generate significant revenues, our net losses in any given period
could be greater than expected.
Critical
Accounting Policies
The
Securities and Exchange Commission ("SEC") defines "critical accounting
policies" as those that require application of management's most difficult,
subjective or complex judgments, often as a result of the need to make estimates
about the effect of matters that are inherently uncertain and may change in
subsequent periods. Not all of the accounting policies require management to
make difficult, subjective or complex judgments or estimates. However, the
following policies could be deemed to be critical within the SEC
definition.
Revenue
and Cost Recognition
Revenue
on product sales is recognized when persuasive evidence of an arrangement
exists, such as when a purchase order or contract is received from the customer,
the price is fixed, title and risk of loss to the goods has changed and there is
a reasonable assurance of collection of the sales proceeds. We obtain written
purchase authorizations from our customers for a specified amount of product at
a specified price and consider delivery to have occurred at the time of
shipment. We record a reserve for estimated sales returns, which is reflected as
a reduction of revenue at the time of revenue
recognition. Products sold directly to consumers have a fifteen
day right of return. Revenue on consumer products is deferred until
the right of return has expired.
Revenues
from research and development activities relating to firm fixed-price contracts
are generally recognized on the percentage-of-completion method of accounting as
costs are incurred (cost-to-cost basis). Revenues from research and development
activities relating to cost-plus-fee contracts include costs incurred plus a
portion of estimated fees or profits based on the relationship of costs incurred
to total estimated costs. Contract costs include all direct material and labor
costs and an allocation of allowable indirect costs as defined by each contract,
as periodically adjusted to reflect revised agreed upon rates. These rates are
subject to audit by the other party.
Use
of Estimates
The
preparation of financial statements in conformity with generally accepted
accounting principles in the United States requires management to make estimates
and assumptions that affect the reported amounts of assets and liabilities and
the disclosure of contingent assets and liabilities at the date of the financial
statements as well as the reported amounts of revenues and expenses during the
reporting period. Actual results could differ from those estimates. These
estimates and assumptions relate to recording net revenue, collectibility of
accounts receivable, useful lives and impairment of tangible and intangible
assets, accruals, income taxes, inventory realization and other factors.
Management has exercised reasonable judgment in deriving these estimates.
Consequently, a change in conditions could affect these estimates.
Fair
Value of Financial Instruments
eMagin’s
cash, cash equivalents, accounts receivable, short-term investments, accounts
payable and debt are stated at cost which approximates fair value due to the
short-term nature of these instruments.
Stock-based
Compensation
eMagin
maintains several stock equity incentive plans. The 2005 Employee
Stock Purchase Plan (the “ESPP”) provides our employees with the opportunity to
purchase common stock through payroll deductions. Employees purchase
stock semi-annually at a price that is 85% of the fair market value at certain
plan-defined dates. As of June 30, 2008, the number of shares of
common stock available for issuance was 300,000. As of June 30, 2008,
the plan had not been implemented.
The 2003
Stock Option Plan (the”2003 Plan”) provides for grants of shares of common stock
and options to purchase shares of common stock to employees, officers, directors
and consultants. Under the 2003 plan, an ISO grant is granted
at the market value of our common stock at the date of the grant and a non-ISO
is granted at a price not to be less than 85% of the market value of the common
stock. These options have a term of up to 10 years and vest over a
schedule determined by the Board of Directors, generally over a five year
period. The amended 2003 Plan provides for an annual increase of 3%
of the diluted shares outstanding on January 1 of each year for a period of 9
years which commenced January 1, 2005.
Effective
January 1, 2006, the Company adopted the provisions of SFAS No. 123R,
“Share-Based Payment” (“SFAS 123R”), which requires the Company to recognize
expense related to the fair value of the Company’s share-based compensation
issued to employees and directors. SFAS 123R requires companies to estimate the
fair value of share-based payment awards on the date of grant using an
option-pricing model. The value of the portion of the award that is ultimately
expected to vest is recognized as expense over the requisite service periods in
the Company’s consolidated statement of operations. The Company uses the
straight-line method for recognizing compensation expense. An estimate for
forfeitures is included in compensation expense for awards under SFAS
123R.
Results of
Operations
The
following table presents certain financial data as a percentage of total revenue
for the periods indicated. Our historical operating results are not necessarily
indicative of the results for any future period.
|
|
Year
ended December 31,
|
|
|
Six
Months Ended
June
30,
|
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
2008
|
|
|
2007
|
|
|
|
|
|
|
|
|
|
|
|
|
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenue
|
|
|
100
|
%
|
|
|
100
|
%
|
|
|
100
|
%
|
|
|
100
|
%
|
|
|
100
|
%
|
Cost
of goods sold
|
|
|
72
|
|
|
|
139
|
|
|
|
273
|
|
|
|
64
|
|
|
|
77
|
|
Gross
profit (loss)
|
|
|
28
|
|
|
|
(39
|
)
|
|
|
(173
|
)
|
|
|
36
|
|
|
|
23
|
|
Operating
expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Research
and development
|
|
|
17
|
|
|
|
54
|
|
|
|
107
|
|
|
|
16
|
|
|
|
22
|
|
Selling,
general and administrative
|
|
|
38
|
|
|
|
109
|
|
|
|
169
|
|
|
|
42
|
|
|
|
48
|
|
Total operating expenses
|
|
|
55
|
|
|
|
163
|
|
|
|
276
|
|
|
|
58
|
|
|
|
70
|
|
Loss
from operations
|
|
|
(27
|
)
|
|
|
(202
|
)
|
|
|
(449
|
)
|
|
|
(22
|
)
|
|
|
(47
|
)
|
Other
income (expense), net
|
|
|
(78
|
)
|
|
|
15
|
|
|
|
8
|
|
|
|
(12
|
)
|
|
|
(12
|
)
|
Net
loss
|
|
|
(105
|
)
%
|
|
|
(187
|
)
%
|
|
|
(441
|
)
%
|
|
|
(34
|
)
%
|
|
|
(59
|
)
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The
following table presents certain financial data for the periods indicated.
Our historical operating results are not necessarily indicative of the results
for any future period.
|
|
|
Year
ended December 31,
|
|
|
|
Six
Months Ended
June
30,
|
|
|
|
|
2007
|
|
|
|
2006
|
|
|
|
2005
|
|
|
|
2008
|
|
|
|
2007
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Unaudited)
|
|
|
|
|
(In
thousands, except per share data)
|
|
Revenue
|
|
$
|
17,554
|
|
|
$
|
8,169
|
|
|
$
|
3,745
|
|
|
$
|
8,284
|
|
|
$
|
7,841
|
|
Cost
of goods sold
|
|
|
12,628
|
|
|
|
11,359
|
|
|
|
10,219
|
|
|
|
5,309
|
|
|
|
6,061
|
|
Gross
profit (loss)
|
|
|
4,926
|
|
|
|
(3,190
|
)
|
|
|
(6,474
|
)
|
|
|
2,975
|
|
|
|
1,780
|
|
Operating
expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Research
and development
|
|
|
2,949
|
|
|
|
4,406
|
|
|
|
4,020
|
|
|
|
1,308
|
|
|
|
1,740
|
|
Selling,
general and administrative
|
|
|
6,591
|
|
|
|
8,860
|
|
|
|
6,316
|
|
|
|
3,504
|
|
|
|
3,764
|
|
Total operating expenses
|
|
|
9,540
|
|
|
|
13,266
|
|
|
|
10,336
|
|
|
|
4,812
|
|
|
|
5,504
|
|
Loss
from operations
|
|
|
(4,614
|
)
|
|
|
(16,456
|
)
|
|
|
(16,810
|
)
|
|
|
(1,837
|
)
|
|
|
(3,724
|
)
|
Other
income (expense), net
|
|
|
(13,874
|
)
|
|
|
1,190
|
|
|
|
282
|
)
|
|
|
(959
|
)
|
|
|
(941
|
)
|
Net
loss
|
|
$
|
(18,488
|
)
|
|
$
|
(15,266
|
)
|
|
$
|
(16,528
|
)
|
|
$
|
(2,796
|
)
|
|
$
|
(4,665
|
)
|
Net
loss per share, basic and diluted
|
|
$
|
(1.59
|
)
|
|
$
|
(1.52
|
)
|
|
$
|
(1.94
|
)
|
|
$
|
(0.21
|
)
|
|
$
|
(0.42
|
)
|
Revenues
Revenues
for the three and six months ended June 30, 2008 were approximately $5.6
million and $8.3 million, respectively, as compared to approximately $4.2
million and $7.8 million for the three and six months ended June 30, 2007,
respectively, an increase of approximately 33% and 6%,
respectively. Higher revenue for the three and six month periods was
due to increased availability of finished displays as a result of increased
production volume and improved yields. In addition, an increase in
the number of contracts the Company is currently performing has resulted in
increased contract revenue.
Cost
of Goods Sold
Cost of
goods sold includes direct and indirect costs associated with
production. Cost of goods sold for the three and six months ended June 30,
2008 were approximately $3.0 million and $5.3 million as compared to
approximately $2.9 million and $6.1 million for the three and six months ended
June 30, 2007. There was an increase of $0.1 million for the three
months ended June 30, 2008 as compared to the three months ended June 30, 2007
and there was a decrease of approximately $0.8 million for the six months ended
June 30, 2008 as compared to the six months ended June 30, 2007. The
gross margin for the three and six months ended June 30, 2008 was
approximately $2.6 million and $3.0 million as compared to approximately $1.3
million and $1.8 million for the three and six months ended June 30, 2007. As a
percentage of revenue this translates to a gross margin for the three and six
months ended June 30, 2008 of 46% and 36%, respectively, as compared to 30% and
23%, respectively, for the three and six months ended June 30,
2007. The increase in the gross margin was attributed to fuller
utilization of our fixed production overhead due to higher unit production
volume and improved yields.
Operating
Expenses
Research and
Development
. Research and development expenses include salaries,
development materials and other costs specifically allocated to the development
of new microdisplay products, OLED materials and subsystems. Research
and development expenses for the three and six months ended June 30,
2008 were approximately $0.6 million and $1.3 million, respectively, as compared
to $0.9 million and $1.7 million for the three and six months ended June
30, 2007, a decrease of approximately $0.3 million and $0.4 million,
respectively. The decrease was due to the re-deployment of research and
development personnel to production contract services which are included in cost
of goods sold.
Selling, General and
Administrative
. Selling, general and administrative
expenses consist principally of salaries, fees for professional services
including legal fees, as well as other marketing and administrative
expenses. Selling, general and administrative expenses for the three
and six months ended June 30, 2008 were approximately $1.7 million and $3.5
million, respectively, as compared to approximately $1.5 million and $3.8
million for the three and six months ended June 30, 2007, an increase of $0.2
million and a decrease of $0.3 million, respectively. The increase of
approximately $0.2 million for the three months ended June 30, 2008 was
primarily related to an increase in the allowance for bad debts and professional
services associated with additional SEC filings and SOX
compliance. The decrease of approximately $0.3 million for the six
months ended June 30, 2008 was primarily related to decreases in personnel costs
and service paid in equity offset by increases in allowance for bad debts
and professional services.
Other Income (Expense), net
.
Other income (expense), net consists primarily of interest income earned on
investments, interest expense related to the secured debt, gain from the change
in the derivative liability, and income from the licensing of intangible
assets.
For the
three and six months ended June 30, 2008, interest income was approximately $2
thousand and $4 thousand as compared to approximately $8 thousand and $23
thousand for the three and six months ended June 30, 2007. The
decrease in interest income was primarily a result of lower cash balances
available for investment.
For the
three and six months ended June 30, 2008, interest expense was approximately
$0.6 million and approximately $1.2 million, respectively, as compared to
approximately $1.3 million and approximately $2.2 million, respectively, for the
three and six months ended June 30, 2007. The breakdown of the
interest expense for the three and six month period in 2008 is as
follows: interest expense associated with debt of approximately $164
thousand and $323 thousand, respectively; the amortization of the deferred costs
and waiver fees associated with the debt of approximately $373 thousand and $821
thousand, respectively; and the amortization of the debt discount associated
with the debt of approximately $0 and $25 thousand, respectively. The
breakdown of the interest expense for the three and six month period in 2007 is
as follows: interest expense associated with debt of approximately
$305 and $457 thousand, respectively; the amortization of the deferred costs
associated with the notes payable of approximately $133 thousand and $266
thousand, respectively; and the amortization of the debt discount of
approximately $878 thousand and $1.5 million, respectively.
The gain
from the change in the derivative liability was $0 for the three and six months
ended June 30, 2008 as compared to $182 thousand and $642 thousand,
respectively, for the three and six months ended June 30, 2007.
Other
income, net (excluding interest income), for the three and six months ended June
30, 2008 was approximately $121 thousand and $205, respectively, as
compared to approximately $560 thousand and $567 thousand, respectively, for the
three and six months ended June 30, 2007. Other income primarily consists of
income from the licensing of intangible assets.
Year
Ended December 31, 2007 Compared to Year Ended December 31, 2006
Revenues
Revenues
increased by approximately $9.4 million to a total of approximately $17.6
million for the year ended December 31, 2007 from approximately $8.2 million for
the year ended December 31, 2006, representing an increase of 115%. This
increase was primarily due to increased microdisplay sales and increased
availability of finished displays due to manufacturing improvements. Our
contract revenue increased approximately $1.2 million while our product revenue
increased approximately $8.2 million. Average price per unit for microdisplays
was $371 in 2007 and $386 in 2006. Our current expectation is that
revenue will continue to grow in 2008 if we successfully execute our business
plan.
Cost
of Goods Sold
Cost of
goods sold includes direct and indirect costs associated with production of our
products. Cost of goods sold for the years ended December 31, 2007 and 2006 was
approximately $12.6 million and $11.4, respectively, an increase of $1.3
million. The increase included an inventory write-off of
approximately $0.4 million and an increase in our warranty return reserve of
approximately $0.6 million, both related to a non-recurring production issue
that occurred during the fourth quarter of 2007.
The
gross profit was approximately $4.9 million for the year ended December 31, 2007
and the gross loss was approximately ($3.2) million for the year ended December
31, 2006. The gross margin was 28% for the year ended December 31,
2007 as compared to the gross loss of (39%) for the year ended December 31,
2006. The gross margin improvement was attributed to fuller
utilization of our fixed production overhead due to higher unit production
volume.
Research
and development expenses include salaries, development materials and other costs
specifically allocated to the development of new microdisplay products, OLED
materials and subsystems. Research and development expenses for the
year ended December 31, 2007 were approximately $2.9 million as compared to
approximately $4.4 million for the year ended December 31, 2006. The
decrease was due to the re-deployment of research and development personnel to
production contract services which are included in cost of goods
sold.
Selling,
General and Administrative Expenses
Selling,
general and administrative expenses consist primarily of salaries and fees for
professional services, legal fees incurred in connection with patent filings,
SEC and related matters, as well as other marketing and administrative
expenses. General and administrative expenses decreased by
approximately $2.3 million to a total of approximately $6.6 million for the year
ended December 31, 2007 from $8.9 million for the year ended December 31, 2006.
The decrease was primarily related to a reduction of marketing, tradeshow and
personnel costs.
Other
(Expense
)
Income
Other
(expense) income, net consists primarily of interest income earned on
investments, interest expense related to the secured debt, loss from the change
in the derivative liability, loss on the extinguishment of debt and other income
from the licensing of intangible assets.
For the
year ended December 31, 2007, interest expense was approximately $3.1 million as
compared to $1.3 million for the year ended December 31,
2006. Interest expense for 2007 consisted of interest expense
associated with debt of approximately $744 thousand; the amortization of the
deferred costs associated with debt of approximately $418 thousand; and the
amortization of the debt discount associated with the debt of approximately $1.9
million. Interest expense for the year ended December 31, 2006 was
comprised of interest associated with debt of approximately $124 thousand; the
amortization of the deferred costs associated with the notes payable of
approximately $221 thousand; and the amortization of the debt discount
associated with the debt of approximately $956 thousand.
For the
year ended December 31, 2007, the change in the derivative liability was a loss
of approximately $853 thousand as compared to a gain of approximately $2.4
million ended December 31, 2006.
The loss
on extinguishment of debt was $10.7 million for the year ended December 31, 2007
as compared to $0 for the year ended December 31, 2006. See Note 8 to the
financial statements: Debt for additional information.
Other
income for the year ended December 31, 2007 was approximately $815 thousand
which consisted of interest income of approximately $43 million, a gain on the
license of intangible assets of $869 thousand, offset by a write-off of a
miscellaneous receivable of $103 thousand, and other income of $7 thousand as
compared to $91 thousand for the year ended December 31, 2006. See
Note 12 to the December 31, 2007 consolidated financial
statements: Commitments and Contingencies – Royalties for additional
information.
Revenues
Revenues
increased by approximately $4.5 million to a total of approximately $8.2 million
for the year ended December 31, 2006 from approximately $3.7 million for the
year ended December 31, 2005, representing an increase of 118%. This increase
was due to increased microdisplay demand and the broadening of our product
revenue through the sales of the Z800 3D Visor. Our contract revenue increased
approximately $150 thousand while our product revenue increased approximately
$4.3 million. Average price per unit for microdisplays was $386 in 2006 and $372
in 2005.
Cost
of Goods Sold
Cost of
goods sold includes direct and indirect costs associated with production of our
products. Cost of goods sold for the years ended December 31, 2006 and 2005 was
approximately $11.4 million and approximately $10.2, respectively, an increase
of $1.2 million. The gross loss was approximately ($3.2) million and
approximately ($6.5) million, respectively, for the years ended December 31,
2006 and 2005, respectively. The gross loss was (39%) for the year
ended December 31, 2006 as compared to (173%) for the year ended December 31,
2005. The increase in cost of goods sold for the year ended December
31, 2006 was attributed to higher materials usage to support increased
production as well as approximately $343 thousand of stock compensation expense
reflected in accordance with SFAS No. 123R in 2006. The
decrease in gross loss was attributed to fuller utilization of our fixed
production overhead due to higher unit volume.
Research
and Development Expenses
Research
and development expenses included salaries, development materials and other
costs specifically allocated to the development of new microdisplay products,
OLED materials and subsystems. Research and development expenses for
the year ended December 31, 2006 were approximately $4.4 million as compared to
approximately $4.0 million for the year ended December 31, 2005. The
increase was primarily due to the stock-based compensation expense of
approximately $435 thousand in 2006.
Selling, General
and Administrative Expenses
Selling,
general and administrative expenses consist primarily of salaries and fees for
professional services, legal fees incurred in connection with patent filings and
related matters, as well as other marketing and administrative
expenses. General and administrative expenses increased by
approximately $2.9 million to a total of approximately $8.9 million for the year
ended December 31, 2006 from $6.3 million for the year ended December 31, 2005.
The increase in selling, general and administrative expenses was due primarily
to stock-based compensation expense of approximately $2.9 million and an
increase in marketing expenses related to our Z800 3DVisor.
Other Income
(Expense
)
Other
income, net consists primarily of interest income earned on investments,
interest expense related to the secured debentures, and gain from the change in
the derivative liability. For the year ended December 31, 2006,
interest income was approximately $91 thousand as compared to approximately $210
thousand for the year ended December 31, 2005. The decrease in
interest income was primarily a result of lower cash balances available for
investment. For the year ended December 31, 2006, interest expense
was approximately $1.3 million as compared to approximately $4 thousand for the
year ended December 31, 2005. The increase in the interest
expense was a result of interest associated with our notes payable of
approximately $124 thousand, the amortization of the deferred costs associated
with the notes payable of approximately $221 thousand, and the amortization of
the debt discount of approximately $956 thousand. For the year ended
December 31, 2006, income from the change in the derivative liability was
approximately $2.4 million as compared to $0 for the year ended December 31,
2005.
As of
June 30, 2008, we had approximately $1.1 million of cash and investments as
compared to $0.8 million as of December 31, 2007. The change in cash
and investments was primarily due to cash provided by financing activities of
$2.6 million offset by cash used for operating activities and investing
activities of $2.3 million.
Sources
and Uses of Cash
|
Year
ended December 31,
|
|
Six
Months Ended
June
30,
|
|
|
2007
|
|
2006
|
|
2005
|
|
2008
|
|
2007
|
|
Cash
flow data:
|
|
|
|
|
|
|
(unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
Net
cash used in operating activities
|
|
$
|
(1,943
|
)
|
|
$
|
(10,389
|
)
|
|
$
|
(15,713
|
)
|
|
$
|
(2,025
|
)
|
|
$
|
(1,151
|
)
|
Net
cash provided (used) in investing activities
|
|
|
61
|
|
|
|
(257
|
)
|
|
|
(1,072
|
)
|
|
|
(236
|
)
|
|
|
(4
|
)
|
Net
cash provided by financing activities
|
|
|
1,180
|
|
|
|
5,334
|
|
|
|
10,055
|
|
|
|
2,586
|
|
|
|
430
|
|
Net
(decrease) increase in cash and cash equivalents
|
|
|
(702
|
)
|
|
|
(5,312
|
)
|
|
|
(6,730
|
)
|
|
|
325
|
|
|
|
(725
|
)
|
Cash
and cash equivalents, beginning of period
|
|
|
1,415
|
|
|
|
6,727
|
|
|
|
13,457
|
|
|
|
713
|
|
|
|
1,415
|
|
Cash
and cash equivalents, end of period
|
|
$
|
713
|
|
|
$
|
1,415
|
|
|
$
|
6,727
|
|
|
$
|
1,038
|
|
|
$
|
690
|
|
Cash
Flows from Operating Activities
Cash flow
used in operating activities during the six months ended June 30, 2008 was
approximately $2.0 million primarily attributable to our net loss of $2.8
million and an increase in accounts receivable of $1.4 million offset by
non-cash expenses of $1.9 million. During the six months ended June 30, 2007,
operating activities used cash of $1.2 million attributable to our net loss of
$4.7 million and primarily offset by non-cash expenses of $2.8
million.
Cash used
in operating activities was $1.9 million in 2007, $10.4 million in 2006 and
$15.7 million in 2005. For the year ended December 31, 2007, net cash
used by operating activities was approximately $1.9 million, primarily
attributable to our $18.5 million net loss offset by the non-cash expense
components of loss on extinguishment of debt of $10.7 million, stock based
compensation of $1.7 million, amortization of discount on notes payable of $1.9
million, and issuance of common stock for services of $1.3 million. For 2006,
net cash used in operating activities was approximately $10.4 million, primarily
attributable to our net loss of approximately $15.3 million. For 2005, net cash
used by operating activities was approximately $15.7 million, primarily
attributable to our net loss of approximately $16.5 million.
Cash
Flows from Investing Activities
Cash used
in investing activities during the six months ended June 30, 2008 was
approximately $236 thousand used for equipment purchases. During the
six months ended June 30, 2007, the cash used in investing activities was $4
thousand used for investment purchases.
Cash
provided by investing activities was $61 thousand in 2007 which was primarily
related to the maturing of investments. Cash used in investing
activities was $257 thousand in 2006 and $1.1 million in 2005 which were
primarily related to capital expenditures.
Cash
Flows from Financing Activities
Cash
provided by financing activities during the six months ended June 30, 2008 was
approximately $2.6 million and was comprised of approximately $1.6 million from
the sale of common stock, $1.7 million from the line of credit, and offset by
payments on debt of $0.7 million. The cash provided by financing
activities during the six months ended June 30, 2007 was approximately $0.4
million primarily consisting of $0.5 million, net, from debt issuance and offset
by payments against debt of approximately $33 thousand.
Cash
provided by financing activities was $1.2 million in 2007, $5.3 million in 2006
and, $10.1 million in 2005. Net cash provided by financing activities for the
year ended December 31, 2007 was comprised primarily of approximately $1.6
million in proceeds from debt issuance and offset by payments on long-term debt
and capitalized lease obligations of approximately $63 thousand and deferred
financing costs of approximately $368 thousand. Net cash provided by financing
activities in 2006 was comprised primarily of approximately $5.4 million in
proceeds from debt issuance and offset by payments on long-term debt and
capitalized lease obligations of approximately $55 thousand. Net cash provided
by financing activities during 2005 consisted primarily of approximately $8.4
million in proceeds from the sale of common stock and approximately $1.6 million
from the exercise of stock options and warrants.
Working
Capital and Capital Expenditure Needs
Our
unaudited condensed consolidated financial statements as of June 30, 2008 have
been prepared under the assumption that we will continue as a going concern. Our
independent registered public accounting firm has issued a report dated April 9,
2008 for the audit of the financial statements included in the Form 10-K for the
year ended December 31, 2007 that included an explanatory paragraph
expressing substantial doubt in our ability to continue as a going concern
without additional capital becoming available. Our ability to continue as a
going concern ultimately is dependent on our ability to generate a profit which
is likely dependent upon our ability to obtain additional equity or debt
financing, attain further operating efficiencies and, ultimately, to achieve
profitable operations. The financial statements do not include any adjustments
that might result from the outcome of this uncertainty.
We
anticipate our business to experience revenue growth during the year
ending December 31, 2008. This trend may result in higher accounts
receivable levels and may require increased production and/or higher inventory
levels. In addition, in December 2008, we will be obligated to repay
approximately $6.0 million to the note holders. If the funds are not
available, we will negotiate with the note holders to defer the payment but no
assurances can be made that they will agree. We anticipate that our cash
requirements to fund these requirements as well as other operating or
investing cash requirements over the next twelve months will be greater than our
current cash on hand. We anticipate that we will still require
additional funds over the next twelve months. We do not currently
have commitments for these funds and no assurance can be given that additional
financing will be available, or if available, will be on acceptable
terms.
The
Company’s ability to obtain additional funding is impacted by its present
indebtedness. The Company’s notes payable have covenants which the
Company currently is in compliance with. The Company has a line of credit with a
maximum of $3.0 million which is secured by accounts receivable and inventory
which effectively eliminates any additional secured indebtedness under the note
covenants. Effective August 9, 2008, the Company’s line of credit was
extended until August 9, 2009. In addition, pursuant to the notes payable
agreement, the Company cannot enter into a consolidation, merger, or acquisition
under certain conditions without consent of the note holders. The
Company may raise additional unsecured debt under the note covenants given
certain restrictions. In addition, the notes payable allow for
additional equity financing.
If we are
unable to obtain sufficient funds during the next twelve months, we will further
reduce the size of our organization and may be forced to reduce and/or curtail
our production and operations, all of which could have a material adverse impact
on our business prospects. The Company is reviewing its cost structures for cost
efficiencies and is taking measures to reduce non-production costs.
In
addition to the foregoing, as previously reported, we have retained CIBC World
Markets Corporation and Larkspur Capital Corporation to assist us in
investigating and evaluating various strategic alternatives, ranging from
investment to acquisition.
Contractual
Obligations
The
following chart describes the outstanding contractual obligations of eMagin as
of June 30, 2008 (in thousands):
|
Payments
due by period
|
|
Total
|
|
1
Year
|
|
2-3
Years
|
|
4-5
Years
|
Operating
lease obligations
|
$1,469
|
|
$1,214
|
|
$ 255
|
|
$
—
|
Purchase
obligations (a)
|
1,154
|
|
1,154
|
|
—
|
|
—
|
Other
long-term liabilities (b)
|
6,894
|
|
6,391
|
|
253
|
|
250
|
Total
|
$9,517
|
|
$8,759
|
|
$ 508
|
|
$250
|
|
(a)
The majority of purchase orders outstanding contain no cancellation fees
except for minor re-stocking fees.
|
|
(b)
This amount represents the obligation for Notes and estimated interest,
royalty payments, capitalized software and the New York Urban Development
settlement.
|
Off-Balance
Sheet Arrangements
We do not
have any off balance sheet arrangements that are reasonably likely to have a
current or future effect on our financial condition, revenues, results of
operations, liquidity or capital expenditures.
Effect
of Recently Issued Accounting Pronouncements
In
September 2006, the FASB issued Statement of Financial Accounting Standards
No. 157, “Fair Value Measurements,” (“SFAS 157”), which defines fair value,
establishes a framework for measuring fair value under generally accepted
accounting principles and expands disclosures about fair value measurements.
SFAS 157 does not require any new fair value measurements, but provides guidance
on how to measure fair value by providing a fair value hierarchy used to
classify the source of the information. In February 2008, the FASB issued
FASB Staff Position No. FSP 157-2, “Effective Date of FASB Statement
No. 157”, which provides a one year deferral of the effective date of SFAS
157 for non-financial assets and non-financial liabilities, except those that
are recognized or disclosed in the financial statements at fair value on a
recurring basis. The Company adopted SFAS 157 as of January 1, 2008, with
the exception of the application of the statement to non-recurring non-financial
assets and non-financial liabilities which it will defer the adoption until
January 1, 2009. The adoption of SFAS 157 did not have a material impact on the
Company’s consolidated results of operations, financial condition or cash
flows.
In
February 2007, the FASB issued SFAS No. 159, “The Fair Value Option
for Financial Assets and Financial Liabilities — including an amendment of FASB
Statement No. 115,” (“SFAS 159”) which is effective for fiscal years
beginning after November 15, 2007. This statement permits entities to
choose to measure many financial instruments and certain other items at fair
value. This statement also establishes presentation and disclosure requirements
designed to facilitate comparisons between entities that choose different
measurement attributes for similar types of assets and liabilities. Unrealized
gains and losses on items for which the fair value option is elected would be
reported in earnings. The Company has adopted SFAS 159 and has elected not to
measure any additional financial instruments and other items at fair value and
therefore the adoption of SFAS 159 did not have a material impact on the
Company’s consolidated results of operations, financial condition or cash
flows.
In
March 2008, the FASB issued Statement of Financial Accounting Standards
No. 161, Disclosures about Derivative Instruments and Hedging Activities,
an amendment of FASB Statement No. 133 (“SFAS 161”). SFAS 161 requires
entities to provide greater transparency about (a) how and why an entity
uses derivative instruments, (b) how derivative instruments and related
hedged items are accounted for under Statement 133 and its related
interpretations and (c) how derivative instruments and related hedged items
affect an entity’s financial position, results of operations, and cash flows.
SFAS 161 is effective prospectively for financial statements issued for fiscal
years and interim periods beginning after November 15, 2008, with early
application permitted. The Company is currently evaluating the disclosure
implications of this statement.
In May
2008, the FASB issued SFAS No. 162,
The Hierarchy of Generally Accepted
Accounting Principles
, (“SFAS 162”), which identifies the sources of
accounting principles and the framework for selecting principles to be used in
the preparation of financial statements of nongovernmental entities that are
presented in conformity with generally accepted accounting principles in the
United States. This statement shall be effective 60 days following the
SEC's approval of the Public Company Accounting Oversight Board's amendments to
AU section 411, The Meaning of Present Fairly in Conformity with Generally
Accepted Accounting Principles. The Company is currently evaluating the impact
of SFAS 162, but does not expect the adoption of this
pronouncement will have a
material impact on the Company's financial statements.
Quantitative
and Qualitative Disclosures About Market Risk
Market Rate Risk
.
We
are exposed to market risk related to changes in interest rates and foreign
currency exchanges rates.
Interest Rate Risk.
We
hold our assets in cash and cash equivalents. We do not hold derivative
financial instruments other than a derivative liability on our balance sheet or
equity securities. We are exposed to interest rate risk on our line of
credit. Annual interest on our line of credit is equal to the greater of the sum
of the prime rate plus 2% or 10%.
Foreign Currency Exchange Rate
Risk.
Our
revenue and expenses are denominated in U.S. dollars. We have conducted some
transactions in foreign currencies and expect to continue to do so; we do not
anticipate that foreign exchange gains or losses will be significant. We have
not engaged in foreign currency hedging to date.
Our
international business is subject to risks typical of international activity,
including, but not limited to, differing economic conditions; change in
political climates; differing tax structures; and other regulations and
restrictions. Accordingly, our future results could be impacted by changes in
these or other factors.
BUSINESS
Recent
Developments
Amendment
of Stillwater Note Purchase Agreement (the “Note”) - April 2007
As stated
above, as previously reported in the Form 8-K dated July 25, 2006, on July 21,
2006, eMagin Corporation (the “Company”) entered into a Note Purchase Agreement
(the “Stillwater Agreement”) with Stillwater LLC (“Stillwater”) which provides
for the purchase and sale of a 6% senior secured convertible note in the
principal amount of up to $500,000 (the “Stillwater Note”), together with a
warrant (the “Stillwater Warrant”) to purchase 70% of the number of shares
issuable upon conversion of the Stillwater Note, at the sole discretion of the
Company by delivery of a notice to Stillwater on December 14,
2006. Interest payments from the Stillwater Note are to be made in
cash, unless Stillwater elects to convert any portion of the principal of the
Stillwater Note plus any accrued and unpaid interest for such principal
amount.
As
previously reported in the Form 8-K dated April 13, 2007, by way of amendment to
the Stillwater Agreement, dated March 28, 2007 (the “Amendment”), the Company
and Stillwater agreed to certain amendments to the Stillwater Agreement. Based
upon the provisions of the Stillwater Agreement, Stillwater was bound to
purchase the Stillwater Note and the Stillwater Warrant so long as the
conditions to closing as set forth in the Stillwater Agreement were satisfied by
the Company. However, prior to Stillwater’s obligation to purchase
the Stillwater Note and Stillwater Warrant, the Company received notice from the
American Stock Exchange (“AMEX”) that it was no longer in compliance with their
listing requirements, and the Company was subsequently de-listed in March of
2007. Since compliance with the AMEX listing requirements was a condition of
closing in the Stillwater Agreement, Stillwater was no longer obligated to
purchase the Stillwater Note and Stillwater Warrant. Therefore, among
other things, pursuant to the Amendment, the parties agreed to a new conversion
price for the Stillwater Note of $0.35 per share, a new exercise price for the
Stillwater Warrant of $0.48 per share, a new closing date, and amended certain
closing conditions, including the following: on the closing date, (i) trading in
securities on the New York Stock Exchange, Inc., the AMEX, Nasdaq, the Nasdaq
Capital Market, the Over-The-Counter Bulletin Board, the Pink Sheets, LLC or any
similar organization shall not have been suspended or materially limited, (ii) a
general moratorium on commercial banking activities in the State of New York
shall not have been declared by either federal or state authorities, and (iii)
the Company has obtained waivers from all the note holders of the other notes or
has executed an additional Allonge with the majority holders to amend Section
3.2 of the Note and other notes to provide that the Company maintain cash and
cash equivalents balances of at least equal to $200,000 from April 1, 2007
through and including May 15, 2007 and that subsequent to
May 15, 2007 the Company maintain cash and cash equivalents balances
of at least equal to $600,000.
If all of
the Stillwater Warrants are exercised for cash, the Company would receive
$480,000, which would be used for working capital and other corporate purposes.
There cannot be any assurances that any of the Stillwater Warrants will be
exercised. The closing for the sale of the Stillwater Note and Stillwater
Warrant was completed on April 9, 2007 and the Company issued Stillwater the
Stillwater Note in a 6% Senior Secured Convertible Note in the principal amount
of $500,000 and the Stillwater Warrant to purchase 1,000,000 shares of the
Company’s common stock at an exercise price of $0.48 in accordance with the
terms of the Stillwater Agreement and Amendment. Interest payments from the
Stillwater Note are to be made in cash, unless Stillwater elects to convert any
portion of the principal of the Stillwater Note plus any accrued and unpaid
interest for such principal amount. The principal of the Stillwater
Note was due in installments as follows:
Principal
Amount
|
|
Due
Date*
|
$
|
250,000
|
|
July
23, 2007**
|
|
|
|
|
$
|
250,000
|
|
January
21, 2008
|
* If the
due date falls on a non-business day, the payment date will be the next business
day.
**On
July, 23 2007, Stillwater elected to convert $252,166.50 of the
Note representing $250,000 of the principal amount of the Note due on July
23, 2007 and $2,166.50 of accrued and unpaid interest into shares of common
stock. Stillwater will receive 720,476 shares of the common stock at the
conversion price of $0.35.
This
prospectus covers the resale by Stillwater of the above-referenced common stock
underlying the Stillwater Note and the Stillwater Warrant.
Amendment
Agreements - July 2007
As
previously reported in the Form 8-K of the Company dated as of July 25, 2006,
the Company entered into several Note Purchase Agreements (the “Original
Purchase Agreements”), including the Stillwater Agreement, to sell to certain
qualified institutional buyers and accredited investors $5,990,000 in principal
amount 6% Senior Secured Convertible Notes Due July 21, 2007 and January 21,
2008 (the “Notes”), together with warrants (the “Warrants”) to purchase
1,612,700 shares of the Company’s common stock, par value $0.001 per share at
$3.60 per share.
As
previously reported in the Form 8-K of the Company dated as of July 25, 2007, by
way of Amendment Agreements dated July 23, 2007 (the “Amendment Agreements”)
between the Company and each of the holders of the Notes, including Stillwater
(each a “Holder” and collectively, the “Holders”), the Company agreed to issue
each Holder an amended and restated Note for the outstanding Notes (the “Amended
Notes”) in the principal amount equal to the principal amount outstanding as of
July 23, 2007 and an amended restated Warrant (the “Amended
Warrants”). The changes to the Amended Notes and Amended
Warrants include the following:
·
|
The
maturity date for the Amended Notes (totaling after conversions an
aggregate of $6,020,000) was extended to December 21,
2008;
|
·
|
Liquidated
damages of 1% per month related to the Company’s delisting from the
American Stock Exchange will no longer accrue and the deferred interest
balance of approximately $230,000 has been forgiven;
|
·
|
The
Company no longer has to maintain a minimum cash or cash equivalents
balances of $600,000;
|
·
|
The
Amended Notes may not be prepaid without the consent of the
Holders;
|
·
|
As
of July 23, 2007 the interest rate was raised from 6% per annum to 8% per
annum;
|
·
|
The
Amended Notes are convertible into (i) 8,407,612 shares of the Company’s
common stock. The conversion price for the Amended Notes was
revised from $2.60 to $.75 per share except for the Stillwater Note which
remained $.35 per share for $250,000 of principal (which represents the
remaining portion of the original principal balance of $500,000 after
Stillwater’s partial conversion);
|
·
|
In
addition to the right to convert the Amended Notes in the Company’s common
stock, up to $3,010,000 of the Amended Notes can be converted into (ii)
3,010 shares of the Company’s newly formed Series A Senior Secured
Convertible Preferred Stock (the “Preferred”) at a stated value of $1,000
per share. The Preferred is convertible into common stock at
$.75 per share, subject to adjustment as provided for in the Certificate
of Designations (discussed below);
|
·
|
Except
for the Stillwater Warrant whose exercise price was unchanged,, the
Amendment Agreements adjusted the exercise price of the Amended Warrants
from $3.60 to $1.03 per share for 1,553,468 shares of common stock and
requires the issuance of Warrants exercisable for an additional 3,831,859
shares of common stock at $1.03 per share with an
expiration date of July 21, 2011;
|
·
|
The
Amended Notes eliminate the requirement that the Company comply with
certain covenants of management contained in the Notes. Specifically,
among other things, the requirements to defer management compensation and
to maintain a management committee were removed; and
|
·
|
The
Amended Notes and/or the Preferred are subject to certain anti-dilution
adjustment rights in the event the Company issues shares of its common
stock or securities convertible into its common stock at a price per share
that is less than the Conversion Price, in which case the Conversion Price
shall be adjusted to such lower price. The Amended Warrants are
subject to certain anti-dilution adjustment rights in the event the
Company issues shares of its common stock or securities convertible into
its common stock at a price per share that is less than the Strike Price,
in which case the Strike Price shall be adjusted to the lower of (1) 138%
of the price at which such common stock is issued or issuable and (2) the
exercise price of warrants, issued in such
transaction.
|
Pursuant
to the Amended Notes, the Company cannot enter into a transaction that
constitutes a Fundamental Change without the consent of the
Holders. A Fundamental Change includes the following:
·
|
the
consolidation or merger of the Company or any of its
subsidiaries;
|
·
|
the
acquisition by a person or group of entities acting in concert of 50% or
more of the combined voting power of the outstanding securities
of the Company; and
|
·
|
the
occurrence of any transaction or event in which all or substantially all
of the shares of the Company’s common stock is exchanged for converted
into acquired for or constitutes the right to receive consideration which
is not all or substantially all common stock which is listed on a national
securities exchange or approved for quotation on Nasdaq or any similar
United States system of automated dissemination of transaction reporting
securities prices.
|
Pursuant
to the Amendment Agreements, the Company filed a Certificate of Designations of
Series A Senior Secured Convertible Preferred Stock (the “Certificate of
Designations”). The Certificate of Designations designates 3,198 shares of the
Company’s preferred stock as Series A Senior Secured Convertible Preferred Stock
(the “Preferred Stock”). Each share of the Preferred Stock has a
stated value of $1,000. The Preferred Stock is entitled to cumulative
dividends which accrue at a rate of 8% per annum, payable on December 21, 2008.
Each share of Preferred Stock has voting rights equal to (1) in any case in
which the Preferred Stock votes together with the Company’s common stock or any
other class or series of stock of the Company, the number of shares of common
stock issuable upon conversion of such shares of Preferred Stock at such time
(determined without regard to the shares of common stock so issuable upon such
conversion in respect of accrued and unpaid dividends on such share of Preferred
Stock) and (2) in any case not covered by the immediately preceding clause one
vote per share of Preferred Stock. The Certificate of Designations
prohibits the Company from entering into a Fundamental Change without consent of
the Holders and contains antidilution adjustments rights that are comparable to
the antidilution adjustments contained in the Amended Notes.
Pursuant
to the Amendment Agreements, the Company was required to file a registration
statement with the Securities and Exchange Commission by August 31, 2007
covering the resale of 100% of the sum of (a) the number of shares issuable upon
conversion of the Amended Notes and Preferred Stock, and (b) the number of
shares issuable upon exercise of the Warrants.
Pursuant
to the Amendment Agreement, the Company and the Collateral Agent, on behalf of
the note holders, executed Amendment No. 1 to the Pledge and Security Agreement;
Amendment No. 1 to Patent and Trademark Security Agreement; Amendment No. 1 to
Lockbox Agreement. The Pledge and Security Agreement, Trademark
Security Agreement and Lockbox Agreement were previously entered into on July
21, 2006 (collectively, the “Ancillary Agreements”). The Ancillary
Agreements were amended to cover obligations that may become payable to holders
of Preferred Stock, to delete certain definitions used in the Ancillary
Agreements and substitute definitions of terms used in the Ancillary
Agreements.
The
summary of amendment terms contained herein does not include all information
included in the Amendment Agreement, the Amended Notes, the Amended Warrants,
the Certificate of Designations or the Ancillary Agreements and, consequently,
is qualified in its entirety by reference to the entire text of the Amendment
Agreements and the forms of the Amended Notes, Amended Warrants, Certificate of
Designations, Amendment No. 1 to Pledge and Security Agreement, Amendment No. 1
to Patent and Trademark Security Agreement and Amendment No. 1 to Lockbox
Agreement.
Securities
Purchase Agreement – April 2008
As
previously reported on a Form 8-K that was filed with the Securities and
Exchange Commission on April 4, 2008, the Company entered into a Securities
Purchase Agreement on April 2, 2008, (the “Purchase Agreement”) pursuant to
which it sold to certain qualified institutional buyers and accredited investors
(the “Investors”) an aggregate of 1,586,539 shares of the Company’s common
stock, par value $0.001 per share (the “Shares”), and warrants to purchase an
additional 793,273 shares of common stock, for an aggregate purchase price of
$1,650,000. The purchase price of the common stock was $1.04 per share and the
strike price of the corresponding warrant was $1.30 per share. The warrants
expire April 2, 2013.
The
Company entered into a Registration Rights Agreement with the Investors to
register the resale of the Shares sold in the offering and the shares of common
stock issuable upon exercise of the warrants. Subject to the terms of
the Registration Rights Agreement, the Company was required to file a
registration statement on Form S-1 with the Securities and Exchange Commission
(the “SEC”) within 45 days of the closing, to use its best efforts to cause the
registration statement to be declared effective under the Securities Act of 1933
(the “Act”) as promptly as possible after the filing thereof, but in no event
later than 90 days after the filing date and no later than 120 days after the
filing date in the event of SEC review of the registration statement. The
Company filed the registration statement within the 45 day period however the
Company was notified that the registration statement was under review by the
SEC. The Company failed to file the amended registration statement by
August 2, 2008 which was the 120th day from the signing of the Purchase
Agreement and therefore the registration statement is not
effective.
As the
registration statement is not effective within the grace periods (“Event Date”),
the Company must pay partial liquidated damages (“damages”) in cash to each
investor equal to 2% of the aggregate purchase price paid by each investor under
the Purchase Agreement on the Event Date and each monthly anniversary of the
Event Date (or on a pro-rata basis for any portion of a month) until the
registration statement is effective. The Company is not liable for
any damages with respect to the warrants or warrant shares. The
maximum damages payable to each investor is 36% of the aggregate purchase
price. If the Company fails to pay the damages to the investors
within 7 days after the date payable, the Company must pay interest at a rate of
15% per annum to each investor which accrues daily from the date payable until
damages are paid in full. The Company estimated $399 thousand to be
the maximum potential damages that the Company may be required to pay the
investors if the registration statement is not effective within three years of
the signing of the agreement. The Company estimated $66 thousand to be a
reasonable estimate of the potential damages that may be due to the investors
based on the anticipated filing date.
The
Company claims an exemption from the registration requirements of the Act for
the private placement of these securities pursuant to Section 4(2) of the Act
and/or Regulation D promulgated thereunder since, among other things, the
transaction did not involve a public offering, the investors were accredited
investors and/or qualified institutional buyers, the investors had access to
information about the company and their investment, the investors took the
securities for investment and not resale, and the Company took appropriate
measures to restrict the transfer of the securities.
Moriah
Capital Loan Agreement and Amendments
As
previously reported on a Form 8-K that was filed with the Securities and
Exchange Commission on August 10, 2007, the Company and Moriah Capital LP
(“Moriah”) entered into a Loan and Security Agreement, dated as of August
7, 2007 (the “Loan and Security Agreement”), which was amended as of January 30,
2008 by Amendment No. 1 and on March 18, 2008 by Amendment No. 2 (collectively,
the “Original Agreement”).
As
previously reported on a Form 8-K that was filed with the Securities and
Exchange Commission on August 26, 2008, the Company and Moriah entered into
Amendment No. 3 to the Loan and Security Agreement dated August 20, 2008 (the
“Amendment No. 3”). Pursuant to Amendment No. 3, the Company issued Moriah an
Amended and Restated Convertible Revolving Loan Note (the “Amended
Note”). The maturity date of the Amended Note has been extended
to August 7, 2009 and the maximum amount that the Company can borrow pursuant to
the Amended Note was increased to $3,000,000. The maturity date of the original
revolving loan note had previously been extended to August 20,
2008.
Pursuant
to Amendment No. 3, the Company issued Moriah a warrant, which terminates on
August 7, 2013, to purchase up to 370,000 shares of the Company’s common stock
at an exercise price of $1.30 per share. In connection with Amendment No 3, the
Company will pay Moriah $85,000 in fees. As previously reported,
pursuant to Original Agreement, the Company issued Moriah warrants to purchase
up to 1,000,000 shares of the Company’s common stock at an exercise price of
$1.50 per share.
Pursuant
to Amendment No. 3, the Company and Moriah entered into an Amended and
Restated Securities Issuance agreement (the “Amended and Restated Securities
Issuance Agreement”). In connection with a Securities Issuance Agreement, dated
as of August 7, 2007 (the “Original Securities Issuance Agreement”), the Company
issued Moriah 162,500 shares of the Company’s common stock (the “2007
Shares”). Pursuant to the Amended and Restated Securities Issuance
Agreement, Moriah agreed to waive the Company’s obligation to buy back the
2007 Shares with respect to 125,000 of such shares and to defer the Company’s
obligation to buy back 37,500 of such 2007 Shares (collectively, the
“Put Waiver”). Pursuant to the Amended and Restated Securities Agreement, the
Company is issuing Moriah 485,000 shares of its Common Stock (of which 125,000
shares were issued in consideration for the Put Waiver from Moriah and 360,000
shares were issued in lieu of the issuance to Moriah of the Contingent
Issued Shares (as described in the Original Securities Issuance Agreement)).
Additionally, pursuant to the Amended and Restated Securities Issuance
Agreement, the Company has also granted Moriah a put option pursuant to which
Moriah can sell to the Company 162,500 shares of its common stock issued under
the Amended and Restated Securities Agreement for $195,000, pro-rated for any
portion thereof (the “2007 Put Price”). The 2007 Put Option shall automatically
be deemed exercised by Moriah unless Moriah delivers written notice to the
Company at any time between July 1, 2009 and August 1, 2009 that it does not
wish to exercise the 2007 Put Option. The Company also granted Moriah a second
put option pursuant to which Moriah can sell 360,000 of the shares issued to
Moriah pursuant to the Amended and Restated Securities Purchase Agreement to the
Company for $234,000 (the “2008 Put Option”). The 2008 Put Option
shall automatically be deemed exercised by Moriah unless Moriah delivers written
notice to the Company at any time between July 1, 2009 and August 1, 2009 that
Moriah does not wish to exercise the 2008 Put option in whole or in
part.
Pursuant
to Amendment No. 3, the Company and Moriah entered into an Amendment to
Registration Rights Agreement (the “Amended Registration Rights
Agreement”). Pursuant to the Amended Registration Rights
Agreement, the Company agreed to use its best efforts to file a registration
statement to register the 485,000 shares of the Company’s common stock
issued pursuant to the Amended and Restated Securities Issuance Agreement and
the shares of common stock issuable upon exercise of the Warrant, provided that
the Company is permitted under applicable securities rules and regulations and
after the certain other registration statements that the Company was obligated
to file on behalf of selling shareholders have been declared
effective.
On August
19, 2008, the Holders of the Amended Notes and the Investors in
the Purchase Agreement consented to the Company’s execution of the Amended
Note, Amendment No. 3, Amended and Restated Securities Issuance Agreement, and
the Amended Registration Rights Agreement. In consideration for the
consent, a total of 144,000 shares of common stock were issued to the Holders
and Investors based on individual participation in the Amended Notes and
Securities Purchase Agreement on September 4, 2008.
The
Company claims an exemption from the registration requirements of the
Securities Act of 1933, amended (the "Act") for the private placement
of the above-referenced securities pursuant to Section 4(2) of the Act
since, among other things, these transactions did not involve a public offering
and the Company took appropriate measures to restrict the transfer of the
securities.
The
foregoing description of Amendment No. 3 to the Loan and Security
Agreement, the Amended and Restated Revolving Loan Note, the Amended and
Restated Securities Issuance Agreement, and the Amendment to the Registration
Rights Agreement does not purport to be complete and is qualified in its
entirety by reference to the entire text of the agreements.
General
eMagin
Corporation designs, develops, manufactures, and markets virtual imaging
products which utilize OLEDs, or organic light emitting diodes, OLED-on-silicon
microdisplays and related information technology solutions. We integrate OLED
technology with silicon chips to produce high-resolution microdisplays smaller
than one-inch diagonally which, when viewed through a magnifier, create virtual
images that appear comparable in size to that of a computer monitor or a
large-screen television. Our products enable our original equipment
manufacturer, or OEM, customers to develop and market improved or new electronic
products. We believe that virtual imaging will become an important way for
increasingly mobile people to have quick access to high resolution data, work,
and experience new more immersive forms of communications and
entertainment.
Our first
commercial product, the SVGA+ (Super Video Graphics Array of 800x600 picture
elements plus 52 added columns of data) OLED microdisplay was initially offered
for sampling in 2001, and our first SVGA-3D (Super Video Graphics Array plus
built-in stereovision capability) OLED microdisplay was shipped in early 2002.
These products have received award recognition including: SID Display of the
Year and
Electronic
Products
Magazine
Product of the Year.
These products are being applied or considered for near-eye and headset
applications in products such as entertainment and gaming headsets, handheld
Internet and telecommunication appliances, viewfinders, and wearable computers
to be manufactured by OEM customers for military, medical, industrial, and
consumer applications. We market our products globally.
In 2006
we introduced our OLED-XL technology, which provides longer luminance half life
and enhanced efficiency of eMagin's SVGA+ and SVGA-3D product lines. We are in
the process of completing development of 2 additional OLED microdisplays, namely
the SVGA 3DS (SVGA 3D shrink, a smaller format SVGA display with a new cell
architecture with embedded features) and an SXGA (1280 x 1024 picture
elements).
In
January 2005 we announced the world's first personal display system to combine
OLED technology with head-tracking and 3D stereovision, the Z800 3DVisor(tm),
which was first shipped in mid-2005. This product was recognized as a Digital
Living Class of 2005 Innovators, and received the Consumer Electronics
Association’s coveted Consumer Electronics Show (CES) 2006 Best of Innovation
Awards for the entire display category as well as a Design and Innovations Award
for the electronic gaming category. In February 2007 the Z800 3DVisor, as
integrated in Chatten Associates’ head-aimed remote viewer, was recognized as
one of Advanced Imaging's Solutions of the Year.
We
believe that our OLED-on-silicon microdisplays offer a number of advantages over
current liquid crystal microdisplays, including greatly increased system level
power efficiency, less weight and wider viewing angles. Using our active matrix
OLED technology, many computer and video electronic system functions can be
built directly into the OLED-on-silicon microdisplay, resulting in compact
systems with expected lower overall system costs relative to alternative
microdisplay technologies. We have developed our own technology to create high
performance OLED-on-silicon microdisplays and related optical systems and we
have licensed certain fundamental OLED and display technology from Eastman
Kodak.
As the
first to exploit OLED technology for microdisplays, and with the support of our
partners and the development of our intellectual property, we believe that we
enjoy a significant advantage in the commercialization of this display
technology for virtual imaging. We believe we are the only company to sell
full-color active matrix small molecule OLED-on-silicon
microdisplays.
eMagin
Corporation was created through the merger of Fashion Dynamics Corporation
("FDC"), which was organized on January 23, 1996 under the laws of the State of
Nevada and FED Corporation ("FED"), a developer and manufacturer of optical
systems and microdisplays for use in the electronics industry. FDC had no active
business operations other than to acquire an interest in a business. On March
16, 2000, FDC acquired FED. Simultaneous with this merger, we changed our name
to eMagin Corporation. Following the merger, the business conducted by eMagin is
the business conducted by FED prior to the merger.
Our
website is located at
www.emagin.com
and
our e-commerce site is
www.3dvisor.com
. We
make available on our website, free of charge, our annual report on Forms 10-K,
our proxy statement, our quarterly reports on Forms 10Q, our current reports on
Form 8K, and all amendments to such reports filed under the Securities and
Exchange Act, earnings press releases, and other business-related press
releases. We also post on our website the charters of our Audit, Compensation,
Governance and Nominating committees, our Codes of Ethics and any amendments of
or waiver to those codes of ethics, and other corporate governance materials
recommended by the Securities and Exchange Commission as they
occur.
A study
by NanoMarkets (February 2007) predicts the overall OLED market will approach
$10.9 billion in 2010 and grow to $15.5 billion by 2014. These markets include
various sizes devices for a range of applications from cell phone size to
viewfinder displays to televisions to lighting. Displays in general are sold as
independent products (such as TV monitors) or as components of other systems
(such as laptop computers). Our products target one segment of the display
industry, the near-eye, personal display, which is viewed through a lens rather
than directly, in comparison to desktop computer screens which are known as
direct view displays. As an off-shoot of our work in microdisplays, we are also
participating in government-funded development studies for OLED-based
lighting.
Personal
displays, that is, near-eye systems based on microdisplays and optics, include
video headsets, camcorders, viewfinders and other portable devices.
Microdisplays are typically of such high resolution that they can be practically
viewed only with magnifying optics. Although microdisplays are typically
physically smaller than a postage stamp, they can provide a magnified viewing
area similar to that of a full-size computer screen. For example, when magnified
through a lens, a high-resolution 0.6-inch diagonal display can appear
comparable to a 19- to 21-inch computer screen at about 2 feet from the viewer
or a 60-inch TV screen at about 6 feet. The wearable display market,
according to DisplaySearch, is expected to grow to at least $153 million in
2010. McLaughlin Consulting, in a report published December 2006, projects that,
with effective marketing, the Personal Viewer market could reach nearly $1
billion in 2010.
We
believe that the most significant driver of the longer term near-eye virtual
imaging microdisplay market is growing consumer demand for mobile access to
larger volumes of information and entertainment in smaller packages. This desire
for mobility has resulted in the development of near-eye microdisplay products
in two general categories: (i) an established market for electronic viewers
incorporated in products such as viewfinders for digital cameras and video
cameras which may potentially also be developed as personal viewers for cell
phones and (ii) an emerging market for headset-application platforms which
include accessories for mobile devices such as notebook and sub-notebook
computers, portable DVD systems, electronic games, and other entertainment, and
wearable computers.
Until
now, near-eye virtual imaging microdisplay technologies have not simultaneously
met all of the requirements for high resolution, full color, low power
consumption, brightness, lifetime, size and cost which are required for
successful commercialization in OEM consumer products. We believe that our new
OLED-on-silicon microdisplay product line meets these requirements better than
alternative products and will help to enable virtual imaging to emerge as an
important display industry segment.
Our
Approach: OLED-on-Silicon Microdisplays and Optics
There are
two basic classes of organic light emitting diode, or OLED, technology, dubbed
single molecule or small molecule (monomer) and polymer. Our microdisplays are
currently based upon active matrix molecular OLED technology, which we call
OLED-on-silicon because we build the displays directly on silicon chips. Our
OLED-on-silicon technology uniquely permits millions of individual low-voltage
light sources to be built on low-cost, silicon computer chips to produce single
color, white or full-color display arrays. OLED-on-silicon microdisplays offer a
number of advantages over current liquid crystal microdisplays, including
increased brightness, lower power requirements, less weight and wider viewing
angles. Using our OLED technology, many computer and video electronic system
functions can be built directly into the silicon chip, under the OLED film,
resulting in very compact, integrated systems with lowered overall system costs
relative to alternative technologies.
We have
developed our own proprietary and patented technology to create high performance
OLED-on-silicon microdisplays and related optical systems, and we license
fundamental OLED technology from Eastman Kodak. (See "Intellectual Property" and
"Strategic Relationships"). We expect that the integration of our
OLED-on-silicon microdisplays into mobile electronic products will result in
lower overall system costs to our OEM customers.
We
believe that our OLED-on-silicon microdisplays will initiate a new generation of
virtual imaging products that could have a profound impact on many industries.
Headsets providing virtual screens surrounding the user in a sphere of data
become a practical reality with our displays and a low cost head tracker.
Because our microdisplays generate and emit light, they have a wider viewing
angle than competing liquid crystal microdisplays, and because they have the
same high brightness at all forward viewing angles, our microdisplays permit a
large field-of-view and superior optical image.
The wider
viewing angle of our display results in the following superior optical
characteristics in comparison with LCDs and other near-eye display
technologies:
·
|
the
user does not need to accurately position the head-wearable display to the
eye;
|
·
|
the
image will change minimally with eye movement and appear more natural;
and
|
·
|
the
display can be placed further from the eye and not cut off part of the
image.
|
In
addition, our OLED-on-silicon microdisplays offer faster response times and use
much less power than competitive liquid crystal microdisplay systems. Our
subsystem-level power consumption is so low that two SVGA, full color, full
speed motion video computer displays can easily be run in stereovision off the
power from a single USB port on a portable computer. Battery life is extended
and weight is greatly reduced in systems using our products.
Our SVGA+
OLED microdisplay stores all the color and luminance value information at each
of the more than 1.5 million picture elements, or pixels, between refresh cycles
in the display array, eliminating the flicker or color breakup seen by most
other high-resolution microdisplay technologies. Even power efficient frame
rates as low as 30 Hz can usually be used effectively. Power consumption at the
system level is expected to be the lowest of any full-color, full-video SVGA
resolution range, large view microdisplay on the market. The OLED's ability to
emit light at wide angles allows customers to create large field of view
(approx. 40 degrees), wide image capture range images from very compact,
low-cost, one-piece optical systems. The display contains the majority of the
electronics required for connection to the RGB (red, green, blue signal) port of
a portable computer imbedded in its silicon chip backplane, thereby eliminating
many other components required by other display technologies such as
digital-analog converters, application-specific integrated circuits (ASICs),
light sources, multiple optical elements, and other components. We believe that
these features will enable our new class of microdisplay to potentially be the
most compact, highest image quality, and lowest cost solution for high
resolution near-eye applications, once they are in full production.
We have
also developed advanced lens technology which permits our OLED-on-silicon
microdisplays to provide large field of view images that can be viewed for
extended periods with reduced eye-fatigue. Molded plastic prism lenses have been
developed to help our OEM customers obtain better quality, large area virtual
images using our displays at relatively low cost in comparison to alternate
approaches.
Our
Products
Our first
commercial microdisplay products are based on our "SVGA series" OLED
microdisplays. We offer products utilizing both our proprietary “OLED” or
“OLED-XL” technologies, applied to the same integrated circuit base. We offer
our products to OEMs and other large volume buyers as both separate components,
integrated bundles coupled with our own optics, or full systems. We also offer
engineering support to enable customers to quickly integrate our products into
their own product development programs.
(1) OLED
Microdisplay Component Products
SVGA+ OLED
Microdisplay (Super Video Graphics Array of 800x600 plus 52 added columns of
data).
Our 0.62 inch diagonal SVGA+ OLED microdisplays have a
resolution of 852x600 triad pixels (1.53 million picture elements). The product
was dubbed "SVGA+" because it has 52 more display columns than a standard SVGA
display, permitting users to run either (1) standard SVGA (800 x 600 pixels) to
interface to the analog output of many portable computers or (2) 852 x 480,
using all the data available from a DVD player in a 16:9 wide screen
entertainment format. The display also has an internal NTSC monochrome video
decoder for low power night vision systems.
SVGA-3D OLED
Microdisplay (Super Video Graphics Array plus built-in stereovision
capability).
Our 0.59 inch diagonal SVGA-3D OLED microdisplays
have a resolution of 800x600 triad pixels (1.44 million picture elements). A
built-in circuit provides compatibility with single channel frame sequential
stereoscopic vision without additional external components.
Microdisplays
Under Development.
We are developing two additional display
products, a smaller format (SVGA-3DS) version of our SVGA display, which will
have 800 x 600 triad pixels and be 0.44 inch diagonal and a 0.77 inch SXGA OLED
microdisplay with resolution of 1280x 1024 triad pixels. These new products
offer both analog and digital signal inputs in a compact display with greater
power efficiency. With the world’s finest pitch (11.1 microns) and a high level
of integrated functionality, the SVGA-3DS provides a simple path to system
integration in a small format. The SXGA split chip architecture offers
unprecedented power consumption savings for this display format in addition to a
highly flexible system interface configuration.
Lens and Design
Reference Kit
s
.
We offer a WF05 prism optic, with mounting brackets or combined with OLED
microdisplays to form an optic-display module. We provide Design Reference Kits,
which include a microdisplay and associated electronics to help OEMs evaluate
our microdisplay products and to assist their efforts to build and test new
products incorporating our microdisplays.
Integrated
Modules.
We provide near-eye virtual imaging modules that incorporate our
OLED-on-silicon microdisplays with our lenses and electronic interfaces for
integration into OEM products. We have shipped customized modules to several
customers, some of which have incorporated our products into their own
commercial products.
(2)
Personal Display Systems (Head-Wearable and Headset Systems)
Our Z800
3DVisors(tm) give users the ability to work with their hands while
simultaneously viewing information or video on the display. The Z800 3DVisor
enables more versatile portable computing, using a 0.59-inch diagonal
microdisplay (SVGA-3D capable of delivering an image that appears comparable to
that of a 19-inch monitor at 22 to 24 inches from the eye, or a 105 inch movie
screen at 12 foot distance. Our systems are currently being used for personal
entertainment, electronic gaming, and military training and simulation, among
other applications. We believe that personal display systems will fill the
increasing demand for instant data accessibility and privacy in mobile
workplaces. We sell the personal display systems to OEM systems and equipment
customers, through distributors, and through our e-commerce website,
www.3dvisor.com.
The
growth potential of our selected target market segments have been investigated
using information gathered from key industry market research firms, including
DisplaySearch, Frost and Sullivan, Fuji-Chimera, International Data Corporation,
Nikkei, SEMI, Stanford Resources-iSuppli and others. Such data was obtained
using published reports and data obtained at industry symposia. We have also
relied substantially on market projections obtained privately from industry
leaders, industry analysts, and current and potential customers.
The
virtual-imaging markets we are targeting include industrial, medical, military,
arcade games, 3-D CAD/Virtual Reality, and wearable computers. Within each of
these market sectors, we believe that our microdisplays, when combined with
compact optic lenses, will become a key component for a number of mobile
electronic products. Applications we are targeting the following:
Head-wearable
displays incorporate microdisplays mounted in or on eyeglasses, goggles, simple
headbands, helmets, or hardhats, and are often referred to as head-mounted
displays (HMDs) or headsets. Head-wearable displays may block out surroundings
for a fully immersive experience, or be designed as "see-through" or
"see-around" to the user's surroundings. They may contain one (monocular) or two
(binocular) displays. Some of the increased current interest is due to
accelerating the timetable to adapt such systems to military applications such
as night vision and fire and rescue applications. These have military,
commercial, and consumer applications.
Military
demand for head-wearable displays is currently being met with microdisplay
technologies that we believe to be inferior to our OLED-on-silicon products. The
new generation of soldiers will be highly mobile, and will often need to carry
highly computerized communications and surveillance equipment. To enable
interaction with the digital battlespace, rugged, yet lightweight and energy
efficient technology is required. Currently available microdisplay technologies
do not meet the requirements for low power, hands-free, day and night-viewable
displays. As a COTS (commercial off the shelf) component, OLED microdisplays
demonstrate performance characteristics important to military and other
demanding commercial and industrial applications including high brightness and
resolution, wide dimming range, wider temperature operating ranges, shock and
vibration resistance and insensitivity to high G-forces. The image does not
suffer from flicker or color breakup in vibrating environments, and the
microdisplay's wide viewing angle allows ease of viewing for long periods of
time. The OLED's very low power consumption reduces battery weight and increases
allowed mission length. Properly implemented, we believe that head-mounted
systems incorporating our microdisplays will increase effectiveness by allowing
hands-free operation and increasing situational awareness with enough brightness
to be used in daylight, yet controllable for nighttime light security. The
OLED's inherent wide temperature range is especially of interest for military
applications because the display can turn on instantly at temperatures far below
freezing and can operate at very high temperatures in desert
conditions.
Our OLED
microdisplays have been selected for a range of defense-security applications,
including a situational awareness HMD for the US Army Land Warrior programs, a
handheld thermal imager for border patrol and training, and simulation virtual
monitors for Quantum 3D. The Land Warrior, a baseline program in the Army's
drive to digitize the battlefield, is an integrated digital system that
incorporates computerized communication, navigation, targeting and protection
systems for use by the twenty-first century infantry soldier. Rockwell Collins,
the principal contractor for the US Army's Land Warrior HMD system, and eMagin
applied their respective expertise in HMD and imaging technology to develop
rugged, yet lightweight and energy efficient products meeting the requirements
of tomorrow's soldier. Our display is also used in Rockwell Collins’
commercially available ProView S035 Monocular HMD. Night Vision Equipment
Corporation's HelmetIR-50(TM), a lightweight, military helmet mounted thermal
imager, which provides hands-free operation and allows viewers to see through
total darkness, battlefield obscurants, and even foliage, is the first
OLED-equipped product to be listed on the US Government's GSA schedule.
Virtually Better Inc. has incorporated our Z800 3DVisor into its “Virtual Iraq”
treatment for post-traumatic stress disorders. In addition, our
displays have been commercialized, or planned to be commercialized, by military
systems integrators including DRS, Elbit, Insight Technologies, Nivisys,
Qioptiq, Saab, Sagem, and Thales, , among others. We cannot assure that
Government projects will remain on schedule, or that they will be fully
implemented. Similar systems are of interest for other military applications as
well as for related operations such as urban security, fire and
rescue.
Commercial,
Industrial, and Medical
We
believe that a wide variety of commercial and industrial markets offer
significant opportunities due to increasing demand for instant data
accessibility in mobile workplaces. Some examples of microdisplay applications
include: immediate access to inventory such as parts, tools and equipment
availability; instant accessibility to maintenance or construction manuals;
routine quality assurance inspection; endoscopic surgery; and real-time viewing
of images and data for a variety of applications. As one potential example, a
user wearing a HMD while using test equipment, such as oscilloscopes, can view
technical data while simultaneously probing printed circuit boards. Commercial
products in these sectors include Sage Technologies, Ltd.'s Helmet Vue (TM)
Thermal Imaging System and Liteye's 500. VRmagic GmbH, a leading developer of
virtual reality simulators, is using our OLED microdisplays in their EYESI(TM)
Virtual Reality Surgical Simulator, which provides real-time simulation of
ophthalmic surgery, high performance biomechanical tissue simulation, precision
tracking, and realistic stereo imaging. Sensics has incorporated our OLED
displays in their immersive SkyVizor (TM) virtual reality headset to serve as
the "eyes" of the Robonaut, a humanoid robot being developed by NASA and
Department of Defense agencies. The Robonaut system can work side by side with
humans, or alone in high-risk situations. Telepresence uses virtual reality
display technology to visually immerse the operator into the robot's workspace,
facilitating operation and interaction with the Robonaut, and potentially
reducing the number of dangerous space walks required of real
astronauts. Another recent example is Saab Avitronics, which has
chosen eMagin microdisplays for its new Multi-Purpose Virtual Image Display
(VID) which comprises high-performance magnifying optics and the OLED, sealed in
an aluminum casing.
Once our
displays are manufactured in high volumes at reduced costs, we believe that our
head-wearable display products may enhance the following consumer
products:
·
|
Entertainment
and gaming video headset systems, which permit individuals to view
television, including HDTV, video CDs, DVDs and video games on virtual
large screens or stereovision in private without disturbing others. We
believe that these new headset game systems can provide a game or
telepresence experience not otherwise practical using conventional direct
view display technology. The advent of video iPods and the rapidly
increasing amount of downloadable content have accelerated the movement
toward portable video technology. At the same time, the desire for larger
screen sizes while retaining the iPod portability has been referenced in
many publications. Virtual imaging uniquely provides a large, high
resolution view in a small portable package, and we believe that our OLED
on silicon technology is a best fit to help open this
market.
|
·
|
Notebook
computers, which can use head-wearable devices to reduce power
requirements as well as expand the apparent screen size and increase
privacy. Current notebook computers do not use microdisplays. Our products
can apply not only to new models of notebook computers, but also as
aftermarket attachments to older notebooks still in use. The display can
be easily used as a second monitor on notebook computers for ease of
editing multiple documents to provide multiple screens or for data privacy
while traveling. It can also be used to provide larger screen capability
for viewing spreadsheets or complex computer aided design (CAD) files. We
expect to market our head-wearable displays to be used as plug-in
peripherals to be compatible with most notebook computers. We believe that
the SVGA-3D microdisplay is well suited for most portable PC headsets. Our
microdisplays can be operated using the USB power source of most portable
computers. This eliminates added power supplies, batteries, and rechargers
and reduces system complexity and
cost.
|
·
|
Handheld
personal computers, whose small, direct view screens are often
limitations, but which are now capable of running software applications
that would benefit from a larger display. Microdisplays can be built into
handheld computers to display more information content on virtual screens
without forfeiting portability or adding the cost a larger direct view
screen. Microdisplays are not currently used in this market. We believe
that GPS viewers and other novel products are likely to develop as our
displays become more available.
|
The
combination of power efficiency, high resolution, low systems cost, brightness
and compact size offered by our OLED-on-silicon microdisplays has not been made
available to makers and integrators of existing entertainment and gaming video
headset systems, notebook computers and handheld computers. We believe that our
microdisplays have the potential to propel the growth of new products and
applications such as lightweight wearable computer systems.
Our
Strategy
Our
strategy is to establish and maintain a leadership position as a worldwide
supplier of microdisplays and virtual imaging technology solutions for
applications in high growth segments of the electronics industry by capitalizing
on our leadership in both OLED-on-silicon technology and microdisplay lens
technology. We aim to provide microdisplay and complimentary accessories to
enable OEM customers to develop and manufacture new and enhanced electronic
products. Some key elements of our strategy to achieve these objectives includes
the following:
·
|
Leverage
our superior technology to establish a leading market position. As the
first to exploit OLED-on-silicon microdisplays, we believe that we enjoy a
significant advantage in bringing this technology to
market.
|
·
|
Optimize
manufacturing efficiencies by outsourcing while protecting proprietary
processes. We outsource certain portions of microdisplay production, such
as chip fabrication, to minimize both our costs and time to market. We
intend to retain the OLED application and OLED sealing processes in-house.
We believe that these areas are where we have a core competency and
manufacturing expertise. We also believe that by keeping these processes
under tight control we can better protect our proprietary technology and
process know-how. This strategy will also enhance our ability to continue
to optimize and customize processes and devices to meet customer needs. By
performing the processes in-house we can continue to directly make
improvements in the processes, which will improve device performance. We
also retain the ability to customize certain aspects such as color
balance, which is known as chromaticity, as well as specialized boards or
interfaces, and to adjust other parameters at the customer's request. In
the area of lenses and head-wearable displays, we intend to focus on
design and development, while working with third parties for the
manufacture and distribution of finished products. We intend to prototype
new optical systems, provide customization of optical systems, and
manufacture limited volumes, but we intend to outsource high volume
manufacturing operations. There are numerous companies that provide these
outsource services.
|
·
|
Build
and maintain strong internal design capabilities. As more circuitry is
added to OLED-on-silicon devices, the cost of the end product using the
display can be decreased; therefore integrated circuit design capability
will become increasingly important to us. To meet these requirements, we
utilize in-house design capabilities supplemented by outsourced design
services. Building and maintaining this capacity will allow us to reduce
engineering costs, accelerate the design process and enhance design
accuracy to respond to our customers' needs as new markets develop. In
addition, we intend to maintain a product design staff capable of rapidly
developing prototype products for our customers and strategic partners.
Contracting third party design support to meet demand and for specialized
design skills will also remain a part of our overall long term strategy.
|
Our
Strategic Relationships
Strategic
relationships have been an important part of our research and development
efforts to date and are an integral part of our plans for commercial product
launch. We have forged strategic relationships with major OEMs and strategic
suppliers. We believe that strategic relationships allow us to better determine
the demands of the marketplace and, as a result, allow us to focus our future
research and development activities to better meet our customer's requirements.
Moreover, we expect to provide microdisplays and Microviewers(TM) to some of
these partners, thereby taking advantage of established distribution channels
for our products.
Eastman
Kodak is a technology partner in OLED development, OLED materials, and a
potential future customer for both specialty market display systems and consumer
market microdisplays. We license Eastman Kodak's OLED and optics technology
portfolio. We have a nonexclusive; perpetual, worldwide license to use Eastman
Kodak patented OLED technology and associated intellectual property in the
development, use, manufacture, import and sale of microdisplays. The license
covers emissive active matrix microdisplays with a diagonal size of less than 2
inches for all OLED display technology previously developed by Kodak. An annual
minimum royalty is paid at the beginning of each calendar year and is fully
creditable against the royalties we are obligated to pay based on net sales
throughout the year. Eastman Kodak and eMagin have engaged in numerous
discussions regarding potential product applications for eMagin's microdisplays
by Eastman Kodak.
We are
working cooperatively with the US Army, US Navy, and with several military
system integrators to further characterize operation of our displays in rugged
military environments. We have a Cooperative Research and Development Agreement
(CRADA) with the US Army Night Vision Electronic Sensors Directorate (NVESD) to
characterize performance of our displays. We are currently partnering with the
University of Michigan to develop advanced display process via a
government-sponsored research program. We intend to continue to establish
additional strategic relationships in the future.
We are a
member of the United States Display Consortium (USDC), a cooperative effort
between industry and government whose charter is to develop an infrastructure to
support North American flat panel display manufacturing. It has more than 100
members, as well as support from the Department of Defense. The USDC’s role is
to provide a common platform for flat panel display manufacturers, developers,
users and the manufacturing equipment and supplier base.
Our
Technology Platforms
OLED-on-Silicon
Technology
Scientists
working at Eastman Kodak invented OLEDs in the early 1980s. OLEDs are thin films
of stable organic materials that emit light of various colors when a voltage is
impressed across them. OLEDs are emissive devices, which mean they create their
own light, as opposed to liquid crystal displays, which require a separate light
source. As a result, OLED devices use less power and can be capable of higher
brightness and fuller color than liquid crystal microdisplays. Because the light
they emit is Lambertian, which means that it appears equally bright from most
forward directions, a moderate movement in the eye does not change the image
brightness or color as it does in existing technologies. OLED films may be
coated on computer chips, permitting millions of individual low-voltage light
sources to be built on silicon integrated circuits to produce single color,
white or full-color display arrays. Many computer and video electronic system
functions can be built directly into a silicon integrated circuit as part of the
OLED display, resulting in an ultra-compact system. We believe these features,
together with the well-established silicon integrated circuit fabrication
technology of the semiconductor industry, make our OLED-on-silicon microdisplays
attractive for numerous applications.
We
believe our technology licensing agreement with Eastman Kodak, coupled with our
own intellectual property portfolio, gives us a leadership position in OLED and
OLED-on-silicon microdisplay technology. Eastman Kodak provides OLED technology
and we provide additional technology advancements that have enabled us to coat
the silicon integrated circuits with OLEDs.
We have
developed numerous and significant enhancements to OLED technology as well as
key silicon circuit designs to effectively incorporate the OLED film on a
silicon integrated circuit. For example, we have developed a unique,
top-emitting structure for our OLED-on-silicon devices that enables OLED
displays to be built on opaque silicon integrated circuits rather than only on
glass. Our OLED devices can emit full visible spectrum light that can be
isolated with color filters to create full color images. Our microdisplay
prototypes have a brightness that can be greater than that of a typical notebook
computer and can have a potential useful life of over 50,000 operating hours, in
certain applications. New materials and device improvements in development offer
future potential for even better performance for brightness, efficiency, and
lifespan. Additionally, we have invested considerable work over several years to
develop unique electronics control and drive designs for OLED-on-silicon
microdisplays.
In
addition to our OLED-on-silicon technology, we have developed compact optic and
lens enhancements which, when coupled with the microdisplay, provide the high
quality large screen appearance that we believe a large proportion of the
marketplace demands.
Advantages
of OLED Technology
We
believe that our OLED-on-silicon technology provides significant advantages over
existing solutions in our targeted microdisplay markets. We believe these key
advantages will include:
·
|
Low
manufacturing cost;
|
·
|
Low
cost system solutions;
|
·
|
Wide
angle light emission resulting in large apparent screen
size;
|
·
|
Low
power consumption for improved battery life and longer system
life;
|
·
|
High
brightness for improved viewing;
|
·
|
High-speed
performance resulting in clear video images;
|
·
|
Wide
operating temperature range; and
|
·
|
Good
environmental stability (vibration and
humidity).
|
Low manufacturing
cost.
Many OLED-on-silicon microdisplays can be built on an
8-inch silicon wafer using existing automated OLED and color filter processing
tools. The level of automation used lowers labor costs. Only a minute amount of
OLED material is used in each OLED-on-silicon microdisplay so that material
costs, other than the integrated circuit itself, are small. The number of
displays per silicon wafer may be higher on OLEDs than on liquid crystal
displays, or LCDs, because OLEDs do not require a space-wasting perimeter seal
band. Expensive transparent wafers with CMOS silicon laminated onto quartz are
not required for OLED microdisplays, as standard CMOS chips may be used as
backplanes.
Low cost systems
solutions.
In general, an OEM using OLED-on-silicon
microdisplays will not need to purchase and incorporate lighting assemblies,
color converter related Applications Specific Integrated Circuits, or ASICs, or
beam splitter lenses as is the case in liquid crystal microdisplays, which also
require illumination. Many important display-related system functions can be
incorporated into an OLED-on-silicon microdisplay, reducing the size and cost of
the system. Non-polarized light from OLEDs permit lenses for many
OLED-on-silicon applications that are made of a single piece of molded plastic,
which reduces size, weight and assembly cost when compared to the multipiece
lens systems used for liquid crystal microdisplays. System cost relative to
liquid crystal and liquid crystal on silicon, or LCOS, competitive products is
thus reduced. Because our displays are power efficient, they typically require
less power at the system level than other display technologies at a given
display size and brightness.
Wide-angle light
emission simplifies optics for large apparent screen
size.
OLEDs emit light at most forward directions from each
pixel. This permits the display to be placed close to the lens in compact
optical systems. It also provides the added benefit of less angular dependence
on the image quality relative to pupil and eye position when showing a large
field of view, unlike reflective LCOS microdisplays. This results in less eye
fatigue and makes it relatively easy to low power consumption for improved
battery life and longer system life. OLEDs emit light rather than transmitting
it, so no power-consuming backlight or front light, as required for liquid
crystal displays, is required. OLEDs can be energy efficient because of their
high efficiency light generation. Furthermore, OLEDs conserve power by powering
only those pixels that are on while liquid crystal on silicon requires light at
all pixels all the time. Most optical systems used for our OLEDs are highly
efficient, permitting over 80% of the light to reach the eye, whereas reflective
technologies such as liquid crystal on silicon require multiple beam splitters
to get light to the display, and then into the optical system. This results in
typically less than 25% light throughput efficiency in reflective microdisplay
systems. Most important, we do not need a power-hungry video frame buffer, as
required in liquid crystal frame-sequential color systems. Battery life can
therefore be extended.
High brightness
for improved viewing.
This feature can be of great value to
military applications, where there is a need to see the computer image overlaid
onto brightly lit real-life backgrounds such as desert sand, water reflections
or sunlit clouds. The OLED can be operated over a large luminance range without
loss of gray level control, permitting the displays to be used in a range of
dark environments to very bright ambient applications. Since military simulation
and situation awareness applications, including night vision, typically require
large fields of view, the OLED's Lambertian optical characteristics make it an
excellent choice.
High-speed
performance resulting in clear video image.
OLEDs switch much
more rapidly than liquid crystals or most cathode ray tubes, or CRTs. This
results in smear-free video rate imagery and provides improved image quality for
DVD playback applications. This eliminates visible image smear and makes
practicable three-dimensional stereo imaging using a split frame rate. This
advantage of our OLED-on-silicon is very important for 3-D stereovision gaming
applications.
Flicker-free and
no color breakup.
Because the OLED-on-silicon stores
brightness and color information at each pixel, the display can be run with no
noticeable flicker and no color sequential breakup, even at low refresh rates. A
lower refresh rate not only helps reduce power, but it also facilitates system
integration. Color sequential breakup occurs in systems such as liquid crystal
on silicon and some liquid crystal display microdisplays when red, green and
blue frames are sequentially imaged in time for the eye to combine. Since the
different color screens occur at different times, movement of the eye due to
vibration or just fast pupil movement can create color bands at each dark-light
edge, making the image unpleasant to view and making text difficult to read. For
example, the liquid crystal on silicon display needs to run at least three times
the "normal" frame rate or speed to produce color sequential images, which
wastes power and makes for a difficult technological challenge as display
resolutions increase.
Wide operating
temperature range.
Our OLEDs offer much less temperature
sensitivity at both high and low temperatures than LCDs. LCDs are sluggish or
non-operative much below freezing unless heaters are added and lose contrast
above 50 degrees Celsius, while our OLEDs turn on instantly and can operate
between -55 degrees Celsius and 130 degrees Celsius. We specify a smaller
temperature range on most consumer products to accommodate lower cost packaging.
This is an important characteristic for many portable products that may be used
outdoors in many varying environmental conditions. It is especially important
for military customers. Insensitivity to vibration, shock, and pressure are also
important environmental control attributes.
Complementary lens and system
technologies.
We have developed a wide range of technologies
which complement our core OLED and lens technologies and which will enhance our
competitive position in the microdisplay and head-wearable display markets.
These include:
Lens technology
. High
quality, large view lenses with a wide range for eye positioning are essential
for using our displays in near-eye systems. We have developed advanced lens
technology for microdisplays and personal head-wearable display systems and hold
key patents in these areas. Our lens technology permits our OLED-on-silicon
microdisplays to provide large field of view images that can be viewed for
extended periods with reduced eye-fatigue. We have engaged a firm to manufacture
our lenses in order to provide them in larger quantities to our customers and
are using them in our own personal display systems.
We
believe that the key advantages of our lens technology include:
·
|
Can
be very low cost, with minimal assembly. A one piece, molded plastic optic
attached to the microdisplay has been introduced and may potentially serve
consumer end-product markets. Since our process is plastic molding, our
per unit production costs are low;
|
·
|
Allows
a compact and lightweight lens system that can greatly magnify a
microdisplay to produce a large field of view. For example, our WF05 prism
lens, in combination with our SVGA OLED microdisplay, provides a virtual
view equivalent to that of a 105-inch diagonal display viewed at 12
feet;
|
·
|
Can
use single-piece molded microdisplay lenses to permit high light
throughput making the display image brighter or permitting the use of less
power for an acceptable brightness;
|
·
|
Can
be designed to provide focusing to enable users with various eyesight
qualities to view images clearly; and
|
·
|
Can
optionally provide focal plane adjustment for simultaneous focusing of
computer images and real world objects. For example, this characteristic
is beneficial for word processing or spreadsheet applications where a
person is typing data in from reference material. This feature can make it
easier for people with moderately poor accommodation to use a
head-wearable display as a portable computer-viewing
accessory.
|
Personal display system
technology
. We have developed ergonomic technologies that make
head-wearable displays easier to use in a wide variety of applications. For
example, the use of our patented rotatable Eyeblocker(TM) provides a sharp image
without requiring most users to squint. The Eyeblocker can also be moved to
create an effective see-through appearance. To our knowledge, we have made the
lightest weight, high-resolution head-wearable display with an over 35 degree
diagonal field of view ever publicly demonstrated. We have also incorporated low
cost, small size, high speed headtrackers to further enhance game and
telepresence applications.
Sales
and Marketing
We
primarily provide display components for OEMs to incorporate into their branded
products and sell through their own well-established distribution channels. In
addition, we market head-wearable displays directly to various vertical market
channels, such as medical, industrial, and government customers. A typical buyer
is a manufacturer of a product requiring a specific resolution of visual display
or viewfinder for insertion into a product such as a portable DVD headset, a
PC-gaming headset, or an instrument.
We market
our services in North America, Asia, and Europe primarily through direct
technical sales from our headquarters. Regular purchase orders are processed by
our customer service coordinators and technical questions related to product
purchases or product applications are processed by our technical support team.
As a market-driven company, we assess customer needs both quantitatively and
qualitatively, through market research and direct communications. Because our
microdisplays are the main functional component that defines many of our
customers' end products, we work closely with potential customers to define our
products to optimize the final design, typically on a senior
engineer-to-engineer basis. Our personal display systems are sold through select
value-added resellers and on-line through PC Mall, Google Checkout, and our
e-commerce site,
www.3dvisor.com
.
We
identify companies with end products and applications for which we believe that
our products will provide a system level solution and for which our products can
be a key differentiator. We target both market leaders and select early adopter
companies; their acceptance validates our technology and approach in the market.
We believe successful marketing will require relationships with recognized
consumer brand companies.
Near term
sales efforts for OLED microdisplays have been focused on our military,
industrial, and medical customers. We have received production orders and design
wins for both the SVGA+ and SVGA 3D displays. To date, we have shipped products
and evaluation kits to more than 200 OEM customers. An OEM design cycle
typically requires between 6 and 36 months, depending on the uniqueness of the
market and the complexity of the end product. New product development may
require several design iterations prior to commercialization. Some of our
initial customers have completed their initial evaluation cycle and we continue
to receive follow-on orders and notification of product purchase decisions. (See
"Our Market Opportunity: Military; Commercial, Industrial, and Medical; and
Consumer")
Customers
Customers
for our products include both large multinational and smaller OEMs. We maintain
relationships with OEMs in a diverse range of industries encompassing the
military, industrial, medical, and consumer market sectors. During 2007, 51% of
our net revenue was to firms based in the United States and 49% was to
international firms as compared to 59% domestic revenue and 41% international
revenue during 2006. In 2007, we had 10 customers that accounted for
more than 54% of our total revenue as compared to 5 customers that accounted for
more than 68% of our total revenue in 2006. In 2007, we did not have any
customers that accounted for more than 10% of our total revenue as compared to
2006, when we had one customer that accounted for 13% of our total
revenues.
Backlog
As of
September 30, 2008, we had a backlog of approximately $4.6 million for purchases
through December 31, 2009. This backlog consists of purchase orders and purchase
agreements but does not include expected revenue from R&D contracts or
expected NRE (non-recurring engineering) programs under
development.
The
majority of our backlog consists of purchase agreements for delivery over the
next 12 months. Most purchase orders are subject to rescheduling or cancellation
by the customer with no or limited penalties. Because of the possibility of
customer changes in delivery schedules or cancellations and potential delays in
product shipments, our backlog as of a particular date may not be indicative of
net sales for any succeeding period. Some customers have experienced delays in
their expected product launch schedules due to their own product development
delays not directly related to our microdisplays, such as development of custom
optics or other aspects of their end product, or by delays in government
programs contracted to them.
Research
and Development
Near-to-the-eye
virtual imaging and OLED technology are relatively new technologies that have
considerable room for substantial improvements in luminance, life, power
efficiency, voltage swing, design compactness, field of view, optical range of
visibility, headtracking options, wireless control and many other parameters. We
anticipate that achieving reductions in manufacturing costs will require new
technology developments. We also anticipate that improving the performance,
capability and cost of our products will provide an important competitive
advantage in our fast moving, high technology marketplace. Past and current
research activities include development of improved OLED and display device
structures, developing and/or evaluating new materials (including the synthesis
of new organic molecules), manufacturing equipment and process development,
electronics design methodologies and new circuits and the development of new
lenses and related systems. In 2007, we spent approximately $2.9 million on
research and development. In 2007 we continued to research more efficient
materials and processes. We also completed the primary designs of our new
smaller display, the SVGA 3DS, as well as the design of the SXGA.
External
relationships play an important role in our research and development efforts.
Suppliers, equipment vendors, government organizations, contract research
groups, external design companies, customer and corporate partners, consortia,
and university relationships all enhance the overall research and development
effort and bring us new ideas (See "Strategic Relationships").
U.S.
Government-Funded Research
We have
entered into several U.S. government contracts to fund a portion of our efforts
to develop next-generation OLED technologies for a variety of applications.
These include, among others, Small Business Innovation Research (SBIR) Phase II
program contracts for continued research and development and the fabrication of
prototypes. On contracts for which we are the prime contractor, we subcontract
portions of the work to various entities and institutions, including the
University of Michigan. Our recent government contracts include the
following:
OLED Performance and Reliability
Improvement for Active Matrix OLED Microdisplays.
Armed forces as well as
other security related agencies are relying increasingly on the benefits of OLED
technology in active matrix microdisplays. Applications range from night vision
thermal imaging to tactical awareness and communication systems to
weapons-mounted sights, among others. As the systems capabilities are expanded,
the need for higher brightness and ability to display static imagery such as
maps and drawings is growing, placing higher demands on the OLED technology. In
2007 eMagin was awarded a contract managed by the Night Vision Electronic
Sensors Directorate (NVESD) with funding by the Department of Defense
Appropriations Bill. The objective of the program is to improve on the present
performance of the microdisplay-based OLED technology from lifetime, efficiency
and reliability standpoints. For 2007, we received approximately $360 thousand
of the $1.12 million program. The FY 2008 Department of Defense Appropriations
Bill has provided for continuation of a second phase of the program
Organic Light Emitting Diode (OLED)
Display Technology for Military Aircraft.
In 2007 we continued our
efforts to develop a robust thin film encapsulation technique for OLED displays
under a Small Business Technology Transfer (STTR) program from the US Navy.
University of Michigan, Ann Arbor, MI is the university partner for this STTR.
Many new schemes to encapsulate OLED devices with thin film techniques were
developed, evaluated and tested under accelerated environmental condition. The
contract expired on February 29, 2008. For 2007 we received approximately $328
thousand in funding under this program.
Ultra High Resolution Display for
Army Medicine
.
In 2007 we formally initiated efforts on a multiple year program under contract
with the US Army TATRC (Telemedicine and
Advanced Technologies Research Center) with funding provided by
the FY 2006 and 2007 Department of Defense Appropriations Bills. The culmination
of this multiple year effort will provide an ultra-high resolution, wide field
of view display system suitable for dual-use application within Army medicine,
U.S. military simulation and training, and commercial uses. We received
approximately $698 thousand in funding during 2007 under this contract and
expect to receive approximately $2 million during 2008.
High Dynamic Range Microdisplay
Feasibility Study.
The US Army/RDECOM/NVESD and eMagin Corporation have
established a CRADA (Cooperative Research and Development Agreement) with the
goal of evaluating and characterizing new and existing AMOLED microdisplay
configurations with an emphasis on the usable lifetime of the displays. This
work is aimed at developing AMOLED microdisplays capable of being fielded in a
wide range of US Army applications. The effort is for a 3 month period and is a
feasibility study aimed at evaluating several concepts leading to a higher
dynamic range without changing the existing pixel driver design of the
microdisplays. If successful, a second phase can be considered addressing a
complete high dynamic range OLED microdisplay. The total program cost for the 3
month program is approximately $236 thousand. The program started on March 14,
2008.
Manufacturing
Facilities
We are
located at IBM's Microelectronics Division facility, known as the Hudson Valley
Research Park, located about 70 miles north of New York City in Hopewell
Junction, New York. We lease approximately 33,000 square feet of space which
houses our own equipment for OLED microdisplay fabrication and research and
development, includes a 16,300 square foot class 10 clean room space, additional
lower level clean room space, assembly space and administrative
offices.
Facilities
services provided by IBM include our clean room, pure gases, high purity
de-ionized water, compressed air, chilled water systems, and waste disposal
support. This infrastructure provided by our lease with IBM provides us with
many of the resources of a larger corporation without the added overhead costs.
It further allows us to focus our resources more efficiently on our product
development and manufacturing goals.
We lease
additional non-clean room facilities for chemical mixing, cleaning, chemical
systems, and glass/silicon cutting. OLED chemicals can be purified in our
facility with our own equipment, permitting the company to evaluate new
chemicals in pilot production that are not yet available in suitable purity for
OLED applications on the market.
Our
display fabrication process starts with the silicon wafer, which is manufactured
by a semiconductor foundry using conventional CMOS process. After a device is
designed by a combination of internal and external designers with customer
participation, we outsource wafer fabrication.
Our
manufacturing process for OLED-on-silicon microdisplays has three main
components: organic film deposition, organic film encapsulation (also known as
sealing), and color filter processing. All steps are performed in
semi-automated, hands-free environment suitable for high volume throughput. An
automated cluster tool provides all OLED deposition steps in a highly controlled
environment that is the centerpiece of our OLED fabrication. After wafer
processing, each part is inspected using an automated inspection system, prior
to shipment. We have electrical and optical instrumentation required to
characterize the performance of our displays including photometric and color
coordinate analysis. We are also equipped for integrated circuit and electronics
design and display testing.
We also
lease a facility in Bellevue, Washington where we operate our system development
effort and business development activities. The facilities are well suited for
designing and building limited volume prototypes and small quantity industrial
or government products. Cables and electronic interfaces have recently been
produced to permit our OEM customers to more rapidly create products and shorten
their time-to-market. We plan to outsource medium to high volume subsystem
production to low cost plastics, lenses, and assembly manufacturers. We are
currently using domestic and international outside manufacturers and we are
investigating new outsource opportunities.
We
believe that manufacturing efficiency is an important factor for success in the
consumer markets. We believe that high yield and maximum utilization of our
equipment set will be key for profitability. The equipment required for initial
profitable production is in place. Some equipment will be added when our
production volume increases or as needed.
We have
developed a significant intellectual property portfolio of patents, trade
secrets and know-how, supported by our license from Eastman Kodak and our
current patent portfolio.
Our
license from Eastman Kodak gives us the right to use in miniature displays a
portfolio in organic light emitting diode and optics technology, some of which
are fundamental. Our agreement with Eastman Kodak provides for perpetual access
to the OLED technology for our OLED-on-silicon applications, provided we remain
active in the field and meet our contractual requirements to Eastman Kodak. We
also generate intellectual property as a result of our internal research and
development activities.
Our
patents and patent applications cover a wide range of materials, device
structures, processes, and fabrication techniques, such as methods of
fabricating full color OLEDs. We believe that our patent applications relating
to up-emitting structures on opaque substrates such as silicon wafers, which are
critical for OLED microdisplays, and applications relating to the hermetic
sealing of such structures are particularly important.
Our
patents are concentrated in the following areas:
·
|
OLED
Materials, Structures, and Processes;
|
·
|
Display
Color Processing and Sealing;
|
·
|
Active
Matrix Circuit Methodologies and Designs;
|
·
|
Field
Emission and General Display Technologies;
|
·
|
Lenses
and Tracking (Eye and Head);
|
·
|
Ergonomics
and Industrial Design; and
|
·
|
Wearable
Computer Interface
Methodology
|
We also
rely on proprietary processes, trade secrets, and know-how related to OLED
technologies and materials which are not patented. To protect this information
and know-how from unauthorized use or disclosure, we require all employees, and
where appropriate, contractors, consultants, advisors and collaborators to enter
into confidentiality and non-competition agreements. There can be no assurance,
however, that these agreements will provide meaningful protection for our trade
secrets, know-how or other proprietary information in the event of any
unauthorized use, misappropriation or disclosure of such trade secrets, know-how
or other proprietary information.
We
believe that our intellectual property portfolio, coupled with our strategic
relationships and accumulated experience in the OLED field, gives us an
advantage over potential competitors.
The industry in which we
operate is highly competitive. We may face competition from legacy technologies
such as CRTs as well as from alternative flat
panel display technologies.
We believe that our key competition will come from liquid crystal on silicon
microdisplays, or LCOS, also known as reflective liquid crystal displays and
small transmissive LCDs. While we believe that OLED-on-silicon
has
the ca
pability to
provide higher quality image quality images, greater environmental
ruggedness, reduced electronics cost and complexity, and improved power
efficiency advantages over either type of liquid crystal based microdisplays,
there is no assurance that
these benefits will be fully
realized or that liquid crystal manufacturers will not suitably improve these
parameters to reduce these potential advantages of OLEDs.
Most companies pursuing
liquid crystal on silicon technology, such
as Syntax
/Brillian Cor
poration, among
others, have primarily focused on projection microdisplays, which do not
compete directly with us. In most near-to-the-eye
imaging markets, we face more serious competition from developers of
transmissive liquid crystal displays, such as t
h
ose developed by Kopin, or
possibly laser scanning systems, such as those developed by Microvision
Corporation. Large amounts of investment in
an
intrinsically weaker
technology can potentially overcome advantages of one technology over
another.
To our k
nowledge, the only other
company that has publicly stated plans to develop OLED microdisplays for
near-eye applications is MicroEmissive Displays
(
MED) in
Britain
. MED has raised substantial
funds and created a newer facility than ours. This competition
h
as not been
significant to date, but could become more serious if they enter our markets
with directly relevant display designs and resolve their manufacturing and
reliability-lifetime issues.
We may also compete with
potential licensees of Universal Dis
play Corporation, Eastman
Kodak, or Sumitomo Corporation and other companies, each of which
potentially can license OLED technology portfolios. Even though we could also
potentially license technology from these developers, potential competitors
could als
o
obtain such licenses and may
do so at more favorable royalty rates or allocate more resources to the
competitive effort than we could obtain. However, should they decide to embark
on developing microdisplays on silicon, we believe that our progress to
da
t
e in this area gives us a
substantial head start.
Employees
As of
October 14, 2008, we had a total of 60 full time and part time staff. None of
our employees are represented by a labor union. We have not experienced any work
stoppages and consider our relations with our employees to be
good.
DESCRIPTION
OF PROPERTY
Our
corporate offices are located in Bellevue, Washington. Our Washington
location includes administrative, finance, operations, research and development
and sales and marketing functions and consists of leased space of approximately
19,000 square feet. The lease expires in 2009. Our
manufacturing facility is located in Hopewell Junction, New York, where we lease
approximately 33,000 square feet from IBM. The NY facility houses our
equipment for OLED microdisplay fabrication, assembly operations, research and
development, and administrative functions. The lease expires in
2009. We believe our facilities are adequate for our current and
near-term needs. See Note 12 to our December 31, 2007 consolidated
financial statements for more information about our lease
commitments.
LEGAL
PROCEEDINGS
From time
to time, we may become involved in various lawsuits and legal proceedings which
arise in the ordinary course of business. However, litigation is subject to
inherent uncertainties, and an adverse result in these or other matters may
arise from time to time that may harm our business. We are currently not aware
of any such legal proceedings or claims that we believe will have, individually
or in the aggregate, a material adverse affect on our business, financial
condition or operating results.
A former
employee (“plaintiff”) of the Company commenced legal action in the United
States District Court for the Southern District of New York, on or about October
12, 2007, alleging that the plaintiff was subject to gender based discrimination
and retaliation in violation of Title VII of the Civil Rights Act of 1964 (
Case No. 07-CV-8827
(KMK)
. The plaintiff seeks unspecified compensatory damages,
punitive damages and attorneys’ fees. On November 26, 2007, the
Company served and filed its Answer, in which it denied the material allegations
of the Complaint and asserted numerous affirmative defenses. This
action is presently in the discovery stage. The Company disputes the
allegations of the Complaint and intends on vigorously defending this
action.
On
December 6, 2005, New York State Urban Development Corporation commenced action
against eMagin in the Supreme Court of the State of New York, County of New York
against eMagin, asserting breach of contract and seeking to recover a $150,000
grant which was made to eMagin based on goals set forth in the agreement for
recruitment of employees. On July 13, 2006, eMagin agreed to a
settlement with the New York State Urban Development Corporation to repay
$112,200 of the $150,000 grant. The settlement requires that repayments be made
on a monthly basis in the amount of $3,116.67 per month commencing August 1,
2006 and ending on July 1, 2009.
The
following table sets forth the names of our directors and executive officers as
of September 30, 2008:
Name
|
Age
|
Position
|
Andrew
G. Sculley (5)
|
57
|
Chief
Executive Officer and President
|
Paul
Campbell (4)
|
52
|
Interim
Chief Financial Officer
|
Susan
K. Jones
|
56
|
Chief
Business Officer, Secretary
|
Adm.
Thomas Paulsen (Ret.) (2)(3*)
|
71
|
Chairman
of the Board, Director
|
Claude
Charles (1)
|
71
|
Director
|
Paul
Cronson
|
51
|
Director
|
Irwin
Engelman (1*)
|
73
|
Director
|
Dr.
Jacob Goldman (2*)(3)
|
86
|
Director
|
Brig.
Gen. Stephen Seay (Ret.) (1)(3)
|
61
|
Director
|
(1)
|
Audit
Committee
|
(2)
|
Governance
& nominating Committee
|
(3)
|
Compensation
Committee
|
(4)
|
On
April 14, 2008, Michael D. Fowler resigned from his position as Interim
Chief Financial Officer of the Company
|
(5)
|
As
of June 1, 2008, Andrew G. Sculley is Chief Executive Officer and
President. Admiral Paulsen resigned from his position as
interim Chief Executive Officer and continues to serve as Chairman of the
Board.
|
*
Committee Chair
Andrew G.
Sculley became the Company’s Chief Executive Officer and President on June 1,
2008. Mr. Sculley served as the General Manager of Kodak’s OLED
systems Business Unit and Vice President of Kodak’s Display Business from 2004
to 2008. From 2003 to 2006, he served on the Board of Directors of SK Display, a
joint venture between Sanyo and Kodak. From 1996 to 2001 Mr. Sculley served as
the Manager of Operations, CFO and member of the Board of Directors of Kodak
Japan Ltd., where he managed Distribution, Information Technologies, Legal,
Purchasing and Finance. Previously, he held positions in strategic planning and
finance in Eastman Kodak Company. Mr. Sculley holds an MBA from
Carnegie-Mellon University and an MS in physics from Cornell University. He
attended Harvard University’s International Senior Management Program while an
executive at Kodak.
Paul
Campbell became the Company’s Interim Chief Financial Officer on April 15, 2008.
Mr. Campbell has been a partner with Tatum, LLC (“Tatum”), an executive services
firm, since November 2007. Mr. Campbell served as the Chief Financial
Officer of four public companies, including Checkers Drive-In Restaurants, Inc,
which until 2006 was traded on the Nasdaq and as Chief Financial Officer of
Famous Dave’s of America, Inc., a publicly held company currently trading on the
Nasdaq. Mr. Campbell also served as Chief Financial Officer of Sonus
Corporation, a medical device retailer, and of Organic To Go, Inc., an emerging
publicly-held food company, from May 2007 through October 2007. From
2001 through April 2007, Mr. Campbell owned and operated Campbell Capital, LLC,
a consulting and investment firm in Seattle, Washington providing strategic
planning and financing services to small businesses. Mr. Campbell received
his Masters of Business Administration from Pepperdine University and his
Bachelor of Arts degree in Business Economics from the University of California
at Santa Barbara.
Susan K.
Jones has served as Executive Vice President and Secretary since 1992, and
assumed responsibility of Chief Business Officer in 2008. Ms. Jones has more
than 30 years of industrial experience, including senior research, management,
and marketing assignments at Texas Instruments and Merck, Sharp, & Dohme
Pharmaceuticals. Ms. Jones serves on the boards or chairs committees for
industry organizations including IEEE, SPIE, and SID. Ms. Jones served as a
director of eMagin Corporation from 1993 to 2000 and was a director of Virtual
Vision, Inc. Ms. Jones graduated from Lamar University with a B.S. in
chemistry and biology, holds more than a dozen patents, and has authored more
than 100 papers and talks.
Rear
Admiral Thomas Paulsen resigned from his position as Interim CEO and President
on June 1, 2008 and continues to serve as Chairman of the Board. He
has served as a director since July 2003. Admiral Thomas Paulsen served for over
34 years in the US Navy in Command Control, Communications and Intelligence
(C3I), Telecommunications, Network Systems Operations, Computers and Computer
Systems Operations until his retirement in 1994 as a Rear Admiral. He then
served as Chief Information Officer for Williams Telecommunications. Admiral
Paulsen has served as a director of Umbanet, Inc. since 2002. Since 2000,
Admiral Paulsen has served on the Board of Governors of the Institute of
Knowledge Management, George Washington University. Since 1994, he has served as
the Chairman of the Advisory Board and President Emeritus of the Center for
Advanced Technologies (CAT) and a Managing Partner on the National Knowledge and
Intellectual Property Management Taskforce, a not-for-profit company
headquartered in Dallas, Texas, and is a member of the Board of Governors for
the Japanese American National Museum, Los Angeles, California.
Claude
Charles has served as a director since April of 2000. Mr. Charles has served as
President of Azure Capital Limited since 1999. From 1996 to 1998 Mr. Charles was
Chairman of Equinox Group Holdings. Prior to 1996, Mr. Charles has also served
as a director and in senior executive positions at SG Warburg and Co. Ltd.,
Peregrine Investment Holdings, Trident International Finance Ltd., and Dow
Banking Corporation. Mr. Charles holds a B.S. in economics from the Wharton
School at the University of Pennsylvania and a M.S. in international finance
from Columbia University.
Paul
Cronson has served as a director since July of 2003. Mr. Cronson is Managing
Director of Larkspur Capital Corporation, which he founded in 1992. Larkspur is
a broker dealer that is a member of the National Association of Securities
Dealers and advises companies seeking private equity or debt. Mr. Cronson's
career in finance began in 1979 at Laidlaw, Adams Peck where he worked in asset
management and corporate finance. From 1983 to 1985, Mr. Cronson worked with
Samuel Montagu Co., Inc. in London, where he marketed eurobond issuers and
structured transactions. Subsequently from 1985 to 1987, he was employed by
Chase Investment Bank Ltd., where he structured international debt securities
and he developed "synthetic asset" products using derivatives. Returning to the
U.S., he joined Peter Sharp Co., where he managed a real estate portfolio,
structured financings and assisted with capital market investments until 1992.
Mr. Cronson received his BA from Columbia College in 1979, and his MBA from
Columbia University School of Business Administration in 1982. He is on the
Board of Umbanet, in New York City, a private company specializing in email
based distributed applications and secure messaging.
Irwin
Engelman has served as a director since May of 2005. He is currently a
consultant to various industrial companies. He is currently a director of
Sanford Bernstein Mutual Funds, a publicly-traded company, and a member of its
audit committee. From November 1999 until April 2002, he served as
Executive Vice President and Chief Financial Officer of YouthStream Media
Networks, Inc., a media and retailing company serving high school and
college markets. From 1992 until April 1999, he served as Executive Vice
President and Chief Financial Officer of MacAndrews and Forbes
Holdings, Inc., a privately-held financial holding company. From
November 1998 until April 1999, he also served as Vice Chairman, Chief
Administrative Officer and a director of Revlon, Inc., a publicly-traded
consumer products company. From 1978 until 1992, he served as an executive
officer of various public companies including International Specialty
Products, Inc. (a subsidiary of GAF Holdings Inc.), CitiTrust
Bancorporation, General Foods Corporation and The Singer Company. Mr. Engelman
received a BBA in Accounting from Baruch College in 1955 and a Juris Doctorate
from Brooklyn Law School in 1961. He was admitted practice law in the State of
New York in 1962. In addition, he was licensed as a CPA in the State of New
Jersey in 1966.
Dr. Jack
Goldman joined our board of directors in February of 2003. Dr. Goldman is the
retired senior vice-president for R&D and chief technical officer of the
Xerox Corporation. While at Xerox, he founded and directed the celebrated Xerox
PARC laboratory. Prior to joining Xerox, Dr. Goldman was Director of Ford Motor
Company's Scientific Research Laboratory. He also served as Visiting Edwin
Webster Professor at MIT. Dr. Goldman presently serves on the Boards of
Directors of Umbanet Inc. and Medis Technologies Inc., and he has served on the
Boards of Xerox, General Instrument Corp., United Brands, Intermagnetics
General, GAF and Bank Leumi USA. He has also been active in government and
professional advisory roles including service on the US Dept. of Commerce
Technical Advisory Board, chairman of Statutory Visiting Committee of The
National Bureau of Standards (National Institute of Standards and Technology),
vice-president of the American Association for the Advancement of Science and
president of the Connecticut Academy of Science and Engineering.
General
Stephen Seay was elected to the Board of Directors in January 2006. In his
33-year Army career, General Stephen Seay held a wide variety of command and
staff positions, most importantly as a soldier's soldier volunteering for his
final assignment with his troops in Iraq. Most recently he was Program Executive
Officer for Simulation, Training and Instrumentation, and Commanding General,
Joint Contracting Command-Iraq/Head of Contracting Authority, Operation Iraqi
Freedom. He has also served as Program Manager for a joint system, headed the
Joint Target Oversight Council and was Commanding General, Simulation, Training
and Instrumentation Command (STRICOM), Army Materiel Command. Earlier, as a
Field Artillery officer, he commanded at all levels, rising to corps artillery
commander. He served as Chief of Staff, United States Army, Europe (Forward) and
National Security Element, Taszar, Hungary, during Operation Joint Endeavor. He
held resource management, operations research, and acquisition positions during
three tours on Department of the Army staff. Stephen Seay holds a Bachelor of
Science degree from the University of New Hampshire and a Master of Science
degree from North Carolina State University.
Code
of Ethics
We have
adopted a Code of Business Conduct and Ethics that applies to all of our
directors, officers and employees, including our principal executive officer,
principal financial officer and principal accounting officer. The Code of
Business Conduct and Ethics is posted on our website at
http://www.emagin.com/investors.
We intend
to satisfy the disclosure requirement under Item 10 of Form 8-K regarding an
amendment to, or waiver from, a provision of this Code of Business Conduct and
Ethics by filing a Current Report on Form 8-K with the SEC, disclosing such
information.
Section
16(a) Beneficial Ownership Reporting Compliance
Section 16(a)
of the Securities Exchange Act of 1934, as amended, requires our directors and
executive officers and persons who own more than 10% of the issued and
outstanding shares of eMagin common stock to file reports of initial ownership
of common stock and other equity securities and subsequent changes in that
ownership with the SEC and the NYSE. Officers, directors and greater than ten
percent stockholders are required by SEC regulation to furnish us with copies of
all Section 16(a) forms they file. To our knowledge, based solely on a
review of the copies of such reports furnished to us and written representations
that no other reports were required, during the fiscal year ended December 31,
2007 all Section 16(a) filing requirements applicable to our officers, directors
and greater than 10% beneficial owners were complied with except as noted
below:
As of
December 31, 2007, there was one Form 4 filed late by Dr. K. C.
Park and Susan K. Jones filed a Form 5 as a result of certain unfiled Form
4 filings.
General Information Concerning the
Board of Directors
The Board
of Directors of eMagin is classified into three classes: Class A, Class B and
Class C. As of June 30, 2008, Irwin Engelman is the only Class A Director, and
will hold office until the next Annual Meeting of our stockholders. Paul
Cronson, Admiral Thomas Paulsen, and General Stephen Seay are Class B directors
who will hold office until the 2009 Annual Meeting. Claude Charles and Dr.
Jacob Goldman are Class C directors who will hold office until the next Annual
Meeting. There was no Annual Meeting held during
2007. In each case, each director will hold office until his
successor is duly elected or appointed and qualified in the manner provided in
our Amended and Restated Certificate of Incorporation and our Amended and
Restated Bylaws, or as otherwise provided by applicable law.
Our Board
of Directors held 20 meetings during 2007. Our independent directors met in
executive session on a periodic basis in connection with regular meetings, as
well as in their capacity as members of our Audit Committee and Compensation
Committee.
Compensation
of Directors
Non-management
directors receive options under the Company’s stock option
plan. A grant of options to purchase 15,000 shares of common stock
will automatically be granted on the date a director is first elected or
reelected or otherwise validly appointed to the Board with an exercise price per
share equal to 100% of the market value of one share on the date of grant. Such
options granted will expire ten years after the date of grant and will become
exercisable on December 31 of the year granted. For calendar years 2007 and
2008, Directors shall receive an annual cash retainer of $10,000 and an annual
stock retainer of 25,000 options at market price on the date of issuance that
will become fully exercisable on December 31 of the year granted.
Directors are also granted options based on committee assignments
consisting of options to purchase 5,000 shares per year for members of the
compensation committee, 10,000 shares for the governance committee and 15,000
shares for the audit committee. Each committee chair will receive 5,000
additional shares. The governance and audit committee chairs will each
receive an additional 10,000 option shares. In addition, each non-management
director receives $1,000 for each in-person Board meeting, and $500 for each
teleconference meeting or Committee meeting. Directors are eligible for
reimbursement for ordinary expenses incurred in connection with attendance at
such meetings.
The Audit
Committee is responsible for determining the adequacy of our internal accounting
and financial controls, supervising matters relating to audit functions,
reviewing and setting internal policies and procedures regarding audits,
accounting and other financial controls, reviewing the results of our audit
performed by the independent public accountants, and recommending the selection
of independent public accountants. The Audit Committee has adopted an Audit
Charter, which is posted on our website at http://www.emagin.com/investors.The
Audit Committee is composed of three Directors, Claude Charles, Irwin Engelman,
and Adm. Stephen Seay. The Board has determined that each of the members of the
Audit Committee is unrelated, an outside member with no other affiliation with
us and is independent. The Board has determined that Mr. Engelman is an “audit
committee financial expert” as defined by the SEC. During 2007, the Audit
Committee held 5 meetings via teleconference.
Compensation
Committee
.
The
Compensation Committee determines matters pertaining to the compensation and
expense reporting of certain of our executive officers, and administers our
stock option, incentive compensation, and employee stock purchase plans. The
Compensation Committee is presently composed of three Directors, Jack Goldman,
Thomas Paulsen, and Stephen Seay, each of whom the Board has determined to be
independent and none of whom has been an employee of the Company. During 2007,
the Compensation Committee held 4 meetings in person or through a conference
call.
Governance and
Nominating Committee
. The Governance and Nominating Committee is
responsible for considering potential Board members, nominating Directors for
election to the Board, implementing the Company’s corporate governance and
ethics policies, and for all other purposes outlined in the Governance and
Nominating Committee Charter, which is posted on our website at
http://www.emagin.com/investors. The Governance and Nominating
Committee is composed of Jack Goldman and Thomas Paulsen, each of whom the Board
has determined to be independent. During 2007, the Governance and Nominating
Committee held 1meeting.
Nomination
of Directors
As
provided in its charter and our company’s corporate governance principles, the
Governance and Nominating Committee is responsible for identifying individuals
qualified to become directors. The Governance and Nominating Committee seeks to
identify director candidates based on input provided by a number of sources,
including (1) the Governance and Nominating Committee members, (2) our other
directors, (3) our stockholders, (4) our Chief Executive Officer or Chairman,
and (5) third parties such as professional search firms. In evaluating potential
candidates for director, the Nominating and Corporate Governance Committee
considers the entirety of each candidate’s credentials.
Qualifications
for consideration as a director nominee may vary according to the particular
areas of expertise being sought as a complement to the existing composition of
the Board of Directors. However, at a minimum, candidates for director must
possess:
|
•
|
high
personal and professional ethics and integrity;
|
|
•
|
the
ability to exercise sound judgment;
|
|
•
|
the
ability to make independent analytical inquiries;
|
|
•
|
a
willingness and ability to devote adequate time and resources to
diligently perform Board and committee duties; and
|
|
•
|
the
appropriate and relevant business experience and
acumen
|
In
addition to these minimum qualifications, the Governance and Nominating
Committee also takes into account when considering whether to nominate a
potential director candidate the following factors:
|
•
|
whether
the person possesses specific industry expertise and familiarity with
general issues affecting our business;
|
|
•
|
whether
the person’s nomination and election would enable the Board to have a
member that qualifies as an “audit committee financial expert” as such
term is defined by the Securities and Exchange Commission (the “SEC”) in
Item 401 of Regulation S-K;
|
|
•
|
whether
the person would qualify as an “independent” director under the listing
standards of the OTC Bulletin
Board;
|
|
•
|
the
importance of continuity of the existing composition of the Board of
Directors to provide long term stability and experienced oversight;
and
|
|
•
|
the
importance of diversified Board membership, in terms of both the
individuals involved and their various experiences and areas of
expertise.
|
EXECUTIVE
COMPENSATION
COMPENSATION
DISCUSSION AND ANALYSIS
This
section describes the compensation program for our executive officers. In
particular, this section focuses on our 2007 compensation program and related
decisions.
Compensation
Discussion and Analysis
The
objectives of our compensation program are as follows:
|
•
|
Reward performance
that drives substantial increases in shareholder value, as evidenced
through both future operating profits and increased market price of our
common shares; and
|
|
•
|
Attract, hire and
retain well-qualified executives.
|
The
compensation level of our executives generally reflects their unique position
and incentive to positively affect our future operating performance and
shareholder value. Part of the compensation of our executives is from equity
compensation, primarily through stock option grants or restricted stock awards.
The stock option exercise price is generally the fair market value of the stock
on the date of grant. Therefore, a gain is only recognized if the value of the
stock increases, which promotes a long term alignment between the interests of
the Company’s executives and its shareholders. For that reason, stock options
are a component of 100% of our employees’ salary package.
Specific
salary and bonus levels, as well as the amount and timing of equity incentive
grants, are determined informally and judgmentally, on an individual-case basis,
taking into consideration each executive's unique talents and experience as they
relate to our needs. Executive compensation is paid or granted pursuant to each
executive's compensation agreement. Compensation adjustments are made
occasionally based on changes in an executive's level of responsibility or on
changed local and specific executive employment market conditions.
The Board
of Directors has established a Compensation Committee, comprised exclusively of
independent outside directors which approves all compensation and awards to
executive management. The members of the Compensation Committee have extensive
executive level experience in other companies and bring a perspective of
reasonableness to compensation matters with our Company. In addition, the
Compensation committee compares executive compensation practices of similar
companies at similar stages of development.
Generally
on its own initiative, at least annually, the Compensation Committee reviews the
performance of executives and establishes compensation levels based on the
performance evaluation, historical compensation levels of the executives, levels
of responsibility and contributions to the Company, and comparable position
studies provided by independent sources. With respect to equity
compensation, the Compensation Committee approves all option grants, generally
based on the recommendation of the president and chief executive officer and has
delegated granting authority to the president and chief executive officer or, on
occasion, his designee. Executives are eligible to receive bonus compensation at
the discretion of the Compensation Committee, which is primarily based on the
achievement of certain goals and objectives and the executive’s contributions to
the Company. Executives also are entitled to participate in the same benefit
plans that are available to other Company employees.
Compensation
for the Chairman
From
January through May 2008, Admiral Paulsen served as Interim Chief Executive
Officer. Admiral Paulsen receives an annual stipend of $60,000 for serving as
Non-Executive Chairman of the Board. No change occurred in Admiral Paulsen’s
compensation as a director of the Company as a result of his accepting the
temporary position of Interim Chief Executive Officer and
President.
Summary
Compensation Table
SUMMARY
COMPENSATION TABLE
|
|
|
Salary
|
Bonus
|
Stock
Awards
|
|
Option
awards
|
Non-equity
incentive plan
compensation
|
Change
in pension value and non qualified deferred compensation
|
All
Other Compensation
|
|
Total
|
Name
and principal position
|
Year
|
($)
|
($)
|
($)
|
|
($),
(a)
|
($)
|
($)
|
($)
|
|
($)
|
|
|
|
|
|
|
|
|
|
|
|
|
K.C. Park,
Interim President and Chief Executive Officer (1)
|
2007
|
313,462
|
-
|
40,000
|
(4)
|
-
|
-
|
-
|
-
|
|
353,462
|
|
2006
|
200,000
|
-
|
-
|
|
-
|
-
|
-
|
-
|
|
-
|
|
2005
|
119,923
|
-
|
-
|
|
141,362
|
-
|
-
|
-
|
|
141,362
|
|
|
|
|
|
|
|
|
|
|
|
|
Gary
Jones, President and Chief Executive Officer (2)
|
2007
|
102,060
|
-
|
430,000
|
(5)
|
-
|
-
|
-
|
51,638
|
(6)
|
583,698
|
|
2006
|
368,170
|
-
|
-
|
|
-
|
-
|
-
|
127,928
|
(7)
|
496,098
|
|
2005
|
320,313
|
-
|
-
|
|
404,150
|
-
|
-
|
147,420
|
(7)
|
871,883
|
|
|
|
|
|
|
|
|
|
|
|
|
John
D. Atherly, Chief Financial Officer (3)
|
2007
|
243,000
|
-
|
-
|
|
-
|
-
|
-
|
-
|
|
243,000
|
|
2006
|
242,308
|
-
|
-
|
|
-
|
-
|
-
|
-
|
|
242,308
|
|
2005
|
221,406
|
-
|
-
|
|
316,240
|
-
|
-
|
-
|
|
537,646
|
|
|
|
|
|
|
|
|
|
|
|
|
Susan
Jones, Executive Vice President, Chief Marketing and Strategy Officer, and
Secretary
|
2007
|
278,888
|
-
|
-
|
|
-
|
-
|
-
|
175,184
|
(8)
|
454,072
|
|
2006
|
289,163
|
-
|
-
|
|
-
|
-
|
-
|
81,379
|
(8)
|
370,542
|
|
2005
|
259,568
|
26,049
|
-
|
|
316,240
|
-
|
-
|
26,049
|
(8)
|
627,906
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)
Dr. Park was appointed Interim President and Chief Executive Officer in
January 2007 and resigned his post in January 2008. Prior to
January 2007, Dr. Park served as Executive Vice President of International
Operations.
|
(2)
Mr. Jones resigned as President and Chief Executive Officer in January
2007.
|
(3)
Mr. Atherly resigned as Chief Financial Officer in January
2008.
|
(4)
This amount represents a retention bonus in the form of a stock grant that
was issued to the named executive officer.
|
(5)
This amount represents a payment in the form of a stock grant pursuant to
Mr. Jones' severance agreement. Previously granted options that
remained unexercised were also forfeited pursuant to the severance
agreement.
|
(6)
This amount represents legal and accounting fee reimbursement for the
benefit of the named executive officer.
|
(7)
This amount represents relocation expense reimbursement for the benefit of
the named executive officer.
|
(8)
This amount represents deferred dollar amount earned in sales incentive
compensation by the named executive officer.
|
|
Column
note:
|
(a) The
amounts in this column represent the fair value of option awards to the
named executive officer as computed on the date of the option grants using
the Black-Scholes option-pricing model.
|
Grants
of Plan-Based Awards
There
were no grants of plan-based awards to named executive officers for the year
ended December 31, 2007.
Outstanding
Equity Awards at Fiscal Year-End
The
following table sets forth information with respect to the outstanding equity
awards of our principal executive officers and principal financial officer
during 2007, and each person who served as an executive officer of eMagin
Corporation as of December 31, 2007:
OUTSTANDING
EQUITY AWARDS AT YEAR-END
|
|
Option
awards
|
Stock
awards
|
|
Number
of securities underlying unexercised options (#)
|
Number
of securities underlying unexercised options (#)
|
Equity
incentive plan awards: Number of securities underlying
unexercised options
|
Options
exercise price
|
Option
expiration
|
Number
of shares or units of stock that have not vested
|
Market
value of shares or units of stock that have not vested
|
Equity
incentive plan awards:
Number
of unearned shares other rights that have not vested
|
Equity
incentive plan awards:
Market
or payout value of unearned shares, units or other rights that have not
vested
|
Name
and principal position
|
Exercisable
|
|
(#),
(a)
|
($)
|
Date
|
(#)
|
($)
|
(#)
|
($)
|
K.C. Park,
Interim President and Chief Executive Officer (1)
|
465
|
-
|
465
|
2.60
|
July
21, 2008
|
-
|
-
|
-
|
-
|
19,500
|
-
|
19,500
|
2.60
|
May
10, 2009
|
|
|
|
|
3,676
|
-
|
3,676
|
2.60
|
January
11, 2010
|
|
|
|
|
6,500
|
-
|
6,500
|
2.60
|
March
17, 2010
|
|
|
|
|
6,500
|
-
|
6,500
|
2.60
|
November
30, 2012
|
|
|
|
|
6,846
|
-
|
6,846
|
2.60
|
April
24, 2013
|
|
|
|
|
4,108
|
-
|
4,108
|
2.60
|
August
30, 2013
|
|
|
|
|
4,108
|
-
|
4,108
|
2.60
|
December
1, 2013
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
John
D. Atherly, Chief Financial Officer (2)
|
24,375
|
8,125
|
32,500
|
2.60
|
June
16, 2011
|
-
|
-
|
-
|
-
|
-
|
25,000(3)
|
25,000
|
2.60
|
June
16, 2011
|
|
|
|
|
16,250
|
-
|
16,250
|
2.60
|
March
17, 2012
|
|
|
|
|
11,700
|
-
|
11,700
|
2.60
|
November
30, 2012
|
|
|
|
|
|
|
|
|
|
|
|
|
|
OUTSTANDING
EQUITY AWARDS AT YEAR-END (cont.)
|
|
Option
awards
|
Stock
awards
|
|
Number
of securities underlying unexercised options (#)
|
Number
of securities underlying unexercised options (#)
|
Equity
incentive plan awards: Number of securities underlying
unexercised options
|
Options
exercise price
|
Option
expiration
|
Number
of shares or units of stock that have not vested
|
Market
value of shares or units of stock that have not vested
|
Equity
incentive plan awards:
Number
of unearned shares other rights that have not vested
|
Equity
incentive plan awards:
Market
or payout value of unearned shares, units or other rights that have not
vested
|
Name
and principal position
|
Exercisable
|
|
(#),
(a)
|
($)
|
Date
|
(#)
|
($)
|
(#)
|
($)
|
Susan
Jones, Executive Vice President, Chief Marketing and Strategy Officer, and
Secretary
|
48,750
|
-
|
48,750
|
2.60
|
May
17, 2009
|
-
|
-
|
-
|
-
|
16,770
|
-
|
16,770
|
2.60
|
January
11, 2010
|
|
|
|
|
9,685
|
-
|
9,685
|
2.60
|
January
11, 2010
|
|
|
|
|
16,250
|
-
|
16,250
|
2.60
|
March
17, 2010
|
|
|
|
|
11,700
|
-
|
11,700
|
2.60
|
November
30, 2012
|
|
|
|
|
11,932
|
-
|
11,932
|
2.60
|
April
24, 2013
|
|
|
|
|
7,159
|
-
|
7,159
|
2.60
|
August
30, 2013
|
|
|
|
|
7,159
|
-
|
7,159
|
2.60
|
December
1, 2013
|
|
|
|
|
(1)
Dr. Park was appointed Interim President and Chief Executive Officer in
January 2007 and resigned his post in January 2008.
|
(2)
Mr. Atherly resigned as Chief Financial Officer in January 2008 and has
forfeited all options shown above.
|
(3)
25,000 options subject to vesting when the Company completes four
consecutive EBITDA positive quarters.
|
Column
note:
|
On
November 3, 2006, a reverse stock split, ratio of 1-for-10, became
effective. All stock options presented reflect the stock
split.
|
(a)
The options in this column were repriced. On July 21,
2006, certain employees agreed to cancel a portion of their existing stock
options in return for repricing the remaining stock options at $2.60 per
share. The repriced unvested options continued to vest on the
original schedule.
|
Option Exercises and Stock
Vested
No
executive officer identified in the Summary Compensation Table above exercised
an option in fiscal year 2007. There were no shares of stock awarded
or vested with respect to any of those executive officers.
Pension
Benefits
eMagin
does not have any plan which provides for payments or other benefits at,
following, or in connection with retirement.
Non-qualified
Deferred Compensation
eMagin
does not have any defined contribution or other plan which provides for the
deferral of compensation on a basis that is not tax-qualified.
Employment
Agreements
Effective
January 1, 2006, the Company entered into a revised executive employment
agreement with Susan K. Jones, Chief Marketing and Strategy Officer. The
agreement is effective for an initial term of three years. The agreement
provides for an annual salary, benefits made available by the Company to its
employees and eligibility for an incentive bonus pursuant to one or more
incentive compensation plans established by the Company from time to time. The
Company may terminate the employment of Ms. Jones at any time with or without
notice and with or without cause (as such term is defined in the
agreements). If Ms. Jones’ employment is terminated without cause, or if
Ms. Jones resigns with good reason (as such term is defined in the agreements),
or Ms. Jones’ position is terminated or significantly changed as result of
change of control (as such term is defined in the agreements), Ms. Jones shall
be entitled to receive salary until the end of the agreement’s full term or
twelve months, whichever is greater, payment for accrued vacation, and bonuses
which would have been accrued during the term of the agreement. If Ms. Jones
voluntarily terminates employment with the Company, other than for good reason
or is terminated with cause (as such term is defined in the agreement), she
shall cease to accrue salary, vacation, benefits, and other compensation on the
date of the voluntary or with cause termination. The Executive Employment
Agreement includes other conventional terms and also contains invention
assignment, non-competition, non-solicitation and non-disclosure
provisions. On April 17, 2006, the parties entered into amendments to
the employment agreements pursuant to which the parties clarified that the
Company has agreed to pay for health benefits equivalent to medical and dental
benefits provided during Ms. Jones’ full time employment until the end of the
agreement’s full term or twenty-four (24) months, whichever is
greater.
Effective
January 30, 2008, the Company entered into an amended employment agreement with
Susan K. Jones, Chief Business Officer. The amended agreement
provides for an annual base salary of $315 thousand, an extension of the term of
the agreement to January 31, 2010, modification and clarification of the basis
for the incentive component of her salary, and extension of the
change-of-control/material change/termination-without-cause compensation payout
periods to the greater of 18 months or the remaining term of the amended
employment agreement.
On
January 11, 2007, Dr. K.C. Park was appointed Interim Chief Executive Officer,
President, and a Director of the Company. On February 12, 2007, the
Company entered in a Compensation Agreement (“the Agreement”) with Dr.
Park. Under the Agreement, the Company has agreed to pay Dr. Park an
annual base salary equal to $300 thousand plus a quarterly increase in his base
salary in the amount of $12.5 thousand per fiscal quarter through December 31,
2007. The Company agreed to issue Dr. Park an aggregate of 250,000
restricted shares of common stock within 10 business days of the completion of a
change of control of the Company. In addition, if a change of control
transaction is completed and Dr. Park is not offered a senior executive position
in the new organization, the Company has agreed to pay Dr. Park three month’s
salary. On January 31, 2008, Dr. Park resigned his positions as
Interim Chief Executive Officer, President and Director.
Effective
April 2, 2008, Mr. Campbell is serving as the Company’s Chief Financial Officer
pursuant to an agreement between the Company and Tatum, dated April 2, 2008 (the
“Tatum Agreement”). Pursuant to the Tatum Agreement, for a minimum
term of three months, Mr. Campbell will be paid a salary of $24,500 per month
and the Company will also pay Tatum a fee of $10,500 per month plus $300 per
business day. Either party may terminate the Tatum Agreement by
providing the other with at least 30 days notice.
Potential
Payments Upon Termination or Change-in-Control
The
following table sets forth information regarding potential payments and benefits
Ms. Jones would receive upon termination of employment under specified
circumstances, assuming that the triggering event in question occurred on
December 31, 2007, the last business day of the fiscal year:
Name
|
|
Voluntary
Resignation w/o Good Reason
|
|
|
Voluntary
Resignation for Good Reason
|
|
|
Involuntary
Termination without Cause
|
|
|
Involuntary
Termination with Cause
|
|
|
Involuntary
Termination with a Change in Control
|
|
Susan
Jones
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash
severance
|
|
$
|
—
|
|
|
$
|
566,860
|
(1)
|
|
$
|
566,860
|
(1)
|
|
$
|
—
|
|
|
$
|
566,860
|
(1)
|
Post-termination
health and welfare
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
11,988
|
(2)
|
|
$
|
—
|
|
|
$
|
—
|
|
Vesting
of stock options
|
|
$
|
—
|
|
|
$
|
—
|
(3)
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
(3)
|
(1) This
amount reflects the lump sum that is payable within thirty days of the
triggering event to the named executive. All calculations were made
as of December 31, 2007 using then current salary figures for the named
executive.
(2) This
amount reflects the COBRA payments for health and dental benefits that eMagin
would make on behalf of the named executive.
(3) This
amount would reflect the value of the stock option awards that were unvested as
of December 31, 2007 which would accelerate and vest under the terms of eMagin’s
option plans following a triggering event. As of December 31, 2007,
all stock options were fully vested.
Director
Compensation Arrangements
The
following table sets forth with respect to the named director, compensation
information inclusive of equity awards and payments made in the year ended
December 31, 2007. The table includes only directors that were not
employees of eMagin Corporation. Any director who was also an
executive officer is included in the Summary Compensation Table.
DIRECTOR
COMPENSATION
|
|
Name
|
|
Fees
earned or paid in cash($)
|
|
|
Stock
awards
($)
|
|
|
Option
awards($)
|
|
|
Non-equity
incentive plan compensation($)
|
|
|
Change
in pension value and nonqualified deferred compensation
earnings($)
|
|
|
All
other compensation
($)
|
|
|
Total($)
|
|
Claude
Charles
|
|
|
8,000
|
|
|
|
-
|
|
|
|
42,932
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
50,932
|
|
Paul
Cronson
|
|
|
8,000
|
|
|
|
-
|
|
|
|
40,228
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
48,228
|
|
Irwin
Engelman
|
|
|
8,000
|
|
|
|
-
|
|
|
|
33,924
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
41,924
|
|
Jack
Goldman
|
|
|
8,000
|
|
|
|
-
|
|
|
|
42,139
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
50,139
|
|
Thomas
Paulsen
|
|
|
66,672
|
|
|
|
-
|
|
|
|
41,184
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
107,856
|
|
Stephen
Seay
|
|
|
8,000
|
|
|
|
-
|
|
|
|
32,586
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
40,586
|
|
The
following table sets forth information with respect to the outstanding equity
awards of our directors as of December 31, 2007:
OUTSTANDING
EQUITY AWARDS AT YEAR-END
|
|
Option
awards
|
Stock
awards
|
|
Number
of securities underlying unexercised options (#)
|
Number
of securities underlying unexercised options (#)
|
Equity
incentive plan awards: Number of securities underlying
unexercised options
|
Options
exercise price
|
Option
expiration
|
Number
of shares or units of stock that have not vested
|
Market
value of shares or units of stock that have not vested
|
Equity
incentive plan awards:
Number
of unearned shares other rights that have not vested
|
Equity
incentive plan awards:
Market
or payout value of unearned shares, units or other rights that have not
vested
|
Name
and principal position
|
Exercisable
|
Unexercisable
|
(#),
(a)
|
($)
|
Date
|
(#)
|
($)
|
(#)
|
($)
|
Claude
Charles
|
1,000
|
-
|
1,000
|
3.50
|
January
2, 2010
|
-
|
-
|
-
|
-
|
975
|
-
|
975
|
2.60
|
July
2, 2010
|
|
|
|
|
650
|
-
|
650
|
2.60
|
September
2, 2010
|
|
|
|
|
3,250
|
-
|
3,250
|
2.60
|
April
5, 2011
|
|
|
|
|
1,950
|
-
|
1,950
|
2.60
|
June
15, 2014
|
|
|
|
|
975
|
-
|
975
|
2.60
|
September
30, 2015
|
|
|
|
|
3,900
|
-
|
3,900
|
2.60
|
December
31, 2015
|
|
|
|
|
12,700
|
-
|
12,700
|
1.51
|
November
23, 2017
|
|
|
|
|
25,000
|
-
|
25,000
|
1.44
|
December
3, 2017
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Paul
Cronson
|
4,875
|
-
|
4,875
|
2.60
|
July
2, 2010
|
-
|
-
|
-
|
-
|
1,625
|
-
|
1,625
|
2.60
|
June
15, 2014
|
|
|
|
|
3,900
|
-
|
3,900
|
2.60
|
December
31, 2015
|
|
|
|
|
10,400
|
-
|
10,400
|
1.51
|
November
23, 2017
|
|
|
|
|
25,000
|
-
|
25,000
|
1.44
|
December
3, 2017
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Irwin
Engelman
|
3,900
|
-
|
3,900
|
2.60
|
October
3, 2012
|
-
|
-
|
-
|
-
|
975
|
-
|
975
|
2.60
|
September
30, 2015
|
|
|
|
|
163
|
-
|
163
|
2.60
|
October
3, 2015
|
|
|
|
|
5,038
|
-
|
5,038
|
1.51
|
November
23, 2017
|
|
|
|
|
25,000
|
-
|
25,000
|
1.44
|
December
3, 2017
|
|
|
|
|
|
|
|
|
|
|
|
|
|
OUTSTANDING
EQUITY AWARDS AT YEAR-END (cont.)
|
|
Option
awards
|
Stock
awards
|
|
Number
of securities underlying unexercised options (#)
|
Number
of securities underlying unexercised options (#)
|
Equity
incentive plan awards: Number of securities underlying
unexercised options
|
Options
exercise price
|
Option
expiration
|
Number
of shares or units of stock that have not vested
|
Market
value of shares or units of stock that have not vested
|
Equity
incentive plan awards:
Number
of unearned shares other rights that have not vested
|
Equity
incentive plan awards:
Market
or payout value of unearned shares, units or other rights that have not
vested
|
Name
and principal position
|
Exercisable
|
Unexercisable
|
(#),
(a)
|
($)
|
Date
|
(#)
|
($)
|
(#)
|
($)
|
Jacob
Goldman
|
650
|
-
|
650
|
2.60
|
July
2, 2010
|
|
|
|
|
3,900
|
-
|
3,900
|
2.60
|
September
2, 2010
|
|
|
|
|
2,113
|
-
|
2,113
|
2.60
|
June
15, 2014
|
|
|
|
|
650
|
-
|
650
|
2.60
|
September
30, 2015
|
|
|
|
|
488
|
-
|
488
|
2.60
|
October
3, 2015
|
|
|
|
|
3,900
|
-
|
3,900
|
2.60
|
December
31, 2015
|
|
|
|
|
12,026
|
-
|
12,026
|
1.51
|
November
23, 2017
|
|
|
|
|
25,000
|
-
|
25,000
|
1.44
|
December
3, 2017
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Thomas
Paulsen
|
3,900
|
|
3,900
|
2.60
|
July
30, 2010
|
|
|
|
|
1,300
|
-
|
1,300
|
2.60
|
June
15, 2014
|
|
|
|
|
1,625
|
-
|
1,625
|
2.60
|
September
30, 2015
|
|
|
|
|
3,250
|
-
|
3,250
|
2.60
|
October
3, 2015
|
|
|
|
|
813
|
-
|
813
|
2.60
|
December
31, 2015
|
|
|
|
|
11,213
|
-
|
11,213
|
1.51
|
November
23, 2017
|
|
|
|
|
25,000
|
-
|
25,000
|
1.44
|
December
3, 2017
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stephen
Seay
|
3,900
|
-
|
3,900
|
2.60
|
February
14, 2016
|
|
|
|
|
3,900
|
-
|
3,900
|
1.51
|
November
23, 2017
|
|
|
|
|
25,000
|
-
|
25,000
|
1.44
|
December
3, 2017
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Column
note:
|
|
On
November 3, 2006, a reverse stock split, ratio of 1-for-10, became
effective. All stock options presented reflect the stock
split.
|
Compensation
Committee Interlocks and Insider Participation
None of
the members of our Compensation Committee has been an officer or employee of
eMagin during years ending December 31, 2005, 2006 and 2007. In addition,
during the most recent fiscal year, no eMagin executive officer served on the
Compensation Committee (or equivalent), or the Board, of another entity whose
executive officer(s) served on our Compensation Committee or
Board. On January 31, 2008, Dr. K.C. Park resigned as our
Interim Chief Executive Officer and President; and Thomas Paulsen, a director
and Chairman of both the Board of Directors and the Compensation Committee,
assumed that role on an interim basis until June 1
,
2008
when Andrew G. Sculley, Jr. joined the Company as Chief Executive Officer and
President. No change in Admiral Paulsen’s compensation as a director
of the Company occurred as a result of his accepting the temporary position of
Interim Chief Executive Officer and President.
Compensation
Committee Report
The
Committee has reviewed the Compensation Discussion and Analysis and discussed
that analysis with management. Based on its review and discussions with
management, the Committee recommended to the Board that the Compensation
Discussion and Analysis be included in eMagin’s 10-K. This report is
provided by the following independent directors, who comprise the
Committee:
Thomas
Paulsen (Chairman)
Jacob
Goldman
Stephen
Seay
Security
Ownership of Certain Beneficial Owners and Management and Related Stockholder
Matters
The following
table sets forth the number of shares known to be owned by all persons who own
at least 5% of eMagin's outstanding common stock, the Company's directors, the
executive officers, and the directors and executive officers as a group as of
October 14, 2008, unless otherwise noted. Unless otherwise indicated, the
stockholders listed in the table have sole voting and investment power with
respect to the shares indicated.
Name
of Beneficial Owner
|
|
Common
Stock Beneficially Owned
|
|
|
Percentage
of Common Stock
|
|
Moriah
Capital L.P. (1)
|
|
|
2,017,500
|
|
|
|
5.7
|
%
|
Stillwater
LLC (2)
|
|
|
5,877,823
|
|
|
|
16.6
|
%
|
Alexandra
Global Master Fund Ltd (3)
|
|
|
3,488,569
|
|
|
|
9.9
|
%
|
Ginola
Limited (4)
|
|
|
5,071,856
|
|
|
|
14.4
|
%
|
Susan
K Jones (5)
|
|
|
683,465
|
|
|
|
1.9
|
%
|
Rainbow
Gate Corporation (6)
|
|
|
1,947,038
|
|
|
|
5.5
|
%
|
Kettle
Hill (7)
|
|
|
1,467,662
|
|
|
|
4.2
|
%
|
Paul
Cronson (8)
|
|
|
568,682
|
|
|
|
1.6
|
%
|
Claude
Charles (9)
|
|
|
105,400
|
|
|
|
*
|
|
Jack
Goldman (10)
|
|
|
103,727
|
|
|
|
*
|
|
Thomas
Paulsen (11)
|
|
|
92,101
|
|
|
|
*
|
|
Irwin
Engelman(12)
|
|
|
90,076
|
|
|
|
*
|
|
Stephen
Seay( 13)
|
|
|
76,825
|
|
|
|
*
|
|
Andrew
G. Sculley (14)
|
|
|
166,667
|
|
|
|
*
|
|
All
executive officers and directors as a group (consisting of 8 individuals)
(15)
|
|
|
1,886,943
|
|
|
|
5.3
|
%
|
*Less
than 1*% of the outstanding common stock
**
Beneficial Ownership is determined in accordance with the rules of the
Securities and Exchange Commission and generally includes voting or investment
power with respect to securities. Shares of common stock subject to options,
warrants, or convertible debt currently exercisable or convertible, or
exercisable or convertible within 60 days of October 14, 2008 are deemed
outstanding for computing the percentage of the person holding such option or
warrant. Percentages are based on a total of 35,317,523
shares: 15,018,839 shares of common stock outstanding on October 14,
2008 and 20,298,684 shares issuable upon the exercise of options, warrants
exercisable, and debt convertible on or within 60 days of October 14, 2008, as
described below.
(1) This
figure represents (i) 647,500 shares owned by Moriah Capital, L.P and (ii)
warrants held by Moriah Capital L.P. to purchase 1,370,000
shares. Alexandre Speaker and Greg Zilberstein exercise the shared
voting power with respect to the shares.
(2) This
figure represents: (i) 2,252,199 shares owned by Stillwater LLC, which includes
276,084 shares owned by Rainbow Gate Corporation, in which the sole member of
Stillwater LLC is the investment manager of Rainbow Gate Corporation; (ii)
warrants held by Stillwater LLC to purchase 1,978,006 shares, which includes
warrants to purchase 737,621 shares held by Rainbow Gate Corporation, in which
the sole member of Stillwater LLC is the investment manager of Rainbow Gate
Corporation; and (iii) 1,647,618 shares of common stock underlying an 8%
senior convertible note which includes 933,333 shares of common stock underlying
an 8% senior convertible note held by Rainbow Gate Corporation, which the sole
member of Stillwater LLC is the investment manager of Rainbow Gate Corporation.
Mortimer D.A. Sackler exercises the sole voting power with respect to the shares
held in the name of Stillwater LLC as sole member, and Mortimer D.A. Sackler
exercises the sole voting power with respect to the shares held in the name of
Rainbow Gate Corporation as investment manager; therefore Stillwater LLC is
deemed to beneficially own the shares held by Rainbow Gate as “beneficially
owned” but Stillwater LLC disclaims beneficial ownership of such
shares.
(3) This
figure represents: (1) 420,387 shares owned by Alexandra Global
Master Fund; (ii) warrants held to purchase 1,068,182 shares; and (iii)
2,000,000 shares of common stock underlying an 8% senior convertible note.
Alexandra Investment Management, LLC, a Delaware limited liability company
(“AIM”), serves as investment adviser to Alexandra Global Master Fund Ltd., a
British Virgin Islands company (“Alexandra”). By reason of such
relationship, AIM may be deemed to share dispositive power over the shares of
common stock stated as beneficially owned by Alexandra. AIM disclaims beneficial
ownership of such shares of common stock. Mr. Mikhail A. Filimonov (“Filimonov”)
is the Chairman, Chief Executive Officer, Chief Investment Officer and a
managing member of AIM. By reason of such relationships, Filimonov
may be deemed to share dispositive power over the shares of common stock stated
as beneficially owned by Alexandra. Filimonov disclaims beneficial
ownership of such shares of common stock.
(4) This
figure represents: (i) 1,257,629 shares owned by Ginola Limited, which include
276,084 shares held indirectly by Rainbow Gate Corporation; 65,080 shares owned
by Mount Union Corp.; 57,372 shares owned by Chelsea Trust Company Limited, as
trustee; and 284,736 shares owned by Crestflower Corporation (Ginola Limited
disclaims beneficial ownership of the shares owned by Crestflower Corporation;
Mount Union Corp.; and Chelsea Trust Company Limited, as trustee); and (ii)
warrants held by Ginola Limited to purchase 1,814,228 common shares, which
includes warrants to purchase 737,620 shares held by Rainbow Gate Corporation,
in which the sole shareholder of Ginola Limited is also the sole shareholder of
Rainbow Gate Corporation, and warrants to purchase 32,540 shares owned by Mount
Union Corp., 27,273 shares of common stock issuable upon exercise of a common
stock purchase warrant held indirectly by Chelsea Trust Company Limited, as
trustee, and 120,193 shares of common stock issuable upon exercise of common
stock purchase warrant held by Crestflower Corporation (Ginola Limited disclaims
beneficial ownership of the shares owned by Crestflower Corporation, Mount Union
Corp. and Chelsea Trust Company Limited, as trustee); and (iii) 1,999,999
shares of common stock underlying an 8% senior convertible note, which includes
933,333 shares of common stock underlying an 8% senior convertible note held by
Rainbow Gate Corporation, in which the sole shareholder of Ginola Limited is
also the sole shareholder of Rainbow Gate Corporation. Stillwater LLC and Ginola
Limited are beneficially owned by separate individuals and therefore do not
exert voting control over one another. However, Stillwater LLC does include the
shares held by Rainbow Gate as “beneficially owned” since the sole member of
Stillwater LLC is investment manager and sole director of Rainbow Gate
Corporation and exerts voting control over such shares but Stillwater LLC
disclaims beneficial ownership of such shares. Jonathan White, Steven
Meiklejohn, and Joerg Fischer exercise the shared voting power with respect to
the shares held in the name of Mount Union Corp.. Stuart Baker, Joerg Fischer,
Charles Lubar, Christopher Mitchell, Leslie Schreyer and Jonathan White exercise
the shared voting power with respect to the shares held in the name of Chelsea
Trust Company Limited. Jonathan White, Joerg Fischer and Steven
Meiklejohn exercise the shared voting power with respect to the shares held in
the name of Crestflower Corporation. Jonathan White, Joerg Fischer
and Steven Meiklejohn are the directors of Ginola Limited and exercise the
shared voting power with respect to the shares held in the name of Ginola
Limited.
(5) This
figure represents shares owned by Gary Jones and Susan Jones who are married to
each other, including (i) 395,268 shares owned by Gary Jones and 158,792 shares
owned by Susan Jones; and (ii) 129,405 shares of common stock issuable upon
exercise of stock options held by Susan Jones.
(6) This
figure represents (1) 276,084 shares owned by Rainbow Gate Corporation; (ii)
warrants held by to purchase 737,621 shares; and (iii) 933,333 shares of common
stock underlying an 8% senior convertible note. Mortimer D.A. Sackler
exercises the sole voting power with respect to the shares held in the name of
Rainbow Gate Corporation but disclaims beneficial ownership of such
shares.
7) This
figure represents (i) 1,227,276 shares of common stock owned by Kettle Hill of
which 195,941 shares held by Kettle Hill Partners, LP, 724,800 shares held by
Kettle Hill Partners II, LP, and 306,534 shares held by Kettle Hill Offshore,
Ltd. and (ii) warrants held by Kettle Hill to purchase 240,386 common shares
which includes warrants to purchase 55,289 shares held by Kettle Hill Partners,
LP, warrants to purchase 98,558 shares held by Kettle Hill Partners II, LP, and
warrants to purchase 86,539 shares held by Kettle Hill Offshore,
Ltd. Kettle Hill Capital Management, LLC acts as investment manager
for Kettle Hill Partners, LP, Kettle Hill Partners II LP, and Kettle Hill
Offshore, Ltd. Andrew Kurita exercises the voting power with respect
to the shares.
(8) This
figure represents 22,198 shares owned by Mr. Cronson, 208,235 shares underlying
warrants, 70,800 shares underlying options, and 266,666 shares of common stock
underlying an 8% senior convertible note held directly and indirectly by Paul
Cronson. This includes (i) 12,097 common stock shares and 4,286 shares
underlying warrants held indirectly by a family member of Paul Cronson; (ii)
4,366 shares underlying warrants held indirectly by Larkspur Corporation of
which he is the Managing Director and (iii) 3,783 shares of common stock,
186,666 shares underlying warrants and 266,666 shares of common stock underlying
an 8% senior convertible note held indirectly by Navacorp III, LLC. Mr. Paul
Cronson exercises the sole voting power with respect to the shares held in the
name of Larkspur Corporation, and Paul Cronson exercises the sole voting power
with respect to the shares held in the name of Navacorp III, LLC.
(9) This figure represents
shares underlying options.
(10) This
figure represents shares underlying options.
(11) This
figure represents shares underlying options.
(12) This
figure represents shares underlying options.
(13) This
figure represents shares underlying options.
(14) This
figure represents shares underlying options.
(15)
This
figure represents: (i) 577,041 shares; (ii) warrants held to purchase
208,235 shares; (iii) 266,666 shares of common stock underlying an 8% senior
convertible note; and (iv) 835,001 shares of common stock issuable upon exercise
of stock options.
Equity
Compensation Plan Information
The
following table sets forth the aggregate information of our equity compensation
plans in effect as of December 31, 2007:
Plan
|
|
Number of
securities to be
issued upon exercise
of outstanding options,
warrants and rights
|
|
|
Weighted-average
exercise price of
outstanding options,
warrants and rights
|
|
|
Number of securities
remaining available for
future issuance under
equity compensation plans
(excluding securities reflected
in first column
|
|
Equity
compensation plans approved by security holders
|
|
|
487,674
|
|
|
$
|
2.14
|
|
|
|
817,215
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity
compensation plans not approved by security holders
|
|
|
406,649
|
|
|
$
|
3.02
|
|
|
|
|
|
TRANSFER
AGENT
Our
transfer agent for our common stock is Continental Stock Transfer, 17 Battery
Place, New York, NY 10004.
INDEMNIFICATION FOR SECURITIES ACT
LIABILITIES
Our
Articles of Incorporation, as amended and restated, provide to the fullest
extent permitted by Section 145 of the General Corporation Law of the State of
Delaware that our directors or officers shall not be personally liable to us or
our shareholders for damages for breach of such director's or officer's
fiduciary duty. The effect of this provision of our Articles of Incorporation,
as amended and restated, is to eliminate our rights and our shareholders
(through shareholders' derivative suits on behalf of our company) to recover
damages against a director or officer for breach of the fiduciary duty of care
as a director or officer (including breaches resulting from negligent or grossly
negligent behavior), except under certain situations defined by statute. We
believe that the indemnification provisions in our Articles of Incorporation, as
amended, are necessary to attract and retain qualified persons as directors and
officers.
Our By
Laws also provide that the Board of Directors may also authorize us to indemnify
our employees or agents, and to advance the reasonable expenses of such persons,
to the same extent, following the same determinations and upon the same
conditions as are required for the indemnification of and advancement of
expenses to our directors and officers. As of the date of this Registration
Statement, the Board of Directors has not extended indemnification rights to
persons other than directors and officers.
Insofar
as indemnification for liabilities arising under the Securities Act of 1933 may
be permitted to directors, officers or persons controlling us pursuant to the
foregoing provisions, or otherwise, we have been advised that in the opinion of
the Securities and Exchange Commission, such indemnification is against public
policy as expressed in the Securities Act of 1933 and is, therefore,
unenforceable.
We are
registering the shares of common stock issuable upon exercise of the warrants
and conversion of the notes to permit the resale of these shares of common stock
by the holders of the warrants from time to time after the date of this
prospectus. We will receive proceeds of $480,000 from the exercise of
the warrants. We will bear all fees and expenses incident to our
obligation to register the shares of common stock.
The
selling stockholders and any of their pledgees, donees, transferees, assignees
and successors-in-interest may, from time to time, sell any or all of their
shares of common stock on any stock exchange, market or trading facility on
which the shares are traded or in private transactions. These sales may be
at fixed prices, at prevailing market prices at the time of sale, at varying
prices determined at the time of sale or negotiated prices. The selling
stockholders may use any one or more of the following methods when selling
shares:
|
·
ordinary brokerage transactions and
transactions in which the broker-dealer solicits
investors;
|
|
·
block trades in which the broker-dealer
will attempt to sell the shares as agent but may position and resell a
portion of the block as principal to facilitate the
transaction;
|
|
·
purchases by a broker-dealer as principal
and resale by the broker-dealer for its account;
|
|
·
an exchange distribution in accordance with
the rules of the applicable exchange;
|
|
·
privately negotiated
transactions;
|
|
·
to cover short sales made after the date
that this registration statement is declared effective by the
Commission;
|
|
·
through the writing or settlement of
options or other hedging transactions, whether through an options exchange
or otherwise;
|
|
·
broker-dealers may agree with the selling
stockholders to sell a specified number of such shares at a stipulated
price per share;
|
|
·
a combination of any such methods of sale;
and
|
|
·
any other method permitted pursuant to
applicable law.
|
|
|
Broker-dealers
engaged by the selling stockholders may arrange for other brokers-dealers to
participate in sales. Broker-dealers may receive commissions or discounts
from the selling stockholders (or, if any broker-dealer acts as agent for the
purchaser of shares, from the purchaser) in amounts to be negotiated. The
selling stockholders do not expect these commissions and discounts to exceed
what is customary in the types of transactions involved.
The
selling stockholders may from time to time pledge or grant a security interest
in some or all of the shares owned by them and, if they default in the
performance of their secured obligations, the pledgees or secured parties may
offer and sell shares of common stock from time to time under this prospectus,
or under an amendment to this prospectus under Rule 424(b)(3) or other
applicable provision of the Securities Act of 1933 amending the list of selling
stockholders to include the pledgee, transferee or other successors in interest
as selling stockholders under this prospectus.
In
connection with the sale of our common stock or interests therein, the selling
stockholders may enter into hedging transactions with broker-dealers or other
financial institutions, which may in turn engage in short sales of the common
stock in the course of hedging the positions they assume. The selling
stockholders may also sell shares of our common stock short and if such short
sale shall take place after the date that this registration statement is
declared effective by the Commission, the selling stockholders may deliver these
securities to close out such short sales, or loan or pledge the common stock to
broker-dealers that in turn may sell these securities. The selling
stockholders may also enter into option or other transactions with
broker-dealers or other financial institutions or the creation of one or more
derivative securities which require the delivery to such broker-dealer or other
financial institution of shares offered by this prospectus, which shares such
broker-dealer or other financial institution may resell pursuant to this
prospectus (as supplemented or amended to reflect such
transaction).
Upon us
being notified in writing by a selling stockholder that any material arrangement
has been entered into with a broker-dealer for the sale of common stock through
a block trade, special offering, exchange distribution or secondary distribution
or a purchase by a broker or dealer, a supplement to this prospectus will be
filed, if required, pursuant to Rule 424(b) under the Securities Act, disclosing
(i) the name of each such selling stockholder and of the participating
broker-dealer(s), (ii) the number of shares involved, (iii) the price at which
such the shares of common stock were sold, (iv)the commissions paid or discounts
or concessions allowed to such broker-dealer(s), where applicable, (v) that such
broker-dealer(s) did not conduct any investigation to verify the information set
out or incorporated by reference in this prospectus, and (vi) other facts
material to the transaction. In addition, upon us being notified in
writing by a selling stockholder that a donee or pledgee intends to sell more
than 500 shares of common stock, a supplement to this prospectus will be filed
if then required in accordance with applicable securities law.
The
selling stockholders also may transfer the shares of common stock in other
circumstances, in which case the transferees, pledgees or other successors in
interest will be the selling beneficial owners for purposes of this
prospectus.
The
selling stockholders and any broker-dealers or agents that are involved in
selling the shares may be deemed to be “underwriters” within the meaning of the
Securities Act in connection with such sales. In such event, any
commissions received by such broker-dealers or agents and any profit on the
resale of the shares purchased by them may be deemed to be underwriting
commissions or discounts under the Securities Act. Discounts, concessions,
commissions and similar selling expenses, if any, that can be attributed to the
sale of securities will be paid by the selling stockholder and/or the
purchasers.
We have
advised each selling stockholder that it may not use shares registered on this
registration statement to cover short sales of common stock made prior to the
date on which this registration statement shall have been declared effective by
the Commission. If a selling stockholder uses this prospectus for any sale
of the common stock, it will be subject to the prospectus delivery requirements
of the Securities Act unless an exemption therefrom is available. The
selling stockholders will be responsible to comply with the applicable
provisions of the Securities Act and Exchange Act, and the rules and regulations
thereunder promulgated, including, without limitation, Regulation M, as
applicable to such selling stockholders in connection with resales of their
respective shares under this registration statement.
Under the
securities laws of some states, the shares of common stock may be sold in such
states only through registered or licensed brokers or dealers. In
addition, in some states the shares of common stock may not be sold unless such
shares have been registered or qualified for sale in such state or an exemption
from registration or qualification is available and is complied
with.
There can
be no assurance that any selling stockholder will sell any or all of the shares
of common stock registered pursuant to the registration statement, of which this
prospectus forms a part.
Once sold
under the registration statement, of which this prospectus forms a part, the
shares of common stock will be freely tradable in the hands of persons other
than our affiliates.
We have
agreed to indemnify the selling stockholders against certain losses, claims,
damages and liabilities, including liabilities under the Securities
Act.
DESCRIPTION OF SECURITIES
COMMON
STOCK
We are
authorized to issue up to 200,000,000 shares of common stock, $0.001 par value.
As of October 14, 2008, there were 15,018,839 shares of common stock
outstanding. Holders of the common stock are entitled to one vote per share on
all matters to be voted upon by the stockholders. Holders of common stock are
entitled to receive ratably such dividends, if any, as may be declared by the
Board of Directors out of funds legally available therefor. Upon the
liquidation, dissolution, or winding up of our company, the holders of common
stock are entitled to share ratably in all of our assets which are legally
available for distribution after payment of all debts and other liabilities and
liquidation preference of any outstanding common stock. Holders of common stock
have no preemptive, subscription, redemption or conversion rights. The
outstanding shares of common stock are validly issued, fully paid and
non-assessable.
PREFERRED
STOCK
We are
authorized to issue up to 10,000,000 shares of Preferred Stock, $0.001 par
value. The 10,000,000 shares of Preferred Stock authorized are undesignated as
to preferences, privileges and restrictions. As the shares are issued, the Board
of Directors must establish a “series” of the shares to be issued and designate
the preferences, privileges and restrictions applicable to that
series.
Pursuant
to the Agreements entered into on July 23, 2007, as outlined above in our Recent
Developments section, the Company has designated but not issued 3,198
shares of the Company’s preferred stock as Series A Senior Secured Convertible
Preferred Stock (the “Preferred Stock”) at a stated value of $1,000. The
Preferred Stock is entitled to cumulative dividends which accrue at a rate of 8%
per annum, payable on December 21, 2008. Each share of Preferred Stock has
voting rights equal to (1) in any case in which the Preferred Stock votes
together with the Company’s Common Stock or any other class or series of stock
of the Company, the number of shares of Common Stock issuable upon conversion of
such shares of Preferred Stock at such time (determined without regard to the
shares of Common Stock so issuable upon such conversion in respect of accrued
and unpaid dividends on such share of Preferred Stock) and (2) in any case not
covered by the immediately preceding clause one vote per share of Preferred
Stock.
SELLING STOCKHOLDERS
The table
below sets forth information concerning the resale of the shares of common stock
by the selling stockholders. We will not receive any proceeds from the resale of
the common stock by the selling stockholders. We will receive proceeds from the
exercise of the warrants. Assuming all the shares registered below are sold by
the selling stockholders, none of the selling stockholders will continue to own
any shares of our common stock registered pursuant to the registration statement
of which this prospectus forms a part.
The
following table also sets forth the name of each person who is offering the
resale of shares of common stock by this prospectus, the number of shares of
common stock beneficially owned by each person based on its ownership of the
shares of common stock and the warrants, as of October 14, 2008, assuming
exercise of the warrants held by the selling stockholders on that date, without
regard to any limitations on exercise, the number of shares of common stock that
may be sold in this offering and the number of shares of common stock each
person will own after the offering, assuming they sell all of the shares
offered.
Except as described below
the selling stockholders do not have and within the past three years have not
had any position, office or other material relationship with us or any of our
predecessors or affiliates.
In
accordance with the terms of registration rights agreements with the holders of
the shares of common stock and the warrants, this prospectus generally covers
the resale of at least the sum of (i) the number of shares of common stock
issued and (ii) the shares of common stock issued and issuable upon exercise of
the related warrants, determined as if the outstanding warrants were exercised,
as applicable, in full, as of the trading day immediately preceding the date
this registration statement was initially filed with the SEC.
Name of Selling Security
Holder
|
Beneficial
Ownership Prior to Offering (1)
|
Shares
Offered (3)
|
|
|
Shares
|
Percentage
(2)
|
|
Stillwater
LLC (4)
|
5,877,823
|
16.6%
|
2,450,000
|
(
1)
|
Beneficial
ownership is determined in accordance with the rules of the Securities and
Exchange Commission and generally includes voting or investment power with
respect to securities. Shares of common stock subject to options,
warrants, or debt currently exercisable or convertible, or exercisable or
convertible within 60 days of October 14, 2008 are deemed outstanding for
computing the percentage of the person holding such option, warrant, or
debt but are not deemed outstanding for computing the percentage of any
other person.
|
(2)
|
Percentage
prior to offering is based on 35,317,523 shares of common stock
outstanding as of October 14, 2008 and the shares issuable upon exercise
of options, warrants exercisable, and debt convertible on or within 60
days of October 14, 2008.
|
(3)
|
Represents
(i) 1,000,000 shares issuable upon the exercise of common stock purchase
warrants, (ii) 729,524 shares of common stock issuable upon conversion of
the remaining $250,000 Stillwater Note (original Stillwater Note of
$500,000 less $250,000 partial Note coversion (as described in
iii)) and accrued interest of $5,333 at a conversion price
of $0.35 per share, and (iii) 720,476 shares of common stock issued (but
not registered) to Stillwater due to Stillwater's election to
partially convert the Stillwater Note pursuant to its terms. With respect
to the aforementioned subpart (iii) above, on July, 23 2007, Stillwater
elected to convert $252,166.50 of the Stillwater Note representing
$250,000 of the principal amount of the Note due on July 23, 2007 and
$2,166.50 of accrued and unpaid interest into shares of common stock.
Stillwater received 720,476 shares of the common stock at the conversion
price of $0.35.
|
(4)
|
The
total number of shares underlying the Note amounted to 1,428,571 shares,
which was derived by dividing the Note amount, $500,000, by $0.35, the
conversion price. The market price on March 28, 2007 was $0.46 per share,
and the value of shares underlying notes was
$657,142.66.
|
Additional
Disclosures
Conversion
Price
With
respect to the shares being registered pursuant to this registration statement,
the conversion price was based on the average closing price of our
stock on the five trading days prior to the March 28, 2007
agreement. Those prices were $.40, $.34, $.33, $.33 and $.34,
respectively, or an average of $.35 per share. The $500,000 Stillwater
Notes converts into 1,428,571 shares of common stock at $.35 per share. The
number of warrants issued was established at 70% of the underlying conversion
shares. The Stillwater Notes allow the investor at the time of conversion
to also convert any outstanding interest into shares of common
stock. Interest is paid quarterly therefore the maximum outstanding
interest would be three months interest on $500,000 or at 6% per annum
$7,500. This interest could be converted into 21,429 shares of common
stock at the $.35 conversion price if the principal is converted and such
interest is accrued and unpaid at the time of conversion of
principal.
Shares
underlying conversion rights
|
|
|
1,428,571
|
|
Shares
underlying warrants
|
|
|
1,000,000
|
|
Shares
underlying interest conversion
|
|
|
21,429
|
|
Total
shares to register
|
|
|
2,450,000
|
|
Payments to be made in
connection with the transaction
In
connection with the transaction, below is a disclosure of the dollar amount of
each payment (including the value of any payments to be made in common stock) in
connection with the transaction that the Company has made or may be required to
make to the selling stockholder, any affiliate of the selling stockholder, or
any person with whom any selling shareholder has a contractual relationship
regarding the transaction (including any interest payments, liquidated damages,
payments made to “finders” or “placement agents,” and any other payments or
potential
payments):
Fees
|
|
Amount
($)
|
|
|
|
|
|
Accounting
Fees (1)
|
|
|
25,000
|
|
SEC
Registration Fees (2)
|
|
|
113
|
|
Legal
Fees (3)
|
|
|
65,000
|
|
Roth
Capital (4)
|
|
|
35,000
|
|
Total
|
|
|
125,113
|
|
(1)
Represents the estimated amount of services by the Company’s auditors,
Eisner LLP, in connection with services rendered for this
transaction.
|
|
(2)
Represents the Company’s previously paid filing fees in connection with
the registration statement.
|
|
(3)
Amount represents estimated fees. As of the date of the filing of this
registration statement, $33,000 in legal fees have been
incurred.
|
|
(4)
Represents the placement agent fee.
|
|
Potential Net Proceeds to
the Company in the Convertible Note Transaction
Below are
the potential net proceeds to the Company from the sale of the Convertible Notes
and the total possible payments to the selling stockholder and its affiliates in
the first year following the sale of convertible notes:
Net
Proceeds
To
Issuer
|
|
|
Interest
(10
months)
|
|
|
Note
Redemption
|
|
|
Total
Payments
|
|
$
|
391,417
|
|
|
$
|
25,000
|
|
|
$
|
500,000
|
|
|
$
|
525,000
|
|
Potential Total Profit to
the Selling Stockholders from the Secured Convertible
Debentures
Below is
the total possible profit the selling stockholder could realize as a result of
the conversion discount for the securities underlying the convertible note,
along with the following information:
·
|
the
market price per share of the securities underlying the convertible note
on the date of the sale of the convertible note;
|
·
|
the
conversion price per share of the underlying securities on the date of the
sale of the convertible note;
|
·
|
the
total possible shares underlying the convertible note (assuming no
interest payments and complete conversion throughout the term of the
note);
|
·
|
the
combined market price of the total number of shares underlying the
convertible note, calculated by using the market price per share on the
date of the sale of the convertible note and the total possible shares
underlying the convertible note;
|
·
|
the
total possible shares the selling stockholder may receive and the combine
conversion price of the total number of shares underlying the convertible
note; and
|
·
|
the
total possible discount to the market price as of the date of the sale of
the convertible note.
|
Market
Price
Per
Share of
Securities
|
|
|
Conversion
Price
Per Share of
Underlying
Securities
|
|
|
Total
Possible
Shares
Underlying
The
Convertible
Debentures
(1)
|
|
|
Market
Value
(Market
Price
Per Share *
Total
Possible
Shares)
(1)
|
|
|
Conversion
Value
of the Total Number
Shares
Underlying
The
Convertible
Debentures
|
|
|
Total
Possible Discount
To
Market Price as of
The
Date of Sale of
The
Convertible Note
(1)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
0.46
|
|
|
$
|
0.35
|
|
|
|
1,428,571
|
|
$ 657,143
|
|
|
$
|
500,000
|
|
|
$
|
157,143
|
|
|
|
(1) The
Secured Convertible Debenture contains a reset provision, in that the conversion
price of the convertible debenture shall be lowered in the event that we issue
shares of common stock, or securities convertible into shares of common stock,
at a lower price than the then current conversion price. As of the date of the
filing of this registration statement, the conversion price of the convertible
debenture has not been reduced as a result of any stock issuances or the
issuances of any securities convertible into shares of common stock, at a lower
price than the current conversion price.
Potential Profit to be
Realized as a Result of any Conversion Discounts Held by the Selling
Stockholder
The below
table discloses the total possible profit to be realized as a result of any
conversion discounts for securities underlying any other warrants, options,
notes, or other securities of the registrant that are held by the selling
stockholder or any affiliates of the selling stockholder, along
with:
·
|
the
market price per share of the underlying securities on the date of the
sale of that other security;
|
·
|
the
conversion/exercise price per share as of the date of the sale of that
other security;
|
·
|
the
combined market price of the total number of underlying shares, calculated
by using the market price per share on the date of the sale of that other
security and the total possible shares to be received;
|
·
|
the
total possible shares to be received and the combined conversion price of
the total number of shares underlying the other security calculated by
using the conversion price on the date of the sale of that other security
and the total possible number of underlying shares; and
|
·
|
the
total possible discount (premium) to the market price as of the date of
the sale of that other security, calculated by subtracting the total
conversion/exercise price on the date of the sale of that other security
from the combined market price of the total number of underlying shares on
that date:
|
·
|
the
market price per share of the underlying securities on the date of the
sale of that other security;
|
·
|
the
conversion/exercise price per share as of the date of the sale of that
other security;
|
·
|
the
combined market price of the total number of underlying shares, calculated
by using the market price per share on the date of the sale of that other
security and the total possible shares to be received;
|
·
|
the
total possible shares to be received and the combined conversion price of
the total number of shares underlying the other security calculated by
using the conversion price on the date of the sale of that other security
and the total possible number of underlying shares; and
|
·
|
the
total possible discount (premium) to the market price as of the date of
the sale of that other security, calculated by subtracting the total
conversion/exercise price on the date of the sale of that other security
from the combined market price of the total number of underlying shares on
that date:
|
Date
|
Entity
|
|
Shares
|
|
Instrument
|
|
Market
|
|
|
Conversion
|
|
|
Market
|
|
|
Conversion
|
|
|
Discount
|
|
|
|
|
|
|
|
|
Price
|
|
|
Price
|
|
|
Value
|
|
|
Value
|
|
|
(Premium)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3/28/2007
|
Stillwater
|
|
|
1,000,000
|
|
Warrant
|
|
$
|
0.46
|
|
|
$
|
0.48
|
|
|
$
|
460,000
|
|
|
$
|
480,000
|
|
|
$
|
(20,000
|
)
|
7/21/2006
|
Rainbow
Gate (Stillwater Affiliate )
|
|
|
269,231
|
|
Convertible
Note
|
|
$
|
2.60
|
|
|
$
|
2.60
|
|
|
$
|
700,001
|
|
|
$
|
700,001
|
|
|
$
|
-
|
|
7/21/2006
|
Rainbow
Gate (Stillwater Affiliate )
|
|
|
188,462
|
|
Warrant
|
|
$
|
2.60
|
|
|
$
|
3.60
|
|
|
$
|
490,001
|
|
|
$
|
678,463
|
|
|
$
|
(188,462
|
)
|
10/20/2005
|
Rainbow
Gate (Stillwater Affiliate)
|
|
|
54,546
|
|
Warrant
|
|
$
|
8.70
|
|
|
$
|
10.00
|
|
|
$
|
474,550
|
|
|
$
|
545,460
|
|
|
$
|
(70,910
|
)
|
10/28/2004
|
Rainbow
Gate (Stillwater Affiliate)
|
|
|
29,742
|
|
Warrant
|
|
$
|
10.40
|
|
|
$
|
8.60
|
|
|
$
|
309,317
|
|
|
$
|
255,781
|
|
|
$
|
53,536
|
|
3/4/2004
|
Stillwater
|
|
|
51,778
|
|
Warrant
|
|
$
|
24.90
|
|
|
$
|
27.60
|
|
|
$
|
1,289,272
|
|
|
$
|
1,429,073
|
|
|
$
|
(139,801
|
)
|
6/20/2002
|
Stillwater
|
|
|
30,000
|
|
Warrant
|
|
$
|
3.20
|
|
|
$
|
4.26
|
|
|
$
|
96,000
|
|
|
$
|
127,800
|
|
|
$
|
(31,800
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
|
1,623,759
|
|
|
|
|
|
|
|
|
|
|
|
$
|
3,819,141
|
|
|
$
|
4,216,578
|
|
|
$
|
(397,437
|
)
|
Gross Proceeds Paid or
Payable to the Company in the Convertible Note Transactions
The below
table discloses the gross proceeds paid or payable to the registrant in the
convertible note transaction, along with the following information:
·
|
all
payments that have been made or that may be required to be made by the
registrant;
|
·
|
the
resulting net proceeds to the registrant; and
|
·
|
the
combined total possible profit to be realized as a result of any
conversion discounts regarding the securities underlying the convertible
notes and any other warrants, options, notes, or other securities of the
registrant that are held by the selling stockholder or any affiliates of
the selling stockholder (as disclosed elsewhere in this registration
statement).
|
Gross
|
|
|
Fees
|
|
|
Net
|
|
|
Discount
|
|
|
Premium
|
|
|
Combined
|
|
Proceeds
|
|
|
|
|
|
Proceeds
|
|
|
|
|
|
|
|
|
Premium
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
500,000
|
|
|
$
|
108,583
|
|
|
$
|
391,417
|
|
|
|
157,143
|
|
|
$
|
(397,437
|
)
|
|
$
|
(240,294
|
)
|
The below
table discloses the total amount of all possible payments and the total possible
discount to the market price of the shares underlying the convertible note
divided by the net proceeds to the registrant from the sale of the convertible
notes as well as the amount of that resulting percentage averaged over the term
of the convertible notes:
|
|
|
|
|
%
of Net
|
|
|
Monthly
|
|
Item
|
|
Amount
|
|
|
Proceeds
|
|
|
Average
|
|
Total
Potential Payments
|
|
$
|
525,000
|
|
|
|
134
|
%
|
|
|
13
|
%
|
Total
Possible Discount
|
|
$
|
157,143
|
|
|
|
40
|
%
|
|
|
4
|
%
|
Prior Securities
Transactions Between the Issuer and the Selling Stockholder
Below is
a tabular disclosure of prior securities transactions after March 2004 between
the issuer (or any of its predecessors) and the selling stockholder, any
affiliates of the selling stockholder, or any person with whom the selling
stockholder has a contractual relationship regarding the transaction (or any
predecessors of those persons), with the table including the following
information disclosed separately for each transaction:
·
|
the
date of the transaction;
|
·
|
the
number of shares of the class of securities subject to the transaction
that were outstanding prior to the transaction;
|
·
|
the
number of shares of the class of securities subject to the transaction
that were outstanding prior to the transaction and held by persons other
than the selling stockholder, affiliates of the company, or affiliates of
the selling stockholder;
|
·
|
the
number of shares of the class of securities subject to the transaction
that were issued or issuable in connection with the
transaction;
|
·
|
the
percentage of total issued and outstanding securities that were issued or
issuable in the transaction (assuming full issuance), with the percentage
calculated by taking the number of shares issued or issuable in connection
with the applicable transaction and dividing that number by the number of
shares issued and outstanding prior to the applicable transaction and held
by persons other than the selling stockholder, affiliates of the company,
or affiliates of the selling stockholder;
|
·
|
the
market price per share of the class of securities subject to the
transaction immediately prior to the transaction; and
|
·
|
the
current market price per share of the class of securities subject to the
transaction.
|
Date
|
|
Prior
|
|
|
Shares
Held
|
|
|
Prior
|
|
|
Shares
|
|
|
Shares
|
|
|
%
of
|
|
|
Market
|
|
|
Current
|
|
|
|
Outstanding
|
|
|
and
Affiliates
|
|
|
(a)
- (b)
|
|
|
Transaction
|
|
|
To
Selling
|
|
|
Net
|
|
|
Day
|
|
|
Price
|
|
|
|
(a)
|
|
|
(b)
|
|
|
Shares
|
|
|
Stock
& Warrants
|
|
|
Shareholder
|
|
|
Offer
|
|
|
Prior
|
|
|
10/08/07
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3/28/2007
|
|
|
11,049,164
|
|
|
|
2,043,987
|
|
|
|
9,005,177
|
|
|
|
2,450,000
|
|
|
|
2,450,000
|
|
|
|
27
|
%
|
|
$
|
0.40
|
|
|
$
|
0.90
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
7/21/2006
|
|
|
10,052,249
|
|
|
|
1,523,832
|
|
|
|
8,528,417
|
|
|
|
4,108,845
|
|
|
|
650,001
|
|
|
|
48
|
%
|
|
$
|
2.60
|
|
|
$
|
0.90
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10/20/2005
|
|
|
9,978,786
|
|
|
|
1,496,832
|
|
|
|
8,481,954
|
|
|
|
2,659,049
|
|
|
|
145,454
|
|
|
|
31
|
%
|
|
$
|
7.90
|
|
|
$
|
0.90
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10/28/2004
|
|
|
6,625,759
|
|
|
|
1,309,152
|
|
|
|
5,309,152
|
|
|
|
1,950,000
|
|
|
|
276,071
|
|
|
|
37
|
%
|
|
$
|
10.70
|
|
|
$
|
0.90
|
|
Relationship Between Shares
Issued and Outstanding and Shares Held by Selling
Stockholders
The
following tabular disclosure reflects:
·
|
the
number of shares outstanding prior to the convertible note transaction
that are held by persons other than the selling stockholder, affiliates of
the Company, and affiliates of the selling stockholder;
|
·
|
the
number of shares registered for resale by the selling stockholder or
affiliates of the selling stockholder in prior registration
statements;
|
·
|
the
number of shares registered for resale by the selling stockholder or
affiliates of the selling stockholder that continue to be held by the
selling stockholder or affiliates of the selling
stockholder;
|
·
|
the
number of shares that have been sold in registered resale transactions by
the selling stockholder or affiliates of the selling stockholder;
and
|
·
|
the
number of shares registered for resale on behalf of the selling
stockholder or affiliates of the selling stockholder in the current
transaction.
|
The
number of shares stated in the first column of the table
below,
“Shares not held by affiliates or selling stockholder prior to
Note”, is based solely upon shares actually issued and outstanding as of the
March 28, 2007. However, the other columns of the table include securities
underlying outstanding convertible securities, options, or warrants held by
selling stockholder.
Shares
Not
|
Shares
|
|
Shares
|
Shares
to be
|
|
Held
by
|
Registered
by
|
Registered
|
Sold
in
|
Registered
in
|
Affiliates
or
|
Selling
Stockholder
|
Shares
|
Registered
|
Current
|
Selling
Stockholder
|
in
Previous
|
To
Be Held
|
Resale
|
Transaction
|
Prior
to Note
|
Filings
|
Selling
Stockholder
|
Transactions
|
|
|
|
|
|
|
|
|
9,005,177
|
1,757,744
|
1,610,244
|
147,500
|
2,450,000
|
|
Company’s Financial Ability
to Satisfy its Obligations to the Selling Shareholder
The
Company has the intention, and a reasonable basis to believe that it will have
the financial ability, to make payments on the overlying securities. The Company
has duly accounted for such payments in its 2007 - 2009 comprehensive strategy
and financial plan.
Existing Short Positions by
Selling Shareholder
Based
upon information provided by the selling shareholder, to the best of
management’s knowledge, the Company is not aware of the selling shareholder
having an existing short position in the Company’s common stock.
Relationships Between the
Company and Selling Shareholder and Affiliates
The
Company hereby confirms that a description of the relationships and arrangements
between and among those parties already is presented in the prospectus and that
all agreements between and/or among those parties are included as exhibits to
the registration statement by incorporation by reference.
TRANSACTIONS WITH RELATED PERSONS,
PROMOTERS AND CERTAIN
CONTROL PERSONS
2008
On April
2, 2008, the Company completed a private placement of its common stock with
several institutional investors for gross proceeds of $1,650,000. The
transaction involved the sale of 1,586,539 shares of common stock at $1.04 per
share, or the 5-day average closing price of the Company’s common stock on the
trading days immediately preceding the closing date. The Company also
issued to the investors 793,273 warrants to buy our common stock at a price of
$1.30 per share. Pursuant to the transaction, the Company filed a
registration statement for the shares issued as well as shares underlying the
warrants on April 29, 2008. Stillwater (as defined above) and Ginola
Limited participated in the private placement. Stillwater and Ginola
Limited are beneficial owners of more than 5% of the Company’s common
stock.
2007
As
previously reported in the Form 8-K of the Company dated as of July 25, 2007, on
July 23, 2007, the Company entered into Amendment Agreements (the Amendment
Agreements”) with the note holders and issued 8% Amended Senior Secured
Convertible Notes (“Amended Notes”) to the note holders in the principal amount
equal to the principal amount outstanding as of July 23, 2007. The due date for
the principal payment was extended to December 21, 2008 and the interest rate
increased to 8%. The Amended Notes are convertible into 8,407,612 shares of the
Company’s common stock. The conversion price for approximately $5,770,000 of
principal was revised from $2.60 to $.75 per share and the conversion price of
$.35 per share for $250,000 of principal was unchanged. $3,010,000 of the Notes
can convert into 3,010 shares of the Company’s newly formed Series A Convertible
Preferred Stock (the “Preferred”) at a conversion price of $1,000 per share. The
Preferred is convertible into common stock at the same price allowable by
the Amended Notes, subject to adjustment as provided for in the Certificate
of Designations. The Amendment Agreements adjusted the exercise price, except
for the Stillwater Warrant (as defined above), from $3.60 to $1.03
per share for 1,553,468 warrants and require the issuance of 3,831,859 warrants
exercisable at $1.03 per share pursuant to which the note holders may acquire
common stock, until July 21, 2011.
Two
employees and one board member participated in the Amendment Agreements. Olivier
Prache, Senior VP of Display Operations, has an Amended Note of $10,000 which
may be converted into 13,333 shares, received 9,333 warrants which are
exercisable at $1.03 per share, and has 5,385 warrants which are exercisable at
$3.60 per share. John Atherly, former CFO as of January 2, 2008, has
an Amended Note of $40,000 which may be converted into 53,333 shares and
received 37,333 warrants which are exercisable at $1.03 per
share. Paul Cronson, Board member, through Navacorp III, LLC,
has an Amended Note of $200,000 which may be converted into 266,666 shares and
received 186,666 warrants which are exercisable at $1.03 per share.
Stillwater
is a beneficial owner of more than 5% of the Company’s common
stock. Rainbow Gate Corporation, a corporation in which its
investment manager is the sole member of Stillwater and its controlling
shareholder is the same as Ginola Limited, has an Amended Note of $700,000 which
may be converted into 933,333 shares and received 653,333 warrants exercisable
at $1.03 per share. Ginola Limited has an Amended Note of $800,000
which may be converted into 1,066,333 shares and received 746,666 warrants
exercisable at $1.03 per share.
Alexandra
Global Master Fund Ltd (“Alexandra”) is a beneficial owner of more than 5% of
the Company’s common stock. Alexandra has an Amended Note of $3
million which may be converted into 4 million shares and received 2.8 million
warrants exercisable at $1.03 per share.
On March
28, 2007, the Company entered into an amendment to the Stillwater Agreement (as
defined above), originally dated July 21, 2006. On April 9, 2007, the sale of
the Stillwater Note (as defined above) and Stillwater Warrant was complete and
the Company issued a 6% Senior Secured Convertible Note in the principal amount
of $500,000 and warrants to purchase 1,000,000 shares of the Company’s common
stock at an exercise price of $0.48. On July 23, 2007, Stillwater elected to
convert $250,000 of the principal amount of the Stillwater Note and
approximately $2,167 of accrued and unpaid interest. Stillwater received 720,476
shares of Common Stock at the conversion price of $0.35. The
remaining 50% was amended to an 8% Amended Senior Secured Convertible Note on
July 23, 2007.
A family
member of an outside director of the Company is the holder of a Series A warrant
to purchase an aggregate of 4,286 shares of common stock. As a result of the
Stillwater transaction, the exercise price of all Series A warrants was reduced
from $5.50 to $0.35 per share. Family members of an outside
director of the Company are holders of Series F warrants to purchase an
aggregate of 10,000 shares of common stock. As a result of the
debt transactions, the exercise price of all Series F warrants was ultimately
reduced from $8.60 to $4.09 per share.
On July
21, 2006, the Company entered into several Note Purchase Agreements for the sale
of approximately $5.99 million of senior secured debentures (the “Notes”) and
warrants to purchase approximately 1.8 million shares of common stock, par value
$.001 per share. The investors purchased $5.99 million principal amount of Notes
with conversion prices of $2.60 per share that may convert into approximately
2.3 million shares of common stock and 5 year warrants exercisable at $3.60 per
share into approximately 1.6 million shares of common stock. If the Notes are
not converted, 50% of the principal amount will be due on July 21, 2007 and the
remaining 50% will be due on January 21, 2008. If the due date falls on a
non-business day, the payment date will be due on the next business day.
Commencing September 1, 2006, 6% interest is payable in quarterly installments
on outstanding notes.
In the
Note Purchase transaction, two employees and one board member participated.
Olivier Prache, Senior VP of Display Operations, purchased a $30,000 promissory
note which may be converted into 11,539 shares and received 8,077 warrants which
are exercisable at $3.60 per share. Mr. Prache converted $20,000 of his
promissory note and received 7,693 shares. John Atherly, CFO, purchased a
$40,000 promissory note which may be converted into 15,385 shares and received
10,770 warrants exercisable at $3.60 per share. Paul Cronson, board
member, through Navacorp III, LLC purchased a $200,000 promissory
note which may be converted into 76,923 shares and received 53,847 warrants
exercisable at $3.60 per share.
Stillwater
is a beneficial owner of more than 5% of the Company’s common stock. Rainbow
Gate Corporation, a corporation in which its investment manager is the sole
member of Stillwater and its controlling shareholder is the same as Ginola
Limited, purchased a $700,000 promissory note which may be converted into
269,231 shares and received 188,462 warrants exercisable at $3.60 per share.
Ginola Limited purchased an $800,000 promissory note which may be converted into
307,693 shares and received 215,385 warrants exercisable at $3.60 per share.
Stillwater disclaims beneficial ownership of shares owned by Rainbow Gate
Corporation.
A family
member of an outside director of the Company is the holder of a Series A warrant
to purchase an aggregate of 4,286 shares of common stock. As a result of the
Note Purchase transaction, the exercise price of all Series A warrants was
reduced from $5.50 to $2.60 per share. Family members of an outside director of
the Company are holders of Series F warrants to purchase an aggregate of 10
thousand shares of common stock. As a result of the Note Purchase transaction,
the exercise price of all Series F warrants was reduced from $10.90 to $8.60 per
share.
The
Company has entered into a financial advisory agreement with Larkspur Capital
Corporation. Paul Cronson, a director of the Company, is a founder and
shareholder of Larkspur Capital Corporation. The Company has agreed to pay a
minimum fee of $500 thousand to Larkspur Capital Corporation in the event
certain transactions occur, i.e. sale of the Company’s assets or change of
control.
2005
On
October 20, 2005, the Company entered into a Securities Purchase Agreement to
sell to certain qualified institutional buyers and accredited investors an
aggregate of 1,661,906 shares of the Company’s common stock, par value $0.001
per share (the “Shares”), and warrants to purchase an additional 997,143 shares
of common stock, for an aggregate purchase price of approximately $9.1 million.
The purchase price of the common stock and corresponding warrant was $5.50 per
share.
Rainbow
Gate Corporation, a corporation in which its investment manager is the sole
member of Stillwater and its controlling shareholder is the same as Ginola
Limited, participated in the sale of equity pursuant to the Securities Purchase
Agreement by investing $500,000. Stillwater disclaims beneficial ownership of
shares owned by Rainbow Gate Corporation.
Chelsea
Trust Company, as trustee of a trust with the same directors and/or controlling
shareholders as Ginola Limited, participated in the sale of equity pursuant to
the Securities Purchase Agreement by investing $250,000. Ginola Limited
disclaims beneficial ownership of shares owned by Chelsea Trust
Company.
In
connection with the issuance of the Shares and the warrants pursuant to the
Securities Purchase Agreement, the Company was required to lower the exercise
prices of existing Series A and F warrants from $10.50 and $12.10, respectively,
to $5.50 and $10.90 per share, respectively, pursuant to the anti-dilution
provisions of the Series A and F warrants.
A family
member of an outside director of the Company is the holder of a Series A warrant
to purchase an aggregate of 4,286 shares of common stock. Accordingly, the
exercise price of all Series A warrants was reduced from $10.50 to $5.50 per
share.
Director
Independence
Board of
Directors has determined that Messrs. Thomas Paulsen, Claude Charles, Jacob
Goldman, Irwin Engelman, and Stephen Seay are
each independent directors as of December 31, 2007. Thomas
Paulsen was not an independent director during the period January through May
2008 when he was acting Interim CEO and President. As of June 1,
2008, Thomas Paulsen is an independent director.
The Board
of Directors has established a compensation committee which is
currently comprised of Thomas Paulsen, Jacob Goldman, and Stephen Seay each of
whom is independent as of December 31, 2007. Thomas Paulsen was
not an independent director during the period January through May 2008 when he
was acting Interim CEO and President. As of June 1, 2008, Thomas
Paulsen is an independent director.
The Board of Directors has established
a corporate governance and nominating committee, which is comprised of
Thomas Paulsen and Jacob Goldman, each of whom is independent as of
December 31, 2007. Thomas Paulsen was not an independent director during the
period January through May 2008 when he was acting Interim CEO and
President. As of June 1, 2008, Thomas Paulsen is an independent
director.
The
Board of Directors has a separately
designated audit committee established in accordance with
Section 3(a)(58)(A) of the Securities Exchange Act of 1934, which is
currently comprised of Claude Charles, Irwin Engelman, and Steve Seay. The
members of the Audit Committee are independent.
All
future transactions, if any, between us and any of our officers, directors and
principal security holders and their affiliates, as well as any transactions
between us and any entity with which our officers, directors or principal
security holders are affiliated, will be approved in accordance with applicable
law governing the approval of the transactions.
Promoter
and Certain Control Persons
Not
applicable.
LEGAL MATTERS
Sichenzia
Ross Friedman & Ference LLP will issue an opinion with respect to the
validity of the shares of common stock being offered hereby.
EXPERTS
Eisner
LLP, Independent Registered Public Accountants, have audited, as set forth in
their report thereon appearing in this Prospectus and Registration Statement,
our financial statements as of December 31, 2007 and 2006 and for each of the
years in the three year period ended December 31, 2007, which report
included an explanatory paragraph expressing substantial doubt as to our
ability to continue as a going concern. The financial statements referred to
above are included herein in reliance upon the auditors’ opinion based on their
expertise in accounting and auditing.
We have
filed a registration statement on Form S-1 under the Securities Act of 1933, as
amended, relating to the shares of common stock being offered by this
prospectus, and reference is made to such registration statement. This
prospectus constitutes the prospectus of eMagin Corp., filed as part of the
registration statement, and it does not contain all information in the
registration statement, as certain portions have been omitted in accordance with
the rules and regulations of the Securities and Exchange
Commission.
We are
subject to the informational requirements of the Securities Exchange Act of 1934
which requires us to file reports, proxy statements and other information with
the Securities and Exchange Commission. Such reports, proxy statements and other
information may be inspected at public reference facilities of the SEC at 100 F
Street, N.E., Washington D.C. 20549. Copies of such material can be obtained
from the Public Reference Section of the SEC at 100 F Street, N.E., Washington,
D.C. 20549 at prescribed rates. Because we file documents electronically with
the SEC, you may also obtain this information by visiting the SEC’s Internet
website at http://www.sec.gov.
INDEX
TO CONSOLIDATED FINANCIAL STATEMENTS
|
|
|
Page
|
|
|
Report
of Independent Registered Public Accounting Firm
|
67
|
Consolidated
Balance Sheets as of December 31, 2007 and 2006
|
68
|
Consolidated
Statements of Operations for the years ended December 31, 2007, 2006, and
2005
|
69
|
Consolidated
Statements of Changes in Shareholders’ Equity (Capital Deficit) for the
years ended December 31, 2007,
2006,
and 2005
|
70
|
Consolidated
Statements of Cash Flows for the years ended December 31, 2007, 2006, and
2005
|
71
|
Notes
to the Consolidated Financial Statements
|
72
|
|
73
|
REPORT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
Board of
Directors and Stockholders
eMagin
Corporation
We have
audited the accompanying consolidated balance sheets of eMagin Corporation (the
"Company") as of December 31, 2007 and 2006, and the related consolidated
statements of operations, shareholders' equity (capital deficit) and cash flows
for each of the three years in the period ended December 31,
2007. These financial statements are the responsibility of the
Company's management. Our responsibility is to express an opinion on
these financial statements based on our audits.
We
conducted our audits in accordance with the standards of the Public Company
Accounting Oversight Board (United States). Those standards require
that we plan and perform the audit to obtain reasonable assurance about whether
the financial statements are free of material misstatement. We were
not engaged to perform an audit of the Company's internal control over financial
reporting. Our audits include consideration of internal control over
financial reporting as a basis for designing audit procedures that are
appropriate in the circumstances, but not for the purpose of expressing an
opinion on the effectiveness of the Company's internal control over financial
reporting. Accordingly, we express no such opinion. An
audit includes examining, on a test basis, evidence supporting the amounts and
disclosures in the financial statements. An audit also includes
assessing the accounting principles used and significant estimates made by
management, as well as evaluating the overall financial statement
presentation. We believe that our audits provide a reasonable basis
for our opinion.
In our
opinion, the financial statements referred to above present fairly, in all
material respects, the consolidated financial position of eMagin Corporation as
of December 31, 2007 and 2006, and the consolidated results of its
operations and its consolidated cash flows for each of the three years in the
period ended December 31, 2007 in conformity with accounting principles
generally accepted in the United States of America.
The
accompanying financial statements have been prepared assuming that the Company
will continue as a going concern. As discussed in Note 2 to the
consolidated financial statements, the Company has had recurring losses from
operations which it believes will continue, and has working capital and capital
deficits at December 31, 2007. These factors raise substantial
doubt about the Company's ability to continue as a going
concern. Management's plans in regard to these matters are also
discussed in Note 2. The consolidated financial statements do not
include any adjustments that might result from the outcome of this
uncertainty.
As
discussed in Note 2 to the consolidated financial statements, the Company
changed its method of accounting for stock-based compensation effective
January 1, 2006.
\
s\ Eisner
LLP
New York,
New York
April 9,
2008
eMAGIN
CORPORATION
CONSOLIDATED
BALANCE SHEETS
|
|
December 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
|
(In
thousands, except
|
|
|
|
share
and per share amounts)
|
|
ASSETS
|
|
Current
assets:
|
|
|
|
|
|
|
Cash
and cash equivalents
|
|
$
|
713
|
|
|
$
|
1,415
|
|
Investments
– held to maturity
|
|
|
94
|
|
|
|
171
|
|
Accounts
receivable, net
|
|
|
2,383
|
|
|
|
908
|
|
Inventory
|
|
|
1,815
|
|
|
|
2,485
|
|
Prepaid
expenses and other current assets
|
|
|
850
|
|
|
|
656
|
|
Total
current assets
|
|
|
5,855
|
|
|
|
5,635
|
|
Equipment,
furniture and leasehold improvements, net
|
|
|
292
|
|
|
|
666
|
|
Intangible
assets, net
|
|
|
51
|
|
|
|
55
|
|
Other
assets
|
|
|
232
|
|
|
|
233
|
|
Deferred
financing costs, net
|
|
|
218
|
|
|
|
416
|
|
Total
assets
|
|
$
|
6,648
|
|
|
$
|
7,005
|
|
|
|
LIABILITIES
AND CAPITAL DEFICIT
|
|
Current
liabilities:
|
|
|
|
|
|
|
|
|
Accounts
payable
|
|
$
|
620
|
|
|
$
|
1,192
|
|
Accrued
compensation
|
|
|
891
|
|
|
|
959
|
|
Other
accrued expenses
|
|
|
729
|
|
|
|
749
|
|
Advance
payments
|
|
|
35
|
|
|
|
444
|
|
Deferred
revenue
|
|
|
179
|
|
|
|
126
|
|
Current
portion of debt
|
|
|
7,089
|
|
|
|
1,223
|
|
Derivative
liability - warrants
|
|
|
—
|
|
|
|
1,195
|
|
Other
current liabilities
|
|
|
1,020
|
|
|
|
52
|
|
Total
current liabilities
|
|
|
10,563
|
|
|
|
5,940
|
|
|
|
|
|
|
|
|
|
|
Long-term
debt
|
|
|
60
|
|
|
|
2,229
|
|
Total
liabilities
|
|
|
10,623
|
|
|
|
8,169
|
|
|
|
|
|
|
|
|
|
|
Commitments
and contingencies
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Capital
deficit:
|
|
|
|
|
|
|
|
|
Preferred
stock, $.001 par value: authorized 10,000,000 shares; no shares issued and
outstanding
|
|
|
—
|
|
|
|
—
|
|
Series
A Senior Secured Convertible Preferred stock, stated value $1,000 per
share, $.001 par value: 3,198 shares designated and none
issued
|
|
|
—
|
|
|
|
—
|
|
Common
stock, $.001 par value: authorized 200,000,000 shares, issued and
outstanding, 12,620,900 shares in 2007 and 10,341,029 shares in
2006
|
|
|
12
|
|
|
|
10
|
|
Additional
paid in capital
|
|
|
195,326
|
|
|
|
179,651
|
|
Accumulated
deficit
|
|
|
(199,313
|
)
|
|
|
(180,825
|
)
|
Total
capital deficit
|
|
|
( 3,975
|
)
|
|
|
( 1,164
|
)
|
Total
liabilities and capital deficit
|
|
$
|
6,648
|
|
|
$
|
7,005
|
|
|
|
|
|
|
|
|
|
|
See notes to Consolidated Financial
Statements
.
eMAGIN
CORPORATION
CONSOLIDATED
STATEMENTS OF OPERATIONS
|
|
For the Year Ended December
31,
|
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
|
(In
thousands, except per share data)
|
|
Revenue:
|
|
|
|
|
|
|
|
|
|
Product
revenue
|
|
$
|
16,169
|
|
|
$
|
7,983
|
|
|
$
|
3,709
|
|
Contract
revenue
|
|
|
1,385
|
|
|
|
186
|
|
|
|
36
|
|
Total
revenue, net
|
|
|
17,554
|
|
|
|
8,169
|
|
|
|
3,745
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost
of goods sold
|
|
|
12,628
|
|
|
|
11,359
|
|
|
|
10,219
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross
profit (loss)
|
|
|
4,926
|
|
|
|
(3,190
|
)
|
|
|
(6,474
|
)
|
Operating
expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
Research
and development
|
|
|
2,949
|
|
|
|
4,406
|
|
|
|
4,020
|
|
Selling,
general and administrative
|
|
|
6,591
|
|
|
|
8,860
|
|
|
|
6,316
|
|
Total
operating expenses
|
|
|
9,540
|
|
|
|
13,266
|
|
|
|
10,336
|
|
Loss
from operations
|
|
|
(4,614
|
)
|
|
|
(16,456
|
)
|
|
|
(16,810
|
)
|
Other
income (expense):
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest
expense
|
|
|
(3,087
|
)
|
|
|
(1,306
|
)
|
|
|
(4
|
)
|
Loss
on extinguishment of debt
|
|
|
(10,749
|
)
|
|
|
—
|
|
|
|
—
|
|
(Loss)
gain on warrant derivative liability
|
|
|
(853
|
)
|
|
|
2,405
|
|
|
|
—
|
|
Other
income, net
|
|
|
815
|
|
|
|
91
|
|
|
|
286
|
|
Total
other (expense) income, net
|
|
|
(13,874
|
)
|
|
|
1,190
|
|
|
|
282
|
|
Net
loss
|
|
$
|
(18,488
|
)
|
|
$
|
(15,266
|
)
|
|
$
|
(16,528
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss
per share, basic and diluted
|
|
$
|
(1.59
|
)
|
|
$
|
(1.52
|
)
|
|
$
|
(1.94
|
)
|
Weighted
average number of shares outstanding:
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
and diluted
|
|
|
11,633
|
|
|
|
10,058
|
|
|
|
8,541
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
See notes to Consolidated Financial
Statements
.
eMAGIN
CORPORATION
CONSOLIDATED
STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY (CAPITAL DEFICIT)
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
|
Common
Stock
|
|
|
Additional
|
|
|
Accumulated
|
|
|
Shareholders’
Equity
|
|
|
|
Shares
|
|
|
Amount
|
|
|
Paid
–in Capital
|
|
|
Deficit
|
|
|
(Capital
Deficit)
|
|
|
|
(In
thousands)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance,
December 31, 2004
|
|
|
7,964
|
|
|
$
|
8
|
|
|
$
|
165,471
|
|
|
$
|
(149,031
|
)
|
|
$
|
16,448
|
|
Sale
of common stock, net of issuance costs
|
|
|
1,662
|
|
|
|
2
|
|
|
|
8,398
|
|
|
|
—
|
|
|
|
8,400
|
|
Stock
options exercised
|
|
|
11
|
|
|
|
—
|
|
|
|
37
|
|
|
|
—
|
|
|
|
37
|
|
Exercise
of common stock warrants
|
|
|
306
|
|
|
|
—
|
|
|
|
1,584
|
|
|
|
—
|
|
|
|
1,584
|
|
Issuance
of common stock for services
|
|
|
54
|
|
|
|
—
|
|
|
|
461
|
|
|
|
—
|
|
|
|
460
|
|
Net
loss
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
(16,528
|
)
|
|
|
(16,528
|
)
|
Balance,
December 31, 2005
|
|
|
9,997
|
|
|
$
|
10
|
|
|
$
|
175,950
|
|
|
$
|
(165,559
|
)
|
|
$
|
10,401
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt
to equity conversion
|
|
|
85
|
|
|
|
—
|
|
|
|
220
|
|
|
|
—
|
|
|
|
220
|
|
Issuance
of common stock for services
|
|
|
254
|
|
|
|
—
|
|
|
|
580
|
|
|
|
—
|
|
|
|
580
|
|
Stock-based
compensation
|
|
|
—
|
|
|
|
—
|
|
|
|
2,891
|
|
|
|
—
|
|
|
|
2,891
|
|
Stock
options exercised
|
|
|
5
|
|
|
|
—
|
|
|
|
10
|
|
|
|
—
|
|
|
|
10
|
|
Net
loss
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
(15,266
|
)
|
|
|
(15,266
|
)
|
Balance,
December 31, 2006
|
|
|
10,341
|
|
|
$
|
10
|
|
|
|
179,651
|
|
|
$
|
(180,825
|
)
|
|
$
|
(1,164
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt
to equity conversion
|
|
|
797
|
|
|
|
1
|
|
|
|
310
|
|
|
|
—
|
|
|
|
311
|
|
Issuance
of common stock for services
|
|
|
1,473
|
|
|
|
1
|
|
|
|
1,324
|
|
|
|
—
|
|
|
|
1,325
|
|
Exercise
of common stock warrants
|
|
|
10
|
|
|
|
—
|
|
|
|
3
|
|
|
|
—
|
|
|
|
3
|
|
Stock-based
compensation
|
|
|
—
|
|
|
|
—
|
|
|
|
1,652
|
|
|
|
—
|
|
|
|
1,652
|
|
Expiration
of derivative liability- warrants
|
|
|
—
|
|
|
|
—
|
|
|
|
2,653
|
|
|
|
—
|
|
|
|
2,653
|
|
Beneficial
conversion premium
|
|
|
—
|
|
|
|
—
|
|
|
|
5,078
|
|
|
|
—
|
|
|
|
5,078
|
|
Fair
value of warrants issued
|
|
|
—
|
|
|
|
—
|
|
|
|
4,655
|
|
|
|
—
|
|
|
|
4,655
|
|
Net
loss
|
|
|
—
|
|
|
|
—
|
|
|
|
|
|
|
|
(18,488
|
)
|
|
|
(18,488
|
)
|
Balance,
December 31, 2007
|
|
|
12,621
|
|
|
$
|
12
|
|
|
$
|
195,326
|
|
|
$
|
(199,313
|
)
|
|
$
|
(
3,975
|
)
|
See notes
to Consolidated Financial Statements.
eMAGIN
CORPORATION
CONSOLIDATED
STATEMENTS OF CASH FLOWS
|
|
Year Ended December 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
|
(In
thousands)
|
|
Cash
flows from operating activities:
|
|
|
|
|
|
|
|
|
|
Net
loss
|
|
$
|
(18,488
|
)
|
|
$
|
(15,266
|
)
|
|
$
|
(16,528
|
)
|
Adjustments
to reconcile net loss to net cash used in operating
activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation
and amortization
|
|
|
392
|
|
|
|
841
|
|
|
|
908
|
|
Amortization
of deferred financing fees
|
|
|
418
|
|
|
|
221
|
|
|
|
---
|
|
Reduction
of provision for sales returns and doubtful accounts
|
|
|
(79
|
)
|
|
|
(39
|
)
|
|
|
(284
|
)
|
Stock
based compensation
|
|
|
1,652
|
|
|
|
2,891
|
|
|
|
---
|
|
Issuance
of common stock for services, net
|
|
|
1,325
|
|
|
|
553
|
|
|
|
470
|
|
Amortization
of discount on notes payable
|
|
|
1,925
|
|
|
|
956
|
|
|
|
---
|
|
Loss
(gain) on warrant derivative liability
|
|
|
853
|
|
|
|
(2,405
|
)
|
|
|
---
|
|
Loss
on extinguishment of debt
|
|
|
10,749
|
|
|
|
---
|
|
|
|
---
|
|
Loss
on other asset
|
|
|
---
|
|
|
|
157
|
|
|
|
---
|
|
Write-off
of miscellaneous receivable
|
|
|
103
|
|
|
|
---
|
|
|
|
---
|
|
Changes
in operating assets and liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Accounts
receivable
|
|
|
(1,390
|
)
|
|
|
(42
|
)
|
|
|
(2
|
)
|
Inventory
|
|
|
670
|
|
|
|
1,354
|
|
|
|
(1,821
|
)
|
Prepaid
expenses and other current assets
|
|
|
(194
|
)
|
|
|
389
|
|
|
|
(175
|
)
|
Advance
payments
|
|
|
(409
|
)
|
|
|
384
|
|
|
|
(4
|
)
|
Deferred
revenue
|
|
|
53
|
|
|
|
30
|
|
|
|
96
|
|
Accounts
payable, accrued compensation, and accrued expenses
|
|
|
(381
|
)
|
|
|
(566
|
)
|
|
|
1,613
|
|
Other
current liabilities
|
|
|
858
|
|
|
|
153
|
|
|
|
14
|
|
Net
cash used in operating activities
|
|
|
(1,943
|
)
|
|
|
(10,389
|
)
|
|
|
(15,713
|
)
|
Cash
flows from investing activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Purchase
of equipment
|
|
|
(16
|
)
|
|
|
(204
|
)
|
|
|
(898
|
)
|
Proceeds
from maturity of (purchase of) investments – held to
maturity
|
|
|
77
|
|
|
|
(51
|
)
|
|
|
(120
|
)
|
Purchase
of intangibles and other assets
|
|
|
---
|
|
|
|
(2
|
)
|
|
|
(54
|
)
|
Net
cash provided by (used in) investing activities
|
|
|
61
|
|
|
|
(257
|
)
|
|
|
(1,072
|
)
|
Cash
flows from financing activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds
from sale of common stock, net of issuance costs
|
|
|
---
|
|
|
|
---
|
|
|
|
8,400
|
|
Proceeds
from exercise of stock options and warrants
|
|
|
3
|
|
|
|
10
|
|
|
|
1,621
|
|
Proceeds
from long-term debt
|
|
|
1,608
|
|
|
|
5,970
|
|
|
|
50
|
|
Payments
related to deferred financing costs
|
|
|
(368
|
)
|
|
|
(591
|
)
|
|
|
---
|
|
Payments
of long-term debt and capitalized lease obligations
|
|
|
(63
|
)
|
|
|
(55
|
)
|
|
|
(16
|
)
|
Net
cash provided by financing activities
|
|
|
1,180
|
|
|
|
5,334
|
|
|
|
10,055
|
|
Net
decrease in cash and cash equivalents
|
|
|
(702
|
)
|
|
|
(5,312
|
)
|
|
|
(6,730
|
)
|
Cash
and cash equivalents, beginning of year
|
|
|
1,415
|
|
|
|
6,727
|
|
|
|
13,457
|
|
Cash
and cash equivalents, end of year
|
|
$
|
713
|
|
|
$
|
1,415
|
|
|
$
|
6,727
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash
paid for interest
|
|
$
|
426
|
|
|
$
|
128
|
|
|
$
|
4
|
|
Cash
paid for taxes
|
|
$
|
78
|
|
|
$
|
40
|
|
|
$
|
15
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Supplemental
non-cash transactions:
|
|
|
|
|
|
|
|
|
|
|
|
|
Conversion
of debt to equity
|
|
$
|
311
|
|
|
$
|
220
|
|
|
$
|
---
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
During
the year ended December 31, 2007, the Company
|
|
|
|
|
|
|
|
|
|
|
|
|
·
|
Entered into an
intellectual property agreement with Kodak where Kodak was assigned the
rights to a specific patent and as part of the consideration waived the
royalty payments for the first six months of 2007 and reduced the royalty
payment to 50% for the third and fourth quarters of 2007. $869
thousand was recorded as other income from the gain on the licensing of
intangible assets
;
|
·
|
Entered
into an amended Note Purchase Agreement with investors and issued warrants
that are exercisable at $1.03 per share into approximately 5.4 million
shares of common stock valued at $5.5
million.
|
See notes
to Consolidated Financial Statements
.
NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS
Note
1 - NATURE OF BUSINESS
eMagin
Corporation and its wholly owned subsidiary (the “Company”)
designs, develops, manufactures, and markets virtual imaging products
for consumer, commercial, industrial and military applications. The
Company’s products are sold mainly in North America, Asia, and
Europe.
Note
2 - SIGNIFICANT ACCOUNTING POLICIES
Principles
of consolidation
The
accompanying audited consolidated financial statements include the accounts of
eMagin Corporation and its wholly owned subsidiary. All intercompany
transactions have been eliminated in consolidation.
Basis
of presentation
The
consolidated financial statements have been prepared assuming that the Company
will continue as a going concern. The Company has had recurring losses
from operations which it believes will continue for the foreseeable
future. The Company’s cash requirements over the next twelve months are
greater than the Company’s current cash, cash equivalents, and
investments. At December 31, 2007, the Company has working capital
and capital deficits. These factors raise substantial doubt regarding the
Company’s ability to continue as a going concern without continuing to obtain
additional funding. The Company does not have commitments for such
financing and no assurance can be given that additional financing will be
available, or if available, will be on acceptable terms. If the Company is
unable to obtain sufficient funds during the next twelve months, the Company
will further reduce the size of its organization and/or curtail operations which
will have a material adverse impact on the Company’s business prospects. The
consolidated financial statements do not include any adjustments that might
result from the outcome of this uncertainty. To partially address the liquidity
issue, the Company completed a private placement of its common stock for gross
proceeds of $1.65 million on April 2, 2008. Please see Note 17 –
Subsequent Events for additional information.
On
November 3, 2006, the Company effected a one-for-ten (1-for-10) reverse stock
split of its issued and outstanding common stock. All common
and per share amounts in the accompanying financial statements have been
adjusted to reflect the 1-for-10 reverse stock split.
Use
of estimates
In
accordance with accounting principles generally accepted in the United States of
America, management utilizes certain estimates and assumptions that affect the
reported amounts of assets and liabilities at the date of the financial
statements and the reported amounts of revenues and expenses during the
reporting period. On an on-going basis, management evaluates its estimates and
judgments. Management bases its estimates and judgments on historical experience
and on various other assumptions that are believed to be reasonable under the
circumstances, the results of which form the basis for making judgments about
the carrying values of assets and liabilities that are not readily apparent from
other sources. Actual results could differ from those estimates.
Revenue and cost
recognition
Revenue
is recognized when products are shipped to customers, net of allowances for
anticipated returns. The Company’s revenue-earning
activities generally involve delivering products and revenues
are considered to be earned when the Company has completed the process
by which it is entitled to such revenues.
Revenue is recognized when persuasive evidence of
an arrangement exists, delivery has occurred, selling price is
fixed or determinable and collection is reasonably assured. The
Company defers revenue recognition on products sold directly to the consumer
with a fifteen day right of return. Revenue is recognized upon the
expiration of the right of return.
The
Company also earns revenues from certain R&D activities under
both firm fixed-price contracts and cost-type
contracts, including some cost-plus-fee contracts.
Revenues relating to firm fixed-price contracts are
generally recognized on the percentage-of-completion method
of accounting as costs are incurred (cost-to-cost basis).
Revenues on cost-plus-fee contracts include costs incurred plus a
portion of estimated fees or profits based on the relationship of costs incurred
to total estimated costs. Contract costs include all direct material and
labor costs and an allocation of allowable indirect costs as
defined by each contract, as periodically adjusted to reflect revised
agreed upon rates. These rates are subject to audit by the other
party.
Research and
development expenses
Research
and development costs are expensed as incurred.
Cash
and cash equivalents
All
highly liquid instruments with an original maturity of three months or less at
the date of purchase are considered to be cash equivalents.
Investments-held
to maturity
Securities
that the Company has the positive intent and ability to hold to maturity are
classified as held-to-maturity and are carried at amortized cost on the
accompanying balance sheet.
Accounts
receivable
The
majority of the Company’s commercial accounts receivable is due from Original
Equipment Manufacturers ("OEM’s”). Credit is extended based on evaluation of a
customer’s financial condition and, generally, collateral is not required.
Accounts receivable are payable in U.S. dollars, are due within 30-90 days and
are stated at amounts due from customers net of an allowance for doubtful
accounts. Any account outstanding longer than the contractual payment terms is
considered past due.
Allowance for doubtful
account
The
allowance for doubtful accounts reflects an estimate of probable losses inherent
in the accounts receivable balance. The allowance is determined based on a
variety of factors, including the length of time receivables are past due,
historical experience, the customer's current ability to pay its obligation, and
the condition of the general economy and the industry as a whole. The
Company will record a specific reserve for individual accounts when the Company
becomes aware of a customer's inability to meet its financial obligations, such
as in the case of bankruptcy filings or deterioration in the customer's
operating results or financial position. If circumstances related to customers
change, the Company would further adjust estimates of the recoverability of
receivables.
Inventory
Inventory
is stated at the lower of cost or market. Cost is determined using the first-in
first-out method. Cost includes materials, labor, and manufacturing overhead
related to the purchase and production of inventories. The Company regularly
reviews inventory quantities on hand, future purchase commitments with the
Company’s suppliers, and the estimated utility of the inventory. If the Company
review indicates a reduction in utility below carrying value, the inventory is
reduced to a new cost basis.
Equipment,
furniture and leasehold improvements
Equipment,
furniture and leasehold improvements are stated at cost. Depreciation on
equipment is calculated using the straight-line method of depreciation over its
estimated useful life. Amortization of leasehold improvements is calculated by
using the straight-line method over the shorter of their estimated useful lives
or lease terms. Expenditures for maintenance and repairs are charged to expense
as incurred.
In
accordance with SFAS No. 144, "Accounting for the Impairment or Disposal of
Long-Lived Assets," the Company performs impairment tests on its long-lived
assets when circumstances indicate that their carrying amounts may not be
recoverable. If required, recoverability is tested by comparing the estimated
future undiscounted cash flows of the asset or asset group to its carrying
value. Impairment losses, if any, are recognized based on the excess of the
assets' carrying amounts over their estimated fair values.
Intangible
Assets
The
Company’s intangible assets consist of patents that are amortized over their
estimated useful lives of fifteen years using the straight line
method. Total intangible amortization expense was approximately $4
thousand for each of the years ended December 31, 2007, 2006, and 2005,
respectively.
Advertising
Costs
related to advertising and promotion of products is charged to sales and
marketing expense as incurred. Advertising expense for the years
ended December 31, 2007, 2006, and 2005 was $10 thousand, $296 thousand, and
$108 thousand, respectively.
Income
taxes
The
Company accounts for income taxes in accordance with the provisions of Statement
of Financial Accounting Standards No. 109, “Accounting for Income Taxes” (“SFAS
No. 109”). SFAS No. 109 requires that the Company recognize deferred
tax liabilities and assets for the expected future tax consequences of events
that have been included in the financial statements or tax
returns. Under this method, deferred tax liabilities and assets are
determined on the basis of the difference between the tax basis of assets and
liabilities and their respective financial reporting amounts (“temporary
differences”) at enacted tax rates in effect for the years in which the
temporary differences are expected to reverse. The Company records an
estimated valuation allowance on its deferred income tax assets if it is more
likely than not that these deferred income tax assets will not be
realized.
Loss
per common share
In
accordance with SFAS No. 128, "Basic Earnings Per Share", net loss per common
share amounts ("basic EPS") is computed by dividing net loss by the weighted
average number of common shares outstanding and excluding any potential
dilution. Net loss per common share amounts assuming dilution ("diluted EPS")
reflects the potential dilution from the exercise of stock options and warrants.
These common equivalent shares have been excluded from the computation of
diluted EPS for all periods presented as their effect is antidilutive. The years
ended December 31, 2007, 2006, and 2005 do not include options and warrants to
purchase common equivalent shares of 9,234,832, 4,613,919, and 4,424,988,
respectively, as their effect would be antidilutive.
Comprehensive
income (loss)
SFAS No.
130, "Reporting Comprehensive Income", requires companies to report all changes
in equity during a period, except those resulting from investment by owners and
distributions to owners, for the period in which they are recognized.
Comprehensive income (loss) is the total of net income (loss) and other
comprehensive income (loss) items, such as unrealized gains or losses on foreign
currency translation adjustments. Comprehensive income (loss) must be reported
on the face of the annual financial statements. The Company's operations did not
give rise to any material items includable in comprehensive income (loss), which
were not already in net loss for the years ended December 31, 2007, 2006, and
2005. Accordingly, the Company's comprehensive loss is the same as its net
income (loss) for the periods presented.
Stock-based
compensation
On
January 1, 2006, the Company adopted the provisions of SFAS No. 123R,
“Share-Based Payment”, which requires the Company to recognize expense related
to the fair value of the Company’s share-based compensation issued to employees
and directors. Prior to January 1, 2006, the Company accounted for
share-based compensation under the recognition and measurement provisions of
APB No. 25 and related interpretations, as permitted by SFAS No.
123. We adopted SFAS No. 123R using the modified prospective
transition method. Accordingly, periods prior to adoption have not
been restated. Compensation cost recognized for the twelve months
ended December 31, 2007 and 2006 includes a) compensation cost for all
share-based compensation granted prior to, but not vested as of January 1, 2006,
based on the grant-date fair value estimated in accordance with the original
provisions of SFAS No.123 and b) compensation cost for all share-based
compensation granted beginning January 1, 2006, based on the grant-date fair
value estimated in accordance with the provisions of SFAS
No.123R. The compensation cost was recognized using the straight-line
attribution method. See Note 11 for a further discussion
on stock-based compensation.
Fair value of financial
instruments
At
December 31, 2007, the Company's cash, cash equivalents, accounts receivable,
short-term investments, accounts payable and debt are shown at cost which
approximates fair value due to the short-term nature of these
instruments.
Concentration
of Credit Risk
Financial
instruments which potentially subject the Company to concentrations of credit
risk consist of cash and cash equivalents. The Company’s cash and
cash equivalents are deposited with financial institutions which, at times, may
exceed federally insured limits. To date, the Company has not
experienced any loss associated with this risk.
Note
3- RECENTLY ISSUED ACCOUNTING STANDARDS
In
September 2006, the FASB issued SFAS No. 157, “Fair Value Measurements” (SFAS
157”). SFAS 157 provides guidance for using fair value to measure
assets and liabilities. It also responds to investors’ requests for
expanded information about the extent to which companies measure assets and
liabilities at fair value, the information used to measure fair value, and the
effect of fair value measurements on earnings. SFAS 157 applies
whenever other standards require (or permit) assets or liabilities to be
measured at fair value, and does not expand the use of fair value in any new
circumstances. SFAS 157 is effective for financial statements issued
for fiscal years beginning after November 15, 2007. SFAS 157 is
effective for the Company on January 1, 2008 and is not expected to have a
material impact on its consolidated results of operations and financial
condition.
In
February 2007, the FASB issued Statement No. 159, “The Fair Value Option for
Financial Assets and Financial
Liabilities: (“SFAS159”). SFAS159 allows entities the
option to measure eligible financial instruments at fair value as of specified
dates. Such election, which may be applied on an instrument by instrument basis,
is typically irrevocable once elected. SFAS 159 is effective for fiscal years
beginning after November 15, 2007, and early application is allowed under
certain circumstances. SFAS 159 is effective for the Company on January 1, 2008
and is not expected to have a material impact on its consolidated results of
operations and financial condition.
In June
2007, the FASB ratified EITF No. 07-03, “Accounting for Nonrefundable Advance
Payments for Goods or Services Received for Future Research and Development
Activities (“EITF 07-03”). EITF 07-03 requires that
nonrefundable advance payments for goods or services that will be used or
rendered for future research and development activities be deferred and
capitalized and recognized as an expense as the goods are delivered or the
related services are performed. EITF 07-03 is effective, on a
prospective basis, for fiscal years beginning after December 15,
2007. The Company will be required to adopt EITF 07-03 in the first
quarter of 2008. The Company does not expect the adoption of EITF
07-03 to have a material effect on its operations or financial
position.
Note
4- RECEIVABLES
Receivables
consisted of the following (in thousands):
|
|
December
31,
|
|
|
|
2007
|
|
|
2006
|
|
Trade
receivables
|
|
$
|
2,741
|
|
|
$
|
1,351
|
|
Less
allowance for doubtful accounts
|
|
|
(358
|
)
|
|
|
(443
|
)
|
Net
receivables
|
|
$
|
2,383
|
|
|
$
|
908
|
|
Note
5 - INVENTORY
The
components of inventories were as follows (in thousands):
|
|
December
31,
|
|
|
|
2007
|
|
|
2006
|
|
Raw
materials
|
|
$
|
1,069
|
|
|
$
|
1,146
|
|
Work
in process
|
|
|
370
|
|
|
|
558
|
|
Finished
goods
|
|
|
376
|
|
|
|
781
|
|
Total
inventory
|
|
$
|
1,815
|
|
|
$
|
2,485
|
|
Note
6 – PREPAID EXPENSES AND OTHER CURRENT ASSETS
Prepaid
expenses and other current assets consist of the following (in
thousands):
|
|
December
31,
|
|
|
|
2007
|
|
|
2006
|
|
Vendor
prepayments
|
|
$
|
537
|
|
|
$
|
294
|
|
Other
prepaid expenses*
|
|
|
310
|
|
|
|
353
|
|
Other
current assets
|
|
|
3
|
|
|
|
9
|
|
Total
prepaid expenses and other current assets
|
|
$
|
850
|
|
|
$
|
656
|
|
*No
individual amounts greater than 5% of current assets.
Note
7 – EQUIPMENT, FURNITURE AND LEASEHOLD IMPROVEMENTS
Equipment,
furniture and leasehold improvements consist of the following (in
thousands):
|
|
December
31,
|
|
|
|
2007
|
|
|
2006
|
|
Computer
hardware and software
|
|
$
|
1,025
|
|
|
$
|
1,017
|
|
Lab
and factory equipment
|
|
|
3,318
|
|
|
|
3,312
|
|
Furniture,
fixtures, and office equipment
|
|
|
306
|
|
|
|
306
|
|
Assets
under capital leases
|
|
|
66
|
|
|
|
66
|
|
Leasehold
improvements
|
|
|
473
|
|
|
|
473
|
|
Total
equipment, furniture and leasehold improvements
|
|
|
5,188
|
|
|
|
5,174
|
|
Less: accumulated
depreciation
|
|
|
(4,896
|
)
|
|
|
(4,508
|
)
|
Equipment,
furniture and leasehold improvements, net
|
|
$
|
292
|
|
|
$
|
666
|
|
Depreciation
expense was $388 thousand, $837 thousand, and $904 thousand for the years ended
December 31, 2007, 2006, and 2005, respectively. Assets under capital
leases are fully amortized.
Note
8 - DEBT
Debt is
as follows (in thousands):
|
|
December
31,
|
|
|
|
2007
|
|
|
2006
|
|
Current
portion of long-term debt:
|
|
|
|
|
|
|
Capitalized
lease obligations
|
|
$
|
—
|
|
|
$
|
6
|
|
Other
debt
|
|
|
44
|
|
|
|
58
|
|
Line
of credit
|
|
|
1,108
|
|
|
|
|
|
6%
Senior Secured Convertible Notes
|
|
|
—
|
|
|
|
2,880
|
|
Less: Unamortized
discount on notes payable
|
|
|
—
|
|
|
|
(1,721
|
)
|
8%
Amended Senior Secured Convertible Notes
|
|
|
5,962
|
|
|
|
—
|
|
Less: Unamortized
discount on notes payable
|
|
|
(25
|
)
|
|
|
—
|
|
Current
portion of long-term debt, net
|
|
|
7,089
|
|
|
|
1,223
|
|
Long-term
debt:
|
|
|
|
|
|
|
|
|
Other
debt
|
|
|
60
|
|
|
|
104
|
|
6%
Senior Secured Convertible Notes
|
|
|
—
|
|
|
|
2,890
|
|
Less: Unamortized
discount on notes payable
|
|
|
—
|
|
|
|
(765
|
)
|
Long-term
debt, net
|
|
|
60
|
|
|
|
2,229
|
|
Total
debt, net
|
|
$
|
7,149
|
|
|
$
|
3,452
|
|
Maturities
with respect to the other debt, line of credit and the 8% Amended Senior Secured
Convertible Notes as of December 31, 2007 are as follows (in
thousands):
Years
Ending December 31,
|
|
|
|
2008
|
|
$
|
7,089
|
|
2009
|
|
|
60
|
|
On July
23, 2007, an investor elected to convert approximately $252 thousand of the 6%
Senior Secured Convertible Note (“Original Note”) representing $250 thousand of
the principal amount of the Note due on July 23, 2007 and approximately $2
thousand of accrued and unpaid interest. The investor received 720,476 shares of
Common Stock at the conversion price of $0.35.
On July
23, 2007, the Company entered into Amended Agreements with the note holders of
the Original Notes issued July 21, 2006 and March 28, 2007 and agreed to issue
each holder an 8% Amended Senior Secured Convertible Note (“Amended
Note”)
in the
principal amount equal to the principal amount outstanding as of July 23, 2007
which was in total approximately $6.0 million. The significant changes to the
Amended Notes include the following:
·
|
The
due dates have been changed from July 23, 2007 and January 21, 2008 to
December 21, 2008;
|
·
|
The
annual interest has been changed from 6% to 8%;
|
·
|
The
Amended Notes are convertible into 8,407,612 shares of the Company’s
common stock. The conversion price for $5.8 million of
principal is at a conversion price of $0.75, originally $2.60 and the
conversion price for $250,000 of principal remains the same at
$0.35;
|
·
|
The
Agreement adjusts the exercise price of the amended Warrants from $3.60 to
$1.03 per share for 1,553,468 shares of common stock and requires the
issuance of warrants for an additional 3,831,859 shares of common stock at
$1.03 per share with an expiration date of July 21,
2011. The warrants are subject to anti-dilution
adjustment rights;
|
·
|
50%
of the Amended Notes can be converted into the Company’s newly designated
Series A Senior Secured Convertible Preferred Stock which is convertible
into common stock at the same rate as the Amended
Notes;
|
·
|
The
liquidated damages of 1% per month will no longer accrue and the deferred
balance at July 23, 2007 is forgiven; and
|
·
|
There
is no minimum cash or cash equivalents balance
requirement.
|
Under the
guidance of EITF 96-19, “Debtor’s Accounting for a Modification or Exchange of
Debt Instruments”, the Company determined the change in the present value of the
expected cash flows between the Amended Notes and the Original Notes issued July
21, 2006 was greater than 10%; therefore (a) for financial reporting purposes,
the modifications to the Original Notes issued July 21, 2006 were treated as an
extinguishment of debt and (b) on July 23, 2007, the Company recorded a loss on
extinguishment of debt of approximately $10.7 million reflecting the difference
between (i) the recorded amount of debt, net of related discounts, of
approximately $4.8 million and (ii) the fair value of the new debt instrument of
approximately $10.7 plus the change in the fair value of the
warrants on July 23, 2007, the date of the modification, of
approximately $4.7 million. The Company has also recorded a
beneficial conversion charge of approximately $5.1 million on the Amended Notes
adjusting the Amended Notes to their face value of approximately $5.8
million. The Original Note issued on March 28, 2007 and amended on
July 23, 2007 was not treated as an extinguishment but a
modification.
On August
16, 2007, an investor elected to convert approximately $58 thousand of the
Amended Note. The investor received 76,923 shares of Common Stock at the
conversion price of $0.75.
On August
7, 2007, the Company entered
into a loan agreement
with Moriah Capital, L.P. (“Moriah)
and established a
revolving line of credit (the “Loan”) of $2.5 million. The Company is
permitted to borrow an amount not to exceed 90% of its eligible accounts
receivable and 50% of its eligible inventory capped at $600
thousand. As part of the transaction, the Company issued 162,500
shares of unregistered common stock valued at $195 thousand and paid a servicing
fee of $82,500 to Moriah which will be amortized to interest expense over the
life of the agreement. For the year ended December 31, 2007,
approximately $93 thousand was amortized to interest expense. In
conjunction with entering into this loan and issuing unregistered common stock,
the Company granted Moriah registration rights. The Loan can be
converted into shares of the Company’s common stock pursuant to the terms of the
Loan Conversion agreement. The Loan matures on August 8, 2008 however
the Company has the option of extending it an additional year. On
January 30 and on March 25, 2008, the loan agreement was
amended. Please see Note 17 - Subsequent Events for additional
information.
For the
year ended December 31, 2007, interest expense consisted of interest paid or
accrued on outstanding debt of $836 thousand.
Note
9 - INCOME TAXES
The
difference between the statutory federal income tax rate on the Company's
pre-tax income and the Company's effective income tax rate is summarized as
follows:
|
|
For
the years ended December 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
U.S.
Federal income tax provision (benefit) at federal statutory
rate
|
|
|
(34)%
|
|
|
|
(34)%
|
|
|
|
(35)%
|
|
Change
in valuation allowance
|
|
|
2
%
|
|
|
|
32%
|
|
|
|
35%
|
|
Permanent
difference
|
|
|
32%
|
|
|
|
2%
|
|
|
|
—
|
|
|
|
|
0
%
|
|
|
|
0%
|
|
|
|
0%
|
|
The tax
effects of significant items comprising the Company’s deferred taxes as of
December 31 are as follows (numbers are in thousands):
|
|
For
the years ended December 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
Federal
and state net operating loss carry-forwards
|
|
$
|
42,266
|
|
|
$
|
41,554
|
|
|
$
|
37,159
|
|
Research
and development carry-forwards
|
|
|
1,397
|
|
|
|
—
|
|
|
|
—
|
|
Other
provision and expenses not currently deductible
|
|
|
1,746
|
|
|
|
520
|
|
|
|
216
|
|
Total
deferred tax assets
|
|
|
45,409
|
|
|
|
42,074
|
|
|
|
37,375
|
|
Less
valuation allowance
|
|
|
(45,409
|
)
|
|
|
(42,074
|
)
|
|
|
(37,375
|
)
|
Net
deferred tax asset
|
|
$
|
0
|
|
|
$
|
0
|
|
|
$
|
0
|
|
As of
December 31, 2007, eMagin has federal and state net operating loss carryforwards
of approximately $150 million and $1.4 million that will be available to offset
future taxable income, if any, through December 2027. The utilization of net
operating losses is subject to a limitation due to the change of ownership
provisions under Section 382 of the Internal Revenue Code and similar state
provisions. Such limitation may result in the expiration of the net operating
losses before their utilization. The Company has done preliminary analysis
regarding prior year ownership changes, and although more analysis needs to be
done, we have tentatively determined that the Section 382 limitation on the
utilization of net operating losses is not material.
As of
December 31, 2007 and 2006, the Company has net deferred tax assets of
approximately of $45 and $42 million
,
respectively, primarily
resulting from the future tax benefit of net operating loss
carryforwards. Such net deferred tax assets are fully offset by a
valuation allowance due to the uncertainty as to their
realizability. A valuation allowance has been established to reserve
for the deferred tax assets arising from the net operating losses and other
temporary differences due to the uncertainty that their benefit will be realized
in the future. The valuation allowance increased approximately $3.3 million for
the year ended December 31, 2007 and $4.7 million for the year ended December
31, 2006.
The
Company adopted the provisions of FASB Interpretation No. 48, Accounting for
Uncertainty in Income Taxes, on January 1, 2007. The Company did not
have unrecognized tax benefits which would require an adjustment to the January
1, 2007 beginning balance of retained earnings. The Company did not
have any unrecognized tax benefits at January 1, 2007 and December 31,
2007.
The
Company recognizes interest accrued and penalties related to unrecognized tax
benefits in tax expense. During the years ended December 31, 2007 and
2006 the Company recognized no interest and penalties.
The
Company files income tax returns in the U.S. federal jurisdiction and New
York. The tax years 2004-2006 remain open to examination by major
taxing jurisdictions to which the Company is subject.
Note
10 - SHAREHOLDERS' EQUITY
Preferred
Stock
2007
The
Company has designated but not issued 3,198 shares of the Company’s preferred
stock as Series A Senior Secured Convertible Preferred Stock (“the Preferred
Stock”) at a stated value of $1,000 per share. The Preferred Stock is
entitled to cumulative dividends which accrue at a rate of 8% per annum, payable
on December 21, 2008. Each share of the Preferred Stock has voting
rights equal to (1) in any case in which the Preferred Stock votes
together with the Company's Common Stock or any other class or series of stock
of the Company, the number of shares of Common Stock issuable upon conversion of
such shares of Preferred Stock at such time (determined without regard to the
shares of Common Stock so issuable upon such conversion in respect of accrued
and unpaid dividends on such share of Preferred Stock) and (2) in any case not
covered by the immediately preceding clause one vote per share of Preferred
Stock. The Preferred Stock has a mandatory redemption at December 21,
2008.
Common
Stock
2007
On August
16, 2007, an investor elected to convert approximately $58 thousand of the
Amended Note. The investor received 76,923 shares of Common Stock at the
conversion price of $0.75.
On August
7, 2007, the Company entered
into a loan agreement
with Moriah Capital, L.P. (“Moriah)
and established a
revolving line of credit (the “Loan”) of $2.5 million. As part of the
transaction, the Company issued 162,500 shares of unregistered common stock
valued at $195 thousand, recognized as deferred financing costs, and paid a
servicing fee of $82,500 to Moriah which will be amortized to interest expense
over the life of the agreement. For the year ended December 31, 2007
approximately $116 thousand was amortized to interest expense. In
conjunction with entering into this loan and issuing unregistered common stock,
the Company granted Moriah registration rights. The Loan can be
converted to shares of the Company’s common stock pursuant to the terms of the
Loan Conversion agreement. The Loan matures on August 8, 2008 however
the Company has the option of extending it an additional year. On
January 30, and March 25, 2008, the loan agreement was
amended. Please see Note 17 - Subsequent Events for additional
information.
A
registration rights agreement was entered into in connection with the Loan which
requires the Company to file a registration statement for the resale of the
common stock issued. The Company must use its best efforts to have
the registration statement declared effective by the end of a specified grace
period and also maintain the effectiveness of the registration statement until
all shares of common stock have been sold or may be sold without volume
restrictions pursuant to Rule 144(k) of the Securities Act. Please
see Note 17 – Subsequent Events for additional information.
On July
23, 2007, the Company entered into Agreements with the note holders and agreed
to issue each holder an Amended Note in the principal amount equal to the
principal amount outstanding as of July 23, 2007 which was in total
approximately $6.0 million. The Amended Notes are convertible into 8,407,612
shares of the Company’s common stock. The conversion price for $5.8
million of principal is at a conversion price of $0.75 and the conversion price
for $250 thousand of principal remains the same at $0.35. The
Agreement adjusts the exercise price of the amended Warrants from $3.60 to $1.03
per share for 1,553,468 shares of common stock and requires the issuance of
warrants for an additional 3,831,859 shares of common stock at $1.03 per share
with an expiration date of July 21, 2011. The warrants are
subject to anti-dilution adjustment rights. 50% of the Amended Notes
can be converted into the Company’s newly designated Series A Senior Secured
Convertible Preferred Stock which is convertible into common stock at the same
rate as the Amended Notes.
The
Company had recorded the fair value of the warrants associated with the Note as
a liability as the warrant agreement required a potential net-cash settlement in
the first year of the warrant agreement if the registration statement is not
effective as required by EITF 00-19 “Accounting for Derivative Financial
Instruments Indexed to and Potentially Settled in, a Company’s Own Stock” (“EITF
00-19”). The liability was adjusted to fair value at each reporting
period. As of July 23, 2007, the potential net-cash settlement had
expired. As a result, the fair value of the warrant liability on July
23, 2007, approximately $2.7 million, was reversed. For the year
ended December 31, 2007, the Company recorded losses of approximately $0.8
million from the change in the fair value of the warrant derivative liability.
The change in the fair value of the warrant liability was recorded in the
Consolidated Statement of Operations as other income (expense).
On July
23, 2007, an investor converted $250 thousand of the principal amount of the
Original Note due on July 23, 2007 and approximately $2 thousand of accrued and
unpaid interest totaling $252 thousand and received 720,476 shares of Common
Stock at the conversion price of $0.35. On August 16, 2007, an
investor elected to convert approximately $58 thousand of the Amended Note. The
investor received 76,923 shares of Common Stock at the conversion price of
$0.75.
On March
28, 2007, the Company entered into a Note Purchase Agreement for the sale of
$500 thousand of 6% senior secured convertible debentures (the “Note”) and
warrants to purchase approximately 1,000,000 shares of common stock, par value
$.001 per share. The investor purchased the Note with a conversion
price of $0.35 per share that may convert into approximately 1,400,000 shares of
common stock and issued warrants exercisable at $0.48 per share for
approximately 1,000,000 shares of common stock expiring in July
2011. On April 9, 2007, the Company closed the transaction and
received approximately $460 thousand, net of offering costs of approximately $40
thousand, which are amortized over the life of the Note. The
Note was amended on July 23, 2007 as described in Note
8: Debt.
As a
result of the issuance of the Note, the outstanding 116,573 Series A Common
Stock Purchase Warrants, that were issued to certain accredited and/or
institutional investors pursuant to the Securities Purchase Agreement dated
January 9, 2004, were re-priced from $2.60 to $0.35 and the outstanding 650,000
Series F Common Stock Purchase Warrants, that were issued to certain accredited
and/or institutional investors pursuant to the Securities Purchase Agreement
dated October 25, 2004, were re-priced from $8.60 to $7.12. As a result of the
issuance of the Amended Notes the outstanding 650,000 Series F Common Stock
Purchase Warrants that were issued to certain accredited and/or institutional
investors pursuant to the Securities Purchase Agreement dated October 25, 2004,
were re-priced from $7.12 to $4.39 in accordance with the anti-dilution
provision of the original agreement. These warrants were further
re-priced in connection with the loan agreement with Moriah from $4.39 to
$4.09. The repricing of the warrants has no effect on the financial
statements.
For
the year ended December 31, 2007, there were no stock options exercised and the
Company received approximately $3 thousand in proceeds for warrants exercised.
For the year ended December 31, 2007, the Company also issued approximately 1.5
million shares of common stock for payment of approximately $1.3 million for
services rendered and to be rendered in the future. As such, the
Company recorded the fair value of the services rendered in
prepaid expenses and selling, general and administrative expenses
in the accompanying consolidated statement of operations for the year ended
December 31, 2007.
2006
At the
Company’s 2006 Annual Meeting of Shareholders held on October 20, 2006, the
Company’s shareholders approved an amendment to the Company’s certificate of
incorporation to effect a reverse stock split of the issued and outstanding
common stock on a ratio of 1-for-10. On November 3, 2006, the reverse
stock split became effective. The Company has adjusted its shareholders’ equity
accounts by reducing its stated capital and increasing its additional paid-in
capital by approximately $91 thousand as of December 31, 2006 and 2005 to
reflect the reduction in outstanding shares as a result of the reverse stock
split.
On July
21, 2006, the Company entered into several Note Purchase Agreements for the sale
of approximately $5.99 million of senior secured debentures (the “Notes”) and
warrants to purchase approximately 1.8 million shares of common stock, par value
$.001 per share. The investors purchased $5.99 million principal
amount of Notes with conversion prices of $2.60 per share that may convert into
approximately 2.3 million shares of common stock and 5 year warrants exercisable
at $3.60 per share into approximately 1.6 million shares of common
stock. If the Notes are not converted, 50% of the principal amount
will be due on July 23, 2007 and the remaining 50% will be due on January 21,
2008. Commencing September 1, 2006, 6% interest is payable in
quarterly installments on outstanding notes. For the year ended
December 31, 2006, the Company paid approximately $124 thousand of interest to
investors. The Company received approximately $5.4 million, net of deferred
financing costs of approximately $0.6 million which are amortized over the life
of the Notes. The Company amortized approximately $221 thousand
of deferred financing costs in 2006. For the year ended December 31, 2006, two
note holders converted their promissory notes valued at approximately $220
thousand and were issued an aggregate of approximately 85,000
shares.
Under
EITF 00-19 “Accounting for Derivative Financial Instruments Indexed to and
Potentially Settled in, a Company’s Own Stock”, the fair value of the warrants,
$3.6 million, have been recorded as a liability since the warrant agreement
requires a potential net-cash settlement in the first year of the warrant
agreement if the registration statement is not effective. As of
December 31, 2006, the registration statement is effective. The
liability will be adjusted to fair value at each reporting
period. The change in the fair value of the warrants will be recorded
in the Consolidated Statement of Operations as other income
(expense). For the twelve months ended December 31, 2006, the Company
recorded approximately $2.4 million of gain from the change in the fair value of
the derivative liability.
An
additional $0.5 million was to be invested through the exercise of a warrant to
purchase approximately 192,000 shares of common stock at $2.60 per share on or
prior to December 14, 2006, or at the election of the Company, by the purchase
of additional Notes and warrants. The Company determined the relative
fair value of the warrants to be approximately $157,000 which was recorded as an
other asset. The following assumptions were used to determine the
fair value of the warrant:
Dividend
yield
|
|
0%
|
Risk
free interest rates
|
|
5.25%
|
Expected volatility
|
|
122%
|
Expected
term (in years)
|
|
0.4
years
|
|
|
|
The
investor elected not to exercise its warrants prior to December 14,
2006. The fair value of the warrants which was recorded as an other
asset was written off as a sales, general and administrative
expense.
In
connection with the Notes, a registration rights agreement was entered into
which requires the Company to file a registration statement for the resale of
the common stock underlying the Notes and the warrants. The Company
must use its best efforts to have the registration statement declared effective
by the end of a specified grace period and also maintain the effectiveness of
the registration statement until all shares of common stock underlying the Notes
and the warrants have been sold or may be sold without volume restrictions
pursuant to Rule 144(k) of the Securities Act. If the Company fails
to have the registration statement declared effective within the grace period or
fails to maintain the effectiveness as set forth in the preceding sentence, the
Company is required to pay each investor cash payments equal to 1.0% of the
aggregate purchase price monthly until the failure is cured. If the
Company fails to pay the liquidated damages, interest at 16.0% will accrue until
the liquidated damages are paid in full. The registration statement
was filed and declared effective by the Securities and Exchange Commission
within the specified grace period.
The
Company accounts for the registration rights agreement as a separate
freestanding instrument and accounts for the liquidated damages provision as a
derivative liability subject to SFAS 133. The estimated fair value of
the derivative liability is based on an estimate of the probability and costs of
cash penalties being incurred. The Company determined that the fair
value of the liability was immaterial and it is not recorded in accrued
liabilities. The Company will revalue the potential liability at each
balance sheet date.
As a
result of the issuance of the Notes, the outstanding 116,576 Series A Common
Stock Purchase Warrants, that were issued to certain accredited and/or
institutional investors pursuant to the Securities Purchase Agreement dated
January 9, 2004, were re-priced from $5.50 to $2.60 and the outstanding 650,001
Series F Common Stock Purchase Warrants, that were issued to certain accredited
and/or institutional investors pursuant to the Securities Purchase Agreement
dated October 25, 2004, were re-priced from $10.90 to $8.60.
For the
year ended December 31, 2006, the Company received approximately $10 thousand
for the exercise of 5,000 options and there were no warrants
exercised. For year ended December 31, 2006, the Company issued
approximately 254,000 shares of common stock in lieu of cash payments in the
amount of approximately $580 thousand as compensation for services rendered
and to be rendered in the future. The fair value of the services was
measured at market value of the common stock at the time of
payment. As such, the Company recorded the fair value of the services
rendered in selling, general and administrative expenses in the accompanying
audited consolidated statement of operations for the year ended December 31,
2006.
The 2004
Non-Employee Compensation Plan (the “2004 Plan”) was established to help the
Company retain consultants, professionals and service providers. The
Board of Directors will select the recipient of the awards, the nature of the
awards and the amount. At the 2006 Annual Shareholder meeting, the shareholders
approved an increase in the number of authorized shares of common stock usable
from 200,000 to 950,000. This number is subject to adjustment in the
event of a recapitalization, reorganization or similar event.
2005
On
October 20, 2005, the Company entered into a Securities Purchase Agreement,
pursuant to which the Company sold and issued 1,661,906 shares of common stock,
par value $0.001 per share, at a price of $5.50 per share and warrants to
purchase up to 997,143 shares of common stock for an aggregate purchase price of
approximately $9.14 million. The net proceeds received after expenses
were approximately $8.4 million.
The
warrants are exercisable at a price of $10.00 per share and expire on April 20,
2011. Of the 997,143 warrants, 664,763 of the warrants are
exercisable on or after May 20, 2006. The remaining 332,381 are
exercisable after March 31, 2007, however these warrants will be cancelled if
the Company’s net revenue for fiscal year 2006 exceeds $20 million or if the
investor has sold more than 25% of the shares purchased under the securities
purchase agreement prior to December 31, 2006.
As a
result of the above transaction, the outstanding 121,335 Series A Common Stock
Purchase Warrants, that were issued to participants of the Securities Purchase
Agreement dated January 9, 2004, were re-priced from $10.50 to $5.50 and the
outstanding 650,001 Series F Common Stock Purchase Warrants, that were issued to
participants of the Securities Purchase Agreement dated October 25, 2004, were
re-priced from $12.10 to $10.90.
A
registration rights agreement was entered into in connection with the private
placement which requires the Company to file a registration statement for the
resale of the common stock and the shares underlying the
warrants. The Company must use its best efforts to have the
registration statement declared effective by the end of a specified grace period
and also maintain the effectiveness of the registration statement until all
common stock have been sold or may be sold without volume restrictions pursuant
to Rule 144(k) of the Securities Act. If the Company fails to have
the registration statement declared effective within the grace period or fails
to maintain the effectiveness, the agreement requires the Company to pay each
investor cash payments equal to 2.0% of the aggregate purchase price monthly
until the failure is cured. If the Company fails to pay the
liquidated damages, interest at 15.0% will accrue until the liquidated damages
are paid in full. The registration statement was filed and declared
effective within the specified grace period. As of December 31, 2006,
the registration statement remains effective.
The
Company accounts for the registration rights agreement as a separate
freestanding instrument and accounts for the liquidated damages provision as a
derivative liability subject to SFAS 133. The estimated fair value of
the liability is based on an estimate of the probability and costs of cash
penalties being incurred. The Company determined that the fair value
of the liability was
immaterial
and it is not recorded in accrued liabilities. The Company will
revalue the potential liability at each balance sheet date.
In 2005,
the Company received approximately $1.6 million for the exercise of
approximately 11,100 options and 306,000 warrants. The Company also
issued approximately 54,300 shares of common stock for the payment of $461
thousand of services rendered and to be rendered in the future. The
fair value of the services was measured at market value of the common stock at
the time of payment. As such, the Company recorded the fair value of
the services rendered in selling, general and administrative expenses in the
accompanying audited consolidated statement of operations for the year ended
December 31, 2005.
Note
11 - STOCK COMPENSATION
Employee
stock purchase plan
In 2005,
the stockholders approved the 2005 Employee Stock Purchase Plan
(“ESPP”). The ESPP provides the Company’s employees with the
opportunity to purchase common stock through payroll deductions. Employees
purchase stock semi-annually at a price that is 85% of the fair market value at
certain plan-defined dates. At December 31, 2007, the number of shares of common
stock available for issuance was 225,000 and the plan will automatically
increase 75,000 shares on January 1 of each year for a period of three years
starting January 1, 2006. As of December 31, 2007, the plan had not been
implemented.
Incentive
compensation plans
In 2000,
the Company established the 2000 Stock Option Plan (the "2000 Plan"). The Plan
permits the granting of options and stock purchase rights to employees and
consultants of the Company. The 2000 Plan allows for the grant of incentive
stock options meeting the requirements of Section 422 of the Internal Revenue
Code of 1986 (the "Code") or non-qualified stock options which are not intended
to meet such requirements.
In 2003,
the Company established the 2003 Stock Option Plan (the "2003 Plan"). The 2003
Plan provided for the granting of options to purchase an aggregate of 9,200,000
shares of the common stock to employees and consultants. On July 2, 2003, the
shareholders approved the plan and the 2003 Plan was subsequently amended by the
Board of Directors on July 2, 2003 to reduce the number of additional shares
that may be provided for issuance under the "evergreen" provisions of the 2003
Plan. The amended 2003 Plan provides for an increase of 2,000,000 shares in
January 2004 and an annual increase on January 1 of each year for a period of
nine (9) years commencing on January 1, 2005 of 3% of the diluted shares
outstanding. The shareholders approved an amendment to the 2003 Plan
to provide grants of shares of common stock in addition to options to purchase
shares of common stock. In 2005, approximately 2.4 million shares
were added to the plan.
On
February 20, 2008, the Board of Directors authorized the establishment of the
2008 Incentive Stock Plan. Please see Note 17 - Subsequent events for
addition information.
Vesting
terms of the options range from immediate vesting to a ratable vesting period of
5 years. Option activity for the years ended December 31, 2007, 2006 and 2005 is
summarized as follows:
|
|
Number
of Shares
|
|
Weighted
Average Exercise Price
|
|
Weighted
Average Remaining Contractual Life (In Years)
|
|
Aggregate
Intrinsic Value
|
Balances
at December 31, 2004
|
|
1,355,916
|
|
$11.40
|
|
|
|
|
Options
granted
|
|
582,400
|
|
9.60
|
|
|
|
|
Options
exercised
|
|
(11,059)
|
|
3.40
|
|
|
|
|
Options
cancelled
|
|
(121,993)
|
|
13.90
|
|
|
|
|
Balances
at December 31, 2005
|
|
1,805,264
|
|
10.90
|
|
|
|
|
Options
granted
|
|
185,744
|
|
4.30
|
|
|
|
|
Options
exercised
|
|
(5,000)
|
|
2.10
|
|
|
|
|
Options
forfeited
|
|
(453,115)
|
|
7.47
|
|
|
|
|
Options
cancelled
|
|
(467,148)
|
|
11.97
|
|
|
|
|
Balances
at December 31, 2006
|
|
1,065,745
|
|
2.94
|
|
|
|
|
Options
granted
|
|
228,577
|
|
1.41
|
|
|
|
|
Options
exercised
|
|
—
|
|
—
|
|
|
|
|
Options
forfeited
|
|
(203,943)
|
|
2.90
|
|
|
|
|
Options
cancelled
|
|
(196,056)
|
|
2.67
|
|
|
|
|
Balances
at December 31, 2007
|
|
894,323
|
|
$
2.62
|
|
5.36
|
|
$6,524
|
Vested
or expected to vest at
December
31, 2007 (1)
|
|
877,408
|
|
$
2.67
|
|
5.36
|
|
$—
|
Exercisable
at December 31, 2007
|
|
682,883
|
|
$
2.57
|
|
5.53
|
|
$—
|
(1) The
expected to vest options are the result of applying the pre-vesting forfeiture
rate assumptions to total unvested options.
At
December 31, 2007, there were 813,185 shares available for grant under the 2003
Plan and the 2000 Plan.
The
following table summarizes information about stock options outstanding at
December 31, 2007:
|
|
Options
Outstanding
|
|
Options
Exercisable
|
|
|
Number
Outstanding
|
|
Weighted
Average Remaining Contractual Life (In Years)
|
|
Weighted
Average Exercise Price
|
|
Number
Exercisable
|
|
Weighted
Average Exercisable Price
|
$1.00
- $1.51
|
|
228,577
|
|
9.60
|
|
$ 1.41
|
|
205,277
|
|
$
1.46
|
$2.60
- $2.70
|
|
624,546
|
|
3.91
|
|
2.61
|
|
445,506
|
|
2.60
|
$3.50
- $5.80
|
|
12,000
|
|
4.68
|
|
5.61
|
|
12,000
|
|
5.61
|
$6.60
- $22.50
|
|
29,200
|
|
3.57
|
|
10.91
|
|
20,100
|
|
11.23
|
|
|
894,323
|
|
5.36
|
|
$ 2.62
|
|
682,883
|
|
$
2.57
|
(1) The
expected to vest options are the result of applying the pre-vesting forfeiture
rate assumptions to total outstanding options.
The
aggregate intrinsic value in the table above represents the difference between
the exercise price of the underlying options and the quoted price of the
Company’s common stock for the options that were in-the-money. As of
December 31, 2007 there were 23,300 options that were
in-the-money. The Company’s closing stock price was $1.28 as of
December 31, 2007. The Company issues new shares of common stock upon exercise
of stock options.
On July
21, 2006, certain employees and Directors of the Company agreed to cancel
approximately 467,000 shares underlying existing stock options in return for the
re-pricing of approximately 869,000 existing options at $2.60 per share having a
weighted average original exercise price of $11.97. Option grants
that have not been re-priced remain unchanged. The unvested options
which were re-priced continue to vest on original vesting schedules, but in no
event vest prior to January 19, 2007. Previously vested options which
were re-priced were fully vested on January 19, 2007. Re-priced
grants will be forfeited if the individual leaves voluntarily. The
Company has accounted for the re-pricing and cancellation transactions as a
modification under SFAS No. 123R.
Stock based
compensation
On
January 1, 2006, the Company adopted the provisions of SFAS No. 123R, which
requires the Company to recognize expense related to the fair value of the
Company’s share-based compensation issued to employees and
directors. Prior to January 1, 2006, the Company accounted for
share-based compensation under the recognition and measurement provisions of
APB No. 25 and related interpretations, as permitted by SFAS No.
123. The Company adopted SFAS No. 123R using the modified prospective
transition method. Accordingly, periods prior to adoption have not
been restated. Compensation cost recognized for the twelve months
ended December 31, 2007 and 2006 includes a) compensation cost for all
share-based compensation granted prior to, but not vested as of January 1, 2006,
based on the grant-date fair value estimated in accordance with the original
provisions of SFAS No.123 and b) compensation cost for all share-based
compensation granted beginning January 1, 2006, based on the grant-date fair
value estimated in accordance with the provisions of SFAS
No.123R. The compensation cost was recognized using the straight-line
attribution method.
The
following table summarizes the allocation of stock-based compensation to expense
categories for the years ended December 31, 2007 and 2006 (in
thousands):
|
|
For
the years ended
December
31,
|
|
|
|
2007
|
|
|
2006
|
|
Cost
of revenue
|
|
$
|
215
|
|
|
$
|
343
|
|
Research
and development
|
|
|
357
|
|
|
|
435
|
|
Selling,
general and administrative
|
|
|
1,080
|
|
|
|
2,113
|
|
Total
stock compensation expense
|
|
$
|
1,652
|
|
|
$
|
2,891
|
|
For the
year ended December 31, 2007, stock compensation was approximately $1.7
million. At December 31, 2007, total unrecognized compensation costs
related to stock options was approximately $1.7 million, net of estimated
forfeitures. Total unrecognized compensation cost will be adjusted
for future changes in estimated forfeitures and is expected to be recognized
over a weighted average period of approximately 2.6 years. For the
year ended December 31, 2006, stock compensation was approximately $2.9
million.
The
Company recognizes compensation expense for options granted to non-employees in
accordance with the provision of Emerging Issues Task Force (“EITF”) consensus
Issue 96-18, “Accounting for Equity Instruments that are Issued to Other Than
Employees for Acquiring, or in Conjunction with Selling Goods or Services,”
which requires using a fair value options pricing model and re-measuring such
stock options to the current fair market value at each reporting period as the
underlying options vest and services are rendered.
In
determining the fair value of stock options granted during the years ended
December 31, 2007, 2006, and 2005, the following key assumptions were used in
the Black-Scholes option pricing model:
|
|
For
the years ended December 31,
|
|
|
2007
|
|
2006
|
|
2005
|
|
|
|
|
|
|
|
Dividend
yield
|
|
0%
|
|
0%
|
|
0%
|
Risk
free interest rates
|
|
3.28%
- 4.23%
|
|
4.59%
- 4.82%
|
|
4.4%
|
Expected volatility
|
|
105%
-106%
|
|
123%
- 126%
|
|
126%
|
Expected
term ( in years)
|
|
5
years
|
|
5
years
|
|
5
years
|
We have
not declared or paid any dividends and do not currently expect to do so in the
near future. The risk-free interest rate used in the Black-Scholes is
based on the implied yield currently available on U.S. Treasury securities with
an equivalent term. Expected volatility is based on the
weighted average historical volatility of the Company’s common stock for the
most recent five year period. The expected term of options represents
the period that eMagin’s stock-based awards are expected to be outstanding and
was determined based on historical experience and vesting schedules of similar
awards.
The
following table shows the proforma effect on eMagin’s net loss and net loss per
share had compensation expense been determined based on the fair value at the
award grant date in accordance with SFAS No. 123 for the twelve months ended
December 31, 2005 (in thousands, except per share data):
|
|
For
the year ended December 31, 2005
|
|
|
|
|
|
Net
loss applicable to common stockholders, as reported
|
|
$
|
(16,528
|
)
|
Add: Stock-based
employee compensation expense included in reported net
loss
|
|
|
—
|
|
Deduct:
Stock-based employee compensation expense determined under fair value
method
|
|
|
(3,035
|
)
|
Pro
forma net loss
|
|
$
|
(19,563
|
)
|
Net
loss per share:
|
|
|
|
|
Basic
and diluted, as reported
|
|
$
|
(1.94
|
)
|
Basic
and diluted, pro
forma
|
|
$
|
(2.29
|
)
|
|
|
|
|
|
Warrants
At
December 31, 2007, 8,340,509 warrants to purchase shares of common stock are
outstanding and exercisable at exercise prices ranging from $0.35 to $27.60 and
expiration dates ranging from June 10, 2008 to February 27, 2012.
|
|
Outstanding
Warrants
|
|
|
|
Shares
|
|
|
Weighted
Average Exercise Price
|
|
Balances
at December 31, 2004
|
|
|
2,161,823
|
|
|
$
|
11.40
|
|
Warrants
granted
|
|
|
997,143
|
|
|
|
10.00
|
|
Warrants
exercised
|
|
|
(370,820
|
)
|
|
|
6.10
|
|
Warrants
cancelled
|
|
|
(168,421
|
)
|
|
|
26.70
|
|
Balances
at December 31, 2005
|
|
|
2,619,725
|
|
|
$
|
10.20
|
|
Warrants
granted
|
|
|
1,805,037
|
|
|
|
3.49
|
|
Warrants
exercised
|
|
|
—
|
|
|
|
—
|
|
Warrants
expired
|
|
|
(876,588
|
)
|
|
|
6.90
|
|
Balances
at December 31, 2006
|
|
|
3,548,174
|
|
|
$
|
7.05
|
|
Warrants
granted
|
|
|
4,831,859
|
|
|
|
0.88
|
|
Warrants
exercised
|
|
|
(9,524
|
)
|
|
|
0.35
|
|
Warrants
expired
|
|
|
(30,000
|
)
|
|
|
4.26
|
|
Balances
at December 31, 2007
|
|
|
8,340,509
|
|
|
$
|
2.65
|
|
|
|
|
|
|
|
|
|
|
On
January 30 and March 25, 2008, the loan agreement with Moriah was amended and
restated and 750,000 warrants and 250,000 warrants, respectively, were issued
with exercise prices of $1.50 per share. Please see Note 17 –
Subsequent Events for additional information.
Note
12 - COMMITMENTS AND CONTINGENCIES
Royalties
The Company, in accordance with
a royalty agreement with Eastman Kodak, is obligated to make
minimum annual royalty payments of $125 thousand which commenced on January
1, 2001. Under this agreement, the Company must pay to Eastman Kodak a certain
percentage of net sales with respect to certain products, which
percentages are defined in the agreement. The percentages are on a sliding scale
depending on the amount of sales generated. Any minimum royalties
paid will be credited against the amounts due based on the percentage of
sales. The royalty agreement terminates upon the expiration of the issued
patent which is the last to expire.
Effective
May 30, 2007, Kodak and eMagin entered into an intellectual property agreement
where eMagin has assigned Kodak the rights, title, and interest to a Company
owned patent currently not being used by the Company and in consideration, Kodak
has waived the royalties due under existing licensing agreements for the first
six months of 2007, and reduced the royalty payments by 50% for the second half
of 2007 and for the entire calendar year of 2008. In addition, the minimum
royalty payment is delayed until December 1
st
for the
years 2007 and 2008. The Company recorded approximately $868 thousand
for the year ended December 31, 2007 as income from the license of intangible
assets and included this amount in other income on the Consolidated Statement of
Operations.
For the
years ended December 31, 2007, 2006, and 2005, royalty expense of approximately
$1.2 million, $515 thousand, and $191 thousand, respectively, is included in
cost of goods sold.
Operating
leases
The
Company leases office facilities and office, lab and factory equipment under
operating leases expiring through 2009. The Company currently
has lease commitments for space in Hopewell Junction, New York and Bellevue,
Washington.
The
Company’s manufacturing facilities are leased from IBM in New
York. eMagin leases approximately 40,000 square feet to house its
equipment for OLED microdisplay fabrication and for research and development, an
assembly area and administrative offices. In 2004, eMagin
entered into an agreement to extend the term of the lease until
2009.
In July
2005, eMagin signed a sub-lease agreement for approximately 19,000 square feet
in Bellevue Washington. The leased space is used as the Company’s corporate
headquarters. This lease will expire in 2009. The
Company’s lease at the Redmond Washington location expired in August 2005 and
was not renewed.
The
future minimum lease payments through 2009 are as follows (in
thousands):
2008
|
|
$
|
1,444
|
|
2009
|
|
|
538
|
|
|
|
$
|
1,982
|
|
|
|
|
|
|
Employee
benefit plans
eMagin
has a defined contribution plan (the 401(k) Plan) under Section 401(k) of the
Internal Revenue Code, which is available to all employees who meet established
eligibility requirements. Employee contributions are generally limited to 15% of
the employee's compensation. Under the provisions of the 401(k) Plan, eMagin may
match a portion of the participating employees' contributions. There was no
matching contribution to the 401(k) Plan for the years ended December 31, 2007,
2006 and 2005.
Legal
proceedings
A former
employee (“plaintiff”) of the Company commenced legal action in the United
States District Court for the Southern District of New York, on or about October
12, 2007, alleging that the plaintiff was subject to gender based discrimination
and retaliation in violation of Title VII of the Civil Rights Act of 1964 (
Case No. 07-CV-8827
(KMK)
. The plaintiff seeks unspecified compensatory damages,
punitive damages and attorneys’ fees. On November 26, 2007, the
Company served and filed its Answer, in which it denied the material allegations
of the Complaint and asserted numerous affirmative defenses. This
action is presently in the discovery stage. The Company disputes the
allegations of the Complaint and intends on vigorously defending this
action.
On
December 6, 2005, New York State Urban Development Corporation commenced action
against eMagin in the Supreme Court of the State of New York, County of New York
against eMagin, asserting breach of contract and seeking to recover a $150,000
grant which was made to eMagin based on goals set forth in the agreement for
recruitment of employees. On July 13, 2006, eMagin agreed to a
settlement with the New York State Urban Development Corporation to repay
$112,200 of the $150,000 grant. The settlement requires that repayments be made
on a monthly basis in the amount of $3,116.67 per month commencing August 1,
2006 and ending on July 1, 2009.
Note
13 – RELATED PARTY TRANSACTIONS
2007
On July
23, 2007, the Company entered into Agreements with the note holders and issued
8% Amended Senior Secured Convertible Notes (“Amended Notes”) to the note
holders in the principal amount equal to the principal amount outstanding as of
July 23, 2007. The due date for the principal payment has been extended to
December 21, 2008 and the interest rate increased to 8%. The Amended Notes are
convertible into 8,407,612 shares of the Company’s common stock. The conversion
price for approximately $5,770,000 of principal was revised from $2.60 to $.75
per share and the conversion price of $.35 per share for $250,000 of principal
was unchanged. $3,010,000 of the Notes can convert into 3,010 shares of the
Company’s newly formed Series A Convertible Preferred Stock (the “Preferred”) at
a conversion price of $1,000 per share. The Preferred is convertible into common
stock at the same price allowable by the Amended Notes, subject to
adjustment as provided for in the Certificate of Designations. The Amended Notes
adjust the exercise price from $3.60 to $1.03 per share for 1,553,468 warrants
and require the issuance of 3,831,859 warrants exercisable at $1.03 per share
pursuant to which the note holders may acquire common stock, until July 21,
2011.
Two
employees and one board member participated in the Agreements. Olivier Prache,
Senior VP of Display Operations, has an Amended Note of $10 thousand which may
be converted into 13,333 shares, received 9,333 warrants which are exercisable
at $1.03 per share, and has 5,385 warrants which are exercisable at $3.60 per
share. John Atherly, former CFO as of January 2, 2008, has an Amended
Note of $40 thousand which may be converted into 53,333 shares and received
37,333 warrants which are exercisable at $1.03 per share. Paul
Cronson, Board member, through Navacorp III, LLC, has an Amended Note of $200
thousand which may be converted into 266,666 shares and received 186,666
warrants which are exercisable at $1.03 per share.
Stillwater
LLC is a beneficial owner of more than 5% of the Company’s common
stock. Rainbow Gate Corporation, a corporation in which its
investment manager is the sole member of Stillwater LLC and its controlling
shareholder is the same as Ginola Limited, has an Amended Note of $700 thousand
which may be converted into 933,333 shares and received 653,333 warrants
exercisable at $1.03 per share. Ginola Limited has an Amended Note of
$800 thousand which may be converted into 1,066,333 shares and received 746,666
warrants exercisable at $1.03 per share. Stillwater LLC disclaims
beneficial ownership of shares owned by Rainbow Gate Corporation.
Alexandra
Global Master Fund Ltd (“Alexandra”) is a beneficial owner of more than 5% of
the Company’s common stock. Alexandra has an Amended Note of $3
million which may be converted into 4 million shares and received 2.8 million
warrants exercisable at $1.03 per share.
On March
28, 2007, the Company entered into an amendment to the Stillwater Agreement,
originally dated July 21, 2006. On April 9, 2007, the sale of the Stillwater
Note and Warrant was complete and the Company issued a 6% Senior Secured
Convertible Note in the principal amount of $500,000 and warrants to purchase
1,000,000 shares of the Company’s common stock at an exercise price of $0.48. On
July 23, 2007, Stillwater elected to convert $250,000 of the principal amount of
the Note and approximately $2,167 of accrued and unpaid interest. Stillwater
received 720,476 shares of Common Stock at the conversion price of
$0.35. The remaining 50% was amended to an 8% Amended Senior Secured
Convertible Note on July 23, 2007.
A family
member of an outside director of eMagin is the holder of a Series A warrant to
purchase an aggregate of 4,286 shares of common stock. As a result of the
Stillwater transaction, the exercise price of all Series A warrants was reduced
from $5.50 to $0.35 per share. Family members of an outside
director of eMagin are holders of Series F warrants to purchase an aggregate of
10,000 shares of common stock. As a result of the debt
transactions, the exercise price of all Series F warrants was ultimately reduced
from $8.60 to $4.09 per share.
2006
On July
21, 2006, the Company entered into several Note Purchase Agreements for the sale
of approximately $5.99 million of senior secured debentures (the “Notes”) and
warrants to purchase approximately 1,800,000 shares of common stock, par value
$.001 per share. The investors purchased $5.99 million principal
amount of Notes with conversion prices of $2.60 per share that may convert into
approximately 2.3 million shares of common stock and 5 year warrants exercisable
at $3.60 per share into approximately 1,600,000 million shares of common
stock. If the Notes are not converted, 50% of the principal amount
will be due on July 23, 2007 and the remaining 50% will be due on January 21,
2008. Commencing September 1, 2006, 6% interest was payable in
quarterly installments on outstanding notes. The Notes were amended
on July 23, 2007.
In the
Note Purchase transaction, two employees and a board member
participated. Olivier Prache, Senior VP of Display Operations,
purchased a $30 thousand promissory note which may be converted into 11,539
shares and received 8,077 warrants which are exercisable at $3.60 per
share. Mr. Prache converted $20 thousand of his promissory note and
received 7,693 shares. John Atherly, CFO, purchased a $40
thousand promissory note which may be converted into 15,385 shares and received
10,770 warrants exercisable at $3.60 per share. Paul Cronson, Board
member, through Navacorp III, LLC purchased a $200 thousand promissory note
which may be converted into 76,923 shares and received 53,847 warrants
exercisable at $3.60 per share. The Notes were amended on July 23,
2007.
Stillwater
LLC is a beneficial owner of more than 5% of the Company’s common
stock. Rainbow Gate Corporation, a corporation in which its
investment manager is the sole member of Stillwater LLC and its controlling
shareholder is the same as Ginola Limited, purchased a $700 thousand promissory
note which may be converted into 269,231 shares and received 188,462 warrants
exercisable at $3.60 per share. Ginola Limited purchased an $800
thousand promissory note which may be converted into 307,693 shares and received
215,385 warrants exercisable at $3.60 per share. Stillwater LLC
disclaims beneficial ownership of shares owned by Rainbow Gate
Corporation. The Notes were amended on July 23, 2007.
A family
member of an outside director of eMagin is the holder of a Series A warrant to
purchase an aggregate of 4,286 shares of common stock. As a result of the Note
Purchase transaction, the exercise price of all Series A warrants was reduced
from $5.50 to $2.60 per share. Family members of an outside
director of eMagin are holders of Series F warrants to purchase an aggregate of
10,000 shares of common stock. As a result of the Note Purchase
transaction, the exercise price of all Series F warrants was reduced from $10.90
to $8.60 per share.
eMagin
has entered into a financial advisory agreement with Larkspur Capital
Corporation. Paul Cronson, a director of eMagin, is a founder and shareholder of
Larkspur Capital Corporation. The Company has agreed to pay a minimum fee of
$500 thousand to Larkspur Capital Corporation in the event certain transactions
occur, i.e. sale of the Company’s assets or change of control.
2005
On
October 20, 2005, the Company entered into a Securities Purchase Agreement to
sell to certain qualified institutional buyers and accredited investors an
aggregate of 1,661,906 shares of eMagin’s common stock, par value $0.001 per
share (the “Shares”), and warrants to purchase an additional 997,143 shares of
common stock, for an aggregate purchase price of approximately $9.1 million. The
purchase price of the common stock and corresponding warrant was $5.50 per
share.
The
warrants are exercisable at a price of $10.00 per share and expire on October
20, 2010. Of the 997,143 warrants, 664,762 of the warrants are exercisable on or
after May 20, 2006. The remaining 332,380 are exercisable after March 31,
2007.
Stillwater
LLC is a beneficial owner of more than 5% of the Company’s common
stock. Rainbow Gate Corporation, a corporation in which its
investment manager is the sole member of Stillwater LLC and its controlling
shareholder is the same as Ginola Limited, participated in the sale of equity
pursuant to the Securities Purchase Agreement by investing $500
thousand. Stillwater LLC disclaims beneficial ownership of shares
owned by Rainbow Gate Corporation.
Chelsea
Trust Company, as trustee of a trust with the same directors and/or controlling
shareholders as Ginola Limited, participated in the sale of equity pursuant to
the Securities Purchase Agreement by investing $250 thousand. Ginola
Limited disclaims beneficial ownership of shares owned by Chelsea Trust
Company.
In
connection with the issuance of the Shares and the warrants pursuant to the
Securities Purchase Agreement, the Company was required to lower the exercise
prices of existing Series A and F warrants from $10.50 and $12.10 per share,
respectively, to $5.50 and $10.90 per share, respectively, pursuant to the
anti-dilution provisions of the Series A and F warrants.
A family
member of an outside director of eMagin is the holder of a Series A warrant to
purchase an aggregate of 4,286 shares of common stock. Accordingly, the exercise
price of all Series A warrants was reduced from $10.50 to $5.50 per
share.
Note
14 – SEPARATION AND EMPLOYMENT AGREEMENTS
Executive
Separation and Consulting Agreement
On
January 11, 2007, Gary Jones resigned as the President, Chief Executive Officer,
and as a Director of the Company. Mr. Jones and the Company entered
into an Executive Separation and Consulting Agreement (“the
Agreement”). Under the Agreement, the Company made a payment to Mr.
Jones in an amount equal to: all accrued salary as of the date of the Agreement
plus an additional 30 days of salary (approximately $47 thousand); 360
hours of unused vacation (approximately $55 thousand); advance for legal and
accounting fees associated with 2004 stock options ($30 thousand); and an
advance for future travel expenditures ($5 thousand). Mr. Jones also received
500,000 shares of registered common stock of the Company valued at $430
thousand. In his consulting relationship, Mr. Jones will be paid $460 thousand
upon the consummation of a strategic transaction. The Company
will provide up to $7.5 thousand for reasonable moving expenses of personal
property from the New York office. In addition, the Company will pay
up to an additional $30 thousand to Mr. Jones related to personal legal
fees.
Compensation
Agreement
On
January 11, 2007, Dr. K.C. Park was appointed Interim Chief Executive Office,
President, and a Director of the Company. On February 12, 2007, the
Company entered into a Compensation Agreement (“the Agreement”) with Dr.
Park. Under the Agreement, the Company paid Dr. Park an annual base
salary equal to $300 thousand plus a quarterly increase in his base salary in
the amount of $12.5 thousand per fiscal quarter through December 31,
2007. The Company agreed to issue Dr. Park an aggregate of 250,000
restricted shares of common stock within 10 business days of the completion of a
change of control of the Company. In addition, if a change of control
transaction is completed and Dr. Park is not offered a senior executive position
in the new organization, the Company has agreed to pay Dr. Park three month’s
salary. K.C. Park resigned effective January 31,
2008. Please see Note 17 - Subsequent Events.
Effective
January 30, 2008, the Company entered into an amended employment agreement with
Susan K. Jones, its Chief Marketing and Strategy Officer. The amended
agreement provides for an increase in compensation, extends the term of the
agreement to January 31, 2010, changes certain incentive award payment
requirements, clarifies the basis for incentive award determination, and extends
the change-of-control/material change/termination-without-cause compensation
payout periods. Please see Note 17 - Subsequent Events.
Note
15 - CONCENTRATIONS
The
Company had no customers that accounted for more than 10% of its total revenues
in 2007. In 2006, the Company had one customer that accounted for 13%
of its total revenues. In 2005, the Company had no customers that
accounted for more than 10% of its total revenues.
For the
year ended December 31, 2007, approximately 51% of the Company’s net revenues
were made to customers in the United States and approximately 49% of the
Company’s net revenues were made to international customers. For the
year ended December 31, 2006, approximately 59% of the Company's net revenues
were made to customers in the United States and approximately 41% of the
Company's net revenues were made to international customers. For the
year ended December 31, 2005, approximately 49% of the Company’s net revenues
were made to customers in the United States and approximately 51% of the
Company’s net revenues were made to international customers.
There
were 5 customers which comprised 54% of the outstanding accounts receivable at
December 31, 2007. At December 31, 2006, there were 5 customers which
comprised 69% of the outstanding accounts receivable.
The
Company purchases principally all of its silicon wafers from a single supplier
located in Taiwan.
Note
16 – AMEX DELISTING
On
October 9, 2006, the Company received notice from the American Stock Exchange
(the “AMEX”) Listing Qualifications Department stating that the Company does not
meet certain continued listing standards as set forth in Part 10 of the AMEX
Company Guide (the “Company Guide”). Specifically, pursuant to a review by the
AMEX of the Company’s 10-Q for the three and six months ended June 30, 2006, the
AMEX has determined that the Company is not in compliance with Sections
1003(a)(ii) and 1003(a)(iii) of the Company Guide, respectively, which state, in
relevant part, that the AMEX will normally consider suspending dealings in, or
removing from the list, securities of a company that (a) has stockholders'
equity of less than $4.0 million if such company has sustained losses from
continuing operations and/or net losses in three of its four most recent fiscal
years; or (b) has stockholders' equity of less than $6.0 million if such company
has sustained losses from continuing operations and/or net losses in its five
most recent fiscal years, respectively.
On
November 6, 2006, the Company submitted a plan advising the AMEX of actions that
it would take, which may bring it into compliance with Sections 1003 (a)(ii) and
1003(a)(iii) of the Company Guide within a maximum of 18 months of receipt of
the notice letter. On January 5, 2007, the Company received notice from the
staff of the AMEX indicating that it intended to strike the Company’s common
stock from listing on AMEX by filing a delisting application with the Securities
and Exchange Commission as it had determined that the Company has failed to
comply with the continued listing standards. The Company requested a
verbal hearing which was held on February 27, 2007.
On March
1, 2007, the Company received notice from the AMEX indicating that the AMEX
would initiate the delisting process with respect to the Company’s common
stock. On March 12, 2007, in accordance with Part 12 of the Company
Guide, the Company was suspended from trading on the AMEX. The
Company’s common stock is trading on the Over-the-Counter Bulletin Board under
the symbol, EMAN.
The
delisting from the AMEX triggered a compliance condition on the notes
payable. As a result the Company was required to pay the note holders
monthly interest at 1% rather than .5% on the outstanding principal of the notes
payable. The Company received a waiver from the note holders that
allowed the Company to accrue the interest and delay the interest payment until
the earliest of the Company (i) completing $2 million of debt or equity
financing or (ii) the occurrence of a Repurchase Event per the
note. On July 23, 2007, the Company entered into Amended Agreements
with the note holders where the 1% monthly interest will no longer accrue and
the accrued interest was forgiven.
Note
17 – SUBSEQUENT EVENTS
Effective
January 2, 2008, John Atherly resigned as Chief Financial
Officer. There was no separation agreement executed between Mr.
Atherly and the Company. Michael D. Fowler became the Company’s
Interim Chief Financial Officer effective December 27, 2007.
Effective
January 31, 2008, K.C. Park resigned as Interim Chief Executive Officer,
President and Director. Dr. Park and the Company entered into a
Separation Agreement and General Release (“Separation
Agreement”). The Company will pay Dr. Park severance of $60 thousand
to be payable over a three month period. Dr. Park and the Company
also entered into a Consulting Agreement (“Agreement”) for a term beginning
February 1 and ending on August 1, 2008. He will be paid a sum of $75
thousand, payable in monthly installments of $10 thousand for the first three
months of the term and $15 thousand for the remaining three months of the
term. In addition to the compensation, Dr. Park will be entitled to
receive non-qualified stock options to acquire 18,750 shares of common stock on
each three month anniversary of the Agreement at the fair market value on the
date of the grant and will be fully vested and exercisable on the date of the
grant. If the Agreement is not renewed at the end of the term, he
will be entitled to an additional grant of 18,750 shares of common stock with
the same terms. In addition, on May 1, 2008, Dr. Park will be
entitled to receive non-qualified stock options to acquire 51,703 shares of
common stock at the fair market value and will be fully vested.
Effective
January 30, 2008, the Company entered into an amended employment agreement with
Susan K. Jones, its Chief Marketing and Strategy Officer. The amended
agreement provides for an increase in compensation, extends the term of the
agreement to January 31, 2010, changes certain incentive award payment
requirements, clarifies the basis for incentive award determination, and extends
the change-of-control/material change/termination-without-cause compensation
payout periods.
Michael
D. Fowler, the Company’s Interim Chief Financial Officer, has indicated his
intention to resign his position with the Company following the filing of the
Annual Report on Form 10-K for December 31, 2007 to pursue other
interests.
Line of
Credit
On
January 30, 2008, the Company amended and restated its Loan and Security
Agreement (“Amended Loan Agreement”) with Moriah. The Amended Loan
Agreement’s borrowing base calculation was modified to include 70% of eligible
foreign accounts. The Loan conversion agreement was terminated. The
amendment eliminated optional conversion of principal up to $2.0 million into
common stock at $1.50, in lieu of issuance of a Warrant to purchase 750,000
shares of its common stock at a price of $1.50 per share with an expiration date
of January 29, 2013.
The
Amended Loan Agreement has specific terms to which the Company must comply
including (a) maintaining a lockbox account into which payments from related
accounts receivable must be deposited, (b) periodic certifications as to
borrowing base amounts equaling or exceeding net balances outstanding under the
Line of Credit, and (c) a requirement that a registration statement with respect
to shares held or to be issued to the lender be filed within thirty days of
January 30, 2008. A delay in establishing the required lockbox
account created a technical default under the Line of Credit
agreement. Similarly, the production and subsequent discovery of
defective displays resulted in an inadvertent overstatement of inventory during
December, January and early February that created a technical default under the
agreement. Finally, the Company was not able to complete the
registration of shares within the thirty day timeframe mandated in the amended
agreement. On March 25, 2008 the Company received a waiver from the
lender (a) waiving compliance with the lockbox account requirement through March
14, 2008, (b) waiving compliance with the borrowing base requirement in so far
as it related exclusively to the defective displays inadvertently included in
inventory, and (c) extending the period for filing a registration statement for
certain shares held or to be issued to the lender until April 29,
2008.
Effective
March 25, 2008, the Company amended the Warrant Issuance Agreement (“Amended
Warrant Agreement”) with Moriah. In connection with such amendment, the Company
issued a Warrant to purchase an additional 250,000 shares of its common stock at
a price of $1.50 expiring March 25, 2013.
Incentive Compensation
Plan
On
February 20, 2008, the Board of Directors authorized the establishment of the
20087 Incentive Stock Plan with 2,000,000 options available for
grant. The 2008 Incentive Stock Plan is intended to provide long-term
performance incentives to directors, executives, selected employees and
consultants and reward them for making major contributions to the success and
well being of the Company.
Private
Placement
On April
2, 2008, the Company completed a private placement of its common stock with
several institutional investors for gross proceeds of $1.65
million. The transaction involved the sale of 1,586,539 shares of
common stock at $1.04 per share, or the 5-day average closing price of the
Company’s common stock on the trading days immediately preceding the closing
date. The Company also issued to the investors 793,273 warrants to
buy our common stock at a price of $1.30 per share. Pursuant to the
transaction, the Company is obligated to file a registration statement for the
shares issued as well as shares underlying the warrants by May 17,
2008.
Note
18 – QUARTERLY FINANCIAL INFORMATION (UNAUDITED)
Summarized
quarterly financial information for 2007 and 2006 are as follows (in thousands
except per share data):
|
|
Quarters
Ended
|
|
|
|
March
31, 2007
|
|
|
June
30, 2007
|
|
|
September
30, 2007
|
|
|
December
31, 2007
|
|
Revenues
|
|
$
|
3,609
|
|
|
$
|
4,232
|
|
|
$
|
5,071
|
|
|
$
|
4,642
|
|
Gross
margin
|
|
$
|
494
|
|
|
$
|
1,286
|
|
|
$
|
2,012
|
|
|
$
|
1,134
|
|
Net
loss
|
|
$
|
(2,937
|
)
|
|
$
|
(1,728
|
)
|
|
$
|
(12,651
|
)
|
|
$
|
(1,172
|
)
|
Net
loss per share – basic and diluted
|
|
$
|
(0.27
|
)
|
|
$
|
(0.15
|
)
|
|
$
|
(1.06
|
)
|
|
$
|
(0.10
|
)
|
Weighted
average number of shares outstanding – basic and diluted
|
|
|
10,792
|
|
|
|
11,176
|
|
|
|
11,935
|
|
|
|
12,249
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quarters
Ended
|
|
|
|
March
31, 2006
|
|
|
June
30, 2006
|
|
|
September
30, 2006
|
|
|
December
31, 2006
|
|
Revenues
|
|
$
|
1,641
|
|
|
$
|
1,674
|
|
|
$
|
2,292
|
|
|
$
|
2,562
|
|
Gross
margin (loss)
|
|
$
|
(1,388
|
)
|
|
$
|
(1,291
|
)
|
|
$
|
(648
|
)
|
|
$
|
137
|
|
Net
loss
|
|
$
|
(5,160
|
)
|
|
$
|
(4,838
|
)
|
|
$
|
(3,769
|
)
|
|
$
|
(1,499
|
)
|
Net
loss per share – basic and diluted
|
|
$
|
(0.52
|
)
|
|
$
|
(0.48
|
)
|
|
$
|
(0.37
|
)
|
|
$
|
(0.15
|
)
|
Weighted
average number of shares outstanding – basic and diluted
|
|
|
10,004
|
|
|
|
10,011
|
|
|
|
10,077
|
|
|
|
10,196
|
|
eMagin
Corporation
June
30, 2008
|
|
|
|
|
Page
|
PART
I FINANCIAL INFORMATION
|
|
Item
1
|
Condensed
Consolidated Financial Statements
|
|
|
|
|
|
Condensed
Consolidated Balance Sheets as of June 30, 2008 (unaudited) and December
31, 2007
|
93
|
|
|
|
|
Condensed
Consolidated Statements of Operations for the Three and Six Months ended
June 30, 2008 and 2007 (unaudited)
|
94
|
|
|
|
|
Condensed
Consolidated Statements of Changes in Capital Deficit for the Six Months
ended June 30, 2008 (unaudited)
|
95
|
|
|
|
|
Condensed
Consolidated Statements of Cash Flows for the Six Months ended June 30,
2008 and 2007 (unaudited)
|
96
|
|
|
|
|
Notes
to Condensed Consolidated Financial Statements (unaudited)
|
97
|
eMAGIN
CORPORATION
CONDENSED
CONSOLIDATED BALANCE SHEETS
(In
thousands, except share data)
|
|
June
30,
|
|
|
|
|
|
|
2008
(unaudited)
|
|
|
December
31, 2007
|
|
|
|
|
|
|
|
|
ASSETS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current
assets:
|
|
|
|
|
|
|
Cash
and cash equivalents
|
|
$
|
1,038
|
|
|
$
|
713
|
|
Investments
– held to maturity
|
|
|
94
|
|
|
|
94
|
|
Accounts
receivable, net
|
|
|
3,601
|
|
|
|
2,383
|
|
Inventory
|
|
|
1,726
|
|
|
|
1,815
|
|
Prepaid
expenses and other current assets
|
|
|
750
|
|
|
|
850
|
|
Total
current assets
|
|
|
7,209
|
|
|
|
5,855
|
|
Equipment,
furniture and leasehold improvements, net
|
|
|
401
|
|
|
|
292
|
|
Intangible
assets, net
|
|
|
49
|
|
|
|
51
|
|
Other
assets
|
|
|
232
|
|
|
|
232
|
|
Deferred
financing costs, net
|
|
|
135
|
|
|
|
218
|
|
Total
assets
|
|
$
|
8,026
|
|
|
$
|
6,648
|
|
|
|
|
|
|
|
|
|
|
LIABILITIES
AND CAPITAL DEFICIT
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current
liabilities:
|
|
|
|
|
|
|
|
|
Accounts
payable
|
|
$
|
1,135
|
|
|
$
|
620
|
|
Accrued
compensation
|
|
|
962
|
|
|
|
891
|
|
Other
accrued expenses
|
|
|
704
|
|
|
|
729
|
|
Advance
payments
|
|
|
13
|
|
|
|
35
|
|
Deferred
revenue
|
|
|
80
|
|
|
|
179
|
|
Current
portion of debt
|
|
|
8,148
|
|
|
|
7,089
|
|
Other
current liabilities
|
|
|
596
|
|
|
|
1,020
|
|
Total
current liabilities
|
|
|
11,638
|
|
|
|
10,563
|
|
|
|
|
|
|
|
|
|
|
Long-term
debt
|
|
|
41
|
|
|
|
60
|
|
Total
liabilities
|
|
|
11,679
|
|
|
|
10,623
|
|
|
|
|
|
|
|
|
|
|
Commitments
and contingencies
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Capital
deficit:
|
|
|
|
|
|
|
|
|
Preferred
stock, $.001 par value: authorized 10,000,000 shares; no shares issued and
outstanding
|
|
|
—
|
|
|
|
—
|
|
Series
A Senior Secured Convertible Preferred stock, stated value $1,000 per
share, $.001 par value: 3,198 shares designated and none
issued
|
|
|
—
|
|
|
|
—
|
|
Common
stock, $.001 par value: authorized 200,000,000 shares, issued and
outstanding, 14,389,439 shares as of June 30, 2008 and 12,620,900 shares
as of December 31, 2007
|
|
|
14
|
|
|
|
12
|
|
Additional
paid-in capital
|
|
|
198,442
|
|
|
|
195,326
|
|
Accumulated
deficit
|
|
|
(202,109
|
)
|
|
|
(199,313
|
)
|
Total
capital deficit
|
|
|
( 3,653
|
)
|
|
|
( 3,975
|
)
|
Total
liabilities and capital deficit
|
|
$
|
8,026
|
|
|
$
|
6,648
|
|
|
|
|
|
|
|
|
|
|
See notes
to Condensed Consolidated Financial Statements.
eMAGIN
CORPORATION
CONDENSED
CONSOLIDATED STATEMENTS OF OPERATIONS
(In
thousands, except share and per share data)
(unaudited)
|
|
Three
Months Ended
June
30,
|
|
|
Six
Months Ended
June
30,
|
|
|
|
2008
|
|
|
2007
|
|
|
2008
|
|
|
2007
|
|
Revenue:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Product
revenue
|
|
$
|
4,496
|
|
|
$
|
4,144
|
|
|
$
|
6,958
|
|
|
$
|
7,667
|
|
Contract
revenue
|
|
|
1,123
|
|
|
|
88
|
|
|
|
1,326
|
|
|
|
174
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
revenue, net
|
|
|
5,619
|
|
|
|
4,232
|
|
|
|
8,284
|
|
|
|
7,841
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost
of goods sold
|
|
|
2,996
|
|
|
|
2,946
|
|
|
|
5,309
|
|
|
|
6,061
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross
profit
|
|
|
2,623
|
|
|
|
1,286
|
|
|
|
2,975
|
|
|
|
1,780
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating
expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Research
and development
|
|
|
634
|
|
|
|
887
|
|
|
|
1,308
|
|
|
|
1,740
|
|
Selling,
general and administrative
|
|
|
1,697
|
|
|
|
1,543
|
|
|
|
3,504
|
|
|
|
3,764
|
|
Total
operating expenses
|
|
|
2,331
|
|
|
|
2,430
|
|
|
|
4,812
|
|
|
|
5,504
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income
(loss) from operations
|
|
|
292
|
|
|
|
(1,144
|
)
|
|
|
(1,837
|
)
|
|
|
(3,724
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other
income (expense):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest
expense
|
|
|
(537
|
)
|
|
|
(1,333
|
)
|
|
|
(1,168
|
)
|
|
|
(2,174
|
)
|
Gain
on warrant derivative liability
|
|
|
—
|
|
|
|
182
|
|
|
|
—
|
|
|
|
643
|
|
Other
income, net
|
|
|
123
|
|
|
|
567
|
|
|
|
209
|
|
|
|
590
|
|
Total
other expense
|
|
|
(414
|
)
|
|
|
(584
|
)
|
|
|
(959
|
)
|
|
|
(941
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net
loss
|
|
$
|
(122
|
)
|
|
$
|
(1,728
|
)
|
|
$
|
(2,796
|
)
|
|
$
|
(4,665
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss
per share, basic and diluted
|
|
$
|
(0.01
|
)
|
|
$
|
(0.15
|
)
|
|
$
|
(0.21
|
)
|
|
$
|
(0.42
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted
average number of shares outstanding:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
and diluted
|
|
|
14,320,570
|
|
|
|
11,175,888
|
|
|
|
13,470,735
|
|
|
|
10,983,981
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
See notes
to Condensed Consolidated Financial Statements
.
eMAGIN
CORPORATION
CONDENSED
CONSOLIDATED STATEMENT OF CHANGES IN CAPITAL DEFICIT
(In
thousands)
|
|
|
|
|
Additional
|
|
|
|
|
|
Total
|
|
|
|
Common
Stock
|
|
|
Paid-In
|
|
|
Accumulated
|
|
|
Shareholders’
|
|
|
|
Shares
|
|
|
Amount
|
|
|
Capital
|
|
|
Deficit
|
|
|
Deficit
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance,
December 31, 2007
|
|
|
12,621
|
|
|
$
|
12
|
|
|
$
|
195,326
|
|
|
$
|
(199,313
|
)
|
|
$
|
(
3,975
|
)
|
Sale
of common stock, net of issuance costs
|
|
|
1,587
|
|
|
|
2
|
|
|
|
1,578
|
|
|
|
—
|
|
|
|
1,580
|
|
Issuance
of common stock for services
|
|
|
181
|
|
|
|
—
|
|
|
|
202
|
|
|
|
—
|
|
|
|
202
|
|
Stock-based
compensation
|
|
|
—
|
|
|
|
—
|
|
|
|
607
|
|
|
|
—
|
|
|
|
607
|
|
Fair
value of warrants issued
|
|
|
—
|
|
|
|
—
|
|
|
|
729
|
|
|
|
—
|
|
|
|
729
|
|
Net
loss
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
(2,796
|
)
|
|
|
(2,796
|
)
|
Balance,
June 30, 2008 (unaudited)
|
|
|
14,389
|
|
|
$
|
14
|
|
|
$
|
198,442
|
|
|
$
|
(202,109
|
)
|
|
$
|
(3,653
|
)
|
See notes
to Condensed Consolidated Financial Statements
.
eMAGIN
CORPORATION
CONDENSED
CONSOLIDATED STATEMENTS OF CASH FLOWS
(In
thousands)
|
|
Six
months Ended
|
|
|
|
June
30,
|
|
|
|
2008
|
|
|
2007
|
|
|
|
(unaudited)
|
|
Cash
flows from operating activities:
|
|
|
|
|
|
|
Net
loss
|
|
$
|
(2,796
|
)
|
|
$
|
(4,665
|
)
|
Adjustments
to reconcile net loss to net cash used in operating
activities:
|
|
|
|
|
|
|
|
|
Depreciation
and amortization
|
|
|
129
|
|
|
|
227
|
|
Amortization
of deferred financing and waiver fees
|
|
|
821
|
|
|
|
265
|
|
Increase
in (reduction of) provision for sales returns and doubtful
accounts
|
|
|
146
|
|
|
|
(35
|
)
|
Stock-based
compensation
|
|
|
607
|
|
|
|
899
|
|
Amortization
of common stock issued for services
|
|
|
88
|
|
|
|
677
|
|
Amortization
of discount on notes payable
|
|
|
25
|
|
|
|
1,452
|
|
Gain
on warrant derivative liability
|
|
|
—
|
|
|
|
(643
|
)
|
|
|
|
|
|
|
|
|
|
Changes
in operating assets and liabilities:
|
|
|
|
|
|
|
|
|
Accounts
receivable
|
|
|
(1,364
|
)
|
|
|
(329
|
)
|
Inventory
|
|
|
89
|
|
|
|
675
|
|
Prepaid
expenses and other current assets
|
|
|
214
|
|
|
|
55
|
|
Deferred
revenue
|
|
|
(99
|
)
|
|
|
(45
|
)
|
Accounts
payable, accrued compensation, other accrued expenses, and advance
payments
|
|
|
539
|
|
|
|
323
|
|
Other
current liabilities
|
|
|
(424
|
)
|
|
|
(7
|
)
|
Net
cash used in operating activities
|
|
|
(2,025
|
)
|
|
|
(1,151
|
)
|
Cash
flows from investing activities:
|
|
|
|
|
|
|
|
|
Purchase
of equipment
|
|
|
(236
|
)
|
|
|
—
|
|
Purchase
of investments – held to maturity
|
|
|
—
|
|
|
|
(4
|
)
|
Net
cash used in investing activities
|
|
|
(236
|
)
|
|
|
(4
|
)
|
Cash
flows from financing activities:
|
|
|
|
|
|
|
|
|
Proceeds
from sale of common stock, net of issuance costs
|
|
|
1,580
|
|
|
|
—
|
|
Proceeds
from exercise of warrants
|
|
|
—
|
|
|
|
3
|
|
Proceeds
from debt
|
|
|
1,700
|
|
|
|
500
|
|
Payments
related to deferred financing costs
|
|
|
(9
|
)
|
|
|
(40
|
)
|
Payments
of debt and capital leases
|
|
|
(685
|
)
|
|
|
(33
|
)
|
Net
cash provided by financing activities
|
|
|
2,586
|
|
|
|
430
|
|
Net
increase (decrease) in cash and cash equivalents
|
|
|
325
|
|
|
|
(725
|
)
|
Cash
and cash equivalents beginning of period
|
|
|
713
|
|
|
|
1,415
|
|
Cash
and cash equivalents end of period
|
|
$
|
1,038
|
|
|
$
|
690
|
|
|
|
|
|
|
|
|
|
|
Cash
paid for interest
|
|
$
|
314
|
|
|
$
|
180
|
|
Cash
paid for taxes
|
|
$
|
21
|
|
|
$
|
46
|
|
|
|
|
|
|
|
|
|
|
During
the six months ended June 30, 2008, the Company:
|
|
|
|
|
|
|
|
|
·
|
Entered
into amended Loan and Security Agreement and issued warrants that are
exercisable at $1.50 per share into 1.0 million shares of common stock
valued at approximately $0.7
million.
|
See notes
to Condensed Consolidated Financial Statements
.
eMAGIN
CORPORATION
(Unaudited)
Note
1: Description of the Business and Summary of Significant Accounting
Policies
The
Business
eMagin
Corporation (the “Company”) designs, develops, manufactures, and markets virtual
imaging products for consumer, commercial, industrial and military
applications. The Company’s products are sold mainly in North
America, Asia, and Europe.
Basis
of Presentation
In the
opinion of management, the accompanying unaudited condensed consolidated
financial statements of eMagin Corporation and its subsidiary reflect all
adjustments, including normal recurring accruals, necessary for a fair
presentation. Certain information and footnote disclosure normally
included in annual financial statements prepared in accordance with accounting
principles generally accepted in the United States have been condensed or
omitted pursuant to instructions, rules and regulations prescribed by the
Securities and Exchange Commission. The Company believes that the
disclosures provided herein are adequate to make the information presented not
misleading when these unaudited condensed consolidated financial statements are
read in conjunction with the audited consolidated financial statements contained
in the Company’s Annual Report on Form 10-K for the year ended December 31,
2007. The results of operations for the period ended June 30, 2008
are not necessarily indicative of the results to be expected for the full
year.
The
unaudited condensed consolidated financial statements have been prepared
assuming that the Company will continue as a going concern. The Company
has had recurring losses from operations which it believes will continue through
the foreseeable future. The Company’s cash requirements over the next
twelve months are greater than the Company’s current cash, cash equivalents, and
investments at June 30, 2008. In addition, the Company’s line of
credit was temporarily extended (see Notes 8 and 15). The Company has working
capital and capital deficits as of June 30, 2008. These factors raise
substantial doubt regarding the Company’s ability to continue as a going concern
without continuing to obtain additional funding. The Company does not have
commitments for such financing and no assurance can be given that additional
financing will be available, or if available, will be on acceptable terms. If
the Company is unable to obtain sufficient funds during the next twelve months,
the Company will further reduce the size of its organization and/or curtail
operations which will have a material adverse impact on the Company’s business
prospects. The Company is reviewing its cost structures for cost efficiencies
and is taking measures to reduce costs. The unaudited condensed consolidated
financial statements do not include any adjustments that might result from the
outcome of this uncertainty.
Use
of Estimates
In
accordance with accounting principles generally accepted in the United States of
America, management utilizes certain estimates and assumptions that affect the
reported amounts of assets and liabilities at the date of the financial
statements and the reported amounts of revenues and expenses during the
reporting period. On an on-going basis, management evaluates its estimates and
judgments. Management bases its estimates and judgments on historical experience
and on various other assumptions that are believed to be reasonable under the
circumstances, the results of which form the basis for making judgments about
the carrying values of assets and liabilities that are not readily apparent from
other sources. Actual results could differ from those estimates.
Revenue
Recognition
Revenue
is recognized when products are shipped to customers, net of allowances for
anticipated returns. The Company’s revenue-earning
activities generally involve delivering products.
Revenue is recognized when persuasive evidence of
an arrangement exists, delivery has occurred, selling price is
fixed or determinable and collection is reasonably
assured.
The
Company also earns revenues from certain R&D activities under
both firm fixed-price contracts and cost-type
contracts, including some cost-plus-fee contracts. Revenues on
cost-plus-fee contracts include costs incurred plus a portion of
estimated fees or profits based on the relationship of costs incurred to total
estimated costs. Contract costs include all direct material and labor costs
and an allocation of allowable indirect costs as defined by each
contract, as periodically adjusted to reflect revised agreed upon
rates. These rates are subject to audit by the other party.
Note
2: Recently Issued Accounting Pronouncements
In
September 2006, the FASB issued Statement of Financial Accounting Standards
No. 157, “Fair Value Measurements,” (“SFAS 157”), which defines fair value,
establishes a framework for measuring fair value under generally accepted
accounting principles and expands disclosures about fair value measurements.
SFAS 157 does not require any new fair value measurements, but provides guidance
on how to measure fair value by providing a fair value hierarchy used to
classify the source of the information. In February 2008, the FASB issued
FASB Staff Position No. FSP 157-2, “Effective Date of FASB Statement
No. 157”, which provides a one year deferral of the effective date of SFAS
157 for non-financial assets and non-financial liabilities, except those that
are recognized or disclosed in the financial statements at fair value on a
recurring basis. The Company adopted SFAS 157 as of January 1, 2008, with
the exception of the application of the statement to non-recurring non-financial
assets and non-financial liabilities which it will defer the adoption until
January 1, 2009. The adoption of SFAS 157 did not have a material impact on the
Company’s consolidated results of operations, financial condition or cash
flows.
In
February 2007, the FASB issued SFAS No. 159, “The Fair Value Option
for Financial Assets and Financial Liabilities — including an amendment of FASB
Statement No. 115,” (“SFAS 159”) which is effective for fiscal years
beginning after November 15, 2007. This statement permits entities to
choose to measure many financial instruments and certain other items at fair
value. This statement also establishes presentation and disclosure requirements
designed to facilitate comparisons between entities that choose different
measurement attributes for similar types of assets and liabilities. Unrealized
gains and losses on items for which the fair value option is elected would be
reported in earnings. The Company has adopted SFAS 159 and has elected not to
measure any additional financial instruments and other items at fair value and
therefore the adoption of SFAS 159 did not have a material impact on the
Company’s condensed consolidated results of operations, financial condition or
cash flows.
In
March 2008, the FASB issued Statement of Financial Accounting Standards
No. 161, Disclosures about Derivative Instruments and Hedging Activities,
an amendment of FASB Statement No. 133 (“SFAS 161”). SFAS 161 requires
entities to provide greater transparency about (a) how and why an entity
uses derivative instruments, (b) how derivative instruments and related
hedged items are accounted for under Statement 133 and its related
interpretations and (c) how derivative instruments and related hedged items
affect an entity’s financial position, results of operations, and cash flows.
SFAS 161 is effective prospectively for financial statements issued for fiscal
years and interim periods beginning after November 15, 2008, with early
application permitted. The Company is currently evaluating the disclosure
implications of this statement.
In May
2008, the FASB issued SFAS No. 162,
The Hierarchy of Generally Accepted
Accounting Principles
, (“SFAS 162”), which identifies the sources of
accounting principles and the framework for selecting principles to be used in
the preparation of financial statements of nongovernmental entities that are
presented in conformity with generally accepted accounting principles in the
United States. This statement shall be effective 60 days following the
SEC's approval of the Public Company Accounting Oversight Board's amendments to
AU section 411, The Meaning of Present Fairly in Conformity with Generally
Accepted Accounting Principles. The Company is currently evaluating the impact
of SFAS 162, but does not expect the adoption of this pronouncement will
have a material impact on the Company's financial statements.
Note
3: Receivables
The
majority of the Company’s commercial accounts receivable are due from Original
Equipment Manufacturers ("OEM’s”). Credit is extended based on evaluation of a
customer’s financial condition and, generally, collateral is not required.
Accounts receivable are payable in U.S. dollars, are due within 30-90 days and
are stated at amounts due from customers, net of an allowance for doubtful
accounts. Any account outstanding longer than the contractual payment terms is
considered past due.
The
Company determines the allowance for doubtful accounts
by considering a number of factors, including the length of time the
trade accounts receivable are past due, eMagin's previous loss history, the
customer's current ability to pay its obligation, and the condition of
the general economy and the industry as a whole. The Company will
record a specific reserve for individual accounts when the Company becomes aware
of a customer's inability to meet its financial obligations, such as in the case
of bankruptcy filings or deterioration in the customer's operating results or
financial position. If circumstances related to customers change, the
Company would further adjust estimates of the recoverability of
receivables.
Receivables
consisted of the following (in thousands):
|
|
June
30,
2008
(unaudited)
|
|
|
December
31, 2007
|
|
Accounts
receivable
|
|
$
|
4,105
|
|
|
$
|
2,741
|
|
Less
allowance for doubtful accounts
|
|
|
(504
|
)
|
|
|
(358
|
)
|
Net
receivables
|
|
$
|
3,601
|
|
|
$
|
2,383
|
|
Note
4: Research and Development Costs
Research
and development costs are expensed as incurred.
Note
5: Net Loss per Common Share
In
accordance with SFAS No. 128, net loss per common share amounts ("basic EPS")
was computed by dividing net loss by the weighted average number
of common shares outstanding and excluding any
potential dilution. Net loss per common share assuming dilution
("diluted EPS") was computed by reflecting potential dilution from the
exercise of stock options and warrants. As of June 30, 2008 and
2007, there were stock options, warrants and convertible notes outstanding to
acquire 11,508,295 and 5,297,927 shares of our common stock,
respectively. These shares were excluded from the computation
of diluted loss per share because their effect would be
antidilutive.
Note
6: Inventory
Inventory
is stated at the lower of cost or market. Cost is determined using the first-in
first-out method. The Company reviews the value of its inventory and
reduces the inventory value to its net realizable value based upon current
market prices and contracts for future sales. The components of inventories are
as follows (in thousands):
|
|
June
30,
2008
(unaudited)
|
|
|
December
31, 2007
|
|
Raw
materials
|
|
$
|
945
|
|
|
$
|
1,069
|
|
Work
in process
|
|
|
260
|
|
|
|
370
|
|
Finished
goods
|
|
|
521
|
|
|
|
376
|
|
Total
inventory
|
|
$
|
1,726
|
|
|
$
|
1,815
|
|
Note
7: Prepaid Expenses and Other Current Assets:
Prepaid
expenses and other current assets consist of the following (in
thousands):
|
|
June
30,
2008
(unaudited)
|
|
|
December
31, 2007
|
|
Vendor
prepayments
|
|
$
|
339
|
|
|
$
|
537
|
|
Other
prepaid expenses *
|
|
|
408
|
|
|
|
310
|
|
Other
assets
|
|
|
3
|
|
|
|
3
|
|
Total
prepaid expenses and other current assets
|
|
$
|
750
|
|
|
$
|
850
|
|
*
No individual amounts greater
than 5% of current assets.
Note
8: Debt
Debt is
as follows (in thousands):
|
|
June
30,
|
|
|
|
|
|
|
2008
(unaudited)
|
|
|
December
31,
2007
|
|
Current
portion of long-term debt:
|
|
|
|
|
|
|
Other
debt
|
|
$
|
38
|
|
|
$
|
44
|
|
Line
of credit
|
|
|
2,148
|
|
|
|
1,108
|
|
8%
Senior Secured Convertible Notes
|
|
|
5,962
|
|
|
|
5,962
|
|
Less: Unamortized
discount on notes payable
|
|
|
—
|
|
|
|
(25
|
)
|
Current
portion of long-term debt, net
|
|
|
8,148
|
|
|
|
7,089
|
|
Long-term
debt:
|
|
|
|
|
|
|
|
|
Other
debt
|
|
|
41
|
|
|
|
60
|
|
Long-term
debt, net
|
|
|
41
|
|
|
|
60
|
|
Total
debt, net
|
|
$
|
8,189
|
|
|
$
|
7,149
|
|
On August
7, 2007, the Company entered
into a loan agreement
with Moriah Capital, L.P. (“Moriah)
and established a
revolving line of credit (the “Loan”) of $2.5 million. The Company is
permitted to borrow an amount not to exceed 90% of its domestic eligible
accounts receivable and 50% of its eligible inventory capped at $600
thousand. As part of the transaction, the Company issued 162,500
shares of unregistered common stock valued at $195 thousand and paid a servicing
fee of $82,500 to Moriah which are amortized to interest expense over the life
of the agreement. In conjunction with entering into this loan and issuing
unregistered common stock, the Company granted Moriah registration
rights. The Loan can be converted into shares of the Company’s common
stock pursuant to the terms of the Loan Conversion agreement. The
Loan matures on August 8, 2008 with an option to extend it an additional year if
the Company meets certain requirements. On August 8, 2008, Moriah
granted to the Company an extension of the Loan with the same terms for 8
days.
On
January 30, 2008, the Company amended and restated its Loan and Security
Agreement (“Amended Loan Agreement”) with Moriah. The Amended Loan
Agreement’s borrowing base calculation was modified to include 70% of eligible
foreign accounts. The Amended Loan Agreement eliminated the optional
conversion of principal up to $2.0 million into common stock at
$1.50. In connection with the amendment, the Company issued a Warrant
to purchase 750,000 shares of its common stock at a price of $1.50 per share
with an expiration date of January 29, 2013.
The
Amended Loan Agreement has specific terms to which the Company must comply
including (a) maintaining a lockbox account into which payments from related
accounts receivable must be deposited, (b) periodic certifications as to
borrowing base amounts equaling or exceeding net balances outstanding under the
Line of Credit, and (c) a requirement that a registration statement with respect
to shares held or to be issued to the lender be filed within thirty days of
January 30, 2008. A delay in establishing the required lockbox
account created a technical default under the Line of Credit
agreement. Similarly, the production and subsequent discovery of
defective displays resulted in an inadvertent overstatement of inventory during
December, January and early February that created a technical default under the
agreement. Finally, the Company was not able to complete the
registration of shares within the thirty day timeframe mandated in the amended
agreement. On March 25, 2008 the Company received a waiver from the
lender (a) waiving compliance with the lockbox account requirement through March
14, 2008, (b) waiving compliance with the borrowing base requirement in so far
as it related exclusively to the defective displays inadvertently included in
inventory, and (c) extending the period for filing a registration statement for
certain shares held or to be issued to the lender until April 29,
2008. The Company established a lockbox account by March 14, 2008 and
filed a registration statement with the SEC on April 29, 2008.
Effective
March 25, 2008, the Company amended the Warrant Issuance Agreement (“Amended
Warrant Agreement”) with Moriah. In connection with such amendment, the Company
issued a Warrant to purchase an additional 250,000 shares of its common stock at
a price of $1.50 expiring March 25, 2013.
The
Company determined the fair value of the 1,000,000 warrants to be $729 thousand
which was recorded as deferred debt issuance and waiver fees of which $168
thousand was expensed immediately and $561 thousand will be amortized over the
life of the loan. The following assumptions were used to determine
the fair value of the warrants: dividend yield of 0%; risk free
interest rates of 2.61 % and 2.96%; expected volatility of 90.9% and 92.3%; and
expected contractual term of 5 years. The deferred debt issuance
costs are being amortized to interest expense over the life of the
loan.
In the
three and six months ended June 30, 2008, approximately $373 thousand and $821
thousand, respectively, of deferred debt issuance and waiver fees were amortized
to interest expense. For the three and six months ended June 30,
2008, interest expense includes interest paid or accrued on outstanding debt of
approximately $164 thousand and $323 thousand, respectively.
The 8%
Senior Secured Convertible Notes can also convert into the Company’s Series A
convertible Preferred Stock (the “Preferred Stock”). See Note
10: Shareholders’ Equity for additional information.
Note
9: Stock-based Compensation
The
Company accounts for the measurement and recognition of compensation expense for
all share-based payment awards made to employees and directors under Statement
of Financial Accounting Standards No. 123 (revised 2004),
Share-Based Payment
, (SFAS
123(R)). Under SFAS 123(R), the fair value of stock awards is estimated at the
date of grant using the Black-Scholes option valuation
model. Stock-based compensation expense is reduced for estimated
forfeitures and is amortized over the vesting period using the straight-line
method.
The
following table summarizes the allocation of non-cash stock-based compensation
to our expense categories for the three and six month periods ended June 30,
2008 and 2007 (in thousands):
|
|
Three
Months Ended June 30,
|
|
|
Six
Months Ended June 30,
|
|
|
|
2008
|
|
|
2007
|
|
|
2008
|
|
|
2007
|
|
Cost
of revenue
|
|
$
|
23
|
|
|
$
|
61
|
|
|
|
75
|
|
|
$
|
130
|
|
Research
and development
|
|
|
52
|
|
|
|
97
|
|
|
|
134
|
|
|
|
200
|
|
Selling,
general and administrative
|
|
|
176
|
|
|
|
227
|
|
|
|
398
|
|
|
|
569
|
|
Total
stock compensation expense
|
|
$
|
251
|
|
|
$
|
385
|
|
|
$
|
607
|
|
|
$
|
899
|
|
At June
30, 2008, total unrecognized non-cash compensation cost related to stock options
was approximately $964 thousand, net of forfeitures. Total
unrecognized compensation cost will be adjusted for future changes in estimated
forfeitures and is expected to be recognized over a weighted average period of
approximately 1.7 years.
The
Company recognizes compensation expense for options granted to non-employees in
accordance with the provisions of Emerging Issues Task Force (“EITF”) consensus
Issue 96-18, “
Accounting for
Equity Instruments that are Issued to Other Than Employees for Acquiring, or in
Conjunction with Selling Goods or Services,”
which requires using a fair
value options pricing model and re-measuring such stock options to the current
fair market value at each reporting period as the underlying options vest and
services are rendered.
There
were approximately 588,000 and 748,000 options granted to employees and
directors during the three and six months ended June 30, 2008. The following key
assumptions were used in the Black-Scholes option pricing model to determine the
fair value of stock options granted:
|
|
For
the Six Months Ended
June
30, 2008
|
|
Dividend
yield
|
|
|
0
|
%
|
Risk
free interest rates
|
|
2.46
to 3.28%
|
|
Expected volatility
|
|
89.6
to 92.3%
|
|
Expected
term (in years)
|
|
|
5
|
|
There
were no stock options granted during the three and six month period ended June
30, 2007. We have not declared or paid any dividends and do not
currently expect to do so in the near future. The risk-free interest
rate used in the Black-Scholes option pricing model is based on the implied
yield currently available on U.S. Treasury securities with an equivalent
term. Expected volatility is based on the weighted average
historical volatility of the Company’s common stock for the most recent five
year period. The expected term of options represents the period that
our stock-based awards are expected to be outstanding and was determined based
on historical experience and vesting schedules of similar awards.
On
February 20, 2008, the Board of Directors authorized the establishment of the
2008 Incentive Stock Plan with 2,000,000 options available for
grant. The 2008 Incentive Stock Plan is intended to provide long-term
performance incentives to directors, executives, selected employees and
consultants and reward them for making major contributions to the success and
well being of the Company. No options were granted from this plan as
of June 30, 2008.
A summary
of the Company’s stock option activity for the six months ended June 30, 2008 is
presented in the following tables:
|
|
Number
of Shares
|
|
|
Weighted
Average Exercise Price
|
|
|
Weighted
Average Remaining Contractual Life (In Years)
|
|
|
Aggregate
Intrinsic Value
|
|
Outstanding
at January 1, 2008
|
|
|
894,323
|
|
|
$
|
2.62
|
|
|
|
|
|
|
|
Options
granted
|
|
|
748,153
|
|
|
|
0.94
|
|
|
|
|
|
|
|
Options
exercised
|
|
|
—
|
|
|
|
|
|
|
|
|
|
|
|
Options
forfeited
|
|
|
(167,953
|
)
|
|
|
2.60
|
|
|
|
|
|
|
|
Options
cancelled
|
|
|
—
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding
at June 30, 2008
|
|
|
1,474,523
|
|
|
$
|
1.77
|
|
|
|
6.50
|
|
|
$
|
15,000
|
|
Vested
or expected to vest at June 30, 2008 (1)
|
|
|
1,434,149
|
|
|
$
|
1.68
|
|
|
|
6.50
|
|
|
$
|
14,200
|
|
Exercisable
at June 30, 2008
|
|
|
969,855
|
|
|
$
|
1.96
|
|
|
|
6.60
|
|
|
$
|
5,000
|
|
|
|
Options
Outstanding
|
|
Options
Exercisable
|
|
|
Number
Outstanding
|
|
Weighted
Average Remaining Contractual Life (In Years)
|
|
Weighted
Average Exercise Price
|
|
Number
Exercisable
|
|
Weighted
Average Exercisable Price
|
$0.81
- $1.51
|
|
976,730
|
|
8.04
|
|
$ 1.05
|
|
592,397
|
|
$ 1.19
|
$2.60
- $2.70
|
|
456,593
|
|
3.49
|
|
2.61
|
|
345,358
|
|
2.60
|
$3.50
- $5.80
|
|
12,000
|
|
4.18
|
|
5.61
|
|
12,000
|
|
5.61
|
$6.60
- $22.50
|
|
29,200
|
|
3.07
|
|
10.91
|
|
20,100
|
|
11.23
|
|
|
1,474,523
|
|
6.50
|
|
$ 1.77
|
|
969,855
|
|
$ 1.96
|
(1) The
expected to vest options are the result of applying the pre-vesting forfeiture
rate assumptions to total unvested options.
The
aggregate intrinsic value in the table above represents the difference between
the exercise price of the underlying options and the quoted price of the
Company’s common stock. There were 500,000 options in-the-money at
June 30, 2008. The Company’s closing stock price was $0.84 as
of June 30, 2008. The Company issues new shares of common stock upon exercise of
stock options.
Note
10: Shareholders’ Equity
Preferred
Stock
The
Company has designated but not issued 3,198 shares of the Company’s Preferred
Stock at a stated value of $1,000 per share. The Preferred Stock is
entitled to cumulative dividends which accrue at a rate of 8% per annum, payable
on December 21, 2008. Each share of the Preferred Stock has voting
rights equal to (1) in any case in which the Preferred Stock votes
together with the Company's Common Stock or any other class or series of stock
of the Company, the number of shares of Common Stock issuable upon conversion of
such shares of Preferred Stock at such time (determined without regard to the
shares of Common Stock so issuable upon such conversion in respect of accrued
and unpaid dividends on such share of Preferred Stock) and (2) in any case not
covered by the immediately preceding clause one vote per share of Preferred
Stock. The Preferred Stock, if issued, has a mandatory redemption at
December 21, 2008.
Common
Stock
On
January 30, 2008, the Company amended and restated its Loan and Security
Agreement (“Amended Loan Agreement”) with Moriah. As part of the
amended agreement, the Loan Conversion agreement was terminated which eliminated
the optional conversion of principal up to $2.0 million into common stock at
$1.50. In connection with the Amended Loan agreement, the
Company issued a Warrant to purchase 750,000 shares of its common stock at a
price of $1.50 per share with an expiration date of January 29,
2013.
Effective
March 25, 2008, the Company amended the Warrant Issuance Agreement (“Amended
Warrant Agreement”) with Moriah. In connection with such amendment, the Company
issued a Warrant to purchase an additional 250,000 shares of its common stock at
a price of $1.50 expiring March 25, 2013.
On April
2, 2008, the Company entered into a Securities Purchase Agreement (“Purchase
Agreement”), pursuant to which the Company sold and issued 1,586,539 shares of
common stock, par value of $0.001 per share, at a price of $1.04 per share and
warrants to purchase an additional 793,273 shares of common stock for an
aggregate purchase price of approximately $1.65 million. The net
proceeds received after expenses were approximately $1.58
million. The warrants are exercisable at a price of $1.30 per share
and expire on April 2, 2013.
As a
result of the Purchase Agreement, the outstanding 650,000 Series F Common Stock
Purchase Warrants that were issued to participants of the Securities Purchase
Agreement dated October 25, 2004, were repriced from $4.09 to
$3.45.
A
registration rights agreement was entered into on April 2, 2008 in connection
with the private placement which required the Company to file a registration
statement for the resale of the common stock and the shares underlying the
warrants within 45 days of the signing of the agreement. The Company
must use its best efforts to have the registration statement declared effective
within 90 days of the signing of the agreement or if a SEC review, 120
days. In addition, the Company must use its best efforts to maintain
the effectiveness of the registration statement until all common stock have been
sold or may be sold without volume restrictions pursuant to Rule 144(k) of the
Securities Act.
If the
registration statement is not effective within the grace periods (“Event Date”)
or the Company cannot maintain its effectiveness (“Event Date”), the Company
must pay partial liquidated damages (“damages”) in cash to each investor equal
to 2% of the aggregate purchase price paid by each investor under the Purchase
Agreement on the Event Date and each monthly anniversary of the Event Date (or
on a pro-rata basis for any portion of a month) until the registration statement
is effective. The Company is not liable for any damages with respect
to the warrants or warrant shares. The maximum damages payable to
each investor is 36% of the aggregate purchase price. If the Company
fails to pay the damages to the investors within 7 days after the date payable,
the Company must pay interest at a rate of 15% per annum to each investor which
accrues daily from the date payable until damages are paid in full.
The
Company filed the registration statement within the 45 day period however the
Company was notified that the registration statement was under review by the
SEC. The Company failed to file the amended registration statement by
August 2, 2008 which was the 120th day from the signing of the purchase
agreement and therefore the registration statement is not
effective.
The
Company accounted for the registration payment arrangement under the guidance of
EITF 00-19-2, “Accounting for Registration Payment Arrangements”, (“EITF
00-19-2”) which requires the contingent obligation to make future payments be
recognized and measured in accordance with FASB Statement No. 5, “Accounting for
Contingencies”, (“Statement 5”) and FASB Interpretation No. 14, “Reasonable
Estimation of the Amount of a Loss”, (“Interpretation 14”). The Company
estimated $399 thousand to be the maximum potential damages that the Company may
be required to pay the investors if the registration statement is not effective
within three years of the signing of the agreement. The Company estimated $66
thousand to be a reasonable estimate of the potential damages that may be due to
the investors. As a result, the Company recorded a liability of $66
thousand in the condensed consolidated balance sheets and the associated expense
in other income in the condensed consolidated statements of operations for the
three and six months ended June 30, 2008.
For the
three and six months ended June 30, 2008 and 2007, there were no stock options
exercised. For the three and six months ended June 30, 2008, there
were no warrants exercised and for the three and six months ended June 30, 2007,
the Company received approximately $3 thousand in proceeds for warrants
exercised.
For the
three and six months ended June 30, 2008, the Company issued approximately
182,000 shares of common stock for payment of approximately $202 thousand for
services rendered or to be rendered in the future. For the three and
six months ended June 30, 2007, the Company issued approximately 206,000 and
914,000 shares of common stock, respectively, for payment of approximately $138
thousand and $758 thousand, respectively, for services rendered and to be
rendered in the future. As such, the Company recorded the fair value
of the services to be rendered in prepaid expenses and rendered in selling,
general and administrative expenses in the accompanying unaudited condensed
consolidated statement of operations for the three and six months ended June 30,
2008 and 2007, respectively.
Note
11: Income Taxes
The
Company adopted the provisions of Financial Standards Accounting Board
Interpretation No. 48 Accounting for Uncertainty in Income Taxes (“FIN 48”) an
interpretation of FASB Statement No. 109 (“SFAS 109”) on January 1, 2007. As a
result of the implementation of FIN 48, we did not recognize any adjustment in
the liability for unrecognized income tax benefits. The tax years 2004-2007
remain open to examination by the major taxing jurisdictions to which we are
subject. In the event that the Company is assessed interest or penalties at some
point in the future, they will be classified in the financial statements as
general and administrative expense. The Company has not provided for
income taxes in the three and six months ended June 30, 2008 as the Company
expects its effective interest rate to be zero due to continuing
losses.
Note
12: Commitments and Contingencies
Royalty
Payments
The Company, in accordance with
a royalty agreement with Eastman Kodak, must pay to Eastman Kodak a
certain percentage of net sales with respect to certain
products, which percentages are defined in the agreement. The percentages
are on a sliding scale depending on the amount of sales generated. Any
minimum royalties paid will be credited against the amounts due based on
the percentage of sales. The royalty agreement terminates upon the
expiration of the issued patent which is the last to expire.
Effective
May 30, 2007, Kodak and eMagin entered into an intellectual property agreement
where eMagin has assigned Kodak the rights, title, and interest to a Company
owned patent currently not being used by the Company and in consideration, Kodak
waived the royalties due under the existing licensing agreements for the first
six months of 2007, and reduced the royalty payments by 50% for the second half
of 2007 and for the entire calendar year of 2008. In addition, the minimum
royalty payment is delayed until December 1
st
for the
years 2007 and 2008. The Company recorded approximately $170 thousand
and $254 thousand for the three and six months ended June 30, 2008,
respectively, and $560 thousand for the three and six months ended June 30, 2007
as income from the license of intangible assets and included this amount as
other income in the condensed consolidated statements of
operations. The income from the license of intangible assets is
equivalent to the royalty payments that have been waived by Kodak.
Royalty
expense (including amounts imputed – see above) was approximately $341 thousand
and $509 thousand, respectively, for the three and six months ended June
30, 2008 and approximately $304 thousand and $560 thousand, respectively, for
the three and six months ended June 30, 2007.
Contractual
Obligations
The Company leases
office facilities and office, lab and factory equipment under operating leases
expiring through 2009. Certain leases provide for payments of monthly
operating expenses. The Company currently has lease commitments for space in
Hopewell Junction, New York and Bellevue, Washington. Rent expense
was approximately $332 thousand and $664 thousand, respectively, for the three
and six months ended June 30, 2008 and 2007.
Note
13: Legal Proceedings
A former
employee (“plaintiff”) of the Company commenced legal action in the United
States District Court for the Southern District of New York, on or about October
12, 2007, alleging that the plaintiff was subject to gender based discrimination
and retaliation in violation of Title VII of the Civil Rights Act of 1964 (
Case No. 07-CV-8827 (KMK)). The plaintiff seeks unspecified compensatory
damages, punitive damages and attorneys’ fees. On November 26, 2007,
the Company served and filed its Answer, in which it denied the material
allegations of the Complaint and asserted numerous affirmative
defenses. This action is presently in the discovery
stage. The Company disputes the allegations of the Complaint and
intends on vigorously defending this action.
Note
14: Separation and Employment Agreements
Effective
April 14, 2008, Michael D. Fowler, the Company’s Interim Chief Financial
Officer, resigned his position with the Company. There was no separation
agreement executed between Mr. Fowler and the Company. On April 15, 2008, Paul
Campbell was appointed as Interim Chief Financial Officer of the
Company. There is no employment agreement between the Company and Mr.
Campbell.
On May
13, 2008, the Company signed an executive employment agreement with Andrew
Sculley, Jr. to serve as the Company’s Chief Executive Officer and President
effective June 1, 2008. Pursuant to the Employment Agreement, Mr.
Sculley is paid a salary of $300,000. The salary will increase to
$310,000, per annum, after six months and to $320,000 per annum at the end of
the first year. If Mr. Sculley voluntarily terminates his employment
with the Company, other than for Good Reason as defined in the Employment
Agreement, he shall cease to accrue salary, personal time off, benefits and
other compensation on the date of voluntary termination. The Company may
terminate Mr. Sculley’s employment with or without cause. If the Company
terminates without cause, Mr. Sculley will be entitled to, at the Company’s sole
discretion, either (i) monthly salary payments for twelve (12) months, based on
his monthly rate of base salary at the date of such termination, or (ii) a
lump-sum payment of his salary for such 12 month period, based on his monthly
rate of base salary at the date of such termination. Mr. Sculley shall also be
entitled to receive (i) payment for accrued and unpaid vacation pay and (ii) all
bonuses that have accrued during the term of the Employment Agreement, but not
been paid. Mr. Sculley was granted 500,000 options of which one
third vested immediately and one third will vest annually on the subsequent two
anniversary dates.
Effective
June 1, 2008, Admiral Thomas Paulsen resigned from his position as Interim Chief
Executive Officer. Admiral Paulsen continues to serve as the
Company’s Chairman of the Board.
Note
15: Subsequent Events
On August
8, 2008, Moriah granted to the Company an extension of the Loan with the same
terms for 8 days.
PART
II
INFORMATION
NOT REQUIRED IN PROSPECTUS
ITEM
13. OTHER EXPENSES OF ISSUANCE AND DISTRIBUTION.
The
following table sets forth an itemization of all estimated expenses, all of
which we will pay, in connection with the issuance and distribution of the
securities being registered:
NATURE
OF EXPENSE AMOUNT
SEC
Registration fee
|
|
$
|
113
|
|
Accounting
fees and expenses
|
|
25,000
|
*
|
Legal
fees and expenses
|
|
65,000
|
*
|
Miscellaneous
|
|
35,000
|
|
TOTAL
|
|
$
|
125,113
|
*
|
* Estimated.
ITEM
14. INDEMNIFICATION OF DIRECTORS AND OFFICERS.
Our
Articles of Incorporation, as amended and restated, provide to the fullest
extent permitted by Section 145 of the General Corporation Law of the State of
Delaware that our directors or officers shall not be personally liable to us or
our shareholders for damages for breach of such director's or officer's
fiduciary duty. The effect of this provision of our Articles of Incorporation,
as amended and restated, is to eliminate our rights and our shareholders
(through shareholders' derivative suits on behalf of our company) to recover
damages against a director or officer for breach of the fiduciary duty of care
as a director or officer (including breaches resulting from negligent or grossly
negligent behavior), except under certain situations defined by statute. We
believe that the indemnification provisions in our Articles of Incorporation, as
amended, are necessary to attract and retain qualified persons as directors and
officers.
Our By
Laws also provide that the Board of Directors may also authorize us to indemnify
our employees or agents, and to advance the reasonable expenses of such persons,
to the same extent, following the same determinations and upon the same
conditions as are required for the indemnification of and advancement of
expenses to our directors and officers. As of the date of this Registration
Statement, the Board of Directors has not extended indemnification rights to
persons other than directors and officers.
Insofar
as indemnification for liabilities arising under the Securities Act of 1933 may
be permitted to directors, officers or persons controlling us pursuant to the
foregoing provisions, or otherwise, we have been advised that in the opinion of
the Securities and Exchange Commission, such indemnification is against public
policy as expressed in the Securities Act of 1933 and is, therefore,
unenforceable.
ITEM
15. RECENT SALES OF UNREGISTERED SECURITIES.
On August
26, 2008, the Company and Moriah Capital, L.P. (“Moriah”) entered into Amendment
No. 3 to the Loan and Security Agreement dated as of August 20, 2008 (the
“Amendment No. 3”). Pursuant to Amendment No. 3, the Company issued Moriah
a warrant, which terminates on August 7, 2013, to purchase up to 370,000 shares
of the Company’s common stock at an exercise price of $1.30 per
share.
Pursuant
to Amendment No. 3, the Company and Moriah entered into an Amended and
Restated Securities Issuance agreement (the “Amended and Restated Securities
Issuance Agreement”). In connection with a Securities Issuance Agreement, dated
as of August 7, 2007 (the “Original Securities Issuance Agreement”), the Company
issued Moriah 162,500 shares of the Company’s common stock (the “2007
Shares”). Pursuant to the Amended and Restated Securities Issuance
Agreement, Moriah agreed to waive the Company’s obligation to buy back the
2007 Shares with respect to 125,000 of such shares and to defer the Company’s
obligation to buy back 37,500 of such 2007 Shares (collectively, the
“Put Waiver”). Pursuant to the Amended and Restated Securities Agreement, the
Company is issuing Moriah 485,000 shares of its Common Stock (of which 125,000
shares were issued in consideration for the Put Waiver from Moriah and 360,000
shares were issued in lieu of the issuance to Moriah of the Contingent
Issued Shares (as described in the Original Securities Issuance Agreement)).
Additionally, pursuant to the Amended and Restated Securities Issuance
Agreement, the Company has also granted Moriah a put option pursuant to which
Moriah can sell 162,500 shares of its common stock issued under the Amended and
Restated Securities Agreement for $195,000, pro-rated for any
portion thereof (the “2007 Put Price”). The 2007 Put Option shall
automatically be deemed exercised by Moriah unless Moriah delivers written
notice to the Company at any time between July 1, 2009 and August 1, 2009 that
it does not wish to exercise the 2007 Put Option. The Company also granted
Moriah a second put option pursuant to which Moriah can sell 360,000 of the
shares issued to Moriah pursuant to the Amended and Restated Securities Purchase
Agreement to the Company for $234,000 (the “2008 Put
Option”). The 2008 Put Option shall automatically be deemed
exercised by Moriah unless Moriah delivers written notice to the Company at any
time between July 1, 2009 and August 1, 2009 that Moriah does not wish to
exercise the 2008 Put option in whole or in part.
On August
19, 2008, the Holders of the Amended Notes and the Investors in
the Purchase Agreement consented to the Company’s execution of the Amended
Note, Amendment No. 3, Amended and Restated Securities Issuance Agreement, and
the Amended Registration Rights Agreement. In consideration for the
consent, a total of 144,000 shares of common stock were issued to the Holders
and Investors based on individual participation in the Amended Notes and
Securities Purchase Agreement on September 4, 2008.
On April
2, 2008, the Company entered into a Securities Purchase Agreement, pursuant to
which it sold to certain qualified institutional buyers and accredited investors
an aggregate of 1,586,539 shares of the Company’s common stock, par value $0.001
per share, and warrants to purchase an additional 793,273 shares of common
stock, for an aggregate purchase price of $1,650,000. The purchase price of the
common stock was $1.04 per share and the strike price of the corresponding
warrant was $1.30 per share. The warrants expire April 2, 2013.
The
Company and Moriah entered into Amendment No. 2 to the Loan and Security
Agreement dated as of March 25, 2008 (the “Amendment No.
2”). Pursuant to Amendment No. 2, Moriah waived the Company’s
noncompliance with Sections 7.2, 7.3, 8.11, 9.1, 9.3, 9.5(c) and 11.5 of the
Loan and Security Agreement to the extent such noncompliance resulted solely
from the Company’s inadvertently misstating the amount of its inventory that
contained defective parts (the “Defective Inventory Count”), provided that on or
before April 8, 2008 the Company repays Moriah all prior Advances (as defined in
the Loan and Security Agreement), which exceed the Maximum Credit (as defined in
the Loan and Security Agreement) if any, as a result of the Defective Inventory
Count.
Pursuant
to Amendment No. 2 the Company has advised Moriah of certain delays in
implementing the Lockbox Agreement, as required under the Loan and
Security Agreement, which, if unwaived, would result in the Company’s
noncompliance with section 2.1(f) of the Loan and Security Agreement and with
Section 3 of the Post-Closing Agreement between the Company and Moriah, dated
August 7, 2007. Moriah agreed to waive noncompliance with Sections
2.1(f) of the Loan and Security Agreement and Section 3 of the Post-Closing
Agreement in reliance on the Company’s representation and warranty that all
lockbox arrangements required to be implemented under Section 2.1(f) of the Loan
and Security Agreement and under Section 3 of the Post-Closing Agreement have
been consummated and are in full force and effect as of March 12,
2008.
On
January 30, 2008, the Company and Moriah entered into a Warrant Issuance
Agreement (the “Warrant Issuance Agreement”). The Company and Moriah
entered into Amendment No. 1 to the Warrant Issuance Agreement. Pursuant to the
Amendment No. 1 to Warrant Issuance Agreement, the Company issued Moriah a
Warrant to purchase 250,000 shares of the Company’s common stock at an exercise
price of $1.50 per share until March 25, 2013 (the “March 2008 Warrant”).
Pursuant to the Amendment No. 1 to the Warrant Issuance Agreement, Section 3.2
of the Warrant Issuance Agreement was amended to provide that the Company has to
file by April 29, 2008 a registration statement with the Securities and Exchange
Commission to register 1,000,000 shares of the Company’s common stock issuable
upon exercise of warrants issued to Moriah (including the March 2008 Warrant and
a warrant to purchase 750,000 shares of the Common Stock which was previously
issued to Moriah).
The
Company entered into a Loan and Security Agreement, effective as of August 7,
2007 with Moriah. In connection with the transaction, a Securities
Issuance Agreement pursuant to which the Company issued 162,500 shares of its
common stock, which shares had an aggregate market value at the Closing Date of
$195,000.
On July
23, 2007, the Company entered into Amendment Agreements with the holders of the
Notes issued July 21, 2006 and March 28, 2007 (each a “Holder” and collectively,
the “Holders”) and agreed to issue each Holder an amended and restated Note (the
“Amended Notes”) in the principal amount equal to the principal amount
outstanding as of July 23, 2007.
The
changes to the Amended Notes include the following:
·
|
The
due date for the outstanding Notes (totaling after conversions an
aggregate of $6,020,000) has been extended to December 21,
2008;
|
·
|
The
Amended Notes are convertible into (i) 8,407,612 shares of the Company’s
common stock. The conversion price for $5,770,000 of principal was revised
from $2.60 to $0.75 per share. The conversion price of $0.35 per share for
$250,000 of principal was
unchanged;
|
·
|
$3,010,000
of the Notes can convert into (ii) 3,010 shares of the Company’s newly
formed Series A Convertible Preferred Stock (the “Preferred”) at a
conversion price of $1,000 per share. The Preferred is convertible into
common stock at the same price allowable by the Amended Notes,
subject to adjustment as provided for in the Certificate of
Designations;
|
·
|
The
Amended Notes adjust the exercise price from $3.60 to $1.03 per share for
1,553,468 Warrants and require the issuance of 3,831,859 Warrants
exercisable at $1.03 per share pursuant to which the holders may acquire
common stock, until July 21, 2011;
and
|
·
|
As
of July 23, 2007 the interest rate was raised from 6% to
8%.
|
On March
28, 2007, we entered into an amendment of the Note Purchase Agreement (the
“Stillwater Note Purchase Agreement”) for the sale of $500 thousand of senior
secured debentures (the “Stillwater Note”) and warrants to purchase
approximately 1.0 million shares of common stock, par value $.001 per share. The
investor purchased the Stillwater Note with a conversion price of $0.35 per
share that may convert into approximately 1.4 million shares of common stock and
warrants exercisable at $0.48 per share into approximately 1.0 million shares of
common stock expiring in 4.2 years. If the Stillwater Notes are not converted,
50% of the principal amount will be due on July 21, 2007 and the remaining 50%
will be due on January 21, 2008. 6% interest is payable in quarterly
installments on outstanding notes with the first installment to be paid June 1,
2007. On April 9, 2007, we closed the transaction and received approximately
$460 thousand, net of offering costs of approximately $40 thousand which are
amortized over the life of the Stillwater Note.
In 2006,
we issued options to purchase an aggregate of 114,855 shares of common stock at
a weighted average price of $2.64 per share to employees as compensation for
services performed on behalf of our company. In addition, we issued options to
purchase an aggregate of 3,900 shares of common stock at a price equal to $2.60
per share to a director as compensation for services performed on our behalf as
his capacity as director of our company.
On July
21, 2006, we entered into several Note Purchase Agreements, including the
Stillwater Note Purchase Agreement, for the sale of approximately $5.99 million
of senior secured debentures (the “Notes”) together with warrants to purchase
approximately 1.8 million shares of common stock. The Notes may convert into
approximately $2.3 million shares at a conversion price of $2.60. The 5 year
warrants are exercisable at $3.60 per share into approximately 1.6 million
shares of common stock. 50% of the aggregate principal amount matures on July
21, 2007 and the remaining 50% matures on January 21, 2008. For the year ended
December 31, 2006, two note holders converted their promissory notes valued at
approximately $0.22 million and were issued an aggregate of approximately 85
thousand shares.
On October
20, 2005, the Company entered into a Securities Purchase Agreement, pursuant to
which the Company sold and issued 1,661,906 shares of common stock, par value
$0.001 per share, at a price of $5.50 per share and warrants to purchase up to
997,143 shares of common stock for an aggregate purchase price of approximately
$9.14 million. The warrants are exercisable at a price of $10.00 per share and
expire on April 20, 2011. Of the 997,143 warrants, 664,763 of the warrants are
exercisable on or after May 20, 2006. The remaining 332,381 are exercisable
after March 31, 2007.
In 2005,
we issued options to purchase an aggregate of 267,900 shares of common stock at
a weighted average price of $12.10 per share to employees as compensation for
services performed on behalf of our company. In addition, we issued options to
purchase an aggregate of 49,750 shares of common stock at a weighted average
price of $6.80 per share to directors as compensation for services performed on
our behalf in each of their capacities as directors of our company.
On
January 9, 2004, the Company entered into a Securities Purchase Agreement with
several accredited institutional and private investors whereby such investors
purchased an aggregate of 333,336 shares of common stock and 431,221 warrant
shares for an aggregate purchase price of approximately $4.2 million. The shares
of common stock were priced at a 20% discount to the average closing price of
the stock from December 30, 2003 to January 6, 2004, which ranged from $13.80 to
$19.40 per share during the period for an average closing price of $12.60 per
share. In addition, the investors received warrants to purchase an aggregate of
200,002 shares of common stock (subject to anti-dilution adjustments)
exercisable at a price of $17.40 per share for a period of five (5) years. The
warrants were priced at a 10% premium to the average closing price of the stock
for the pricing period. In connection with the Securities Purchase Agreement,
eMagin also issued additional warrants to the investors to acquire an aggregate
of 231,219 shares of common stock. On April 9, 2007, the 116,573 outstanding
Series A Common Stock Purchase Warrants were re-priced to $0.35.
In
February 2004, the Company and all of the holders of the Secured Convertible
Notes (the "Notes"), which were due in November 2005, entered into an agreement
whereby the holders agreed to an early conversion of 100% of the principal
amount of the Notes aggregating $7.825 million, together with all of the accrued
interest of approximately $742,000 on the Notes, into 1,139,462 shares of the
Company's common stock. In consideration of the Note holders agreeing to the
early conversion of the Notes, eMagin agreed to issue the Note holders warrants
to purchase an aggregate of 250,000 shares of common stock (the "warrants"),
which warrants are exercisable at a price of $27.60 per share. 150,000 of the
warrants (series D warrants) expired on December 31, 2005. The remaining 100,000
of the warrants (series E warrants) are exercisable until June 10,
2008.
In August
2004, the Company and certain of the holders of its outstanding Class A, B and C
common stock purchase warrants entered into an agreement pursuant to which the
Company and the holders of the warrants agreed to the $9.00 re-pricing and
exercise of Class A, B and C common stock purchase warrants. As a condition to
the transaction, the holders of the warrants agreed to limit the right of
participation that they were granted in January 9, 2004. As a result of the
transaction, the holders agreed to re-price and exercise approximately, 209,989
Class A, B and/or C common stock purchase warrants for an aggregate of
$1,889,900.
On
October 21, 2004, the Company entered into a Securities Purchase Agreement,
pursuant to which eMagin sold and issued 1,033,453 shares of common stock, and
series F common stock warrants to purchase 512,976 of common stock for an
aggregate purchase price of $10,772,500. The common stock was priced at $10.50.
The Series F Warrants are exercisable from April 25, 2005 until April 25, 2010
at an exercise price of $12.10 per share, subject to adjustment upon the
occurrence of specific events, including stock dividends, stock splits,
combinations or reclassifications of the Company’s common stock or distributions
of cash or other assets. In addition, the Series F Warrants contain provisions
protecting against dilution resulting from the sale of additional shares of the
Company’s common stock for less than the exercise price of the Series F
Warrants, or the market price of the common stock, on the date of such issuance
or sale.
On
October 28, 2004, eMagin entered into a Securities Purchase Agreement, pursuant
to which eMagin sold and issued 274,048 shares of common stock, and series F
common stock purchase warrants to purchase eMagin’s common stock to purchasers
for an aggregate purchase price of $2,877,500. The common stock was priced at
$10.50. The Series F Warrants are exercisable from April 25, 2005 until April
25, 2010 to purchase up to 137,024 shares of common stock at an exercise price
of $12.10 per share, subject to adjustment upon the occurrence of specific
events, including stock dividends, stock splits, combinations or
reclassifications of eMagin’s common stock or distributions of cash or other
assets. In addition, the Series F Warrants contain provisions protecting against
dilution resulting from the sale of additional shares of eMagin’s common stock
for less than the exercise price of the Series F Warrants, or the market price
of the common stock, on the date of such issuance or sale. On April 9, 2007, the
outstanding 650,001 Series F Common Stock Purchase Warrants were re-priced to
$7.12.
*All of
the above issuances and sales were deemed to be exempt under Rule 506 of
Regulation D and Section (2) of the Securities Act of 1933, as amended. No
advertising or general solicitation was employed in offering the securities. The
offerings and sales were made to a limited number of persons, all of whom were
accredited investors, business associates of eMagin or executive officers of
eMagin, and transfer was restricted by eMagin in accordance with the requirement
of the Securities Act of 1933. In addition to representations by the
above-reference persons, we have made independent determinations that 11 of the
above-referenced person were accredited or sophisticated investors, and that
they were capable of analyzing the merits and risks of their investment, and
that they understood the speculative nature of their investment. Furthermore,
all of the above-referenced persons were provided with access to our Securities
and Exchange Commission filings.
ITEM
16. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES.
The
following exhibits are included as part of this Form S-1. References to “the
Company” in this Exhibit List mean eMagin Corp., a Delaware
corporation.
Exhibit
Number
|
|
Description
|
|
|
|
2.1
|
|
Agreement
and Plan of Merger between Fashion Dynamics Corp., FED Capital Acquisition
Corporation and FED Corporation dated March 13, 2000 (incorporated by
reference to exhibit 2.1 to the Registrant's Current Report on Form 8-K/A
filed on March 17, 2000).
|
|
|
|
3.1
|
|
Amended
and Restated Articles of Incorporation (incorporated by reference to
exhibit 99.2 to the Registrant's Definitive Proxy Statement filed on June
14, 2001).
|
|
|
|
3.2
|
|
Amended
Articles of Incorporation (incorporated by reference to exhibit A to the
Registrant's Definitive Proxy Statement filed on June 13,
2003).
|
|
|
|
3.3
|
|
Bylaws
of the Registrant (incorporated by reference to exhibit 99.3 to the
Registrant's Definitive Proxy Statement filed on June 14,
2001).
|
|
|
|
4.1
|
|
Form
of Warrant dated as of April 25, 2003 (incorporated by reference to
exhibit 4.3 to the Registrant's Current Report on Form 8-K filed on April
28, 2003).
|
|
|
|
4.2
|
|
Form
of Series A Common Stock Purchase Warrant dated as of January 9, 2004
(incorporated by reference to exhibit 4.1 to the Registrant's Current
Report on Form 8-K filed on January 9, 2004).
|
|
|
|
4.3
|
|
Form
of Series B Common Stock Purchase Warrant dated as of January 9, 2004
(incorporated by reference to exhibit 4.2 to the Registrant’s Current
Report on Form 8-K filed on January 9, 2004).
|
|
|
|
4.4
|
|
Form
of Series C Common Stock Purchase Warrant dated as of January 9, 2004
(incorporated by reference to exhibit 4.3 to the Registrant's Current
Report on Form 8-K filed on January 9, 2004).
|
|
|
|
4.5
|
|
Form
of Series D Warrant (incorporated by reference to exhibit 4.1 to the
Registrant's current report on Form 8-K filed on March 4,
2004).
|
|
|
|
4.6
|
|
Form
of Series E Warrant (incorporated by reference to exhibit 4.2 to the
Registrant's current report on Form 8-K filed on March 4,
2004).
|
|
|
|
4.7
|
|
Form
of Common Stock Purchase Warrant (incorporated by reference to exhibit 4.1
to the Registrant's current report on Form 8-K filed on August 26,
2008).
|
|
|
|
4.8
|
|
Form
of Amended and Restated Secured Revolving Loan Note (incorporated by
reference to exhibit 4.2 to the Registrant's current report on Form 8-K
filed on August 26, 2008).
|
|
|
|
4.9
|
|
Form
of Series F Warrant (incorporated by reference to exhibit 4.1 to the
Registrant's current report on Form 8-K filed on October 26,
2004).
|
|
|
|
4.10
|
|
Form
of Common Stock Purchase Warrant dated October 20, 2005, filed October 31,
2005, as filed in the Registrant's Form 8-K incorporated herein by
reference.
|
|
|
|
5.1
|
|
Consent
of Sichenzia Ross Friedman Ference LLP (filed
herewith).
|
|
|
|
10.1
|
|
2000
Stock Option Plan, (incorporated by reference to Annex A to Exhibit
99.1 to the Registrant's Registration Statement on Form S-8 filed on March
14, 2000).*
|
|
|
|
10.2
|
|
Form
of Agreement for Stock Option Grant pursuant to 2003 Stock Option Plan
(incorporated by reference to exhibit 99.2 to the Registrant's
Registration Statement on Form S-8 filed on March 14,
2000).*
|
|
|
|
10.3
|
|
Nonexclusive
Field of Use License Agreement relating to OLED Technology for miniature,
high resolution displays between the Eastman Kodak Company and FED
Corporation dated March 29, 1999 (incorporated by reference to exhibit
10.6 to the Registrant's Annual Report on Form 10-K/A for the year ended
December 31, 2000 filed on April 30,
2001).
|
10.4
|
|
Amendment
Number 1 to the Nonexclusive Field of Use License Agreement relating to
the LED Technology for miniature, high resolution displays between the
Eastman Kodak Company and FED Corporation dated March 16, 2000
(incorporated by reference to exhibit 10.7 to the Registrant's Annual
Report on Form 10-K/A for the year ended December 31, 2000 filed on April
30, 2001).
|
|
|
|
10.5
|
|
Lease
between International Business Machines Corporation and FED Corporation
dated May 28, 1999 (incorporated by reference to exhibit 10.9 to the
Registrant's Annual Report on Form 10-K for the year ended December 31,
2000 filed on March 30 , 2001).
|
|
|
|
10.6
|
|
Amendment
Number 1 to the Lease between International Bushiness Machines Corporation
and FED Corporation dated July 9, 1999 (incorporated by reference to
exhibits 10.8 to the Registrant's Annual Report on Form 10-K for the year
ended December 31, 2000 filed on March 30, 2001)
|
|
|
|
10.7
|
|
Amendment
Number 2 to the Lease between International Business Machines Corporation
and FED Corporation dated January 29, 2001 (incorporated by reference to
exhibit 10.11 to the Registrant’s Annual Report on Form 10-K for
the year ended December 31, 2000 filed on March 30,
2001).
|
|
|
|
10.8
|
|
Amendment
Number 3 to Lease between International Business Machines Corporation and
FED Corporation dated May 28, 2002 (filed
herewith).
|
|
|
|
10.9
|
|
Amendment
Number 4 to Lease between International Business Machines Corporation and
FED Corporation dated December 14, 2004 (incorporated by reference to
the Registrant’s Current Report on Form 8-K filed on December 20,
2004).
|
|
|
|
10.10
|
|
Securities
Purchase Agreement dated as of April 25, 2003 by and among eMagin and the
investors identified on the signature pages thereto, filed April 28, 2003,
as filed in the Registrant's Form 8-K incorporated herein by
reference.
|
|
|
|
10. 11
|
|
Registration
Rights Agreement dated as of April 25, 2003 by and among eMagin and
certain initial investors identified on the signature pages thereto
(incorporated by reference to exhibit 10.3 to the Registrant's Current
Report on Form 8-K filed on April 28, 2003).
|
|
|
|
10. 12
|
|
Securities
Purchase Agreement dated as of January 9, 2004 by and among eMagin and the
investors identified on the signature pages thereto (incorporated by
reference to exhibit 10.1 to the Registrant's Current Report on Form 8-K
filed on January 9, 2004).
|
|
|
|
10. 13
|
|
Registration
Rights Agreement dated as of January 9, 2004 by and among eMagin and
certain initial investors identified on the signature pages thereto
(incorporated by reference to exhibit 10.2 to the Registrant's Current
Report on Form 8-K filed on January 9, 2004).
|
|
|
|
10. 14
|
|
Master
Amendment Agreement dated as of February 17, 2004 by and among eMagin and
the investors identified on the signature pages thereto (incorporated by
reference to exhibit 10.1 to the Registrant's Current Report on Form 8-K
filed on March 4, 2004).
|
|
|
|
10. 15
|
|
Registration Rights Agreement dated
as of February 17, 2004 by and among eMagin and certain initial
investors identified on the signature
pages thereto (incorporated by reference
to exhibit 10.2 to the Registrant's
Current Report on Form 8-K filed on March 4, 2004).
|
|
|
|
10. 16
|
|
Letter
Agreement amending the Master Amendment Agreement
dated as of March 1, 2004 by
and among eMagin and
the parties to
the Master Amendment
Agreement (incorporated by reference to exhibit 10.3 to the
Registrant's Current Report on Form 8-K filed on March 4,
2004).
|
|
|
|
10. 17
|
|
Lease
between International Business Machines Corporation and
FED Corporation dated May 28, 1999, as
filed in the Registrant's Form 10-K/A for the year
ended December 31, 2000 (incorporated by
reference to the Form 10-K filed on March 30,
2001).
|
|
|
|
10. 18
|
|
Amendment Number 2 to the Lease between International Business
Machines Corporation and
FED Corporation dated January 29, 2001,
as filed in the Registrant's Form 10-K/A for the
year ended December 31, 2000 (incorporated by reference to
Form 10-K filed March 30, 2001).
|
|
|
|
10. 19
|
|
Secured
Note Purchase Agreement entered into as of November 27, 2001,
by and among eMagin Corporation and
certain investors named therein,
as filed in
the Registrant's Form 8-K dated December 18, 2001
(incorporated by reference to Form 8-K filed December 18,
2001).
|
10. 20
|
|
2004
Non-Employee Compensation Plan, filed July 7, 2004, as filed in the
Registrant’s Form S-8, incorporated herein by
reference.*
|
|
|
|
10. 21
|
|
Form
of Letter Agreement by and among eMagin and the holders of the Class A,
Class B and Class C common stock purchase warrants, filed August 9, 2004 ,
as filed in the Registrant's Form 8-K incorporated herein by
reference.
|
|
|
|
10. 22
|
|
Securities
Purchase Agreement dated as of October 21, 2004 by and among eMagin and
the purchasers listed on the signature pages thereto, filed October 26,
2004 as filed in the Registrant's Form 8-K incorporated herein by
reference.
|
|
|
|
10. 23
|
|
Placement
Agency Agreement dated as of October 21, 2004 by and among eMagin and W.R.
Hambrecht & Co., LLC, filed October 26, 2004, as filed in the
Registrant's Form 8-K incorporated herein by reference.
|
|
|
|
10. 24
|
|
Agreement,
dated as of June 29, 2004, by and between eMagin and Larkspur Capital
Corporation, filed October 26, 2004, as filed in the Registrant's Form 8-K
incorporated herein by reference.
|
|
|
|
10. 25
|
|
Sublease
Agreement dated as of July 14, 2005 by and between eMagin and
Cap Gemini U.S., LLC, filed August 2, 2005, as filed in the
Registrant's Form 8-K incorporated herein by reference.
|
|
|
|
10. 26
|
|
Amended
and Restated 2003 Stock Option Plan, filed September 1, 2005, as filed in
the Registrant’s Definitive Proxy Statement, incorporated herein by
reference.*
|
|
|
|
10. 27
|
|
Amended
and Restated 2004 Non-Employee Compensation Plan, filed September 1, 2005,
as filed in the Registrant’s Definitive Proxy Statement, incorporated
herein by reference.*
|
10. 28
|
|
2005
Employee Stock Purchase Plan, filed September 1, 2005, as filed in the
Registrant’s Definitive Proxy Statement, incorporated herein by
reference.*
|
|
|
|
10. 29
|
|
Securities
Purchase Agreement dated as of October 20, 2005, by and among eMagin and
the purchasers listed on the signature pages thereto, filed October 31,
2005, as filed in the Registrant's Form 8-K incorporated herein by
reference.
|
|
|
|
10. 30
|
|
Registration
Rights Agreement dated as of October 20, 2005, by and among eMagin and the
purchasers listed on the signature pages thereto, filed October 31, 2005,
as filed in the Registrant's Form 8-K incorporated herein by
reference.
|
|
|
|
10. 31
|
|
Employment
Agreement effective as of January 1, 2006 by and between eMagin and Gary
Jones, filed January 27, 2006, as filed in the Registrant's Form 8-K
incorporated herein by reference.
|
|
|
|
10. 32
|
|
Employment
Agreement effective as of January 1, 2006 by and between eMagin and Susan
Jones, filed January 27, 2006, as filed in the Registrant's Form 8-K
incorporated herein by reference.
|
|
|
|
10. 33
|
|
Amendment
to Employment Agreement as of April 17, 2006 by and between eMagin and
Gary Jones.
|
|
|
|
10. 34
|
|
Amendment
to Employment Agreement as of April 17, 2006 by and between eMagin and
Susan Jones.
|
|
|
|
10. 35
|
|
Form
of Note Purchase Agreement dated July 21, 2006, by and among the Company
and the investors named on the signature pages thereto, (filed herewith)
.
|
|
|
|
10. 36
|
|
Form
of Note Purchase Agreement dated July 21, 2006, by and between the Company
and Stillwater LLC, (filed herewith)
|
|
|
|
10. 37*
|
|
2004
Amended and Restated Non-Employee Compensation Plan, filed September 21,
2006, as filed in the Registrant's Definitive Proxy Statement incorporated
herein by reference.
|
|
|
|
10. 38
|
|
Executive
Separation and Consulting Agreement dated as of January 11, 2007 by and
between eMagin Corporation and Gary W. Jones, filed January 19, 2007, as
filed in the Registrant's Form 8-K/A incorporated herein by
reference.
|
|
|
|
10. 39
|
|
Letter
Agreement dated as of February 12, 2007 by and between eMagin Corporation
and Dr. K.C. Park, filed February 16, 2007, as filed in the Registrant's
Form 8-K incorporated herein by reference.
|
|
|
|
10. 40
|
|
Allonge
to the 6% Senior Secured Convertible Notes Due 2007-2008 of eMagin
Corporation dated as of March 9, 2007, filed March 13, 2007, as filed in
the Registrant's Form 8-K incorporated herein by
reference.
|
|
|
|
10. 41
|
|
First
Amendment to Note Purchase Agreement as of March 28, 2007 by and between
eMagin Corporation and Stillwater LLC, as filed in the Registrant's
Form 8-K dated April 26, 2007 incorporated herein by
reference.
|
|
|
|
10. 42
|
|
Note
Purchase Agreement as of April 9, 2007 by and between eMagin
Corporation and Stillwater LLC, as filed in the Registrant's Form 8-K
dated April 25, 2007 (filed herewith).
|
|
|
|
10. 43
|
|
6%
Senior Secured Convertible Note, dated April 9, 2007, by and between the
Company and Stillwater LLC, incorporated by reference to the Company’s
Form 8-K as filed on April 26, 2007.
|
|
|
|
10. 44
|
|
Common
Stock Purchase Warrant, dated April 9, 2007, by and between the Company
and Stillwater LLC, incorporated by reference to the Company’s Form 8-K as
filed on April 26, 2007.
|
|
|
|
10. 45
|
|
Employment
Agreement between the Company and Tatum, LLC, dated December 26, 2007,
incorporated by reference to the Company’s Form 8-K as filed on January 3,
2008.
|
|
|
|
10. 46
|
|
Form
of Common Stock Purchase Warrant, incorporated by reference to the
Company’s Form 8-K/A as filed on February 8, 2008.
|
|
|
|
10. 47
|
|
Amendment
No. 1 to Loan and Security Agreement, dated as of January 30, 2008, to the
Loan and Security Agreement, dated August 7, 2007, incorporated by
reference to the Company’s Form 8-K/A as filed February 8,
2008.
|
|
|
|
10. 48
|
|
Warrant
Issuance Agreement, dated January 30, 2008, incorporated by reference to
the Company’s Form 8-K/A as filed February 8, 2008.
|
|
|
|
10. 49
|
|
Form
of Common Stock Purchase Warrant, incorporated by reference to the
Company’s Form 8-K, as filed on March 31, 2008.
|
|
|
|
10. 50
|
|
Amendment
No. 2 to Loan and Security Agreement, dated as of March 25, 2008 to the
Loan and Security Agreement, dated August 7, 2007, as amended on January
30, 2008, incorporated by reference to the Company’s Form 8-K, as filed
March 31, 2008.
|
|
|
|
10. 51
|
|
Amendment
No. 1 to Warrant Issuance Agreement, dated as of March 25, 2008, as
amended on January 30, 2008, incorporated by reference to the Company’s
Form 8-K, as filed March 31, 2008.
|
|
|
|
10 .52
|
|
Form
of Common Stock Purchase Warrant, incorporated by reference to the
Company’s Form 8-K, as filed on April 4,
2008.
|
10. 53
|
|
Securities
Purchase Agreement, dated as of April 2, 2008, incorporated by reference
to the Company’s Form 8-K, as filed April 4, 2008 (filed
herewith).
|
|
|
|
10. 54
|
|
Registration
Rights Agreement, dated as of April 2, 2008, incorporated by reference to
the Company’s Form 8-K, as filed April 4, 2008.
|
|
|
|
10 .55
|
|
Agreement
between the Company and Tatum, LLC, incorporated by reference to the
Company’s Form 8-K, filed April 18, 2008
|
|
|
|
10. 56
|
|
Employment
Agreement effective as of June 1, 2008 by and between eMagin and Andrew
Sculley, incorporated by reference to the Company’s Form 8-K/A as filed
August 19, 2008.
|
|
|
|
10. 57
|
|
Amendment
No. 3 to Loan and Security Agreement, dated as of August 20,
2008 to the Loan and Security Agreement, dated August 7, 2007,
incorporated by reference to the Company’s Form 8-K, as filed August 26,
2008.
|
|
|
|
10. 58
|
|
Warrant
Issuance Agreement No. 2, dated August 20, 2008, incorporated by reference
to the Company’s Form 8-K as filed August 26, 2008.
|
|
|
|
10. 59
|
|
Amended
and restated Securities Issuance Agreement, dated as of August 20, 2008,
incorporated by reference to the Company’s Form 8-K, as filed August 26,
2008.
|
|
|
|
10. 60
|
|
Amendment,
dated August 20, 2008, to Registration Rights Agreement, dated as of
August 7, 2007, incorporated by reference to the Company’s Form 8-K, as
filed August 26, 2008.
|
|
|
|
10. 61
|
|
Loan
and Security Agreement between Moriah Capital, L.P. and eMagin
Corporation, dated as of August 7, 2007, (filed
herewith).
|
|
|
|
23.1
|
|
Consent
of Sichenzia Ross Friedman Ference LLP (included in
Exhibit
5.1).
|
|
|
|
23.2
|
|
Consent
of Independent Registered Public Accounting Firm (filed
herewith).
|
*
Each of the Exhibits noted by an asterisk is a management compensatory
plan or arrangement.
|
The
undersigned registrant hereby undertakes to:
(1) File,
during any period in which offers or sales are being made, a post-effective
amendment to this registration statement to:
(i)
Include any prospectus required by Section 10(a)(3) of the Securities Act of
1933, as amended (the “Securities Act”);
(ii)
Reflect in the prospectus any facts or events which, individually or together,
represent a fundamental change in the information in the registration statement.
Notwithstanding the foregoing, any increase or decrease in volume of securities
offered (if the total dollar value of the securities offered would not exceed
that which was registered) and any deviation from the low or high end of the
estimated maximum offering range may be reflected in the form of prospectus
filed with the Commission pursuant to Rule 424(b) under the Securities Act if,
in the aggregate, the changes in volume and price represent no more than a 20%
change in the maximum aggregate offering price set forth in the “Calculation of
Registration Fee” table in the effective registration statement,
and,
(iii)
Include any additional or changed material information on the plan of
distribution.
(2) For
determining liability under the Securities Act, treat each post-effective
amendment as a new registration statement of the securities offered, and the
offering of the securities at that time to be the initial bona fide
offering.
(3) File
a post-effective amendment to remove from registration any of the securities
that remain unsold at the end of the offering.
(4) For
purposes of determining any liability under the Securities Act, treat the
information omitted from the form of prospectus filed as part of this
registration statement in reliance upon Rule 430A and contained in a form of
prospectus filed by the registrant pursuant to Rule 424(b)(1) or (4) or 497(h)
under the Securities Act as part of this registration statement as of the time
it was declared effective.
(5) For
the purpose of determining liability of the registrant under the Securities Act
of 1933 to any purchaser in the initial distribution of the securities: The
undersigned registrant undertakes that in a primary offering of securities of
the undersigned registrant pursuant to this registration statement, regardless
of the underwriting method used to sell the securities to the purchaser, if the
securities are offered or sold to such purchaser by means of any of the
following communications, the undersigned registrant will be a seller to the
purchaser and will be considered to offer or sell such securities to such
purchaser:
1.
|
Any
preliminary prospectus or prospectus of the undersigned registrant
relating to the offering required to be filed pursuant to Rule
424;
|
2.
|
Any
free writing prospectus relating to the offering prepared by or on behalf
of the undersigned registrant or used or referred to by the undersigned
registrant;
|
3.
|
The
portion of any other free writing prospectus relating to the offering
containing material information about the undersigned registrant or its
securities provided by or on behalf of the undersigned registrant;
and
|
4.
|
Any
other communication that is an offer in the offering made by the
undersigned registrant to the
purchaser.
|
(6) For
determining any liability under the Securities Act, treat each post-effective
amendment that contains a form of prospectus as a new registration statement for
the securities offered in the registration statement, and that offering of the
securities at that time as the initial bona fide offering of those
securities.
(7)
Insofar as indemnification for liabilities arising under the Securities Act may
be permitted to directors, officers and controlling persons of the registrant
pursuant to the foregoing provisions, or otherwise, the registrant has been
advised that in the opinion of the Securities and Exchange Commission such
indemnification is against public policy as expressed in the Securities Act and
is, therefore, unenforceable. In the event that a claim for indemnification
against such liabilities (other than the payment by the registrant of expenses
incurred or paid by a director, officer or controlling person of the registrant
in the successful defense of any action, suit or proceeding) is asserted by such
director, officer or controlling person in connection with the securities being
registered, the registrant will, unless in the opinion of its counsel the matter
has been settled by controlling precedent, submit to a court of appropriate
jurisdiction the question whether such indemnification by it is against public
policy as expressed in the Securities Act and will be governed by the final
adjudication of such issue.
(8) Each
prospectus filed pursuant to Rule 424(b) as part of a registration statement
relating to an offering shall be deemed to be part of and included in the
registration statement as of the date it is first used after effectiveness.
Provided, however, that no statement made in a registration statement or
prospectus that is part of the registration statement or made in a document
incorporated or deemed incorporated by reference into the registration statement
or prospectus that is part of the registration statement will, as to a purchaser
with a time of contract of sale prior to such first use, supersede or modify any
statement that was made in the registration statement or prospectus that was
part of the registration statement or made in any such document immediately
prior to such date of first use.
SIGNATURES
In
accordance with the requirements of the Securities Act of 1933, the registrant
certifies that it has reasonable grounds to believe that it meets all of the
requirements of filing on Form S-1 and authorizes this registration statement to
be signed on its behalf by the undersigned, in the City of Bellevue, State of
Washington, on November 12, 2008.
|
EMAGIN
CORP.
|
|
|
|
|
Date:
November
12 ,
2008
|
By:
/s/ ANDREW G.
SCULLEY
|
|
Andrew
G. Sculley
|
|
Chief
Executive Officer and President
(Principal
Executive Officer)
|
|
|
Date:
November
12
, 2008
|
By:
/s/ PAUL
CAMPBELL
|
|
Paul
Campbell
|
|
Chief
Financial Officer
(Principal
Financial Officer and Principal Accounting
Officer)
|
In
accordance with the requirements of the Securities Act of 1933, this
registration statement was signed by the following persons in the capacities and
on the dates stated.
Signature
|
|
Title
|
|
Date
|
|
|
|
|
|
/s/ Andrew G. Sculley
Andrew
G. Sculley
|
|
Chief
Executive Officer and President
(Principal
Executive Officer)
|
|
November
12, 2008
|
|
|
|
|
|
|
|
|
|
|
/s/ Paul S. Campbell
Paul
S. Campbell
|
|
Chief
Financial Officer
(Principal
Financial Officer and Principal Accounting Officer)
|
|
November 12,
2008
|
*
|
|
Director
|
|
November
12
,
2008
|
*
|
|
Director
|
|
November
12
,
2008
|
*
|
|
Director
|
|
November
12
,
2008
|
*
|
|
Director
|
|
November
12
,
2008
|
*
|
|
Director
|
|
November
12, 2008
|
*
|
|
Director
|
|
November
12
,
2008
|
* By:
|
/s/ THOMAS
PAULSEN
|
|
|
|
Thomas
Paulsen
|
|
|
|
Attorney-in-fact
|
|
|
118
Exhibit
10.35
NOTE PURCHASE
AGREEMENT
dated as of July 21,
2006
by and
between
EMAGIN
CORPORATION
and
[NAME OF
INVESTOR]
6% SENIOR SECURED
CONVERTIBLE NOTES DUE 2007-2008
AND
COMMON STOCK PURCHASE
WARRANTS
|
EMAGIN
CORPORATION
NOTE PURCHASE
AGREEMENT
6% SENIOR SECURED CONVERTIBLE NOTES
DUE 2007-2008
AND
COMMON STOCK PURCHASE
WARRANTS
TABLE OF CONTENTS
Page
1.
DEFINITIONS
|
|
1
|
2.
PURCHASE
AND SALE; PURCHASE PRICE.
|
|
10
|
(a)
|
Purchase.
|
|
10
|
(b)
|
Form of Payment.
|
|
10
|
(c)
|
Closing.
|
|
10
|
3.
REPRESENTATIONS,
WARRANTIES, COVENANTS, ETC. OF THE BUYER.
|
|
11
|
(a)
|
Circumstances
of Purchase.
|
|
11
|
(b)
|
Accredited
Investor; Residence.
|
|
11
|
(c)
|
Reoffers
and Resales.
|
|
11
|
(d)
|
Company
Reliance.
|
|
11
|
(e)
|
Information
Provided.
|
|
12
|
(f)
|
Absence
of Approvals.
|
|
12
|
(g)
|
Note
Purchase Agreement.
|
|
12
|
(h)
|
Buyer
Status.
|
|
13
|
(i)
|
Experience
of the Buyer.
|
|
13
|
(j))
|
General
Solicitation.
|
|
13
|
(k)
|
Short
Sales and Confidentiality Prior To The Date Hereof.
|
|
13
|
4.
REPRESENTATIONS,
WARRANTIES, COVENANTS, ETC. OF THE COMPANY.
|
|
13
|
(a)
|
Organization
and Authority.
|
|
13
|
(b)
|
Qualifications.
|
|
14
|
(c)
|
Concerning
the Shares and the Common Stock.
|
|
14
|
(d)
|
Corporate
Authorization.
|
|
14
|
(e)
|
Non-contravention.
|
|
15
|
(f)
|
Approvals,
Filings, Etc.
|
|
15
|
(g)
|
Information
Provided.
|
|
15
|
(h)
|
Investment
Company.
|
|
16
|
(i)
|
Absence
of Brokers, Finders, Etc.
|
|
16
|
(j)
|
No
Solicitation.
|
|
16
|
(k)
|
No
Integrated Offering.
|
|
16
|
(l)
|
Dilutive
Effect.
|
|
17
|
(m)
|
Absence
of Certain Changes.
|
|
17
|
(n)
|
No
Undisclosed Events, Liabilities, Developments or
Circumstances.
|
|
17
|
(o)
|
Conduct
of Business; Regulatory Permits.
|
|
17
|
(p)
|
Indebtedness
and Other Contracts.
|
|
18
|
(q)
|
Absence
of Litigation.
|
|
18
|
(r)
|
Insurance.
|
|
18
|
(s)
|
Employee
Relations
|
.
|
18
|
(t)
|
Title.
|
|
19
|
(u)
|
Intellectual
Property.
|
|
19
|
(v)
|
Environmental
Laws.
|
|
20
|
(w)
|
Subsidiary
Rights.
|
|
20
|
(x)
|
Tax
Status.
|
|
20
|
(y)
|
Internal
Accounting Controls; Financial Statements.
|
|
20
|
(z)
|
Sarbanes-Oxley
Act.
|
|
21
|
(aa)
|
S-3
Eligibility.
|
|
21
|
(bb)
|
Concerning
the Collateral.
|
|
21
|
(cc)
|
Disclosures.
|
|
21
|
(dd)
|
Absence
of Rights Agreement.
|
|
21
|
5. CERTAIN
COVENANTS.
|
|
21
|
(a)
|
Transfer
Restrictions.
|
|
21
|
(b)
|
Restrictive
Legends.
|
|
22
|
(c)
|
Reporting
Status.
|
|
24
|
(d)
|
Form
D.
|
|
24
|
(e)
|
State
Securities Laws.
|
|
24
|
(f)
|
Limitation
on Certain Actions.
|
|
25
|
(g)
|
Use
of Proceeds.
|
|
25
|
(h)
|
Best
Efforts.
|
|
25
|
(i)
|
Debt
Obligation.
|
|
25
|
(j)
|
Right
of the Buyer to Participate in Future Transactions
|
.
|
25
|
(k)
|
Press
Releases.
|
|
27
|
(l)
|
Form
8-K; Limitation on Information and Buyer Obligations.
|
|
28
|
(m)
|
Limitation
on Certain Transactions.
|
|
28
|
(n)
|
Debt
Obligation.
|
|
29
|
(o)
|
Security
Agreement; Financing Statements, Etc.
|
|
29
|
(p)
|
Stockholder
Approval; Reverse Stock Split.
|
|
29
|
(q)
|
Short
Sales and Confidentiality After The Date Hereof.
|
|
30
|
6.
CONDITIONS
TO THE COMPANYS OBLIGATION TO SELL.
|
|
31
|
7.
CONDITIONS
TO THE BUYERS OBLIGATION TO PURCHASE.
|
|
31
|
8.
REGISTRATION
RIGHTS.
|
|
33
|
(a)
|
Mandatory
Registration.
|
|
33
|
(b)
|
Obligations
of the Company.
|
|
34
|
(c)
|
Obligations
of the Buyer and other Investors.
|
|
38
|
(d)
|
Rule
144.
|
|
39
|
9.
INDEMNIFICATION
AND CONTRIBUTION.
|
|
39
|
(a)
|
Indemnification.
|
|
39
|
(b)
|
Contribution.
|
|
41
|
(c)
|
Other
Rights.
|
|
41
|
10.
MISCELLANEOUS.
|
|
42
|
(a)
|
Governing
Law.
|
|
42
|
(b)
|
Headings.
|
|
42
|
(c)
|
Severability.
|
|
42
|
(d)
|
Notices.
|
|
42
|
(e)
|
Counterparts.
|
|
42
|
(f)
|
Entire
Agreement; Benefit.
|
|
42
|
(g)
|
Waiver.
|
|
43
|
(h)
|
Amendment.
|
|
43
|
(i)
|
Further
Assurances.
|
|
43
|
(j)
|
Assignment
of Certain Rights and Obligations
|
.
|
43
|
(k)
|
Expenses.
|
|
44
|
(l)
|
Termination.
|
|
44
|
(m)
|
Survival.
|
|
45
|
(n)
|
Construction;
Buyer Status.
|
|
45
|
ANNEXES
Annex
I
|
Form
of 6% Senior Secured Convertible Note due 2007-2008
|
Annex
II
|
Form
of Common Stock Purchase Warrant
|
Annex
III
|
Form
of Patent and Trademark Security Agreement
|
Annex
IV
|
Form
of Pledge and Security Agreement
|
Annex
V
|
Form
of Lockbox Agreement
|
Annex
VI
|
Form
of Press Release
|
Annex
VII
|
Form
of Legal Opinion of Company Counsel
|
Annex
VIII
|
Form
of Legal Opinion of Intellectual Property Counsel
|
Annex
IX
|
Form
of Lockup Agreement
|
NOTE PURCHASE
AGREEMENT
THIS NOTE PURCHASE
AGREEMENT,
dated as
of July 21, 2006 (this Agreement), by and between
eMagin Corporation
, a
Delaware corporation (the Company), with headquarters located at 10500 N.E.
8
th
Street,
Suite 1400,
Bellevue,
Washington 98004, and
[NAME OF BUYER]
(the
Buyer).
W
I
T
N
E
S
S
E
T
H
:
WHEREAS
, upon
the terms and subject to the conditions of this Agreement, the Buyer wishes to
purchase from the Company and the Company wishes to sell to the Buyer, the Note
(such capitalized term and all other capitalized terms used in this Agreement
having the meanings provided in Section 1) of the Company to be issued by the
Company in the principal amount set forth on the signature page of this
Agreement, which Note will be convertible into shares of Common Stock, and in
connection with the sale and issuance of the Note the Company shall issue to the
Buyer a warrant to purchase shares of Common Stock;
NOW THEREFORE
, in
consideration of the premises and the mutual covenants contained herein and
other good and valuable consideration, the receipt and sufficiency of which are
hereby acknowledged, the parties agree as follows:
1.
DEFINITIONS
(a)
As used
in this Agreement, the terms Agreement, Buyer and Company shall have the
respective meanings assigned to such terms in the introductory paragraph of this
Agreement.
(b)
All the
agreements or instruments herein defined shall mean such agreements or
instruments as the same may from time to time be supplemented or amended or the
terms thereof waived or modified to the extent permitted by, and in accordance
with, the terms thereof and of this Agreement.
(c)
The
following terms shall have the following meanings (such meanings to be equally
applicable to both the singular and plural forms of the terms
defined):
Affiliate
means, with respect to any Person, any other Person that directly, or indirectly
through one or more intermediaries, controls, is controlled by or is under
common control with the subject Person. For purposes of this definition, control
(including, with correlative meaning, the terms controlled by and under common
control with), as used with respect to any Person, shall mean the possession,
directly or indirectly, of the power to direct or cause the direction of the
management and policies of such Person, whether through the ownership of voting
securities or by contract or otherwise.
AMEX
means the American Stock Exchange, Inc.
Blackout
Period means the period of up to twenty Trading Days (whether or not
consecutive) during any period of 365 consecutive days after the date the
Company notifies the Investors that they are required, pursuant to Section
8(c)(4), to suspend offers and sales of Registrable Securities as a result of an
event or circumstance described in Section 8(b)(5)(A), during which period, by
reason of Section 8(b)(5)(B), the Company is not required to amend a particular
Registration Statement or supplement the related Prospectus.
Business
Day means any day other than a Saturday, Sunday or a day on which commercial
banks in The City of New York are authorized or required by law or executive
order to remain closed.
Claims
means any losses, claims, damages, liabilities or expenses, including, without
limitation, reasonable fees and expenses of legal counsel (joint or several),
incurred by a Person.
Closing
Date means 10:00 a.m., New York City time, on July 21, 2006, or such other
mutually agreed to time.
Collateral
shall have the meaning to be provided or provided in each Security
Agreement.
Collateral
Agent shall have the meaning to be provided or provided in each Security
Agreement.
Common
Stock means the Common Stock, par value $.001 per share, of the
Company.
Common
Stock Equivalent means any warrant, option, subscription or purchase right with
respect to shares of Common Stock, any security convertible into, exchangeable
for, or otherwise entitling the holder thereof to acquire, shares of Common
Stock or any warrant, option, subscription or purchase right with respect to any
such convertible, exchangeable or other security.
Conversion
Price shall have the meaning to be provided or provided in the
Note.
Conversion
Shares means the shares of Common Stock or other securities issuable upon
conversion of the Note.
Encumbrance
means any mortgage, deed of trust, claim, security interest, lien, pledge,
lease, sublease, charge, escrow, option, proxy, right of occupancy, right of
first refusal, preemptive right, covenant, conditional limitation,
hypothecation, prior assignment, easement, title retention agreement, indenture,
security agreement or any other encumbrance of any kind.
Environmental
Law means any federal, state, local or foreign law relating to pollution or
protection of human health or the environment (including, without limitation,
ambient air, surface water, groundwater, land surface or subsurface strata),
including, without limitation, laws relating to emissions, discharges, releases
or threatened releases of Hazardous Materials into the environment, or otherwise
relating to the manufacture, processing, distribution, use, treatment, storage,
disposal, transport or handling of Hazardous Materials, as well as all
authorizations, codes, decrees, demands or demand letters, injunctions,
judgments, licenses, notices or notice letters, orders, permits, plans or
regulations issued, entered, promulgated or approved thereunder.
ERISA
means the Employee Retirement Income Security Act of 1974, as amended, and the
regulations thereunder and published interpretations thereof.
Exempt
Issuance shall have the meaning set forth in Section 5(m) of this
Agreement.
Event of
Default shall have the meaning to be provided or provided in the
Note.
Generally
Accepted Accounting Principles means, for any Person, the United States
generally accepted accounting principles and practices applied by such Person
from time to time in the preparation of its audited financial
statements.
Hazardous
Material means any chemical, pollutant, contaminant, or toxic or hazardous
substance or waste.
Indebtedness
shall have the meaning to be provided or provided in the Note.
Indemnified
Party means the Company, each of its directors, each of its officers who signs
the Registration Statement, each Person, if any, who controls the Company within
the meaning of the 1933 Act or the 1934 Act, any underwriter and any other
stockholder selling securities pursuant to the Registration Statement or any of
its directors or officers or any Person who controls such stockholder or
underwriter within the meaning of the 1933 Act or the 1934 Act.
Indemnified
Person means the Buyer and any Investor and their respective investment advisers
and investment managers, the directors, officers, employees and agents of the
Buyer, any such Investor and any such investment adviser or investment manager,
each Person, if any, who controls the Buyer, any such Investor or any such
investment adviser or investment manager within the meaning of the 1933 Act or
the 1934 Act, any underwriter (as defined in the 1933 Act) acting on behalf of
an Investor who participates in the offering of Registrable Securities of such
Investor in accordance with the plan of distribution contained in the
Prospectus, the directors, if any, of such underwriter and the officers, if any,
of such underwriter, and each Person, if any, who controls any such underwriter
within the meaning of the 1933 Act or the 1934 Act.
Inspector
means any attorney, accountant or other agent retained by an Investor for the
purposes provided in Section 8(b)(9).
Insolvent
means (i) the present fair saleable value of the Company's assets is less than
the amount required to pay the Company's total indebtedness, contingent or
otherwise, (ii) the Company is unable to pay its debts and liabilities,
subordinated, contingent or otherwise, as such debts and liabilities become
absolute and matured, (iii) the Company intends to incur debts beyond its
ability to pay as such debts as they mature (taking into account the timing and
amounts of cash to be payable on or in respect of its debt) or (iv) the Company
has unreasonably small capital with which to conduct the business in which it is
engaged for the current fiscal year as such business is now conducted and is
proposed to be conducted.
Intellectual
Property means all franchises, patents, trademarks, service marks, trade names
(whether registered or unregistered), copyrights, corporate names, licenses,
trade secrets, proprietary software or hardware, proprietary technology,
technical information, discoveries, designs and other proprietary rights,
whether or not patentable, and confidential information (including, without
limitation, know-how, processes and technology) used in the conduct of the
business of the Company or any Subsidiary.
Investor
means the Buyer and any transferee or assignee who agrees to become bound by the
provisions of Sections 5(a), 5(b), 8, 9, and 10 of this Agreement.
Lockbox
Agent means the Person from time to time serving as Lockbox Agent under the
Lockbox Agreement.
Lockbox
Agreement means the Lockbox Agreement by and between the Company and the Lockbox
Agent in the form attached as
Annex V
.
Liens
shall have the meaning to be provided or provided in the Note.
Margin
Stock shall have the meaning provided in Regulation U of the Board of Governors
of the Federal Reserve System (12 C.F.R. Part 221).
Material
Adverse Effect means (i) a material adverse effect on (A) the business,
properties, operations, condition (financial or other), results of operations or
prospects of the Company and the Subsidiaries, taken as a whole; (B) the
validity or enforceability of, or the ability of the Company to perform its
obligations under, the Transaction Documents; (C) the existence, validity or
priority of the Lien on and Security Interest in the Collateral granted pursuant
to any Security Agreement; or (D) the rights and remedies of the Buyer under or
in connection with the Transaction Documents or (ii) any event or circumstance
that would cause any Registration Statement or Prospectus to contain any untrue
statement of a material fact or omit to state any material fact necessary to
make the statements made not misleading except if such untrue statement of a
material fact in such Registration Statement or Prospectus or omission to state
a material fact required to be stated in such Registration Statement or
Prospectus in order to make the statements therein not misleading, results from
a misstatement or omission made by the Buyer in written information it furnished
to the Company specifically for inclusion in such Registration Statement or such
Prospectus or in any amendment or supplement thereto, unless the Company shall
have failed timely to amend or supplement such Registration Statement or
Prospectus after the Buyer shall have corrected such misstatement or
omission.
Nasdaq
means the Nasdaq Global Market.
Nasdaq
Capital Market means the Nasdaq Capital Market.
1934 Act
means the Securities Exchange Act of 1934, as amended.
1933 Act
means the Securities Act of 1933, as amended.
Note
means the 6% Senior Secured Convertible Note due 2007-2008 of the Company in the
form attached as
Annex I
.
Other
Note Purchase Agreements means the several Note Purchase Agreements, dated of
even date herewith, by and between the Company and the buyers of the Other
Notes.
Other
Notes shall have the meaning to be provided or provided in the
Note.
Other
Warrants means the Common Stock Purchase Warrants issuable or issued pursuant to
the Other Note Purchase Agreements.
Patent
and Trademark Security Agreement means the Patent and Trademark Security
Agreement from the Company to the Collateral Agent in the form attached as
Annex III
.
Payment
Event means any of the following events:
(i)
the
Company fails to file with the SEC any Registration Statement meeting the
requirements of this Agreement on or before the date by which the Company is
required to file such Registration Statement pursuant to Section
8(a),
(ii)
the SEC
Effective Date of the Registration Statement required by Section 8(a)(1)
covering Registrable Securities does not occur within 90 days following the
Closing Date or the SEC Effective Date of any Registration Statement required by
Section 8(a)(3) covering Registrable Securities does not occur within 90 days
following the date the Company shall become obligated to commence preparation of
such Registration Statement:
provided, however
, that if
any such Registration Statement shall be reviewed by the SEC staff a Payment
Event shall not occur until 120 days following (x) the Closing Date, in the case
of the Registration Statement required by Section 8(a)(1), or (y) such date as
the Company becomes obligated to commence preparation of such Registration
Statement, in the case of any Registration Statement required by Section
8(a)(3),
(iii)
The
Company fails to file with the SEC a request for acceleration of effectiveness
of a Registration Statement within three Trading Days after the date the Company
learns that no review of such Registration Statement will be made by the staff
of the SEC or that the staff of the SEC has no further comments on such
Registration Statement, as the case may be, or any such request for acceleration
fails to request acceleration of such Registration Statement to a time and date
not more than 48 hours after the submission of such request,
(iv)
after the
SEC Effective Date of any Registration Statement, sales cannot be made pursuant
to such Registration Statement for any reason (including, without limitation, by
reason of a stop order, any untrue statement of a material fact or omission of a
material fact in such Registration Statement, or the Companys failure to update
such Registration Statement), except to the extent permitted pursuant to Section
8(b)(5),
(v)
the
Common Stock generally or the Registrable Securities specifically are not listed
or included for quotation on a Trading Market, or
(vi)
the
Company fails, refuses or is otherwise unable timely to issue and deliver to or
upon the order of the Person entitled thereto Conversion Shares upon conversion
of the Note or shares of Common Stock issuable upon conversion of any Other
Note, Warrant Shares upon exercise of the Warrant or shares of Common Stock
issuable upon exercise of any Other Warrant in accordance with the terms of the
Warrant or any Other Warrant, as the case may be, as and when required under the
Transaction Documents, in any such case within five Trading Days after the due
date thereof in accordance with the Note, Other Note, Warrant or Other Warrant
or the Company fails, refuses or is otherwise unable timely to transfer any
Shares as and when required by the Transaction Documents.
Payment
Period means any period following the Closing Date during which any Payment
Event occurs and is continuing.
Person
means any natural person, corporation, partnership, limited liability company,
trust, incorporated organization, unincorporated association or similar entity
or any government, governmental agency or political subdivision.
Placement
Agent means Roth Capital Partners.
Pledge
and Security Agreement means the Pledge and Security Agreement from the Company
to the Collateral Agent in the form attached as
Annex IV
.
Pro Rata
Share means with respect to each capital raising transaction to which Section
5(j) applies an amount equal to the product obtained by multiplying (x) an
amount equal to one-half of the securities being issued in such capital raising
transaction
times
(y) a
fraction of which the numerator is the sum of (A) the total number of shares of
Common Stock which would then be issuable upon conversion of the Note and upon
exercise of the Warrant for cash
plus
(B) the
number of outstanding Shares beneficially owned by the Buyer at the time the Pro
Rata Share is being determined and the denominator is the sum of (C) the number
of shares issuable upon conversion of the Note and the Other Notes at the time
of original issuance thereof
plus
(D) the
total number of shares of Common Stock issuable upon exercise of the Warrant and
the Other Warrants for cash (in each case determined without regard to any
limitation on conversion of exercise thereof), subject to adjustment of the
amounts specified in the immediately preceding clauses (C) and (D) for stock
splits, stock dividends and similar capital changes affecting the Common Stock
that occur on or after the Closing Date and on or prior to the date Pro Rata
Share is being determined.
Prospectus
means the prospectus forming part of the Registration Statement at the time the
Registration Statement is declared effective and any amendment or supplement
thereto (including any information or documents incorporated therein by
reference).
PTO means
the United States Patent and Trademark Office.
Purchase
Price means the purchase price for the Note set forth on the signature page of
this Agreement.
QIB means
a qualified institutional buyer as defined in Rule 144A.
Record
means all pertinent financial and other records, pertinent corporate documents
and properties of the Company subject to inspection for the purposes provided in
Section 8(b)(9).
register,
registered, and registration refer to a registration effected by preparing and
filing a Registration Statement or Statements in compliance with the 1933 Act
and pursuant to Rule 415, and the declaration or ordering of effectiveness of
such Registration Statement by the SEC.
Registrable
Securities means (1) the Shares, (2) if the Common Stock is changed, converted
or exchanged by the Company or its successor, as the case may be, into any other
stock or other securities on or after the date hereof, such other stock or other
securities which are issued or issuable in respect of or in lieu of the Shares
and (3) if any other securities are issued to holders of Common Stock (or such
other shares or other securities into which or for which the Common Stock is so
changed, converted or exchanged as described in the immediately preceding clause
(2)) upon any reclassification, share combination, share subdivision, share
dividend, merger, consolidation or similar transaction or event, such other
securities which are issued or issuable in respect of or in lieu of the
Shares.
Registration
Period means, with respect to each Registration Statement, the period from the
SEC Effective Date for such Registration Statement, to the earlier of (A) the
date which is five years
after the
Closing Date or such date after which each Investor may sell all of its
Registrable Securities without registration under the 1933 Act pursuant to Rule
144, free of any limitation on the volume of such securities which may be sold
in any period) and (B) the date on which the Investors no longer own any
Registrable Securities.
Registration
Statement means a registration statement on Form S-3 or such other form as may
be available to the Company to be filed with the SEC under the 1933 Act relating
to the Registrable Securities and which names any Investor as a selling
stockholder.
Regulation
D means Regulation D under the 1933 Act.
Repurchase
Event shall have the meaning to be provided or provided in the
Note.
Restricted
Ownership Percentage shall have the meaning provided in Section
5(j)(2).
Reverse
Stock Split means a reverse split of the Common Stock of not less than one for
each ten shares of Common Stock outstanding prior thereto.
Rule 144
means Rule 144 promulgated under the 1933 Act or any other similar rule or
regulation of the SEC that may at any time provide a safe harbor exemption from
registration under the 1933 Act so as to permit a holder to sell securities of
the Company to the public without registration under the 1933 Act.
Rule 144A
means Rule 144A under the 1933 Act or any successor rule thereto.
SEC means
the Securities and Exchange Commission.
SEC
Effective Date means, with respect to any Registration Statement, the date such
Registration Statement is first declared effective by the SEC.
SEC
Filing Date means the date the Registration Statement is first filed with the
SEC pursuant to Section 8.
SEC
Reports means the Companys (1) Annual Report on Form 10-K for the year ended
December 31, 2005, (2) Quarterly Report on Form
10-Q
for the
quarter ended March 31, 2006,
and (3)
all other periodic and other reports filed by the Company with the SEC pursuant
to the 1934 Act subsequent to December 31, 2005, and prior to the date hereof,
in each case as filed with the SEC and including the information and documents
(other than exhibits) incorporated therein by reference.
Securities
means, collectively, the Note, the Shares and the Warrant.
Security
Agreement means either or both of the Pledge and Security Agreement and the
Patent and Trademark Security Agreement.
Security
Interest shall have the meaning to be provided or provided in each Security
Agreement.
Shares
means the Conversion Shares and the Warrant Shares.
Short
Sales shall have the meaning provided in Rule 200 of Regulation SHO under the
1934 Act as in effect on the date of this Agreement (but shall not be deemed to
include the location and/or reservation of borrowable shares of Common
Stock).
Stockholder
Approval shall have the meaning provided in Section 5(p).
Stockholder
Meeting shall have the meaning provided in Section 5(p).
Strategic
Issuance means the issuance by the Company for cash of Common Stock or Common
Stock Equivalents in connection with a strategic alliance, collaboration, joint
venture, partnership, manufacturing, marketing, distributing or similar
arrangement of the Company with another Person which strategic alliance,
collaboration, joint venture, partnership manufacturing, marketing, distributing
or similar arrangement relates to the Companys business as conducted immediately
prior thereto and which Person is engaged in a business similar or related to
the business of the Company.
Subsidiary
means any corporation or other entity of which a majority of the capital stock
or other ownership interests having ordinary voting power to elect a majority of
the board of directors or other persons performing similar functions are at the
time directly or indirectly owned by the Company.
Trading
Day means at any time a day on which any of a national securities exchange,
Nasdaq,
Nasdaq
Capital Market
or such
other securities market as at such time constitutes the principal securities
market for the Common Stock is open for general trading of
securities.
Trading
Market means the AMEX, the Nasdaq, the
Nasdaq
Capital Market
or the
New York Stock Exchange, Inc.
Transaction
Documents means, collectively, this Agreement, the Security Agreement, the
Securities, the Lockbox Agreement and the other agreements, instruments and
documents contemplated hereby and thereby.
Transaction
Form 8-K shall have the meaning provided in Section 5(l).
Violation
means
(i)
any
untrue statement or alleged untrue statement of a material fact contained in a
Registration Statement or any post-effective amendment thereof or the omission
or alleged omission to state therein a material fact required to be stated
therein or necessary to make the statements therein not misleading,
(ii)
any
untrue statement or alleged untrue statement of a material fact contained in any
Prospectus (as amended or supplemented, if the Company files any amendment
thereof or supplement thereto with the SEC) or the omission or alleged omission
to state therein any material fact necessary to make the statements made
therein, in light of the circumstances under which the statements therein were
made, not misleading,
(iii)
any
violation or alleged violation by the Company of the 1933 Act, the 1934 Act, any
state securities law or any rule or regulation under the 1933 Act, the 1934 Act
or any state securities law, or
(iv)
any
breach or alleged breach by the Company of any representation, warranty,
covenant, agreement or other term of any of the Transaction Documents.
Warrant
means the Common Stock Purchase Warrant in the form attached hereto as
Annex II
.
Warrant
Shares means the shares of Common Stock and any other securities issuable upon
exercise of the Warrant.
2.
PURCHASE AND SALE; PURCHASE
PRICE.
(a)
Purchase.
Upon the
terms and subject to the conditions of this Agreement, the Buyer hereby agrees
to purchase from the Company, and the Company hereby agrees to sell to the
Buyer, on the Closing Date, the Note in the principal amount set forth on the
signature page of this Agreement and having the terms and conditions as set
forth in the form of the Note attached hereto as
Annex I
for the
Purchase Price. In connection with the purchase of the Note by the Buyer, the
Company shall issue to the Buyer at the closing on the Closing Date a Warrant
initially entitling the holder to purchase the number of shares of Common Stock
set forth on the signature page of this Agreement.
(b)
Form of Payment.
Payment
by the Buyer of the Purchase Price to the Company on the Closing Date shall be
made by wire transfer of immediately available funds to:
[INTENTIONALLY
OMITTED]
For
credit to account No.
For
credit to the account of
Reference:
[
Name of
Buyer
]
(c)
Closing.
The
issuance and sale of the Note and the issuance of the Warrant shall occur on the
Closing Date at Law Offices of Brian W Pusch, Penthouse Suite, 29 West
57
th
Street,
New York, New York 10019 or at such other location and time as the parties may
agree. At the closing, upon the terms and subject to the conditions of this
Agreement, (1) the Company shall issue and deliver to the Buyer the Note and the
Warrant against payment by the Buyer to the Company of an amount equal to the
Purchase Price, and (2) the Buyer shall pay to the Company an amount equal to
the Purchase Price against delivery by the Company to the Buyer of the Note and
the Warrant.
3.
REPRESENTATIONS, WARRANTIES,
COVENANTS, ETC. OF THE BUYER.
The Buyer
represents and warrants to, and covenants and agrees with, the Company as
follows:
(a)
Circumstances of Purchase.
The Buyer
is purchasing the Note and acquiring the Warrant for its own account and not
with a view towards the public sale or distribution thereof within the meaning
of the 1933 Act; and the Buyer will acquire any Shares issued to the Buyer prior
to the SEC Effective Date of a Registration Statement covering the resale of
such Shares by the Buyer for its own account and not with a view towards the
public sale or distribution thereof within the meaning of the 1933 Act prior to
such SEC Effective Date; and the Buyer has no intention of making any
distribution, within the meaning of the 1933 Act, of the Shares except in
compliance with the registration requirements of the 1933 Act or pursuant to an
exemption therefrom. The Buyer is acquiring the Securities hereunder in the
ordinary course of its business.
(b)
Accredited Investor;
Residence.
At the
time the Buyer was offered the Securities, it was, and at the date hereof it is,
and on each date on which it exercises any Warrants for cash it will be, an
accredited investor as that term is defined in Rule 501 of Regulation D under
the 1933 Act by reason of Rule 501(a)(3) thereof. The office or offices of the
Buyer in which its investment decision was made is located at the address or
addresses of such Investor set forth on the signature page hereto.
(c)
Reoffers and Resales.
The Buyer
will not offer, sell, pledge, transfer or otherwise dispose of (or solicit any
offers to buy, purchase or otherwise acquire or take a pledge of) any of the
Securities unless registered under the 1933 Act, pursuant to an exemption from
registration under the 1933 Act or in a transaction not requiring registration
under the 1933 Act;
provided
,
however
, that
the Securities may be pledged in connection with a bona fide margin account or
other loan or financing arrangement secured by the Securities and such pledge of
Securities shall not be deemed to be a transfer, sale or assignment of the
Securities prohibited hereby, and in effecting any pledge of Securities the
Buyer shall not be required to provide the Company with any notice thereof or
otherwise make any delivery to the Company pursuant to this Agreement or any
other Transaction Document, including, without limitation, this Section 3(c);
provided
,
further
,
however
, the
Buyer acknowledges that in connection with any sale, transfer or assignment by
the pledgee of such Securities, such pledgee may be required by applicable law
to make such sale, transfer or assignment in accordance with, or pursuant to a
registration statement or an exemption under, the 1933 Act.
(d)
Company Reliance.
T
he Buyer
understands that (1) the Note is being offered and sold and the Warrant is being
issued to the Buyer, (2) upon conversion of the Note prior to two years after
the Closing Date, the Conversion Shares will be issued to the Buyer upon such
conversion and (3) upon exercise of the Warrant for cash, or upon cashless
exercise of the Warrant prior to two years after the Closing Date, the Warrant
Shares issued upon such exercise will be issued to the Buyer, in each such case
in reliance on one or more exemptions from the registration requirements of the
1933 Act, including, without limitation, Regulation D, and exemptions from state
securities laws and that the Company is relying upon the truth and accuracy of,
and the Buyers compliance with, the representations, warranties, agreements,
acknowledgments and understandings of the Buyer set forth herein in order to
determine the availability of such exemptions and the eligibility of the Buyer
to acquire or receive an offer to acquire the Securities.
(e)
Information Provided.
The Buyer
and its advisors, if any, have requested, received and considered all
information relating to the business, properties, operations, condition
(financial or other), results of operations or prospects of the Company and
information relating to the offer and sale of the Note and the offer of the
Warrant deemed relevant by them (assuming the accuracy and completeness of the
SEC Reports and of the Companys responses to the Buyers requests); the Buyer and
its advisors, if any, have been afforded the opportunity to ask questions of the
Company concerning the terms of the offering of the Securities and the business,
properties, operations, condition (financial or other), results of operations
and prospects of the Company and the Subsidiaries; without limiting the
generality of the foregoing, the Buyer has had the opportunity to obtain and to
review the SEC Reports; in connection with its decision to purchase the Note and
to acquire the Warrant, the Buyer has relied solely upon the SEC Reports, the
representations, warranties, covenants and agreements of the Company set forth
in this Agreement and to be contained in the other Transaction Documents, as
well as any investigation of the Company completed by the Buyer or its advisors;
the Buyer understands that its investment in the Securities involves a high
degree of risk; and the Buyer understands that the offering of the Note is being
made to the Buyer as part of an offering without any minimum amount of the
offering but subject to a maximum amount of $7 million aggregate principal
amount of the Note and the Other Notes (subject, however, to the right of the
Company at any time prior to execution and delivery of this Agreement by the
Company, in its sole discretion, to accept or reject an offer by the Buyer to
purchase the Note and to acquire the Warrant).
(f)
Absence of Approvals.
The Buyer
understands that no United States federal or state agency or any other
government or governmental agency has passed on or made any recommendation or
endorsement of the Securities.
(g)
Note Purchase Agreement.
The Buyer
has all requisite power and authority, corporate or otherwise, to execute,
deliver and perform its obligations under this Agreement and the other
agreements executed by the Buyer in connection herewith and to consummate the
transactions on the Buyers part contemplated hereby and thereby; Buyer is an
entity duly organized, validly existing and in good standing under the laws of
the jurisdiction of its organization; and this Agreement and the Transaction
Documents to which the Buyer is a party have been duly and validly authorized,
duly executed and delivered by the Buyer and, assuming due execution and
delivery by the Company, constitute valid and legally binding obligations of the
Buyer enforceable in accordance with their terms, except as the enforceability
hereof may be limited by bankruptcy, insolvency, reorganization, moratorium,
fraudulent conveyance or other similar laws now or hereafter in effect relating
to or affecting creditors rights generally and general principles of equity,
regardless of whether enforcement is considered in a proceeding in equity or at
law.
(h)
Buyer Status.
The Buyer
is not a broker or dealer as those terms are defined in the 1934 Act, which is
required to be registered with the SEC pursuant to Section 15 of the 1934
Act.
(i)
Experience of the Buyer.
T
he Buyer,
either alone or together with its representatives, has such knowledge,
sophistication and experience in business and financial matters so as to be
capable of evaluating the merits and risks of the prospective investment in the
Securities, and has so evaluated the merits and risks of such investment. The
Buyer is able to bear the economic risk of an investment in the Securities and,
at the present time, is able to afford a complete loss of such investment. The
Buyer has had the opportunity to ask questions of management of the
Company.
(j)
General Solicitation.
T
he
Buyer
did not
learn of the offering of the Securities through any public advertising or
general solicitation (as these terms are used in Regulation D).
(k)
Short Sales and Confidentiality Prior
To The Date Hereof.
Other
than the transaction contemplated hereunder, the Buyer has not directly or
indirectly, nor has any Person acting on behalf of or pursuant to any
understanding with the Buyer, executed any disposition, including Short Sales
(but not including the location and/or reservation of borrowable shares of
Common Stock), in the securities of the Company during the period
commencing from
the time
that
the Buyer
first
received a term sheet from the Company or any other Person setting forth the
material terms of the transactions contemplated hereunder until the date hereof
(the
Discussion Time)
.
Notwithstanding
the foregoing, in the case of a
Buyer
that is a
multi-managed investment vehicle whereby separate portfolio managers manage
separate portions of such
Buyer
's assets
and the portfolio managers have no direct knowledge of the investment decisions
made by the portfolio managers managing other portions of such
Buyer
's
assets, the representation set forth above shall only apply with respect to the
portion of assets managed by the portfolio manager that made the investment
decision to purchase the Securities covered by this Agreement. Other than to
other Persons party to this Agreement and its professional advisors,
the Buyer
has
maintained the confidentiality of all disclosures made to it in connection with
this transaction (including the existence and terms of this
transaction).
4.
REPRESENTATIONS, WARRANTIES,
COVENANTS, ETC. OF THE COMPANY.
The
Company represents and warrants to, and covenants and agrees with, the Buyer as
follows:
(a)
Organization and Authority.
The
Company and each of the Subsidiaries is a corporation duly organized, validly
existing and in good standing under the laws of the jurisdiction of its
incorporation, and (i) each of the Company and the Subsidiaries has all
requisite corporate power and authority to own, lease and operate its properties
and to carry on its business as described in the SEC Reports and as currently
conducted, and (ii) the Company has all requisite corporate power and authority
to execute, deliver and perform its obligations under this Agreement and the
other Transaction Documents to be executed and delivered by the Company in
connection herewith, and to consummate the transactions contemplated hereby and
thereby; and the Company does not have any equity investment in any other Person
other than (x) the Subsidiaries listed in the SEC Reports and (y) Subsidiaries
which do not, individually or in the aggregate, have any material revenue,
assets or liabilities.
(b)
Qualifications.
The
Company and each of the Subsidiaries are duly qualified to do business as
foreign corporations and are in good standing in all jurisdictions where such
qualification is necessary and where failure so to qualify could have a Material
Adverse Effect.
(c)
Concerning the Shares and the Common
Stock.
The
Shares have been duly authorized and the Conversion Shares, when issued upon
conversion of the Note, and the Warrant Shares, when issued upon exercise of the
Warrant, in each such case will be duly and validly issued, fully paid and
non-assessable and will not subject the holder thereof to personal liability by
reason of being such holder. There are no unwaived preemptive or similar rights
of any stockholder of the Company or any other Person to acquire any of the
Securities issued or to be issued to the Buyer. The Company has duly reserved
40,000,000 shares of Common Stock exclusively for issuance upon conversion of
the Note and the Other Notes and exercise of the Warrant and the Other Warrants,
and such shares shall remain so reserved, and the Company shall from time to
time reserve such additional shares of Common Stock as shall be required to be
reserved pursuant to the Note, the Other Notes and the Warrant, so long as the
Note, the Other Notes or the Warrant are outstanding. The Common Stock is listed
for trading on the AMEX and, except as described on Schedule 4(c), (1) the
Company and the Common Stock meet the criteria for continued listing and trading
on the AMEX; (2) the Company has not been notified since December 31, 2004 by
the AMEX of any failure or potential failure to meet the criteria for continued
listing and trading on the AMEX and (3) no suspension of trading in the Common
Stock is in effect. Except as described on
Schedule 4(c)
, the
Company knows of no reason that the Shares will not be eligible for listing on
the AMEX. The Company acknowledges that the Securities may be pledged in
connection with a bona fide margin account or other loan or financing
arrangement secured by the Securities and such pledge of Securities shall not be
deemed to be a transfer, sale or assignment of the Securities hereunder, and the
Buyer shall not be required to provide the Company with any notice thereof or
otherwise make any delivery to the Company pursuant to this Agreement or any
other Transaction Document;
provided, however
, that in
order to make any sale, transfer or assignment of Securities in connection with
a foreclosure or realization on such pledge, the Buyer or its pledgee shall make
such disposition in accordance with, or pursuant to a registration statement or
an exemption under, the 1933 Act.
(d)
Corporate Authorization.
This
Agreement and the other Transaction Documents to which the Company is or will be
a party have been duly and validly authorized by the Company; this Agreement has
been duly executed and delivered by the Company and, assuming due execution and
delivery by the Buyer, this Agreement is, and the Note, and the Warrant will be,
when executed and delivered by the Company, valid and binding obligations of the
Company enforceable in accordance with their respective terms, except as the
enforceability hereof or thereof may be limited by bankruptcy, insolvency,
reorganization, moratorium or other similar laws now or hereafter in effect
relating to or affecting creditors rights generally and general principles of
equity, regardless of whether enforcement is considered in a proceeding in
equity or at law.
(e)
Non-contravention.
The
execution and delivery of the Transaction Documents by the Company and the
consummation by the Company of the issuance of the Securities as contemplated by
this Agreement and consummation by the Company of the other transactions
contemplated by the Transaction Documents do not and will not, with or without
the giving of notice or the lapse of time, or both, (i) result in any violation
of any term or provision of the Certificate of Incorporation or Bylaws of the
Company or any Subsidiary, (ii) conflict with or result in a breach by the
Company or any Subsidiary of any of the terms or provisions of, or constitute a
default under, or result in the modification of, or result in the creation or
imposition of any lien, security interest, charge or encumbrance (other than
pursuant to the Security Agreement) upon any of the properties or assets of the
Company or any Subsidiary pursuant to, any indenture, mortgage, deed of trust or
other agreement or instrument to which the Company or any Subsidiary is a party
or by which the Company or any Subsidiary or any of their respective properties
or assets are bound or affected, in any such case which would be reasonably
likely to have a Material Adverse Effect, (iii) violate or contravene any
applicable law, rule or regulation or any applicable decree, judgment or order
of any court, United States federal or state regulatory body, administrative
agency or other governmental body having jurisdiction over the Company or any
Subsidiary or any of their respective properties or assets, in any such case
which could have a Material Adverse Effect, or (iv) have any material adverse
effect on any permit, certification, registration, approval, consent, license or
franchise necessary for the Company or any Subsidiary to own or lease and
operate any of its properties and to conduct any of its business or the ability
of the Company or any Subsidiary to make use thereof.
(f)
Approvals, Filings, Etc.
No
authorization, approval or consent of, or filing with, any United States or
foreign court, governmental body, regulatory agency, self-regulatory
organization, or stock exchange or market or the stockholders of the Company is
required to be obtained or made by the Company or any Subsidiary for (x) the
execution, delivery and performance by the Company of the Transaction Documents,
(y) the issuance and sale of the Securities as contemplated by this Agreement
and the terms of the Note and the Warrant and (z) the performance by the Company
of its obligations under the Transaction Documents, other than (1) registration
of the resale of the Shares under the 1933 Act as contemplated by Section 8, (2)
as may be required under applicable state securities or blue sky laws, (3)
filing of one or more Forms D with respect to the Securities as required under
Regulation D, (4) filing of financing statements as required under
the
Pledge and Security Agreement, (5) the filings with the PTO as required by the
Patent and Trademark Security Agreement and
(6)
the
filing
of
the
Transaction
Form 8-K.
(g)
Information Provided.
The SEC
Reports (together with the press release issued by the Company), the Transaction
Documents and the instruments delivered by the Company to the Buyer in
connection with the execution and delivery of this Agreement and in connection
with the closing on the Closing Date do not and will not on the date of
execution and delivery of this Agreement, the date of delivery thereof to the
Buyer and on the Closing Date contain any untrue statement of a material fact or
omit to state any material fact necessary in order to make the statements
therein, in the light of the circumstances under which they are made, not
misleading, it being understood that for purposes of this Section 4(g), any
statement contained in such information shall be deemed to be modified or
superseded for purposes of this Section 4(g) to the extent that a statement in
any document included in such information which was prepared and furnished to
the Buyer on a later date (but on or before the date of this Agreement) or filed
with the SEC on a later date (but on or before the date of this Agreement)
modifies or replaces such statement, whether or not such later prepared or filed
statement so states.
(h)
Investment Company.
Neither
the Company nor any Subsidiary is an investment company within the meaning of
such term under the Investment Company Act of 1940, as amended, and the rules
and regulations of the SEC thereunder.
(i)
Absence of Brokers, Finders,
Etc.
No
broker, finder or similar Person is entitled to any commission, fee or other
compensation by reason of action taken by or on behalf of the Company in
connection with the transactions contemplated by this Agreement other than the
Placement Agent (whose commissions, fees and compensation shall be payable
solely by the Company in accordance with a written agreement between the Company
and the Placement Agent), and the Company shall pay, and indemnify and hold
harmless the Buyer from, any claim made against the Buyer by any Person for any
such commission, fee or other compensation.
(j)
No Solicitation.
Neither
the Company nor, to the best of its knowledge, any other Person acting on behalf
of the Company, used any form of general solicitation or general advertising in
respect of the Securities or in connection with the offer and sale of the
Securities. Neither the Company nor, to its knowledge, any Person acting on
behalf of the Company has, either directly or indirectly, sold or offered for
sale to any Person any of the Securities or, within the six months prior to the
date hereof, any other similar security of the Company, except as contemplated
by this Agreement and the Other Note Purchase Agreements; and neither the
Company nor any Person authorized to act on its behalf will sell or offer for
sale any promissory notes, warrants, shares of Common Stock or other securities
to, or solicit any offers to buy any such security from, any Person so as
thereby to cause the issuance or sale of any of the Securities to be in
violation of any of the provisions of Section 5 of the 1933 Act.
(k)
No Integrated
Offering
.
None of
the Company, any Subsidiary, any of their respective Affiliates, or any Person
acting on behalf of any of them has, directly or indirectly, made any offers or
sales of any security or solicited any offers to buy any security, under
circumstances that would require registration of any of the Securities under the
1933 Act or cause the offering of the Securities, the Other Notes and the Other
Warrants to be integrated with prior offerings by the Company for purposes of
the 1933 Act or any applicable stockholder approval provisions, including,
without limitation, under the rules and regulations of any exchange or automated
quotation system on which any of the securities of the Company are listed,
quoted or designated. None of the Company, any Subsidiary, their respective
Affiliates or any Person acting on behalf of any of them will take any action or
steps referred to in the preceding sentence that would require registration of
any of the Securities under the 1933 Act or cause the offering of the Securities
to be integrated with other offerings.
(l)
Dilutive Effect.
The
Company understands and acknowledges that the number of Shares issuable upon
conversion of the Note and the Other Notes and upon exercise of the Warrant and
the Other Warrants will be substantial and may increase in certain
circumstances. The Company further acknowledges that, subject to the terms and
conditions of the Transaction Documents, its obligation to issue Shares upon
conversion of the Note and upon exercise of the Warrant in accordance with this
Agreement, the Note and the Warrant is, in each case, absolute and unconditional
regardless of the dilutive effect that such issuance may have on the ownership
interests of other stockholders of the Company.
(m)
Absence of Certain
Changes
.
Except as
disclosed in the SEC Reports, since December 31, 2005, there has been no
material adverse change and no material adverse development in the business,
properties, operations, condition (financial or otherwise), results of
operations or prospects of the Company and the Subsidiaries taken as a whole.
Except as disclosed in the SEC Reports, since December 31, 2005, neither the
Company nor any Subsidiary has (i) declared or paid any dividends, (ii) sold any
assets, individually or in the aggregate, outside of the ordinary course of
business, (iii) had capital expenditures outside of the ordinary course of
business, (iv) engaged in any transaction with any Affiliate except as set forth
in the SEC Reports or (v) engaged in any other transaction outside of the
ordinary course of business. The Company has not taken any steps to seek
protection pursuant to any bankruptcy law nor does the Company have any
knowledge or reason to believe that its creditors intend to initiate involuntary
bankruptcy proceedings or any actual knowledge of any fact that would reasonably
lead a creditor to do so. The Company is not as of the date hereof, after giving
effect to the transactions contemplated hereby to occur on the Closing Date and
the transactions contemplated by the Other Note Purchase Agreements,
Insolvent.
(n)
No Undisclosed Events, Liabilities,
Developments or Circumstances
.
No event,
liability, development, circumstance or transaction has occurred or exists, with
respect to the Company or any Subsidiary or their respective business,
properties, operations, condition (financial or other), results of operations or
prospects, that would be required to be disclosed by the Company under
applicable securities laws (including pursuant to the anti-fraud provisions
thereof) on a registration statement on Form S-3 filed with the SEC relating to
an issuance and sale by the Company of its Common Stock and which has not been
publicly disclosed.
(o)
Conduct of Business; Regulatory
Permits
.
N
either
the Company nor any Subsidiary is in violation of any term of or in default
under its Certificate of Incorporation, or its Bylaws. Neither the Company nor
any Subsidiary is in violation of any judgment, decree or order or any statute,
ordinance, rule or regulation applicable to the Company or any Subsidiary which
violation could have a Material Adverse Effect, and neither the Company nor any
Subsidiary will conduct its business in violation of any of the foregoing,
except for possible violations which could not, individually or in the
aggregate, reasonably be expected to have a Material Adverse Effect. Without
limiting the generality of the foregoing, the Company is not in violation of any
of the rules, regulations or requirements of the AMEX and has no knowledge of
any facts or circumstances that would be likely to lead to delisting or
suspension of the Common Stock by the AMEX in the future. Since December 31,
2005, (i) the Common Stock has been listed on the AMEX, (ii) trading in the
Common Stock has not been suspended by the SEC or the AMEX and (iii) the Company
has received no communication, written or oral, from the SEC or the AMEX
regarding the suspension or delisting of the Common Stock from the AMEX. The
Company and the Subsidiaries possess all certificates, authorizations and
permits issued by the appropriate federal, state or foreign regulatory
authorities necessary to conduct their respective businesses, except where the
failure to possess such certificates, authorizations or permits could not
reasonably be expected to have, individually or in the aggregate, a Material
Adverse Effect, and neither the Company nor any Subsidiary has received any
notice of proceedings relating to the revocation or modification of any such
certificate, authorization or permit.
(p)
Indebtedness and Other
Contracts
.
Except as
set forth on the SEC Reports, neither the Company nor any Subsidiary (i) has any
outstanding Indebtedness, (ii) is a party to any contract, agreement or
instrument, the violation of which, or default under which, by any other party
to such contract, agreement or instrument could reasonably be expected to result
in a Material Adverse Effect, (iii) is in violation of any term of or in default
under any contract, agreement or instrument, except where such violations and
defaults could not reasonably be expected to result, individually or in the
aggregate, in a Material Adverse Effect, or (iv) is a party to any contract,
agreement or instrument, the performance of which, in the judgment of the
Company's officers, has or is expected to have a Material Adverse Effect. The
Company has filed all material contracts required to be filed in accordance with
the applicable requirements of the SEC Reports as exhibits to such reports.
(q)
Absence of
Litigation
.
Except as
set forth in the SEC Reports, there is no action, suit, proceeding, inquiry or
investigation, whether criminal, civil or otherwise, before or by the AMEX, any
court, arbitrational body, public board, government agency, self-regulatory
organization or body pending or, to the knowledge of the Company, threatened
against or affecting the Company, the Common Stock or any of the Subsidiaries or
any of the Company's or any Subsidiary's officers or directors in their
capacities as such. To the knowledge of the Company, none of the directors or
officers of the Company has been a party to any securities related litigation
during the past ten years, other than as disclosed in the SEC
Reports.
(r)
Insurance
.
The
Company and each Subsidiary is insured by insurers of recognized financial
responsibility against such losses and risks and in such amounts as management
of the Company believes to be prudent and customary in the businesses in which
the Company and the Subsidiaries are engaged. Neither the Company nor any
Subsidiary has been refused any insurance coverage sought or applied for and
neither the Company nor any Subsidiary has any reason to believe that it will
not be able to renew its existing insurance coverage as and when such coverage
expires or to obtain similar coverage from similar insurers as may be necessary
to continue its business at a cost that could not have a Material Adverse
Effect.
(s)
Employee
Relations
.
Neither
the Company nor any Subsidiary is a party to any collective bargaining agreement
or employs any member of a union. No executive officer of the Company (as
defined in Rule 405 under the 1933 Act) has notified the Company that such
officer intends to leave the Company or otherwise terminate such officer's
employment with the Company. No executive officer of the Company, to the
knowledge of the Company, is, or is now expected to be, in violation of any
material term of any employment contract, confidentiality, disclosure or
proprietary information agreement, non-competition agreement, or any other
contract or agreement or any restrictive covenant, and, to the knowledge of the
Company, the continued employment of each such executive officer does not
subject the Company or any Subsidiary to any material liability with respect to
any of the foregoing matters. The Company and the Subsidiaries are in compliance
with all federal, state, local and foreign laws and regulations respecting
employment and employment practices, terms and conditions of employment and
wages and hours, except where failure to be in compliance could not, either
individually or in the aggregate, reasonably be expected to result in a Material
Adverse Effect.
(t)
Title
.
The
Company and the Subsidiaries have good and marketable title to all personal
property owned by them which is material to the business of the Company and the
Subsidiaries, in each case free and clear of all Liens except (i) immaterial
Liens for taxes not yet delinquent, (ii) immaterial carriers, warehousemens,
mechanics', materialmen's, repairmens, landlords Liens (and other similar
Liens), and immaterial Liens under operating and similar agreements, to the
extent the same relate to expenses incurred in the ordinary course of business
consistent with past practice and that are not yet due, (iii) that are routine
governmental approvals, or (iv) such as do not materially affect the value of
such property and do not interfere with the use made and proposed to be made of
such property by the Company and any of its Subsidiaries. Neither the Company
nor any Subsidiary owns any real property. Any real property and facilities held
under lease by the Company or any Subsidiary are held by it under valid,
subsisting and enforceable leases with such exceptions as are not material and
do not interfere with the use made and proposed to be made of such property and
buildings by the Company and the Subsidiaries.
(u)
Intellectual Property.
Except as
provided in the Security Agreement, (1) the Company and each Subsidiary holds
all Intellectual Property that it owns free and clear of all Encumbrances and
restrictions on use or transfer, whether or not recorded, and has sole title to
and ownership of or has the full, exclusive (subject to the rights of its
licensees) right to use in its field of business such Intellectual Property; and
the Company and each Subsidiary holds all Intellectual Property that it uses but
does not own under valid licenses or sub-licenses from others; (2) the use of
the Intellectual Property by the Company or any Subsidiary does not, to the
knowledge of the Company, violate or infringe on the rights of any other Person;
(3) neither the Company nor any Subsidiary has received any notice of any
conflict between the asserted rights of others and the Company or any Subsidiary
with respect to any Intellectual Property; (4) the Company and each Subsidiary
has used its commercially reasonable best efforts to protect its rights in and
to all Intellectual Property; (5) the Company and each Subsidiary are in
compliance with all material terms and conditions of its agreements relating to
the Intellectual Property; (6) neither the Company nor any Subsidiary is, or
since December 31, 2005 has been, a defendant in any action, suit, investigation
or proceeding relating to infringement or misappropriation by the Company or any
Subsidiary of any Intellectual Property nor has the Company or any Subsidiary
been notified of any alleged claim of infringement or misappropriation by the
Company or any Subsidiary of any Intellectual Property; (7) to the knowledge of
the Company, none of the products or services the Company and the Subsidiaries
are researching, developing, propose to research and develop, make, have made,
use, or sell, infringes or misappropriates any Intellectual Property right of
any third party; (8) none of the trademarks and service marks used by the
Company or any Subsidiary, to the knowledge of the Company, infringes the
trademark or service mark rights of any third party; and (9) to the Companys
knowledge none of the material processes and formulae, research and development
results and other know-how relating to the Company's or the Subsidiaries'
respective businesses, the value of which to the Company or any Subsidiary is
contingent upon maintenance of the confidentiality thereof, has been disclosed
to any Person other than Persons bound by written confidentiality
agreements.
(v)
Environmental Laws
.
To the
Companys knowledge, the Company and the Subsidiaries (i) are in compliance with
all Environmental Laws, (ii) have received all permits, licenses or other
approvals required of them under applicable Environmental Laws to conduct their
respective businesses and (iii) are in compliance with all terms and conditions
of any such permit, license or approval where, in any such case in the foregoing
clauses (i), (ii) or (iii), the failure to so comply could be reasonably
expected to have, individually or in the aggregate, a Material Adverse
Effect.
(w)
Subsidiary
Rights
.
The
Company or one of the Subsidiaries has the unrestricted right to vote, and
(subject to limitations imposed by the applicable corporation or company law
under which each Subsidiary is formed) to receive dividends and distributions
on, all stock of the Subsidiaries that is owned by the Company or such other
Subsidiary as owns such stock.
(x)
Tax Status
.
The
Company and each Subsidiary (i) has made or filed all federal and state income
and all other tax returns, reports and declarations required by any jurisdiction
to which it is subject, (ii) has paid all taxes and other governmental
assessments and charges that are shown or determined to be due on such returns,
reports and declarations, except those being contested in good faith and for
which it has set aside on its books a provision in the amount of such taxes
being contested in good faith and (iii) has set aside on its books provisions
reasonably adequate for the payment of all taxes for periods subsequent to the
periods to which such returns, reports or declarations apply. There are no
unpaid taxes claimed to be due by the taxing authority of any jurisdiction, and
the officers of the Company know of no basis for any such claim.
(y)
Internal Accounting Controls;
Financial Statements
.
The
Company maintains disclosure controls and procedures (as such term is defined in
Rule 13a-15 under the 1934 Act) that are effective in ensuring that information
required to be disclosed by the Company in the reports that it files or submits
under the 1934 Act is recorded, processed, summarized and reported, within the
time periods specified in the rules and forms of the SEC, including, without
limitation, controls and procedures designed to ensure that information required
to be disclosed by the Company in the reports that it files or submits under the
1934 Act is accumulated and communicated to the Company's management, including
its principal executive officer or officers and its principal financial officer
or officers, as appropriate, to allow timely decisions regarding required
disclosure. The consolidated financial statements, if any, included in each SEC
Report present fairly and accurately in all material respects the consolidated
financial position of the Company and the Subsidiaries as of the dates reported
and the consolidated results of operations, changes in stockholders' equity and
cash flows for the periods reported, all in conformity with Generally Accepted
Accounting Principles applied on a consistent basis and in conformity with the
rules and regulations of the SEC under the 1934 Act applicable to the Company,
subject, in the case of unaudited financial statements, to (1) normal recurring
year-end adjustments, all of which that are necessary for a fair presentation of
such financial statements have been included, and (2) the absence of all
required notes thereto. Except as set forth in the consolidated financial
statements of the Company included in the SEC Reports, neither the Company nor
any Subsidiary has any liabilities, contingent or otherwise, except those which
individually or in the aggregate are not material to the financial condition or
operating results of the Company and the Subsidiaries, taken as a
whole.
(z)
Sarbanes-Oxley
Act
.
The
Company is in compliance with any and all applicable requirements of the
Sarbanes-Oxley Act of 2002 that are effective as of the date hereof, and any and
all applicable rules and regulations promulgated by the SEC thereunder that are
effective as of the date hereof.
(aa)
S-3 Eligibility.
T
he
Company meets the requirements of Form S-3 for the registration of the resale of
the Registrable Securities.
(bb)
Concerning the Collateral.
Upon
execution and delivery of the Security Agreement by the Company and the
Collateral Agent and completion of the filings referred to in
Schedule I
to the
Pledge and Security Agreement and
Exhibit C
to the
Patent and Trademark Security Agreement, the Collateral Agent will have a first
priority perfected security interest in the Collateral for the ratable benefit
of the holders of the Note and the Other Notes.
(cc)
Disclosures.
For
purposes of this Agreement and the transactions contemplated hereby, none of the
representations or warranties made by the Company under any of the Transaction
Documents and no written information furnished by the Company pursuant hereto,
or in any other document, certificate or written statement furnished by the
Company to the Buyer or any authorized representative of the Buyer, pursuant to
the Transaction Documents or in connection therewith, contains any untrue
statement of a material fact or omits to state a material fact necessary in
order to make the statements contained herein and therein, in light of the
circumstances under which they were made, not misleading.
(dd)
Absence of Rights Agreement.
The
Company has not adopted a shareholder rights plan or similar arrangement
relating to accumulations of beneficial ownership of Common Stock or a change of
control in the Company.
5.
CERTAIN
COVENANTS.
(a)
Transfer Restrictions.
T
he Buyer
acknowledges and agrees that (1) the Note and the Warrant have not been and are
not being registered under the provisions of the 1933 Act or any state
securities laws and, except as provided in Section 8, the Shares have not been
and are not being registered under the 1933 Act or any state securities laws,
and that the Note and the Warrant may not be transferred unless the Buyer shall
have delivered to the Company an opinion of counsel, reasonably satisfactory in
form, scope and substance to the Company, to the effect that the Note or the
Warrant to be transferred may be transferred without such registration; (2) no
sale, conveyance assignment or other transfer of the Note or the Warrant or any
interest therein may be made except in accordance with the terms hereof and
thereof; (3) the Shares may not be resold by the Buyer unless the resale has
been registered under the 1933 Act or is made pursuant to an applicable
exemption from such registration and the Company shall have received the opinion
of counsel provided for in the second to last sentence of this Section 5(a); (4)
any sale of Shares under a Registration Statement shall be made only in
compliance with the terms of this Section 5(a)
and
Section 8 (including, without limitation, Section 8(c)(4)); (5) any sale of the
Securities made in reliance on Rule 144 may be made only in accordance with the
terms of Rule 144 and further, if the exemption provided by Rule 144 is not
available, any resale of the Securities under circumstances in which the seller,
or the Person through whom the sale is made, may be deemed to be an underwriter,
as that term is used in the 1933 Act, may require compliance with some other
exemption under the 1933 Act or the rules and regulations of the SEC
thereunder;
and (6) the Company is under no obligation to register the Securities (other
than registration of the resale of the Registrable Securities in accordance with
Section 8) under the 1933 Act or, except as provided in Section 5(d) and Section
8, to comply with the terms and conditions of any exemption thereunder. Prior to
the time particular Shares are eligible for resale under Rule 144(k), the Buyer
may not sell the Shares in a transaction which does not constitute a sale
thereof pursuant to the applicable Registration Statement in accordance with the
plan of distribution set forth therein or in any supplement to the related
Prospectus unless the Buyer shall have delivered to the Company an opinion of
counsel, reasonably satisfactory in form, scope and substance to the Company,
that such Shares may be so sold without registration under the 1933 Act. Nothing
in any of the Transaction Documents shall limit the right of a holder of the
Securities to make a bona fide pledge thereof to an institutional lender and the
Company agrees to cooperate with any Investor who seeks to effect any such
pledge by providing such information and making such confirmations as reasonably
requested. The Buyer agrees that any sale by the Buyer of Shares pursuant to a
particular Registration Statement shall be sold in a manner described in the
plan of distribution set forth in the related Prospectus and, if the prospectus
delivery requirement cannot be satisfied by compliance with Rule 153 or 172
under the 1933 Act, (A) if such sale is made through a broker, the Buyer shall
instruct its broker to deliver the Prospectus to the purchaser or purchasers (or
the broker or brokers therefor) in connection with such sale, shall supply
copies of the Prospectus to its broker or brokers and shall instruct its broker
or brokers to deliver such Prospectus to the purchaser in such sale or such
purchasers broker, (B) if such sale is made in a transaction directly with a
purchaser and not through the facilities of any securities exchange or market,
the Buyer shall deliver, or cause to be delivered, the Prospectus to such
purchaser; and (C) if such sale is made by any means other than those described
in the immediately preceding clauses (A) and (B), the Buyer shall otherwise use
its best efforts to comply with the prospectus delivery requirements of the 1933
Act applicable to such sale.
(b)
Restrictive Legends.
(1) The
Buyer acknowledges and agrees that the Note shall bear a restrictive legend in
substantially the following form (and a stop-transfer order may be placed
against transfer of the Note):
NEITHER
THE ISSUANCE OF THIS NOTE NOR THE ISSUANCE OF THE SECURITIES INTO WHICH THIS
NOTE IS CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS
AMENDED (THE 1933 ACT), AND, ACCORDINGLY, MAY NOT BE, NOR MAY ANY INTEREST
THEREIN BE, OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION
STATEMENT UNDER THE 1933 ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A
TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE 1933 ACT AND IN
ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY, SUBJECT TO
CERTAIN EXCEPTIONS, A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT,
THE SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO THE COMPANY. THESE
SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT SECURED
BY SUCH SECURITIES.
(2)
The Buyer
further acknowledges and agrees that the Warrant shall bear a restrictive legend
in substantially the following form (and a stop-transfer order may be placed
against transfer of the Warrant):
NEITHER
THIS WARRANT NOR THE SECURITIES INTO WHICH THIS WARRANT IS EXERCISABLE HAVE BEEN
REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES
REGULATORS OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER
THE SECURITIES ACT OF 1933, AS AMENDED (THE 1933 ACT), AND, ACCORDINGLY, MAY NOT
BE, NOR MAY ANY INTEREST THEREIN BE, OFFERED OR SOLD EXCEPT PURSUANT TO AN
EFFECTIVE REGISTRATION STATEMENT UNDER THE 1933 ACT OR PURSUANT TO AN AVAILABLE
EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION
REQUIREMENTS OF THE 1933 ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES
LAWS AS EVIDENCED BY, SUBJECT TO CERTAIN EXCEPTIONS, A LEGAL OPINION OF COUNSEL
TO THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY
ACCEPTABLE TO THE COMPANY. THESE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A
BONA FIDE MARGIN ACCOUNT SECURED BY SUCH SECURITIES.
(3)
The Buyer
further acknowledges and agrees that until such time as the Shares have been
registered for resale under the 1933 Act as contemplated by Section 8 or are
eligible for resale under Rule 144(k) under the 1933 Act, the certificates for
the Shares may bear a restrictive legend in substantially the following form
(and a stop-transfer order may be placed against transfer of the certificates
for the Shares):
The
securities represented by this certificate have not been registered under the
Securities Act of 1933, as amended (the 1933 Act). The securities have been
acquired for investment and may not be resold, transferred or assigned in the
absence of an effective registration statement for the securities under the 1933
Act or an opinion of counsel that registration is not required under the 1933
Act.
(4)
Certificates
evidencing the Shares shall not contain any legend (including the legend set
forth in Section 5(b)(3) hereof): (i) while a registration statement (including
the Registration Statement) covering the resale of such Security is effective
under the 1933 Act, or (ii) following any sale of such Shares pursuant to Rule
144, or (iii) if such Shares are eligible for sale under Rule 144(k), or (iv) if
such legend is not required under applicable requirements of the 1933Act
(including judicial interpretations and pronouncements issued by the SEC). The
Company shall cause its counsel to issue a legal opinion to the Companys
transfer agent promptly after the SEC Effective Date if required by the Companys
transfer agent to effect the removal of the legend hereunder. If all or any
portion of a Securities are converted or exercised (as applicable) at a time
when there is an effective registration
statement
to cover the resale of the Shares, or if such Shares may be sold under Rule
144(k) or if such legend is not otherwise required under applicable requirements
of the 1933 Act (including judicial interpretations thereof) then such Shares
shall be issued free of all legends. The Company agrees that following the SEC
Effective Date or at such time as such legend is no longer required under this
Section 5(b)(4), it will, no later than five Trading Days following the delivery
by a Buyer to the Company or the Companys transfer agent of a certificate
representing Shares, as applicable, deliver or cause to be delivered to such
Buyer a certificate representing such shares that is free from all restrictive
and other legends. The Company may not make any notation on its records or give
instructions to any transfer agent of the Company that enlarge the restrictions
on transfer set forth in this Section. Certificates for Securities subject to
legend removal hereunder shall be transmitted by the transfer agent of the
Company to the Buyers by crediting the account of the Buyers prime broker with
the Depository Trust Company System.
(c)
Reporting
Status.
During
the Registration Period, the Company shall timely file all reports required to
be filed with the SEC pursuant to Section 13 or 15(d) of the 1934 Act, and the
Company shall not terminate its status as an issuer required to file reports
under the 1934 Act even if the 1934 Act or the rules and regulations thereunder
would permit such termination.
(d)
Form D.
The
Company agrees to file with the SEC on a timely basis one or more Forms D with
respect to the Securities as required under Regulation D to claim the exemption
provided by Rule 506 of Regulation D and to provide a copy thereof to the Buyer
within five Business Days after Buyer requests in writing a copy of such
filing.
(e)
State Securities Laws.
On or
before the Closing Date, the Company shall take such action as shall be
necessary to qualify, or to obtain an exemption for, the offer and sale of the
Securities to the Buyer as contemplated by the Transaction Documents under such
of the securities laws of jurisdictions in the United States as shall be
applicable thereto. Notwithstanding the foregoing obligations of the Company in
this Section 5(e), the Company shall not be required (1) to qualify to do
business in any jurisdiction where it would not otherwise be required to qualify
but for this Section 5(e), (2) to subject itself to general taxation in any such
jurisdiction, (3) to file a general consent to service of process in any such
jurisdiction, (4) to provide any undertakings that cause more than nominal
expense or burden to the Company or (5) to make any change in its certificate or
articles of incorporation or by-laws which the Company determines to be contrary
to the best interests of the Company and its stockholders. The Company shall
furnish the Buyer with copies of all filings, applications, orders and grants or
confirmations of exemptions relating to such securities laws on or before the
Closing Date.
(f)
Limitation on Certain Actions.
From the
date of execution and delivery of this Agreement by the parties hereto to the
date of issuance of the Note, the Company (1) shall comply with Article III of
the Note as if the Note were outstanding, (2) shall not take any action which,
if the Note were outstanding, (A) would constitute an Event of Default or, with
the giving of notice or the passage of time or both, would constitute an Event
of Default or (B) would constitute a Repurchase Event or, with the giving of
notice or the passage of time or both, would constitute a Repurchase
Event.
(g)
Use of Proceeds.
T
he
Company represents and warrants to the Buyer, and covenants and agrees with the
Buyer, that: (1) it does not own or have any present intention of acquiring any
Margin Stock; (2) the proceeds of sale of the Note and the Warrant Shares will
be used for general working capital purposes and in the operation of the
Companys business
; provided,
however,
that up
to $100,000 of the proceeds of this Note and the Other Notes may be used in
connection with the search for an additional member of senior management
described in Section 3.17(b) of the Note; (3) none of such proceeds will be
used, directly or indirectly (A) to pay any existing debt obligations (other
than normal payables), (B) to make any loan to or investment in any other Person
or (C) for the purpose, whether immediate, incidental or ultimate, of purchasing
or carrying any margin stock or for the purpose of maintaining, reducing or
retiring any indebtedness which was originally incurred to purchase or carry any
stock that is currently a Margin Stock or for any other purpose which might
constitute the transactions contemplated by this Agreement a purpose credit
within the meaning of such Regulation U of the Board of Governors of the Federal
Reserve System; and (4) neither the Company nor any agent acting on its behalf
has taken or will take any action which might cause this Agreement or the
transactions contemplated hereby to violate Regulation T, Regulation U or any
other regulation of the Board of Governors of the Federal Reserve System or to
violate the 1934 Act, in each case as in effect now or as the same may hereafter
be in effect.
(h)
Best Efforts.
Each of
the Company, on the one hand, and the Buyer, on the other hand, agree to use
their best efforts timely to satisfy each of the conditions to the others
obligations to sell and purchase the Note set forth in Section 6 or 7, as the
case may be, of this Agreement on or before the Closing Date.
(i)
Debt Obligation.
So long
as any portion of the Note is outstanding, the Company shall cause its books and
records to reflect the Note as a debt of the Company in its unpaid principal
amount, shall cause its financial statements to reflect the Note as a debt of
the Company in such amount as shall be the greatest amount permitted in
accordance with Generally Accepted Accounting Principles and, whenever
appropriate, as a valid senior debt obligation of the Company for money
borrowed.
(j)
Right of the Buyer to Participate in
Future Transactions.
(1)
Right to
Participate.
The
Buyer will have a right to participate, on the terms and conditions set forth in
this Section 5(j), in all sales by the Company of any of the Companys equity
securities or other securities that are convertible into or exchangeable for any
of the Companys equity securities in each capital raising transaction, if any,
that occurs at any time when the Note, or any instrument issued upon transfer or
split up thereof, remains outstanding (in whole or in part), other than any such
sale that is a public offering underwritten on a firm commitment basis and
registered with the SEC under the 1933 Act and other than a Strategic Issuance;
provided,
however,
that if
under legal requirements applicable to a particular transaction the only Persons
eligible to purchase securities in such transaction are accredited investors, as
defined in Regulation D, then the Buyer must be
an
accredited investor in order to purchase securities in such transaction. For any
such transaction during such period, the Company shall give at least
four Business Days advance
written
notice to the Buyer prior to any offer or sale of any of the Company's
securities in such transaction by providing to the Buyer a term sheet which (A)
contains all significant business terms of such proposed transaction, (B) is
sufficiently detailed so as to reasonably permit the Buyer the opportunity to
determine whether or not to exercise its rights under this Section 5(j) and (C)
is at least as detailed as the term sheet or summary of such transaction as the
Company shall furnish to any offeree or broker in such transaction. The Buyer
shall have the right to participate in such proposed transaction and to purchase
its Pro Rata Share
of such
securities which are the subject of such proposed transaction for the same
consideration and on the same terms and conditions as contemplated for sales to
third parties in such transaction (or such lesser portion thereof as specified
by the Buyer). If the Buyer elects to exercise its rights hereunder for a
particular transaction, it shall deliver written notice to the Company within
four Business Days following receipt from the Company of the notice and term
sheet meeting the requirements of this Section 5(j), which notice from the Buyer
shall be conditional upon (A) the Buyers receipt of satisfactory definitive
documents for such transaction from the Company if the Company has not furnished
final, definitive documents for such transaction to the Buyer at or before the
time the Company gives such notice of such transaction to the Buyer, and (B) the
satisfaction of the other conditions precedent to the obligations of buyers
generally in such transaction to complete such transaction. If, subsequent to
the Company giving notice to the Buyer hereunder but prior to any of (i) the
Buyer exercising its right to participate, (ii) the expiration of the four
Business Day period without response from the Buyer or (iii) the rejection of
such offer for such financing by the Buyer, the terms and conditions of the
proposed sale to third parties in such transaction are changed from those
disclosed in the term sheet provided to the Buyer, the Company shall be required
to provide a new notice and term sheet meeting the requirements of this Section
5(j), reflecting such revised terms, to the Buyer hereunder and the Buyer shall
have the right, which must be exercised within four Business Days of the date
the Buyer receives such new notice and such revised term sheet, to exercise its
rights to purchase the securities on such changed terms and conditions and
otherwise as provided hereunder. If the Buyer does not exercise its rights
hereunder with respect to a proposed transaction within the period or periods
provided, or affirmatively declines to engage in such proposed transaction with
the Company, then the Company may proceed with such proposed transaction on the
same terms and conditions as noticed to the Buyer (assuming the Buyer has
consented to the transaction, if required, pursuant to Section 5(n) and such
transaction does not violate any other term or provision of the Transaction
Documents),
provided
that if
such proposed transaction is not consummated within 75 days following the
Companys notice hereunder, then the rights hereunder shall again be afforded to
the Buyer for such proposed transaction. The rights and obligations of this
Section 5(j) shall in no way limit or restrict the other rights of the Buyer
pursuant to this Section 5. Notwithstanding anything herein to the contrary,
failure of the Buyer to affirmatively elect in writing to participate in any
proposed transaction within the required time frames shall be deemed to be the
equivalent of Buyers decision not to participate in such proposed transaction.
Notwithstanding the foregoing, this Section 5(j)(1) shall not apply in respect
of an Exempt Issuance.
(2)
Limitation on Right of
Participation.
Notwithstanding
anything to the contrary contained herein, the number of shares of Common Stock
that may be acquired directly or through acquisition of Common Stock Equivalents
by the Buyer pursuant to any transaction to which this Section 5(j) applies
shall not at any one time exceed a number that, when added to the total number
of shares of Common Stock deemed beneficially owned by the Buyer (other than by
virtue of the ownership of securities or rights to acquire securities (including
the Note and the Warrant) that have limitations on the Buyers right to convert,
exercise or purchase similar to the limitation set forth herein (the Excluded
Shares)), together with all shares of Common Stock deemed beneficially owned at
such time (other than by virtue of ownership of Excluded Shares) by Persons
whose beneficial ownership of Common Stock would be aggregated with the
beneficial ownership of the Buyer for purposes of determining whether a group
exists or for purposes of determining the Buyers beneficial ownership, in either
such case for purposes of Section 13(d) of the 1934 Act and Regulation 13D-G
thereunder, would result in beneficial ownership by the Buyer or such group of
more than 9.9% of the shares of the Company's Common Stock (the Restricted
Ownership Percentage), computed in accordance with Regulation 13D-G. The Buyer
shall have the right at any time and from time to time to reduce its Restricted
Ownership Percentage immediately upon notice to the Company in the event and
only to the extent that Section 16 of the 1934 Act or the rules promulgated
thereunder (or any successor statute or rules) is changed to reduce the
beneficial ownership percentage threshold thereunder to a percentage less than
10%. If the Buyer would otherwise be unable by reason of the Restricted
Ownership Percentage to acquire the full amount of securities which the Buyer
would otherwise be entitled to acquire in a particular transaction pursuant to
this Section 5(j) then (A) the Company shall include in the terms of the
securities which the Buyer is entitled to purchase in such transaction under
this Section 5(j) a provision comparable to Section 6.7
of the
Note and (B) if, notwithstanding the inclusion of the provision required by the
immediately preceding clause (1), the Buyer remains unable to acquire the full
amount of securities which the Buyer would otherwise be entitled to acquire
under this Section 5(j), the Buyers right to acquire such securities shall be
deferred and if thereafter, at any time or from time to time the Buyer could
acquire all or any part of such securities without exceeding its Restricted
Ownership Percentage, then the Buyer shall be entitled to acquire such
securities at such time or form time to time. The Buyer will provide notice to
the Company when it becomes able to purchase all or any part of such securities
and the closing of each such purchase shall occur on the date that is five
Business Days after the Buyer gives such notice.
(3)
Right Applicable to Successive
Transactions.
The
rights of the Buyer under this Section 5(j) shall apply to all capital raising
transactions described in Section 5(j)(1) that occur during the period specified
in Section 5(j)(1).
(k)
Press
Releases.
Any press
release or other publicity concerning this Agreement or the transactions
contemplated by this Agreement shall be submitted to the Buyer for comment at
least one Business Day prior to issuance, unless the release is required to be
issued within a shorter period of time pursuant to this Agreement or by law or
pursuant to the rules of the securities exchange or market which at the time
constitutes the principal market for the Common Stock.
The
Company shall, contemporaneously with the closing on the Closing Date or as
promptly as possible thereafter on the Closing Date, issue a press release, in
the form of
Annex VI
hereto,
concerning the transactions contemplated hereby. The Company's other press
releases and other public information, to the extent concerning the Transaction
Documents, shall contain such information as reasonably requested by the Buyer
and be reasonably approved by the Buyer prior to issuance.
(l)
Form 8-K; Limitation on Information
and Buyer Obligations.
(1)
Within two Business Days after the Closing Date, the Company will publicly
report the issue and sale of the Note and Warrant and the securities issued
pursuant to the Other Purchase Agreements entered into on or before the Closing
Date by filing with the SEC a Current Report on Form 8-K under the 1934 Act,
which report shall describe the material terms of the transactions contemplated
hereby and thereby and include copies of the forms of the Transaction Documents
as exhibits to such report (the Transaction Form 8-K). The Company acknowledges
and agrees that, upon the filing of the Transaction Form 8-K with the SEC, the
Buyer shall not be in possession of any material nonpublic information received
from the Company, any Subsidiary or any of their respective officers, directors,
employees or agents.
(2)
The
Company shall not provide, and shall cause each Subsidiary and the respective
officers, directors, employees and agents of the Company and the Subsidiaries
not to provide, the Buyer any material nonpublic information regarding the
Company or any Subsidiary from and after the date the Company files, or is
required by this Agreement to file, the Transaction Form 8-K with the SEC
without the prior express written consent of the Buyer.
(m)
Limitation on Certain
Transactions.
From the
date of this Agreement until after the SEC Effective Date of the Registration
Statement contemplated by Section 8(a)(1), without the prior written consent of
the Buyer (which consent may be withheld in the Buyers sole discretion), the
Company shall not issue or sell or agree to issue or sell any securities (aside
from the Other Notes and the Other Warrants) in a capital raising transaction,
unless such securities will not be, and are not, registered for sale or resale
under the 1933 Act until on or after such SEC Effective Date; provided, however,
that the limitation of this Section 5(m) shall not apply to (a) shares of Common
Stock or options to employees, officers, directors or consultants of the Company
pursuant to any stock or option plan duly adopted by a majority of the
non-employee members of the Board of Directors of the Company or a majority of
the members of a committee of non-employee directors established for such
purpose, (b) securities upon the exercise or exchange of or conversion of any
Securities issued hereunder and/or securities exercisable or exchangeable for or
convertible into shares of Common Stock issued and outstanding on the date of
this Agreement, provided that such securities have not been amended since the
date of this Agreement to increase the number of such securities or to decrease
the exercise, exchange or conversion price of any such securities, and (c)
securities issued pursuant to acquisitions or strategic transactions, provided
any such issuance shall only be to a Person which is, itself or through its
subsidiaries, an operating company in a business synergistic with the business
of the Company and in which the Company receives benefits in addition to the
investment of funds, but shall not include a transaction in which the Company is
issuing securities primarily for the purpose of raising capital or to an entity
whose primary business is investing in securities (collectively, an Exempt
Issuance). The Company agrees that, except for the amounts of securities to be
purchased and the name of the buyer and the Restricted Ownership Percentage, the
terms and provisions of the Other Notes and the Other Warrants shall be
identical to the Note and the Warrant.
(n)
Debt Obligation.
So long
as any portion of the Note is outstanding, the Company shall cause its books and
records to reflect the Note as a debt of the Company in its unpaid principal
amount, shall cause its financial statements to reflect the Note as a debt of
the Company in accordance with Generally Accepted Accounting Principles and as a
valid senior debt obligation of the Company for money borrowed that is secured
by the Collateral (unless all Collateral shall have been released pursuant to
the Security Agreement and the security interest thereunder shall have
terminated).
(o)
Security Agreement; Financing
Statements, Etc.
The
Company agrees to execute and deliver to the Collateral Agent at or before the
closing on the Closing Date the Patent and Trademark Security Agreement in the
form attached hereto as
Annex III
and the
Pledge and Security Agreement in the form attached hereto as
Annex IV
. The
Company shall prepare and at or before the closing on the Closing Date file with
the appropriate officials, Uniform Commercial Code financing statements on Form
UCC-1 relating to the Collateral in which the Company is granting a security
interest to the Collateral Agent for the benefit of the holders of the Note and
the Other Notes pursuant to the Pledge and Security Agreement and prepare and
file with the PTO appropriate documents relating to the Collateral in which the
Company is granting a security interest to the Collateral Agent for the benefit
of the holders of the Note and the Other Note pursuant to the Patent and
Trademark Security Agreement. Prior to the closing on the Closing Date, the
Company shall provide to the Buyer evidence of such filings and customary,
current search reports of the relevant Uniform Commercial Code filing offices
and the PTO.
(p)
Stockholder Approval;
Reverse Stock
Split.
(1)
Stockholder
Approval.
The
Company shall seek, and use its best efforts to obtain, on or before the date
which is 90 days after the Closing Date, stockholder approval of the issuance of
the Shares in accordance with the terms of the Notes and the Warrants, which
approval shall meet the requirements of Rule 713 of the AMEX set forth in the
AMEX Company Guide (Stockholder Approval). The Company shall call a meeting of
stockholders (the Stockholder Meeting) to be held within 90 days after the
Closing Date, shall prepare and file with the SEC as promptly as practical, but
in no event later than 30 days after the Closing Date, preliminary proxy
materials which set forth a proposal to seek the Stockholder Approval, and the
Board of Directors shall recommend approval thereof by the Companys
stockholders. The Company shall mail and distribute its proxy materials for the
Stockholder Meeting to its stockholders at least 30 days prior to the date of
the Stockholder Meeting, shall actively solicit proxies to vote for the
Stockholder Approval, and within 30 days after the Closing Date shall retain a
proxy solicitation firm of recognized national standing to assist in the
solicitation. The Company shall provide the Buyer an opportunity to review and
comment on such proxy materials by providing (which may be by e-mail) copies of
such proxy materials and any revised preliminary proxy materials to the Buyer a
reasonable period of time prior to their filing with the SEC. The Company shall
provide the Buyer (which may be by e-mail) copies of all correspondence from or
to the SEC or its staff concerning the proxy materials for the Stockholder
Meeting promptly after the same is sent or received by the Company and summaries
of any comments of the SEC staff which the Company receives orally promptly
after receiving such oral comments. The Company shall furnish to the Buyer and
its legal counsel (which may be by e-mail) a copy of its definitive proxy
materials for the Stockholder Meeting and any amendments or supplements thereto
promptly after the same are first used, mailed to stockholders or filed with the
SEC, shall inform the Buyer of the progress of solicitation of proxies for such
meeting and shall inform the Buyer of any adjournment of the Stockholder Meeting
and shall report the result of the vote of stockholders on such proposition at
the conclusion of the Stockholder Meeting. If the Company fails to obtain such
Stockholder Approval, the Company shall call a meeting of stockholders every 90
days thereafter until such Stockholder Approval is obtained, and the Companys
seeking of such Stockholder Approval shall be conducted in accordance with the
requirements of this Section 5(p)(1).
(2)
Reverse Stock
Split.
In
connection with the Stockholder Meeting, the Company shall also seek, and use
its best efforts to obtain, on or before the date that is 90 days after the
Closing Date a reverse split of its Common Stock of not less than one for each
ten shares of Common Stock outstanding prior thereto (the Reverse Stock Split).
The Company shall include the Reverse Stock Split in the preliminary, revised
preliminary and definitive proxy materials prepared, filed with the SEC and used
for the Stockholder Approval, and the Companys seeking of approval of the
Reverse Stock Split shall be conducted in accordance with the requirements of
Section 5(p)(1).
(q)
Short Sales and Confidentiality
After The Date Hereof.
The Buyer
covenants that neither it nor any affiliates acting on its behalf or pursuant to
any understanding with it will execute any Short Sales during the period
commencing
from
the time
that the Buyer first received a term sheet from the Company or any other Person
setting forth the material terms of the transactions contemplated hereunder and
ending on the earlier of (i) the date that the transactions contemplated by this
Agreement are first publicly announced as described in Section 5(k) and (ii) the
date, if applicable, that this Agreement is terminated pursuant to Section
10(l). The Buyer covenants that until such time as the transactions contemplated
by this Agreement are publicly disclosed by the Company as described in Section
5(k) or the earlier termination of this Agreement, the Buyer will maintain the
confidentiality of all disclosures made to it in connection with this
transaction (including the existence and terms of this transaction). The Buyer
understands and acknowledges that the SEC currently takes the position that
coverage of short sales of shares of the Common Stock against the box prior to
the effective date of the Registration Statement with the Securities is a
violation of Section 5 of the 1933 Act, as set forth in Item 65, Section 5 under
Section A, of the Manual of Publicly Available Telephone Interpretations, dated
July 1997, compiled by the Office of Chief Counsel, Division of Corporation
Finance. Notwithstanding the foregoing, the Buyer does not make any
representation, warranty or covenant hereby that it will not engage in Short
Sales in the securities of the Company after the earlier of (i) the date that
the transactions contemplated by this Agreement are first publicly announced as
described in Section 5(k) and (ii) the date, if applicable, that this Agreement
is terminated pursuant to Section 10(l). Notwithstanding the foregoing, in the
case of a Buyer that is a multi-managed investment vehicle whereby separate
portfolio managers manage separate portions of such Buyer's assets and the
portfolio managers have no direct knowledge of the investment decisions made by
the portfolio managers managing other portions of such Buyer's assets, the
covenant set forth above shall only apply with respect to the portion of assets
managed by the portfolio manager that made the investment decision to purchase
the Securities covered by this Agreement.
6.
CONDITIONS TO THE COMPANYS
OBLIGATION TO SELL.
The Buyer
understands that the Companys obligation to sell the Note and issue the Warrant
to the Buyer pursuant to this Agreement is conditioned upon satisfaction of the
following conditions precedent on or before the Closing Date (any or all of
which may be waived by the Company in its sole discretion):
(a)
On the
Closing Date, no legal action, suit or proceeding shall be pending or threatened
which seeks to restrain or prohibit the transactions contemplated by this
Agreement; and
(b)
The
representations and warranties of the Buyer contained in this Agreement shall
have been true and correct on the date of this Agreement and on the Closing Date
as if made on the Closing Date and on or before the Closing Date the Buyer shall
have performed all covenants and agreements of the Buyer contained in this
Agreement and required to be performed by the Buyer on or before the Closing
Date.
7.
CONDITIONS TO THE BUYERS OBLIGATION
TO PURCHASE.
The
Company understands that the Buyers obligation to purchase the Note and acquire
the Warrant is conditioned upon satisfaction of the following conditions
precedent on or before the Closing Date (any or all of which may be waived by
the Buyer in its sole discretion):
(a)
No legal
action, suit or proceeding shall be pending or threatened which seeks to
restrain or prohibit the transactions contemplated by this
Agreement;
(b)
The
representations and warranties of the Company contained in this Agreement shall
have been true and correct on the date of this Agreement and shall be true and
correct on the Closing Date as if given on and as of the Closing Date (except
for representations given as of a specific date, which representations shall be
true and correct as of such date), and on or before the Closing Date the Company
shall have performed all covenants and agreements of the Company contained
herein or in any of the other Transaction Documents required to be performed by
the Company on or before the Closing Date;
(c)
No event
which, if the Note were outstanding, (1) would constitute an Event of Default or
which, with the giving of notice or the passage of time, or both, would
constitute an Event of Default shall have occurred and be continuing or (2)
would constitute a Repurchase Event or which, with the giving of notice or the
passage of time, or both, would constitute a Repurchase Event shall have
occurred and be continuing;
(d)
The
Company shall have delivered to the Buyer a certificate, dated the Closing Date,
duly executed by its Chief Executive Officer or Chief Financial Officer, to the
effect set forth in subparagraphs (a), (b) and (c) of this Section
7;
(e)
The
Company shall have delivered to the Buyer a certificate, dated the Closing Date,
of the Secretary of the Company certifying (1) the Certificate of Incorporation
and By-Laws of the Company as in effect on the Closing Date, (2) all resolutions
of the Board of Directors (and committees thereof) of the Company relating to
this Agreement and the other Transaction Documents and the transactions
contemplated hereby and thereby and (3) such other matters as reasonably
requested by the Buyer;
(f)
The
Collateral Agent shall have executed and delivered to the Company the Pledge and
Security Agreement and a copy thereof duly executed and delivered by the
Company, shall have been furnished to the Buyer;
(g)
The Buyer
shall have received from the Company customary, current search reports of the
relevant Uniform Commercial Code filing offices, the content of which reports
shall be satisfactory to the Buyer;
(h)
All
filings of financing statements necessary or appropriate under the Uniform
Commercial Code in connection with the Pledge and Security Agreement shall have
been made, and the Buyer shall have received satisfactory evidence of such
filings;
(i)
The
Collateral Agent shall have executed and delivered to the Company the Patent and
Trademark Security Agreement
and a
copy thereof duly executed and delivered by the Company, shall have been
furnished to the Buyer;
(j)
The Buyer
shall have received from the Company customary, current search reports of the
PTO, the content of which reports shall be satisfactory to the
Buyer;
(k)
All
filings with the PTO necessary or appropriate in connection with the Patent and
Trademark Security Agreement shall have been made, and the Buyer shall have
received satisfactory evidence of such filings;
(l)
The
Lockbox Agent shall have executed and delivered to the Company the Lockbox
Agreement and a copy thereof duly executed and delivered by the Company shall
have been furnished to the Buyer;
(m)
The
Conversion Shares and the Warrant Shares shall have been approved for listing,
subject only to official notice of issuance, by the AMEX and the Buyer shall
have received written evidence of such approval by the AMEX;
(n)
On the
Closing Date, the Buyer shall have received an opinion of Sichenzia Ross
Friedman Ference LLP, counsel for the Company, dated the Closing Date, addressed
to the Buyer, in the form attached as
Annex VII
and
otherwise in form, scope and substance reasonably satisfactory to the Buyer and
an opinion of Epstein Drangel Bazerman & James, LLP, intellectual property
counsel for the Company, dated the Closing Date, addressed to the Buyer, in the
form attached as
Annex VIII
and
otherwise in form, scope and substance reasonably satisfactory to the Buyer;
and
(o)
On the
Closing Date, (i) trading in securities on the New York Stock Exchange, Inc.,
the AMEX, Nasdaq or the Nasdaq Capital Market shall not have been suspended or
materially limited and (ii) a general moratorium on commercial banking
activities in the State of New York shall not have been declared by either
federal or state authorities.
(p)
John
Atherly shall have executed and delivered to the Buyers and the Company a Lockup
Agreement in the form attached as
Annex IX
.
8.
REGISTRATION
RIGHTS.
(a)
Mandatory Registration.
(1) The
Company shall prepare and, as expeditiously as possible, but in no event later
than the date which is 30 days after the Closing Date, file with the SEC a
Registration Statement which covers the resale by the Buyer of a number of
shares of Common Stock equal to 100% of the sum of (A) the number of Conversion
Shares issuable upon conversion of the Note
plus
(B) the
number of Warrant Shares issuable upon exercise of the Warrant, as Registrable
Securities, and which Registration Statement shall state that, in accordance
with Rule 416 under the 1933 Act, such Registration Statement also covers such
indeterminate number of additional shares of Common Stock as may become issuable
upon conversion of the Note or exercise of the Warrant to prevent dilution
resulting from stock splits, stock dividends or similar transactions.
(2)
Prior to
the earlier of the (i) SEC Effective Date, or (ii) two (2) years from the date
hereof, the Company shall not file any other registration statement or any
amendment thereto with the SEC under the 1933 Act or request the acceleration of
the effectiveness of any other registration statement previously filed with the
SEC, other than (A) any registration statement on Form S-8 and (B) any
registration statement or amendment which the Company is required to file, or as
to which the Company is required to request acceleration, pursuant to any
obligation in effect on the date of execution and delivery of this
Agreement.
(3)
If at any
time or from time to time after the Closing Date any Investor shall hold or be
the beneficial owner of any Registrable Securities, other than those Registrable
Securities included in the Registration Statement that the Company is required
to file under Section 8(a)(1), which Registrable Securities are not covered by a
Registration Statement, then promptly following the written demand of any
Investor following the issuance of such additional Registrable Securities or the
issuance of any securities convertible into, exchangeable for, or otherwise
entitling an Investor to acquire, such additional Registrable Securities, and in
any event within 30 days following such demand, the Company shall prepare and
file with the SEC a new Registration Statement on Form S-3 (or, if Form S-3 is
not then available to the Company, on such form of registration statement as is
then available to effect a registration for resale of such additional
Registrable Securities) covering the resale by such Investor of such additional
Registrable Securities. Such Registration Statement also shall cover, to the
extent permitted by the 1933 Act and the rules promulgated thereunder (including
Rule 416), such indeterminate number of additional securities resulting from
stock splits, stock dividends or similar transactions with respect to such
additional Registrable Securities. Nothing herein shall limit the Companys
obligations or any Investors rights under Section 6.4 of the Note or Section 9
of the Warrant.
(4)
If a
Payment Event occurs, then the Company will make payments to the Buyer, in
immediately available funds in lawful money of the United States, as partial
liquidated damages for the minimum amount of damages to the Buyer by reason
thereof, and not as a penalty, which payments shall accrue at the rate of 1.0%
per month of the principal amount of the Note at the time outstanding during
each Payment Period. Each such payment shall be due and payable within five
Business Days after the end of each calendar month during which any Payment
Period occurs until the termination of such Payment Period and within five
Business Days after such termination. Such payments shall be in partial
compensation to the Buyer, and shall not constitute the Buyers exclusive remedy
for any Payment Event. A particular Payment Period shall terminate upon (u) the
filing of the applicable Registration Statement, in the case of clause (i) of
the definition of Payment Event; (v) the applicable SEC Effective Date for the
particular Registration Statement, in the case of clause (ii) or (iii) of the
definition of Payment Event; (w) the ability of the Buyer to effect sales
pursuant to the applicable Registration Statement, in the case of clause (iv) of
the definition of Payment Event; (x) the listing or inclusion and/or trading of
the Common Stock on a Trading Market, as the case may be, in the case of clause
(v) of the definition of Payment Event; (y) the issuance and delivery of the
shares, in the case of clause (vi) of the definition of Payment Event; and (z)
in the case of the events described in clauses (ii), (iii) and (iv) of the
definition of Payment Event, the earlier termination of the Registration Period,
and in each such case in the preceding clauses (u) thorough (z), any Payment
Period that commenced by reason of the occurrence of any Payment Event shall
terminate if at the time (1) no other Payment Event is continuing or (2) subject
to the rights of any transferee under Section 10(j), the Buyer no longer holds
any portion of the Note or any Registrable Securities. Notwithstanding any other
provision of this Section 8(a)(4) to the contrary, the Company shall not be
obligated to make any payments hereunder for Payment Periods in excess of an
aggregate of 548 days. If the Company fails to pay any liquidated damages
pursuant to this Section in full within three days after the date payable, the
Company will pay interest thereon at a rate of 16% per annum (or such lesser
rate as is the highest rate permitted by applicable law) to the Buyer, accruing
daily from the date such liquidated damages are due until such amounts, plus all
such interest thereon, are paid in full.
(b)
Obligations of the Company.
In
connection with the registration of the Registrable Securities, the Company
shall:
(1)
use its
best efforts to cause each Registration Statement to become effective as
promptly as possible after the filing thereof
and to
keep such Registration Statement effective at all times during the Registration
Period. The Company shall submit to the SEC, within three Business Days after
the Company learns that no review of such Registration Statement will be made by
the staff of the SEC or that the staff of the SEC has no further comments on
such Registration Statement, as the case may be, a request for acceleration of
effectiveness of such Registration Statement to a time and date not later than
48 hours after the submission of such request. The Company represents and
warrants to the Investors that (a) each Registration Statement (including any
amendment or supplement thereto and prospectus contained therein), at the time
it is first filed with the SEC, at the time it is ordered effective by the SEC
and at all times during which it is required to be effective hereunder (and each
such amendment and supplement at the time it is filed with the SEC and at all
times during which it is available for use in connection with the offer and sale
of the Registrable Securities) shall not contain any untrue statement of a
material fact or omit to state a material fact required to be stated therein or
necessary to make the statements therein not misleading and (b) each Prospectus,
at the time the related Registration Statement is declared effective by the SEC
and at all times that such Prospectus is required by this Agreement to be
available for use by any Investor and, in accordance with Section 8(c)(4), any
Investor is entitled to sell Registrable Securities pursuant to such Prospectus,
shall not contain any untrue statement of a material fact or omit to state a
material fact required to be stated therein, or necessary to make the statements
therein, in light of the circumstances in which they were made, not
misleading;
(2)
subject
to Section 8(b)(5), prepare and file with the SEC such amendments (including
post-effective amendments) and supplements to each Registration Statement and
Prospectus as may be necessary to keep such Registration Statement effective,
and such Prospectus current, at all times during the Registration Period, and,
during the Registration Period (other than during any Blackout Period during
which the provisions of Section 8(b)(5)(B) are applicable), comply with the
provisions of the 1933 Act applicable to the Company in order to permit the
disposition by the Investors of all Registrable Securities covered by such
Registration Statement;
(3)
furnish
to Investors whose Registrable Securities are included in a particular
Registration Statement and such Investors respective legal counsel, promptly
after the same is prepared and publicly distributed, filed with the SEC or
received by the Company, (1) one conformed copy of such Registration Statement
and any amendment thereto and the related Prospectus and each amendment or
supplement thereto and (2) such number of copies of such Prospectus and all
amendments and supplements thereto and such other documents, as such Investor
may reasonably request in order to facilitate the disposition of the Registrable
Securities owned by such Investor; and notify the Investor and its legal counsel
within one Business Day after the same is filed with the SEC, or received by the
Company, of the filing or receipt of each letter written by or on behalf on the
Company to the SEC or the staff of the SEC, and each item of correspondence from
the SEC or the staff of the SEC, in each case relating to such Registration
Statement (other than any portion of any thereof which contains information for
which the Company has sought confidential treatment), and permit counsel
designed by the Investor to review letters and items of correspondence upon the
request of such counsel;
(4)
subject
to Section 8(b)(5), use its best efforts (i) to register and qualify the
Registrable Securities covered by each Registration Statement under the
securities or blue sky laws of such jurisdictions as any Investor who owns or
holds any Registrable Securities reasonably requests, (ii) to prepare and to
file in those jurisdictions such amendments (including post-effective
amendments) and supplements to such registrations and qualifications as may be
necessary to maintain the effectiveness thereof at all times during the
Registration Period and (iii) to take all other actions reasonably necessary or
advisable to qualify the Registrable Securities for sale by the Investors in
such jurisdictions;
provided,
however,
that the
Company shall not be required in connection therewith or as a condition thereto
(I) to qualify to do business in any jurisdiction where it would not otherwise
be required to qualify but for this Section 8(b)(4), (II) to subject itself to
general taxation in any such jurisdiction, (III) to file a general consent to
service of process in any such jurisdiction, (IV) to provide any undertakings
that cause more than nominal expense or burden to the Company or (V) to make any
change in its certificate or article of incorporation or by-laws which the Board
of Directors of the Company determines to be contrary to the best interests of
the Company and its stockholders;
(5)
(A) as
promptly as practicable after becoming aware of such event or circumstance,
notify each Investor of the occurrence of any event or circumstance of which the
Company has knowledge (x) as a result of which any Prospectus, as then in
effect, includes an untrue statement of a material fact or omits to state a
material fact required to be stated therein or necessary to make the statements
therein, in light of the circumstances under which they were made, not
misleading, (y) which requires the Company to amend or supplement any
Registration Statement due to the receipt from an Investor or any other selling
stockholder named in the Prospectus of new or additional information about such
Investor or selling stockholder or its intended plan of distribution of its
Registrable Securities or other securities covered by such Registration
Statement, or (z) which requires the Company to amend or supplement any
Registration Statement pursuant to the Companys undertakings as set forth in the
Registration Statement and in Item 512 of Regulation S-K under the 1933 Act, and
use its best efforts promptly to prepare a supplement or amendment to such
Registration Statement and Prospectus to correct such untrue statement or
omission or to add any new or additional information, and deliver a number of
copies of such supplement or amendment to each Investor as such Investor may
reasonably request;
(B)
notwithstanding
Section 8(b)(5)(A) above, if at any time the Company notifies the Investors as
contemplated by Section 8(b)(5)(A) with respect to a particular Registration
Statement or Prospectus the Company also notifies the Investors that the event
giving rise to such notice relates to a development involving the Company which
occurred subsequent to the later of (x) the SEC Effective Date of the applicable
Registration Statement and (y) the latest date prior to such notice on which the
Company has amended or supplemented such Registration Statement, then the
Company shall not be required to use best efforts to make such amendment during
a Blackout Period;
provided,
however,
that in
any period of 365 consecutive days the Company shall not be entitled to avail
itself of its rights under this Section 8(b)(5)(B) with respect to more than two
Blackout Periods; and
provided further, however,
that no
Blackout Period may commence sooner than 90 days after the end of an earlier
Blackout Period;
(6)
as
promptly as practicable after becoming aware of such event, notify each Investor
who holds Registrable Securities being offered or sold pursuant to a particular
Registration Statement of the issuance by the SEC of any stop order or other
suspension of effectiveness of such Registration Statement at the earliest
possible time;
(7)
permit
the Investors who hold Registrable Securities being included in a particular
Registration Statement (or their designee) and their counsel to review and have
a reasonable opportunity to comment on such Registration Statement and any
related Prospectus and all amendments and supplements thereto at least two
Business Days prior to their filing with the SEC;
(8)
make
generally available to its security holders as soon as practical, but not later
than 90 days after the close of the period covered thereby, an earning statement
(in form complying with the provisions of Rule 158 under the 1933 Act) covering
a 12-month period beginning not later than the first day of the Companys fiscal
quarter next following the SEC Effective Date of each Registration
Statement;
(9)
make
available for inspection by any Investor and any Inspector retained by such
Investor, at such Investors sole expense, all Records as shall be reasonably
necessary or appropriate to enable such Investor to exercise due diligence for
purposes of the 1933 Act and the 1934 Act as it relates to the Registration
Statement and cause the Companys and the Subsidiaries officers, directors and
employees to supply all information which such Investor or Inspector may
reasonably request for purposes of such due diligence;
provided, however,
that such
Investor shall hold in confidence and shall not make any disclosure of any
Record or other information which the Company determines in good faith to be
confidential, and of which determination such Investor is so notified, unless
(i) the disclosure of such Record is necessary to avoid or correct a
misstatement or omission in a Registration Statement or Prospectus and a
reasonable time prior to such disclosure the Investor shall have notified the
Company of the need to so correct such misstatement or omission and the Company
shall have failed to correct such misstatement or omission, (ii) the release of
such Record is ordered pursuant to a subpoena or other order from a court or
governmental body of competent jurisdiction or (iii) the information in such
Record has been made generally available to the public other than by disclosure
in violation of this or any other agreement. The Company shall not be required
to disclose any confidential information in such Records to any Inspector until
and unless such Inspector shall have entered into a confidentiality agreement
with the Company with respect thereto, substantially in the form of this Section
8(b)(9), which agreement shall permit such Inspector to disclose Records to the
Investor who has retained such Inspector. Each Investor agrees that it shall,
upon learning that disclosure of such Records is sought in or by a court or
governmental body of competent jurisdiction or through other means, give prompt
notice to the Company and allow the Company, at the Companys expense, to
undertake appropriate action to prevent disclosure of, or to obtain a protective
order for, the Records deemed confidential. The Company shall hold in confidence
and shall not make any disclosure of information concerning an Investor provided
to the Company pursuant to this Agreement unless (i) the disclosure of such
information is necessary to comply with federal or state securities laws, (ii)
the disclosure of such information is necessary to avoid or correct a
misstatement or omission in a Registration Statement or the related Prospectus,
(iii) the release of such information is ordered pursuant to a subpoena or other
order from a court or governmental body of competent jurisdiction, or (iv) such
information has been made generally available to the public other than by
disclosure in violation of this or any other agreement. The Company agrees that
it shall, upon learning that disclosure of such information concerning an
Investor is sought in or by a court or governmental body of competent
jurisdiction or through other means, give prompt notice to such Investor and
allow such Investor, at such Investors expense, to undertake appropriate action
to prevent disclosure of, or to obtain a protective order for, such
information;
(10)
use its
best efforts to cause all the Registrable Securities covered by a particular
Registration Statement as of the SEC Effective Date of such Registration
Statement to be listed, quoted or traded on the principal securities market on
which securities of the same class or series issued by the Company are then
listed, quoted or traded;
(11)
provide a
transfer agent and registrar, which may be a single entity, for the Registrable
Securities at all times;
(12)
cooperate
with the Investors who hold Registrable Securities being offered pursuant to a
particular Registration Statement to facilitate the timely preparation and
delivery of certificates (not bearing any restrictive legends) representing
Registrable Securities to be offered pursuant to such Registration Statement and
enable such certificates to be in such denominations or amounts as the Investors
may reasonably request and registered in such names as the Investors may
request; and, not later than the SEC Effective Date of such Registration
Statement, the Company shall cause legal counsel selected by the Company to
deliver to the Investors whose Registrable Securities are included in the
Registration Statement opinions of counsel in form and substance as is
customarily given to underwriters in an underwritten public offering;
(13)
advise
the Investors in writing on the date that the Registration Statement is declared
effective by the SEC that the form of Prospectus contained in the Registration
Statement at the time of effectiveness meets the requirements of Section 10(a)
of the 1933 Act or that it intends to file a Prospectus pursuant to Rule 424(b)
that meets the requirements of Section 10(a) of the 1933 Act;
(14)
during
the Registration Period, the Company shall not bid for or purchase any Common
Stock or any right to purchase Common Stock or attempt to induce any Person to
purchase any such security or right if such bid, purchase or attempt would in
any way limit the right of the Investors to sell Registrable Securities by
reason of the limitations set forth in Regulation M under the 1934 Act;
and
(15)
take all
other reasonable actions necessary to expedite and facilitate disposition by the
Investors of the Registrable Securities pursuant to the Registration Statement
relating thereto.
(c)
Obligations of the Buyer and other
Investors.
In
connection with the registration of the Registrable Securities, the Investors
shall have the following obligations:
(1)
It shall
be a condition precedent to the obligations of the Company to complete the
registration pursuant to this Agreement with respect to the Registrable
Securities of a particular Investor that such Investor shall furnish to the
Company completed Selling Securityholder Questionnaire in the form attached
hereto as
Exhibit A
and
shall execute such other documents in connection with such registration as the
Company may reasonably request.
(2)
Each
Investor by such Investors acceptance of the Registrable Securities agrees to
cooperate with the Company as reasonably requested by the Company in connection
with the preparation and filing of each Registration Statement hereunder that
covers such Registrable Securities, unless such Investor has notified the
Company of such Investors election to exclude all of such Investors Registrable
Securities from such Registration Statement;
(3)
Each
Investor agrees that it will not effect any disposition of the Registrable
Securities except as contemplated in the applicable Registration Statement or
Prospectus or as otherwise is in compliance with applicable securities laws and
that it will promptly notify the Company of any material changes in the
information set forth in the Registration Statement regarding such Investor or
its plan of distribution before selling any Registrable Securities pursuant to
such Registration Statement or Prospectus subsequent to such material change;
each Investor agrees (a) to notify the Company in writing in the event that such
Investor enters into any material agreement with a broker or a dealer for the
sale pursuant to a Registration Statement of Registrable Securities through a
block trade, special offering, exchange distribution or a purchase by a broker
or dealer and (b) in connection with such agreement, to provide to the Company
in writing the information necessary to prepare any supplemental Prospectus
pursuant to Rule 424(c) under the 1933 Act which is required with respect to
such transaction; and
(4)
Each
Investor acknowledges that there may occasionally be times as specified in
Section 8(b)(5) or 8(b)(6) when the Company must suspend the use of a Prospectus
until such time as an amendment to the related Registration Statement has been
filed by the Company and declared effective by the SEC, the Company has prepared
a supplement to such Prospectus or the Company has filed an appropriate report
with the SEC pursuant to the 1934 Act. Each Investor hereby covenants that it
will not sell any Registrable Securities pursuant to such Prospectus during the
period commencing at the time at which the Company gives such Investor notice of
the suspension of the use of such Prospectus in accordance with Section 8(b)(5)
or 8(b)(6) and ending at the time the Company gives such Investor notice that
such Investor may thereafter effect sales pursuant to the Prospectus, or until
the Company delivers to such Investor or files with the SEC an amended or
supplemented Prospectus.
(d)
Rule 144.
With a
view to making available to each Investor the benefits of Rule 144, the Company
agrees:
(1)
so long
as any Investor owns Registrable Securities, promptly upon request of such
Investor, to furnish to such Investor such information as may be necessary to
permit such Investor to sell Registrable Securities pursuant to Rule 144 without
registration and otherwise reasonably to cooperate with such Investor
and
(2)
if at any
time the Company is not required by applicable law or this Agreement to file
reports with the SEC pursuant to Section 13 or 15(d) of the 1934 Act, to use its
best efforts, upon the request of an Investor, to make publicly available other
information so long as is necessary to permit publication by brokers and dealers
of quotations for the Common Stock and sales of the Registrable Securities in
accordance with Rule 15c2-11 under the 1934 Act.
9.
INDEMNIFICATION AND
CONTRIBUTION.
(a)
Indemnification.
(1) To
the extent not prohibited by applicable law, the Company will indemnify and hold
harmless each Indemnified Person against any Claims to which any of them may
become subject under the 1933 Act, the 1934 Act or otherwise, insofar as such
Claims (or actions or proceedings, whether commenced or threatened, in respect
thereof) arise out of or are based upon any Violation. Subject to the
restrictions set forth in Section 9(a)(3) with respect to the number of legal
counsel, the Company shall reimburse the
Investors
and each such controlling Person, promptly as such expenses are incurred and are
due and payable, for any documented reasonable legal fees or other documented
and reasonable expenses incurred by them in connection with investigating or
defending any such Claim. Notwithstanding anything to the contrary contained
herein, the indemnification agreement contained in this Section 9(a)(1) shall
not apply to: (I) a Claim arising out of or based upon a Violation which occurs
in reliance upon and in conformity with information relating to an Indemnified
Person furnished in writing to the Company by such Indemnified Person or an
underwriter for such Indemnified Person expressly for use in connection with the
preparation of any Registration Statement or any such amendment thereof or
supplement thereto; (II) any Claim arising out of or based on any statement or
omission in any Prospectus, which statement or omission was corrected in any
subsequent Prospectus that was delivered to the Indemnified Person prior to the
pertinent sale or sales of Registrable Securities by such Indemnified Person;
and (III) amounts paid in settlement of any Claim if such settlement is effected
without the prior written consent of the Company. Such indemnity shall remain in
full force and effect regardless of any investigation made by or on behalf of
the Indemnified Person and shall survive the transfer of the Registrable
Securities by the Investors.
(2)
In
connection with each Registration Statement, each Investor who is named as a
selling stockholder in such Registration Statement agrees to indemnify and hold
harmless, to the same extent and in the same manner set forth in Section
9(a)(1), each Indemnified Party against any Claim to which any of them may
become subject, under the 1933 Act, the 1934 Act or otherwise, insofar as such
Claim arises out of or is based upon any Violation, in each case to the extent
(and only to the extent) that such Violation occurs in reliance upon and in
conformity with written information furnished to the Company by such Investor
expressly for use in connection with such Registration Statement or any
amendment thereof or supplement thereto; and such Investor will reimburse any
legal or other expenses reasonably incurred by them in connection with
investigating or defending any such Claim;
provided
,
however
, that
the indemnity agreement contained in this Section 9(a)(2) shall not apply to
amounts paid in settlement of any Claim if such settlement is effected without
the prior written consent of such Investor;
provided
,
further
,
however
, that an
Investor shall be liable under this Section 9(a)(2) for only that amount of all
Claims in the aggregate as does not exceed the amount by which the proceeds to
such Investor as a result of the sale of Registrable Securities pursuant to such
Registration Statement exceeds the amount paid by such Investor for such
Registrable Securities or for the Common Stock Equivalents pursuant to which
such Registrable Securities were issued, as the case may be. Such indemnity
shall remain in full force and effect regardless of any investigation made by or
on behalf of such Indemnified Party and shall survive the transfer of the
Registrable Securities by the Investors. Notwithstanding anything to the
contrary contained herein, the indemnification agreement contained in this
Section 9(a)(2) with respect to any preliminary prospectus shall not inure to
the benefit of any Indemnified Party if the untrue statement or omission of
material fact contained in such preliminary prospectus was corrected on a timely
basis in the related Prospectus, as then amended or supplemented.
(3)
Promptly
after receipt by an Indemnified Person or Indemnified Party under this Section
9(a) of notice of the commencement of any action (including any governmental
action), such Indemnified Person or Indemnified Party shall, if a Claim in
respect thereof is to be made against any indemnifying party under this Section
9(a), deliver to the indemnifying party a notice of the commencement thereof and
the indemnifying party shall have the right to participate in, and, to the
extent the indemnifying party so desires, jointly with any other indemnifying
party similarly noticed, to assume control of the defense thereof with counsel
reasonably satisfactory to the Indemnified Person or the Indemnified Party, as
the case may be;
provided
,
however
, that an
Indemnified Person or Indemnified Party shall have the right to retain its own
counsel with the fees and expenses to be paid by the indemnifying party, if, in
the reasonable opinion of counsel retained by the indemnifying party, the
representation by such counsel of the Indemnified Person or Indemnified Party
and the indemnifying party would be inappropriate due to actual or potential
differing interests between such Indemnified Person or Indemnified Party and any
other party represented by such counsel in such proceeding, in which case the
indemnifying party shall not be responsible for more than one such separate
counsel, and one local counsel in each jurisdiction in which an action is
pending, for all Indemnified Persons or Indemnified Parties, as the case may be.
The failure to deliver notice to the indemnifying party within a reasonable time
of the commencement of any such action shall not relieve such indemnifying party
of any liability to the Indemnified Person or Indemnified Party under this
Section 9(a), except to the extent that the indemnifying party is prejudiced in
its ability to defend such action. The indemnification required by this Section
9(a) shall be made by periodic payments of the amount thereof during the course
of the investigation or defense, as such expense, loss, damage or liability is
incurred and is due and payable.
(b)
Contribution.
To the
extent any indemnification by an indemnifying party as set forth in Section 9(a)
above is applicable by its terms but is prohibited or limited by law, the
indemnifying party agrees to make the maximum contribution with respect to any
amounts for which it would otherwise be liable under Section 9(a) to the fullest
extent permitted by law. In determining the amount of contribution to which the
respective parties are entitled, there shall be considered the relative fault of
each party, the parties relative knowledge of and access to information
concerning the matter with respect to which the claim was asserted, the
opportunity to correct and prevent any statement or omission and any other
equitable considerations appropriate under the circumstances;
provided
,
however
, that
(a) no contribution shall be made under circumstances where the maker would not
have been liable for indemnification under the fault standards set forth in
Section 9(a), (b) no Person guilty of fraudulent misrepresentation (within the
meaning of Section 11(f) of the 1933 Act) shall be entitled to contribution from
any other Person who was not guilty of such fraudulent misrepresentation and (c)
the aggregate contribution by any seller of Registrable Securities shall be
limited to the amount by which the proceeds received by such seller from the
sale of such Registrable Securities exceeds the amount paid by such Investor for
such Registrable Securities or for the Common Stock Equivalents pursuant to
which such Registrable Securities were issued, as the case may be.
(c)
Other Rights.
The
indemnification and contribution provided in this Section shall be in addition
to any other rights and remedies available at law or in equity.
10.
MISCELLANEOUS.
(a)
Governing Law.
THIS
AGREEMENT SHALL BE GOVERNED BY AND INTERPRETED IN ACCORDANCE WITH THE LAWS OF
THE STATE OF NEW YORK.
(b)
Headings.
The
headings, captions and footers of this Agreement are for convenience of
reference and shall not form part of, or affect the interpretation of, this
Agreement.
(c)
Severability.
If any
provision of this Agreement shall be invalid or unenforceable in any
jurisdiction, such invalidity or unenforceability shall not affect the validity
or enforceability of the remainder of this Agreement or the validity or
enforceability of this Agreement in any other jurisdiction.
(d)
Notices.
Any
notices required or permitted to be given under the terms of this Agreement
shall be in writing and shall be sent by certified mail, personal delivery,
telephone line facsimile transmission or courier and shall be effective five
days after being placed in the mail, if mailed, or upon receipt, if delivered
personally, by telephone line facsimile transmission or by courier, in each case
addressed to a party at such partys address (or telephone line facsimile
transmission number) shown in the introductory paragraph or on the signature
page of this Agreement or such other address (or telephone line facsimile
transmission number) as a party shall have provided by notice to the other party
in accordance with this provision. In the case of any notice to the Company,
such notice shall be addressed to the Company at its address shown in the
introductory paragraph of this Agreement, Attention: Chief Executive Officer
(telephone line facsimile number (425) 749-3601).
(e)
Counterparts.
This
Agreement may be executed in counterparts and by the parties hereto on separate
counterparts, each of which shall be deemed to be an original and all of which
together shall constitute one and the same instrument. A telephone line
facsimile transmission of this Agreement bearing a signature on behalf of a
party hereto shall be legal and binding on such party. Although this Agreement
is dated as of the date first set forth above, the actual date of execution and
delivery of this Agreement by each party is the date set forth below such partys
signature on the signature page hereof. Any reference in this Agreement or in
any of the documents executed and delivered by the parties hereto in connection
herewith to (1) the date of execution and delivery of this Agreement by the
Buyer shall be deemed a reference to the date set forth below the Buyers
signature on the signature page hereof, (2) the date of execution and delivery
of this Agreement by the Company shall be deemed a reference to the date set
forth below the Companys signature on the signature page hereof and (3) the date
of execution and delivery of this Agreement, or the date of execution and
delivery of this Agreement by the Buyer and the Company, shall be deemed a
reference to the later of the dates set forth below the signatures of the
parties on the signature page hereof.
(f)
Entire Agreement; Benefit.
This
Agreement, including the Annexes, Schedules and Exhibits hereto, constitutes the
entire agreement between the parties hereto with respect to the subject matter
hereof. There are no restrictions, promises, warranties, or undertakings, other
than those set forth or referred to herein and in the Annexes and Exhibits. This
Agreement, including the Annexes and Exhibits, supersedes all prior agreements
and understandings, whether written or oral, between the parties hereto with
respect to the subject matter hereof. This Agreement and the terms and
provisions hereof are for the sole benefit of only the Company, the Buyer and
their respective successors and permitted assigns.
(g)
Waiver.
Failure
of any party to exercise any right or remedy under this Agreement or otherwise,
or delay by a party in exercising such right or remedy, or any course of dealing
between the parties, shall not operate as a waiver thereof or an amendment
hereof, nor shall any single or partial exercise of any such right or power, or
any abandonment or discontinuance of steps to enforce such a right or power,
preclude any other or further exercise thereof or exercise of any other right or
power.
(h)
Amendment.
(1) No
amendment, modification, waiver, discharge or termination of any provision of
this Agreement on or prior to the Closing Date nor consent to any departure by
the Buyer or the Company therefrom on or prior to the Closing Date shall in any
event be effective unless the same shall be in writing and signed by the party
to be charged with enforcement, and in any such case shall be effective only in
the specific instance and for the purpose for which given.
(2)
No
amendment, modification, waiver, discharge or termination of any provision of
this Agreement after the Closing Date nor consent to any departure by the
Company therefrom after the Closing Date shall in any event be effective unless
the same shall be in writing and signed (x) by the Company, if the Company is to
be charged with enforcement or (y) by the Majority Holders, if the Buyer is to
be charged with enforcement, and in any such case shall be effective only in the
specific instance and for the purpose for which given but shall nonethless bind
the Buyer and its transferees, successors and assigns;
provided, however
, that no
such amendment modification, waiver, discharge or termination which (i)
increases the Buyers liability, (ii) amends this Section 10(h) or (iii)
adversely affects the Buyers rights under Sections 5(a), 5(b), 5(c), 5(d), 5(e),
5(f), 5(j), 5(k), 5(l), 5(m), 8(a), 8(b) and 9, shall be effective unless in
writing signed by the Buyer.
(3)
No course
of dealing between the parties hereto shall operate as an amendment of this
Agreement.
(i)
Further Assurances.
Each
party to this Agreement will perform any and all acts and execute any and all
documents as may be necessary and proper under the circumstances in order to
accomplish the intents and purposes of this Agreement and to carry out its
provisions.
(j)
Assignment of Certain Rights and
Obligations.
The
rights of an Investor under Sections 5(a), 5(b), 8, 9, and 10 of this Agreement
shall be automatically assigned by such Investor to any transferee of all or any
portion of such Investors Registrable Securities (or all or any portion of the
Note or the Warrant) if: (1) such Investor agrees in writing with such
transferee to assign such rights, and a copy of such agreement is furnished to
the Company within a reasonable time after such assignment, (2) the Company is,
within a
reasonable
time after such transfer, furnished with notice of (A) the name and address of
such transferee and (B) the securities with respect to which such rights and
obligations are
being
transferred, (3) in the case of assignment of rights under Section
8, immediately following such transfer or assignment the further
disposition of Registrable Securities by the
transferee
or assignee is restricted under the 1933 Act and applicable state securities
laws, (4) at or before the time the Company received the notice contemplated by
clause (2) of this sentence the transferee agrees in writing with the Company to
be bound with respect to such assigned securities by such of the provisions
contained in Sections 5(a), 5(b), 8, 9, and 10 hereof as shall have been so
assigned to such transferee and (5) if Section 5(a) shall be applicable to such
transfer, such Investor shall have complied with Section 5(a). Upon any such
transfer, the Company shall be obligated to such transferee to perform all of
its covenants under Sections 5(a), 5(b), 8, 9, and 10 of this Agreement, to the
extent the same have been so assigned to such transferee, as if such transferee
were the Buyer. In connection with any such transfer the Company shall, at its
sole cost and expense, promptly after such transfer take such actions as shall
be reasonably acceptable to the transferring Investor and such transferee to
assure that each Registration Statement and related Prospectus for which the
transferring Investor is a selling stockholder are or become available for use
by such transferee for sales of the Registrable Securities in respect of which
such rights and obligations have been so transferred.
(k)
Expenses.
The
Company shall be responsible for its expenses (including, without limitation,
the legal fees and expenses of its counsel), incurred by it in connection with
the negotiation and execution of, and closing under, and performance of, this
Agreement. Whether or not the closing occurs, the Company shall be obligated to
pay or reimburse the legal fees and expenses and out-of-pocket due diligence
expenses of Alexandra Global Master Fund Ltd., not in excess of $40,000, in
connection with the negotiation and execution of, and closing under, this
Agreement. All expenses incurred in connection with registrations, filings or
qualifications pursuant to Sections 5(d), 5(e), 5(g)
and 8 of
this Agreement shall be paid by the Company, including, without limitation, all
registration, listing and qualifications fees, printers and accounting fees and
the fees and disbursements of counsel for the Company but excluding (a) fees and
expenses of investment bankers or other advisors retained by any Investor and
(b) brokerage commissions incurred by any Investor. The Company shall pay
promptly upon demand all expenses incurred by the Buyer after the Closing Date,
including reasonable attorneys fees and expenses, as a consequence of, or in
connection with (1) the negotiation, preparation or execution of any amendment,
modification or waiver of any of the Transaction Documents, (2) any default or
breach of any of the Companys representations, warranties, covenants or
obligations set forth in any of the Transaction Documents, and (3) the
enforcement or restructuring of any right of, including the collection of any
payments due, the Buyer under any of the Transaction Documents, including,
without limitation, any action or proceeding relating to such enforcement or any
order, injunction or other process seeking to restrain the Company from paying
any amount due the Buyer. Except as otherwise provided in Section 9 and this
Section 10(k), each of the Company and the Buyer shall bear its own expenses in
connection with this Agreement and the transactions contemplated hereby.
(l)
Termination.
(1) The
Buyer shall have the right to terminate this Agreement by giving notice to the
Company at any time at or prior to the Closing Date if:
(A)
the
Company shall have failed, refused, or been unable at or prior to the date of
such termination of this Agreement to perform any of its obligations hereunder
required to be performed prior to the time of such termination;
(B)
any
condition to the Buyers obligations hereunder is not fulfilled at or prior to
the time such condition is required to be satisfied; or
(C)
the
closing shall not have occurred on a Closing Date on or before July 21, 2006,
other than solely by reason of a breach of this Agreement by the
Buyer.
Any such
termination shall be effective upon the giving of notice thereof by the Buyer.
Upon such termination, the Buyer shall have no further obligation to the Company
hereunder and the Company shall remain liable for any breach of this Agreement
or the other documents contemplated hereby which occurred on or prior to the
date of such termination.
(2)
The
Company shall have the right to terminate this Agreement by giving notice to the
Buyer at any times at or prior to the Closing Date if the closing shall not have
occurred on a Closing Date on or before July 21, 2006, other than solely by
reason of a breach of this Agreement by the Company, so long as the Company is
not in breach of this Agreement at the time it gives such notice. Any such
termination shall be effective upon the giving of notice thereof by the Company.
Upon such termination, neither the Company nor the Buyer shall have any further
obligation to one another hereunder, except for the Companys liability for the
Buyers expenses as provided in Section 10(k).
(m)
Survival.
T
he
respective representations, warranties, covenants and agreements of the Company
and the Buyer contained in this Agreement and the documents delivered in
connection with this Agreement shall survive the execution and delivery of this
Agreement and the other Transaction Documents and the closing hereunder and
delivery of and payment for the Note and the issuance of the Warrant, and shall
remain in full force and effect regardless of any investigation made by or on
behalf of the Buyer or any Person controlling or acting on behalf of the Buyer
or by the Company or any Person controlling or acting on behalf of the
Company.
(n)
Construction; Buyer Status.
The
language used in this Agreement will be deemed to be the language chosen by the
parties to express their mutual intent, and no rules of strict construction will
be applied against any party. The Buyer is not acting as part of a group (as
that term is used in Section 13(d) of the 1934 Act) with any other Person who is
or proposes to become a party to any Other Note Purchase Agreement, or who is
acquiring or holds any Other Note or Other Warrant, in negotiating and entering
into this Agreement or purchasing the Note and the Warrant or acquiring,
disposing of or voting any of the Shares. The Company hereby confirms that it
understands and agrees that the Buyer is not acting as part of any such group.
If the Buyer is other than AGMF, such Buyer acknowledges and agrees that such
Buyer is not relying on AGMF or AGMFs legal counsel in making a decision to
enter into this Agreement, purchase the Note, acquire the Warrant or otherwise
in connection with the Transaction Documents, and such legal counsel are not
acting as the Buyers legal counsel in connection therewith.
[Signature pages
follow]
I
N WITNESS WHEREOF
, the
parties hereto have caused this Agreement to be duly executed by their
respective officers or other representatives thereunto duly authorized on the
respective dates set forth below their signatures hereto.
Purchase
Price: $
Principal
Amount of Note: $
Initial
Conversion Price of Note: $0.26
Warrant
Shares Initially
Issuable
Upon Exercise of Warrant:
Initial
Exercise Price of Warrant: $0.36
|
|
|
|
EMAGIN
CORPORATION
|
|
|
|
Date: July 21,
2006
|
By:
|
/s/ Gary W.
Jones
|
|
Gary W. Jones
|
|
Chief Executive
Officer
|
With a
copy to:
|
|
|
|
Sichenzia Ross
Friedman Ference LLP
1065
Avenue of the Americas, 21
st
Floor
New
York, New York 10018
Attention:
Richard A. Friedman, Esq.
Facsimile
No: (212) 930-9725
|
|
THE BUYER:
[NAME]
|
|
By:
|
[NAME],
|
|
its Investment
Advisor
|
|
|
|
|
|
|
|
|
|
|
|
By:
|
|
|
Name:
|
|
Title
Date:
July 21, 2006
|
Address
for Notices:
eMagin
Corporation
Selling Securityholder
Questionnaire
The
undersigned beneficial owner (the Selling Securityholder) of Common Stock, par
value $.001 per share, of eMagin Corporation, a Delaware corporation (the
Company), understands that the Company intends to file with the Securities and
Exchange Commission (the SEC) a registration statement (the Registration
Statement) for registration of the resale under the Securities Act of 1933, as
amended (the Securities Act), of such securities (the Registrable Securities).
This Questionnaire is delivered pursuant to the terms of the Note Purchase
Agreement, dated as of July 21,
2006 (the
Purchase Agreement), between the Company and the Buyer named therein. All
capitalized terms not otherwise defined herein shall have the meanings ascribed
thereto in the Purchase Agreement.
Certain
legal consequences arise from being named as a selling securityholder in the
Registration Statement and the related prospectus. Accordingly, the Selling
Securityholder is advised to consult its own securities law counsel regarding
the consequences of being named or not being named as a selling securityholder
in the Registration Statement and the related prospectus.
The
Selling Securityholder hereby provides the following information to the Company
in connection with the Companys preparation of the Registration
Statement:
1.
Name.
|
(a)
|
Full
Legal Name of Selling
Securityholder
|
|
(b)
|
Full
Legal Name of Registered Holder (if not the same as (a) above) through
which Registrable Securities listed in Item 3 below are
held:
|
|
(c)
|
Full
Legal Name of the natural person who directly or indirectly has power to
vote or dispose of the Registrable Securities listed in Item 3
below:
|
2.
Address for Notices to Selling
Securityholder:
Complete
the following only if the Selling Securityholder wishes to receive notices
relating to the Registration at a different address or to a different person
than the current notice address for purposes of the Purchase
Agreement.
Telephone: ________________________________________________
Fax:
______________________________________________________
Contact
Person: _____________________________________________
3.
Beneficial Ownership of Registrable
Securities:
|
(a)
|
Number
of Registrable Securities (all of which are shares of Common Stock)
beneficially owned:
|
4.
Broker-Dealer
Status:
|
(a)
|
Are
you a broker-dealer?
|
Yes
__
No
__
|
Note:
|
If
yes, the SEC staff has indicated that you should be identified as an
underwriter in the Registration
Statement.
|
|
(b)
|
Are
you an affiliate of a
broker-dealer?
|
Yes
__
No
__
|
(c)
|
If
you are an affiliate of a broker-dealer, do you certify that you bought
the Registrable Securities in the ordinary course of business, and at the
time of the purchase of the Registrable Securities to be resold, you had
no agreements or understandings, directly or indirectly, with any person
to distribute the Registrable
Securities?
|
Yes
__
No
__
|
Note:
|
If
no, the SEC staff has indicated that you should be identified as an
underwriter in the Registration
Statement.
|
5.
|
Other Beneficial Ownership of
Common Stock by the Selling
Securityholder.
|
Except as set forth below in this
Item 5, the Selling Securityholder is not the beneficial or registered owner of
any shares of Common Stock of the Company other than the Registrable Securities
listed above in Item 3.
|
(a)
|
Number
of other shares of Common Stock held of record or beneficially owned by
the Selling Securityholder:
|
6.
Relationships with the
Company:
Except for the Purchase Agreement
and transactions related thereto and except as set forth below, the Selling
Securityholder has not held any position or office or had any other material
relationship with the Company (or its predecessors or affiliates) during the
past three years.
State any
exceptions here:
The
Selling Securityholders obligations with respect to the information it provides
in response to this Questionnaire are set forth in Section 8(c) of the Purchase
Agreement.
IN
WITNESS WHEREOF the undersigned, by authority duly given, has caused this
Questionnaire to be executed and delivered either in person or by its duly
authorized agent.
Dated:________________________________
|
Beneficial
Owner:_________________________________
|
|
By:____________________________________________
|
|
Name:
|
|
Title:
|
|
|
PLEASE FAX OR E-MAIL THE
COMPLETED
AND EXECUTED QUESTIONNAIRE
TO:
Sichenzia
Ross Friedman Ference LLP
1065
Avenue of the Americas, 21
st
Floor
New York,
New York 10018
Attention:
Richard A. Friedman, Esq.
e-Mail
address: rfriedman@srff.com
Annex 1
NEITHER THIS NOTE NOR THE SECURITIES
INTO WHICH THIS NOTE IS CONVERTIBLE HAVE REGISTERED UNDER THE SECURITIES ACT OF
1933, AS AMENDED (THE “1933 ACT”), AND, ACCORDINGLY, MAY NOT BE, NOR MAY ANY
INTEREST THEREIN BE, OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE
REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE
EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION
REQUIREMENTS OF THE 1933 ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES
LAWS AS EVIDENCED BY, SUBJECT TO CERTAIN EXCEPTIONS, A LEGAL OPINION OF COUNSEL
TO THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY
ACCEPTABLE TO THE COMPANY. THESE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A
BONA FIDE MARGIN ACCOUNT SECURED BY SUCH SECURITIES.
THIS NOTE DOES NOT REQUIRE PHYSICAL
SURRENDER OF THIS NOTE IN THE EVENT OF A PARTIAL CONVERSION. AS A RESULT,
FOLLOWING ANY CONVERSION OF ANY PORTION OF THIS NOTE, THE OUTSTANDING PRINCIPAL
AMOUNT REPRESENTED BY THIS NOTE MAY BE LESS THAN THE PRINCIPAL AMOUNT SET FORTH
BELOW.
EMAGIN
CORPORATION
6% SENIOR SECURED CONVERTIBLE NOTE
DUE 2007-2008
No.
$
New York,
New York
July
21, 2006
FOR VALUE RECEIVED
,
EMAGIN
CORPORATION
,
a
Delaware
corporation (hereinafter called the “Company”), hereby promises to pay to
[NAME]
,
[ADDRESS]
, or
registered assigns (the “Holder”), or order, the sum of
Dollars
($
), in
installments on the Installment Maturity Date and on the Final Maturity Date,
and to pay interest on the unpaid principal balance hereof at the Applicable
Rate from the date hereof, until the same becomes due and payable, whether at
maturity or upon acceleration or by redemption or repurchase in accordance with
the terms hereof or otherwise. Any amount, including, without limitation,
principal of or interest on this Note, the Optional Redemption Price and the
Repurchase Price, that is payable under this Note that is not paid when due
shall bear interest at the Default Rate from the due date thereof until the same
is paid (“Default Interest”). Regular interest shall be payable in arrears on
each Interest Payment Date, commencing on September 1, 2006, on the principal
amount outstanding on such date. Regular interest on this Note shall be computed
on the basis of a 360-day year of 12 30-day months and actual days elapsed. No
regular interest shall be payable on an Interest Payment Date on any portion of
the principal amount of this Note which shall have been redeemed prior to such
Interest Payment Date so long as the Company shall have complied in full with
its obligations with respect to such redemption.
All
payments of principal of and premium, if any, interest, and other amounts on
this Note shall be made in lawful money of the United States of America.
All payments shall be made by wire transfer of immediately available funds to
such account as the Holder may from time to time designate by written notice in
accordance with the provisions of this Note. Whenever any amount expressed to be
due by the terms of this Note is due on any day which is not a Business Day, the
same shall instead be due on the next succeeding day which is a Business Day
and, in the case of any Interest Payment Date which is not the date on which
this Note is paid in full, the extension of the due date thereof shall not be
taken into account for purposes of determining the amount of interest due on
such date. Certain capitalized terms used in this Note are defined in Article
I.
The
obligations of the Company under this Note shall rank in right of payment on a
parity with all other unsubordinated obligations of the Company for indebtedness
for borrowed money or the purchase price of property. This Note is issued
pursuant to the Note Purchase Agreement and the Holder and this Note are subject
to the terms and entitled to the benefits of the Note Purchase Agreement. This
Note is entitled to the benefits of the Security Agreements and the Lockbox
Agreement.
This Note
is one of a duly authorized issue of the Company’s 6% Senior Secured Convertible
Notes due 2007-2008 limited to an aggregate principal amount of $7,000,000.00
(excluding 6% Senior Secured Convertible Notes due 2007-2008 issued in
replacement of lost, stolen, destroyed or mutilated notes or issued on transfer
of such notes).
The
following terms shall apply to this Note:
ARTICLE I
DEFINITIONS
1.1
Certain Defined
Terms.
(a) All
the agreements or instruments herein defined shall mean such agreements or
instruments as the same may from time to time be supplemented or amended or the
terms thereof waived or modified to the extent permitted by, and in accordance
with, the terms thereof and of this Note.
(b)
The
following terms shall have the following meanings (such meanings to be equally
applicable to both the singular and plural forms of the terms
defined):
“Accredited
Investor” means an “accredited investor” as that term is defined in Rule 501 of
Regulation D under the 1933 Act.
“Affiliate”
means, with respect to any Person, any other Person that directly, or indirectly
through one or more intermediaries, controls, is controlled by or is under
common control with the subject Person. For purposes of this definition,
“control” (including, with correlative meaning, the terms “controlled by” and
“under common control with”), as used with respect to any Person, shall mean the
possession, directly or indirectly, of the power to direct or cause the
direction of the management and policies of such Person, whether through the
ownership of voting securities or by contract or otherwise.
“Aggregation
Parties” shall have the meaning provided in Section 6.7(a).
“Alexandra”
means Alexandra Global Master Fund Ltd., a British Virgin Islands international
business company.
“AMEX”
means the American Stock Exchange, Inc.
“Applicable
Rate” means 6 percent per annum; provided,
however
, that if
an Event of Default shall have occurred, then the Applicable Rate shall be
increased to 12 percent per annum during the period from the date of such Event
of Default until the date no Event of Default is continuing (or such lesser rate
as shall be the highest rate permitted by applicable law).
“Average
Daily Trading Volume Threshold” means, with respect to any period, that the
average daily trading volume of the Common Stock during such period as reported
by Bloomberg, L.P. (or if such source ceases to be available, a comparable
source selected by the Holder and acceptable to the Company in its reasonable
judgment) shall be at least 500,000 shares (such amount to be subject to
equitable adjustment for stock splits, stock dividends and similar events
relating to the Common Stock that are reflected in the trading market for the
Common Stock on or before the last Trading Day in such period).
“Board of
Directors” means the Board of Directors of the Company.
“Board
Resolution”
means a
copy of a resolution certified by the Secretary or an Assistant Secretary of the
Company to have been duly adopted by the Board of Directors, or duly authorized
committee thereof (to the extent permitted by applicable law), and to be in full
force and effect on the date of such certification, and delivered to the
Holder.
“Business
Day” means any day other than a Saturday, Sunday or a day on which commercial
banks in The City of New York are authorized or required by law or executive
order to remain closed.
"Cash and
Cash Equivalents Balances" of any Person on any date shall be determined on an
unconsolidated basis from such Person's books maintained in accordance with
Generally Accepted Accounting Principles, and means, without duplication, the
sum of (1) the cash held by such Person on such date and available for use by
such Person on such date, (2) all assets which would, on a balance sheet of such
Person prepared as of such date in accordance with Generally Accepted Accounting
Principles, be classified as cash equivalents;
provided,
however,
that (x)
for purposes of computing the Cash and Cash Equivalents Balances as of any date,
no amount shall be included as cash or a cash equivalent if such amount is
subject to any lien, charge, equity or encumbrance in favor of any other Person
or is subject to any agreement, arrangement or understanding by the Company with
any other Person to maintain the amount thereof or which restricts the use
thereof by the Company (in any such case, other than as provided in Section 3.9
of this Note and the Other Notes and other than the lien and security interest
in favor of the Collateral Agent arising under the Security Agreement) (y) cash
and cash equivalents described in the preceding clauses (1) and (2) that are
held at any time as Collateral under the Security Agreement and in which the
Collateral Agent has a perfected first priority security interest and which
are not subject to any lien, charge, equity or encumbrance in favor of any other
Person shall be included in determining the amount of Cash and Cash Equivalents
Balances at such time.
“Collateral”
shall have the meaning provided in the Security Agreements or in either of
them.
“Collateral
Agent” means Alexandra, as collateral agent under the Security Agreements, or
its successors.
“Common
Stock” means the Common Stock, par value $.001 per share, or any shares of
capital stock of the Company into which such shares shall be changed or
reclassified after the Issuance Date.
“Common
Stock Equivalent” means any warrant, option, subscription or purchase right with
respect to shares of Common Stock, any security convertible into, exchangeable
for, or otherwise entitling the holder thereof to acquire, shares of Common
Stock or any warrant, option, subscription or purchase right with respect to any
such convertible, exchangeable or other security.
“Company”
shall have the meaning provided in the first paragraph of this
Note.
“Company
Certificate” means a certificate of the Company signed by an
Officer.
“Company
Notice” means a Company Notice in the form attached hereto as
Exhibit A
.
“Computed
Market Price”
shall
mean the arithmetic average of the daily VWAPs for each of the three Trading
Days immediately preceding the applicable Measurement Date (such VWAPs being
appropriately and equitably adjusted for any stock splits, stock dividends,
recapitalizations and the like occurring or for which the record date occurs
during such three Trading Days).
“Conversion
Date” means the date on which a Conversion Notice is given in accordance with
Section 6.2(a).
“Conversion
Notice”
means a
duly executed Notice of Conversion of 6% Senior Secured Convertible Note Due
2007-2008 substantially in the form of
Exhibit C
to this
Note.
“Conversion
Price”
means
$0.26, subject to adjustment as provided in Section 6.3.
“Current
Fair Market Value” when used with respect to the Common Stock as of a specified
date means with respect to each share of Common Stock the average of the closing
prices of the Common Stock sold on all securities exchanges (including the NYSE,
the AMEX, the Nasdaq and the Nasdaq Capital Market) on which the Common Stock
may at the time be listed, or, if there have been no sales on any such exchange
on such day, the average of the highest bid and lowest asked prices on all such
exchanges at the end of regular trading such day,
or, if on
such day the Common Stock is not so listed, the average of
the representative bid and asked prices quoted in the NASDAQ
System as of 4:00 p.m.,
New York City time, or, if on such day the Common Stock is not quoted in
the NASDAQ System, the average of the highest bid and lowest asked price on such
day in the domestic over-the-counter market as reported by the Pink Sheets, LLC,
or any similar successor organization, in each such case averaged over a period
of five Trading Days consisting of the day as of which the Current Fair Market
Value of Common Stock is being determined (or if such day is not a Trading Day,
the Trading Day next preceding such day) and the four consecutive Trading Days
prior to such day. If on the date for which Current Fair Market Value is to be
determined the Common Stock is not listed on any securities exchange or quoted
in the NASDAQ System or the over-the-counter market, the Current Fair Market
Value of Common Stock shall be the greater of (i) the highest price per share of
Common Stock at which the Company has sold shares of Common Stock or Common
Stock Equivalents during the 365 days prior to the date of such determination
and (ii) the highest price per share which the Company could then obtain from a
willing buyer (not an employee or director of the Company at the time of
determination) for shares of Common Stock sold by the Company, from authorized
but unissued shares, as determined in good faith by the Board of
Directors.
“Current
Market Price”
shall
mean the arithmetic average of the daily Market Prices per share of Common Stock
for the five consecutive Trading Days immediately prior to the date in question;
provided, however,
that (1)
if the “ex” date (as hereinafter defined) for any event (other than the issuance
or distribution requiring such computation) that requires an adjustment to the
Conversion Price pursuant to Section 6.3(a), (b), (c), (d) or (e), occurs during
such five consecutive Trading Days, the Market Price for each Trading Day prior
to the “ex” date for such other event shall be adjusted by multiplying such
Market Price by the same fraction by which the Conversion Price is so required
to be adjusted as a result of such other event, (2) if the “ex” date for any
event (other than the issuance or distribution requiring such computation) that
requires an adjustment to the Conversion Price pursuant to Section 6.3(a), (b),
(c), (d) or (e), occurs on or after the “ex” date for the issuance or
distribution requiring such computation and prior to the day in question, the
Market Price for each Trading Day on and after the “ex” date for such other
event shall be adjusted by multiplying such Market Price by the reciprocal of
the fraction by which the Conversion Price is so required to be adjusted as a
result of such other event, and (3) if the “ex” date for the issuance or
distribution requiring such computation is prior to the day in question, after
taking into account any adjustment required pursuant to clause (1) or (2) of
this proviso, the Market Price for each Trading Day on or after such “ex” date
shall be adjusted by adding thereto the amount of any cash and the fair market
value (as determined by the Board of Directors in a manner consistent with any
determination of such value for purposes of Section 6.3(d), whose determination
shall be conclusive and described in a Board Resolution) of the evidences of
indebtedness, shares of capital stock or assets being distributed applicable to
one share of Common Stock as of the close of business on the day before such
“ex” date. Notwithstanding the foregoing, whenever successive adjustments to the
Conversion Price are called for pursuant to Section 6.3, such adjustments shall
be made to the Current Market Price as may be necessary or appropriate to
effectuate the intent of Section 6.3 and to avoid unjust or inequitable results
as determined in good faith by the Board of Directors.
“Default
Interest” shall have the meaning provided in the first paragraph of this
Note.
“Default
Rate” means 12 percent per annum (or such lesser rate equal to the highest rate
permitted by applicable law).
“Designated
Person” means any of Mr. John Atherly, Mr. Gary Jones and Ms. Susan
Jones.
“DTC”
shall have the meaning provided in Section 6.2(b).
“EBITDA”
for any period shall mean the consolidated net income before taxes of the
Company and its Subsidiaries, as shown on its consolidated financial statements
filed with the SEC for such period and prepared in accordance with Generally
Accepted Accounting Principles, on a basis consistent with the Company’s audited
consolidated financial statements most recently filed with the SEC prior to the
Issuance Date, increased by the amount of depreciation, amortization and
interest expenses charged in computing such consolidated net income for such
period.
“EBITDA
Positive Quarter” means a fiscal quarter of the Company during which its EBITDA
is greater than zero, as shown in the Company’s Quarterly Report on Form 10-Q
filed with the SEC, in the case of the first three fiscal quarters of any fiscal
year, or as shown in the Company’s Annual Report on Form 10-K, in the case of
the fourth fiscal quarter of any fiscal year. In the case of the fourth fiscal
quarter of any year, an EBITDA Positive Quarter may be shown by the quarterly
financial data shown in the notes to the Company’s audited financial statements
included in the Company’s Annual Report on Form 10-K for such fiscal year, if
such information is presented in sufficient detail to make such calculation, or
by subtracting the EBITDA for the first three fiscal quarters of such fiscal
year from the EBITDA for such fiscal year.
“Eligible
Bank” means a corporation organized or existing under the laws of the United
States or any other state, having combined capital and surplus of at least $100
million and subject to supervision by federal or state authority and which has a
branch located in New York, New York.
“Event of
Default” shall have the meaning provided in Section 4.1.
“Excluded
Shares” shall have the meaning provided in Section 6.7.
“Extended
Optional Redemption Date” means with respect to any portion of this Note to
which Section 2.1(e) applies, the date that is 30 Trading Days, after the latest
date on which the Restricted Ownership Percentage no longer restricts the
Holder’s right to convert the remaining Uncovered Portion, but in no event later
than the Final Maturity Date.
“FAST”
shall have the meaning provided in Section 6.2(b)
“Final
Maturity Date” means January 21, 2008.
“Fundamental
Change” means
(a)
Any
consolidation or merger of the Company or any Subsidiary with or into another
entity (other than a merger or consolidation of a Subsidiary into the Company or
a wholly-owned Subsidiary in connection with which no change in outstanding
Common Stock occurs) where the stockholders of the Company immediately prior to
such transaction do not collectively own at least 51% of the outstanding voting
securities of the surviving corporation of such consolidation or merger
immediately following such transaction; or the sale of all or substantially all
of the assets of the Company and the Subsidiaries in a single transaction or a
series of related transactions; or
(b)
The
occurrence of any transaction or event in connection with which all or
substantially all the Common Stock shall be exchanged for, converted into,
acquired for or constitute the right to receive consideration (whether by means
of an exchange offer, liquidation, tender offer, consolidation, merger,
combination, reclassification, recapitalization or otherwise) which is not all
or substantially all common stock which is (or, upon consummation of or
immediately following such transaction or event, will be) listed on a national
securities exchange or approved for quotation on Nasdaq or any similar United
States system of automated dissemination of transaction reporting of securities
prices; or
(c)
The
acquisition by a Person or entity or group of Persons or entities acting in
concert as a partnership, limited partnership, syndicate or group, as a result
of a tender or exchange offer, open market purchases, privately negotiated
purchases or otherwise, of beneficial ownership of securities of the Company
representing 50% or more of the combined voting power of the outstanding voting
securities of the Company ordinarily (and apart from rights accruing in special
circumstances) having the right to vote in the election of
directors.
“Generally
Accepted Accounting Principles” for any Person means the generally accepted
accounting principles and practices applied by such Person from time to time in
the preparation of its audited financial statements.
“Holder”
shall have the meaning provided in the first paragraph of this
Note.
“Holder
Notice” means a Holder Notice in the form attached hereto as
Exhibit B
.
“Indebtedness”
means, when used with respect to any Person, without duplication:
(1)
all
indebtedness, obligations and other liabilities (contingent or otherwise) of
such Person for borrowed money (including obligations of such Person in respect
of overdrafts, foreign exchange contracts, currency exchange agreements,
currency purchase or similar agreements, Interest Rate Protection Agreements,
and any loans or advances from banks, whether or not evidenced by notes or
similar instruments) or evidenced by bonds, debentures, notes or other
instruments for the payment of money, or incurred in connection with the
acquisition of any property, services or assets (whether or not the recourse of
the lender is to the whole of the assets of such Person or to only a portion
thereof), other than any account payable or other accrued current liability or
obligation to trade creditors incurred in the ordinary course of business in
connection with the obtaining of materials or services;
(2)
all
reimbursement obligations and other liabilities (contingent or otherwise) of
such Person with respect to letters of credit, bank guarantees, bankers’
acceptances, surety bonds, performance bonds or other guaranty of contractual
performance;
(3)
all
obligations and liabilities (contingent or otherwise) in respect of (a) leases
of such Person required, in conformity with Generally Accepted Accounting
Principles, to be accounted for as capitalized lease obligations on the balance
sheet of such Person and (b) any lease or related documents (including a
purchase agreement) in connection with the lease of real property which provides
that such Person is contractually obligated to purchase or cause a third party
to purchase the leased property and thereby guarantee a minimum residual value
of the leased property to the landlord and the obligations of such Person under
such lease or related document to purchase or to cause a third party to purchase
the leased property;
(4)
all
direct or indirect guaranties or similar agreements by such Person in respect
of, and obligations or liabilities (contingent or otherwise) of such Person to
purchase or otherwise acquire or otherwise assure a creditor against loss in
respect of, indebtedness, obligations or liabilities of another Person of the
kind described in clauses (1) through (3);
(5)
any
indebtedness or other obligations described in clauses (1) through (4) secured
by any mortgage, pledge, lien or other encumbrance existing on property which is
owned or held by such Person, regardless of whether the indebtedness or other
obligation secured thereby shall be payable by or shall have been assumed by
such Person; and
(6)
any and
all deferrals, renewals, extensions and refundings of, or amendments,
modifications or supplements to, any indebtedness, obligation or liability of
the kind described in clauses (1) through (5).
“Installment
Maturity Date” means July 21, 2007.
“Interest
Payment Dates” means each March 1, June 1, September 1 and December 1 and the
Final Maturity Date.
“Interest
Rate Protection Agreement” means, with respect to any Person, any interest rate
swap agreement, interest rate cap or collar agreement or other financial
agreement or arrangement designed to protect such Person against fluctuations in
interest rates, as in effect from time to time.
“Issuance
Date” means July 21, 2006.
“Lien”
means any mortgage, lien, pledge, security interest or other charge or
encumbrance, including, without limitation, the lien or retained security title
of a conditional vendor.
“Lockbox
Agent” means the Person serving from time to time as Lockbox Agent under the
Lockbox Agreement.
“Lockbox
Agreement” means that certain Lockbox Agreement, dated as of July 21, 2006, by
and between the Company, the Lockbox Agent and the Collateral
Agent.
“Majority
Holders” means, at any time, the holders of a majority
of the
aggregate principal amount of this Note and the Other Notes outstanding at such
time.
“Market
Price”
with
respect to any security on any day shall mean the closing bid price of such
security on such day on the Nasdaq, the Nasdaq Capital Market, the NYSE or the
AMEX, as applicable, or, if such security is not listed or admitted to trading
on the Nasdaq, the Nasdaq Capital Market, the NYSE or the AMEX, on the principal
national securities exchange or quotation system on which such security is
quoted or listed or admitted to trading, in any such case as reported by
Bloomberg, L.P. (or if such source ceases to be available, comparable source
selected by the Holder and acceptable to the Company in its reasonable judgment)
or, if not quoted or listed or admitted to trading on any national securities
exchange or quotation system, the average of the closing bid and asked prices of
such security on the over-the-counter market on the day in question, as reported
by Pink Sheets, LLC, or a similar generally accepted reporting service, or if
not so available, in such manner as furnished by any NYSE member firm selected
from time to time by the Board of Directors for that purpose, or a price
determined in good faith by the Board of Directors, whose determination shall be
conclusive and described in a Board Resolution.
“Measurement
Date” for any sale, transfer or disposition (but not including the cancellation
or expiration) of Common Stock or Common Stock Equivalents by a Designated
Person means the date that is three Trading Days after the earlier of (i) the
date such Designated Person files a Form 4 with the SEC with respect to such
sale, transfer or disposition and (ii) the date such Designated Person is
required to file a Form 4 with the SEC with respect to such sale, transfer or
disposition;
provided,
however,
that if
such Designated Person is not required, or is no longer required, to file a Form
4 with respect to such sale, transfer or disposition, the Measurement Date shall
be the date that is five Trading Days after the date of such sale, transfer or
disposition.
“Nasdaq”
means the Nasdaq Global Market.
“1934
Act” means the Securities Exchange Act of 1934, as amended.
“1933
Act” means the Securities Act of 1933, as amended.
“Note”
means this instrument as originally executed, or if later amended or
supplemented in accordance with its terms, then as so amended or supplemented.
“Note
Purchase Agreement” means the Note Purchase Agreement, dated as of July 21,
2006, by and between the Company and the original Holder of this Note or its
predecessor instrument.
“NYSE”
means the New York Stock Exchange, Inc.
“Officer”
means the Chairman of the Board, the Chief Executive Officer, the President or
the Chief Financial Officer of the Company.
“Optional
Redemption Date” means the Business Day on which this Note is to be redeemed
pursuant to Section 2.1.
“Optional
Redemption Notice” means an Optional Redemption Notice in the form attached
hereto as
Exhibit D
.
“Optional
Redemption Period” means the period which commences on the date that is ten days
after the SEC Effective Date and ends on the Final Maturity Date.
“Optional
Redemption Price” means an amount in cash equal to the sum of (1) 100% of the
outstanding principal amount of this Note
plus
(2)
accrued and unpaid interest on such principal amount to the Optional Redemption
Date
plus
(3)
accrued and unpaid Default Interest, if any, on the amount referred to in the
immediately preceding clause (2) at the rate provided in this Note to the
Optional Redemption Date
plus
(4) an
amount equal to the interest that would have accrued on this Note from the
Optional Redemption Date until the Final Maturity Date (assuming, in case the
Optional Redemption Date is prior to the Installment Maturity Date, the Company
paid when due the installment of principal due on the Installment Maturity Date)
had this Note not been redeemed on the Optional Redemption Date.
“Other
Note Purchase Agreements” means the several Note Purchase Agreements, dated as
of July 21, 2006, by and between the Company and the respective original holders
of the Other Notes.
“Other
Notes” means the several 6% Senior Secured Convertible Notes due 2007-2008,
issued by the Company pursuant to the Other Note Purchase
Agreements.
“Other
Warrants” means the Common Stock Purchase Warrants issued by the Company to the
original holders of the Other Notes or their respective predecessor
instruments.
“Patent
and Trademark Security Agreement” means the Patent and Trademark Security
Agreement, dated as of July 21, 2006, by and between the Company and the
Collateral Agent.
“Pledge
and Security Agreement” means the Pledge and Security Agreement, dated as of
July 21, 2006, by and between the Company and the Collateral Agent.
“Permitted
Designated Person Sale” means a sale by John Atherly, occurring on or after
January 1, 2007, of shares of Common Stock in an amount not to exceed 50,000
shares in the aggregate in any fiscal quarter of the Company (such number of
shares subject to equitable adjustments for stock splits, stock dividends,
combinations, capital reorganizations and similar events relating to the Common
Stock occurring after the Issuance Date).
“Permitted
Indebtedness” means
(1)
Indebtedness
outstanding on the Issuance Date prior to issuance of this Note and reflected in
the Company’s financial statements included in the SEC Reports;
(2)
Indebtedness
evidenced by this Note and the Other Notes;
(3)
Indebtedness
outstanding on, or incurred after, the Issuance Date in an aggregate amount not
to exceed $2,500,000 at any one time outstanding so long as (A) such
Indebtedness (x) is incurred for the purpose of acquiring equipment owned or
used or to be owned or used by the Company or any Subsidiary (or for the purpose
of acquiring the capital stock or similar equity interests of a Subsidiary that
is formed for the limited purpose of owning same and does not own or hold any
other material assets) and does not exceed the purchase price of the equipment,
capital stock or other equity interest so acquired plus reasonable transaction
expenses and (y) if secured, is secured solely by the interest of the Company or
one of its Subsidiaries in the equipment so acquired and rights related thereto
or (B) is the reimbursement obligations and other liabilities (contingent or
otherwise) of the Company or any Subsidiary with respect to letters of credit
issued in lieu of cash security deposits for leases of real property or
equipment used by the Company or any Subsidiary, or commercial or standby
letters of credit issued in the ordinary course of the business of the Company
and its Subsidiaries (the amount of which shall for this purpose be deemed to be
the maximum reimbursement obligations and other liabilities (contingent or
otherwise) with respect to such letters of credit, whether or not a drawing
thereunder has been made);
(4)
Indebtedness
incurred after the Issuance Date not to exceed $2,500,000 at any one time
outstanding that is secured solely by raw materials, works in progress and
finished goods inventory and accounts receivable in a financing by a bank,
finance company or other institutional lender providing receivables or inventory
financing;
(5)
Indebtedness
incurred after the Issuance Date which is unsecured, subordinated to the Note
and the Other Notes as to payment on terms approved in advance of such
incurrence by the Majority Holders as evidenced by the written approval of the
Majority Holders, and for which no payment of principal of such Indebtedness is
scheduled to be due prior to the date that is six months after the Final
Maturity Date;
(6)
endorsements
for collection or deposit in the ordinary course of business;
(7)
in the
case of any Subsidiary, Indebtedness owed by such Subsidiary to the Company;
and
(8)
Permitted
Refinancing Indebtedness;
in each
such case so long as at the time of incurrence of such Indebtedness no Event of
Default has occurred and is continuing or would result from such incurrence and
no event which, with notice or passage of time, or both, would become an Event
of Default has occurred and is continuing or would result from such incurrence
and so long as in the case of such Indebtedness referred to in the preceding
clauses (3) through (5), inclusive, incurrence of such Indebtedness shall have
been approved by the Board of Directors prior to the incurrence
thereof.
“Permitted
Liens” means:
(a)
Liens
upon any property of any Subsidiary or Subsidiaries as security for indebtedness
owing by such Subsidiary to the Company;
(b)
purchase
money Liens upon any property acquired by the Company or any Subsidiary or Liens
existing on such property at the time of acquisition and in any such case
securing Permitted Indebtedness described in clause (3) of the definition of the
term Permitted Indebtedness; provided that (i) no such Lien shall extend to or
cover any other property of the Company or any Subsidiary, (ii) the principal
amount of Indebtedness secured by each such Lien on any such property shall not
exceed the cost (including such principal amount of the Indebtedness secured
thereby) to the Company or the Subsidiary of the property subject thereto, and
(iii) the aggregate principal amount of all Indebtedness of the Company and all
Subsidiaries secured by all Liens described in this subsection (b) and any
extensions, renewals or replacements thereof, at any one time outstanding, shall
not exceed $2,500,000 for the Company and the Subsidiaries; and any Lien
securing Indebtedness that extends, renews or replaces any Indebtedness secured
by any Lien permitted by this subsection (b);
provided,
however,
that in
any such case the Lien securing any Indebtedness so extended, renewed or
replaced shall not extend to or cover any other property of the Company or any
Subsidiary and the principal amount of such Indebtedness extended, renewed or
replaced shall not be increased;
(c)
Liens
securing Indebtedness permitted under clause (4) of the definition of the term
Permitted Indebtedness so long as in each such case such Lien does not extend to
any property of the Company or the Subsidiaries other than the accounts
receivables or inventory of the Company and the Subsidiaries so
financed;
(d)
Liens
securing this Note and the Other Notes ratably and not securing any other
Indebtedness;
(e)
Liens for
taxes or assessments or governmental charges or levies on its property if such
taxes or assessments or charges or levies shall not at the time be due and
payable or if the amount, applicability, or validity of any such tax,
assessment, charge or levy shall currently be contested in good faith by
appropriate proceedings or necessary preliminary steps are being taken to
contest, compromise or settle the amount thereof or to determine the
applicability or validity thereof and if the Company or such Subsidiary, as the
case may be, shall have set aside on its books reserves (segregated to the
extent required by sound accounting practice) deemed by it adequate with respect
thereto; deposits or pledges to secure payment of worker's compensation,
unemployment insurance, old age pensions or other social security; deposits or
pledges to secure performance of bids, tenders, contracts (other than contracts
for the payment of money borrowed or credit extended), leases, public or
statutory obligations, surety or appeal bonds, or other deposits or pledges for
purposes of like general nature in the ordinary
course of
business; mechanics', carriers', workers', repairmen's or other like Liens
arising
in the
ordinary course of business securing obligations which are not overdue for a
period of 60 days, or which are in good faith being contested or litigated, or
deposits to obtain the release of such Liens; Liens created by or resulting from
any litigation or legal proceedings or proceedings being contested in good faith
by appropriate proceedings, provided any execution levied thereon shall be
stayed; leases made, or existing on property acquired, in the ordinary course of
business; landlords' Liens under leases to which the Company or any Subsidiary
is a party; and zoning restrictions, easements, licenses or restrictions on the
use of real property or minor irregularities in title thereto; provided that all
such Liens described in this subsection (d) do not, in the aggregate, materially
impair the use of such property in the operations of the business of the Company
or any Subsidiary or the value of such property for the purpose of such
business; and
(f)
Liens
existing on the Issuance Date and listed in Schedule 4(t) to the Note Purchase
Agreement.
“Permitted
Refinancing Indebtedness” means any Indebtedness of the Company issued in
exchange for, or the net proceeds of which are used to redeem Indebtedness
represented by this Note and the Other Notes in accordance with Section 2.1;
provided that so long as on or before the date of incurrence of such Permitted
Refinancing Indebtedness the Company shall have (a) given the Optional
Redemption Notice to the Holder and the holders of the Other Notes in accordance
with Section 2.1 and (b) irrevocably deposited in trust with a trustee (other
than the Company or any Subsidiary), for the exclusive benefit of the Holder and
the holders of the Other Notes being redeemed, an amount at least equal to the
aggregate amount that the Company will be obligated to pay in respect of such
Indebtedness from such date to the date of payment in full of such
Indebtedness.
“Person”
means any natural person, corporation, partnership, limited liability company,
trust, incorporated organization, unincorporated association or similar entity
or any government, governmental agency or political subdivision.
“Principal
Market” means, at any time, whichever of the Nasdaq, Nasdaq Capital Market,
AMEX, NYSE or such other U.S. market or exchange is at the time the principal
market on which the Common Stock is then listed for trading.
“Record
Date”
shall
mean, with respect to any dividend, distribution or other transaction or event
in which the holders of Common Stock have the right to receive any cash,
securities or other property or in which the Common Stock (or other applicable
security) is exchanged for or converted into any combination of cash, securities
or other property, the date fixed for determination of stockholders entitled to
receive such cash, securities or other property (whether such date is fixed by
the Board of Directors or by statute, contract or otherwise).
“Registration
Statement” means the Registration Statement required to be filed by the Company
with the SEC pursuant to Section 8(a)(1) of the Note Purchase
Agreement.
“Repurchase
Event” means the occurrence of any one or more of the following
events:
(a)
The
Common Stock ceases to be traded on the AMEX and is not listed for trading on
the Nasdaq, the Nasdaq Capital Market or the NYSE;
(b)
Any
Fundamental Change;
(c)
The
adoption of any amendment to the Company's Certificate of Incorporation (other
than any certificate designating a series of preferred stock of the Company)
which materially and adversely affects the rights of the Holder or the taking of
any other action by the Company which materially and adversely affects the
rights of the Holder in respect of the Holder’s interest in the Common Stock in
a different and more adverse manner than it affects the rights of holders of
Common Stock generally; or
(d)
The
inability of the Holder for 20 Trading Days (whether or not consecutive) during
any period of 365 consecutive days occurring on or after the SEC Effective Date
to sell shares of Common Stock issued or issuable upon conversion of this Note
or exercise of the Warrants pursuant to the Registration Statement (1) by reason
of the requirements of the 1933 Act, the 1934 Act or any of the rules or
regulations under either thereof or (2) due to the Registration Statement
containing any untrue statement of material fact or omitting to state a material
fact required to be stated therein or necessary to make the statements therein
not misleading or other failure of the Registration Statement to comply with the
rules and regulations of the SEC other than by reason of a review by the SEC
staff of the Registration Statement or a post effective amendment to the
Registration Statement excluding any such inability to sell that results from an
untrue statement of a material fact in such Registration Statement or omission
to state a material fact required to be stated in such Registration Statement in
order to make the statements therein not misleading, which misstatement or
omission was made by the Holder in written information it furnished to the
Company specifically for inclusion in such Registration Statement which such
information was substantially relied upon by the Company in preparation of the
Registration Statement or any amendment or supplement thereto, unless the
Company shall have failed timely to amend or supplement such Registration
Statement after the Holder shall have corrected such misstatement or omission;
or
(e)
Any Event
of Default specified in Article IV of this Note.
“Repurchase
Price” means with respect to any repurchase pursuant to Sections 5.1 and 5.2 an
amount in cash equal to the sum of (1) 100% of the outstanding principal amount
of this Note that the Holder has elected to be repurchased
plus
(2)
accrued and unpaid interest on such principal amount to the date of such
repurchase
plus
(3)
accrued and unpaid Default Interest, if any, thereon at the rate provided in
this Note to the date of such repurchase.
“Restricted
Ownership Percentage” shall have the meaning provided in Section
6.7(a).
“Rule
144A” means Rule 144A as promulgated under the 1933 Act.
“SEC”
means the Securities and Exchange Commission.
“SEC
Effective Date” means the date the Registration Statement is first declared
effective by the SEC.
“SEC
Reports” shall have the meaning provided in the Note Purchase
Agreement.
“Security
Agreement” means either or both of the Pledge and Security Agreement and the
Patent and Trademark Security Agreement.
“Stockholder
Approval” shall have the meaning provided in the Note Purchase
Agreement.
“Subsidiary”
means any corporation or other entity of which a majority of the capital stock
or other ownership interests having ordinary voting power to elect a majority of
the board of directors or other Persons performing similar functions are at the
time directly or indirectly owned by the Company.
“Tender
Offer” means a tender offer or exchange offer.
“Trading
Day” means at any time a day on which the Principal Market is open for general
trading of securities.
“Transaction
Documents” means this Note, the Note Purchase Agreement, the Security
Agreements, the Lockbox Agreement, the Warrants and the other agreements,
instruments and documents contemplated hereby and thereby.
“Transfer
Agent” means Continental Stock Transfer & Trust Company, or its successor as
transfer agent and registrar for the Common Stock.
“Trigger
Event” shall have the meaning provided in Section 6.3(d).
“Unconverted
Portion” shall have the meaning provided in Section 2.1(d)(1).
“VWAP” of
any security on any Trading Day means the volume-weighted average price of such
security on such Trading Day on the Principal Market, as reported by Bloomberg
Financial, L.P., based on a Trading Day from 9:30 a.m., Eastern Time, to 4:00
p.m., Eastern Time, using the AQR Function, for such Trading Day;
provided,
however,
that
during any period the VWAP is being determined, the VWAP shall be subject to
equitable adjustments from time to time on terms consistent with Section 6.3 and
otherwise reasonably acceptable to the Majority Holders for (i) stock splits,
(ii) stock dividends, (iii) combinations, (iv) capital reorganizations, (v)
issuance to all holders of Common Stock of rights or warrants to purchase shares
of Common Stock, (vi) distribution by the Company to all holders of Common Stock
of evidences of indebtedness of the Company or cash (other than regular
quarterly cash dividends), and (vii) similar events relating to the Common
Stock, in each case which occur, or with respect to which the “ex” date occurs,
during such period.
“Warrants”
means Common Stock Purchase Warrants of the Company issued to
the
original Holder of this Note pursuant to the Note Purchase Agreement or any such
instrument issued upon transfer or split up thereof.
ARTICLE II
OPTIONAL REDEMPTION; INSTALLMENT OF
PRINCIPAL
2.1
Optional
Redemption.
(a) At
any time during the Optional Redemption Period, the Company shall have the right
to redeem at any one time all of the outstanding principal amount of this Note
at the Optional Redemption Price pursuant to this Section 2.1 on any
Optional Redemption Date, so long as the following conditions are
met:
(1)
on the
date the Company gives the Optional Redemption Notice and at all times to and
including the Optional Redemption Date, no Event of Default and no event which,
with notice or passage of time, or both, would become an Event of Default has
occurred and is continuing (unless the requirements of this clause (1) will be
satisfied immediately after the redemption of this Note and the Other Notes on
the Optional Redemption Date and the Company shall furnish Company Certificates
to the Holder to such effect on the date the Optional Redemption Notice is given
to the Holder and on the Optional Redemption Date),
(2)
on the
date the Company gives the Optional Redemption Notice and at all times to and
including the Optional Redemption Date, no Repurchase Event has occurred with
respect to which the Holder has the right to exercise repurchase rights pursuant
to Sections 5.1 and 5.2 or with respect to which the Holder has exercised such
repurchase rights and the Repurchase Price has not been paid to the Holder and
no event which, with notice or passage of time, or both, would become a
Repurchase Event has occurred and is continuing,
(3)
on the
date the Company gives the Optional Redemption Notice and at all times
thereafter to and including the Optional Redemption Date, the Registration
Statement shall be effective and available for use by the Holder, the holders of
the Other Notes and the holders of the Warrants for the resale of the shares of
Common Stock issued and issuable upon conversion of this Note and the Other
Notes and issued or issuable upon exercise of the Warrants, as the case may be,
and is reasonably expected to remain effective and available for such use for at
least 30 Trading Days after the Optional Redemption Date; and
(4)
on the
date the Company gives the Optional Redemption Notice, the Company (x) has funds
available to pay the Optional Redemption Price of this Note and the redemption
prices of the Other Notes, or (y) has funds which, together with the proceeds to
be paid to the Company at the closing of a transaction in which the Company
proposes to issue Permitted Refinancing Indebtedness, will be sufficient to pay
the Optional Redemption Price of this Note and the redemption prices of the
Other Notes.
In order
to exercise its right of redemption under this Section 2.1, the Company
shall give the Optional Redemption Notice to the Holder not less than ten
Trading Days or more than 30 Trading Days prior to the Optional Redemption Date
stating: (1) that the Company is exercising its right to redeem this Note in
accordance with this Section 2.1, (2) the principal amount of this Note to
be redeemed, (3) the Optional Redemption Price, (4) the Optional Redemption Date
and (5) that all of the conditions of this Section 2.1 entitling the Company to
call this Note for redemption have been met. On the Optional Redemption Date (or
such later date as the Holder surrenders this Note to the Company) the Company
shall pay to or upon the order of the Holder, by wire transfer of immediately
available funds to such account as shall be specified for such purpose by the
Holder at least one Business Day prior to the Optional Redemption Date, an
amount equal to the Optional Redemption Price of the portion (which may be all)
of this Note to be redeemed.
(b)
In order
that the Company shall not discriminate among the Holder and the holders of the
Other Notes, the Company agrees that it shall not redeem any of the Other Notes
pursuant to the provisions thereof similar to this Section 2.1 or
repurchase or otherwise acquire any of the Other Notes (other than a mandatory
redemption pursuant to provisions of the Other Notes comparable to Article V)
unless the Company offers simultaneously to redeem, repurchase or otherwise
acquire this Note for cash at the same unit price as the Other Note or Other
Notes.
(c)
The
Company shall not be entitled to give an Optional Redemption Notice or to redeem
any portion of this Note with respect to which the Holder has given a Conversion
Notice on or prior to the date the Company gives such Optional Redemption
Notice. Notwithstanding the giving of the Optional Redemption Notice, the Holder
shall be entitled to convert all or any portion of this Note, in accordance with
the terms of this Note, by giving a Conversion Notice at any time on or prior to
the later of (1) the date which is one Trading Day prior to the Optional
Redemption Date and (2) if the Company fails to pay and deliver to the Holder,
or deposit in accordance with Section 7.10, the Optional Redemption Price
payable on the Optional Redemption Date on or before the Optional Redemption
Date, the date on which the Company pays and delivers to the Holder, or deposits
in accordance with Section 7.10, such Optional Redemption Price. If after giving
effect to any such conversion of this Note that occurs after the date the
Company gives the Optional Redemption Notice to the Holder, the principal amount
of this Note remaining outstanding is less than the amount thereof to be
redeemed as stated in the Optional Redemption Notice, then the Optional
Redemption Price set forth in the Optional Redemption Notice shall be adjusted
to reflect the reduced outstanding principal amount of this Note and related
accrued interest (and Default Interest, if any, thereon at the Default Rate) on
the Optional Redemption Date resulting from any such conversions of this Note
after the Company gives the Optional Redemption Notice to the
Holder.
(d)
(1)
Notwithstanding
any other provision of this Note or applicable law to the contrary, in case the
Company shall give the Optional Redemption Notice to the Holder, and on the date
the Company gives the Optional Redemption Notice or at any time thereafter to
and including the Optional Redemption Date, the Holder shall be restricted from
converting any portion of this Note by reason of the Restricted Ownership
Percentage (the “Unconverted Portion”), then the Optional Redemption Date for
the Unconverted Portion so called for redemption by the Company and which the
Holder may not convert at any such time during such period from the date the
Company gives the Optional Redemption Notice to the Optional Redemption Date
may, at the election of the Holder exercised by notice to the Company given on
or before the Optional Redemption Date, be extended to be the
Extended
Optional
Redemption Date. On the applicable Extended Optional Redemption Date, the
Company shall pay the Optional Redemption Price for any portion of this Note
redeemed on such Extended Optional Redemption Date. Any portion of this Note for
which there is an Extended Optional Redemption Date shall remain convertible by
the Holder in accordance with Section 6 at any time to and including the close
of business on the Business Day prior to the applicable Extended Optional
Redemption Date.
(2)
Notwithstanding
anything to the contrary contained in Section 6.7, solely for the purposes of
calculating the Restricted Ownership Percentage for purposes of this Section
2.1(d), the shares of Common Stock issuable upon exercise of the Warrants held
by the Holder shall not be deemed to be Excluded Shares and shall be taken into
account in calculating the Restricted Ownership Percentage to determine the
amount of the Unconverted Portion.
2.2
Installments of Principal.
The
principal of this Note shall become due in installments as follows:
Principal
Amount
|
Due
Date
|
$
[PRIOR
TO ISSUANCE, INSERT 50%
|
|
OF PRINCIPAL
AMOUNTOF NOTE]
|
Installment
Maturity Date
|
|
|
$
[PRIOR
TO ISSUANCE, INSERT 50%
|
|
OF PRINCIPAL
AMOUNTOF NOTE]
|
Final
Maturity Date
|
The
amounts of such installments that are payable on each such date are subject to
reduction as provided in Sections 5 and 6
.
2.3
No Other
Prepayment
. Except
as specifically provided in Section 2.1, this Note may not be prepaid, redeemed
or repurchased at the option of the Company prior to the applicable Installment
Maturity Date or the Final Maturity Date, as the case may be.
ARTICLE III
CERTAIN COVENANTS
So long
as the Company shall have any obligation under this Note, unless otherwise
consented to in advance by the Majority Holders:
3.1
Limitations on Certain
Indebtedness.
The
Company will not itself, and will not permit any Subsidiary to, create, assume,
incur or in any manner become liable in respect of, including, without
limitation, by reason of any business combination transaction (all of which are
referred to herein as “incurring”), any Indebtedness other than Permitted
Indebtedness.
3.2
Maintenance of Cash and Cash
Equivalents Balances.
The
Company
shall at
all times maintain Cash and Cash Equivalents Balances at least equal to
$600,000. The Company shall certify the amount of its Cash and Cash Equivalents
Balances to the Holder as of the end of each calendar quarter, and from time to
time upon request of the Majority Holders, as provided herein. Not later than
the due date for filing with the SEC (determined without regard to any extension
thereof permitted by the SEC) the Company’s Quarterly Report on Form 10-Q (in
the case of the first three calendar quarters of each year) or the Company’s
Annual Report on Form 10-K (in the case of the fourth calendar quarter of each
year), and within five Business Days after a request therefor made by notice to
the Company from the Majority Holders, the Company shall furnish to the Holder a
Company Certificate, setting forth the amount of the Company's Cash and Cash
Equivalents Balances as of the end of such calendar quarter or as of the date of
such notice, as the case may be. Each Company Certificate delivered pursuant to
this Section 3.2 shall state (1) the amount of the Company’s Cash and Cash
Equivalents Balances and the date as of which such amount has been determined,
(2) separately, the amount of cash and the amount of cash equivalents included
in the amount of Cash and Cash Equivalents Balances shown in such Company
Certificate and (3) that the amount of Cash and Cash Equivalents Balances stated
in such Company Certificate has been determined in accordance with the terms of
this Note. If necessary in order to avoid furnishing the Holder information
that, for purposes of the 1934 Act, would be considered to be material
non-public information if not publicly disclosed, at the time the Company
furnishes each Company Certificate to the Holder the Company shall make an
appropriate public announcement disclosing the information contained in such
Company Certificate relating to the Cash and Cash Equivalents Balances;
provided,
however,
that in
case the Company makes no such public disclosure the Holder expressly undertakes
no agreement, obligation or duty to refrain from trading in the Company’s
securities while in possession of such information.
3.3
Payment of
Obligations.
The
Company will pay and discharge, and will cause each Subsidiary to pay and
discharge, all their respective material obligations and liabilities, including,
without limitation, tax liabilities, except where the same may be contested in
good faith by appropriate proceedings and the Company shall have established
adequate reserves therefor on its books.
3.4
Maintenance of Property;
Insurance.
(a) The
Company will keep, and will cause each Subsidiary to keep, all property useful
and necessary in its business in good working order and condition, ordinary wear
and tear excepted.
(b)
The
Company will maintain, and will cause each Subsidiary to maintain, with
financially sound and responsible insurance companies, insurance, in at least
such amounts and against such risks as is reasonably adequate for the conduct of
their respective businesses and the value of their respective
properties.
3.5
Conduct of Business and Maintenance
of Existence.
The
Company will continue, and will cause each Subsidiary to continue, to engage in
business of the same general type as now conducted by the Company, and will
preserve, renew and keep in full force and effect, and will cause each
Subsidiary to preserve, renew and keep in full force and effect their respective
corporate existence and their respective rights, privileges and franchises
necessary or desirable in the normal conduct of business except where (other
than the Company’s corporate existence) the failure to do so would not have a
material adverse effect on (i) the business, properties, operations, condition
(financial or other), results of operation or prospects of the Company and the
Subsidiaries, taken as a whole, (ii) the ability of the Company to perform and
comply with its obligations under the Transaction Documents or (iii) the rights
and remedies of the Holder or the Collateral Agent under or in connection with
the Transaction Documents.
3.6
Compliance with
Laws.
The
Company will comply, and will cause each Subsidiary to comply, in all material
respects with all applicable laws, ordinances, rules, regulations, decisions,
orders and requirements of governmental authorities and courts (including,
without limitation, environmental laws) except (i) where compliance therewith is
contested in good faith by appropriate proceedings or (ii) where non-compliance
therewith could not reasonably be expected to have a material adverse effect on
the business, condition (financial or otherwise), operations, performance,
properties or prospects of the Company and the Subsidiaries, taken as a
whole.
3.7
Investment Company
Act.
The
Company will not be or become an open-end investment trust, unit investment
trust or face-amount certificate company that is or is required to be registered
under Section 8 of the Investment Company Act of 1940, as
amended.
3.8
Limitations on Asset Sales,
Liquidations, Etc.; Certain Matters.
The
Company shall not
(a)
sell,
convey or otherwise dispose of all or substantially all of the assets of the
Company as an entirety or substantially as an entirety in a single transaction
or in a series of related transactions; or
(b)
sell one
or more Subsidiaries, or permit any one or more Subsidiaries to sell their
respective assets, if such sale individually or in the aggregate is material to
the Company and the Subsidiaries taken as a whole, other than any such sale or
sales which individually or in the aggregate could not reasonably be expected to
have a material adverse effect on (i) the business, properties, operations,
condition (financial or other), results of operation or financial prospects of
the Company and the Subsidiaries, taken as a whole, (ii) the validity or
enforceability of, or the ability of the Company to perform its obligations
under, the Transaction Documents, or (iii) the rights and remedies of the Holder
under the terms of the Transaction Documents; or
(c)
liquidate,
dissolve or otherwise wind up the affairs of the Company.
3.9
Limitations on
Liens.
The
Company will not itself, and will not permit any Subsidiary to, create, assume
or suffer to exist any Lien upon all or any part of its property of any
character, whether owned at the date hereof or thereafter acquired, except
Permitted Liens.
3.10
Transactions with
Affiliates.
The
Company will not, and will not permit any Subsidiary, directly or indirectly, to
pay any funds to or for the account of, make any investment (whether by
acquisition of stock or Indebtedness, by loan, advance, transfer of property,
guarantee or other agreement to pay, purchase or service, directly or
indirectly, any Indebtedness, or otherwise) in, lease, sell, transfer or
otherwise dispose of any assets, tangible or intangible, to, or participate in,
or effect any transaction in connection with, any joint enterprise or other
joint arrangement with, any Affiliate of the Company, except, on terms to the
Company or such Subsidiary no less favorable than terms that could be obtained
by the Company or such Subsidiary from a Person that is not an Affiliate of the
Company, as determined in good faith by the Board of Directors.
3.11
Rule 144A Information
Requirement.
Within
the period prior to the expiration of the holding period applicable to sales
hereof under Rule 144(k) under the 1933 Act (or any successor provision), the
Company shall, during any period in which it is not subject to Section 13 or
15(d) under the 1934 Act, make available to the Holder and any prospective
purchaser of this Note from the Holder, the information required pursuant to
Rule 144A(d)(4) under the 1933 Act upon the request of the Holder and it will
take such further action as the Holder may reasonably request, all to the extent
required from time to time to enable the Holder to sell this Note without
registration under the 1933 Act within the limitation of the exemption provided
by Rule 144A, as Rule 144A may be amended from time to time. Upon the request of
the Holder, the Company will deliver to the Holder a written statement as to
whether it has complied with such requirements.
3.12
Limitation on Certain
Issuances.
The
Company shall not offer, sell or issue, or enter into any agreement, arrangement
or understanding to offer, sell or issue, any Common Stock or Common Stock
Equivalent (A) that is convertible into, exchangeable or exercisable for, or
includes the right to receive additional shares of Common Stock either (x) at a
conversion, exercise or exchange rate or other price that is based upon and/or
varies with the trading prices of or quotations for the Common Stock at any time
after the initial issuance of such Common Stock or Common Stock Equivalent, or
(y) with a fixed conversion, exercise, exchange or purchase price that is
subject to being reset at some future date after the initial issuance of such
Common Stock or Common Stock Equivalent or upon the occurrence of specified or
contingent events directly or indirectly related to the business of the Company
or the market for the Common Stock (but excluding customary stock split, reverse
stock split, stock dividend and similar anti-dilution provisions substantially
similar to those set forth in clauses (a) through (e) of Section 6.3), or (B)
pursuant to an “equity line” structure in which one or more Persons commits to
provide capital to the Company by the purchase of securities of the Company from
time to time, whether at specified times, times determined by the Company or by
such Person(s) or by mutual agreement between the Company and such Person(s), at
prices based on the market prices of the Common Stock at or near the time of
each purchase, which securities are registered for sale or resale pursuant to
the 1933 Act;
provided, however,
that
nothing in this Section 3.11 shall prohibit the Company from issuing shares of
Common Stock for cash for the account of the Company in an offering that is
underwritten on a firm commitment basis and registered with the SEC under the
1933 Act.
3.13
Certain
Obligations.
The
Company shall not enter into any agreement which would adversely affect the
Collateral Agent's Lien on and Security Interest in the Collateral. The Company
shall perform, and comply in all material respects with each agreement it enters
into relating to the Collateral, the failure to comply with which could affect
the Collateral Agent's lien on and security interest in the
Collateral.
3.14
Notice of
Defaults.
The
Company shall notify the Holder promptly, but in any event not later than five
days after the Company becomes aware of the fact, of any failure by the Company
to comply with this Article III.
3.15
Listing Eligibility
Reporting.
The
Company shall notify the Holder from time to time within five Business Days
after the Company first learns that it does not meet any of the applicable
requirements for the continued listing of the Common Stock on the Principal
Market and shall make appropriate public announcement thereof so that the
content of such notice shall not constitute material non-public information for
purposes of the 1934 Act.
3.16
Designation of
Directors.
(a)
So long
as any principal amount of this Note or the Other Notes remains outstanding, the
Majority Holders shall be entitled, from time to time, to select a Person who
shall not be an Affiliate of Alexandra and who shall have the right to designate
by notice to the Company up to two persons (the first of whom, subject to his
completion of the D&O Questionnaire and the prompt completion of background
and other reasonable due diligence investigations to the Company’s reasonable
satisfaction, shall initially be Radu Auf Der Hyde) to serve from time to time
as members of the Board of Directors, provided, that each of such person(s)
designated to serve as a member of the Board of Directors (1) so long as
Alexandra holds all or any portion of this Note or any Other Note, is reasonably
acceptable to Alexandra and at least one other holder of this Note or any Other
Notes and (2) is not an Affiliate of Alexandra. Any person(s) so designated for
election to the Board of Directors shall enter into an agreement with Alexandra
on such terms as shall be acceptable to Alexandra pursuant to which such
person(s) shall agree not to share or convey any non-public information such
person(s) learns in its role as a director. The Company shall, from time to
time, use its best efforts to cause the election of the person(s) so designated
to serve as members of the Board of Directors as promptly as possible. If for
any reason under applicable law or the Company’s By-laws any such designee
cannot immediately be elected to the Board of Directors, then until such time as
such person(s) is elected to the Board of Directors (i) the person(s) so
designated shall have the right to be present at all meetings of the Board of
Directors, but shall not be entitled to vote on any action taken at such
meeting, (ii) the Company shall provide notice to such person(s) of the date,
place and time of each such meeting at least the same period in advance as the
shortest such notice provided to any member of the Board of Directors, (iii) the
Company shall provide such person(s) all agendas and other information and
materials provided to the Board of Directors contemporaneously with the time the
Company provides the same to the Board of Directors and (iv) the Company shall
provide to such person(s) copies of each proposed unanimous written consent of
the Board of Directors which consent is given to all members of the Board of
Directors for execution by the directors during such period, at the same time
such written consent is given to all members of the Board of Directors. In case
any person designated as a member of the Board of Directors pursuant to this
Section 3.16 shall resign, die, be removed from office or otherwise be unable to
serve, the Majority Holders shall be entitled to appoint a Person to designate a
replacement pursuant to, and in accordance with, this Section 3.16.
(b)
In the
event that approval of the stockholders of the Company shall be required to
elect the person(s) designated to serve as a member of the Board of Directors
pursuant to this Section 3.16, the Company shall call a meeting of stockholders
to be held within 90 days after the date such person(s) is so designated, shall
prepare and file with the SEC as promptly as practical, but in no event later
than 30 days after such date, preliminary proxy materials which set forth a
proposal to seek the approval of the election of such designee(s), and the Board
of Directors shall recommend approval thereof by the Company’s stockholders. The
Company shall mail and distribute its proxy materials for such stockholder
meeting to its
stockholders
at least 30 days prior to the date of such stockholder meeting and shall
actively solicit proxies to vote for the election of such
designee(s).
(c)
Notwithstanding
anything herein to the contrary, so long as Alexandra holds all or any portion
of this Note or any Other Note, the rights and obligations under this Section
3.16 may not be waived or amended without the consent of Alexandra.
3.17
Management Covenants.
(a)
Commencing on the Issuance Date, the Company shall withhold 10% of all cash
compensation payable to each of its Chief Executive Officer, President and Chief
Strategy Officer until such time as the Company shall have reported an EBITDA
Positive Quarter. The Company shall give notice to the holder of the occurrence
of the EBITDA Positive Quarter and once it shall have given such notice shall
pay the amounts so withheld, without interest, to the respective officers in
equal monthly installments during the 12-month period following such EBITDA
Positive Quarter so long as such officer continues to be employed by the Company
during such 12-month period. The Company shall not increase the compensation
payable in any form to any of its Chief Executive Officer, President and Chief
Strategy Officer from the Issuance Date until the EBITDA Positive Quarter has
occurred. Notwithstanding anything to the contrary contained herein, if (1) at
any time during any period of 45 consecutive Trading Days commencing after the
Issuance Date on each such Trading Day (i) the Market Price of the Common Stock
shall be at least 250% of the Conversion Price in effect on each such Trading
Day, (ii) the Average Daily Trading Volume Threshold is met, (iii) no Event of
Default shall have occurred or be continuing and no Repurchase Event shall have
occurred with respect to which the Holder has the right to require repurchase of
this Note pursuant to Article V or with respect to which the Holder has
exercised such right and the Company shall not have paid or deposited in
accordance with Section 7.10 the applicable Repurchase Price and (iv) the
Registration Statement shall be effective and available for use by the Holder
and the holders of the Warrants for the resale of shares of Common Stock issued
or issuable upon conversion of this Note and upon exercise of the Warrants and
is reasonably expected to remain effective and available for a reasonable period
after such period of 45 Trading Days, and (2) the Company shall have furnished
to the Holder a Company Certificate certifying the matters set forth in the
immediately preceding clause (1), then thereafter the Company shall no longer be
obligated to comply with this Section 3.17(a) and the Company shall pay the
amounts withheld by reason of this Section 3.17(a), without interest, to the
respective officers in equal monthly installments during the 12-month period
following the date the Company Certificate described in the immediately
preceding clause (2) was delivered to the Holder so long as such officer
continues to serve in such position during such 12-month period.
(b)
The
Company shall use its best efforts to successfully complete a search for a
qualified additional member of senior management and, subject to approval by the
Board of Directors, to hire such additional member of senior management.
Until
such time as such additional member of senior management has been hired the
Board of Directors shall form a three person committee to supervise the
management of the Company of which at least one person shall be a director
designated as a member of the Board of Directors pursuant to Section 3.16, one
person shall initially be John Atherly and the other person shall be Gary W.
Jones.
(c)
The
Company shall use its best efforts to design, develop, manufacture and market
the display, subsystem and personal display systems, and focus on funded
research
business
consistent with Company’s business plan in effect on the Issuance Date and shall
limit new market business development until the EBITDA Positive Quarter has
occurred.
(d)
Unless
the Company’s “Statement of Company Policy Regarding Confidentiality and
Securities Trades by Company Personnel” shall have been amended by the unanimous
approval of the three person committee set forth in Section 3.17(b), all
transactions in securities of the Company, including, without limitation,
acquisitions, dispositions and transfers, by directors, officers, managers and
all accounting and administrative personnel, must be pre-cleared by the office
of the Chief Financial Officer of the Company and such persons shall be
prohibited from making any trades in Company securities during the period
commencing 15 days prior to the end of each fiscal quarter and ending on the
third Business Day after the financial results of the Company for such fiscal
quarter are publicly released.
ARTICLE IV
EVENTS OF DEFAULT
4.1
If any of
the following events of default (each, an “Event of Default”) shall
occur:
(a)
Failure to Pay Principal, Interest,
Etc.
The
Company fails (1) to pay the principal, the Optional Redemption Price or the
Repurchase Price hereof when due, whether at maturity, upon acceleration or
otherwise, as applicable, or (2) to pay any installment of interest hereon when
due and, in the case of this clause (2) of this Section 4.1(a) only, such
failure continues for a period of five Business Days after the due date thereof;
or
(b)
Conversion and the
Shares.
The
Company fails to issue or cause to be issued shares of Common Stock to the
Holder or the holder of any Other Note upon exercise of the conversion rights of
the Holder or such holder or to the holder of any Warrant or Other Warrant upon
exercise of the purchase rights of the holder thereof, in any such case within
five Trading Days after the due date therefor in accordance with the terms of
this Note, any Other Note or any Warrant or Other Warrant or fails to transfer
any certificate for any such shares of Common Stock or any shares of Common
Stock issued in payment of interest on this Note or any Other Note as and when
required by this Note and the Note Purchase Agreement or any Other Note or Other
Note Purchase Agreement, as the case may be; or
(c)
Breach of
Covenant.
The
Company (1) fails to comply with Sections 3.1, 3.2, 3.8, 3.9, 3.12, 3.13, 3.15,
3.16 or 3.17(a) (2) fails to comply in any material respect with any provision
of Article III of this Note (other than Sections 3.1, 3.2, 3.8, 3.9, 3.12, 3.13,
3.15, 3.16 or 3.17(a)) or breaches any other material covenant or other material
term or condition of this Note or any of the other Transaction Documents (other
than as specifically provided in clauses (a), (b) or (c)(1) of this Section
4.1), and in the case of this clause (2) of this Section 4.1(c) only, such
breach continues for a period of ten days after written notice thereof to the
Company from the Holder; or
(d)
Breach of Representations and
Warranties.
Any
representation or warranty of the Company made herein or in any agreement,
statement or certificate given in writing pursuant hereto or in connection
herewith (including, without limitation, the Transaction Documents) shall be
false or misleading in any material respect when made; or
(e)
Certain Voluntary
Proceedings.
The
Company or any Subsidiary shall commence a voluntary case or other proceeding
seeking liquidation, reorganization or other relief with respect to itself or
its debts under any bankruptcy, insolvency or other similar law now or hereafter
in effect or seeking the appointment of a trustee, receiver, liquidator,
custodian or other similar official of it or any substantial part of its
property, or shall consent to any such relief or to the appointment of or taking
possession by any such official in an involuntary case or other proceeding
commenced against it, or shall make a general assignment for the benefit of
creditors, or shall fail generally to pay its debts as they become due or shall
admit in writing its inability generally to pay its debts as they become due;
or
(f)
Certain Involuntary
Proceedings.
An
involuntary case or other proceeding shall be commenced against the Company or
any Subsidiary seeking liquidation, reorganization or other relief with respect
to it or its debts under any bankruptcy, insolvency or other similar law now or
hereafter in effect or seeking the appointment of a trustee, receiver,
liquidator, custodian or other similar official of it or any substantial part of
its property, and such involuntary case or other proceeding shall remain
undismissed and unstayed for a period of 60 consecutive days; or
(g)
Judgments.
Any
court of competent jurisdiction shall enter one or more final judgments against
the Company or any Subsidiary or any of their respective properties or other
assets in an aggregate amount in excess of $250,000, which is not vacated,
bonded, stayed, discharged, satisfied or waived for a period of 30 consecutive
days; or
(h)
Default Under Other Agreements and
Instruments.
(1) The
Company or any Subsidiary shall (i) default in any payment with respect to any
Indebtedness for borrowed money (other than this Note) which Indebtedness has an
outstanding principal amount in excess of $250,000, individually or $500,000 in
the aggregate, for the Company and its Subsidiaries, beyond the period of grace,
if any, provided in the instrument or agreement under which such Indebtedness
was created or (ii) default in the observance or performance of any agreement,
covenant or condition relating to any such Indebtedness or contained in any
instrument or agreement evidencing, securing or relating thereto, or any other
event shall occur or condition exist, the effect of which default or other event
or condition is to cause, or to permit the holder or holders of such
Indebtedness (or a trustee or agent on behalf of such holder or holders) to
cause, any such Indebtedness to become due prior to its stated maturity and such
default or event shall continue beyond the period of grace, if any, provided in
the instrument or agreement under which such Indebtedness was created (after
giving effect to any consent or waiver obtained and then in effect thereunder);
or (2) any Indebtedness of the Company or any Subsidiary which has an
outstanding principal amount in excess of $250,000, individually or $500,000 in
the aggregate, shall, in accordance with its terms, be declared to be due and
payable, or required to be prepaid other than by a regularly scheduled or
required payment prior to the stated maturity thereof; or
(i)
Security
Agreements.
The
occurrence of any “Event of Default” as defined in the Security Agreements or
any breach or failure by the Company to perform its obligations under the
Lockbox Agreement; or
(j)
Delisting of Common
Stock.
The
Common Stock shall cease to be listed on any of Nasdaq Capital Market, Nasdaq,
the NYSE or the AMEX;
then, (W)
upon the occurrence and during the continuation of any Event of Default
specified in clause (a), (b), (c), (d), (g), (h), (i) or (j) of this
Section 4.1, at the option of the Holder the Company shall, and upon the
occurrence of any Event of Default specified in clause (e) or (f) of this
Section 4.1, the Company shall, in any such case, pay to the Holder an
amount equal to the sum of (1) the outstanding principal amount of this Note
plus
(2)
accrued and unpaid interest on such principal amount to the date of payment
plus
(3)
accrued and unpaid Default Interest, if any, thereon at the rate provided in
this Note to the date of payment, (X) all other amounts payable hereunder or
under any of the other Transaction Documents shall immediately become due and
payable, all without demand, presentment or notice, all of which hereby are
expressly waived, together with all costs, including, without limitation,
reasonable legal fees and expenses, of collection, (Y) the Collateral Agent
shall be entitled to exercise all rights and remedies under the Security
Agreement, and (Z) the Holder shall be entitled to exercise all other rights and
remedies available at law or in equity.
ARTICLE V
REPURCHASE UPON A REPURCHASE EVENT
5.1
Repurchase Right Upon Repurchase
Event.
If a
Repurchase Event occurs, in addition to any other right of the Holder, the
Holder shall have the right, at the Holder’s option, to require the Company to
repurchase all of this Note, or any portion hereof on the repurchase date that
is five Business Days after the date of the Holder Notice delivered with respect
to such Repurchase Event. The Holder shall have the right to require the Company
to repurchase all or any such portion of this Note if a Repurchase Event occurs
at any time while any portion of the principal amount of this Note is
outstanding at a price equal to the Repurchase Price. If the Holder exercises
its right to require the repurchase of less than all of the outstanding
principal amount of this Note, the Holder may specify the manner in which the
principal amount repurchased shall be allocated between the outstanding
installments of principal.
5.2
Notices; Method of Exercising
Repurchase Rights, Etc.
(a) On
or before the fifth Business Day after the occurrence of a Repurchase Event, the
Company shall give to the Holder a Company Notice of the occurrence of the
Repurchase Event and of the repurchase right set forth herein arising as a
result thereof. Such Company Notice shall set forth:
(i)
the date
by which the repurchase right must be exercised, and
(ii)
a
description of the procedure (set forth in this Section 5.2) which the
Holder must follow to exercise the repurchase right.
No
failure of the Company to give a Company Notice or defect therein shall limit
the Holder’s right to exercise the repurchase right or affect the validity of
the proceedings for the repurchase of this Note or portion hereof.
(b)
To
exercise the repurchase right, the Holder shall deliver to the Company on or
before the 30th day after a Company Notice (or if no such Company Notice has
been given, within 40 days after the Holder first learns of the Repurchase
Event) (i) a Holder Notice setting forth the name of the Holder and the
principal amount of this Note to be repurchased, which amount may be allocated
between the installments of principal outstanding at such time as determined by
the Holder in its sole discretion, and (ii) this Note, duly endorsed for
transfer to the Company of the portion of the outstanding principal amount of
this Note to be repurchased. A Holder Notice may be revoked by the Holder at any
time prior to the time the Company pays the applicable Repurchase Price to the
Holder.
(c)
If the
Holder shall have given a Holder Notice, then on the date which is five Business
Days after the date such Holder Notice is given (or such later date as the
Holder surrenders this Note) the Company shall make payment in immediately
available funds of the applicable Repurchase Price to such account as specified
by the Holder in writing to the Company at least one Business Day prior to the
applicable repurchase date.
5.3
Other.
(a) If
the Company fails to repurchase on the applicable repurchase date this Note (or
portion hereof) as to which the repurchase right has been properly exercised
pursuant to this Article V, then the Repurchase Price for the portion (which, if
applicable, may be all) of this Note which is required to have been so
repurchased shall bear interest to the extent not prohibited by applicable law
from the applicable repurchase date until paid at the Default Rate.
(b)
If a
portion of this Note is to be repurchased, upon surrender of this Note to the
Company in accordance with the terms of this Article V, the Company shall
execute and deliver to the Holder without service charge, a new Note or Notes,
having the same date hereof and containing identical terms and conditions, in
such denomination or denominations as requested by the Holder in aggregate
principal amount equal to, and in exchange for, the unrepurchased portion of the
principal amount of the Note so surrendered.
(c)
A Holder
Notice given by the Holder shall be deemed for all purposes to be in proper form
unless the Company notifies the Holder within three Business Days after such
Holder Notice has been given (which notice shall specify all defects in such
Holder Notice), and any Holder Notice containing any such defect shall
nonetheless be effective on the date given if the Holder promptly undertakes to
correct all such defects. No such claim of defect shall limit or delay
performance of the Company's obligation to repurchase any portion of this Note,
the repurchase of which is not in dispute.
ARTICLE VI
CONVERSION
6.1
Right to
Convert
.
Subject
to and upon compliance with the provisions of this Note, the Holder shall have
the right, at the Holder's option, at any time prior to the close of business on
the Final Maturity Date (except that, if the Holder shall have exercised
repurchase rights under Sections 5.1 and 5.2 or the Company shall have exercised
its redemption rights under Section 2.1, such conversion right shall terminate
with respect to the portion of this Note to be repurchased or redeemed, as the
case may be, at the close of business on the last Trading Day prior to the later
of (x) the date the Company is required to make such repurchase or the Optional
Redemption Date, as the case may be, and (y) the date the Company pays or
deposits in accordance with Section 7.10 the applicable Repurchase Price or the
Optional Redemption Price unless in any such case the Company shall default in
payment due upon repurchase or redemption hereof) to convert the principal
amount of this Note, or any portion of such principal amount which is at least
$1,000 (or such lesser principal amount of this Note as shall be outstanding at
such time), plus accrued and unpaid interest, into that number of fully paid and
non-assessable shares of Common Stock (as such shares shall then be constituted)
obtained by dividing (1) the sum of (x) the principal amount of this Note or
portion thereof being converted
plus
(y)
accrued and unpaid interest on the portion of the principal amount of this Note
being converted to the applicable Conversion Date
plus
(z)
accrued and unpaid Default Interest, if any, on the amount referred to in the
immediately preceding clause (y) to the applicable Conversion Date
by
(2) the
Conversion Price in effect on the applicable Conversion Date, by giving a
Conversion Notice in the manner provided in Section 6.2;
provided, however,
that, if
at any time this Note is converted in whole or in part pursuant to this Section
6.1, the Company does not have available for issuance upon such conversion as
authorized and unissued shares or in its treasury at least the number of shares
of Common Stock required to be issued pursuant hereto, then, at the election of
the Holder made by notice from the Holder to the Company, this Note (or portion
hereof as to which conversion has been requested), to the extent that sufficient
shares of Common Stock are not then available for issuance upon conversion,
shall be converted into the right to receive from the Company, in lieu of the
shares of Common Stock into which this Note or such portion hereof would
otherwise be converted and which the Company is unable to issue, payment in an
amount equal to the product obtained by multiplying (x) the number of shares of
Common Stock which the Company is unable to issue
times
(y) the
arithmetic average of the Market Price for the Common Stock during the five
consecutive Trading Days immediately prior to the applicable Conversion Date.
Any such payment shall, for all purposes of this Note, be deemed to be a payment
of principal plus a premium equal to the total amount payable less the principal
portion of this Note converted as to which such payment is required to be made
because shares of Common Stock are not then available for issuance upon such
conversion. The Holder is not entitled to any rights of a holder of Common Stock
until the Holder has converted this Note to Common Stock, and only to the extent
this Note is deemed to have been converted to Common Stock under this Article
VI. For purposes of Sections 6.5 and 6.6, whenever a provision references the
shares of Common Stock into which this Note (or a portion hereof) is convertible
or the shares of Common Stock issuable upon conversion of this Note (or a
portion hereof) or words of similar import, any determination required by such
provision shall be made as if a sufficient number of shares of Common Stock were
then available for issuance upon conversion in full of this
Note.
6.2
Exercise of Conversion Privilege;
Issuance of Common Stock on Conversion; No Adjustment for Interest or
Dividends
.
(a) In
order to exercise the conversion privilege with respect to this Note, the Holder
shall give a Conversion Notice (or such other notice which is acceptable to the
Company) to the Company and the Transfer Agent or to the office or agency
designated by the Company for such purpose by notice to the Holder. A Conversion
Notice may be given by telephone line facsimile transmission to the numbers set
forth on the form of Conversion Notice. In connection with any conversion of
this Note, the Holder may allocate such conversion between the outstanding
installments of principal as determined by the Holder in its sole discretion, as
set forth in a particular Conversion Notice.
(b)
As
promptly as practicable, but in no event later than three Trading Days, after a
Conversion Notice is given, the Company shall issue and shall deliver to the
Holder or the Holder's designee the number of full shares of Common Stock
issuable upon such conversion of this Note or portion hereof in accordance with
the provisions of this Article and deliver a check or cash in respect of any
fractional interest in respect of a share of Common Stock arising upon such
conversion, as provided in Section 6.2(f) and, if applicable, any cash payment
required pursuant to the proviso to the first sentence of Section 6.1 (which
payment, if any, shall be paid no later than three Trading Days after the
applicable Conversion Date). In lieu of delivering physical certificates for the
shares of Common Stock issuable upon any conversion of this Note, provided the
Company's transfer agent is participating in the Depository Trust Company
(“DTC”) Fast Automated Securities Transfer (“FAST”) program, upon request of the
Holder, the Company shall use commercially reasonable efforts to cause its
transfer agent electronically to transmit such shares of Common Stock issuable
upon conversion to the Holder (or its designee), by crediting the account of the
Holder’s (or such designee’s) broker with DTC through its Deposit Withdrawal
Agent Commission system (provided that the same time periods herein as for stock
certificates shall apply).
(c)
Each
conversion of this Note (or portion hereof) shall be deemed to have been
effected on the applicable Conversion Date, and the person in whose name any
certificate or certificates for shares of Common Stock shall be issuable upon
such conversion shall be deemed to have become on such Conversion Date the
holder of record of the shares represented thereby;
provided, however,
that if a
Conversion Date is a date on which the stock transfer books of the Company shall
be closed such conversion shall constitute the person in whose name the
certificates are to be issued as the record holder thereof for all purposes on
the next succeeding day on which such stock transfer books are open, but such
conversion shall be at the Conversion Price in effect on the applicable
Conversion Date.
Upon
conversion of this Note or any portion hereof, the accrued and unpaid interest
on this Note (or portion hereof) to (but excluding) the applicable Conversion
Date shall be deemed to be paid to the Holder of this Note through receipt of
such number of shares of Common Stock issued upon conversion of this Note or
portion hereof as shall have an aggregate Current Fair Market Value on the
Trading Day immediately preceding such Conversion Date equal to the amount of
such accrued and unpaid interest.
(d)
A
Conversion Notice shall be deemed for all purposes to be in proper form absent
timely notice from the Company to the Holder of manifest error therein. The
Company shall notify the Holder of any claim by the Company of manifest error in
a Conversion Notice within two Trading Days after the Holder gives such
Conversion Notice (which notice from the
Company
shall specify all defects in the Conversion Notice) and no such
claim of error shall limit or delay performance of the Company's
obligation to issue upon such
conversion
the number of shares of Common Stock which are not in dispute. Time shall be of
the essence in the giving of any such notice by the Company. Any Conversion
Notice containing any such defect shall nonetheless be effective on the date
given if the Holder promptly undertakes to correct all such defects. The Company
shall not be required to pay any tax which may be payable in respect of any
transfer involved in the issuance and delivery of shares of Common Stock or
other securities or property on conversion of this Note in a name other than
that of the Holder, and the Company shall not be required to issue or deliver
any such shares or other securities or property unless and until the person or
persons requesting the issuance thereof shall have paid to the Company the full
amount of any such tax or shall have established to the satisfaction of the
Company that such tax has been paid. The Holder shall be responsible for the
amount of any withholding tax payable in connection with any conversion of this
Note.
(e)
(1) If
the Holder shall have given a Conversion Notice in accordance with the terms of
this Note, the Company's obligation to issue and deliver the shares of Common
Stock upon such conversion shall be absolute and unconditional, irrespective of
any action or inaction by the Holder to enforce the same, any waiver or consent
with respect to any provision hereof, the recovery of any judgment against any
person or any action to enforce the same, any failure or delay in the
enforcement of any other obligation of the Company to the Holder, or any setoff,
counterclaim, recoupment, limitation or termination, or any breach or alleged
breach by the Holder or any other person of any obligation to the Company or any
violation or alleged violation of law by the Holder or any other person, and
irrespective of any other circumstance which might otherwise limit such
obligation of the Company to the Holder in connection with such conversion;
provided, however,
that
nothing herein shall limit or prejudice the right of the Company to pursue any
such claim in any other manner permitted by applicable law. The occurrence of an
event which requires an adjustment of the Conversion Price as contemplated by
Section 6.3 shall in no way restrict or delay the right of the Holder to receive
certificates for Common Stock upon conversion of this Note and the Company shall
use its best efforts to implement such adjustment on terms reasonably acceptable
to the Holder within two Trading Days of such occurrence.
(2)
If in any
case the Company shall fail to issue and deliver the shares of Common Stock to
the Holder in connection with a particular conversion of this Note within five
Trading Days after the Holder gives the Conversion Notice for such conversion,
in addition to any other liabilities the Company may have hereunder and under
applicable law (A) the Company shall pay or reimburse the Holder on demand for
all out-of-pocket expenses, including, without limitation, reasonable fees and
expenses of legal counsel, incurred by the Holder as a result of such failure,
(B) if as a result of such failure the Holder shall suffer any direct damages or
liabilities from such failure (including, without limitation, margin interest
and the cost of purchasing securities to cover a sale (whether by the Holder or
the Holder's securities broker) or borrowing of shares of Common Stock by the
Holder for purposes of settling any trade involving a sale of shares of Common
Stock made by the Holder during the period beginning on the Issuance Date and
ending on the date the Company delivers or causes to be delivered to the Holder
such shares of Common Stock), then the Company shall upon demand of the Holder
pay to the Holder an amount equal to the actual direct, out-of-pocket damages
and liabilities suffered by the Holder by reason thereof which the Holder
documents to the reasonable satisfaction of the Company, and (C) the Holder may
by written notice (which may be given by mail, courier,
personal
service or telephone line facsimile transmission), given at any time prior to
delivery to the Holder of the shares of Common Stock issuable in connection with
such exercise of the Holder's conversion right, rescind such exercise and the
Conversion Notice relating thereto, in which case the Holder shall thereafter
be
entitled
to convert that portion of this Note as to which such exercise is so rescinded
and to exercise its other rights and remedies with respect to such failure by
the Company. Notwithstanding the foregoing the Company shall not be liable to
the Holder under clause (B) of the immediately preceding sentence to the extent
the failure of the Company to deliver or to cause to be delivered such shares of
Common Stock results from fire, flood, storm, earthquake, shipwreck, strike,
war, acts of terrorism, crash involving facilities of a common carrier, acts of
God, or any similar event outside the control of the Company (it being
understood that the action or failure to act of the Transfer Agent shall not be
deemed an event outside the control of the Company except to the extent
resulting from fire, flood, storm, earthquake, shipwreck, strike, war, acts of
terrorism, crash involving facilities of a common carrier, acts of God, or any
similar event outside the control of the Transfer Agent or the bankruptcy,
liquidation or reorganization of the Transfer Agent under any bankruptcy,
insolvency or other similar law). In the case of the Company’s failure to issue
and deliver or cause to be delivered the shares of Common Stock to the Holder
within three Trading Days of a particular conversion of the Note, the amount
payable by the Company pursuant to clause (B) of this Section 6.2(e)(2) with
respect to such conversion shall be reduced by the amount of payments previously
paid by the Company to the Holder pursuant to Section 8(a)(4) of the Purchase
Agreement with respect to such conversion. The Holder shall notify the Company
in writing (or by telephone conversation, confirmed in writing) as promptly as
practicable following the third Trading Day after the Holder gives a Conversion
Notice if the Holder becomes aware that such shares of Common Stock so issuable
have not been received as provided herein, but any failure so to give such
notice shall not affect the Holder's rights under this Note or otherwise. If the
Holder shall have exercised the conversion right in any particular instance and
either (1) the Company shall notify the Holder on or after the date the Holder
gives such Conversion Notice that the shares of Common Stock issuable upon such
conversion might not be delivered within three Trading Days after the date the
Holder gives such Conversion Notice or (2) the Holder learns after the date
which is three Trading Days after the date the Holder gives such Conversion
Notice that the Holder has not received such shares of Common Stock, then,
without releasing the Company of its obligations with respect thereto, from and
after the Trading Day next succeeding the earlier of the events described in the
preceding clauses (1) and (2) of this sentence the Holder shall make reasonable
efforts not to sell shares of Common Stock in anticipation of receipt of such
shares of Common Stock in a manner which is likely to increase materially the
liability of the Company under clause (B) of the first sentence of this Section
6.2(e)(2).
(f)
No
fractional shares of Common Stock shall be issued upon conversion of this Note
but, in lieu of any fraction of a share of Common Stock which would otherwise be
issuable in respect of such conversion, the Company may round the number of
shares of Common Stock issued on such conversion up to the next highest whole
share or may pay lawfulmoney of the United States of America for such fractional
share, based on a value of one share of Common Stock being equal to the Market
Price of the Common Stock on the applicable Conversion Date.
6.3
Adjustment of Conversion
Price
.
The
Conversion Price shall be adjusted from time to time by the Company as
follows:
(a)
Adjustments for Certain Dividends
and Distributions in Common Stock.
In case
the Company shall on or after the Issuance Date pay a dividend or make a
distribution to all holders of the outstanding Common Stock in shares of Common
Stock, the Conversion Price in effect at the opening of business on the date
following the date fixed for the determination of stockholders entitled to
receive such dividend or other distribution shall be reduced by multiplying such
Conversion Price by a fraction of which the numerator shall be the number of
shares of Common Stock outstanding at the close of business on the Record Date
fixed for such determination and the denominator shall be the sum of such number
of shares and the total number of shares constituting such dividend or other
distribution, such reduction to become effective immediately after the opening
of business on the day following the Record Date. If any dividend or
distribution of the type described in this Section 6.3(a) is declared but not so
paid or made, the Conversion Price shall again be adjusted to the Conversion
Price which would then be in effect if such dividend or distribution had not
been declared.
(b)
Weighted Adjustments for Certain
Issuances of Rights or Warrants.
In case
the Company shall on or after the Issuance Date issue rights or warrants (other
than any rights or warrants referred to in Section 6.3(d)) to all holders of its
outstanding shares of Common Stock entitling them (for a period expiring within
45 days after the date fixed for the determination of stockholders entitled to
receive such rights or warrants) to subscribe for or purchase shares of Common
Stock at a price per share less than the Current Market Price on the Record Date
fixed for the determination of stockholders entitled to receive such rights or
warrants, the Conversion Price shall be adjusted so that the same shall equal
the price determined by multiplying the Conversion Price in effect at the
opening of business on the date after such Record Date by a fraction of which
the numerator shall be the number of shares of Common Stock outstanding at the
close of business on the Record Date plus the number of shares which the
aggregate offering price of the total number of shares so offered would purchase
at such Current Market Price, and the denominator shall be the number of shares
of Common Stock outstanding on the close of business on the Record Date plus the
total number of additional shares of Common Stock so offered for subscription or
purchase. Such adjustment shall become effective immediately after the opening
of business on the day following the Record Date fixed for determination of
stockholders entitled to receive such rights or warrants. To the extent that
shares of Common Stock are not delivered pursuant to such rights or warrants,
upon the expiration or termination of such rights or warrants, the Conversion
Price shall be readjusted to the Conversion Price which would then be in effect
had the adjustments made upon the issuance of such rights or warrants been made
on the basis of delivery of only the number of shares of Common Stock actually
delivered. In the event that such rights or warrants are not so issued, the
Conversion Price shall again be adjusted to be the Conversion Price which would
then be in effect if such date fixed for the determination of stockholders
entitled to receive such rights or warrants had not been fixed. In determining
whether any rights or warrants entitle the holder to subscribe for or purchase
shares of Common Stock at less than such Current Market Price, and in
determining the aggregate offering price of such shares of Common Stock, there
shall be taken into account any consideration received for such rights or
warrants, the value of such consideration, if other than cash, to be determined
by the Board of Directors. Notwithstanding the foregoing, if any of the
adjustments as set forth in this Section 6.3(b) will require the Company to seek
stockholder approval pursuant to Rule 713 of the AMEX and such stockholder
approval has not yet been obtained, then the adjustment shall not take effect
until such stockholder approval is obtained. The Company shall use its
commercially reasonable best efforts to obtain, as promptly as practicable, but
in no event later than 90 days thereafter, the stockholder approval that is
necessary under the rules of the AMEX.
(c)
Adjustments for Certain Subdivisions
of the Common Stock.
In case
the outstanding shares of Common Stock shall on or after the Issuance Date be
subdivided into a greater number of shares of Common Stock, the Conversion Price
in effect at the opening of business on the earlier of the day following the day
upon which such subdivision becomes effective and the day on which “ex-” trading
of the Common Stock begins with respect to such subdivision shall be
proportionately reduced, and conversely, in case outstanding shares of Common
Stock shall be combined into a smaller number of shares of Common Stock, the
Conversion Price in effect at the opening of business on the earlier of the day
following the day upon which such combination becomes effective and the day on
which “ex-” trading of the Common Stock with respect to such combination begins
shall be proportionately increased, such reduction or increase, as the case may
be, to become effective immediately after the opening of business on the earlier
of the day following the day upon which such subdivision or combination becomes
effective and the day on which “ex-” trading of the Common Stock begins with
respect to such subdivision or combination.
(d)
Adjustments for Certain Dividends
and Distributions.
In case
the Company shall on or after the Issuance Date, by dividend or otherwise,
distribute to all holders of its Common Stock shares of any class of capital
stock of the Company (other than any dividends or distributions to which Section
6.3(a) applies) or evidences of its indebtedness, cash or other assets
(including securities, but excluding any rights or warrants referred to in
Section 6.3(b) and dividends and distributions paid exclusively in cash and
excluding any capital stock, evidences of indebtedness, cash or assets
distributed upon a merger or consolidation to which Section 6.6 applies) (the
foregoing hereinafter in this Section 6.3(d) called the “Securities”)), then, in
each such case, subject to the second paragraph of this Section 6.3(d), the
Conversion Price shall be reduced so that the same shall be equal to the price
determined by multiplying the Conversion Price in effect immediately prior to
the close of business on the Record Date with respect to such distribution by a
fraction of which the numerator shall be the Current Market Price on such date
less the fair market value (as determined by the Board of Directors, whose
determination shall be conclusive and described in a Board Resolution) on such
date of the portion of the Securities so distributed applicable to one share of
Common Stock and the denominator shall be such Current Market Price, such
reduction to become effective immediately prior to the opening of business on
the day following the Record Date;
provided, however,
that in
the event the then fair market value (as so determined) of the portion of the
Securities so distributed applicable to one share of Common Stock is equal to or
greater than the Current Market Price on the Record Date, in lieu of the
foregoing adjustment, adequate provision shall be made so that the Holder shall
have the right to receive upon conversion of this Note (or any portion hereof)
the amount of Securities such holder would have received had such holder
converted this Note (or portion hereof) immediately prior to such Record Date.
In the event that such dividend or distribution is not so paid or made, the
Conversion Price shall again be adjusted to be the Conversion Price which would
then be in effect if such dividend or distribution had not been declared. If the
Board of Directors determines the fair market value of any distribution for
purposes of this Section 6.3(d) by reference to the actual or when issued
trading market for any Securities comprising all or part of such distribution,
it must in doing so consider the prices in such market over the same period used
in computing the Current Market Price, to the extent possible.
Rights or
warrants distributed by the Company to all holders of Common Stock entitling the
holders thereof to subscribe for or purchase shares of the Company's capital
stock (either initially or under certain circumstances), which rights or
warrants, until the occurrence of a specified event or events (a “Trigger
Event”): (i) are deemed to be transferred with such shares of Common Stock; (ii)
are not exercisable; and (iii) are also issued in respect of future issuances of
Common Stock, shall not be deemed to have been distributed for purposes of this
Section 6.3 (and no adjustment to the Conversion Price under this Section 6.3
will be required) until the occurrence of the earliest Trigger Event. If any
such rights or warrants, including any such existing rights or warrants
distributed prior to the Issuance Date, are subject to Trigger Events, upon the
satisfaction of each of which such rights or warrants shall become exercisable
to purchase different securities, evidences of indebtedness or other assets,
then the occurrence of each such Trigger Event shall be deemed to be such date
of issuance and record date with respect to new rights or warrants (and a
termination or expiration of the existing rights or warrants without exercise by
the holder thereof) (so that, by way of illustration and not limitation, the
dates of issuance of any such rights shall be deemed to be the dates on which
such rights become exercisable to purchase capital stock of the Company, and not
the date on which such rights may be issued, or may become evidenced by separate
certificates, if such rights are not then so exercisable). In addition, in the
event of any distribution of rights or warrants, or any Trigger Event with
respect thereto, that was counted for purposes of calculating a distribution
amount for which an adjustment to the Conversion Price under this Section 6.3
was made (1) in the case of any such rights or warrants which shall all have
been redeemed or repurchased without exercise by any holders thereof, the
Conversion Price shall be readjusted upon such final redemption or repurchase to
give effect to such distribution or Trigger Event, as the case may be, as though
it were a cash distribution, equal to the per share redemption or repurchase
price received by a holder or holders of Common Stock with respect to such
rights or warrants (assuming such holder had retained such rights or warrants),
made to all holders of Common Stock as of the date of such redemption or
repurchase, and (2) in the case of such rights or warrants which shall have
expired or been terminated without exercise by any holders thereof, the
Conversion Price shall be readjusted as if such rights and warrants had not been
issued.
For
purposes of this Section 6.3(d) and Sections 6.3(a) and (b), any dividend or
distribution to which this Section 6.3(d) is applicable that also includes
shares of Common Stock, or rights or warrants to subscribe for or purchase
shares of Common Stock to which Section 6.3(b) applies (or both), shall be
deemed instead to be (1) a dividend or distribution of the evidences of
indebtedness, assets, shares of capital stock, rights or warrants other than
such shares of Common Stock or rights or warrants to which Section 6.3(b)
applies (and any Conversion Price reduction required by this Section 6.3(d) with
respect to such dividend or distribution shall then be made) immediately
followed by (2) a dividend or distribution of such shares of Common Stock or
such rights or warrants (and any further Conversion Price reduction required by
Sections 6.3(a) and (b) with respect to such dividend or distribution shall then
be made), except (A) the Record Date of such dividend or distribution shall be
substituted as “the date fixed for the determination of stockholders entitled to
receive such dividend or other distribution”, “Record Date fixed for such
determination” and “Record Date” within the meaning of Section 6.3(a) and as
“the date fixed for the determination of stockholders entitled to receive such
rights or warrants”, “the Record Date fixed for the determination of the
stockholders entitled to receive such rights or warrants” and “such Record Date”
within the meaning of Section 6.3(b)
and (B)
any shares of Common Stock included in such dividend or distribution shall not
be deemed “outstanding at the close of business on the Record Date fixed for
such determination” within the meaning of Section
6.3(a).
(e)
Adjustments for Certain Cash
Dividends.
In case
the Company shall on or after the Issuance Date, by dividend or otherwise,
distribute to all holders of its Common Stock cash (excluding any cash that is
distributed upon a merger or consolidation to which Section 6.5 applies or as
part of a distribution referred to in Section 6.3(d)) in an aggregate amount
that, combined with (1) the aggregate amount of any other such distributions to
all holders of its Common Stock made exclusively in cash within the 12 months
preceding the date of payment of such distribution, and in respect of which no
adjustment pursuant to this Section 6.3(e) has been made, and (2) the aggregate
of any cash plus the fair market value (as determined by the Board of Directors,
whose determination shall be conclusive and set forth in a Board Resolution) of
consideration payable in respect of any Tender Offer by the Company or any
Subsidiary for all or any portion of the Common Stock concluded within the 12
months preceding the date of payment of such distribution, exceeds 1% of the
product of (x) the Current Market Price on the Record Date with respect to such
distribution
times
(y) the
number of shares of Common Stock outstanding on such date, then, and in each
such case, immediately after the close of business on such date, unless the
Company elects to reserve such cash for distribution to the Holder upon the
conversion of this Note (and shall have made adequate provision) so that the
Holder will receive upon such conversion, in addition to the shares of Common
Stock to which the Holder is entitled, the amount of cash which the Holder would
have received if the Holder had, immediately prior to the Record Date for such
distribution of cash, converted this Note into Common Stock, the Conversion
Price shall be reduced so that the same shall equal the price determined by
multiplying the Conversion Price in effect immediately prior to the close of
business on such Record Date by a fraction (i) the numerator of which shall be
equal to the Current Market Price on the Record Date less an amount equal to the
quotient of (x) the excess of such combined amount over such 1% and (y) the
number of shares of Common Stock outstanding on the Record Date and (ii) the
denominator of which shall be equal to the Current Market Price on the Record
Date;
provided, however,
that in
the event the portion of the cash so distributed applicable to one share of
Common Stock is equal to or greater than the Current Market Price of the Common
Stock on the Record Date, in lieu of the foregoing adjustment, adequate
provision shall be made so that the Holder shall have the right to receive upon
conversion of this Note (or any portion hereof) the amount of cash the Holder
would have received had the Holder converted this Note (or portion hereof)
immediately prior to such Record Date. In the event that such dividend or
distribution is not so paid or made, the Conversion Price shall again be
adjusted to be the Conversion Price which would then be in effect if such
dividend or distribution had not been declared.
(
f
)
Adjustment in Connection Sales by a
Designated Person.
(1) If at
any time on or after the Issuance Date any Designated Person, directly or
indirectly, sells, transfers or disposes of shares of Common Stock or Common
Stock Equivalents other than a Permitted Designated Person Sale and on the
Measurement Date for such sale, transfer or disposition the Conversion Price in
effect on such Measurement Date is greater than the Computed Market Price on
such Measurement Date, then, subject to the next succeeding sentence, the
Conversion
Price shall be reduced to such Computed Market Price
, such
adjustment to become effective immediately after the opening of business on the
day following the Measurement Date. If a reduction of the Conversion Price to
such Computed Market Price pursuant to the immediately preceding sentence would
require the Company to seek stockholder approval of the transactions
contemplated by the Note Purchase Agreement pursuant to Rule 713 of the AMEX and
the Stockholder Approval has not yet been obtained, then the adjustment provided
in this Section 6.3(f) shall not take effect until such time as the Stockholder
Approval is obtained at which time the Conversion Price shall be reduced to such
Computed Market Price.
(2)
The
Company shall enter into an agreement with each Designated Person, on or before
the date that is 30 days after the Issuance Date, pursuant to which each
Designated Person shall agree that upon the written request of the Company or
any Holder, the Designated Person shall provide the Company and such Holder, a
written statement setting forth the dates, if any, upon which the Designated
Person has sold, transferred or disposed of any shares of Common Stock or Common
Stock Equivalents during such period as shall be reasonably requested by the
Company or such Holder to determine whether or not a sale, transfer or
disposition that requires an adjustment pursuant to Section 6.3(f)(1) has
occurred. The Company shall instruct the Transfer Agent to inform the Company
immediately upon the sale, transfer or disposition of any shares of Common Stock
or Common Stock Equivalents by any Designated Person. The Company shall inform
the Holder immediately by phone and electronic transmission upon becoming aware
of any sale, transfer or disposition of any shares of Common Stock or Common
Stock Equivalents by any Designated Person and will follow up with formal
written notice to the Holder pursuant to Section 7.2.
(
g
)
Additional Reductions in Conversion
Price.
The
Company may make such reductions in the Conversion Price, in addition to those
required by Sections 6.3(a), (b), (c), (d), (e) and (f), as the Board of
Directors considers to be advisable to avoid or diminish any income tax to
holders of Common Stock or rights to purchase Common Stock resulting from any
dividend or distribution of stock (or rights to acquire stock) or from any event
treated as such for income tax purposes.
(
h
)
De Minimus
Adjustments.
No
adjustment in the Conversion Price shall be required unless such adjustment
would require an increase or decrease of at least 1% in such price;
provided, however,
that any
adjustments which by reason of this Section 6.3(h) are not required to be made
shall be carried forward and taken into account in any subsequent adjustment.
All calculations under this Article VI shall be made by the Company and shall be
made to the nearest cent or to the nearest one hundredth of a share, as the case
may be.
No
adjustment need be made for a change in the par value of the Common Stock or
from par value to no par value or from no par value to par value.
(
i
)
Company Notice of
Adjustments.
Whenever
the Conversion Price is adjusted as herein provided, the Company shall promptly,
but in no event later than five days thereafter, give a notice to the Holder
setting forth the Conversion Price after such adjustment and setting forth a
brief statement of the facts requiring such adjustment, but which statement
shall not include any information which would be material non-public information
for purposes of the 1934 Act. Failure to deliver such notice shall not affect
the legality or validity of any such adjustment.
(j)
Effectiveness of Certain
Adjustments.
In any
case in which this Section 6.3 provides that an adjustment shall become
effective immediately after a Record Date for an event, the Company may defer
until the occurrence of such event (i) issuing to the Holder in connection with
any conversion of this Note after such Record Date and before the occurrence of
such event the additional shares of Common Stock issuable upon such conversion
by reason of the adjustment required by such event over and above the Common
Stock issuable upon such conversion before giving effect to such adjustment and
(ii) paying to such holder any amount in cash in lieu of any fraction pursuant
to Section 6.2(f).
(k)
Outstanding
Shares.
For
purposes of this Section 6.3, the number of shares of Common Stock at any time
outstanding shall not include shares held in the treasury of the Company but
shall include shares issuable in respect of scrip certificates issued in lieu of
fractions of shares of Common Stock. The Company will not pay any dividend or
make any distribution on shares of Common Stock held in the treasury of the
Company other than dividends or distributions payable only in shares of Common
Stock.
6.4
Effect of Reclassification,
Consolidation, Merger or Sale.
(a) If
any of the following events occur, namely:
(i)
any
reclassification or change of the outstanding shares of Common Stock (other than
a change in par value, or from par value to no par value, or from no par value
to par value, or as a result of a subdivision or combination),
(ii)
any
consolidation, merger or combination of the Company with another corporation as
a result of which holders of Common Stock shall be entitled to receive stock,
securities or other property or assets (including cash) with respect to or in
exchange for such Common Stock, or
(iii)
any sale
or conveyance of the properties and assets of the Company as, or substantially
as, an entirety to any other corporation as a result of which holders of Common
Stock shall be entitled to receive stock, securities or other property or assets
(including cash) with respect to or in exchange for such Common
Stock,
then the
Company or the successor or purchasing Person, as the case may be, shall execute
with the Holder a written agreement providing that:
(x)
this Note
shall be convertible into the kind and amount of shares of stock and other
securities or property or assets (including cash) receivable upon such
reclassification, change, consolidation, merger, statutory exchange,
combination, sale or conveyance by the holder of the number of shares of Common
Stock issuable upon conversion of this Note in full (assuming, for such
purposes, a sufficient number of authorized shares of Common Stock available to
convert this Note) immediately prior to such reclassification, change,
consolidation, merger, statutory exchange, combination, sale or conveyance
assuming such holder of Common Stock did not exercise such holder's rights of
election, if any, as to the kind or amount of securities, cash or other property
receivable upon such consolidation, merger, statutory exchange, combination,
sale or conveyance (
provided
that, if
the kind or amount of securities, cash or other property receivable upon such
consolidation, merger, statutory exchange, sale or conveyance is not the same
for each share of Common Stock in respect of which such rights of election shall
not have been exercised (“non-electing share”), then for the purposes of this
Section 6.4 the kind and amount of securities, cash or other property receivable
upon such consolidation, merger, statutory exchange, combination, sale or
conveyance for each non-electing share shall be deemed to be the kind and amount
so receivable per share by a plurality of the non-electing
shares),
(y)
in the
case of any such successor or purchasing Person, upon such consolidation,
merger, statutory exchange, combination, sale or conveyance such successor or
purchasing Person shall be jointly and severally liable with the Company for the
performance of all of the Company's obligations under this Note and the Note
Purchase Agreement and
(z)
if
registration or qualification is required under the 1933 Act or applicable state
law for the public resale by the Holder of such shares of stock and other
securities so issuable upon conversion of this Note, such registration or
qualification shall be completed prior to such reclassification, change,
consolidation, merger, statutory exchange, combination, sale or
conveyance.
Such
written agreement shall provide for adjustments which shall be as nearly
equivalent as may be practicable to the adjustments provided for in this
Article. If, in the case of any such reclassification, change, consolidation,
merger, statutory exchange, combination, sale or conveyance, the stock or other
securities and assets receivable thereupon by a holder of shares of Common Stock
includes shares of stock or other securities and assets of a corporation other
than the successor or purchasing corporation, as the case may be, in such
reclassification, change, consolidation, merger, statutory exchange,
combination, sale or conveyance, then such written agreement shall also be
executed by such other corporation and shall contain such additional provisions
to protect the interests of the Holder as the Board of Directors shall
reasonably consider necessary by reason of the foregoing, including, to the
extent practicable, the provisions providing for the repurchase rights set forth
in Article V herein.
(b)
The above
provisions of this Section shall similarly apply to successive
reclassifications, changes, consolidations, mergers, statutory exchanges,
combinations, sales and conveyances.
(c)
If this
Section 6.4 applies to any event or occurrence, Section 6.3 shall not
apply.
6.5
Reservation of Shares; Shares to Be
Fully Paid; Listing of Common Stock
.
(a)
The
Company shall reserve and keep available, free from preemptive rights, out of
its authorized but unissued shares of Common Stock or shares of Common Stock
held in treasury, solely for issuance upon conversion of this Note, and in
addition to the shares of Common Stock required to be reserved by the terms of
the Other Notes, Warrants and the Other
Warrants,
sufficient shares to provide for the conversion of this Note from time to time
as this Note is converted.
(b)
Before
taking any action which would cause an adjustment reducing the Conversion Price
below the then par value, if any, of the shares of Common Stock issuable upon
conversion of this Note, the Company will take all corporate action which may,
in the opinion of its counsel, be necessary in order that the Company may
validly and legally issue shares of such Common Stock at such adjusted
Conversion Price.
(c)
The
Company covenants that all shares of Common Stock issued upon conversion of this
Note will be fully paid and non-assessable by the Company and free from all
taxes, liens and charges with respect to the issue thereof.
(d)
The
Company covenants that if any shares of Common Stock to be provided for the
purpose of conversion of, or payment of interest on, this Note hereunder require
registration with or approval of any governmental authority under any federal or
state law before such shares may be validly issued upon conversion or in payment
of interest, the Company will in good faith and as expeditiously as possible
endeavor to secure such registration or approval, as the case may
be.
(e)
The
Company covenants that, in the event the Common Stock shall be listed on the
Nasdaq, the Nasdaq Capital Market, the NYSE, the AMEX or any other national
securities exchange, the Company shall obtain and, so long as the Common Stock
shall be so listed on such market or exchange, maintain approval for listing
thereon of all Common Stock issuable upon conversion of or in payment of
interest on this Note.
6.6
Notice to Holder Prior to Certain
Actions
.
In case
on or after the Issuance Date:
(a)
the
Company shall declare a dividend (or any other distribution) on its Common Stock
(other than in cash out of retained earnings); or
(b)
the
Company shall authorize the granting to the holders of its Common Stock of
rights or warrants to subscribe for or purchase any share of any class or any
other rights or warrants; or
(c)
the Board
of Directors shall authorize any reclassification of the Common Stock of the
Company (other than a subdivision or combination of its outstanding Common
Stock, or a change in par value, or from par value to no par value, or from no
par value to par value), or any consolidation or merger or other business
combination transaction to which the Company is a party and for which approval
of any stockholders of the Company is required, or the sale or transfer of all
or substantially all of the assets of the Company; or
(d)
there
shall be pending the voluntary or involuntary dissolution, liquidation or
winding-up of the Company;
the
Company shall give the Holder, as promptly as possible but in any event at least
ten Trading Days prior to the applicable date hereinafter specified, a notice
stating (x) the date on which a record is to be taken for the purpose of such
dividend, distribution or rights or warrants, or, if a record is not to be
taken, the date as of which the holders of Common Stock of record to be entitled
to such dividend, distribution or rights are to be determined, or (y) the date
on which such reclassification, consolidation, merger, other business
combination transaction, sale, transfer, dissolution, liquidation or winding-up
is expected to become effective or occur, and the date as of which it is
expected that holders of Common Stock of record who shall be entitled to
exchange their Common Stock for securities or other property deliverable upon
such reclassification, consolidation, merger, other business combination
transaction, sale, transfer, dissolution, liquidation or winding-up shall be
determined. Such notice shall not include any information which would be
material non-public information for purposes of the 1934 Act. Failure to give
such notice, or any defect therein, shall not affect the legality or validity of
such dividend, distribution, reclassification, consolidation, merger, sale,
transfer, dissolution, liquidation or winding-up. In the case of any such action
of which the Company gives such notice to the Holder or is required to give such
notice to the Holder, the Holder shall be entitled to give a Conversion Notice
which is contingent on the completion of such action.
6.7
Restricted Ownership Percentage
Limitation
.
(a)
Notwithstanding anything to the contrary contained herein, the number of shares
of Common Stock that may be acquired at any time by the Holder upon conversion
of the Note shall not exceed a number that, when added to the total number of
shares of Common Stock deemed beneficially owned by such Holder (other than by
virtue of the ownership of securities or rights to acquire securities (including
the Warrants) that have limitations on the holder's right to convert, exercise
or purchase similar to the limitation set forth herein (the “Excluded Shares”)),
together with all shares of Common Stock beneficially owned at such time (other
than by virtue of the ownership of Excluded Shares) by Persons whose beneficial
ownership of Common Stock would be aggregated with the beneficial ownership by
the Holder for purposes of determining whether a group exists or for purposes of
determining the Holder’s beneficial ownership (the “Aggregation Parties”), in
either such case for purposes of Section 13(d) of the 1934 Act and Regulation
13D-G thereunder (including, without limitation, as the same is made applicable
to Section 16 of the 1934 Act and the rules promulgated thereunder), would
result in beneficial ownership by the Holder or such group of more than 9.9% of
the shares of Common Stock for purposes of Section 13(d) or Section 16 of the
1934 Act and the rules promulgated thereunder (as the same may be modified by a
particular Holder as provided herein, the “Restricted Ownership Percentage”).
The Holder shall have the right at any time and from time to time to reduce its
Restricted Ownership Percentage immediately upon notice to the Company in the
event and only to the extent that Section 16 of the 1934 Act or the rules
promulgated thereunder (or any successor statute or rules) is changed to reduce
the beneficial ownership percentage threshold thereunder to a percentage less
than 10%. If at any time the limits in this Section 6.7 make the Note
inconvertible in whole or in part, the Company shall not by reason thereof be
relieved of its obligation to issue shares of Common Stock at any time or from
time to time thereafter upon conversion of the Note as and when shares of Common
Stock may be issued in compliance with such restrictions.
(b)
For
purposes of this Section 6.7, in determining the number of outstanding shares of
Common Stock at any time the Holder may rely on the number of outstanding shares
of Common Stock as reflected in (1) the Company's then most recent Form 10-Q,
Form 10-K or
other
public filing with the SEC, as the case may be, (2) a public announcement by the
Company that is later than any such filing referred to in the preceding clause
(1) or (3) any other notice by the Company or its transfer agent setting forth
the number shares of Common Stock outstanding and knowledge the Holder may have
about the number of shares of Common Stock issued upon conversions or exercises
of this Note, the Other Notes, the Warrants, the Other Warrants or other Common
Stock Equivalents by any Person, including the Holder, which are not reflected
in the information referred to in the preceding clauses (1) through (3). Upon
the written request of any Holder, the Company shall within three Business Days
confirm in writing to such Holder the number of shares of Common Stock then
outstanding. In any case, the number of outstanding shares of Common Stock shall
be determined after giving effect to the conversion or exercise of Common Stock
Equivalents, including the Notes and the Warrants, by the Holder or its
Affiliates, in each such case subsequent to, the date as of which such number of
outstanding shares of Common Stock was reported.
ARTICLE VII
MISCELLANEOUS
7.1
Failure or Indulgency Not
Waiver.
No
failure or delay on the part of the Holder in the exercise of any power, right
or privilege hereunder shall operate as a waiver thereof, nor shall any single
or partial exercise of any such power, right or privilege preclude other or
further exercise thereof or of any other right, power or privileges. All rights
and remedies existing hereunder are cumulative to, and not exclusive of, any
rights or remedies otherwise available. The Company stipulates that the remedies
at law of the Holder in the event of any default or threatened default by the
Company in the performance of or compliance with any of the terms of this Note
are not and will not be adequate, and that such terms may be specifically
enforced (x) by a decree for the specific performance of any agreement contained
herein, including, without limitation, a decree for issuance of the shares of
Common Stock (or other securities) issuable upon conversion of this Note or (y)
by an injunction against a violation of any of the terms hereof or (z)
otherwise.
7.2
Notices.
Except
as otherwise specifically provided herein, any notice herein required or
permitted to be given shall be in writing and may be personally served, sent by
telephone line facsimile transmission or delivered by courier or sent by United
States mail and shall be deemed to have been given upon receipt if personally
served, sent by telephone line facsimile transmission or sent by courier or
three days after being deposited in the facilities of the United States Postal
Service, certified, with postage pre-paid and properly addressed, if sent by
mail. For the purposes hereof, the address and facsimile line transmission
number of the Holder shall be as furnished by the Holder for such purpose and
shown on the records of the Company; and the address of the Company shall be
eMagin Corporation, 10500 N.E. 8
th
Street,
Suite 1400, Bellevue, Washington 98004, Attention: Chief Financial Officer
(telephone line facsimile number (425) 749-3601. The Holder or the Company may
change its address for notice by service of written notice to the other as
herein provided.
7.3
Amendment,
Waiver.
(a)
Neither this Note or any Other Note nor any terms hereof or thereof may be
changed, amended, discharged or terminated unless such change,amend
ment,
discharge or termination is in writing signed by the Company and the Majority
Holders, provided that no such change, amendment, discharge or termination
shall, without the consent of the Holder and the holders of the Other Notes
affected thereby (i) extend the scheduled Installment Maturity Date or Final
Maturity Date of this Note or any Other Note, or reduce the rate or extend the
time of payment of interest (other than as a result of waiving the applicability
of any post-default increase in interest rates) hereon or thereon or reduce the
principal amount hereof or thereof or the Repurchase Price or the Optional
Redemption Price hereof or thereof, (ii) increase or decrease the Conversion
Price except as set forth in this Note, (iii) release the Collateral or reduce
the amount of Collateral required to be deposited or maintained by the Company
pursuant to the Security Agreement, except as expressly provided in the Security
Agreement, (iv) amend, modify or waive any provision of this Section 7.3 or
(v) reduce any percentage specified in, or otherwise modify, the definition of
Majority Holders.
Notwithstanding anything
to the contrary contained herein, no amendment or waiver shall increase or
eliminate the Restricted Ownership Percentage, whether permanently or
temporarily, unless, in addition to complying with the other requirements of
this Note, such amendment or waiver shall have been approved in accordance with
the General Corporation Law of the State of Delaware and the Company's By-laws
by holders of the outstanding shares of Common Stock entitled to vote at a
meeting or by written consent in lieu of such
meeting
.
(b)
Any term
or condition of this Note may be waived by the Holder or the Company at any time
if the waiving party is entitled to the benefit thereof, but no such waiver
shall be effective unless set forth in a written instrument duly executed by or
on behalf of the party waiving such term or condition. No waiver by any party of
any term or condition of this Note, in any one or more instances, will be deemed
to be or construed as a waiver of the same or any other term or condition of
this Note on any future occasion.
7.4
Assignability.
This
Note shall be binding upon the Company and its successors, and shall inure to
the benefit of and be binding upon the Holder and its successors and permitted
assigns. The Company may not assign its rights or obligations under this
Note.
7.5
Certain
Expenses.
The
Company shall pay on demand all expenses incurred by the Holder, including
reasonable attorneys' fees and expenses, as a consequence of, or in connection
with (x) any amendment or waiver of this Note or any other Transaction Document,
(y) any default or breach of any of the Company’s obligations set forth in the
Transaction Documents and (z) the enforcement or restructuring of any right of,
including the collection of any payments due, the Holder under the Transaction
Documents, including any action or proceeding relating to such enforcement or
any order, injunction or other process seeking to restrain the Company from
paying any amount due the Holder.
7.6
Governing
Law.
This
Note shall be governed by the internal laws of the State of New York, without
regard to the principles of conflict of laws.
7.7
Transfer of
Note.
This
Note has not been and is not being registered under the provisions of the 1933
Act or any state securities laws and this Note may not be transferred prior to
the end of the holding period applicable to sales hereof under Rule 144(k)
unless (1) the transferee is an “accredited investor” (as defined in Regulation
D under the 1933 Act) and (2) the Holder shall have delivered to the Company an
opinion of counsel, reasonably
satisfactory
in form, scope and substance to the Company, to the effect that this Note may be
sold or transferred without registration under the 1933 Act. Prior to any such
transfer, such transferee shall have represented in writing to the Company that
such transferee has requested and received from the Company all information
relating to the business, properties, operations, condition (financial or
other), results of operations or prospects of the Company and the Subsidiaries
deemed relevant by such transferee; that such transferee has been afforded the
opportunity to ask questions of the Company concerning the foregoing and has had
the opportunity to obtain and review the reports and other information
concerning the Company which at the time of such transfer have been filed by the
Company with the SEC pursuant to the 1934 Act. If such transfer is intended to
assign the rights and obligations under Section 5, 8, 9 and 10 of the Note
Purchase Agreement, such transfer shall otherwise be made in compliance with
Section 10(j) of the Note Purchase Agreement.
7.8
Enforceable
Obligation.
The
Company represents and warrants that at the time of the original issuance of
this Note it received the full purchase price payable pursuant to the Note
Purchase Agreement in an amount at least equal to the original principal amount
of this Note, and that this Note is an enforceable obligation of the Company
which is not subject to any offset, reduction, counterclaim or disallowance of
any sort.
7.9
Note Register; Replacement of
Notes.
The
Company shall maintain a register showing the names, addresses and telephone
line facsimile numbers of the Holder and the registered holders of the Other
Notes. The Company shall also maintain a facility for the registration of
transfers of this Note and the Other Notes and at which this Note and the Other
Notes may be surrendered for split up into instruments of smaller denominations
or for combination into instruments of larger denominations. Upon receipt by the
Company of evidence reasonably satisfactory to it of the ownership of and the
loss, theft, destruction or mutilation of this Note and (a) in the case of loss,
theft or destruction, of indemnity from the Holder reasonably satisfactory in
form to the Company (and without the requirement to post any bond or other
security) or (b) in the case of mutilation, upon surrender and cancellation of
this Note, the Company will execute and deliver to the Holder a new Note of like
tenor without charge to the Holder.
7.10
Payment of Note on Redemption or
Repurchase; Deposit of Optional Redemption Price or Repurchase Price,
Etc
.
(a) If
this Note or any portion of this Note is to be redeemed as provided in Section
2.1 or repurchased as provided in Sections 5.1 and 5.2 and any notice required
in connection therewith shall have been given as provided therein and the
Company shall have otherwise complied with the requirements of this Note with
respect thereto, then this Note or the portion of this Note to be so redeemed or
repurchased and with respect to which any such notice has been given shall
become due and payable on the date stated in such notice at the Optional
Redemption Price or Repurchase Price. On and after the Optional Redemption Date
or repurchase date so stated in such notice, provided that the Company shall
have deposited with an Eligible Bank on or prior to such Optional Redemption
Date or repurchase date, an amount in cash sufficient to pay the Optional
Redemption Price or Repurchase Price, interest on this Note or the portion of
this Note to be so redeemed or repurchased shall cease to accrue, and this Note
or such portion hereof shall be deemed not to be outstanding and shall not be
entitled to any benefit with respect
to
principal of or interest on the portion to be so redeemed or repurchased except
to receive payment of the Optional Redemption P
rice or
Repurchase Price. On presentation and
surrender
of this Note or such portion hereof, this Note or the specified portion hereof
shall be paid and repurchased at the Optional Redemption Price or Repurchase
Price. If a portion of this Note is to be redeemed or repurchased, upon
surrender of this Note to the Company in accordance with the terms hereof, the
Company shall execute and deliver to the Holder without service charge, a new
Note or Notes, having the same date hereof and containing identical terms and
conditions, in such denomination or denominations as requested by the Holder in
aggregate principal amount equal to, and in exchange for, the unredeemed or
unrepurchased portion of the principal amount of this Note so
surrendered.
(b)
Upon the
payment in full of all amounts payable by the Company under this Note or the
deposit thereof as provided in Section 7.10(a), thereafter the obligations of
the Company under this Note shall be as set forth in this Article VII, and, in
the case of such deposit, to pay the Repurchase Price, from the funds so
deposited. Upon such payment or deposit, any Event of Default which occurred
prior to such payment or deposit by reason of one or more provisions of this
Note with which the Company thereafter is no longer obligated to comply, then
shall no longer exist.
7.11
Conversion
Schedule.
Promptly
after each conversion of this Note pursuant to Section 6, the Holder shall
record on a schedule, in substantially the form attached as
Exhibit E
, the
amount by which the outstanding principal of this Note has been reduced by
reason of such conversion. Such schedule shall be conclusive and binding on the
Company and the Holder, in the absence of manifest error. The Holder shall from
time to time, upon request made by notice from the Company, furnish a copy of
such schedule to the Company. The Holder shall also furnish a copy of such
schedule upon request to any proposed transferee of this Note.
7.12
Construction.
The
language used in this Note will be deemed to be the language chosen by the
Company and the original Holder of this Note (or its predecessor instrument) to
express their mutual intent, and no rules of strict construction will be applied
against the Company or the Holder.
[Remainder of Page Intentionally
Left Blank]
IN WITNESS WHEREOF
, the
Company has caused this Note to be signed in its name by its duly authorized
officer on of the day and in the year first above written.
|
|
|
|
EMAGIN
CORPORATION
|
|
|
|
Date: July 21,
2006
|
By:
|
/s/ Gary W.
Jones
|
|
Name: Gary W. Jones
|
|
Title: Chief
Executive Officer
|
ASSIGNMENT
FOR VALUE
RECEIVED,
_________________________ hereby sell(s), assign(s) and transfer(s) unto
_________________________ (Please insert social security or other Taxpayer
Identification Number of assignee: ______________________________) the within
Note, and hereby irrevocably constitutes and appoints _________________________
attorney to transfer the said Note on the books of eMagin Corporation, a
Delaware corporation (the “Company”), with full power of substitution in the
premises.
In
connection with any transfer of the Note within the period prior to the
expiration of the holding period applicable to sales thereof under Rule 144(k)
under the 1933 Act (or any successor provision) (other than any transfer
pursuant to a registration statement that has been declared effective under the
1933 Act), the undersigned confirms that such Note is being
transferred:
|
[
|
]
|
To
the Company or a subsidiary thereof;
or
|
|
[
|
]
|
To
a “qualified institutional buyer” pursuant to and in compliance with Rule
144A; or
|
|
[
|
]
|
To
an Accredited Investor pursuant to and in compliance with the 1933 Act;
or
|
|
[
|
]
|
Pursuant
to and in compliance with Rule 144 under the 1933
Act;
|
and
unless the box below is checked, the undersigned confirms that, to the knowledge
of the undersigned, such Note is not being transferred to an Affiliate of the
Company.
|
[
|
]
|
The
transferee is an Affiliate of the
Company.
|
Capitalized
terms used in this Assignment and not defined in this Assignment shall have the
respective meanings provided in the Note.
Dated:____________________________________
|
NAME:__________________________________________
|
|
__________________________________________
|
|
Signature(s)
|
Exhibit A
COMPANY NOTICE
(Section 5.2(a) of 6% Senior
Secured Convertible Note due 2007-2008)
TO:
______________________________
(Name of
Holder)
(1)
A
Repurchase Event described in the 6% Senior Secured Convertible Note due
2007-2008 (the “Note”) of eMagin Corporation, a Delaware corporation (the
“Company”), occurred on
,
. As a
result of such Repurchase Event, the Holder is entitled to exercise its
repurchase rights pursuant to Section 5.2 of the Note.
(2)
The
Holder’s repurchase right must be exercised on or before
,
.
(3)
At or
before the date set forth in the preceding paragraph (2), the Holder
must:
(a)
deliver
to the Company a Holder Notice, in the form attached as
Exhibit B
to the
Note; and
(b)
the Note,
duly endorsed for transfer to the Company of the portion of the principal amount
to be repurchased.
(4)
Capitalized
terms used herein and not otherwise defined herein have the respective meanings
provided in the Note.
Date
_________________________________
|
EMAGIN
CORPORATION
|
|
By
:____________________________________
|
|
Title:
|
Exhibit B
HOLDER NOTICE
(Section 5.2(b) of 6% Senior
Secured Convertible Note due 2007-2008)
TO:
EMAGIN
CORPORATION
(1)
Pursuant
to the terms of the 6% Senior Secured Convertible Note due 2007-2008 (the
“Note”), the undersigned Holder hereby elects to exercise its right to require
repurchase by the Company pursuant to Sections 5.2(a) and 5.2(b) of
$
of the
Note, equal to the sum of $
principal amount of the Note, $
of
accrued and unpaid interest on such principal amount and $
of
Default Interest on the Note at the Repurchase Price provided in the
Note.
(2)
Capitalized
terms used herein and not otherwise defined herein have the respective meanings
provided in the Note.
Date
:_____________________
|
NAME OF
HOLDER:
|
|
___________________________________
|
|
|
|
By
____________________________________________
|
|
Signature
of Registered Holder
(Must
be signed exactly as name
appears
in the Note.)
|
Exhibit C
NOTICE OF
CONVERSION
OF 6% SENIOR SECURED CONVERTIBLE NOTE
DUE 2007-2008
OF EMAGIN
CORPORATION
To:
eMagin
Corporation
10500 N.E. 8th
Street, Suite 1400
Bellevue,
Washington 98004
Attention:
Chief Financial Officer
Facsimile
No.: (425) 749-3601
|
|
|
|
1.
Pursuant
to the terms of the 6% Senior Secured Convertible Note Due 2007-2008 (the
“Note”), the undersigned hereby elects to convert $_______________ of the Note,
equal to the sum of $_______________ principal amount of the Note,
$_______________ of accrued and unpaid interest on such principal amount and
$_______________ of Default Interest on such interest into shares of Common
Stock of eMagin Corporation, a Delaware corporation (the “Company”), at a
Conversion Price per share equal to $_______________. Capitalized terms used
herein and not otherwise defined herein have the respective meanings provided in
the Note.
2.
The
number of shares of Common Stock issuable upon the conversion of the Note to
which this Notice relates is _______________ (the “Conversion Shares”).
3.
Please
issue a certificate or certificates for _______________ shares of Common Stock
in the name(s) specified immediately below or, if additional space is necessary,
on an attachment hereto:
____________________________________________
|
____________________________________________
|
Name
|
Name
|
|
|
____________________________________________
|
____________________________________________
|
Address
|
Address
|
____________________________________________
|
____________________________________________
|
SS or Tax ID
Number
|
SS or Tax ID Number
|
|
|
|
|
Delivery
Instructions
for
Common
Stock:_____________________________________________________________________________________________________________________________
|
Portions
of installments of principal to which this conversion is allocated:
Due Initial
Installment Date:
|
$____________
|
Due Maturity
Date:
|
$____________
|
|
|
|
|
|
NAME:
___________________________________________
|
|
|
|
|
|
|
Date: _____________________________
|
___________________________________________
|
|
Signature
of Registered Holder
(Must
be signed exactly as name
appears
in the Note.)
|
:
Exhibit D
OPTIONAL REDEMPTION
NOTICE
(Section 2.1 of 6% Senior
Secured
Convertible Note due
2007-2008)
TO:_________________________________
(Name of
Holder)
(1)
Pursuant
to the terms of the 6% Senior Secured Convertible Note due 2007-2008 (the
“Note”), eMagin Corporation, a Delaware corporation (the “Company”), hereby
notifies the above-named Holder that the Company is exercising its right to
redeem the Note in accordance with Section 2.1 of the Note as set forth
below:
(i)
The
principal amount of the Note to be redeemed is $
.
(ii)
The
Optional Redemption Price is $
.
(iii)
The
Optional Redemption Date is
.
(2)
All of
the conditions specified in Section 2.1 of the Note entitling the Company to
call the Note for redemption have been satisfied.
(3)
Capitalized
terms used herein and not otherwise defined herein have the respective meanings
provided in the Note.
Date
|
EMAGIN
CORPORATION
|
|
|
|
By:______________________________________
|
|
Name:
|
|
Title:
|
Exhibit E
EMAGIN
CORPORATION
CONVERSION
SCHEDULE
This
Conversion Schedule shows reductions in the outstanding principal amount of the
6% Senior Secured Convertible Note due 2007-2008 (the “Note”) of eMagin
Corporation, a Delaware corporation, upon conversions pursuant to Section 6 of
the Note. Capitalized terms used in this Schedule and not otherwise defined
herein shall have the respective meanings provided in the Note.
|
Date
of Conversion
(or
for first entry, the Issuance Date)
|
Principal
Amount
of Conversion
(if
applicable)
|
Principal
Amount Remaining
Subsequent
to Conversion
(or
original Principal Amount)
|
1.
|
7/_/06
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
[continue
as necessary]
Annex
II
NEITHER THIS WARRANT NOR THE
SECURITIES INTO WHICH THIS WARRANT IS EXERCISABLE HAVE BEEN REGISTERED WITH THE
SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES REGULATORS OF ANY STATE IN
RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933,
AS AMENDED (THE “1933 ACT”), AND, ACCORDINGLY, MAY NOT BE, NOR MAY ANY INTEREST
THEREIN BE, OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION
STATEMENT UNDER THE 1933 ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A
TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE 1933 ACT AND IN
ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY, SUBJECT TO
CERTAIN EXCEPTIONS, A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT,
IN FORM AND SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO THE COMPANY.
THESE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT
SECURED BY SUCH SECURITIES.
THIS WARRANT MAY NOT BE TRANSFERRED
EXCEPT AS PROVIDED IN SECTION 24.
No.
W-
|
Right
to Purchase __________ Shares
of
Common
Stock
of
eMagin
Corporation
|
EMAGIN
CORPORATION
Common Stock Purchase
Warrant
EMAGIN CORPORATION
,
a
Delaware
corporation, hereby certifies that, for value received,
______________________
or
registered assigns (the “Holder”), is entitled, subject to the terms set forth
below, to purchase from the Company at any time or from time to time before 5:00
p.m., New York City time, on the Expiration Date (such capitalized term and all
other capitalized terms used herein having the respective meanings provided
herein),
[BEFORE ISSUANCE INSERT AMOUNT OF
SHARES EQUAL TO 70% OF THE NUMBER OF SHARES INITIALLY ISSUABLE UPON CONVERSION
OF THE NOTE BEING ISSUED TO THE HOLDER OF THIS WARRANT, DETERMINED WITHOUT
REGARD TO ANY LIMITATION ON CONVERSION]
paid and
nonassessable shares of Common Stock at a purchase price per share equal to the
Purchase Price. The number of such shares of Common Stock and the Purchase Price
are subject to adjustment as provided in this Warrant.
1.
Definitions.
(a)
As used
in this Warrant, the term “Holder” shall have the meaning assigned to such term
in the first paragraph of this Warrant.
(b)
All the
agreements or instruments herein defined shall mean such agreements or
instruments as the same may from time to time be supplemented or amended or the
terms thereof waived or modified to the extent permitted by, and in accordance
with, the terms thereof and of this Warrant.
(c)
The
following terms shall have the following meanings (such meanings to be equally
applicable to both the singular and plural forms of the terms
defined):
“Affiliate”
means, with respect to any Person, any other Person that directly, or indirectly
through one or more intermediaries, controls, is controlled by or is under
common control with the subject Person. For purposes of this definition,
“control” (including, with correlative meaning, the terms “controlled by” and
“under common control with”), as used with respect to any Person, shall mean the
possession, directly or indirectly, of the power to direct or cause the
direction of the management and policies of such Person, whether through the
ownership of voting securities or by contract or otherwise.
“Aggregate
Purchase Price” means at any time an amount equal to the product obtained by
multiplying (x) the Purchase Price
times
(y) the
number of shares of Common Stock for which this Warrant may be exercised at such
time, determined without regard to any limitations on exercise of this Warrant
contained in Section 2(c).
“Aggregation
Parties” shall have the meaning provided in Section 2(c).
“AMEX”
means the American Stock Exchange, Inc.
“Board of
Directors” means the Board of Directors of the Company.
“Business
Day” means any day other than a Saturday, Sunday or other day on which
commercial banks in The City of New York are authorized or required by law or
executive order to remain closed.
“Common
Stock” includes the Company's Common Stock, par value $0.001 per share, (and any
purchase rights issued with respect to the Common Stock in the future) as
authorized on the date hereof, and any other securities into which or for which
the Common Stock (and any such rights issued with respect to the Common Stock)
may be converted or exchanged pursuant to a plan of recapitalization,
reorganization, merger, sale of assets or otherwise and any stock (other than
Common Stock) and other securities of the Company or any other Person which the
Holder at any time shall be entitled to receive, or shall have received, on the
exercise of this Warrant, in lieu of or in addition to Common
Stock.
“Common
Stock Equivalents” means any warrant, option, subscription or purchase right
with respect to shares of Common Stock, any security convertible into,
exchangeable for, or otherwise entitling the holder thereof to acquire, shares
of Common Stock or any warrant, option, subscription or purchase right with
respect to any such convertible, exchangeable or other security.
“Company”
shall include eMagin Corporation, a Delaware corporation, and any corporation
that shall succeed to or assume the obligations of eMagin Corporation hereunder
in accordance with the terms hereof.
“Computed
Market Price”
shall
mean the arithmetic average of the daily VWAPs for each of the three Trading
Days immediately preceding the applicable Measurement Date (such VWAPs being
appropriately and equitably adjusted for any stock splits, stock dividends,
recapitalizations and the like occurring or for which the record date occurs
during such three Trading Days).
“Current
Fair Market Value” means when used with respect to the Common Stock as of a
specified date with respect to each share of Common Stock, the average of the
closing prices of the Common Stock sold on all securities exchanges (including
the NYSE, the AMEX, the Nasdaq and the Nasdaq Capital Market) on which the
Common Stock may at the time be listed, or, if there have been no sales on any
such exchange on such day, the average of the highest bid and lowest asked
prices on all such exchanges at the end of regular trading on such day, or, if
on such day the Common Stock is not so listed, the average of the representative
bid and asked prices quoted in the Nasdaq System as of 4:00 p.m., New York City
time, or, if on such day the Common Stock is not quoted in the Nasdaq System,
the average of the highest bid and lowest asked price on such day in the
domestic over-the-counter market as reported by Pink Sheets, LLC, or any similar
successor organization, in each such case averaged over a period of five Trading
Days consisting of the day as of which the Current Fair Market Value of Common
Stock is being determined (or if such day is not a Trading Day, the Trading Day
next preceding such day) and the four consecutive Trading Days prior to such
day. If on the date for which Current Fair Market Value is to be determined the
Common Stock is not listed on any securities exchange or quoted in the Nasdaq
System or the over-the-counter market, the Current Fair Market Value of Common
Stock shall be the highest price per share which the Company could then obtain
from a willing buyer (not an employee or director of the Company at the time of
determination) in an arms'-length transaction for shares of Common Stock sold by
the Company, from authorized but unissued shares, as determined in good faith by
the Board of Directors.
“Designated
Person” means any of Mr. John Atherly, Mr. Gary Jones and Ms. Susan
Jones.
“DTC”
shall have the meaning provided in Section 2(c).
“Event of
Default” shall have the meaning provided in the Notes.
“Excluded
Shares” shall have the meaning provided in Section 2(c).
“Expiration
Date” means July 21, 2011.
“FAST”
shall have the meaning provided in Section 2(c).
“Issuance
Date” means the date of original issuance of this Warrant or its predecessor
instrument.
“Market
Price” means with respect to any security on any day the closing bid price of
such security on such day on the Nasdaq or the Nasdaq Capital Market or the NYSE
or the AMEX, as applicable, or, if such security is not listed or admitted to
trading on the Nasdaq, the Nasdaq Capital Market, the NYSE or the AMEX, on the
principal national securities exchange or quotation system on which such
security is quoted or listed or admitted to trading, in any such case as
reported by Bloomberg, L.P. or, if not quoted or listed or admitted to trading
on any national securities exchange or quotation system, the average of the
closing bid and asked prices of such security on the over-the-counter market on
the day in question, as reported by the Pink Sheets, LLC, or a similar generally
accepted reporting service, or if not so available, in such manner as furnished
by any New York Stock Exchange member firm selected from time to time by the
Board of Directors for that purpose, or a price determined in good faith by the
Board of Directors.
“Measurement
Date” for any sale, transfer or disposition (but not including the cancellation
or expiration) of Common Stock or Common Stock Equivalents by a Designated
Person means the date that is three Trading Days after the earlier of (i) the
date such Designated Person files a Form 4 with the SEC with respect to such
sale, transfer or disposition and (ii) the date such Designated Person is
required to file a Form 4 with the SEC with respect to such sale, transfer or
disposition;
provided,
however,
that if
such Designated Person is not required, or is no longer required, to file a Form
4 with respect to such sale, transfer or disposition, the Measurement Date shall
be the date that is five Trading Days after the date of such sale, transfer or
disposition.
“Nasdaq”
means the Nasdaq Global Market.
“1934
Act” means the Securities Exchange Act of 1934, as amended.
“1933
Act” means the Securities Act of 1933, as amended.
“Note”
means any of the 6% Senior Secured Convertible Notes due 2007-2008 issued by the
Company pursuant to the Note Purchase Agreement and the Other Note Purchase
Agreements.
“Note
Purchase Agreement” means the Note Purchase Agreement, dated as of July 21,
2006, by and between the Company and the original Holder of this
Warrant.
“NYSE”
means the New York Stock Exchange, Inc.
“Other
Note Purchase Agreements” means the several Note Purchase Agreements by and
between the Company and the several buyers named therein in the form of the Note
Purchase Agreement pursuant to which certain of the Notes are being or will be
issued.
“Other
Securities” means any stock (other than Common Stock) and other securities of
the Company or any other Person which the Holder at any time shall be entitled
to receive, or shall have received, on the exercise of this Warrant, in lieu of
or in addition to Common Stock, or which at any time shall be issuable or shall
have been issued in exchange for or in replacement of Common Stock or Other
Securities pursuant to Section 5.
“Other
Warrants” shall mean the Common Stock Purchase Warrants (other than this
Warrant) issued or issuable pursuant to the Other Note Purchase
Agreements.
“Permitted
Designated Person Sale” means a sale by John Atherly, occurring on or after
January 1, 2007, of shares of Common Stock in an amount not to exceed 50,000
shares in the aggregate in any fiscal quarter of the Company (such number of
shares subject to equitable adjustments for stock splits, stock dividends,
combinations, capital reorganizations and similar events relating to the Common
Stock occurring after the Issuance Date).
“Person”
means an individual, corporation, partnership, limited liability company, trust,
business trust, association, joint stock company, joint venture, pool,
syndicate, sole proprietorship, unincorporated organization, governmental
authority or any other form of entity not specifically listed
herein.
“Purchase
Price” means $
0.36,
subject
to adjustment as provided in this Warrant.
“Registration
Period” shall have the meaning provided in the Note Purchase
Agreement.
“Registration
Statement” shall have the meaning provided in the Note Purchase
Agreement.
“Reorganization
Event” means the occurrence of any one or more of the following events:
(i)
any
consolidation, merger or similar transaction of the Company or any Subsidiary
with or into another entity (other than a merger or consolidation or similar
transaction of a Subsidiary into the Company or a wholly-owned Subsidiary in
which there is no change in the outstanding Common Stock); or the sale or
transfer of all or substantially all of the assets of the Company and the
Subsidiaries in a single transaction or a series of related transactions;
or
(ii)
the
occurrence of any transaction or event in connection with which all or
substantially all the Common Stock shall be exchanged for, converted into,
acquired for or constitute the right to receive securities of any other Person
(whether by means of a Tender Offer, liquidation, consolidation, merger, share
exchange, combination, reclassification, recapitalization, or otherwise);
or
(iii)
the
acquisition by a Person or group of Persons acting in concert as a partnership,
limited partnership, syndicate or group, as a result of a tender or exchange
offer, open market purchases, privately negotiated purchases or otherwise, of
beneficial ownership of securities of the Company representing 50% or more of
the combined voting power of the outstanding voting securities of the Company
ordinarily (and apart from rights accruing in special circumstances) having the
right to vote in the election of directors.
“Restricted
Ownership Percentage” shall have the meaning provided in Section
2(c).
“Restricted
Securities” means securities that are not eligible for resale pursuant to Rule
144(k) under the 1933 Act (or any successor provision).
“Rule
144A” means Rule 144A as promulgated under the 1933 Act.
“SEC”
means the Securities and Exchange Commission.
“Subsidiary”
means any corporation or other entity of which a majority of the capital stock
or other ownership interests having ordinary voting power to elect a majority of
the board of directors or other Persons performing similar functions are at the
time directly or indirectly owned by the Company.
“Tender
Offer” means a tender offer, exchange offer or other offer by the Company to
repurchase outstanding shares of its capital stock.
“Trading
Day” means a day on whichever of the national securities exchange, the Nasdaq,
the Nasdaq Capital Market or other securities market which then constitutes the
principal securities market for the Common Stock is open for general trading of
securities.
“VWAP” of
any security on any Trading Day means the volume-weighted average price of such
security on such Trading Day on the Principal Market, as reported by Bloomberg
Financial, L.P., based on a Trading Day from 9:30 a.m., Eastern Time, to 4:00
p.m., Eastern Time, using the AQR Function, for such Trading Day;
provided,
however,
that
during any period the VWAP is being determined, the VWAP shall be subject to
equitable adjustments from time to time on terms consistent with Section 6.3 of
the Note and otherwise reasonably acceptable to the Holder for (i) stock splits,
(ii) stock dividends, (iii) combinations, (iv) capital reorganizations, (v)
issuance to all holders of Common Stock of rights or warrants to purchase shares
of Common Stock, (vi) distribution by the Company to all holders of Common Stock
of evidences of indebtedness of the Company or cash (other than regular
quarterly cash dividends), and (vii) similar events relating to the Common
Stock, in each case which occur, or with respect to which the “ex” date occurs,
during such period.
“Warrant”
means this instrument as originally executed or if later amended or supplemented
in accordance with its terms, then as so amended or supplemented.
“Warrant
Shares” means the shares of Common Stock issuable upon exercise of this
Warrant.
2.
Exercise of
Warrant.
(a)
Exercise.
This
Warrant may be exercised by the Holder in whole at any time or in part from time
to time on or before the Expiration Date by (x) giving a subscription form in
the form of
Exhibit 1
to this
Warrant (duly executed by the Holder) to the Company, (y) making payment, in
cash or by certified or official bank check payable to the order of the Company,
or by wire transfer of funds to the account of the Company, in any such case, in
the amount obtained by multiplying (a) the number of shares of Common Stock
designated by the Holder in the subscription form by (b) the Purchase Price then
in effect and (z) surrendering this Warrant to the Company within three Trading
Days after such submission of a subscription form. An exercise of this Warrant
shall be deemed to have occurred on the date when the Holder shall have so given
the subscription form and made such payment. On any partial exercise the Company
will forthwith issue and deliver to or upon the order of the Holder a new
Warrant or Warrants of like tenor, in the name of the Holder or as the Holder
(upon payment by the Holder of any applicable transfer taxes) may request,
providing in the aggregate on the face or faces thereof for the purchase of the
number of shares of Common Stock for which such Warrant or Warrants may still be
exercised. The subscription form may be surrendered by telephone line facsimile
transmission to such telephone number for the Company as shall have been
specified in writing to the Holder by the Company;
provided, however
, that if
the subscription form is given to the Company by telephone line facsimile
transmission the Holder shall send an original of such subscription form to the
Company within ten Business Days after such subscription form is so given to the
Company;
provided further
,
however
, that
any failure or delay on the part of the Holder in giving such original of any
subscription form shall not affect the validity or the date on which such
subscription form is so given by telephone line facsimile
transmission.
(b)
Net
Exercise.
Notwithstanding
anything to the contrary contained in Section 2(a), if the Holder shall exercise
this Warrant (1) during the period beginning one year after the Issuance Date
and at a time when a Registration Statement covering the resale by the Holder of
shares of Common Stock (or Other Securities) issuable upon exercise of this
Warrant is not effective or is not available for use by the Holder or (2) an
Event of Default shall have occurred and be continuing, then in either such case
in the preceding clause (1) or (2) the Holder may elect to exercise this
Warrant, in whole at any time or in part from time to time, by receiving upon
each such exercise a number of shares of Common Stock as determined below, upon
submission of the subscription form annexed hereto (duly executed by the Holder)
to the Company (followed by surrender of this Warrant to the Company within
three Trading Days after such submission of a subscription form), in which event
the Company shall issue to the Holder a number of shares of Common Stock
computed using the following formula:
where,
|
|
X
=
|
the
number of shares of Common Stock to be issued to the Holder
|
|
|
Y
=
|
the
number of shares of Common Stock as to which this Warrant is to be
exercised
|
|
|
A
=
|
the
Current Fair Market Value of one share of Common Stock calculated as of
the latest Trading Day immediately preceding the exercise of this
Warrant
|
(c)
9.9%
Limitation.
(1)
Notwithstanding
anything to the contrary contained herein, the number of shares of Common Stock
that may be acquired by the Holder upon exercise pursuant to the terms hereof at
any time shall not exceed a number that, when added to the total number of
shares of Common Stock deemed beneficially owned by the Holder (other than by
virtue of the ownership of securities or rights to acquire securities that have
limitations on the Holder's right to convert, exercise or purchase similar to
the limitation set forth herein (the “Excluded Shares”), together with all
shares of Common Stock deemed beneficially owned at such time (other than by
virtue of the ownership of the Excluded Shares) by Persons whose beneficial
ownership of Common Stock would be aggregated with the beneficial ownership by
the Holder for purposes of determining whether a group exists or for purposes of
determining the Holder’s beneficial ownership (the “Aggregation Parties”), in
either such case for purposes of Section 13(d) of the 1934 Act and Regulation
13D-G thereunder (including, without limitation, as the same is made applicable
to Section 16 of the 1934 Act and the rules promulgated thereunder), would
result in beneficial ownership by the Holder or such group of more than 9.9% of
the shares of Common Stock for purposes of Section 13(d) or Section 16 of the
1934 Act and the rules promulgated thereunder (as the same may be modified by
the Holder as provided herein, the “Restricted Ownership Percentage”). The
Holder shall have the right at any time and from time to time to reduce its
Restricted Ownership Percentage immediately upon notice to the Company in the
event and only to the extent that Section 16 of the 1934 Act or the rules
promulgated thereunder (or any successor statute or rules) is changed to reduce
the beneficial ownership percentage threshold thereunder to a percentage less
than 10%. If at any time the limits in this Section 2(c) make this Warrant
unexercisable in whole or in part, the Company shall not by reason thereof be
relieved of its obligation to issue shares of Common Stock at any time or from
time to time thereafter but prior to the Expiration Date upon exercise of this
Warrant as and when shares of Common Stock may be issued in compliance with such
restrictions.
(2)
For
purposes of this Section 2(c), in determining the number of outstanding shares
of Common Stock at any time the Holder may rely on the number of outstanding
shares of Common Stock as reflected in (1) the Company's then most recent Form
10-Q, Form 10-K or other public filing with the SEC, as the case may be, (2) a
public announcement by the Company that is later than any such filing referred
to in the preceding clause (1) or (3) any other notice by the Company or its
transfer agent setting forth the number shares of Common Stock outstanding and
knowledge the Holder may have about the number of shares of Common Stock issued
upon conversion or exercise of Common Stock Equivalents by any Person, including
the Holder, which are not reflected in the preceding clauses (1) through (3).
Upon the written request of the Holder, the Company shall within three Business
Days confirm in writing to the Holder the number of shares of Common Stock then
outstanding. In any case, the number of outstanding shares of Common Stock shall
be determined after giving effect to the conversion or exercise of Common Stock
Equivalents, including the Warrants, by the Holder or its Affiliates, in each
such case subsequent to, the date as of which such number of outstanding shares
of Common Stock was reported.
3.
Delivery of Stock Certificates,
etc., on Exercise.
(a) As
soon as practicable after the exercise of this Warrant and in any event within
three Trading Days thereafter, upon the terms and subject to the conditions of
this Warrant, the Company at its expense (including the payment by it of any
applicable issue or stamp taxes) will cause to be issued in the name of and
delivered to the Holder, or as the Holder (upon payment by the Holder of any
applicable transfer taxes) may direct, a certificate or certificates for the
number of fully paid and nonassessable shares of Common Stock (or Other
Securities) to which the Holder shall be entitled on such exercise, in such
denominations as may be requested by the Holder, which certificate or
certificates shall be free of restrictive and trading legends (except to the
extent permitted under Section 5(b) of the Note Purchase Agreement), plus, in
lieu of any fractional share to which the Holder would otherwise be entitled,
cash equal to such fraction multiplied by the then Current Fair Market Value of
one full share of Common Stock, together with any other stock or Other
Securities or any property (including cash, where applicable) to which the
Holder is entitled upon such exercise pursuant to Section 2 or otherwise.
In lieu
of delivering physical certificates for the shares of Common Stock or (Other
Securities) issuable upon any exercise of this Warrant, provided the Company's
transfer agent is participating in the Depository Trust Company (“DTC”) Fast
Automated Securities Transfer (“FAST”) program, upon request of the Holder, the
Company shall use commercially reasonable efforts to cause its transfer agent
electronically to transmit such shares of Common Stock (or Other Securities)
issuable upon conversion to the Holder (or its designee), by crediting the
account of the Holder’s (or such designee’s) broker with DTC through its Deposit
Withdrawal Agent Commission system (provided that the same time periods herein
as for stock certificates shall apply). The Company shall pay any taxes and
other governmental charges that may be imposed under the laws of the United
States of America or any political subdivision or taxing authority thereof or
therein in respect of the issue or delivery of shares of Common Stock (or Other
Securities) or payment of cash upon exercise of this Warrant (other than income
taxes imposed on the Holder). The Company shall not be required, however, to pay
any tax or other charge imposed in connection with any transfer involved in the
issue of any certificate for shares of Common Stock (or Other Securities)
issuable upon exercise of this Warrant or payment of cash to any Person other
than the Holder, and in case of such transfer or payment the Company shall not
be required to deliver any certificate for shares of Common Stock (or Other
Securities) upon such exercise or pay any cash until such tax or charge has been
paid or it has been established to the Company's reasonable satisfaction that no
such tax or charge is due.
(b)
If in any
case the Company shall fail to issue and deliver or cause to be delivered the
shares of Common Stock to the Holder within five Trading Days of a particular
exercise of this Warrant, in addition to any other liabilities the Company may
have hereunder, under the Note Purchase Agreement and under applicable law, (A)
the Company shall pay or reimburse the Holder on demand for all out-of-pocket
expenses, including, without limitation, reasonable fees and expenses of legal
counsel, incurred by the Holder as a result of such failure; (B) if as a result
of such failure the Holder shall suffer any direct damages or liabilities from
such failure (including, without limitation, margin interest and the cost of
purchasing securities to cover a sale (whether by the Holder or the Holder's
securities broker) or borrowing of shares of Common Stock by the Holder for
purposes of settling any trade involving a sale of shares of Common Stock made
by the Holder during the period beginning on the Issuance Date and ending on the
date the Company delivers or causes to be delivered to the Holder such shares of
Common Stock), then, in addition to any amounts payable pursuant to Section
3(a), the Company shall upon demand of the Holder pay to the Holder an amount
equal to the actual, direct, demonstrable out-of-pocket damages and liabilities
suffered by the Holder by reason thereof which the Holder documents, and (C) the
Holder may by written notice (which may be given by mail, courier, personal
service or telephone line facsimile transmission) or oral notice (promptly
confirmed in writing), given at any time prior to delivery to the Holder of the
shares of Common Stock issuable in connection with such exercise of the Holder's
right, rescind such exercise and the subscription form relating thereto, in
which case the Holder shall thereafter be entitled to exercise that portion of
this Warrant as to which such exercise is so rescinded and to exercise its other
rights and remedies with respect to such failure by the Company. Notwithstanding
the foregoing the Company shall not be liable to the Holder under clauses (A) or
(B) of the immediately preceding sentence to the extent the failure of the
Company to deliver or to cause to be delivered such shares of Common Stock
results from fire, flood, storm, earthquake, shipwreck, strike, war, acts of
terrorism, crash involving facilities of a common carrier, acts of God, or any
similar event outside the control of the Company (it being understood that the
action or failure to act of the Company's Transfer Agent shall not be deemed an
event outside the control of the Company except to the extent resulting from
fire, flood, storm, earthquake, shipwreck, strike, war, acts of terrorism, crash
involving facilities of a common carrier, acts of God, or any similar event
outside the control of such Transfer Agent or the bankruptcy, liquidation or
reorganization of such Transfer Agent under any bankruptcy, insolvency or other
similar law). The Holder shall notify the Company in writing (or by telephone
conversation, confirmed in writing) as promptly as practicable following the
third Trading Day after the Holder exercises this Warrant if the Holder becomes
aware that such shares of Common Stock so issuable have not been received as
provided herein, but any failure so to give such notice shall not affect the
Holder's rights under this Warrant or otherwise. In the case of the Company’s
failure to issue and deliver or cause to be delivered the shares of Common Stock
to the Holder within five Trading Days of a particular exercise of this Warrant,
the amount payable by the Company pursuant to clause (B) of this Section 3(b)
with respect to such exercise shall be reduced by the amount of payments
previously paid by the Company to the Holder pursuant to Section 8(a)(4) of the
Note Purchase Agreement with respect to such exercise.
4.
Adjustment for Dividends in Other
Stock, Property, etc.; Reclassification, etc.
In case
at any time or from time to time on or after the Issuance Date, all holders of
Common Stock (or Other Securities) shall have received, or (on or after the
record date fixed for the determination of stockholders eligible to receive)
shall have become entitled to receive, without payment therefor,
(a)
other or
additional stock, rights, warrants or other securities or property (other than
cash) by way of dividend, or
(b)
any cash
(excluding cash dividends payable solely out of earnings or earned surplus of
the Company), or
(c)
other or
additional stock, rights, warrants or other securities or property (including
cash) by way of spin-off, split-up, reclassification, recapitalization,
combination of shares or similar corporate rearrangement,
other
than (i) additional shares of Common Stock (or Other Securities) issued as a
stock dividend or in a stock-split (adjustments in respect of which are provided
for in Section 6) and (ii) rights or warrants to subscribe for Common Stock at
less than the Current Fair Market Value (adjustments in respect of which are
provided in Section 7), then and in each such case the Holder, on the exercise
hereof as provided in Section 2, shall be entitled to receive the amount of
stock, rights, warrants and Other Securities and property (including cash in the
cases referred to in subdivisions (b) and (c) of this Section 4) which the
Holder would hold on the date of such exercise if on the date of such action
specified in the preceding clauses (a) through (c) (or the record date therefor)
the Holder had been the holder of record of the number of shares of Common Stock
called for on the face of this Warrant and had thereafter, during the period
from the date thereof to and including the date of such exercise, retained such
shares and all such other or additional stock, rights, warrants and Other
Securities and property (including cash in the case referred to in subdivisions
(b) and (c) of this Section 4) receivable by the Holder as aforesaid during such
period, giving effect to all adjustments called for during such period by
Section 5.
5.
Exercise upon a Reorganization
Event.
In case
of any Reorganization Event the Company shall, as a condition precedent to the
consummation of the transactions constituting, or announced as, such
Reorganization Event, cause effective provisions to be made so that the Holder
shall have the right thereafter, by exercising this Warrant (in lieu of the
shares of Common Stock of the Company and Other Securities or property
purchasable and receivable upon exercise of the rights represented hereby
immediately prior to such Reorganization Event) to purchase the kind and amount
of shares of stock and Other Securities and property (including cash) receivable
upon such Reorganization Event by a holder of the number of shares of Common
Stock that might have been received upon exercise of this Warrant immediately
prior to such Reorganization Event. Any such provision shall include provisions
for adjustments in respect of such shares of stock and Other Securities and
property that shall be as nearly equivalent as may be practicable to the
adjustments provided for in this Warrant. The provisions of this Section 5 shall
apply to successive Reorganization Events.
6.
Adjustment for Certain Extraordinary
Events.
If on or
after the Issuance Date the Company shall (i) issue additional shares of the
Common Stock as a dividend or other distribution on outstanding Common Stock,
(ii) subdivide or reclassify its outstanding shares of Common Stock, or (iii)
combine its outstanding shares of Common Stock into a smaller number of shares
of Common Stock, then, in each such event, the Purchase Price shall,
simultaneously with the happening of such event, be adjusted by multiplying the
Purchase Price in effect immediately prior to such event by a fraction, the
numerator of which shall be the number of shares of Common Stock outstanding
immediately prior to such event and the denominator of which shall be the number
of shares of Common Stock outstanding immediately after such event, and the
product so obtained shall thereafter be the Purchase Price then in effect. The
Purchase Price, as so adjusted, shall be readjusted in the same manner upon the
happening of any successive event or events described herein in this Section 6.
The Holder shall thereafter, on the exercise hereof as provided in Section 2, be
entitled to receive that number of shares of Common Stock determined by
multiplying the number of shares of Common Stock which would be issuable on such
exercise immediately prior to such issuance, subdivision or combination, as the
case may be, by a fraction of which (i) the numerator is the Purchase Price in
effect immediately prior to such issuance and (ii) the denominator is the
Purchase Price in effect on the date of such exercise.
7.
Issuance of Rights or Warrants to
Common Stockholders at less than Current Fair Market
Value.
If the
Company shall on or after the Issuance Date issue rights or warrants to all
holders of its outstanding shares of Common Stock entitling them to subscribe
for or purchase shares of Common Stock at a price per share less than the
Current Fair Market Value on the record date fixed for the determination of
stockholders entitled to receive such rights or warrants, then
(a)
the
Purchase Price shall be adjusted so that the same shall equal the price
determined by multiplying the Purchase Price in effect at the opening of
business on the day after such record date by a fraction of which the numerator
shall be the number of shares of Common Stock outstanding at the close of
business on such record date plus the number of shares which the aggregate
offering price of the total number of shares so offered would purchase at such
Current Fair Market Value, and the denominator shall be the number of shares of
Common Stock outstanding on the close of business on such record date plus the
total number of additional shares of Common Stock so offered for subscription or
purchase; and
(b)
the
number of shares of Common Stock which the Holder may thereafter purchase upon
exercise of this Warrant at the opening of business on the day after such record
date shall be increased to a number equal to the quotient obtained by dividing
(x) the Aggregate Purchase Price in effect immediately prior to such adjustment
in the Purchase Price pursuant to clause (a) of this Section 7
by
(y) the
Purchase Price in effect immediately after such adjustment in the Purchase Price
pursuant to clause (a) of this Section 7.
Such
adjustment shall become effective immediately after the opening of business on
the day following the record date fixed for determination of stockholders
entitled to receive such rights or warrants. To the extent that shares of Common
Stock are not delivered pursuant to such rights or warrants, upon the expiration
or termination of such rights or warrants, the Purchase Price shall be
readjusted to the Purchase Price which would then be in effect had the
adjustments made upon the issuance of such rights or warrants been made on the
basis of delivery of only the number of shares of Common Stock actually
delivered and the number of shares of Common Stock for which this Warrant may
thereafter be exercised shall be readjusted (subject to proportionate adjustment
for any intervening exercises of this Warrant) to the number which would then be
in effect had the adjustments made upon the issuance of such rights or warrants
been made on the basis of delivery of only the number of shares of Common Stock
actually delivered. In the event that such rights or warrants are not so issued,
the Purchase Price shall again be adjusted to be the Purchase Price which would
then be in effect if such record date had not been fixed and the number of
shares of Common Stock for which this Warrant may thereafter be exercised shall
again be adjusted (subject to proportionate adjustment for any intervening
exercises of this Warrant) to be the number which would then be in effect if
such record date had not been fixed. In determining whether any rights or
warrants entitle the Holder to subscribe for or purchase shares of Common Stock
at less than such Current Fair Market Value, and in determining the aggregate
offering price of such shares of Common Stock, there shall be taken into account
any consideration received for such rights or warrants, the value of such
consideration, if other than cash, to be determined by the Board of Directors.
Notwithstanding the foregoing, if any of the adjustments to the Purchase Price
as set forth in this Section 7 will require the Company to seek stockholder
approval pursuant to Rule 713 of the AMEX and such stockholder approval has not
yet been obtained, then the adjustment shall not take effect until such
stockholder approval is obtained. The Company shall use its commercially
reasonable best efforts to obtain, as promptly as practicable, but in no event
later than 90 days thereafter, the stockholder approval that is necessary under
the rules of the AMEX.
8.
Adjustment in Connection Sales by a
Designated Person.
So long
as any Note is outstanding, if at any time on or after the Issuance Date any
Designated Person, directly or indirectly, sells, transfers or disposes of
shares of Common Stock or Common Stock Equivalents other than a Permitted
Designated Person Sale and on the Measurement Date for such sale, transfer or
disposition the Purchase Price in effect on such Measurement Date is greater
than the Computed Market Price on such Measurement Date, then, subject to the
next succeeding sentence, the
Purchase
Price shall be reduced to such Computed Market Price
, such
adjustment to become effective immediately after the opening of business on the
day following the Measurement Date. If a reduction of the Purchase Price to such
Computed Market Price pursuant to the immediately preceding sentence would
require the Company to seek stockholder approval of the transactions
contemplated by the Note Purchase Agreement pursuant to Rule 713 of the AMEX and
the Stockholder Approval has not yet been obtained, then the Purchase Price
shall be reduced to a price equal to the Conversion Price (as defined in the
Note) then in effect until such time as the Stockholder Approval is obtained at
which time the Purchase Price shall be reduced to such Computed Market Price.
The Company shall inform the Holder immediately by phone and electronic
transmission upon becoming aware of any sale, transfer or disposition of any
shares of Common Stock or Common Stock Equivalents by any Designated Person and
will follow up with formal written notice to the Holder pursuant to Section
23.
9.
Effect of Reclassification,
Consolidation, Merger or Sale.
(a)
If any of
the following events occur, namely:
(i)
any
reclassification or change of the outstanding shares of Common Stock (other than
a change in par value, or from par value to no par value, or from no par value
to par value, or as a result of a subdivision or combination),
(ii)
any
consolidation, merger statutory exchange or combination of the Company with
another corporation as a result of which holders of Common Stock shall be
entitled to receive stock, securities or other property or assets (including
cash) with respect to or in exchange for such Common Stock, or
(iii)
any sale
or conveyance of the properties and assets of the Company as, or substantially
as, an entirety to any other Person as a result of which holders of Common Stock
shall be entitled to receive stock, securities or other property or assets
(including cash) with respect to or in exchange for such Common Stock,
then the
Company or the successor or purchasing Person, as the case may be, shall execute
with the Holder a written agreement providing that:
(x)
this
Warrant shall thereafter entitle the Holder to purchase the kind and amount of
shares of stock and Other Securities or property or assets (including cash)
receivable upon such reclassification, change, consolidation, merger, statutory
exchange, combination, sale or conveyance by the holder of a number of shares of
Common Stock issuable upon exercise of this Warrant (assuming, for such
purposes, a sufficient number of authorized shares of Common Stock available to
exercise this Warrant) immediately prior to such reclassification, change,
consolidation, merger, statutory exchange, combination, sale or conveyance
assuming such holder of Common Stock did not exercise such holder's rights of
election, if any, as to the kind or amount of securities, cash or other property
receivable upon such consolidation, merger, statutory exchange, combination,
sale or conveyance (
provided
that, if
the kind or amount of securities, cash or other property receivable upon such
consolidation, merger, statutory exchange, sale or conveyance is not the same
for each share of Common Stock in respect of which such rights of election shall
not have been exercised (“non-electing share”), then for the purposes of this
Section 8 the kind and amount of securities, cash or other property receivable
upon such consolidation, merger, statutory exchange, sale or conveyance for each
non-electing share shall be deemed to be the kind and amount so receivable per
share by a plurality of the non-electing shares),
(y)
in the
case of any such successor or purchasing Person, upon such consolidation,
merger, statutory exchange, combination, sale or conveyance such successor or
purchasing Person shall be jointly and severally liable with the Company for the
performance of all of the Company's obligations under this Warrant and the Note
Purchase Agreement and
(z)
if
registration or qualification is required under the 1933 Act or applicable state
law for the public resale by the Holder of such shares of stock and Other
Securities so issuable upon exercise of this Warrant, such registration or
qualification shall be completed prior to such reclassification, change,
consolidation, merger, statutory exchange, combination or sale.
Such
written agreement shall provide for adjustments which shall be as nearly
equivalent as may be practicable to the adjustments provided for in this
Warrant. If, in the case of any such reclassification, change, consolidation,
merger, statutory exchange, combination, sale or conveyance, the stock or other
securities or other property or assets receivable thereupon by a holder of
shares of Common Stock includes shares of stock, other securities, other
property or assets of a Person other than the Company or any such successor or
purchasing Person, as the case may be, in such reclassification, change,
consolidation, merger, statutory exchange, combination, sale or conveyance, then
such written agreement shall also be executed by such other Person and shall
contain such additional provisions to protect the interests of the Holder as the
Board of Directors shall reasonably consider necessary by reason of the
foregoing.
(b)
The above
provisions of this Section 9 shall similarly apply to successive
reclassifications, changes, consolidations, mergers, combinations, sales and
conveyances.
(c)
If this
Section 9 applies to any event or occurrence, Section 5 shall not
apply.
10.
Tax
Adjustments.
The
Company may make such reductions in the Purchase Price, in addition to those
required by Sections 4, 5, 6, 7 and 8 as the Board of Directors considers to be
advisable to avoid or diminish any income tax to holders of Common Stock or
rights to purchase Common Stock resulting from any dividend or distribution of
stock (or rights to acquire stock) or from any event treated as such for income
tax purposes.
11.
Minimum
Adjustment.
(a) No
adjustment in the Purchase Price (and no related adjustment in the number of
shares of Common Stock which may thereafter be purchased upon exercise of this
Warrant) shall be required unless such adjustment would require an increase or
decrease of at least 1% in the Purchase Price;
provided, however,
that any
adjustments which by reason of this Section 11 are not required to be made shall
be carried forward and taken into account in any subsequent adjustment. All such
calculations under this Warrant shall be made by the Company and shall be made
to the nearest cent or to the nearest one hundredth of a share, as the case may
be.
(b)
No
adjustment need be made for a change in the par value of the Common Stock or
from par value to no par value or from no par value to par value.
12.
Notice of
Adjustments.
Whenever
the Purchase Price is adjusted as herein provided, the Company shall promptly,
but in no event later than five Trading Days thereafter, give a notice to the
Holder setting forth the Purchase Price and number of shares of Common Stock
which may be purchased upon exercise of this Warrant after such adjustment and
setting forth a brief statement of the facts requiring such adjustment but which
such statement shall not include any information which would be material
non-public information for purposes of the 1934 Act. Failure to deliver such
notice shall not affect the legality or validity of any such
adjustment.
13.
Further
Assurances.
The
Company will take all action that may be necessary or appropriate in order that
the Company may validly and legally issue fully paid and nonassessable shares of
stock, free from all taxes, liens and charges with respect to the issue thereof,
on the exercise of all or any portion of this Warrant from time to time
outstanding.
14.
Notice to Holder Prior to Certain
Actions.
In case
on or after the Issuance Date:
(a)
the
Company shall declare a dividend (or any other distribution) on its Common Stock
(other than in cash out of retained earnings); or
(b)
the
Company shall authorize the granting to the holders of its Common Stock of
rights or warrants to subscribe for or purchase any share of any class or any
other rights or warrants; or
(c)
the Board
of Directors shall authorize any reclassification of the Common Stock (other
than a subdivision or combination of its outstanding Common Stock, or a change
in par value, or from par value to no par value, or from no par value to par
value), or any consolidation or merger or other business combination transaction
to which the Company is a party and for which approval of any stockholders of
the Company is required, or the sale or transfer of all or substantially all of
the assets of the Company; or
(d)
there
shall be pending the voluntary or involuntary dissolution, liquidation or
winding-up of the Company;
the
Company shall give the Holder, as promptly as possible but in any event at least
ten Trading Days prior to the applicable date hereinafter specified, a notice
stating (x) the date on which a record is to be taken for the purpose of such
dividend, distribution or rights or warrants, or, if a record is not to be
taken, the date as of which the holders of Common Stock of record to be entitled
to such dividend, distribution or rights are to be determined, or (y) the date
on which such reclassification, consolidation, merger, other business
combination transaction, sale, transfer, dissolution, liquidation or winding-up
is expected to become effective or occur, and the date as of which it is
expected that holders of Common Stock of record who shall be entitled to
exchange their Common Stock for securities or other property deliverable upon
such reclassification, consolidation, merger, other business combination
transaction, sale, transfer, dissolution, liquidation or winding-up shall be
determined. Such notice shall not include any information which would be
material non-public information for purposes of the 1934 Act. Failure to give
such notice, or any defect therein, shall not affect the legality or validity of
such dividend, distribution, reclassification, consolidation, merger, sale,
transfer, dissolution, liquidation or winding-up. In the case of any such action
of which the Company gives such notice to the Holder or is required to give such
notice to the Holder, the Holder shall be entitled to give a subscription form
to exercise this Warrant in whole or in part that is contingent on the
completion of such action.
15.
Reservation of Stock, etc., Issuable
on Exercise of Warrants.
The
Company will at all times reserve and keep available out of its authorized but
unissued shares of capital stock, solely for issuance and delivery on the
exercise of this Warrant, a sufficient number of shares of Common Stock (or
Other Securities) to effect the full exercise of this Warrant and the exercise,
conversion or exchange of all other Common Stock Equivalents from time to time
outstanding (or Other Securities), and if at any time the number of authorized
but unissued shares of Common Stock (or Other Securities) shall not be
sufficient to effect such exercise, conversion or exchange, the Company shall
take such action as may be necessary to increase its authorized but unissued
shares of Common Stock (or Other Securities) to such number as shall be
sufficient for such purposes.
16.
Transfer of
Warrant.
This
Warrant shall inure to the benefit of the successors to and assigns of the
Holder. This Warrant and all rights hereunder, in whole or in part, are
registrable at the office or agency of the Company referred to below by the
Holder in person or by his duly authorized attorney, upon surrender of this
Warrant properly endorsed accompanied by an assignment form in the form
attached
to this
Warrant, or other customary form, duly executed by the transferring
Holder.
17.
Register of
Warrants.
The
Company shall maintain, at the principal office of the Company (or such other
office as it may designate by notice to the Holder), a register in which the
Company shall record the name and address of the Person in whose name this
Warrant has been issued, as well as the name and address of each successor and
prior owner of such Warrant. The Company shall be entitled to treat the Person
in whose name this Warrant is so registered as the sole and absolute owner of
this Warrant for all purposes.
18.
Exchange of
Warrant.
This
Warrant is exchangeable, upon the surrender hereof by the Holder at the office
or agency of the Company referred to in Section 16, for one or more new Warrants
of like tenor representing in the aggregate the right to subscribe for and
purchase the number of shares of Common Stock which may be subscribed for and
purchased hereunder, each of such new Warrants to represent the right to
subscribe for and purchase such number of shares as shall be designated by the
Holder at the time of such surrender.
19.
Replacement of
Warrant.
On
receipt by the Company of evidence reasonably satisfactory to it of the
ownership of and the loss, theft, destruction or mutilation of this Warrant and
(a) in the case of loss, theft or destruction, of indemnity from the Holder
reasonably satisfactory in form to the Company (and without the requirement to
post any bond or other security), or (b) in the case of mutilation, upon
surrender and cancellation of this Warrant, the Company will execute and deliver
to the Holder a new Warrant of like tenor without charge to the
Holder.
20.
Warrant
Agent.
The
Company may, by written notice to the Holder, appoint the transfer agent and
registrar for the Common Stock as the Company's agent for the purpose of issuing
Common Stock (or Other Securities) on the exercise of this Warrant pursuant to
Section 2, and the Company may, by written notice to the Holder, appoint an
agent having an office in the United States of America for the purpose of
exchanging this Warrant pursuant to Section 18, and replacing this Warrant
pursuant to Section 19, or any of the foregoing, and thereafter any such
exchange or replacement, as the case may be, shall be made at such office by
such agent.
21.
Remedies.
The
Company stipulates that the remedies at law of the Holder in the event of any
default or threatened default by the Company in the performance of or compliance
with any of the terms of this Warrant are not and will not be adequate, and that
such terms may be specifically enforced (x) by a decree for the specific
performance of any agreement contained herein, including, without limitation, a
decree for issuance of the shares of Common Stock (or Other Securities) issuable
upon exercise of this Warrant or (y) by an injunction against a violation of any
of the terms hereof or (z) otherwise.
22.
No Rights or Liabilities as a
Stockholder.
This
Warrant shall not entitle the Holder to any voting rights or other rights as a
stockholder of the Company. Nothing contained in this Warrant shall be construed
as conferring upon the Holder the right to vote or to consent or to receive
notice as a stockholder of the Company on any matters or with respect to any
rights whatsoever as a stockholder of the Company. No dividends or interest
shall be payable or accrued in respect of this Warrant or the interest
represented hereby or the Common Stock (or Other Securities) purchasable
hereunder until, and only to the extent that, this Warrant shall have been
exercised in accordance with its terms.
23.
Notices,
etc.
All
notices and other communications from the Company to the Holder shall be in
writing and delivered personally, by confirmed facsimile, by a nationally
recognized overnight courier service or mailed by first class certified mail,
postage prepaid, at such facsimile telephone number or address as may have been
furnished to the Company in writing by the Holder or at such facsimile telephone
number or the address shown for the Holder on the register of Warrants referred
to in Section 17.
24.
Transfer
Restrictions.
This
Warrant has not been and is not being registered under the provisions of the
1933 Act or any state securities laws and this Warrant may not be transferred
prior to the end of the holding period applicable to sales hereof under Rule
144(k) unless (1) the transferee is an “accredited investor” (as defined in
Regulation D under the 1933 Act) and (2) the Holder shall have delivered to the
Company an opinion of counsel, reasonably satisfactory in form, scope and
substance to the Company, to the effect that this Warrant may be sold or
transferred without registration under the 1933 Act. Prior to any such transfer,
such transferee shall have represented in writing to the Company that such
transferee has requested and received from the Company all information relating
to the business, properties, operations, condition (financial or other), results
of operations or prospects of the Company deemed relevant by such transferee;
that such transferee has been afforded the opportunity to ask questions of the
Company concerning the foregoing and has had the opportunity to obtain and
review the Registration Statement and the prospectus related thereto, each as
amended or supplemented to the date of transfer to such transferee, and the
reports and other information concerning the Company which at the time of such
transfer have been filed by the Company with the SEC pursuant to the 1934 Act
and which are incorporated by reference in such prospectus as of the date of
such transfer. If such transfer is intended to assign the rights and obligations
of the Holder under Section 5,8,9 and 10 of the Note Purchase Agreement, such
transfer shall otherwise be made in compliance with the applicable provisions of
the Note Purchase Agreement.
25.
Rule 144A Information
Requirement.
Within
the period prior to the expiration of the holding period applicable to sales
hereof under Rule 144(k) under the 1933 Act (or any successor provision), the
Company covenants and agrees that it shall, during any period in which it is not
subject to Section 13 or 15(d) under the 1934 Act, make available to the Holder
and the holder of any shares of Common Stock issued upon exercise of this
Warrant which continue to be Restricted Securities in connection with any sale
thereof and any prospective purchaser of this Warrant from the Holder, the
information required pursuant to Rule 144A(d)(4) under the 1933 Act upon the
request of the Holder and it will take such further action as the Holder may
reasonably request, all to the extent required from time to time to enable the
Holder to sell this Warrant without registration under the 1933 Act within the
limitation of the exemption provided by Rule 144A, as Rule 144A may be
amended from time to time. Upon the request of the Holder, the Company will
deliver to the Holder a written statement as to whether it has complied with
such requirements.
26.
Legend.
The
provisions of Section 5(b) of the Note Purchase Agreement and the related
definitions of capitalized terms used therein and defined in the Note Purchase
Agreement are by this reference incorporated herein as if set forth in full at
this place.
27.
Amendment;
Waiver.
(a) This
Warrant and any terms hereof may be changed, modified or amended only by an
instrument in writing signed by the party against which enforcement of such
change, modification or amendment is sought. Notwithstanding anything to the
contrary contained herein, no amendment or waiver shall increase or eliminate
the Restricted Ownership Percentage, whether permanently or temporarily, unless,
in addition to complying with the other requirements of this Warrant, such
amendment or waiver shall have been approved in accordance with the General
Corporation Law of the State of Delaware and the Company's By-laws by holders of
the outstanding shares of Common Stock entitled to vote at a meeting or by
written consent in lieu of such meeting.
(b)
Any term
or condition of this Warrant may be waived by the Holder or Company at any time
if the waiving party is entitled to the benefit thereof, but no such waiver will
be effective unless set forth in a written instrument duly executed by or on
behalf of the party waiving such term or condition. No waiver by any party of
any term or condition of this Warrant, in any one or more instances, will be
deemed to be or construed as a waiver of the same or any other term or condition
of this Warrant on any future occasion.
28.
Miscellaneous.
This
Warrant shall be construed and enforced in accordance with and governed by the
internal laws of the State of New York. The headings, captions and footers in
this Warrant are for purposes of reference only, and shall not limit or
otherwise affect any of the terms hereof. The invalidity or unenforceability of
any provision hereof shall in no way affect the validity or enforceability of
any other provision.
29.
Attorneys'
Fees.
In any
litigation, arbitration or court proceeding between the Company and Holder
relating hereto, the prevailing party shall be entitled to attorneys’ fees and
expenses and all costs of proceedings incurred in enforcing this
Warrant.
[Signature Page
Follows]
IN WITNESS
WHEREOF,
the
Company has caused this Warrant to be duly executed on its behalf by one of its
officers thereunto duly authorized.
|
|
|
|
EMAGIN
CORPORATION
|
|
|
|
Date: July 21,
2006
|
By:
|
/s/ Gary W.
Jones
|
|
Name: Gary W. Jones
|
|
Title: Chief Executive
Officer
|
ASSIGNMENT
For value
hereby
sell(s), assign(s) and transfer(s) unto
(Please
insert social security or other Taxpayer Identification Number of assignee:
) the
attached original, executed Warrant to purchase
share of
Common Stock of eMagin Corporation, a Delaware corporation (the “Company”), and
hereby irrevocably constitutes and appoints
attorney
to transfer the Warrant on the books of the Company, with full power of
substitution in the premises.
In
connection with any transfer of the Warrant within the period prior to the
expiration of the holding period applicable to sales thereof under Rule 144(k)
under the 1933 Act (or any successor provision) (other than any transfer
pursuant to a registration statement that has been declared effective under the
1933 Act), the undersigned confirms that such Warrant is being
transferred:
[
]
To the
Company or a Subsidiary; or
[
]
To an
“accredited investor” (as defined in Regulation D under the 1933 Act) pursuant
to and in compliance with the 1933 Act; or
[
]
Pursuant
to and in compliance with Rule 144 under the 1933 Act;
and
unless the box below is checked, the undersigned confirms that, to the knowledge
of the undersigned, such Warrant is not being transferred to an “affiliate” (as
defined in Rule 144 under the 1933 Act) of the Company.
[
]
The
transferee is an affiliate of the Company.
Capitalized
terms used in this Assignment and not defined in this Assignment shall have the
respective meanings provided in the Warrant.
Dated:
____________________________________
|
NAME
:____________________________________________
|
|
|
|
____________________________________________________________
|
|
Signature(s)
|
|
|
Exhibit 1
FORM OF
SUBSCRIPTION
EMAGIN
CORPORATION
(To be
signed only on exercise of Warrant)
TO:
|
eMagin Corporation
|
|
10500 N.E. 8
th
Street, Suite 1400
|
|
Bellevue,
WA 98004
|
Attention:
Chief Financial Officer
Facsimile
No.: (425) 749-3601
1.
The
undersigned Holder of the attached original, executed Warrant hereby elects to
exercise its purchase right under such Warrant with respect to
shares
(the “Exercise Shares”) of Common Stock, as defined in the Warrant, of eMagin
Corporation, a Delaware corporation (the “Company”).
2.
The
undersigned Holder (check one):
q
(a)
elects to
pay the Aggregate Purchase Price for such shares of Common Stock (i) in lawful
money of the United States or by the enclosed certified or official bank check
payable in United States dollars to the order of the Company in the amount of
$
, or (ii)
by wire transfer of United States funds to the account of the Company in the
amount of $
, which
transfer has been made before or simultaneously with the delivery of this Form
of Subscription pursuant to the instructions of the Company;
or
q
(b)
elects to
receive shares of Common Stock having a value equal to the value of the Warrant
calculated in accordance with Section 2(b) of the Warrant.
3.
Please
issue a stock certificate or certificates representing the appropriate number of
shares of Common Stock in the name of the undersigned or in such other name(s)
as is specified below:
Name:_________________________________________________________________
Address_______________________________________________________________
Social
Security or Tax Identification Number (if any):
____________________________________________________________
Dated:
________________________________________________________
(Signature
must conform to name of Holder as
specified
on the face of the Warrant)
________________________________________________________
(Address)
Annex
III
PATENT AND TRADEMARK SECURITY
AGREEMENT
This
PATENT AND TRADEMARK SECURITY
AGREEMENT
, dated
as of July 21, 2006 (this “Agreement”), made by
EMAGIN CORPORATION
, a
Delaware corporation (the “Grantor”), to
ALEXANDRA GLOBAL MASTER FUND LTD.,
a British
Virgin Islands international business company, as collateral agent (in such
capacity, the “Collateral Agent”) on behalf of the Holders (such capitalized
term and all other capitalized terms used in this Agreement having the
respective meanings provided in this Agreement).
W I T N E S S E T
H:
WHEREAS
, the
Grantor and the several Buyers are parties to the several Note Purchase
Agreements pursuant to which, among other things, the Buyers have agreed to
purchase up to $7,000,000 aggregate principal amount of Notes of the
Grantor;
WHEREAS
, the
Grantor has certain right, title and interest in and to certain patents, patent
applications and trademarks and related property;
WHEREAS,
the
Grantor has agreed to grant to the Collateral Agent a security interest in its
right, title and interest in and to certain patents, patent applications,
trademarks and related rights to secure the payment and performance of certain
obligations of the Grantor, including, without limitation, obligations of the
Grantor under the Notes, the Note Purchase Agreements, the Security Agreement
and this Agreement;
WHEREAS
, it is a
condition precedent to the several obligations of the Buyers to purchase their
respective Notes that the Grantor shall have executed and delivered this
Agreement to the Collateral Agent for the ratable benefit of the
Holders;
WHEREAS
, the
Grantor is contemporaneously herewith entering into the Security Agreement and
the Lockbox Agreement with the Collateral Agent for the ratable benefit of the
Holders;
NOW, THEREFORE
, in
consideration of the premises and to induce the Buyers to purchase their
respective Notes pursuant to the Note Purchase Agreements, the Grantor hereby
agrees with the Collateral Agent, for the ratable benefit of the Holders, as
follows:
1.
Definitions.
(a)
As used
in this Agreement, the terms “Agreement”, “Grantor” and “Collateral Agent” shall
have the respective meanings assigned to such terms in the introductory
paragraph of and the recitals to this Agreement.
(b)
All the
agreements or instruments herein defined shall mean such agreements or
instruments as the same may from time to time be supplemented or amended or the
terms thereof waived or modified to the extent permitted by, and in accordance
with, the terms thereof and of this Agreement.
(c)
Capitalized
terms used herein without definition shall have the respective meanings assigned
to such terms in the Notes.
(d)
The
following terms shall have the following meanings (such meanings to be equally
applicable to both the singular and plural forms of the terms
defined):
“Accounts”
means all rights to payment for goods sold or leased or for services rendered,
whether or not such rights have been earned by performance.
“Additional
Note” means the Note issued pursuant to the Additional Note Purchase
Agreement.
“Additional
Note Purchase Agreement” means the Note Purchase Agreement, dated as of July 21,
2006, by and between the Grantor and Stillwater LLC, which by its terms
contemplates the issuance of up to $500,000 aggregate principal amount of Notes
on or after December 10, 2006.
“Affiliate”
means, with respect to any Person, any other Person that directly, or indirectly
through one or more intermediaries, controls, is controlled by or is under
common control with the subject Person. For purposes of this definition,
“control” (including, with correlative meaning, the terms “controlled by” and
“under common control with”), as used with respect to any Person, shall mean the
possession, directly or indirectly, of the power to direct or cause the
direction of the management and policies of such Person, whether through the
ownership of voting securities or by contract or otherwise.
“Buyer”
means any of the several buyers party to a Note Purchase Agreement.
“Code”
means the Uniform Commercial Code as from time to time in effect in the State of
Delaware.
“Collateral”
means all of the Grantor’s right, title and interest in and to each of the
following, whether now owned or at any time hereafter acquired by the Grantor or
in which the Grantor now has or at any time in the future may acquire any right,
title or interest:
(1)
all
Patents;
(2)
all
Patent Licenses;
(3)
all
Trademarks;
(4)
all
Trademark Licenses;
(5)
all
Contracts, Documents and General Intangibles developed or acquired by the
Grantor relating to any and all of the foregoing;
(6)
all
insurance policies to the extent they relate to the preceding items (1) through
(5); and
(7)
to the
extent not otherwise included in the preceding items (1) through (6), all
Proceeds, products, rents, issues, profits and returns of and arising from any
and all of the foregoing.
“Contracts”
shall have the meaning assigned to such term under the Code.
“Documents”
shall have the meaning assigned to such term under the Code.
“Event of
Default” means:
(1)
the
failure by the Grantor to perform in any material respect any obligation of the
Grantor under this Agreement as and when required by this Agreement;
(2)
any
representation or warranty made by the Grantor pursuant to this Agreement shall
have been untrue in any material respect when made or deemed to be
made;
(3)
the
failure by the Grantor to perform in any material respect any obligation of the
Grantor under the Security Agreement as and when required by the Security
Agreement;
(4)
any
representation or warranty made by the Grantor pursuant to the Security
Agreement shall have been untrue in any material respect when made or deemed to
be made;
(5)
the
failure by the Grantor to perform in any material respect any obligation of the
Grantor under the Lockbox Agreement as and when required by the Lockbox
Agreement;
(6)
any
representation or warranty made by the Grantor pursuant to the Lockbox Agreement
shall have been untrue in any material respect when made or deemed to be made;
or
(7)
any Event
of Default, as that term is defined in any of the Notes.
“General
Intangibles” shall have the meaning ascribed to such term in the Code.
“Holder”
means any Buyer or any holder from time to time of any Note.
“Issuance
Date” means the date on which the Notes are initially issued.
“Lien”
shall mean any lien, mortgage, security interest, chattel mortgage, pledge or
other encumbrance (statutory or otherwise) of any kind securing satisfaction or
performance of an obligation, including any agreement to give any of the
foregoing, any conditional sales or other title retention agreement, any lease
in the nature thereof, and the filing of or the agreement to give any financing
statement under the Code of any jurisdiction or similar evidence of any
encumbrance, whether within or outside the United States.
“Lockbox
Agent” means the Person from time to time serving as Lockbox Agent under the
Lockbox Agreement.
“Lockbox
Agreement” means that certain Lockbox Agreement, dated as of July 21, 2006, by
and between the Grantor and the Lockbox Agent.
“Majority
Holders” means at any time such of the holders of Notes, which based on the
outstanding principal amount of the Notes, represents a majority of the
aggregate outstanding principal amount of the Notes.
“Note
Purchase Agreements” means the several Note Purchase Agreements, dated as of
July 21, 2006, by and between the Grantor and the respective Buyer party thereto
pursuant to which the Grantor issued the Notes
,
including, without limitation, the Additional Note Purchase
Agreement
.
“Notes”
means the Grantor’s 6% Senior Secured Convertible Notes due 2007-2008 originally
issued pursuant to the Note Purchase Agreements, including, without limitation,
the Additional Note.
“Obligations”
shall mean:
(1)
the full
and prompt payment when due of all obligations and liabilities to the Holders,
whether now existing or hereafter arising, under the Notes, this Agreement or
the other Transaction Documents and the due performance and compliance with the
terms of the Notes and the other Transaction Documents;
(2)
any and
all sums advanced by the Collateral Agent or any Holder in order to preserve the
Collateral or to preserve the Collateral Agent’s security interest in the
Collateral;
(3)
in the
event of any proceeding for the collection or enforcement of any obligations or
liabilities of the Grantor referred to in the immediately preceding clauses (1)
and (2) in accordance with the terms of the Notes and this Agreement, the
reasonable expenses of re-taking, holding, preparing for sale, selling or
otherwise disposing of or realizing on the Collateral, or of any other exercise
by the Collateral Agent of its rights hereunder, together with reasonable
attorneys’ fees and court costs; and
(4)
any
amounts for which any Holder is entitled to indemnification under Section
4(n).
“Patent(s)”
means all patents, patent applications and patent disclosures which are
presently, or in the future may be, owned, issued, acquired or used (whether
pursuant to a license or otherwise) anywhere in the world by the Grantor, in
whole or in part, and all of the Grantor’s right, title and interest in and to
all patentable inventions and to file applications for patents under patent laws
of the United States or of any other jurisdiction, including any and all
extensions, reissues, substitutes, continuations, continuations-in-part,
divisional, patents of addition, re-examinations and renewals thereof, and
patents issuing therefrom, and any other proprietary rights related to any of
the foregoing (including, without limitation, remedies against infringements
thereof and rights of protection of an interest therein under the laws of all
jurisdictions) and any and all foreign counterparts of any of the foregoing,
including without limitation, those listed on
Exhibit A
to this
Agreement.
“Patent
Licenses” means each license agreement identified in
Exhibit A
to this
Agreement as it may be amended, supplemented or otherwise modified from time to
time, and each license agreement relating to Patents hereafter granted
to, used
or acquired by the Grantor, in each case together with the right to use and rely
upon the inventions and other intellectual property conveyed
thereunder.
“Person”
means any natural person, corporation, partnership, limited liability company,
trust, incorporated organization, unincorporated association or similar entity
or any government, governmental agency or political subdivision.
“Proceeds”
shall have the meaning assigned to such term under the Code.
“PTO”
means the United States Patent and Trademark Office.
“Security
Agreement” means the Pledge and Security Agreement, dated as of July 21, 2006,
between the Grantor and the Collateral Agent.
“Security
Interest” means the security interest and collateral assignment granted in the
Collateral pursuant to this Agreement.
“Subsidiary”
means any corporation or other entity of which a majority of the capital stock
or other ownership interests having ordinary voting power to elect a majority of
the board of directors or other Persons performing similar functions are at the
time directly or indirectly owned by the Company.
“Trademark
License” means each license agreement identified in
Exhibit B
hereto
as it may be amended, supplemented or otherwise modified from time to time, and
each license agreement relating to Trademarks hereafter used, adopted or
acquired by the Grantor.
“Trademarks”
means (a) all trademarks, trade names, corporate names, company names, business
names, fictitious business names, trade styles, service marks, logos and other
source or business identifiers of the Grantor adopted for use in conjunction
with the sale of Medical Devices or Competitive Products, now existing anywhere
in the world or hereinafter adopted or acquired, whether currently in use or
not, and the goodwill associated therewith, all registrations and recordings
thereof, and all applications in connection therewith, including, without
limitation, those identified in
Exhibit B
to this
Agreement, and (b) all renewals thereof by the Grantor.
“Transaction
Documents” means the Notes, the Note Purchase Agreements, this Agreement, the
Security Agreement, the Lockbox Agreement, the Warrants and the other
agreements, instruments and documents contemplated hereby and thereby, and any
amendments, extensions or renewals thereof or replacements
therefor.
2.
Grant of Security
Interest.
As
collateral security for the prompt and complete payment and performance when due
of the Obligations and for the other purposes provided in this Agreement, the
Grantor hereby grants, assigns and conveys to the Collateral Agent, for the
ratable benefit of the Holders, all of the Grantor’s right, title and interest
in and to the Collateral as collateral security and hereby grants the Collateral
Agent a continuing first priority security interest therein. Such grant
includes, without limitation, a grant of the security interest to secure the
payment and performance of Obligations relating to the Additional Note upon the
date of issuance of such Additional Note. Notwithstanding the foregoing
assignment, unless and until there shall have occurred and be continuing an
Event of Default, the Grantor shall retain and the Collateral Agent hereby
grants to the Grantor the exclusive, non-transferable, revocable right and
license to use the Collateral on and in connection with making, having made,
using and selling products sold by the Grantor, for the Grantor’s own benefit
and account and for none other (except as provided in the Patent Licenses
identified on
Exhibit A
and the
Trademark Licenses identified on
Exhibit B
). The
Grantor agrees not to sell or assign its interest in, or grant any sublicense
under, the foregoing license granted to the Grantor without the prior written
consent of the Collateral Agent, which may be withheld in the Collateral Agent’s
sole and absolute discretion.
3.
Representations and
Warranties
. The
Grantor hereby represents and warrants that:
(a)
Description of Collateral.
True and
complete schedules setting forth all Patents, Patent Licenses, Trademarks and
Trademark Licenses owned, held, controlled or used by the Grantor or to which
the Grantor is a party on the date of this Agreement, together with a summary
description and full information in respect of the filing, registration,
issuance and expiration dates thereof, as applicable, are set forth on
Exhibit A
with
respect to Patents and Patent Licenses and on
Exhibit B
with
respect to Trademarks and Trademark Licenses, respectively, to this
Agreement.
(b)
Title; No Other
Liens.
Except
for the Lien granted to the Collateral Agent for the ratable benefit of the
Holders pursuant to this Agreement and the Lien granted to the Collateral Agent
for the ratable benefit of the Holders pursuant to the Security Agreement, the
Grantor is the sole and exclusive owner of and has good and marketable title to
each item of the Collateral free and clear of any and all Liens or claims of
others, except as permitted by Section 3.9 of the Notes. None of the Grantor’s
Subsidiaries or other entities controlled by the Grantor has any right, title or
interest in or to any of the Collateral. No security agreement, financing
statement or other public notice with respect to all or any part of the
Collateral is on file or of record in any public office, except such as may have
been filed in favor of the Collateral Agent, for the ratable benefit of the
Holders, pursuant to this Agreement or the Security Agreement.
(c)
Perfected First Priority
Liens
. The
Liens granted pursuant to this Agreement will constitute, upon the completion of
all the filings or notices listed in
Exhibit C
to this
Agreement, which Exhibit includes all UCC-1 financing statements to be filed
pursuant to the terms of the Security Agreement, all requisite filings to be
made with the PTO in the forms substantially similar to that of
Exhibit E
and
Exhibit F
to this
Agreement, valid and perfected Liens on all Collateral in favor of the
Collateral Agent for the ratable benefit of the Holders, which are prior to all
other Liens on such Collateral and which are enforceable as such against all
Persons.
(d)
Consents under
Contracts
. No
consent (other than consents that have been obtained) of any party (other than
the Grantor) to any Contract that constitutes part of the Collateral is
required, or purports to be required, in connection with the execution, delivery
and performance of this Agreement or the exercise of the Collateral Agent’s
rights and remedies provided herein or at law.
(e)
Chief Executive
Office
. The
Grantor’s chief executive office and chief place of business is located at 10500
N.E. 8
th
Street,
Suite 1400,
Bellevue,
WA 98004.
(f)
Authority.
The
Grantor has full power, authority and legal right to grant the Collateral Agent
the Lien on the Collateral pursuant to this Agreement.
(g)
Approvals, Filings,
Etc.
No
authorization, approval or consent of, or filing, registration, recording or
other action with, any United States or foreign court, governmental body,
regulatory agency, self-regulatory organization, or stock exchange or market,
the stockholders of the Company or any other Person, including, without
limitation, the PTO, is required to be obtained or made by the Company or any
Subsidiary (x) for the grant by the Grantor of the Lien on the Collateral
pursuant to this Agreement, (y) the collateral assignment of the Collateral to
the Collateral Agent pursuant to this Agreement or (z) to perfect the Lien
purported to be created by this Agreement, in each case except as has been
obtained or made or (z) for the exercise of the Collateral Agent’s rights and
remedies provided herein or at law.
(h)
No Claims.
Each of
the Patents and Trademarks existing on the date hereof is valid and enforceable,
and the Grantor is not presently aware of any past, present or prospective claim
by any third party that any of such Patents or Trademarks are invalid or
unenforceable, or that the use of any Patents does or may violate the rights of
any third person, or of any basis for any such claims.
(i)
Statutory Notice.
The
Grantor has used and will continue to use proper statutory notice in connection
with its use of the Patents.
(j)
Certain Patent
Matters.
To its
knowledge, the Grantor does not lack any material rights or licenses to use the
Patents or to make, have made, use, sell, or offer for sale the claimed subject
matter of the Patents. To the knowledge of the Grantor, there are no facts which
would form a basis for a finding that any of the claims of the Patents is
unpatentable, unenforceable or invalid. To the knowledge of the Grantor, there
are no pending U.S. or foreign patent applications which, if issued, would limit
or prohibit the ability of the Grantor or the Collateral Agent to make, have
made, use, sell, or offer for sale the claimed subject matter of the
Patents.
(k)
Custom License Matters.
Each
Patent License or Trademark License is the legal, valid and binding obligation
of the Grantor and the respective licensor thereunder; the Grantor is not, and,
to the best knowledge of the Grantor, each licensor is not, in default of any of
its obligations under any Patent License or Trademark License; no event has
occurred and no circumstance exists that with the giving of notice or the
passage of time, or both, would constitute such a default by the Grantor; and,
to the best knowledge of the Grantor, no such event has occurred or circumstance
exists that would constitute a default by the licensor under any Patent License
or Trademark License.
4.
Covenants.
The
Grantor covenants and agrees with the Collateral Agent that from and after the
date of this Agreement until the payment and performance in full by the Grantor
of all of the Obligations:
(a)
Further
Documentation.
At any
time and from time to time, upon the written request of the Collateral Agent,
and at the sole expense of the Grantor, the Grantor will promptly and duly
execute and deliver such further instruments and documents and take such further
action as the Collateral Agent may request for the purpose of obtaining or
preserving the full benefits of this Agreement and of the rights and powers
herein granted, including, without limitation, any applicable filing with the
PTO and the filing of any financing or continuation statements under the Code or
similar laws in effect in any such jurisdiction with respect to the Liens
created hereby. The Grantor also hereby authorizes the Collateral Agent to file
any such financing or continuation statement without the signature of the
Grantor to the extent permitted by applicable law. A carbon, photographic or
other reproduction of this Agreement shall be sufficient as a financing
statement for filing in any jurisdiction.
(b)
Maintenance of
Records
. The
Grantor will keep and maintain at its own cost and expense satisfactory and
complete records of the Collateral. For the further security of the Collateral
Agent for the ratable benefit of the Holders, the Grantor hereby grants to the
Collateral Agent, for the ratable benefit of the Holders, a security interest in
all of the Grantor’s books and records pertaining to the Collateral, and the
Grantor shall turn over any such books and records for
inspection
at the office of the Grantor to the Collateral Agent or to its representatives
during normal business hours at the request of the Collateral
Agent.
(c)
Limitation on Liens on
Collateral.
The
Grantor (x) will not create, incur or permit to exist, will defend the
Collateral against, and will take such other action as is necessary to remove,
any Lien or claim on or to the Collateral, other than the Liens created hereby
and by the Security Agreement and Liens permitted by Section 3.9 of the Notes,
and (y) will defend the right, title and interest of the Collateral Agent in and
to any of the Collateral against the claims and demands of all
Persons.
(d)
Limitations on Dispositions of
Collateral.
The
Grantor will not sell, transfer, assign, grant any participation in, sublicense
or otherwise dispose of any of the Collateral to any Persons, including, without
limitation, any Subsidiary or Affiliate, or attempt, offer or contract to do so.
(e)
Limitations on Modifications,
Waivers, Extensions of Patent Licenses and Trademark
Licenses.
The
Grantor will not (i) amend, modify, terminate or waive any provision of any
Patent License with respect to any Patent or Trademark License with respect to
any Trademark in any manner which could reasonably be expected to materially
adversely affect the value of such Patent License or Trademark License as
Collateral, (ii) fail to exercise promptly and diligently each and every
material right and perform each material obligation which it may have under each
Patent License and Trademark License with respect to any Trademarks. Within two
Business Days of receipt thereof, the Grantor will deliver to the Collateral
Agent a copy of each material demand, notice or document received by it relating
in any way to each Patent License and Trademark License.
(f)
Further Identification of
Collateral.
The
Grantor shall furnish to the Collateral Agent from time to time, upon the
request of the Collateral Agent, statements and schedules further identifying
and describing the Collateral and such other reports in connection with the
Collateral as the Collateral Agent may reasonably request, all in reasonable
detail.
(g)
Notices.
The
Grantor shall advise the Collateral Agent promptly, but in no event later than
two Business Days after the occurrence thereof, in reasonable detail, at its
address specified in accordance with Section 15 (i) of any Lien on, or claim
asserted against, any of the Collateral, other than as created hereby or as
permitted hereby, (ii) of any Event of Default or any event which, with the
giving of notice or the passage of time, or both, would become an Event of
Default and (iii) of the occurrence of any other event which could reasonably be
expected to have a material adverse effect on the Liens created hereunder or the
rights of the Collateral Agent hereunder.
(h)
Patents.
(1)
The
Grantor will notify the Collateral Agent immediately if it knows, or has reason
to know, that any application relating to any Patent may become abandoned or of
any adverse determination or development (including, without limitation, the
institution of, or any such determination or development in, any proceeding in
the PTO or any court or tribunal in any country) regarding the Grantor’s
ownership of or license rights or other rights with respect to any
Patent.
(2)
The
Grantor will, with respect to any Patent that the Grantor obtains after the
Issuance Date or any Patent License that the Grantor acquires after the Issuance
Date, promptly, but in no event later than five Business Days thereafter, (i)
take all actions necessary so that the Collateral Agent shall obtain a perfected
security interest in such Patent or Patent License and (ii) provide to the
Collateral Agent a revised
Exhibit A
, listing
all Patents and all Patent Licenses in which the Grantor has an
interest.
(3)
Upon
request of the Collateral Agent, the Grantor shall execute and deliver any and
all agreements, instruments, documents, and papers as the Collateral Agent may
request to evidence the Collateral Agent’s security interest in such Patents or
Patent Licenses, and the Grantor hereby constitutes the Collateral Agent its
attorney-in-fact to execute and file all such writings for the foregoing
purposes, all acts of such attorney being hereby ratified and confirmed; such
power being coupled with an interest is irrevocable until the Grantor shall have
paid and performed in full all of its obligations under this Agreement and the
other Transaction Documents.
(4)
The
Grantor will take all reasonable and necessary steps, including, without
limitation, in any proceeding before the PTO to maintain and pursue each Patent
including, without limitation, payment of maintenance fees.
(5)
In the
event that any Patent included in the Collateral is infringed by a third party,
the Grantor shall promptly notify the Collateral Agent after it learns thereof
and shall, if appropriate, sue for infringement, seeking injunctive relief where
appropriate and to recover any and all damages for such infringement, or take
such other actions as the Grantor shall reasonably deem appropriate under the
circumstances to protect such Patent.
(6)
The
Grantor hereby grants to the Collateral Agent and its employees and agents the
right, upon prior written notice, to visit the Grantor’s plants and facilities,
and the Grantor shall use its best efforts to arrange for the Collateral Agent
and its employees and agents to have access to such plants and facilities of
third parties which manufacture or supply goods or services, for or under
contract with the Grantor.
(i)
Trademarks.
(1)
The
Grantor (either itself or through licensees) will, with respect to each
Trademark identified in
Exhibit B
, as
Exhibit B
may be
amended, supplemented or otherwise modified from time to time, (i) continue to
use or have used such Trademark to the extent necessary to maintain such
Trademark in full force free from any claim of abandonment for non-use, (ii)
maintain as in the past the quality of products and services offered under such
Trademark, (iii) employ such Trademark with the appropriate notice of
registration, (iv) not adopt or use any mark which is confusingly similar or a
colorable imitation of such Trademark unless the Collateral Agent, for the
ratable benefit of the Holders, shall obtain a first priority perfected security
interest in the Company’s interest in such mark pursuant to this Agreement, and
(v) not (and not permit any licensee or sublicensee thereof to) do any act or
knowingly omit to do any act whereby any such Trademark may become
invalidated.
(2)
The
Grantor will promptly notify the Collateral Agent if any application or
registration relating to any Trademark may become abandoned, canceled or denied,
or of any adverse determination or development (including, without limitation,
the institution of, or any such determination or development in, any proceeding
in the PTO or any court or tribunal in any country) regarding the Grantor’s
ownership interest in such Trademark or its right to register the same or to
keep and maintain the same.
(3)
The
Grantor will, with respect to any Trademark that the Grantor registers after the
Issuance Date or any Trademark License that the Grantor acquires after the
Issuance Date, promptly (i) take all actions necessary so that the Collateral
Agent, for the ratable benefit of the Holders, shall obtain a perfected security
interest in such Trademark or Trademark License and (ii) provide to the
Collateral Agent a revised
Exhibit B
listing
all registered Trademarks and all Trademark Licenses in which the Grantor has an
interest.
(4)
Upon
request of the Collateral Agent, the Grantor shall execute and deliver any and
all agreements, instruments, documents, and papers as the Collateral Agent may
request to evidence the Collateral Agent’s security interest in any Trademark
and the goodwill and general intangibles of the Grantor relating thereto or
represented thereby, and the Grantor hereby constitutes the Collateral Agent its
attorney-in-fact to execute and file
all such
writings for the foregoing purposes, all acts of such attorney being hereby
ratified and confirmed; such power being coupled with an interest is irrevocable
until the Grantor shall have paid and performed in full all of its obligations
under the Transaction Documents.
(5)
The
Grantor will take all reasonable and necessary steps, including, without
limitation, in any proceeding before the PTO, to maintain and pursue each
application (and to obtain the relevant registration) and to maintain the
registration of the Trademarks, including, without limitation, filing of
applications for renewal, affidavits of use and affidavits of
incontestability.
(6)
In the
event that any Trademark included in the Collateral is infringed,
misappropriated or diluted by a third party, the Grantor shall notify the
Collateral Agent and shall, if appropriate, sue for infringement,
misappropriation or dilution, seeking injunctive relief where appropriate and to
recover any and all damages for such infringement, misappropriation or dilution,
or take such other action as the Grantor reasonably deems appropriate under the
circumstances to protect such Trademark.
(j)
Further Actions.
Without
limiting the foregoing provisions of this Section 4, the Grantor further agrees
for itself and its successors and assigns to execute upon request any other
lawful documents and likewise to perform any other lawful acts which may be
necessary or desirable to secure fully for the Collateral Agent, for the ratable
benefit of the Holders, all right, title and interest in and to the Collateral,
including, but not limited to, the execution of substitution, reissue,
divisional or continuation patent applications; and preliminary or other
statement of the giving of testimony in any interference or other proceeding in
which the Collateral or any application, Patent or Trademark directed thereto or
derived therefrom may be involved.
(k)
License Agreements
. The
Grantor shall comply with its obligations under each of its Patent Licenses and
Trademark Licenses.
(l)
Changes in Locations, Name,
Etc.
The
Grantor will not (i) change the location of its chief executive office/chief
place of business from that specified in Section 3(e) or (ii) change its name,
identity or corporate structure to such an extent that any statement filed by
the Collateral Agent with the PTO in connection with this Agreement would become
misleading, unless it shall have given the Collateral Agent at least 30 days
prior written notice thereof and, prior to such action or event, shall have
taken appropriate action satisfactory to the Collateral Agent to preserve and
protect the Collateral Agent’s collateral assignment and the Security Interest
under this Agreement.
(m)
Subsidiaries.
This
Agreement is entered into on behalf of and for the benefit of the Grantor. The
Grantor will not permit any of its Subsidiaries or Affiliates or any other
entities controlled by the Grantor to have any ownership or other rights in or
to exercise any control over the Collateral.
(n)
Indemnification
. The
Grantor agrees to indemnify and hold harmless the Collateral Agent and each
Holder and their respective officers, directors, Affiliates, agents and
investment advisors (each, an “Indemnified Person”) from and against any and all
claims, demands, losses, judgments and liabilities (including liabilities for
penalties) of whatsoever kind or nature, and to reimburse the Collateral Agent
and each Holder for all costs and expenses, including reasonable attorneys’ fees
and expenses, arising out of or resulting from this Agreement, including any
breach hereof or Event of Default hereunder, or the exercise by the Collateral
Agent or any Holder, as the case may be, of any right or remedy granted to it
hereunder or under the other Transaction Documents or under applicable law;
provided,
however,
that the
Grantor shall not be required to indemnify a particular Indemnified Person to
the extent any claim, demand, loss, judgment, liability, cost or expense is
determined by final judgment (not subject to further appeal) of a court of
competent jurisdiction to have arisen primarily from the gross negligence or
willful misconduct of such Indemnified Person. In no event shall any Indemnified
Person other than the Collateral Agent have any liability or obligation to the
Grantor under this Agreement or applicable law (liability under which the
Grantor hereby waives) for any matter or thing in connection with this
Agreement, and in no event shall the Collateral Agent or any Holder be liable,
in the absence of a determination of gross negligence or willful misconduct on
its part by final judgment (not subject to further appeal) of a court of
competent jurisdiction, for any matter or thing in connection with this
Agreement other than to account for moneys actually received by it in accordance
with the terms hereof. If and to the extent that the obligations of the Grantor
under this Section 4(n) are unenforceable for any reason, the Grantor hereby
agrees to make the maximum contribution to the payment and satisfaction of such
obligations which is permissible under applicable law. In any suit, proceeding
or action brought by the Collateral Agent or any Holder under any Account or
Contract that constitutes part of the Collateral for any sum owing thereunder,
or to enforce any provisions of any such Account or Contract, the Grantor will
save, indemnify and keep the Collateral Agent and each Holder harmless from and
against all expense, loss or damage suffered by reason of any defense, setoff,
counterclaim, recoupment or reduction or liability whatsoever of the account
debtor or obligor thereunder, arising out of a breach by the Grantor of any
obligation thereunder or arising out of any other agreement, indebtedness or
liability at any time owing to or in favor of such account debtor or obligor or
its successors from the Grantor.
5.
Collateral Agent’s
Powers
.
(a)
Powers
. The
Grantor hereby irrevocably constitutes and appoints the Collateral Agent and any
officer or agent thereof or investment advisor thereto, with full power of
substitution, as its true and lawful attorney-in-fact with full irrevocable
power and authority in the place and stead of the Grantor and in the name of the
Grantor or in its own name, from time to time in the Collateral Agent’s
discretion, during any period in which an Event of Default is continuing, for
the purpose of carrying out the terms of this Agreement, to take any and all
appropriate action and to execute any and all documents and instruments which
may be necessary or desirable to accomplish the purposes of this Agreement, and,
without limiting the generality of the foregoing, the Grantor hereby gives the
Collateral Agent and each such officer, agent and investment advisor the power
and right, on behalf of the Grantor, without notice to or assent by the Grantor,
except any notice required by law, to do the following:
(1)
to take
possession of and endorse and collect any checks, drafts, notes, acceptances or
other instruments for the payment of moneys due under or with respect to any
Collateral and to file any claim or to take any other action or proceeding in
any court of law or equity or otherwise deemed appropriate by the Collateral
Agent for the purpose of collecting any and all such moneys due under or with
respect to any such Collateral whenever payable, in each case in the name of the
Grantor or its own name, or otherwise;
(2)
to pay or
discharge taxes and Liens levied or placed on or threatened against the
Collateral and to pay all or any part of the premiums therefor and the costs
thereof; and
(3)
(A) to
direct any party liable for any payment under any of the Collateral to make
payment of any and all moneys due or to become due thereunder directly to the
Collateral Agent or as the Collateral Agent shall direct; (B) to ask or demand
for, collect, receive payment of and receipt for, any and all moneys, claims and
other amounts due or to become due at any time in respect of or arising out of
any Collateral; (C) to sign and endorse any invoices, freight or express bills,
bills of lading, storage or warehouse receipts, drafts against debtors,
assignments, verifications, notices and other documents in connection with any
of the Collateral; (D) to commence and prosecute any suits, actions or
proceedings at law or in equity in any court of competent jurisdiction to
collect the Collateral or any thereof and to enforce any other right in respect
of any Collateral; (E) to defend any suit, action or proceeding brought against
the Grantor with respect to any Collateral; (F) to settle, compromise or adjust
any suit, action or proceeding described in clause (E) above and, in connection
therewith, to give such discharges or releases as the Collateral Agent may deem
appropriate; (G) to assign (along with the goodwill of the business
pertaining thereto) any Patent or Trademark for such term or terms,
on such conditions, and in such manner, as the Collateral Agent shall
in
its sole
discretion determine; and (H) generally, to sell, transfer, pledge and make any
agreement with respect to or otherwise deal with any of the Collateral as fully
and completely as though the Collateral Agent were the absolute owner thereof
for all purposes, and to do, at the Collateral Agent’s option and the Grantor’s
expense, at any time, or from time to time, all acts and things which the
Collateral Agent deems necessary to protect, preserve or realize upon the
Collateral and the Collateral Agent’s Liens thereon and to effect the intent of
this Agreement, all as fully and effectively as the Grantor might
do.
The
Grantor hereby ratifies all that said attorneys shall lawfully do or cause to be
done by virtue hereof. This power of attorney is a power coupled with an
interest and shall be irrevocable until the Grantor shall have paid and
performed in full all of the Obligations.
(b)
Filing and
Recordation.
In
addition to the filings the Grantor is required to make as specified in
Exhibit C
, this
Agreement or an instrument referring hereto may be filed and recorded in such
public offices and with such governmental authorities, including the PTO, as the
Collateral Agent may determine from time to time. The Collateral Agent may so
file and record this Agreement as a “security interest”, “collateral
assignment”, “assignment” or similar designation as the Collateral Agent may
determine (so long as such designation is consistent with the terms of this
Agreement) and the Collateral Agent may from time to time rerecord and refile or
take other action to change the designation under which this Agreement is filed
or recorded (so long as such designation is consistent with the terms of this
Agreement).
(c)
Other Powers.
The
Grantor also authorizes the Collateral Agent, at any time and from time to time,
to execute, in connection with the sale provided for herein, any endorsements,
assignments or other instruments of conveyance or transfer with respect to the
Collateral.
(d)
No Duty on Collateral Agent’s
Part.
The
powers conferred on the Collateral Agent hereunder are solely to protect the
Collateral Agent’s interests in the Collateral for the ratable benefit of the
Holders and shall not impose any duty upon the Collateral Agent to exercise any
such powers. The Collateral Agent shall be accountable only for amounts that it
actually receives as a result of the exercise of such powers, and neither it nor
any of its officers, directors, employees or agents shall be responsible to the
Grantor for any act or failure to act hereunder, except for their own gross
negligence or willful misconduct.
(e)
Grantor Remains Liable under
Contracts
.
Anything herein to the contrary notwithstanding, the Grantor shall remain liable
under each of the
ontracts
that constitute part of the Collateral to observe and perform all the conditions
and obligations to be observed and performed by it thereunder, all in accordance
with and pursuant to the terms and provisions of each such Contract. The
Collateral Agent shall not have any obligation or liability under any Contract
that constitutes part of the Collateral by reason of or arising out of this
Agreement or the receipt by the Collateral Agent of any payment relating to such
Contract pursuant hereto, nor shall the Collateral Agent be obligated in any
manner to perform any of the obligations of the Grantor under or pursuant to any
such Contract, to make any payment, to make any inquiry as to the nature or the
sufficiency of any payment received by it or as to the sufficiency of any
performance by any party under any such Contract, to present or file any claim,
to take any action to enforce any performance or to collect the payment of any
amounts which may have been assigned to it or to which it may be entitled at any
time or times.
6.
Performance by Collateral Agent of
Grantor’s Obligations.
If the
Grantor fails to perform or comply with any of its agreements contained herein
and the Collateral Agent, as provided for by the terms of this Agreement and
following reasonable notice to the Grantor, may itself perform or comply, or
otherwise cause performance or compliance, with such agreement, and the expenses
of the Collateral Agent incurred in connection with such performance or
compliance shall be payable by the Grantor to the Collateral Agent on demand and
shall constitute Obligations secured hereby.
7.
Remedies.
If an
Event of Default has occurred and is continuing, but in the case of Events of
Default that are solely ones covered by the final clause (2) of Section 4.01 of
any Note, only after the expiration of the 120-day period specified in such
clause (2) the Collateral Agent may exercise, in addition to all other rights
and remedies granted to it in this Agreement and in any other instrument or
agreement securing, evidencing or relating to the Obligations, all rights and
remedies of a secured party under the Code. Without limiting the generality of
the foregoing, if an Event of Default has occurred and is continuing, but in the
case of Events of Default that are solely ones covered by the final clause (2)
of Section 4.01 of any Note, only after the expiration of the 120-day period
specified in such clause (2) the Collateral Agent, without demand of performance
or other demand, presentment, protest, advertisement or notice of any kind
(except any notice required by law referred to below or expressly provided for)
to or upon the Grantor or any other Person (all and each of which demands,
defenses, advertisements and notices are, to the extent permitted by applicable
law, hereby waived), may in such circumstances forthwith collect, receive,
appropriate and realize upon the Collateral, or any part thereof, and/or may
forthwith sell, license, assign, give option or options to purchase, or
otherwise dispose of and deliver the Collateral or any part thereof (or contract
to do any of the foregoing), at public or private sale or sales, at any
exchange, broker’s board or office of the Collateral Agent or elsewhere upon
such terms and conditions as it may deem advisable and at such prices as it may
deem best, for cash or on credit or for future delivery w
ithout
assumption of any credit risk. The Collateral Agent shall have the right upon
any such public sale or sales, and, to the extent permitted by law, upon any
such private sale or sales, to purchase the whole or any part of the Collateral
so sold, free of any right or equity of redemption in the Grantor, which right
or equity is hereby waived, to the extent permitted by applicable law, or
released.
The
Grantor further agrees, if an Event of Default has occurred and is continuing,
at the Collateral Agent’s request, to assemble the Collateral and make it
available to the Collateral Agent at places which the Collateral Agent shall
reasonably select, whether at the Grantor’s premises or elsewhere. The
Collateral Agent shall apply the net proceeds of any such collection, recovery,
receipt, appropriation, realization or sale, after deducting all reasonable
costs and expenses of every kind incurred therein or incidental to the care or
safekeeping of any of the Collateral or in any way relating to the Collateral or
the rights of the Collateral Agent hereunder, including, without limitation,
reasonable attorneys’ fees and disbursements, to the payment in whole or in part
of the Obligations, in such order as the Collateral Agent may elect, and only
after such application and after the payment by the Collateral Agent of any
other amount required by any provision of law, need the Collateral Agent account
for the surplus, if any, to the Grantor. To the extent permitted by applicable
law, the Grantor waives all claims, damages and demands it may acquire against
the Collateral Agent arising out of the exercise by it of any rights hereunder,
provided,
that
nothing contained in this Section shall relieve the Collateral Agent from
liability arising solely from its gross negligence or willful misconduct. If any
notice of a proposed sale or other disposition of Collateral shall be required
by law, such notice shall be deemed reasonable and proper if given at least ten
days before such sale or other disposition. The Grantor shall remain liable for
any deficiency if the proceeds of any sale or other disposition of the
Collateral are insufficient to pay the Obligations and the fees and
disbursements of any attorneys employed by the Collateral Agent to collect such
deficiency.
8.
Limitation on Duties Regarding
Preservation of Collateral.
The
Collateral Agent’s sole duty with respect to the custody, safekeeping and
physical preservation of the Collateral in its possession, under the Code or
otherwise, shall be to deal with it in the same manner as the Collateral Agent
deals with similar property for its own account. Neither the Collateral Agent
nor any of its directors, officers, employees or agents shall be liable for
failure to demand, collect or realize upon all or any part of the Collateral or
for any delay in doing so or shall be under any obligation to sell or otherwise
dispose of any Collateral upon the request of the Grantor or
otherwise.
9.
Powers Coupled with an
Interest.
All
authorizations and agencies herein contained with respect to the Collateral are
irrevocable and powers coupled with an interest until the Grantor has paid and
performed in full all of the Obligations.
10.
Severability.
Any
provision of this Agreement which is prohibited or unenforceable in any
jurisdiction shall, as to such jurisdiction, be ineffective to the extent of
such prohibition or unenforceability without invalidating the remaining
provisions hereof, and any such prohibition or unenforceability in any
jurisdiction shall not invalidate or render unenforceable such provision in any
other jurisdiction.
11.
Paragraph Headings, Captions,
Etc.
The
paragraph headings, the captions and the footers, used in this Agreement are for
convenience of reference only and are not to affect the construction hereof or
be taken into consideration in the interpretation hereof.
12.
No Waiver; Cumulative
Remedies.
The
Collateral Agent shall not by any act, delay, indulgence, omission or otherwise
be deemed to have waived any right or remedy hereunder or to have acquiesced in
any Event of Default or in any breach of any of the terms and conditions hereof.
No failure to exercise, nor any delay in exercising, on the part of the
Collateral Agent, any right, power or privilege hereunder shall operate as a
waiver thereof. No single or partial exercise of any right, power or privilege
hereunder shall preclude any other or further exercise thereof or the exercise
of any other right, power or privilege. A waiver by the Collateral Agent of any
right or remedy hereunder on any one occasion shall not be construed as a bar to
any right or remedy which the Collateral Agent would otherwise have on any
future occasion. The rights and remedies herein and in the other Transaction
Documents provided are cumulative, may be exercised singly or concurrently and
are not exclusive of any rights or remedies provided by law or in equity or by
statute.
13.
Waivers and Amendments; Successors
and Assigns.
None of
the terms or provisions of this Agreement may be waived, amended, supplemented
or otherwise modified except by a written instrument executed by the party to be
charged with enforcement;
provided, however,
that any
provision of this Agreement may be waived, amended, supplemented or otherwise
modified by the Collateral Agent only with the prior written approval of the
Majority Holders. This Agreement shall be binding upon the successors and
assigns of the Grantor and shall inure to the benefit of the Collateral Agent
and its successors and assigns. The Grantor may not assign its rights or
obligations under this Agreement without the prior written consent of the
Collateral Agent, which the Collateral Agent may withhold in the discretion of
the Majority Holders. The requirements for resignation, and appointment of a
successor to, the Collateral Agent are established by
Exhibit D
hereto
and not by this Agreement.
14.
Termination of Security Interest;
Release of Collateral.
(a) Upon
the payment and performance in full by the Grantor of the Obligations, all
right, title and interest of the Collateral Agent in and to the Collateral,
including the Security Interest, pursuant to this Agreement shall terminate and
all rights to the Collateral shall revert to the Grantor.
(b)
At any
time and from time to time prior to termination of the right, title and interest
of the Collateral Agent in and to the Collateral pursuant to Section 14(a), the
Collateral Agent shall release any of the Collateral only with the prior written
consent of the Majority Holders.
(c)
Upon any
such termination of the Security Interest, the Collateral Agent will, at the
expense of the Grantor, execute and deliver to the Grantor such documents and
take such other actions as the Grantor shall reasonably request to evidence the
reassignment of the Collateral to the Grantor and the termination of the
Security Interest. The Collateral Agent shall deliver to the Grantor all
Collateral so released then in its possession.
15.
Notices.
Any
notices required or permitted to be given under the terms of this Agreement
shall be in writing and shall be sent by mail, personal delivery, telephone line
facsimile transmission or courier and shall be effective five days after being
placed in the mail, if mailed, or upon receipt, if delivered personally, by
telephone line facsimile transmission or by courier, in each case addressed to a
party at such party’s address (or telephone line facsimile transmission number)
shown below or such other address (or telephone line facsimile transmission
number) as a party shall have provided by notice to the other party in
accordance with this provision. In the case of any notice to the Grantor, such
notice shall be addressed to the Grantor at 10500 N.E. 8
th
Street,
Suite 1400,Bellevue, WA 98004, Attention: Chief Financial Officer (telephone
line facsimile number (425) 749-3601), with a copy to Sichenzia Ross Friedman
Ference LLP, 1065 Avenue of the Americas, 21
st
Floor,
New York, New York 10018, Attention: Richard A. Friedman, Esq. (telephone line
facsimile number (212) 930-9725), and in the case of any notice to the
Collateral Agent, such notice shall be addressed to the Collateral Agent at c/o
Alexandra Investment Management, LLC, 767 Third Avenue, 39
th
Floor,
New York, New York 10017, Attention: Chief Compliance Officer (telephone line
facsimile transmission number (212) 301-1800).
16.
Fees and Expenses
. The
Grantor agrees to pay the fees of the Collateral Agent in performing its
services under this Agreement and all reasonable expenses (including but not
limited to attorneys’ fees and costs for legal services, costs of insurance and
payments of taxes or other charges) of, or incidental to, the custody, care,
sale or realization on any of the Collateral or in any way relating to the
performance of the obligations or the enforcement or protection of the rights of
the Collateral Agent hereunder.
17.
Concerning Collateral
Agent.
The
Grantor acknowledges that the rights and responsibilities of the Collateral
Agent under this Agreement with respect to any action taken by the Collateral
Agent or the exercise or
nonexercise
by the Collateral Agent of any option, right, request, judgment or other right
or remedy provided for herein or resulting or arising out of this Agreement
shall, as between the Collateral Agent and the Holders, be governed by
Exhibit D
to this
Agreement and by such other agreements with respect thereto as may exist from
time to time among them, but, as between the Collateral Agent and the Grantor,
except as expressly provided in Sections 13 and 14, the Collateral Agent shall
be conclusively presumed to be acting as agent for the Holders with full and
valid authority so to act or refrain from acting, and the Grantor shall not be
under any obligation to make any inquiry respecting such authority. The
Collateral Agent hereby waives for the benefit of the Holders any claim, right
or Lien of the Collateral Agent against the Collateral arising under applicable
law or arising from any business or transaction between the Collateral Agent and
the Grantor other than pursuant to this Agreement or any of the other
Transaction Documents.
18.
Survival.
All
representations, warranties, covenants and agreements of the Grantor and of the
Collateral Agent contained herein will survive the execution and delivery hereof
and the release of any Collateral pursuant hereto and shall remain operative and
in full force and effect regardless of any investigation made by or on behalf of
the Collateral Agent or the Grantor or any person who controls the Collateral
Agent or the Grantor.
19.
Grantor’s Obligations Absolute, Etc.
The
obligations of the Grantor under this Agreement shall be absolute and
unconditional and shall remain in full force and effect without regard to, and
shall not be released, suspended, discharged, terminated or otherwise affected
by, any circumstance or occurrence whatsoever, including, without limitation:
(a) any renewal, extension, amendment or modification of or addition or
supplement to or deletion from any of the Transaction Documents or any other
agreement or instrument referred to therein, or any assignment or transfer of
any thereof; (b) any waiver, consent, extension, indulgence or other action or
inaction under or in respect of any such Transaction Document or other agreement
or instrument; (c) any furnishing of any additional security to the Collateral
Agent or its assignees or any acceptance thereof or any release of any security
by the Collateral Agent or its assignees; (d) any limitation on any party’s
liability or obligations under any such Transaction Document or other agreement
or instrument or any invalidity or unenforceability, in whole or in part, of any
such Transaction Document or other agreement or instrument or any term thereof;
or (e) any bankruptcy, insolvency, reorganization, composition, adjustment,
dissolution, liquidation or other like proceeding relating to the Grantor, or
any action taken with respect to this Agreement by any trustee or receiver, or
by any court, in any such proceeding, whether or not the Grantor shall have
notice or knowledge of any of the foregoing.
20.
Integration.
This
Agreement and the Security Agreement represent the entire agreement of the
Grantor and the Collateral Agent with respect to the subject matter hereof, and
there are no promises, undertakings,
representations
or warranties by the Collateral Agent relative to subject matter hereof not
expressly set forth or referred to herein or therein.
21.
Counterparts;
Execution
. This
Agreement may be executed in any number of counterparts and all the counterparts
taken together shall be deemed to constitute one and the same instrument. This
Agreement, once executed by a party, may be delivered to the other party hereto
by telephone line facsimile transmission of a copy of this Agreement bearing the
signature of the party so delivering this Agreement.
22.
Governing Law.
This
Agreement and the rights and obligations of the Grantor under this Agreement
shall be governed by, and construed and interpreted in accordance with, the law
of the State of New York, except to the extent that under the New York Uniform
Commercial Code the laws of another jurisdiction govern matters of perfection
and the effect of perfection or non-perfection of any security interest granted
hereunder.
23.
Construction.
The
language used in this Agreement will be deemed to be the language chosen by the
parties to express their mutual intent, and no rules of strict construction will
be applied against any party.
[signature page
follows]
IN WITNESS WHEREOF
, the
Grantor and the Collateral Agent have caused this Agreement to be duly executed
and delivered by their respective officers or other representatives thereunto
duly authorized as of the date first above written.
|
|
|
|
EMAGIN
CORPORATION
|
|
|
|
|
By:
|
/s/ Gary W.
Jones
|
|
Name: Gary W. Jones
|
|
Title: Chief Executive
Officer
|
|
|
|
|
ALEXANDRA GLOBAL MASTER
FUND LTD., as Collateral
Agent
|
|
|
ALEXANDRA INVESTMENT
MANAGEMENT, LLC, as Investment Advisor
|
|
By:
|
/s/ Mikhail
Filimonov
|
|
Name: Mikhail Filimonov
|
|
Title: Chairman and
Chief Executive Officer
|
STATE
OF_________________________)
)
SS:
COUNTY
OF_______________________)
[CHECK FOR APPLICABLE FORM OF
ACKNOWLEDGEMENT WHERE SIGNED]
On this
day of
July __, 2006, before me personally appeared
proved
to me on the basis of satisfactory evidence to be the person who executed the
above Patent and Trademark Security Agreement as
on
behalf of eMagin Corporation, a Delaware corporation, and acknowledged to me
that the corporation executed it.
WITNESS
my hand and official seal.
________________________________________
NOTARY
PUBLIC
STATE
OF__________________
)
)
SS:
COUNTY
OF________________
)
On this
day of
July __, 2006, before me personally appeared
proved
to me on the basis of satisfactory evidence to be the person who executed the
above Patent and Trademark Security Agreement as
on
behalf of Alexandra Investment Management, LLC, as Investment Adviser to
Alexandra Global Master Fund Ltd., and acknowledged to me that the limited
liability company executed it.
WITNESS
my hand and official seal.
________________________________________
NOTARY
PUBLIC
EXHIBIT A
Patents, Patent Licenses and Patent
Applications
ISSUED PATENTS
Patent
Number
|
Title
|
Issue
Date
|
7,068,258
|
Portable
communication device with virtual image display module
|
June
27, 2006
|
2,173,248
(Canada)
|
Head
Mounted Display System with Aspheric Optics (corr. to
5,543,816)
|
May
27, 2005
|
6,885,147
|
Organic
Light Emitting Diode Devices with Improved Anode Stability
|
April
26, 2005
|
2,173,624
(Canada)
|
Binocular
Head Mounted Display System
|
March
29, 2005
|
6,858,989
|
Method
and System for Stabilizing Thin Film Transistors in AMOLED
displays
|
February
22, 2005
|
6,809,710
|
Grey
Scale Pixel Driver for Electronic Display and Method of Operation
Therefor
|
October
26, 2004
|
6,809,710
|
Grey
Scale Pixel Driver for Electronic Display and Method of Operation
Therefor
|
October
26, 2004
|
6,760,034
|
Three
Dimensional Display Emulation Method and System
|
July
6, 2004
|
98808734,0
|
Laser
Ablation Method to Fabricate Color Organic Light Emitting Diode
Displays
|
May
26, 2004
|
6,657,224
|
Organic
Light Emitting Diode Devices Using Thermostable Hole-Injection and
Hole-Transport Compounds
|
December
2, 2003
|
6,608,283
|
Apparatus
and Method for Solder-Sealing an active Matrix Organic Light Emitting
Diode
|
August
19, 2003
|
6,608,439
|
Inorganic-Based
Color Conversion Matrix Element for Organic Color Display Devices and
Method of Fabrication
|
August
19, 2003
|
6,337,492
|
Serially-Connected
Organic Light Emitting Diode Stack Having Conductors Sandwiching Each
Light Emitting Layer
|
January
8, 2002
|
6,288,232
|
Synthesis
of Pyrazolinynaphthalic Acid Derivatives
|
September
11, 2001
|
6,278,237
|
Laterally
Structured High Resolution Multicolor Organic Electroluminescence Display
Device
|
August
21, 2001
|
6,265,820
|
Heat
Removal System for use in Organic Light Emitting Diode Displays Having
High Brightness
|
July
24, 2001
|
6,255,771
|
Flashover
Control Structure for Field Emitter Displays and Method of making the
same
|
July
3, 2001
|
6,232,934
|
Binocular
Head Mounted Display System
|
May
15, 2001
|
6,218,777
|
Field
Emission Display Spacer with Guard Electrode
|
April
14, 2001
|
6,215,840
|
Method
and Apparatus for Sequential Memory Addressing
|
April
10, 2001
|
6,204,975
|
Reflective
Micro-Display System
|
March
20, 2001
|
6,198,214
|
Large
Area Spacer-Less Field Emissive Display Package
|
March
6, 2001
|
6,198,220
|
Sealing
Structure for Organic Light Emitting Devices
|
March
6, 2001
|
6,181,304
|
Convertible
Right Eye/Left Eye Monocular Head Mounted Display System
|
January
30, 2001
|
6,169,358
|
Method
and Apparatus for Flashover Control Including a High Voltage Spacer for
Parallel Plate Electron Beam Array Devices and Method of Making
Thereof
|
January
2, 2001
|
6,166,820
|
Laser
Interferometric Lithographic System Providing Automatic Change of Fringe
Spacing
|
December
26, 2000
|
6,157,291
|
Head
Mounted Display System
|
December
5, 2000
|
6,144,145
|
High
Performance Field Emitter and Method of Producing the Same
|
November
7, 2000
|
6,136,621
|
High
Aspect Ratio Gated Emitter Structure and Method of Making
|
October
24, 2000
|
6,101,028
|
Miniature
Microscope
|
August
8, 2000
|
6,069,443
|
Passive
Matrix OLED Display
|
May
30, 2000
|
6,060,728
|
Organic
Light Emitting Device Structure and Process
|
May
9, 2000
|
6,027,388
|
Lithographic
Structure and Method for Making Field Emitters
|
February
22, 2000
|
6,023,259
|
OLED
Active Matrix Using a Single Transistor Current Mode Pixel
Design
|
February
8, 2000
|
6,016,033
|
Electrode
Structure for High Resolution Organic Light-Emitting Diode Displays and
Method for Making the Same
|
January
18, 2000
|
6,005,720
|
Reflective
Micro-Display System
|
December
21, 1999
|
5,965,898
|
High
Aspect Ratio Gated Emitter Structure and Method of Making
|
October
12, 1999
|
5,959,725
|
Large
Area Energy Beam Intensity Profiler
|
September
28, 1999
|
5,920,080
|
Emissive
Display Using Organic Light Emitting Diodes
|
July
6, 1999
|
5,903,098
|
Field
Emission Display Device Having Multiplicity of Through Conductive Vias and
a Backside Connector
|
May
11, 1999
|
5,903,243
|
Compact
body-Mountable Field Emission Display Device and Display Panel Having
Utility for use Therewith
|
May
11, 1999
|
5,771,098
|
Laser
Interferometric Lithographic System Providing Automatic Change of Fringe
Spacing
|
June
23, 1998
|
5,708,449
|
Binocular
Head Mounted Display System
|
January
13, 1998
|
5,688,158
|
Planarizing
Process for Field Emitter Displays and Other Electron Source
Applications
|
November
18, 1997
|
5,672,938
|
Light
Emission Device Comprising Light Emitting Organic Material and Electron
Injection Enhancement Structure
|
September
30, 1997
|
5,663,608
|
Field
Emission Display Devices, and Field Emission Electron Beam Source and
Isolation Structure Components Therefor
|
September
2, 1997
|
5,647,785
|
Methods
of Making Vertical Microelectronic Field Emission Devices
|
July
15, 1997
|
Des
380,482
|
Head
Mounted Display System
|
July
1, 1997
|
5,629,583
|
Flat
Panel Display Assembly Comprising Photoformed Spacer Structure and Method
of Making the Same
|
May
13, 1997
|
5,619,889
|
Method
of Making Microstructural Surgical Instruments
|
April
15, 1997
|
5,619,097
|
Panel
Display with Dielectric Spacer Structure
|
April
8, 1997
|
5,587,623
|
Field
Emitter Structure and Method of Making the Same
|
December
24, 1996
|
5,583,393
|
Selectively
Shaped Field Emission Electron Beam Source and Phosphor Array for use
Therewith
|
December
10, 1996
|
5,561,339
|
Field
Emission Array Magnetic Sensor Devices
|
October
1, 1996
|
5,548,181
|
Field
Emission Device Comprising Dielectric Overlayer
|
August
20, 1996
|
5,546,099
|
Head
Mounted Display System Light Blocking Structure
|
August
13, 1996
|
5,543,816
|
Head
Mounted Display System with Aspheric Optics
|
August
6, 1996
|
5,539,422
|
Head
Mounted Display System
|
July
23, 1996
|
5,534,743
|
Field
Emission Display Devices, and Field Emission Electron Beam Source and
Isolation Structure Components Therefor
|
July
9, 1996
|
5,529,524
|
Method
of Forming a Spacer Structure Between Opposedly Facing Plate
Members
|
June
25, 1996
|
Des
359,729
|
Portable
Interface Unit for a Head-Up Display System
|
June
27, 1995
|
5,144,191
|
Horizontal
Microelectronic Field Emission Devices
|
September
1, 1992
|
5,126,287
|
Self-Aligned
Electron Emitter Fabrication Method and Device Formed
Thereby
|
June
30, 1992
|
4,902,898
|
Wand
Optices Column and Associated Array Wand and Charged Particle
Source
|
February
20, 1990
|
98808734.0
(China)
|
Laser
Ablation Method To Fabricate Color OLED Displays
|
May
26, 2004
|
PATENT APPLICATIONS IN
PROGRESS
Patent
Application
No.
|
Title
|
Issue
Date
|
11/169,154
|
Method
of Clearing Electrical Contact Pads in Thin Film Sealed OLED
Devices
|
N/A
|
09/785,270
|
Display
Method and System
|
N/A
|
09/849,745
|
Portable
Communication Device With Virtual Image Display Module
|
N/A
|
60/684,633
|
Tapered
Fiber Optic Bundle Megadisplay
|
N/A
|
60/583,158
|
Photoresist
Laser Ablation
|
N/A
|
09/814,853
|
Light
Extraction from Color Changing Medium Layers in Organic Light Emitting
Diode Devices
|
N/A
|
504797/99
(Japan)
|
Emissive
Display Using Organic Light Emitting Diodes
|
N/A
|
2000-550128
(Japan)
|
An
Improved Electrode Structure for Organic Light Emitting Diode
Devices
|
N/A
|
6-523218
(Japan)
|
Head
Mounted Display System
|
N/A
|
9-531760
(Japan)
|
Support
for a Head Mounted Display System
|
N/A
|
2004-261527
(Japan; divisional)
|
Binocular
Head Mounted Display System
|
N/A
|
2000-565526
(Japan)
|
Convertible
Right Eye/Left Eye Monocular Head Mounted Display System
|
N/A
|
2000-589993
(Japan)
|
Reflective
Micro-Display System; Miniature Microscope and Reflective Micro-display
system respectively
|
N/A
|
01950594,0
(Europe)
|
OLED
Devices Using Thermostable Hole-Injection and Hole-Transport
Compounds
|
N/A
|
11/439,014
|
Tapered
Fiber Optic Bundle Metadisplay
|
N/A
|
11/402,092
|
Auto-calibrating
Gamma Correction Circuit
|
N/A
|
11/399,170
|
OLED
Active Matrix Cell Designed For Optimal Uniformity
|
N/A
|
133,678
(Israel)
|
Emissive
Display Using Organic Light Emitting Diodes
|
N/A
|
60/755,907
|
Automatic
Timeout Image Orientation System For FOLED Micro-display
|
N/A
|
60/725,406
|
Novel
OLED Lighting Device
|
N/A
|
2,490,344
(Canada;
divisional)
|
Binocular
Head-Mounted Display System
|
N/A
|
KODAK PATENTS (partial
list)
Topic
|
U.S. Pat.
No.
|
Issued
|
|
|
|
Multilayer
structure
|
4,356,429
|
1982
|
Multilayer
structure - Alq
|
4,539,507
|
1985
|
Porphyrin
injecting layer
|
4,720,432
|
1988
|
Luminescent
zone - dye dopant
|
4,769,292
|
1988
|
Improved
cathode
|
4,885,211
|
1989
|
Silazane
HTL
|
4,950,950
|
1990
|
Improved
intensity circuit
|
4,996,523
|
1991
|
Cathode
overlayer for stability
|
5,047,687
|
1991
|
Cathode
metal cap
|
5,059,861
|
1991
|
Mg,
Al cathode
|
5,059,862
|
1991
|
Organic
amines HTL
|
5,061,569
|
1991
|
Fused
metal cathode
|
5,073,446
|
1991
|
Blue
emitters
|
5,141,671
|
1992
|
Blue
emitters
|
5,150,006
|
1992
|
Blue
emitters
|
5,151,629
|
1992
|
Integral
shadow mask
|
5,276,380
|
1994
|
Integral
shadow mask color
|
5,294,869
|
1994
|
Color
change medium
|
5,294,870
|
1994
|
White
emitter (2-layer) BAlq
|
5,405,709
|
1995
|
Phalocyanine
dopant
|
5,409,783
|
1995
|
OLED
ultra thin device
|
5,482,896
|
1996
|
ALQ
blue
|
5,484,922
|
1996
|
OLED
ultra thin substrate
|
5,530,269
|
1996
|
OLED
TFT process
|
5,550,066
|
1996
|
AC
drive scheme
|
5,552,678
|
1997
|
Polyaromatic
amine HTL
|
5,554,450
|
1996
|
Quinacridone
green
|
5,593,788
|
1997
|
Electron
injector (silicides etc.)
|
5,608,287
|
1997
|
Camera
data printer
|
5,634,156
|
1997
|
Blue
emitter oxadizoles
|
5,645,948
|
1997
|
Camera
Information Display
|
5,652,930
|
1997
|
White
emitter structure
|
5,683,823
|
1997
|
OLED
TFT device
|
5,684,365
|
1997
|
Blue
emitter metal complex
|
5,755,999
|
1998
|
LiF
cathode
|
5,776,622
|
1998
|
EXHIBIT B
Trademarks and Trademark
Licenses
Serial App. No.
|
Item
|
Status
|
Filing
Date
|
Published, Allowed, or
Registered
|
78-463416
|
VIRTUAL
VISION VERACITY (Block letters)
|
Allowed
- 1st extension of time granted
|
Aug
6, 2004
|
P
May 2, 2006
|
78-463402
|
VERACITY
(Block letters)
|
|
Aug
6, 2004
|
A
Sep 27, 2005
|
78-235749
|
EGLASS
|
Registered,
Int'l
|
Apr
9, 2003
|
R
Aug 17, 2004
|
78-853656
|
PRIVATE
EYES (Block letters)
|
Pending
- Initialized, Int'l
|
Apr
4, 2006
|
|
78-853655
|
PRIVATE
EYE
|
Pending
- Initialized, Int'l
|
Apr
4, 2006
|
|
78-852411
|
EYEVIEWER
|
Pending
- Initialized, Int'l
|
Apr
3, 2006
|
|
78-852409
|
EYEWITNESS
(
|
Pending
- Initialized, Int'l
|
Apr
3, 2006
|
|
78-541421
|
Z800
3D VISOR
|
Pending
- Non-final action, Int'l
|
Jan
3, 2005
|
|
78-667562
|
PERSONAL
VIEWER
|
Pending
- Non-final action, Int'l
|
Jul
11, 2005
|
|
78-667564
|
3DVISOR
|
Pending
- Suspension letter, Int'l
|
Jul
11, 2005
|
|
78-667565
|
GET
INSIDE THE GAME
|
Pending
- Non-final action, Int'l
|
Jul
11, 2005
|
|
78-720607
|
EYEBUD
|
Pending
- Non-final action, Int'l
|
Sep
26, 2005
|
|
75-856770
|
EMAGIN
|
Registered,
Int'l
|
Nov
23, 1999
|
R
Mar 23, 2004
|
74-285,321
|
VIRTUAL
VISION
|
Registered
|
June
16, 1992
|
Dec.
6, 1994
|
EXHIBIT C
Filings Required for Collateral
Assignment
and to Perfect Security
Interest
1.
Filing
with the PTO
2.
Filing of
UCC-1 Financing Statement with the State of Delaware
3.
Filing of
UCC-1 Financing Statement with
the State
of Washington
4.
Filing of
UCC-1 Financing Statement with the State of New York
EXHIBIT D
The Collateral
Agent
1.
Appointment.
The
Holders (all capitalized terms used in this Exhibit D and not otherwise defined
shall have the respective meanings provided in the Patent and Trademark Security
Agreement to which this Exhibit D is attached (the “Patent and Trademark
Security Agreement”)), by their acceptance of the benefits of the Patent and
Trademark Security Agreement, hereby irrevocably designate Alexandra Global
Master Fund Ltd., as Collateral Agent, to act as specified herein and in the
Patent and Trademark Security Agreement. Each Buyer hereby irrevocably
authorizes, and each other Holder of any Note by the acceptance of such Note
shall be deemed irrevocably to authorize, the Collateral Agent to take such
action on its behalf under the provisions of the Patent and Trademark Security
Agreement and any other instruments and agreements referred to herein or therein
and to exercise such powers and to perform such duties hereunder and thereunder
as are specifically delegated to or required of the Collateral Agent by the
terms hereof and thereof and such other powers as are reasonably incidental
thereto. The Collateral Agent may perform any of its duties hereunder by or
through its agents or employees.
2.
Nature of
Duties.
The
Collateral Agent shall have no duties or responsibilities except those expressly
set forth in the Patent and Trademark Security Agreement. Neither the Collateral
Agent nor any of its officers, directors, employees or agents shall be liable
for any action taken or omitted by it as such under the Patent and Trademark
Security Agreement or hereunder or in connection herewith or therewith, unless
caused by its or their gross negligence or willful misconduct. The duties of the
Collateral Agent shall be mechanical and administrative in nature; the
Collateral Agent shall not have by reason of the Patent and Trademark Security
Agreement or any other Transaction Document a fiduciary relationship in respect
of any Holder; and nothing in the Patent and Trademark Security Agreement,
expressed or implied, is intended to or shall be so construed as to impose upon
the Collateral Agent any obligations in respect of the Patent and Trademark
Security Agreement except as expressly set forth herein. The Collateral Agent
shall not take any material action or exercise any material right or power
pursuant to Section 5, 6 or 7 of this Agreement without the authorization or
direction of the Majority Holders;
provided,
however,
that if
the Collateral Agent determines that it is unable to contact the Majority
Holders for purposes of seeking such authorization or direction or time will not
permit the Collateral Agent to so contact the Majority Holders prior to such
time as detriment may occur to the rights of the Collateral Agent or the Holders
from any failure of the Collateral Agent to act or exercise such right, then in
any such case the Collateral Agent may take such action or exercise such right
without specific authorization or direction from the Majority
Holders.
The
Collateral Agent shall not be liable for any act it may do or omit to do while
acting in good faith and in the exercise of its own best judgment. Any act done
or omitted by the Collateral Agent on the advice of its own attorneys shall be
deemed conclusively to have been done or omitted in good faith. The Collateral
Agent shall have the right at any time to consult with counsel on any question
arising under this Patent and Trademark Security Agreement. The Collateral Agent
shall incur no liability for any delay reasonably required to obtain the advice
of counsel.
3.
Lack of Reliance on the Collateral
Agent
.
Independently
and without reliance upon the Collateral Agent, each Holder, to the extent it
deems appropriate, has made and shall continue to make (i) its own independent
investigation of the financial condition and affairs of the Grantor and its
subsidiaries in connection with the making and the continuance of the
Obligations and the taking or not taking of any action in connection therewith,
and (ii) its own appraisal of the creditworthiness of the Grantor and its
subsidiaries, and the Collateral Agent shall have no duty or responsibility,
either initially or on a continuing basis, to provide any Holder with any credit
or other information with respect thereto, whether coming into its possession
before any Obligation arises or the purchase of any Note, or at any time or
times thereafter. The Collateral Agent shall not be responsible to any Holder
for any recitals, statements, information, representations or warranties herein
or in any document, certificate or other writing delivered in connection
herewith or for the execution, effectiveness, genuineness, validity,
enforceability, perfection, collectibility, priority or sufficiency of the
Patent and Trademark Security Agreement or the financial condition of the
Grantor or be required to make any inquiry concerning either the performance or
observance of any of the terms, provisions or conditions of the Patent and
Trademark Security Agreement, or the financial condition of the Grantor, or the
existence or possible existence of any Event of Default.
4.
Certain Rights of the Collateral
Agent.
No
Holder shall have the right to cause the Collateral Agent to take any action
with respect to the Collateral, with only the Majority Holders having the right
to direct the Collateral Agent to take any such action. If the Collateral Agent
shall request instructions from the Majority Holders with respect to any act or
action (including failure to act) in connection with the Patent and Trademark
Security Agreement, the Collateral Agent shall be entitled to refrain from such
act or taking such action unless and until it shall have received instructions
from the Majority Holders, and to the extent requested, appropriate
indemnification in respect of actions to be taken by the Collateral Agent; and
the Collateral Agent shall not incur liability to any person by reason of so
refraining. Without limiting the foregoing, no Holder shall have any right of
action whatsoever against the Collateral Agent as a result of the Collateral
Agent acting or refraining from acting hereunder in accordance with the
instructions of the Majority Holders or as otherwise specifically provided in
the Patent and Trademark Security Agreement.
5.
Reliance
.
The
Collateral Agent shall be entitled to rely, and shall be fully protected in
relying, upon any note, writing, resolution, notice, statement, certificate,
telex, teletype or telecopier message, cablegram, radiogram, order or other
document or telephone message signed, sent or made by the proper person or
entity, and, with respect to all legal matters pertaining to the Patent and
Trademark Security Agreement and its duties thereunder, upon advice of counsel
selected by it.
6.
Limitation of Holder
Liability.
The
Holders shall not be liable for any liabilities, obligations, losses, damages,
penalties, actions, judgments, suits, costs, expenses or disbursements of any
kind or nature whatsoever which may be imposed on, incurred by or asserted
against the Collateral Agent in performing its duties hereunder or under the
Patent and Trademark Security Agreement.
7.
The Collateral Agent in its
Individual Capacity.
The
Collateral Agent and its affiliates may lend money to, purchase, sell and trade
in securities of and generally engage in any kind of business with the Grantor
or any affiliate or subsidiary of the Grantor as if it were not performing the
duties specified herein, and may accept fees and other consideration from the
Grantor for services to the Grantor in connection with the Transaction Documents
and otherwise without having to account for the same to the Holders;
provided,
however,
that the
Collateral Agent on behalf of itself and such affiliates, hereby waives any
claim, right or Lien against the Collateral in any way arising from or relating
to any such loan, securities transaction or business with the
Grantor.
8.
Holders
.
The
Collateral Agent may deem and treat the holder of record of any Note as the
owner thereof for all purposes hereof unless and until a written notice of the
assignment or transfer thereof, as the case may be, shall have been filed with
the Collateral Agent. Any request, authority or consent of any person or entity
who, at the time of making such request or giving such authority or consent, is
the holder of record of any Note shall be conclusive and binding on any
subsequent holder, transferee or assignee, as the case may be, of such Note or
of any Note(s) issued in exchange therefor.
9.
Resignation by the Collateral
Agent.
(a) The
Collateral Agent may resign from the performance of all its functions and duties
under the Patent and Trademark Security Agreement at any time by giving 60
Business Days’ prior written notice (as provided in the Patent and Trademark
Security Agreement) to the Grantor and the Holders. Such resignation shall take
effect upon the appointment of a successor Collateral Agent pursuant to clauses
(b) and (c) below.
(b)
Upon any
such notice of resignation, the Majority Holders shall appoint a successor
Collateral Agent hereunder.
(c)
If a
successor Collateral Agent shall not have been so appointed within said 60
Business Day period, the Collateral Agent shall then appoint a successor
Collateral Agent who shall serve as Collateral Agent hereunder or thereunder
until such time, if any, as the Majority Holders appoint a successor Collateral
Agent as provided above. If a successor Collateral Agent has not been appointed
within such 60-day period, the Collateral Agent may petition any court of
competent jurisdiction or may interplead the Grantor and Holders in a proceeding
for the appointment of a successor Collateral Agent, and all fees, including but
not limited to extraordinary fees associated with the filing of interpleader,
and expenses associated therewith shall be payable by the Grantor.
(d)
The fees
of any successor Collateral Agent for its services as such shall be payable by
the Grantor.
EXHIBIT E
FORM OF PATENT COLLATERAL ASSIGNMENT
AND SECURITY
AGREEMENT
This
PATENT SECURITY
AGREEMENT,
dated as
of July 21, 2006, made by eMagin Corporation, a Delaware corporation (the
“Grantor”), to Alexandra Global Master Fund Ltd., a British Virgin Islands
international business company, as collateral agent (in such capacity, the
“Collateral Agent”) on behalf of the Holders.
W I T N E S S E T
H:
WHEREAS,
the
Grantor has acquired certain right, title and interest in certain United States
patents and patent applications identified in
Exhibit 1
hereto
(the “Patents”);
WHEREAS,
the
Grantor and the Buyers are parties to certain Note Purchase Agreements, dated as
of July 21, 2006 (as from time to time amended or supplemented, the “Note
Purchase Agreements”), pursuant to which, among other things, the Buyers have
agreed to purchase up to $7,000,000 aggregate principal amount of 6% Senior
Secured Convertible Notes due 2007-2008 (the “Notes”) of the
Grantor;
WHEREAS,
it is a
condition precedent to the several obligations of the Buyers to purchase their
respective Notes that the Grantor shall have executed and delivered a Patent and
Trademark Security Agreement to the Collateral Agent for the ratable benefit of
the Holders;
WHEREAS,
the
Grantor wishes to grant to the Collateral Agent a security interest in certain
of its property and assets to secure the performance of its obligations under
the Notes;
WHEREAS,
the
Grantor is contemporaneously entering into a Security Agreement and a Patent and
Trademark Security Agreement with the Collateral Agent for the ratable benefit
of the Holders; and
WHEREAS,
the
Grantor and Collateral Agent by this instrument seek to confirm and make a
record of the collateral assignment of and grant of a security interest in the
Patents.
NOW,
THEREFORE, for good and valuable consideration, the receipt and adequacy of
which are hereby acknowledged, the Grantor does hereby acknowledge and confirm
that it has made a collateral assignment to the Collateral Agent of, and has
granted to the Collateral Agent a security interest in, all of the Grantor’s
right, title and interest in, to, and under the Patents. The Grantor also
acknowledges and confirms that the rights and remedies of the Collateral Agent
with respect to the collateral assignment of and security interests in the
Patents acknowledged and confirmed hereby are more fully set forth in the Patent
and Trademark Security Agreement and the Security Agreement, the terms and
provisions of which are incorporated herein by reference.
|
|
|
|
EMAGIN
CORPORATION
|
|
|
|
|
By:
|
|
|
Name
|
|
Title
|
|
|
|
|
ALEXANDRA GLOBAL MASTER
FUND LTD., as Collateral
Agent
|
|
|
ALEXANDRA INVESTMENT
MANAGEMENT, LLC, as Investment Advisor
|
|
By:
|
|
|
Name:
Mikhail Filimonov
|
|
Title: Chairman
and Chief Executive Officer
|
For
eMagin Corporation:
STATE
OF____________________
)
)
SS:
COUNTY
OF__________________
)
Subscribed
and sworn to this
day of
,
2006.
_________________________________________________
Notary
Public
My
Commission Expires:
For
Alexandra Global Master Fund Ltd.,
as
Collateral Agent:
STATE
OF_______________________
)
)
SS:
COUNTY
OF_____________________
)
Subscribed
and sworn to this
day of
,
2006.
_______________________________________________
Notary
Public
My
Commission Expires:
EXHIBIT 1
Patents and Patent
Applications
EXHIBIT F
FORM OF TRADEMARK COLLATERAL
ASSIGNMENT
AND SECURITY
AGREEMENT
This
TRADEMARK SECURITY
AGREEMENT,
dated as
of July 21, 2006, made by eMagin Corporation, a Delaware corporation (the
“Grantor”), to Alexandra Global Master Fund Ltd., a British Virgin Islands
international business company, as collateral agent (in such capacity, the
“Collateral Agent”) on behalf of the Holders.
W I T N E S S E T
H:
WHEREAS,
the
Grantor has acquired an interest in certain trademarks identified in
Exhibit B
hereto
(the “Trademarks”);
WHEREAS,
the
Grantor and the Buyers are parties to certain Note Purchase Agreements, dated as
of July 21, 2006 (as from time to time amended or supplemented, the “Note
Purchase Agreements”), pursuant to which, among other things, the Buyers have
agreed to purchase up to $7,000,000 aggregate principal amount of 6% Senior
Secured Convertible Notes due 2007-2008 (the “Notes”) of the
Grantor;
WHEREAS,
it is a
condition precedent to the several obligations of the Buyers to purchase their
respective Notes that the Grantor shall have executed and delivered a Patent and
Trademark Security Agreement to the Collateral Agent for the ratable benefit of
the Holders;
WHEREAS,
the
Grantor wishes to grant to Collateral Agent a security interest in certain of
its property and assets to secure the performance of its obligations under the
Notes;
WHEREAS,
the
Grantor is contemporaneously entering into a Security Agreement and a Patent and
Trademark Security Agreement with the Collateral Agent for the ratable benefit
of the Holders;
WHEREAS,
the
Grantor and the Collateral Agent by this instrument seek to confirm and make a
record of the collateral assignment of and grant of a security interest in the
Trademarks.
NOW, THEREFORE,
for good
and valuable consideration, the receipt and adequacy of which are hereby
acknowledged, the Grantor does hereby acknowledge and confirm that it has made a
collateral assignment to the Collateral Agent of, and has granted to the
Collateral Agent a security interest in, all of the Grantor’s interests the
Trademarks. The Grantor also acknowledges and confirms that the rights and
remedies of Collateral Agent with respect to the collateral assignment of and
security interests in the Trademarks acknowledged and confirmed hereby are more
fully set forth in the Patent and Trademark Security Agreement and the Security
Agreement, the terms and provisions of which are incorporated herein by
reference.
|
|
|
|
EMAGIN
CORPORATION
|
|
|
|
|
By:
|
/s/
|
|
Name:
|
|
Title:
|
|
|
|
|
ALEXANDRA GLOBAL MASTER
FUND LTD., as Collateral
Agent
|
|
By:
|
ALEXADRA INVESTMENT MANAGEMENT,
LLC, as Investment Advisor
|
|
By:
|
|
|
Name:
Mikhail Filimonov
|
|
Title: Chairman
and Chief Executive Officer
|
For
eMagin Corporation:
STATE
OF_____________________
)
)
SS:
COUNTY
OF___________________
)
Subscribed
and sworn to this
day of
,
2006.
___________________________________________
Notary
Public
My
Commission Expires:
For
Alexandra Global Master Fund Ltd., as
Collateral
Agent:
STATE
OF_____________________
)
)
SS:
COUNTY
OF
)
Subscribed
and sworn to this
day of
,
2006.
_____________________________________________
Notary
Public
My
Commission Expires:
Annex
IV
PLEDGE AND SECURITY
AGREEMENT
THIS
PLEDGE AND SECURITY
AGREEMENT
, dated
as of July 21, 2006 (this “Agreement”), made by
EMAGIN
CORPORATION
, a
Delaware corporation (the “Grantor”), to
ALEXANDRA GLOBAL MASTER FUND
LTD.
, a
British Virgin Islands international business company, as collateral agent (in
such capacity, the “Collateral Agent”) on behalf of the Holders (such
capitalized term and all other capitalized terms used in this Agreement having
the respective meanings provided in this Agreement).
W
I
T
N
E
S
S
E
T
H
:
WHEREAS
, the
Grantor and the several Buyers are parties to the several Note Purchase
Agreements, pursuant to which, among other things, the Buyers have agreed to
purchase up to $7,000,000 aggregate principal amount of Notes of the
Grantor;
WHEREAS
, in
connection with the transactions contemplated by the Note Purchase Agreements,
the Grantor has agreed to grant to the Collateral Agent a security interest in
certain of its property, assets and rights;
WHEREAS
, it is a
condition precedent to the several obligations of the Buyers to purchase their
respective Notes and Warrants pursuant to the Note Purchase Agreements that the
Grantor shall have executed and delivered this Agreement to the Collateral Agent
for the ratable benefit of the Holders;
WHEREAS
,
contemporaneously with the execution and delivery of this Agreement the Company
and the Collateral Agent are executing and delivering the Patent and Trademark
Security Agreement and the Lockbox Agreement; and
NOW, THEREFORE
, in
consideration of the premises and to induce the Buyers to purchase their
respective Notes and Warrants, the Grantor hereby agrees with the Collateral
Agent, for the ratable benefit of the Holders, as follows:
1.
Definitions.
(a)
As used
in this Agreement, the terms “Agreement”, “Grantor” and “Collateral Agent” shall
have the respective meanings assigned to such terms in the introductory
paragraph of and the recitals to this Agreement.
(b)
All the
agreements or instruments herein defined shall mean such agreements or
instruments as the same may from time to time be supplemented or amended or the
terms thereof waived or modified to the extent permitted by, and in accordance
with, the terms thereof and of this Agreement.
(c)
Capitalized
terms used herein without definition shall have the respective meanings assigned
to such terms in the Notes.
(d)
The
following terms shall have the following meanings (such meanings to be equally
applicable to both the singular and plural forms of the terms
defined):
“Accounts”
means all rights to payment for goods sold or leased or for services rendered,
whether or not such rights have been earned by performance.
“Additional
Note” means the Note issued pursuant to the Additional Note Purchase
Agreement.
“Additional
Note Purchase Agreement” means the Note Purchase Agreement, dated as of July 21,
2006, by and between the Grantor and Stillwater LLC, which by its terms
contemplates the issuance of up to $500,000 aggregate principal amount of Notes
on or after December 10, 2006.
“Affiliate”
means, with respect to any Person, any other Person that directly, or indirectly
through one or more intermediaries, controls, is controlled by or is under
common control with the subject Person. For purposes of this definition,
“control” (including, with correlative meaning, the terms “controlled by” and
“under common control with”), as used with respect to any Person, shall mean the
possession, directly or indirectly, of the power to direct or cause the
direction of the management and policies of such Person, whether through the
ownership of voting securities or by contract or otherwise.
“Business
Day” means any day other than a Saturday, Sunday or a day on which commercial
banks in The City of New York are authorized or required by law or executive
order to remain closed.
“Buyer”
means any of the several buyers party to a Note Purchase Agreement.
“Chattel
Paper” shall have the meaning assigned to such term under the Code.
“Code”
means the Uniform Commercial Code as from time to time in effect in the State of
Delaware.
“Collateral”
means each of the following, whether now existing or hereafter
arising:
(1)
all
Accounts of the Grantor and, if the Collateral Agent exercises its rights under
Section 3(b), the Lockbox and each and every General Intangible relating
thereto;
(2)
all
Inventory of the Grantor;
(3)
all
Equipment of the Grantor;
(4)
all
Proprietary Information owned or licensed by the Grantor, whether existing on
the date hereof or developed or acquired hereafter;
(5)
all of
the Grantor’s right, title and interest in and to all Contracts, Documents,
Chattel Paper, Instruments, Investment Property and General Intangibles, whether
existing on the date hereof or hereafter arising;
(6)
all cash,
securities, rights and other property at any time and from time to time
received, receivable or otherwise distributed in respect of the Collateral,
including, without limitation in respect of the cash or other property held in
the Lockbox or the Collateral Account;
(7)
all
Patents, Patent Licenses, Trademarks and Trademark Licenses;
(8)
all
insurance policies to the extent they relate to items (1) through (7)
above;
(9)
all
books, ledgers, books of account, records, writings, databases, information and
other property relating to, used or useful in connection with, evidencing,
embodying, incorporating, or referring to any of the foregoing; and
(10)
to the
extent not otherwise included, all Proceeds, products, rents, issues, profits
and returns of and from any and all of the foregoing, which Proceeds may be in
the form of Accounts, Chattel Paper, Inventory or otherwise.
“Collateral
Account” shall have the meaning provided in the Lockbox Agreement.
“Contracts”
shall have the meaning assigned to that term under the Code.
“Documents”
shall have the meaning assigned to such term under the Code.
“Event of
Default” means:
(1)
the
failure by the Grantor to perform in any material respect any obligation of the
Grantor under this Agreement as and when required by this Agreement;
or
(2)
any
representation or warranty made by the Grantor pursuant to this Agreement shall
have been untrue in any material respect when made or deemed to have been made;
or
(3)
the
failure by the Grantor to perform in any material respect any obligation of the
Grantor under the Patent and Trademark Security Agreement as and when required
by the Patent and Trademark Security Agreement;
(4)
any
representation or warranty made by the Grantor pursuant to the Patent and
Trademark Security Agreement shall have been untrue in any material respect when
made or deemed to have been made;
(5)
the
failure by the Grantor to perform in any material respect any obligation of the
Grantor under the Lockbox Agreement as and when required by the Lockbox
Agreement;
(6)
any
representation or warranty made by the Grantor pursuant to the Lockbox Agreement
shall have been untrue in any material respect when made or deemed to have been
made; or
(7)
any Event
of Default, as that term is defined in any of the Notes.
“General
Intangibles” shall have the meaning assigned to such term under the
Code.
“Holder”
means any Buyer or any holder from time to time of any Note.
“Indemnified
Person” shall have the meaning provided in Section 5(j).
“Inventory”
shall have the meaning assigned to such term under the Code, and in any event,
including, without limitation, all raw material, work-in process and finished
goods, inventory, merchandise, goods and other personal property that are held
by or on behalf of a Person for sale or lease or to be furnished under a
contract of service or which give rise to any Account, including, without
limitation, returned goods.
“Issuance
Date” means the date on which the Notes are initially issued.
“Lien”
shall mean any lien, mortgage, security interest, chattel mortgage, pledge or
other encumbrance (statutory or otherwise) of any kind securing satisfaction or
performance of an obligation, including any agreement to give any of the
foregoing, any conditional sales or other title retention agreement, any lease
in the nature thereof, and the filing of or the agreement to give any financing
statement under the Code of any jurisdiction or similar evidence of any
encumbrance, whether within or outside the United States.
“Lockbox”
shall have the meaning assigned to such term in the Lockbox Agreement.
“Lockbox
Agent” means the Person from time to time serving as Lockbox Agent under the
Lockbox Agreement.
“Lockbox
Agreement” means that certain Lockbox Agreement dated as of the date hereof, by
and between the Grantor and the Lockbox Agent.
“Majority
Holders” means at any time such of the holders of the Notes who hold Notes
which, based on the outstanding principal amounts thereof, represent a majority
of the aggregate outstanding principal amount of the Notes at such
time.
“Note
Purchase Agreements” means the several Note Purchase Agreements, dated as of
July 21, 2006, by and between the Grantor and the respective Buyer party thereto
pursuant to which the Grantor issued the Notes, including, without limitation,
the Additional Note Purchase Agreement.
“Notes”
means the Grantor’s 6% Senior Secured Convertible Notes due 2007-2008 originally
issued pursuant to the Note Purchase Agreements, including, without limitation,
the Additional Note.
“Obligations”
means:
(1)
the full
and prompt payment when due of all obligations and liabilities to the Holders,
whether now existing or hereafter arising, under the Transaction Documents and
the due performance and compliance with the terms of the Transaction
Documents;
(2)
any and
all sums advanced by the Collateral Agent or any Holder in order to preserve the
Collateral or to preserve the Security Interest;
(3)
in the
event of any proceeding for the collection or enforcement of any obligations or
liabilities of the Grantor referred to in the immediately preceding clauses (1)
and (2) in accordance with the terms of the Transaction Documents, the
reasonable expenses of re-taking, holding, preparing for sale, selling or
otherwise disposing of or realizing on the Collateral, or of any other exercise
by the Collateral Agent of its rights hereunder, together with reasonable
attorneys' fees and court costs; and
(4)
any
amounts for which the Collateral Agent or any Holder is entitled to
indemnification under Section 5(j).
“Patent(s)”
means all present and future patents, patent applications and patent disclosures
which are presently, or in the future may be, owned, issued, acquired or used
(whether pursuant to a license or otherwise) anywhere in the world by the
Grantor, in whole or in part, and all of the Grantor's right, title and interest
in and to all patentable inventions and to file applications for patents under
patent laws of the United States or of any other jurisdiction, including,
without limitation, any and all extensions, reissues, substitutes,
continuations, continuations-in-part, divisional, patents of addition,
re-examinations and renewals thereof, and patents issuing therefrom, and any
other proprietary rights related to any of the foregoing (including, without
limitation, remedies against infringements thereof and rights of protection of
an interest therein under the laws of all jurisdictions) and any and all foreign
counterparts of any of the foregoing.
“Patent
Licenses” means each license agreement relating to Patents granted to, used or
acquired by the Grantor, in each case together with the right to use and rely
upon the inventions and other intellectual property conveyed
thereunder.
“Patent
and Trademark Security Agreement” means that certain Patent and Trademark
Security Agreement, dated as of July 21, 2006, between the Grantor and the
Collateral Agent.
“Permitted
Liens” shall have the meaning assigned to such term in the Notes.
“Person”
means any natural person, corporation, partnership, limited liability company,
trust, incorporated organization, unincorporated association or similar entity
or any government, governmental agency or political subdivision.
“Proceeds”
shall have the meaning assigned to such term under the Code.
“Proprietary
Information” means information in whatever form generally unavailable to the
public that has been created, discovered, developed or otherwise become known to
the Grantor or in which property rights have been assigned or otherwise conveyed
to the Grantor, which information has economic value or potential economic value
to the creation, operation, use, modification, extension, upgrade, application,
marketing, sale and distribution of the Grantor’s products and services.
Proprietary Information shall include, but not be limited to, trade secrets,
processes, formulas, writings, data, know-how, negative know-how, improvements,
discoveries, developments, designs, inventions, techniques, technical data,
customer and supplier lists, financial information, business plans or
projections and modifications or enhancements to any of the above. Proprietary
Information shall include all information existing on the date hereof and all
information developed or acquired hereafter.
“Security
Interest” means the security interest granted in the Collateral pursuant to this
Agreement.
“Subsidiary”
means any corporation or other entity of which a majority of the capital stock
or other ownership interests having ordinary voting power to elect a majority of
the board of directors or other Persons performing similar functions are at the
time directly or indirectly owned by the Grantor.
“Trademark
License” means each license agreement relating to Trademarks used, adopted or
acquired by the Grantor.
“Trademarks”
means (a) all trademarks, trade names, corporate names, company names, business
names, fictitious business names, trade styles, service marks, logos and other
source or business identifiers of the Grantor adopted for use in conjunction
with the Grantor’s business products and services, now existing anywhere in the
world or hereinafter adopted or acquired, whether currently in use or not, and
the goodwill associated therewith, all registrations and recordings thereof, and
all applications in connection therewith, and (b) all renewals thereof by the
Grantor.
“Transaction
Documents” means the Notes, the Note Purchase Agreements, this Agreement, the
Patent and Trademark Security Agreement, the Lockbox Agreement, the Warrants,
and the other agreements, instruments and documents contemplated hereby and
thereby.
2.
Grant of Security
Interest
. As
collateral security for the prompt and complete payment and performance of the
Obligations and for the other purposes provided in this Agreement, the Grantor
hereby grants to the Collateral Agent for the ratable benefit of the Holders a
first priority security interest in all of the Collateral. Such grant includes,
without limitation, a grant of the security interest to secure the payment and
performance of Obligations relating to the Additional Note upon the date of
issuance of such Additional Note.
3.
Rights of Collateral Agent;
Limitations on Collateral Agent's Obligations.
(a)
Grantor Remains Liable under Accounts
and Contracts
.
Anything herein to the contrary notwithstanding, the Grantor shall remain liable
under each of the Accounts and Contracts that constitute part of the Collateral
to observe and perform all the conditions and obligations to be observed and
performed by it thereunder, all in accordance with the terms of any agreement
giving rise to each such Account and in accordance with and pursuant to the
terms and provisions of each such Contract. The Collateral Agent shall not have
any obligation or liability under any Account that constitutes part of the
Collateral (or any agreement giving rise thereto) or under any Contract that
constitutes part of the Collateral by reason of or arising out of this Agreement
or the receipt by the Collateral Agent of any payment relating to such Account
or Contract pursuant hereto, nor shall the Collateral Agent be obligated in any
manner to perform any of the obligations of the Grantor under or pursuant to any
such Account (or any agreement giving rise thereto) or under or pursuant to any
such Contract, to make any payment, to make any inquiry as to the nature or the
sufficiency of any payment received by it or as to the sufficiency of any
performance by any party under any such Account (or any agreement giving rise
thereto) or under any such Contract, to present or file any claim, to take any
action to enforce any performance or to collect the payment of any amounts which
may have been assigned to it or to which it may be entitled at any time or
times.
(b)
Notice to Account Debtors and
Contracting Parties
. Upon
the direction of the Collateral Agent at any time that an Event of Default has
occurred and is continuing,
the
Grantor shall promptly, but in no event later than five Business Days, after
such direction is given, notify all the account debtors on the Accounts that
constitute part of the Collateral and parties to the Contracts that constitute
part of the Collateral that such Accounts and such Contracts have been assigned
to the Collateral Agent for the ratable benefit of the Holders and that payments
in respect thereof shall be made directly to the Collateral Agent or as the
Collateral Agent shall direct in accordance with the Lockbox Agreement.
(c)
Verification and Analysis of
Accounts
. If an
Event of Default has occurred and the Collateral Agent shall have directed the
Grantor to notify the account debtors on the Accounts and parties to the
Contracts in accordance with Section 3(b), in addition to its rights pursuant to
clause (1) of this Section 3(c) the Collateral Agent shall have the right in its
own name or in the name of others to communicate with account debtors on the
Accounts that constitute part of the Collateral and parties to the Contracts
that constitute part of the Collateral to verify with them to its satisfaction
the existence, amount and terms of any such Accounts or Contracts and to make
test verifications of such Accounts in any manner and through any medium that it
reasonably considers advisable, and the Grantor shall furnish all such
assistance and information as the Collateral Agent may require in connection
therewith. At any time and from time to time, upon the Collateral Agent's
reasonable request and at the expense of the Grantor, the Grantor shall cause
independent public accountants or others satisfactory to the Collateral Agent to
furnish to the Collateral Agent reports showing reconciliations, aging and test
verifications of, and trial balances for, such Accounts.
4.
Representations and
Warranties
. The
Grantor hereby represents and warrants that:
(a)
Title; No Other
Liens
. Except
for the Lien granted to the Collateral Agent for the ratable benefit of the
Holders pursuant to this Agreement, the Patent and Trademark Security Agreement,
the Lockbox Agreement and the Lien granted to the Collateral Agent for the
ratable benefit of the Holders pursuant to the Patent and Trademark Security
Agreement, the Grantor owns and has good and marketable title to each item of
the Collateral free and clear of any and all Liens or claims of others except
Permitted Liens. No security agreement, financing statement or other public
notice with respect to all or any part of the Collateral is on file or of record
in any public office, except such as may have been filed in favor of the
Collateral Agent, for the ratable benefit of the Holders, pursuant to this
Agreement or pursuant to the Patent and Trademark Security
Agreement.
(b)
Perfected First Priority
Liens
. The
Liens granted pursuant to this Agreement will constitute upon the completion of
all the filings or notices listed in
Schedule I
hereto,
perfected Liens on all Collateral in favor of the Collateral Agent for the
benefit of the Holders, which are prior to all other Liens (except Permitted
Liens, if any) on such Collateral and which are enforceable as such against all
Persons.
(c)
Accounts
. No
amount payable to the Grantor under or in connection with any Account that
constitutes part of the Collateral is evidenced by any Instrument (other than
checks in the ordinary course of business) or Chattel Paper which has not been
delivered to the Collateral Agent. The place where the Grantor keeps its records
concerning the Accounts that constitute part of the Collateral is set forth on
Schedule II
hereto.
(d)
Consents under
Contracts
. No
consent (other than consents that have been obtained) of any party (other than
the Grantor), to any Contract that constitutes part of the Collateral is
required, or purports to be required, in connection with the execution, delivery
and performance of this Agreement or the exercise of the Collateral Agent's
rights and remedies provided herein or at law.
(e)
Inventory
. The
items of Inventory that constitute part of the Collateral are, as of the
Issuance Date, kept at the locations listed on
Schedule III
hereto
and have not been kept at any other location within the six-month period ending
on the Issuance Date.
(f)
Chief Executive
Office
. The
Grantor's chief executive office and chief place of business is located at 10500
N.E. 8
th
Street,
Suite 1400,
Bellevue,
WA 98004
.
(g)
Power and
Authority
. The
Grantor has full power, authority and legal right to grant the Collateral Agent
the Lien on the Collateral pursuant to this Agreement.
(h)
Approvals, Filings,
Etc.
No
authorization, approval or consent of, or filing, registration, recording or
other action with, any United States or foreign court, governmental body,
regulatory agency, self-regulatory organization, or stock exchange or market,
the stockholders of the Grantor or any other Person, is required to be obtained
or made by the Grantor or any Subsidiary (x) for the grant by the Grantor of the
Security Interest in the Collateral pursuant to this Agreement, (y) to perfect
the Security Interest purported to be created by this Agreement, or (z) for the
exercise of the Collateral Agent's rights and remedies provided herein or at
law, in each case except as has been obtained or made.
5.
Covenants
. The
Grantor covenants and agrees with the Collateral Agent that from and after the
date of this Agreement until the payment or performance in full by the Grantor
of all of the Obligations:
(a)
Further Documentation; Pledge of
Instruments and Chattel Paper
. At any
time and from time to time, upon the written request of the Collateral Agent,
and at the sole expense of the Grantor, the Grantor will promptly and duly
execute and deliver such further instruments and documents and take such further
action as the Collateral Agent may reasonably request for the purpose of
obtaining or preserving the full benefits of this Agreement and of the rights
and powers herein granted, including, without limitation, the filing of any
financing or continuation statements under the Code or similar laws in effect in
any such jurisdiction with respect to the Liens created hereby. The Grantor also
hereby authorizes the Collateral Agent to file any such financing or
continuation statement without the signature of the Grantor to the extent
permitted by applicable law. A carbon, photographic or other reproduction of
this Agreement shall be sufficient as a financing statement for filing in any
jurisdiction. If any amount payable under or in connection with any of the
Collateral shall be or become evidenced by any Instrument or Chattel Paper, such
Instrument or Chattel Paper shall be immediately delivered to the Collateral
Agent, duly endorsed in a manner satisfactory to the Collateral Agent, to be
held as Collateral pursuant to this Agreement.
(b)
Maintenance of
Records
.
The
Grantor will keep and maintain at its own cost and expense satisfactory and
complete records of the Collateral, including, without limitation, a record of
all payments received and all credits granted with respect to any Accounts that
may constitute part of the Collateral. For the further security of the
Collateral Agent, the Grantor hereby grants to the Collateral Agent a security
interest in all of the Grantor's books and records pertaining to the Collateral,
and the Grantor shall turn over any such books and records for inspection at the
office of the Grantor to the Collateral Agent or to its representatives during
normal business hours at the request of the Collateral Agent.
(c)
Limitation on Liens on
Collateral
. The
Grantor (x) will not create, incur or permit to exist, will defend the
Collateral against, and will take such other action as is necessary to remove,
any Lien or claim on or to the Collateral, other than the Security Interest
created hereby and Liens created by the Patent and Trademark Security Agreement,
and (y) will defend the right, title and interest of the Collateral Agent in and
to any of the Collateral against the claims and demands of all
Persons.
(d)
Limitations on Dispositions of
Collateral
. The
Grantor will not sell, transfer, lease, assign, grant any participation or
interest in, or otherwise dispose of, any of the Collateral to any Person,
including, without limitation, any Subsidiary or Affiliate of the Grantor, or
attempt, offer or contract to do so.
(e)
Performance of Contracts and
Agreements Giving Rise to Accounts.
The
Grantor shall (i) exercise promptly and diligently each and every material right
and perform each material obligation which it may have under each Contract that
constitutes part of the Collateral and each agreement giving rise to an Account
that constitutes part of the Collateral (other than any right of termination)
and (ii) deliver to the Collateral Agent, upon request, a copy of each material
demand, notice or document received by it relating in any way to any Contract
that constitutes part of the Collateral or any agreement giving rise to an
Account that constitutes part of the Collateral. The Grantor shall not amend or
modify the terms of, or waive any rights under, any Contracts, in a manner which
would materially adversely affect the Security Interest or the value of such
Contracts.
(f)
Further Identification of
Collateral.
The
Grantor shall furnish to the Collateral Agent from time to time, upon the
request of the Collateral Agent, statements and schedules further identifying
and describing the Collateral and such other reports in connection with the
Collateral as the Collateral Agent may reasonably request, all in reasonable
detail.
(g)
Notices.
The
Grantor will advise the Collateral Agent within two Business Days of the
occurrence thereof, in reasonable detail, at its address in accordance with
Section 16, (i) of any Lien (other than Liens permitted hereunder) on, or claim
asserted against, any of the Collateral, (ii) of any Event of Default or any
event which, with notice or the lapse of time, or both, would become an Event of
Default and (iii) of the occurrence of any other event which could reasonably be
expected to have a material adverse effect on the Collateral, the Security
Interest or the rights of the Collateral Agent hereunder.
(h)
Changes in Locations, Name, Etc.
The
Grantor will not
(1)
change
the location of its chief executive office/chief place of business from that
specified in Section 4(f) or remove its books and records from the location
specified in Section 4(c), or
(2)
change
its name, identity or corporate structure to such an extent that any financing
statement filed in connection with this Agreement and naming the Collateral
Agent as secured party would become misleading or invalid, or
(3)
change
the location at which any item of Inventory that constitutes Collateral is kept
from the locations specified in Section 4(e),
unless in
any such case it shall have given the Collateral Agent at least 30 days prior
written notice thereof and, prior to such action or event, shall have taken
appropriate action satisfactory to the Collateral Agent to preserve and protect
the Collateral Agent's security interest under this Agreement.
(i)
Subsidiaries.
This
Agreement is entered into on behalf of and for the benefit of the Grantor. The
Subsidiaries and the Affiliates of the Grantor have no ownership or other rights
in the Collateral. The Grantor will not permit any Subsidiary or any Affiliate
of the Grantor to have any ownership or other rights in or to exercise any
control over the Collateral.
(j)
Indemnification
. The
Grantor agrees to indemnify and hold harmless the Collateral Agent and each
Holder and their respective officers, directors, Affiliates, agents, members,
shareholders and investment advisors (each, an “Indemnified Person”) from and
against any and all claims, demands, losses, judgments and liabilities
(including liabilities for penalties) of whatsoever kind or nature, and to
reimburse the Collateral Agent and each Holder for all costs and expenses,
including reasonable attorneys’ fees and expenses, arising out of or resulting
from this Agreement, including any breach hereof or Event of Default hereunder,
or the exercise by the Collateral Agent or any Holder, as the case may be, of
any right or remedy granted to it hereunder or under the other Transaction
Documents under applicable law;
provided,
however,
that the
Grantor shall not be required to indemnify a particular Indemnified Person to
the extent any claim, demand, loss, judgment, liability, cost or expense is
determined by final judgment (not subject to further appeal) of a court of
competent jurisdiction to have arisen primarily from the gross negligence or
willful misconduct of such Indemnified Person. In no event shall any Indemnified
Person other than the Collateral Agent have any liability or obligation to the
Grantor under this Agreement or applicable law (liability under which the
Grantor hereby waives) for any matter or thing in connection with this
Agreement, and in no event shall the Collateral Agent be liable, in the absence
of a determination of gross negligence or willful misconduct on its part by
final judgment (not subject to further appeal) of a court of competent
jurisdiction, for any matter or thing in connection with this Agreement other
than to account for moneys actually received by it in accordance with the terms
hereof. If and to the extent that the obligations of the Grantor under this
Section 4(j) are unenforceable for any reason, the Grantor hereby agrees to make
the maximum contribution to the payment and satisfaction of such obligations
which is permissible under applicable law.
6.
Collateral Agent's
Powers.
(a)
Powers.
The
Grantor hereby irrevocably constitutes and appoints the Collateral Agent and any
officer or agent thereof or investment advisor thereto, with full power of
substitution, as its true and lawful attorney-in-fact with full irrevocable
power and authority in the place and stead of the Grantor and in the name of the
Grantor or in its own name, from time to time in the Collateral Agent's
discretion, during any period in which an Event of Default is continuing, for
the purpose of carrying out the terms of this Agreement, to take any and all
appropriate action and to execute any and all documents and instruments which
may be necessary or desirable to accomplish the purposes of this Agreement, and,
without limiting the generality of the foregoing, the Grantor hereby gives the
Collateral Agent and each such officer, agent and investment advisor the power
and right, on behalf of the Grantor, without notice to or assent by the Grantor,
except any notice required by law, to do the following:
(i)
to take
possession of and endorse and collect any checks, drafts, notes, acceptances or
other instruments for the payment of moneys due under or with respect to any
Collateral and to file any claim or to take any other action or proceeding in
any court of law or equity or otherwise deemed appropriate by the Collateral
Agent for the purpose of collecting any and all such moneys due under or with
respect to any such Collateral whenever payable, in each case in the name of the
Grantor or its own name, or otherwise;
(ii)
to pay or
discharge taxes and liens levied or placed on or threatened against the
Collateral and to pay all or any part of the premiums therefor and the costs
thereof; and
(iii)
(A) to
direct any party liable for any payment under any of the Collateral to make
payment of any and all moneys due or to become due thereunder directly to the
Collateral Agent or as the Collateral Agent shall direct; (B) to ask or demand
for, collect, receive payment of and receipt for, any and all moneys, claims and
other amounts due or to become due at any time in respect of or arising out of
any Collateral; (C) to sign and endorse any invoices, freight or express bills,
bills of lading, storage or warehouse receipts, drafts against debtors,
assignments, verifications, notices and other documents in connection with any
of the Collateral; (D) to commence and prosecute any suits, actions or
proceedings at law or in equity in any court of competent jurisdiction to
collect the Collateral or any thereof and to enforce any other right in respect
of any Collateral; (E) to defend any suit, action or proceeding brought against
the Grantor with respect to any Collateral; (F) to settle, compromise or adjust
any suit, action or proceeding described in clause (E) above and, in connection
therewith, to give such discharges or releases as the Collateral Agent may deem
appropriate; and (G) generally, to sell, transfer, pledge and make any agreement
with respect to or otherwise deal with any of the Collateral as fully and
completely as though the Collateral Agent were the absolute owner thereof for
all purposes, and to do, at the Collateral Agent's option and the Grantor's
expense, at any time, or from time to time, all acts and things which the
Collateral Agent deems necessary to protect, preserve or realize upon the
Collateral and the Collateral Agent's Liens thereon and to effect the intent of
this Agreement, all as fully and effectively as the Grantor might
do.
The
Grantor hereby ratifies all that said attorneys shall lawfully do or cause to be
done by virtue hereof. This power of attorney is a power coupled with an
interest and shall be irrevocable until the Grantor shall have paid and
performed in full all of the Obligations.
(b)
Other Powers.
The
Grantor also authorizes the Collateral Agent, from time to time during any
period in which an Event of Default is continuing,
to
execute, in connection with the sale provided for herein, any endorsements,
assignments or other instruments of conveyance or transfer with respect to the
Collateral.
(c)
No Duty on Collateral Agent's
Part.
The
powers conferred on the Collateral Agent hereunder are solely to protect the
Collateral Agent's interests in the Collateral for the
pro rata
benefit
of the Holders and shall not impose any duty upon the Collateral Agent to
exercise any such powers. The Collateral Agent shall be accountable only for
amounts that it actually receives as a result of the exercise of such powers,
and neither it nor any of its officers, directors, employees or agents shall be
responsible to the Grantor for any act or failure to act hereunder, except for
their own gross negligence or willful misconduct.
7.
Performance by Collateral Agent of
Grantor's Obligations.
If the
Grantor fails to perform or comply with any of its agreements contained herein
and the Collateral Agent, as provided for by the terms of this Agreement and
following reasonable notice to the Grantor, may itself perform or comply, or
otherwise cause performance or compliance, with such agreement, and the expenses
of the Collateral Agent incurred in connection with such performance or
compliance shall be payable by the Grantor to the Collateral Agent on demand and
shall constitute Obligations secured hereby.
8.
Remedies in
General.
If an
Event of Default has occurred and is continuing, the Collateral Agent may
exercise, in addition to all other rights and remedies granted to it in this
Agreement and in any other instrument or agreement securing, evidencing or
relating to the Obligations, all rights and remedies of a secured party under
the Code. Without limiting the generality of the foregoing, if an Event of
Default has occurred and is continuing, the Collateral Agent, without demand of
performance or other demand, presentment, protest, advertisement or notice of
any kind (except any notice required by law referred to below or expressly
provided for) to or upon the Grantor or any other Person (all and each of which
demands, defenses, advertisements and notices are, to the extent permitted by
applicable law, hereby waived), may in such circumstances forthwith collect,
receive, appropriate and realize upon the Collateral, or any part thereof,
and/or may forthwith sell, license, assign, give option or options to purchase,
or otherwise dispose of and deliver the Collateral or any part thereof (or
contract to do any of the foregoing), at public or private sale or sales, at any
exchange, broker's board or office of the Collateral Agent or elsewhere upon
such terms and conditions as it may deem advisable and at such prices as it may
deem best, for cash or on credit or for future delivery without assumption of
any credit risk. The Collateral Agent shall have the right upon any such public
sale or sales, and, to the extent permitted by law, upon any such private sale
or sales, to purchase the whole or any part of the Collateral so sold, free of
any right or equity of redemption in the Grantor, which right or equity is
hereby waived, to the extent permitted by applicable law, or released.
The
Grantor further agrees that, if an Event of Default has occurred and is
continuing,
at the
Collateral Agent's request, to assemble the Collateral and make it available to
the Collateral Agent at places which the Collateral Agent shall reasonably
select, whether at the Grantor's premises or elsewhere. The Collateral Agent
shall apply the net proceeds of any such collection, recovery, receipt,
appropriation, realization or sale, after deducting all reasonable costs and
expenses of every kind incurred therein or incidental to the care or safekeeping
of any of the Collateral or in any way relating to the Collateral or the rights
of the Collateral Agent hereunder, including, without limitation, reasonable
attorneys' fees and disbursements, to the payment in whole or in part of the
Obligations, in such order as the Collateral Agent may elect, and only after
such application and after the payment by the Collateral Agent of any other
amount required by any provision of law, need the Collateral Agent account for
the surplus, if any, to the Grantor. To the extent permitted by applicable law,
the Grantor waives all claims, damages and demands it may acquire against the
Collateral Agent arising out of the exercise by it of any rights hereunder,
provided,
that
nothing contained in this Section 8 shall relieve the Collateral Agent from
liability arising solely from its gross negligence or willful misconduct. If any
notice of a proposed sale or other disposition of Collateral shall be required
by law, such notice shall be deemed reasonable and proper if given at least ten
days before such sale or other disposition. The Grantor shall remain liable for
any deficiency if the proceeds of any sale or other disposition of the
Collateral are insufficient to pay the Obligations and the fees and
disbursements of any attorneys employed by the Collateral Agent to collect such
deficiency.
9.
Limitation on Duties Regarding
Preservation of Collateral.
The
Collateral Agent's sole duty with respect to the custody, safekeeping and
physical preservation of the Collateral in its possession, under the Code or
otherwise, shall be to deal with it in the same manner as the Collateral Agent
deals with similar property for its own account. Neither the Collateral Agent
nor any of its directors, officers, employees or agents shall be liable for
failure to demand, collect or realize upon all or any part of the Collateral or
for any delay in doing so or shall be under any obligation to sell or otherwise
dispose of any Collateral upon the request of the Grantor or
otherwise.
10.
Powers Coupled with an
Interest.
All
authorizations and agencies herein contained with respect to the Collateral are
irrevocable and powers coupled with an interest until the Grantor has paid and
performed in full all of its obligations under the Transaction
Documents.
11.
Severability.
Any
provision of this Agreement which is prohibited or unenforceable in any
jurisdiction shall, as to such jurisdiction, be ineffective to the extent of
such prohibition or unenforceability without invalidating the remaining
provisions hereof, and any such prohibition or unenforceability in any
jurisdiction shall not invalidate or render unenforceable such provision in any
other jurisdiction.
12.
Paragraph Headings, Captions,
Etc.
The
paragraph headings, the captions and the footers used in this Agreement are for
convenience of reference only and are not to affect the construction hereof or
be taken into consideration in the interpretation hereof.
13.
No Waiver; Cumulative
Remedies.
The
Collateral Agent shall not by any act, delay, indulgence, omission or otherwise
be deemed to have waived any right or remedy hereunder or to have acquiesced in
any Event of Default or in any breach of any of the terms and conditions hereof.
No failure to exercise, nor any delay in exercising, on the part of the
Collateral Agent, any right, power or privilege hereunder shall operate as a
waiver thereof. No single or partial exercise of any right, power or privilege
hereunder shall preclude any other or further exercise thereof or the exercise
of any other right, power or privilege. A waiver by the Collateral Agent of any
right or remedy hereunder on any one occasion shall not be construed as a bar to
any right or remedy which the Collateral Agent would otherwise have on any
future occasion. The rights and remedies herein and in the Notes and the other
Transaction Documents are cumulative, may be exercised singly or concurrently
and are not exclusive of any rights or remedies provided by law or in equity or
by statute.
14.
Waivers and Amendments; Successors
and Assigns.
None of
the terms or provisions of this Agreement may be waived, amended, supplemented
or otherwise modified except by a written instrument executed by the party to be
charged with enforcement;
provided, however,
that any
provision of this Agreement may be waived, amended, supplemented or otherwise
modified by the Collateral Agent only with the prior written approval of the
Majority Holders. This Agreement shall be binding upon the successors and
permitted assigns of the Grantor and shall inure to the benefit of the
Collateral Agent and its successors and assigns. The Grantor may not assign its
rights or obligations under this Agreement without the prior written consent of
the Collateral Agent, which the Collateral Agent may withhold in the sole
discretion of the Majority Holders. The requirements for resignation, and
appointment of a successor to, the Collateral Agent are established by
Schedule IV
hereto
and not by this Agreement.
15.
Termination of Security Interest;
Release of Collateral.
(a)
Upon the
payment in full of all principal of and premium, if any, and interest on the
Notes and the payment in full of all other amounts for Obligations that are due
and payable at such time, and if no claims for payment by the Company of any
Obligations are at the time pending, the Security Interest shall terminate and
all rights to the Collateral shall revert to the Grantor.
(b)
If an
Event of Default shall have occurred and be continuing, the Collateral Agent
shall disburse the funds held by it pursuant to this Agreement as
follows:
(i)
First, to
pay any amounts payable to the Collateral Agent pursuant to Section 17 that have
not been paid by the Grantor;
(ii)
Second,
to pay each Holder on a pro rata basis the amount of all accrued and unpaid
interest (and interest, if any, thereon at the Default Rate) then due each
Holder in accordance with the terms of their respective Notes through the most
recent Interest Payment Date;
(iii)
Third, to
pay each Holder on a pro rata basis the amount, if any, of unpaid principal then
due on the Maturity Date of any installment of principal of such Holder’s Notes;
(iv)
Fourth,
to pay each Holder, on a pro rata basis, the amount then due upon acceleration,
if any, pursuant to Section 4 of such Holder’s Note(s); and then
(v)
Fifth, to
pay each Holder who has exercised its repurchase rights under Section 5 of the
Notes, on a pro rata basis, all of the applicable unpaid Repurchase Price for
each of the Notes or portions thereof required to be repurchased; and
then
(vi)
Sixth, to
pay each Holder any other amount due and payable to such Holder under the
Transaction Documents; and then
(vii)
Seventh,
the remaining amount, if any, to the Grantor.
provided,
however,
that if
the amount of funds held by the Collateral Agent is insufficient to pay all
amounts due to the Holders pursuant to clauses (ii) and (iv) above, then the
amount paid to the Holders pursuant to this Section 15(b) shall be prorated
among the Holders in proportion to the respective amounts due each Holder
pursuant to the particular such clause or clauses for which such funds are
insufficient.
(c)
At any
time and from time to time prior to termination of the Security Interest
pursuant to Section 15(a), the Collateral Agent shall release any of the
Collateral only with the prior written consent of the Majority Holders.
(d)
Upon any
such termination of the Security Interest or release of all the Collateral, the
Collateral Agent will, at the expense of the Grantor, execute and deliver to the
Grantor such documents and take such other actions as the Grantor shall
reasonably request to evidence the termination of the Security Interest and
deliver to the Grantor all Collateral so released then in its
possession.
16.
Notices.
Any
notices required or permitted to be given under the terms of this Agreement
shall be in writing and shall be sent by mail, personal delivery, telephone line
facsimile transmission or courier and shall be effective five days after being
placed in the mail, if mailed, or upon receipt, if delivered personally, by
telephone line facsimile transmission or by courier, in each case addressed to a
party at such party's address (or telephone line facsimile transmission number)
shown below or such other address (or telephone line facsimile transmission
number) as a party shall have provided by notice to the other party in
accordance with this provision. In the case of any notice to the Grantor, such
notice shall be addressed to the Grantor at 10500 N.E. 8
th
Street,
Suite 1400,Bellevue, WA 98004, Attention: Chief Financial Officer (telephone
line facsimile number (425) 749-3601), with a copy to Sichenzia Ross Friedman
Ference LLP, 1065 Avenue of the Americas, 21
st
Floor,
New York, New York 10018, Attention: Richard A. Friedman, Esq. (telephone line
facsimile number (212) 930-9725) and in the case of any notice to the Collateral
Agent, such notice shall be addressed to the Collateral Agent at c/o Alexandra
Investment Management, LLC, 767 Third Avenue, 39
th
Floor,
New York, New York 10017 (telephone line facsimile number (212) 301-1810), with
a copy to Law Offices of Brian W Pusch, Penthouse Suite, 29 West 57
th
Street,
New York, New York (telephone line facsimile number (212)
980-7055).
17.
Fees and Expenses
. The
Grantor agrees to pay the fees of the Collateral Agent in performing its
services under this Agreement and all expenses (including but not limited to
reasonable attorneys' fees and costs for legal services, costs of insurance and
payments of taxes or other charges) of, or incidental to, the custody, care,
sale or realization on any of the Collateral or in any way relating to the
performance of the obligations or the enforcement or protection of the rights of
the Collateral Agent hereunder.
18.
Concerning Collateral
Agent.
The
Grantor acknowledges that the rights and responsibilities of the Collateral
Agent under this Agreement with respect to any action taken by the Collateral
Agent or the exercise or nonexercise by the Collateral Agent of any option,
right, request, judgment or other right or remedy provided for herein or
resulting or arising out of this Agreement shall, as between the Collateral
Agent and the Holders, be governed by
Schedule IV
hereto
and by such other agreements with respect thereto as may exist from time to time
among them, but, as between the Collateral Agent and the Grantor, except as
expressly provided in Sections 14 and 15, the Collateral Agent shall be
conclusively presumed to be acting as agent for the Holders with full and valid
authority so to act or refrain from acting, and the Grantor shall not be under
any obligation to make any inquiry respecting such authority. The Collateral
Agent hereby waives for the benefit of the Holders any claim, right or lien of
the Collateral Agent against the Collateral arising under applicable law or
arising from any business or transaction between the Collateral Agent and the
Grantor other than pursuant to this Agreement or any of the other Transaction
Documents.
19.
Survival.
All
representations, warranties, covenants and agreements of the Grantor and of the
Collateral Agent contained herein will survive the execution and delivery hereof
and the release of any Collateral pursuant hereto and shall remain operative and
in full force and effect regardless of any investigation made by or on behalf of
the Collateral Agent or the Grantor or any person who controls the Collateral
Agent or the Grantor.
20.
Grantor’s Obligations Absolute, Etc.
The
obligations of the Grantor under this Agreement shall be absolute and
unconditional and shall remain in full force and effect without regard to, and
shall not be released, suspended, discharged, terminated or otherwise affected
by, any circumstance or occurrence whatsoever, including, without limitation:
(a) any renewal, extension, amendment or modification of or addition or
supplement to or deletion from any of the Transaction Documents or any other
agreement or instrument referred to therein, or any assignment or transfer of
any thereof; (b) any waiver, consent, extension, indulgence or other action or
inaction under or in respect of any such Transaction Document or other agreement
or instrument; (c) any furnishing of any additional security to the Collateral
Agent or its assignees or any acceptance thereof or any release of any security
by the Collateral Agent or its assignees; (d) any limitation on any party’s
liability or obligations under any such Transaction Document or other agreement
or instrument or any invalidity or unenforceability, in whole or in part, of any
such Transaction Document or other agreement or instrument or any term thereof;
or (e) any bankruptcy, insolvency, reorganization, composition, adjustment,
dissolution, liquidation or other like proceeding relating to the Grantor, or
any action taken with respect to this Agreement by any trustee or receiver, or
by any court, in any such proceeding, whether or not the Grantor shall have
notice or knowledge of any of the foregoing.
21.
Integration.
This
Agreement represents the entire agreement of the Grantor and the Collateral
Agent with respect to the subject matter hereof, and there are no promises,
undertakings, representations or warranties by the parties relative to the
subject matter hereof not expressly set forth or referred to herein or
therein.
22.
Governing Law.
This
Agreement and the rights and obligations of the Grantor under this Agreement
shall be governed by, and construed and interpreted in accordance with, the law
of the State of New York, except to the extent that under the New York Uniform
Commercial Code the laws of another jurisdiction govern matters of perfection
and the effect of perfection or non-perfection of any security interest granted
hereunder.
23.
Counterparts;
Execution
. This
Agreement may be executed in any number of counterparts and by the parties
hereto on separate counterparts, but all the counterparts taken together shall
be deemed to constitute one and the same instrument. This Agreement, once
executed by a party, may be delivered to the other party hereto by telephone
line facsimile transmission of a copy of this Agreement bearing the signature of
the party so delivering this Agreement.
24.
Construction
. The
language used in this Agreement will be deemed to be the language chosen by the
parties to express their mutual intent, and no rules of strict construction will
be applied against any party.
[
Signature page
follows
]
IN WITNESS WHEREOF
, the
Grantor and the Collateral Agent have caused this Agreement to be duly executed
and delivered by their respective officers or other representatives thereunto
duly authorized as of the date first above written.
|
|
|
|
EMAGIN
CORPORATION
|
|
|
|
|
By:
|
/s/ Gary W.
Jones
|
|
Name:
Gary W. Jones
|
|
Title: Chief
Executive Officer
|
|
|
|
|
ALEXANDRA GLOBAL MASTER
FUND LTD., as Collateral
Agent
|
|
|
ALEXANDRA INVESTMENT
MANAGEMENT, LLC, as Investment Advisor
|
|
By:
|
/s/ Mikhail
Filimonov
|
|
Name:
Mikhail Filimonov
|
|
Title: Chairman
and Chief Executive Officer
|
SCHEDULE I
Filings Required to Perfect
Security Interest
1.
Secretary
of State of the State of Delaware
2.
Department
of State of the State of New York
SCHEDULE II
Location of Records
Concerning Accounts
eMagin
Corporation
10500 NE
8
th
Street,
Suite 1400
Bellevue,
WA. 98004
SCHEDULE III
Inventory
Locations
eMagin
Corporation
2070
Route 52
Hopewell
Junction, NY 12533
eMagin
Corporation
10500 NE
8
th
Street,
Suite 1400
Bellevue,
WA. 98004
Asteria Manufacturing and
Brimal Holding (same address)
:
Wisma
AIC
Lot
3
Persiaran
Kemajuan
Seksyen
16
40200
Shah Alam
Selangor
Darul Ehsan
Malaysia
SCHEDULE IV
The Collateral
Agent
1.
Appointment.
The
Holders (all capitalized terms used in this
Schedule IV
and
not otherwise defined shall have the respective meanings provided
in the Security agreement to which this
Schedule IV
is
attached (the “Agreement”)), by their acceptance of the benefits of the
Agreement, hereby irrevocably designate Alexandra Global Master Fund Ltd., as
Collateral Agent, to act as specified herein and in the Agreement. Each Buyer
hereby irrevocably authorizes, and each other Holder of any Note by the
acceptance of such Note shall be deemed irrevocably to authorize, the Collateral
Agent to take such action on its behalf under the provisions of the Agreement
and any other instruments and agreements referred to herein or therein and to
exercise such powers and to perform such duties hereunder and thereunder as are
specifically delegated to or required of the Collateral Agent by the terms
hereof and thereof and such other powers as are reasonably incidental thereto.
The Collateral Agent may perform any of its duties hereunder by or through its
agents or employees.
2.
Nature of
Duties.
The
Collateral Agent shall have no duties or responsibilities except those expressly
set forth in the Agreement. Neither the Collateral Agent nor any of its
officers, directors, employees or agents shall be liable for any action taken or
omitted by it as such under the Agreement or hereunder or in connection herewith
or therewith, unless caused by its or their gross negligence or willful
misconduct. The duties of the Collateral Agent shall be mechanical and
administrative in nature; the Collateral Agent shall not have by reason of the
Agreement or any other Transaction Document a fiduciary relationship in respect
of any Holder; and nothing in the Agreement, expressed or implied, is intended
to or shall be so construed as to impose upon the Collateral Agent any
obligations in respect of the Agreement except as expressly set forth herein.
The Collateral Agent shall not take any material action or exercise any material
right or power pursuant to Section 5, 6 or 7 of this Agreement without the
authorization or direction of the Majority Holders;
provided
,
however
, that if
the Collateral Agent determines that it is unable to contact the Majority
Holders for purposes of seeking such authorization or direction or time will not
permit the Collateral Agent to so contact the Majority Holders prior to such
time as detriment may occur to the rights of the Collateral Agent or the Holders
from any failure of the Collateral Agent to act or exercise such right, then in
any such case the Collateral Agent may take such action or exercise such right
without specific authorization or direction from the Majority
Holders.
The
Collateral Agent shall not be liable for any act it may do or omit to do while
acting in good faith and in the exercise of its own best judgment. Any act done
or omitted by the Collateral Agent on the advice of its own attorneys shall be
deemed conclusively to have been done or omitted in good faith. The Collateral
Agent shall have the right at any time to consult with counsel on any question
arising under the Agreement. The Collateral Agent shall incur no liability for
any delay reasonably required to obtain the advice of counsel.
3.
Lack of Reliance on the Collateral
Agent
.
Independently and without reliance upon the Collateral Agent, each Holder, to
the extent it deems appropriate, has made and shall continue to make (i) its own
independent investigation of the financial condition and affairs of the Grantor
and its subsidiaries in connection with the making and the continuance of the
Obligations and the taking or not taking of any action in connection therewith,
and (ii) its own appraisal of the creditworthiness of the Grantor and its
subsidiaries, and the Collateral Agent shall have no duty or responsibility,
either initially or on a continuing basis, to provide any Holder with any credit
or other information with respect thereto, whether coming into its possession
before any Obligation arises or the purchase of any Note, or at any time or
times thereafter. The Collateral Agent shall not be responsible to any Holder
for any recitals, statements, information, representations or warranties herein
or in any document, certificate or other writing delivered in connection
herewith or for the execution, effectiveness, genuineness, validity,
enforceability, perfection, collectibility, priority or sufficiency of the
Agreement or the financial condition of the Grantor or be required to make any
inquiry concerning either the performance or observance of any of the terms,
provisions or conditions of the Agreement, or the financial condition of the
Grantor, or the existence or possible existence of any Event of
Default.
4.
Certain Rights of the Collateral
Agent.
No
Holder shall have the right to cause the Collateral Agent to take any action
with respect to the Collateral, with only the Majority Holders having the right
to direct the Collateral Agent to take any such action. If the Collateral Agent
shall request instructions from the Majority Holders with respect to any act or
action (including failure to act) in connection with the Agreement, the
Collateral Agent shall be entitled to refrain from such act or taking such
action unless and until it shall have received instructions from the Majority
Holders, and to the extent requested, appropriate indemnification in respect of
actions to be taken by the Collateral Agent; and the Collateral Agent shall not
incur liability to any person by reason of so refraining. Without limiting the
foregoing, no Holder shall have any right of action whatsoever against the
Collateral Agent as a result of the Collateral Agent acting or refraining from
acting hereunder in accordance with the instructions of the Majority Holders or
as otherwise specifically provided in the Agreement.
5.
Reliance
.
The
Collateral Agent shall be entitled to rely, and shall be fully protected in
relying, upon any note, writing, resolution, notice, statement, certificate,
telex, teletype or telecopier message, cablegram, radiogram, order or other
document or telephone message signed, sent or made by the proper person or
entity, and, with respect to all legal matters pertaining to the Agreement and
its duties thereunder, upon advice of counsel selected by it.
6.
Limitation of Holder
Liability.
The
Holders shall not be liable for any liabilities, obligations, losses, damages,
penalties, actions, judgments, suits, costs, expenses or disbursements of any
kind or nature whatsoever which may be imposed on, incurred by or asserted
against the Collateral Agent in performing its duties hereunder or under the
Agreement, or in any way relating to or arising out of the
Agreement.
7.
The Collateral Agent in its
Individual Capacity.
The
Collateral Agent and its affiliates may lend money to, purchase, sell and trade
in securities of and generally engage in any kind of business with the Grantor
or any affiliate or subsidiary of the Grantor as if it were not performing the
duties specified herein, otherwise without having to account for the same to the
Holders;
provided,
however,
that the
Collateral Agent on behalf of itself and such affiliates, hereby waives any
claim, right or lien against the Collateral in any way arising from or relating
to any such loan, securities transaction or business with the Grantor.
8.
Holders
.
The
Collateral Agent may deem and treat the holder of record of any Note as the
owner thereof for all purposes hereof unless and until a written notice of the
assignment or transfer thereof, as the case may be, shall have been filed with
the Collateral Agent. Any request, authority or consent of any person or entity
who, at the time of making such request or giving such authority or consent, is
the holder of record of any Note shall be conclusive and binding on any
subsequent holder, transferee or assignee, as the case may be, of such Note or
of any Note(s) issued in exchange therefor.
9.
Resignation by the Collateral
Agent.
(a) The
Collateral Agent may resign from the performance of all its functions and duties
under the Agreement at any time by giving 60 days' prior written notice (as
provided in the Agreement) to the Grantor and the Holders. Such resignation
shall take effect upon the appointment of a successor Collateral Agent pursuant
to clauses (b) and (c) below.
(b)
Upon any
such notice of resignation, the Majority Holders shall appoint a successor
Collateral Agent hereunder.
(c)
If a
successor Collateral Agent shall not have been so appointed within said 60-day
period, the Collateral Agent shall then appoint a successor Collateral Agent who
shall serve as Collateral Agent hereunder or thereunder until such time, if any,
as the Majority Holders appoint a successor Collateral Agent as provided above.
If a successor Collateral Agent has not been appointed within such 60-day
period, the Collateral Agent may petition any court of competent jurisdiction or
may interplead the Grantor and Holders in a proceeding for the appointment of a
successor Collateral Agent, and all fees, including but not limited to
extraordinary fees associated with the filing of interpleader, and expenses
associated therewith shall be payable by the Grantor.
(d)
The fees
of any successor Collateral Agent for its services as such shall be payable by
the Grantor.
Annex
V
LOCKBOX AGREEMENT
THIS LOCKBOX
AGREEMENT
, dated
as of July 21, 2006 (this “Agreement”), by and between
EMAGIN CORPORATION
, a
Delaware corporation (the “Company”), the bank or other financial institution
which may become a party hereto in accordance with Section 25, as lockbox agent
(the “Lockbox Agent”), and
ALEXANDRA GLOBAL MASTER FUND
LTD.
, a
British Virgin Islands international business company (the “Collateral
Agent”).
W
I
T
N
E
S
S
E
T
H
:
WHEREAS,
the
Company and the several Buyers (such capitalized term and all other capitalized
terms used in this Agreement having the meanings provided in Section 1) are
parties to the several Note Purchase Agreements, pursuant to which, among other
things, the Buyers have agreed to purchase the Notes from the Company;
WHEREAS,
contemporaneously with the execution and delivery of this Agreement, the Company
and the Collateral Agent are executing and delivering the Security Agreement
with the Collateral Agent pursuant to which, among other things, the Company is
granting a security interest in the Collateral, including, without limitation,
all of the Company's right, title and interest in and to all Accounts and
Contracts arising thereunder and the Collateral Account to the Collateral Agent
for the ratable benefit of the Holders;
WHEREAS,
in order
to give effect to and perfect the security interest in certain of the collateral
subject to the Security Agreement, this Agreement provides that all payments to
the Company pursuant to the Security Agreement shall be paid into a lockbox or a
Collateral Account controlled by the Lockbox Agent and disbursed from the
Collateral Account in accordance with the terms of this Agreement;
and
WHEREAS,
it is a
condition precedent to the several obligations of the Buyers to purchase their
respective Notes pursuant to the Note Purchase Agreements that the Company and
the Collateral Agent shall have executed and delivered this Agreement for the
ratable benefit of the Holders;
NOW THEREFORE
, in
consideration of the premises and the mutual covenants contained herein and
other good and valuable consideration, the receipt and sufficiency of which are
hereby acknowledged, the parties agree as follows:
1.
Definitions.
(a)
As used
in this Agreement, the terms “Agreement”, “Company”, “Collateral Agent”, and
“Lockbox Agent” shall have the respective meanings assigned to such terms in the
introductory paragraph of this Agreement.
(b)
All the
agreements or instruments herein defined shall mean such agreements or
instruments as the same may from time to time be supplemented or amended or the
terms thereof waived or modified to the extent permitted by, and in accordance
with, the terms thereof and of this Agreement.
(c)
Capitalized
terms used herein without definition shall have the respective meanings assigned
to such terms in the Notes.
(d)
The
following terms shall have the following meanings (such meanings to be equally
applicable to both the singular and plural forms of the terms
defined):
“Accounts”
shall have the meaning given such term in the Security Agreement.
“Additional
Note” means the Note issued pursuant to the Additional Note Purchase
Agreement.
“Additional
Note Purchase Agreement” means the Note Purchase Agreement, dated as of July 21,
2006, by and between the Company and Stillwater LLC, which by its terms
contemplates the issuance of up to $500,000 aggregate principal amount of Notes
on or after December 10, 2006.
“Agreement”
means this Lockbox Agreement, as amended, supplemented or otherwise modified
from time to time.
“Available
Specified Funds” means with respect to each Deposit Date the amount of the
Specified Funds less the Retained Amount.
“Buyer”
means any of the several buyers party to a Note Purchase Agreement.
“Collateral”
shall have the meaning given such term in the Security Agreement.
“Collateral
Account” means the account maintained at the Collateral Agent for the ratable
benefit of the Holders which is identified in clause (b) of Section 2 and
entitled “eMagin Noteholder Collateral Account”, and any successor or
replacement account.
“Deposit
Date” shall have the meaning given such term in Section 7(a).
“Event of
Default” means:
(1)
the
failure by the Company to perform in any material respect any obligation of the
Company under this Agreement as and when required by this
Agreement;
(2)
any
representation or warranty made by the Company pursuant to this Agreement shall
have been untrue in any material respect when made or deemed to have been made;
or
(3)
any Event
of Default, as that term is defined in the Security Agreement;
(4)
any Event
of Default, as that term is defined in the Patent and Trademark Security
Agreement; or
(5)
any Event
of Default, as that term is defined in any of the Notes.
“Event of
Default Notice” means a notice given by the Company, the Collateral Agent or a
Holder to the Lockbox Agent of the occurrence of an Event of
Default.
“Holder”
means any Buyer or any holder from time to time of any Note.
“Instruction”
shall have the meaning provided in Section 2(a).
“Lien”
shall mean any lien, mortgage, security interest, chattel mortgage, pledge or
other encumbrance (statutory or otherwise) of any kind securing satisfaction or
performance of an obligation, including any agreement to give any of the
foregoing, any conditional sales or other title retention agreement, any lease
in the nature thereof, and the filing of or the agreement to give any financing
statement under the Code of any jurisdiction or similar evidence of any
encumbrance, whether within or outside the United States.
“Lockbox”
means the lockbox administered by the Lockbox Agent for the ratable benefit of
the Holders which is identified in clause (a) of Section 2, and any successor or
replacement lockbox.
“Lockbox
Agent's Designees” shall have the meaning given such term in Section
10(a).
“Majority
Holders” means at any time such of the holders of Notes, which based on the
outstanding principal amount of the Notes, represents a majority
of the
aggregate outstanding principal amount of the Notes.
“Note
Purchase Agreements” means the several Note Purchase Agreements, dated as of
July 21, 2006, by and between the Company and the respective Buyer party thereto
pursuant to which the Company issued the Notes, including, without limitation,
the Additional Note Purchase Agreement.
“Notes”
means the Company’s 6% Senior Secured Convertible Notes due 2007-2008 originally
issued pursuant to the Note Purchase Agreements, including, without limitation,
the Additional Note.
“Notice
Date” means the date on which the Company gives the Instruction in accordance
with Section 2.
“Obligations
Schedule” means a schedule prepared by the Company which for each Holder and
each Note held thereby states, as of the date thereof, the
following:
(i)
such
Holder's name, address, telephone line facsimile transmission number and payment
instructions, including wire transfer instructions,
(ii)
the
original principal amount, the outstanding principal amount and the and the
maturity date of the Note,
(iii)
the
amount of accrued and unpaid interest on each Note,
(iv)
the
amount of unpaid interest due on each Note as of the most recent Interest
Payment Date,
(v)
the
amount of unpaid Default Interest, if any, due on each Note,
(vi)
the
occurrence or continuation of any Event of Default with respect to each Note,
(vii)
the
occurrence of any event which with notice or the passage of time, or both, could
become an Event of Default,
(viii)
the
amount, due date of, and reasons for any unpaid obligation due with respect to
each Note by reason of (A) an Event of Default or (B) any other repurchase,
redemption or acceleration obligation, and
(ix)
the
aggregate amount then due to the Holder with respect to each Note.
“Patent
and Trademark Security Agreement” means the Patent and Trademark Security
Agreement, dated as of July 21, 2006, between the Company and the Collateral
Agent.
“Person”
means any natural person, corporation, partnership, limited liability company,
trust, incorporated organization, unincorporated association or similar entity
or any government, governmental agency or political subdivision.
“Retained
Amount” means that portion, which may be all, of the Specified Funds for each
Deposit Date which equal (to the extent of the Specified Funds available) the
sum of all amounts with respect to the Notes which are scheduled to accrue or
which otherwise are expected to become due to the Holders during the Retention
Period for principal of and interest and Default Interest on the Notes or for
costs and expenses arising under the Transaction Documents and payable by the
Company.
“Retention
Period” means the 45-day period after each Deposit Date.
“Security
Agreement” means the Pledge and Security Agreement, dated as of July 21, 2006,
between the Company and the Collateral Agent.
“Specified
Funds” shall have the meaning given such term in Section 7(a).
“Subsidiary”
means any corporation or other entity of which a majority of the capital stock
or other ownership interests having ordinary voting power to elect a majority of
the board of directors or other Persons performing similar functions are at the
time directly or indirectly owned by the Company.
“Termination
Notice” means a notice given to the Lockbox Agent by and signed by the Company,
the Majority Holders and the Collateral Agent, which notice states that a
particular Event of Default has terminated or has been satisfied or waived and
no Holder has any continuing rights with respect thereto.
“Transaction
Documents” means the Notes, the Note Purchase Agreements, this Agreement, the
Security Agreement, the Patent and Trademark Security Agreement, the Warrants
and the other agreements, instruments and documents contemplated hereby and
thereby.
2.
Payments.
(a) The
Company agrees, that, upon the direction of the Collateral Agent given at any
time that an Event of Default has occurred and is continuing, in accordance with
Section 3(b) of the Security Agreement the Company shall irrevocably instruct in
writing (the “Instruction”) all the account debtors on the Accounts that
constitute part of the Collateral and all of the parties (other than the
Company) who are parties to Contracts that constitute part of the Collateral
that such Accounts and Contracts have been assigned to the Collateral Agent for
the ratable benefit of the Holders and that payments in respect thereof shall be
shall be made either
(i)
by check
or money order to the address of the Lockbox, which address shall be identified
to the Company by the Collateral Agent or if the Lockbox Agent is a bank shall
be the address of the office of the Lockbox Agent, or
(ii)
by wire
transfer of funds to the Collateral Account, which account shall be identified
to the Company by the Collateral Agent.
If the
Company fails to give the Instruction in accordance with Section 3(b) of the
Security Agreement, the Collateral Agent may, in its own name or in the name of
the Company, give the Instruction directly to the account debtors on the
Accounts that constitute part of the Collateral and to all of the parties to
Contracts that constitute part of the Collateral.
(b)
If the
Collateral Agent shall so require, at or prior to the time any Person who has
not already received the Instruction is to become an account debtor on Accounts
that constitute part of the Collateral or a party to Contracts that constitute
part of the Collateral, the Company shall instruct such Person that such
Accounts and Contracts have been assigned to the Collateral Agent for the
ratable benefit of the Holders and that payments in respect thereof shall be
made in the manner set forth in Section 2(a). If the Company fails to give the
instructions in accordance with this Section 2(b), the Collateral Agent may, in
its own name or in the name of the Company, give such instructions directly to
such Person.
3.
No Contrary Instructions.
Without
the prior written consent of the Collateral Agent and the Majority Holders, the
Company shall not revoke, rescind or modify the Instruction or take any other
action which is contrary to or inconsistent with this Agreement or the Security
Agreement. If for any reason the Company receives any payment from an account
debtor or party to a Contract on or after the Notice Date, the Company shall
immediately deposit such payment, and any interest or proceeds thereon, in the
Collateral Account. Prior to such deposit, the Company shall hold all such funds
in trust for the exclusive benefit of the Collateral Agent and the Holders
pursuant to this Agreement.
4.
Lockbox.
The
Lockbox shall be under the sole and exclusive control of the Lockbox Agent, as
agent for the Collateral Agent only. On each Business Day on or after the date
the Company gives or is required to give the Instruction, the Lockbox Agent will
remove all items from the Lockbox and promptly deposit all checks, money orders
and other payments included in such items in the Collateral Account. The Company
irrevocably authorizes and directs the Lockbox Agent to endorse and deposit all
such checks and money orders in the Collateral Account on the Business Day of
receipt by the Lockbox.
5.
Collateral
Account.
The
Collateral Account shall be under the sole and exclusive control of the Lockbox
Agent, as agent for the Collateral Agent only. All cash deposited in the
Collateral Account pursuant to this Agreement, and all interest earned thereon,
shall be held in the Collateral Account and shall at all times be segregated
from the funds and property of any other Person. The Collateral Account shall be
an interest-bearing account which pays interest at the rate determined from time
to time by the Lockbox Agent for comparable, fully liquid commercial accounts.
Without the prior consent of the Company, the Collateral Agent and the Majority
Holders, the assets in the Collateral Account shall be held in cash only and
shall not be invested in any securities. Funds may be withdrawn from the
Collateral Account only as expressly provided in this Agreement.
6.
Events of
Default.
Upon the
occurrence of an Event of Default, the Company shall immediately, and the
Collateral Agent may at any time, notify the Lockbox Agent thereof by giving an
Event of Default Notice. If an Event of Default Notice is so given to the
Lockbox Agent by the Company or the Collateral Agent, then thereafter the
Lockbox Agent shall deem an Event of Default to have occurred and be continuing
for all purposes unless and until the Lockbox Agent receives a Termination
Notice executed by the Company, the Majority Holders and the Collateral
Agent.
7.
Release of
Funds.
(a) Three
Business Days after the Business Day on which funds received from any person are
deposited into the Collateral Account in a minimum amount of
$100,000
(or which
would increase the balance in the Collateral Account to at least $100,000) (the
“Deposit Date”), the Lockbox Agent shall disburse the amount of funds, including
interest received, held in the Collateral Account on such Deposit Date (the
“Specified Funds”) as follows:
(i)
First, to
pay each Holder on a pro rata basis the amount of all accrued and unpaid
interest and Default Interest, if any, then due each Holder in accordance with
the terms of their respective Notes through the most recent Interest Payment
Date;
(ii)
Second,
to pay each Holder on a pro rata basis the unpaid amount, if any, then due such
Holder pursuant to Article II of the Notes for any Determination Period ended at
least 45 days prior to the date of such payment;
(iii)
Third, to
pay each Holder on a pro rata basis the amount, if any, of unpaid principal then
due on the maturity date of any installment of principal of such Holder's Notes;
(iv)
Fourth,
to the Holders and the Collateral Agent to pay or reimburse them for their
respective amounts of costs and expenses payable by the Company pursuant to the
Transaction Documents and not theretofore paid or reimbursed by the Company
(including under this Section 7(a)); and
(v)
Fifth, if
no Event of Default shall have occurred and be deemed continuing pursuant to
Section 6, to pay the Available Specified Funds remaining in the Collateral
Account to the Company.
(b)
During
each Retention Period, the Lockbox Agent shall hold the Retained Amount in the
Lockbox Account. On the Business Day following the end of such Retention Period,
the Lockbox Agent shall (1) pay each Holder, on a pro rata basis, from the
Retained Amount any unpaid amounts due to the Holders for interest, Default
Interest and principal as described in clauses (i)-(iii) of Section 7(a) which
have accrued and become due during the Retention Period and then (2) pay costs
and expenses of the Holders and the Collateral Agent as described in clause (iv)
of Section 7(a) and then (3) provided no Event of Default shall have occurred
and be continuing, pay the remaining Retained Amount to the
Company.
(c)
If an
Event of Default shall have occurred and be continuing, after disbursing the
Specified Funds in the Collateral Account pursuant to clauses (i) through (iv)
of Section 7(a), the Lockbox Agent shall disburse the remaining Specified Funds
to pay each Holder, on a pro rata basis, the amount of unpaid principal then due
upon acceleration, if any, pursuant to Article IV of such Holder's Note(s);
provided, however,
that if
the amount of such Specified Funds is insufficient to pay all amounts due to the
Holders, then the amount paid to the Holders pursuant to this Section 7(c) shall
be prorated among the Holders in proportion to the respective amounts due each
Holder.
(d)
For each
Deposit Date, after making the payments to the Holders required by Sections 7(b)
and 7(c) and after the Company shall have paid the Holders any other amounts
then due under the Notes, the Lockbox Agent shall pay to the Company all
Specified Funds remaining in the Collateral Account. Funds received in the
Collateral Account and interest received thereon after any Deposit Date shall be
deemed new Specified Funds to be disbursed, three Business Days after the next
Deposit Date to occur, in accordance with all of the provisions and priorities
of this Section 7 before being paid to the Company.
8.
Reporting Requirements; Payment
Instructions.
(a) On
or before the Notice Date, on the first Business Day of each calendar month
thereafter, and at such other times as requested by the Lockbox Agent in order
to comply with its obligations under this Agreement or by the Collateral Agent,
the Company shall furnish to the Lockbox Agent and the Collateral Agent an
updated Obligations Schedule. The Company shall promptly correct any errors in
any Obligations Schedule and furnish copies of such corrected Obligations
Schedule to the Lockbox Agent and the Collateral Agent. If the Collateral Agent
or any Holder shall notify the Lockbox Agent and the Company of any error in or
dispute concerning an Obligations Schedule, the Lockbox Agent shall not release
any funds from the Collateral Account which are the subject of such error or
dispute until such error is corrected or such dispute is resolved with the
consent of the affected Holders and the Company. The Lockbox Agent may release
from the Collateral Account, in accordance with this Agreement, funds which are
not subject to such error or dispute.
(b)
All
payments by the Lockbox Agent to the Holders under this Agreement shall be made
by wire transfer of immediately available funds to the applicable account, or if
no wire transfer instructions are given to the address, specified for each
Holder in the Obligations Schedule or in a superseding notice given by a Holder
to the Lockbox Agent. All payments by the Lockbox Agent to the Company under
this Agreement shall be deposited in the Company's separate account maintained
at the Lockbox Agent or shall be sent by wire transfer of immediately available
funds to such other account as the Company shall have specified by notice to the
Lockbox Agent.
9.
Representations and
Warranties.
The
Company hereby represents and warrants to and for the benefit of the Lockbox
Agent, the Collateral Agent and the Holders that:
(a)
Power and
Authority.
The
Company has full power, authority and legal right to enter into this
Agreement.
(b)
Binding Obligation
.
This
Agreement has been duly authorized by the Company and has been duly executed and
delivered by the Company and constitutes a legal, valid and binding obligation
of the Company enforceable against the Company in accordance with its
terms.
(c)
Non-Contravention.
The
execution, delivery and performance of this Agreement will not violate any
provision of any applicable law or regulation or of any order, judgment, writ,
award or decree of any court, arbitrator or governmental authority, domestic or
foreign, or of any securities issued by the Company or any Subsidiary, or of any
mortgage, indenture, lease, contract or other agreement, instrument or
undertaking to which the Company or any Subsidiary is a party or which purports
to be binding upon the Company or any Subsidiary or upon any of their respective
assets and will not result in the creation or imposition of any Lien on any of
the assets of the Company or any Subsidiary except as expressly permitted by
this Agreement and the other Transaction Documents.
(d)
Consents
.
No
consent (other than consents which have been obtained) of any party, and no
filing, approval, registration, recording or other action is required in
connection with the execution, delivery or performance of this Agreement by the
Company.
10.
Limitation of
Liability.
The
Lockbox Agent's liability in connection with the performance of the transactions
covered by this Agreement shall be strictly limited as follows:
(a)
The
Lockbox Agent shall exercise ordinary care in selecting agents and independent
contractors, adequately bonded, to pick up and deliver the contents of the
Lockbox (“Lockbox Agent's Designees”) but shall not be liable for loss caused by
Lockbox Agent's Designees' negligence or misconduct. In the event of such loss,
the Lockbox Agent will exercise its commercially reasonable best efforts, at the
Company's cost and expense, to assist the Company in obtaining redress from the
responsible party.
(b)
The
Lockbox Agent shall exercise its commercially reasonable best efforts in
determining the optimum time to pick up mail at the Lockbox and the best carrier
to deliver that mail to the Lockbox Agent’s designated processing facility.
However, the Lockbox Agent shall not be liable if the chosen pickup time and
carrier prove not to result in the earliest possible availability of
funds.
(c)
In
performing it duties hereunder, the Lockbox Agent will exercise ordinary care
and will act in good faith. The Lockbox Agent will not be accountable for its
failure to perform any of its obligations hereunder, except for its gross
negligence or willful misconduct, or that of its employees, officers or agents.
If, as a result of such gross negligence or willful misconduct, the Lockbox
Agent is liable for mishandling any item, such liability shall be limited to the
lesser of the face amount of any check involved or the amount of the Company's
direct loss as a result of such mishandling, and in no event shall the Lockbox
Agent be responsible for any incidental or consequential damages. IN NO EVENT
SHALL THE LOCKBOX AGENT BE LIABLE FOR ANY INDIRECT OR CONSEQUENTIAL DAMAGES OR
LOSS OF PROFIT, NOTWITHSTANDING NOTICE TO THE LOCKBOX AGENT OF THE POSSIBILITY
OF SUCH DAMAGES OR LOSSES.
11.
Indemnification.
The
Company agrees to pay, indemnify, and to save the Lockbox Agent, the Collateral
Agent and each Holder harmless from, any and all liabilities, costs and expenses
(including, without limitation, legal fees and expenses) (i) with respect to, or
resulting from, any delay in paying any and all excise, sales or other taxes
which may be payable or determined to be payable with respect to the Collateral
Account, (ii) with respect to, or resulting from, any failure or delay by the
Company in complying with any law or regulation applicable to the Collateral
Account or (iii) in connection with this Agreement, any breach or alleged breach
hereof, or any action taken by the Lockbox Agent, the Collateral Agent or any
Holder in exercising its rights hereunder.
12.
Security
Agreement.
The
Collateral Account and the Lockbox, and all funds due to the Company and
deposited in the Lockbox and the Collateral Account, are subject to the security
interest of the Collateral Agent pursuant to the Security Agreement in
accordance with the terms thereof.
13.
Paragraph Headings, Captions,
Etc.
The
paragraph headings, the captions and the footers used in this Agreement are for
convenience of reference only and are not to affect the construction hereof or
be taken into consideration in the interpretation hereof.
14.
No Waiver; Cumulative
Remedies.
The
Lockbox Agent shall not by any act, delay, indulgence, omission or otherwise be
deemed to have waived any right or remedy hereunder or to have acquiesced in any
default or breach of any of the terms and conditions hereof. No failure to
exercise, nor any delay in exercising, on the part of the Lockbox Agent, any
right, power or privilege hereunder shall operate as a waiver thereof. No single
or partial exercise of any right, power or privilege hereunder shall preclude
any other or further exercise thereof or the exercise of any other right, power
or privilege. A waiver by the Lockbox Agent, the Collateral Agent or the Holders
of any right or remedy hereunder on any one occasion shall not be construed as a
bar to any right or remedy which the Lockbox Agent, the Collateral Agent or the
Holders would otherwise have on any future occasion. The rights and remedies
herein and in the Transaction Documents are cumulative, may be exercised singly
or concurrently and are not exclusive of any rights or remedies provided by law
or in equity or by statute.
15.
Waivers and Amendments; Successors
and Assigns.
None of
the terms or provisions of this Agreement may be waived, amended, supplemented
or otherwise modified except by a written instrument executed by the party to be
charged with enforcement;
provided, however,
that any
provision of this Agreement may be waived, amended, supplemented or otherwise
modified by the Lockbox Agent only with the prior written approval of the
Collateral Agent or the Majority Holders. This Agreement shall be binding upon
the successors and permitted assigns of the Company and shall inure to the
benefit of the Lockbox Agent and its successors and assigns. The Company may not
assign its rights or obligations under this Agreement without the prior written
consent of the Lockbox Agent, which the Lockbox Agent may withhold in its sole
discretion.
16.
Effective Date;
Termination.
This
Agreement shall become effective at the time of first issuance of any Note on
the earliest Issuance Date when executed and delivered by the Company and the
Collateral Agent. Upon the payment and performance in full by the Company of its
obligations under the Transaction Documents, the Company's obligations to the
Lockbox Agent and the Holders pursuant to Sections 2 through 8 shall terminate,
any funds remaining in the Collateral Account shall be paid to the Company, and
promptly thereafter the parties shall instruct the account debtors on all
Accounts that theretofore constituted Collateral and all parties to Contracts
that theretofore constituted Collateral to make all further payments due to the
Company directly to the Company.
17.
Notices.
Except
as otherwise specifically provided herein, any notice required or permitted to
be given under the terms of this Agreement shall be given in writing and shall
be deemed effectively given upon personal delivery to the party to be notified
or five days after deposit with the United States Postal Service, by registered
or certified mail, postage prepaid to the party to be notified at such party’s
address indicated in this Section 17 or at such other address as such party may
designate by ten days’ advance written notice to the other parties. Notices in
writing shall also be deemed effectively given upon delivery by an overnight
courier, or upon transmission by facsimile, except that the time at which the
notice is given will be the time at which confirmation of receipt is generated
by the receiving facsimile
machine. In the case of any notice to
the Company, such notice shall be addressed to the Company at, 10500 N.E.
8th Street, Suite 1400, Bellevue, WA 98004 Attention: Chief Financial
Officer (telephone line facsimile number (425) 749-3601), with a copy to
Sichenzia Ross Friedman Ference LLP, 1065 Avenue of the Americas,
21st Floor, New York, New York 10018, Attention: Richard A. Friedman, Esq.
(telephone line facsimile number (212) 930-9725), and in the case of any notice
to the Collateral Agent or to the Collateral Agent while it serves as Lockbox
Agent, such notice shall be addressed to the Collateral Agent (or Lockbox Agent,
as applicable) at Alexandra Global Master Fund Ltd., c/o Alexandra Investment
Management, LLC, 767 Third Avenue, 39th Floor, New York, New York 10017
(telephone line facsimile number (212) 301-1810), and if the Collateral Agent is
not the Lockbox Agent, in the case of any notice to the Lockbox Agent, such
notice shall be addressed to the Lockbox Agent at its address or telephone line
facsimile transmission number provided in writing to the Company and the
Collateral Agent at the time it becomes the Lockbox Agent.
18.
Fees and
Expenses.
The
Company agrees to pay the fees of the Lockbox Agent in performing its services
under this Agreement and all reasonable expenses (including, but not limited to,
attorneys' fees and costs for legal services, costs of insurance and payments of
taxes or other charges) of, incidental to, or in any way relating to the
performance by the Lockbox Agent of its obligations and the enforcement or
protection of the rights of the Lockbox Agent hereunder.
19.
Concerning
Lockbox
Agent.
The
Company acknowledges that the rights and responsibilities of the Lockbox Agent
under this Agreement with respect to any action taken by the Lockbox Agent or
the exercise or nonexercise by the Lockbox Agent of any option, right, request,
judgment or other right or remedy provided for herein or resulting or arising
out of this Agreement shall, as between the Lockbox Agent and the Holders, be
governed by
Exhibit A
to this
Agreement and by such other agreements with respect thereto as may exist from
time to time among them, but, as between the Lockbox Agent and the Company,
except as expressly provided in Section 16, the Lockbox Agent shall be
conclusively presumed to be acting as agent for the Collateral Agent with full
and valid authority so to act or refrain from acting, and the Company shall not
be under any obligation to make any inquiry respecting such authority.
20.
Concerning the Collateral
Agent.
The
Collateral Agent hereby appoints the Lockbox Agent as its agent upon the terms
provided in this Agreement, with the Lockbox Agent to act exclusively for the
benefit of the Collateral Agent. The Collateral Agent is executing and
delivering this Agreement solely for purposes of this Section 20.
21.
Integration.
This
Agreement represents the entire agreement of the Company and the Lockbox Agent
with respect to the subject matter hereof, and there are no promises,
undertakings, representations or warranties by the parties relative to the
subject matter hereof not expressly set forth or referred to
herein.
22.
Governing
Law.
This
Agreement and the rights and obligations of the Company under this Agreement
shall be governed by, and construed and interpreted in accordance with, the law
of the State of New York.
23.
Counterparts;
Execution.
This
Agreement may be executed in any number of counterparts and all the counterparts
taken together shall be deemed to constitute one and the same instrument. This
Agreement, once executed by a party, may be delivered to the other party hereto
by telephone line facsimile transmission of a copy of this Agreement bearing the
signature of the party so delivering this Agreement.
24.
Third Party
Beneficiaries.
The
Collateral Agent and the Holders shall be third party beneficiaries of this
Agreement.
25.
Collateral Agent as Lockbox
Agent.
Whenever
there shall not be a bank or other financial institution serving as Lockbox
Agent, the Collateral Agent shall serve as Lockbox Agent. The Collateral Agent
may select a bank or financial institution to serve as Lockbox Agent. During any
period that the Collateral Agent serves as Lockbox Agent any reference to the
Collateral Agent in this Agreement shall be a nullity. A bank selected by the
Collateral Agent to serve as Lockbox Agent may, by executing and delivering to
the Company and the Collateral Agent a counterpart of this Agreement, become a
party to this Agreement, as Lockbox Agent, whereupon, the Collateral Agent shall
cease to be the Lockbox Agent, and the Company agrees to all amendments to the
form of this Agreement as such bank or financial institution so selected by the
Collateral Agent to serve as Lockbox Agent may require. While the Collateral
Agent serves as Lockbox Agent, it may maintain the Collateral Account at a bank
selected by the Collateral Agent, notwithstanding any provision of this
Agreement to the contrary.
26.
Construction.
The
language used in this Agreement will be deemed to be the language chosen by the
parties to express their mutual intent, and no rules of strict construction will
be applied against any party.
[Signature page
follows]
IN WITNESS WHEREOF
, the
Company has caused this Agreement to be duly executed and delivered as of the
date first above written.
|
|
|
|
EMAGIN
CORPORATION
|
|
|
|
|
By:
|
/s/ Gary W.
Jones
|
|
Name: Gary W. Jones
|
|
Title:
Chief Executive Officer
|
ACKNOWLEDGED
AND AGREED:
ALEXANDRA GLOBAL MASTER FUND
LTD.,
as Collateral Agent and Lockbox
Agent
BY: Alexandra Investment Management,
LLC,
as Investment
Advisor
|
|
|
|
/s/ Mikhail
Filimonov
|
|
|
|
Name
Mikhail Filimonov
Title Chairman and Chief Executive Officer
|
|
|
|
|
|
|
|
Exhibit A
The Lockbox Agent
1.
Appointment.
The
Holders (all capitalized terms used in this Exhibit A and not otherwise defined
herein shall have the respective meanings provided in the Lockbox Agreement to
which this Exhibit A is attached (the “Agreement”)), by their acceptance of the
benefits of the Agreement, hereby irrevocably designate Alexandra Global Master
Fund Ltd. as Lockbox Agent to act as specified herein and in the Agreement. Each
Investor hereby irrevocably authorizes, and each other Holder of any Note by the
acceptance of such Note shall be deemed irrevocably to authorize, the Lockbox
Agent to take such action on its behalf under the provisions of the Agreement
and any other instruments and agreements referred to herein or therein and to
exercise such powers and to perform such duties hereunder and thereunder as are
specifically delegated to or required of the Lockbox Agent by the terms hereof
and thereof and such other powers as are reasonably incidental thereto. The
Lockbox Agent may perform any of its duties hereunder by or through its agents
or employees.
2.
Nature of
Duties.
The
Lockbox Agent shall have no duties or responsibilities except those expressly
set forth in the Agreement. Neither the Lockbox Agent nor any of its officers,
directors, employees or agents shall be liable for any action taken or omitted
by it as such under the Agreement or hereunder or in connection herewith or
therewith, unless caused by its or their gross negligence or willful misconduct.
The duties of the Lockbox Agent shall be mechanical and administrative in
nature; the Lockbox Agent shall not have by reason of the Agreement or any other
Transaction Document a fiduciary relationship in respect of the Collateral Agent
or any Holder; and nothing in the Agreement, expressed or implied, is intended
to or shall be so construed as to impose upon the Lockbox Agent any obligations
in respect of the Agreement except as expressly set forth herein.
The
Lockbox Agent shall not be liable for any act it may do or omit to do while
acting in good faith and in the exercise of its own best judgment. Any act done
or omitted by the Lockbox Agent on the advice of its own attorneys shall be
deemed conclusively to have been done or omitted in good faith. The Lockbox
Agent shall have the right at any time to consult with counsel on any question
arising under the Agreement. The Lockbox Agent shall incur no liability for any
delay reasonably required to obtain the advice of counsel. Nothing herein shall
constitute a release or waiver of such legal counsel from any liability it may
have for the advice given to the Lockbox Agent.
3.
Lack of Reliance on the
Lockbox
Agent
.
Independently and without reliance upon the Lockbox Agent, the Collateral Agent
and each Holder, to the extent it deems appropriate, has made and shall continue
to make (i) its own independent investigation of the financial condition and
affairs of the Company and its subsidiaries in connection with the making and
the continuance of the Company's obligations under the Transaction Documents and
the taking or not taking of any action in connection therewith, and (ii) its own
appraisal of the creditworthiness of the Company and its subsidiaries, and the
Lockbox Agent shall have no duty or responsibility, either initially or on a
continuing basis, to provide the Collateral Agent or any Holder with any credit
or other information with respect thereto, whether coming into its possession
before any such obligation arises or the purchase of any Note, or at any time or
times thereafter. The Lockbox Agent shall not be responsible to the Collateral
Agent or any Holder for any recitals, statements, information, representations
or warranties herein or in any document, certificate or other writing delivered
in connection herewith or for the execution, effectiveness, genuineness,
validity, enforceability or sufficiency of the Agreement or the financial
condition of the Company or be required to make any inquiry concerning either
the performance or observance of any of the terms, provisions or conditions of
the Agreement, or the financial condition of the Company, or the existence or
possible existence of any Event of Default.
4.
Certain Rights of the Lockbox
Agent.
No Holder
shall have the right to cause the Lockbox Agent to take any action with respect
to the Lockbox or the Collateral Account, with only the Collateral Agent or the
Majority Holders having the right to direct the Lockbox Agent to take any such
action. If the Lockbox Agent shall request instructions from the Collateral
Agent or the Majority Holders with respect to any act or action (including
failure to act) in connection with the Agreement, the Lockbox Agent shall be
entitled to refrain from such act or taking such action unless and until it
shall have received instructions from the Collateral Agent or the Majority
Holders, and to the extent requested, appropriate indemnification in respect of
actions to be taken by the Lockbox Agent; and the Lockbox Agent shall not incur
liability to any Person by reason of so refraining. Without limiting the
foregoing, neither the Collateral Agent nor any Holder shall have any right of
action whatsoever against the Lockbox Agent as a result of the Lockbox Agent
acting or refraining from acting hereunder in accordance with the instructions
of the Collateral Agent or the Majority Holders or as otherwise specifically
provided in the Agreement.
5.
Reliance
.
The
Lockbox Agent shall be entitled to rely, and shall be fully protected in
relying, upon any note, writing, resolution, notice, statement, certificate,
telephone line facsimile transmission, email, telex, teletype or telecopier
message, cablegram, radiogram, order or other document or telephone message
signed, sent or made by the proper Person, and, with respect to all legal
matters pertaining to the Agreement and its duties thereunder, upon advice of
counsel selected by it.
6.
Limitation of Collateral Agent and
Holder Liability.
The
Collateral Agent and the Holders shall not be liable for any liabilities,
obligations, losses, damages, penalties, actions, judgments, suits, costs,
expenses or disbursements of any kind or nature whatsoever which may be imposed
on, incurred by or asserted against the Lockbox Agent in performing its duties
hereunder or under the Agreement, or in any way relating to or arising out of
the Agreement.
7.
The Lockbox Agent in its Individual
Capacity.
The
Lockbox Agent and its affiliates may lend money to, purchase, sell and trade in
securities of and generally engage in any kind of business with the Company or
any affiliate or subsidiary of the Company as if it were not performing the
duties specified herein, and may accept fees and other consideration from the
Company for services to the Company in connection with the Transaction Documents
and otherwise without having to account for the same to the Holders;
provided,
however,
that the
Collateral Agent on behalf of itself and such affiliates, hereby waives any
claim, right or Lien against the Collateral Account in any way arising from or
relating to any such loan, securities transaction or business with the
Company.
8.
Holders
.
The
Lockbox Agent may deem and treat the holder of record of any Note as the owner
thereof for all purposes hereof unless and until a written notice of the
assignment or transfer thereof, as the case may be, shall have been filed with
the Lockbox Agent. Any request, authority or consent of any Person or entity
who, at the time of making such request or giving such authority or consent, is
the holder of record of any Note shall be conclusive and binding on any
subsequent holder, transferee or assignee, as the case may be, of such Note or
of any Note(s) issued in exchange therefor.
9.
Resignation by the
Lockbox
Agent.
(a) The
Lockbox Agent may resign from the performance of all its functions and duties
under the Agreement at any time by giving 60 Business Days' prior written notice
(as provided in the Agreement) to the Company, the Collateral Agent and the
Holders. Such resignation shall take effect upon the appointment of a successor
Lockbox Agent pursuant to clauses (b) and (c) below.
(b)
Upon any
such notice of resignation, the Collateral Agent shall appoint a successor
Lockbox Agent hereunder.
(c)
If a
successor Lockbox Agent shall not have been so appointed within said 60 Business
Day period, the Lockbox Agent shall then appoint a successor Lockbox Agent who
shall serve as Lockbox Agent hereunder or thereunder until such time, if any, as
the Collateral Agent appoints a successor Lockbox Agent as provided above. If a
successor Lockbox Agent has not been appointed within such 60-day period, the
Lockbox Agent may, at the sole cost and expense of the Company, petition any
court of competent jurisdiction or may interplead the Company, the Collateral
Agent and the Holders in a proceeding for the appointment of a successor Lockbox
Agent, and all fees, including but not limited to extraordinary fees associated
with the filing of interpleader, and expenses associated therewith shall be
payable by the Company.
(d)
The fees
of any successor Lockbox Agent for its services as such shall be payable by the
Company.
Annex
VI
Press
Release
eMagin
Enters Into Agreements To Raise
Approximately
$6.5 Million Private Placement
BELLEVUE,
Wash., July 24, 2006 – eMagin Corporation (AMEX: EMA), a leader in virtual
imaging technology, has entered into definitive agreements with institutional
and accredited investors for the sale of approximately $6.5 million of senior
secured convertible debentures and warrants. The net proceeds from the financing
will be used for general working capital purposes.
Under the
agreements, investors agreed to purchase $5,970,000 principal amount of notes
with conversion prices of $0.26 per share that may convert into 22,192,301
shares of common stock and 5 year warrants exercisable at $0.36 per share for
15,534,607 shares of common stock. An additional $500,000 will be invested
through exercise of a warrant to purchase approximately 1.92 million shares of
common stock at $0.26 per share prior to December 14, 2006 or, at the request of
the Company, by the purchase of additional notes and warrants. If not converted
half of the principal amount will be due July 21, 2007 and the remaining balance
due January 21, 2008. Interest at 6% per annum is payable in quarterly
installments on outstanding Notes during their term commencing on September 1,
2006.
In a
showing of commitment to the Company’s prospects, Paul Cronson, Director, John
Atherly, Chief Financial Officer, and Olivier Prache, Senior Vice President of
Display Manufacturing and Development Operations participated in the
transaction, and Gary Jones, Chief Executive Officer and Susan Jones, Chief
Marketing and Strategy Officer, who collectively own 5% of the Company’s
outstanding shares, agreed to defer 10% of their compensation until eMagin
becomes EBITDA positive or until the occurrence of certain other
events.
In
conjunction with the note purchase transaction the Company will submit to
shareholders at its annual meeting a resolution to enact a reverse stock split
of 1 for 10 which, if approved, normalizes the company’s share price and shares
outstanding.
In order
to reestablish performance incentives employees and Directors have also agreed
to forfeit approximately 4.7 million shares of existing stock options in return
for re-pricing 8.8 million existing options at $0.26 per share. Re-priced
options will not be exercisable until 2007 or in some cases not until 2011,
depending on individual grant-vesting schedules.
In
addition, to further strengthen its management team the Company intends to add
two new Directors recommended by the new investors and to recruit additional
senior management.
Additional
details regarding the private placement are provided on Form 8-K which is being
filed today. Representing the company in this transaction was Sichenzia
Ross Friedman Ference, LLP.
The note
shares and warrants are being issued in a private placement under regulation D
of the Securities Act of 1933, as amended. The company has agreed to file a
registration statement covering the resale of the common stock and underlying
the notes and warrants purchased by these investors following the closing.
This press release does not constitute an offer to sell, or the solicitation of
an offer to buy, any securities, nor shall there be any sale of the securities
in any jurisdiction in which such offering would be unlawful.
About
eMagin Corporation
A leader
in OLED microdisplay and virtual imaging technologies, eMagin integrates
high-resolution OLED microdisplays, magnifying optics, and systems technologies
to create a virtual image that appears comparable to that of a computer monitor
or a large-screen television. eMagin’s OLED displays have broad market reach and
are incorporated into a variety of near-to-eye imaging products by military,
industrial, medical and consumer OEMs who choose eMagin’s award-winning
technology as a core component for their solutions. eMagin has recently
introduced its first direct-to-consumer system, the Z800 3DVisor, which provides
superb 3D stereovision and headtracking for PC gaming, training and simulation,
and business applications. eMagin's microdisplay manufacturing and R&D
operations are co-located with IBM on its campus in East Fishkill, New
York. System design facilities and sales and marketing are located in
Bellevue, Washington. A sales office is located in Tokyo, Japan. For additional
information, please visit www.emagin.com and www.3dvisor.com.
Forward
Looking Statements
This
press release contains forward-looking statements within the meaning of Section
27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act
of 1934, including those regarding eMagin Corporation and its subsidiaries'
expectations, intentions, strategies and beliefs pertaining to future events or
future financial performance. All statements contained herein are based upon
information available to eMagin's management as of the date hereof, and actual
results may vary based upon future events, both within and without eMagin
management's control. In some cases, you can identify forward-looking statements
by terminology such as "may," "will," "should," "expect," "plan," "anticipate,"
"believe," "estimate," "predict," "potential" or "continue," the negative of
such terms, or other comparable terminology. These statements are only
predictions. Actual events or results may differ materially from those in the
forward-looking statements as a result of various important factors, including
those described in the Company's most recent filings with the SEC. Although we
believe that the expectations reflected in the forward-looking statements are
reasonable, such statements should not be regarded as a representation by the
Company, or any other person, that such forward-looking statements will be
achieved. The business and operations of the Company are subject to substantial
risks which increase the uncertainty inherent in forward-looking statements. We
undertake no duty to update any of the forward-looking statements, whether as a
result of new information, future events or otherwise. In light of the
foregoing, readers are cautioned not to place undue reliance on such
forward-looking statements.
Note:
eMagin and 3DVisor
are trademarks of eMagin Corporation.
Media
Contact:
Joe
Runde, 425-749-3636, jrunde@emagincorp.com
Investor
Contact:
John
Atherly, 425-749-3622, jatherly@emagincorp.com
Annex
VII
|
Annex
VII
to
Note
Purchase
Agreement
|
[Letterhead
of Company Counsel]
[Closing
Date]
The
Buyers listed on
Exhibit A
Hereto
Re:
eMagin Corporation
Ladies
and Gentlemen:
We have
acted as counsel to eMagin Corporation, a Delaware corporation (the "Company"),
in connection with the issuance by the Company of $[7,000,000] aggregate
principal amount of 6% Senior Secured Convertible Note due 2007-2008 (the
-"Notes"), and related Common Stock Purchase Warrants (the "Warrants"), pursuant
to the several Note Purchase Agreements, dated as of July , 2006 (the
"Agreements"), by and between the Company and the several Buyers named therein
(the "Buyers"). Capitalized terms used herein and not otherwise defined herein
shall have the respective meanings assigned to such terms in the Agreements.
This opinion is being delivered to you pursuant to Section 7(n) of the
Agreements.
In so
acting, we have examined originals or copies (certified or otherwise identified
to our satisfaction) of the Agreements, the Notes, the Warrants, the Pledge and
Security Agreement, dated as of July , 2006, by and between the Company and the
Collateral Agent named therein (the "Security Agreement"), the Patent and
Trademark Security Agreement, dated as of July , 2006, by and between the
Company and the Collateral Agent named therein (the "Patent and Trademark
Security Agreement"), the Lockbox Agreement, dated as of July 2006, by and
between the Company and the Lockbox Agent named therein (the "Lockbox
Agreement"), and such corporate records, agreements, documents and other
instruments, and such certificates or comparable' documents of public officials
and of officers and representatives of the Company, and have made such inquiries
of such officers and representatives, as we have deemed relevant and necessary
as a basis for the opinions hereinafter set forth. The Agreements, the Notes,
the Warrants, the Security Agreement, the Patent and Trademark Security
Agreement and the Lockbox Agreement are hereinafter referred to collectively as
the "Transaction Documents."
In
rendering the opinions set forth in this opinion letter, we assume the
following:
(a) - the
legal capacity of each natural person;
(b) the
legal existence of all parties to the transactions referred to in the
Transaction Documents excluding the Company;
(c) the
power and authority of each person other than the Company or person(s) acting on
behalf of the Company to execute, deliver and perform each document executed and
delivered and to do each other act done or to be done by such
person;
(d) the
authorization, execution and delivery by each person other than the Company or
person(s) acting on behalf of the Company of each document executed and
delivered or to be executed and delivered by such person;
(e) the
legality, validity, binding effect and enforceability as to each person other
than the Company or person(s) acting on behalf of the Company of each document
executed and delivered or to be executed or delivered and of each other act done
or to be done by such person;
(f) the
transactions referred to in the Transaction Documents have been
consummated;
(g) the
payment of all the required documentary stamps taxes and fees imposed upon the
execution, filing or recording of the Transaction Documents;
(h) that
there have been no undisclosed modifications of any provision of any document
reviewed by us in connection with the rendering of the opinions set forth in
this opinion letter and no undisclosed prior waiver of any right or remedy
contained in the Transaction Documents;
(i) the
genuineness of each signature (other than the signatures of the officers of the
Company), the completeness of each document submitted to us, the authenticity of
each document reviewed by us as an original, the conformity to the original of
each document reviewed by us as a copy and the authenticity of the original of
each document received by us as a copy;
(j) the
truthfulness of each statement as to all factual matters otherwise not known to
us to be untruthful contained in any document encompassed within the due
diligence review undertaken by us;
(k) the
accuracy on the date of this letter as well as on the date stated in all
governmental certifications of each statement as to each factual matter
contained in such governmental certifications;
(l) that
the addressee has acted in good faith, without notice of adverse claims, and has
complied with all laws applicable to it that affect the transactions referred to
in the Transaction Documents;
(m) that
the transactions referred to in the Transaction Documents comply with all tests
of good faith, fairness and conscionability required by law;
(n) that
routine procedural matters such as service of process or qualification to do
business in the relevant jurisdictions will be satisfied by the parties seeking
to enforce the Transaction Documents;
(o) that
all statutes, judicial and administrative decisions, and rules and regulations
of governmental agencies constituting the law for which we are assuming
responsibility are published (e.g., reported court decisions and the specialized
reporting services of BNA, CCH and Prentice-Hall) or otherwise generally
accessible (e.g., LEXIS or WESTLAW) in each case in a manner generally available
(i.e., in terms of access and distribution following publication) to lawyers
practicing in our judicial circuit;
(p) that
other agreements related to the transactions referred to in the Transaction
Documents will be enforced as written;
(q) that
no action, discretionary or otherwise, will be taken by or on behalf of the
Company in the future that might result in a violation of law;
(r) that
there are no other agreements or understandings among the parties that would
modify the terms of the Transaction Documents or the respective rights or
obligations of the parties to the Transaction Documents;
(s) that
with respect to the Transaction Documents and to the transactions referred to
therein, there has been no mutual mistake of fact and there exists no fraud or
duress; and
(t) the
constitutionality and validity of all relevant laws, regulations and agency
actions unless a reported case has otherwise held or widespread concern has been
expressed by commentators as reflected in materials which lawyers routinely
consult.
As to
certain questions of fact material to this opinion, we have relied upon
statements or certificates of public officials and officers of the
Company.
Whenever
a statement herein is qualified by "to our knowledge" or similar phrase, it
means that, during the course of our representation of the Company for the
purposes of this opinion letter, (1) no information that would give those
lawyers who participated in the preparation of the letter (collectively, the
"Opinion Letter Participants") current actual knowledge of the inaccuracy of
such statement has come to their attention; (2) we have not undertaken any
independent investigation or inquiry to determine the accuracy of such
statement; (3) any limited investigation or inquiry otherwise undertaken by the
Opinion Letter Participants during the preparation of this opinion letter
should–not be regarded as such an investigation or inquiry; and (4) no inference
as to our knowledge of any matters bearing on the accuracy of any such statement
should be drawn from the fact of our representation of the Company. We also call
to your attention to the fact that we are not general counsel to the Company and
we are not familiar with all aspects of the Company's business affairs. We have
not conducted an independent audit of the Company or its files.
The
validity, binding effect and enforceability of Transaction Documents may be
limited or otherwise affected by (a) bankruptcy, insolvency, reorganization,
moratorium, fraudulent conveyance or other similar statutes, rules, regulations
or other laws affecting the enforcement of creditors' rights and remedies
generally and (b) the unavailability of, or limitation on the availability of, a
particular right or remedy (whether in a proceeding in equity or at law) because
of an equitable principle or a requirement as to commercial reasonableness,
conscionability or good faith. In addition, certain remedies, waivers and other
provisions contained in the Transaction Documents might not be enforceable;
nevertheless, such unenforceability will not render such agreements invalid as a
whole or preclude the practical realization of the benefits to the Secured Party
thereunder. We express no opinions as to the application of the laws of usury to
the Transaction Documents.
Based on
the foregoing, and subject to the qualifications stated herein, we are of the
opinion that:
1. The
Company and each Subsidiary is a corporation duly organized, validly existing
and in good standing under the laws of its jurisdiction of incorporation and has
all requisite corporate power and authority to own, lease and operate its
properties and to carry on its business as now being conducted.
2. The
Company has all necessary corporate power and authority to execute, deliver and
perform its obligations under each of the the Transaction Documents and to
consummate the transactions contemplated thereby.
3. The
Transaction Documents have been duly and validly authorized, executed and
delivered by the Company and (assuming the due authorization, execution and
delivery thereof by the other parties thereto) constitute the legal, valid and
binding obligations of the Company, enforceable against it in accordance with
there respective terms, subject, as to enforceability, to applicable bankruptcy,
insolvency, fraudulent conveyance, reorganization, moratorium and similar laws
affecting creditors' rights and remedies generally and subject to general
principles of equity, whether enforcement is sought in a proceeding at law or in
equity.
4. The
Shares have been duly authorized and, when issued upon conversion of the Notes
in accordance with the terms of the Notes or upon exercise of the Warrants in
accordance with the tern-is of the Warrants, as the case may be, will be validly
issued, fully-paid and non-assessable.
5.
Assuming the representations and warranties of the Buyers in Section 3 of the
Agreements are true and correct, the Notes and the Warrants may be offered and
issued to the Buyers pursuant to the Agreements, the Conversion Shares may be
offered and issued to the Buyers upon conversion of the Notes, and the Warrant
Shares may be offered and issued to the Buyers upon exercise of the Warrants, in
each such case, without registration under the 1933 Act.
6. The
execution and delivery of the Transaction Documents by the Company, and the
consummation by the Company of the issuance of the Securities and the other
transactions contemplated by the Transaction Documents do not and will not, with
or without the giving of notice or the lapse of time, or both, (i) result in any
violation of any term of the Certificate of Incorporation or by-laws of the
Company or any Subsidiary, (ii) violate or contravene any applicable law, rule
or regulation or any applicable decree, judgment or order of any court, United
States federal or state regulatory body, administrative agency or other
governmental body having jurisdiction over the Company or any Subsidiary or any
of their respective properties or assets or (iii) have any material adverse
effect on any permit, certification, registration, approval, consent, license or
franchise necessary for the Company or any Subsidiary to own or lease and
operate any of its properties and to conduct any of its businesses or the
ability of the Company or any Subsidiary to make use thereof.
7.
Assuming the representations and warranties of the Buyers in Section 3 of the
Agreements are true and correct, no authorization, approval or consent of, or
filing with, any court, governmental body, regulatory agency, self-regulatory
organization, or stock exchange or market or the stockholders of the Company is
required to be obtained or made by the Company for the offer, issuance and sale
of the Notes and the offer and issuance of the Warrants as contemplated by the
Agreements or the offer and issuance of the Conversion Shares upon conversion of
the Notes in accordance with the terms thereof or the offer and issuance of the
Warrant Shares upon exercise of the Warrants in accordance with the terms
thereof except such as have been obtained or made and other than (a) the filing
pursuant to the Agreements of a Registration Statement with the SEC covering the
resale of the Shares (b) such as may be required under the securities or "blue
sky" laws of certain jurisdictions (as to which we express no opinion) and (c)
the Form D to be filed by the Company with the SEC.
8. The
Security Agreement is effective to create in favor of the Collateral Agent, for
the benefit of the holders from time to time of the Notes, as secured party,
valid security interests in the Collateral (as defined in the Security
Agreement) including, without limitation, the funds and proceeds from time to
time deposited or held in the Collateral Account (as defined in the Lockbox
Agreement), as security for the Obligations (as defined in the Security
Agreement), financing statements in proper form covering such security interests
will be duly filed in the offices listed on Schedule I hereto, and when filed,
such security interests in the Collateral will be perfected to the extent that
security interests in such Collateral may be perfected by the filing of
financing statements under the Uniform Commercial Code. Our opinions expressed
above are specifically subject to the following limitations, exceptions,
qualifications and assumptions:
A. The
effect of bankruptcy, insolvency, reorganization, moratorium and other similar
laws relating to or affecting the relief of debtors or the rights and remedies
of creditors generally, including without limitation the effect of statutory or
other law regarding fraudulent conveyances and preferential
transfers.
B.
Limitations imposed by state law, federal law or general equitable principles
upon the specific enforceability of any of the remedies, covenants or other
provisions of any applicable agreement and upon the availability of injunctive
relief or other equitable remedies, regardless of whether enforcement of any
such agreement is considered in a proceeding in equity or at law.
We are
counsel admitted to practice in the State of New York and we do not express any
opinion with respect to the effect or applicability of the laws of any
jurisdiction, other than the laws of the State of New York, Delaware General
Corporation Law and the federal laws of the United States of America. In
furnishing the opinion regarding the valid existence and good standing of the
Company, we have relied solely upon a good standing certificate issued by the
Secretary of State of Delaware on June 27, 2006.
This
opinion is rendered as of the date first written above, is solely for your
benefit in connection with the Agreements and may not be relief upon or used by,
circulated, quoted, or referred to nor may any copies hereof by delivered to any
other person without our prior written consent. We disclaim any obligation to
update this opinion letter or to advise you of facts, circumstances, events or
developments which hereafter may be brought to our attention and which may
alter, affect or modify the opinions expressed herein.
|
Very
truly yours,
|
|
|
|
|
|
|
By:
|
/s/
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exhibit
A
Alexandra
Global Master Fund Ltd.
do
Alexandra Investnient Management, LLC
767 Third
Avenue
39th
Floor
New York,
New York 10017
[NAME]
[ADDRESS]
Schedule
II
[Secretary
of State of the State of Delaware]
Schedule
II
[Secretary
of State of the State of Delaware]
[Department
of State of the State of New York]
Annex
VIII
|
|
|
Annex
VIII
to
Note
Purchase
Agreement
|
[Closing
Date]
The
Buyers listed on
Exhibit A
Hereto
Re:
eMagin Corporation
Ladies
and Gentlemen:
We have
acted as intellectual property counsel to eMagin Corporation, a Delaware
corporation (the "Company"), in connection with the issuance by the Company of
$[7,000,000] aggregate principal amount of 6% Senior Secured Convertible Note
due 2007-2008 (the "Notes"), and related Common Stock Purchase Warrants (the
"Warrants"), pursuant to the several Note Purchase Agreements, dated as of July
2006 (the "Agreements"), by and between the Company and the several Buyers named
therein (the "Buyers"). Capitalized terms used herein and not otherwise defined
herein shall have the respective meanings assigned to such terms in the
Agreements. This opinion is being delivered to you pursuant to Section 7(n) of
the Agreements.
In so
acting, we have examined originals or copies (certified or otherwise identified
to our satisfaction) of the Patent and Trademark Security Agreement, dated as of
July , 2006, by and between the Company and the Collateral Agent named therein
(the "Patent and Trademark Security Agreement") and such corporate records,
agreements, documents and other instruments, and such certificates or comparable
documents of public officials and of officers and representatives of the
Company, and have made such inquiries of such officers and representatives, as
we have deemed relevant and necessary as a basis for the opinions hereinafter
set forth.
Based on
the foregoing, and subject to the qualifications stated herein, we are of the
opinion that:
1. The
Patent and Trademark Security Agreement, taken together with the Security
Agreement, creates valid and enforceable security interests in favor of the
Collateral Agent, for the benefit of the holders from time to time of the Notes,
as secured parties, in all of the Company's right, title and interest in, to and
under the Collateral (as defined in the Patent and Trademark Security Agreement
for purposes of this opinion). The Patent Security Agreement and the Trademark
Security Agreement (attached as Exhibits E and F to the Patent and Trademark
Security Agreement) have or will be filed in the PTO, and together with the
filing of financing statements, have or will result in the perfection of the
Collateral Agent's security interests in the Collateral in the United
States.
The
opinion herein is subject to (i) the limitations on perfection of security
interests in proceeds resulting from the operation of Section 9-315 of the UCC;
(ii) the limitations with respect to securities imposed by Sections 8-302 and
9-312 of the UCC; (iii) the provisions of Section 9-203 of the UCC relating to
the time of attachment; and (iv) Section 552 of Title 11 of the United States
Code (the "Bankruptcy Code") with respect to any Collateral acquired by the
Company subsequent to the commencement of a case against or by the Company under
the Bankruptcy Code.
The
opinions expressed herein are limited to the laws of the State of New York, the
laws of the State of Delaware and the federal laws of the United States, and we
express no opinion as to the effect on the matters covered by this letter of the
laws of any other jurisdiction.
The
opinions expressed herein are rendered solely for your benefit in connection
with the transactions described herein. Those opinions may not be used or relied
upon by any other person, nor may this letter or any copies hereof be furnished
to a third party, filed with a governmental agency, quoted, cited or otherwise
referred to without our prior written consent.
|
|
Very
truly yours,
|
|
|
|
|
|
|
|
/s/
Jason M. Drangel
|
|
|
|
Epstein
Drangel Bazerman & James, LLP
|
|
|
|
|
|
|
|
|
|
Annex
IX
|
|
|
Annex
IX
to
Note
Purchase
Agreement
|
LOCKUP
AGREEMENT
July __,
2006
To:
eMagin Corporation
and the
Buyers Parties to the Note Purchase
Agreements
Referred to Below
Re:
eMagin Corporation Note Purchase Agreements
Dear Sir
or Madam:
Reference
is made to the several Note Purchase Agreements, dated as of the date hereof, by
and between eMagin Corporation, a Delaware corporation (the "Company"), and the
respective buyers who are parties thereto and hereto (each, a "Buyer" and
collectively, the "Buyers"), and any successors and assigns thereto (the "Note
Purchase Agreements"). Capitalized terms used herein and not otherwise defined
herein shall have the respective meanings assigned to such terms in the
Agreements.
The
undersigned stockholder (the "Stockholder") of the Company understands that it
is a condition precedent to the several obligations of the Buyers to purchase
their respective Notes and Warrants pursuant to the Note Purchase Agreements
that the Stockholder shall have executed and delivered this Agreement to the
Buyers and the Company. Pursuant to a Note Purchase Agreement, the Stockholder
is purchasing a 6% Senior Secured Convertible Note due 2007-2008 of the Company
in the aggregate principal amount of $40,000.00 (the Note") and a Warrant to
purchaseshares of Common Stock (the "Warrant"). The Note, the Warrant and the
shares of Common Stock issuable upon conversion of the Note and upon exercise of
the Warrant are collectively referred to herein as the
"Securities".
The
Stockholder hereby agrees that, except for transfers occurring upon the death of
Stockholder and except for intra-family transfers or transfers to trusts for
estate planning purposes (provided that in each such case, the transferee first
agrees to become bound by the provisions of this letter agreement), the
Stockholder will not, directly or indirectly, offer, sell, pledge, contract to
sell, grant any option for the sale of, transfer or otherwise dispose of: yle
Securities or any interest therein for a period beginning on the date of this
letter agreement and ending on January , 2008. Notwithstanding the foregoing,
(A) this letter agreement and the obligations hereunder shall terminate and be
of no further force and effect upon the date of consummation of a sale of all or
substantially all of the assets of the Company and (B) the Stockholder may sell
shares of Common Stock issued upon conversion of the Note or upon exercise of
the Warrant in accordance with the following schedule:
Period
|
Number
of Shares
|
Prior
to December 31, 2006
|
NONE
|
After
December 31, 2006
|
Up
to 50,000 shares of Common Stock in each fiscal quarter of the Company
(such number of shares subject to equitable adjustments for stock splits,
stock dividends, combinations, capital reorganizations and similar events
relating to the Common Stock occurring after the date of this
Agreement)
|
The
Company hereby agrees to notify its transfer agent of the provisions of this
letter agreement. The Stockholder acknowledges and agrees that the Company may
enter a stop transfer order with its transfer agent prohibiting transfer of the
Securities, except in compliance with the requirements of this letter
agreement.
This
letter agreement may be executed in any number of counterparts, all of which
shall together constitute one and the same instrument. This letter agreement
shall be governed by and construed in accordance with the laws of the State of
New York. In the event of the invalidity or unenforceability of any part or
provision of this letter agreement, such invalidity or unenforceability shall
not affect the validity or enforceability of any other part or provision of this
letter agreement.
Please
indicate your agreement with the terms of this letter by signing and returning
to the undersigned a copy hereof.
|
|
Very
truly yours,
|
|
|
|
|
|
|
|
/s/
|
|
|
|
John
Atherly
|
|
|
|
|
|
|
|
|
|
Accepted
and Agreed as of the above date.
EMAGIN
CORPORATION
174
Exhibit 10.36
NOTE PURCHASE
AGREEMENT
dated as of July
21, 2006
by and
between
EMAGIN
CORPORATION
and
STILLWATER
LLC
6% SENIOR SECURED
CONVERTIBLE NOTES DUE 2007-2008
AND
COMMON STOCK
PURCHASE WARRANTS
EMAGIN
CORPORATION
NOTE PURCHASE
AGREEMENT
6% SENIOR SECURED CONVERTIBLE NOTES
DUE 2007-2008
AND
COMMON STOCK PURCHASE
WARRANTS
TABLE OF
CONTENTS
|
|
Page
|
|
|
|
1.
|
DEFINITIONS
|
5
|
|
|
|
16
|
2.
|
PURCHASE AND
SALE; PURCHASE PRICE.
|
16
|
|
(a)
|
Purchase.
|
17
|
|
(b)
|
Form of
Payment.
|
17
|
|
(c)
|
Closing.
|
17
|
3.
|
REPRESENTATIONS, WARRANTIES, COVENANTS, ETC. OF THE
BUYER.
|
17
|
|
(a)
|
Circumstances
of Purchase.
|
18
|
|
(b)
|
Accredited
Investor; Residence
|
18
|
|
(c)
|
Reoffers and
Resales.
|
18
|
|
(d)
|
Company
Reliance.
|
18
|
|
(e)
|
Information
Provided.
|
19
|
|
(f)
|
Absence of
Approvals.
|
19
|
|
(g)
|
Note Purchase
Agreement.
|
19
|
|
(h)
|
Buyer
Status
|
20
|
|
(i)
|
Experience of
the Buyer.
|
20
|
|
(j)
|
General
Solicitation.
|
20
|
|
(k)
|
Short Sales
and Confidentiality Prior To The Date Hereof.
|
20
|
4.
|
REPRESENTATIONS, WARRANTIES, COVENANTS, ETC. OF THE
COMPANY.
|
20
|
|
(a)
|
Organization
and Authority.
|
20
|
|
(b)
|
Qualifications.
|
21
|
|
(c)
|
Concerning
the Shares and the Common Stock.
|
21
|
|
(d)
|
Corporate
Authorization.
|
22
|
|
(e)
|
Non-contravention.
|
22
|
|
(f)
|
Approvals,
Filings, Etc.
|
22
|
|
(g)
|
Information
Provided.
|
23
|
|
(h)
|
Investment
Company.
|
23
|
|
(i)
|
Absence of
Brokers, Finders, Etc.
|
23
|
|
(j)
|
No
Solicitation.
|
24
|
|
(k)
|
No Integrated
Offering
|
24
|
|
(l)
|
Dilutive
Effect.
|
24
|
|
(m)
|
Absence of
Certain Changes.
|
24
|
|
(n)
|
No
Undisclosed Events, Liabilities, Developments or Circumstances.
|
25
|
|
(o)
|
Conduct of
Business; Regulatory Permits.
|
25
|
|
(p)
|
Indebtedness
and Other Contracts.
|
26
|
|
(q)
|
Absence of
Litigation.
|
26
|
|
(r)
|
Insurance.
|
26
|
|
(s)
|
Employee
Relations
|
26
|
|
(t)
|
Title.
|
27
|
|
(u)
|
Intellectual
Property.
|
27
|
|
(v)
|
Environmental
Law
|
28
|
|
(w)
|
Subsidiary
Rights.
|
28
|
|
(x)
|
Tax
Status.
|
28
|
|
(y)
|
Internal
Accounting Controls; Financial Statements.
|
29
|
|
(z)
|
Sarbanes-Oxley
Act.
|
29
|
|
(aa)
|
S-3
Eligibility.
|
29
|
|
(bb)
|
Concerning
the Collateral.
|
29
|
|
(cc)
|
Disclosures.
|
30
|
|
(dd)
|
Absence of
Rights Agreement.
|
30
|
5.
|
CERTAIN
COVENANTS.
|
30
|
|
(a)
|
Transfer
Restrictions.
|
30
|
|
(b)
|
Restrictive
Legends.
|
31
|
|
(c)
|
Reporting
Status.
|
33
|
|
(d)
|
Form
D.
|
33
|
|
(e)
|
State
Securities Laws
|
33
|
|
(f)
|
Limitation on
Certain Actions.
|
34
|
|
(g)
|
Use of
Proceeds.
|
34
|
|
(h)
|
Best
Efforts.
|
34
|
|
(i)
|
Debt
Obligation.
|
35
|
|
(j)
|
Right of the
Buyer to Participate in Future Transactions.
|
35
|
|
(k)
|
Press
Releases.
|
37
|
|
(l)
|
Form 8-K;
Limitation on Information and Buyer Obligations.
|
38
|
|
(m)
|
Limitation on
Certain Transactions.
|
38
|
|
(n)
|
Debt
Obligation.
|
39
|
|
(o)
|
Security
Agreement; Financing Statements, Etc.
|
39
|
|
(p)
|
Short Sales
and Confidentiality After The Date Hereof.
|
39
|
6.
|
CONDITIONS TO
THE COMPANY’S OBLIGATION TO SELL.
|
40
|
7.
|
CONDITIONS TO
THE BUYER’S OBLIGATION TO PURCHASE
|
41
|
8.
|
REGISTRATION
RIGHTS.
|
42
|
|
(a)
|
Mandatory
Registration.
|
42
|
|
(b)
|
Obligations
of the Company.
|
44
|
|
(c)
|
Obligations
of the Buyer and other Investors.
|
49
|
|
(d)
|
Rule
144.
|
50
|
9.
|
INDEMNIFICATION AND CONTRIBUTION.
|
50
|
|
(a)
|
Indemnification.
|
50
|
|
(b)
|
Contribution.
|
52
|
|
(c)
|
Other
Rights.
|
53
|
10.
|
MISCELLANEOUS.
|
53
|
|
(a)
|
Governing
Law.
|
53
|
|
(b)
|
Headings.
|
53
|
|
(c)
|
Severability.
|
53
|
|
(d)
|
Notices
|
53
|
|
(e)
|
Counterparts.
|
53
|
|
(f)
|
Entire
Agreement; Benefit.
|
54
|
|
(g)
|
Waiver.
|
54
|
|
(h)
|
Amendment.
|
54
|
|
(i)
|
Further
Assurances.
|
55
|
|
(j)
|
Assignment of
Certain Rights and Obligations.
|
55
|
|
(k)
|
Expenses.
|
56
|
|
(l)
|
Termination.
|
56
|
|
(m)
|
Survival.
|
57
|
|
(n)
|
Construction;
Buyer Status.
|
57
|
Annex
I
|
Form
of 6% Senior Secured Convertible Note due 2007-2008
|
Annex
II
|
Form
of Common Stock Purchase Warrant to be issued on the Closing Date (Closing
Date Warrant)
|
Annex
III
|
Form
of Patent and Trademark Security Agreement
|
Annex
IV
|
Form
of Pledge and Security Agreement
|
Annex
V
|
Form
of Lockbox Agreement
|
Annex
VI
|
Form
of Press Release
|
Annex
VII
|
Form
of Legal Opinion of Company Counsel
|
Annex
VIII
|
Form
of Legal Opinion of Intellectual Property Counsel
|
Annex
IX
|
Form
of Lock Up Agreement
|
Annex
X
|
Form
of Company Put Notice
|
Annex
XI
|
Form
of Common Stock Purchase Warrant to be issued on the closing date of the
Other Note Purchase Agreement (July 2006
Warrant)
|
NOTE PURCHASE
AGREEMENT
THIS NOTE PURCHASE
AGREEMENT,
dated as
of July 21, 2006 (this “Agreement”), by and between
eMagin Corporation
, a
Delaware corporation (the “Company”), with headquarters located at 10500 N.E.
8
th
Street,
Suite 1400,
Bellevue,
Washington 98004, and
Stillwater LLC
(the
“Buyer”)
W
I
T
N
E
S
S
E
T
H
:
WHEREAS
, upon
the terms and subject to the conditions of this Agreement, the Buyer wishes to
agree to purchase from the Company and the Company wishes to agree to sell to
the Buyer, which except as set forth herein shall be on the same terms and
conditions as the securities sold pursuant to the Other Note Purchase Agreements
(such capitalized term and all other capitalized terms used in this Agreement
having the meanings provided in Section 1), the Note of the Company to be issued
by the Company in the principal amount set forth on the signature page of this
Agreement, which Note will be convertible into shares of Common Stock, and in
connection with the sale and issuance of the Note the Company shall issue to the
Buyer (i) a warrant to purchase shares of Common Stock on the closing date of
the Other Note Purchase Agreement (Annex XI) and (ii) a warrant to purchase
shares of Common Stock on the Closing Date (Annex II).
NOW THEREFORE
, in
consideration of the premises and the mutual covenants contained herein and
other good and valuable consideration, the receipt and sufficiency of which are
hereby acknowledged, the parties agree as follows:
1.
DEFINITIONS
(a)
As used
in this Agreement, the terms “Agreement”, “Buyer” and “Company” shall have the
respective meanings assigned to such terms in the introductory paragraph of this
Agreement.
(b)
All the
agreements or instruments herein defined shall mean such agreements or
instruments as the same may from time to time be supplemented or amended or the
terms thereof waived or modified to the extent permitted by, and in accordance
with, the terms thereof and of this Agreement.
(c)
The
following terms shall have the following meanings (such meanings to be equally
applicable to both the singular and plural forms of the terms
defined):
“Affiliate”
means, with respect to any Person, any other Person that directly, or indirectly
through one or more intermediaries, controls, is controlled by or is under
common control with the subject Person. For purposes of this definition,
“control” (including, with correlative meaning, the terms “controlled by” and
“under common control with”), as used with respect to any Person, shall mean the
possession, directly or indirectly, of the power to direct or cause the
direction of the management and policies of such Person, whether through the
ownership of voting securities or by contract or otherwise.
“AMEX”
means the American Stock Exchange, Inc.
“Blackout
Period” means the period of up to twenty Trading Days (whether or not
consecutive) during any period of 365 consecutive days after the date the
Company notifies the Investors that they are required, pursuant to Section
8(c)(4), to suspend offers and sales of Registrable Securities as a result of an
event or circumstance described in Section 8(b)(5)(A), during which period, by
reason of Section 8(b)(5)(B), the Company is not required to amend a particular
Registration Statement or supplement the related Prospectus.
“Business
Day” means any day other than a Saturday, Sunday or a day on which commercial
banks in The City of New York are authorized or required by law or executive
order to remain closed.
“Claims”
means any losses, claims, damages, liabilities or expenses, including, without
limitation, reasonable fees and expenses of legal counsel (joint or several),
incurred by a Person.
“Closing
Date” means the
date ten
(10) Business Days after the Company Put Notice or such other
mutually agreed to time by the Company and the Buyer.
“Collateral”
shall have the meaning to be provided or provided in each Security
Agreement.
“Collateral
Agent” shall have the meaning to be provided or provided in each Security
Agreement.
“Common
Stock” means the Common Stock, par value $.001 per share, of the
Company.
“Common
Stock Equivalent” means any warrant, option, subscription or purchase right with
respect to shares of Common Stock, any security convertible into, exchangeable
for, or otherwise entitling the holder thereof to acquire, shares of Common
Stock or any warrant, option, subscription or purchase right with respect to any
such convertible, exchangeable or other security.
“Company
Put Notice” means the written notice required to be provided by the Company to
the Buyer, in the form attached as
Annex X,
in
accordance with the provisions of Section 2(a) of this Agreement to effectuate
the purchase and sale of the Note and December Closing Date Warrant.
“Company
Put Notice Date” means December 14, 2006.
“Conversion
Price” shall have the meaning to be provided or provided in the
Note.
“Conversion
Shares” means the shares of Common Stock or other securities issuable upon
conversion of the Note.
“December
Closing Date Warrant” means the Common Stock Purchase Warrant in the form
attached hereto as
Annex II
.
“Encumbrance”
means any mortgage, deed of trust, claim, security interest, lien, pledge,
lease, sublease, charge, escrow, option, proxy, right of occupancy, right of
first refusal, preemptive right, covenant, conditional limitation,
hypothecation, prior assignment, easement, title retention agreement, indenture,
security agreement or any other encumbrance of any kind.
“Environmental
Law” means any federal, state, local or foreign law relating to pollution or
protection of human health or the environment (including, without limitation,
ambient air, surface water, groundwater, land surface or subsurface strata),
including, without limitation, laws relating to emissions, discharges, releases
or threatened releases of Hazardous Materials into the environment, or otherwise
relating to the manufacture, processing, distribution, use, treatment, storage,
disposal, transport or handling of Hazardous Materials, as well as all
authorizations, codes, decrees, demands or demand letters, injunctions,
judgments, licenses, notices or notice letters, orders, permits, plans or
regulations issued, entered, promulgated or approved thereunder.
“ERISA”
means the Employee Retirement Income Security Act of 1974, as amended, and the
regulations thereunder and published interpretations thereof.
“Exempt
Issuance” shall have the meaning set forth in Section 5(m) of this
Agreement.
“Event of
Default” shall have the meaning to be provided or provided in the
Note.
“Generally
Accepted Accounting Principles” means, for any Person, the United States
generally accepted accounting principles and practices applied by such Person
from time to time in the preparation of its audited financial
statements.
“Hazardous
Material” means any chemical, pollutant, contaminant, or toxic or hazardous
substance or waste.
“Indebtedness”
shall have the meaning to be provided or provided in the Note.
“Indemnified
Party” means the Company, each of its directors, each of its officers who signs
the Registration Statement, each Person, if any, who controls the Company within
the meaning of the 1933 Act or the 1934 Act, any underwriter and any other
stockholder selling securities pursuant to the Registration Statement or any of
its directors or officers or any Person who controls such stockholder or
underwriter within the meaning of the 1933 Act or the 1934 Act.
“Indemnified
Person” means the Buyer and any Investor and their respective investment
advisers and investment managers, the directors, officers, employees and agents
of the Buyer, any such Investor and any such investment adviser or investment
manager, each Person, if any, who controls the Buyer, any such Investor or any
such investment adviser or investment manager within the meaning of the 1933 Act
or the 1934 Act, any underwriter (as defined in the 1933 Act) acting on behalf
of an Investor who participates in the offering of Registrable Securities of
such Investor in accordance with the plan of distribution contained in the
Prospectus, the directors, if any, of such underwriter and the officers, if any,
of such underwriter, and each Person, if any, who controls any such underwriter
within the meaning of the 1933 Act or the 1934 Act.
“Inspector”
means any attorney, accountant or other agent retained by an Investor for the
purposes provided in Section 8(b)(9).
“Insolvent”
means (i) the present fair saleable value of the Company's assets is less than
the amount required to pay the Company's total indebtedness, contingent or
otherwise, (ii) the Company is unable to pay its debts and liabilities,
subordinated, contingent or otherwise, as such debts and liabilities become
absolute and matured, (iii) the Company intends to incur debts beyond its
ability to pay as such debts as they mature (taking into account the timing and
amounts of cash to be payable on or in respect of its debt) or (iv) the Company
has unreasonably small capital with which to conduct the business in which it is
engaged for the current fiscal year as such business is now conducted and is
proposed to be conducted.
“Intellectual
Property” means all franchises, patents, trademarks, service marks, trade names
(whether registered or unregistered), copyrights, corporate names, licenses,
trade secrets, proprietary software or hardware, proprietary technology,
technical information, discoveries, designs and other proprietary rights,
whether or not patentable, and confidential information (including, without
limitation, know-how, processes and technology) used in the conduct of the
business of the Company or any Subsidiary.
“Investor”
means the Buyer and any transferee or assignee who agrees to become bound by the
provisions of Sections 5(a), 5(b), 8, 9, and 10 of this Agreement.
“July
2006 Warrant” means the Common Stock Purchase Warrant in the form attached
hereto as
Annex XI
.
“Lockbox
Agent” means the Person from time to time serving as Lockbox Agent under the
Lockbox Agreement.
“Lockbox
Agreement” means the Lockbox Agreement by and between the Company and the
Lockbox Agent in the form attached as
Annex V
.
“Liens”
shall have the meaning to be provided or provided in the Note.
“Margin
Stock” shall have the meaning provided in Regulation U of the Board of Governors
of the Federal Reserve System (12 C.F.R. Part 221).
“Material
Adverse Effect” means (i) a material adverse effect on (A) the business,
properties, operations, condition (financial or other), results of operations or
prospects of the Company and the Subsidiaries, taken as a whole; (B) the
validity or enforceability of, or the ability of the Company to perform its
obligations under, the Transaction Documents; (C) the existence, validity or
priority of the Lien on and Security Interest in the Collateral granted pursuant
to any Security Agreement; or (D) the rights and remedies of the Buyer under or
in connection with the Transaction Documents or (ii) any event or circumstance
that would cause any Registration Statement or Prospectus to contain any untrue
statement of a material fact or omit to state any material fact necessary to
make the statements made not misleading except if such untrue statement of a
material fact in such Registration Statement or Prospectus or omission to state
a material fact required to be stated in such Registration Statement or
Prospectus in order to make the statements therein not misleading, results from
a misstatement or omission made by the Buyer in written information it furnished
to the Company specifically for inclusion in such Registration Statement or such
Prospectus or in any amendment or supplement thereto, unless the Company shall
have failed timely to amend or supplement such Registration Statement or
Prospectus after the Buyer shall have corrected such misstatement or
omission.
“Nasdaq”
means the Nasdaq Global Market.
“Nasdaq
Capital Market” means the Nasdaq Capital Market.
“1934
Act” means the Securities Exchange Act of 1934, as amended.
“1933
Act” means the Securities Act of 1933, as amended.
“Note”
means the 6% Senior Secured Convertible Note due 2007-2008 of the Company in the
form attached as
Annex I
.
“Other
Note Purchase Agreements” means the several Note Purchase Agreements, dated as
of even date herewith, by and between the Company and the buyers of the Other
Notes.
“Other
Notes” means the Notes issued pursuant to the Other Note Purchase
Agreements.
“Other
Warrants” means the Common Stock Purchase Warrants issued pursuant to the Other
Note Purchase Agreements.
“Patent
and Trademark Security Agreement” means the Patent and Trademark Security
Agreement from the Company to the Collateral Agent in the form attached as
Annex III
.
“Payment
Event” means any of the following events:
(i)
the
Company fails to file with the SEC any Registration Statement meeting the
requirements of this Agreement on or before the date by which the Company is
required to file such Registration Statement pursuant to Section
8(a),
(ii)
the SEC
Effective Date of the Registration Statement required by Section 8(a)(1)
covering Registrable Securities does not occur within 150 days following the
Closing Date or the SEC Effective Date of any Registration Statement required by
Section 8(a)(3) covering Registrable Securities does not occur within 90 days
following the date the Company shall become obligated to commence preparation of
such Registration Statement:
provided, however
, that if
any such Registration Statement shall be reviewed by the SEC staff a Payment
Event shall not occur until 180 days following (x) the Closing Date, in the case
of the Registration Statement required by Section 8(a)(1), or (y) such date as
the Company becomes obligated to commence preparation of such Registration
Statement, in the case of any Registration Statement required by Section
8(a)(3),
(iii)
The
Company fails to file with the SEC a request for acceleration of effectiveness
of a Registration Statement within three Trading Days after the date the Company
learns that no review of such Registration Statement will be made by the staff
of the SEC or that the staff of the SEC has no further comments on such
Registration Statement, as the case may be, or any such request for acceleration
fails to request acceleration of such Registration Statement to a time and date
not more than 48 hours after the submission of such request,
(iv)
after the
SEC Effective Date of any Registration Statement, sales cannot be made pursuant
to such Registration Statement for any reason (including, without limitation, by
reason of a stop order, any untrue statement of a material fact or omission of a
material fact in such Registration Statement, or the Company’s failure to update
such Registration Statement), except to the extent permitted pursuant to Section
8(b)(5),
(v)
the
Common Stock generally or the Registrable Securities specifically are not listed
or included for quotation on a Trading Market, or
(vi)
the
Company fails, refuses or is otherwise unable timely to issue and deliver to or
upon the order of the Person entitled thereto Conversion Shares upon conversion
of the Note or shares of Common Stock issuable upon conversion of any Other
Note, Warrant Shares upon exercise of the Warrants or shares of Common Stock
issuable upon exercise of any Other Warrants in accordance with the terms of the
Warrants or any Other Warrants, as the case may be, as and when required under
the Transaction Documents, in any such case within five Trading Days after the
due date thereof in accordance with the Note, Other Note, Warrants or Other
Warrants or the Company fails, refuses or is otherwise unable timely to transfer
any Shares as and when required by the Transaction Documents.
“Payment
Period” means any period following the Closing Date during which any Payment
Event occurs and is continuing.
“Person”
means any natural person, corporation, partnership, limited liability company,
trust, incorporated organization, unincorporated association or similar entity
or any government, governmental agency or political subdivision.
“Placement
Agent” means Roth Capital Partners.
“Pledge
and Security Agreement” means the Pledge and Security Agreement from the Company
to the Collateral Agent in the form attached as
Annex IV
.
“Pro Rata
Share” means with respect to each capital raising transaction to which Section
5(j) applies an amount equal to the product obtained by multiplying (x) an
amount equal to one-half of the securities being issued in such capital raising
transaction
times
(y) a
fraction of which the numerator is the sum of (A) the total number of shares of
Common Stock which would then be issuable upon conversion of the Note and upon
exercise of the Warrants for cash
plus
(B) the
number of outstanding Shares beneficially owned by the Buyer at the time the Pro
Rata Share is being determined and the denominator is the sum of (C) the number
of shares issuable upon conversion of the Note and the Other Notes at the time
of original issuance thereof
plus
(D) the
total number of shares of Common Stock issuable upon exercise of the Warrants
and the Other Warrants for cash (in each case determined without regard to any
limitation on conversion of exercise thereof), subject to adjustment of the
amounts specified in the immediately preceding clauses (C) and (D) for stock
splits, stock dividends and similar capital changes affecting the Common Stock
that occur on or after the Closing Date and on or prior to the date Pro Rata
Share is being determined.
“Prospectus”
means the prospectus forming part of the Registration Statement at the time the
Registration Statement is declared effective and any amendment or supplement
thereto (including any information or documents incorporated therein by
reference).
“PTO”
means the United States Patent and Trademark Office.
“Purchase
Price” means up to [$500,000.]
[Prior to execution of this NPA,
please reduce the $500,000 amount by the difference, if any, between the
principal amount of the Other Notes in this round of financing and $6.5
million]
. The
Purchase Price will be adjusted downward in the event that (i) the Company
obtains additional financing prior to the Closing Date, or (ii) all or a portion
of any common stock purchase warrant of the Company owned by the Buyer is
exercised prior to the Closing Date and the Company receives the exercise price
of such warrants in cash. On the Closing Date, the Purchase Price will be the
difference between [$500,000]
[Prior to execution of this NPA,
please reduce the $500,000 amount by the difference, if any, between the
principal amount of the Other Notes in this round of financing and $6.5
million]
and the
sum of (i) the amount of additional financing raised by the Company prior to the
Closing Date, and (ii) the aggregate exercise price paid by the Buyer to the
Company upon exercise of all or a portion of any common stock purchase warrant
owned by the Buyer prior to the Closing Date.
“QIB”
means a “qualified institutional buyer” as defined in Rule 144A.
“Record”
means all pertinent financial and other records, pertinent corporate documents
and properties of the Company subject to inspection for the purposes provided in
Section 8(b)(9).
“register,”
“registered,” and “registration” refer to a registration effected by preparing
and filing a Registration Statement or Statements in compliance with the 1933
Act and pursuant to Rule 415, and the declaration or ordering of effectiveness
of such Registration Statement by the SEC.
“Registrable
Securities” means (1) the Shares, (2) if the Common Stock is changed, converted
or exchanged by the Company or its successor, as the case may be, into any other
stock or other securities on or after the date hereof, such other stock or other
securities which are issued or issuable in respect of or in lieu of the Shares
and (3) if any other securities are issued to holders of Common Stock (or such
other shares or other securities into which or for which the Common Stock is so
changed, converted or exchanged as described in the immediately preceding clause
(2)) upon any reclassification, share combination, share subdivision, share
dividend, merger, consolidation or similar transaction or event, such other
securities which are issued or issuable in respect of or in lieu of the
Shares.
“Registration
Period” means, with respect to each Registration Statement, the period from the
SEC Effective Date for such Registration Statement, to the earlier of (A) the
date which is five years
after the
Closing Date or such date after which each Investor may sell all of its
Registrable Securities without registration under the 1933 Act pursuant to Rule
144, free of any limitation on the volume of such securities which may be sold
in any period) and (B) the date on which the Investors no longer own any
Registrable Securities.
“Registration
Statement” means a registration statement on Form S-3 or such other form as may
be available to the Company to be filed with the SEC under the 1933 Act relating
to the Registrable Securities and which names any Investor as a selling
stockholder.
“Regulation
D” means Regulation D under the 1933 Act.
“Repurchase
Event” shall have the meaning to be provided or provided in the
Note.
“Restricted
Ownership Percentage” shall have the meaning provided in Section
5(j)(2).
“Reverse
Stock Split” means a reverse split of the Common Stock of not less than one for
each ten shares of Common Stock outstanding prior thereto.
“Rule
144” means Rule 144 promulgated under the 1933 Act or any other similar rule or
regulation of the SEC that may at any time provide a “safe harbor” exemption
from registration under the 1933 Act so as to permit a holder to sell securities
of the Company to the public without registration under the 1933
Act.
“Rule
144A” means Rule 144A under the 1933 Act or any successor rule
thereto.
“SEC”
means the Securities and Exchange Commission.
“SEC
Effective Date” means, with respect to any Registration Statement, the date such
Registration Statement is first declared effective by the SEC.
“SEC
Filing Date” means the date the Registration Statement is first filed with the
SEC pursuant to Section 8.
“SEC
Reports” means the Company’s (1) Annual Report on Form 10-K for the year ended
December 31, 2005, (2) Quarterly Report on Form
10-Q
for the
quarter ended March 31, 2006,
and (3)
all other periodic and other reports filed by the Company with the SEC pursuant
to the 1934 Act subsequent to December 31, 2005, and prior to the date hereof,
in each case as filed with the SEC and including the information and documents
(other than exhibits) incorporated therein by reference.
“Securities”
means, collectively, the Note, the Shares and the Warrants.
“Security
Agreement” means either or both of the Pledge and Security Agreement and the
Patent and Trademark Security Agreement.
“Security
Interest” shall have the meaning to be provided or provided in each Security
Agreement.
“Shares”
means collectively the Conversion Shares and the Warrant Shares;
“Short
Sales” shall have the meaning provided in Rule 200 of Regulation SHO under the
1934 Act as in effect on the date of this Agreement (but shall not be deemed to
include the location and/or reservation of borrowable shares of Common
Stock).
“Stockholder
Approval” shall have the meaning provided in Section 5(p).
“Stockholder
Meeting” shall have the meaning provided in Section 5(p).
“Strategic
Issuance” means the issuance by the Company for cash of Common Stock or Common
Stock Equivalents in connection with a strategic alliance, collaboration, joint
venture, partnership, manufacturing, marketing, distributing or similar
arrangement of the Company with another Person which strategic alliance,
collaboration, joint venture, partnership manufacturing, marketing, distributing
or similar arrangement relates to the Company’s business as conducted
immediately prior thereto and which Person is engaged in a business similar or
related to the business of the Company.
“Subsidiary”
means any corporation or other entity of which a majority of the capital stock
or other ownership interests having ordinary voting power to elect a majority of
the board of directors or other persons performing similar functions are at the
time directly or indirectly owned by the Company.
“Trading
Day” means at any time a day on which any of a national securities exchange,
Nasdaq,
Nasdaq
Capital Market
or such
other securities market as at such time constitutes the principal securities
market for the Common Stock is open for general trading of
securities.
“Trading
Market” means the AMEX, the Nasdaq, the
Nasdaq
Capital Market
or the
New York Stock Exchange, Inc.
“Transaction
Documents” means, collectively, this Agreement, the Security Agreement, the
Securities, the Lockbox Agreement and the other agreements, instruments and
documents contemplated hereby and thereby.
“Transaction
Form 8-K” shall have the meaning provided in Section 5(l).
“Violation”
means
(i)
any
untrue statement or alleged untrue statement of a material fact contained in a
Registration Statement or any post-effective amendment thereof or the omission
or alleged omission to state therein a material fact required to be stated
therein or necessary to make the statements therein not misleading,
(ii)
any
untrue statement or alleged untrue statement of a material fact contained in any
Prospectus (as amended or supplemented, if the Company files any amendment
thereof or supplement thereto with the SEC) or the omission or alleged omission
to state therein any material fact necessary to make the statements made
therein, in light of the circumstances under which the statements therein were
made, not misleading,
(iii)
any
violation or alleged violation by the Company of the 1933 Act, the 1934 Act, any
state securities law or any rule or regulation under the 1933 Act, the 1934 Act
or any state securities law, or
(iv)
any
breach or alleged breach by the Company of any representation, warranty,
covenant, agreement or other term of any of the Transaction Documents.
“Warrants”
means both the December Closing Date Warrant and the July 2006
Warrant.
“Warrant
Shares” means the shares of Common Stock and any other securities issuable upon
exercise of the Warrants.
2.
PURCHASE AND SALE; PURCHASE
PRICE.
(a)
Purchase.
Upon the
terms and subject to the conditions of this Agreement, the Buyer hereby agrees
to purchase from the Company, and the Company hereby agrees to sell to the
Buyer, on the Closing Date, the Note in the principal amount equal to the
Purchase Price and having the terms and conditions as set forth in the form of
the Note attached hereto as
Annex I
for the
Purchase Price. The Company shall have the right to require the Buyer to
purchase the Note by delivering to the Buyer a Company Put Notice on December
14, 2006 by electronic mail and facsimile by the Company Put Notice Date and the
Buyer shall be obligated to purchase the Notes specified in such Company Put
Notice if the conditions to closing set forth in Section 7 are satisfied. In
connection with the purchase of the Note by the Buyer, the Company shall issue
to the Buyer at the closing on the Closing Date the December Closing Date
Warrant initially entitling the holder to purchase the number of shares of
Common Stock equal to seventy percent (70%) of the number of shares issuable
upon conversion of the Note on the Closing Date. The Company shall not be
obligated to sell the Note or issue such December Closing Date Warrant to the
Buyer until the Company shall, in its sole discretion, have given the Company
Put Notice to the Buyer, whereupon the Company shall be obligated to sell the
Note and issue such December Closing Date Warrant to the Buyer upon the terms
and subject to the conditions of this Agreement. The Buyer acknowledges and
agrees that it will be irrevocably bound to purchase the Note and December
Closing Date Warrant on the Closing Date so long as (i) the Company Put Notice
has been delivered to the Buyer, and (ii) the conditions to closing as set forth
in Section 7 of this Agreement have been satisfied by the Company. In
consideration of the Buyer agreeing to enter into this Agreement, the Company
shall also issue to the Buyer on the closing date of the Other Note Purchase
Agreement the July 2006 Warrant, attached hereto as Annex XI.
(b)
Form of
Payment.
Payment
by the Buyer of the Purchase Price to the Company on the Closing Date shall be
made by wire transfer of immediately available funds to:
[INTENTIONALLY
OMITTED]
For
credit to account No.
For
credit to the account of
Reference:
(c)
Closing.
The
issuance and sale of the Note and the issuance of the December Closing Date
Warrant shall occur on the Closing Date at Chadbourne & Parke LLP, 30
Rockefeller Plaza, New York, New York 10112 or at such other location and time
as the parties may agree. At the closing, upon the terms and subject to the
conditions of this Agreement, (1) the Company shall issue and deliver to the
Buyer the Note and the December Closing Date Warrant against payment by the
Buyer to the Company of an amount equal to the Purchase Price, and (2) the Buyer
shall pay to the Company an amount equal to the Purchase Price against delivery
by the Company to the Buyer of the Note and the December Closing Date
Warrant.
3.
REPRESENTATIONS, WARRANTIES,
COVENANTS, ETC. OF THE BUYER.
The Buyer
represents and warrants to, and covenants and agrees with, the Company as
follows:
(a)
Circumstances of
Purchase.
The Buyer
is purchasing the Note and acquiring the Warrants for its own account and not
with a view towards the public sale or distribution thereof within the meaning
of the 1933 Act; and the Buyer will acquire any Shares issued to the Buyer prior
to the SEC Effective Date of a Registration Statement covering the resale of
such Shares by the Buyer for its own account and not with a view towards the
public sale or distribution thereof within the meaning of the 1933 Act prior to
such SEC Effective Date; and the Buyer has no intention of making any
distribution, within the meaning of the 1933 Act, of the Shares except in
compliance with the registration requirements of the 1933 Act or pursuant to an
exemption therefrom. The Buyer is acquiring the Securities hereunder in the
ordinary course of its business.
(b)
Accredited Investor;
Residence.
At the
time the Buyer was offered the Securities, it was, and at the date hereof it is,
and on each date on which it exercises any Warrants for cash it will be, an
“accredited investor” as that term is defined in Rule 501 of Regulation D under
the 1933 Act by reason of Rule 501(a)(3) thereof. The office or offices of the
Buyer in which its investment decision was made is located at the address or
addresses of such Investor set forth on the signature page hereto.
(c)
Reoffers and
Resales.
The Buyer
will not offer, sell, pledge, transfer or otherwise dispose of (or solicit any
offers to buy, purchase or otherwise acquire or take a pledge of) any of the
Securities unless registered under the 1933 Act, pursuant to an exemption from
registration under the 1933 Act or in a transaction not requiring registration
under the 1933 Act;
provided
,
however
, that
the Securities may be pledged in connection with a bona fide margin account or
other loan or financing arrangement secured by the Securities and such pledge of
Securities shall not be deemed to be a transfer, sale or assignment of the
Securities prohibited hereby, and in effecting any pledge of Securities the
Buyer shall not be required to provide the Company with any notice thereof or
otherwise make any delivery to the Company pursuant to this Agreement or any
other Transaction Document, including, without limitation, this Section 3(c);
provided
,
further
,
however
, the
Buyer acknowledges that in connection with any sale, transfer or assignment by
the pledgee of such Securities, such pledgee may be required by applicable law
to make such sale, transfer or assignment in accordance with, or pursuant to a
registration statement or an exemption under, the 1933 Act.
(d)
Company
Reliance.
The Buyer
understands that (1) the Note is being offered and sold and the Warrants are
being issued to the Buyer, (2) upon conversion of the Note prior to two years
after the Closing Date, the Conversion Shares will be issued to the Buyer upon
such conversion and (3) upon exercise of the Warrants for cash, or upon cashless
exercise of the Warrants prior to two years after the Closing Date, the Warrant
Shares issued upon such exercise will be issued to the Buyer, in each such case
in reliance on one or more exemptions from the registration requirements of the
1933 Act, including, without limitation, Regulation D, and exemptions from state
securities laws and that the Company is relying upon the truth and accuracy of,
and the Buyer’s compliance with, the representations, warranties, agreements,
acknowledgments and understandings of the Buyer set forth herein in order to
determine the availability of such exemptions and the eligibility of the Buyer
to acquire or receive an offer to acquire the Securities.
(e)
Information
Provided.
The Buyer
and its advisors, if any, have requested, received and considered all
information relating to the business, properties, operations, condition
(financial or other), results of operations or prospects of the Company and
information relating to the offer and sale of the Note and the offer of the
Warrants deemed relevant by them (assuming the accuracy and completeness of the
SEC Reports and of the Company’s responses to the Buyer’s requests); the Buyer
and its advisors, if any, have been afforded the opportunity to ask questions of
the Company concerning the terms of the offering of the Securities and the
business, properties, operations, condition (financial or other), results of
operations and prospects of the Company and the Subsidiaries; without limiting
the generality of the foregoing, the Buyer has had the opportunity to obtain and
to review the SEC Reports; in connection with its decision to purchase the Note
and to acquire the Warrants, the Buyer has relied solely upon the SEC Reports,
the representations, warranties, covenants and agreements of the Company set
forth in this Agreement and to be contained in the other Transaction Documents,
as well as any investigation of the Company completed by the Buyer or its
advisors; the Buyer understands that its investment in the Securities involves a
high degree of risk; and the Buyer understands that the offering of the Note is
being made to the Buyer as part of an offering without any minimum amount of the
offering but subject to a maximum amount of $7 million aggregate principal
amount of the Note and the Other Notes (subject, however, to the right of the
Company at any time prior to execution and delivery of this Agreement by the
Company, in its sole discretion, to accept or reject an offer by the Buyer to
purchase the Note and to acquire the Warrants).
(f)
Absence of
Approvals.
The Buyer
understands that no United States federal or state agency or any other
government or governmental agency has passed on or made any recommendation or
endorsement of the Securities.
(g)
Note Purchase
Agreement.
The Buyer
has all requisite power and authority, corporate or otherwise, to execute,
deliver and perform its obligations under this Agreement and the other
agreements executed by the Buyer in connection herewith and to consummate the
transactions on the Buyer’s part contemplated hereby and thereby; Buyer is an
entity duly organized, validly existing and in good standing under the laws of
the jurisdiction of its organization; and this Agreement and the Transaction
Documents to which the Buyer is a party have been duly and validly authorized,
duly executed and delivered by the Buyer and, assuming due execution and
delivery by the Company, constitute valid and legally binding obligations of the
Buyer enforceable in accordance with their terms, except as the enforceability
hereof may be limited by bankruptcy, insolvency, reorganization, moratorium,
fraudulent conveyance or other similar laws now or hereafter in effect relating
to or affecting creditors’ rights generally and general principles of equity,
regardless of whether enforcement is considered in a proceeding in equity or at
law.
(h)
Buyer
Status.
The Buyer
is not a “broker” or “dealer” as those terms are defined in the 1934 Act, which
is required to be registered with the SEC pursuant to Section 15 of the 1934
Act.
(i)
Experience of the
Buyer.
The
Buyer, either alone or together with its representatives, has such knowledge,
sophistication and experience in business and financial matters so as to be
capable of evaluating the merits and risks of the prospective investment in the
Securities, and has so evaluated the merits and risks of such investment. The
Buyer is able to bear the economic risk of an investment in the Securities and,
at the present time, is able to afford a complete loss of such investment. The
Buyer has had the opportunity to ask questions of management of the
Company.
(j))
General
Solicitation.
The
Buyer
did not
learn of the offering of the Securities through any public advertising or
general solicitation (as these terms are used in Regulation D).
(k)
Short Sales and Confidentiality Prior
To The Date Hereof.
Other
than the transaction contemplated hereunder, the Buyer has not directly or
indirectly, nor has any Person acting on behalf of or pursuant to any
understanding with the Buyer, executed any disposition, including Short Sales
(but not including the location and/or reservation of borrowable shares of
Common Stock), in the securities of the Company during the period
commencing from
the time
that
the Buyer
first
received a term sheet from the Company or any other Person setting forth the
material terms of the transactions contemplated hereunder until the date hereof
(the
“Discussion Time”)
.
Notwithstanding
the foregoing, in the case of a
Buyer
that is a
multi-managed investment vehicle whereby separate portfolio managers manage
separate portions of such
Buyer
's assets
and the portfolio managers have no direct knowledge of the investment decisions
made by the portfolio managers managing other portions of such
Buyer
's
assets, the representation set forth above shall only apply with respect to the
portion of assets managed by the portfolio manager that made the investment
decision to purchase the Securities covered by this Agreement. Other than to
other Persons party to this Agreement and its professional advisors,
the Buyer
has
maintained the confidentiality of all disclosures made to it in connection with
this transaction (including the existence and terms of this
transaction).
4.
REPRESENTATIONS, WARRANTIES,
COVENANTS, ETC. OF THE COMPANY.
The
Company represents and warrants to, and covenants and agrees with, the Buyer as
follows:
(a)
Organization and
Authority.
The
Company and each of the Subsidiaries is a corporation duly organized, validly
existing and in good standing under the laws of the jurisdiction of its
incorporation, and (i) each of the Company and the Subsidiaries has all
requisite corporate power and authority to own, lease and operate its properties
and to carry on its business as described in the SEC Reports and as currently
conducted, and (ii) the Company has all requisite corporate power and authority
to execute, deliver and perform its obligations under this Agreement and the
other Transaction Documents to be executed and delivered by the Company in
connection herewith, and to consummate the transactions contemplated hereby and
thereby; and the Company does not have any equity investment in any other Person
other than (x) the Subsidiaries listed in the SEC Reports and (y) Subsidiaries
which do not, individually or in the aggregate, have any material revenue,
assets or liabilities.
(b)
Qualifications.
The
Company and each of the Subsidiaries are duly qualified to do business as
foreign corporations and are in good standing in all jurisdictions where such
qualification is necessary and where failure so to qualify could have a Material
Adverse Effect.
(c)
Concerning the Shares and the Common
Stock.
The
Shares have been duly authorized and the Conversion Shares, when issued upon
conversion of the Note, and the Warrant Shares, when issued upon exercise of the
Warrants, in each such case will be duly and validly issued, fully paid and
non-assessable and will not subject the holder thereof to personal liability by
reason of being such holder. There are no unwaived preemptive or similar rights
of any stockholder of the Company or any other Person to acquire any of the
Securities issued or to be issued to the Buyer. The Company has duly reserved
[40,000,000] shares of Common Stock exclusively for issuance upon conversion of
the Note and the Other Notes and exercise of the Warrants and the Other
Warrants, and such shares shall remain so reserved, and the Company shall from
time to time reserve such additional shares of Common Stock as shall be required
to be reserved pursuant to the Note, the Other Notes and the Warrants, so long
as the Note, the Other Notes or the Warrants are outstanding. The Common Stock
is listed for trading on the AMEX and, except as described on Schedule 4(c), (1)
the Company and the Common Stock meet the criteria for continued listing and
trading on the AMEX; (2) the Company has not been notified since December 31,
2004 by the AMEX of any failure or potential failure to meet the criteria for
continued listing and trading on the AMEX and (3) no suspension of trading in
the Common Stock is in effect. Except as described on
Schedule 4(c)
, the
Company knows of no reason that the Shares will not be eligible for listing on
the AMEX. The Company acknowledges that the Securities may be pledged in
connection with a bona fide margin account or other loan or financing
arrangement secured by the Securities and such pledge of Securities shall not be
deemed to be a transfer, sale or assignment of the Securities hereunder, and the
Buyer shall not be required to provide the Company with any notice thereof or
otherwise make any delivery to the Company pursuant to this Agreement or any
other Transaction Document;
provided, however
, that in
order to make any sale, transfer or assignment of Securities in connection with
a foreclosure or realization on such pledge, the Buyer or its pledgee shall make
such disposition in accordance with, or pursuant to a registration statement or
an exemption under, the 1933 Act.
(d)
Corporate
Authorization.
This
Agreement and the other Transaction Documents to which the Company is or will be
a party have been duly and validly authorized by the Company; this Agreement has
been duly executed and delivered by the Company and, assuming due execution and
delivery by the Buyer, this Agreement is, and the Note, and the Warrants will
be, when executed and delivered by the Company, valid and binding obligations of
the Company enforceable in accordance with their respective terms, except as the
enforceability hereof or thereof may be limited by bankruptcy, insolvency,
reorganization, moratorium or other similar laws now or hereafter in effect
relating to or affecting creditors’ rights generally and general principles of
equity, regardless of whether enforcement is considered in a proceeding in
equity or at law.
(e)
Non-contravention.
The
execution and delivery of the Transaction Documents by the Company and the
consummation by the Company of the issuance of the Securities as contemplated by
this Agreement and consummation by the Company of the other transactions
contemplated by the Transaction Documents do not and will not, with or without
the giving of notice or the lapse of time, or both, (i) result in any violation
of any term or provision of the Certificate of Incorporation or Bylaws of the
Company or any Subsidiary, (ii) conflict with or result in a breach by the
Company or any Subsidiary of any of the terms or provisions of, or constitute a
default under, or result in the modification of, or result in the creation or
imposition of any lien, security interest, charge or encumbrance (other than
pursuant to the Security Agreement) upon any of the properties or assets of the
Company or any Subsidiary pursuant to, any indenture, mortgage, deed of trust or
other agreement or instrument to which the Company or any Subsidiary is a party
or by which the Company or any Subsidiary or any of their respective properties
or assets are bound or affected, in any such case which would be reasonably
likely to have a Material Adverse Effect, (iii) violate or contravene any
applicable law, rule or regulation or any applicable decree, judgment or order
of any court, United States federal or state regulatory body, administrative
agency or other governmental body having jurisdiction over the Company or any
Subsidiary or any of their respective properties or assets, in any such case
which could have a Material Adverse Effect, or (iv) have any material adverse
effect on any permit, certification, registration, approval, consent, license or
franchise necessary for the Company or any Subsidiary to own or lease and
operate any of its properties and to conduct any of its business or the ability
of the Company or any Subsidiary to make use thereof.
(f)
Approvals, Filings,
Etc.
No
authorization, approval or consent of, or filing with, any United States or
foreign court, governmental body, regulatory agency, self-regulatory
organization, or stock exchange or market or the stockholders of the Company is
required to be obtained or made by the Company or any Subsidiary for (x) the
execution, delivery and performance by the Company of the Transaction Documents,
(y) the issuance and sale of the Securities as contemplated by this Agreement
and the terms of the Note and the Warrants and (z) the performance by the
Company of its obligations under the Transaction Documents, other than (1)
registration of the resale of the Shares under the 1933 Act as contemplated by
Section 8, (2) as may be required under applicable state securities or “blue
sky” laws, (3) filing of one or more Forms D with respect to the Securities as
required under Regulation D, (4) filing of financing statements as required
under
the
Pledge and Security Agreement, (5) the filings with the PTO as required by the
Patent and Trademark Security Agreement and
(6)
the
filing
of
the
Transaction
Form 8-K.
(g)
Information
Provided.
The SEC
Reports (together with the press release issued by the Company), the Transaction
Documents and the instruments delivered by the Company to the Buyer in
connection with the execution and delivery of this Agreement and in connection
with the closing on the Closing Date do not and will not on the date of
execution and delivery of this Agreement, the date of delivery thereof to the
Buyer and on the Closing Date contain any untrue statement of a material fact or
omit to state any material fact necessary in order to make the statements
therein, in the light of the circumstances under which they are made, not
misleading, it being understood that for purposes of this Section 4(g), any
statement contained in such information shall be deemed to be modified or
superseded for purposes of this Section 4(g) to the extent that a statement in
any document included in such information which was prepared and furnished to
the Buyer on a later date (but on or before the date of this Agreement) or filed
with the SEC on a later date (but on or before the date of this Agreement)
modifies or replaces such statement, whether or not such later prepared or filed
statement so states.
(h)
Investment
Company.
Neither
the Company nor any Subsidiary is an “investment company” within the meaning of
such term under the Investment Company Act of 1940, as amended, and the rules
and regulations of the SEC thereunder.
(i)
Absence of Brokers, Finders,
Etc.
No
broker, finder or similar Person is entitled to any commission, fee or other
compensation by reason of action taken by or on behalf of the Company in
connection with the transactions contemplated by this Agreement other than the
Placement Agent (whose commissions, fees and compensation shall be payable
solely by the Company in accordance with a written agreement between the Company
and the Placement Agent), and the Company shall pay, and indemnify and hold
harmless the Buyer from, any claim made against the Buyer by any Person for any
such commission, fee or other compensation.
(j)
No
Solicitation.
Neither
the Company nor, to the best of its knowledge, any other Person acting on behalf
of the Company, used any form of general solicitation or general advertising in
respect of the Securities or in connection with the offer and sale of the
Securities. Neither the Company nor, to its knowledge, any Person acting on
behalf of the Company has, either directly or indirectly, sold or offered for
sale to any Person any of the Securities or, within the six months prior to the
date hereof, any other similar security of the Company, except as contemplated
by this Agreement and the Other Note Purchase Agreements; and neither the
Company nor any Person authorized to act on its behalf will sell or offer for
sale any promissory notes, warrants, shares of Common Stock or other securities
to, or solicit any offers to buy any such security from, any Person so as
thereby to cause the issuance or sale of any of the Securities to be in
violation of any of the provisions of Section 5 of the 1933 Act.
(k)
No Integrated
Offering
.
None of
the Company, any Subsidiary, any of their respective Affiliates, or any Person
acting on behalf of any of them has, directly or indirectly, made any offers or
sales of any security or solicited any offers to buy any security, under
circumstances that would require registration of any of the Securities under the
1933 Act or cause the offering of the Securities, the Other Notes and the Other
Warrants to be integrated with prior offerings by the Company for purposes of
the 1933 Act or any applicable stockholder approval provisions, including,
without limitation, under the rules and regulations of any exchange or automated
quotation system on which any of the securities of the Company are listed,
quoted or designated. None of the Company, any Subsidiary, their respective
Affiliates or any Person acting on behalf of any of them will take any action or
steps referred to in the preceding sentence that would require registration of
any of the Securities under the 1933 Act or cause the offering of the Securities
to be integrated with other offerings.
(l)
Dilutive
Effect.
The
Company understands and acknowledges that the number of Shares issuable upon
conversion of the Note and the Other Notes and upon exercise of the Warrants and
the Other Warrants will be substantial and may increase in certain
circumstances. The Company further acknowledges that, subject to the terms and
conditions of the Transaction Documents, its obligation to issue Shares upon
conversion of the Note and upon exercise of the Warrants in accordance with this
Agreement, the Note and the Warrants are, in each case, absolute and
unconditional regardless of the dilutive effect that such issuance may have on
the ownership interests of other stockholders of the Company.
(m)
Absence of Certain
Changes
.
Except as
disclosed in the SEC Reports, since December 31, 2005, there has been no
material adverse change and no material adverse development in the business,
properties, operations, condition (financial or otherwise), results of
operations or prospects of the Company and the Subsidiaries taken as a whole.
Except as disclosed in the SEC Reports, since December 31, 2005, neither the
Company nor any Subsidiary has (i) declared or paid any dividends, (ii) sold any
assets, individually or in the aggregate, outside of the ordinary course of
business, (iii) had capital expenditures outside of the ordinary course of
business, (iv) engaged in any transaction with any Affiliate except as set forth
in the SEC Reports or (v) engaged in any other transaction outside of the
ordinary course of business. The Company has not taken any steps to seek
protection pursuant to any bankruptcy law nor does the Company have any
knowledge or reason to believe that its creditors intend to initiate involuntary
bankruptcy proceedings or any actual knowledge of any fact that would reasonably
lead a creditor to do so. The Company is not as of the date hereof, after giving
effect to the transactions contemplated hereby to occur on the Closing Date and
the transactions contemplated by the Other Note Purchase Agreements,
Insolvent.
(n)
No Undisclosed Events, Liabilities,
Developments or Circumstances
.
No event,
liability, development, circumstance or transaction has occurred or exists, with
respect to the Company or any Subsidiary or their respective business,
properties, operations, condition (financial or other), results of operations or
prospects, that would be required to be disclosed by the Company under
applicable securities laws (including pursuant to the anti-fraud provisions
thereof) on a registration statement on Form S-3 filed with the SEC relating to
an issuance and sale by the Company of its Common Stock and which has not been
publicly disclosed.
(o)
Conduct of Business; Regulatory
Permits
.
Neither
the Company nor any Subsidiary is in violation of any term of or in default
under its Certificate of Incorporation, or its Bylaws. Neither the Company nor
any Subsidiary is in violation of any judgment, decree or order or any statute,
ordinance, rule or regulation applicable to the Company or any Subsidiary which
violation could have a Material Adverse Effect, and neither the Company nor any
Subsidiary will conduct its business in violation of any of the foregoing,
except for possible violations which could not, individually or in the
aggregate, reasonably be expected to have a Material Adverse Effect. Without
limiting the generality of the foregoing, the Company is not in violation of any
of the rules, regulations or requirements of the AMEX and has no knowledge of
any facts or circumstances that would be likely to lead to delisting or
suspension of the Common Stock by the AMEX in the future. Since December 31,
2005, (i) the Common Stock has been listed on the AMEX, (ii) trading in the
Common Stock has not been suspended by the SEC or the AMEX and (iii) the Company
has received no communication, written or oral, from the SEC or the AMEX
regarding the suspension or delisting of the Common Stock from the AMEX. The
Company and the Subsidiaries possess all certificates, authorizations and
permits issued by the appropriate federal, state or foreign regulatory
authorities necessary to conduct their respective businesses, except where the
failure to possess such certificates, authorizations or permits could not
reasonably be expected to have, individually or in the aggregate, a Material
Adverse Effect, and neither the Company nor any Subsidiary has received any
notice of proceedings relating to the revocation or modification of any such
certificate, authorization or permit.
(p)
Indebtedness and Other
Contracts
.
Except as
set forth on the SEC Reports, neither the Company nor any Subsidiary (i) has any
outstanding Indebtedness, (ii) is a party to any contract, agreement or
instrument, the violation of which, or default under which, by any other party
to such contract, agreement or instrument could reasonably be expected to result
in a Material Adverse Effect, (iii) is in violation of any term of or in default
under any contract, agreement or instrument, except where such violations and
defaults could not reasonably be expected to result, individually or in the
aggregate, in a Material Adverse Effect, or (iv) is a party to any contract,
agreement or instrument, the performance of which, in the judgment of the
Company's officers, has or is expected to have a Material Adverse Effect. The
Company has filed all material contracts required to be filed in accordance with
the applicable requirements of the SEC Reports as exhibits to such reports.
(q)
Absence of
Litigation
.
Except as
set forth in the SEC Reports, there is no action, suit, proceeding, inquiry or
investigation, whether criminal, civil or otherwise, before or by the AMEX, any
court, arbitrational body, public board, government agency, self-regulatory
organization or body pending or, to the knowledge of the Company, threatened
against or affecting the Company, the Common Stock or any of the Subsidiaries or
any of the Company's or any Subsidiary's officers or directors in their
capacities as such. To the knowledge of the Company, none of the directors or
officers of the Company has been a party to any securities related litigation
during the past ten years, other than as disclosed in the SEC
Reports.
(r)
Insurance
.
The
Company and each Subsidiary is insured by insurers of recognized financial
responsibility against such losses and risks and in such amounts as management
of the Company believes to be prudent and customary in the businesses in which
the Company and the Subsidiaries are engaged. Neither the Company nor any
Subsidiary has been refused any insurance coverage sought or applied for and
neither the Company nor any Subsidiary has any reason to believe that it will
not be able to renew its existing insurance coverage as and when such coverage
expires or to obtain similar coverage from similar insurers as may be necessary
to continue its business at a cost that could not have a Material Adverse
Effect.
(s)
Employee
Relations
.
Neither
the Company nor any Subsidiary is a party to any collective bargaining agreement
or employs any member of a union. No executive officer of the Company (as
defined in Rule 405 under the 1933 Act) has notified the Company that such
officer intends to leave the Company or otherwise terminate such officer's
employment with the Company. No executive officer of the Company, to the
knowledge of the Company, is, or is now expected to be, in violation of any
material term of any employment contract, confidentiality, disclosure or
proprietary information agreement, non-competition agreement, or any other
contract or agreement or any restrictive covenant, and, to the knowledge of the
Company, the continued employment of each such executive officer does not
subject the Company or any Subsidiary to any material liability with respect to
any of the foregoing matters. The Company and the Subsidiaries are in compliance
with all federal, state, local and foreign laws and regulations respecting
employment and employment practices, terms and conditions of employment and
wages and hours, except where failure to be in compliance could not, either
individually or in the aggregate, reasonably be expected to result in a Material
Adverse Effect.
(t)
Title
.
The
Company and the Subsidiaries have good and marketable title to all personal
property owned by them which is material to the business of the Company and the
Subsidiaries, in each case free and clear of all Liens except (i) immaterial
Liens for taxes not yet delinquent, (ii) immaterial carriers’, warehousemen’s,
mechanics', materialmen's, repairmen’s, landlord’s Liens (and other similar
Liens), and immaterial Liens under operating and similar agreements, to the
extent the same relate to expenses incurred in the ordinary course of business
consistent with past practice and that are not yet due, (iii) that are routine
governmental approvals, or (iv) such as do not materially affect the value of
such property and do not interfere with the use made and proposed to be made of
such property by the Company and any of its Subsidiaries. Neither the Company
nor any Subsidiary owns any real property. Any real property and facilities held
under lease by the Company or any Subsidiary are held by it under valid,
subsisting and enforceable leases with such exceptions as are not material and
do not interfere with the use made and proposed to be made of such property and
buildings by the Company and the Subsidiaries.
(u)
Intellectual
Property.
Except as
provided in the Security Agreement, (1) the Company and each Subsidiary holds
all Intellectual Property that it owns free and clear of all Encumbrances and
restrictions on use or transfer, whether or not recorded, and has sole title to
and ownership of or has the full, exclusive (subject to the rights of its
licensees) right to use in its field of business such Intellectual Property; and
the Company and each Subsidiary holds all Intellectual Property that it uses but
does not own under valid licenses or sub-licenses from others; (2) the use of
the Intellectual Property by the Company or any Subsidiary does not, to the
knowledge of the Company, violate or infringe on the rights of any other Person;
(3) neither the Company nor any Subsidiary has received any notice of any
conflict between the asserted rights of others and the Company or any Subsidiary
with respect to any Intellectual Property; (4) the Company and each Subsidiary
has used its commercially reasonable best efforts to protect its rights in and
to all Intellectual Property; (5) the Company and each Subsidiary are in
compliance with all material terms and conditions of its agreements relating to
the Intellectual Property; (6) neither the Company nor any Subsidiary is, or
since December 31, 2005 has been, a defendant in any action, suit, investigation
or proceeding relating to infringement or misappropriation by the Company or any
Subsidiary of any Intellectual Property nor has the Company or any Subsidiary
been notified of any alleged claim of infringement or misappropriation by the
Company or any Subsidiary of any Intellectual Property; (7) to the knowledge of
the Company, none of the products or services the Company and the Subsidiaries
are researching, developing, propose to research and develop, make, have made,
use, or sell, infringes or misappropriates any Intellectual Property right of
any third party; (8) none of the trademarks and service marks used by the
Company or any Subsidiary, to the knowledge of the Company, infringes the
trademark or service mark rights of any third party; and (9) to the Company’s
knowledge none of the material processes and formulae, research and development
results and other know-how relating to the Company's or the Subsidiaries'
respective businesses, the value of which to the Company or any Subsidiary is
contingent upon maintenance of the confidentiality thereof, has been disclosed
to any Person other than Persons bound by written confidentiality
agreements.
(v)
Environmental Laws
.
To the
Company’s knowledge, the Company and the Subsidiaries (i) are in compliance with
all Environmental Laws, (ii) have received all permits, licenses or other
approvals required of them under applicable Environmental Laws to conduct their
respective businesses and (iii) are in compliance with all terms and conditions
of any such permit, license or approval where, in any such case in the foregoing
clauses (i), (ii) or (iii), the failure to so comply could be reasonably
expected to have, individually or in the aggregate, a Material Adverse
Effect.
(w)
Subsidiary
Rights
.
The
Company or one of the Subsidiaries has the unrestricted right to vote, and
(subject to limitations imposed by the applicable corporation or company law
under which each Subsidiary is formed) to receive dividends and distributions
on, all stock of the Subsidiaries that is owned by the Company or such other
Subsidiary as owns such stock.
(x)
Tax Status
.
The
Company and each Subsidiary (i) has made or filed all federal and state income
and all other tax returns, reports and declarations required by any jurisdiction
to which it is subject, (ii) has paid all taxes and other governmental
assessments and charges that are shown or determined to be due on such returns,
reports and declarations, except those being contested in good faith and for
which it has set aside on its books a provision in the amount of such taxes
being contested in good faith and (iii) has set aside on its books provisions
reasonably adequate for the payment of all taxes for periods subsequent to the
periods to which such returns, reports or declarations apply. There are no
unpaid taxes claimed to be due by the taxing authority of any jurisdiction, and
the officers of the Company know of no basis for any such claim.
(y)
Internal Accounting Controls;
Financial Statements
.
The
Company maintains disclosure controls and procedures (as such term is defined in
Rule 13a-15 under the 1934 Act) that are effective in ensuring that information
required to be disclosed by the Company in the reports that it files or submits
under the 1934 Act is recorded, processed, summarized and reported, within the
time periods specified in the rules and forms of the SEC, including, without
limitation, controls and procedures designed to ensure that information required
to be disclosed by the Company in the reports that it files or submits under the
1934 Act is accumulated and communicated to the Company's management, including
its principal executive officer or officers and its principal financial officer
or officers, as appropriate, to allow timely decisions regarding required
disclosure. The consolidated financial statements, if any, included in each SEC
Report present fairly and accurately in all material respects the consolidated
financial position of the Company and the Subsidiaries as of the dates reported
and the consolidated results of operations, changes in stockholders' equity and
cash flows for the periods reported, all in conformity with Generally Accepted
Accounting Principles applied on a consistent basis and in conformity with the
rules and regulations of the SEC under the 1934 Act applicable to the Company,
subject, in the case of unaudited financial statements, to (1) normal recurring
year-end adjustments, all of which that are necessary for a fair presentation of
such financial statements have been included, and (2) the absence of all
required notes thereto. Except as set forth in the consolidated financial
statements of the Company included in the SEC Reports, neither the Company nor
any Subsidiary has any liabilities, contingent or otherwise, except those which
individually or in the aggregate are not material to the financial condition or
operating results of the Company and the Subsidiaries, taken as a
whole.
(z)
Sarbanes-Oxley
Act
.
The
Company is in compliance with any and all applicable requirements of the
Sarbanes-Oxley Act of 2002 that are effective as of the date hereof, and any and
all applicable rules and regulations promulgated by the SEC thereunder that are
effective as of the date hereof.
(aa)
S-3
Eligibility.
The
Company meets the requirements of Form S-3 for the registration of the resale of
the Registrable Securities.
(bb)
Concerning the
Collateral.
Upon
execution and delivery of the Security Agreement by the Company and the
Collateral Agent and completion of the filings referred to in
Schedule I
to the
Pledge and Security Agreement and
Exhibit C
to the
Patent and Trademark Security Agreement, the Collateral Agent will have a first
priority perfected security interest in the Collateral for the ratable benefit
of the holders of the Other Notes and, when issued by the Company to the Buyer,
this Note.
(cc)
Disclosures.
For
purposes of this Agreement and the transactions contemplated hereby, none of the
representations or warranties made by the Company under any of the Transaction
Documents and no written information furnished by the Company pursuant hereto,
or in any other document, certificate or written statement furnished by the
Company to the Buyer or any authorized representative of the Buyer, pursuant to
the Transaction Documents or in connection therewith, contains any untrue
statement of a material fact or omits to state a material fact necessary in
order to make the statements contained herein and therein, in light of the
circumstances under which they were made, not misleading.
(dd)
Absence of Rights
Agreement.
The
Company has not adopted a shareholder rights plan or similar arrangement
relating to accumulations of beneficial ownership of Common Stock or a change of
control in the Company.
5.
CERTAIN
COVENANTS.
(a)
Transfer
Restrictions.
The Buyer
acknowledges and agrees that (1) the Note and the Warrants have not been and are
not being registered under the provisions of the 1933 Act or any state
securities laws and, except as provided in Section 8, the Shares have not been
and are not being registered under the 1933 Act or any state securities laws,
and that the Note and the Warrants may not be transferred unless the Buyer shall
have delivered to the Company an opinion of counsel, reasonably satisfactory in
form, scope and substance to the Company, to the effect that the Note or the
Warrants to be transferred may be transferred without such registration; (2) no
sale, conveyance assignment or other transfer of the Note or the Warrants or any
interest therein may be made except in accordance with the terms hereof and
thereof; (3) the Shares may not be resold by the Buyer unless the resale has
been registered under the 1933 Act or is made pursuant to an applicable
exemption from such registration and the Company shall have received the opinion
of counsel provided for in the second to last sentence of this Section 5(a); (4)
any sale of Shares under a Registration Statement shall be made only in
compliance with the terms of this Section 5(a) and Section 8 (including, without
limitation, Section 8(c)(4)); (5) any sale of the Securities made in reliance on
Rule 144 may be made only in accordance with the terms of Rule 144 and further,
if the exemption provided by Rule 144 is not available, any resale of the
Securities under circumstances in which the seller, or the Person through whom
the sale is made, may be deemed to be an underwriter, as that term is used in
the 1933 Act, may require compliance with some other exemption under the 1933
Act or the rules and regulations of the SEC thereunder; and (6) the Company is
under no obligation to register the Securities (other than registration of the
resale of the Registrable Securities in accordance with Section 8) under the
1933 Act or, except as provided in Section 5(d) and Section 8, to comply with
the terms and conditions of any exemption thereunder. Prior to the time
particular Shares are eligible for resale under Rule 144(k), the Buyer may not
sell the Shares in a transaction which does not constitute a sale thereof
pursuant to the applicable Registration Statement in accordance with the plan of
distribution set forth therein or in any supplement to the related Prospectus
unless the Buyer shall have delivered to the Company an opinion of counsel,
reasonably satisfactory in form, scope and substance to the Company, that such
Shares may be so sold without registration under the 1933 Act. Nothing in any of
the Transaction Documents shall limit the right of a holder of the Securities to
make a bona fide pledge thereof to an institutional lender and the Company
agrees to cooperate with any Investor who seeks to effect any such pledge by
providing such information and making such confirmations as reasonably
requested. The Buyer agrees that any sale by the Buyer of Shares pursuant to a
particular Registration Statement shall be sold in a manner described in the
plan of distribution set forth in the related Prospectus and, if the prospectus
delivery requirement cannot be satisfied by compliance with Rule 153 or 172
under the 1933 Act, (A) if such sale is made through a broker, the Buyer shall
instruct its broker to deliver the Prospectus to the purchaser or purchasers (or
the broker or brokers therefor) in connection with such sale, shall supply
copies of the Prospectus to its broker or brokers and shall instruct its broker
or brokers to deliver such Prospectus to the purchaser in such sale or such
purchaser’s broker, (B) if such sale is made in a transaction directly with a
purchaser and not through the facilities of any securities exchange or market,
the Buyer shall deliver, or cause to be delivered, the Prospectus to such
purchaser; and (C) if such sale is made by any means other than those described
in the immediately preceding clauses (A) and (B), the Buyer shall otherwise use
its best efforts to comply with the prospectus delivery requirements of the 1933
Act applicable to such sale.
(b)
Restrictive
Legends.
(1) The
Buyer acknowledges and agrees that the Note shall bear a restrictive legend in
substantially the following form (and a stop-transfer order may be placed
against transfer of the Note):
NEITHER
THE ISSUANCE OF THIS NOTE NOR THE ISSUANCE OF THE SECURITIES INTO WHICH THIS
NOTE IS CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS
AMENDED (THE “1933 ACT”), AND, ACCORDINGLY, MAY NOT BE, NOR MAY ANY INTEREST
THEREIN BE, OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION
STATEMENT UNDER THE 1933 ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A
TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE 1933 ACT AND IN
ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY, SUBJECT TO
CERTAIN EXCEPTIONS, A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT,
THE SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO THE COMPANY. THESE
SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT SECURED
BY SUCH SECURITIES.
(2)
The Buyer
further acknowledges and agrees that the Warrants shall bear a restrictive
legend in substantially the following form (and a stop-transfer order may be
placed against transfer of the Warrants):
NEITHER
THIS WARRANT NOR THE SECURITIES INTO WHICH THIS WARRANT IS EXERCISABLE HAVE BEEN
REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES
REGULATORS OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER
THE SECURITIES ACT OF 1933, AS AMENDED (THE “1933 ACT”), AND, ACCORDINGLY, MAY
NOT BE, NOR MAY ANY INTEREST THEREIN BE, OFFERED OR SOLD EXCEPT PURSUANT TO AN
EFFECTIVE REGISTRATION STATEMENT UNDER THE 1933 ACT OR PURSUANT TO AN AVAILABLE
EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION
REQUIREMENTS OF THE 1933 ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES
LAWS AS EVIDENCED BY, SUBJECT TO CERTAIN EXCEPTIONS, A LEGAL OPINION OF COUNSEL
TO THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY
ACCEPTABLE TO THE COMPANY. THESE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A
BONA FIDE MARGIN ACCOUNT SECURED BY SUCH SECURITIES.
(3)
The Buyer
further acknowledges and agrees that until such time as the Shares have been
registered for resale under the 1933 Act as contemplated by Section 8 or are
eligible for resale under Rule 144(k) under the 1933 Act, the certificates for
the Shares may bear a restrictive legend in substantially the following form
(and a stop-transfer order may be placed against transfer of the certificates
for the Shares):
The
securities represented by this certificate have not been registered under the
Securities Act of 1933, as amended (the “1933 Act”). The securities have been
acquired for investment and may not be resold, transferred or assigned in the
absence of an effective registration statement for the securities under the 1933
Act or an opinion of counsel that registration is not required under the 1933
Act.
(4)
Certificates
evidencing the Shares shall not contain any legend (including the legend set
forth in Section 5(b)(3) hereof): (i) while a registration statement (including
the Registration Statement) covering the resale of such Security is effective
under the 1933 Act, or (ii) following any sale of such Shares pursuant to Rule
144, or (iii) if such Shares are eligible for sale under Rule 144(k), or (iv) if
such legend is not required under applicable requirements of the 1933Act
(including judicial interpretations and pronouncements issued by the SEC). The
Company shall cause its counsel to issue a legal opinion to the Company’s
transfer agent promptly after the SEC Effective Date if required by the
Company’s transfer agent to effect the removal of the legend hereunder. If all
or any portion of a Securities are converted or exercised (as applicable) at a
time when there is an effective registration statement to cover the resale of
the Shares, or if such Shares may be sold under Rule 144(k) or if such legend is
not otherwise required under applicable requirements of the 1933 Act (including
judicial interpretations thereof) then such Shares shall be issued free of all
legends. The Company agrees that following the SEC Effective Date or at such
time as such legend is no longer required under this Section 5(b)(4), it will,
no later than five Trading Days following the delivery by a Buyer to the Company
or the Company’s transfer agent of a certificate representing Shares, as
applicable, deliver or cause to be delivered to such Buyer a certificate
representing such shares that is free from all restrictive and other legends.
The Company may not make any notation on its records or give instructions to any
transfer agent of the Company that enlarge the restrictions on transfer set
forth in this Section. Certificates for Securities subject to legend removal
hereunder shall be transmitted by the transfer agent of the Company to the
Buyers by crediting the account of the Buyer’s prime broker with the Depository
Trust Company System.
(c)
Reporting
Status.
During
the Registration Period, the Company shall timely file all reports required to
be filed with the SEC pursuant to Section 13 or 15(d) of the 1934 Act, and the
Company shall not terminate its status as an issuer required to file reports
under the 1934 Act even if the 1934 Act or the rules and regulations thereunder
would permit such termination.
(d)
Form D.
The
Company agrees to file with the SEC on a timely basis one or more Forms D with
respect to the Securities as required under Regulation D to claim the exemption
provided by Rule 506 of Regulation D and to provide a copy thereof to the Buyer
within five Business Days after Buyer requests in writing a copy of such
filing.
(e)
State Securities
Laws.
On or
before the Closing Date, the Company shall take such action as shall be
necessary to qualify, or to obtain an exemption for, the offer and sale of the
Securities to the Buyer as contemplated by the Transaction Documents under such
of the securities laws of jurisdictions in the United States as shall be
applicable thereto. Notwithstanding the foregoing obligations of the Company in
this Section 5(e), the Company shall not be required (1) to qualify to do
business in any jurisdiction where it would not otherwise be required to qualify
but for this Section 5(e), (2) to subject itself to general taxation in any such
jurisdiction, (3) to file a general consent to service of process in any such
jurisdiction, (4) to provide any undertakings that cause more than nominal
expense or burden to the Company or (5) to make any change in its certificate or
articles of incorporation or by-laws which the Company determines to be contrary
to the best interests of the Company and its stockholders. The Company shall
furnish the Buyer with copies of all filings, applications, orders and grants or
confirmations of exemptions relating to such securities laws on or before the
Closing Date.
(f)
Limitation on Certain
Actions.
From the
date of execution and delivery of this Agreement by the parties hereto to the
date of issuance of the Note, the Company (1) shall comply with Article III of
the Note as if the Note were outstanding, (2) shall not take any action which,
if the Note were outstanding, (A) would constitute an Event of Default or, with
the giving of notice or the passage of time or both, would constitute an Event
of Default or (B) would constitute a Repurchase Event or, with the giving of
notice or the passage of time or both, would constitute a Repurchase
Event.
(g)
Use of
Proceeds.
The
Company represents and warrants to the Buyer, and covenants and agrees with the
Buyer, that: (1) it does not own or have any present intention of acquiring any
Margin Stock; (2) the proceeds of sale of the Note and the Warrant Shares will
be used for general working capital purposes and in the operation of the
Company’s business
; provided,
however,
that up
to $100,000 of the proceeds of this Note and the Other Notes may be used in
connection with the search for an additional member of senior management
described in Section 3.17(b) of the Note; (3) none of such proceeds will be
used, directly or indirectly (A) to pay any existing debt obligations (other
than normal payables), (B) to make any loan to or investment in any other Person
or (C) for the purpose, whether immediate, incidental or ultimate, of purchasing
or carrying any margin stock or for the purpose of maintaining, reducing or
retiring any indebtedness which was originally incurred to purchase or carry any
stock that is currently a Margin Stock or for any other purpose which might
constitute the transactions contemplated by this Agreement a “purpose credit”
within the meaning of such Regulation U of the Board of Governors of the Federal
Reserve System; and (4) neither the Company nor any agent acting on its behalf
has taken or will take any action which might cause this Agreement or the
transactions contemplated hereby to violate Regulation T, Regulation U or any
other regulation of the Board of Governors of the Federal Reserve System or to
violate the 1934 Act, in each case as in effect now or as the same may hereafter
be in effect.
(h)
Best
Efforts.
Each of
the Company, on the one hand, and the Buyer, on the other hand, agree to use
their best efforts timely to satisfy each of the conditions to the other’s
obligations to sell and purchase the Note set forth in Section 6 or 7, as the
case may be, of this Agreement on or before the Closing Date.
(i)
Debt
Obligation.
So long
as any portion of the Note is outstanding, the Company shall cause its books and
records to reflect the Note as a debt of the Company in its unpaid principal
amount, shall cause its financial statements to reflect the Note as a debt of
the Company in such amount as shall be the greatest amount permitted in
accordance with Generally Accepted Accounting Principles and, whenever
appropriate, as a valid senior debt obligation of the Company for money
borrowed.
(j)
Right of the Buyer to Participate in
Future Transactions.
(1)
Right to
Participate.
The
Buyer will have a right to participate, on the terms and conditions set forth in
this Section 5(j), in all sales by the Company of any of the Company’s equity
securities or other securities that are convertible into or exchangeable for any
of the Company’s equity securities in each capital raising transaction, if any,
that occurs at any time when the Note, or any instrument issued upon transfer or
split up thereof, remains outstanding (in whole or in part), other than any such
sale that is a public offering underwritten on a firm commitment basis and
registered with the SEC under the 1933 Act and other than a Strategic Issuance;
provided,
however,
that if
under legal requirements applicable to a particular transaction the only Persons
eligible to purchase securities in such transaction are “accredited investors,”
as defined in Regulation D, then the Buyer must be an accredited investor in
order to purchase securities in such transaction. For any such transaction
during such period, the Company shall give at least four Business Days advance
written notice to the Buyer prior to any offer or sale of any of the Company's
securities in such transaction by providing to the Buyer a term sheet which (A)
contains all significant business terms of such proposed transaction, (B) is
sufficiently detailed so as to reasonably permit the Buyer the opportunity to
determine whether or not to exercise its rights under this Section 5(j) and (C)
is at least as detailed as the term sheet or summary of such transaction as the
Company shall furnish to any offeree or broker in such transaction. The Buyer
shall have the right to participate in such proposed transaction and to purchase
its Pro Rata Share
of such
securities which are the subject of such proposed transaction for the same
consideration and on the same terms and conditions as contemplated for sales to
third parties in such transaction (or such lesser portion thereof as specified
by the Buyer). If the Buyer elects to exercise its rights hereunder for a
particular transaction, it shall deliver written notice to the Company within
four Business Days following receipt from the Company of the notice and term
sheet meeting the requirements of this Section 5(j), which notice from the Buyer
shall be conditional upon (A) the Buyer’s receipt of satisfactory definitive
documents for such transaction from the Company if the Company has not furnished
final, definitive documents for such transaction to the Buyer at or before the
time the Company gives such notice of such transaction to the Buyer, and (B) the
satisfaction of the other conditions precedent to the obligations of buyers
generally in such transaction to complete such transaction. If, subsequent to
the Company giving notice to the Buyer hereunder but prior to any of (i) the
Buyer exercising its right to participate, (ii) the expiration of the four
Business Day period without response from the Buyer or (iii) the rejection of
such offer for such financing by the Buyer, the terms and conditions of the
proposed sale to third parties in such transaction are changed from those
disclosed in the term sheet provided to the Buyer, the Company shall be required
to provide a new notice and term sheet meeting the requirements of this Section
5(j), reflecting such revised terms, to the Buyer hereunder and the Buyer shall
have the right, which must be exercised within four Business Days of the date
the Buyer receives such new notice and such revised term sheet, to exercise its
rights to purchase the securities on such changed terms and conditions and
otherwise as provided hereunder. If the Buyer does not exercise its rights
hereunder with respect to a proposed transaction within the period or periods
provided, or affirmatively declines to engage in such proposed transaction with
the Company, then the Company may proceed with such proposed transaction on the
same terms and conditions as noticed to the Buyer (assuming the Buyer has
consented to the transaction, if required, pursuant to Section 5(n) and such
transaction does not violate any other term or provision of the Transaction
Documents),
provided
that if
such proposed transaction is not consummated within 75 days following the
Company’s notice hereunder, then the rights hereunder shall again be afforded to
the Buyer for such proposed transaction. The rights and obligations of this
Section 5(j) shall in no way limit or restrict the other rights of the Buyer
pursuant to this Section 5. Notwithstanding anything herein to the contrary,
failure of the Buyer to affirmatively elect in writing to participate in any
proposed transaction within the required time frames shall be deemed to be the
equivalent of Buyer’s decision not to participate in such proposed transaction.
Notwithstanding the foregoing, this Section 5(j)(1) shall not apply in respect
of an Exempt Issuance.
(2)
Limitation on Right of
Participation.
Notwithstanding
anything to the contrary contained herein, the number of shares of Common Stock
that may be acquired directly or through acquisition of Common Stock Equivalents
by the Buyer pursuant to any transaction to which this Section 5(j) applies
shall not at any one time exceed a number that, when added to the total number
of shares of Common Stock deemed beneficially owned by the Buyer (other than by
virtue of the ownership of securities or rights to acquire securities (including
the Note and the Warrants) that have limitations on the Buyer’s right to
convert, exercise or purchase similar to the limitation set forth herein (the
“Excluded Shares”)), together with all shares of Common Stock deemed
beneficially owned at such time (other than by virtue of ownership of Excluded
Shares) by Persons whose beneficial ownership of Common Stock would be
aggregated with the beneficial ownership of the Buyer for purposes of
determining whether a group exists or for purposes of determining the Buyer’s
beneficial ownership, in either such case for purposes of Section 13(d) of the
1934 Act and Regulation 13D-G thereunder, would result in beneficial ownership
by the Buyer or such group of more than 9.9% of the shares of the Company's
Common Stock (the “Restricted Ownership Percentage”), computed in accordance
with Regulation 13D-G. The Buyer shall have the right (x) at any time and from
time to time to reduce its Restricted Ownership Percentage immediately upon
notice to the Company in the event and only to the extent that Section 16 of the
1934 Act or the rules promulgated thereunder (or any successor statute or rules)
is changed to reduce the beneficial ownership percentage threshold thereunder to
a percentage less than 10% and (y) at any time and from time to time, to
increase its Restricted Ownership Percentage unless the Buyer shall have, by
written instrument delivered to the Company, irrevocably waived its rights to so
increase its Restricted Ownership Percentage. If the Buyer would otherwise be
unable by reason of the Restricted Ownership Percentage to acquire the full
amount of securities which the Buyer would otherwise be entitled to acquire in a
particular transaction pursuant to this Section 5(j) then (A) the Company shall
include in the terms of the securities which the Buyer is entitled to purchase
in such transaction under this Section 5(j) a provision comparable to Section
6.7
of the
Note and (B) if, notwithstanding the inclusion of the provision required by the
immediately preceding clause (1), the Buyer remains unable to acquire the full
amount of securities which the Buyer would otherwise be entitled to acquire
under this Section 5(j), the Buyer’s right to acquire such securities shall be
deferred and if thereafter, at any time or from time to time the Buyer could
acquire all or any part of such securities without exceeding its Restricted
Ownership Percentage, then the Buyer shall be entitled to acquire such
securities at such time or form time to time. The Buyer will provide notice to
the Company when it becomes able to purchase all or any part of such securities
and the closing of each such purchase shall occur on the date that is five
Business Days after the Buyer gives such notice.
(3)
Right Applicable to Successive
Transactions.
The
rights of the Buyer under this Section 5(j) shall apply to all capital raising
transactions described in Section 5(j)(1) that occur during the period specified
in Section 5(j)(1).
(k)
Press
Releases.
Any press
release or other publicity concerning this Agreement or the transactions
contemplated by this Agreement shall be submitted to the Buyer for comment at
least one Business Day prior to issuance, unless the release is required to be
issued within a shorter period of time pursuant to this Agreement or by law or
pursuant to the rules of the securities exchange or market which at the time
constitutes the principal market for the Common Stock.
The
Company shall, contemporaneously with the Closing on the Closing Date or as
promptly as possible thereafter on the Closing Date, issue a press release, in
the form of
Annex VI
hereto,
concerning the transactions contemplated hereby. The Company's other press
releases and other public information, to the extent concerning the Transaction
Documents, shall contain such information as reasonably requested by the Buyer
and be reasonably approved by the Buyer prior to issuance.
(l)
Form 8-K; Limitation on Information
and Buyer Obligations.
(1)
Within two Business Days after the Closing Date, the Company will publicly
report the issue and sale of the Note and Warrants and the securities issued
pursuant to the Other Purchase Agreements entered into on or before the Closing
Date by filing with the SEC a Current Report on Form 8-K under the 1934 Act,
which report shall describe the material terms of the transactions contemplated
hereby and thereby and include copies of the forms of the Transaction Documents
as exhibits to such report (the “Transaction Form 8-K”). The Company
acknowledges and agrees that, upon the filing of the Transaction Form 8-K with
the SEC, the Buyer shall not be in possession of any material nonpublic
information received from the Company, any Subsidiary or any of their respective
officers, directors, employees or agents.
(2)
The
Company shall not provide, and shall cause each Subsidiary and the respective
officers, directors, employees and agents of the Company and the Subsidiaries
not to provide, the Buyer any material nonpublic information regarding the
Company or any Subsidiary from and after the date the Company files, or is
required by this Agreement to file, the Transaction Form 8-K with the SEC
without the prior express written consent of the Buyer.
(m)
Limitation on Certain
Transactions.
From the
date of this Agreement until after the SEC Effective Date of the Registration
Statement contemplated by Section 8(a)(1), without the prior written consent of
the Buyer (which consent may be withheld in the Buyer’s sole discretion), the
Company shall not issue or sell or agree to issue or sell any securities (aside
from the Other Notes and the Other Warrants and the shares of Common Stock
issuable upon conversion or exercise thereof) in a capital raising transaction,
unless such securities will not be, and are not, registered for sale or resale
under the 1933 Act until on or after such SEC Effective Date; provided, however,
that the limitation of this Section 5(m) shall not apply to (a) shares of Common
Stock or options to employees, officers, directors or consultants of the Company
pursuant to any stock or option plan duly adopted by a majority of the
non-employee members of the Board of Directors of the Company or a majority of
the members of a committee of non-employee directors established for such
purpose, (b) securities upon the exercise or exchange of or conversion of any
Securities issued hereunder and/or securities exercisable or exchangeable for or
convertible into shares of Common Stock issued and outstanding on the date of
this Agreement, provided that such securities have not been amended since the
date of this Agreement to increase the number of such securities or to decrease
the exercise, exchange or conversion price of any such securities, and (c)
securities issued pursuant to acquisitions or strategic transactions, provided
any such issuance shall only be to a Person which is, itself or through its
subsidiaries, an operating company in a business synergistic with the business
of the Company and in which the Company receives benefits in addition to the
investment of funds, but shall not include a transaction in which the Company is
issuing securities primarily for the purpose of raising capital or to an entity
whose primary business is investing in securities (collectively, an “Exempt
Issuance”). The Company agrees that, except for the amounts of securities to be
purchased and the name of the buyer and the Restricted Ownership Percentage, the
terms and provisions of the Other Notes and the Other Warrants shall be
identical to the Note and the Warrants.
(n)
Debt Obligation.
So long
as any portion of the Note is outstanding, the Company shall cause its books and
records to reflect the Note as a debt of the Company in its unpaid principal
amount, shall cause its financial statements to reflect the Note as a debt of
the Company in accordance with Generally Accepted Accounting Principles and as a
valid senior debt obligation of the Company for money borrowed that is secured
by the Collateral (unless all Collateral shall have been released pursuant to
the Security Agreement and the security interest thereunder shall have
terminated).
(o)
Security Agreement; Financing
Statements, Etc.
The
Company agrees to execute and deliver to the Collateral Agent at or before the
Closing the Patent and Trademark Security Agreement in the form attached hereto
as
Annex III
and the
Pledge and Security Agreement in the form attached hereto as
Annex IV
. The
Company shall prepare and at or before the Closing Date file with the
appropriate officials, Uniform Commercial Code financing statements on Form
UCC-1 relating to the Collateral in which the Company is granting a security
interest to the Collateral Agent for the benefit of the holders of the Note and
the Other Notes pursuant to the Pledge and Security Agreement; and prepare and
file with the PTO appropriate documents relating to the Collateral in which the
Company is granting a security interest to the Collateral Agent for the benefit
of the holders of the Note and the Other Notes pursuant to the Patent and
Trademark Security Agreement. Prior to the Closing, the Company shall provide to
the Buyer evidence of such filings and customary, current search reports of the
relevant Uniform Commercial Code filing offices and the PTO.
(p)
Short Sales and Confidentiality
After The Date Hereof.
The Buyer
covenants that neither it nor any affiliates acting on its behalf or pursuant to
any understanding with it will execute any Short Sales during the period
commencing
from
the time
that the Buyer first received a term sheet from the Company or any other Person
setting forth the material terms of the transactions contemplated hereunder and
ending on the earlier of (i) the date that the transactions contemplated by this
Agreement are first publicly announced subsequent to the Closing Date as
described in Section 5(k) and (ii) the date, if applicable, that this Agreement
is terminated pursuant to Section 10(l). The Buyer covenants that until such
time as the transactions contemplated by this Agreement are publicly disclosed
by the Company as described in Section 5(k) or the earlier termination of this
Agreement, the Buyer will maintain the confidentiality of all disclosures made
to it in connection with this transaction (including the existence and terms of
this transaction). The Buyer understands and acknowledges that the SEC currently
takes the position that coverage of short sales of shares of the Common Stock
“against the box” prior to the effective date of the Registration Statement with
the Securities is a violation of Section 5 of the 1933 Act, as set forth in Item
65, Section 5 under Section A, of the Manual of Publicly Available Telephone
Interpretations, dated July 1997, compiled by the Office of Chief Counsel,
Division of Corporation Finance. Notwithstanding the foregoing, the Buyer does
not make any representation, warranty or covenant hereby that it will not engage
in Short Sales in the securities of the Company after the earlier of (i) the
date that the transactions contemplated by this Agreement are first publicly
announced subsequent to the Closing Date as described in Section 5(k) and (ii)
the date, if applicable, that this Agreement is terminated pursuant to Section
10(l). Notwithstanding the foregoing, in the case of a Buyer that is a
multi-managed investment vehicle whereby separate portfolio managers manage
separate portions of such Buyer's assets and the portfolio managers have no
direct knowledge of the investment decisions made by the portfolio managers
managing other portions of such Buyer's assets, the covenant set forth above
shall only apply with respect to the portion of assets managed by the portfolio
manager that made the investment decision to purchase the Securities covered by
this Agreement.
6.
CONDITIONS TO THE COMPANY’S
OBLIGATION TO SELL.
The Buyer
understands that the Company’s obligation to sell the Note and issue the
December Closing Date Warrant to the Buyer pursuant to this Agreement is
conditioned upon satisfaction of the following conditions precedent on or before
the Closing Date (any or all of which may be waived by the Company in its sole
discretion):
(a)
On the
Closing Date, no legal action, suit or proceeding shall be pending or threatened
which seeks to restrain or prohibit the transactions contemplated by this
Agreement; and
(b)
The
representations and warranties of the Buyer contained in this Agreement shall
have been true and correct on the date of this Agreement and on the Closing Date
as if made on the Closing Date and on or before the Closing Date the Buyer shall
have performed all covenants and agreements of the Buyer contained in this
Agreement and required to be performed by the Buyer on or before the Closing
Date.
7.
CONDITIONS TO THE BUYER’S OBLIGATION
TO PURCHASE.
The
Company understands that the Buyer’s obligation to purchase the Note and acquire
the December Closing Date Warrant is conditioned upon satisfaction of the
following conditions precedent on or before the Closing Date (any or all of
which may be waived by the Buyer in its sole discretion):
(a)
No legal
action, suit or proceeding shall be pending or threatened which seeks to
restrain or prohibit the transactions contemplated by this
Agreement;
(b)
The
representations and warranties of the Company contained in this Agreement shall
have been true and correct on the date of this Agreement and shall be true and
correct on the Closing Date as if given on and as of the Closing Date (except
for representations given as of a specific date, which representations shall be
true and correct as of such date), and on or before the Closing Date the Company
shall have performed all covenants and agreements of the Company contained
herein or in any of the other Transaction Documents required to be performed by
the Company on or before the Closing Date;
(c)
No event
which, if the Note were outstanding, (1) would constitute an Event of Default or
which, with the giving of notice or the passage of time, or both, would
constitute an Event of Default shall have occurred and be continuing or (2)
would constitute a Repurchase Event or which, with the giving of notice or the
passage of time, or both, would constitute a Repurchase Event shall have
occurred and be continuing;
(d)
The
Company shall have delivered to the Buyer a certificate, dated the Closing Date,
duly executed by its Chief Executive Officer or Chief Financial Officer, to the
effect set forth in subparagraphs (a), (b) and (c) of this Section
7;
(e) The
Company shall have delivered to the Buyer an appropriate certificate, dated the
Closing Date, of the Secretary of the Company certifying (1) the Certificate of
Incorporation and By-Laws of the Company as in effect on the Closing Date, and
(2) all resolutions of the Board of Directors (and committees thereof) of the
Company relating to this Agreement and the other Transaction Documents and the
transactions contemplated hereby and thereby;
(f) The
closings under the Other Note Purchase Agreements shall have
occurred;
(g)
The
Conversion Shares and the Warrant Shares shall have been approved for listing,
subject only to official notice of issuance, by the AMEX and the Buyer shall
have received written evidence of such approval by the AMEX;
(h)
On the
Closing Date, the Buyer shall have received an opinion of Sichenzia Ross
Friedman Ference LLP, counsel for the Company, dated the Closing Date, addressed
to the Buyer, in the form substantially similar to the attached as
Annex VII
and an
opinion of Epstein Drangel Bazerman & James, LLP, intellectual property
counsel for the Company, dated the Closing Date, addressed to the Buyer, in the
form substantially similar to the attached as
Annex VIII
;
and
(i)
On the
Closing Date, (i) trading in securities on the New York Stock Exchange, Inc.,
the AMEX, Nasdaq or the Nasdaq Capital Market shall not have been suspended or
materially limited and (ii) a general moratorium on commercial banking
activities in the State of New York shall not have been declared by either
federal or state authorities.
(j) All
filings of financing statements necessary or appropriate under the Uniform
Commercial Code in connection with the Pledge and Security Agreement shall have
been made, and the Buyer shall have received satisfactory evidence of such
filings; and
(k) None
of the Other Notes shall have been redeemed by the Company;
8.
REGISTRATION
RIGHTS.
(a)
Mandatory
Registration.
(1) The
Company shall prepare and, as expeditiously as possible, but in no event later
than the date which is 90 days after the Closing Date, file with the SEC a
Registration Statement which covers the resale by the Buyer of a number of
shares of Common Stock equal to the sum of (A) the number of Conversion Shares
issuable upon conversion of the Note
plus
(B) the
number of Warrant Shares issuable upon exercise of the Warrants, as Registrable
Securities, and which Registration Statement shall state that, in accordance
with Rule 416 under the 1933 Act, such Registration Statement also covers such
indeterminate number of additional shares of Common Stock as may become issuable
upon conversion of the Note or exercise of the Warrants to prevent dilution
resulting from stock splits, stock dividends or similar transactions. Such
Registration Statement may also cover the resale by other holders of shares of
Common Stock issued or issuable by the Company pursuant to any equity or
convertible debt financing completed by the Company prior to the SEC Filing
Date.
(2)
Prior to
the earlier of the (i) SEC Effective Date, or (ii) two (2) years from the date
hereof, the Company shall not file any other registration statement or any
amendment thereto with the SEC under the 1933 Act or request the acceleration of
the effectiveness of any other registration statement previously filed with the
SEC, other than (A) any registration statement on Form S-8 and (B) any
registration statement or amendment which the Company is required to file, or as
to which the Company is required to request acceleration, pursuant to any
obligation in effect on the date of execution and delivery of this
Agreement.
(3)
If at any
time or from time to time after the Closing Date any Investor shall hold or be
the beneficial owner of any Registrable Securities, other than those Registrable
Securities included in the Registration Statement that the Company is required
to file under Section 8(a)(1), which Registrable Securities are not covered by a
Registration Statement, then promptly following the written demand of any
Investor following the issuance of such additional Registrable Securities or the
issuance of any securities convertible into, exchangeable for, or otherwise
entitling an Investor to acquire, such additional Registrable Securities, and in
any event within 30 days following such demand, the Company shall prepare and
file with the SEC a new Registration Statement on Form S-3 (or, if Form S-3 is
not then available to the Company, on such form of registration statement as is
then available to effect a registration for resale of such additional
Registrable Securities) covering the resale by such Investor of such additional
Registrable Securities. Such Registration Statement also shall cover, to the
extent permitted by the 1933 Act and the rules promulgated thereunder (including
Rule 416), such indeterminate number of additional securities resulting from
stock splits, stock dividends or similar transactions with respect to such
additional Registrable Securities. Nothing herein shall limit the Company’s
obligations or any Investor’s rights under Section 6.4 of the Note or Section 9
of the Warrants.
(4)
If a
Payment Event occurs, then the Company will make payments to the Buyer, in
immediately available funds in lawful money of the United States, as partial
liquidated damages for the minimum amount of damages to the Buyer by reason
thereof, and not as a penalty, which payments shall accrue at the rate of 1.0%
per month of the principal amount of the Note at the time outstanding during
each Payment Period. Each such payment shall be due and payable within five
Business Days after the end of each calendar month during which any Payment
Period occurs until the termination of such Payment Period and within five
Business Days after such termination. Such payments shall be in partial
compensation to the Buyer, and shall not constitute the Buyer’s exclusive remedy
for any Payment Event. A particular Payment Period shall terminate upon (u) the
filing of the applicable Registration Statement, in the case of clause (i) of
the definition of “Payment Event”; (v) the applicable SEC Effective Date for the
particular Registration Statement, in the case of clause (ii) or (iii) of the
definition of “Payment Event”; (w) the ability of the Buyer to effect sales
pursuant to the applicable Registration Statement, in the case of clause (iv) of
the definition of “Payment Event”; (x) the listing or inclusion and/or trading
of the Common Stock on a Trading Market, as the case may be, in the case of
clause (v) of the definition of “Payment Event”; (y) the issuance and delivery
of the shares, in the case of clause (vi) of the definition of “Payment Event”;
and (z) in the case of the events described in clauses (ii), (iii) and (iv) of
the definition of “Payment Event”, the earlier termination of the Registration
Period, and in each such case in the preceding clauses (u) thorough (z), any
Payment Period that commenced by reason of the occurrence of any Payment Event
shall terminate if at the time (1) no other Payment Event is continuing or (2)
subject to the rights of any transferee under Section 10(j), the Buyer no longer
holds any portion of the Note or any Registrable Securities. Notwithstanding any
other provision of this Section 8(a)(4) to the contrary, the Company shall not
be obligated to make any payments hereunder for Payment Periods in excess of an
aggregate of 548 days. If the Company fails to pay any liquidated damages
pursuant to this Section in full within three days after the date payable, the
Company will pay interest thereon at a rate of 16% per annum (or such lesser
rate as is the highest rate permitted by applicable law) to the Buyer, accruing
daily from the date such liquidated damages are due until such amounts, plus all
such interest thereon, are paid in full.
(5) Notwithstanding
the foregoing, the registration rights set forth in this Section 8 apply to the
Note and December Closing Date Warrant. The July 2006 Warrant shall have the
same registration rights
mutatis mutandis
as, and
be registered with, the Other Warrants pursuant to the registration rights set
forth in the Other Note Purchase Agreement.
(b)
Obligations of the
Company.
In
connection with the registration of the Registrable Securities, the Company
shall:
(1)
use its
best efforts to cause each Registration Statement to become effective as
promptly as possible after the filing thereof
and to
keep such Registration Statement effective at all times during the Registration
Period. The Company shall submit to the SEC, within three Business Days after
the Company learns that no review of such Registration Statement will be made by
the staff of the SEC or that the staff of the SEC has no further comments on
such Registration Statement, as the case may be, a request for acceleration of
effectiveness of such Registration Statement to a time and date not later than
48 hours after the submission of such request. The Company represents and
warrants to the Investors that (a) each Registration Statement (including any
amendment or supplement thereto and prospectus contained therein), at the time
it is first filed with the SEC, at the time it is ordered effective by the SEC
and at all times during which it is required to be effective hereunder (and each
such amendment and supplement at the time it is filed with the SEC and at all
times during which it is available for use in connection with the offer and sale
of the Registrable Securities) shall not contain any untrue statement of a
material fact or omit to state a material fact required to be stated therein or
necessary to make the statements therein not misleading and (b) each Prospectus,
at the time the related Registration Statement is declared effective by the SEC
and at all times that such Prospectus is required by this Agreement to be
available for use by any Investor and, in accordance with Section 8(c)(4), any
Investor is entitled to sell Registrable Securities pursuant to such Prospectus,
shall not contain any untrue statement of a material fact or omit to state a
material fact required to be stated therein, or necessary to make the statements
therein, in light of the circumstances in which they were made, not
misleading;
(2)
subject
to Section 8(b)(5), prepare and file with the SEC such amendments (including
post-effective amendments) and supplements to each Registration Statement and
Prospectus as may be necessary to keep such Registration Statement effective,
and such Prospectus current, at all times during the Registration Period, and,
during the Registration Period (other than during any Blackout Period during
which the provisions of Section 8(b)(5)(B) are applicable), comply with the
provisions of the 1933 Act applicable to the Company in order to permit the
disposition by the Investors of all Registrable Securities covered by such
Registration Statement;
(3)
furnish
to Investors whose Registrable Securities are included in a particular
Registration Statement and such Investors’ respective legal counsel, promptly
after the same is prepared and publicly distributed, filed with the SEC or
received by the Company, (1) one conformed copy of such Registration Statement
and any amendment thereto and the related Prospectus and each amendment or
supplement thereto and (2) such number of copies of such Prospectus and all
amendments and supplements thereto and such other documents, as such Investor
may reasonably request in order to facilitate the disposition of the Registrable
Securities owned by such Investor; and notify the Investor and its legal counsel
within one Business Day after the same is filed with the SEC, or received by the
Company, of the filing or receipt of each letter written by or on behalf on the
Company to the SEC or the staff of the SEC, and each item of correspondence from
the SEC or the staff of the SEC, in each case relating to such Registration
Statement (other than any portion of any thereof which contains information for
which the Company has sought confidential treatment), and permit counsel
designed by the Investor to review letters and items of correspondence upon the
request of such counsel;
(4)
subject
to Section 8(b)(5), use its best efforts (i) to register and qualify the
Registrable Securities covered by each Registration Statement under the
securities or blue sky laws of such jurisdictions as any Investor who owns or
holds any Registrable Securities reasonably requests, (ii) to prepare and to
file in those jurisdictions such amendments (including post-effective
amendments) and supplements to such registrations and qualifications as may be
necessary to maintain the effectiveness thereof at all times during the
Registration Period and (iii) to take all other actions reasonably necessary or
advisable to qualify the Registrable Securities for sale by the Investors in
such jurisdictions;
provided,
however,
that the
Company shall not be required in connection therewith or as a condition thereto
(I) to qualify to do business in any jurisdiction where it would not otherwise
be required to qualify but for this Section 8(b)(4), (II) to subject itself to
general taxation in any such jurisdiction, (III) to file a general consent to
service of process in any such jurisdiction, (IV) to provide any undertakings
that cause more than nominal expense or burden to the Company or (V) to make any
change in its certificate or article of incorporation or by-laws which the Board
of Directors of the Company determines to be contrary to the best interests of
the Company and its stockholders;
(5)
(A) as
promptly as practicable after becoming aware of such event or circumstance,
notify each Investor of the occurrence of any event or circumstance of which the
Company has knowledge (x) as a result of which any Prospectus, as then in
effect, includes an untrue statement of a material fact or omits to state a
material fact required to be stated therein or necessary to make the statements
therein, in light of the circumstances under which they were made, not
misleading, (y) which requires the Company to amend or supplement any
Registration Statement due to the receipt from an Investor or any other selling
stockholder named in the Prospectus of new or additional information about such
Investor or selling stockholder or its intended plan of distribution of its
Registrable Securities or other securities covered by such Registration
Statement, or (z) which requires the Company to amend or supplement any
Registration Statement pursuant to the Company’s undertakings as set forth in
the Registration Statement and in Item 512 of Regulation S-K under the 1933 Act,
and use its best efforts promptly to prepare a supplement or amendment to such
Registration Statement and Prospectus to correct such untrue statement or
omission or to add any new or additional information, and deliver a number of
copies of such supplement or amendment to each Investor as such Investor may
reasonably request;
(B)
notwithstanding
Section 8(b)(5)(A) above, if at any time the Company notifies the Investors as
contemplated by Section 8(b)(5)(A) with respect to a particular Registration
Statement or Prospectus the Company also notifies the Investors that the event
giving rise to such notice relates to a development involving the Company which
occurred subsequent to the later of (x) the SEC Effective Date of the applicable
Registration Statement and (y) the latest date prior to such notice on which the
Company has amended or supplemented such Registration Statement, then the
Company shall not be required to use best efforts to make such amendment during
a Blackout Period;
provided,
however,
that in
any period of 365 consecutive days the Company shall not be entitled to avail
itself of its rights under this Section 8(b)(5)(B) with respect to more than two
Blackout Periods; and
provided further, however,
that no
Blackout Period may commence sooner than 90 days after the end of an earlier
Blackout Period;
(6)
as
promptly as practicable after becoming aware of such event, notify each Investor
who holds Registrable Securities being offered or sold pursuant to a particular
Registration Statement of the issuance by the SEC of any stop order or other
suspension of effectiveness of such Registration Statement at the earliest
possible time;
(7)
permit
the Investors who hold Registrable Securities being included in a particular
Registration Statement (or their designee) and their counsel to review and have
a reasonable opportunity to comment on such Registration Statement and any
related Prospectus and all amendments and supplements thereto at least two
Business Days prior to their filing with the SEC;
(8)
make
generally available to its security holders as soon as practical, but not later
than 90 days after the close of the period covered thereby, an earning statement
(in form complying with the provisions of Rule 158 under the 1933 Act) covering
a 12-month period beginning not later than the first day of the Company’s fiscal
quarter next following the SEC Effective Date of each Registration
Statement;
(9)
make
available for inspection by any Investor and any Inspector retained by such
Investor, at such Investor’s sole expense, all Records as shall be reasonably
necessary or appropriate to enable such Investor to exercise due diligence for
purposes of the 1933 Act and the 1934 Act as it relates to the Registration
Statement and cause the Company’s and the Subsidiaries officers, directors and
employees to supply all information which such Investor or Inspector may
reasonably request for purposes of such due diligence;
provided, however,
that such
Investor shall hold in confidence and shall not make any disclosure of any
Record or other information which the Company determines in good faith to be
confidential, and of which determination such Investor is so notified, unless
(i) the disclosure of such Record is necessary to avoid or correct a
misstatement or omission in a Registration Statement or Prospectus and a
reasonable time prior to such disclosure the Investor shall have notified the
Company of the need to so correct such misstatement or omission and the Company
shall have failed to correct such misstatement or omission, (ii) the release of
such Record is ordered pursuant to a subpoena or other order from a court or
governmental body of competent jurisdiction or (iii) the information in such
Record has been made generally available to the public other than by disclosure
in violation of this or any other agreement. The Company shall not be required
to disclose any confidential information in such Records to any Inspector until
and unless such Inspector shall have entered into a confidentiality agreement
with the Company with respect thereto, substantially in the form of this Section
8(b)(9), which agreement shall permit such Inspector to disclose Records to the
Investor who has retained such Inspector. Each Investor agrees that it shall,
upon learning that disclosure of such Records is sought in or by a court or
governmental body of competent jurisdiction or through other means, give prompt
notice to the Company and allow the Company, at the Company’s expense, to
undertake appropriate action to prevent disclosure of, or to obtain a protective
order for, the Records deemed confidential. The Company shall hold in confidence
and shall not make any disclosure of information concerning an Investor provided
to the Company pursuant to this Agreement unless (i) the disclosure of such
information is necessary to comply with federal or state securities laws, (ii)
the disclosure of such information is necessary to avoid or correct a
misstatement or omission in a Registration Statement or the related Prospectus,
(iii) the release of such information is ordered pursuant to a subpoena or other
order from a court or governmental body of competent jurisdiction, or (iv) such
information has been made generally available to the public other than by
disclosure in violation of this or any other agreement. The Company agrees that
it shall, upon learning that disclosure of such information concerning an
Investor is sought in or by a court or governmental body of competent
jurisdiction or through other means, give prompt notice to such Investor and
allow such Investor, at such Investor’s expense, to undertake appropriate action
to prevent disclosure of, or to obtain a protective order for, such
information;
(10)
use its
best efforts to cause all the Registrable Securities covered by a particular
Registration Statement as of the SEC Effective Date of such Registration
Statement to be listed, quoted or traded on the principal securities market on
which securities of the same class or series issued by the Company are then
listed, quoted or traded;
(11)
provide a
transfer agent and registrar, which may be a single entity, for the Registrable
Securities at all times;
(12)
cooperate
with the Investors who hold Registrable Securities being offered pursuant to a
particular Registration Statement to facilitate the timely preparation and
delivery of certificates (not bearing any restrictive legends) representing
Registrable Securities to be offered pursuant to such Registration Statement and
enable such certificates to be in such denominations or amounts as the Investors
may reasonably request and registered in such names as the Investors may
request; and, not later than the SEC Effective Date of such Registration
Statement, the Company shall cause legal counsel selected by the Company to
deliver to the Investors whose Registrable Securities are included in the
Registration Statement opinions of counsel in form and substance as is
customarily given to underwriters in an underwritten public offering;
(13)
advise
the Investors in writing on the date that the Registration Statement is declared
effective by the SEC that the form of Prospectus contained in the Registration
Statement at the time of effectiveness meets the requirements of Section 10(a)
of the 1933 Act or that it intends to file a Prospectus pursuant to Rule 424(b)
that meets the requirements of Section 10(a) of the 1933 Act;
(14)
during
the Registration Period, the Company shall not bid for or purchase any Common
Stock or any right to purchase Common Stock or attempt to induce any Person to
purchase any such security or right if such bid, purchase or attempt would in
any way limit the right of the Investors to sell Registrable Securities by
reason of the limitations set forth in Regulation M under the 1934 Act;
and
(15)
take all
other reasonable actions necessary to expedite and facilitate disposition by the
Investors of the Registrable Securities pursuant to the Registration Statement
relating thereto.
(c)
Obligations of the Buyer and other
Investors.
In
connection with the registration of the Registrable Securities, the Investors
shall have the following obligations:
(1)
It shall
be a condition precedent to the obligations of the Company to complete the
registration pursuant to this Agreement with respect to the Registrable
Securities of a particular Investor that such Investor shall furnish to the
Company completed Selling Securityholder Questionnaire in the form attached
hereto as
Exhibit A
and
shall execute such other documents in connection with such registration as the
Company may reasonably request.
(2)
Each
Investor by such Investor’s acceptance of the Registrable Securities agrees to
cooperate with the Company as reasonably requested by the Company in connection
with the preparation and filing of each Registration Statement hereunder that
covers such Registrable Securities, unless such Investor has notified the
Company of such Investor’s election to exclude all of such Investor’s
Registrable Securities from such Registration Statement;
(3)
Each
Investor agrees that it will not effect any disposition of the Registrable
Securities except as contemplated in the applicable Registration Statement or
Prospectus or as otherwise is in compliance with applicable securities laws and
that it will promptly notify the Company of any material changes in the
information set forth in the Registration Statement regarding such Investor or
its plan of distribution before selling any Registrable Securities pursuant to
such Registration Statement or Prospectus subsequent to such material change;
each Investor agrees (a) to notify the Company in writing in the event that such
Investor enters into any material agreement with a broker or a dealer for the
sale pursuant to a Registration Statement of Registrable Securities through a
block trade, special offering, exchange distribution or a purchase by a broker
or dealer and (b) in connection with such agreement, to provide to the Company
in writing the information necessary to prepare any supplemental Prospectus
pursuant to Rule 424(c) under the 1933 Act which is required with respect to
such transaction; and
(4)
Each
Investor acknowledges that there may occasionally be times as specified in
Section 8(b)(5) or 8(b)(6) when the Company must suspend the use of a Prospectus
until such time as an amendment to the related Registration Statement has been
filed by the Company and declared effective by the SEC, the Company has prepared
a supplement to such Prospectus or the Company has filed an appropriate report
with the SEC pursuant to the 1934 Act. Each Investor hereby covenants that it
will not sell any Registrable Securities pursuant to such Prospectus during the
period commencing at the time at which the Company gives such Investor notice of
the suspension of the use of such Prospectus in accordance with Section 8(b)(5)
or 8(b)(6) and ending at the time the Company gives such Investor notice that
such Investor may thereafter effect sales pursuant to the Prospectus, or until
the Company delivers to such Investor or files with the SEC an amended or
supplemented Prospectus.
(d)
Rule 144.
With a
view to making available to each Investor the benefits of Rule 144, the Company
agrees:
(1)
so long
as any Investor owns Registrable Securities, promptly upon request of such
Investor, to furnish to such Investor such information as may be necessary to
permit such Investor to sell Registrable Securities pursuant to Rule 144 without
registration and otherwise reasonably to cooperate with such Investor
and
(2)
if at any
time the Company is not required by applicable law or this Agreement to file
reports with the SEC pursuant to Section 13 or 15(d) of the 1934 Act, to use its
best efforts, upon the request of an Investor, to make publicly available other
information so long as is necessary to permit publication by brokers and dealers
of quotations for the Common Stock and sales of the Registrable Securities in
accordance with Rule 15c2-11 under the 1934 Act.
9.
INDEMNIFICATION AND
CONTRIBUTION.
(a)
Indemnification.
(1) To
the extent not prohibited by applicable law, the Company will indemnify and hold
harmless each Indemnified Person against any Claims to which any of them may
become subject under the 1933 Act, the 1934 Act or otherwise, insofar as such
Claims (or actions or proceedings, whether commenced or threatened, in respect
thereof) arise out of or are based upon any Violation. Subject to the
restrictions set forth in Section 9(a)(3) with respect to the number of legal
counsel, the Company shall reimburse the Investors and each such controlling
Person, promptly as such expenses are incurred and are due and payable, for any
documented reasonable legal fees or other documented and reasonable expenses
incurred by them in connection with investigating or defending any such Claim.
Notwithstanding anything to the contrary contained herein, the indemnification
agreement contained in this Section 9(a)(1) shall not apply to: (I) a Claim
arising out of or based upon a Violation which occurs in reliance upon and in
conformity with information relating to an Indemnified Person furnished in
writing to the Company by such Indemnified Person or an underwriter for such
Indemnified Person expressly for use in connection with the preparation of any
Registration Statement or any such amendment thereof or supplement thereto; (II)
any Claim arising out of or based on any statement or omission in any
Prospectus, which statement or omission was corrected in any subsequent
Prospectus that was delivered to the Indemnified Person prior to the pertinent
sale or sales of Registrable Securities by such Indemnified Person; and (III)
amounts paid in settlement of any Claim if such settlement is effected without
the prior written consent of the Company. Such indemnity shall remain in full
force and effect regardless of any investigation made by or on behalf of the
Indemnified Person and shall survive the transfer of the Registrable Securities
by the Investors.
(2)
In
connection with each Registration Statement, each Investor who is named as a
selling stockholder in such Registration Statement agrees to indemnify and hold
harmless, to the same extent and in the same manner set forth in Section
9(a)(1), each Indemnified Party against any Claim to which any of them may
become subject, under the 1933 Act, the 1934 Act or otherwise, insofar as such
Claim arises out of or is based upon any Violation, in each case to the extent
(and only to the extent) that such Violation occurs in reliance upon and in
conformity with written information furnished to the Company by such Investor
expressly for use in connection with such Registration Statement or any
amendment thereof or supplement thereto; and such Investor will reimburse any
legal or other expenses reasonably incurred by them in connection with
investigating or defending any such Claim;
provided
,
however
, that
the indemnity agreement contained in this Section 9(a)(2) shall not apply to
amounts paid in settlement of any Claim if such settlement is effected without
the prior written consent of such Investor;
provided
,
further
,
however
, that an
Investor shall be liable under this Section 9(a)(2) for only that amount of all
Claims in the aggregate as does not exceed the amount by which the proceeds to
such Investor as a result of the sale of Registrable Securities pursuant to such
Registration Statement exceeds the amount paid by such Investor for such
Registrable Securities or for the Common Stock Equivalents pursuant to which
such Registrable Securities were issued, as the case may be. Such indemnity
shall remain in full force and effect regardless of any investigation made by or
on behalf of such Indemnified Party and shall survive the transfer of the
Registrable Securities by the Investors. Notwithstanding anything to the
contrary contained herein, the indemnification agreement contained in this
Section 9(a)(2) with respect to any preliminary prospectus shall not inure to
the benefit of any Indemnified Party if the untrue statement or omission of
material fact contained in such preliminary prospectus was corrected on a timely
basis in the related Prospectus, as then amended or supplemented.
(3)
Promptly
after receipt by an Indemnified Person or Indemnified Party under this Section
9(a) of notice of the commencement of any action (including any governmental
action), such Indemnified Person or Indemnified Party shall, if a Claim in
respect thereof is to be made against any indemnifying party under this Section
9(a), deliver to the indemnifying party a notice of the commencement thereof and
the indemnifying party shall have the right to participate in, and, to the
extent the indemnifying party so desires, jointly with any other indemnifying
party similarly noticed, to assume control of the defense thereof with counsel
reasonably satisfactory to the Indemnified Person or the Indemnified Party, as
the case may be;
provided
,
however
, that an
Indemnified Person or Indemnified Party shall have the right to retain its own
counsel with the fees and expenses to be paid by the indemnifying party, if, in
the reasonable opinion of counsel retained by the indemnifying party, the
representation by such counsel of the Indemnified Person or Indemnified Party
and the indemnifying party would be inappropriate due to actual or potential
differing interests between such Indemnified Person or Indemnified Party and any
other party represented by such counsel in such proceeding, in which case the
indemnifying party shall not be responsible for more than one such separate
counsel, and one local counsel in each jurisdiction in which an action is
pending, for all Indemnified Persons or Indemnified Parties, as the case may be.
The failure to deliver notice to the indemnifying party within a reasonable time
of the commencement of any such action shall not relieve such indemnifying party
of any liability to the Indemnified Person or Indemnified Party under this
Section 9(a), except to the extent that the indemnifying party is prejudiced in
its ability to defend such action. The indemnification required by this Section
9(a) shall be made by periodic payments of the amount thereof during the course
of the investigation or defense, as such expense, loss, damage or liability is
incurred and is due and payable.
(b)
Contribution.
To the
extent any indemnification by an indemnifying party as set forth in Section 9(a)
above is applicable by its terms but is prohibited or limited by law, the
indemnifying party agrees to make the maximum contribution with respect to any
amounts for which it would otherwise be liable under Section 9(a) to the fullest
extent permitted by law. In determining the amount of contribution to which the
respective parties are entitled, there shall be considered the relative fault of
each party, the parties’ relative knowledge of and access to information
concerning the matter with respect to which the claim was asserted, the
opportunity to correct and prevent any statement or omission and any other
equitable considerations appropriate under the circumstances;
provided
,
however
, that
(a) no contribution shall be made under circumstances where the maker would not
have been liable for indemnification under the fault standards set forth in
Section 9(a), (b) no Person guilty of fraudulent misrepresentation (within the
meaning of Section 11(f) of the 1933 Act) shall be entitled to contribution from
any other Person who was not guilty of such fraudulent misrepresentation and (c)
the aggregate contribution by any seller of Registrable Securities shall be
limited to the amount by which the proceeds received by such seller from the
sale of such Registrable Securities exceeds the amount paid by such Investor for
such Registrable Securities or for the Common Stock Equivalents pursuant to
which such Registrable Securities were issued, as the case may be.
(c)
Other
Rights.
The
indemnification and contribution provided in this Section shall be in addition
to any other rights and remedies available at law or in equity.
10.
MISCELLANEOUS.
(a)
Governing
Law.
THIS
AGREEMENT SHALL BE GOVERNED BY AND INTERPRETED IN ACCORDANCE WITH THE LAWS OF
THE STATE OF NEW YORK.
(b)
Headings.
The
headings, captions and footers of this Agreement are for convenience of
reference and shall not form part of, or affect the interpretation of, this
Agreement.
(c)
Severability.
If any
provision of this Agreement shall be invalid or unenforceable in any
jurisdiction, such invalidity or unenforceability shall not affect the validity
or enforceability of the remainder of this Agreement or the validity or
enforceability of this Agreement in any other jurisdiction.
(d)
Notices.
Any
notices required or permitted to be given under the terms of this Agreement
shall be in writing and shall be sent by certified mail, personal delivery,
telephone line facsimile transmission or courier and shall be effective five
days after being placed in the mail, if mailed, or upon receipt, if delivered
personally, by telephone line facsimile transmission or by courier, in each case
addressed to a party at such party’s address (or telephone line facsimile
transmission number) shown in the introductory paragraph or on the signature
page of this Agreement or such other address (or telephone line facsimile
transmission number) as a party shall have provided by notice to the other party
in accordance with this provision. In the case of any notice to the Company,
such notice shall be addressed to the Company at its address shown in the
introductory paragraph of this Agreement, Attention: Chief Executive Officer
(telephone line facsimile number (425) 749-3601).
(e)
Counterparts.
This
Agreement may be executed in counterparts and by the parties hereto on separate
counterparts, each of which shall be deemed to be an original and all of which
together shall constitute one and the same instrument. A telephone line
facsimile transmission of this Agreement bearing a signature on behalf of a
party hereto shall be legal and binding on such party. Although this Agreement
is dated as of the date first set forth above, the actual date of execution and
delivery of this Agreement by each party is the date set forth below such
party’s signature on the signature page hereof. Any reference in this Agreement
or in any of the documents executed and delivered by the parties hereto in
connection herewith to (1) the date of execution and delivery of this Agreement
by the Buyer shall be deemed a reference to the date set forth below the Buyer’s
signature on the signature page hereof, (2) the date of execution and delivery
of this Agreement by the Company shall be deemed a reference to the date set
forth below the Company’s signature on the signature page hereof and (3) the
date of execution and delivery of this Agreement, or the date of execution and
delivery of this Agreement by the Buyer and the Company, shall be deemed a
reference to the later of the dates set forth below the signatures of the
parties on the signature page hereof.
(f)
Entire Agreement;
Benefit.
This
Agreement, including the Annexes, Schedules and Exhibits hereto, and Section 8
of the Other Note Purchase Agreement with regard to the registration rights for
the July 2006 Warrant set forth in Section 8(a)(5) of this Agreement,
constitutes the entire agreement between the parties hereto with respect to the
subject matter hereof. There are no restrictions, promises, warranties, or
undertakings, other than those set forth or referred to herein and in the
Annexes and Exhibits. This Agreement, including the Annexes and Exhibits,
supersedes all prior agreements and understandings, whether written or oral,
between the parties hereto with respect to the subject matter hereof. This
Agreement and the terms and provisions hereof are for the sole benefit of only
the Company, the Buyer and their respective successors and permitted
assigns.
(g)
Waiver.
Failure
of any party to exercise any right or remedy under this Agreement or otherwise,
or delay by a party in exercising such right or remedy, or any course of dealing
between the parties, shall not operate as a waiver thereof or an amendment
hereof, nor shall any single or partial exercise of any such right or power, or
any abandonment or discontinuance of steps to enforce such a right or power,
preclude any other or further exercise thereof or exercise of any other right or
power.
(h)
Amendment.
(1)
No
amendment, modification, waiver, discharge or termination of any provision of
this Agreement on or prior to the Closing Date nor consent to any departure by
the Buyer or the Company therefrom on or prior to the Closing Date shall in any
event be effective unless the same shall be in writing and signed by the party
to be charged with enforcement, and in any such case shall be effective only in
the specific instance and for the purpose for which given.
(2)
No
amendment, modification, waiver, discharge or termination of any provision of
this Agreement after the Closing Date nor consent to any departure by the
Company therefrom after the Closing Date shall in any event be effective unless
the same shall be in writing and signed (x) by the Company, if the Company is to
be charged with enforcement or (y) by the Majority Holders, if the Buyer is to
be charged with enforcement, and in any such case shall be effective only in the
specific instance and for the purpose for which given but shall nonethless bind
the Buyer and its transferees, successors and assigns;
provided, however
, that no
such amendment modification, waiver, discharge or termination which (i)
increases the Buyer’s liability, (ii) amends this Section 10(h) or (iii)
adversely affects the Buyer’s rights under Sections 5(a), 5(b), 5(c), 5(d),
5(e), 5(f), 5(j), 5(k), 5(l), 5(m), 8(a), 8(b) and 9, shall be effective unless
in writing signed by the Buyer.
(3)
No course
of dealing between the parties hereto shall operate as an amendment of this
Agreement.
(i)
Further
Assurances.
Each
party to this Agreement will perform any and all acts and execute any and all
documents as may be necessary and proper under the circumstances in order to
accomplish the intents and purposes of this Agreement and to carry out its
provisions.
(j)
Assignment of Certain Rights and
Obligations.
The
rights of an Investor under Sections 5(a), 5(b), 8, 9, and 10 of this Agreement
shall be automatically assigned by such Investor to any transferee of all or any
portion of such Investor’s Registrable Securities (or all or any portion of the
Note or the Warrants) if: (1) such Investor agrees in writing with such
transferee to assign such rights, and a copy of such agreement is furnished to
the Company within a reasonable time after such assignment, (2) the Company is,
within a reasonable time after such transfer, furnished with notice of (A) the
name and address of such transferee and (B) the securities with respect to which
such rights and obligations are being transferred, (3) in the case of assignment
of rights under Section 8, immediately following such transfer or assignment the
further disposition of Registrable Securities by the transferee or assignee is
restricted under the 1933 Act and applicable state securities laws, (4) at or
before the time the Company received the notice contemplated by clause (2) of
this sentence the transferee agrees in writing with the Company to be bound with
respect to such assigned securities by such of the provisions contained in
Sections 5(a), 5(b), 8, 9, and 10 hereof as shall have been so assigned to such
transferee and (5) if Section 5(a) shall be applicable to such transfer, such
Investor shall have complied with Section 5(a). Upon any such transfer, the
Company shall be obligated to such transferee to perform all of its covenants
under Sections 5(a), 5(b), 8, 9, and 10 of this Agreement, to the extent the
same have been so assigned to such transferee, as if such transferee were the
Buyer. In connection with any such transfer the Company shall, at its sole cost
and expense, promptly after such transfer take such actions as shall be
reasonably acceptable to the transferring Investor and such transferee to assure
that each Registration Statement and related Prospectus for which the
transferring Investor is a selling stockholder are or become available for use
by such transferee for sales of the Registrable Securities in respect of which
such rights and obligations have been so transferred.
(k)
Expenses.
The
Company shall be responsible for its expenses (including, without limitation,
the legal fees and expenses of its counsel), incurred by it in connection with
the negotiation and execution of, and closing under, and performance of, this
Agreement. All expenses incurred in connection with registrations, filings or
qualifications pursuant to Sections 5(d), 5(e), 5(g)
and 8 of
this Agreement shall be paid by the Company, including, without limitation, all
registration, listing and qualifications fees, printers and accounting fees and
the fees and disbursements of counsel for the Company but excluding (a) fees and
expenses of investment bankers or other advisors retained by any Investor and
(b) brokerage commissions incurred by any Investor. The Company shall pay
promptly upon demand all expenses incurred by the Buyer after the Closing Date,
including reasonable attorneys’ fees and expenses, as a consequence of, or in
connection with (1) the negotiation, preparation or execution of any amendment,
modification or waiver of any of the Transaction Documents, (2) any default or
breach of any of the Company’s representations, warranties, covenants or
obligations set forth in any of the Transaction Documents, and (3) the
enforcement or restructuring of any right of, including the collection of any
payments due, the Buyer under any of the Transaction Documents, including,
without limitation, any action or proceeding relating to such enforcement or any
order, injunction or other process seeking to restrain the Company from paying
any amount due the Buyer. Except as otherwise provided in Section 9 and this
Section 10(k), each of the Company and the Buyer shall bear its own expenses in
connection with this Agreement and the transactions contemplated hereby.
(l)
Termination.
(1) The
Buyer shall have the right to terminate this Agreement by giving notice to the
Company at any time at or prior to the Closing Date if:
(A)
the
Company shall have failed, refused, or been unable at or prior to the date of
such termination of this Agreement to perform any of its obligations hereunder
required to be performed prior to the time of such termination;
(B)
any
condition to the Buyer’s obligations hereunder is not fulfilled at or prior to
the time such condition is required to be satisfied; or
(C)
the
closing shall not have occurred on a Closing Date on or before December 29,
2006, other than solely by reason of a breach of this Agreement by the
Buyer.
Any such
termination shall be effective upon the giving of notice thereof by the Buyer.
Upon such termination, the Buyer shall have no further obligation to the Company
hereunder and the Company shall remain liable for any breach of this Agreement
or the other documents contemplated hereby which occurred on or prior to the
date of such termination.
(2)
The
Company shall have the right to terminate this Agreement by giving notice to the
Buyer at any times at or prior to the Closing Date if the closing shall not have
occurred on a Closing Date on or before December 29, 2006, other than solely by
reason of a breach of this Agreement by the Company, so long as the Company is
not in breach of this Agreement at the time it gives such notice. Any such
termination shall be effective upon the giving of notice thereof by the Company.
Upon such termination, neither the Company nor the Buyer shall have any further
obligation to one another hereunder, except for the Company’s liability for the
Buyer’s expenses as provided in Section 10(k).
(m)
Survival.
The
respective representations, warranties, covenants and agreements of the Company
and the Buyer contained in this Agreement and the documents delivered in
connection with this Agreement shall survive the execution and delivery of this
Agreement and the other Transaction Documents and the closing hereunder and
delivery of and payment for the Note and the issuance of the Warrants, and shall
remain in full force and effect regardless of any investigation made by or on
behalf of the Buyer or any Person controlling or acting on behalf of the Buyer
or by the Company or any Person controlling or acting on behalf of the
Company.
(n)
Construction; Buyer
Status.
The
language used in this Agreement will be deemed to be the language chosen by the
parties to express their mutual intent, and no rules of strict construction will
be applied against any party. The Buyer is not acting as part of a “group” (as
that term is used in Section 13(d) of the 1934 Act) with any other Person who is
or proposes to become a party to any Other Note Purchase Agreement, or who is
acquiring or holds any Other Note or Other Warrant, in negotiating and entering
into this Agreement or purchasing the Note and the Warrants or acquiring,
disposing of or voting any of the Shares. The Company hereby confirms that it
understands and agrees that the Buyer is not acting as part of any such group.
If the Buyer is other than AGMF, such Buyer acknowledges and agrees that such
Buyer is not relying on AGMF or AGMF’s legal counsel in making a decision to
enter into this Agreement, purchase the Note, acquire the Warrants or otherwise
in connection with the Transaction Documents, and such legal counsel are not
acting as the Buyer’s legal counsel in connection therewith.
[Signature pages
follow]
IN WITNESS WHEREOF
, the
parties hereto have caused this Agreement to be duly executed by their
respective officers or other representatives thereunto duly authorized on the
respective dates set forth below their signatures hereto.
Purchase
Price:
See defined term in this
Agreement
Principal
Amount of Note:
TBD
Initial
Conversion Price of Note:
TBD
December
Closing Date Warrant Shares
Initially
Issuable Upon Exercise of Warrant:
TBD
Initial
Exercise Price of December Closing
Date
Warrant:
TBD
July 2006
Warrant Shares Initially Issuable
Upon
Exercise of Warrant: 1,923,076
Initial
Exercise Price of July 2006 Warrant: $0.26
|
|
|
|
EMAGIN
CORPORATION
|
|
|
|
|
By:
|
/s/
Gary
W. Jones
|
|
Name:
Gary W. Jones
|
|
Title:
Chief Executive Officer
|
|
Date:
July 21, 2006
|
|
|
|
With
a copy to:
|
|
|
|
Sichenzia
Ross Friedman Ference LLP
|
|
1065
Avenue of the Americas, 21
st
Floor
|
|
New
York, New York 10018
|
|
Attention:
Richard A. Friedman, Esq.
|
|
|
|
Facsimile
No: (212) 930-9725
|
|
|
|
|
STILLWATER
LLC
|
|
|
|
|
By:
|
/s/
Mortimer
D.A. Sackler
|
|
Name:
Mortimer D.A. Sackler
|
|
Title:
President
|
|
|
|
Date:
July 21, 2006
|
|
Address
for Notices:
|
|
|
eMagin
Corporation
Selling Securityholder
Questionnaire
The
undersigned beneficial owner (the “Selling Securityholder”) of Common Stock, par
value $.001 per share, of eMagin Corporation, a Delaware corporation (the
“Company”), understands that the Company intends to file with the Securities and
Exchange Commission (the “SEC”) a registration statement (the “Registration
Statement”) for registration of the resale under the Securities Act of 1933, as
amended (the “Securities Act”), of such securities (the “Registrable
Securities”). This Questionnaire is delivered pursuant to the terms of the Note
Purchase Agreement, dated as of July
21,
2006 (the
“Purchase Agreement”), between the Company and the Buyer named therein. All
capitalized terms not otherwise defined herein shall have the meanings ascribed
thereto in the Purchase Agreement.
Certain
legal consequences arise from being named as a selling securityholder in the
Registration Statement and the related prospectus. Accordingly, the Selling
Securityholder is advised to consult its own securities law counsel regarding
the consequences of being named or not being named as a selling securityholder
in the Registration Statement and the related prospectus.
The
Selling Securityholder hereby provides the following information to the Company
in connection with the Company’s preparation of the Registration
Statement:
1.
Name.
|
(a)
|
Full
Legal Name of Selling
Securityholder
|
|
(b)
|
Full
Legal Name of Registered Holder (if not the same as (a) above) through
which Registrable Securities listed in Item 3 below are
held:
|
|
(c)
|
Full
Legal Name of the natural person who directly or indirectly has power to
vote or dispose of the Registrable Securities listed in Item 3
below:
|
2.
Address for Notices to Selling
Securityholder:
Complete
the following only if the Selling Securityholder wishes to receive notices
relating to the Registration at a different address or to a different person
than the current notice address for purposes of the Purchase
Agreement.
Telephone:_______________________________________
Fax:_____________________________________________
Contact
Person:____________________________________
3.
Beneficial Ownership of Registrable
Securities:
|
(a)
|
Number
of Registrable Securities (all of which are shares of Common Stock)
beneficially owned:
|
4.
Broker-Dealer
Status:
|
(a)
|
Are
you a broker-dealer?
|
Yes
__
No
__
|
Note:
|
If
yes, the SEC staff has indicated that you should be identified as an
underwriter in the Registration
Statement.
|
|
(b)
|
Are
you an affiliate of a
broker-dealer?
|
Yes
__
No
__
|
(c)
|
If
you are an affiliate of a broker-dealer, do you certify that you bought
the Registrable Securities in the ordinary course of business, and at the
time of the purchase of the Registrable Securities to be resold, you had
no agreements or understandings, directly or indirectly, with any person
to distribute the Registrable
Securities?
|
Yes
__
No
__
|
Note:
|
If
no, the SEC staff has indicated that you should be identified as an
underwriter in the Registration
Statement.
|
5.
|
Other Beneficial Ownership of
Common Stock by the Selling
Securityholder.
|
Except as set forth below in this
Item 5, the Selling Securityholder is not the beneficial or registered owner of
any shares of Common Stock of the Company other than the Registrable Securities
listed above in Item 3.
|
(a)
|
Number
of other shares of Common Stock held of record or beneficially owned by
the Selling Securityholder:
|
6.
Relationships with the
Company:
Except for the Purchase Agreement
and transactions related thereto and except as set forth below, the Selling
Securityholder has not held any position or office or had any other material
relationship with the Company (or its predecessors or affiliates) during the
past three years.
State any
exceptions here:
The
Selling Securityholder’s obligations with respect to the information it provides
in response to this Questionnaire are set forth in Section 8(c) of the Purchase
Agreement.
IN
WITNESS WHEREOF the undersigned, by authority duly given, has caused this
Questionnaire to be executed and delivered either in person or by its duly
authorized agent.
Dated:____________________________________________
|
Beneficial
Owner:
_____________________________________________
|
|
|
|
By:
|
|
Name:
|
|
Title:
|
PLEASE FAX OR E-MAIL THE
COMPLETED
AND EXECUTED QUESTIONNAIRE
TO:
Sichenzia
Ross Friedman Ference LLP
1065
Avenue of the Americas, 21
st
Floor
New York,
New York 10018
Attention:
Richard A. Friedman, Esq.
e-Mail
address:
rfriedman@srff.com
Annex X
to
Note Purchase
Agreement
COMPANY PUT
NOTICE
(6% Senior Secured Convertible Notes
due 2007-2008
of eMagin
Corporation)
TO:
[NAME OF BUYER]
[FACSIMILE NO.]
(1)
Pursuant
to the terms of the Note Purchase Agreement, dated as of July
__
, 2006
(the "Note Purchase Agreement"), by and between eMagin Corporation, a Delaware
corporation (the “Company”), and ______________________, a _______________
organized and existing under the laws of the State of _____________ (the
“Buyer”), the Company hereby exercises its right to sell the Securities to the
Buyer, subject to the closing conditions set forth in Sections 6 and 7 of the
Note Purchase Agreement being satisfied prior to the Closing Date.
(2)
The
principal amount of the Notes to be sold to the Buyer is $
[INSERT AN AMOUNT UP TO [$500,000]
BASED ON THE PURCHASE PRICE ADJUSTMENTS - SEE DEFINITION OF PURCHASE
PRICE
[Prior to execution of this NPA,
please reduce the $500,000 amount by the difference, if any, between the
principal amount of the Other Notes in this round of financing and $6.5
million]
]
____________________
.
(3)
Subject
to the closing conditions set forth in Sections 6 and 7 of the Note Purchase
Agreement being satisfied, the Closing Date for the sale and purchase of Notes
will be December __
, 2006 [INSERT DATE WHICH IS TEN
BUSINESS DAYS AFTER THE DATE THIS NOTICE IS GIVEN]
,
or such
other mutually agreed to time by the Company and the Buyer.
(4)
Capitalized
terms used in this Notice and not defined in this Notice have the respective
meanings provided in the Note Purchase Agreement.
Dated:
December _____, 2006
|
|
|
|
EMAGIN
CORPORATION
|
|
|
|
Date:
|
By:
|
/s/
|
|
|
|
Title
|
Annex 1
NEITHER THIS NOTE NOR THE SECURITIES
INTO WHICH THIS NOTE IS CONVERTIBLE HAVE REGISTERED UNDER THE SECURITIES ACT OF
1933, AS AMENDED (THE “1933 ACT”), AND, ACCORDINGLY, MAY NOT BE, NOR MAY ANY
INTEREST THEREIN BE, OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE
REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE
EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION
REQUIREMENTS OF THE 1933 ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES
LAWS AS EVIDENCED BY, SUBJECT TO CERTAIN EXCEPTIONS, A LEGAL OPINION OF COUNSEL
TO THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY
ACCEPTABLE TO THE COMPANY. THESE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A
BONA FIDE MARGIN ACCOUNT SECURED BY SUCH SECURITIES.
THIS NOTE DOES NOT REQUIRE PHYSICAL
SURRENDER OF THIS NOTE IN THE EVENT OF A PARTIAL CONVERSION. AS A RESULT,
FOLLOWING ANY CONVERSION OF ANY PORTION OF THIS NOTE, THE OUTSTANDING PRINCIPAL
AMOUNT REPRESENTED BY THIS NOTE MAY BE LESS THAN THE PRINCIPAL AMOUNT SET FORTH
BELOW.
EMAGIN
CORPORATION
6% SENIOR SECURED CONVERTIBLE NOTE
DUE 2007-2008
No.
$
New York,
New York
July
21, 2006
FOR VALUE RECEIVED
,
EMAGIN
CORPORATION
,
a
Delaware
corporation (hereinafter called the “Company”), hereby promises to pay to
[NAME]
,
[ADDRESS]
, or
registered assigns (the “Holder”), or order, the sum of
Dollars
($
), in
installments on the Installment Maturity Date and on the Final Maturity Date,
and to pay interest on the unpaid principal balance hereof at the Applicable
Rate from the date hereof, until the same becomes due and payable, whether at
maturity or upon acceleration or by redemption or repurchase in accordance with
the terms hereof or otherwise. Any amount, including, without limitation,
principal of or interest on this Note, the Optional Redemption Price and the
Repurchase Price, that is payable under this Note that is not paid when due
shall bear interest at the Default Rate from the due date thereof until the same
is paid (“Default Interest”). Regular interest shall be payable in arrears on
each Interest Payment Date, commencing on September 1, 2006, on the principal
amount outstanding on such date. Regular interest on this Note shall be computed
on the basis of a 360-day year of 12 30-day months and actual days elapsed. No
regular interest shall be payable on an Interest Payment Date on any portion of
the principal amount of this Note which shall have been redeemed prior to such
Interest Payment Date so long as the Company shall have complied in full with
its obligations with respect to such redemption.
All
payments of principal of and premium, if any, interest, and other amounts on
this Note shall be made in lawful money of the United States of America.
All payments shall be made by wire transfer of immediately available funds to
such account as the Holder may from time to time designate by written notice in
accordance with the provisions of this Note. Whenever any amount expressed to be
due by the terms of this Note is due on any day which is not a Business Day, the
same shall instead be due on the next succeeding day which is a Business Day
and, in the case of any Interest Payment Date which is not the date on which
this Note is paid in full, the extension of the due date thereof shall not be
taken into account for purposes of determining the amount of interest due on
such date. Certain capitalized terms used in this Note are defined in Article
I.
The
obligations of the Company under this Note shall rank in right of payment on a
parity with all other unsubordinated obligations of the Company for indebtedness
for borrowed money or the purchase price of property. This Note is issued
pursuant to the Note Purchase Agreement and the Holder and this Note are subject
to the terms and entitled to the benefits of the Note Purchase Agreement. This
Note is entitled to the benefits of the Security Agreements and the Lockbox
Agreement.
This Note
is one of a duly authorized issue of the Company’s 6% Senior Secured Convertible
Notes due 2007-2008 limited to an aggregate principal amount of $7,000,000.00
(excluding 6% Senior Secured Convertible Notes due 2007-2008 issued in
replacement of lost, stolen, destroyed or mutilated notes or issued on transfer
of such notes).
The
following terms shall apply to this Note:
ARTICLE I
DEFINITIONS
1.1
Certain Defined
Terms.
(a) All
the agreements or instruments herein defined shall mean such agreements or
instruments as the same may from time to time be supplemented or amended or the
terms thereof waived or modified to the extent permitted by, and in accordance
with, the terms thereof and of this Note.
(b)
The
following terms shall have the following meanings (such meanings to be equally
applicable to both the singular and plural forms of the terms
defined):
“Accredited
Investor” means an “accredited investor” as that term is defined in Rule 501 of
Regulation D under the 1933 Act.
“Affiliate”
means, with respect to any Person, any other Person that directly, or indirectly
through one or more intermediaries, controls, is controlled by or is under
common control with the subject Person. For purposes of this definition,
“control” (including, with correlative meaning, the terms “controlled by” and
“under common control with”), as used with respect to any Person, shall mean the
possession, directly or indirectly, of the power to direct or cause the
direction of the management and policies of such Person, whether through the
ownership of voting securities or by contract or otherwise.
“Aggregation
Parties” shall have the meaning provided in Section 6.7(a).
“Alexandra”
means Alexandra Global Master Fund Ltd., a British Virgin Islands international
business company.
“AMEX”
means the American Stock Exchange, Inc.
“Applicable
Rate” means 6 percent per annum; provided,
however
, that if
an Event of Default shall have occurred, then the Applicable Rate shall be
increased to 12 percent per annum during the period from the date of such Event
of Default until the date no Event of Default is continuing (or such lesser rate
as shall be the highest rate permitted by applicable law).
“Average
Daily Trading Volume Threshold” means, with respect to any period, that the
average daily trading volume of the Common Stock during such period as reported
by Bloomberg, L.P. (or if such source ceases to be available, a comparable
source selected by the Holder and acceptable to the Company in its reasonable
judgment) shall be at least 500,000 shares (such amount to be subject to
equitable adjustment for stock splits, stock dividends and similar events
relating to the Common Stock that are reflected in the trading market for the
Common Stock on or before the last Trading Day in such period).
“Board of
Directors” means the Board of Directors of the Company.
“Board
Resolution”
means a
copy of a resolution certified by the Secretary or an Assistant Secretary of the
Company to have been duly adopted by the Board of Directors, or duly authorized
committee thereof (to the extent permitted by applicable law), and to be in full
force and effect on the date of such certification, and delivered to the
Holder.
“Business
Day” means any day other than a Saturday, Sunday or a day on which commercial
banks in The City of New York are authorized or required by law or executive
order to remain closed.
"Cash and
Cash Equivalents Balances" of any Person on any date shall be determined on an
unconsolidated basis from such Person's books maintained in accordance with
Generally Accepted Accounting Principles, and means, without duplication, the
sum of (1) the cash held by such Person on such date and available for use by
such Person on such date, (2) all assets which would, on a balance sheet of such
Person prepared as of such date in accordance with Generally Accepted Accounting
Principles, be classified as cash equivalents;
provided,
however,
that (x)
for purposes of computing the Cash and Cash Equivalents Balances as of any date,
no amount shall be included as cash or a cash equivalent if such amount is
subject to any lien, charge, equity or encumbrance in favor of any other Person
or is subject to any agreement, arrangement or understanding by the Company with
any other Person to maintain the amount thereof or which restricts the use
thereof by the Company (in any such case, other than as provided in Section 3.9
of this Note and the Other Notes and other than the lien and security interest
in favor of the Collateral Agent arising under the Security Agreement) (y) cash
and cash equivalents described in the preceding clauses (1) and (2) that are
held at any time as Collateral under the Security Agreement and in which the
Collateral Agent has a perfected first priority security interest and which
are not subject to any lien, charge, equity or encumbrance in favor of any other
Person shall be included in determining the amount of Cash and Cash Equivalents
Balances at such time.
“Collateral”
shall have the meaning provided in the Security Agreements or in either of
them.
“Collateral
Agent” means Alexandra, as collateral agent under the Security Agreements, or
its successors.
“Common
Stock” means the Common Stock, par value $.001 per share, or any shares of
capital stock of the Company into which such shares shall be changed or
reclassified after the Issuance Date.
“Common
Stock Equivalent” means any warrant, option, subscription or purchase right with
respect to shares of Common Stock, any security convertible into, exchangeable
for, or otherwise entitling the holder thereof to acquire, shares of Common
Stock or any warrant, option, subscription or purchase right with respect to any
such convertible, exchangeable or other security.
“Company”
shall have the meaning provided in the first paragraph of this
Note.
“Company
Certificate” means a certificate of the Company signed by an
Officer.
“Company
Notice” means a Company Notice in the form attached hereto as
Exhibit A
.
“Computed
Market Price”
shall
mean the arithmetic average of the daily VWAPs for each of the three Trading
Days immediately preceding the applicable Measurement Date (such VWAPs being
appropriately and equitably adjusted for any stock splits, stock dividends,
recapitalizations and the like occurring or for which the record date occurs
during such three Trading Days).
“Conversion
Date” means the date on which a Conversion Notice is given in accordance with
Section 6.2(a).
“Conversion
Notice”
means a
duly executed Notice of Conversion of 6% Senior Secured Convertible Note Due
2007-2008 substantially in the form of
Exhibit C
to this
Note.
“Conversion
Price”
means
$0.26, subject to adjustment as provided in Section 6.3.
“Current
Fair Market Value” when used with respect to the Common Stock as of a specified
date means with respect to each share of Common Stock the average of the closing
prices of the Common Stock sold on all securities exchanges (including the NYSE,
the AMEX, the Nasdaq and the Nasdaq Capital Market) on which the Common Stock
may at the time be listed, or, if there have been no sales on any such exchange
on such day, the average of the highest bid and lowest asked prices on all such
exchanges at the end of regular trading such day,
or, if on
such day the Common Stock is not so listed, the average of
the representative bid and asked prices quoted in the NASDAQ
System as of 4:00 p.m.,
New York City time, or, if on such day the Common Stock is not quoted in
the NASDAQ System, the average of the highest bid and lowest asked price on such
day in the domestic over-the-counter market as reported by the Pink Sheets, LLC,
or any similar successor organization, in each such case averaged over a period
of five Trading Days consisting of the day as of which the Current Fair Market
Value of Common Stock is being determined (or if such day is not a Trading Day,
the Trading Day next preceding such day) and the four consecutive Trading Days
prior to such day. If on the date for which Current Fair Market Value is to be
determined the Common Stock is not listed on any securities exchange or quoted
in the NASDAQ System or the over-the-counter market, the Current Fair Market
Value of Common Stock shall be the greater of (i) the highest price per share of
Common Stock at which the Company has sold shares of Common Stock or Common
Stock Equivalents during the 365 days prior to the date of such determination
and (ii) the highest price per share which the Company could then obtain from a
willing buyer (not an employee or director of the Company at the time of
determination) for shares of Common Stock sold by the Company, from authorized
but unissued shares, as determined in good faith by the Board of
Directors.
“Current
Market Price”
shall
mean the arithmetic average of the daily Market Prices per share of Common Stock
for the five consecutive Trading Days immediately prior to the date in question;
provided, however,
that (1)
if the “ex” date (as hereinafter defined) for any event (other than the issuance
or distribution requiring such computation) that requires an adjustment to the
Conversion Price pursuant to Section 6.3(a), (b), (c), (d) or (e), occurs during
such five consecutive Trading Days, the Market Price for each Trading Day prior
to the “ex” date for such other event shall be adjusted by multiplying such
Market Price by the same fraction by which the Conversion Price is so required
to be adjusted as a result of such other event, (2) if the “ex” date for any
event (other than the issuance or distribution requiring such computation) that
requires an adjustment to the Conversion Price pursuant to Section 6.3(a), (b),
(c), (d) or (e), occurs on or after the “ex” date for the issuance or
distribution requiring such computation and prior to the day in question, the
Market Price for each Trading Day on and after the “ex” date for such other
event shall be adjusted by multiplying such Market Price by the reciprocal of
the fraction by which the Conversion Price is so required to be adjusted as a
result of such other event, and (3) if the “ex” date for the issuance or
distribution requiring such computation is prior to the day in question, after
taking into account any adjustment required pursuant to clause (1) or (2) of
this proviso, the Market Price for each Trading Day on or after such “ex” date
shall be adjusted by adding thereto the amount of any cash and the fair market
value (as determined by the Board of Directors in a manner consistent with any
determination of such value for purposes of Section 6.3(d), whose determination
shall be conclusive and described in a Board Resolution) of the evidences of
indebtedness, shares of capital stock or assets being distributed applicable to
one share of Common Stock as of the close of business on the day before such
“ex” date. Notwithstanding the foregoing, whenever successive adjustments to the
Conversion Price are called for pursuant to Section 6.3, such adjustments shall
be made to the Current Market Price as may be necessary or appropriate to
effectuate the intent of Section 6.3 and to avoid unjust or inequitable results
as determined in good faith by the Board of Directors.
“Default
Interest” shall have the meaning provided in the first paragraph of this
Note.
“Default
Rate” means 12 percent per annum (or such lesser rate equal to the highest rate
permitted by applicable law).
“Designated
Person” means any of Mr. John Atherly, Mr. Gary Jones and Ms. Susan
Jones.
“DTC”
shall have the meaning provided in Section 6.2(b).
“EBITDA”
for any period shall mean the consolidated net income before taxes of the
Company and its Subsidiaries, as shown on its consolidated financial statements
filed with the SEC for such period and prepared in accordance with Generally
Accepted Accounting Principles, on a basis consistent with the Company’s audited
consolidated financial statements most recently filed with the SEC prior to the
Issuance Date, increased by the amount of depreciation, amortization and
interest expenses charged in computing such consolidated net income for such
period.
“EBITDA
Positive Quarter” means a fiscal quarter of the Company during which its EBITDA
is greater than zero, as shown in the Company’s Quarterly Report on Form 10-Q
filed with the SEC, in the case of the first three fiscal quarters of any fiscal
year, or as shown in the Company’s Annual Report on Form 10-K, in the case of
the fourth fiscal quarter of any fiscal year. In the case of the fourth fiscal
quarter of any year, an EBITDA Positive Quarter may be shown by the quarterly
financial data shown in the notes to the Company’s audited financial statements
included in the Company’s Annual Report on Form 10-K for such fiscal year, if
such information is presented in sufficient detail to make such calculation, or
by subtracting the EBITDA for the first three fiscal quarters of such fiscal
year from the EBITDA for such fiscal year.
“Eligible
Bank” means a corporation organized or existing under the laws of the United
States or any other state, having combined capital and surplus of at least $100
million and subject to supervision by federal or state authority and which has a
branch located in New York, New York.
“Event of
Default” shall have the meaning provided in Section 4.1.
“Excluded
Shares” shall have the meaning provided in Section 6.7.
“Extended
Optional Redemption Date” means with respect to any portion of this Note to
which Section 2.1(e) applies, the date that is 30 Trading Days, after the latest
date on which the Restricted Ownership Percentage no longer restricts the
Holder’s right to convert the remaining Uncovered Portion, but in no event later
than the Final Maturity Date.
“FAST”
shall have the meaning provided in Section 6.2(b)
“Final
Maturity Date” means January 21, 2008.
“Fundamental
Change” means
(a)
Any
consolidation or merger of the Company or any Subsidiary with or into another
entity (other than a merger or consolidation of a Subsidiary into the Company or
a wholly-owned Subsidiary in connection with which no change in outstanding
Common Stock occurs) where the stockholders of the Company immediately prior to
such transaction do not collectively own at least 51% of the outstanding voting
securities of the surviving corporation of such consolidation or merger
immediately following such transaction; or the sale of all or substantially all
of the assets of the Company and the Subsidiaries in a single transaction or a
series of related transactions; or
(b)
The
occurrence of any transaction or event in connection with which all or
substantially all the Common Stock shall be exchanged for, converted into,
acquired for or constitute the right to receive consideration (whether by means
of an exchange offer, liquidation, tender offer, consolidation, merger,
combination, reclassification, recapitalization or otherwise) which is not all
or substantially all common stock which is (or, upon consummation of or
immediately following such transaction or event, will be) listed on a national
securities exchange or approved for quotation on Nasdaq or any similar United
States system of automated dissemination of transaction reporting of securities
prices; or
(c)
The
acquisition by a Person or entity or group of Persons or entities acting in
concert as a partnership, limited partnership, syndicate or group, as a result
of a tender or exchange offer, open market purchases, privately negotiated
purchases or otherwise, of beneficial ownership of securities of the Company
representing 50% or more of the combined voting power of the outstanding voting
securities of the Company ordinarily (and apart from rights accruing in special
circumstances) having the right to vote in the election of
directors.
“Generally
Accepted Accounting Principles” for any Person means the generally accepted
accounting principles and practices applied by such Person from time to time in
the preparation of its audited financial statements.
“Holder”
shall have the meaning provided in the first paragraph of this
Note.
“Holder
Notice” means a Holder Notice in the form attached hereto as
Exhibit B
.
“Indebtedness”
means, when used with respect to any Person, without duplication:
(1)
all
indebtedness, obligations and other liabilities (contingent or otherwise) of
such Person for borrowed money (including obligations of such Person in respect
of overdrafts, foreign exchange contracts, currency exchange agreements,
currency purchase or similar agreements, Interest Rate Protection Agreements,
and any loans or advances from banks, whether or not evidenced by notes or
similar instruments) or evidenced by bonds, debentures, notes or other
instruments for the payment of money, or incurred in connection with the
acquisition of any property, services or assets (whether or not the recourse of
the lender is to the whole of the assets of such Person or to only a portion
thereof), other than any account payable or other accrued current liability or
obligation to trade creditors incurred in the ordinary course of business in
connection with the obtaining of materials or services;
(2)
all
reimbursement obligations and other liabilities (contingent or otherwise) of
such Person with respect to letters of credit, bank guarantees, bankers’
acceptances, surety bonds, performance bonds or other guaranty of contractual
performance;
(3)
all
obligations and liabilities (contingent or otherwise) in respect of (a) leases
of such Person required, in conformity with Generally Accepted Accounting
Principles, to be accounted for as capitalized lease obligations on the balance
sheet of such Person and (b) any lease or related documents (including a
purchase agreement) in connection with the lease of real property which provides
that such Person is contractually obligated to purchase or cause a third party
to purchase the leased property and thereby guarantee a minimum residual value
of the leased property to the landlord and the obligations of such Person under
such lease or related document to purchase or to cause a third party to purchase
the leased property;
(4)
all
direct or indirect guaranties or similar agreements by such Person in respect
of, and obligations or liabilities (contingent or otherwise) of such Person to
purchase or otherwise acquire or otherwise assure a creditor against loss in
respect of, indebtedness, obligations or liabilities of another Person of the
kind described in clauses (1) through (3);
(5)
any
indebtedness or other obligations described in clauses (1) through (4) secured
by any mortgage, pledge, lien or other encumbrance existing on property which is
owned or held by such Person, regardless of whether the indebtedness or other
obligation secured thereby shall be payable by or shall have been assumed by
such Person; and
(6)
any and
all deferrals, renewals, extensions and refundings of, or amendments,
modifications or supplements to, any indebtedness, obligation or liability of
the kind described in clauses (1) through (5).
“Installment
Maturity Date” means July 21, 2007.
“Interest
Payment Dates” means each March 1, June 1, September 1 and December 1 and the
Final Maturity Date.
“Interest
Rate Protection Agreement” means, with respect to any Person, any interest rate
swap agreement, interest rate cap or collar agreement or other financial
agreement or arrangement designed to protect such Person against fluctuations in
interest rates, as in effect from time to time.
“Issuance
Date” means July 21, 2006.
“Lien”
means any mortgage, lien, pledge, security interest or other charge or
encumbrance, including, without limitation, the lien or retained security title
of a conditional vendor.
“Lockbox
Agent” means the Person serving from time to time as Lockbox Agent under the
Lockbox Agreement.
“Lockbox
Agreement” means that certain Lockbox Agreement, dated as of July 21, 2006, by
and between the Company, the Lockbox Agent and the Collateral
Agent.
“Majority
Holders” means, at any time, the holders of a majority
of the
aggregate principal amount of this Note and the Other Notes outstanding at such
time.
“Market
Price”
with
respect to any security on any day shall mean the closing bid price of such
security on such day on the Nasdaq, the Nasdaq Capital Market, the NYSE or the
AMEX, as applicable, or, if such security is not listed or admitted to trading
on the Nasdaq, the Nasdaq Capital Market, the NYSE or the AMEX, on the principal
national securities exchange or quotation system on which such security is
quoted or listed or admitted to trading, in any such case as reported by
Bloomberg, L.P. (or if such source ceases to be available, comparable source
selected by the Holder and acceptable to the Company in its reasonable judgment)
or, if not quoted or listed or admitted to trading on any national securities
exchange or quotation system, the average of the closing bid and asked prices of
such security on the over-the-counter market on the day in question, as reported
by Pink Sheets, LLC, or a similar generally accepted reporting service, or if
not so available, in such manner as furnished by any NYSE member firm selected
from time to time by the Board of Directors for that purpose, or a price
determined in good faith by the Board of Directors, whose determination shall be
conclusive and described in a Board Resolution.
“Measurement
Date” for any sale, transfer or disposition (but not including the cancellation
or expiration) of Common Stock or Common Stock Equivalents by a Designated
Person means the date that is three Trading Days after the earlier of (i) the
date such Designated Person files a Form 4 with the SEC with respect to such
sale, transfer or disposition and (ii) the date such Designated Person is
required to file a Form 4 with the SEC with respect to such sale, transfer or
disposition;
provided,
however,
that if
such Designated Person is not required, or is no longer required, to file a Form
4 with respect to such sale, transfer or disposition, the Measurement Date shall
be the date that is five Trading Days after the date of such sale, transfer or
disposition.
“Nasdaq”
means the Nasdaq Global Market.
“1934
Act” means the Securities Exchange Act of 1934, as amended.
“1933
Act” means the Securities Act of 1933, as amended.
“Note”
means this instrument as originally executed, or if later amended or
supplemented in accordance with its terms, then as so amended or supplemented.
“Note
Purchase Agreement” means the Note Purchase Agreement, dated as of July 21,
2006, by and between the Company and the original Holder of this Note or its
predecessor instrument.
“NYSE”
means the New York Stock Exchange, Inc.
“Officer”
means the Chairman of the Board, the Chief Executive Officer, the President or
the Chief Financial Officer of the Company.
“Optional
Redemption Date” means the Business Day on which this Note is to be redeemed
pursuant to Section 2.1.
“Optional
Redemption Notice” means an Optional Redemption Notice in the form attached
hereto as
Exhibit D
.
“Optional
Redemption Period” means the period which commences on the date that is ten days
after the SEC Effective Date and ends on the Final Maturity Date.
“Optional
Redemption Price” means an amount in cash equal to the sum of (1) 100% of the
outstanding principal amount of this Note
plus
(2)
accrued and unpaid interest on such principal amount to the Optional Redemption
Date
plus
(3)
accrued and unpaid Default Interest, if any, on the amount referred to in the
immediately preceding clause (2) at the rate provided in this Note to the
Optional Redemption Date
plus
(4) an
amount equal to the interest that would have accrued on this Note from the
Optional Redemption Date until the Final Maturity Date (assuming, in case the
Optional Redemption Date is prior to the Installment Maturity Date, the Company
paid when due the installment of principal due on the Installment Maturity Date)
had this Note not been redeemed on the Optional Redemption Date.
“Other
Note Purchase Agreements” means the several Note Purchase Agreements, dated as
of July 21, 2006, by and between the Company and the respective original holders
of the Other Notes.
“Other
Notes” means the several 6% Senior Secured Convertible Notes due 2007-2008,
issued by the Company pursuant to the Other Note Purchase
Agreements.
“Other
Warrants” means the Common Stock Purchase Warrants issued by the Company to the
original holders of the Other Notes or their respective predecessor
instruments.
“Patent
and Trademark Security Agreement” means the Patent and Trademark Security
Agreement, dated as of July 21, 2006, by and between the Company and the
Collateral Agent.
“Pledge
and Security Agreement” means the Pledge and Security Agreement, dated as of
July 21, 2006, by and between the Company and the Collateral Agent.
“Permitted
Designated Person Sale” means a sale by John Atherly, occurring on or after
January 1, 2007, of shares of Common Stock in an amount not to exceed 50,000
shares in the aggregate in any fiscal quarter of the Company (such number of
shares subject to equitable adjustments for stock splits, stock dividends,
combinations, capital reorganizations and similar events relating to the Common
Stock occurring after the Issuance Date).
“Permitted
Indebtedness” means
(1)
Indebtedness
outstanding on the Issuance Date prior to issuance of this Note and reflected in
the Company’s financial statements included in the SEC Reports;
(2)
Indebtedness
evidenced by this Note and the Other Notes;
(3)
Indebtedness
outstanding on, or incurred after, the Issuance Date in an aggregate amount not
to exceed $2,500,000 at any one time outstanding so long as (A) such
Indebtedness (x) is incurred for the purpose of acquiring equipment owned or
used or to be owned or used by the Company or any Subsidiary (or for the purpose
of acquiring the capital stock or similar equity interests of a Subsidiary that
is formed for the limited purpose of owning same and does not own or hold any
other material assets) and does not exceed the purchase price of the equipment,
capital stock or other equity interest so acquired plus reasonable transaction
expenses and (y) if secured, is secured solely by the interest of the Company or
one of its Subsidiaries in the equipment so acquired and rights related thereto
or (B) is the reimbursement obligations and other liabilities (contingent or
otherwise) of the Company or any Subsidiary with respect to letters of credit
issued in lieu of cash security deposits for leases of real property or
equipment used by the Company or any Subsidiary, or commercial or standby
letters of credit issued in the ordinary course of the business of the Company
and its Subsidiaries (the amount of which shall for this purpose be deemed to be
the maximum reimbursement obligations and other liabilities (contingent or
otherwise) with respect to such letters of credit, whether or not a drawing
thereunder has been made);
(4)
Indebtedness
incurred after the Issuance Date not to exceed $2,500,000 at any one time
outstanding that is secured solely by raw materials, works in progress and
finished goods inventory and accounts receivable in a financing by a bank,
finance company or other institutional lender providing receivables or inventory
financing;
(5)
Indebtedness
incurred after the Issuance Date which is unsecured, subordinated to the Note
and the Other Notes as to payment on terms approved in advance of such
incurrence by the Majority Holders as evidenced by the written approval of the
Majority Holders, and for which no payment of principal of such Indebtedness is
scheduled to be due prior to the date that is six months after the Final
Maturity Date;
(6)
endorsements
for collection or deposit in the ordinary course of business;
(7)
in the
case of any Subsidiary, Indebtedness owed by such Subsidiary to the Company;
and
(8)
Permitted
Refinancing Indebtedness;
in each
such case so long as at the time of incurrence of such Indebtedness no Event of
Default has occurred and is continuing or would result from such incurrence and
no event which, with notice or passage of time, or both, would become an Event
of Default has occurred and is continuing or would result from such incurrence
and so long as in the case of such Indebtedness referred to in the preceding
clauses (3) through (5), inclusive, incurrence of such Indebtedness shall have
been approved by the Board of Directors prior to the incurrence
thereof.
“Permitted
Liens” means:
(a)
Liens
upon any property of any Subsidiary or Subsidiaries as security for indebtedness
owing by such Subsidiary to the Company;
(b)
purchase
money Liens upon any property acquired by the Company or any Subsidiary or Liens
existing on such property at the time of acquisition and in any such case
securing Permitted Indebtedness described in clause (3) of the definition of the
term Permitted Indebtedness; provided that (i) no such Lien shall extend to or
cover any other property of the Company or any Subsidiary, (ii) the principal
amount of Indebtedness secured by each such Lien on any such property shall not
exceed the cost (including such principal amount of the Indebtedness secured
thereby) to the Company or the Subsidiary of the property subject thereto, and
(iii) the aggregate principal amount of all Indebtedness of the Company and all
Subsidiaries secured by all Liens described in this subsection (b) and any
extensions, renewals or replacements thereof, at any one time outstanding, shall
not exceed $2,500,000 for the Company and the Subsidiaries; and any Lien
securing Indebtedness that extends, renews or replaces any Indebtedness secured
by any Lien permitted by this subsection (b);
provided,
however,
that in
any such case the Lien securing any Indebtedness so extended, renewed or
replaced shall not extend to or cover any other property of the Company or any
Subsidiary and the principal amount of such Indebtedness extended, renewed or
replaced shall not be increased;
(c)
Liens
securing Indebtedness permitted under clause (4) of the definition of the term
Permitted Indebtedness so long as in each such case such Lien does not extend to
any property of the Company or the Subsidiaries other than the accounts
receivables or inventory of the Company and the Subsidiaries so
financed;
(d)
Liens
securing this Note and the Other Notes ratably and not securing any other
Indebtedness;
(e)
Liens for
taxes or assessments or governmental charges or levies on its property if such
taxes or assessments or charges or levies shall not at the time be due and
payable or if the amount, applicability, or validity of any such tax,
assessment, charge or levy shall currently be contested in good faith by
appropriate proceedings or necessary preliminary steps are being taken to
contest, compromise or settle the amount thereof or to determine the
applicability or validity thereof and if the Company or such Subsidiary, as the
case may be, shall have set aside on its books reserves (segregated to the
extent required by sound accounting practice) deemed by it adequate with respect
thereto; deposits or pledges to secure payment of worker's compensation,
unemployment insurance, old age pensions or other social security; deposits or
pledges to secure performance of bids, tenders, contracts (other than contracts
for the payment of money borrowed or credit extended), leases, public or
statutory obligations, surety or appeal bonds, or other deposits or pledges for
purposes of like general nature in the ordinary
course of
business; mechanics', carriers', workers', repairmen's or other like Liens
arising
in the
ordinary course of business securing obligations which are not overdue for a
period of 60 days, or which are in good faith being contested or litigated, or
deposits to obtain the release of such Liens; Liens created by or resulting from
any litigation or legal proceedings or proceedings being contested in good faith
by appropriate proceedings, provided any execution levied thereon shall be
stayed; leases made, or existing on property acquired, in the ordinary course of
business; landlords' Liens under leases to which the Company or any Subsidiary
is a party; and zoning restrictions, easements, licenses or restrictions on the
use of real property or minor irregularities in title thereto; provided that all
such Liens described in this subsection (d) do not, in the aggregate, materially
impair the use of such property in the operations of the business of the Company
or any Subsidiary or the value of such property for the purpose of such
business; and
(f)
Liens
existing on the Issuance Date and listed in Schedule 4(t) to the Note Purchase
Agreement.
“Permitted
Refinancing Indebtedness” means any Indebtedness of the Company issued in
exchange for, or the net proceeds of which are used to redeem Indebtedness
represented by this Note and the Other Notes in accordance with Section 2.1;
provided that so long as on or before the date of incurrence of such Permitted
Refinancing Indebtedness the Company shall have (a) given the Optional
Redemption Notice to the Holder and the holders of the Other Notes in accordance
with Section 2.1 and (b) irrevocably deposited in trust with a trustee (other
than the Company or any Subsidiary), for the exclusive benefit of the Holder and
the holders of the Other Notes being redeemed, an amount at least equal to the
aggregate amount that the Company will be obligated to pay in respect of such
Indebtedness from such date to the date of payment in full of such
Indebtedness.
“Person”
means any natural person, corporation, partnership, limited liability company,
trust, incorporated organization, unincorporated association or similar entity
or any government, governmental agency or political subdivision.
“Principal
Market” means, at any time, whichever of the Nasdaq, Nasdaq Capital Market,
AMEX, NYSE or such other U.S. market or exchange is at the time the principal
market on which the Common Stock is then listed for trading.
“Record
Date”
shall
mean, with respect to any dividend, distribution or other transaction or event
in which the holders of Common Stock have the right to receive any cash,
securities or other property or in which the Common Stock (or other applicable
security) is exchanged for or converted into any combination of cash, securities
or other property, the date fixed for determination of stockholders entitled to
receive such cash, securities or other property (whether such date is fixed by
the Board of Directors or by statute, contract or otherwise).
“Registration
Statement” means the Registration Statement required to be filed by the Company
with the SEC pursuant to Section 8(a)(1) of the Note Purchase
Agreement.
“Repurchase
Event” means the occurrence of any one or more of the following
events:
(a)
The
Common Stock ceases to be traded on the AMEX and is not listed for trading on
the Nasdaq, the Nasdaq Capital Market or the NYSE;
(b)
Any
Fundamental Change;
(c)
The
adoption of any amendment to the Company's Certificate of Incorporation (other
than any certificate designating a series of preferred stock of the Company)
which materially and adversely affects the rights of the Holder or the taking of
any other action by the Company which materially and adversely affects the
rights of the Holder in respect of the Holder’s interest in the Common Stock in
a different and more adverse manner than it affects the rights of holders of
Common Stock generally; or
(d)
The
inability of the Holder for 20 Trading Days (whether or not consecutive) during
any period of 365 consecutive days occurring on or after the SEC Effective Date
to sell shares of Common Stock issued or issuable upon conversion of this Note
or exercise of the Warrants pursuant to the Registration Statement (1) by reason
of the requirements of the 1933 Act, the 1934 Act or any of the rules or
regulations under either thereof or (2) due to the Registration Statement
containing any untrue statement of material fact or omitting to state a material
fact required to be stated therein or necessary to make the statements therein
not misleading or other failure of the Registration Statement to comply with the
rules and regulations of the SEC other than by reason of a review by the SEC
staff of the Registration Statement or a post effective amendment to the
Registration Statement excluding any such inability to sell that results from an
untrue statement of a material fact in such Registration Statement or omission
to state a material fact required to be stated in such Registration Statement in
order to make the statements therein not misleading, which misstatement or
omission was made by the Holder in written information it furnished to the
Company specifically for inclusion in such Registration Statement which such
information was substantially relied upon by the Company in preparation of the
Registration Statement or any amendment or supplement thereto, unless the
Company shall have failed timely to amend or supplement such Registration
Statement after the Holder shall have corrected such misstatement or omission;
or
(e)
Any Event
of Default specified in Article IV of this Note.
“Repurchase
Price” means with respect to any repurchase pursuant to Sections 5.1 and 5.2 an
amount in cash equal to the sum of (1) 100% of the outstanding principal amount
of this Note that the Holder has elected to be repurchased
plus
(2)
accrued and unpaid interest on such principal amount to the date of such
repurchase
plus
(3)
accrued and unpaid Default Interest, if any, thereon at the rate provided in
this Note to the date of such repurchase.
“Restricted
Ownership Percentage” shall have the meaning provided in Section
6.7(a).
“Rule
144A” means Rule 144A as promulgated under the 1933 Act.
“SEC”
means the Securities and Exchange Commission.
“SEC
Effective Date” means the date the Registration Statement is first declared
effective by the SEC.
“SEC
Reports” shall have the meaning provided in the Note Purchase
Agreement.
“Security
Agreement” means either or both of the Pledge and Security Agreement and the
Patent and Trademark Security Agreement.
“Stockholder
Approval” shall have the meaning provided in the Note Purchase
Agreement.
“Subsidiary”
means any corporation or other entity of which a majority of the capital stock
or other ownership interests having ordinary voting power to elect a majority of
the board of directors or other Persons performing similar functions are at the
time directly or indirectly owned by the Company.
“Tender
Offer” means a tender offer or exchange offer.
“Trading
Day” means at any time a day on which the Principal Market is open for general
trading of securities.
“Transaction
Documents” means this Note, the Note Purchase Agreement, the Security
Agreements, the Lockbox Agreement, the Warrants and the other agreements,
instruments and documents contemplated hereby and thereby.
“Transfer
Agent” means Continental Stock Transfer & Trust Company, or its successor as
transfer agent and registrar for the Common Stock.
“Trigger
Event” shall have the meaning provided in Section 6.3(d).
“Unconverted
Portion” shall have the meaning provided in Section 2.1(d)(1).
“VWAP” of
any security on any Trading Day means the volume-weighted average price of such
security on such Trading Day on the Principal Market, as reported by Bloomberg
Financial, L.P., based on a Trading Day from 9:30 a.m., Eastern Time, to 4:00
p.m., Eastern Time, using the AQR Function, for such Trading Day;
provided,
however,
that
during any period the VWAP is being determined, the VWAP shall be subject to
equitable adjustments from time to time on terms consistent with Section 6.3 and
otherwise reasonably acceptable to the Majority Holders for (i) stock splits,
(ii) stock dividends, (iii) combinations, (iv) capital reorganizations, (v)
issuance to all holders of Common Stock of rights or warrants to purchase shares
of Common Stock, (vi) distribution by the Company to all holders of Common Stock
of evidences of indebtedness of the Company or cash (other than regular
quarterly cash dividends), and (vii) similar events relating to the Common
Stock, in each case which occur, or with respect to which the “ex” date occurs,
during such period.
“Warrants”
means Common Stock Purchase Warrants of the Company issued to
the
original Holder of this Note pursuant to the Note Purchase Agreement or any such
instrument issued upon transfer or split up thereof.
ARTICLE II
OPTIONAL REDEMPTION; INSTALLMENT OF
PRINCIPAL
2.1
Optional
Redemption.
(a) At
any time during the Optional Redemption Period, the Company shall have the right
to redeem at any one time all of the outstanding principal amount of this Note
at the Optional Redemption Price pursuant to this Section 2.1 on any
Optional Redemption Date, so long as the following conditions are
met:
(1)
on the
date the Company gives the Optional Redemption Notice and at all times to and
including the Optional Redemption Date, no Event of Default and no event which,
with notice or passage of time, or both, would become an Event of Default has
occurred and is continuing (unless the requirements of this clause (1) will be
satisfied immediately after the redemption of this Note and the Other Notes on
the Optional Redemption Date and the Company shall furnish Company Certificates
to the Holder to such effect on the date the Optional Redemption Notice is given
to the Holder and on the Optional Redemption Date),
(2)
on the
date the Company gives the Optional Redemption Notice and at all times to and
including the Optional Redemption Date, no Repurchase Event has occurred with
respect to which the Holder has the right to exercise repurchase rights pursuant
to Sections 5.1 and 5.2 or with respect to which the Holder has exercised such
repurchase rights and the Repurchase Price has not been paid to the Holder and
no event which, with notice or passage of time, or both, would become a
Repurchase Event has occurred and is continuing,
(3)
on the
date the Company gives the Optional Redemption Notice and at all times
thereafter to and including the Optional Redemption Date, the Registration
Statement shall be effective and available for use by the Holder, the holders of
the Other Notes and the holders of the Warrants for the resale of the shares of
Common Stock issued and issuable upon conversion of this Note and the Other
Notes and issued or issuable upon exercise of the Warrants, as the case may be,
and is reasonably expected to remain effective and available for such use for at
least 30 Trading Days after the Optional Redemption Date; and
(4)
on the
date the Company gives the Optional Redemption Notice, the Company (x) has funds
available to pay the Optional Redemption Price of this Note and the redemption
prices of the Other Notes, or (y) has funds which, together with the proceeds to
be paid to the Company at the closing of a transaction in which the Company
proposes to issue Permitted Refinancing Indebtedness, will be sufficient to pay
the Optional Redemption Price of this Note and the redemption prices of the
Other Notes.
In order
to exercise its right of redemption under this Section 2.1, the Company
shall give the Optional Redemption Notice to the Holder not less than ten
Trading Days or more than 30 Trading Days prior to the Optional Redemption Date
stating: (1) that the Company is exercising its right to redeem this Note in
accordance with this Section 2.1, (2) the principal amount of this Note to
be redeemed, (3) the Optional Redemption Price, (4) the Optional Redemption Date
and (5) that all of the conditions of this Section 2.1 entitling the Company to
call this Note for redemption have been met. On the Optional Redemption Date (or
such later date as the Holder surrenders this Note to the Company) the Company
shall pay to or upon the order of the Holder, by wire transfer of immediately
available funds to such account as shall be specified for such purpose by the
Holder at least one Business Day prior to the Optional Redemption Date, an
amount equal to the Optional Redemption Price of the portion (which may be all)
of this Note to be redeemed.
(b)
In order
that the Company shall not discriminate among the Holder and the holders of the
Other Notes, the Company agrees that it shall not redeem any of the Other Notes
pursuant to the provisions thereof similar to this Section 2.1 or
repurchase or otherwise acquire any of the Other Notes (other than a mandatory
redemption pursuant to provisions of the Other Notes comparable to Article V)
unless the Company offers simultaneously to redeem, repurchase or otherwise
acquire this Note for cash at the same unit price as the Other Note or Other
Notes.
(c)
The
Company shall not be entitled to give an Optional Redemption Notice or to redeem
any portion of this Note with respect to which the Holder has given a Conversion
Notice on or prior to the date the Company gives such Optional Redemption
Notice. Notwithstanding the giving of the Optional Redemption Notice, the Holder
shall be entitled to convert all or any portion of this Note, in accordance with
the terms of this Note, by giving a Conversion Notice at any time on or prior to
the later of (1) the date which is one Trading Day prior to the Optional
Redemption Date and (2) if the Company fails to pay and deliver to the Holder,
or deposit in accordance with Section 7.10, the Optional Redemption Price
payable on the Optional Redemption Date on or before the Optional Redemption
Date, the date on which the Company pays and delivers to the Holder, or deposits
in accordance with Section 7.10, such Optional Redemption Price. If after giving
effect to any such conversion of this Note that occurs after the date the
Company gives the Optional Redemption Notice to the Holder, the principal amount
of this Note remaining outstanding is less than the amount thereof to be
redeemed as stated in the Optional Redemption Notice, then the Optional
Redemption Price set forth in the Optional Redemption Notice shall be adjusted
to reflect the reduced outstanding principal amount of this Note and related
accrued interest (and Default Interest, if any, thereon at the Default Rate) on
the Optional Redemption Date resulting from any such conversions of this Note
after the Company gives the Optional Redemption Notice to the
Holder.
(d)
(1)
Notwithstanding
any other provision of this Note or applicable law to the contrary, in case the
Company shall give the Optional Redemption Notice to the Holder, and on the date
the Company gives the Optional Redemption Notice or at any time thereafter to
and including the Optional Redemption Date, the Holder shall be restricted from
converting any portion of this Note by reason of the Restricted Ownership
Percentage (the “Unconverted Portion”), then the Optional Redemption Date for
the Unconverted Portion so called for redemption by the Company and which the
Holder may not convert at any such time during such period from the date the
Company gives the Optional Redemption Notice to the Optional Redemption Date
may, at the election of the Holder exercised by notice to the Company given on
or before the Optional Redemption Date, be extended to be the
Extended
Optional
Redemption Date. On the applicable Extended Optional Redemption Date, the
Company shall pay the Optional Redemption Price for any portion of this Note
redeemed on such Extended Optional Redemption Date. Any portion of this Note for
which there is an Extended Optional Redemption Date shall remain convertible by
the Holder in accordance with Section 6 at any time to and including the close
of business on the Business Day prior to the applicable Extended Optional
Redemption Date.
(2)
Notwithstanding
anything to the contrary contained in Section 6.7, solely for the purposes of
calculating the Restricted Ownership Percentage for purposes of this Section
2.1(d), the shares of Common Stock issuable upon exercise of the Warrants held
by the Holder shall not be deemed to be Excluded Shares and shall be taken into
account in calculating the Restricted Ownership Percentage to determine the
amount of the Unconverted Portion.
2.2
Installments of Principal.
The
principal of this Note shall become due in installments as follows:
Principal
Amount
|
Due
Date
|
$
[PRIOR
TO ISSUANCE, INSERT 50%
|
|
OF PRINCIPAL
AMOUNTOF NOTE]
|
Installment
Maturity Date
|
|
|
$
[PRIOR
TO ISSUANCE, INSERT 50%
|
|
OF PRINCIPAL
AMOUNTOF NOTE]
|
Final
Maturity Date
|
The
amounts of such installments that are payable on each such date are subject to
reduction as provided in Sections 5 and 6
.
2.3
No Other
Prepayment
. Except
as specifically provided in Section 2.1, this Note may not be prepaid, redeemed
or repurchased at the option of the Company prior to the applicable Installment
Maturity Date or the Final Maturity Date, as the case may be.
ARTICLE III
CERTAIN COVENANTS
So long
as the Company shall have any obligation under this Note, unless otherwise
consented to in advance by the Majority Holders:
3.1
Limitations on Certain
Indebtedness.
The
Company will not itself, and will not permit any Subsidiary to, create, assume,
incur or in any manner become liable in respect of, including, without
limitation, by reason of any business combination transaction (all of which are
referred to herein as “incurring”), any Indebtedness other than Permitted
Indebtedness.
3.2
Maintenance of Cash and Cash
Equivalents Balances.
The
Company
shall at
all times maintain Cash and Cash Equivalents Balances at least equal to
$600,000. The Company shall certify the amount of its Cash and Cash Equivalents
Balances to the Holder as of the end of each calendar quarter, and from time to
time upon request of the Majority Holders, as provided herein. Not later than
the due date for filing with the SEC (determined without regard to any extension
thereof permitted by the SEC) the Company’s Quarterly Report on Form 10-Q (in
the case of the first three calendar quarters of each year) or the Company’s
Annual Report on Form 10-K (in the case of the fourth calendar quarter of each
year), and within five Business Days after a request therefor made by notice to
the Company from the Majority Holders, the Company shall furnish to the Holder a
Company Certificate, setting forth the amount of the Company's Cash and Cash
Equivalents Balances as of the end of such calendar quarter or as of the date of
such notice, as the case may be. Each Company Certificate delivered pursuant to
this Section 3.2 shall state (1) the amount of the Company’s Cash and Cash
Equivalents Balances and the date as of which such amount has been determined,
(2) separately, the amount of cash and the amount of cash equivalents included
in the amount of Cash and Cash Equivalents Balances shown in such Company
Certificate and (3) that the amount of Cash and Cash Equivalents Balances stated
in such Company Certificate has been determined in accordance with the terms of
this Note. If necessary in order to avoid furnishing the Holder information
that, for purposes of the 1934 Act, would be considered to be material
non-public information if not publicly disclosed, at the time the Company
furnishes each Company Certificate to the Holder the Company shall make an
appropriate public announcement disclosing the information contained in such
Company Certificate relating to the Cash and Cash Equivalents Balances;
provided,
however,
that in
case the Company makes no such public disclosure the Holder expressly undertakes
no agreement, obligation or duty to refrain from trading in the Company’s
securities while in possession of such information.
3.3
Payment of
Obligations.
The
Company will pay and discharge, and will cause each Subsidiary to pay and
discharge, all their respective material obligations and liabilities, including,
without limitation, tax liabilities, except where the same may be contested in
good faith by appropriate proceedings and the Company shall have established
adequate reserves therefor on its books.
3.4
Maintenance of Property;
Insurance.
(a) The
Company will keep, and will cause each Subsidiary to keep, all property useful
and necessary in its business in good working order and condition, ordinary wear
and tear excepted.
(b)
The
Company will maintain, and will cause each Subsidiary to maintain, with
financially sound and responsible insurance companies, insurance, in at least
such amounts and against such risks as is reasonably adequate for the conduct of
their respective businesses and the value of their respective
properties.
3.5
Conduct of Business and Maintenance
of Existence.
The
Company will continue, and will cause each Subsidiary to continue, to engage in
business of the same general type as now conducted by the Company, and will
preserve, renew and keep in full force and effect, and will cause each
Subsidiary to preserve, renew and keep in full force and effect their respective
corporate existence and their respective rights, privileges and franchises
necessary or desirable in the normal conduct of business except where (other
than the Company’s corporate existence) the failure to do so would not have a
material adverse effect on (i) the business, properties, operations, condition
(financial or other), results of operation or prospects of the Company and the
Subsidiaries, taken as a whole, (ii) the ability of the Company to perform and
comply with its obligations under the Transaction Documents or (iii) the rights
and remedies of the Holder or the Collateral Agent under or in connection with
the Transaction Documents.
3.6
Compliance with
Laws.
The
Company will comply, and will cause each Subsidiary to comply, in all material
respects with all applicable laws, ordinances, rules, regulations, decisions,
orders and requirements of governmental authorities and courts (including,
without limitation, environmental laws) except (i) where compliance therewith is
contested in good faith by appropriate proceedings or (ii) where non-compliance
therewith could not reasonably be expected to have a material adverse effect on
the business, condition (financial or otherwise), operations, performance,
properties or prospects of the Company and the Subsidiaries, taken as a
whole.
3.7
Investment Company
Act.
The
Company will not be or become an open-end investment trust, unit investment
trust or face-amount certificate company that is or is required to be registered
under Section 8 of the Investment Company Act of 1940, as
amended.
3.8
Limitations on Asset Sales,
Liquidations, Etc.; Certain Matters.
The
Company shall not
(a)
sell,
convey or otherwise dispose of all or substantially all of the assets of the
Company as an entirety or substantially as an entirety in a single transaction
or in a series of related transactions; or
(b)
sell one
or more Subsidiaries, or permit any one or more Subsidiaries to sell their
respective assets, if such sale individually or in the aggregate is material to
the Company and the Subsidiaries taken as a whole, other than any such sale or
sales which individually or in the aggregate could not reasonably be expected to
have a material adverse effect on (i) the business, properties, operations,
condition (financial or other), results of operation or financial prospects of
the Company and the Subsidiaries, taken as a whole, (ii) the validity or
enforceability of, or the ability of the Company to perform its obligations
under, the Transaction Documents, or (iii) the rights and remedies of the Holder
under the terms of the Transaction Documents; or
(c)
liquidate,
dissolve or otherwise wind up the affairs of the Company.
3.9
Limitations on
Liens.
The
Company will not itself, and will not permit any Subsidiary to, create, assume
or suffer to exist any Lien upon all or any part of its property of any
character, whether owned at the date hereof or thereafter acquired, except
Permitted Liens.
3.10
Transactions with
Affiliates.
The
Company will not, and will not permit any Subsidiary, directly or indirectly, to
pay any funds to or for the account of, make any investment (whether by
acquisition of stock or Indebtedness, by loan, advance, transfer of property,
guarantee or other agreement to pay, purchase or service, directly or
indirectly, any Indebtedness, or otherwise) in, lease, sell, transfer or
otherwise dispose of any assets, tangible or intangible, to, or participate in,
or effect any transaction in connection with, any joint enterprise or other
joint arrangement with, any Affiliate of the Company, except, on terms to the
Company or such Subsidiary no less favorable than terms that could be obtained
by the Company or such Subsidiary from a Person that is not an Affiliate of the
Company, as determined in good faith by the Board of Directors.
3.11
Rule 144A Information
Requirement.
Within
the period prior to the expiration of the holding period applicable to sales
hereof under Rule 144(k) under the 1933 Act (or any successor provision), the
Company shall, during any period in which it is not subject to Section 13 or
15(d) under the 1934 Act, make available to the Holder and any prospective
purchaser of this Note from the Holder, the information required pursuant to
Rule 144A(d)(4) under the 1933 Act upon the request of the Holder and it will
take such further action as the Holder may reasonably request, all to the extent
required from time to time to enable the Holder to sell this Note without
registration under the 1933 Act within the limitation of the exemption provided
by Rule 144A, as Rule 144A may be amended from time to time. Upon the request of
the Holder, the Company will deliver to the Holder a written statement as to
whether it has complied with such requirements.
3.12
Limitation on Certain
Issuances.
The
Company shall not offer, sell or issue, or enter into any agreement, arrangement
or understanding to offer, sell or issue, any Common Stock or Common Stock
Equivalent (A) that is convertible into, exchangeable or exercisable for, or
includes the right to receive additional shares of Common Stock either (x) at a
conversion, exercise or exchange rate or other price that is based upon and/or
varies with the trading prices of or quotations for the Common Stock at any time
after the initial issuance of such Common Stock or Common Stock Equivalent, or
(y) with a fixed conversion, exercise, exchange or purchase price that is
subject to being reset at some future date after the initial issuance of such
Common Stock or Common Stock Equivalent or upon the occurrence of specified or
contingent events directly or indirectly related to the business of the Company
or the market for the Common Stock (but excluding customary stock split, reverse
stock split, stock dividend and similar anti-dilution provisions substantially
similar to those set forth in clauses (a) through (e) of Section 6.3), or (B)
pursuant to an “equity line” structure in which one or more Persons commits to
provide capital to the Company by the purchase of securities of the Company from
time to time, whether at specified times, times determined by the Company or by
such Person(s) or by mutual agreement between the Company and such Person(s), at
prices based on the market prices of the Common Stock at or near the time of
each purchase, which securities are registered for sale or resale pursuant to
the 1933 Act;
provided, however,
that
nothing in this Section 3.11 shall prohibit the Company from issuing shares of
Common Stock for cash for the account of the Company in an offering that is
underwritten on a firm commitment basis and registered with the SEC under the
1933 Act.
3.13
Certain
Obligations.
The
Company shall not enter into any agreement which would adversely affect the
Collateral Agent's Lien on and Security Interest in the Collateral. The Company
shall perform, and comply in all material respects with each agreement it enters
into relating to the Collateral, the failure to comply with which could affect
the Collateral Agent's lien on and security interest in the
Collateral.
3.14
Notice of
Defaults.
The
Company shall notify the Holder promptly, but in any event not later than five
days after the Company becomes aware of the fact, of any failure by the Company
to comply with this Article III.
3.15
Listing Eligibility
Reporting.
The
Company shall notify the Holder from time to time within five Business Days
after the Company first learns that it does not meet any of the applicable
requirements for the continued listing of the Common Stock on the Principal
Market and shall make appropriate public announcement thereof so that the
content of such notice shall not constitute material non-public information for
purposes of the 1934 Act.
3.16
Designation of
Directors.
(a)
So long
as any principal amount of this Note or the Other Notes remains outstanding, the
Majority Holders shall be entitled, from time to time, to select a Person who
shall not be an Affiliate of Alexandra and who shall have the right to designate
by notice to the Company up to two persons (the first of whom, subject to his
completion of the D&O Questionnaire and the prompt completion of background
and other reasonable due diligence investigations to the Company’s reasonable
satisfaction, shall initially be Radu Auf Der Hyde) to serve from time to time
as members of the Board of Directors, provided, that each of such person(s)
designated to serve as a member of the Board of Directors (1) so long as
Alexandra holds all or any portion of this Note or any Other Note, is reasonably
acceptable to Alexandra and at least one other holder of this Note or any Other
Notes and (2) is not an Affiliate of Alexandra. Any person(s) so designated for
election to the Board of Directors shall enter into an agreement with Alexandra
on such terms as shall be acceptable to Alexandra pursuant to which such
person(s) shall agree not to share or convey any non-public information such
person(s) learns in its role as a director. The Company shall, from time to
time, use its best efforts to cause the election of the person(s) so designated
to serve as members of the Board of Directors as promptly as possible. If for
any reason under applicable law or the Company’s By-laws any such designee
cannot immediately be elected to the Board of Directors, then until such time as
such person(s) is elected to the Board of Directors (i) the person(s) so
designated shall have the right to be present at all meetings of the Board of
Directors, but shall not be entitled to vote on any action taken at such
meeting, (ii) the Company shall provide notice to such person(s) of the date,
place and time of each such meeting at least the same period in advance as the
shortest such notice provided to any member of the Board of Directors, (iii) the
Company shall provide such person(s) all agendas and other information and
materials provided to the Board of Directors contemporaneously with the time the
Company provides the same to the Board of Directors and (iv) the Company shall
provide to such person(s) copies of each proposed unanimous written consent of
the Board of Directors which consent is given to all members of the Board of
Directors for execution by the directors during such period, at the same time
such written consent is given to all members of the Board of Directors. In case
any person designated as a member of the Board of Directors pursuant to this
Section 3.16 shall resign, die, be removed from office or otherwise be unable to
serve, the Majority Holders shall be entitled to appoint a Person to designate a
replacement pursuant to, and in accordance with, this Section 3.16.
(b)
In the
event that approval of the stockholders of the Company shall be required to
elect the person(s) designated to serve as a member of the Board of Directors
pursuant to this Section 3.16, the Company shall call a meeting of stockholders
to be held within 90 days after the date such person(s) is so designated, shall
prepare and file with the SEC as promptly as practical, but in no event later
than 30 days after such date, preliminary proxy materials which set forth a
proposal to seek the approval of the election of such designee(s), and the Board
of Directors shall recommend approval thereof by the Company’s stockholders. The
Company shall mail and distribute its proxy materials for such stockholder
meeting to its
stockholders
at least 30 days prior to the date of such stockholder meeting and shall
actively solicit proxies to vote for the election of such
designee(s).
(c)
Notwithstanding
anything herein to the contrary, so long as Alexandra holds all or any portion
of this Note or any Other Note, the rights and obligations under this Section
3.16 may not be waived or amended without the consent of Alexandra.
3.17
Management Covenants.
(a)
Commencing on the Issuance Date, the Company shall withhold 10% of all cash
compensation payable to each of its Chief Executive Officer, President and Chief
Strategy Officer until such time as the Company shall have reported an EBITDA
Positive Quarter. The Company shall give notice to the holder of the occurrence
of the EBITDA Positive Quarter and once it shall have given such notice shall
pay the amounts so withheld, without interest, to the respective officers in
equal monthly installments during the 12-month period following such EBITDA
Positive Quarter so long as such officer continues to be employed by the Company
during such 12-month period. The Company shall not increase the compensation
payable in any form to any of its Chief Executive Officer, President and Chief
Strategy Officer from the Issuance Date until the EBITDA Positive Quarter has
occurred. Notwithstanding anything to the contrary contained herein, if (1) at
any time during any period of 45 consecutive Trading Days commencing after the
Issuance Date on each such Trading Day (i) the Market Price of the Common Stock
shall be at least 250% of the Conversion Price in effect on each such Trading
Day, (ii) the Average Daily Trading Volume Threshold is met, (iii) no Event of
Default shall have occurred or be continuing and no Repurchase Event shall have
occurred with respect to which the Holder has the right to require repurchase of
this Note pursuant to Article V or with respect to which the Holder has
exercised such right and the Company shall not have paid or deposited in
accordance with Section 7.10 the applicable Repurchase Price and (iv) the
Registration Statement shall be effective and available for use by the Holder
and the holders of the Warrants for the resale of shares of Common Stock issued
or issuable upon conversion of this Note and upon exercise of the Warrants and
is reasonably expected to remain effective and available for a reasonable period
after such period of 45 Trading Days, and (2) the Company shall have furnished
to the Holder a Company Certificate certifying the matters set forth in the
immediately preceding clause (1), then thereafter the Company shall no longer be
obligated to comply with this Section 3.17(a) and the Company shall pay the
amounts withheld by reason of this Section 3.17(a), without interest, to the
respective officers in equal monthly installments during the 12-month period
following the date the Company Certificate described in the immediately
preceding clause (2) was delivered to the Holder so long as such officer
continues to serve in such position during such 12-month period.
(b)
The
Company shall use its best efforts to successfully complete a search for a
qualified additional member of senior management and, subject to approval by the
Board of Directors, to hire such additional member of senior management.
Until
such time as such additional member of senior management has been hired the
Board of Directors shall form a three person committee to supervise the
management of the Company of which at least one person shall be a director
designated as a member of the Board of Directors pursuant to Section 3.16, one
person shall initially be John Atherly and the other person shall be Gary W.
Jones.
(c)
The
Company shall use its best efforts to design, develop, manufacture and market
the display, subsystem and personal display systems, and focus on funded
research
business
consistent with Company’s business plan in effect on the Issuance Date and shall
limit new market business development until the EBITDA Positive Quarter has
occurred.
(d)
Unless
the Company’s “Statement of Company Policy Regarding Confidentiality and
Securities Trades by Company Personnel” shall have been amended by the unanimous
approval of the three person committee set forth in Section 3.17(b), all
transactions in securities of the Company, including, without limitation,
acquisitions, dispositions and transfers, by directors, officers, managers and
all accounting and administrative personnel, must be pre-cleared by the office
of the Chief Financial Officer of the Company and such persons shall be
prohibited from making any trades in Company securities during the period
commencing 15 days prior to the end of each fiscal quarter and ending on the
third Business Day after the financial results of the Company for such fiscal
quarter are publicly released.
ARTICLE IV
EVENTS OF DEFAULT
4.1
If any of
the following events of default (each, an “Event of Default”) shall
occur:
(a)
Failure to Pay Principal, Interest,
Etc.
The
Company fails (1) to pay the principal, the Optional Redemption Price or the
Repurchase Price hereof when due, whether at maturity, upon acceleration or
otherwise, as applicable, or (2) to pay any installment of interest hereon when
due and, in the case of this clause (2) of this Section 4.1(a) only, such
failure continues for a period of five Business Days after the due date thereof;
or
(b)
Conversion and the
Shares.
The
Company fails to issue or cause to be issued shares of Common Stock to the
Holder or the holder of any Other Note upon exercise of the conversion rights of
the Holder or such holder or to the holder of any Warrant or Other Warrant upon
exercise of the purchase rights of the holder thereof, in any such case within
five Trading Days after the due date therefor in accordance with the terms of
this Note, any Other Note or any Warrant or Other Warrant or fails to transfer
any certificate for any such shares of Common Stock or any shares of Common
Stock issued in payment of interest on this Note or any Other Note as and when
required by this Note and the Note Purchase Agreement or any Other Note or Other
Note Purchase Agreement, as the case may be; or
(c)
Breach of
Covenant.
The
Company (1) fails to comply with Sections 3.1, 3.2, 3.8, 3.9, 3.12, 3.13, 3.15,
3.16 or 3.17(a) (2) fails to comply in any material respect with any provision
of Article III of this Note (other than Sections 3.1, 3.2, 3.8, 3.9, 3.12, 3.13,
3.15, 3.16 or 3.17(a)) or breaches any other material covenant or other material
term or condition of this Note or any of the other Transaction Documents (other
than as specifically provided in clauses (a), (b) or (c)(1) of this Section
4.1), and in the case of this clause (2) of this Section 4.1(c) only, such
breach continues for a period of ten days after written notice thereof to the
Company from the Holder; or
(d)
Breach of Representations and
Warranties.
Any
representation or warranty of the Company made herein or in any agreement,
statement or certificate given in writing pursuant hereto or in connection
herewith (including, without limitation, the Transaction Documents) shall be
false or misleading in any material respect when made; or
(e)
Certain Voluntary
Proceedings.
The
Company or any Subsidiary shall commence a voluntary case or other proceeding
seeking liquidation, reorganization or other relief with respect to itself or
its debts under any bankruptcy, insolvency or other similar law now or hereafter
in effect or seeking the appointment of a trustee, receiver, liquidator,
custodian or other similar official of it or any substantial part of its
property, or shall consent to any such relief or to the appointment of or taking
possession by any such official in an involuntary case or other proceeding
commenced against it, or shall make a general assignment for the benefit of
creditors, or shall fail generally to pay its debts as they become due or shall
admit in writing its inability generally to pay its debts as they become due;
or
(f)
Certain Involuntary
Proceedings.
An
involuntary case or other proceeding shall be commenced against the Company or
any Subsidiary seeking liquidation, reorganization or other relief with respect
to it or its debts under any bankruptcy, insolvency or other similar law now or
hereafter in effect or seeking the appointment of a trustee, receiver,
liquidator, custodian or other similar official of it or any substantial part of
its property, and such involuntary case or other proceeding shall remain
undismissed and unstayed for a period of 60 consecutive days; or
(g)
Judgments.
Any
court of competent jurisdiction shall enter one or more final judgments against
the Company or any Subsidiary or any of their respective properties or other
assets in an aggregate amount in excess of $250,000, which is not vacated,
bonded, stayed, discharged, satisfied or waived for a period of 30 consecutive
days; or
(h)
Default Under Other Agreements and
Instruments.
(1) The
Company or any Subsidiary shall (i) default in any payment with respect to any
Indebtedness for borrowed money (other than this Note) which Indebtedness has an
outstanding principal amount in excess of $250,000, individually or $500,000 in
the aggregate, for the Company and its Subsidiaries, beyond the period of grace,
if any, provided in the instrument or agreement under which such Indebtedness
was created or (ii) default in the observance or performance of any agreement,
covenant or condition relating to any such Indebtedness or contained in any
instrument or agreement evidencing, securing or relating thereto, or any other
event shall occur or condition exist, the effect of which default or other event
or condition is to cause, or to permit the holder or holders of such
Indebtedness (or a trustee or agent on behalf of such holder or holders) to
cause, any such Indebtedness to become due prior to its stated maturity and such
default or event shall continue beyond the period of grace, if any, provided in
the instrument or agreement under which such Indebtedness was created (after
giving effect to any consent or waiver obtained and then in effect thereunder);
or (2) any Indebtedness of the Company or any Subsidiary which has an
outstanding principal amount in excess of $250,000, individually or $500,000 in
the aggregate, shall, in accordance with its terms, be declared to be due and
payable, or required to be prepaid other than by a regularly scheduled or
required payment prior to the stated maturity thereof; or
(i)
Security
Agreements.
The
occurrence of any “Event of Default” as defined in the Security Agreements or
any breach or failure by the Company to perform its obligations under the
Lockbox Agreement; or
(j)
Delisting of Common
Stock.
The
Common Stock shall cease to be listed on any of Nasdaq Capital Market, Nasdaq,
the NYSE or the AMEX;
then, (W)
upon the occurrence and during the continuation of any Event of Default
specified in clause (a), (b), (c), (d), (g), (h), (i) or (j) of this
Section 4.1, at the option of the Holder the Company shall, and upon the
occurrence of any Event of Default specified in clause (e) or (f) of this
Section 4.1, the Company shall, in any such case, pay to the Holder an
amount equal to the sum of (1) the outstanding principal amount of this Note
plus
(2)
accrued and unpaid interest on such principal amount to the date of payment
plus
(3)
accrued and unpaid Default Interest, if any, thereon at the rate provided in
this Note to the date of payment, (X) all other amounts payable hereunder or
under any of the other Transaction Documents shall immediately become due and
payable, all without demand, presentment or notice, all of which hereby are
expressly waived, together with all costs, including, without limitation,
reasonable legal fees and expenses, of collection, (Y) the Collateral Agent
shall be entitled to exercise all rights and remedies under the Security
Agreement, and (Z) the Holder shall be entitled to exercise all other rights and
remedies available at law or in equity.
ARTICLE V
REPURCHASE UPON A REPURCHASE EVENT
5.1
Repurchase Right Upon Repurchase
Event.
If a
Repurchase Event occurs, in addition to any other right of the Holder, the
Holder shall have the right, at the Holder’s option, to require the Company to
repurchase all of this Note, or any portion hereof on the repurchase date that
is five Business Days after the date of the Holder Notice delivered with respect
to such Repurchase Event. The Holder shall have the right to require the Company
to repurchase all or any such portion of this Note if a Repurchase Event occurs
at any time while any portion of the principal amount of this Note is
outstanding at a price equal to the Repurchase Price. If the Holder exercises
its right to require the repurchase of less than all of the outstanding
principal amount of this Note, the Holder may specify the manner in which the
principal amount repurchased shall be allocated between the outstanding
installments of principal.
5.2
Notices; Method of Exercising
Repurchase Rights, Etc.
(a) On
or before the fifth Business Day after the occurrence of a Repurchase Event, the
Company shall give to the Holder a Company Notice of the occurrence of the
Repurchase Event and of the repurchase right set forth herein arising as a
result thereof. Such Company Notice shall set forth:
(i)
the date
by which the repurchase right must be exercised, and
(ii)
a
description of the procedure (set forth in this Section 5.2) which the
Holder must follow to exercise the repurchase right.
No
failure of the Company to give a Company Notice or defect therein shall limit
the Holder’s right to exercise the repurchase right or affect the validity of
the proceedings for the repurchase of this Note or portion hereof.
(b)
To
exercise the repurchase right, the Holder shall deliver to the Company on or
before the 30th day after a Company Notice (or if no such Company Notice has
been given, within 40 days after the Holder first learns of the Repurchase
Event) (i) a Holder Notice setting forth the name of the Holder and the
principal amount of this Note to be repurchased, which amount may be allocated
between the installments of principal outstanding at such time as determined by
the Holder in its sole discretion, and (ii) this Note, duly endorsed for
transfer to the Company of the portion of the outstanding principal amount of
this Note to be repurchased. A Holder Notice may be revoked by the Holder at any
time prior to the time the Company pays the applicable Repurchase Price to the
Holder.
(c)
If the
Holder shall have given a Holder Notice, then on the date which is five Business
Days after the date such Holder Notice is given (or such later date as the
Holder surrenders this Note) the Company shall make payment in immediately
available funds of the applicable Repurchase Price to such account as specified
by the Holder in writing to the Company at least one Business Day prior to the
applicable repurchase date.
5.3
Other.
(a) If
the Company fails to repurchase on the applicable repurchase date this Note (or
portion hereof) as to which the repurchase right has been properly exercised
pursuant to this Article V, then the Repurchase Price for the portion (which, if
applicable, may be all) of this Note which is required to have been so
repurchased shall bear interest to the extent not prohibited by applicable law
from the applicable repurchase date until paid at the Default Rate.
(b)
If a
portion of this Note is to be repurchased, upon surrender of this Note to the
Company in accordance with the terms of this Article V, the Company shall
execute and deliver to the Holder without service charge, a new Note or Notes,
having the same date hereof and containing identical terms and conditions, in
such denomination or denominations as requested by the Holder in aggregate
principal amount equal to, and in exchange for, the unrepurchased portion of the
principal amount of the Note so surrendered.
(c)
A Holder
Notice given by the Holder shall be deemed for all purposes to be in proper form
unless the Company notifies the Holder within three Business Days after such
Holder Notice has been given (which notice shall specify all defects in such
Holder Notice), and any Holder Notice containing any such defect shall
nonetheless be effective on the date given if the Holder promptly undertakes to
correct all such defects. No such claim of defect shall limit or delay
performance of the Company's obligation to repurchase any portion of this Note,
the repurchase of which is not in dispute.
ARTICLE VI
CONVERSION
6.1
Right to
Convert
.
Subject
to and upon compliance with the provisions of this Note, the Holder shall have
the right, at the Holder's option, at any time prior to the close of business on
the Final Maturity Date (except that, if the Holder shall have exercised
repurchase rights under Sections 5.1 and 5.2 or the Company shall have exercised
its redemption rights under Section 2.1, such conversion right shall terminate
with respect to the portion of this Note to be repurchased or redeemed, as the
case may be, at the close of business on the last Trading Day prior to the later
of (x) the date the Company is required to make such repurchase or the Optional
Redemption Date, as the case may be, and (y) the date the Company pays or
deposits in accordance with Section 7.10 the applicable Repurchase Price or the
Optional Redemption Price unless in any such case the Company shall default in
payment due upon repurchase or redemption hereof) to convert the principal
amount of this Note, or any portion of such principal amount which is at least
$1,000 (or such lesser principal amount of this Note as shall be outstanding at
such time), plus accrued and unpaid interest, into that number of fully paid and
non-assessable shares of Common Stock (as such shares shall then be constituted)
obtained by dividing (1) the sum of (x) the principal amount of this Note or
portion thereof being converted
plus
(y)
accrued and unpaid interest on the portion of the principal amount of this Note
being converted to the applicable Conversion Date
plus
(z)
accrued and unpaid Default Interest, if any, on the amount referred to in the
immediately preceding clause (y) to the applicable Conversion Date
by
(2) the
Conversion Price in effect on the applicable Conversion Date, by giving a
Conversion Notice in the manner provided in Section 6.2;
provided, however,
that, if
at any time this Note is converted in whole or in part pursuant to this Section
6.1, the Company does not have available for issuance upon such conversion as
authorized and unissued shares or in its treasury at least the number of shares
of Common Stock required to be issued pursuant hereto, then, at the election of
the Holder made by notice from the Holder to the Company, this Note (or portion
hereof as to which conversion has been requested), to the extent that sufficient
shares of Common Stock are not then available for issuance upon conversion,
shall be converted into the right to receive from the Company, in lieu of the
shares of Common Stock into which this Note or such portion hereof would
otherwise be converted and which the Company is unable to issue, payment in an
amount equal to the product obtained by multiplying (x) the number of shares of
Common Stock which the Company is unable to issue
times
(y) the
arithmetic average of the Market Price for the Common Stock during the five
consecutive Trading Days immediately prior to the applicable Conversion Date.
Any such payment shall, for all purposes of this Note, be deemed to be a payment
of principal plus a premium equal to the total amount payable less the principal
portion of this Note converted as to which such payment is required to be made
because shares of Common Stock are not then available for issuance upon such
conversion. The Holder is not entitled to any rights of a holder of Common Stock
until the Holder has converted this Note to Common Stock, and only to the extent
this Note is deemed to have been converted to Common Stock under this Article
VI. For purposes of Sections 6.5 and 6.6, whenever a provision references the
shares of Common Stock into which this Note (or a portion hereof) is convertible
or the shares of Common Stock issuable upon conversion of this Note (or a
portion hereof) or words of similar import, any determination required by such
provision shall be made as if a sufficient number of shares of Common Stock were
then available for issuance upon conversion in full of this
Note.
6.2
Exercise of Conversion Privilege;
Issuance of Common Stock on Conversion; No Adjustment for Interest or
Dividends
.
(a) In
order to exercise the conversion privilege with respect to this Note, the Holder
shall give a Conversion Notice (or such other notice which is acceptable to the
Company) to the Company and the Transfer Agent or to the office or agency
designated by the Company for such purpose by notice to the Holder. A Conversion
Notice may be given by telephone line facsimile transmission to the numbers set
forth on the form of Conversion Notice. In connection with any conversion of
this Note, the Holder may allocate such conversion between the outstanding
installments of principal as determined by the Holder in its sole discretion, as
set forth in a particular Conversion Notice.
(b)
As
promptly as practicable, but in no event later than three Trading Days, after a
Conversion Notice is given, the Company shall issue and shall deliver to the
Holder or the Holder's designee the number of full shares of Common Stock
issuable upon such conversion of this Note or portion hereof in accordance with
the provisions of this Article and deliver a check or cash in respect of any
fractional interest in respect of a share of Common Stock arising upon such
conversion, as provided in Section 6.2(f) and, if applicable, any cash payment
required pursuant to the proviso to the first sentence of Section 6.1 (which
payment, if any, shall be paid no later than three Trading Days after the
applicable Conversion Date). In lieu of delivering physical certificates for the
shares of Common Stock issuable upon any conversion of this Note, provided the
Company's transfer agent is participating in the Depository Trust Company
(“DTC”) Fast Automated Securities Transfer (“FAST”) program, upon request of the
Holder, the Company shall use commercially reasonable efforts to cause its
transfer agent electronically to transmit such shares of Common Stock issuable
upon conversion to the Holder (or its designee), by crediting the account of the
Holder’s (or such designee’s) broker with DTC through its Deposit Withdrawal
Agent Commission system (provided that the same time periods herein as for stock
certificates shall apply).
(c)
Each
conversion of this Note (or portion hereof) shall be deemed to have been
effected on the applicable Conversion Date, and the person in whose name any
certificate or certificates for shares of Common Stock shall be issuable upon
such conversion shall be deemed to have become on such Conversion Date the
holder of record of the shares represented thereby;
provided, however,
that if a
Conversion Date is a date on which the stock transfer books of the Company shall
be closed such conversion shall constitute the person in whose name the
certificates are to be issued as the record holder thereof for all purposes on
the next succeeding day on which such stock transfer books are open, but such
conversion shall be at the Conversion Price in effect on the applicable
Conversion Date.
Upon
conversion of this Note or any portion hereof, the accrued and unpaid interest
on this Note (or portion hereof) to (but excluding) the applicable Conversion
Date shall be deemed to be paid to the Holder of this Note through receipt of
such number of shares of Common Stock issued upon conversion of this Note or
portion hereof as shall have an aggregate Current Fair Market Value on the
Trading Day immediately preceding such Conversion Date equal to the amount of
such accrued and unpaid interest.
(d)
A
Conversion Notice shall be deemed for all purposes to be in proper form absent
timely notice from the Company to the Holder of manifest error therein. The
Company shall notify the Holder of any claim by the Company of manifest error in
a Conversion Notice within two Trading Days after the Holder gives such
Conversion Notice (which notice from the
Company
shall specify all defects in the Conversion Notice) and no such
claim of error shall limit or delay performance of the Company's
obligation to issue upon such
conversion
the number of shares of Common Stock which are not in dispute. Time shall be of
the essence in the giving of any such notice by the Company. Any Conversion
Notice containing any such defect shall nonetheless be effective on the date
given if the Holder promptly undertakes to correct all such defects. The Company
shall not be required to pay any tax which may be payable in respect of any
transfer involved in the issuance and delivery of shares of Common Stock or
other securities or property on conversion of this Note in a name other than
that of the Holder, and the Company shall not be required to issue or deliver
any such shares or other securities or property unless and until the person or
persons requesting the issuance thereof shall have paid to the Company the full
amount of any such tax or shall have established to the satisfaction of the
Company that such tax has been paid. The Holder shall be responsible for the
amount of any withholding tax payable in connection with any conversion of this
Note.
(e)
(1) If
the Holder shall have given a Conversion Notice in accordance with the terms of
this Note, the Company's obligation to issue and deliver the shares of Common
Stock upon such conversion shall be absolute and unconditional, irrespective of
any action or inaction by the Holder to enforce the same, any waiver or consent
with respect to any provision hereof, the recovery of any judgment against any
person or any action to enforce the same, any failure or delay in the
enforcement of any other obligation of the Company to the Holder, or any setoff,
counterclaim, recoupment, limitation or termination, or any breach or alleged
breach by the Holder or any other person of any obligation to the Company or any
violation or alleged violation of law by the Holder or any other person, and
irrespective of any other circumstance which might otherwise limit such
obligation of the Company to the Holder in connection with such conversion;
provided, however,
that
nothing herein shall limit or prejudice the right of the Company to pursue any
such claim in any other manner permitted by applicable law. The occurrence of an
event which requires an adjustment of the Conversion Price as contemplated by
Section 6.3 shall in no way restrict or delay the right of the Holder to receive
certificates for Common Stock upon conversion of this Note and the Company shall
use its best efforts to implement such adjustment on terms reasonably acceptable
to the Holder within two Trading Days of such occurrence.
(2)
If in any
case the Company shall fail to issue and deliver the shares of Common Stock to
the Holder in connection with a particular conversion of this Note within five
Trading Days after the Holder gives the Conversion Notice for such conversion,
in addition to any other liabilities the Company may have hereunder and under
applicable law (A) the Company shall pay or reimburse the Holder on demand for
all out-of-pocket expenses, including, without limitation, reasonable fees and
expenses of legal counsel, incurred by the Holder as a result of such failure,
(B) if as a result of such failure the Holder shall suffer any direct damages or
liabilities from such failure (including, without limitation, margin interest
and the cost of purchasing securities to cover a sale (whether by the Holder or
the Holder's securities broker) or borrowing of shares of Common Stock by the
Holder for purposes of settling any trade involving a sale of shares of Common
Stock made by the Holder during the period beginning on the Issuance Date and
ending on the date the Company delivers or causes to be delivered to the Holder
such shares of Common Stock), then the Company shall upon demand of the Holder
pay to the Holder an amount equal to the actual direct, out-of-pocket damages
and liabilities suffered by the Holder by reason thereof which the Holder
documents to the reasonable satisfaction of the Company, and (C) the Holder may
by written notice (which may be given by mail, courier,
personal
service or telephone line facsimile transmission), given at any time prior to
delivery to the Holder of the shares of Common Stock issuable in connection with
such exercise of the Holder's conversion right, rescind such exercise and the
Conversion Notice relating thereto, in which case the Holder shall thereafter
be
entitled
to convert that portion of this Note as to which such exercise is so rescinded
and to exercise its other rights and remedies with respect to such failure by
the Company. Notwithstanding the foregoing the Company shall not be liable to
the Holder under clause (B) of the immediately preceding sentence to the extent
the failure of the Company to deliver or to cause to be delivered such shares of
Common Stock results from fire, flood, storm, earthquake, shipwreck, strike,
war, acts of terrorism, crash involving facilities of a common carrier, acts of
God, or any similar event outside the control of the Company (it being
understood that the action or failure to act of the Transfer Agent shall not be
deemed an event outside the control of the Company except to the extent
resulting from fire, flood, storm, earthquake, shipwreck, strike, war, acts of
terrorism, crash involving facilities of a common carrier, acts of God, or any
similar event outside the control of the Transfer Agent or the bankruptcy,
liquidation or reorganization of the Transfer Agent under any bankruptcy,
insolvency or other similar law). In the case of the Company’s failure to issue
and deliver or cause to be delivered the shares of Common Stock to the Holder
within three Trading Days of a particular conversion of the Note, the amount
payable by the Company pursuant to clause (B) of this Section 6.2(e)(2) with
respect to such conversion shall be reduced by the amount of payments previously
paid by the Company to the Holder pursuant to Section 8(a)(4) of the Purchase
Agreement with respect to such conversion. The Holder shall notify the Company
in writing (or by telephone conversation, confirmed in writing) as promptly as
practicable following the third Trading Day after the Holder gives a Conversion
Notice if the Holder becomes aware that such shares of Common Stock so issuable
have not been received as provided herein, but any failure so to give such
notice shall not affect the Holder's rights under this Note or otherwise. If the
Holder shall have exercised the conversion right in any particular instance and
either (1) the Company shall notify the Holder on or after the date the Holder
gives such Conversion Notice that the shares of Common Stock issuable upon such
conversion might not be delivered within three Trading Days after the date the
Holder gives such Conversion Notice or (2) the Holder learns after the date
which is three Trading Days after the date the Holder gives such Conversion
Notice that the Holder has not received such shares of Common Stock, then,
without releasing the Company of its obligations with respect thereto, from and
after the Trading Day next succeeding the earlier of the events described in the
preceding clauses (1) and (2) of this sentence the Holder shall make reasonable
efforts not to sell shares of Common Stock in anticipation of receipt of such
shares of Common Stock in a manner which is likely to increase materially the
liability of the Company under clause (B) of the first sentence of this Section
6.2(e)(2).
(f)
No
fractional shares of Common Stock shall be issued upon conversion of this Note
but, in lieu of any fraction of a share of Common Stock which would otherwise be
issuable in respect of such conversion, the Company may round the number of
shares of Common Stock issued on such conversion up to the next highest whole
share or may pay lawfulmoney of the United States of America for such fractional
share, based on a value of one share of Common Stock being equal to the Market
Price of the Common Stock on the applicable Conversion Date.
6.3
Adjustment of Conversion
Price
.
The
Conversion Price shall be adjusted from time to time by the Company as
follows:
(a)
Adjustments for Certain Dividends
and Distributions in Common Stock.
In case
the Company shall on or after the Issuance Date pay a dividend or make a
distribution to all holders of the outstanding Common Stock in shares of Common
Stock, the Conversion Price in effect at the opening of business on the date
following the date fixed for the determination of stockholders entitled to
receive such dividend or other distribution shall be reduced by multiplying such
Conversion Price by a fraction of which the numerator shall be the number of
shares of Common Stock outstanding at the close of business on the Record Date
fixed for such determination and the denominator shall be the sum of such number
of shares and the total number of shares constituting such dividend or other
distribution, such reduction to become effective immediately after the opening
of business on the day following the Record Date. If any dividend or
distribution of the type described in this Section 6.3(a) is declared but not so
paid or made, the Conversion Price shall again be adjusted to the Conversion
Price which would then be in effect if such dividend or distribution had not
been declared.
(b)
Weighted Adjustments for Certain
Issuances of Rights or Warrants.
In case
the Company shall on or after the Issuance Date issue rights or warrants (other
than any rights or warrants referred to in Section 6.3(d)) to all holders of its
outstanding shares of Common Stock entitling them (for a period expiring within
45 days after the date fixed for the determination of stockholders entitled to
receive such rights or warrants) to subscribe for or purchase shares of Common
Stock at a price per share less than the Current Market Price on the Record Date
fixed for the determination of stockholders entitled to receive such rights or
warrants, the Conversion Price shall be adjusted so that the same shall equal
the price determined by multiplying the Conversion Price in effect at the
opening of business on the date after such Record Date by a fraction of which
the numerator shall be the number of shares of Common Stock outstanding at the
close of business on the Record Date plus the number of shares which the
aggregate offering price of the total number of shares so offered would purchase
at such Current Market Price, and the denominator shall be the number of shares
of Common Stock outstanding on the close of business on the Record Date plus the
total number of additional shares of Common Stock so offered for subscription or
purchase. Such adjustment shall become effective immediately after the opening
of business on the day following the Record Date fixed for determination of
stockholders entitled to receive such rights or warrants. To the extent that
shares of Common Stock are not delivered pursuant to such rights or warrants,
upon the expiration or termination of such rights or warrants, the Conversion
Price shall be readjusted to the Conversion Price which would then be in effect
had the adjustments made upon the issuance of such rights or warrants been made
on the basis of delivery of only the number of shares of Common Stock actually
delivered. In the event that such rights or warrants are not so issued, the
Conversion Price shall again be adjusted to be the Conversion Price which would
then be in effect if such date fixed for the determination of stockholders
entitled to receive such rights or warrants had not been fixed. In determining
whether any rights or warrants entitle the holder to subscribe for or purchase
shares of Common Stock at less than such Current Market Price, and in
determining the aggregate offering price of such shares of Common Stock, there
shall be taken into account any consideration received for such rights or
warrants, the value of such consideration, if other than cash, to be determined
by the Board of Directors. Notwithstanding the foregoing, if any of the
adjustments as set forth in this Section 6.3(b) will require the Company to seek
stockholder approval pursuant to Rule 713 of the AMEX and such stockholder
approval has not yet been obtained, then the adjustment shall not take effect
until such stockholder approval is obtained. The Company shall use its
commercially reasonable best efforts to obtain, as promptly as practicable, but
in no event later than 90 days thereafter, the stockholder approval that is
necessary under the rules of the AMEX.
(c)
Adjustments for Certain Subdivisions
of the Common Stock.
In case
the outstanding shares of Common Stock shall on or after the Issuance Date be
subdivided into a greater number of shares of Common Stock, the Conversion Price
in effect at the opening of business on the earlier of the day following the day
upon which such subdivision becomes effective and the day on which “ex-” trading
of the Common Stock begins with respect to such subdivision shall be
proportionately reduced, and conversely, in case outstanding shares of Common
Stock shall be combined into a smaller number of shares of Common Stock, the
Conversion Price in effect at the opening of business on the earlier of the day
following the day upon which such combination becomes effective and the day on
which “ex-” trading of the Common Stock with respect to such combination begins
shall be proportionately increased, such reduction or increase, as the case may
be, to become effective immediately after the opening of business on the earlier
of the day following the day upon which such subdivision or combination becomes
effective and the day on which “ex-” trading of the Common Stock begins with
respect to such subdivision or combination.
(d)
Adjustments for Certain Dividends
and Distributions.
In case
the Company shall on or after the Issuance Date, by dividend or otherwise,
distribute to all holders of its Common Stock shares of any class of capital
stock of the Company (other than any dividends or distributions to which Section
6.3(a) applies) or evidences of its indebtedness, cash or other assets
(including securities, but excluding any rights or warrants referred to in
Section 6.3(b) and dividends and distributions paid exclusively in cash and
excluding any capital stock, evidences of indebtedness, cash or assets
distributed upon a merger or consolidation to which Section 6.6 applies) (the
foregoing hereinafter in this Section 6.3(d) called the “Securities”)), then, in
each such case, subject to the second paragraph of this Section 6.3(d), the
Conversion Price shall be reduced so that the same shall be equal to the price
determined by multiplying the Conversion Price in effect immediately prior to
the close of business on the Record Date with respect to such distribution by a
fraction of which the numerator shall be the Current Market Price on such date
less the fair market value (as determined by the Board of Directors, whose
determination shall be conclusive and described in a Board Resolution) on such
date of the portion of the Securities so distributed applicable to one share of
Common Stock and the denominator shall be such Current Market Price, such
reduction to become effective immediately prior to the opening of business on
the day following the Record Date;
provided, however,
that in
the event the then fair market value (as so determined) of the portion of the
Securities so distributed applicable to one share of Common Stock is equal to or
greater than the Current Market Price on the Record Date, in lieu of the
foregoing adjustment, adequate provision shall be made so that the Holder shall
have the right to receive upon conversion of this Note (or any portion hereof)
the amount of Securities such holder would have received had such holder
converted this Note (or portion hereof) immediately prior to such Record Date.
In the event that such dividend or distribution is not so paid or made, the
Conversion Price shall again be adjusted to be the Conversion Price which would
then be in effect if such dividend or distribution had not been declared. If the
Board of Directors determines the fair market value of any distribution for
purposes of this Section 6.3(d) by reference to the actual or when issued
trading market for any Securities comprising all or part of such distribution,
it must in doing so consider the prices in such market over the same period used
in computing the Current Market Price, to the extent possible.
Rights or
warrants distributed by the Company to all holders of Common Stock entitling the
holders thereof to subscribe for or purchase shares of the Company's capital
stock (either initially or under certain circumstances), which rights or
warrants, until the occurrence of a specified event or events (a “Trigger
Event”): (i) are deemed to be transferred with such shares of Common Stock; (ii)
are not exercisable; and (iii) are also issued in respect of future issuances of
Common Stock, shall not be deemed to have been distributed for purposes of this
Section 6.3 (and no adjustment to the Conversion Price under this Section 6.3
will be required) until the occurrence of the earliest Trigger Event. If any
such rights or warrants, including any such existing rights or warrants
distributed prior to the Issuance Date, are subject to Trigger Events, upon the
satisfaction of each of which such rights or warrants shall become exercisable
to purchase different securities, evidences of indebtedness or other assets,
then the occurrence of each such Trigger Event shall be deemed to be such date
of issuance and record date with respect to new rights or warrants (and a
termination or expiration of the existing rights or warrants without exercise by
the holder thereof) (so that, by way of illustration and not limitation, the
dates of issuance of any such rights shall be deemed to be the dates on which
such rights become exercisable to purchase capital stock of the Company, and not
the date on which such rights may be issued, or may become evidenced by separate
certificates, if such rights are not then so exercisable). In addition, in the
event of any distribution of rights or warrants, or any Trigger Event with
respect thereto, that was counted for purposes of calculating a distribution
amount for which an adjustment to the Conversion Price under this Section 6.3
was made (1) in the case of any such rights or warrants which shall all have
been redeemed or repurchased without exercise by any holders thereof, the
Conversion Price shall be readjusted upon such final redemption or repurchase to
give effect to such distribution or Trigger Event, as the case may be, as though
it were a cash distribution, equal to the per share redemption or repurchase
price received by a holder or holders of Common Stock with respect to such
rights or warrants (assuming such holder had retained such rights or warrants),
made to all holders of Common Stock as of the date of such redemption or
repurchase, and (2) in the case of such rights or warrants which shall have
expired or been terminated without exercise by any holders thereof, the
Conversion Price shall be readjusted as if such rights and warrants had not been
issued.
For
purposes of this Section 6.3(d) and Sections 6.3(a) and (b), any dividend or
distribution to which this Section 6.3(d) is applicable that also includes
shares of Common Stock, or rights or warrants to subscribe for or purchase
shares of Common Stock to which Section 6.3(b) applies (or both), shall be
deemed instead to be (1) a dividend or distribution of the evidences of
indebtedness, assets, shares of capital stock, rights or warrants other than
such shares of Common Stock or rights or warrants to which Section 6.3(b)
applies (and any Conversion Price reduction required by this Section 6.3(d) with
respect to such dividend or distribution shall then be made) immediately
followed by (2) a dividend or distribution of such shares of Common Stock or
such rights or warrants (and any further Conversion Price reduction required by
Sections 6.3(a) and (b) with respect to such dividend or distribution shall then
be made), except (A) the Record Date of such dividend or distribution shall be
substituted as “the date fixed for the determination of stockholders entitled to
receive such dividend or other distribution”, “Record Date fixed for such
determination” and “Record Date” within the meaning of Section 6.3(a) and as
“the date fixed for the determination of stockholders entitled to receive such
rights or warrants”, “the Record Date fixed for the determination of the
stockholders entitled to receive such rights or warrants” and “such Record Date”
within the meaning of Section 6.3(b)
and (B)
any shares of Common Stock included in such dividend or distribution shall not
be deemed “outstanding at the close of business on the Record Date fixed for
such determination” within the meaning of Section
6.3(a).
(e)
Adjustments for Certain Cash
Dividends.
In case
the Company shall on or after the Issuance Date, by dividend or otherwise,
distribute to all holders of its Common Stock cash (excluding any cash that is
distributed upon a merger or consolidation to which Section 6.5 applies or as
part of a distribution referred to in Section 6.3(d)) in an aggregate amount
that, combined with (1) the aggregate amount of any other such distributions to
all holders of its Common Stock made exclusively in cash within the 12 months
preceding the date of payment of such distribution, and in respect of which no
adjustment pursuant to this Section 6.3(e) has been made, and (2) the aggregate
of any cash plus the fair market value (as determined by the Board of Directors,
whose determination shall be conclusive and set forth in a Board Resolution) of
consideration payable in respect of any Tender Offer by the Company or any
Subsidiary for all or any portion of the Common Stock concluded within the 12
months preceding the date of payment of such distribution, exceeds 1% of the
product of (x) the Current Market Price on the Record Date with respect to such
distribution
times
(y) the
number of shares of Common Stock outstanding on such date, then, and in each
such case, immediately after the close of business on such date, unless the
Company elects to reserve such cash for distribution to the Holder upon the
conversion of this Note (and shall have made adequate provision) so that the
Holder will receive upon such conversion, in addition to the shares of Common
Stock to which the Holder is entitled, the amount of cash which the Holder would
have received if the Holder had, immediately prior to the Record Date for such
distribution of cash, converted this Note into Common Stock, the Conversion
Price shall be reduced so that the same shall equal the price determined by
multiplying the Conversion Price in effect immediately prior to the close of
business on such Record Date by a fraction (i) the numerator of which shall be
equal to the Current Market Price on the Record Date less an amount equal to the
quotient of (x) the excess of such combined amount over such 1% and (y) the
number of shares of Common Stock outstanding on the Record Date and (ii) the
denominator of which shall be equal to the Current Market Price on the Record
Date;
provided, however,
that in
the event the portion of the cash so distributed applicable to one share of
Common Stock is equal to or greater than the Current Market Price of the Common
Stock on the Record Date, in lieu of the foregoing adjustment, adequate
provision shall be made so that the Holder shall have the right to receive upon
conversion of this Note (or any portion hereof) the amount of cash the Holder
would have received had the Holder converted this Note (or portion hereof)
immediately prior to such Record Date. In the event that such dividend or
distribution is not so paid or made, the Conversion Price shall again be
adjusted to be the Conversion Price which would then be in effect if such
dividend or distribution had not been declared.
(
f
)
Adjustment in Connection Sales by a
Designated Person.
(1) If at
any time on or after the Issuance Date any Designated Person, directly or
indirectly, sells, transfers or disposes of shares of Common Stock or Common
Stock Equivalents other than a Permitted Designated Person Sale and on the
Measurement Date for such sale, transfer or disposition the Conversion Price in
effect on such Measurement Date is greater than the Computed Market Price on
such Measurement Date, then, subject to the next succeeding sentence, the
Conversion
Price shall be reduced to such Computed Market Price
, such
adjustment to become effective immediately after the opening of business on the
day following the Measurement Date. If a reduction of the Conversion Price to
such Computed Market Price pursuant to the immediately preceding sentence would
require the Company to seek stockholder approval of the transactions
contemplated by the Note Purchase Agreement pursuant to Rule 713 of the AMEX and
the Stockholder Approval has not yet been obtained, then the adjustment provided
in this Section 6.3(f) shall not take effect until such time as the Stockholder
Approval is obtained at which time the Conversion Price shall be reduced to such
Computed Market Price.
(2)
The
Company shall enter into an agreement with each Designated Person, on or before
the date that is 30 days after the Issuance Date, pursuant to which each
Designated Person shall agree that upon the written request of the Company or
any Holder, the Designated Person shall provide the Company and such Holder, a
written statement setting forth the dates, if any, upon which the Designated
Person has sold, transferred or disposed of any shares of Common Stock or Common
Stock Equivalents during such period as shall be reasonably requested by the
Company or such Holder to determine whether or not a sale, transfer or
disposition that requires an adjustment pursuant to Section 6.3(f)(1) has
occurred. The Company shall instruct the Transfer Agent to inform the Company
immediately upon the sale, transfer or disposition of any shares of Common Stock
or Common Stock Equivalents by any Designated Person. The Company shall inform
the Holder immediately by phone and electronic transmission upon becoming aware
of any sale, transfer or disposition of any shares of Common Stock or Common
Stock Equivalents by any Designated Person and will follow up with formal
written notice to the Holder pursuant to Section 7.2.
(
g
)
Additional Reductions in Conversion
Price.
The
Company may make such reductions in the Conversion Price, in addition to those
required by Sections 6.3(a), (b), (c), (d), (e) and (f), as the Board of
Directors considers to be advisable to avoid or diminish any income tax to
holders of Common Stock or rights to purchase Common Stock resulting from any
dividend or distribution of stock (or rights to acquire stock) or from any event
treated as such for income tax purposes.
(
h
)
De Minimus
Adjustments.
No
adjustment in the Conversion Price shall be required unless such adjustment
would require an increase or decrease of at least 1% in such price;
provided, however,
that any
adjustments which by reason of this Section 6.3(h) are not required to be made
shall be carried forward and taken into account in any subsequent adjustment.
All calculations under this Article VI shall be made by the Company and shall be
made to the nearest cent or to the nearest one hundredth of a share, as the case
may be.
No
adjustment need be made for a change in the par value of the Common Stock or
from par value to no par value or from no par value to par value.
(
i
)
Company Notice of
Adjustments.
Whenever
the Conversion Price is adjusted as herein provided, the Company shall promptly,
but in no event later than five days thereafter, give a notice to the Holder
setting forth the Conversion Price after such adjustment and setting forth a
brief statement of the facts requiring such adjustment, but which statement
shall not include any information which would be material non-public information
for purposes of the 1934 Act. Failure to deliver such notice shall not affect
the legality or validity of any such adjustment.
(j)
Effectiveness of Certain
Adjustments.
In any
case in which this Section 6.3 provides that an adjustment shall become
effective immediately after a Record Date for an event, the Company may defer
until the occurrence of such event (i) issuing to the Holder in connection with
any conversion of this Note after such Record Date and before the occurrence of
such event the additional shares of Common Stock issuable upon such conversion
by reason of the adjustment required by such event over and above the Common
Stock issuable upon such conversion before giving effect to such adjustment and
(ii) paying to such holder any amount in cash in lieu of any fraction pursuant
to Section 6.2(f).
(k)
Outstanding
Shares.
For
purposes of this Section 6.3, the number of shares of Common Stock at any time
outstanding shall not include shares held in the treasury of the Company but
shall include shares issuable in respect of scrip certificates issued in lieu of
fractions of shares of Common Stock. The Company will not pay any dividend or
make any distribution on shares of Common Stock held in the treasury of the
Company other than dividends or distributions payable only in shares of Common
Stock.
6.4
Effect of Reclassification,
Consolidation, Merger or Sale.
(a) If
any of the following events occur, namely:
(i)
any
reclassification or change of the outstanding shares of Common Stock (other than
a change in par value, or from par value to no par value, or from no par value
to par value, or as a result of a subdivision or combination),
(ii)
any
consolidation, merger or combination of the Company with another corporation as
a result of which holders of Common Stock shall be entitled to receive stock,
securities or other property or assets (including cash) with respect to or in
exchange for such Common Stock, or
(iii)
any sale
or conveyance of the properties and assets of the Company as, or substantially
as, an entirety to any other corporation as a result of which holders of Common
Stock shall be entitled to receive stock, securities or other property or assets
(including cash) with respect to or in exchange for such Common
Stock,
then the
Company or the successor or purchasing Person, as the case may be, shall execute
with the Holder a written agreement providing that:
(x)
this Note
shall be convertible into the kind and amount of shares of stock and other
securities or property or assets (including cash) receivable upon such
reclassification, change, consolidation, merger, statutory exchange,
combination, sale or conveyance by the holder of the number of shares of Common
Stock issuable upon conversion of this Note in full (assuming, for such
purposes, a sufficient number of authorized shares of Common Stock available to
convert this Note) immediately prior to such reclassification, change,
consolidation, merger, statutory exchange, combination, sale or conveyance
assuming such holder of Common Stock did not exercise such holder's rights of
election, if any, as to the kind or amount of securities, cash or other property
receivable upon such consolidation, merger, statutory exchange, combination,
sale or conveyance (
provided
that, if
the kind or amount of securities, cash or other property receivable upon such
consolidation, merger, statutory exchange, sale or conveyance is not the same
for each share of Common Stock in respect of which such rights of election shall
not have been exercised (“non-electing share”), then for the purposes of this
Section 6.4 the kind and amount of securities, cash or other property receivable
upon such consolidation, merger, statutory exchange, combination, sale or
conveyance for each non-electing share shall be deemed to be the kind and amount
so receivable per share by a plurality of the non-electing
shares),
(y)
in the
case of any such successor or purchasing Person, upon such consolidation,
merger, statutory exchange, combination, sale or conveyance such successor or
purchasing Person shall be jointly and severally liable with the Company for the
performance of all of the Company's obligations under this Note and the Note
Purchase Agreement and
(z)
if
registration or qualification is required under the 1933 Act or applicable state
law for the public resale by the Holder of such shares of stock and other
securities so issuable upon conversion of this Note, such registration or
qualification shall be completed prior to such reclassification, change,
consolidation, merger, statutory exchange, combination, sale or
conveyance.
Such
written agreement shall provide for adjustments which shall be as nearly
equivalent as may be practicable to the adjustments provided for in this
Article. If, in the case of any such reclassification, change, consolidation,
merger, statutory exchange, combination, sale or conveyance, the stock or other
securities and assets receivable thereupon by a holder of shares of Common Stock
includes shares of stock or other securities and assets of a corporation other
than the successor or purchasing corporation, as the case may be, in such
reclassification, change, consolidation, merger, statutory exchange,
combination, sale or conveyance, then such written agreement shall also be
executed by such other corporation and shall contain such additional provisions
to protect the interests of the Holder as the Board of Directors shall
reasonably consider necessary by reason of the foregoing, including, to the
extent practicable, the provisions providing for the repurchase rights set forth
in Article V herein.
(b)
The above
provisions of this Section shall similarly apply to successive
reclassifications, changes, consolidations, mergers, statutory exchanges,
combinations, sales and conveyances.
(c)
If this
Section 6.4 applies to any event or occurrence, Section 6.3 shall not
apply.
6.5
Reservation of Shares; Shares to Be
Fully Paid; Listing of Common Stock
.
(a)
The
Company shall reserve and keep available, free from preemptive rights, out of
its authorized but unissued shares of Common Stock or shares of Common Stock
held in treasury, solely for issuance upon conversion of this Note, and in
addition to the shares of Common Stock required to be reserved by the terms of
the Other Notes, Warrants and the Other
Warrants,
sufficient shares to provide for the conversion of this Note from time to time
as this Note is converted.
(b)
Before
taking any action which would cause an adjustment reducing the Conversion Price
below the then par value, if any, of the shares of Common Stock issuable upon
conversion of this Note, the Company will take all corporate action which may,
in the opinion of its counsel, be necessary in order that the Company may
validly and legally issue shares of such Common Stock at such adjusted
Conversion Price.
(c)
The
Company covenants that all shares of Common Stock issued upon conversion of this
Note will be fully paid and non-assessable by the Company and free from all
taxes, liens and charges with respect to the issue thereof.
(d)
The
Company covenants that if any shares of Common Stock to be provided for the
purpose of conversion of, or payment of interest on, this Note hereunder require
registration with or approval of any governmental authority under any federal or
state law before such shares may be validly issued upon conversion or in payment
of interest, the Company will in good faith and as expeditiously as possible
endeavor to secure such registration or approval, as the case may
be.
(e)
The
Company covenants that, in the event the Common Stock shall be listed on the
Nasdaq, the Nasdaq Capital Market, the NYSE, the AMEX or any other national
securities exchange, the Company shall obtain and, so long as the Common Stock
shall be so listed on such market or exchange, maintain approval for listing
thereon of all Common Stock issuable upon conversion of or in payment of
interest on this Note.
6.6
Notice to Holder Prior to Certain
Actions
.
In case
on or after the Issuance Date:
(a)
the
Company shall declare a dividend (or any other distribution) on its Common Stock
(other than in cash out of retained earnings); or
(b)
the
Company shall authorize the granting to the holders of its Common Stock of
rights or warrants to subscribe for or purchase any share of any class or any
other rights or warrants; or
(c)
the Board
of Directors shall authorize any reclassification of the Common Stock of the
Company (other than a subdivision or combination of its outstanding Common
Stock, or a change in par value, or from par value to no par value, or from no
par value to par value), or any consolidation or merger or other business
combination transaction to which the Company is a party and for which approval
of any stockholders of the Company is required, or the sale or transfer of all
or substantially all of the assets of the Company; or
(d)
there
shall be pending the voluntary or involuntary dissolution, liquidation or
winding-up of the Company;
the
Company shall give the Holder, as promptly as possible but in any event at least
ten Trading Days prior to the applicable date hereinafter specified, a notice
stating (x) the date on which a record is to be taken for the purpose of such
dividend, distribution or rights or warrants, or, if a record is not to be
taken, the date as of which the holders of Common Stock of record to be entitled
to such dividend, distribution or rights are to be determined, or (y) the date
on which such reclassification, consolidation, merger, other business
combination transaction, sale, transfer, dissolution, liquidation or winding-up
is expected to become effective or occur, and the date as of which it is
expected that holders of Common Stock of record who shall be entitled to
exchange their Common Stock for securities or other property deliverable upon
such reclassification, consolidation, merger, other business combination
transaction, sale, transfer, dissolution, liquidation or winding-up shall be
determined. Such notice shall not include any information which would be
material non-public information for purposes of the 1934 Act. Failure to give
such notice, or any defect therein, shall not affect the legality or validity of
such dividend, distribution, reclassification, consolidation, merger, sale,
transfer, dissolution, liquidation or winding-up. In the case of any such action
of which the Company gives such notice to the Holder or is required to give such
notice to the Holder, the Holder shall be entitled to give a Conversion Notice
which is contingent on the completion of such action.
6.7
Restricted Ownership Percentage
Limitation
.
(a)
Notwithstanding anything to the contrary contained herein, the number of shares
of Common Stock that may be acquired at any time by the Holder upon conversion
of the Note shall not exceed a number that, when added to the total number of
shares of Common Stock deemed beneficially owned by such Holder (other than by
virtue of the ownership of securities or rights to acquire securities (including
the Warrants) that have limitations on the holder's right to convert, exercise
or purchase similar to the limitation set forth herein (the “Excluded Shares”)),
together with all shares of Common Stock beneficially owned at such time (other
than by virtue of the ownership of Excluded Shares) by Persons whose beneficial
ownership of Common Stock would be aggregated with the beneficial ownership by
the Holder for purposes of determining whether a group exists or for purposes of
determining the Holder’s beneficial ownership (the “Aggregation Parties”), in
either such case for purposes of Section 13(d) of the 1934 Act and Regulation
13D-G thereunder (including, without limitation, as the same is made applicable
to Section 16 of the 1934 Act and the rules promulgated thereunder), would
result in beneficial ownership by the Holder or such group of more than 9.9% of
the shares of Common Stock for purposes of Section 13(d) or Section 16 of the
1934 Act and the rules promulgated thereunder (as the same may be modified by a
particular Holder as provided herein, the “Restricted Ownership Percentage”).
The Holder shall have the right at any time and from time to time to reduce its
Restricted Ownership Percentage immediately upon notice to the Company in the
event and only to the extent that Section 16 of the 1934 Act or the rules
promulgated thereunder (or any successor statute or rules) is changed to reduce
the beneficial ownership percentage threshold thereunder to a percentage less
than 10%. If at any time the limits in this Section 6.7 make the Note
inconvertible in whole or in part, the Company shall not by reason thereof be
relieved of its obligation to issue shares of Common Stock at any time or from
time to time thereafter upon conversion of the Note as and when shares of Common
Stock may be issued in compliance with such restrictions.
(b)
For
purposes of this Section 6.7, in determining the number of outstanding shares of
Common Stock at any time the Holder may rely on the number of outstanding shares
of Common Stock as reflected in (1) the Company's then most recent Form 10-Q,
Form 10-K or
other
public filing with the SEC, as the case may be, (2) a public announcement by the
Company that is later than any such filing referred to in the preceding clause
(1) or (3) any other notice by the Company or its transfer agent setting forth
the number shares of Common Stock outstanding and knowledge the Holder may have
about the number of shares of Common Stock issued upon conversions or exercises
of this Note, the Other Notes, the Warrants, the Other Warrants or other Common
Stock Equivalents by any Person, including the Holder, which are not reflected
in the information referred to in the preceding clauses (1) through (3). Upon
the written request of any Holder, the Company shall within three Business Days
confirm in writing to such Holder the number of shares of Common Stock then
outstanding. In any case, the number of outstanding shares of Common Stock shall
be determined after giving effect to the conversion or exercise of Common Stock
Equivalents, including the Notes and the Warrants, by the Holder or its
Affiliates, in each such case subsequent to, the date as of which such number of
outstanding shares of Common Stock was reported.
ARTICLE VII
MISCELLANEOUS
7.1
Failure or Indulgency Not
Waiver.
No
failure or delay on the part of the Holder in the exercise of any power, right
or privilege hereunder shall operate as a waiver thereof, nor shall any single
or partial exercise of any such power, right or privilege preclude other or
further exercise thereof or of any other right, power or privileges. All rights
and remedies existing hereunder are cumulative to, and not exclusive of, any
rights or remedies otherwise available. The Company stipulates that the remedies
at law of the Holder in the event of any default or threatened default by the
Company in the performance of or compliance with any of the terms of this Note
are not and will not be adequate, and that such terms may be specifically
enforced (x) by a decree for the specific performance of any agreement contained
herein, including, without limitation, a decree for issuance of the shares of
Common Stock (or other securities) issuable upon conversion of this Note or (y)
by an injunction against a violation of any of the terms hereof or (z)
otherwise.
7.2
Notices.
Except
as otherwise specifically provided herein, any notice herein required or
permitted to be given shall be in writing and may be personally served, sent by
telephone line facsimile transmission or delivered by courier or sent by United
States mail and shall be deemed to have been given upon receipt if personally
served, sent by telephone line facsimile transmission or sent by courier or
three days after being deposited in the facilities of the United States Postal
Service, certified, with postage pre-paid and properly addressed, if sent by
mail. For the purposes hereof, the address and facsimile line transmission
number of the Holder shall be as furnished by the Holder for such purpose and
shown on the records of the Company; and the address of the Company shall be
eMagin Corporation, 10500 N.E. 8
th
Street,
Suite 1400, Bellevue, Washington 98004, Attention: Chief Financial Officer
(telephone line facsimile number (425) 749-3601. The Holder or the Company may
change its address for notice by service of written notice to the other as
herein provided.
7.3
Amendment,
Waiver.
(a)
Neither this Note or any Other Note nor any terms hereof or thereof may be
changed, amended, discharged or terminated unless such change,amend
ment,
discharge or termination is in writing signed by the Company and the Majority
Holders, provided that no such change, amendment, discharge or termination
shall, without the consent of the Holder and the holders of the Other Notes
affected thereby (i) extend the scheduled Installment Maturity Date or Final
Maturity Date of this Note or any Other Note, or reduce the rate or extend the
time of payment of interest (other than as a result of waiving the applicability
of any post-default increase in interest rates) hereon or thereon or reduce the
principal amount hereof or thereof or the Repurchase Price or the Optional
Redemption Price hereof or thereof, (ii) increase or decrease the Conversion
Price except as set forth in this Note, (iii) release the Collateral or reduce
the amount of Collateral required to be deposited or maintained by the Company
pursuant to the Security Agreement, except as expressly provided in the Security
Agreement, (iv) amend, modify or waive any provision of this Section 7.3 or
(v) reduce any percentage specified in, or otherwise modify, the definition of
Majority Holders.
Notwithstanding anything
to the contrary contained herein, no amendment or waiver shall increase or
eliminate the Restricted Ownership Percentage, whether permanently or
temporarily, unless, in addition to complying with the other requirements of
this Note, such amendment or waiver shall have been approved in accordance with
the General Corporation Law of the State of Delaware and the Company's By-laws
by holders of the outstanding shares of Common Stock entitled to vote at a
meeting or by written consent in lieu of such
meeting
.
(b)
Any term
or condition of this Note may be waived by the Holder or the Company at any time
if the waiving party is entitled to the benefit thereof, but no such waiver
shall be effective unless set forth in a written instrument duly executed by or
on behalf of the party waiving such term or condition. No waiver by any party of
any term or condition of this Note, in any one or more instances, will be deemed
to be or construed as a waiver of the same or any other term or condition of
this Note on any future occasion.
7.4
Assignability.
This
Note shall be binding upon the Company and its successors, and shall inure to
the benefit of and be binding upon the Holder and its successors and permitted
assigns. The Company may not assign its rights or obligations under this
Note.
7.5
Certain
Expenses.
The
Company shall pay on demand all expenses incurred by the Holder, including
reasonable attorneys' fees and expenses, as a consequence of, or in connection
with (x) any amendment or waiver of this Note or any other Transaction Document,
(y) any default or breach of any of the Company’s obligations set forth in the
Transaction Documents and (z) the enforcement or restructuring of any right of,
including the collection of any payments due, the Holder under the Transaction
Documents, including any action or proceeding relating to such enforcement or
any order, injunction or other process seeking to restrain the Company from
paying any amount due the Holder.
7.6
Governing
Law.
This
Note shall be governed by the internal laws of the State of New York, without
regard to the principles of conflict of laws.
7.7
Transfer of
Note.
This
Note has not been and is not being registered under the provisions of the 1933
Act or any state securities laws and this Note may not be transferred prior to
the end of the holding period applicable to sales hereof under Rule 144(k)
unless (1) the transferee is an “accredited investor” (as defined in Regulation
D under the 1933 Act) and (2) the Holder shall have delivered to the Company an
opinion of counsel, reasonably
satisfactory
in form, scope and substance to the Company, to the effect that this Note may be
sold or transferred without registration under the 1933 Act. Prior to any such
transfer, such transferee shall have represented in writing to the Company that
such transferee has requested and received from the Company all information
relating to the business, properties, operations, condition (financial or
other), results of operations or prospects of the Company and the Subsidiaries
deemed relevant by such transferee; that such transferee has been afforded the
opportunity to ask questions of the Company concerning the foregoing and has had
the opportunity to obtain and review the reports and other information
concerning the Company which at the time of such transfer have been filed by the
Company with the SEC pursuant to the 1934 Act. If such transfer is intended to
assign the rights and obligations under Section 5, 8, 9 and 10 of the Note
Purchase Agreement, such transfer shall otherwise be made in compliance with
Section 10(j) of the Note Purchase Agreement.
7.8
Enforceable
Obligation.
The
Company represents and warrants that at the time of the original issuance of
this Note it received the full purchase price payable pursuant to the Note
Purchase Agreement in an amount at least equal to the original principal amount
of this Note, and that this Note is an enforceable obligation of the Company
which is not subject to any offset, reduction, counterclaim or disallowance of
any sort.
7.9
Note Register; Replacement of
Notes.
The
Company shall maintain a register showing the names, addresses and telephone
line facsimile numbers of the Holder and the registered holders of the Other
Notes. The Company shall also maintain a facility for the registration of
transfers of this Note and the Other Notes and at which this Note and the Other
Notes may be surrendered for split up into instruments of smaller denominations
or for combination into instruments of larger denominations. Upon receipt by the
Company of evidence reasonably satisfactory to it of the ownership of and the
loss, theft, destruction or mutilation of this Note and (a) in the case of loss,
theft or destruction, of indemnity from the Holder reasonably satisfactory in
form to the Company (and without the requirement to post any bond or other
security) or (b) in the case of mutilation, upon surrender and cancellation of
this Note, the Company will execute and deliver to the Holder a new Note of like
tenor without charge to the Holder.
7.10
Payment of Note on Redemption or
Repurchase; Deposit of Optional Redemption Price or Repurchase Price,
Etc
.
(a) If
this Note or any portion of this Note is to be redeemed as provided in Section
2.1 or repurchased as provided in Sections 5.1 and 5.2 and any notice required
in connection therewith shall have been given as provided therein and the
Company shall have otherwise complied with the requirements of this Note with
respect thereto, then this Note or the portion of this Note to be so redeemed or
repurchased and with respect to which any such notice has been given shall
become due and payable on the date stated in such notice at the Optional
Redemption Price or Repurchase Price. On and after the Optional Redemption Date
or repurchase date so stated in such notice, provided that the Company shall
have deposited with an Eligible Bank on or prior to such Optional Redemption
Date or repurchase date, an amount in cash sufficient to pay the Optional
Redemption Price or Repurchase Price, interest on this Note or the portion of
this Note to be so redeemed or repurchased shall cease to accrue, and this Note
or such portion hereof shall be deemed not to be outstanding and shall not be
entitled to any benefit with respect
to
principal of or interest on the portion to be so redeemed or repurchased except
to receive payment of the Optional Redemption P
rice or
Repurchase Price. On presentation and
surrender
of this Note or such portion hereof, this Note or the specified portion hereof
shall be paid and repurchased at the Optional Redemption Price or Repurchase
Price. If a portion of this Note is to be redeemed or repurchased, upon
surrender of this Note to the Company in accordance with the terms hereof, the
Company shall execute and deliver to the Holder without service charge, a new
Note or Notes, having the same date hereof and containing identical terms and
conditions, in such denomination or denominations as requested by the Holder in
aggregate principal amount equal to, and in exchange for, the unredeemed or
unrepurchased portion of the principal amount of this Note so
surrendered.
(b)
Upon the
payment in full of all amounts payable by the Company under this Note or the
deposit thereof as provided in Section 7.10(a), thereafter the obligations of
the Company under this Note shall be as set forth in this Article VII, and, in
the case of such deposit, to pay the Repurchase Price, from the funds so
deposited. Upon such payment or deposit, any Event of Default which occurred
prior to such payment or deposit by reason of one or more provisions of this
Note with which the Company thereafter is no longer obligated to comply, then
shall no longer exist.
7.11
Conversion
Schedule.
Promptly
after each conversion of this Note pursuant to Section 6, the Holder shall
record on a schedule, in substantially the form attached as
Exhibit E
, the
amount by which the outstanding principal of this Note has been reduced by
reason of such conversion. Such schedule shall be conclusive and binding on the
Company and the Holder, in the absence of manifest error. The Holder shall from
time to time, upon request made by notice from the Company, furnish a copy of
such schedule to the Company. The Holder shall also furnish a copy of such
schedule upon request to any proposed transferee of this Note.
7.12
Construction.
The
language used in this Note will be deemed to be the language chosen by the
Company and the original Holder of this Note (or its predecessor instrument) to
express their mutual intent, and no rules of strict construction will be applied
against the Company or the Holder.
[Remainder of Page Intentionally
Left Blank]
IN WITNESS WHEREOF
, the
Company has caused this Note to be signed in its name by its duly authorized
officer on of the day and in the year first above written.
|
|
|
|
EMAGIN
CORPORATION
|
|
|
|
Date: July 21,
2006
|
By:
|
/s/ Gary W.
Jones
|
|
Name: Gary W. Jones
|
|
Title: Chief
Executive Officer
|
ASSIGNMENT
FOR VALUE
RECEIVED,
_________________________ hereby sell(s), assign(s) and transfer(s) unto
_________________________ (Please insert social security or other Taxpayer
Identification Number of assignee: ______________________________) the within
Note, and hereby irrevocably constitutes and appoints _________________________
attorney to transfer the said Note on the books of eMagin Corporation, a
Delaware corporation (the “Company”), with full power of substitution in the
premises.
In
connection with any transfer of the Note within the period prior to the
expiration of the holding period applicable to sales thereof under Rule 144(k)
under the 1933 Act (or any successor provision) (other than any transfer
pursuant to a registration statement that has been declared effective under the
1933 Act), the undersigned confirms that such Note is being
transferred:
|
[
|
]
|
To
the Company or a subsidiary thereof;
or
|
|
[
|
]
|
To
a “qualified institutional buyer” pursuant to and in compliance with Rule
144A; or
|
|
[
|
]
|
To
an Accredited Investor pursuant to and in compliance with the 1933 Act;
or
|
|
[
|
]
|
Pursuant
to and in compliance with Rule 144 under the 1933
Act;
|
and
unless the box below is checked, the undersigned confirms that, to the knowledge
of the undersigned, such Note is not being transferred to an Affiliate of the
Company.
|
[
|
]
|
The
transferee is an Affiliate of the
Company.
|
Capitalized
terms used in this Assignment and not defined in this Assignment shall have the
respective meanings provided in the Note.
Dated:____________________________________
|
NAME:__________________________________________
|
|
__________________________________________
|
|
Signature(s)
|
Exhibit A
COMPANY NOTICE
(Section 5.2(a) of 6% Senior
Secured Convertible Note due 2007-2008)
TO:
______________________________
(Name of
Holder)
(1)
A
Repurchase Event described in the 6% Senior Secured Convertible Note due
2007-2008 (the “Note”) of eMagin Corporation, a Delaware corporation (the
“Company”), occurred on
,
. As a
result of such Repurchase Event, the Holder is entitled to exercise its
repurchase rights pursuant to Section 5.2 of the Note.
(2)
The
Holder’s repurchase right must be exercised on or before
,
.
(3)
At or
before the date set forth in the preceding paragraph (2), the Holder
must:
(a)
deliver
to the Company a Holder Notice, in the form attached as
Exhibit B
to the
Note; and
(b)
the Note,
duly endorsed for transfer to the Company of the portion of the principal amount
to be repurchased.
(4)
Capitalized
terms used herein and not otherwise defined herein have the respective meanings
provided in the Note.
Date
_________________________________
|
EMAGIN
CORPORATION
|
|
By
:____________________________________
|
|
Title:
|
Exhibit B
HOLDER NOTICE
(Section 5.2(b) of 6% Senior
Secured Convertible Note due 2007-2008)
TO:
EMAGIN
CORPORATION
(1)
Pursuant
to the terms of the 6% Senior Secured Convertible Note due 2007-2008 (the
“Note”), the undersigned Holder hereby elects to exercise its right to require
repurchase by the Company pursuant to Sections 5.2(a) and 5.2(b) of
$
of the
Note, equal to the sum of $
principal amount of the Note, $
of
accrued and unpaid interest on such principal amount and $
of
Default Interest on the Note at the Repurchase Price provided in the
Note.
(2)
Capitalized
terms used herein and not otherwise defined herein have the respective meanings
provided in the Note.
Date
:_____________________
|
NAME OF
HOLDER:
|
|
___________________________________
|
|
|
|
By
____________________________________________
|
|
Signature
of Registered Holder
(Must
be signed exactly as name
appears
in the Note.)
|
Exhibit C
NOTICE OF
CONVERSION
OF 6% SENIOR SECURED CONVERTIBLE NOTE
DUE 2007-2008
OF EMAGIN
CORPORATION
To:
eMagin
Corporation
10500 N.E. 8th
Street, Suite 1400
Bellevue,
Washington 98004
Attention:
Chief Financial Officer
Facsimile
No.: (425) 749-3601
|
|
|
|
1.
Pursuant
to the terms of the 6% Senior Secured Convertible Note Due 2007-2008 (the
“Note”), the undersigned hereby elects to convert $_______________ of the Note,
equal to the sum of $_______________ principal amount of the Note,
$_______________ of accrued and unpaid interest on such principal amount and
$_______________ of Default Interest on such interest into shares of Common
Stock of eMagin Corporation, a Delaware corporation (the “Company”), at a
Conversion Price per share equal to $_______________. Capitalized terms used
herein and not otherwise defined herein have the respective meanings provided in
the Note.
2.
The
number of shares of Common Stock issuable upon the conversion of the Note to
which this Notice relates is _______________ (the “Conversion Shares”).
3.
Please
issue a certificate or certificates for _______________ shares of Common Stock
in the name(s) specified immediately below or, if additional space is necessary,
on an attachment hereto:
____________________________________________
|
____________________________________________
|
Name
|
Name
|
|
|
____________________________________________
|
____________________________________________
|
Address
|
Address
|
____________________________________________
|
____________________________________________
|
SS or Tax ID
Number
|
SS or Tax ID Number
|
|
|
|
|
Delivery
Instructions
for
Common
Stock:_____________________________________________________________________________________________________________________________
|
Portions
of installments of principal to which this conversion is allocated:
Due Initial
Installment Date:
|
$____________
|
Due Maturity
Date:
|
$____________
|
|
|
|
|
|
NAME:
___________________________________________
|
|
|
|
|
|
|
Date: _____________________________
|
___________________________________________
|
|
Signature
of Registered Holder
(Must
be signed exactly as name
appears
in the Note.)
|
:
Exhibit D
OPTIONAL REDEMPTION
NOTICE
(Section 2.1 of 6% Senior
Secured
Convertible Note due
2007-2008)
TO:_________________________________
(Name of
Holder)
(1)
Pursuant
to the terms of the 6% Senior Secured Convertible Note due 2007-2008 (the
“Note”), eMagin Corporation, a Delaware corporation (the “Company”), hereby
notifies the above-named Holder that the Company is exercising its right to
redeem the Note in accordance with Section 2.1 of the Note as set forth
below:
(i)
The
principal amount of the Note to be redeemed is $
.
(ii)
The
Optional Redemption Price is $
.
(iii)
The
Optional Redemption Date is
.
(2)
All of
the conditions specified in Section 2.1 of the Note entitling the Company to
call the Note for redemption have been satisfied.
(3)
Capitalized
terms used herein and not otherwise defined herein have the respective meanings
provided in the Note.
Date
|
EMAGIN
CORPORATION
|
|
|
|
By:______________________________________
|
|
Name:
|
|
Title:
|
Exhibit E
EMAGIN
CORPORATION
CONVERSION
SCHEDULE
This
Conversion Schedule shows reductions in the outstanding principal amount of the
6% Senior Secured Convertible Note due 2007-2008 (the “Note”) of eMagin
Corporation, a Delaware corporation, upon conversions pursuant to Section 6 of
the Note. Capitalized terms used in this Schedule and not otherwise defined
herein shall have the respective meanings provided in the Note.
|
Date
of Conversion
(or
for first entry, the Issuance Date)
|
Principal
Amount
of Conversion
(if
applicable)
|
Principal
Amount Remaining
Subsequent
to Conversion
(or
original Principal Amount)
|
1.
|
7/_/06
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
[continue
as necessary]
Annex
II
NEITHER THIS WARRANT NOR THE
SECURITIES INTO WHICH THIS WARRANT IS EXERCISABLE HAVE BEEN REGISTERED WITH THE
SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES REGULATORS OF ANY STATE IN
RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933,
AS AMENDED (THE “1933 ACT”), AND, ACCORDINGLY, MAY NOT BE, NOR MAY ANY INTEREST
THEREIN BE, OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION
STATEMENT UNDER THE 1933 ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A
TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE 1933 ACT AND IN
ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY, SUBJECT TO
CERTAIN EXCEPTIONS, A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT,
IN FORM AND SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO THE COMPANY.
THESE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT
SECURED BY SUCH SECURITIES.
THIS WARRANT MAY NOT BE TRANSFERRED
EXCEPT AS PROVIDED IN SECTION 24.
No.
W-
|
Right
to Purchase __________ Shares
of
Common
Stock
of
eMagin
Corporation
|
EMAGIN
CORPORATION
Common Stock Purchase
Warrant
EMAGIN CORPORATION
,
a
Delaware
corporation, hereby certifies that, for value received,
______________________
or
registered assigns (the “Holder”), is entitled, subject to the terms set forth
below, to purchase from the Company at any time or from time to time before 5:00
p.m., New York City time, on the Expiration Date (such capitalized term and all
other capitalized terms used herein having the respective meanings provided
herein),
[BEFORE ISSUANCE INSERT AMOUNT OF
SHARES EQUAL TO 70% OF THE NUMBER OF SHARES INITIALLY ISSUABLE UPON CONVERSION
OF THE NOTE BEING ISSUED TO THE HOLDER OF THIS WARRANT, DETERMINED WITHOUT
REGARD TO ANY LIMITATION ON CONVERSION]
paid and
nonassessable shares of Common Stock at a purchase price per share equal to the
Purchase Price. The number of such shares of Common Stock and the Purchase Price
are subject to adjustment as provided in this Warrant.
1.
Definitions.
(a)
As used
in this Warrant, the term “Holder” shall have the meaning assigned to such term
in the first paragraph of this Warrant.
(b)
All the
agreements or instruments herein defined shall mean such agreements or
instruments as the same may from time to time be supplemented or amended or the
terms thereof waived or modified to the extent permitted by, and in accordance
with, the terms thereof and of this Warrant.
(c)
The
following terms shall have the following meanings (such meanings to be equally
applicable to both the singular and plural forms of the terms
defined):
“Affiliate”
means, with respect to any Person, any other Person that directly, or indirectly
through one or more intermediaries, controls, is controlled by or is under
common control with the subject Person. For purposes of this definition,
“control” (including, with correlative meaning, the terms “controlled by” and
“under common control with”), as used with respect to any Person, shall mean the
possession, directly or indirectly, of the power to direct or cause the
direction of the management and policies of such Person, whether through the
ownership of voting securities or by contract or otherwise.
“Aggregate
Purchase Price” means at any time an amount equal to the product obtained by
multiplying (x) the Purchase Price
times
(y) the
number of shares of Common Stock for which this Warrant may be exercised at such
time, determined without regard to any limitations on exercise of this Warrant
contained in Section 2(c).
“Aggregation
Parties” shall have the meaning provided in Section 2(c).
“AMEX”
means the American Stock Exchange, Inc.
“Board of
Directors” means the Board of Directors of the Company.
“Business
Day” means any day other than a Saturday, Sunday or other day on which
commercial banks in The City of New York are authorized or required by law or
executive order to remain closed.
“Common
Stock” includes the Company's Common Stock, par value $0.001 per share, (and any
purchase rights issued with respect to the Common Stock in the future) as
authorized on the date hereof, and any other securities into which or for which
the Common Stock (and any such rights issued with respect to the Common Stock)
may be converted or exchanged pursuant to a plan of recapitalization,
reorganization, merger, sale of assets or otherwise and any stock (other than
Common Stock) and other securities of the Company or any other Person which the
Holder at any time shall be entitled to receive, or shall have received, on the
exercise of this Warrant, in lieu of or in addition to Common
Stock.
“Common
Stock Equivalents” means any warrant, option, subscription or purchase right
with respect to shares of Common Stock, any security convertible into,
exchangeable for, or otherwise entitling the holder thereof to acquire, shares
of Common Stock or any warrant, option, subscription or purchase right with
respect to any such convertible, exchangeable or other security.
“Company”
shall include eMagin Corporation, a Delaware corporation, and any corporation
that shall succeed to or assume the obligations of eMagin Corporation hereunder
in accordance with the terms hereof.
“Computed
Market Price”
shall
mean the arithmetic average of the daily VWAPs for each of the three Trading
Days immediately preceding the applicable Measurement Date (such VWAPs being
appropriately and equitably adjusted for any stock splits, stock dividends,
recapitalizations and the like occurring or for which the record date occurs
during such three Trading Days).
“Current
Fair Market Value” means when used with respect to the Common Stock as of a
specified date with respect to each share of Common Stock, the average of the
closing prices of the Common Stock sold on all securities exchanges (including
the NYSE, the AMEX, the Nasdaq and the Nasdaq Capital Market) on which the
Common Stock may at the time be listed, or, if there have been no sales on any
such exchange on such day, the average of the highest bid and lowest asked
prices on all such exchanges at the end of regular trading on such day, or, if
on such day the Common Stock is not so listed, the average of the representative
bid and asked prices quoted in the Nasdaq System as of 4:00 p.m., New York City
time, or, if on such day the Common Stock is not quoted in the Nasdaq System,
the average of the highest bid and lowest asked price on such day in the
domestic over-the-counter market as reported by Pink Sheets, LLC, or any similar
successor organization, in each such case averaged over a period of five Trading
Days consisting of the day as of which the Current Fair Market Value of Common
Stock is being determined (or if such day is not a Trading Day, the Trading Day
next preceding such day) and the four consecutive Trading Days prior to such
day. If on the date for which Current Fair Market Value is to be determined the
Common Stock is not listed on any securities exchange or quoted in the Nasdaq
System or the over-the-counter market, the Current Fair Market Value of Common
Stock shall be the highest price per share which the Company could then obtain
from a willing buyer (not an employee or director of the Company at the time of
determination) in an arms'-length transaction for shares of Common Stock sold by
the Company, from authorized but unissued shares, as determined in good faith by
the Board of Directors.
“Designated
Person” means any of Mr. John Atherly, Mr. Gary Jones and Ms. Susan
Jones.
“DTC”
shall have the meaning provided in Section 2(c).
“Event of
Default” shall have the meaning provided in the Notes.
“Excluded
Shares” shall have the meaning provided in Section 2(c).
“Expiration
Date” means July 21, 2011.
“FAST”
shall have the meaning provided in Section 2(c).
“Issuance
Date” means the date of original issuance of this Warrant or its predecessor
instrument.
“Market
Price” means with respect to any security on any day the closing bid price of
such security on such day on the Nasdaq or the Nasdaq Capital Market or the NYSE
or the AMEX, as applicable, or, if such security is not listed or admitted to
trading on the Nasdaq, the Nasdaq Capital Market, the NYSE or the AMEX, on the
principal national securities exchange or quotation system on which such
security is quoted or listed or admitted to trading, in any such case as
reported by Bloomberg, L.P. or, if not quoted or listed or admitted to trading
on any national securities exchange or quotation system, the average of the
closing bid and asked prices of such security on the over-the-counter market on
the day in question, as reported by the Pink Sheets, LLC, or a similar generally
accepted reporting service, or if not so available, in such manner as furnished
by any New York Stock Exchange member firm selected from time to time by the
Board of Directors for that purpose, or a price determined in good faith by the
Board of Directors.
“Measurement
Date” for any sale, transfer or disposition (but not including the cancellation
or expiration) of Common Stock or Common Stock Equivalents by a Designated
Person means the date that is three Trading Days after the earlier of (i) the
date such Designated Person files a Form 4 with the SEC with respect to such
sale, transfer or disposition and (ii) the date such Designated Person is
required to file a Form 4 with the SEC with respect to such sale, transfer or
disposition;
provided,
however,
that if
such Designated Person is not required, or is no longer required, to file a Form
4 with respect to such sale, transfer or disposition, the Measurement Date shall
be the date that is five Trading Days after the date of such sale, transfer or
disposition.
“Nasdaq”
means the Nasdaq Global Market.
“1934
Act” means the Securities Exchange Act of 1934, as amended.
“1933
Act” means the Securities Act of 1933, as amended.
“Note”
means any of the 6% Senior Secured Convertible Notes due 2007-2008 issued by the
Company pursuant to the Note Purchase Agreement and the Other Note Purchase
Agreements.
“Note
Purchase Agreement” means the Note Purchase Agreement, dated as of July 21,
2006, by and between the Company and the original Holder of this
Warrant.
“NYSE”
means the New York Stock Exchange, Inc.
“Other
Note Purchase Agreements” means the several Note Purchase Agreements by and
between the Company and the several buyers named therein in the form of the Note
Purchase Agreement pursuant to which certain of the Notes are being or will be
issued.
“Other
Securities” means any stock (other than Common Stock) and other securities of
the Company or any other Person which the Holder at any time shall be entitled
to receive, or shall have received, on the exercise of this Warrant, in lieu of
or in addition to Common Stock, or which at any time shall be issuable or shall
have been issued in exchange for or in replacement of Common Stock or Other
Securities pursuant to Section 5.
“Other
Warrants” shall mean the Common Stock Purchase Warrants (other than this
Warrant) issued or issuable pursuant to the Other Note Purchase
Agreements.
“Permitted
Designated Person Sale” means a sale by John Atherly, occurring on or after
January 1, 2007, of shares of Common Stock in an amount not to exceed 50,000
shares in the aggregate in any fiscal quarter of the Company (such number of
shares subject to equitable adjustments for stock splits, stock dividends,
combinations, capital reorganizations and similar events relating to the Common
Stock occurring after the Issuance Date).
“Person”
means an individual, corporation, partnership, limited liability company, trust,
business trust, association, joint stock company, joint venture, pool,
syndicate, sole proprietorship, unincorporated organization, governmental
authority or any other form of entity not specifically listed
herein.
“Purchase
Price” means $
0.36,
subject
to adjustment as provided in this Warrant.
“Registration
Period” shall have the meaning provided in the Note Purchase
Agreement.
“Registration
Statement” shall have the meaning provided in the Note Purchase
Agreement.
“Reorganization
Event” means the occurrence of any one or more of the following events:
(i)
any
consolidation, merger or similar transaction of the Company or any Subsidiary
with or into another entity (other than a merger or consolidation or similar
transaction of a Subsidiary into the Company or a wholly-owned Subsidiary in
which there is no change in the outstanding Common Stock); or the sale or
transfer of all or substantially all of the assets of the Company and the
Subsidiaries in a single transaction or a series of related transactions;
or
(ii)
the
occurrence of any transaction or event in connection with which all or
substantially all the Common Stock shall be exchanged for, converted into,
acquired for or constitute the right to receive securities of any other Person
(whether by means of a Tender Offer, liquidation, consolidation, merger, share
exchange, combination, reclassification, recapitalization, or otherwise);
or
(iii)
the
acquisition by a Person or group of Persons acting in concert as a partnership,
limited partnership, syndicate or group, as a result of a tender or exchange
offer, open market purchases, privately negotiated purchases or otherwise, of
beneficial ownership of securities of the Company representing 50% or more of
the combined voting power of the outstanding voting securities of the Company
ordinarily (and apart from rights accruing in special circumstances) having the
right to vote in the election of directors.
“Restricted
Ownership Percentage” shall have the meaning provided in Section
2(c).
“Restricted
Securities” means securities that are not eligible for resale pursuant to Rule
144(k) under the 1933 Act (or any successor provision).
“Rule
144A” means Rule 144A as promulgated under the 1933 Act.
“SEC”
means the Securities and Exchange Commission.
“Subsidiary”
means any corporation or other entity of which a majority of the capital stock
or other ownership interests having ordinary voting power to elect a majority of
the board of directors or other Persons performing similar functions are at the
time directly or indirectly owned by the Company.
“Tender
Offer” means a tender offer, exchange offer or other offer by the Company to
repurchase outstanding shares of its capital stock.
“Trading
Day” means a day on whichever of the national securities exchange, the Nasdaq,
the Nasdaq Capital Market or other securities market which then constitutes the
principal securities market for the Common Stock is open for general trading of
securities.
“VWAP” of
any security on any Trading Day means the volume-weighted average price of such
security on such Trading Day on the Principal Market, as reported by Bloomberg
Financial, L.P., based on a Trading Day from 9:30 a.m., Eastern Time, to 4:00
p.m., Eastern Time, using the AQR Function, for such Trading Day;
provided,
however,
that
during any period the VWAP is being determined, the VWAP shall be subject to
equitable adjustments from time to time on terms consistent with Section 6.3 of
the Note and otherwise reasonably acceptable to the Holder for (i) stock splits,
(ii) stock dividends, (iii) combinations, (iv) capital reorganizations, (v)
issuance to all holders of Common Stock of rights or warrants to purchase shares
of Common Stock, (vi) distribution by the Company to all holders of Common Stock
of evidences of indebtedness of the Company or cash (other than regular
quarterly cash dividends), and (vii) similar events relating to the Common
Stock, in each case which occur, or with respect to which the “ex” date occurs,
during such period.
“Warrant”
means this instrument as originally executed or if later amended or supplemented
in accordance with its terms, then as so amended or supplemented.
“Warrant
Shares” means the shares of Common Stock issuable upon exercise of this
Warrant.
2.
Exercise of
Warrant.
(a)
Exercise.
This
Warrant may be exercised by the Holder in whole at any time or in part from time
to time on or before the Expiration Date by (x) giving a subscription form in
the form of
Exhibit 1
to this
Warrant (duly executed by the Holder) to the Company, (y) making payment, in
cash or by certified or official bank check payable to the order of the Company,
or by wire transfer of funds to the account of the Company, in any such case, in
the amount obtained by multiplying (a) the number of shares of Common Stock
designated by the Holder in the subscription form by (b) the Purchase Price then
in effect and (z) surrendering this Warrant to the Company within three Trading
Days after such submission of a subscription form. An exercise of this Warrant
shall be deemed to have occurred on the date when the Holder shall have so given
the subscription form and made such payment. On any partial exercise the Company
will forthwith issue and deliver to or upon the order of the Holder a new
Warrant or Warrants of like tenor, in the name of the Holder or as the Holder
(upon payment by the Holder of any applicable transfer taxes) may request,
providing in the aggregate on the face or faces thereof for the purchase of the
number of shares of Common Stock for which such Warrant or Warrants may still be
exercised. The subscription form may be surrendered by telephone line facsimile
transmission to such telephone number for the Company as shall have been
specified in writing to the Holder by the Company;
provided, however
, that if
the subscription form is given to the Company by telephone line facsimile
transmission the Holder shall send an original of such subscription form to the
Company within ten Business Days after such subscription form is so given to the
Company;
provided further
,
however
, that
any failure or delay on the part of the Holder in giving such original of any
subscription form shall not affect the validity or the date on which such
subscription form is so given by telephone line facsimile
transmission.
(b)
Net
Exercise.
Notwithstanding
anything to the contrary contained in Section 2(a), if the Holder shall exercise
this Warrant (1) during the period beginning one year after the Issuance Date
and at a time when a Registration Statement covering the resale by the Holder of
shares of Common Stock (or Other Securities) issuable upon exercise of this
Warrant is not effective or is not available for use by the Holder or (2) an
Event of Default shall have occurred and be continuing, then in either such case
in the preceding clause (1) or (2) the Holder may elect to exercise this
Warrant, in whole at any time or in part from time to time, by receiving upon
each such exercise a number of shares of Common Stock as determined below, upon
submission of the subscription form annexed hereto (duly executed by the Holder)
to the Company (followed by surrender of this Warrant to the Company within
three Trading Days after such submission of a subscription form), in which event
the Company shall issue to the Holder a number of shares of Common Stock
computed using the following formula:
where,
|
|
X
=
|
the
number of shares of Common Stock to be issued to the Holder
|
|
|
Y
=
|
the
number of shares of Common Stock as to which this Warrant is to be
exercised
|
|
|
A
=
|
the
Current Fair Market Value of one share of Common Stock calculated as of
the latest Trading Day immediately preceding the exercise of this
Warrant
|
(c)
9.9%
Limitation.
(1)
Notwithstanding
anything to the contrary contained herein, the number of shares of Common Stock
that may be acquired by the Holder upon exercise pursuant to the terms hereof at
any time shall not exceed a number that, when added to the total number of
shares of Common Stock deemed beneficially owned by the Holder (other than by
virtue of the ownership of securities or rights to acquire securities that have
limitations on the Holder's right to convert, exercise or purchase similar to
the limitation set forth herein (the “Excluded Shares”), together with all
shares of Common Stock deemed beneficially owned at such time (other than by
virtue of the ownership of the Excluded Shares) by Persons whose beneficial
ownership of Common Stock would be aggregated with the beneficial ownership by
the Holder for purposes of determining whether a group exists or for purposes of
determining the Holder’s beneficial ownership (the “Aggregation Parties”), in
either such case for purposes of Section 13(d) of the 1934 Act and Regulation
13D-G thereunder (including, without limitation, as the same is made applicable
to Section 16 of the 1934 Act and the rules promulgated thereunder), would
result in beneficial ownership by the Holder or such group of more than 9.9% of
the shares of Common Stock for purposes of Section 13(d) or Section 16 of the
1934 Act and the rules promulgated thereunder (as the same may be modified by
the Holder as provided herein, the “Restricted Ownership Percentage”). The
Holder shall have the right at any time and from time to time to reduce its
Restricted Ownership Percentage immediately upon notice to the Company in the
event and only to the extent that Section 16 of the 1934 Act or the rules
promulgated thereunder (or any successor statute or rules) is changed to reduce
the beneficial ownership percentage threshold thereunder to a percentage less
than 10%. If at any time the limits in this Section 2(c) make this Warrant
unexercisable in whole or in part, the Company shall not by reason thereof be
relieved of its obligation to issue shares of Common Stock at any time or from
time to time thereafter but prior to the Expiration Date upon exercise of this
Warrant as and when shares of Common Stock may be issued in compliance with such
restrictions.
(2)
For
purposes of this Section 2(c), in determining the number of outstanding shares
of Common Stock at any time the Holder may rely on the number of outstanding
shares of Common Stock as reflected in (1) the Company's then most recent Form
10-Q, Form 10-K or other public filing with the SEC, as the case may be, (2) a
public announcement by the Company that is later than any such filing referred
to in the preceding clause (1) or (3) any other notice by the Company or its
transfer agent setting forth the number shares of Common Stock outstanding and
knowledge the Holder may have about the number of shares of Common Stock issued
upon conversion or exercise of Common Stock Equivalents by any Person, including
the Holder, which are not reflected in the preceding clauses (1) through (3).
Upon the written request of the Holder, the Company shall within three Business
Days confirm in writing to the Holder the number of shares of Common Stock then
outstanding. In any case, the number of outstanding shares of Common Stock shall
be determined after giving effect to the conversion or exercise of Common Stock
Equivalents, including the Warrants, by the Holder or its Affiliates, in each
such case subsequent to, the date as of which such number of outstanding shares
of Common Stock was reported.
3.
Delivery of Stock Certificates,
etc., on Exercise.
(a) As
soon as practicable after the exercise of this Warrant and in any event within
three Trading Days thereafter, upon the terms and subject to the conditions of
this Warrant, the Company at its expense (including the payment by it of any
applicable issue or stamp taxes) will cause to be issued in the name of and
delivered to the Holder, or as the Holder (upon payment by the Holder of any
applicable transfer taxes) may direct, a certificate or certificates for the
number of fully paid and nonassessable shares of Common Stock (or Other
Securities) to which the Holder shall be entitled on such exercise, in such
denominations as may be requested by the Holder, which certificate or
certificates shall be free of restrictive and trading legends (except to the
extent permitted under Section 5(b) of the Note Purchase Agreement), plus, in
lieu of any fractional share to which the Holder would otherwise be entitled,
cash equal to such fraction multiplied by the then Current Fair Market Value of
one full share of Common Stock, together with any other stock or Other
Securities or any property (including cash, where applicable) to which the
Holder is entitled upon such exercise pursuant to Section 2 or otherwise.
In lieu
of delivering physical certificates for the shares of Common Stock or (Other
Securities) issuable upon any exercise of this Warrant, provided the Company's
transfer agent is participating in the Depository Trust Company (“DTC”) Fast
Automated Securities Transfer (“FAST”) program, upon request of the Holder, the
Company shall use commercially reasonable efforts to cause its transfer agent
electronically to transmit such shares of Common Stock (or Other Securities)
issuable upon conversion to the Holder (or its designee), by crediting the
account of the Holder’s (or such designee’s) broker with DTC through its Deposit
Withdrawal Agent Commission system (provided that the same time periods herein
as for stock certificates shall apply). The Company shall pay any taxes and
other governmental charges that may be imposed under the laws of the United
States of America or any political subdivision or taxing authority thereof or
therein in respect of the issue or delivery of shares of Common Stock (or Other
Securities) or payment of cash upon exercise of this Warrant (other than income
taxes imposed on the Holder). The Company shall not be required, however, to pay
any tax or other charge imposed in connection with any transfer involved in the
issue of any certificate for shares of Common Stock (or Other Securities)
issuable upon exercise of this Warrant or payment of cash to any Person other
than the Holder, and in case of such transfer or payment the Company shall not
be required to deliver any certificate for shares of Common Stock (or Other
Securities) upon such exercise or pay any cash until such tax or charge has been
paid or it has been established to the Company's reasonable satisfaction that no
such tax or charge is due.
(b)
If in any
case the Company shall fail to issue and deliver or cause to be delivered the
shares of Common Stock to the Holder within five Trading Days of a particular
exercise of this Warrant, in addition to any other liabilities the Company may
have hereunder, under the Note Purchase Agreement and under applicable law, (A)
the Company shall pay or reimburse the Holder on demand for all out-of-pocket
expenses, including, without limitation, reasonable fees and expenses of legal
counsel, incurred by the Holder as a result of such failure; (B) if as a result
of such failure the Holder shall suffer any direct damages or liabilities from
such failure (including, without limitation, margin interest and the cost of
purchasing securities to cover a sale (whether by the Holder or the Holder's
securities broker) or borrowing of shares of Common Stock by the Holder for
purposes of settling any trade involving a sale of shares of Common Stock made
by the Holder during the period beginning on the Issuance Date and ending on the
date the Company delivers or causes to be delivered to the Holder such shares of
Common Stock), then, in addition to any amounts payable pursuant to Section
3(a), the Company shall upon demand of the Holder pay to the Holder an amount
equal to the actual, direct, demonstrable out-of-pocket damages and liabilities
suffered by the Holder by reason thereof which the Holder documents, and (C) the
Holder may by written notice (which may be given by mail, courier, personal
service or telephone line facsimile transmission) or oral notice (promptly
confirmed in writing), given at any time prior to delivery to the Holder of the
shares of Common Stock issuable in connection with such exercise of the Holder's
right, rescind such exercise and the subscription form relating thereto, in
which case the Holder shall thereafter be entitled to exercise that portion of
this Warrant as to which such exercise is so rescinded and to exercise its other
rights and remedies with respect to such failure by the Company. Notwithstanding
the foregoing the Company shall not be liable to the Holder under clauses (A) or
(B) of the immediately preceding sentence to the extent the failure of the
Company to deliver or to cause to be delivered such shares of Common Stock
results from fire, flood, storm, earthquake, shipwreck, strike, war, acts of
terrorism, crash involving facilities of a common carrier, acts of God, or any
similar event outside the control of the Company (it being understood that the
action or failure to act of the Company's Transfer Agent shall not be deemed an
event outside the control of the Company except to the extent resulting from
fire, flood, storm, earthquake, shipwreck, strike, war, acts of terrorism, crash
involving facilities of a common carrier, acts of God, or any similar event
outside the control of such Transfer Agent or the bankruptcy, liquidation or
reorganization of such Transfer Agent under any bankruptcy, insolvency or other
similar law). The Holder shall notify the Company in writing (or by telephone
conversation, confirmed in writing) as promptly as practicable following the
third Trading Day after the Holder exercises this Warrant if the Holder becomes
aware that such shares of Common Stock so issuable have not been received as
provided herein, but any failure so to give such notice shall not affect the
Holder's rights under this Warrant or otherwise. In the case of the Company’s
failure to issue and deliver or cause to be delivered the shares of Common Stock
to the Holder within five Trading Days of a particular exercise of this Warrant,
the amount payable by the Company pursuant to clause (B) of this Section 3(b)
with respect to such exercise shall be reduced by the amount of payments
previously paid by the Company to the Holder pursuant to Section 8(a)(4) of the
Note Purchase Agreement with respect to such exercise.
4.
Adjustment for Dividends in Other
Stock, Property, etc.; Reclassification, etc.
In case
at any time or from time to time on or after the Issuance Date, all holders of
Common Stock (or Other Securities) shall have received, or (on or after the
record date fixed for the determination of stockholders eligible to receive)
shall have become entitled to receive, without payment therefor,
(a)
other or
additional stock, rights, warrants or other securities or property (other than
cash) by way of dividend, or
(b)
any cash
(excluding cash dividends payable solely out of earnings or earned surplus of
the Company), or
(c)
other or
additional stock, rights, warrants or other securities or property (including
cash) by way of spin-off, split-up, reclassification, recapitalization,
combination of shares or similar corporate rearrangement,
other
than (i) additional shares of Common Stock (or Other Securities) issued as a
stock dividend or in a stock-split (adjustments in respect of which are provided
for in Section 6) and (ii) rights or warrants to subscribe for Common Stock at
less than the Current Fair Market Value (adjustments in respect of which are
provided in Section 7), then and in each such case the Holder, on the exercise
hereof as provided in Section 2, shall be entitled to receive the amount of
stock, rights, warrants and Other Securities and property (including cash in the
cases referred to in subdivisions (b) and (c) of this Section 4) which the
Holder would hold on the date of such exercise if on the date of such action
specified in the preceding clauses (a) through (c) (or the record date therefor)
the Holder had been the holder of record of the number of shares of Common Stock
called for on the face of this Warrant and had thereafter, during the period
from the date thereof to and including the date of such exercise, retained such
shares and all such other or additional stock, rights, warrants and Other
Securities and property (including cash in the case referred to in subdivisions
(b) and (c) of this Section 4) receivable by the Holder as aforesaid during such
period, giving effect to all adjustments called for during such period by
Section 5.
5.
Exercise upon a Reorganization
Event.
In case
of any Reorganization Event the Company shall, as a condition precedent to the
consummation of the transactions constituting, or announced as, such
Reorganization Event, cause effective provisions to be made so that the Holder
shall have the right thereafter, by exercising this Warrant (in lieu of the
shares of Common Stock of the Company and Other Securities or property
purchasable and receivable upon exercise of the rights represented hereby
immediately prior to such Reorganization Event) to purchase the kind and amount
of shares of stock and Other Securities and property (including cash) receivable
upon such Reorganization Event by a holder of the number of shares of Common
Stock that might have been received upon exercise of this Warrant immediately
prior to such Reorganization Event. Any such provision shall include provisions
for adjustments in respect of such shares of stock and Other Securities and
property that shall be as nearly equivalent as may be practicable to the
adjustments provided for in this Warrant. The provisions of this Section 5 shall
apply to successive Reorganization Events.
6.
Adjustment for Certain Extraordinary
Events.
If on or
after the Issuance Date the Company shall (i) issue additional shares of the
Common Stock as a dividend or other distribution on outstanding Common Stock,
(ii) subdivide or reclassify its outstanding shares of Common Stock, or (iii)
combine its outstanding shares of Common Stock into a smaller number of shares
of Common Stock, then, in each such event, the Purchase Price shall,
simultaneously with the happening of such event, be adjusted by multiplying the
Purchase Price in effect immediately prior to such event by a fraction, the
numerator of which shall be the number of shares of Common Stock outstanding
immediately prior to such event and the denominator of which shall be the number
of shares of Common Stock outstanding immediately after such event, and the
product so obtained shall thereafter be the Purchase Price then in effect. The
Purchase Price, as so adjusted, shall be readjusted in the same manner upon the
happening of any successive event or events described herein in this Section 6.
The Holder shall thereafter, on the exercise hereof as provided in Section 2, be
entitled to receive that number of shares of Common Stock determined by
multiplying the number of shares of Common Stock which would be issuable on such
exercise immediately prior to such issuance, subdivision or combination, as the
case may be, by a fraction of which (i) the numerator is the Purchase Price in
effect immediately prior to such issuance and (ii) the denominator is the
Purchase Price in effect on the date of such exercise.
7.
Issuance of Rights or Warrants to
Common Stockholders at less than Current Fair Market
Value.
If the
Company shall on or after the Issuance Date issue rights or warrants to all
holders of its outstanding shares of Common Stock entitling them to subscribe
for or purchase shares of Common Stock at a price per share less than the
Current Fair Market Value on the record date fixed for the determination of
stockholders entitled to receive such rights or warrants, then
(a)
the
Purchase Price shall be adjusted so that the same shall equal the price
determined by multiplying the Purchase Price in effect at the opening of
business on the day after such record date by a fraction of which the numerator
shall be the number of shares of Common Stock outstanding at the close of
business on such record date plus the number of shares which the aggregate
offering price of the total number of shares so offered would purchase at such
Current Fair Market Value, and the denominator shall be the number of shares of
Common Stock outstanding on the close of business on such record date plus the
total number of additional shares of Common Stock so offered for subscription or
purchase; and
(b)
the
number of shares of Common Stock which the Holder may thereafter purchase upon
exercise of this Warrant at the opening of business on the day after such record
date shall be increased to a number equal to the quotient obtained by dividing
(x) the Aggregate Purchase Price in effect immediately prior to such adjustment
in the Purchase Price pursuant to clause (a) of this Section 7
by
(y) the
Purchase Price in effect immediately after such adjustment in the Purchase Price
pursuant to clause (a) of this Section 7.
Such
adjustment shall become effective immediately after the opening of business on
the day following the record date fixed for determination of stockholders
entitled to receive such rights or warrants. To the extent that shares of Common
Stock are not delivered pursuant to such rights or warrants, upon the expiration
or termination of such rights or warrants, the Purchase Price shall be
readjusted to the Purchase Price which would then be in effect had the
adjustments made upon the issuance of such rights or warrants been made on the
basis of delivery of only the number of shares of Common Stock actually
delivered and the number of shares of Common Stock for which this Warrant may
thereafter be exercised shall be readjusted (subject to proportionate adjustment
for any intervening exercises of this Warrant) to the number which would then be
in effect had the adjustments made upon the issuance of such rights or warrants
been made on the basis of delivery of only the number of shares of Common Stock
actually delivered. In the event that such rights or warrants are not so issued,
the Purchase Price shall again be adjusted to be the Purchase Price which would
then be in effect if such record date had not been fixed and the number of
shares of Common Stock for which this Warrant may thereafter be exercised shall
again be adjusted (subject to proportionate adjustment for any intervening
exercises of this Warrant) to be the number which would then be in effect if
such record date had not been fixed. In determining whether any rights or
warrants entitle the Holder to subscribe for or purchase shares of Common Stock
at less than such Current Fair Market Value, and in determining the aggregate
offering price of such shares of Common Stock, there shall be taken into account
any consideration received for such rights or warrants, the value of such
consideration, if other than cash, to be determined by the Board of Directors.
Notwithstanding the foregoing, if any of the adjustments to the Purchase Price
as set forth in this Section 7 will require the Company to seek stockholder
approval pursuant to Rule 713 of the AMEX and such stockholder approval has not
yet been obtained, then the adjustment shall not take effect until such
stockholder approval is obtained. The Company shall use its commercially
reasonable best efforts to obtain, as promptly as practicable, but in no event
later than 90 days thereafter, the stockholder approval that is necessary under
the rules of the AMEX.
8.
Adjustment in Connection Sales by a
Designated Person.
So long
as any Note is outstanding, if at any time on or after the Issuance Date any
Designated Person, directly or indirectly, sells, transfers or disposes of
shares of Common Stock or Common Stock Equivalents other than a Permitted
Designated Person Sale and on the Measurement Date for such sale, transfer or
disposition the Purchase Price in effect on such Measurement Date is greater
than the Computed Market Price on such Measurement Date, then, subject to the
next succeeding sentence, the
Purchase
Price shall be reduced to such Computed Market Price
, such
adjustment to become effective immediately after the opening of business on the
day following the Measurement Date. If a reduction of the Purchase Price to such
Computed Market Price pursuant to the immediately preceding sentence would
require the Company to seek stockholder approval of the transactions
contemplated by the Note Purchase Agreement pursuant to Rule 713 of the AMEX and
the Stockholder Approval has not yet been obtained, then the Purchase Price
shall be reduced to a price equal to the Conversion Price (as defined in the
Note) then in effect until such time as the Stockholder Approval is obtained at
which time the Purchase Price shall be reduced to such Computed Market Price.
The Company shall inform the Holder immediately by phone and electronic
transmission upon becoming aware of any sale, transfer or disposition of any
shares of Common Stock or Common Stock Equivalents by any Designated Person and
will follow up with formal written notice to the Holder pursuant to Section
23.
9.
Effect of Reclassification,
Consolidation, Merger or Sale.
(a)
If any of
the following events occur, namely:
(i)
any
reclassification or change of the outstanding shares of Common Stock (other than
a change in par value, or from par value to no par value, or from no par value
to par value, or as a result of a subdivision or combination),
(ii)
any
consolidation, merger statutory exchange or combination of the Company with
another corporation as a result of which holders of Common Stock shall be
entitled to receive stock, securities or other property or assets (including
cash) with respect to or in exchange for such Common Stock, or
(iii)
any sale
or conveyance of the properties and assets of the Company as, or substantially
as, an entirety to any other Person as a result of which holders of Common Stock
shall be entitled to receive stock, securities or other property or assets
(including cash) with respect to or in exchange for such Common Stock,
then the
Company or the successor or purchasing Person, as the case may be, shall execute
with the Holder a written agreement providing that:
(x)
this
Warrant shall thereafter entitle the Holder to purchase the kind and amount of
shares of stock and Other Securities or property or assets (including cash)
receivable upon such reclassification, change, consolidation, merger, statutory
exchange, combination, sale or conveyance by the holder of a number of shares of
Common Stock issuable upon exercise of this Warrant (assuming, for such
purposes, a sufficient number of authorized shares of Common Stock available to
exercise this Warrant) immediately prior to such reclassification, change,
consolidation, merger, statutory exchange, combination, sale or conveyance
assuming such holder of Common Stock did not exercise such holder's rights of
election, if any, as to the kind or amount of securities, cash or other property
receivable upon such consolidation, merger, statutory exchange, combination,
sale or conveyance (
provided
that, if
the kind or amount of securities, cash or other property receivable upon such
consolidation, merger, statutory exchange, sale or conveyance is not the same
for each share of Common Stock in respect of which such rights of election shall
not have been exercised (“non-electing share”), then for the purposes of this
Section 8 the kind and amount of securities, cash or other property receivable
upon such consolidation, merger, statutory exchange, sale or conveyance for each
non-electing share shall be deemed to be the kind and amount so receivable per
share by a plurality of the non-electing shares),
(y)
in the
case of any such successor or purchasing Person, upon such consolidation,
merger, statutory exchange, combination, sale or conveyance such successor or
purchasing Person shall be jointly and severally liable with the Company for the
performance of all of the Company's obligations under this Warrant and the Note
Purchase Agreement and
(z)
if
registration or qualification is required under the 1933 Act or applicable state
law for the public resale by the Holder of such shares of stock and Other
Securities so issuable upon exercise of this Warrant, such registration or
qualification shall be completed prior to such reclassification, change,
consolidation, merger, statutory exchange, combination or sale.
Such
written agreement shall provide for adjustments which shall be as nearly
equivalent as may be practicable to the adjustments provided for in this
Warrant. If, in the case of any such reclassification, change, consolidation,
merger, statutory exchange, combination, sale or conveyance, the stock or other
securities or other property or assets receivable thereupon by a holder of
shares of Common Stock includes shares of stock, other securities, other
property or assets of a Person other than the Company or any such successor or
purchasing Person, as the case may be, in such reclassification, change,
consolidation, merger, statutory exchange, combination, sale or conveyance, then
such written agreement shall also be executed by such other Person and shall
contain such additional provisions to protect the interests of the Holder as the
Board of Directors shall reasonably consider necessary by reason of the
foregoing.
(b)
The above
provisions of this Section 9 shall similarly apply to successive
reclassifications, changes, consolidations, mergers, combinations, sales and
conveyances.
(c)
If this
Section 9 applies to any event or occurrence, Section 5 shall not
apply.
10.
Tax
Adjustments.
The
Company may make such reductions in the Purchase Price, in addition to those
required by Sections 4, 5, 6, 7 and 8 as the Board of Directors considers to be
advisable to avoid or diminish any income tax to holders of Common Stock or
rights to purchase Common Stock resulting from any dividend or distribution of
stock (or rights to acquire stock) or from any event treated as such for income
tax purposes.
11.
Minimum
Adjustment.
(a) No
adjustment in the Purchase Price (and no related adjustment in the number of
shares of Common Stock which may thereafter be purchased upon exercise of this
Warrant) shall be required unless such adjustment would require an increase or
decrease of at least 1% in the Purchase Price;
provided, however,
that any
adjustments which by reason of this Section 11 are not required to be made shall
be carried forward and taken into account in any subsequent adjustment. All such
calculations under this Warrant shall be made by the Company and shall be made
to the nearest cent or to the nearest one hundredth of a share, as the case may
be.
(b)
No
adjustment need be made for a change in the par value of the Common Stock or
from par value to no par value or from no par value to par value.
12.
Notice of
Adjustments.
Whenever
the Purchase Price is adjusted as herein provided, the Company shall promptly,
but in no event later than five Trading Days thereafter, give a notice to the
Holder setting forth the Purchase Price and number of shares of Common Stock
which may be purchased upon exercise of this Warrant after such adjustment and
setting forth a brief statement of the facts requiring such adjustment but which
such statement shall not include any information which would be material
non-public information for purposes of the 1934 Act. Failure to deliver such
notice shall not affect the legality or validity of any such
adjustment.
13.
Further
Assurances.
The
Company will take all action that may be necessary or appropriate in order that
the Company may validly and legally issue fully paid and nonassessable shares of
stock, free from all taxes, liens and charges with respect to the issue thereof,
on the exercise of all or any portion of this Warrant from time to time
outstanding.
14.
Notice to Holder Prior to Certain
Actions.
In case
on or after the Issuance Date:
(a)
the
Company shall declare a dividend (or any other distribution) on its Common Stock
(other than in cash out of retained earnings); or
(b)
the
Company shall authorize the granting to the holders of its Common Stock of
rights or warrants to subscribe for or purchase any share of any class or any
other rights or warrants; or
(c)
the Board
of Directors shall authorize any reclassification of the Common Stock (other
than a subdivision or combination of its outstanding Common Stock, or a change
in par value, or from par value to no par value, or from no par value to par
value), or any consolidation or merger or other business combination transaction
to which the Company is a party and for which approval of any stockholders of
the Company is required, or the sale or transfer of all or substantially all of
the assets of the Company; or
(d)
there
shall be pending the voluntary or involuntary dissolution, liquidation or
winding-up of the Company;
the
Company shall give the Holder, as promptly as possible but in any event at least
ten Trading Days prior to the applicable date hereinafter specified, a notice
stating (x) the date on which a record is to be taken for the purpose of such
dividend, distribution or rights or warrants, or, if a record is not to be
taken, the date as of which the holders of Common Stock of record to be entitled
to such dividend, distribution or rights are to be determined, or (y) the date
on which such reclassification, consolidation, merger, other business
combination transaction, sale, transfer, dissolution, liquidation or winding-up
is expected to become effective or occur, and the date as of which it is
expected that holders of Common Stock of record who shall be entitled to
exchange their Common Stock for securities or other property deliverable upon
such reclassification, consolidation, merger, other business combination
transaction, sale, transfer, dissolution, liquidation or winding-up shall be
determined. Such notice shall not include any information which would be
material non-public information for purposes of the 1934 Act. Failure to give
such notice, or any defect therein, shall not affect the legality or validity of
such dividend, distribution, reclassification, consolidation, merger, sale,
transfer, dissolution, liquidation or winding-up. In the case of any such action
of which the Company gives such notice to the Holder or is required to give such
notice to the Holder, the Holder shall be entitled to give a subscription form
to exercise this Warrant in whole or in part that is contingent on the
completion of such action.
15.
Reservation of Stock, etc., Issuable
on Exercise of Warrants.
The
Company will at all times reserve and keep available out of its authorized but
unissued shares of capital stock, solely for issuance and delivery on the
exercise of this Warrant, a sufficient number of shares of Common Stock (or
Other Securities) to effect the full exercise of this Warrant and the exercise,
conversion or exchange of all other Common Stock Equivalents from time to time
outstanding (or Other Securities), and if at any time the number of authorized
but unissued shares of Common Stock (or Other Securities) shall not be
sufficient to effect such exercise, conversion or exchange, the Company shall
take such action as may be necessary to increase its authorized but unissued
shares of Common Stock (or Other Securities) to such number as shall be
sufficient for such purposes.
16.
Transfer of
Warrant.
This
Warrant shall inure to the benefit of the successors to and assigns of the
Holder. This Warrant and all rights hereunder, in whole or in part, are
registrable at the office or agency of the Company referred to below by the
Holder in person or by his duly authorized attorney, upon surrender of this
Warrant properly endorsed accompanied by an assignment form in the form
attached
to this
Warrant, or other customary form, duly executed by the transferring
Holder.
17.
Register of
Warrants.
The
Company shall maintain, at the principal office of the Company (or such other
office as it may designate by notice to the Holder), a register in which the
Company shall record the name and address of the Person in whose name this
Warrant has been issued, as well as the name and address of each successor and
prior owner of such Warrant. The Company shall be entitled to treat the Person
in whose name this Warrant is so registered as the sole and absolute owner of
this Warrant for all purposes.
18.
Exchange of
Warrant.
This
Warrant is exchangeable, upon the surrender hereof by the Holder at the office
or agency of the Company referred to in Section 16, for one or more new Warrants
of like tenor representing in the aggregate the right to subscribe for and
purchase the number of shares of Common Stock which may be subscribed for and
purchased hereunder, each of such new Warrants to represent the right to
subscribe for and purchase such number of shares as shall be designated by the
Holder at the time of such surrender.
19.
Replacement of
Warrant.
On
receipt by the Company of evidence reasonably satisfactory to it of the
ownership of and the loss, theft, destruction or mutilation of this Warrant and
(a) in the case of loss, theft or destruction, of indemnity from the Holder
reasonably satisfactory in form to the Company (and without the requirement to
post any bond or other security), or (b) in the case of mutilation, upon
surrender and cancellation of this Warrant, the Company will execute and deliver
to the Holder a new Warrant of like tenor without charge to the
Holder.
20.
Warrant
Agent.
The
Company may, by written notice to the Holder, appoint the transfer agent and
registrar for the Common Stock as the Company's agent for the purpose of issuing
Common Stock (or Other Securities) on the exercise of this Warrant pursuant to
Section 2, and the Company may, by written notice to the Holder, appoint an
agent having an office in the United States of America for the purpose of
exchanging this Warrant pursuant to Section 18, and replacing this Warrant
pursuant to Section 19, or any of the foregoing, and thereafter any such
exchange or replacement, as the case may be, shall be made at such office by
such agent.
21.
Remedies.
The
Company stipulates that the remedies at law of the Holder in the event of any
default or threatened default by the Company in the performance of or compliance
with any of the terms of this Warrant are not and will not be adequate, and that
such terms may be specifically enforced (x) by a decree for the specific
performance of any agreement contained herein, including, without limitation, a
decree for issuance of the shares of Common Stock (or Other Securities) issuable
upon exercise of this Warrant or (y) by an injunction against a violation of any
of the terms hereof or (z) otherwise.
22.
No Rights or Liabilities as a
Stockholder.
This
Warrant shall not entitle the Holder to any voting rights or other rights as a
stockholder of the Company. Nothing contained in this Warrant shall be construed
as conferring upon the Holder the right to vote or to consent or to receive
notice as a stockholder of the Company on any matters or with respect to any
rights whatsoever as a stockholder of the Company. No dividends or interest
shall be payable or accrued in respect of this Warrant or the interest
represented hereby or the Common Stock (or Other Securities) purchasable
hereunder until, and only to the extent that, this Warrant shall have been
exercised in accordance with its terms.
23.
Notices,
etc.
All
notices and other communications from the Company to the Holder shall be in
writing and delivered personally, by confirmed facsimile, by a nationally
recognized overnight courier service or mailed by first class certified mail,
postage prepaid, at such facsimile telephone number or address as may have been
furnished to the Company in writing by the Holder or at such facsimile telephone
number or the address shown for the Holder on the register of Warrants referred
to in Section 17.
24.
Transfer
Restrictions.
This
Warrant has not been and is not being registered under the provisions of the
1933 Act or any state securities laws and this Warrant may not be transferred
prior to the end of the holding period applicable to sales hereof under Rule
144(k) unless (1) the transferee is an “accredited investor” (as defined in
Regulation D under the 1933 Act) and (2) the Holder shall have delivered to the
Company an opinion of counsel, reasonably satisfactory in form, scope and
substance to the Company, to the effect that this Warrant may be sold or
transferred without registration under the 1933 Act. Prior to any such transfer,
such transferee shall have represented in writing to the Company that such
transferee has requested and received from the Company all information relating
to the business, properties, operations, condition (financial or other), results
of operations or prospects of the Company deemed relevant by such transferee;
that such transferee has been afforded the opportunity to ask questions of the
Company concerning the foregoing and has had the opportunity to obtain and
review the Registration Statement and the prospectus related thereto, each as
amended or supplemented to the date of transfer to such transferee, and the
reports and other information concerning the Company which at the time of such
transfer have been filed by the Company with the SEC pursuant to the 1934 Act
and which are incorporated by reference in such prospectus as of the date of
such transfer. If such transfer is intended to assign the rights and obligations
of the Holder under Section 5,8,9 and 10 of the Note Purchase Agreement, such
transfer shall otherwise be made in compliance with the applicable provisions of
the Note Purchase Agreement.
25.
Rule 144A Information
Requirement.
Within
the period prior to the expiration of the holding period applicable to sales
hereof under Rule 144(k) under the 1933 Act (or any successor provision), the
Company covenants and agrees that it shall, during any period in which it is not
subject to Section 13 or 15(d) under the 1934 Act, make available to the Holder
and the holder of any shares of Common Stock issued upon exercise of this
Warrant which continue to be Restricted Securities in connection with any sale
thereof and any prospective purchaser of this Warrant from the Holder, the
information required pursuant to Rule 144A(d)(4) under the 1933 Act upon the
request of the Holder and it will take such further action as the Holder may
reasonably request, all to the extent required from time to time to enable the
Holder to sell this Warrant without registration under the 1933 Act within the
limitation of the exemption provided by Rule 144A, as Rule 144A may be
amended from time to time. Upon the request of the Holder, the Company will
deliver to the Holder a written statement as to whether it has complied with
such requirements.
26.
Legend.
The
provisions of Section 5(b) of the Note Purchase Agreement and the related
definitions of capitalized terms used therein and defined in the Note Purchase
Agreement are by this reference incorporated herein as if set forth in full at
this place.
27.
Amendment;
Waiver.
(a) This
Warrant and any terms hereof may be changed, modified or amended only by an
instrument in writing signed by the party against which enforcement of such
change, modification or amendment is sought. Notwithstanding anything to the
contrary contained herein, no amendment or waiver shall increase or eliminate
the Restricted Ownership Percentage, whether permanently or temporarily, unless,
in addition to complying with the other requirements of this Warrant, such
amendment or waiver shall have been approved in accordance with the General
Corporation Law of the State of Delaware and the Company's By-laws by holders of
the outstanding shares of Common Stock entitled to vote at a meeting or by
written consent in lieu of such meeting.
(b)
Any term
or condition of this Warrant may be waived by the Holder or Company at any time
if the waiving party is entitled to the benefit thereof, but no such waiver will
be effective unless set forth in a written instrument duly executed by or on
behalf of the party waiving such term or condition. No waiver by any party of
any term or condition of this Warrant, in any one or more instances, will be
deemed to be or construed as a waiver of the same or any other term or condition
of this Warrant on any future occasion.
28.
Miscellaneous.
This
Warrant shall be construed and enforced in accordance with and governed by the
internal laws of the State of New York. The headings, captions and footers in
this Warrant are for purposes of reference only, and shall not limit or
otherwise affect any of the terms hereof. The invalidity or unenforceability of
any provision hereof shall in no way affect the validity or enforceability of
any other provision.
29.
Attorneys'
Fees.
In any
litigation, arbitration or court proceeding between the Company and Holder
relating hereto, the prevailing party shall be entitled to attorneys’ fees and
expenses and all costs of proceedings incurred in enforcing this
Warrant.
[Signature Page
Follows]
IN WITNESS
WHEREOF,
the
Company has caused this Warrant to be duly executed on its behalf by one of its
officers thereunto duly authorized.
|
|
|
|
EMAGIN
CORPORATION
|
|
|
|
Date: July 21,
2006
|
By:
|
/s/ Gary W.
Jones
|
|
Name: Gary W. Jones
|
|
Title: Chief Executive
Officer
|
ASSIGNMENT
For value
hereby
sell(s), assign(s) and transfer(s) unto
(Please
insert social security or other Taxpayer Identification Number of assignee:
) the
attached original, executed Warrant to purchase
share of
Common Stock of eMagin Corporation, a Delaware corporation (the “Company”), and
hereby irrevocably constitutes and appoints
attorney
to transfer the Warrant on the books of the Company, with full power of
substitution in the premises.
In
connection with any transfer of the Warrant within the period prior to the
expiration of the holding period applicable to sales thereof under Rule 144(k)
under the 1933 Act (or any successor provision) (other than any transfer
pursuant to a registration statement that has been declared effective under the
1933 Act), the undersigned confirms that such Warrant is being
transferred:
[
]
To the
Company or a Subsidiary; or
[
]
To an
“accredited investor” (as defined in Regulation D under the 1933 Act) pursuant
to and in compliance with the 1933 Act; or
[
]
Pursuant
to and in compliance with Rule 144 under the 1933 Act;
and
unless the box below is checked, the undersigned confirms that, to the knowledge
of the undersigned, such Warrant is not being transferred to an “affiliate” (as
defined in Rule 144 under the 1933 Act) of the Company.
[
]
The
transferee is an affiliate of the Company.
Capitalized
terms used in this Assignment and not defined in this Assignment shall have the
respective meanings provided in the Warrant.
Dated:
____________________________________
|
NAME
:____________________________________________
|
|
|
|
____________________________________________________________
|
|
Signature(s)
|
|
|
Exhibit 1
FORM OF
SUBSCRIPTION
EMAGIN
CORPORATION
(To be
signed only on exercise of Warrant)
TO:
|
eMagin Corporation
|
|
10500 N.E. 8
th
Street, Suite 1400
|
|
Bellevue,
WA 98004
|
Attention:
Chief Financial Officer
Facsimile
No.: (425) 749-3601
1.
The
undersigned Holder of the attached original, executed Warrant hereby elects to
exercise its purchase right under such Warrant with respect to
shares
(the “Exercise Shares”) of Common Stock, as defined in the Warrant, of eMagin
Corporation, a Delaware corporation (the “Company”).
2.
The
undersigned Holder (check one):
q
(a)
elects to
pay the Aggregate Purchase Price for such shares of Common Stock (i) in lawful
money of the United States or by the enclosed certified or official bank check
payable in United States dollars to the order of the Company in the amount of
$
, or (ii)
by wire transfer of United States funds to the account of the Company in the
amount of $
, which
transfer has been made before or simultaneously with the delivery of this Form
of Subscription pursuant to the instructions of the Company;
or
q
(b)
elects to
receive shares of Common Stock having a value equal to the value of the Warrant
calculated in accordance with Section 2(b) of the Warrant.
3.
Please
issue a stock certificate or certificates representing the appropriate number of
shares of Common Stock in the name of the undersigned or in such other name(s)
as is specified below:
Name:_________________________________________________________________
Address_______________________________________________________________
Social
Security or Tax Identification Number (if any):
____________________________________________________________
Dated:
________________________________________________________
(Signature
must conform to name of Holder as
specified
on the face of the Warrant)
________________________________________________________
(Address)
Annex
III
PATENT AND TRADEMARK SECURITY
AGREEMENT
This
PATENT AND TRADEMARK SECURITY
AGREEMENT
, dated
as of July 21, 2006 (this “Agreement”), made by
EMAGIN CORPORATION
, a
Delaware corporation (the “Grantor”), to
ALEXANDRA GLOBAL MASTER FUND LTD.,
a British
Virgin Islands international business company, as collateral agent (in such
capacity, the “Collateral Agent”) on behalf of the Holders (such capitalized
term and all other capitalized terms used in this Agreement having the
respective meanings provided in this Agreement).
W I T N E S S E T
H:
WHEREAS
, the
Grantor and the several Buyers are parties to the several Note Purchase
Agreements pursuant to which, among other things, the Buyers have agreed to
purchase up to $7,000,000 aggregate principal amount of Notes of the
Grantor;
WHEREAS
, the
Grantor has certain right, title and interest in and to certain patents, patent
applications and trademarks and related property;
WHEREAS,
the
Grantor has agreed to grant to the Collateral Agent a security interest in its
right, title and interest in and to certain patents, patent applications,
trademarks and related rights to secure the payment and performance of certain
obligations of the Grantor, including, without limitation, obligations of the
Grantor under the Notes, the Note Purchase Agreements, the Security Agreement
and this Agreement;
WHEREAS
, it is a
condition precedent to the several obligations of the Buyers to purchase their
respective Notes that the Grantor shall have executed and delivered this
Agreement to the Collateral Agent for the ratable benefit of the
Holders;
WHEREAS
, the
Grantor is contemporaneously herewith entering into the Security Agreement and
the Lockbox Agreement with the Collateral Agent for the ratable benefit of the
Holders;
NOW, THEREFORE
, in
consideration of the premises and to induce the Buyers to purchase their
respective Notes pursuant to the Note Purchase Agreements, the Grantor hereby
agrees with the Collateral Agent, for the ratable benefit of the Holders, as
follows:
1.
Definitions.
(a)
As used
in this Agreement, the terms “Agreement”, “Grantor” and “Collateral Agent” shall
have the respective meanings assigned to such terms in the introductory
paragraph of and the recitals to this Agreement.
(b)
All the
agreements or instruments herein defined shall mean such agreements or
instruments as the same may from time to time be supplemented or amended or the
terms thereof waived or modified to the extent permitted by, and in accordance
with, the terms thereof and of this Agreement.
(c)
Capitalized
terms used herein without definition shall have the respective meanings assigned
to such terms in the Notes.
(d)
The
following terms shall have the following meanings (such meanings to be equally
applicable to both the singular and plural forms of the terms
defined):
“Accounts”
means all rights to payment for goods sold or leased or for services rendered,
whether or not such rights have been earned by performance.
“Additional
Note” means the Note issued pursuant to the Additional Note Purchase
Agreement.
“Additional
Note Purchase Agreement” means the Note Purchase Agreement, dated as of July 21,
2006, by and between the Grantor and Stillwater LLC, which by its terms
contemplates the issuance of up to $500,000 aggregate principal amount of Notes
on or after December 10, 2006.
“Affiliate”
means, with respect to any Person, any other Person that directly, or indirectly
through one or more intermediaries, controls, is controlled by or is under
common control with the subject Person. For purposes of this definition,
“control” (including, with correlative meaning, the terms “controlled by” and
“under common control with”), as used with respect to any Person, shall mean the
possession, directly or indirectly, of the power to direct or cause the
direction of the management and policies of such Person, whether through the
ownership of voting securities or by contract or otherwise.
“Buyer”
means any of the several buyers party to a Note Purchase Agreement.
“Code”
means the Uniform Commercial Code as from time to time in effect in the State of
Delaware.
“Collateral”
means all of the Grantor’s right, title and interest in and to each of the
following, whether now owned or at any time hereafter acquired by the Grantor or
in which the Grantor now has or at any time in the future may acquire any right,
title or interest:
(1)
all
Patents;
(2)
all
Patent Licenses;
(3)
all
Trademarks;
(4)
all
Trademark Licenses;
(5)
all
Contracts, Documents and General Intangibles developed or acquired by the
Grantor relating to any and all of the foregoing;
(6)
all
insurance policies to the extent they relate to the preceding items (1) through
(5); and
(7)
to the
extent not otherwise included in the preceding items (1) through (6), all
Proceeds, products, rents, issues, profits and returns of and arising from any
and all of the foregoing.
“Contracts”
shall have the meaning assigned to such term under the Code.
“Documents”
shall have the meaning assigned to such term under the Code.
“Event of
Default” means:
(1)
the
failure by the Grantor to perform in any material respect any obligation of the
Grantor under this Agreement as and when required by this Agreement;
(2)
any
representation or warranty made by the Grantor pursuant to this Agreement shall
have been untrue in any material respect when made or deemed to be
made;
(3)
the
failure by the Grantor to perform in any material respect any obligation of the
Grantor under the Security Agreement as and when required by the Security
Agreement;
(4)
any
representation or warranty made by the Grantor pursuant to the Security
Agreement shall have been untrue in any material respect when made or deemed to
be made;
(5)
the
failure by the Grantor to perform in any material respect any obligation of the
Grantor under the Lockbox Agreement as and when required by the Lockbox
Agreement;
(6)
any
representation or warranty made by the Grantor pursuant to the Lockbox Agreement
shall have been untrue in any material respect when made or deemed to be made;
or
(7)
any Event
of Default, as that term is defined in any of the Notes.
“General
Intangibles” shall have the meaning ascribed to such term in the Code.
“Holder”
means any Buyer or any holder from time to time of any Note.
“Issuance
Date” means the date on which the Notes are initially issued.
“Lien”
shall mean any lien, mortgage, security interest, chattel mortgage, pledge or
other encumbrance (statutory or otherwise) of any kind securing satisfaction or
performance of an obligation, including any agreement to give any of the
foregoing, any conditional sales or other title retention agreement, any lease
in the nature thereof, and the filing of or the agreement to give any financing
statement under the Code of any jurisdiction or similar evidence of any
encumbrance, whether within or outside the United States.
“Lockbox
Agent” means the Person from time to time serving as Lockbox Agent under the
Lockbox Agreement.
“Lockbox
Agreement” means that certain Lockbox Agreement, dated as of July 21, 2006, by
and between the Grantor and the Lockbox Agent.
“Majority
Holders” means at any time such of the holders of Notes, which based on the
outstanding principal amount of the Notes, represents a majority of the
aggregate outstanding principal amount of the Notes.
“Note
Purchase Agreements” means the several Note Purchase Agreements, dated as of
July 21, 2006, by and between the Grantor and the respective Buyer party thereto
pursuant to which the Grantor issued the Notes
,
including, without limitation, the Additional Note Purchase
Agreement
.
“Notes”
means the Grantor’s 6% Senior Secured Convertible Notes due 2007-2008 originally
issued pursuant to the Note Purchase Agreements, including, without limitation,
the Additional Note.
“Obligations”
shall mean:
(1)
the full
and prompt payment when due of all obligations and liabilities to the Holders,
whether now existing or hereafter arising, under the Notes, this Agreement or
the other Transaction Documents and the due performance and compliance with the
terms of the Notes and the other Transaction Documents;
(2)
any and
all sums advanced by the Collateral Agent or any Holder in order to preserve the
Collateral or to preserve the Collateral Agent’s security interest in the
Collateral;
(3)
in the
event of any proceeding for the collection or enforcement of any obligations or
liabilities of the Grantor referred to in the immediately preceding clauses (1)
and (2) in accordance with the terms of the Notes and this Agreement, the
reasonable expenses of re-taking, holding, preparing for sale, selling or
otherwise disposing of or realizing on the Collateral, or of any other exercise
by the Collateral Agent of its rights hereunder, together with reasonable
attorneys’ fees and court costs; and
(4)
any
amounts for which any Holder is entitled to indemnification under Section
4(n).
“Patent(s)”
means all patents, patent applications and patent disclosures which are
presently, or in the future may be, owned, issued, acquired or used (whether
pursuant to a license or otherwise) anywhere in the world by the Grantor, in
whole or in part, and all of the Grantor’s right, title and interest in and to
all patentable inventions and to file applications for patents under patent laws
of the United States or of any other jurisdiction, including any and all
extensions, reissues, substitutes, continuations, continuations-in-part,
divisional, patents of addition, re-examinations and renewals thereof, and
patents issuing therefrom, and any other proprietary rights related to any of
the foregoing (including, without limitation, remedies against infringements
thereof and rights of protection of an interest therein under the laws of all
jurisdictions) and any and all foreign counterparts of any of the foregoing,
including without limitation, those listed on
Exhibit A
to this
Agreement.
“Patent
Licenses” means each license agreement identified in
Exhibit A
to this
Agreement as it may be amended, supplemented or otherwise modified from time to
time, and each license agreement relating to Patents hereafter granted
to, used
or acquired by the Grantor, in each case together with the right to use and rely
upon the inventions and other intellectual property conveyed
thereunder.
“Person”
means any natural person, corporation, partnership, limited liability company,
trust, incorporated organization, unincorporated association or similar entity
or any government, governmental agency or political subdivision.
“Proceeds”
shall have the meaning assigned to such term under the Code.
“PTO”
means the United States Patent and Trademark Office.
“Security
Agreement” means the Pledge and Security Agreement, dated as of July 21, 2006,
between the Grantor and the Collateral Agent.
“Security
Interest” means the security interest and collateral assignment granted in the
Collateral pursuant to this Agreement.
“Subsidiary”
means any corporation or other entity of which a majority of the capital stock
or other ownership interests having ordinary voting power to elect a majority of
the board of directors or other Persons performing similar functions are at the
time directly or indirectly owned by the Company.
“Trademark
License” means each license agreement identified in
Exhibit B
hereto
as it may be amended, supplemented or otherwise modified from time to time, and
each license agreement relating to Trademarks hereafter used, adopted or
acquired by the Grantor.
“Trademarks”
means (a) all trademarks, trade names, corporate names, company names, business
names, fictitious business names, trade styles, service marks, logos and other
source or business identifiers of the Grantor adopted for use in conjunction
with the sale of Medical Devices or Competitive Products, now existing anywhere
in the world or hereinafter adopted or acquired, whether currently in use or
not, and the goodwill associated therewith, all registrations and recordings
thereof, and all applications in connection therewith, including, without
limitation, those identified in
Exhibit B
to this
Agreement, and (b) all renewals thereof by the Grantor.
“Transaction
Documents” means the Notes, the Note Purchase Agreements, this Agreement, the
Security Agreement, the Lockbox Agreement, the Warrants and the other
agreements, instruments and documents contemplated hereby and thereby, and any
amendments, extensions or renewals thereof or replacements
therefor.
2.
Grant of Security
Interest.
As
collateral security for the prompt and complete payment and performance when due
of the Obligations and for the other purposes provided in this Agreement, the
Grantor hereby grants, assigns and conveys to the Collateral Agent, for the
ratable benefit of the Holders, all of the Grantor’s right, title and interest
in and to the Collateral as collateral security and hereby grants the Collateral
Agent a continuing first priority security interest therein. Such grant
includes, without limitation, a grant of the security interest to secure the
payment and performance of Obligations relating to the Additional Note upon the
date of issuance of such Additional Note. Notwithstanding the foregoing
assignment, unless and until there shall have occurred and be continuing an
Event of Default, the Grantor shall retain and the Collateral Agent hereby
grants to the Grantor the exclusive, non-transferable, revocable right and
license to use the Collateral on and in connection with making, having made,
using and selling products sold by the Grantor, for the Grantor’s own benefit
and account and for none other (except as provided in the Patent Licenses
identified on
Exhibit A
and the
Trademark Licenses identified on
Exhibit B
). The
Grantor agrees not to sell or assign its interest in, or grant any sublicense
under, the foregoing license granted to the Grantor without the prior written
consent of the Collateral Agent, which may be withheld in the Collateral Agent’s
sole and absolute discretion.
3.
Representations and
Warranties
. The
Grantor hereby represents and warrants that:
(a)
Description of Collateral.
True and
complete schedules setting forth all Patents, Patent Licenses, Trademarks and
Trademark Licenses owned, held, controlled or used by the Grantor or to which
the Grantor is a party on the date of this Agreement, together with a summary
description and full information in respect of the filing, registration,
issuance and expiration dates thereof, as applicable, are set forth on
Exhibit A
with
respect to Patents and Patent Licenses and on
Exhibit B
with
respect to Trademarks and Trademark Licenses, respectively, to this
Agreement.
(b)
Title; No Other
Liens.
Except
for the Lien granted to the Collateral Agent for the ratable benefit of the
Holders pursuant to this Agreement and the Lien granted to the Collateral Agent
for the ratable benefit of the Holders pursuant to the Security Agreement, the
Grantor is the sole and exclusive owner of and has good and marketable title to
each item of the Collateral free and clear of any and all Liens or claims of
others, except as permitted by Section 3.9 of the Notes. None of the Grantor’s
Subsidiaries or other entities controlled by the Grantor has any right, title or
interest in or to any of the Collateral. No security agreement, financing
statement or other public notice with respect to all or any part of the
Collateral is on file or of record in any public office, except such as may have
been filed in favor of the Collateral Agent, for the ratable benefit of the
Holders, pursuant to this Agreement or the Security Agreement.
(c)
Perfected First Priority
Liens
. The
Liens granted pursuant to this Agreement will constitute, upon the completion of
all the filings or notices listed in
Exhibit C
to this
Agreement, which Exhibit includes all UCC-1 financing statements to be filed
pursuant to the terms of the Security Agreement, all requisite filings to be
made with the PTO in the forms substantially similar to that of
Exhibit E
and
Exhibit F
to this
Agreement, valid and perfected Liens on all Collateral in favor of the
Collateral Agent for the ratable benefit of the Holders, which are prior to all
other Liens on such Collateral and which are enforceable as such against all
Persons.
(d)
Consents under
Contracts
. No
consent (other than consents that have been obtained) of any party (other than
the Grantor) to any Contract that constitutes part of the Collateral is
required, or purports to be required, in connection with the execution, delivery
and performance of this Agreement or the exercise of the Collateral Agent’s
rights and remedies provided herein or at law.
(e)
Chief Executive
Office
. The
Grantor’s chief executive office and chief place of business is located at 10500
N.E. 8
th
Street,
Suite 1400,
Bellevue,
WA 98004.
(f)
Authority.
The
Grantor has full power, authority and legal right to grant the Collateral Agent
the Lien on the Collateral pursuant to this Agreement.
(g)
Approvals, Filings,
Etc.
No
authorization, approval or consent of, or filing, registration, recording or
other action with, any United States or foreign court, governmental body,
regulatory agency, self-regulatory organization, or stock exchange or market,
the stockholders of the Company or any other Person, including, without
limitation, the PTO, is required to be obtained or made by the Company or any
Subsidiary (x) for the grant by the Grantor of the Lien on the Collateral
pursuant to this Agreement, (y) the collateral assignment of the Collateral to
the Collateral Agent pursuant to this Agreement or (z) to perfect the Lien
purported to be created by this Agreement, in each case except as has been
obtained or made or (z) for the exercise of the Collateral Agent’s rights and
remedies provided herein or at law.
(h)
No Claims.
Each of
the Patents and Trademarks existing on the date hereof is valid and enforceable,
and the Grantor is not presently aware of any past, present or prospective claim
by any third party that any of such Patents or Trademarks are invalid or
unenforceable, or that the use of any Patents does or may violate the rights of
any third person, or of any basis for any such claims.
(i)
Statutory Notice.
The
Grantor has used and will continue to use proper statutory notice in connection
with its use of the Patents.
(j)
Certain Patent
Matters.
To its
knowledge, the Grantor does not lack any material rights or licenses to use the
Patents or to make, have made, use, sell, or offer for sale the claimed subject
matter of the Patents. To the knowledge of the Grantor, there are no facts which
would form a basis for a finding that any of the claims of the Patents is
unpatentable, unenforceable or invalid. To the knowledge of the Grantor, there
are no pending U.S. or foreign patent applications which, if issued, would limit
or prohibit the ability of the Grantor or the Collateral Agent to make, have
made, use, sell, or offer for sale the claimed subject matter of the
Patents.
(k)
Custom License Matters.
Each
Patent License or Trademark License is the legal, valid and binding obligation
of the Grantor and the respective licensor thereunder; the Grantor is not, and,
to the best knowledge of the Grantor, each licensor is not, in default of any of
its obligations under any Patent License or Trademark License; no event has
occurred and no circumstance exists that with the giving of notice or the
passage of time, or both, would constitute such a default by the Grantor; and,
to the best knowledge of the Grantor, no such event has occurred or circumstance
exists that would constitute a default by the licensor under any Patent License
or Trademark License.
4.
Covenants.
The
Grantor covenants and agrees with the Collateral Agent that from and after the
date of this Agreement until the payment and performance in full by the Grantor
of all of the Obligations:
(a)
Further
Documentation.
At any
time and from time to time, upon the written request of the Collateral Agent,
and at the sole expense of the Grantor, the Grantor will promptly and duly
execute and deliver such further instruments and documents and take such further
action as the Collateral Agent may request for the purpose of obtaining or
preserving the full benefits of this Agreement and of the rights and powers
herein granted, including, without limitation, any applicable filing with the
PTO and the filing of any financing or continuation statements under the Code or
similar laws in effect in any such jurisdiction with respect to the Liens
created hereby. The Grantor also hereby authorizes the Collateral Agent to file
any such financing or continuation statement without the signature of the
Grantor to the extent permitted by applicable law. A carbon, photographic or
other reproduction of this Agreement shall be sufficient as a financing
statement for filing in any jurisdiction.
(b)
Maintenance of
Records
. The
Grantor will keep and maintain at its own cost and expense satisfactory and
complete records of the Collateral. For the further security of the Collateral
Agent for the ratable benefit of the Holders, the Grantor hereby grants to the
Collateral Agent, for the ratable benefit of the Holders, a security interest in
all of the Grantor’s books and records pertaining to the Collateral, and the
Grantor shall turn over any such books and records for
inspection
at the office of the Grantor to the Collateral Agent or to its representatives
during normal business hours at the request of the Collateral
Agent.
(c)
Limitation on Liens on
Collateral.
The
Grantor (x) will not create, incur or permit to exist, will defend the
Collateral against, and will take such other action as is necessary to remove,
any Lien or claim on or to the Collateral, other than the Liens created hereby
and by the Security Agreement and Liens permitted by Section 3.9 of the Notes,
and (y) will defend the right, title and interest of the Collateral Agent in and
to any of the Collateral against the claims and demands of all
Persons.
(d)
Limitations on Dispositions of
Collateral.
The
Grantor will not sell, transfer, assign, grant any participation in, sublicense
or otherwise dispose of any of the Collateral to any Persons, including, without
limitation, any Subsidiary or Affiliate, or attempt, offer or contract to do so.
(e)
Limitations on Modifications,
Waivers, Extensions of Patent Licenses and Trademark
Licenses.
The
Grantor will not (i) amend, modify, terminate or waive any provision of any
Patent License with respect to any Patent or Trademark License with respect to
any Trademark in any manner which could reasonably be expected to materially
adversely affect the value of such Patent License or Trademark License as
Collateral, (ii) fail to exercise promptly and diligently each and every
material right and perform each material obligation which it may have under each
Patent License and Trademark License with respect to any Trademarks. Within two
Business Days of receipt thereof, the Grantor will deliver to the Collateral
Agent a copy of each material demand, notice or document received by it relating
in any way to each Patent License and Trademark License.
(f)
Further Identification of
Collateral.
The
Grantor shall furnish to the Collateral Agent from time to time, upon the
request of the Collateral Agent, statements and schedules further identifying
and describing the Collateral and such other reports in connection with the
Collateral as the Collateral Agent may reasonably request, all in reasonable
detail.
(g)
Notices.
The
Grantor shall advise the Collateral Agent promptly, but in no event later than
two Business Days after the occurrence thereof, in reasonable detail, at its
address specified in accordance with Section 15 (i) of any Lien on, or claim
asserted against, any of the Collateral, other than as created hereby or as
permitted hereby, (ii) of any Event of Default or any event which, with the
giving of notice or the passage of time, or both, would become an Event of
Default and (iii) of the occurrence of any other event which could reasonably be
expected to have a material adverse effect on the Liens created hereunder or the
rights of the Collateral Agent hereunder.
(h)
Patents.
(1)
The
Grantor will notify the Collateral Agent immediately if it knows, or has reason
to know, that any application relating to any Patent may become abandoned or of
any adverse determination or development (including, without limitation, the
institution of, or any such determination or development in, any proceeding in
the PTO or any court or tribunal in any country) regarding the Grantor’s
ownership of or license rights or other rights with respect to any
Patent.
(2)
The
Grantor will, with respect to any Patent that the Grantor obtains after the
Issuance Date or any Patent License that the Grantor acquires after the Issuance
Date, promptly, but in no event later than five Business Days thereafter, (i)
take all actions necessary so that the Collateral Agent shall obtain a perfected
security interest in such Patent or Patent License and (ii) provide to the
Collateral Agent a revised
Exhibit A
, listing
all Patents and all Patent Licenses in which the Grantor has an
interest.
(3)
Upon
request of the Collateral Agent, the Grantor shall execute and deliver any and
all agreements, instruments, documents, and papers as the Collateral Agent may
request to evidence the Collateral Agent’s security interest in such Patents or
Patent Licenses, and the Grantor hereby constitutes the Collateral Agent its
attorney-in-fact to execute and file all such writings for the foregoing
purposes, all acts of such attorney being hereby ratified and confirmed; such
power being coupled with an interest is irrevocable until the Grantor shall have
paid and performed in full all of its obligations under this Agreement and the
other Transaction Documents.
(4)
The
Grantor will take all reasonable and necessary steps, including, without
limitation, in any proceeding before the PTO to maintain and pursue each Patent
including, without limitation, payment of maintenance fees.
(5)
In the
event that any Patent included in the Collateral is infringed by a third party,
the Grantor shall promptly notify the Collateral Agent after it learns thereof
and shall, if appropriate, sue for infringement, seeking injunctive relief where
appropriate and to recover any and all damages for such infringement, or take
such other actions as the Grantor shall reasonably deem appropriate under the
circumstances to protect such Patent.
(6)
The
Grantor hereby grants to the Collateral Agent and its employees and agents the
right, upon prior written notice, to visit the Grantor’s plants and facilities,
and the Grantor shall use its best efforts to arrange for the Collateral Agent
and its employees and agents to have access to such plants and facilities of
third parties which manufacture or supply goods or services, for or under
contract with the Grantor.
(i)
Trademarks.
(1)
The
Grantor (either itself or through licensees) will, with respect to each
Trademark identified in
Exhibit B
, as
Exhibit B
may be
amended, supplemented or otherwise modified from time to time, (i) continue to
use or have used such Trademark to the extent necessary to maintain such
Trademark in full force free from any claim of abandonment for non-use, (ii)
maintain as in the past the quality of products and services offered under such
Trademark, (iii) employ such Trademark with the appropriate notice of
registration, (iv) not adopt or use any mark which is confusingly similar or a
colorable imitation of such Trademark unless the Collateral Agent, for the
ratable benefit of the Holders, shall obtain a first priority perfected security
interest in the Company’s interest in such mark pursuant to this Agreement, and
(v) not (and not permit any licensee or sublicensee thereof to) do any act or
knowingly omit to do any act whereby any such Trademark may become
invalidated.
(2)
The
Grantor will promptly notify the Collateral Agent if any application or
registration relating to any Trademark may become abandoned, canceled or denied,
or of any adverse determination or development (including, without limitation,
the institution of, or any such determination or development in, any proceeding
in the PTO or any court or tribunal in any country) regarding the Grantor’s
ownership interest in such Trademark or its right to register the same or to
keep and maintain the same.
(3)
The
Grantor will, with respect to any Trademark that the Grantor registers after the
Issuance Date or any Trademark License that the Grantor acquires after the
Issuance Date, promptly (i) take all actions necessary so that the Collateral
Agent, for the ratable benefit of the Holders, shall obtain a perfected security
interest in such Trademark or Trademark License and (ii) provide to the
Collateral Agent a revised
Exhibit B
listing
all registered Trademarks and all Trademark Licenses in which the Grantor has an
interest.
(4)
Upon
request of the Collateral Agent, the Grantor shall execute and deliver any and
all agreements, instruments, documents, and papers as the Collateral Agent may
request to evidence the Collateral Agent’s security interest in any Trademark
and the goodwill and general intangibles of the Grantor relating thereto or
represented thereby, and the Grantor hereby constitutes the Collateral Agent its
attorney-in-fact to execute and file
all such
writings for the foregoing purposes, all acts of such attorney being hereby
ratified and confirmed; such power being coupled with an interest is irrevocable
until the Grantor shall have paid and performed in full all of its obligations
under the Transaction Documents.
(5)
The
Grantor will take all reasonable and necessary steps, including, without
limitation, in any proceeding before the PTO, to maintain and pursue each
application (and to obtain the relevant registration) and to maintain the
registration of the Trademarks, including, without limitation, filing of
applications for renewal, affidavits of use and affidavits of
incontestability.
(6)
In the
event that any Trademark included in the Collateral is infringed,
misappropriated or diluted by a third party, the Grantor shall notify the
Collateral Agent and shall, if appropriate, sue for infringement,
misappropriation or dilution, seeking injunctive relief where appropriate and to
recover any and all damages for such infringement, misappropriation or dilution,
or take such other action as the Grantor reasonably deems appropriate under the
circumstances to protect such Trademark.
(j)
Further Actions.
Without
limiting the foregoing provisions of this Section 4, the Grantor further agrees
for itself and its successors and assigns to execute upon request any other
lawful documents and likewise to perform any other lawful acts which may be
necessary or desirable to secure fully for the Collateral Agent, for the ratable
benefit of the Holders, all right, title and interest in and to the Collateral,
including, but not limited to, the execution of substitution, reissue,
divisional or continuation patent applications; and preliminary or other
statement of the giving of testimony in any interference or other proceeding in
which the Collateral or any application, Patent or Trademark directed thereto or
derived therefrom may be involved.
(k)
License Agreements
. The
Grantor shall comply with its obligations under each of its Patent Licenses and
Trademark Licenses.
(l)
Changes in Locations, Name,
Etc.
The
Grantor will not (i) change the location of its chief executive office/chief
place of business from that specified in Section 3(e) or (ii) change its name,
identity or corporate structure to such an extent that any statement filed by
the Collateral Agent with the PTO in connection with this Agreement would become
misleading, unless it shall have given the Collateral Agent at least 30 days
prior written notice thereof and, prior to such action or event, shall have
taken appropriate action satisfactory to the Collateral Agent to preserve and
protect the Collateral Agent’s collateral assignment and the Security Interest
under this Agreement.
(m)
Subsidiaries.
This
Agreement is entered into on behalf of and for the benefit of the Grantor. The
Grantor will not permit any of its Subsidiaries or Affiliates or any other
entities controlled by the Grantor to have any ownership or other rights in or
to exercise any control over the Collateral.
(n)
Indemnification
. The
Grantor agrees to indemnify and hold harmless the Collateral Agent and each
Holder and their respective officers, directors, Affiliates, agents and
investment advisors (each, an “Indemnified Person”) from and against any and all
claims, demands, losses, judgments and liabilities (including liabilities for
penalties) of whatsoever kind or nature, and to reimburse the Collateral Agent
and each Holder for all costs and expenses, including reasonable attorneys’ fees
and expenses, arising out of or resulting from this Agreement, including any
breach hereof or Event of Default hereunder, or the exercise by the Collateral
Agent or any Holder, as the case may be, of any right or remedy granted to it
hereunder or under the other Transaction Documents or under applicable law;
provided,
however,
that the
Grantor shall not be required to indemnify a particular Indemnified Person to
the extent any claim, demand, loss, judgment, liability, cost or expense is
determined by final judgment (not subject to further appeal) of a court of
competent jurisdiction to have arisen primarily from the gross negligence or
willful misconduct of such Indemnified Person. In no event shall any Indemnified
Person other than the Collateral Agent have any liability or obligation to the
Grantor under this Agreement or applicable law (liability under which the
Grantor hereby waives) for any matter or thing in connection with this
Agreement, and in no event shall the Collateral Agent or any Holder be liable,
in the absence of a determination of gross negligence or willful misconduct on
its part by final judgment (not subject to further appeal) of a court of
competent jurisdiction, for any matter or thing in connection with this
Agreement other than to account for moneys actually received by it in accordance
with the terms hereof. If and to the extent that the obligations of the Grantor
under this Section 4(n) are unenforceable for any reason, the Grantor hereby
agrees to make the maximum contribution to the payment and satisfaction of such
obligations which is permissible under applicable law. In any suit, proceeding
or action brought by the Collateral Agent or any Holder under any Account or
Contract that constitutes part of the Collateral for any sum owing thereunder,
or to enforce any provisions of any such Account or Contract, the Grantor will
save, indemnify and keep the Collateral Agent and each Holder harmless from and
against all expense, loss or damage suffered by reason of any defense, setoff,
counterclaim, recoupment or reduction or liability whatsoever of the account
debtor or obligor thereunder, arising out of a breach by the Grantor of any
obligation thereunder or arising out of any other agreement, indebtedness or
liability at any time owing to or in favor of such account debtor or obligor or
its successors from the Grantor.
5.
Collateral Agent’s
Powers
.
(a)
Powers
. The
Grantor hereby irrevocably constitutes and appoints the Collateral Agent and any
officer or agent thereof or investment advisor thereto, with full power of
substitution, as its true and lawful attorney-in-fact with full irrevocable
power and authority in the place and stead of the Grantor and in the name of the
Grantor or in its own name, from time to time in the Collateral Agent’s
discretion, during any period in which an Event of Default is continuing, for
the purpose of carrying out the terms of this Agreement, to take any and all
appropriate action and to execute any and all documents and instruments which
may be necessary or desirable to accomplish the purposes of this Agreement, and,
without limiting the generality of the foregoing, the Grantor hereby gives the
Collateral Agent and each such officer, agent and investment advisor the power
and right, on behalf of the Grantor, without notice to or assent by the Grantor,
except any notice required by law, to do the following:
(1)
to take
possession of and endorse and collect any checks, drafts, notes, acceptances or
other instruments for the payment of moneys due under or with respect to any
Collateral and to file any claim or to take any other action or proceeding in
any court of law or equity or otherwise deemed appropriate by the Collateral
Agent for the purpose of collecting any and all such moneys due under or with
respect to any such Collateral whenever payable, in each case in the name of the
Grantor or its own name, or otherwise;
(2)
to pay or
discharge taxes and Liens levied or placed on or threatened against the
Collateral and to pay all or any part of the premiums therefor and the costs
thereof; and
(3)
(A) to
direct any party liable for any payment under any of the Collateral to make
payment of any and all moneys due or to become due thereunder directly to the
Collateral Agent or as the Collateral Agent shall direct; (B) to ask or demand
for, collect, receive payment of and receipt for, any and all moneys, claims and
other amounts due or to become due at any time in respect of or arising out of
any Collateral; (C) to sign and endorse any invoices, freight or express bills,
bills of lading, storage or warehouse receipts, drafts against debtors,
assignments, verifications, notices and other documents in connection with any
of the Collateral; (D) to commence and prosecute any suits, actions or
proceedings at law or in equity in any court of competent jurisdiction to
collect the Collateral or any thereof and to enforce any other right in respect
of any Collateral; (E) to defend any suit, action or proceeding brought against
the Grantor with respect to any Collateral; (F) to settle, compromise or adjust
any suit, action or proceeding described in clause (E) above and, in connection
therewith, to give such discharges or releases as the Collateral Agent may deem
appropriate; (G) to assign (along with the goodwill of the business
pertaining thereto) any Patent or Trademark for such term or terms,
on such conditions, and in such manner, as the Collateral Agent shall
in
its sole
discretion determine; and (H) generally, to sell, transfer, pledge and make any
agreement with respect to or otherwise deal with any of the Collateral as fully
and completely as though the Collateral Agent were the absolute owner thereof
for all purposes, and to do, at the Collateral Agent’s option and the Grantor’s
expense, at any time, or from time to time, all acts and things which the
Collateral Agent deems necessary to protect, preserve or realize upon the
Collateral and the Collateral Agent’s Liens thereon and to effect the intent of
this Agreement, all as fully and effectively as the Grantor might
do.
The
Grantor hereby ratifies all that said attorneys shall lawfully do or cause to be
done by virtue hereof. This power of attorney is a power coupled with an
interest and shall be irrevocable until the Grantor shall have paid and
performed in full all of the Obligations.
(b)
Filing and
Recordation.
In
addition to the filings the Grantor is required to make as specified in
Exhibit C
, this
Agreement or an instrument referring hereto may be filed and recorded in such
public offices and with such governmental authorities, including the PTO, as the
Collateral Agent may determine from time to time. The Collateral Agent may so
file and record this Agreement as a “security interest”, “collateral
assignment”, “assignment” or similar designation as the Collateral Agent may
determine (so long as such designation is consistent with the terms of this
Agreement) and the Collateral Agent may from time to time rerecord and refile or
take other action to change the designation under which this Agreement is filed
or recorded (so long as such designation is consistent with the terms of this
Agreement).
(c)
Other Powers.
The
Grantor also authorizes the Collateral Agent, at any time and from time to time,
to execute, in connection with the sale provided for herein, any endorsements,
assignments or other instruments of conveyance or transfer with respect to the
Collateral.
(d)
No Duty on Collateral Agent’s
Part.
The
powers conferred on the Collateral Agent hereunder are solely to protect the
Collateral Agent’s interests in the Collateral for the ratable benefit of the
Holders and shall not impose any duty upon the Collateral Agent to exercise any
such powers. The Collateral Agent shall be accountable only for amounts that it
actually receives as a result of the exercise of such powers, and neither it nor
any of its officers, directors, employees or agents shall be responsible to the
Grantor for any act or failure to act hereunder, except for their own gross
negligence or willful misconduct.
(e)
Grantor Remains Liable under
Contracts
.
Anything herein to the contrary notwithstanding, the Grantor shall remain liable
under each of the
ontracts
that constitute part of the Collateral to observe and perform all the conditions
and obligations to be observed and performed by it thereunder, all in accordance
with and pursuant to the terms and provisions of each such Contract. The
Collateral Agent shall not have any obligation or liability under any Contract
that constitutes part of the Collateral by reason of or arising out of this
Agreement or the receipt by the Collateral Agent of any payment relating to such
Contract pursuant hereto, nor shall the Collateral Agent be obligated in any
manner to perform any of the obligations of the Grantor under or pursuant to any
such Contract, to make any payment, to make any inquiry as to the nature or the
sufficiency of any payment received by it or as to the sufficiency of any
performance by any party under any such Contract, to present or file any claim,
to take any action to enforce any performance or to collect the payment of any
amounts which may have been assigned to it or to which it may be entitled at any
time or times.
6.
Performance by Collateral Agent of
Grantor’s Obligations.
If the
Grantor fails to perform or comply with any of its agreements contained herein
and the Collateral Agent, as provided for by the terms of this Agreement and
following reasonable notice to the Grantor, may itself perform or comply, or
otherwise cause performance or compliance, with such agreement, and the expenses
of the Collateral Agent incurred in connection with such performance or
compliance shall be payable by the Grantor to the Collateral Agent on demand and
shall constitute Obligations secured hereby.
7.
Remedies.
If an
Event of Default has occurred and is continuing, but in the case of Events of
Default that are solely ones covered by the final clause (2) of Section 4.01 of
any Note, only after the expiration of the 120-day period specified in such
clause (2) the Collateral Agent may exercise, in addition to all other rights
and remedies granted to it in this Agreement and in any other instrument or
agreement securing, evidencing or relating to the Obligations, all rights and
remedies of a secured party under the Code. Without limiting the generality of
the foregoing, if an Event of Default has occurred and is continuing, but in the
case of Events of Default that are solely ones covered by the final clause (2)
of Section 4.01 of any Note, only after the expiration of the 120-day period
specified in such clause (2) the Collateral Agent, without demand of performance
or other demand, presentment, protest, advertisement or notice of any kind
(except any notice required by law referred to below or expressly provided for)
to or upon the Grantor or any other Person (all and each of which demands,
defenses, advertisements and notices are, to the extent permitted by applicable
law, hereby waived), may in such circumstances forthwith collect, receive,
appropriate and realize upon the Collateral, or any part thereof, and/or may
forthwith sell, license, assign, give option or options to purchase, or
otherwise dispose of and deliver the Collateral or any part thereof (or contract
to do any of the foregoing), at public or private sale or sales, at any
exchange, broker’s board or office of the Collateral Agent or elsewhere upon
such terms and conditions as it may deem advisable and at such prices as it may
deem best, for cash or on credit or for future delivery w
ithout
assumption of any credit risk. The Collateral Agent shall have the right upon
any such public sale or sales, and, to the extent permitted by law, upon any
such private sale or sales, to purchase the whole or any part of the Collateral
so sold, free of any right or equity of redemption in the Grantor, which right
or equity is hereby waived, to the extent permitted by applicable law, or
released.
The
Grantor further agrees, if an Event of Default has occurred and is continuing,
at the Collateral Agent’s request, to assemble the Collateral and make it
available to the Collateral Agent at places which the Collateral Agent shall
reasonably select, whether at the Grantor’s premises or elsewhere. The
Collateral Agent shall apply the net proceeds of any such collection, recovery,
receipt, appropriation, realization or sale, after deducting all reasonable
costs and expenses of every kind incurred therein or incidental to the care or
safekeeping of any of the Collateral or in any way relating to the Collateral or
the rights of the Collateral Agent hereunder, including, without limitation,
reasonable attorneys’ fees and disbursements, to the payment in whole or in part
of the Obligations, in such order as the Collateral Agent may elect, and only
after such application and after the payment by the Collateral Agent of any
other amount required by any provision of law, need the Collateral Agent account
for the surplus, if any, to the Grantor. To the extent permitted by applicable
law, the Grantor waives all claims, damages and demands it may acquire against
the Collateral Agent arising out of the exercise by it of any rights hereunder,
provided,
that
nothing contained in this Section shall relieve the Collateral Agent from
liability arising solely from its gross negligence or willful misconduct. If any
notice of a proposed sale or other disposition of Collateral shall be required
by law, such notice shall be deemed reasonable and proper if given at least ten
days before such sale or other disposition. The Grantor shall remain liable for
any deficiency if the proceeds of any sale or other disposition of the
Collateral are insufficient to pay the Obligations and the fees and
disbursements of any attorneys employed by the Collateral Agent to collect such
deficiency.
8.
Limitation on Duties Regarding
Preservation of Collateral.
The
Collateral Agent’s sole duty with respect to the custody, safekeeping and
physical preservation of the Collateral in its possession, under the Code or
otherwise, shall be to deal with it in the same manner as the Collateral Agent
deals with similar property for its own account. Neither the Collateral Agent
nor any of its directors, officers, employees or agents shall be liable for
failure to demand, collect or realize upon all or any part of the Collateral or
for any delay in doing so or shall be under any obligation to sell or otherwise
dispose of any Collateral upon the request of the Grantor or
otherwise.
9.
Powers Coupled with an
Interest.
All
authorizations and agencies herein contained with respect to the Collateral are
irrevocable and powers coupled with an interest until the Grantor has paid and
performed in full all of the Obligations.
10.
Severability.
Any
provision of this Agreement which is prohibited or unenforceable in any
jurisdiction shall, as to such jurisdiction, be ineffective to the extent of
such prohibition or unenforceability without invalidating the remaining
provisions hereof, and any such prohibition or unenforceability in any
jurisdiction shall not invalidate or render unenforceable such provision in any
other jurisdiction.
11.
Paragraph Headings, Captions,
Etc.
The
paragraph headings, the captions and the footers, used in this Agreement are for
convenience of reference only and are not to affect the construction hereof or
be taken into consideration in the interpretation hereof.
12.
No Waiver; Cumulative
Remedies.
The
Collateral Agent shall not by any act, delay, indulgence, omission or otherwise
be deemed to have waived any right or remedy hereunder or to have acquiesced in
any Event of Default or in any breach of any of the terms and conditions hereof.
No failure to exercise, nor any delay in exercising, on the part of the
Collateral Agent, any right, power or privilege hereunder shall operate as a
waiver thereof. No single or partial exercise of any right, power or privilege
hereunder shall preclude any other or further exercise thereof or the exercise
of any other right, power or privilege. A waiver by the Collateral Agent of any
right or remedy hereunder on any one occasion shall not be construed as a bar to
any right or remedy which the Collateral Agent would otherwise have on any
future occasion. The rights and remedies herein and in the other Transaction
Documents provided are cumulative, may be exercised singly or concurrently and
are not exclusive of any rights or remedies provided by law or in equity or by
statute.
13.
Waivers and Amendments; Successors
and Assigns.
None of
the terms or provisions of this Agreement may be waived, amended, supplemented
or otherwise modified except by a written instrument executed by the party to be
charged with enforcement;
provided, however,
that any
provision of this Agreement may be waived, amended, supplemented or otherwise
modified by the Collateral Agent only with the prior written approval of the
Majority Holders. This Agreement shall be binding upon the successors and
assigns of the Grantor and shall inure to the benefit of the Collateral Agent
and its successors and assigns. The Grantor may not assign its rights or
obligations under this Agreement without the prior written consent of the
Collateral Agent, which the Collateral Agent may withhold in the discretion of
the Majority Holders. The requirements for resignation, and appointment of a
successor to, the Collateral Agent are established by
Exhibit D
hereto
and not by this Agreement.
14.
Termination of Security Interest;
Release of Collateral.
(a) Upon
the payment and performance in full by the Grantor of the Obligations, all
right, title and interest of the Collateral Agent in and to the Collateral,
including the Security Interest, pursuant to this Agreement shall terminate and
all rights to the Collateral shall revert to the Grantor.
(b)
At any
time and from time to time prior to termination of the right, title and interest
of the Collateral Agent in and to the Collateral pursuant to Section 14(a), the
Collateral Agent shall release any of the Collateral only with the prior written
consent of the Majority Holders.
(c)
Upon any
such termination of the Security Interest, the Collateral Agent will, at the
expense of the Grantor, execute and deliver to the Grantor such documents and
take such other actions as the Grantor shall reasonably request to evidence the
reassignment of the Collateral to the Grantor and the termination of the
Security Interest. The Collateral Agent shall deliver to the Grantor all
Collateral so released then in its possession.
15.
Notices.
Any
notices required or permitted to be given under the terms of this Agreement
shall be in writing and shall be sent by mail, personal delivery, telephone line
facsimile transmission or courier and shall be effective five days after being
placed in the mail, if mailed, or upon receipt, if delivered personally, by
telephone line facsimile transmission or by courier, in each case addressed to a
party at such party’s address (or telephone line facsimile transmission number)
shown below or such other address (or telephone line facsimile transmission
number) as a party shall have provided by notice to the other party in
accordance with this provision. In the case of any notice to the Grantor, such
notice shall be addressed to the Grantor at 10500 N.E. 8
th
Street,
Suite 1400,Bellevue, WA 98004, Attention: Chief Financial Officer (telephone
line facsimile number (425) 749-3601), with a copy to Sichenzia Ross Friedman
Ference LLP, 1065 Avenue of the Americas, 21
st
Floor,
New York, New York 10018, Attention: Richard A. Friedman, Esq. (telephone line
facsimile number (212) 930-9725), and in the case of any notice to the
Collateral Agent, such notice shall be addressed to the Collateral Agent at c/o
Alexandra Investment Management, LLC, 767 Third Avenue, 39
th
Floor,
New York, New York 10017, Attention: Chief Compliance Officer (telephone line
facsimile transmission number (212) 301-1800).
16.
Fees and Expenses
. The
Grantor agrees to pay the fees of the Collateral Agent in performing its
services under this Agreement and all reasonable expenses (including but not
limited to attorneys’ fees and costs for legal services, costs of insurance and
payments of taxes or other charges) of, or incidental to, the custody, care,
sale or realization on any of the Collateral or in any way relating to the
performance of the obligations or the enforcement or protection of the rights of
the Collateral Agent hereunder.
17.
Concerning Collateral
Agent.
The
Grantor acknowledges that the rights and responsibilities of the Collateral
Agent under this Agreement with respect to any action taken by the Collateral
Agent or the exercise or
nonexercise
by the Collateral Agent of any option, right, request, judgment or other right
or remedy provided for herein or resulting or arising out of this Agreement
shall, as between the Collateral Agent and the Holders, be governed by
Exhibit D
to this
Agreement and by such other agreements with respect thereto as may exist from
time to time among them, but, as between the Collateral Agent and the Grantor,
except as expressly provided in Sections 13 and 14, the Collateral Agent shall
be conclusively presumed to be acting as agent for the Holders with full and
valid authority so to act or refrain from acting, and the Grantor shall not be
under any obligation to make any inquiry respecting such authority. The
Collateral Agent hereby waives for the benefit of the Holders any claim, right
or Lien of the Collateral Agent against the Collateral arising under applicable
law or arising from any business or transaction between the Collateral Agent and
the Grantor other than pursuant to this Agreement or any of the other
Transaction Documents.
18.
Survival.
All
representations, warranties, covenants and agreements of the Grantor and of the
Collateral Agent contained herein will survive the execution and delivery hereof
and the release of any Collateral pursuant hereto and shall remain operative and
in full force and effect regardless of any investigation made by or on behalf of
the Collateral Agent or the Grantor or any person who controls the Collateral
Agent or the Grantor.
19.
Grantor’s Obligations Absolute, Etc.
The
obligations of the Grantor under this Agreement shall be absolute and
unconditional and shall remain in full force and effect without regard to, and
shall not be released, suspended, discharged, terminated or otherwise affected
by, any circumstance or occurrence whatsoever, including, without limitation:
(a) any renewal, extension, amendment or modification of or addition or
supplement to or deletion from any of the Transaction Documents or any other
agreement or instrument referred to therein, or any assignment or transfer of
any thereof; (b) any waiver, consent, extension, indulgence or other action or
inaction under or in respect of any such Transaction Document or other agreement
or instrument; (c) any furnishing of any additional security to the Collateral
Agent or its assignees or any acceptance thereof or any release of any security
by the Collateral Agent or its assignees; (d) any limitation on any party’s
liability or obligations under any such Transaction Document or other agreement
or instrument or any invalidity or unenforceability, in whole or in part, of any
such Transaction Document or other agreement or instrument or any term thereof;
or (e) any bankruptcy, insolvency, reorganization, composition, adjustment,
dissolution, liquidation or other like proceeding relating to the Grantor, or
any action taken with respect to this Agreement by any trustee or receiver, or
by any court, in any such proceeding, whether or not the Grantor shall have
notice or knowledge of any of the foregoing.
20.
Integration.
This
Agreement and the Security Agreement represent the entire agreement of the
Grantor and the Collateral Agent with respect to the subject matter hereof, and
there are no promises, undertakings,
representations
or warranties by the Collateral Agent relative to subject matter hereof not
expressly set forth or referred to herein or therein.
21.
Counterparts;
Execution
. This
Agreement may be executed in any number of counterparts and all the counterparts
taken together shall be deemed to constitute one and the same instrument. This
Agreement, once executed by a party, may be delivered to the other party hereto
by telephone line facsimile transmission of a copy of this Agreement bearing the
signature of the party so delivering this Agreement.
22.
Governing Law.
This
Agreement and the rights and obligations of the Grantor under this Agreement
shall be governed by, and construed and interpreted in accordance with, the law
of the State of New York, except to the extent that under the New York Uniform
Commercial Code the laws of another jurisdiction govern matters of perfection
and the effect of perfection or non-perfection of any security interest granted
hereunder.
23.
Construction.
The
language used in this Agreement will be deemed to be the language chosen by the
parties to express their mutual intent, and no rules of strict construction will
be applied against any party.
[signature page
follows]
IN WITNESS WHEREOF
, the
Grantor and the Collateral Agent have caused this Agreement to be duly executed
and delivered by their respective officers or other representatives thereunto
duly authorized as of the date first above written.
|
|
|
|
EMAGIN
CORPORATION
|
|
|
|
|
By:
|
/s/ Gary W.
Jones
|
|
Name: Gary W. Jones
|
|
Title: Chief Executive
Officer
|
|
|
|
|
ALEXANDRA GLOBAL MASTER
FUND LTD., as Collateral
Agent
|
|
|
ALEXANDRA INVESTMENT
MANAGEMENT, LLC, as Investment Advisor
|
|
By:
|
/s/ Mikhail
Filimonov
|
|
Name: Mikhail Filimonov
|
|
Title: Chairman and
Chief Executive Officer
|
STATE
OF_________________________)
)
SS:
COUNTY
OF_______________________)
[CHECK FOR APPLICABLE FORM OF
ACKNOWLEDGEMENT WHERE SIGNED]
On this
day of
July __, 2006, before me personally appeared
proved
to me on the basis of satisfactory evidence to be the person who executed the
above Patent and Trademark Security Agreement as
on
behalf of eMagin Corporation, a Delaware corporation, and acknowledged to me
that the corporation executed it.
WITNESS
my hand and official seal.
________________________________________
NOTARY
PUBLIC
STATE
OF__________________
)
)
SS:
COUNTY
OF________________
)
On this
day of
July __, 2006, before me personally appeared
proved
to me on the basis of satisfactory evidence to be the person who executed the
above Patent and Trademark Security Agreement as
on
behalf of Alexandra Investment Management, LLC, as Investment Adviser to
Alexandra Global Master Fund Ltd., and acknowledged to me that the limited
liability company executed it.
WITNESS
my hand and official seal.
________________________________________
NOTARY
PUBLIC
EXHIBIT A
Patents, Patent Licenses and Patent
Applications
ISSUED PATENTS
Patent
Number
|
Title
|
Issue
Date
|
7,068,258
|
Portable
communication device with virtual image display module
|
June
27, 2006
|
2,173,248
(Canada)
|
Head
Mounted Display System with Aspheric Optics (corr. to
5,543,816)
|
May
27, 2005
|
6,885,147
|
Organic
Light Emitting Diode Devices with Improved Anode Stability
|
April
26, 2005
|
2,173,624
(Canada)
|
Binocular
Head Mounted Display System
|
March
29, 2005
|
6,858,989
|
Method
and System for Stabilizing Thin Film Transistors in AMOLED
displays
|
February
22, 2005
|
6,809,710
|
Grey
Scale Pixel Driver for Electronic Display and Method of Operation
Therefor
|
October
26, 2004
|
6,809,710
|
Grey
Scale Pixel Driver for Electronic Display and Method of Operation
Therefor
|
October
26, 2004
|
6,760,034
|
Three
Dimensional Display Emulation Method and System
|
July
6, 2004
|
98808734,0
|
Laser
Ablation Method to Fabricate Color Organic Light Emitting Diode
Displays
|
May
26, 2004
|
6,657,224
|
Organic
Light Emitting Diode Devices Using Thermostable Hole-Injection and
Hole-Transport Compounds
|
December
2, 2003
|
6,608,283
|
Apparatus
and Method for Solder-Sealing an active Matrix Organic Light Emitting
Diode
|
August
19, 2003
|
6,608,439
|
Inorganic-Based
Color Conversion Matrix Element for Organic Color Display Devices and
Method of Fabrication
|
August
19, 2003
|
6,337,492
|
Serially-Connected
Organic Light Emitting Diode Stack Having Conductors Sandwiching Each
Light Emitting Layer
|
January
8, 2002
|
6,288,232
|
Synthesis
of Pyrazolinynaphthalic Acid Derivatives
|
September
11, 2001
|
6,278,237
|
Laterally
Structured High Resolution Multicolor Organic Electroluminescence Display
Device
|
August
21, 2001
|
6,265,820
|
Heat
Removal System for use in Organic Light Emitting Diode Displays Having
High Brightness
|
July
24, 2001
|
6,255,771
|
Flashover
Control Structure for Field Emitter Displays and Method of making the
same
|
July
3, 2001
|
6,232,934
|
Binocular
Head Mounted Display System
|
May
15, 2001
|
6,218,777
|
Field
Emission Display Spacer with Guard Electrode
|
April
14, 2001
|
6,215,840
|
Method
and Apparatus for Sequential Memory Addressing
|
April
10, 2001
|
6,204,975
|
Reflective
Micro-Display System
|
March
20, 2001
|
6,198,214
|
Large
Area Spacer-Less Field Emissive Display Package
|
March
6, 2001
|
6,198,220
|
Sealing
Structure for Organic Light Emitting Devices
|
March
6, 2001
|
6,181,304
|
Convertible
Right Eye/Left Eye Monocular Head Mounted Display System
|
January
30, 2001
|
6,169,358
|
Method
and Apparatus for Flashover Control Including a High Voltage Spacer for
Parallel Plate Electron Beam Array Devices and Method of Making
Thereof
|
January
2, 2001
|
6,166,820
|
Laser
Interferometric Lithographic System Providing Automatic Change of Fringe
Spacing
|
December
26, 2000
|
6,157,291
|
Head
Mounted Display System
|
December
5, 2000
|
6,144,145
|
High
Performance Field Emitter and Method of Producing the Same
|
November
7, 2000
|
6,136,621
|
High
Aspect Ratio Gated Emitter Structure and Method of Making
|
October
24, 2000
|
6,101,028
|
Miniature
Microscope
|
August
8, 2000
|
6,069,443
|
Passive
Matrix OLED Display
|
May
30, 2000
|
6,060,728
|
Organic
Light Emitting Device Structure and Process
|
May
9, 2000
|
6,027,388
|
Lithographic
Structure and Method for Making Field Emitters
|
February
22, 2000
|
6,023,259
|
OLED
Active Matrix Using a Single Transistor Current Mode Pixel
Design
|
February
8, 2000
|
6,016,033
|
Electrode
Structure for High Resolution Organic Light-Emitting Diode Displays and
Method for Making the Same
|
January
18, 2000
|
6,005,720
|
Reflective
Micro-Display System
|
December
21, 1999
|
5,965,898
|
High
Aspect Ratio Gated Emitter Structure and Method of Making
|
October
12, 1999
|
5,959,725
|
Large
Area Energy Beam Intensity Profiler
|
September
28, 1999
|
5,920,080
|
Emissive
Display Using Organic Light Emitting Diodes
|
July
6, 1999
|
5,903,098
|
Field
Emission Display Device Having Multiplicity of Through Conductive Vias and
a Backside Connector
|
May
11, 1999
|
5,903,243
|
Compact
body-Mountable Field Emission Display Device and Display Panel Having
Utility for use Therewith
|
May
11, 1999
|
5,771,098
|
Laser
Interferometric Lithographic System Providing Automatic Change of Fringe
Spacing
|
June
23, 1998
|
5,708,449
|
Binocular
Head Mounted Display System
|
January
13, 1998
|
5,688,158
|
Planarizing
Process for Field Emitter Displays and Other Electron Source
Applications
|
November
18, 1997
|
5,672,938
|
Light
Emission Device Comprising Light Emitting Organic Material and Electron
Injection Enhancement Structure
|
September
30, 1997
|
5,663,608
|
Field
Emission Display Devices, and Field Emission Electron Beam Source and
Isolation Structure Components Therefor
|
September
2, 1997
|
5,647,785
|
Methods
of Making Vertical Microelectronic Field Emission Devices
|
July
15, 1997
|
Des
380,482
|
Head
Mounted Display System
|
July
1, 1997
|
5,629,583
|
Flat
Panel Display Assembly Comprising Photoformed Spacer Structure and Method
of Making the Same
|
May
13, 1997
|
5,619,889
|
Method
of Making Microstructural Surgical Instruments
|
April
15, 1997
|
5,619,097
|
Panel
Display with Dielectric Spacer Structure
|
April
8, 1997
|
5,587,623
|
Field
Emitter Structure and Method of Making the Same
|
December
24, 1996
|
5,583,393
|
Selectively
Shaped Field Emission Electron Beam Source and Phosphor Array for use
Therewith
|
December
10, 1996
|
5,561,339
|
Field
Emission Array Magnetic Sensor Devices
|
October
1, 1996
|
5,548,181
|
Field
Emission Device Comprising Dielectric Overlayer
|
August
20, 1996
|
5,546,099
|
Head
Mounted Display System Light Blocking Structure
|
August
13, 1996
|
5,543,816
|
Head
Mounted Display System with Aspheric Optics
|
August
6, 1996
|
5,539,422
|
Head
Mounted Display System
|
July
23, 1996
|
5,534,743
|
Field
Emission Display Devices, and Field Emission Electron Beam Source and
Isolation Structure Components Therefor
|
July
9, 1996
|
5,529,524
|
Method
of Forming a Spacer Structure Between Opposedly Facing Plate
Members
|
June
25, 1996
|
Des
359,729
|
Portable
Interface Unit for a Head-Up Display System
|
June
27, 1995
|
5,144,191
|
Horizontal
Microelectronic Field Emission Devices
|
September
1, 1992
|
5,126,287
|
Self-Aligned
Electron Emitter Fabrication Method and Device Formed
Thereby
|
June
30, 1992
|
4,902,898
|
Wand
Optices Column and Associated Array Wand and Charged Particle
Source
|
February
20, 1990
|
98808734.0
(China)
|
Laser
Ablation Method To Fabricate Color OLED Displays
|
May
26, 2004
|
PATENT APPLICATIONS IN
PROGRESS
Patent
Application
No.
|
Title
|
Issue
Date
|
11/169,154
|
Method
of Clearing Electrical Contact Pads in Thin Film Sealed OLED
Devices
|
N/A
|
09/785,270
|
Display
Method and System
|
N/A
|
09/849,745
|
Portable
Communication Device With Virtual Image Display Module
|
N/A
|
60/684,633
|
Tapered
Fiber Optic Bundle Megadisplay
|
N/A
|
60/583,158
|
Photoresist
Laser Ablation
|
N/A
|
09/814,853
|
Light
Extraction from Color Changing Medium Layers in Organic Light Emitting
Diode Devices
|
N/A
|
504797/99
(Japan)
|
Emissive
Display Using Organic Light Emitting Diodes
|
N/A
|
2000-550128
(Japan)
|
An
Improved Electrode Structure for Organic Light Emitting Diode
Devices
|
N/A
|
6-523218
(Japan)
|
Head
Mounted Display System
|
N/A
|
9-531760
(Japan)
|
Support
for a Head Mounted Display System
|
N/A
|
2004-261527
(Japan; divisional)
|
Binocular
Head Mounted Display System
|
N/A
|
2000-565526
(Japan)
|
Convertible
Right Eye/Left Eye Monocular Head Mounted Display System
|
N/A
|
2000-589993
(Japan)
|
Reflective
Micro-Display System; Miniature Microscope and Reflective Micro-display
system respectively
|
N/A
|
01950594,0
(Europe)
|
OLED
Devices Using Thermostable Hole-Injection and Hole-Transport
Compounds
|
N/A
|
11/439,014
|
Tapered
Fiber Optic Bundle Metadisplay
|
N/A
|
11/402,092
|
Auto-calibrating
Gamma Correction Circuit
|
N/A
|
11/399,170
|
OLED
Active Matrix Cell Designed For Optimal Uniformity
|
N/A
|
133,678
(Israel)
|
Emissive
Display Using Organic Light Emitting Diodes
|
N/A
|
60/755,907
|
Automatic
Timeout Image Orientation System For FOLED Micro-display
|
N/A
|
60/725,406
|
Novel
OLED Lighting Device
|
N/A
|
2,490,344
(Canada;
divisional)
|
Binocular
Head-Mounted Display System
|
N/A
|
KODAK PATENTS (partial
list)
Topic
|
U.S. Pat.
No.
|
Issued
|
|
|
|
Multilayer
structure
|
4,356,429
|
1982
|
Multilayer
structure - Alq
|
4,539,507
|
1985
|
Porphyrin
injecting layer
|
4,720,432
|
1988
|
Luminescent
zone - dye dopant
|
4,769,292
|
1988
|
Improved
cathode
|
4,885,211
|
1989
|
Silazane
HTL
|
4,950,950
|
1990
|
Improved
intensity circuit
|
4,996,523
|
1991
|
Cathode
overlayer for stability
|
5,047,687
|
1991
|
Cathode
metal cap
|
5,059,861
|
1991
|
Mg,
Al cathode
|
5,059,862
|
1991
|
Organic
amines HTL
|
5,061,569
|
1991
|
Fused
metal cathode
|
5,073,446
|
1991
|
Blue
emitters
|
5,141,671
|
1992
|
Blue
emitters
|
5,150,006
|
1992
|
Blue
emitters
|
5,151,629
|
1992
|
Integral
shadow mask
|
5,276,380
|
1994
|
Integral
shadow mask color
|
5,294,869
|
1994
|
Color
change medium
|
5,294,870
|
1994
|
White
emitter (2-layer) BAlq
|
5,405,709
|
1995
|
Phalocyanine
dopant
|
5,409,783
|
1995
|
OLED
ultra thin device
|
5,482,896
|
1996
|
ALQ
blue
|
5,484,922
|
1996
|
OLED
ultra thin substrate
|
5,530,269
|
1996
|
OLED
TFT process
|
5,550,066
|
1996
|
AC
drive scheme
|
5,552,678
|
1997
|
Polyaromatic
amine HTL
|
5,554,450
|
1996
|
Quinacridone
green
|
5,593,788
|
1997
|
Electron
injector (silicides etc.)
|
5,608,287
|
1997
|
Camera
data printer
|
5,634,156
|
1997
|
Blue
emitter oxadizoles
|
5,645,948
|
1997
|
Camera
Information Display
|
5,652,930
|
1997
|
White
emitter structure
|
5,683,823
|
1997
|
OLED
TFT device
|
5,684,365
|
1997
|
Blue
emitter metal complex
|
5,755,999
|
1998
|
LiF
cathode
|
5,776,622
|
1998
|
EXHIBIT B
Trademarks and Trademark
Licenses
Serial App. No.
|
Item
|
Status
|
Filing
Date
|
Published, Allowed, or
Registered
|
78-463416
|
VIRTUAL
VISION VERACITY (Block letters)
|
Allowed
- 1st extension of time granted
|
Aug
6, 2004
|
P
May 2, 2006
|
78-463402
|
VERACITY
(Block letters)
|
|
Aug
6, 2004
|
A
Sep 27, 2005
|
78-235749
|
EGLASS
|
Registered,
Int'l
|
Apr
9, 2003
|
R
Aug 17, 2004
|
78-853656
|
PRIVATE
EYES (Block letters)
|
Pending
- Initialized, Int'l
|
Apr
4, 2006
|
|
78-853655
|
PRIVATE
EYE
|
Pending
- Initialized, Int'l
|
Apr
4, 2006
|
|
78-852411
|
EYEVIEWER
|
Pending
- Initialized, Int'l
|
Apr
3, 2006
|
|
78-852409
|
EYEWITNESS
(
|
Pending
- Initialized, Int'l
|
Apr
3, 2006
|
|
78-541421
|
Z800
3D VISOR
|
Pending
- Non-final action, Int'l
|
Jan
3, 2005
|
|
78-667562
|
PERSONAL
VIEWER
|
Pending
- Non-final action, Int'l
|
Jul
11, 2005
|
|
78-667564
|
3DVISOR
|
Pending
- Suspension letter, Int'l
|
Jul
11, 2005
|
|
78-667565
|
GET
INSIDE THE GAME
|
Pending
- Non-final action, Int'l
|
Jul
11, 2005
|
|
78-720607
|
EYEBUD
|
Pending
- Non-final action, Int'l
|
Sep
26, 2005
|
|
75-856770
|
EMAGIN
|
Registered,
Int'l
|
Nov
23, 1999
|
R
Mar 23, 2004
|
74-285,321
|
VIRTUAL
VISION
|
Registered
|
June
16, 1992
|
Dec.
6, 1994
|
EXHIBIT C
Filings Required for Collateral
Assignment
and to Perfect Security
Interest
1.
Filing
with the PTO
2.
Filing of
UCC-1 Financing Statement with the State of Delaware
3.
Filing of
UCC-1 Financing Statement with
the State
of Washington
4.
Filing of
UCC-1 Financing Statement with the State of New York
EXHIBIT D
The Collateral
Agent
1.
Appointment.
The
Holders (all capitalized terms used in this Exhibit D and not otherwise defined
shall have the respective meanings provided in the Patent and Trademark Security
Agreement to which this Exhibit D is attached (the “Patent and Trademark
Security Agreement”)), by their acceptance of the benefits of the Patent and
Trademark Security Agreement, hereby irrevocably designate Alexandra Global
Master Fund Ltd., as Collateral Agent, to act as specified herein and in the
Patent and Trademark Security Agreement. Each Buyer hereby irrevocably
authorizes, and each other Holder of any Note by the acceptance of such Note
shall be deemed irrevocably to authorize, the Collateral Agent to take such
action on its behalf under the provisions of the Patent and Trademark Security
Agreement and any other instruments and agreements referred to herein or therein
and to exercise such powers and to perform such duties hereunder and thereunder
as are specifically delegated to or required of the Collateral Agent by the
terms hereof and thereof and such other powers as are reasonably incidental
thereto. The Collateral Agent may perform any of its duties hereunder by or
through its agents or employees.
2.
Nature of
Duties.
The
Collateral Agent shall have no duties or responsibilities except those expressly
set forth in the Patent and Trademark Security Agreement. Neither the Collateral
Agent nor any of its officers, directors, employees or agents shall be liable
for any action taken or omitted by it as such under the Patent and Trademark
Security Agreement or hereunder or in connection herewith or therewith, unless
caused by its or their gross negligence or willful misconduct. The duties of the
Collateral Agent shall be mechanical and administrative in nature; the
Collateral Agent shall not have by reason of the Patent and Trademark Security
Agreement or any other Transaction Document a fiduciary relationship in respect
of any Holder; and nothing in the Patent and Trademark Security Agreement,
expressed or implied, is intended to or shall be so construed as to impose upon
the Collateral Agent any obligations in respect of the Patent and Trademark
Security Agreement except as expressly set forth herein. The Collateral Agent
shall not take any material action or exercise any material right or power
pursuant to Section 5, 6 or 7 of this Agreement without the authorization or
direction of the Majority Holders;
provided,
however,
that if
the Collateral Agent determines that it is unable to contact the Majority
Holders for purposes of seeking such authorization or direction or time will not
permit the Collateral Agent to so contact the Majority Holders prior to such
time as detriment may occur to the rights of the Collateral Agent or the Holders
from any failure of the Collateral Agent to act or exercise such right, then in
any such case the Collateral Agent may take such action or exercise such right
without specific authorization or direction from the Majority
Holders.
The
Collateral Agent shall not be liable for any act it may do or omit to do while
acting in good faith and in the exercise of its own best judgment. Any act done
or omitted by the Collateral Agent on the advice of its own attorneys shall be
deemed conclusively to have been done or omitted in good faith. The Collateral
Agent shall have the right at any time to consult with counsel on any question
arising under this Patent and Trademark Security Agreement. The Collateral Agent
shall incur no liability for any delay reasonably required to obtain the advice
of counsel.
3.
Lack of Reliance on the Collateral
Agent
.
Independently
and without reliance upon the Collateral Agent, each Holder, to the extent it
deems appropriate, has made and shall continue to make (i) its own independent
investigation of the financial condition and affairs of the Grantor and its
subsidiaries in connection with the making and the continuance of the
Obligations and the taking or not taking of any action in connection therewith,
and (ii) its own appraisal of the creditworthiness of the Grantor and its
subsidiaries, and the Collateral Agent shall have no duty or responsibility,
either initially or on a continuing basis, to provide any Holder with any credit
or other information with respect thereto, whether coming into its possession
before any Obligation arises or the purchase of any Note, or at any time or
times thereafter. The Collateral Agent shall not be responsible to any Holder
for any recitals, statements, information, representations or warranties herein
or in any document, certificate or other writing delivered in connection
herewith or for the execution, effectiveness, genuineness, validity,
enforceability, perfection, collectibility, priority or sufficiency of the
Patent and Trademark Security Agreement or the financial condition of the
Grantor or be required to make any inquiry concerning either the performance or
observance of any of the terms, provisions or conditions of the Patent and
Trademark Security Agreement, or the financial condition of the Grantor, or the
existence or possible existence of any Event of Default.
4.
Certain Rights of the Collateral
Agent.
No
Holder shall have the right to cause the Collateral Agent to take any action
with respect to the Collateral, with only the Majority Holders having the right
to direct the Collateral Agent to take any such action. If the Collateral Agent
shall request instructions from the Majority Holders with respect to any act or
action (including failure to act) in connection with the Patent and Trademark
Security Agreement, the Collateral Agent shall be entitled to refrain from such
act or taking such action unless and until it shall have received instructions
from the Majority Holders, and to the extent requested, appropriate
indemnification in respect of actions to be taken by the Collateral Agent; and
the Collateral Agent shall not incur liability to any person by reason of so
refraining. Without limiting the foregoing, no Holder shall have any right of
action whatsoever against the Collateral Agent as a result of the Collateral
Agent acting or refraining from acting hereunder in accordance with the
instructions of the Majority Holders or as otherwise specifically provided in
the Patent and Trademark Security Agreement.
5.
Reliance
.
The
Collateral Agent shall be entitled to rely, and shall be fully protected in
relying, upon any note, writing, resolution, notice, statement, certificate,
telex, teletype or telecopier message, cablegram, radiogram, order or other
document or telephone message signed, sent or made by the proper person or
entity, and, with respect to all legal matters pertaining to the Patent and
Trademark Security Agreement and its duties thereunder, upon advice of counsel
selected by it.
6.
Limitation of Holder
Liability.
The
Holders shall not be liable for any liabilities, obligations, losses, damages,
penalties, actions, judgments, suits, costs, expenses or disbursements of any
kind or nature whatsoever which may be imposed on, incurred by or asserted
against the Collateral Agent in performing its duties hereunder or under the
Patent and Trademark Security Agreement.
7.
The Collateral Agent in its
Individual Capacity.
The
Collateral Agent and its affiliates may lend money to, purchase, sell and trade
in securities of and generally engage in any kind of business with the Grantor
or any affiliate or subsidiary of the Grantor as if it were not performing the
duties specified herein, and may accept fees and other consideration from the
Grantor for services to the Grantor in connection with the Transaction Documents
and otherwise without having to account for the same to the Holders;
provided,
however,
that the
Collateral Agent on behalf of itself and such affiliates, hereby waives any
claim, right or Lien against the Collateral in any way arising from or relating
to any such loan, securities transaction or business with the
Grantor.
8.
Holders
.
The
Collateral Agent may deem and treat the holder of record of any Note as the
owner thereof for all purposes hereof unless and until a written notice of the
assignment or transfer thereof, as the case may be, shall have been filed with
the Collateral Agent. Any request, authority or consent of any person or entity
who, at the time of making such request or giving such authority or consent, is
the holder of record of any Note shall be conclusive and binding on any
subsequent holder, transferee or assignee, as the case may be, of such Note or
of any Note(s) issued in exchange therefor.
9.
Resignation by the Collateral
Agent.
(a) The
Collateral Agent may resign from the performance of all its functions and duties
under the Patent and Trademark Security Agreement at any time by giving 60
Business Days’ prior written notice (as provided in the Patent and Trademark
Security Agreement) to the Grantor and the Holders. Such resignation shall take
effect upon the appointment of a successor Collateral Agent pursuant to clauses
(b) and (c) below.
(b)
Upon any
such notice of resignation, the Majority Holders shall appoint a successor
Collateral Agent hereunder.
(c)
If a
successor Collateral Agent shall not have been so appointed within said 60
Business Day period, the Collateral Agent shall then appoint a successor
Collateral Agent who shall serve as Collateral Agent hereunder or thereunder
until such time, if any, as the Majority Holders appoint a successor Collateral
Agent as provided above. If a successor Collateral Agent has not been appointed
within such 60-day period, the Collateral Agent may petition any court of
competent jurisdiction or may interplead the Grantor and Holders in a proceeding
for the appointment of a successor Collateral Agent, and all fees, including but
not limited to extraordinary fees associated with the filing of interpleader,
and expenses associated therewith shall be payable by the Grantor.
(d)
The fees
of any successor Collateral Agent for its services as such shall be payable by
the Grantor.
EXHIBIT E
FORM OF PATENT COLLATERAL ASSIGNMENT
AND SECURITY
AGREEMENT
This
PATENT SECURITY
AGREEMENT,
dated as
of July 21, 2006, made by eMagin Corporation, a Delaware corporation (the
“Grantor”), to Alexandra Global Master Fund Ltd., a British Virgin Islands
international business company, as collateral agent (in such capacity, the
“Collateral Agent”) on behalf of the Holders.
W I T N E S S E T
H:
WHEREAS,
the
Grantor has acquired certain right, title and interest in certain United States
patents and patent applications identified in
Exhibit 1
hereto
(the “Patents”);
WHEREAS,
the
Grantor and the Buyers are parties to certain Note Purchase Agreements, dated as
of July 21, 2006 (as from time to time amended or supplemented, the “Note
Purchase Agreements”), pursuant to which, among other things, the Buyers have
agreed to purchase up to $7,000,000 aggregate principal amount of 6% Senior
Secured Convertible Notes due 2007-2008 (the “Notes”) of the
Grantor;
WHEREAS,
it is a
condition precedent to the several obligations of the Buyers to purchase their
respective Notes that the Grantor shall have executed and delivered a Patent and
Trademark Security Agreement to the Collateral Agent for the ratable benefit of
the Holders;
WHEREAS,
the
Grantor wishes to grant to the Collateral Agent a security interest in certain
of its property and assets to secure the performance of its obligations under
the Notes;
WHEREAS,
the
Grantor is contemporaneously entering into a Security Agreement and a Patent and
Trademark Security Agreement with the Collateral Agent for the ratable benefit
of the Holders; and
WHEREAS,
the
Grantor and Collateral Agent by this instrument seek to confirm and make a
record of the collateral assignment of and grant of a security interest in the
Patents.
NOW,
THEREFORE, for good and valuable consideration, the receipt and adequacy of
which are hereby acknowledged, the Grantor does hereby acknowledge and confirm
that it has made a collateral assignment to the Collateral Agent of, and has
granted to the Collateral Agent a security interest in, all of the Grantor’s
right, title and interest in, to, and under the Patents. The Grantor also
acknowledges and confirms that the rights and remedies of the Collateral Agent
with respect to the collateral assignment of and security interests in the
Patents acknowledged and confirmed hereby are more fully set forth in the Patent
and Trademark Security Agreement and the Security Agreement, the terms and
provisions of which are incorporated herein by reference.
|
|
|
|
EMAGIN
CORPORATION
|
|
|
|
|
By:
|
|
|
Name
|
|
Title
|
|
|
|
|
ALEXANDRA GLOBAL MASTER
FUND LTD., as Collateral
Agent
|
|
|
ALEXANDRA INVESTMENT
MANAGEMENT, LLC, as Investment Advisor
|
|
By:
|
|
|
Name:
Mikhail Filimonov
|
|
Title: Chairman
and Chief Executive Officer
|
For
eMagin Corporation:
STATE
OF____________________
)
)
SS:
COUNTY
OF__________________
)
Subscribed
and sworn to this
day of
,
2006.
_________________________________________________
Notary
Public
My
Commission Expires:
For
Alexandra Global Master Fund Ltd.,
as
Collateral Agent:
STATE
OF_______________________
)
)
SS:
COUNTY
OF_____________________
)
Subscribed
and sworn to this
day of
,
2006.
_______________________________________________
Notary
Public
My
Commission Expires:
EXHIBIT 1
Patents and Patent
Applications
EXHIBIT F
FORM OF TRADEMARK COLLATERAL
ASSIGNMENT
AND SECURITY
AGREEMENT
This
TRADEMARK SECURITY
AGREEMENT,
dated as
of July 21, 2006, made by eMagin Corporation, a Delaware corporation (the
“Grantor”), to Alexandra Global Master Fund Ltd., a British Virgin Islands
international business company, as collateral agent (in such capacity, the
“Collateral Agent”) on behalf of the Holders.
W I T N E S S E T
H:
WHEREAS,
the
Grantor has acquired an interest in certain trademarks identified in
Exhibit B
hereto
(the “Trademarks”);
WHEREAS,
the
Grantor and the Buyers are parties to certain Note Purchase Agreements, dated as
of July 21, 2006 (as from time to time amended or supplemented, the “Note
Purchase Agreements”), pursuant to which, among other things, the Buyers have
agreed to purchase up to $7,000,000 aggregate principal amount of 6% Senior
Secured Convertible Notes due 2007-2008 (the “Notes”) of the
Grantor;
WHEREAS,
it is a
condition precedent to the several obligations of the Buyers to purchase their
respective Notes that the Grantor shall have executed and delivered a Patent and
Trademark Security Agreement to the Collateral Agent for the ratable benefit of
the Holders;
WHEREAS,
the
Grantor wishes to grant to Collateral Agent a security interest in certain of
its property and assets to secure the performance of its obligations under the
Notes;
WHEREAS,
the
Grantor is contemporaneously entering into a Security Agreement and a Patent and
Trademark Security Agreement with the Collateral Agent for the ratable benefit
of the Holders;
WHEREAS,
the
Grantor and the Collateral Agent by this instrument seek to confirm and make a
record of the collateral assignment of and grant of a security interest in the
Trademarks.
NOW, THEREFORE,
for good
and valuable consideration, the receipt and adequacy of which are hereby
acknowledged, the Grantor does hereby acknowledge and confirm that it has made a
collateral assignment to the Collateral Agent of, and has granted to the
Collateral Agent a security interest in, all of the Grantor’s interests the
Trademarks. The Grantor also acknowledges and confirms that the rights and
remedies of Collateral Agent with respect to the collateral assignment of and
security interests in the Trademarks acknowledged and confirmed hereby are more
fully set forth in the Patent and Trademark Security Agreement and the Security
Agreement, the terms and provisions of which are incorporated herein by
reference.
|
|
|
|
EMAGIN
CORPORATION
|
|
|
|
|
By:
|
/s/
|
|
Name:
|
|
Title:
|
|
|
|
|
ALEXANDRA GLOBAL MASTER
FUND LTD., as Collateral
Agent
|
|
By:
|
ALEXADRA INVESTMENT MANAGEMENT,
LLC, as Investment Advisor
|
|
By:
|
|
|
Name:
Mikhail Filimonov
|
|
Title: Chairman
and Chief Executive Officer
|
For
eMagin Corporation:
STATE
OF_____________________
)
)
SS:
COUNTY
OF___________________
)
Subscribed
and sworn to this
day of
,
2006.
___________________________________________
Notary
Public
My
Commission Expires:
For
Alexandra Global Master Fund Ltd., as
Collateral
Agent:
STATE
OF_____________________
)
)
SS:
COUNTY
OF
)
Subscribed
and sworn to this
day of
,
2006.
_____________________________________________
Notary
Public
My
Commission Expires:
Annex
IV
PLEDGE AND SECURITY
AGREEMENT
THIS
PLEDGE AND SECURITY
AGREEMENT
, dated
as of July 21, 2006 (this “Agreement”), made by
EMAGIN
CORPORATION
, a
Delaware corporation (the “Grantor”), to
ALEXANDRA GLOBAL MASTER FUND
LTD.
, a
British Virgin Islands international business company, as collateral agent (in
such capacity, the “Collateral Agent”) on behalf of the Holders (such
capitalized term and all other capitalized terms used in this Agreement having
the respective meanings provided in this Agreement).
W
I
T
N
E
S
S
E
T
H
:
WHEREAS
, the
Grantor and the several Buyers are parties to the several Note Purchase
Agreements, pursuant to which, among other things, the Buyers have agreed to
purchase up to $7,000,000 aggregate principal amount of Notes of the
Grantor;
WHEREAS
, in
connection with the transactions contemplated by the Note Purchase Agreements,
the Grantor has agreed to grant to the Collateral Agent a security interest in
certain of its property, assets and rights;
WHEREAS
, it is a
condition precedent to the several obligations of the Buyers to purchase their
respective Notes and Warrants pursuant to the Note Purchase Agreements that the
Grantor shall have executed and delivered this Agreement to the Collateral Agent
for the ratable benefit of the Holders;
WHEREAS
,
contemporaneously with the execution and delivery of this Agreement the Company
and the Collateral Agent are executing and delivering the Patent and Trademark
Security Agreement and the Lockbox Agreement; and
NOW, THEREFORE
, in
consideration of the premises and to induce the Buyers to purchase their
respective Notes and Warrants, the Grantor hereby agrees with the Collateral
Agent, for the ratable benefit of the Holders, as follows:
1.
Definitions.
(a)
As used
in this Agreement, the terms “Agreement”, “Grantor” and “Collateral Agent” shall
have the respective meanings assigned to such terms in the introductory
paragraph of and the recitals to this Agreement.
(b)
All the
agreements or instruments herein defined shall mean such agreements or
instruments as the same may from time to time be supplemented or amended or the
terms thereof waived or modified to the extent permitted by, and in accordance
with, the terms thereof and of this Agreement.
(c)
Capitalized
terms used herein without definition shall have the respective meanings assigned
to such terms in the Notes.
(d)
The
following terms shall have the following meanings (such meanings to be equally
applicable to both the singular and plural forms of the terms
defined):
“Accounts”
means all rights to payment for goods sold or leased or for services rendered,
whether or not such rights have been earned by performance.
“Additional
Note” means the Note issued pursuant to the Additional Note Purchase
Agreement.
“Additional
Note Purchase Agreement” means the Note Purchase Agreement, dated as of July 21,
2006, by and between the Grantor and Stillwater LLC, which by its terms
contemplates the issuance of up to $500,000 aggregate principal amount of Notes
on or after December 10, 2006.
“Affiliate”
means, with respect to any Person, any other Person that directly, or indirectly
through one or more intermediaries, controls, is controlled by or is under
common control with the subject Person. For purposes of this definition,
“control” (including, with correlative meaning, the terms “controlled by” and
“under common control with”), as used with respect to any Person, shall mean the
possession, directly or indirectly, of the power to direct or cause the
direction of the management and policies of such Person, whether through the
ownership of voting securities or by contract or otherwise.
“Business
Day” means any day other than a Saturday, Sunday or a day on which commercial
banks in The City of New York are authorized or required by law or executive
order to remain closed.
“Buyer”
means any of the several buyers party to a Note Purchase Agreement.
“Chattel
Paper” shall have the meaning assigned to such term under the Code.
“Code”
means the Uniform Commercial Code as from time to time in effect in the State of
Delaware.
“Collateral”
means each of the following, whether now existing or hereafter
arising:
(1)
all
Accounts of the Grantor and, if the Collateral Agent exercises its rights under
Section 3(b), the Lockbox and each and every General Intangible relating
thereto;
(2)
all
Inventory of the Grantor;
(3)
all
Equipment of the Grantor;
(4)
all
Proprietary Information owned or licensed by the Grantor, whether existing on
the date hereof or developed or acquired hereafter;
(5)
all of
the Grantor’s right, title and interest in and to all Contracts, Documents,
Chattel Paper, Instruments, Investment Property and General Intangibles, whether
existing on the date hereof or hereafter arising;
(6)
all cash,
securities, rights and other property at any time and from time to time
received, receivable or otherwise distributed in respect of the Collateral,
including, without limitation in respect of the cash or other property held in
the Lockbox or the Collateral Account;
(7)
all
Patents, Patent Licenses, Trademarks and Trademark Licenses;
(8)
all
insurance policies to the extent they relate to items (1) through (7)
above;
(9)
all
books, ledgers, books of account, records, writings, databases, information and
other property relating to, used or useful in connection with, evidencing,
embodying, incorporating, or referring to any of the foregoing; and
(10)
to the
extent not otherwise included, all Proceeds, products, rents, issues, profits
and returns of and from any and all of the foregoing, which Proceeds may be in
the form of Accounts, Chattel Paper, Inventory or otherwise.
“Collateral
Account” shall have the meaning provided in the Lockbox Agreement.
“Contracts”
shall have the meaning assigned to that term under the Code.
“Documents”
shall have the meaning assigned to such term under the Code.
“Event of
Default” means:
(1)
the
failure by the Grantor to perform in any material respect any obligation of the
Grantor under this Agreement as and when required by this Agreement;
or
(2)
any
representation or warranty made by the Grantor pursuant to this Agreement shall
have been untrue in any material respect when made or deemed to have been made;
or
(3)
the
failure by the Grantor to perform in any material respect any obligation of the
Grantor under the Patent and Trademark Security Agreement as and when required
by the Patent and Trademark Security Agreement;
(4)
any
representation or warranty made by the Grantor pursuant to the Patent and
Trademark Security Agreement shall have been untrue in any material respect when
made or deemed to have been made;
(5)
the
failure by the Grantor to perform in any material respect any obligation of the
Grantor under the Lockbox Agreement as and when required by the Lockbox
Agreement;
(6)
any
representation or warranty made by the Grantor pursuant to the Lockbox Agreement
shall have been untrue in any material respect when made or deemed to have been
made; or
(7)
any Event
of Default, as that term is defined in any of the Notes.
“General
Intangibles” shall have the meaning assigned to such term under the
Code.
“Holder”
means any Buyer or any holder from time to time of any Note.
“Indemnified
Person” shall have the meaning provided in Section 5(j).
“Inventory”
shall have the meaning assigned to such term under the Code, and in any event,
including, without limitation, all raw material, work-in process and finished
goods, inventory, merchandise, goods and other personal property that are held
by or on behalf of a Person for sale or lease or to be furnished under a
contract of service or which give rise to any Account, including, without
limitation, returned goods.
“Issuance
Date” means the date on which the Notes are initially issued.
“Lien”
shall mean any lien, mortgage, security interest, chattel mortgage, pledge or
other encumbrance (statutory or otherwise) of any kind securing satisfaction or
performance of an obligation, including any agreement to give any of the
foregoing, any conditional sales or other title retention agreement, any lease
in the nature thereof, and the filing of or the agreement to give any financing
statement under the Code of any jurisdiction or similar evidence of any
encumbrance, whether within or outside the United States.
“Lockbox”
shall have the meaning assigned to such term in the Lockbox Agreement.
“Lockbox
Agent” means the Person from time to time serving as Lockbox Agent under the
Lockbox Agreement.
“Lockbox
Agreement” means that certain Lockbox Agreement dated as of the date hereof, by
and between the Grantor and the Lockbox Agent.
“Majority
Holders” means at any time such of the holders of the Notes who hold Notes
which, based on the outstanding principal amounts thereof, represent a majority
of the aggregate outstanding principal amount of the Notes at such
time.
“Note
Purchase Agreements” means the several Note Purchase Agreements, dated as of
July 21, 2006, by and between the Grantor and the respective Buyer party thereto
pursuant to which the Grantor issued the Notes, including, without limitation,
the Additional Note Purchase Agreement.
“Notes”
means the Grantor’s 6% Senior Secured Convertible Notes due 2007-2008 originally
issued pursuant to the Note Purchase Agreements, including, without limitation,
the Additional Note.
“Obligations”
means:
(1)
the full
and prompt payment when due of all obligations and liabilities to the Holders,
whether now existing or hereafter arising, under the Transaction Documents and
the due performance and compliance with the terms of the Transaction
Documents;
(2)
any and
all sums advanced by the Collateral Agent or any Holder in order to preserve the
Collateral or to preserve the Security Interest;
(3)
in the
event of any proceeding for the collection or enforcement of any obligations or
liabilities of the Grantor referred to in the immediately preceding clauses (1)
and (2) in accordance with the terms of the Transaction Documents, the
reasonable expenses of re-taking, holding, preparing for sale, selling or
otherwise disposing of or realizing on the Collateral, or of any other exercise
by the Collateral Agent of its rights hereunder, together with reasonable
attorneys' fees and court costs; and
(4)
any
amounts for which the Collateral Agent or any Holder is entitled to
indemnification under Section 5(j).
“Patent(s)”
means all present and future patents, patent applications and patent disclosures
which are presently, or in the future may be, owned, issued, acquired or used
(whether pursuant to a license or otherwise) anywhere in the world by the
Grantor, in whole or in part, and all of the Grantor's right, title and interest
in and to all patentable inventions and to file applications for patents under
patent laws of the United States or of any other jurisdiction, including,
without limitation, any and all extensions, reissues, substitutes,
continuations, continuations-in-part, divisional, patents of addition,
re-examinations and renewals thereof, and patents issuing therefrom, and any
other proprietary rights related to any of the foregoing (including, without
limitation, remedies against infringements thereof and rights of protection of
an interest therein under the laws of all jurisdictions) and any and all foreign
counterparts of any of the foregoing.
“Patent
Licenses” means each license agreement relating to Patents granted to, used or
acquired by the Grantor, in each case together with the right to use and rely
upon the inventions and other intellectual property conveyed
thereunder.
“Patent
and Trademark Security Agreement” means that certain Patent and Trademark
Security Agreement, dated as of July 21, 2006, between the Grantor and the
Collateral Agent.
“Permitted
Liens” shall have the meaning assigned to such term in the Notes.
“Person”
means any natural person, corporation, partnership, limited liability company,
trust, incorporated organization, unincorporated association or similar entity
or any government, governmental agency or political subdivision.
“Proceeds”
shall have the meaning assigned to such term under the Code.
“Proprietary
Information” means information in whatever form generally unavailable to the
public that has been created, discovered, developed or otherwise become known to
the Grantor or in which property rights have been assigned or otherwise conveyed
to the Grantor, which information has economic value or potential economic value
to the creation, operation, use, modification, extension, upgrade, application,
marketing, sale and distribution of the Grantor’s products and services.
Proprietary Information shall include, but not be limited to, trade secrets,
processes, formulas, writings, data, know-how, negative know-how, improvements,
discoveries, developments, designs, inventions, techniques, technical data,
customer and supplier lists, financial information, business plans or
projections and modifications or enhancements to any of the above. Proprietary
Information shall include all information existing on the date hereof and all
information developed or acquired hereafter.
“Security
Interest” means the security interest granted in the Collateral pursuant to this
Agreement.
“Subsidiary”
means any corporation or other entity of which a majority of the capital stock
or other ownership interests having ordinary voting power to elect a majority of
the board of directors or other Persons performing similar functions are at the
time directly or indirectly owned by the Grantor.
“Trademark
License” means each license agreement relating to Trademarks used, adopted or
acquired by the Grantor.
“Trademarks”
means (a) all trademarks, trade names, corporate names, company names, business
names, fictitious business names, trade styles, service marks, logos and other
source or business identifiers of the Grantor adopted for use in conjunction
with the Grantor’s business products and services, now existing anywhere in the
world or hereinafter adopted or acquired, whether currently in use or not, and
the goodwill associated therewith, all registrations and recordings thereof, and
all applications in connection therewith, and (b) all renewals thereof by the
Grantor.
“Transaction
Documents” means the Notes, the Note Purchase Agreements, this Agreement, the
Patent and Trademark Security Agreement, the Lockbox Agreement, the Warrants,
and the other agreements, instruments and documents contemplated hereby and
thereby.
2.
Grant of Security
Interest
. As
collateral security for the prompt and complete payment and performance of the
Obligations and for the other purposes provided in this Agreement, the Grantor
hereby grants to the Collateral Agent for the ratable benefit of the Holders a
first priority security interest in all of the Collateral. Such grant includes,
without limitation, a grant of the security interest to secure the payment and
performance of Obligations relating to the Additional Note upon the date of
issuance of such Additional Note.
3.
Rights of Collateral Agent;
Limitations on Collateral Agent's Obligations.
(a)
Grantor Remains Liable under Accounts
and Contracts
.
Anything herein to the contrary notwithstanding, the Grantor shall remain liable
under each of the Accounts and Contracts that constitute part of the Collateral
to observe and perform all the conditions and obligations to be observed and
performed by it thereunder, all in accordance with the terms of any agreement
giving rise to each such Account and in accordance with and pursuant to the
terms and provisions of each such Contract. The Collateral Agent shall not have
any obligation or liability under any Account that constitutes part of the
Collateral (or any agreement giving rise thereto) or under any Contract that
constitutes part of the Collateral by reason of or arising out of this Agreement
or the receipt by the Collateral Agent of any payment relating to such Account
or Contract pursuant hereto, nor shall the Collateral Agent be obligated in any
manner to perform any of the obligations of the Grantor under or pursuant to any
such Account (or any agreement giving rise thereto) or under or pursuant to any
such Contract, to make any payment, to make any inquiry as to the nature or the
sufficiency of any payment received by it or as to the sufficiency of any
performance by any party under any such Account (or any agreement giving rise
thereto) or under any such Contract, to present or file any claim, to take any
action to enforce any performance or to collect the payment of any amounts which
may have been assigned to it or to which it may be entitled at any time or
times.
(b)
Notice to Account Debtors and
Contracting Parties
. Upon
the direction of the Collateral Agent at any time that an Event of Default has
occurred and is continuing,
the
Grantor shall promptly, but in no event later than five Business Days, after
such direction is given, notify all the account debtors on the Accounts that
constitute part of the Collateral and parties to the Contracts that constitute
part of the Collateral that such Accounts and such Contracts have been assigned
to the Collateral Agent for the ratable benefit of the Holders and that payments
in respect thereof shall be made directly to the Collateral Agent or as the
Collateral Agent shall direct in accordance with the Lockbox Agreement.
(c)
Verification and Analysis of
Accounts
. If an
Event of Default has occurred and the Collateral Agent shall have directed the
Grantor to notify the account debtors on the Accounts and parties to the
Contracts in accordance with Section 3(b), in addition to its rights pursuant to
clause (1) of this Section 3(c) the Collateral Agent shall have the right in its
own name or in the name of others to communicate with account debtors on the
Accounts that constitute part of the Collateral and parties to the Contracts
that constitute part of the Collateral to verify with them to its satisfaction
the existence, amount and terms of any such Accounts or Contracts and to make
test verifications of such Accounts in any manner and through any medium that it
reasonably considers advisable, and the Grantor shall furnish all such
assistance and information as the Collateral Agent may require in connection
therewith. At any time and from time to time, upon the Collateral Agent's
reasonable request and at the expense of the Grantor, the Grantor shall cause
independent public accountants or others satisfactory to the Collateral Agent to
furnish to the Collateral Agent reports showing reconciliations, aging and test
verifications of, and trial balances for, such Accounts.
4.
Representations and
Warranties
. The
Grantor hereby represents and warrants that:
(a)
Title; No Other
Liens
. Except
for the Lien granted to the Collateral Agent for the ratable benefit of the
Holders pursuant to this Agreement, the Patent and Trademark Security Agreement,
the Lockbox Agreement and the Lien granted to the Collateral Agent for the
ratable benefit of the Holders pursuant to the Patent and Trademark Security
Agreement, the Grantor owns and has good and marketable title to each item of
the Collateral free and clear of any and all Liens or claims of others except
Permitted Liens. No security agreement, financing statement or other public
notice with respect to all or any part of the Collateral is on file or of record
in any public office, except such as may have been filed in favor of the
Collateral Agent, for the ratable benefit of the Holders, pursuant to this
Agreement or pursuant to the Patent and Trademark Security
Agreement.
(b)
Perfected First Priority
Liens
. The
Liens granted pursuant to this Agreement will constitute upon the completion of
all the filings or notices listed in
Schedule I
hereto,
perfected Liens on all Collateral in favor of the Collateral Agent for the
benefit of the Holders, which are prior to all other Liens (except Permitted
Liens, if any) on such Collateral and which are enforceable as such against all
Persons.
(c)
Accounts
. No
amount payable to the Grantor under or in connection with any Account that
constitutes part of the Collateral is evidenced by any Instrument (other than
checks in the ordinary course of business) or Chattel Paper which has not been
delivered to the Collateral Agent. The place where the Grantor keeps its records
concerning the Accounts that constitute part of the Collateral is set forth on
Schedule II
hereto.
(d)
Consents under
Contracts
. No
consent (other than consents that have been obtained) of any party (other than
the Grantor), to any Contract that constitutes part of the Collateral is
required, or purports to be required, in connection with the execution, delivery
and performance of this Agreement or the exercise of the Collateral Agent's
rights and remedies provided herein or at law.
(e)
Inventory
. The
items of Inventory that constitute part of the Collateral are, as of the
Issuance Date, kept at the locations listed on
Schedule III
hereto
and have not been kept at any other location within the six-month period ending
on the Issuance Date.
(f)
Chief Executive
Office
. The
Grantor's chief executive office and chief place of business is located at 10500
N.E. 8
th
Street,
Suite 1400,
Bellevue,
WA 98004
.
(g)
Power and
Authority
. The
Grantor has full power, authority and legal right to grant the Collateral Agent
the Lien on the Collateral pursuant to this Agreement.
(h)
Approvals, Filings,
Etc.
No
authorization, approval or consent of, or filing, registration, recording or
other action with, any United States or foreign court, governmental body,
regulatory agency, self-regulatory organization, or stock exchange or market,
the stockholders of the Grantor or any other Person, is required to be obtained
or made by the Grantor or any Subsidiary (x) for the grant by the Grantor of the
Security Interest in the Collateral pursuant to this Agreement, (y) to perfect
the Security Interest purported to be created by this Agreement, or (z) for the
exercise of the Collateral Agent's rights and remedies provided herein or at
law, in each case except as has been obtained or made.
5.
Covenants
. The
Grantor covenants and agrees with the Collateral Agent that from and after the
date of this Agreement until the payment or performance in full by the Grantor
of all of the Obligations:
(a)
Further Documentation; Pledge of
Instruments and Chattel Paper
. At any
time and from time to time, upon the written request of the Collateral Agent,
and at the sole expense of the Grantor, the Grantor will promptly and duly
execute and deliver such further instruments and documents and take such further
action as the Collateral Agent may reasonably request for the purpose of
obtaining or preserving the full benefits of this Agreement and of the rights
and powers herein granted, including, without limitation, the filing of any
financing or continuation statements under the Code or similar laws in effect in
any such jurisdiction with respect to the Liens created hereby. The Grantor also
hereby authorizes the Collateral Agent to file any such financing or
continuation statement without the signature of the Grantor to the extent
permitted by applicable law. A carbon, photographic or other reproduction of
this Agreement shall be sufficient as a financing statement for filing in any
jurisdiction. If any amount payable under or in connection with any of the
Collateral shall be or become evidenced by any Instrument or Chattel Paper, such
Instrument or Chattel Paper shall be immediately delivered to the Collateral
Agent, duly endorsed in a manner satisfactory to the Collateral Agent, to be
held as Collateral pursuant to this Agreement.
(b)
Maintenance of
Records
.
The
Grantor will keep and maintain at its own cost and expense satisfactory and
complete records of the Collateral, including, without limitation, a record of
all payments received and all credits granted with respect to any Accounts that
may constitute part of the Collateral. For the further security of the
Collateral Agent, the Grantor hereby grants to the Collateral Agent a security
interest in all of the Grantor's books and records pertaining to the Collateral,
and the Grantor shall turn over any such books and records for inspection at the
office of the Grantor to the Collateral Agent or to its representatives during
normal business hours at the request of the Collateral Agent.
(c)
Limitation on Liens on
Collateral
. The
Grantor (x) will not create, incur or permit to exist, will defend the
Collateral against, and will take such other action as is necessary to remove,
any Lien or claim on or to the Collateral, other than the Security Interest
created hereby and Liens created by the Patent and Trademark Security Agreement,
and (y) will defend the right, title and interest of the Collateral Agent in and
to any of the Collateral against the claims and demands of all
Persons.
(d)
Limitations on Dispositions of
Collateral
. The
Grantor will not sell, transfer, lease, assign, grant any participation or
interest in, or otherwise dispose of, any of the Collateral to any Person,
including, without limitation, any Subsidiary or Affiliate of the Grantor, or
attempt, offer or contract to do so.
(e)
Performance of Contracts and
Agreements Giving Rise to Accounts.
The
Grantor shall (i) exercise promptly and diligently each and every material right
and perform each material obligation which it may have under each Contract that
constitutes part of the Collateral and each agreement giving rise to an Account
that constitutes part of the Collateral (other than any right of termination)
and (ii) deliver to the Collateral Agent, upon request, a copy of each material
demand, notice or document received by it relating in any way to any Contract
that constitutes part of the Collateral or any agreement giving rise to an
Account that constitutes part of the Collateral. The Grantor shall not amend or
modify the terms of, or waive any rights under, any Contracts, in a manner which
would materially adversely affect the Security Interest or the value of such
Contracts.
(f)
Further Identification of
Collateral.
The
Grantor shall furnish to the Collateral Agent from time to time, upon the
request of the Collateral Agent, statements and schedules further identifying
and describing the Collateral and such other reports in connection with the
Collateral as the Collateral Agent may reasonably request, all in reasonable
detail.
(g)
Notices.
The
Grantor will advise the Collateral Agent within two Business Days of the
occurrence thereof, in reasonable detail, at its address in accordance with
Section 16, (i) of any Lien (other than Liens permitted hereunder) on, or claim
asserted against, any of the Collateral, (ii) of any Event of Default or any
event which, with notice or the lapse of time, or both, would become an Event of
Default and (iii) of the occurrence of any other event which could reasonably be
expected to have a material adverse effect on the Collateral, the Security
Interest or the rights of the Collateral Agent hereunder.
(h)
Changes in Locations, Name, Etc.
The
Grantor will not
(1)
change
the location of its chief executive office/chief place of business from that
specified in Section 4(f) or remove its books and records from the location
specified in Section 4(c), or
(2)
change
its name, identity or corporate structure to such an extent that any financing
statement filed in connection with this Agreement and naming the Collateral
Agent as secured party would become misleading or invalid, or
(3)
change
the location at which any item of Inventory that constitutes Collateral is kept
from the locations specified in Section 4(e),
unless in
any such case it shall have given the Collateral Agent at least 30 days prior
written notice thereof and, prior to such action or event, shall have taken
appropriate action satisfactory to the Collateral Agent to preserve and protect
the Collateral Agent's security interest under this Agreement.
(i)
Subsidiaries.
This
Agreement is entered into on behalf of and for the benefit of the Grantor. The
Subsidiaries and the Affiliates of the Grantor have no ownership or other rights
in the Collateral. The Grantor will not permit any Subsidiary or any Affiliate
of the Grantor to have any ownership or other rights in or to exercise any
control over the Collateral.
(j)
Indemnification
. The
Grantor agrees to indemnify and hold harmless the Collateral Agent and each
Holder and their respective officers, directors, Affiliates, agents, members,
shareholders and investment advisors (each, an “Indemnified Person”) from and
against any and all claims, demands, losses, judgments and liabilities
(including liabilities for penalties) of whatsoever kind or nature, and to
reimburse the Collateral Agent and each Holder for all costs and expenses,
including reasonable attorneys’ fees and expenses, arising out of or resulting
from this Agreement, including any breach hereof or Event of Default hereunder,
or the exercise by the Collateral Agent or any Holder, as the case may be, of
any right or remedy granted to it hereunder or under the other Transaction
Documents under applicable law;
provided,
however,
that the
Grantor shall not be required to indemnify a particular Indemnified Person to
the extent any claim, demand, loss, judgment, liability, cost or expense is
determined by final judgment (not subject to further appeal) of a court of
competent jurisdiction to have arisen primarily from the gross negligence or
willful misconduct of such Indemnified Person. In no event shall any Indemnified
Person other than the Collateral Agent have any liability or obligation to the
Grantor under this Agreement or applicable law (liability under which the
Grantor hereby waives) for any matter or thing in connection with this
Agreement, and in no event shall the Collateral Agent be liable, in the absence
of a determination of gross negligence or willful misconduct on its part by
final judgment (not subject to further appeal) of a court of competent
jurisdiction, for any matter or thing in connection with this Agreement other
than to account for moneys actually received by it in accordance with the terms
hereof. If and to the extent that the obligations of the Grantor under this
Section 4(j) are unenforceable for any reason, the Grantor hereby agrees to make
the maximum contribution to the payment and satisfaction of such obligations
which is permissible under applicable law.
6.
Collateral Agent's
Powers.
(a)
Powers.
The
Grantor hereby irrevocably constitutes and appoints the Collateral Agent and any
officer or agent thereof or investment advisor thereto, with full power of
substitution, as its true and lawful attorney-in-fact with full irrevocable
power and authority in the place and stead of the Grantor and in the name of the
Grantor or in its own name, from time to time in the Collateral Agent's
discretion, during any period in which an Event of Default is continuing, for
the purpose of carrying out the terms of this Agreement, to take any and all
appropriate action and to execute any and all documents and instruments which
may be necessary or desirable to accomplish the purposes of this Agreement, and,
without limiting the generality of the foregoing, the Grantor hereby gives the
Collateral Agent and each such officer, agent and investment advisor the power
and right, on behalf of the Grantor, without notice to or assent by the Grantor,
except any notice required by law, to do the following:
(i)
to take
possession of and endorse and collect any checks, drafts, notes, acceptances or
other instruments for the payment of moneys due under or with respect to any
Collateral and to file any claim or to take any other action or proceeding in
any court of law or equity or otherwise deemed appropriate by the Collateral
Agent for the purpose of collecting any and all such moneys due under or with
respect to any such Collateral whenever payable, in each case in the name of the
Grantor or its own name, or otherwise;
(ii)
to pay or
discharge taxes and liens levied or placed on or threatened against the
Collateral and to pay all or any part of the premiums therefor and the costs
thereof; and
(iii)
(A) to
direct any party liable for any payment under any of the Collateral to make
payment of any and all moneys due or to become due thereunder directly to the
Collateral Agent or as the Collateral Agent shall direct; (B) to ask or demand
for, collect, receive payment of and receipt for, any and all moneys, claims and
other amounts due or to become due at any time in respect of or arising out of
any Collateral; (C) to sign and endorse any invoices, freight or express bills,
bills of lading, storage or warehouse receipts, drafts against debtors,
assignments, verifications, notices and other documents in connection with any
of the Collateral; (D) to commence and prosecute any suits, actions or
proceedings at law or in equity in any court of competent jurisdiction to
collect the Collateral or any thereof and to enforce any other right in respect
of any Collateral; (E) to defend any suit, action or proceeding brought against
the Grantor with respect to any Collateral; (F) to settle, compromise or adjust
any suit, action or proceeding described in clause (E) above and, in connection
therewith, to give such discharges or releases as the Collateral Agent may deem
appropriate; and (G) generally, to sell, transfer, pledge and make any agreement
with respect to or otherwise deal with any of the Collateral as fully and
completely as though the Collateral Agent were the absolute owner thereof for
all purposes, and to do, at the Collateral Agent's option and the Grantor's
expense, at any time, or from time to time, all acts and things which the
Collateral Agent deems necessary to protect, preserve or realize upon the
Collateral and the Collateral Agent's Liens thereon and to effect the intent of
this Agreement, all as fully and effectively as the Grantor might
do.
The
Grantor hereby ratifies all that said attorneys shall lawfully do or cause to be
done by virtue hereof. This power of attorney is a power coupled with an
interest and shall be irrevocable until the Grantor shall have paid and
performed in full all of the Obligations.
(b)
Other Powers.
The
Grantor also authorizes the Collateral Agent, from time to time during any
period in which an Event of Default is continuing,
to
execute, in connection with the sale provided for herein, any endorsements,
assignments or other instruments of conveyance or transfer with respect to the
Collateral.
(c)
No Duty on Collateral Agent's
Part.
The
powers conferred on the Collateral Agent hereunder are solely to protect the
Collateral Agent's interests in the Collateral for the
pro rata
benefit
of the Holders and shall not impose any duty upon the Collateral Agent to
exercise any such powers. The Collateral Agent shall be accountable only for
amounts that it actually receives as a result of the exercise of such powers,
and neither it nor any of its officers, directors, employees or agents shall be
responsible to the Grantor for any act or failure to act hereunder, except for
their own gross negligence or willful misconduct.
7.
Performance by Collateral Agent of
Grantor's Obligations.
If the
Grantor fails to perform or comply with any of its agreements contained herein
and the Collateral Agent, as provided for by the terms of this Agreement and
following reasonable notice to the Grantor, may itself perform or comply, or
otherwise cause performance or compliance, with such agreement, and the expenses
of the Collateral Agent incurred in connection with such performance or
compliance shall be payable by the Grantor to the Collateral Agent on demand and
shall constitute Obligations secured hereby.
8.
Remedies in
General.
If an
Event of Default has occurred and is continuing, the Collateral Agent may
exercise, in addition to all other rights and remedies granted to it in this
Agreement and in any other instrument or agreement securing, evidencing or
relating to the Obligations, all rights and remedies of a secured party under
the Code. Without limiting the generality of the foregoing, if an Event of
Default has occurred and is continuing, the Collateral Agent, without demand of
performance or other demand, presentment, protest, advertisement or notice of
any kind (except any notice required by law referred to below or expressly
provided for) to or upon the Grantor or any other Person (all and each of which
demands, defenses, advertisements and notices are, to the extent permitted by
applicable law, hereby waived), may in such circumstances forthwith collect,
receive, appropriate and realize upon the Collateral, or any part thereof,
and/or may forthwith sell, license, assign, give option or options to purchase,
or otherwise dispose of and deliver the Collateral or any part thereof (or
contract to do any of the foregoing), at public or private sale or sales, at any
exchange, broker's board or office of the Collateral Agent or elsewhere upon
such terms and conditions as it may deem advisable and at such prices as it may
deem best, for cash or on credit or for future delivery without assumption of
any credit risk. The Collateral Agent shall have the right upon any such public
sale or sales, and, to the extent permitted by law, upon any such private sale
or sales, to purchase the whole or any part of the Collateral so sold, free of
any right or equity of redemption in the Grantor, which right or equity is
hereby waived, to the extent permitted by applicable law, or released.
The
Grantor further agrees that, if an Event of Default has occurred and is
continuing,
at the
Collateral Agent's request, to assemble the Collateral and make it available to
the Collateral Agent at places which the Collateral Agent shall reasonably
select, whether at the Grantor's premises or elsewhere. The Collateral Agent
shall apply the net proceeds of any such collection, recovery, receipt,
appropriation, realization or sale, after deducting all reasonable costs and
expenses of every kind incurred therein or incidental to the care or safekeeping
of any of the Collateral or in any way relating to the Collateral or the rights
of the Collateral Agent hereunder, including, without limitation, reasonable
attorneys' fees and disbursements, to the payment in whole or in part of the
Obligations, in such order as the Collateral Agent may elect, and only after
such application and after the payment by the Collateral Agent of any other
amount required by any provision of law, need the Collateral Agent account for
the surplus, if any, to the Grantor. To the extent permitted by applicable law,
the Grantor waives all claims, damages and demands it may acquire against the
Collateral Agent arising out of the exercise by it of any rights hereunder,
provided,
that
nothing contained in this Section 8 shall relieve the Collateral Agent from
liability arising solely from its gross negligence or willful misconduct. If any
notice of a proposed sale or other disposition of Collateral shall be required
by law, such notice shall be deemed reasonable and proper if given at least ten
days before such sale or other disposition. The Grantor shall remain liable for
any deficiency if the proceeds of any sale or other disposition of the
Collateral are insufficient to pay the Obligations and the fees and
disbursements of any attorneys employed by the Collateral Agent to collect such
deficiency.
9.
Limitation on Duties Regarding
Preservation of Collateral.
The
Collateral Agent's sole duty with respect to the custody, safekeeping and
physical preservation of the Collateral in its possession, under the Code or
otherwise, shall be to deal with it in the same manner as the Collateral Agent
deals with similar property for its own account. Neither the Collateral Agent
nor any of its directors, officers, employees or agents shall be liable for
failure to demand, collect or realize upon all or any part of the Collateral or
for any delay in doing so or shall be under any obligation to sell or otherwise
dispose of any Collateral upon the request of the Grantor or
otherwise.
10.
Powers Coupled with an
Interest.
All
authorizations and agencies herein contained with respect to the Collateral are
irrevocable and powers coupled with an interest until the Grantor has paid and
performed in full all of its obligations under the Transaction
Documents.
11.
Severability.
Any
provision of this Agreement which is prohibited or unenforceable in any
jurisdiction shall, as to such jurisdiction, be ineffective to the extent of
such prohibition or unenforceability without invalidating the remaining
provisions hereof, and any such prohibition or unenforceability in any
jurisdiction shall not invalidate or render unenforceable such provision in any
other jurisdiction.
12.
Paragraph Headings, Captions,
Etc.
The
paragraph headings, the captions and the footers used in this Agreement are for
convenience of reference only and are not to affect the construction hereof or
be taken into consideration in the interpretation hereof.
13.
No Waiver; Cumulative
Remedies.
The
Collateral Agent shall not by any act, delay, indulgence, omission or otherwise
be deemed to have waived any right or remedy hereunder or to have acquiesced in
any Event of Default or in any breach of any of the terms and conditions hereof.
No failure to exercise, nor any delay in exercising, on the part of the
Collateral Agent, any right, power or privilege hereunder shall operate as a
waiver thereof. No single or partial exercise of any right, power or privilege
hereunder shall preclude any other or further exercise thereof or the exercise
of any other right, power or privilege. A waiver by the Collateral Agent of any
right or remedy hereunder on any one occasion shall not be construed as a bar to
any right or remedy which the Collateral Agent would otherwise have on any
future occasion. The rights and remedies herein and in the Notes and the other
Transaction Documents are cumulative, may be exercised singly or concurrently
and are not exclusive of any rights or remedies provided by law or in equity or
by statute.
14.
Waivers and Amendments; Successors
and Assigns.
None of
the terms or provisions of this Agreement may be waived, amended, supplemented
or otherwise modified except by a written instrument executed by the party to be
charged with enforcement;
provided, however,
that any
provision of this Agreement may be waived, amended, supplemented or otherwise
modified by the Collateral Agent only with the prior written approval of the
Majority Holders. This Agreement shall be binding upon the successors and
permitted assigns of the Grantor and shall inure to the benefit of the
Collateral Agent and its successors and assigns. The Grantor may not assign its
rights or obligations under this Agreement without the prior written consent of
the Collateral Agent, which the Collateral Agent may withhold in the sole
discretion of the Majority Holders. The requirements for resignation, and
appointment of a successor to, the Collateral Agent are established by
Schedule IV
hereto
and not by this Agreement.
15.
Termination of Security Interest;
Release of Collateral.
(a)
Upon the
payment in full of all principal of and premium, if any, and interest on the
Notes and the payment in full of all other amounts for Obligations that are due
and payable at such time, and if no claims for payment by the Company of any
Obligations are at the time pending, the Security Interest shall terminate and
all rights to the Collateral shall revert to the Grantor.
(b)
If an
Event of Default shall have occurred and be continuing, the Collateral Agent
shall disburse the funds held by it pursuant to this Agreement as
follows:
(i)
First, to
pay any amounts payable to the Collateral Agent pursuant to Section 17 that have
not been paid by the Grantor;
(ii)
Second,
to pay each Holder on a pro rata basis the amount of all accrued and unpaid
interest (and interest, if any, thereon at the Default Rate) then due each
Holder in accordance with the terms of their respective Notes through the most
recent Interest Payment Date;
(iii)
Third, to
pay each Holder on a pro rata basis the amount, if any, of unpaid principal then
due on the Maturity Date of any installment of principal of such Holder’s Notes;
(iv)
Fourth,
to pay each Holder, on a pro rata basis, the amount then due upon acceleration,
if any, pursuant to Section 4 of such Holder’s Note(s); and then
(v)
Fifth, to
pay each Holder who has exercised its repurchase rights under Section 5 of the
Notes, on a pro rata basis, all of the applicable unpaid Repurchase Price for
each of the Notes or portions thereof required to be repurchased; and
then
(vi)
Sixth, to
pay each Holder any other amount due and payable to such Holder under the
Transaction Documents; and then
(vii)
Seventh,
the remaining amount, if any, to the Grantor.
provided,
however,
that if
the amount of funds held by the Collateral Agent is insufficient to pay all
amounts due to the Holders pursuant to clauses (ii) and (iv) above, then the
amount paid to the Holders pursuant to this Section 15(b) shall be prorated
among the Holders in proportion to the respective amounts due each Holder
pursuant to the particular such clause or clauses for which such funds are
insufficient.
(c)
At any
time and from time to time prior to termination of the Security Interest
pursuant to Section 15(a), the Collateral Agent shall release any of the
Collateral only with the prior written consent of the Majority Holders.
(d)
Upon any
such termination of the Security Interest or release of all the Collateral, the
Collateral Agent will, at the expense of the Grantor, execute and deliver to the
Grantor such documents and take such other actions as the Grantor shall
reasonably request to evidence the termination of the Security Interest and
deliver to the Grantor all Collateral so released then in its
possession.
16.
Notices.
Any
notices required or permitted to be given under the terms of this Agreement
shall be in writing and shall be sent by mail, personal delivery, telephone line
facsimile transmission or courier and shall be effective five days after being
placed in the mail, if mailed, or upon receipt, if delivered personally, by
telephone line facsimile transmission or by courier, in each case addressed to a
party at such party's address (or telephone line facsimile transmission number)
shown below or such other address (or telephone line facsimile transmission
number) as a party shall have provided by notice to the other party in
accordance with this provision. In the case of any notice to the Grantor, such
notice shall be addressed to the Grantor at 10500 N.E. 8
th
Street,
Suite 1400,Bellevue, WA 98004, Attention: Chief Financial Officer (telephone
line facsimile number (425) 749-3601), with a copy to Sichenzia Ross Friedman
Ference LLP, 1065 Avenue of the Americas, 21
st
Floor,
New York, New York 10018, Attention: Richard A. Friedman, Esq. (telephone line
facsimile number (212) 930-9725) and in the case of any notice to the Collateral
Agent, such notice shall be addressed to the Collateral Agent at c/o Alexandra
Investment Management, LLC, 767 Third Avenue, 39
th
Floor,
New York, New York 10017 (telephone line facsimile number (212) 301-1810), with
a copy to Law Offices of Brian W Pusch, Penthouse Suite, 29 West 57
th
Street,
New York, New York (telephone line facsimile number (212)
980-7055).
17.
Fees and Expenses
. The
Grantor agrees to pay the fees of the Collateral Agent in performing its
services under this Agreement and all expenses (including but not limited to
reasonable attorneys' fees and costs for legal services, costs of insurance and
payments of taxes or other charges) of, or incidental to, the custody, care,
sale or realization on any of the Collateral or in any way relating to the
performance of the obligations or the enforcement or protection of the rights of
the Collateral Agent hereunder.
18.
Concerning Collateral
Agent.
The
Grantor acknowledges that the rights and responsibilities of the Collateral
Agent under this Agreement with respect to any action taken by the Collateral
Agent or the exercise or nonexercise by the Collateral Agent of any option,
right, request, judgment or other right or remedy provided for herein or
resulting or arising out of this Agreement shall, as between the Collateral
Agent and the Holders, be governed by
Schedule IV
hereto
and by such other agreements with respect thereto as may exist from time to time
among them, but, as between the Collateral Agent and the Grantor, except as
expressly provided in Sections 14 and 15, the Collateral Agent shall be
conclusively presumed to be acting as agent for the Holders with full and valid
authority so to act or refrain from acting, and the Grantor shall not be under
any obligation to make any inquiry respecting such authority. The Collateral
Agent hereby waives for the benefit of the Holders any claim, right or lien of
the Collateral Agent against the Collateral arising under applicable law or
arising from any business or transaction between the Collateral Agent and the
Grantor other than pursuant to this Agreement or any of the other Transaction
Documents.
19.
Survival.
All
representations, warranties, covenants and agreements of the Grantor and of the
Collateral Agent contained herein will survive the execution and delivery hereof
and the release of any Collateral pursuant hereto and shall remain operative and
in full force and effect regardless of any investigation made by or on behalf of
the Collateral Agent or the Grantor or any person who controls the Collateral
Agent or the Grantor.
20.
Grantor’s Obligations Absolute, Etc.
The
obligations of the Grantor under this Agreement shall be absolute and
unconditional and shall remain in full force and effect without regard to, and
shall not be released, suspended, discharged, terminated or otherwise affected
by, any circumstance or occurrence whatsoever, including, without limitation:
(a) any renewal, extension, amendment or modification of or addition or
supplement to or deletion from any of the Transaction Documents or any other
agreement or instrument referred to therein, or any assignment or transfer of
any thereof; (b) any waiver, consent, extension, indulgence or other action or
inaction under or in respect of any such Transaction Document or other agreement
or instrument; (c) any furnishing of any additional security to the Collateral
Agent or its assignees or any acceptance thereof or any release of any security
by the Collateral Agent or its assignees; (d) any limitation on any party’s
liability or obligations under any such Transaction Document or other agreement
or instrument or any invalidity or unenforceability, in whole or in part, of any
such Transaction Document or other agreement or instrument or any term thereof;
or (e) any bankruptcy, insolvency, reorganization, composition, adjustment,
dissolution, liquidation or other like proceeding relating to the Grantor, or
any action taken with respect to this Agreement by any trustee or receiver, or
by any court, in any such proceeding, whether or not the Grantor shall have
notice or knowledge of any of the foregoing.
21.
Integration.
This
Agreement represents the entire agreement of the Grantor and the Collateral
Agent with respect to the subject matter hereof, and there are no promises,
undertakings, representations or warranties by the parties relative to the
subject matter hereof not expressly set forth or referred to herein or
therein.
22.
Governing Law.
This
Agreement and the rights and obligations of the Grantor under this Agreement
shall be governed by, and construed and interpreted in accordance with, the law
of the State of New York, except to the extent that under the New York Uniform
Commercial Code the laws of another jurisdiction govern matters of perfection
and the effect of perfection or non-perfection of any security interest granted
hereunder.
23.
Counterparts;
Execution
. This
Agreement may be executed in any number of counterparts and by the parties
hereto on separate counterparts, but all the counterparts taken together shall
be deemed to constitute one and the same instrument. This Agreement, once
executed by a party, may be delivered to the other party hereto by telephone
line facsimile transmission of a copy of this Agreement bearing the signature of
the party so delivering this Agreement.
24.
Construction
. The
language used in this Agreement will be deemed to be the language chosen by the
parties to express their mutual intent, and no rules of strict construction will
be applied against any party.
[
Signature page
follows
]
IN WITNESS WHEREOF
, the
Grantor and the Collateral Agent have caused this Agreement to be duly executed
and delivered by their respective officers or other representatives thereunto
duly authorized as of the date first above written.
|
|
|
|
EMAGIN
CORPORATION
|
|
|
|
|
By:
|
/s/ Gary W.
Jones
|
|
Name:
Gary W. Jones
|
|
Title: Chief
Executive Officer
|
|
|
|
|
ALEXANDRA GLOBAL MASTER
FUND LTD., as Collateral
Agent
|
|
|
ALEXANDRA INVESTMENT
MANAGEMENT, LLC, as Investment Advisor
|
|
By:
|
/s/ Mikhail
Filimonov
|
|
Name:
Mikhail Filimonov
|
|
Title: Chairman
and Chief Executive Officer
|
SCHEDULE I
Filings Required to Perfect
Security Interest
1.
Secretary
of State of the State of Delaware
2.
Department
of State of the State of New York
SCHEDULE II
Location of Records
Concerning Accounts
eMagin
Corporation
10500 NE
8
th
Street,
Suite 1400
Bellevue,
WA. 98004
SCHEDULE III
Inventory
Locations
eMagin
Corporation
2070
Route 52
Hopewell
Junction, NY 12533
eMagin
Corporation
10500 NE
8
th
Street,
Suite 1400
Bellevue,
WA. 98004
Asteria Manufacturing and
Brimal Holding (same address)
:
Wisma
AIC
Lot
3
Persiaran
Kemajuan
Seksyen
16
40200
Shah Alam
Selangor
Darul Ehsan
Malaysia
SCHEDULE IV
The Collateral
Agent
1.
Appointment.
The
Holders (all capitalized terms used in this
Schedule IV
and
not otherwise defined shall have the respective meanings provided
in the Security agreement to which this
Schedule IV
is
attached (the “Agreement”)), by their acceptance of the benefits of the
Agreement, hereby irrevocably designate Alexandra Global Master Fund Ltd., as
Collateral Agent, to act as specified herein and in the Agreement. Each Buyer
hereby irrevocably authorizes, and each other Holder of any Note by the
acceptance of such Note shall be deemed irrevocably to authorize, the Collateral
Agent to take such action on its behalf under the provisions of the Agreement
and any other instruments and agreements referred to herein or therein and to
exercise such powers and to perform such duties hereunder and thereunder as are
specifically delegated to or required of the Collateral Agent by the terms
hereof and thereof and such other powers as are reasonably incidental thereto.
The Collateral Agent may perform any of its duties hereunder by or through its
agents or employees.
2.
Nature of
Duties.
The
Collateral Agent shall have no duties or responsibilities except those expressly
set forth in the Agreement. Neither the Collateral Agent nor any of its
officers, directors, employees or agents shall be liable for any action taken or
omitted by it as such under the Agreement or hereunder or in connection herewith
or therewith, unless caused by its or their gross negligence or willful
misconduct. The duties of the Collateral Agent shall be mechanical and
administrative in nature; the Collateral Agent shall not have by reason of the
Agreement or any other Transaction Document a fiduciary relationship in respect
of any Holder; and nothing in the Agreement, expressed or implied, is intended
to or shall be so construed as to impose upon the Collateral Agent any
obligations in respect of the Agreement except as expressly set forth herein.
The Collateral Agent shall not take any material action or exercise any material
right or power pursuant to Section 5, 6 or 7 of this Agreement without the
authorization or direction of the Majority Holders;
provided
,
however
, that if
the Collateral Agent determines that it is unable to contact the Majority
Holders for purposes of seeking such authorization or direction or time will not
permit the Collateral Agent to so contact the Majority Holders prior to such
time as detriment may occur to the rights of the Collateral Agent or the Holders
from any failure of the Collateral Agent to act or exercise such right, then in
any such case the Collateral Agent may take such action or exercise such right
without specific authorization or direction from the Majority
Holders.
The
Collateral Agent shall not be liable for any act it may do or omit to do while
acting in good faith and in the exercise of its own best judgment. Any act done
or omitted by the Collateral Agent on the advice of its own attorneys shall be
deemed conclusively to have been done or omitted in good faith. The Collateral
Agent shall have the right at any time to consult with counsel on any question
arising under the Agreement. The Collateral Agent shall incur no liability for
any delay reasonably required to obtain the advice of counsel.
3.
Lack of Reliance on the Collateral
Agent
.
Independently and without reliance upon the Collateral Agent, each Holder, to
the extent it deems appropriate, has made and shall continue to make (i) its own
independent investigation of the financial condition and affairs of the Grantor
and its subsidiaries in connection with the making and the continuance of the
Obligations and the taking or not taking of any action in connection therewith,
and (ii) its own appraisal of the creditworthiness of the Grantor and its
subsidiaries, and the Collateral Agent shall have no duty or responsibility,
either initially or on a continuing basis, to provide any Holder with any credit
or other information with respect thereto, whether coming into its possession
before any Obligation arises or the purchase of any Note, or at any time or
times thereafter. The Collateral Agent shall not be responsible to any Holder
for any recitals, statements, information, representations or warranties herein
or in any document, certificate or other writing delivered in connection
herewith or for the execution, effectiveness, genuineness, validity,
enforceability, perfection, collectibility, priority or sufficiency of the
Agreement or the financial condition of the Grantor or be required to make any
inquiry concerning either the performance or observance of any of the terms,
provisions or conditions of the Agreement, or the financial condition of the
Grantor, or the existence or possible existence of any Event of
Default.
4.
Certain Rights of the Collateral
Agent.
No
Holder shall have the right to cause the Collateral Agent to take any action
with respect to the Collateral, with only the Majority Holders having the right
to direct the Collateral Agent to take any such action. If the Collateral Agent
shall request instructions from the Majority Holders with respect to any act or
action (including failure to act) in connection with the Agreement, the
Collateral Agent shall be entitled to refrain from such act or taking such
action unless and until it shall have received instructions from the Majority
Holders, and to the extent requested, appropriate indemnification in respect of
actions to be taken by the Collateral Agent; and the Collateral Agent shall not
incur liability to any person by reason of so refraining. Without limiting the
foregoing, no Holder shall have any right of action whatsoever against the
Collateral Agent as a result of the Collateral Agent acting or refraining from
acting hereunder in accordance with the instructions of the Majority Holders or
as otherwise specifically provided in the Agreement.
5.
Reliance
.
The
Collateral Agent shall be entitled to rely, and shall be fully protected in
relying, upon any note, writing, resolution, notice, statement, certificate,
telex, teletype or telecopier message, cablegram, radiogram, order or other
document or telephone message signed, sent or made by the proper person or
entity, and, with respect to all legal matters pertaining to the Agreement and
its duties thereunder, upon advice of counsel selected by it.
6.
Limitation of Holder
Liability.
The
Holders shall not be liable for any liabilities, obligations, losses, damages,
penalties, actions, judgments, suits, costs, expenses or disbursements of any
kind or nature whatsoever which may be imposed on, incurred by or asserted
against the Collateral Agent in performing its duties hereunder or under the
Agreement, or in any way relating to or arising out of the
Agreement.
7.
The Collateral Agent in its
Individual Capacity.
The
Collateral Agent and its affiliates may lend money to, purchase, sell and trade
in securities of and generally engage in any kind of business with the Grantor
or any affiliate or subsidiary of the Grantor as if it were not performing the
duties specified herein, otherwise without having to account for the same to the
Holders;
provided,
however,
that the
Collateral Agent on behalf of itself and such affiliates, hereby waives any
claim, right or lien against the Collateral in any way arising from or relating
to any such loan, securities transaction or business with the Grantor.
8.
Holders
.
The
Collateral Agent may deem and treat the holder of record of any Note as the
owner thereof for all purposes hereof unless and until a written notice of the
assignment or transfer thereof, as the case may be, shall have been filed with
the Collateral Agent. Any request, authority or consent of any person or entity
who, at the time of making such request or giving such authority or consent, is
the holder of record of any Note shall be conclusive and binding on any
subsequent holder, transferee or assignee, as the case may be, of such Note or
of any Note(s) issued in exchange therefor.
9.
Resignation by the Collateral
Agent.
(a) The
Collateral Agent may resign from the performance of all its functions and duties
under the Agreement at any time by giving 60 days' prior written notice (as
provided in the Agreement) to the Grantor and the Holders. Such resignation
shall take effect upon the appointment of a successor Collateral Agent pursuant
to clauses (b) and (c) below.
(b)
Upon any
such notice of resignation, the Majority Holders shall appoint a successor
Collateral Agent hereunder.
(c)
If a
successor Collateral Agent shall not have been so appointed within said 60-day
period, the Collateral Agent shall then appoint a successor Collateral Agent who
shall serve as Collateral Agent hereunder or thereunder until such time, if any,
as the Majority Holders appoint a successor Collateral Agent as provided above.
If a successor Collateral Agent has not been appointed within such 60-day
period, the Collateral Agent may petition any court of competent jurisdiction or
may interplead the Grantor and Holders in a proceeding for the appointment of a
successor Collateral Agent, and all fees, including but not limited to
extraordinary fees associated with the filing of interpleader, and expenses
associated therewith shall be payable by the Grantor.
(d)
The fees
of any successor Collateral Agent for its services as such shall be payable by
the Grantor.
Annex
V
LOCKBOX AGREEMENT
THIS LOCKBOX
AGREEMENT
, dated
as of July 21, 2006 (this “Agreement”), by and between
EMAGIN CORPORATION
, a
Delaware corporation (the “Company”), the bank or other financial institution
which may become a party hereto in accordance with Section 25, as lockbox agent
(the “Lockbox Agent”), and
ALEXANDRA GLOBAL MASTER FUND
LTD.
, a
British Virgin Islands international business company (the “Collateral
Agent”).
W
I
T
N
E
S
S
E
T
H
:
WHEREAS,
the
Company and the several Buyers (such capitalized term and all other capitalized
terms used in this Agreement having the meanings provided in Section 1) are
parties to the several Note Purchase Agreements, pursuant to which, among other
things, the Buyers have agreed to purchase the Notes from the Company;
WHEREAS,
contemporaneously with the execution and delivery of this Agreement, the Company
and the Collateral Agent are executing and delivering the Security Agreement
with the Collateral Agent pursuant to which, among other things, the Company is
granting a security interest in the Collateral, including, without limitation,
all of the Company's right, title and interest in and to all Accounts and
Contracts arising thereunder and the Collateral Account to the Collateral Agent
for the ratable benefit of the Holders;
WHEREAS,
in order
to give effect to and perfect the security interest in certain of the collateral
subject to the Security Agreement, this Agreement provides that all payments to
the Company pursuant to the Security Agreement shall be paid into a lockbox or a
Collateral Account controlled by the Lockbox Agent and disbursed from the
Collateral Account in accordance with the terms of this Agreement;
and
WHEREAS,
it is a
condition precedent to the several obligations of the Buyers to purchase their
respective Notes pursuant to the Note Purchase Agreements that the Company and
the Collateral Agent shall have executed and delivered this Agreement for the
ratable benefit of the Holders;
NOW THEREFORE
, in
consideration of the premises and the mutual covenants contained herein and
other good and valuable consideration, the receipt and sufficiency of which are
hereby acknowledged, the parties agree as follows:
1.
Definitions.
(a)
As used
in this Agreement, the terms “Agreement”, “Company”, “Collateral Agent”, and
“Lockbox Agent” shall have the respective meanings assigned to such terms in the
introductory paragraph of this Agreement.
(b)
All the
agreements or instruments herein defined shall mean such agreements or
instruments as the same may from time to time be supplemented or amended or the
terms thereof waived or modified to the extent permitted by, and in accordance
with, the terms thereof and of this Agreement.
(c)
Capitalized
terms used herein without definition shall have the respective meanings assigned
to such terms in the Notes.
(d)
The
following terms shall have the following meanings (such meanings to be equally
applicable to both the singular and plural forms of the terms
defined):
“Accounts”
shall have the meaning given such term in the Security Agreement.
“Additional
Note” means the Note issued pursuant to the Additional Note Purchase
Agreement.
“Additional
Note Purchase Agreement” means the Note Purchase Agreement, dated as of July 21,
2006, by and between the Company and Stillwater LLC, which by its terms
contemplates the issuance of up to $500,000 aggregate principal amount of Notes
on or after December 10, 2006.
“Agreement”
means this Lockbox Agreement, as amended, supplemented or otherwise modified
from time to time.
“Available
Specified Funds” means with respect to each Deposit Date the amount of the
Specified Funds less the Retained Amount.
“Buyer”
means any of the several buyers party to a Note Purchase Agreement.
“Collateral”
shall have the meaning given such term in the Security Agreement.
“Collateral
Account” means the account maintained at the Collateral Agent for the ratable
benefit of the Holders which is identified in clause (b) of Section 2 and
entitled “eMagin Noteholder Collateral Account”, and any successor or
replacement account.
“Deposit
Date” shall have the meaning given such term in Section 7(a).
“Event of
Default” means:
(1)
the
failure by the Company to perform in any material respect any obligation of the
Company under this Agreement as and when required by this
Agreement;
(2)
any
representation or warranty made by the Company pursuant to this Agreement shall
have been untrue in any material respect when made or deemed to have been made;
or
(3)
any Event
of Default, as that term is defined in the Security Agreement;
(4)
any Event
of Default, as that term is defined in the Patent and Trademark Security
Agreement; or
(5)
any Event
of Default, as that term is defined in any of the Notes.
“Event of
Default Notice” means a notice given by the Company, the Collateral Agent or a
Holder to the Lockbox Agent of the occurrence of an Event of
Default.
“Holder”
means any Buyer or any holder from time to time of any Note.
“Instruction”
shall have the meaning provided in Section 2(a).
“Lien”
shall mean any lien, mortgage, security interest, chattel mortgage, pledge or
other encumbrance (statutory or otherwise) of any kind securing satisfaction or
performance of an obligation, including any agreement to give any of the
foregoing, any conditional sales or other title retention agreement, any lease
in the nature thereof, and the filing of or the agreement to give any financing
statement under the Code of any jurisdiction or similar evidence of any
encumbrance, whether within or outside the United States.
“Lockbox”
means the lockbox administered by the Lockbox Agent for the ratable benefit of
the Holders which is identified in clause (a) of Section 2, and any successor or
replacement lockbox.
“Lockbox
Agent's Designees” shall have the meaning given such term in Section
10(a).
“Majority
Holders” means at any time such of the holders of Notes, which based on the
outstanding principal amount of the Notes, represents a majority
of the
aggregate outstanding principal amount of the Notes.
“Note
Purchase Agreements” means the several Note Purchase Agreements, dated as of
July 21, 2006, by and between the Company and the respective Buyer party thereto
pursuant to which the Company issued the Notes, including, without limitation,
the Additional Note Purchase Agreement.
“Notes”
means the Company’s 6% Senior Secured Convertible Notes due 2007-2008 originally
issued pursuant to the Note Purchase Agreements, including, without limitation,
the Additional Note.
“Notice
Date” means the date on which the Company gives the Instruction in accordance
with Section 2.
“Obligations
Schedule” means a schedule prepared by the Company which for each Holder and
each Note held thereby states, as of the date thereof, the
following:
(i)
such
Holder's name, address, telephone line facsimile transmission number and payment
instructions, including wire transfer instructions,
(ii)
the
original principal amount, the outstanding principal amount and the and the
maturity date of the Note,
(iii)
the
amount of accrued and unpaid interest on each Note,
(iv)
the
amount of unpaid interest due on each Note as of the most recent Interest
Payment Date,
(v)
the
amount of unpaid Default Interest, if any, due on each Note,
(vi)
the
occurrence or continuation of any Event of Default with respect to each Note,
(vii)
the
occurrence of any event which with notice or the passage of time, or both, could
become an Event of Default,
(viii)
the
amount, due date of, and reasons for any unpaid obligation due with respect to
each Note by reason of (A) an Event of Default or (B) any other repurchase,
redemption or acceleration obligation, and
(ix)
the
aggregate amount then due to the Holder with respect to each Note.
“Patent
and Trademark Security Agreement” means the Patent and Trademark Security
Agreement, dated as of July 21, 2006, between the Company and the Collateral
Agent.
“Person”
means any natural person, corporation, partnership, limited liability company,
trust, incorporated organization, unincorporated association or similar entity
or any government, governmental agency or political subdivision.
“Retained
Amount” means that portion, which may be all, of the Specified Funds for each
Deposit Date which equal (to the extent of the Specified Funds available) the
sum of all amounts with respect to the Notes which are scheduled to accrue or
which otherwise are expected to become due to the Holders during the Retention
Period for principal of and interest and Default Interest on the Notes or for
costs and expenses arising under the Transaction Documents and payable by the
Company.
“Retention
Period” means the 45-day period after each Deposit Date.
“Security
Agreement” means the Pledge and Security Agreement, dated as of July 21, 2006,
between the Company and the Collateral Agent.
“Specified
Funds” shall have the meaning given such term in Section 7(a).
“Subsidiary”
means any corporation or other entity of which a majority of the capital stock
or other ownership interests having ordinary voting power to elect a majority of
the board of directors or other Persons performing similar functions are at the
time directly or indirectly owned by the Company.
“Termination
Notice” means a notice given to the Lockbox Agent by and signed by the Company,
the Majority Holders and the Collateral Agent, which notice states that a
particular Event of Default has terminated or has been satisfied or waived and
no Holder has any continuing rights with respect thereto.
“Transaction
Documents” means the Notes, the Note Purchase Agreements, this Agreement, the
Security Agreement, the Patent and Trademark Security Agreement, the Warrants
and the other agreements, instruments and documents contemplated hereby and
thereby.
2.
Payments.
(a) The
Company agrees, that, upon the direction of the Collateral Agent given at any
time that an Event of Default has occurred and is continuing, in accordance with
Section 3(b) of the Security Agreement the Company shall irrevocably instruct in
writing (the “Instruction”) all the account debtors on the Accounts that
constitute part of the Collateral and all of the parties (other than the
Company) who are parties to Contracts that constitute part of the Collateral
that such Accounts and Contracts have been assigned to the Collateral Agent for
the ratable benefit of the Holders and that payments in respect thereof shall be
shall be made either
(i)
by check
or money order to the address of the Lockbox, which address shall be identified
to the Company by the Collateral Agent or if the Lockbox Agent is a bank shall
be the address of the office of the Lockbox Agent, or
(ii)
by wire
transfer of funds to the Collateral Account, which account shall be identified
to the Company by the Collateral Agent.
If the
Company fails to give the Instruction in accordance with Section 3(b) of the
Security Agreement, the Collateral Agent may, in its own name or in the name of
the Company, give the Instruction directly to the account debtors on the
Accounts that constitute part of the Collateral and to all of the parties to
Contracts that constitute part of the Collateral.
(b)
If the
Collateral Agent shall so require, at or prior to the time any Person who has
not already received the Instruction is to become an account debtor on Accounts
that constitute part of the Collateral or a party to Contracts that constitute
part of the Collateral, the Company shall instruct such Person that such
Accounts and Contracts have been assigned to the Collateral Agent for the
ratable benefit of the Holders and that payments in respect thereof shall be
made in the manner set forth in Section 2(a). If the Company fails to give the
instructions in accordance with this Section 2(b), the Collateral Agent may, in
its own name or in the name of the Company, give such instructions directly to
such Person.
3.
No Contrary Instructions.
Without
the prior written consent of the Collateral Agent and the Majority Holders, the
Company shall not revoke, rescind or modify the Instruction or take any other
action which is contrary to or inconsistent with this Agreement or the Security
Agreement. If for any reason the Company receives any payment from an account
debtor or party to a Contract on or after the Notice Date, the Company shall
immediately deposit such payment, and any interest or proceeds thereon, in the
Collateral Account. Prior to such deposit, the Company shall hold all such funds
in trust for the exclusive benefit of the Collateral Agent and the Holders
pursuant to this Agreement.
4.
Lockbox.
The
Lockbox shall be under the sole and exclusive control of the Lockbox Agent, as
agent for the Collateral Agent only. On each Business Day on or after the date
the Company gives or is required to give the Instruction, the Lockbox Agent will
remove all items from the Lockbox and promptly deposit all checks, money orders
and other payments included in such items in the Collateral Account. The Company
irrevocably authorizes and directs the Lockbox Agent to endorse and deposit all
such checks and money orders in the Collateral Account on the Business Day of
receipt by the Lockbox.
5.
Collateral
Account.
The
Collateral Account shall be under the sole and exclusive control of the Lockbox
Agent, as agent for the Collateral Agent only. All cash deposited in the
Collateral Account pursuant to this Agreement, and all interest earned thereon,
shall be held in the Collateral Account and shall at all times be segregated
from the funds and property of any other Person. The Collateral Account shall be
an interest-bearing account which pays interest at the rate determined from time
to time by the Lockbox Agent for comparable, fully liquid commercial accounts.
Without the prior consent of the Company, the Collateral Agent and the Majority
Holders, the assets in the Collateral Account shall be held in cash only and
shall not be invested in any securities. Funds may be withdrawn from the
Collateral Account only as expressly provided in this Agreement.
6.
Events of
Default.
Upon the
occurrence of an Event of Default, the Company shall immediately, and the
Collateral Agent may at any time, notify the Lockbox Agent thereof by giving an
Event of Default Notice. If an Event of Default Notice is so given to the
Lockbox Agent by the Company or the Collateral Agent, then thereafter the
Lockbox Agent shall deem an Event of Default to have occurred and be continuing
for all purposes unless and until the Lockbox Agent receives a Termination
Notice executed by the Company, the Majority Holders and the Collateral
Agent.
7.
Release of
Funds.
(a) Three
Business Days after the Business Day on which funds received from any person are
deposited into the Collateral Account in a minimum amount of
$100,000
(or which
would increase the balance in the Collateral Account to at least $100,000) (the
“Deposit Date”), the Lockbox Agent shall disburse the amount of funds, including
interest received, held in the Collateral Account on such Deposit Date (the
“Specified Funds”) as follows:
(i)
First, to
pay each Holder on a pro rata basis the amount of all accrued and unpaid
interest and Default Interest, if any, then due each Holder in accordance with
the terms of their respective Notes through the most recent Interest Payment
Date;
(ii)
Second,
to pay each Holder on a pro rata basis the unpaid amount, if any, then due such
Holder pursuant to Article II of the Notes for any Determination Period ended at
least 45 days prior to the date of such payment;
(iii)
Third, to
pay each Holder on a pro rata basis the amount, if any, of unpaid principal then
due on the maturity date of any installment of principal of such Holder's Notes;
(iv)
Fourth,
to the Holders and the Collateral Agent to pay or reimburse them for their
respective amounts of costs and expenses payable by the Company pursuant to the
Transaction Documents and not theretofore paid or reimbursed by the Company
(including under this Section 7(a)); and
(v)
Fifth, if
no Event of Default shall have occurred and be deemed continuing pursuant to
Section 6, to pay the Available Specified Funds remaining in the Collateral
Account to the Company.
(b)
During
each Retention Period, the Lockbox Agent shall hold the Retained Amount in the
Lockbox Account. On the Business Day following the end of such Retention Period,
the Lockbox Agent shall (1) pay each Holder, on a pro rata basis, from the
Retained Amount any unpaid amounts due to the Holders for interest, Default
Interest and principal as described in clauses (i)-(iii) of Section 7(a) which
have accrued and become due during the Retention Period and then (2) pay costs
and expenses of the Holders and the Collateral Agent as described in clause (iv)
of Section 7(a) and then (3) provided no Event of Default shall have occurred
and be continuing, pay the remaining Retained Amount to the
Company.
(c)
If an
Event of Default shall have occurred and be continuing, after disbursing the
Specified Funds in the Collateral Account pursuant to clauses (i) through (iv)
of Section 7(a), the Lockbox Agent shall disburse the remaining Specified Funds
to pay each Holder, on a pro rata basis, the amount of unpaid principal then due
upon acceleration, if any, pursuant to Article IV of such Holder's Note(s);
provided, however,
that if
the amount of such Specified Funds is insufficient to pay all amounts due to the
Holders, then the amount paid to the Holders pursuant to this Section 7(c) shall
be prorated among the Holders in proportion to the respective amounts due each
Holder.
(d)
For each
Deposit Date, after making the payments to the Holders required by Sections 7(b)
and 7(c) and after the Company shall have paid the Holders any other amounts
then due under the Notes, the Lockbox Agent shall pay to the Company all
Specified Funds remaining in the Collateral Account. Funds received in the
Collateral Account and interest received thereon after any Deposit Date shall be
deemed new Specified Funds to be disbursed, three Business Days after the next
Deposit Date to occur, in accordance with all of the provisions and priorities
of this Section 7 before being paid to the Company.
8.
Reporting Requirements; Payment
Instructions.
(a) On
or before the Notice Date, on the first Business Day of each calendar month
thereafter, and at such other times as requested by the Lockbox Agent in order
to comply with its obligations under this Agreement or by the Collateral Agent,
the Company shall furnish to the Lockbox Agent and the Collateral Agent an
updated Obligations Schedule. The Company shall promptly correct any errors in
any Obligations Schedule and furnish copies of such corrected Obligations
Schedule to the Lockbox Agent and the Collateral Agent. If the Collateral Agent
or any Holder shall notify the Lockbox Agent and the Company of any error in or
dispute concerning an Obligations Schedule, the Lockbox Agent shall not release
any funds from the Collateral Account which are the subject of such error or
dispute until such error is corrected or such dispute is resolved with the
consent of the affected Holders and the Company. The Lockbox Agent may release
from the Collateral Account, in accordance with this Agreement, funds which are
not subject to such error or dispute.
(b)
All
payments by the Lockbox Agent to the Holders under this Agreement shall be made
by wire transfer of immediately available funds to the applicable account, or if
no wire transfer instructions are given to the address, specified for each
Holder in the Obligations Schedule or in a superseding notice given by a Holder
to the Lockbox Agent. All payments by the Lockbox Agent to the Company under
this Agreement shall be deposited in the Company's separate account maintained
at the Lockbox Agent or shall be sent by wire transfer of immediately available
funds to such other account as the Company shall have specified by notice to the
Lockbox Agent.
9.
Representations and
Warranties.
The
Company hereby represents and warrants to and for the benefit of the Lockbox
Agent, the Collateral Agent and the Holders that:
(a)
Power and
Authority.
The
Company has full power, authority and legal right to enter into this
Agreement.
(b)
Binding Obligation
.
This
Agreement has been duly authorized by the Company and has been duly executed and
delivered by the Company and constitutes a legal, valid and binding obligation
of the Company enforceable against the Company in accordance with its
terms.
(c)
Non-Contravention.
The
execution, delivery and performance of this Agreement will not violate any
provision of any applicable law or regulation or of any order, judgment, writ,
award or decree of any court, arbitrator or governmental authority, domestic or
foreign, or of any securities issued by the Company or any Subsidiary, or of any
mortgage, indenture, lease, contract or other agreement, instrument or
undertaking to which the Company or any Subsidiary is a party or which purports
to be binding upon the Company or any Subsidiary or upon any of their respective
assets and will not result in the creation or imposition of any Lien on any of
the assets of the Company or any Subsidiary except as expressly permitted by
this Agreement and the other Transaction Documents.
(d)
Consents
.
No
consent (other than consents which have been obtained) of any party, and no
filing, approval, registration, recording or other action is required in
connection with the execution, delivery or performance of this Agreement by the
Company.
10.
Limitation of
Liability.
The
Lockbox Agent's liability in connection with the performance of the transactions
covered by this Agreement shall be strictly limited as follows:
(a)
The
Lockbox Agent shall exercise ordinary care in selecting agents and independent
contractors, adequately bonded, to pick up and deliver the contents of the
Lockbox (“Lockbox Agent's Designees”) but shall not be liable for loss caused by
Lockbox Agent's Designees' negligence or misconduct. In the event of such loss,
the Lockbox Agent will exercise its commercially reasonable best efforts, at the
Company's cost and expense, to assist the Company in obtaining redress from the
responsible party.
(b)
The
Lockbox Agent shall exercise its commercially reasonable best efforts in
determining the optimum time to pick up mail at the Lockbox and the best carrier
to deliver that mail to the Lockbox Agent’s designated processing facility.
However, the Lockbox Agent shall not be liable if the chosen pickup time and
carrier prove not to result in the earliest possible availability of
funds.
(c)
In
performing it duties hereunder, the Lockbox Agent will exercise ordinary care
and will act in good faith. The Lockbox Agent will not be accountable for its
failure to perform any of its obligations hereunder, except for its gross
negligence or willful misconduct, or that of its employees, officers or agents.
If, as a result of such gross negligence or willful misconduct, the Lockbox
Agent is liable for mishandling any item, such liability shall be limited to the
lesser of the face amount of any check involved or the amount of the Company's
direct loss as a result of such mishandling, and in no event shall the Lockbox
Agent be responsible for any incidental or consequential damages. IN NO EVENT
SHALL THE LOCKBOX AGENT BE LIABLE FOR ANY INDIRECT OR CONSEQUENTIAL DAMAGES OR
LOSS OF PROFIT, NOTWITHSTANDING NOTICE TO THE LOCKBOX AGENT OF THE POSSIBILITY
OF SUCH DAMAGES OR LOSSES.
11.
Indemnification.
The
Company agrees to pay, indemnify, and to save the Lockbox Agent, the Collateral
Agent and each Holder harmless from, any and all liabilities, costs and expenses
(including, without limitation, legal fees and expenses) (i) with respect to, or
resulting from, any delay in paying any and all excise, sales or other taxes
which may be payable or determined to be payable with respect to the Collateral
Account, (ii) with respect to, or resulting from, any failure or delay by the
Company in complying with any law or regulation applicable to the Collateral
Account or (iii) in connection with this Agreement, any breach or alleged breach
hereof, or any action taken by the Lockbox Agent, the Collateral Agent or any
Holder in exercising its rights hereunder.
12.
Security
Agreement.
The
Collateral Account and the Lockbox, and all funds due to the Company and
deposited in the Lockbox and the Collateral Account, are subject to the security
interest of the Collateral Agent pursuant to the Security Agreement in
accordance with the terms thereof.
13.
Paragraph Headings, Captions,
Etc.
The
paragraph headings, the captions and the footers used in this Agreement are for
convenience of reference only and are not to affect the construction hereof or
be taken into consideration in the interpretation hereof.
14.
No Waiver; Cumulative
Remedies.
The
Lockbox Agent shall not by any act, delay, indulgence, omission or otherwise be
deemed to have waived any right or remedy hereunder or to have acquiesced in any
default or breach of any of the terms and conditions hereof. No failure to
exercise, nor any delay in exercising, on the part of the Lockbox Agent, any
right, power or privilege hereunder shall operate as a waiver thereof. No single
or partial exercise of any right, power or privilege hereunder shall preclude
any other or further exercise thereof or the exercise of any other right, power
or privilege. A waiver by the Lockbox Agent, the Collateral Agent or the Holders
of any right or remedy hereunder on any one occasion shall not be construed as a
bar to any right or remedy which the Lockbox Agent, the Collateral Agent or the
Holders would otherwise have on any future occasion. The rights and remedies
herein and in the Transaction Documents are cumulative, may be exercised singly
or concurrently and are not exclusive of any rights or remedies provided by law
or in equity or by statute.
15.
Waivers and Amendments; Successors
and Assigns.
None of
the terms or provisions of this Agreement may be waived, amended, supplemented
or otherwise modified except by a written instrument executed by the party to be
charged with enforcement;
provided, however,
that any
provision of this Agreement may be waived, amended, supplemented or otherwise
modified by the Lockbox Agent only with the prior written approval of the
Collateral Agent or the Majority Holders. This Agreement shall be binding upon
the successors and permitted assigns of the Company and shall inure to the
benefit of the Lockbox Agent and its successors and assigns. The Company may not
assign its rights or obligations under this Agreement without the prior written
consent of the Lockbox Agent, which the Lockbox Agent may withhold in its sole
discretion.
16.
Effective Date;
Termination.
This
Agreement shall become effective at the time of first issuance of any Note on
the earliest Issuance Date when executed and delivered by the Company and the
Collateral Agent. Upon the payment and performance in full by the Company of its
obligations under the Transaction Documents, the Company's obligations to the
Lockbox Agent and the Holders pursuant to Sections 2 through 8 shall terminate,
any funds remaining in the Collateral Account shall be paid to the Company, and
promptly thereafter the parties shall instruct the account debtors on all
Accounts that theretofore constituted Collateral and all parties to Contracts
that theretofore constituted Collateral to make all further payments due to the
Company directly to the Company.
17.
Notices.
Except
as otherwise specifically provided herein, any notice required or permitted to
be given under the terms of this Agreement shall be given in writing and shall
be deemed effectively given upon personal delivery to the party to be notified
or five days after deposit with the United States Postal Service, by registered
or certified mail, postage prepaid to the party to be notified at such party’s
address indicated in this Section 17 or at such other address as such party may
designate by ten days’ advance written notice to the other parties. Notices in
writing shall also be deemed effectively given upon delivery by an overnight
courier, or upon transmission by facsimile, except that the time at which the
notice is given will be the time at which confirmation of receipt is generated
by the receiving facsimile
machine. In the case of any notice to
the Company, such notice shall be addressed to the Company at, 10500 N.E.
8th Street, Suite 1400, Bellevue, WA 98004 Attention: Chief Financial
Officer (telephone line facsimile number (425) 749-3601), with a copy to
Sichenzia Ross Friedman Ference LLP, 1065 Avenue of the Americas,
21st Floor, New York, New York 10018, Attention: Richard A. Friedman, Esq.
(telephone line facsimile number (212) 930-9725), and in the case of any notice
to the Collateral Agent or to the Collateral Agent while it serves as Lockbox
Agent, such notice shall be addressed to the Collateral Agent (or Lockbox Agent,
as applicable) at Alexandra Global Master Fund Ltd., c/o Alexandra Investment
Management, LLC, 767 Third Avenue, 39th Floor, New York, New York 10017
(telephone line facsimile number (212) 301-1810), and if the Collateral Agent is
not the Lockbox Agent, in the case of any notice to the Lockbox Agent, such
notice shall be addressed to the Lockbox Agent at its address or telephone line
facsimile transmission number provided in writing to the Company and the
Collateral Agent at the time it becomes the Lockbox Agent.
18.
Fees and
Expenses.
The
Company agrees to pay the fees of the Lockbox Agent in performing its services
under this Agreement and all reasonable expenses (including, but not limited to,
attorneys' fees and costs for legal services, costs of insurance and payments of
taxes or other charges) of, incidental to, or in any way relating to the
performance by the Lockbox Agent of its obligations and the enforcement or
protection of the rights of the Lockbox Agent hereunder.
19.
Concerning
Lockbox
Agent.
The
Company acknowledges that the rights and responsibilities of the Lockbox Agent
under this Agreement with respect to any action taken by the Lockbox Agent or
the exercise or nonexercise by the Lockbox Agent of any option, right, request,
judgment or other right or remedy provided for herein or resulting or arising
out of this Agreement shall, as between the Lockbox Agent and the Holders, be
governed by
Exhibit A
to this
Agreement and by such other agreements with respect thereto as may exist from
time to time among them, but, as between the Lockbox Agent and the Company,
except as expressly provided in Section 16, the Lockbox Agent shall be
conclusively presumed to be acting as agent for the Collateral Agent with full
and valid authority so to act or refrain from acting, and the Company shall not
be under any obligation to make any inquiry respecting such authority.
20.
Concerning the Collateral
Agent.
The
Collateral Agent hereby appoints the Lockbox Agent as its agent upon the terms
provided in this Agreement, with the Lockbox Agent to act exclusively for the
benefit of the Collateral Agent. The Collateral Agent is executing and
delivering this Agreement solely for purposes of this Section 20.
21.
Integration.
This
Agreement represents the entire agreement of the Company and the Lockbox Agent
with respect to the subject matter hereof, and there are no promises,
undertakings, representations or warranties by the parties relative to the
subject matter hereof not expressly set forth or referred to
herein.
22.
Governing
Law.
This
Agreement and the rights and obligations of the Company under this Agreement
shall be governed by, and construed and interpreted in accordance with, the law
of the State of New York.
23.
Counterparts;
Execution.
This
Agreement may be executed in any number of counterparts and all the counterparts
taken together shall be deemed to constitute one and the same instrument. This
Agreement, once executed by a party, may be delivered to the other party hereto
by telephone line facsimile transmission of a copy of this Agreement bearing the
signature of the party so delivering this Agreement.
24.
Third Party
Beneficiaries.
The
Collateral Agent and the Holders shall be third party beneficiaries of this
Agreement.
25.
Collateral Agent as Lockbox
Agent.
Whenever
there shall not be a bank or other financial institution serving as Lockbox
Agent, the Collateral Agent shall serve as Lockbox Agent. The Collateral Agent
may select a bank or financial institution to serve as Lockbox Agent. During any
period that the Collateral Agent serves as Lockbox Agent any reference to the
Collateral Agent in this Agreement shall be a nullity. A bank selected by the
Collateral Agent to serve as Lockbox Agent may, by executing and delivering to
the Company and the Collateral Agent a counterpart of this Agreement, become a
party to this Agreement, as Lockbox Agent, whereupon, the Collateral Agent shall
cease to be the Lockbox Agent, and the Company agrees to all amendments to the
form of this Agreement as such bank or financial institution so selected by the
Collateral Agent to serve as Lockbox Agent may require. While the Collateral
Agent serves as Lockbox Agent, it may maintain the Collateral Account at a bank
selected by the Collateral Agent, notwithstanding any provision of this
Agreement to the contrary.
26.
Construction.
The
language used in this Agreement will be deemed to be the language chosen by the
parties to express their mutual intent, and no rules of strict construction will
be applied against any party.
[Signature page
follows]
IN WITNESS WHEREOF
, the
Company has caused this Agreement to be duly executed and delivered as of the
date first above written.
|
|
|
|
EMAGIN
CORPORATION
|
|
|
|
|
By:
|
/s/ Gary W.
Jones
|
|
Name: Gary W. Jones
|
|
Title:
Chief Executive Officer
|
ACKNOWLEDGED
AND AGREED:
ALEXANDRA GLOBAL MASTER FUND
LTD.,
as Collateral Agent and Lockbox
Agent
BY: Alexandra Investment Management,
LLC,
as Investment
Advisor
|
|
|
|
/s/ Mikhail
Filimonov
|
|
|
|
Name
Mikhail Filimonov
Title Chairman and Chief Executive Officer
|
|
|
|
|
|
|
|
Exhibit A
The Lockbox Agent
1.
Appointment.
The
Holders (all capitalized terms used in this Exhibit A and not otherwise defined
herein shall have the respective meanings provided in the Lockbox Agreement to
which this Exhibit A is attached (the “Agreement”)), by their acceptance of the
benefits of the Agreement, hereby irrevocably designate Alexandra Global Master
Fund Ltd. as Lockbox Agent to act as specified herein and in the Agreement. Each
Investor hereby irrevocably authorizes, and each other Holder of any Note by the
acceptance of such Note shall be deemed irrevocably to authorize, the Lockbox
Agent to take such action on its behalf under the provisions of the Agreement
and any other instruments and agreements referred to herein or therein and to
exercise such powers and to perform such duties hereunder and thereunder as are
specifically delegated to or required of the Lockbox Agent by the terms hereof
and thereof and such other powers as are reasonably incidental thereto. The
Lockbox Agent may perform any of its duties hereunder by or through its agents
or employees.
2.
Nature of
Duties.
The
Lockbox Agent shall have no duties or responsibilities except those expressly
set forth in the Agreement. Neither the Lockbox Agent nor any of its officers,
directors, employees or agents shall be liable for any action taken or omitted
by it as such under the Agreement or hereunder or in connection herewith or
therewith, unless caused by its or their gross negligence or willful misconduct.
The duties of the Lockbox Agent shall be mechanical and administrative in
nature; the Lockbox Agent shall not have by reason of the Agreement or any other
Transaction Document a fiduciary relationship in respect of the Collateral Agent
or any Holder; and nothing in the Agreement, expressed or implied, is intended
to or shall be so construed as to impose upon the Lockbox Agent any obligations
in respect of the Agreement except as expressly set forth herein.
The
Lockbox Agent shall not be liable for any act it may do or omit to do while
acting in good faith and in the exercise of its own best judgment. Any act done
or omitted by the Lockbox Agent on the advice of its own attorneys shall be
deemed conclusively to have been done or omitted in good faith. The Lockbox
Agent shall have the right at any time to consult with counsel on any question
arising under the Agreement. The Lockbox Agent shall incur no liability for any
delay reasonably required to obtain the advice of counsel. Nothing herein shall
constitute a release or waiver of such legal counsel from any liability it may
have for the advice given to the Lockbox Agent.
3.
Lack of Reliance on the
Lockbox
Agent
.
Independently and without reliance upon the Lockbox Agent, the Collateral Agent
and each Holder, to the extent it deems appropriate, has made and shall continue
to make (i) its own independent investigation of the financial condition and
affairs of the Company and its subsidiaries in connection with the making and
the continuance of the Company's obligations under the Transaction Documents and
the taking or not taking of any action in connection therewith, and (ii) its own
appraisal of the creditworthiness of the Company and its subsidiaries, and the
Lockbox Agent shall have no duty or responsibility, either initially or on a
continuing basis, to provide the Collateral Agent or any Holder with any credit
or other information with respect thereto, whether coming into its possession
before any such obligation arises or the purchase of any Note, or at any time or
times thereafter. The Lockbox Agent shall not be responsible to the Collateral
Agent or any Holder for any recitals, statements, information, representations
or warranties herein or in any document, certificate or other writing delivered
in connection herewith or for the execution, effectiveness, genuineness,
validity, enforceability or sufficiency of the Agreement or the financial
condition of the Company or be required to make any inquiry concerning either
the performance or observance of any of the terms, provisions or conditions of
the Agreement, or the financial condition of the Company, or the existence or
possible existence of any Event of Default.
4.
Certain Rights of the Lockbox
Agent.
No Holder
shall have the right to cause the Lockbox Agent to take any action with respect
to the Lockbox or the Collateral Account, with only the Collateral Agent or the
Majority Holders having the right to direct the Lockbox Agent to take any such
action. If the Lockbox Agent shall request instructions from the Collateral
Agent or the Majority Holders with respect to any act or action (including
failure to act) in connection with the Agreement, the Lockbox Agent shall be
entitled to refrain from such act or taking such action unless and until it
shall have received instructions from the Collateral Agent or the Majority
Holders, and to the extent requested, appropriate indemnification in respect of
actions to be taken by the Lockbox Agent; and the Lockbox Agent shall not incur
liability to any Person by reason of so refraining. Without limiting the
foregoing, neither the Collateral Agent nor any Holder shall have any right of
action whatsoever against the Lockbox Agent as a result of the Lockbox Agent
acting or refraining from acting hereunder in accordance with the instructions
of the Collateral Agent or the Majority Holders or as otherwise specifically
provided in the Agreement.
5.
Reliance
.
The
Lockbox Agent shall be entitled to rely, and shall be fully protected in
relying, upon any note, writing, resolution, notice, statement, certificate,
telephone line facsimile transmission, email, telex, teletype or telecopier
message, cablegram, radiogram, order or other document or telephone message
signed, sent or made by the proper Person, and, with respect to all legal
matters pertaining to the Agreement and its duties thereunder, upon advice of
counsel selected by it.
6.
Limitation of Collateral Agent and
Holder Liability.
The
Collateral Agent and the Holders shall not be liable for any liabilities,
obligations, losses, damages, penalties, actions, judgments, suits, costs,
expenses or disbursements of any kind or nature whatsoever which may be imposed
on, incurred by or asserted against the Lockbox Agent in performing its duties
hereunder or under the Agreement, or in any way relating to or arising out of
the Agreement.
7.
The Lockbox Agent in its Individual
Capacity.
The
Lockbox Agent and its affiliates may lend money to, purchase, sell and trade in
securities of and generally engage in any kind of business with the Company or
any affiliate or subsidiary of the Company as if it were not performing the
duties specified herein, and may accept fees and other consideration from the
Company for services to the Company in connection with the Transaction Documents
and otherwise without having to account for the same to the Holders;
provided,
however,
that the
Collateral Agent on behalf of itself and such affiliates, hereby waives any
claim, right or Lien against the Collateral Account in any way arising from or
relating to any such loan, securities transaction or business with the
Company.
8.
Holders
.
The
Lockbox Agent may deem and treat the holder of record of any Note as the owner
thereof for all purposes hereof unless and until a written notice of the
assignment or transfer thereof, as the case may be, shall have been filed with
the Lockbox Agent. Any request, authority or consent of any Person or entity
who, at the time of making such request or giving such authority or consent, is
the holder of record of any Note shall be conclusive and binding on any
subsequent holder, transferee or assignee, as the case may be, of such Note or
of any Note(s) issued in exchange therefor.
9.
Resignation by the
Lockbox
Agent.
(a) The
Lockbox Agent may resign from the performance of all its functions and duties
under the Agreement at any time by giving 60 Business Days' prior written notice
(as provided in the Agreement) to the Company, the Collateral Agent and the
Holders. Such resignation shall take effect upon the appointment of a successor
Lockbox Agent pursuant to clauses (b) and (c) below.
(b)
Upon any
such notice of resignation, the Collateral Agent shall appoint a successor
Lockbox Agent hereunder.
(c)
If a
successor Lockbox Agent shall not have been so appointed within said 60 Business
Day period, the Lockbox Agent shall then appoint a successor Lockbox Agent who
shall serve as Lockbox Agent hereunder or thereunder until such time, if any, as
the Collateral Agent appoints a successor Lockbox Agent as provided above. If a
successor Lockbox Agent has not been appointed within such 60-day period, the
Lockbox Agent may, at the sole cost and expense of the Company, petition any
court of competent jurisdiction or may interplead the Company, the Collateral
Agent and the Holders in a proceeding for the appointment of a successor Lockbox
Agent, and all fees, including but not limited to extraordinary fees associated
with the filing of interpleader, and expenses associated therewith shall be
payable by the Company.
(d)
The fees
of any successor Lockbox Agent for its services as such shall be payable by the
Company.
Annex
VI
Press
Release
eMagin
Enters Into Agreements To Raise
Approximately
$6.5 Million Private Placement
BELLEVUE,
Wash., July 24, 2006 – eMagin Corporation (AMEX: EMA), a leader in virtual
imaging technology, has entered into definitive agreements with institutional
and accredited investors for the sale of approximately $6.5 million of senior
secured convertible debentures and warrants. The net proceeds from the financing
will be used for general working capital purposes.
Under the
agreements, investors agreed to purchase $5,970,000 principal amount of notes
with conversion prices of $0.26 per share that may convert into 22,192,301
shares of common stock and 5 year warrants exercisable at $0.36 per share for
15,534,607 shares of common stock. An additional $500,000 will be invested
through exercise of a warrant to purchase approximately 1.92 million shares of
common stock at $0.26 per share prior to December 14, 2006 or, at the request of
the Company, by the purchase of additional notes and warrants. If not converted
half of the principal amount will be due July 21, 2007 and the remaining balance
due January 21, 2008. Interest at 6% per annum is payable in quarterly
installments on outstanding Notes during their term commencing on September 1,
2006.
In a
showing of commitment to the Company’s prospects, Paul Cronson, Director, John
Atherly, Chief Financial Officer, and Olivier Prache, Senior Vice President of
Display Manufacturing and Development Operations participated in the
transaction, and Gary Jones, Chief Executive Officer and Susan Jones, Chief
Marketing and Strategy Officer, who collectively own 5% of the Company’s
outstanding shares, agreed to defer 10% of their compensation until eMagin
becomes EBITDA positive or until the occurrence of certain other
events.
In
conjunction with the note purchase transaction the Company will submit to
shareholders at its annual meeting a resolution to enact a reverse stock split
of 1 for 10 which, if approved, normalizes the company’s share price and shares
outstanding.
In order
to reestablish performance incentives employees and Directors have also agreed
to forfeit approximately 4.7 million shares of existing stock options in return
for re-pricing 8.8 million existing options at $0.26 per share. Re-priced
options will not be exercisable until 2007 or in some cases not until 2011,
depending on individual grant-vesting schedules.
In
addition, to further strengthen its management team the Company intends to add
two new Directors recommended by the new investors and to recruit additional
senior management.
Additional
details regarding the private placement are provided on Form 8-K which is being
filed today. Representing the company in this transaction was Sichenzia
Ross Friedman Ference, LLP.
The note
shares and warrants are being issued in a private placement under regulation D
of the Securities Act of 1933, as amended. The company has agreed to file a
registration statement covering the resale of the common stock and underlying
the notes and warrants purchased by these investors following the closing.
This press release does not constitute an offer to sell, or the solicitation of
an offer to buy, any securities, nor shall there be any sale of the securities
in any jurisdiction in which such offering would be unlawful.
About
eMagin Corporation
A leader
in OLED microdisplay and virtual imaging technologies, eMagin integrates
high-resolution OLED microdisplays, magnifying optics, and systems technologies
to create a virtual image that appears comparable to that of a computer monitor
or a large-screen television. eMagin’s OLED displays have broad market reach and
are incorporated into a variety of near-to-eye imaging products by military,
industrial, medical and consumer OEMs who choose eMagin’s award-winning
technology as a core component for their solutions. eMagin has recently
introduced its first direct-to-consumer system, the Z800 3DVisor, which provides
superb 3D stereovision and headtracking for PC gaming, training and simulation,
and business applications. eMagin's microdisplay manufacturing and R&D
operations are co-located with IBM on its campus in East Fishkill, New
York. System design facilities and sales and marketing are located in
Bellevue, Washington. A sales office is located in Tokyo, Japan. For additional
information, please visit www.emagin.com and www.3dvisor.com.
Forward
Looking Statements
This
press release contains forward-looking statements within the meaning of Section
27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act
of 1934, including those regarding eMagin Corporation and its subsidiaries'
expectations, intentions, strategies and beliefs pertaining to future events or
future financial performance. All statements contained herein are based upon
information available to eMagin's management as of the date hereof, and actual
results may vary based upon future events, both within and without eMagin
management's control. In some cases, you can identify forward-looking statements
by terminology such as "may," "will," "should," "expect," "plan," "anticipate,"
"believe," "estimate," "predict," "potential" or "continue," the negative of
such terms, or other comparable terminology. These statements are only
predictions. Actual events or results may differ materially from those in the
forward-looking statements as a result of various important factors, including
those described in the Company's most recent filings with the SEC. Although we
believe that the expectations reflected in the forward-looking statements are
reasonable, such statements should not be regarded as a representation by the
Company, or any other person, that such forward-looking statements will be
achieved. The business and operations of the Company are subject to substantial
risks which increase the uncertainty inherent in forward-looking statements. We
undertake no duty to update any of the forward-looking statements, whether as a
result of new information, future events or otherwise. In light of the
foregoing, readers are cautioned not to place undue reliance on such
forward-looking statements.
Note:
eMagin and 3DVisor
are trademarks of eMagin Corporation.
Media
Contact:
Joe
Runde, 425-749-3636, jrunde@emagincorp.com
Investor
Contact:
John
Atherly, 425-749-3622, jatherly@emagincorp.com
Annex
VII
|
Annex
VII
to
Note
Purchase
Agreement
|
[Letterhead
of Company Counsel]
[Closing
Date]
The
Buyers listed on
Exhibit A
Hereto
Re:
eMagin Corporation
Ladies
and Gentlemen:
We have
acted as counsel to eMagin Corporation, a Delaware corporation (the "Company"),
in connection with the issuance by the Company of $[7,000,000] aggregate
principal amount of 6% Senior Secured Convertible Note due 2007-2008 (the
-"Notes"), and related Common Stock Purchase Warrants (the "Warrants"), pursuant
to the several Note Purchase Agreements, dated as of July , 2006 (the
"Agreements"), by and between the Company and the several Buyers named therein
(the "Buyers"). Capitalized terms used herein and not otherwise defined herein
shall have the respective meanings assigned to such terms in the Agreements.
This opinion is being delivered to you pursuant to Section 7(n) of the
Agreements.
In so
acting, we have examined originals or copies (certified or otherwise identified
to our satisfaction) of the Agreements, the Notes, the Warrants, the Pledge and
Security Agreement, dated as of July , 2006, by and between the Company and the
Collateral Agent named therein (the "Security Agreement"), the Patent and
Trademark Security Agreement, dated as of July , 2006, by and between the
Company and the Collateral Agent named therein (the "Patent and Trademark
Security Agreement"), the Lockbox Agreement, dated as of July 2006, by and
between the Company and the Lockbox Agent named therein (the "Lockbox
Agreement"), and such corporate records, agreements, documents and other
instruments, and such certificates or comparable' documents of public officials
and of officers and representatives of the Company, and have made such inquiries
of such officers and representatives, as we have deemed relevant and necessary
as a basis for the opinions hereinafter set forth. The Agreements, the Notes,
the Warrants, the Security Agreement, the Patent and Trademark Security
Agreement and the Lockbox Agreement are hereinafter referred to collectively as
the "Transaction Documents."
In
rendering the opinions set forth in this opinion letter, we assume the
following:
(a) - the
legal capacity of each natural person;
(b) the
legal existence of all parties to the transactions referred to in the
Transaction Documents excluding the Company;
(c) the
power and authority of each person other than the Company or person(s) acting on
behalf of the Company to execute, deliver and perform each document executed and
delivered and to do each other act done or to be done by such
person;
(d) the
authorization, execution and delivery by each person other than the Company or
person(s) acting on behalf of the Company of each document executed and
delivered or to be executed and delivered by such person;
(e) the
legality, validity, binding effect and enforceability as to each person other
than the Company or person(s) acting on behalf of the Company of each document
executed and delivered or to be executed or delivered and of each other act done
or to be done by such person;
(f) the
transactions referred to in the Transaction Documents have been
consummated;
(g) the
payment of all the required documentary stamps taxes and fees imposed upon the
execution, filing or recording of the Transaction Documents;
(h) that
there have been no undisclosed modifications of any provision of any document
reviewed by us in connection with the rendering of the opinions set forth in
this opinion letter and no undisclosed prior waiver of any right or remedy
contained in the Transaction Documents;
(i) the
genuineness of each signature (other than the signatures of the officers of the
Company), the completeness of each document submitted to us, the authenticity of
each document reviewed by us as an original, the conformity to the original of
each document reviewed by us as a copy and the authenticity of the original of
each document received by us as a copy;
(j) the
truthfulness of each statement as to all factual matters otherwise not known to
us to be untruthful contained in any document encompassed within the due
diligence review undertaken by us;
(k) the
accuracy on the date of this letter as well as on the date stated in all
governmental certifications of each statement as to each factual matter
contained in such governmental certifications;
(l) that
the addressee has acted in good faith, without notice of adverse claims, and has
complied with all laws applicable to it that affect the transactions referred to
in the Transaction Documents;
(m) that
the transactions referred to in the Transaction Documents comply with all tests
of good faith, fairness and conscionability required by law;
(n) that
routine procedural matters such as service of process or qualification to do
business in the relevant jurisdictions will be satisfied by the parties seeking
to enforce the Transaction Documents;
(o) that
all statutes, judicial and administrative decisions, and rules and regulations
of governmental agencies constituting the law for which we are assuming
responsibility are published (e.g., reported court decisions and the specialized
reporting services of BNA, CCH and Prentice-Hall) or otherwise generally
accessible (e.g., LEXIS or WESTLAW) in each case in a manner generally available
(i.e., in terms of access and distribution following publication) to lawyers
practicing in our judicial circuit;
(p) that
other agreements related to the transactions referred to in the Transaction
Documents will be enforced as written;
(q) that
no action, discretionary or otherwise, will be taken by or on behalf of the
Company in the future that might result in a violation of law;
(r) that
there are no other agreements or understandings among the parties that would
modify the terms of the Transaction Documents or the respective rights or
obligations of the parties to the Transaction Documents;
(s) that
with respect to the Transaction Documents and to the transactions referred to
therein, there has been no mutual mistake of fact and there exists no fraud or
duress; and
(t) the
constitutionality and validity of all relevant laws, regulations and agency
actions unless a reported case has otherwise held or widespread concern has been
expressed by commentators as reflected in materials which lawyers routinely
consult.
As to
certain questions of fact material to this opinion, we have relied upon
statements or certificates of public officials and officers of the
Company.
Whenever
a statement herein is qualified by "to our knowledge" or similar phrase, it
means that, during the course of our representation of the Company for the
purposes of this opinion letter, (1) no information that would give those
lawyers who participated in the preparation of the letter (collectively, the
"Opinion Letter Participants") current actual knowledge of the inaccuracy of
such statement has come to their attention; (2) we have not undertaken any
independent investigation or inquiry to determine the accuracy of such
statement; (3) any limited investigation or inquiry otherwise undertaken by the
Opinion Letter Participants during the preparation of this opinion letter
should–not be regarded as such an investigation or inquiry; and (4) no inference
as to our knowledge of any matters bearing on the accuracy of any such statement
should be drawn from the fact of our representation of the Company. We also call
to your attention to the fact that we are not general counsel to the Company and
we are not familiar with all aspects of the Company's business affairs. We have
not conducted an independent audit of the Company or its files.
The
validity, binding effect and enforceability of Transaction Documents may be
limited or otherwise affected by (a) bankruptcy, insolvency, reorganization,
moratorium, fraudulent conveyance or other similar statutes, rules, regulations
or other laws affecting the enforcement of creditors' rights and remedies
generally and (b) the unavailability of, or limitation on the availability of, a
particular right or remedy (whether in a proceeding in equity or at law) because
of an equitable principle or a requirement as to commercial reasonableness,
conscionability or good faith. In addition, certain remedies, waivers and other
provisions contained in the Transaction Documents might not be enforceable;
nevertheless, such unenforceability will not render such agreements invalid as a
whole or preclude the practical realization of the benefits to the Secured Party
thereunder. We express no opinions as to the application of the laws of usury to
the Transaction Documents.
Based on
the foregoing, and subject to the qualifications stated herein, we are of the
opinion that:
1. The
Company and each Subsidiary is a corporation duly organized, validly existing
and in good standing under the laws of its jurisdiction of incorporation and has
all requisite corporate power and authority to own, lease and operate its
properties and to carry on its business as now being conducted.
2. The
Company has all necessary corporate power and authority to execute, deliver and
perform its obligations under each of the the Transaction Documents and to
consummate the transactions contemplated thereby.
3. The
Transaction Documents have been duly and validly authorized, executed and
delivered by the Company and (assuming the due authorization, execution and
delivery thereof by the other parties thereto) constitute the legal, valid and
binding obligations of the Company, enforceable against it in accordance with
there respective terms, subject, as to enforceability, to applicable bankruptcy,
insolvency, fraudulent conveyance, reorganization, moratorium and similar laws
affecting creditors' rights and remedies generally and subject to general
principles of equity, whether enforcement is sought in a proceeding at law or in
equity.
4. The
Shares have been duly authorized and, when issued upon conversion of the Notes
in accordance with the terms of the Notes or upon exercise of the Warrants in
accordance with the tern-is of the Warrants, as the case may be, will be validly
issued, fully-paid and non-assessable.
5.
Assuming the representations and warranties of the Buyers in Section 3 of the
Agreements are true and correct, the Notes and the Warrants may be offered and
issued to the Buyers pursuant to the Agreements, the Conversion Shares may be
offered and issued to the Buyers upon conversion of the Notes, and the Warrant
Shares may be offered and issued to the Buyers upon exercise of the Warrants, in
each such case, without registration under the 1933 Act.
6. The
execution and delivery of the Transaction Documents by the Company, and the
consummation by the Company of the issuance of the Securities and the other
transactions contemplated by the Transaction Documents do not and will not, with
or without the giving of notice or the lapse of time, or both, (i) result in any
violation of any term of the Certificate of Incorporation or by-laws of the
Company or any Subsidiary, (ii) violate or contravene any applicable law, rule
or regulation or any applicable decree, judgment or order of any court, United
States federal or state regulatory body, administrative agency or other
governmental body having jurisdiction over the Company or any Subsidiary or any
of their respective properties or assets or (iii) have any material adverse
effect on any permit, certification, registration, approval, consent, license or
franchise necessary for the Company or any Subsidiary to own or lease and
operate any of its properties and to conduct any of its businesses or the
ability of the Company or any Subsidiary to make use thereof.
7.
Assuming the representations and warranties of the Buyers in Section 3 of the
Agreements are true and correct, no authorization, approval or consent of, or
filing with, any court, governmental body, regulatory agency, self-regulatory
organization, or stock exchange or market or the stockholders of the Company is
required to be obtained or made by the Company for the offer, issuance and sale
of the Notes and the offer and issuance of the Warrants as contemplated by the
Agreements or the offer and issuance of the Conversion Shares upon conversion of
the Notes in accordance with the terms thereof or the offer and issuance of the
Warrant Shares upon exercise of the Warrants in accordance with the terms
thereof except such as have been obtained or made and other than (a) the filing
pursuant to the Agreements of a Registration Statement with the SEC covering the
resale of the Shares (b) such as may be required under the securities or "blue
sky" laws of certain jurisdictions (as to which we express no opinion) and (c)
the Form D to be filed by the Company with the SEC.
8. The
Security Agreement is effective to create in favor of the Collateral Agent, for
the benefit of the holders from time to time of the Notes, as secured party,
valid security interests in the Collateral (as defined in the Security
Agreement) including, without limitation, the funds and proceeds from time to
time deposited or held in the Collateral Account (as defined in the Lockbox
Agreement), as security for the Obligations (as defined in the Security
Agreement), financing statements in proper form covering such security interests
will be duly filed in the offices listed on Schedule I hereto, and when filed,
such security interests in the Collateral will be perfected to the extent that
security interests in such Collateral may be perfected by the filing of
financing statements under the Uniform Commercial Code. Our opinions expressed
above are specifically subject to the following limitations, exceptions,
qualifications and assumptions:
A. The
effect of bankruptcy, insolvency, reorganization, moratorium and other similar
laws relating to or affecting the relief of debtors or the rights and remedies
of creditors generally, including without limitation the effect of statutory or
other law regarding fraudulent conveyances and preferential
transfers.
B.
Limitations imposed by state law, federal law or general equitable principles
upon the specific enforceability of any of the remedies, covenants or other
provisions of any applicable agreement and upon the availability of injunctive
relief or other equitable remedies, regardless of whether enforcement of any
such agreement is considered in a proceeding in equity or at law.
We are
counsel admitted to practice in the State of New York and we do not express any
opinion with respect to the effect or applicability of the laws of any
jurisdiction, other than the laws of the State of New York, Delaware General
Corporation Law and the federal laws of the United States of America. In
furnishing the opinion regarding the valid existence and good standing of the
Company, we have relied solely upon a good standing certificate issued by the
Secretary of State of Delaware on June 27, 2006.
This
opinion is rendered as of the date first written above, is solely for your
benefit in connection with the Agreements and may not be relief upon or used by,
circulated, quoted, or referred to nor may any copies hereof by delivered to any
other person without our prior written consent. We disclaim any obligation to
update this opinion letter or to advise you of facts, circumstances, events or
developments which hereafter may be brought to our attention and which may
alter, affect or modify the opinions expressed herein.
|
Very
truly yours,
|
|
|
|
|
|
|
By:
|
/s/
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exhibit
A
Alexandra
Global Master Fund Ltd.
do
Alexandra Investnient Management, LLC
767 Third
Avenue
39th
Floor
New York,
New York 10017
[NAME]
[ADDRESS]
Schedule
II
[Secretary
of State of the State of Delaware]
Schedule
II
[Secretary
of State of the State of Delaware]
[Department
of State of the State of New York]
Annex
VIII
|
|
|
Annex
VIII
to
Note
Purchase
Agreement
|
[Closing
Date]
The
Buyers listed on
Exhibit A
Hereto
Re:
eMagin Corporation
Ladies
and Gentlemen:
We have
acted as intellectual property counsel to eMagin Corporation, a Delaware
corporation (the "Company"), in connection with the issuance by the Company of
$[7,000,000] aggregate principal amount of 6% Senior Secured Convertible Note
due 2007-2008 (the "Notes"), and related Common Stock Purchase Warrants (the
"Warrants"), pursuant to the several Note Purchase Agreements, dated as of July
2006 (the "Agreements"), by and between the Company and the several Buyers named
therein (the "Buyers"). Capitalized terms used herein and not otherwise defined
herein shall have the respective meanings assigned to such terms in the
Agreements. This opinion is being delivered to you pursuant to Section 7(n) of
the Agreements.
In so
acting, we have examined originals or copies (certified or otherwise identified
to our satisfaction) of the Patent and Trademark Security Agreement, dated as of
July , 2006, by and between the Company and the Collateral Agent named therein
(the "Patent and Trademark Security Agreement") and such corporate records,
agreements, documents and other instruments, and such certificates or comparable
documents of public officials and of officers and representatives of the
Company, and have made such inquiries of such officers and representatives, as
we have deemed relevant and necessary as a basis for the opinions hereinafter
set forth.
Based on
the foregoing, and subject to the qualifications stated herein, we are of the
opinion that:
1. The
Patent and Trademark Security Agreement, taken together with the Security
Agreement, creates valid and enforceable security interests in favor of the
Collateral Agent, for the benefit of the holders from time to time of the Notes,
as secured parties, in all of the Company's right, title and interest in, to and
under the Collateral (as defined in the Patent and Trademark Security Agreement
for purposes of this opinion). The Patent Security Agreement and the Trademark
Security Agreement (attached as Exhibits E and F to the Patent and Trademark
Security Agreement) have or will be filed in the PTO, and together with the
filing of financing statements, have or will result in the perfection of the
Collateral Agent's security interests in the Collateral in the United
States.
The
opinion herein is subject to (i) the limitations on perfection of security
interests in proceeds resulting from the operation of Section 9-315 of the UCC;
(ii) the limitations with respect to securities imposed by Sections 8-302 and
9-312 of the UCC; (iii) the provisions of Section 9-203 of the UCC relating to
the time of attachment; and (iv) Section 552 of Title 11 of the United States
Code (the "Bankruptcy Code") with respect to any Collateral acquired by the
Company subsequent to the commencement of a case against or by the Company under
the Bankruptcy Code.
The
opinions expressed herein are limited to the laws of the State of New York, the
laws of the State of Delaware and the federal laws of the United States, and we
express no opinion as to the effect on the matters covered by this letter of the
laws of any other jurisdiction.
The
opinions expressed herein are rendered solely for your benefit in connection
with the transactions described herein. Those opinions may not be used or relied
upon by any other person, nor may this letter or any copies hereof be furnished
to a third party, filed with a governmental agency, quoted, cited or otherwise
referred to without our prior written consent.
|
|
Very
truly yours,
|
|
|
|
|
|
|
|
/s/
Jason M. Drangel
|
|
|
|
Epstein
Drangel Bazerman & James, LLP
|
|
|
|
|
|
|
|
|
|
Annex
IX
|
|
|
Annex
IX
to
Note
Purchase
Agreement
|
LOCKUP
AGREEMENT
July __,
2006
To:
eMagin Corporation
and the
Buyers Parties to the Note Purchase
Agreements
Referred to Below
Re:
eMagin Corporation Note Purchase Agreements
Dear Sir
or Madam:
Reference
is made to the several Note Purchase Agreements, dated as of the date hereof, by
and between eMagin Corporation, a Delaware corporation (the "Company"), and the
respective buyers who are parties thereto and hereto (each, a "Buyer" and
collectively, the "Buyers"), and any successors and assigns thereto (the "Note
Purchase Agreements"). Capitalized terms used herein and not otherwise defined
herein shall have the respective meanings assigned to such terms in the
Agreements.
The
undersigned stockholder (the "Stockholder") of the Company understands that it
is a condition precedent to the several obligations of the Buyers to purchase
their respective Notes and Warrants pursuant to the Note Purchase Agreements
that the Stockholder shall have executed and delivered this Agreement to the
Buyers and the Company. Pursuant to a Note Purchase Agreement, the Stockholder
is purchasing a 6% Senior Secured Convertible Note due 2007-2008 of the Company
in the aggregate principal amount of $40,000.00 (the Note") and a Warrant to
purchaseshares of Common Stock (the "Warrant"). The Note, the Warrant and the
shares of Common Stock issuable upon conversion of the Note and upon exercise of
the Warrant are collectively referred to herein as the
"Securities".
The
Stockholder hereby agrees that, except for transfers occurring upon the death of
Stockholder and except for intra-family transfers or transfers to trusts for
estate planning purposes (provided that in each such case, the transferee first
agrees to become bound by the provisions of this letter agreement), the
Stockholder will not, directly or indirectly, offer, sell, pledge, contract to
sell, grant any option for the sale of, transfer or otherwise dispose of: yle
Securities or any interest therein for a period beginning on the date of this
letter agreement and ending on January , 2008. Notwithstanding the foregoing,
(A) this letter agreement and the obligations hereunder shall terminate and be
of no further force and effect upon the date of consummation of a sale of all or
substantially all of the assets of the Company and (B) the Stockholder may sell
shares of Common Stock issued upon conversion of the Note or upon exercise of
the Warrant in accordance with the following schedule:
Period
|
Number
of Shares
|
Prior
to December 31, 2006
|
NONE
|
After
December 31, 2006
|
Up
to 50,000 shares of Common Stock in each fiscal quarter of the Company
(such number of shares subject to equitable adjustments for stock splits,
stock dividends, combinations, capital reorganizations and similar events
relating to the Common Stock occurring after the date of this
Agreement)
|
The
Company hereby agrees to notify its transfer agent of the provisions of this
letter agreement. The Stockholder acknowledges and agrees that the Company may
enter a stop transfer order with its transfer agent prohibiting transfer of the
Securities, except in compliance with the requirements of this letter
agreement.
This
letter agreement may be executed in any number of counterparts, all of which
shall together constitute one and the same instrument. This letter agreement
shall be governed by and construed in accordance with the laws of the State of
New York. In the event of the invalidity or unenforceability of any part or
provision of this letter agreement, such invalidity or unenforceability shall
not affect the validity or enforceability of any other part or provision of this
letter agreement.
Please
indicate your agreement with the terms of this letter by signing and returning
to the undersigned a copy hereof.
|
|
Very
truly yours,
|
|
|
|
|
|
|
|
/s/
|
|
|
|
John
Atherly
|
|
|
|
|
|
|
|
|
|
Accepted
and Agreed as of the above date.
EMAGIN
CORPORATION
Annex
XI
NEITHER THIS WARRANT NOR THE
SECURITIES INTO WHICH THIS WARRANT IS EXERCISABLE HAVE BEEN REGISTERED WITH THE
SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES REGULATORS OF ANY STATE IN
RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933,
AS AMENDED (THE “1933 ACT”), AND, ACCORDINGLY, MAY NOT BE, NOR MAY ANY INTEREST
THEREIN BE, OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION
STATEMENT UNDER THE 1933 ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A
TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE 1933 ACT AND IN
ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY, SUBJECT TO
CERTAIN EXCEPTIONS, A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT,
IN FORM AND SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO THE COMPANY.
THESE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT
SECURED BY SUCH SECURITIES.
THIS WARRANT MAY NOT BE TRANSFERRED
EXCEPT AS PROVIDED IN SECTION 24.
No.
W-
|
Right
to Purchase __________ Shares
of
Common
Stock
of
eMagin
Corporation
|
EMAGIN
CORPORATION
Common Stock Purchase
Warrant
EMAGIN CORPORATION
,
a
Delaware
corporation, hereby certifies that, for value received,
______________________
or
registered assigns (the “Holder”), is entitled, subject to the terms set forth
below, to purchase from the Company at any time or from time to time before 5:00
p.m., New York City time, on the Expiration Date (such capitalized term and all
other capitalized terms used herein having the respective meanings provided
herein),
[BEFORE ISSUANCE INSERT AMOUNT OF
SHARES EQUAL TO 70% OF THE NUMBER OF SHARES INITIALLY ISSUABLE UPON CONVERSION
OF THE NOTE BEING ISSUED TO THE HOLDER OF THIS WARRANT, DETERMINED WITHOUT
REGARD TO ANY LIMITATION ON CONVERSION]
paid and
nonassessable shares of Common Stock at a purchase price per share equal to the
Purchase Price. The number of such shares of Common Stock and the Purchase Price
are subject to adjustment as provided in this Warrant.
1.
Definitions.
(a)
As used
in this Warrant, the term “Holder” shall have the meaning assigned to such term
in the first paragraph of this Warrant.
(b)
All the
agreements or instruments herein defined shall mean such agreements or
instruments as the same may from time to time be supplemented or amended or the
terms thereof waived or modified to the extent permitted by, and in accordance
with, the terms thereof and of this Warrant.
(c)
The
following terms shall have the following meanings (such meanings to be equally
applicable to both the singular and plural forms of the terms
defined):
“Affiliate”
means, with respect to any Person, any other Person that directly, or indirectly
through one or more intermediaries, controls, is controlled by or is under
common control with the subject Person. For purposes of this definition,
“control” (including, with correlative meaning, the terms “controlled by” and
“under common control with”), as used with respect to any Person, shall mean the
possession, directly or indirectly, of the power to direct or cause the
direction of the management and policies of such Person, whether through the
ownership of voting securities or by contract or otherwise.
“Aggregate
Purchase Price” means at any time an amount equal to the product obtained by
multiplying (x) the Purchase Price
times
(y) the
number of shares of Common Stock for which this Warrant may be exercised at such
time, determined without regard to any limitations on exercise of this Warrant
contained in Section 2(c).
“Aggregation
Parties” shall have the meaning provided in Section 2(c).
“AMEX”
means the American Stock Exchange, Inc.
“Board of
Directors” means the Board of Directors of the Company.
“Business
Day” means any day other than a Saturday, Sunday or other day on which
commercial banks in The City of New York are authorized or required by law or
executive order to remain closed.
“Common
Stock” includes the Company's Common Stock, par value $0.001 per share, (and any
purchase rights issued with respect to the Common Stock in the future) as
authorized on the date hereof, and any other securities into which or for which
the Common Stock (and any such rights issued with respect to the Common Stock)
may be converted or exchanged pursuant to a plan of recapitalization,
reorganization, merger, sale of assets or otherwise and any stock (other than
Common Stock) and other securities of the Company or any other Person which the
Holder at any time shall be entitled to receive, or shall have received, on the
exercise of this Warrant, in lieu of or in addition to Common
Stock.
“Common
Stock Equivalents” means any warrant, option, subscription or purchase right
with respect to shares of Common Stock, any security convertible into,
exchangeable for, or otherwise entitling the holder thereof to acquire, shares
of Common Stock or any warrant, option, subscription or purchase right with
respect to any such convertible, exchangeable or other security.
“Company”
shall include eMagin Corporation, a Delaware corporation, and any corporation
that shall succeed to or assume the obligations of eMagin Corporation hereunder
in accordance with the terms hereof.
“Computed
Market Price”
shall
mean the arithmetic average of the daily VWAPs for each of the three Trading
Days immediately preceding the applicable Measurement Date (such VWAPs being
appropriately and equitably adjusted for any stock splits, stock dividends,
recapitalizations and the like occurring or for which the record date occurs
during such three Trading Days).
“Current
Fair Market Value” means when used with respect to the Common Stock as of a
specified date with respect to each share of Common Stock, the average of the
closing prices of the Common Stock sold on all securities exchanges (including
the NYSE, the AMEX, the Nasdaq and the Nasdaq Capital Market) on which the
Common Stock may at the time be listed, or, if there have been no sales on any
such exchange on such day, the average of the highest bid and lowest asked
prices on all such exchanges at the end of regular trading on such day, or, if
on such day the Common Stock is not so listed, the average of the representative
bid and asked prices quoted in the Nasdaq System as of 4:00 p.m., New York City
time, or, if on such day the Common Stock is not quoted in the Nasdaq System,
the average of the highest bid and lowest asked price on such day in the
domestic over-the-counter market as reported by Pink Sheets, LLC, or any similar
successor organization, in each such case averaged over a period of five Trading
Days consisting of the day as of which the Current Fair Market Value of Common
Stock is being determined (or if such day is not a Trading Day, the Trading Day
next preceding such day) and the four consecutive Trading Days prior to such
day. If on the date for which Current Fair Market Value is to be determined the
Common Stock is not listed on any securities exchange or quoted in the Nasdaq
System or the over-the-counter market, the Current Fair Market Value of Common
Stock shall be the highest price per share which the Company could then obtain
from a willing buyer (not an employee or director of the Company at the time of
determination) in an arms'-length transaction for shares of Common Stock sold by
the Company, from authorized but unissued shares, as determined in good faith by
the Board of Directors.
“Designated
Person” means any of Mr. John Atherly, Mr. Gary Jones and Ms. Susan
Jones.
“DTC”
shall have the meaning provided in Section 2(c).
“Event of
Default” shall have the meaning provided in the Notes.
“Excluded
Shares” shall have the meaning provided in Section 2(c).
“Expiration
Date” means July 21, 2011.
“FAST”
shall have the meaning provided in Section 2(c).
“Issuance
Date” means the date of original issuance of this Warrant or its predecessor
instrument.
“Market
Price” means with respect to any security on any day the closing bid price of
such security on such day on the Nasdaq or the Nasdaq Capital Market or the NYSE
or the AMEX, as applicable, or, if such security is not listed or admitted to
trading on the Nasdaq, the Nasdaq Capital Market, the NYSE or the AMEX, on the
principal national securities exchange or quotation system on which such
security is quoted or listed or admitted to trading, in any such case as
reported by Bloomberg, L.P. or, if not quoted or listed or admitted to trading
on any national securities exchange or quotation system, the average of the
closing bid and asked prices of such security on the over-the-counter market on
the day in question, as reported by the Pink Sheets, LLC, or a similar generally
accepted reporting service, or if not so available, in such manner as furnished
by any New York Stock Exchange member firm selected from time to time by the
Board of Directors for that purpose, or a price determined in good faith by the
Board of Directors.
“Measurement
Date” for any sale, transfer or disposition (but not including the cancellation
or expiration) of Common Stock or Common Stock Equivalents by a Designated
Person means the date that is three Trading Days after the earlier of (i) the
date such Designated Person files a Form 4 with the SEC with respect to such
sale, transfer or disposition and (ii) the date such Designated Person is
required to file a Form 4 with the SEC with respect to such sale, transfer or
disposition;
provided,
however,
that if
such Designated Person is not required, or is no longer required, to file a Form
4 with respect to such sale, transfer or disposition, the Measurement Date shall
be the date that is five Trading Days after the date of such sale, transfer or
disposition.
“Nasdaq”
means the Nasdaq Global Market.
“1934
Act” means the Securities Exchange Act of 1934, as amended.
“1933
Act” means the Securities Act of 1933, as amended.
“Note”
means any of the 6% Senior Secured Convertible Notes due 2007-2008 issued by the
Company pursuant to the Note Purchase Agreement and the Other Note Purchase
Agreements.
“Note
Purchase Agreement” means the Note Purchase Agreement, dated as of July 21,
2006, by and between the Company and the original Holder of this
Warrant.
“NYSE”
means the New York Stock Exchange, Inc.
“Other
Note Purchase Agreements” means the several Note Purchase Agreements by and
between the Company and the several buyers named therein in the form of the Note
Purchase Agreement pursuant to which certain of the Notes are being or will be
issued.
“Other
Securities” means any stock (other than Common Stock) and other securities of
the Company or any other Person which the Holder at any time shall be entitled
to receive, or shall have received, on the exercise of this Warrant, in lieu of
or in addition to Common Stock, or which at any time shall be issuable or shall
have been issued in exchange for or in replacement of Common Stock or Other
Securities pursuant to Section 5.
“Other
Warrants” shall mean the Common Stock Purchase Warrants (other than this
Warrant) issued or issuable pursuant to the Other Note Purchase
Agreements.
“Permitted
Designated Person Sale” means a sale by John Atherly, occurring on or after
January 1, 2007, of shares of Common Stock in an amount not to exceed 50,000
shares in the aggregate in any fiscal quarter of the Company (such number of
shares subject to equitable adjustments for stock splits, stock dividends,
combinations, capital reorganizations and similar events relating to the Common
Stock occurring after the Issuance Date).
“Person”
means an individual, corporation, partnership, limited liability company, trust,
business trust, association, joint stock company, joint venture, pool,
syndicate, sole proprietorship, unincorporated organization, governmental
authority or any other form of entity not specifically listed
herein.
“Purchase
Price” means $
0.36,
subject
to adjustment as provided in this Warrant.
“Registration
Period” shall have the meaning provided in the Note Purchase
Agreement.
“Registration
Statement” shall have the meaning provided in the Note Purchase
Agreement.
“Reorganization
Event” means the occurrence of any one or more of the following events:
(i)
any
consolidation, merger or similar transaction of the Company or any Subsidiary
with or into another entity (other than a merger or consolidation or similar
transaction of a Subsidiary into the Company or a wholly-owned Subsidiary in
which there is no change in the outstanding Common Stock); or the sale or
transfer of all or substantially all of the assets of the Company and the
Subsidiaries in a single transaction or a series of related transactions;
or
(ii)
the
occurrence of any transaction or event in connection with which all or
substantially all the Common Stock shall be exchanged for, converted into,
acquired for or constitute the right to receive securities of any other Person
(whether by means of a Tender Offer, liquidation, consolidation, merger, share
exchange, combination, reclassification, recapitalization, or otherwise);
or
(iii)
the
acquisition by a Person or group of Persons acting in concert as a partnership,
limited partnership, syndicate or group, as a result of a tender or exchange
offer, open market purchases, privately negotiated purchases or otherwise, of
beneficial ownership of securities of the Company representing 50% or more of
the combined voting power of the outstanding voting securities of the Company
ordinarily (and apart from rights accruing in special circumstances) having the
right to vote in the election of directors.
“Restricted
Ownership Percentage” shall have the meaning provided in Section
2(c).
“Restricted
Securities” means securities that are not eligible for resale pursuant to Rule
144(k) under the 1933 Act (or any successor provision).
“Rule
144A” means Rule 144A as promulgated under the 1933 Act.
“SEC”
means the Securities and Exchange Commission.
“Subsidiary”
means any corporation or other entity of which a majority of the capital stock
or other ownership interests having ordinary voting power to elect a majority of
the board of directors or other Persons performing similar functions are at the
time directly or indirectly owned by the Company.
“Tender
Offer” means a tender offer, exchange offer or other offer by the Company to
repurchase outstanding shares of its capital stock.
“Trading
Day” means a day on whichever of the national securities exchange, the Nasdaq,
the Nasdaq Capital Market or other securities market which then constitutes the
principal securities market for the Common Stock is open for general trading of
securities.
“VWAP” of
any security on any Trading Day means the volume-weighted average price of such
security on such Trading Day on the Principal Market, as reported by Bloomberg
Financial, L.P., based on a Trading Day from 9:30 a.m., Eastern Time, to 4:00
p.m., Eastern Time, using the AQR Function, for such Trading Day;
provided,
however,
that
during any period the VWAP is being determined, the VWAP shall be subject to
equitable adjustments from time to time on terms consistent with Section 6.3 of
the Note and otherwise reasonably acceptable to the Holder for (i) stock splits,
(ii) stock dividends, (iii) combinations, (iv) capital reorganizations, (v)
issuance to all holders of Common Stock of rights or warrants to purchase shares
of Common Stock, (vi) distribution by the Company to all holders of Common Stock
of evidences of indebtedness of the Company or cash (other than regular
quarterly cash dividends), and (vii) similar events relating to the Common
Stock, in each case which occur, or with respect to which the “ex” date occurs,
during such period.
“Warrant”
means this instrument as originally executed or if later amended or supplemented
in accordance with its terms, then as so amended or supplemented.
“Warrant
Shares” means the shares of Common Stock issuable upon exercise of this
Warrant.
2.
Exercise of
Warrant.
(a)
Exercise.
This
Warrant may be exercised by the Holder in whole at any time or in part from time
to time on or before the Expiration Date by (x) giving a subscription form in
the form of
Exhibit 1
to this
Warrant (duly executed by the Holder) to the Company, (y) making payment, in
cash or by certified or official bank check payable to the order of the Company,
or by wire transfer of funds to the account of the Company, in any such case, in
the amount obtained by multiplying (a) the number of shares of Common Stock
designated by the Holder in the subscription form by (b) the Purchase Price then
in effect and (z) surrendering this Warrant to the Company within three Trading
Days after such submission of a subscription form. An exercise of this Warrant
shall be deemed to have occurred on the date when the Holder shall have so given
the subscription form and made such payment. On any partial exercise the Company
will forthwith issue and deliver to or upon the order of the Holder a new
Warrant or Warrants of like tenor, in the name of the Holder or as the Holder
(upon payment by the Holder of any applicable transfer taxes) may request,
providing in the aggregate on the face or faces thereof for the purchase of the
number of shares of Common Stock for which such Warrant or Warrants may still be
exercised. The subscription form may be surrendered by telephone line facsimile
transmission to such telephone number for the Company as shall have been
specified in writing to the Holder by the Company;
provided, however
, that if
the subscription form is given to the Company by telephone line facsimile
transmission the Holder shall send an original of such subscription form to the
Company within ten Business Days after such subscription form is so given to the
Company;
provided further
,
however
, that
any failure or delay on the part of the Holder in giving such original of any
subscription form shall not affect the validity or the date on which such
subscription form is so given by telephone line facsimile
transmission.
(b)
Net
Exercise.
Notwithstanding
anything to the contrary contained in Section 2(a), if the Holder shall exercise
this Warrant (1) during the period beginning one year after the Issuance Date
and at a time when a Registration Statement covering the resale by the Holder of
shares of Common Stock (or Other Securities) issuable upon exercise of this
Warrant is not effective or is not available for use by the Holder or (2) an
Event of Default shall have occurred and be continuing, then in either such case
in the preceding clause (1) or (2) the Holder may elect to exercise this
Warrant, in whole at any time or in part from time to time, by receiving upon
each such exercise a number of shares of Common Stock as determined below, upon
submission of the subscription form annexed hereto (duly executed by the Holder)
to the Company (followed by surrender of this Warrant to the Company within
three Trading Days after such submission of a subscription form), in which event
the Company shall issue to the Holder a number of shares of Common Stock
computed using the following formula:
where,
|
|
X
=
|
the
number of shares of Common Stock to be issued to the Holder
|
|
|
Y
=
|
the
number of shares of Common Stock as to which this Warrant is to be
exercised
|
|
|
A
=
|
the
Current Fair Market Value of one share of Common Stock calculated as of
the latest Trading Day immediately preceding the exercise of this
Warrant
|
(c)
9.9%
Limitation.
(1)
Notwithstanding
anything to the contrary contained herein, the number of shares of Common Stock
that may be acquired by the Holder upon exercise pursuant to the terms hereof at
any time shall not exceed a number that, when added to the total number of
shares of Common Stock deemed beneficially owned by the Holder (other than by
virtue of the ownership of securities or rights to acquire securities that have
limitations on the Holder's right to convert, exercise or purchase similar to
the limitation set forth herein (the “Excluded Shares”), together with all
shares of Common Stock deemed beneficially owned at such time (other than by
virtue of the ownership of the Excluded Shares) by Persons whose beneficial
ownership of Common Stock would be aggregated with the beneficial ownership by
the Holder for purposes of determining whether a group exists or for purposes of
determining the Holder’s beneficial ownership (the “Aggregation Parties”), in
either such case for purposes of Section 13(d) of the 1934 Act and Regulation
13D-G thereunder (including, without limitation, as the same is made applicable
to Section 16 of the 1934 Act and the rules promulgated thereunder), would
result in beneficial ownership by the Holder or such group of more than 9.9% of
the shares of Common Stock for purposes of Section 13(d) or Section 16 of the
1934 Act and the rules promulgated thereunder (as the same may be modified by
the Holder as provided herein, the “Restricted Ownership Percentage”). The
Holder shall have the right at any time and from time to time to reduce its
Restricted Ownership Percentage immediately upon notice to the Company in the
event and only to the extent that Section 16 of the 1934 Act or the rules
promulgated thereunder (or any successor statute or rules) is changed to reduce
the beneficial ownership percentage threshold thereunder to a percentage less
than 10%. If at any time the limits in this Section 2(c) make this Warrant
unexercisable in whole or in part, the Company shall not by reason thereof be
relieved of its obligation to issue shares of Common Stock at any time or from
time to time thereafter but prior to the Expiration Date upon exercise of this
Warrant as and when shares of Common Stock may be issued in compliance with such
restrictions.
(2)
For
purposes of this Section 2(c), in determining the number of outstanding shares
of Common Stock at any time the Holder may rely on the number of outstanding
shares of Common Stock as reflected in (1) the Company's then most recent Form
10-Q, Form 10-K or other public filing with the SEC, as the case may be, (2) a
public announcement by the Company that is later than any such filing referred
to in the preceding clause (1) or (3) any other notice by the Company or its
transfer agent setting forth the number shares of Common Stock outstanding and
knowledge the Holder may have about the number of shares of Common Stock issued
upon conversion or exercise of Common Stock Equivalents by any Person, including
the Holder, which are not reflected in the preceding clauses (1) through (3).
Upon the written request of the Holder, the Company shall within three Business
Days confirm in writing to the Holder the number of shares of Common Stock then
outstanding. In any case, the number of outstanding shares of Common Stock shall
be determined after giving effect to the conversion or exercise of Common Stock
Equivalents, including the Warrants, by the Holder or its Affiliates, in each
such case subsequent to, the date as of which such number of outstanding shares
of Common Stock was reported.
3.
Delivery of Stock Certificates,
etc., on Exercise.
(a) As
soon as practicable after the exercise of this Warrant and in any event within
three Trading Days thereafter, upon the terms and subject to the conditions of
this Warrant, the Company at its expense (including the payment by it of any
applicable issue or stamp taxes) will cause to be issued in the name of and
delivered to the Holder, or as the Holder (upon payment by the Holder of any
applicable transfer taxes) may direct, a certificate or certificates for the
number of fully paid and nonassessable shares of Common Stock (or Other
Securities) to which the Holder shall be entitled on such exercise, in such
denominations as may be requested by the Holder, which certificate or
certificates shall be free of restrictive and trading legends (except to the
extent permitted under Section 5(b) of the Note Purchase Agreement), plus, in
lieu of any fractional share to which the Holder would otherwise be entitled,
cash equal to such fraction multiplied by the then Current Fair Market Value of
one full share of Common Stock, together with any other stock or Other
Securities or any property (including cash, where applicable) to which the
Holder is entitled upon such exercise pursuant to Section 2 or otherwise.
In lieu
of delivering physical certificates for the shares of Common Stock or (Other
Securities) issuable upon any exercise of this Warrant, provided the Company's
transfer agent is participating in the Depository Trust Company (“DTC”) Fast
Automated Securities Transfer (“FAST”) program, upon request of the Holder, the
Company shall use commercially reasonable efforts to cause its transfer agent
electronically to transmit such shares of Common Stock (or Other Securities)
issuable upon conversion to the Holder (or its designee), by crediting the
account of the Holder’s (or such designee’s) broker with DTC through its Deposit
Withdrawal Agent Commission system (provided that the same time periods herein
as for stock certificates shall apply). The Company shall pay any taxes and
other governmental charges that may be imposed under the laws of the United
States of America or any political subdivision or taxing authority thereof or
therein in respect of the issue or delivery of shares of Common Stock (or Other
Securities) or payment of cash upon exercise of this Warrant (other than income
taxes imposed on the Holder). The Company shall not be required, however, to pay
any tax or other charge imposed in connection with any transfer involved in the
issue of any certificate for shares of Common Stock (or Other Securities)
issuable upon exercise of this Warrant or payment of cash to any Person other
than the Holder, and in case of such transfer or payment the Company shall not
be required to deliver any certificate for shares of Common Stock (or Other
Securities) upon such exercise or pay any cash until such tax or charge has been
paid or it has been established to the Company's reasonable satisfaction that no
such tax or charge is due.
(b)
If in any
case the Company shall fail to issue and deliver or cause to be delivered the
shares of Common Stock to the Holder within five Trading Days of a particular
exercise of this Warrant, in addition to any other liabilities the Company may
have hereunder, under the Note Purchase Agreement and under applicable law, (A)
the Company shall pay or reimburse the Holder on demand for all out-of-pocket
expenses, including, without limitation, reasonable fees and expenses of legal
counsel, incurred by the Holder as a result of such failure; (B) if as a result
of such failure the Holder shall suffer any direct damages or liabilities from
such failure (including, without limitation, margin interest and the cost of
purchasing securities to cover a sale (whether by the Holder or the Holder's
securities broker) or borrowing of shares of Common Stock by the Holder for
purposes of settling any trade involving a sale of shares of Common Stock made
by the Holder during the period beginning on the Issuance Date and ending on the
date the Company delivers or causes to be delivered to the Holder such shares of
Common Stock), then, in addition to any amounts payable pursuant to Section
3(a), the Company shall upon demand of the Holder pay to the Holder an amount
equal to the actual, direct, demonstrable out-of-pocket damages and liabilities
suffered by the Holder by reason thereof which the Holder documents, and (C) the
Holder may by written notice (which may be given by mail, courier, personal
service or telephone line facsimile transmission) or oral notice (promptly
confirmed in writing), given at any time prior to delivery to the Holder of the
shares of Common Stock issuable in connection with such exercise of the Holder's
right, rescind such exercise and the subscription form relating thereto, in
which case the Holder shall thereafter be entitled to exercise that portion of
this Warrant as to which such exercise is so rescinded and to exercise its other
rights and remedies with respect to such failure by the Company. Notwithstanding
the foregoing the Company shall not be liable to the Holder under clauses (A) or
(B) of the immediately preceding sentence to the extent the failure of the
Company to deliver or to cause to be delivered such shares of Common Stock
results from fire, flood, storm, earthquake, shipwreck, strike, war, acts of
terrorism, crash involving facilities of a common carrier, acts of God, or any
similar event outside the control of the Company (it being understood that the
action or failure to act of the Company's Transfer Agent shall not be deemed an
event outside the control of the Company except to the extent resulting from
fire, flood, storm, earthquake, shipwreck, strike, war, acts of terrorism, crash
involving facilities of a common carrier, acts of God, or any similar event
outside the control of such Transfer Agent or the bankruptcy, liquidation or
reorganization of such Transfer Agent under any bankruptcy, insolvency or other
similar law). The Holder shall notify the Company in writing (or by telephone
conversation, confirmed in writing) as promptly as practicable following the
third Trading Day after the Holder exercises this Warrant if the Holder becomes
aware that such shares of Common Stock so issuable have not been received as
provided herein, but any failure so to give such notice shall not affect the
Holder's rights under this Warrant or otherwise. In the case of the Company’s
failure to issue and deliver or cause to be delivered the shares of Common Stock
to the Holder within five Trading Days of a particular exercise of this Warrant,
the amount payable by the Company pursuant to clause (B) of this Section 3(b)
with respect to such exercise shall be reduced by the amount of payments
previously paid by the Company to the Holder pursuant to Section 8(a)(4) of the
Note Purchase Agreement with respect to such exercise.
4.
Adjustment for Dividends in Other
Stock, Property, etc.; Reclassification, etc.
In case
at any time or from time to time on or after the Issuance Date, all holders of
Common Stock (or Other Securities) shall have received, or (on or after the
record date fixed for the determination of stockholders eligible to receive)
shall have become entitled to receive, without payment therefor,
(a)
other or
additional stock, rights, warrants or other securities or property (other than
cash) by way of dividend, or
(b)
any cash
(excluding cash dividends payable solely out of earnings or earned surplus of
the Company), or
(c)
other or
additional stock, rights, warrants or other securities or property (including
cash) by way of spin-off, split-up, reclassification, recapitalization,
combination of shares or similar corporate rearrangement,
other
than (i) additional shares of Common Stock (or Other Securities) issued as a
stock dividend or in a stock-split (adjustments in respect of which are provided
for in Section 6) and (ii) rights or warrants to subscribe for Common Stock at
less than the Current Fair Market Value (adjustments in respect of which are
provided in Section 7), then and in each such case the Holder, on the exercise
hereof as provided in Section 2, shall be entitled to receive the amount of
stock, rights, warrants and Other Securities and property (including cash in the
cases referred to in subdivisions (b) and (c) of this Section 4) which the
Holder would hold on the date of such exercise if on the date of such action
specified in the preceding clauses (a) through (c) (or the record date therefor)
the Holder had been the holder of record of the number of shares of Common Stock
called for on the face of this Warrant and had thereafter, during the period
from the date thereof to and including the date of such exercise, retained such
shares and all such other or additional stock, rights, warrants and Other
Securities and property (including cash in the case referred to in subdivisions
(b) and (c) of this Section 4) receivable by the Holder as aforesaid during such
period, giving effect to all adjustments called for during such period by
Section 5.
5.
Exercise upon a Reorganization
Event.
In case
of any Reorganization Event the Company shall, as a condition precedent to the
consummation of the transactions constituting, or announced as, such
Reorganization Event, cause effective provisions to be made so that the Holder
shall have the right thereafter, by exercising this Warrant (in lieu of the
shares of Common Stock of the Company and Other Securities or property
purchasable and receivable upon exercise of the rights represented hereby
immediately prior to such Reorganization Event) to purchase the kind and amount
of shares of stock and Other Securities and property (including cash) receivable
upon such Reorganization Event by a holder of the number of shares of Common
Stock that might have been received upon exercise of this Warrant immediately
prior to such Reorganization Event. Any such provision shall include provisions
for adjustments in respect of such shares of stock and Other Securities and
property that shall be as nearly equivalent as may be practicable to the
adjustments provided for in this Warrant. The provisions of this Section 5 shall
apply to successive Reorganization Events.
6.
Adjustment for Certain Extraordinary
Events.
If on or
after the Issuance Date the Company shall (i) issue additional shares of the
Common Stock as a dividend or other distribution on outstanding Common Stock,
(ii) subdivide or reclassify its outstanding shares of Common Stock, or (iii)
combine its outstanding shares of Common Stock into a smaller number of shares
of Common Stock, then, in each such event, the Purchase Price shall,
simultaneously with the happening of such event, be adjusted by multiplying the
Purchase Price in effect immediately prior to such event by a fraction, the
numerator of which shall be the number of shares of Common Stock outstanding
immediately prior to such event and the denominator of which shall be the number
of shares of Common Stock outstanding immediately after such event, and the
product so obtained shall thereafter be the Purchase Price then in effect. The
Purchase Price, as so adjusted, shall be readjusted in the same manner upon the
happening of any successive event or events described herein in this Section 6.
The Holder shall thereafter, on the exercise hereof as provided in Section 2, be
entitled to receive that number of shares of Common Stock determined by
multiplying the number of shares of Common Stock which would be issuable on such
exercise immediately prior to such issuance, subdivision or combination, as the
case may be, by a fraction of which (i) the numerator is the Purchase Price in
effect immediately prior to such issuance and (ii) the denominator is the
Purchase Price in effect on the date of such exercise.
7.
Issuance of Rights or Warrants to
Common Stockholders at less than Current Fair Market
Value.
If the
Company shall on or after the Issuance Date issue rights or warrants to all
holders of its outstanding shares of Common Stock entitling them to subscribe
for or purchase shares of Common Stock at a price per share less than the
Current Fair Market Value on the record date fixed for the determination of
stockholders entitled to receive such rights or warrants, then
(a)
the
Purchase Price shall be adjusted so that the same shall equal the price
determined by multiplying the Purchase Price in effect at the opening of
business on the day after such record date by a fraction of which the numerator
shall be the number of shares of Common Stock outstanding at the close of
business on such record date plus the number of shares which the aggregate
offering price of the total number of shares so offered would purchase at such
Current Fair Market Value, and the denominator shall be the number of shares of
Common Stock outstanding on the close of business on such record date plus the
total number of additional shares of Common Stock so offered for subscription or
purchase; and
(b)
the
number of shares of Common Stock which the Holder may thereafter purchase upon
exercise of this Warrant at the opening of business on the day after such record
date shall be increased to a number equal to the quotient obtained by dividing
(x) the Aggregate Purchase Price in effect immediately prior to such adjustment
in the Purchase Price pursuant to clause (a) of this Section 7
by
(y) the
Purchase Price in effect immediately after such adjustment in the Purchase Price
pursuant to clause (a) of this Section 7.
Such
adjustment shall become effective immediately after the opening of business on
the day following the record date fixed for determination of stockholders
entitled to receive such rights or warrants. To the extent that shares of Common
Stock are not delivered pursuant to such rights or warrants, upon the expiration
or termination of such rights or warrants, the Purchase Price shall be
readjusted to the Purchase Price which would then be in effect had the
adjustments made upon the issuance of such rights or warrants been made on the
basis of delivery of only the number of shares of Common Stock actually
delivered and the number of shares of Common Stock for which this Warrant may
thereafter be exercised shall be readjusted (subject to proportionate adjustment
for any intervening exercises of this Warrant) to the number which would then be
in effect had the adjustments made upon the issuance of such rights or warrants
been made on the basis of delivery of only the number of shares of Common Stock
actually delivered. In the event that such rights or warrants are not so issued,
the Purchase Price shall again be adjusted to be the Purchase Price which would
then be in effect if such record date had not been fixed and the number of
shares of Common Stock for which this Warrant may thereafter be exercised shall
again be adjusted (subject to proportionate adjustment for any intervening
exercises of this Warrant) to be the number which would then be in effect if
such record date had not been fixed. In determining whether any rights or
warrants entitle the Holder to subscribe for or purchase shares of Common Stock
at less than such Current Fair Market Value, and in determining the aggregate
offering price of such shares of Common Stock, there shall be taken into account
any consideration received for such rights or warrants, the value of such
consideration, if other than cash, to be determined by the Board of Directors.
Notwithstanding the foregoing, if any of the adjustments to the Purchase Price
as set forth in this Section 7 will require the Company to seek stockholder
approval pursuant to Rule 713 of the AMEX and such stockholder approval has not
yet been obtained, then the adjustment shall not take effect until such
stockholder approval is obtained. The Company shall use its commercially
reasonable best efforts to obtain, as promptly as practicable, but in no event
later than 90 days thereafter, the stockholder approval that is necessary under
the rules of the AMEX.
8.
Adjustment in Connection Sales by a
Designated Person.
So long
as any Note is outstanding, if at any time on or after the Issuance Date any
Designated Person, directly or indirectly, sells, transfers or disposes of
shares of Common Stock or Common Stock Equivalents other than a Permitted
Designated Person Sale and on the Measurement Date for such sale, transfer or
disposition the Purchase Price in effect on such Measurement Date is greater
than the Computed Market Price on such Measurement Date, then, subject to the
next succeeding sentence, the
Purchase
Price shall be reduced to such Computed Market Price
, such
adjustment to become effective immediately after the opening of business on the
day following the Measurement Date. If a reduction of the Purchase Price to such
Computed Market Price pursuant to the immediately preceding sentence would
require the Company to seek stockholder approval of the transactions
contemplated by the Note Purchase Agreement pursuant to Rule 713 of the AMEX and
the Stockholder Approval has not yet been obtained, then the Purchase Price
shall be reduced to a price equal to the Conversion Price (as defined in the
Note) then in effect until such time as the Stockholder Approval is obtained at
which time the Purchase Price shall be reduced to such Computed Market Price.
The Company shall inform the Holder immediately by phone and electronic
transmission upon becoming aware of any sale, transfer or disposition of any
shares of Common Stock or Common Stock Equivalents by any Designated Person and
will follow up with formal written notice to the Holder pursuant to Section
23.
9.
Effect of Reclassification,
Consolidation, Merger or Sale.
(a)
If any of
the following events occur, namely:
(i)
any
reclassification or change of the outstanding shares of Common Stock (other than
a change in par value, or from par value to no par value, or from no par value
to par value, or as a result of a subdivision or combination),
(ii)
any
consolidation, merger statutory exchange or combination of the Company with
another corporation as a result of which holders of Common Stock shall be
entitled to receive stock, securities or other property or assets (including
cash) with respect to or in exchange for such Common Stock, or
(iii)
any sale
or conveyance of the properties and assets of the Company as, or substantially
as, an entirety to any other Person as a result of which holders of Common Stock
shall be entitled to receive stock, securities or other property or assets
(including cash) with respect to or in exchange for such Common Stock,
then the
Company or the successor or purchasing Person, as the case may be, shall execute
with the Holder a written agreement providing that:
(x)
this
Warrant shall thereafter entitle the Holder to purchase the kind and amount of
shares of stock and Other Securities or property or assets (including cash)
receivable upon such reclassification, change, consolidation, merger, statutory
exchange, combination, sale or conveyance by the holder of a number of shares of
Common Stock issuable upon exercise of this Warrant (assuming, for such
purposes, a sufficient number of authorized shares of Common Stock available to
exercise this Warrant) immediately prior to such reclassification, change,
consolidation, merger, statutory exchange, combination, sale or conveyance
assuming such holder of Common Stock did not exercise such holder's rights of
election, if any, as to the kind or amount of securities, cash or other property
receivable upon such consolidation, merger, statutory exchange, combination,
sale or conveyance (
provided
that, if
the kind or amount of securities, cash or other property receivable upon such
consolidation, merger, statutory exchange, sale or conveyance is not the same
for each share of Common Stock in respect of which such rights of election shall
not have been exercised (“non-electing share”), then for the purposes of this
Section 8 the kind and amount of securities, cash or other property receivable
upon such consolidation, merger, statutory exchange, sale or conveyance for each
non-electing share shall be deemed to be the kind and amount so receivable per
share by a plurality of the non-electing shares),
(y)
in the
case of any such successor or purchasing Person, upon such consolidation,
merger, statutory exchange, combination, sale or conveyance such successor or
purchasing Person shall be jointly and severally liable with the Company for the
performance of all of the Company's obligations under this Warrant and the Note
Purchase Agreement and
(z)
if
registration or qualification is required under the 1933 Act or applicable state
law for the public resale by the Holder of such shares of stock and Other
Securities so issuable upon exercise of this Warrant, such registration or
qualification shall be completed prior to such reclassification, change,
consolidation, merger, statutory exchange, combination or sale.
Such
written agreement shall provide for adjustments which shall be as nearly
equivalent as may be practicable to the adjustments provided for in this
Warrant. If, in the case of any such reclassification, change, consolidation,
merger, statutory exchange, combination, sale or conveyance, the stock or other
securities or other property or assets receivable thereupon by a holder of
shares of Common Stock includes shares of stock, other securities, other
property or assets of a Person other than the Company or any such successor or
purchasing Person, as the case may be, in such reclassification, change,
consolidation, merger, statutory exchange, combination, sale or conveyance, then
such written agreement shall also be executed by such other Person and shall
contain such additional provisions to protect the interests of the Holder as the
Board of Directors shall reasonably consider necessary by reason of the
foregoing.
(b)
The above
provisions of this Section 9 shall similarly apply to successive
reclassifications, changes, consolidations, mergers, combinations, sales and
conveyances.
(c)
If this
Section 9 applies to any event or occurrence, Section 5 shall not
apply.
10.
Tax
Adjustments.
The
Company may make such reductions in the Purchase Price, in addition to those
required by Sections 4, 5, 6, 7 and 8 as the Board of Directors considers to be
advisable to avoid or diminish any income tax to holders of Common Stock or
rights to purchase Common Stock resulting from any dividend or distribution of
stock (or rights to acquire stock) or from any event treated as such for income
tax purposes.
11.
Minimum
Adjustment.
(a) No
adjustment in the Purchase Price (and no related adjustment in the number of
shares of Common Stock which may thereafter be purchased upon exercise of this
Warrant) shall be required unless such adjustment would require an increase or
decrease of at least 1% in the Purchase Price;
provided, however,
that any
adjustments which by reason of this Section 11 are not required to be made shall
be carried forward and taken into account in any subsequent adjustment. All such
calculations under this Warrant shall be made by the Company and shall be made
to the nearest cent or to the nearest one hundredth of a share, as the case may
be.
(b)
No
adjustment need be made for a change in the par value of the Common Stock or
from par value to no par value or from no par value to par value.
12.
Notice of
Adjustments.
Whenever
the Purchase Price is adjusted as herein provided, the Company shall promptly,
but in no event later than five Trading Days thereafter, give a notice to the
Holder setting forth the Purchase Price and number of shares of Common Stock
which may be purchased upon exercise of this Warrant after such adjustment and
setting forth a brief statement of the facts requiring such adjustment but which
such statement shall not include any information which would be material
non-public information for purposes of the 1934 Act. Failure to deliver such
notice shall not affect the legality or validity of any such
adjustment.
13.
Further
Assurances.
The
Company will take all action that may be necessary or appropriate in order that
the Company may validly and legally issue fully paid and nonassessable shares of
stock, free from all taxes, liens and charges with respect to the issue thereof,
on the exercise of all or any portion of this Warrant from time to time
outstanding.
14.
Notice to Holder Prior to Certain
Actions.
In case
on or after the Issuance Date:
(a)
the
Company shall declare a dividend (or any other distribution) on its Common Stock
(other than in cash out of retained earnings); or
(b)
the
Company shall authorize the granting to the holders of its Common Stock of
rights or warrants to subscribe for or purchase any share of any class or any
other rights or warrants; or
(c)
the Board
of Directors shall authorize any reclassification of the Common Stock (other
than a subdivision or combination of its outstanding Common Stock, or a change
in par value, or from par value to no par value, or from no par value to par
value), or any consolidation or merger or other business combination transaction
to which the Company is a party and for which approval of any stockholders of
the Company is required, or the sale or transfer of all or substantially all of
the assets of the Company; or
(d)
there
shall be pending the voluntary or involuntary dissolution, liquidation or
winding-up of the Company;
the
Company shall give the Holder, as promptly as possible but in any event at least
ten Trading Days prior to the applicable date hereinafter specified, a notice
stating (x) the date on which a record is to be taken for the purpose of such
dividend, distribution or rights or warrants, or, if a record is not to be
taken, the date as of which the holders of Common Stock of record to be entitled
to such dividend, distribution or rights are to be determined, or (y) the date
on which such reclassification, consolidation, merger, other business
combination transaction, sale, transfer, dissolution, liquidation or winding-up
is expected to become effective or occur, and the date as of which it is
expected that holders of Common Stock of record who shall be entitled to
exchange their Common Stock for securities or other property deliverable upon
such reclassification, consolidation, merger, other business combination
transaction, sale, transfer, dissolution, liquidation or winding-up shall be
determined. Such notice shall not include any information which would be
material non-public information for purposes of the 1934 Act. Failure to give
such notice, or any defect therein, shall not affect the legality or validity of
such dividend, distribution, reclassification, consolidation, merger, sale,
transfer, dissolution, liquidation or winding-up. In the case of any such action
of which the Company gives such notice to the Holder or is required to give such
notice to the Holder, the Holder shall be entitled to give a subscription form
to exercise this Warrant in whole or in part that is contingent on the
completion of such action.
15.
Reservation of Stock, etc., Issuable
on Exercise of Warrants.
The
Company will at all times reserve and keep available out of its authorized but
unissued shares of capital stock, solely for issuance and delivery on the
exercise of this Warrant, a sufficient number of shares of Common Stock (or
Other Securities) to effect the full exercise of this Warrant and the exercise,
conversion or exchange of all other Common Stock Equivalents from time to time
outstanding (or Other Securities), and if at any time the number of authorized
but unissued shares of Common Stock (or Other Securities) shall not be
sufficient to effect such exercise, conversion or exchange, the Company shall
take such action as may be necessary to increase its authorized but unissued
shares of Common Stock (or Other Securities) to such number as shall be
sufficient for such purposes.
16.
Transfer of
Warrant.
This
Warrant shall inure to the benefit of the successors to and assigns of the
Holder. This Warrant and all rights hereunder, in whole or in part, are
registrable at the office or agency of the Company referred to below by the
Holder in person or by his duly authorized attorney, upon surrender of this
Warrant properly endorsed accompanied by an assignment form in the form
attached
to this
Warrant, or other customary form, duly executed by the transferring
Holder.
17.
Register of
Warrants.
The
Company shall maintain, at the principal office of the Company (or such other
office as it may designate by notice to the Holder), a register in which the
Company shall record the name and address of the Person in whose name this
Warrant has been issued, as well as the name and address of each successor and
prior owner of such Warrant. The Company shall be entitled to treat the Person
in whose name this Warrant is so registered as the sole and absolute owner of
this Warrant for all purposes.
18.
Exchange of
Warrant.
This
Warrant is exchangeable, upon the surrender hereof by the Holder at the office
or agency of the Company referred to in Section 16, for one or more new Warrants
of like tenor representing in the aggregate the right to subscribe for and
purchase the number of shares of Common Stock which may be subscribed for and
purchased hereunder, each of such new Warrants to represent the right to
subscribe for and purchase such number of shares as shall be designated by the
Holder at the time of such surrender.
19.
Replacement of
Warrant.
On
receipt by the Company of evidence reasonably satisfactory to it of the
ownership of and the loss, theft, destruction or mutilation of this Warrant and
(a) in the case of loss, theft or destruction, of indemnity from the Holder
reasonably satisfactory in form to the Company (and without the requirement to
post any bond or other security), or (b) in the case of mutilation, upon
surrender and cancellation of this Warrant, the Company will execute and deliver
to the Holder a new Warrant of like tenor without charge to the
Holder.
20.
Warrant
Agent.
The
Company may, by written notice to the Holder, appoint the transfer agent and
registrar for the Common Stock as the Company's agent for the purpose of issuing
Common Stock (or Other Securities) on the exercise of this Warrant pursuant to
Section 2, and the Company may, by written notice to the Holder, appoint an
agent having an office in the United States of America for the purpose of
exchanging this Warrant pursuant to Section 18, and replacing this Warrant
pursuant to Section 19, or any of the foregoing, and thereafter any such
exchange or replacement, as the case may be, shall be made at such office by
such agent.
21.
Remedies.
The
Company stipulates that the remedies at law of the Holder in the event of any
default or threatened default by the Company in the performance of or compliance
with any of the terms of this Warrant are not and will not be adequate, and that
such terms may be specifically enforced (x) by a decree for the specific
performance of any agreement contained herein, including, without limitation, a
decree for issuance of the shares of Common Stock (or Other Securities) issuable
upon exercise of this Warrant or (y) by an injunction against a violation of any
of the terms hereof or (z) otherwise.
22.
No Rights or Liabilities as a
Stockholder.
This
Warrant shall not entitle the Holder to any voting rights or other rights as a
stockholder of the Company. Nothing contained in this Warrant shall be construed
as conferring upon the Holder the right to vote or to consent or to receive
notice as a stockholder of the Company on any matters or with respect to any
rights whatsoever as a stockholder of the Company. No dividends or interest
shall be payable or accrued in respect of this Warrant or the interest
represented hereby or the Common Stock (or Other Securities) purchasable
hereunder until, and only to the extent that, this Warrant shall have been
exercised in accordance with its terms.
23.
Notices,
etc.
All
notices and other communications from the Company to the Holder shall be in
writing and delivered personally, by confirmed facsimile, by a nationally
recognized overnight courier service or mailed by first class certified mail,
postage prepaid, at such facsimile telephone number or address as may have been
furnished to the Company in writing by the Holder or at such facsimile telephone
number or the address shown for the Holder on the register of Warrants referred
to in Section 17.
24.
Transfer
Restrictions.
This
Warrant has not been and is not being registered under the provisions of the
1933 Act or any state securities laws and this Warrant may not be transferred
prior to the end of the holding period applicable to sales hereof under Rule
144(k) unless (1) the transferee is an “accredited investor” (as defined in
Regulation D under the 1933 Act) and (2) the Holder shall have delivered to the
Company an opinion of counsel, reasonably satisfactory in form, scope and
substance to the Company, to the effect that this Warrant may be sold or
transferred without registration under the 1933 Act. Prior to any such transfer,
such transferee shall have represented in writing to the Company that such
transferee has requested and received from the Company all information relating
to the business, properties, operations, condition (financial or other), results
of operations or prospects of the Company deemed relevant by such transferee;
that such transferee has been afforded the opportunity to ask questions of the
Company concerning the foregoing and has had the opportunity to obtain and
review the Registration Statement and the prospectus related thereto, each as
amended or supplemented to the date of transfer to such transferee, and the
reports and other information concerning the Company which at the time of such
transfer have been filed by the Company with the SEC pursuant to the 1934 Act
and which are incorporated by reference in such prospectus as of the date of
such transfer. If such transfer is intended to assign the rights and obligations
of the Holder under Section 5,8,9 and 10 of the Note Purchase Agreement, such
transfer shall otherwise be made in compliance with the applicable provisions of
the Note Purchase Agreement.
25.
Rule 144A Information
Requirement.
Within
the period prior to the expiration of the holding period applicable to sales
hereof under Rule 144(k) under the 1933 Act (or any successor provision), the
Company covenants and agrees that it shall, during any period in which it is not
subject to Section 13 or 15(d) under the 1934 Act, make available to the Holder
and the holder of any shares of Common Stock issued upon exercise of this
Warrant which continue to be Restricted Securities in connection with any sale
thereof and any prospective purchaser of this Warrant from the Holder, the
information required pursuant to Rule 144A(d)(4) under the 1933 Act upon the
request of the Holder and it will take such further action as the Holder may
reasonably request, all to the extent required from time to time to enable the
Holder to sell this Warrant without registration under the 1933 Act within the
limitation of the exemption provided by Rule 144A, as Rule 144A may be
amended from time to time. Upon the request of the Holder, the Company will
deliver to the Holder a written statement as to whether it has complied with
such requirements.
26.
Legend.
The
provisions of Section 5(b) of the Note Purchase Agreement and the related
definitions of capitalized terms used therein and defined in the Note Purchase
Agreement are by this reference incorporated herein as if set forth in full at
this place.
27.
Amendment;
Waiver.
(a) This
Warrant and any terms hereof may be changed, modified or amended only by an
instrument in writing signed by the party against which enforcement of such
change, modification or amendment is sought. Notwithstanding anything to the
contrary contained herein, no amendment or waiver shall increase or eliminate
the Restricted Ownership Percentage, whether permanently or temporarily, unless,
in addition to complying with the other requirements of this Warrant, such
amendment or waiver shall have been approved in accordance with the General
Corporation Law of the State of Delaware and the Company's By-laws by holders of
the outstanding shares of Common Stock entitled to vote at a meeting or by
written consent in lieu of such meeting.
(b)
Any term
or condition of this Warrant may be waived by the Holder or Company at any time
if the waiving party is entitled to the benefit thereof, but no such waiver will
be effective unless set forth in a written instrument duly executed by or on
behalf of the party waiving such term or condition. No waiver by any party of
any term or condition of this Warrant, in any one or more instances, will be
deemed to be or construed as a waiver of the same or any other term or condition
of this Warrant on any future occasion.
28.
Miscellaneous.
This
Warrant shall be construed and enforced in accordance with and governed by the
internal laws of the State of New York. The headings, captions and footers in
this Warrant are for purposes of reference only, and shall not limit or
otherwise affect any of the terms hereof. The invalidity or unenforceability of
any provision hereof shall in no way affect the validity or enforceability of
any other provision.
29.
Attorneys'
Fees.
In any
litigation, arbitration or court proceeding between the Company and Holder
relating hereto, the prevailing party shall be entitled to attorneys’ fees and
expenses and all costs of proceedings incurred in enforcing this
Warrant.
[Signature Page
Follows]
IN WITNESS
WHEREOF,
the
Company has caused this Warrant to be duly executed on its behalf by one of its
officers thereunto duly authorized.
|
|
|
|
EMAGIN
CORPORATION
|
|
|
|
Date: July 21,
2006
|
By:
|
/s/ Gary W.
Jones
|
|
Name: Gary W. Jones
|
|
Title: Chief Executive
Officer
|
ASSIGNMENT
For value
hereby
sell(s), assign(s) and transfer(s) unto
(Please
insert social security or other Taxpayer Identification Number of assignee:
) the
attached original, executed Warrant to purchase
share of
Common Stock of eMagin Corporation, a Delaware corporation (the “Company”), and
hereby irrevocably constitutes and appoints
attorney
to transfer the Warrant on the books of the Company, with full power of
substitution in the premises.
In
connection with any transfer of the Warrant within the period prior to the
expiration of the holding period applicable to sales thereof under Rule 144(k)
under the 1933 Act (or any successor provision) (other than any transfer
pursuant to a registration statement that has been declared effective under the
1933 Act), the undersigned confirms that such Warrant is being
transferred:
[
]
To the
Company or a Subsidiary; or
[
]
To an
“accredited investor” (as defined in Regulation D under the 1933 Act) pursuant
to and in compliance with the 1933 Act; or
[
]
Pursuant
to and in compliance with Rule 144 under the 1933 Act;
and
unless the box below is checked, the undersigned confirms that, to the knowledge
of the undersigned, such Warrant is not being transferred to an “affiliate” (as
defined in Rule 144 under the 1933 Act) of the Company.
[
]
The
transferee is an affiliate of the Company.
Capitalized
terms used in this Assignment and not defined in this Assignment shall have the
respective meanings provided in the Warrant.
Dated:
____________________________________
|
NAME
:____________________________________________
|
|
|
|
____________________________________________________________
|
|
Signature(s)
|
|
|
Exhibit 1
FORM OF
SUBSCRIPTION
EMAGIN
CORPORATION
(To be
signed only on exercise of Warrant)
TO:
|
eMagin Corporation
|
|
10500 N.E. 8
th
Street, Suite 1400
|
|
Bellevue,
WA 98004
|
Attention:
Chief Financial Officer
Facsimile
No.: (425) 749-3601
1.
The
undersigned Holder of the attached original, executed Warrant hereby elects to
exercise its purchase right under such Warrant with respect to
shares
(the “Exercise Shares”) of Common Stock, as defined in the Warrant, of eMagin
Corporation, a Delaware corporation (the “Company”).
2.
The
undersigned Holder (check one):
q
(a)
elects to
pay the Aggregate Purchase Price for such shares of Common Stock (i) in lawful
money of the United States or by the enclosed certified or official bank check
payable in United States dollars to the order of the Company in the amount of
$
, or (ii)
by wire transfer of United States funds to the account of the Company in the
amount of $
, which
transfer has been made before or simultaneously with the delivery of this Form
of Subscription pursuant to the instructions of the Company;
or
q
(b)
elects to
receive shares of Common Stock having a value equal to the value of the Warrant
calculated in accordance with Section 2(b) of the Warrant.
3.
Please
issue a stock certificate or certificates representing the appropriate number of
shares of Common Stock in the name of the undersigned or in such other name(s)
as is specified below:
Name:_________________________________________________________________
Address_______________________________________________________________
Social
Security or Tax Identification Number (if any):
____________________________________________________________
Dated:
________________________________________________________
(Signature
must conform to name of Holder as
specified
on the face of the Warrant)
________________________________________________________
(Address)
Exhibit 10.53
SECURITIES
PURCHASE AGREEMENT
This
Securities Purchase Agreement (this “
Agreement
”)
is dated as of April 2, 2008, among eMagin Corporation, a Delaware
corporation (the “
Company
”),
and each purchaser identified on the signature pages hereto (each, including its
successors and assigns, a “
Purchaser
”
and collectively the “
Purchasers
”).
WHEREAS,
subject to the terms and conditions set forth in this Agreement and pursuant to
Section 4(2) of the Securities Act (as defined below) and Rule 506 promulgated
thereunder, the Company desires to issue and sell to each Purchaser, and each
Purchaser, severally and not jointly, desires to purchase from the Company,
securities of the Company as more fully described in this
Agreement.
NOW,
THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement,
and for other good and valuable consideration the receipt and adequacy of which
are hereby acknowledged, the Company and each Purchaser agree as
follows:
ARTICLE
I
DEFINITIONS
Section 1.1
Definitions
. In
addition to the terms defined elsewhere in this Agreement, for all purposes of
this Agreement, the following terms have the meanings indicated in this Section
1.1:
“
Action
”
shall have the meaning ascribed to such term in Section 3.1(j).
“
Affiliate
”
means any Person that, directly or indirectly through one or more
intermediaries, controls or is controlled by or is under common control with a
Person as such terms are used in and construed under Rule 144 under the
Securities Act. With respect to a Purchaser, any investment fund or managed
account that is managed on a discretionary basis by the same investment manager
as such Purchaser will be deemed to be an Affiliate of such
Purchaser.
“
Business
Day
”
means
any day except Saturday, Sunday and any day which is a federal legal holiday or
a day on which banking institutions in the State of New York or State of
Washington are authorized or required by law or other governmental action to
close.
“
Closing
”
means the closing of the purchase and sale of the Securities pursuant to Section
2.1.
“
Closing
Date
” means the Trading Day when all of the Transaction Documents have
been executed and delivered by the applicable parties thereto, and all
conditions set forth in Sections 2.3 hereof are satisfied, or such other date as
the parties may agree.
“
Closing
Price
” means on any particular date (a) the last reported closing
bid price per share of Common Stock on such date on the Trading Market (as
reported by Bloomberg L.P. at 4:15 PM (Eastern Time)), or (b) if there is no
such price on such date, then the closing bid price on the Trading Market on the
date nearest preceding such date (as reported by Bloomberg L.P. at 4:15 PM
(Eastern Time)), or (c) if the Common Stock is not then listed or quoted on
the Trading Market and if prices for the Common Stock are then reported in the
“pink sheets” published by the National Quotation Bureau Incorporated (or a
similar organization or agency succeeding to its functions of reporting prices),
the most recent bid price per share of the Common Stock so reported, or
(d) if the shares of Common Stock are not then publicly traded the fair
market value of a share of Common Stock as determined by an appraiser selected
in good faith by the Purchasers of a majority in interest of the Shares then
outstanding.
“
Commission
”
means the United States Securities and Exchange Commission.
“
Common
Stock
” means the common stock of the Company, par value $0.001 per share,
and any other class of securities into which such securities may hereafter have
been reclassified or changed into.
“
Common Stock
Equivalents
” means any securities of the Company or the Subsidiaries
which entitle the holder thereof to acquire Common Stock at any time, including,
without limitation, any debt, preferred stock, rights, options, warrants or
other instrument that is at any time convertible into or exercisable or
exchangeable for, or otherwise entitles the holder thereof to receive, Common
Stock.
“
Company
Counsel
” means Sichenzia Ross Friedman Ference LLP.
“
Disclosure
Schedules
” means the Disclosure Schedules of the Company delivered
concurrently herewith.
“
Effective
Date
” means the date that the initial Registration Statement filed by the
Company pursuant to the Registration Rights Agreement is first declared
effective by the Commission.
“
Evaluation
Date
” shall have the meaning ascribed to such term in Section
3.1(r).
“
Exchange
Act
” means the Securities Exchange Act of 1934, as amended, and the rules
and regulations promulgated thereunder.
“
Exempt
Issuance
” means the issuance of (a) shares of Common Stock or options to
employees, officers, directors or consultants of the Company pursuant to (i) any
existing stock or option plan, or (ii) any stock or option plan duly adopted by
a majority of the non-employee members of the Board of Directors of the Company
or a majority of the members of a committee of non-employee directors
established for such purpose, (b) the issuance of shares of Common Stock
under the Company’s existing Non-Employee Stock Compensation Plan, (c) options
issued to new employees, (d) securities upon the exercise or exchange of or
conversion of any Securities issued hereunder and/or securities exercisable or
exchangeable for or convertible into shares of Common Stock issued and
outstanding on the date of this Agreement,
provided
that such
securities have not been amended since the date of this Agreement to increase
the number of such securities or to decrease the exercise, exchange or
conversion price of any such securities, and (e) securities issued pursuant
to acquisitions or strategic transactions or in connection with a strategic
alliance collaboration, joint venture, partnership, manufacturing, marketing,
distributing or similar arrangement of the Company with another Person which
strategic alliance, collaboration, joint venture, partnership manufacturing,
marketing, distributing or similar arrangement relates to the Company’s business
as conducted immediately prior thereto and which Person is engaged in a business
similar or related to the business of the Company,
provided
any such
issuance shall only be to a Person which is, itself or through its subsidiaries,
an operating company in a business synergistic with the business of the Company
and in which the Company receives benefits in addition to the investment of
funds, but shall not include a transaction in which the Company is issuing
securities primarily for the purpose of raising capital or to an entity whose
primary business is investing in securities.
“
GAAP
”
shall have the meaning ascribed to such term in Section 3.1(h).
“
Intellectual
Property Rights
” shall have the meaning ascribed to such term in Section
3.1(o).
“
Investor
”
shall have the meaning ascribed to such term in Section 3.1(v).
“
Legend Removal
Date
” shall have the meaning ascribed to such term in Section
4.1(c).
“
Liens
”
means a lien, charge, security interest, encumbrance, right of first refusal,
preemptive right or other restriction.
“
Material Adverse
Effect
” shall have the meaning assigned to such term in Section
3.1(b).
“
Material
Permits
” shall have the meaning ascribed to such term in Section
3.1(m).
“
Per Share
Purchase Price
” equals $1.04.
“
Person
”
means an individual or corporation, partnership, trust, incorporated or
unincorporated association, joint venture, limited liability company, joint
stock company, government (or an agency or subdivision thereof) or other entity
of any kind.
“
Pro Rata
Share
” means with respect to each capital raising transaction to which
Section 4.16 applies an amount equal to the product obtained by multiplying (a)
an amount equal to one-half of the securities being issued in such capital
raising transaction
times
(b) a fraction
of which the numerator is the sum of (i) the Purchaser’s Warrant Shares
plus
(ii) the number
of outstanding Shares beneficially owned by the Purchaser at the time the Pro
Rata Share is being determined, and the denominator is the sum of (iii) the
number of Warrant Shares at the time of original issuance thereof
plus
(iv) all of the
Shares issued under this Agreement, subject to adjustment of the amounts
specified in the immediately preceding clauses (iii) and (iv) for stock splits,
stock dividends and similar capital changes affecting the Common Stock that
occur on or after the Closing Date and on or prior to the date Pro Rata Share is
being determined.
“
Proceeding
”
means an action, claim, suit, investigation or proceeding (including, without
limitation, an investigation or partial proceeding, such as a deposition),
whether commenced or threatened.
“
Purchaser
Party
” shall have the meaning ascribed to such term in Section
4.9.
“
Registration
Rights Agreement
” means the Registration Rights Agreement, dated the date
hereof, among the Company and the Purchasers, in the form of
Exhibit A
attached
hereto.
“
Registration
Statement
” means a registration statement meeting the requirements set
forth in the Registration Rights Agreement and covering the resale by the
Purchasers of the Shares and the Warrant Shares.
“
Required
Approvals
” shall have the meaning ascribed to such term in
Section 3.1(e).
“
Rule 144
”
means Rule 144 promulgated by the Commission pursuant to the Securities Act, as
such Rule may be amended from time to time, or any similar rule or regulation
hereafter adopted by the Commission having substantially the same effect as such
Rule.
“
SEC
Reports
” shall have the meaning ascribed to such term in Section
3.1(h).
“
Securities
”
means the Shares, the Warrants and the Warrant Shares.
“
Securities
Act
” means the Securities Act of 1933, as amended.
“
Shares
”
means the shares of Common Stock issued or issuable to each Purchaser pursuant
to this Agreement.
“
Short
Sales
” shall include, without limitation, all “short sales” as defined in
Rule 200 promulgated under Regulation SHO under the Exchange Act and all types
of direct and indirect stock pledges, forward sale contracts, options, puts,
calls, swaps and similar arrangements (including on a total return basis), and
sales and other transactions through non-US broker dealers or foreign regulated
brokers.
“
Subscription
Amount
” means, as to each Purchaser, the aggregate amount to be paid for
Shares and Warrants purchased hereunder as specified below such Purchaser’s name
on the signature page of this Agreement and next to the heading “Subscription
Amount”, in United States Dollars and in immediately available
funds.
“
Subsidiary
”
means any subsidiary of the Company as set forth on
Schedule
3.1(a)
.
“
Trading
Day
” means (i) a day on which the Common Stock is traded on a Trading
Market, or (ii) if the Common Stock is not quoted on any Trading Market, a day
on which the Common Stock is quoted in the over-the-counter market as reported
by the Pink Sheets, LLC (or any similar organization or agency succeeding to its
functions of reporting prices);
provided
, that in the
event that the Common Stock is not listed or quoted as set forth in (i) and (ii)
hereof, then Trading Day shall mean a Business Day.
“
Trading
Market
” means whichever of the New York Stock Exchange, the American
Stock Exchange, the NASDAQ National Market, the NASDAQ SmallCap Market or OTC
Bulletin Board on which the Common Stock is listed or quoted for trading on the
date in question.
“
Transaction
Documents
” means this Agreement, the Warrants, the Registration Rights
Agreement, and any other documents or agreements executed in connection with the
transactions contemplated hereunder.
“
Warrants
”
means collectively the Common Stock purchase warrants, in the form of
Exhibit C
delivered
to the Purchasers at the Closing in accordance with Section 2.2(a)
hereof.
“
Warrant
Shares
” means the shares of Common Stock issuable upon exercise of the
Warrants.
ARTICLE
II
PURCHASE
AND SALE
Section 2.1
Closing
. On
the Closing Date, upon the terms and subject to the conditions set forth herein,
concurrent with the execution and delivery of this Agreement by the parties
hereto, the Company agrees to sell, and each Purchaser agrees to purchase in the
aggregate, severally and not jointly, up to $2,500,000 of Shares and Warrants.
Subject to the terms and conditions set forth in this Agreement, each Purchaser
shall deliver to the Company via wire transfer or a certified check immediately
available funds equal to their Subscription Amount, subject to adjustment
pursuant to Section 5.2, and the Company shall deliver to each Purchaser their
respective Shares and Warrants as determined pursuant to Section 2.2(a) and the
other items set forth in Section 2.2 issuable at the Closing. Upon
satisfaction of the conditions set forth in Sections 2.2 and 2.3, the Closing
shall occur at the offices of Sichenzia Ross Friedman Ference LLP, or such other
location as the parties shall mutually agree.
Section 2.2
Deliveries
.
(a) On
the Closing Date, the Company shall deliver or cause to be delivered to each
Purchaser the following:
(i) this
Agreement duly executed by the Company;
(ii) a
legal opinion of Company Counsel, in the form of
Exhibit B
attached
hereto;
(iii) a
copy of the irrevocable instructions to the Company’s transfer agent instructing
the transfer agent to deliver, on an expedited basis, a certificate evidencing a
number of Shares equal to such Purchaser’s Subscription Amount divided by the
Per Share Purchase Price, registered in the name of such Purchaser;
(iv) a
Warrant registered in the name of such Purchaser to purchase up to a number of
shares of Common Stock equal to 50% of the number of Shares purchased, with an
exercise price equal to $1.29
per share subject to
adjustment therein;
(v) the
Lockup Agreement in the form of
Exhibit D
hereto
executed by each director and each of the senior executive officers named as
such on
Schedule
2.2(a)
attached hereto;
(vi) the
Registration Rights Agreement duly executed by the Company; and
(vii) the
executed waivers from all of the outstanding Holders of the Amended and Restated
8% Senior Secured Convertible Notes Due 2008 waiving Section 3.12 of the Notes,
Section 12(d)(11) of the Certificate of the Designations, and Sections 5(m) and
8(a)(2) from the Note Purchase Agreement, dated July 21, 2006, as amended by the
Amendment Agreement, dated July 23, 2007.
(b) On
the Closing Date, each Purchaser shall deliver or cause to be delivered to the
Company the following:
(i) this
Agreement duly executed by such Purchaser;
(ii) such
Purchaser’s Subscription Amount, subject to adjustment pursuant to Section 5.2,
by wire transfer to the account as specified in writing by the Company;
and
(iii) the
Registration Rights Agreement duly executed by such Purchaser.
Section 2.3
Closing
Conditions
.
(a) The
obligations of the Company hereunder in connection with the Closing are subject
to the following conditions being met:
(i) the
accuracy in all material respects when made and on the Closing Date of the
representations and warranties of the Purchasers contained herein;
(ii) all
obligations, covenants and agreements of the Purchasers required to be performed
at or prior to the Closing Date shall have been performed; and
(iii) the
delivery by the Purchasers of the items set forth in Section 2.2(b) of this
Agreement.
(b) The
respective obligations of the Purchasers hereunder in connection with the
Closing are subject to the following conditions being met:
(i) the
accuracy in all material respects when made and on the Closing Date of the
representations and warranties of the Company contained herein;
(ii) all
obligations, covenants and agreements of the Company required to be performed at
or prior to the Closing Date shall have been performed;
(iii) the
delivery by the Company of the items set forth in Section 2.2(a) of this
Agreement;
(iv) there
shall have been no Material Adverse Effect with respect to the Company since the
date hereof; and
(v) from
the date hereof to the Closing Date, trading in the Common Stock shall not have
been suspended by the Commission (except for any suspension of trading of
limited duration agreed to by the Company, which suspension shall be terminated
prior to the Closing), and, at any time prior to the Closing Date, trading in
securities generally as reported by Bloomberg Financial Markets shall not have
been suspended or limited, or minimum prices shall not have been established on
securities whose trades are reported by such service, or on any Trading Market,
nor shall a banking moratorium have been declared either by the United States or
New York State authorities nor shall there have occurred any material outbreak
or escalation of hostilities or other national or international calamity of such
magnitude in its effect on, or any material adverse change in, any financial
market which, in each case, in the reasonable judgment of each Purchaser, makes
it impracticable or inadvisable to purchase the Shares at the
Closing.
ARTICLE
III
REPRESENTATIONS
AND WARRANTIES
Section 3.1
Representations
and Warranties of the Company
. Except as set forth under the
corresponding section of the Disclosure Schedules which Disclosure Schedules
shall be deemed a part hereof, the Company hereby makes the representations and
warranties set forth below to each Purchaser:
(a)
Subsidiaries
. All
direct and indirect subsidiaries of the Company are set forth on
Schedule
3.1(a)
. Except as set forth on
Schedule 3.1(a)
, the
Company owns, directly or indirectly, all of the capital stock or other equity
interests of each Subsidiary free and clear of any Liens, and all the issued and
outstanding shares of capital stock of each Subsidiary are validly issued and
are fully paid, non-assessable and free of preemptive and similar rights to
subscribe for or purchase securities.
(b)
Organization and
Qualification
. The Company and each of the Subsidiaries is an
entity duly incorporated or otherwise organized, validly existing and in good
standing under the laws of the jurisdiction of its incorporation or organization
(as applicable), with the requisite power and authority to own and use its
properties and assets and to carry on its business as currently
conducted. Neither the Company nor any Subsidiary is in violation or
default of any of the provisions of its respective certificate or articles of
incorporation, bylaws or other organizational or charter
documents. Each of the Company and the Subsidiaries is duly qualified
to conduct its respective business and is in good standing as a foreign
corporation or other entity in each jurisdiction in which the nature of the
business conducted or property owned by it makes such qualification necessary,
except where the failure to be so qualified or in good standing, as the case may
be, could not have or reasonably be expected to result in (i) a material and
adverse effect on the legality, validity or enforceability of any Transaction
Document, (ii) a material and adverse effect on the results of operations,
assets, business, prospects or condition (financial or otherwise) of the Company
and the Subsidiaries, taken as a whole, or (iii) a material adverse effect on
the Company’s ability to perform in any material respect on a timely basis its
obligations under any Transaction Document (any of (i), (ii) or (iii), a “
Material Adverse
Effect
”) and no Proceeding has been instituted in any such jurisdiction
revoking, limiting or curtailing or seeking to revoke, limit or curtail such
power and authority or qualification.
(c)
Authorization;
Enforcement
. The Company has the requisite corporate power and
authority to enter into and to consummate the transactions contemplated by each
of the Transaction Documents and otherwise to carry out its obligations
hereunder and thereunder. The execution and delivery of each of the
Transaction Documents by the Company and the consummation by it of the
transactions contemplated thereby have been duly authorized by all necessary
action on the part of the Company and no further action is required by the
Company, its board of directors or its stockholders in connection therewith
other than in connection with the Required Approvals. Each Transaction Document
has been (or upon delivery will have been) duly executed by the Company and,
when delivered in accordance with the terms hereof and thereof, will constitute
the valid and binding obligation of the Company enforceable against the Company
in accordance with its terms except (i) as such enforceability may be limited by
applicable bankruptcy, insolvency, reorganization, moratorium, liquidation and
other similar laws of general application affecting enforcement of creditors’
rights generally and (ii) as limited by laws relating to the availability of
specific performance, injunctive relief or other equitable
remedies.
(d)
No
Conflicts
. The execution, delivery and performance of the
Transaction Documents by the Company, the issuance and sale of the Securities
and the consummation by the Company of the other transactions contemplated
hereby and thereby do not and will not (i) conflict with or violate any
provision of the Company’s or any Subsidiary’s certificate or articles of
incorporation, bylaws or other organizational or charter documents, or (ii)
conflict with, or constitute a default (or an event that with notice or lapse of
time or both would become a default) under, result in the creation of any Lien
upon any of the properties or assets of the Company or any Subsidiary, or give
to others any rights of termination, amendment, acceleration or cancellation
(with or without notice, lapse of time or both) of, any agreement, credit
facility, debt or other instrument (evidencing a Company or Subsidiary debt or
otherwise) or other understanding to which the Company or any Subsidiary is a
party or by which any property or asset of the Company or any Subsidiary is
bound or affected, or (iii) subject to the Required Approvals, conflict with or
result in a violation of any law, rule, regulation, order, judgment, injunction,
decree or other restriction of any court or governmental authority to which the
Company or a Subsidiary is subject (including federal and state securities laws
and regulations), or by which any property or asset of the Company or a
Subsidiary is bound or affected; except in the case of each of clauses (ii) and
(iii), such as could not have or reasonably be expected to result in a Material
Adverse Effect.
(e)
Filings, Consents and
Approvals
. The Company is not required to obtain any consent,
waiver, authorization or order of, give any notice to, or make any filing or
registration with, any court or other federal, state, local or other
governmental authority or other Person in connection with the execution,
delivery and performance by the Company of the Transaction Documents, other than
(i) filings required pursuant to Section 4.4 of this Agreement, (ii) the filing
with the Commission of the Registration Statement, (iii) application(s) to each
applicable Trading Market for the listing of the Shares and Warrant Shares for
trading thereon in the time and manner required thereby, and (iv) the filing of
Form D with the Commission and such filings as are required to be made under
applicable state securities laws (collectively, the “
Required
Approvals
”).
(f)
Issuance of the
Securities
. The Securities are duly authorized and, when
issued and paid for in accordance with the applicable Transaction Documents,
will be duly and validly issued, fully paid and nonassessable, free and clear of
all Liens imposed by the Company other than restrictions on transfer provided
for in the Transaction Documents. The Warrant Shares, when issued in
accordance with the terms of the Transaction Documents, will be validly issued,
fully paid and nonassessable, free and clear of all Liens imposed by the
Company. As of the Closing, the Company will have reserved from its duly
authorized capital stock the maximum number of shares of Common Stock issuable
pursuant to this Agreement and the Warrants.
(g)
Capitalization
. The
capitalization of the Company is as set forth on
Schedule
3.1(g)
. The Company has not issued any capital stock since its
most recently filed periodic report under the Exchange Act, other than pursuant
to the exercise of employee stock options under the Company’s stock option
plans, the issuance of shares of Common Stock to employees pursuant to the
Company’s employee stock purchase plan, the issuance of shares of Common Stock
pursuant to the Company’s existing Non-Employee Stock Compensation Plan, and
pursuant to the conversion or exercise of outstanding Common Stock
Equivalents. Other than as set forth on
Schedule 3.1(g)
, no
Person has any right of first refusal, preemptive right, right of participation,
or any similar right to participate in the transactions contemplated by the
Transaction Documents. Other than as disclosed on
Schedule 3.1(g)
,
except as a result of the purchase and sale of the Securities, there are no
outstanding options, warrants, script rights to subscribe to, calls or
commitments of any character whatsoever relating to, or securities, rights or
obligations convertible into or exercisable or exchangeable for, or giving any
Person any right to subscribe for or acquire, any shares of Common Stock, or
contracts, commitments, understandings or arrangements by which the Company or
any Subsidiary is or may become bound to issue additional shares of Common Stock
or Common Stock Equivalents. Except as set forth on
Schedule 3.1(g)
, the
issuance and sale of the Securities will not obligate the Company to issue
shares of Common Stock or other securities to any Person (other than the
Purchasers) and will not result in a right of any holder of Company securities
to adjust the exercise, conversion, exchange or reset price under such
securities. All of the outstanding shares of capital stock of the
Company are validly issued, fully paid and nonassessable, have been issued in
compliance with all federal and state securities laws, and none of such
outstanding shares was issued in violation of any preemptive rights or similar
rights to subscribe for or purchase securities. No further approval or
authorization of any stockholder, the Board of Directors of the Company or
others is required for the issuance and sale of the Securities. There
are no stockholders agreements, voting agreements or other similar agreements
with respect to the Company’s capital stock to which the Company is a party or,
to the knowledge of the Company, between or among any of the Company’s
stockholders.
(h)
SEC Reports; Financial
Statements
. The Company has filed all reports, schedules,
forms, statements and other documents required to be filed by it under the
Securities Act and the Exchange Act, including pursuant to Section 13(a) or
15(d) thereof, for the two years preceding the date hereof (or such shorter
period as the Company was required by law to file such material) (the foregoing
materials, including the exhibits thereto and documents incorporated by
reference therein, being collectively referred to herein as the “
SEC
Reports
”) on a timely basis or has received a valid extension of such
time of filing and has filed any such SEC Reports prior to the expiration of any
such extension other than Current Reports on Form 8-K. As of their
respective dates, the SEC Reports complied in all material respects with the
requirements of the Securities Act and the Exchange Act and the rules and
regulations of the Commission promulgated thereunder, and none of the SEC
Reports, when filed, contained any untrue statement of a material fact or
omitted to state a material fact required to be stated therein or necessary in
order to make the statements therein, in the light of the circumstances under
which they were made, not misleading. The financial statements of the Company
included in the SEC Reports comply in all material respects with applicable
accounting requirements and the rules and regulations of the Commission with
respect thereto as in effect at the time of filing. Such financial statements
have been prepared in accordance with United States generally accepted
accounting principles (“
GAAP
”)
applied on a consistent basis during the periods involved, except as may be
otherwise specified in such financial statements or the notes thereto and except
that unaudited financial statements may not contain all footnotes required by
GAAP, and fairly present in all material respects the financial position of the
Company and its consolidated Subsidiaries as of and for the dates thereof and
the results of operations and cash flows for the periods then ended, subject, in
the case of unaudited statements, to normal, immaterial, year-end audit
adjustments.
(i)
Material
Changes
. Since the date of the latest audited financial
statements included within the SEC Reports, except as specifically disclosed in
the SEC Reports, (i) there has been no event, occurrence or development that has
had or that could reasonably be expected to result in a Material Adverse Effect,
(ii) the Company has not incurred any liabilities (contingent or otherwise)
other than (A) trade payables and accrued expenses incurred in the ordinary
course of business consistent with past practice and (B) liabilities not
required to be reflected in the Company’s financial statements pursuant to GAAP
or required to be disclosed in filings made with the Commission, (iii) the
Company has not altered its method of accounting, (iv) the Company has not
declared or made any dividend or distribution of cash or other property to its
stockholders or purchased, redeemed or made any agreements to purchase or redeem
any shares of its capital stock and (v) the Company has not issued any equity
securities to any officer, director or Affiliate, except pursuant to existing
Company stock option or stock plans. The Company does not have pending before
the Commission any request for confidential treatment of
information.
(j)
Litigation
. There
is no action, suit, inquiry, notice of violation, proceeding or investigation
pending or, to the knowledge of the Company, threatened in writing against or
affecting the Company, any Subsidiary or any of their respective properties
before or by any court, arbitrator, governmental or administrative agency or
regulatory authority (federal, state, county, local or foreign) (collectively,
an “
Action
”)
which (i) adversely affects or challenges the legality, validity or
enforceability of any of the Transaction Documents or the Securities or (ii)
could, if there were an unfavorable decision, individually or in the aggregate,
have or reasonably be expected to result in a Material Adverse
Effect. Neither the Company nor any Subsidiary, nor any director or
officer thereof, is or has been the subject of any Action involving a claim of
violation of or liability under federal or state securities laws or a claim of
breach of fiduciary duty. There has not been and, to the knowledge of
the Company, is not pending or contemplated, any investigation by the Commission
involving the Company or any current or former director or officer of the
Company. The Commission has not issued any stop order or other order
suspending the effectiveness of any registration statement filed by the Company
or any Subsidiary under the Exchange Act or the Securities Act.
(k)
Labor
Relations
. No material labor dispute exists or, to the
knowledge of the Company, is imminent with respect to any of the employees of
the Company which could reasonably be expected to result in a Material Adverse
Effect.
(l)
Compliance
. Neither
the Company nor any Subsidiary (i) is in default under or in violation of (and
no event has occurred that has not been waived that, with notice or lapse of
time or both, would result in a default by the Company or any Subsidiary under),
nor has the Company or any Subsidiary received notice of a claim that it is in
default under or that it is in violation of, any indenture, loan or credit
agreement or any other agreement or instrument to which it is a party or by
which it or any of its properties is bound (whether or not such default or
violation has been waived), (ii) is in violation of any order of any court,
arbitrator or governmental body, or (iii) is or has been in violation of any
statute, rule or regulation of any governmental authority, including without
limitation all foreign, federal, state and local laws applicable to its business
except in each case as could not have a Material Adverse Effect.
(m)
Regulatory
Permits
. The Company and the Subsidiaries possess all
certificates, authorizations and permits issued by the appropriate federal,
state, local or foreign regulatory authorities necessary to conduct their
respective businesses as described in the SEC Reports, except where the failure
to possess such permits could not have or reasonably be expected to result in a
Material Adverse Effect (“
Material
Permits
”), and neither the Company nor any Subsidiary has received any
notice of proceedings relating to the revocation or modification of any Material
Permit.
(n)
Title to
Assets
. The Company and the Subsidiaries have good and
marketable title in fee simple to all real property owned by them that is
material to the business of the Company and the Subsidiaries and good and
marketable title in all personal property owned by them that is material to the
business of the Company and the Subsidiaries, in each case free and clear of all
Liens, except for Liens as do not materially affect the value of such property
and do not materially interfere with the use made and proposed to be made of
such property by the Company and the Subsidiaries and Liens for the payment of
federal, state or other taxes, the payment of which is neither delinquent nor
subject to penalties. Any real property and facilities held under lease by the
Company and the Subsidiaries are held by them under valid, subsisting and
enforceable leases of which the Company and the Subsidiaries are in compliance,
except as could not have or reasonably be expected to result in a Material
Adverse Effect.
(o)
Patents and
Trademarks
. The Company and the Subsidiaries have, or have
rights to use, all patents, patent applications, trademarks, trademark
applications, service marks, trade names, copyrights, licenses and other similar
rights that are necessary or material for use in connection with their
respective businesses as described in the SEC Reports and which the failure to
so have could have or reasonably be expected to result in a Material Adverse
Effect (collectively, the “
Intellectual
Property Rights
”). Neither the Company nor any Subsidiary has received a
written notice that the Intellectual Property Rights used by the Company or any
Subsidiary violates or infringes upon the rights of any Person. All
such Intellectual Property Rights are enforceable and there is no existing
infringement by another Person of any of the Intellectual Property Rights of
others.
(p)
Insurance
. The
Company and the Subsidiaries are insured by insurers of recognized financial
responsibility against such losses and risks and in such amounts as are prudent
and customary in the businesses in which the Company and the Subsidiaries are
engaged, including, but not limited to, directors and officers insurance
coverage at least equal to the aggregate Subscription Amount. Such
insurance contracts and policies are accurate and complete. Neither
the Company nor any Subsidiary has any reason to believe that it will not be
able to renew its existing insurance coverage as and when such coverage expires
or to obtain similar coverage from similar insurers as may be necessary to
continue its business on terms consistent with market for the Company’s and such
Subsidiaries respective lines of business.
(q)
Transactions With Affiliates
and Employees
. Except as set forth in the SEC Reports, none of
the officers, directors or employees of the Company is presently a party to any
transaction with the Company or any Subsidiary (other than for services as
officers, directors and employees), including any contract, agreement or other
arrangement providing for the furnishing of services to or by, providing for
rental of real or personal property to or from, or otherwise requiring payments
to or from any officer, director or such employee or any entity in which any
officer, director, or any such employee has a substantial interest or is an
officer, director, trustee or partner, in each case in excess of $60,000 other
than (i) for payment of salary or consulting fees for services rendered,
(ii) reimbursement for expenses incurred on behalf of the Company, and
(iii) for other employee benefits, including stock option agreements under any
stock option plan of the Company.
(r)
Sarbanes-Oxley; Internal
Accounting Controls
. Except as set forth on
Schedule 3.1(r)
, the
Company is in material compliance with all provisions of the Sarbanes-Oxley Act
of 2002 which are applicable to it as of the Closing Date. The
Company is actively taking steps to ensure that it cures all of the items set
forth on
Schedule
3.1(r)
and the Company agrees that such items shall be cured by no later
than
December
31
,
2008. The
Company shall thereafter comply in all material respects with all applicable
provisions of the Sarbanes-Oxley Act. The Company and the Subsidiaries maintain
a system of internal accounting controls sufficient to provide reasonable
assurance that (i) transactions are executed in accordance with
management’s general or specific authorizations, (ii) transactions are recorded
as necessary to permit preparation of financial statements in conformity with
GAAP and to maintain asset accountability, (iii) access to assets is
permitted only in accordance with management’s general or specific
authorization, and (iv) the recorded accountability for assets is compared with
the existing assets at reasonable intervals and appropriate action is taken with
respect to any differences. The Company has established disclosure
controls and procedures (as defined in Exchange Act Rules 13a-15(e) and
15d-15(e)) for the Company and designed such disclosure controls and procedures
to ensure that material information relating to the Company, including its
Subsidiaries, is made known to the certifying officers by others within those
entities, particularly during the period in which the Company’s most recently
filed periodic report under the Exchange Act, as the case may be, is being
prepared. The Company’s certifying officers have evaluated the
effectiveness of the Company’s controls and procedures as of the date prior to
the filing date of the most recently filed periodic report under the Exchange
Act (such date, the “
Evaluation
Date
”). The Company presented in its most recently filed
periodic report under the Exchange Act the conclusions of the certifying
officers about the effectiveness of the disclosure controls and procedures based
on their evaluations as of the Evaluation Date. Since the Evaluation
Date, there have been no significant changes in the Company’s internal controls
(as such term is defined in Item 307(b) of Regulation S-K under the Exchange
Act) or, to the knowledge of the Company, in other factors that could
significantly affect the Company’s internal controls.
(s)
Certain
Fees
. No brokerage or finder’s fees or commissions are or will
be payable by the Company to any broker, financial advisor or consultant,
finder, placement agent, investment banker, bank or other Person with respect to
the transactions contemplated by the Transaction Documents. The
Purchasers shall have no obligation with respect to any fees or with respect to
any claims (other than such fees or commissions owed by an Purchaser pursuant to
written agreements executed by such Purchaser which fees or commissions shall be
the sole responsibility of such Purchaser) made by or on behalf of other Persons
for fees of a type contemplated in this Section that may be due in connection
with the transactions contemplated by the Transaction Documents.
(t)
Private
Placement
. Assuming the accuracy of the Purchasers
representations and warranties set forth in Section 3.2, no registration under
the Securities Act is required for the offer and sale of the Securities by the
Company to the Purchasers as contemplated hereby. The issuance and
sale of the Securities hereunder does not contravene the rules and regulations
of the Trading Market.
(u)
Investment
Company
. The Company is not, and is not an Affiliate of, and
immediately after receipt of payment for the Securities, will not be or be an
Affiliate of, an “investment company” within the meaning of the Investment
Company Act of 1940, as amended. The Company shall conduct its
business in a manner so that it will not become subject to the Investment
Company Act.
(v)
Registration Rights
.
Other than as set forth on
Schedule 3.1(v)
and each of the Purchasers, no Person has any right to cause the
Company to effect the registration under the Securities Act of any securities of
the Company. The Company has received valid waivers from all of the
outstanding Holders of the Amended and Restated 8% Senior Secured Convertible
Notes Due 2008 waiving their rights to allow for the filling of the
Registration Statement before the effectiveness of their registration
statement. The Company is not in default under any agreement or other
arrangement related to registration rights of any investor (the “
Investor
”)
who was a party to the Note Purchase Agreement dated as of July 21, 2006 as
amended by the Amendment Agreement dated as of July 23, 2007 and the
Company does not owe any liquidated damages to any Investor related to any
registration obligation.
(w)
Listing and Maintenance
Requirements
. The Company’s Common Stock is registered
pursuant to Section 12(g) of the Exchange Act, and the Company has taken no
action designed to, or which to its knowledge is likely to have the effect of,
terminating the registration of the Common Stock under the Exchange Act nor has
the Company received any notification that the Commission is contemplating
terminating such registration. The Company has not, in the 12 months
preceding the date hereof, received notice from any Trading Market on which the
Common Stock is or has been listed or quoted to the effect that the Company is
not in compliance with the listing or maintenance requirements of such Trading
Market. The Company is, and has no reason to believe that it will not
in the foreseeable future continue to be, in compliance with all such listing
and maintenance requirements.
(x)
Application of Takeover
Protections
. The Company and its Board of Directors have taken
all necessary action, if any, in order to render inapplicable any control share
acquisition, business combination, poison pill (including any distribution under
a rights agreement) or other similar anti-takeover provision under the Company’s
Certificate of Incorporation (or similar charter documents) or the laws of its
state of incorporation that is or could become applicable to the Purchasers as a
result of the Purchasers and the Company fulfilling their obligations or
exercising their rights under the Transaction Documents, including without
limitation as a result of the Company’s issuance of the Securities and the
Purchasers’ ownership of the Securities.
(y)
Disclosure
. The
Company confirms that, neither it nor any other Person acting on its behalf has
provided any of the Purchasers or their agents or counsel with any information
that the Company believes constitutes or might constitute material, non-public
information, except insofar as the existence and terms of the proposed
transactions hereunder may constitute such information. The Company
understands and confirms that the Purchasers will rely on the foregoing
representations and covenants in effecting transactions in securities of the
Company. All disclosure provided to the Purchasers regarding the
Company, its business and the transactions contemplated hereby, including the
Disclosure Schedules to this Agreement, furnished by or on behalf of the Company
with respect to the representations and warranties made herein are true and
correct with respect to such representations and warranties and do not contain
any untrue statement of a material fact or omit to state any material fact
necessary in order to make the statements made therein, in light of the
circumstances under which they were made, not misleading. The Company
acknowledges and agrees that no Purchaser makes or has made any representations
or warranties with respect to the transactions contemplated hereby other than
those specifically set forth in Section 3.2 hereof.
(z)
No Integrated
Offering
. Assuming the accuracy of the Purchasers’
representations and warranties set forth in Section 3.2, neither the Company,
nor any of its affiliates, nor any Person acting on its or their behalf has,
directly or indirectly, made any offers or sales of any security or solicited
any offers to buy any security, under circumstances that would cause this
offering of the Securities to be integrated with prior offerings by the Company
for purposes of the Securities Act, which would require the registration of any
such securities under the Securities Act or under the rules and regulations of
any Trading Market on which any of the securities of the Company are listed or
designated, if such integration would cause this Agreement or the transactions
contemplated herein to require shareholder approval.
(aa)
Solvency
. Based
on the financial condition of the Company as of the Closing Date after giving
effect to the receipt by the Company of the proceeds from the sale of the
Securities hereunder, (i) the Company’s fair saleable value of its assets
exceeds the amount that will be required to be paid on or in respect of the
Company’s existing debts and other liabilities (including known contingent
liabilities) as they mature; (ii) the Company’s assets do not constitute
unreasonably small capital to carry on its business for the current fiscal year
as now conducted and as proposed to be conducted including its capital needs
taking into account the particular capital requirements of the business
conducted by the Company, and projected capital requirements and capital
availability thereof; and (iii) the current cash flow of the Company, together
with the proceeds the Company would receive, were it to liquidate all of its
assets, after taking into account all anticipated uses of the cash, would be
sufficient to pay all amounts on or in respect of its debt when such amounts are
required to be paid. The Company does not intend to incur debts
beyond its ability to pay such debts as they mature (taking into account the
timing and amounts of cash to be payable on or in respect of its
debt). The Company has no knowledge of any facts or circumstances
which lead it to believe that it will file for reorganization or liquidation
under the bankruptcy or reorganization laws of any jurisdiction within one year
from the Closing Date. The SEC Reports set forth as of the dates
thereof all outstanding secured and unsecured Indebtedness of the Company or any
Subsidiary, or for which the Company or any Subsidiary has
commitments. For the purposes of this Agreement, “
Indebtedness
”
shall mean (a) any liabilities for borrowed money or amounts owed in excess of
$50,000 (other than trade accounts payable incurred in the ordinary course of
business), (b) all guaranties, endorsements and other contingent obligations in
respect of Indebtedness of others, whether or not the same are or should be
reflected in the Company’s balance sheet (or the notes thereto), except
guaranties by endorsement of negotiable instruments for deposit or collection or
similar transactions in the ordinary course of business; and (c) the present
value of any lease payments in excess of $50,000 due under leases required to be
capitalized in accordance with GAAP. Neither the Company nor any
Subsidiary is in default with respect to any Indebtedness.
(bb)
Form S-1
Eligibility
. The Company is eligible to register the resale of
the Securities for resale by the Purchaser on Form S-1 promulgated under the
Securities Act.
(cc)
Tax
Status
. Except for matters that would not, individually or in
the aggregate, have or reasonably be expected to result in a Material Adverse
Effect, the Company and each Subsidiary has filed all necessary federal, state
and foreign income and franchise tax returns and has paid or accrued all taxes
shown as due thereon, and the Company has no knowledge of a tax deficiency which
has been asserted or threatened against the Company or any
Subsidiary.
(dd)
No General
Solicitation
. Neither the Company nor any person acting on
behalf of the Company has offered or sold any of the Securities by any form of
general solicitation or general advertising. The Company has offered
the Securities for sale only to the Purchasers and certain other “accredited
investors” within the meaning of Rule 501 under the Securities Act.
(ee)
Foreign Corrupt
Practices
. Neither the Company, nor to the knowledge of the
Company, any agent or other person acting on behalf of the Company, has (i)
directly or indirectly, used any funds for unlawful contributions, gifts,
entertainment or other unlawful expenses related to foreign or domestic
political activity, (ii) made any unlawful payment to foreign or domestic
government officials or employees or to any foreign or domestic political
parties or campaigns from corporate funds, (iii) failed to disclose fully any
contribution made by the Company (or made by any person acting on its behalf of
which the Company is aware) which is in violation of law, or (iv) violated in
any material respect any provision of the Foreign Corrupt Practices Act of 1977,
as amended.
(ff)
Accountants
. The
Company’s accountants are set forth in the SEC Reports. To the
knowledge of the Company, such accountants, who the Company expects will express
their opinion with respect to the financial statements to be included in the
Company’s Annual Report on Form 10-K for the year ending December 31, 2007, are
a registered public accounting firm as required by the Securities
Act.
(gg)
Acknowledgment Regarding
Purchasers’ Purchase of Securities
. The Company acknowledges
and agrees that each of the Purchasers is acting solely in the capacity of an
arm’s length purchaser with respect to the Transaction Documents and the
transactions contemplated hereby. The Company further acknowledges
that no Purchaser is acting as a financial advisor or fiduciary of the Company
(or in any similar capacity) with respect to this Agreement and the transactions
contemplated hereby and any advice given by any Purchaser or any of their
respective representatives or agents in connection with this Agreement and the
transactions contemplated hereby is merely incidental to the Purchasers’
purchase of the Securities. The Company further represents to each
Purchaser that the Company’s decision to enter into this Agreement has been
based solely on the independent evaluation of the transactions contemplated
hereby by the Company and its representatives.
(hh)
Acknowledgement Regarding
Purchasers’ Trading Activity
. Anything in this Agreement or
elsewhere herein to the contrary notwithstanding (except for Section 4.14
hereof), it is understood and agreed by the Company (i) that none of the
Purchasers have been asked to agree, nor has any Purchaser agreed, to desist
from purchasing or selling, long and/or short, securities of the Company, or
derivative securities based on securities issued by the Company or to hold the
Securities for any specified term; (ii) that past or future open market or other
transactions by any Purchaser, including Short Sales, and specifically
including, without limitation, Short Sales or derivative transactions, before or
after the closing of this or future private placement transactions, may
negatively impact the market price of the Company’s publicly-traded securities;
(iii) that any Purchaser, and counter parties in derivative transactions to
which any such Purchaser is a party, directly or indirectly, presently may have
a short position in the Common Stock, and (iv) that each Purchaser shall not be
deemed to have any affiliation with or control over any arm’s length
counter-party in any derivative transaction. The Company further
understands and acknowledges that (a) one or more Purchasers may engage in
hedging activities at various times during the period that the Securities are
outstanding, including, without limitation, during the periods that the value of
the Warrant Shares deliverable with respect to Securities are being determined
and (b) such hedging activities (if any) could reduce the value of the
existing stockholders’ equity interests in the Company at and after the time
that the hedging activities are being conducted. The Company acknowledges
that such aforementioned hedging activities do not constitute a breach of any of
the Transaction Documents.
(ii)
Manipulation of
Price
. The Company has not, and to its knowledge no one acting
on its behalf has, (i) taken, directly or indirectly, any action designed to
cause or to result in the stabilization or manipulation of the price of any
security of the Company to facilitate the sale or resale of any of the
Securities, (ii) sold, bid for, purchased, or, paid any compensation for
soliciting purchases of, any of the Securities (other than for the placement
agent’s placement of the Securities), or (iii) paid or agreed to pay to any
person any compensation for soliciting another to purchase any other securities
of the Company.
Section 3.2
Representations
and Warranties of the Purchasers
. Each Purchaser hereby, for
itself and for no other Purchaser, represents and warrants as of the date hereof
and as of the Closing Date to the Company as follows:
(a)
Organization;
Authority
. Such Purchaser is an entity duly organized, validly
existing and in good standing under the laws of the jurisdiction of its
organization with full right, corporate or partnership power and authority to
enter into and to consummate the transactions contemplated by the Transaction
Documents and otherwise to carry out its obligations hereunder and
thereunder. The execution, delivery and performance by such Purchaser
of the transactions contemplated by this Agreement have been duly authorized by
all necessary corporate or similar action on the part of such
Purchaser. Each Transaction Document to which it is a party has been
duly executed by such Purchaser, and when delivered by such Purchaser in
accordance with the terms hereof, will constitute the valid and legally binding
obligation of such Purchaser, enforceable against it in accordance with its
terms, except (i) as such enforceability may be limited by general equitable
principles and applicable bankruptcy, insolvency, reorganization, moratorium,
liquidation and other similar laws of general application affecting enforcement
of creditors’ rights generally, (ii) as limited by laws relating to the
availability of specific performance, injunctive relief or other equitable
remedies and (iii) insofar as indemnification and contribution provisions
may be limited by applicable law.
(b)
Own
Account
. Such Purchaser understands that the Securities are
restricted securities and have not been registered under the Securities Act or
any applicable state securities law and is acquiring the Securities as principal
for its own account and not with a view to or for distributing or reselling such
Securities or any part thereof in violation of the Securities Act or any
applicable state securities law, has no present intention of distributing any of
such Securities in violation of the Securities Act or any applicable state
securities law and has no arrangement or understanding with any other persons
regarding the distribution of such Securities (this representation and warranty
not limiting such Purchaser’s right to sell the Securities pursuant to the
Registration Statement or otherwise in compliance with applicable federal and
state securities laws) in violation of the Securities Act or any applicable
state securities law. Such Purchaser is acquiring the Securities hereunder in
the ordinary course of its business. Such Purchaser does not have any
agreement or understanding, directly or indirectly, with any Person to
distribute any of the Securities.
(c)
Purchaser
Status
. At the time such Purchaser was offered the Securities,
it was, and at the date hereof it is, and on each date on which it exercises any
Warrants, it will be either: (i) an “accredited investor” as defined in Rule
501(a)(1), (a)(2), (a)(3), (a)(7) or (a)(8) under the Securities Act or (ii) a
“qualified institutional buyer” as defined in Rule 144A(a) under the Securities
Act. Such Purchaser is not required to be registered as a broker-dealer under
Section 15 of the Exchange Act.
(d)
Experience of Such
Purchaser
. Such Purchaser, either alone or together with its
representatives, has such knowledge, sophistication and experience in business
and financial matters so as to be capable of evaluating the merits and risks of
the prospective investment in the Securities, and has so evaluated the merits
and risks of such investment. Such Purchaser is able to bear the
economic risk of an investment in the Securities and, at the present time, is
able to afford a complete loss of such investment.
(e)
General
Solicitation
. Such Purchaser is not purchasing the Securities
as a result of any advertisement, article, notice or other communication
regarding the Securities published in any newspaper, magazine or similar media
or broadcast over television or radio or presented at any seminar or any other
general solicitation or general advertisement.
(f)
Access to
Information
. Such Purchaser acknowledges that it has reviewed
the Disclosure Schedules and has been afforded (i) the opportunity to ask such
questions as it has deemed necessary of, and to receive answers from,
representatives of the Company concerning the terms and conditions of the
offering of the Shares and the merits and risks of investing in the Securities;
(ii) access to information about the Company and the Subsidiaries and their
respective financial condition, results of operations, business, properties,
management and prospects sufficient to enable it to evaluate its investment; and
(iii) the opportunity to obtain such additional information that the Company
possesses or can acquire without unreasonable effort or expense that is
necessary to make an informed investment decision with respect to the
investment. Neither such inquiries nor any other investigation conducted by or
on behalf of such Purchaser or its representatives or counsel shall modify,
amend or affect such Purchaser’s right to rely on the truth, accuracy and
completeness of the Disclosure Schedules and the Company’s representations and
warranties contained in the Transaction Documents.
(g)
Certain Trading
Activities
. Such Purchaser has not directly or indirectly, nor
has any Person acting on behalf of or pursuant to any understanding with such
Purchaser, engaged in any transactions in the securities of the Company
(including, without limitations, any Short Sales involving the Company’s
securities) since it was contacted by the Company in February 2008 regarding
this transaction. Such Purchaser covenants that neither it nor any Person
acting on its behalf or pursuant to any understanding with it will engage in any
transactions in the securities of the Company (including Short Sales) prior to
the time that the transactions contemplated by this Agreement are publicly
disclosed by the Company. Such Purchaser has maintained, and covenants
that until such time as the transactions contemplated by this Agreement are
publicly disclosed by the Company such Purchaser will maintain, the
confidentiality of all disclosures made to it in connection with this
transaction (including the existence and terms of this
transaction). Notwithstanding the foregoing, in the case of a
Purchaser that is a multi-managed investment vehicle whereby separate portfolio
managers manage separate portions of such Purchaser’s assets and the portfolio
managers have no direct knowledge of the investment decisions made by the
portfolio managers managing other portions of such Purchaser’s assets, the
representation set forth above shall only apply with respect to the portion of
assets managed by the portfolio manager that made the investment decision to
purchase the Securities covered by this Agreement. Other than to
other Persons party to this Agreement, such Purchaser has maintained the
confidentiality of all disclosures made to it in connection with this
transaction (including the existence and terms of this
transaction).
(h)
Independent Investment
Decision
. Such Purchaser has independently evaluated the
merits of its decision to purchase Securities pursuant to the Transaction
Documents, and such Purchaser confirms that it has not relied on the advice of
any other Purchaser’s business and/or legal counsel in making such
decision.
The
Company acknowledges and agrees that each Purchaser does not make or has not
made any representations or warranties with respect to the transactions
contemplated hereby other than those specifically set forth in this Section
3.2.
ARTICLE
IV
OTHER
AGREEMENTS OF THE PARTIES
Section 4.1
Transfer
Restrictions
.
(a) The
Securities may only be disposed of in compliance with state and federal
securities laws. In connection with any transfer of the Securities other than
pursuant to an effective registration statement or Rule 144, to the Company or
to an affiliate of a Purchaser or in connection with a pledge as contemplated in
Section 4.1(b), the Company may require the transferor thereof to provide to the
Company an opinion of counsel selected by the transferor and reasonably
acceptable to the Company, the form and substance of which opinion shall be
reasonably satisfactory to the Company, to the effect that such transfer does
not require registration of such transferred Securities under the Securities
Act. As a condition of such transfer, any such transferee shall agree
in writing to be bound by the terms of this Agreement and shall have the rights
of a Purchaser under this Agreement and the Registration Rights
Agreement.
(b) The
Purchasers agree to the imprinting, so long as is required by this Section
4.1(b), of a legend on any of the Securities in the following form:
THESE
SECURITIES HAVE NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION
OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM
REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES
ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN
EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN
AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION
REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE
SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR TO
SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO THE
COMPANY. THESE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN
ACCOUNT WITH A REGISTERED BROKER-DEALER OR OTHER LOAN WITH A FINANCIAL
INSTITUTION THAT IS AN “ACCREDITED INVESTOR” AS DEFINED IN RULE 501(a) UNDER THE
SECURITIES ACT.
The
Company acknowledges and agrees that a Purchaser may from time to time pledge
pursuant to a bona fide margin agreement with a registered broker-dealer or
grant a security interest in some or all of the Securities to a financial
institution that is an “accredited investor” as defined in Rule 501(a) under the
Securities Act and who agrees to be bound by the provisions of this Agreement
and the Registration Rights Agreement and, if required under the terms of such
arrangement, such Purchaser may transfer pledged or secured Securities to the
pledgees or secured parties. Such a pledge or transfer would not be
subject to approval of the Company and no legal opinion of legal counsel of the
pledgee, secured party or pledgor shall be required in connection
therewith. Further, no notice shall be required of such
pledge. At the appropriate Purchaser’s expense, the Company will
execute and deliver such reasonable documentation as a pledgee or secured party
of Securities may reasonably request in connection with a pledge or transfer of
the Securities, including, if the Securities are subject to registration
pursuant to the Registration Rights Agreement, the preparation and filing of any
required prospectus supplement under Rule 424(b)(3) under the Securities Act or
other applicable provision of the Securities Act to appropriately amend the list
of Selling Stockholders thereunder.
(c) Certificates
evidencing the Shares and Warrant Shares shall not contain any legend (including
the legend set forth in Section 4.1(b)), (i) while a registration statement
(including the Registration Statement) covering the resale of such security is
effective under the Securities Act, or (ii) following any sale of such Shares or
Warrant Shares pursuant to a registration statement or Rule 144 (assuming the
transferor is not an Affiliate of the Company), or (iii) if such Shares or
Warrant Shares are eligible for sale under Rule 144 without volume restrictions,
or (iv) if such legend is not required under applicable requirements of the
Securities Act and the rules and regulations promulgated thereunder (including
judicial interpretations and pronouncements issued by the staff of the
Commission). The Company shall cause its counsel to issue a legal
opinion to the Company’s transfer agent promptly after the Effective Date if
required by the Company’s transfer agent to effect the removal of the legend
hereunder. If all or any portion of a Warrant is exercised at a time
when there is an effective registration statement to cover the resale of the
Warrant Shares, such Warrant Shares shall be issued free of all
legends. The Company agrees that following the Effective Date or at
such time as such legend is no longer required under this Section 4.1(c), it
will, no later than three Trading Days following the delivery by a Purchaser to
the Company or the Company’s transfer agent of a certificate representing Shares
or Warrant Shares, as the case may be, issued with a restrictive legend (such
third Trading Day, the “
Legend Removal
Date
”), deliver or cause to be delivered to such Purchaser a certificate
representing such shares that is free from all restrictive and other
legends. The Company may not make any notation on its records or give
instructions to any transfer agent of the Company that enlarge the restrictions
on transfer set forth in this Section. Certificates for Securities
subject to legend removal hereunder shall be transmitted by the transfer agent
of the Company to the Purchasers by crediting the account of the Purchaser’s
prime broker with the Depository Trust Company System.
(d) In
addition to such Purchaser’s other available remedies, the Company shall pay to
a Purchaser, in cash, as partial liquidated damages and not as a penalty, for
each $1,000 of Shares or Warrant Shares (based on the Closing Price of the
Common Stock on the date such Securities are submitted to the Company’s transfer
agent) delivered for removal of the restrictive legend and subject to Section
4.1(c), $10 per Trading Day (increasing to $20 per Trading Day five (5) Trading
Days after such damages have begun to accrue) for each Trading Day after the
Legend Removal Date until such certificate is delivered without a
legend. Nothing herein shall limit such Purchaser’s right to pursue
actual damages for the Company’s failure to deliver certificates representing
any Securities as required by the Transaction Documents, and such Purchaser
shall have the right to pursue all remedies available to it at law or in equity
including, without limitation, a decree of specific performance and/or
injunctive relief.
(e) Each
Purchaser, severally and not jointly with the other Purchasers, agrees, and
represent and covenants to the Company, that the removal of the restrictive
legend from certificates representing Securities as set forth in this Section
4.1 is predicated upon the Company’s reliance that the Purchaser will sell any
Securities pursuant to either the registration requirements of the Securities
Act, including any applicable prospectus delivery requirements, or an exemption
therefrom.
(f) Until
the six month anniversary of the date hereof, the Company shall not undertake a
reverse or forward stock split or reclassification of the Common Stock without
the prior written consent of the Purchasers holding a then majority in interest
of the Shares.
Section 4.2
Furnishing
of Information
. As long as any Purchaser owns Securities, the
Company covenants to timely file (or obtain extensions in respect thereof and
file within the applicable grace period) all reports required to be filed by the
Company after the date hereof pursuant to the Exchange Act. As long
as any Purchaser owns Securities, if the Company is not required to file reports
pursuant to the Exchange Act, it will prepare and furnish to the Purchasers and
make publicly available in accordance with Rule 144(c) such information as is
required for the Purchasers to sell the Securities under Rule
144. The Company further covenants that it will take such further
action as any holder of Securities may reasonably request, all to the extent
required from time to time to enable such Person to sell such Securities without
registration under the Securities Act within the limitation of the exemptions
provided by Rule 144.
Section 4.3
Integration
. The
Company shall not sell, offer for sale or solicit offers to buy or otherwise
negotiate in respect of any security (as defined in Section 2 of the Securities
Act) that would be integrated with the offer or sale of the Securities in a
manner that would require the registration under the Securities Act of the sale
of the Securities to the Purchasers or that would be integrated with the offer
or sale of the Securities for purposes of the rules and regulations of any
Trading Market such that it would require stockholder approval of the sale of
the Securities to the Purchasers unless stockholder approval is obtained before
the closing of such subsequent transaction.
Section 4.4
Securities
Laws Disclosure; Publicity
. The Company shall, by 8:30 a.m.
Eastern time on the second Trading Day following the date hereof, issue a
Current Report on Form 8-K, disclosing the material terms of the transactions
contemplated hereby, and shall attach the Transaction Documents
thereto. In addition, the Company will make such other filings and
notices in the manner and time required by the Commission and the Trading Market
on which the Common Stock is listed. Notwithstanding the foregoing, the Company
shall not publicly disclose the name of any Purchaser, or include the name of
any Purchaser in any filing with the Commission (other than the Registration
Statement and any exhibits to filings made in respect of this transaction in
accordance with periodic filing requirements under the Exchange Act) or any
regulatory agency or Trading Market, without the prior written consent of such
Purchaser, except to the extent such disclosure is required by law or Trading
Market regulations.
Section 4.5
Stockholder
Rights Plan
. No claim will be made or enforced by the Company
or, to the knowledge of the Company, any other Person that any Purchaser is an
“
Acquiring
Person
” under any stockholder rights plan or similar plan or arrangement
in effect or hereafter adopted by the Company, or that any Purchaser could be
deemed to trigger the provisions of any such plan or arrangement, by virtue of
receiving Securities under the Transaction Documents. The Company
shall conduct its business in a manner so that it will not become subject to the
Investment Company Act.
Section 4.6
Non-Public
Information
. The Company covenants and agrees that neither it
nor any other Person acting on its behalf will provide any Purchaser or its
agents or counsel with any information that the Company believes constitutes
material non-public information, unless prior thereto such Purchaser shall have
executed a written agreement regarding the confidentiality and use of such
information. The Company understands and confirms that each Purchaser
shall be relying on the foregoing representations in effecting transactions in
securities of the Company.
Section 4.7
Use of
Proceeds
. The Company shall use the net proceeds from the sale
of the Securities hereunder for working capital purposes and not for the
satisfaction of any portion of the Company’s debt (other than payment of trade
payables in the ordinary course of the Company’s business and prior practices),
to redeem any Common Stock or Common Stock Equivalents or to settle any
outstanding litigation.
Section 4.8
Reimbursement
. If
any Purchaser becomes involved in any capacity in any Proceeding by or against
any Person who is a stockholder of the Company (except as a result of sales,
pledges, margin sales and similar transactions by such Purchaser to or with any
current stockholder), solely as a result of such Purchaser’s acquisition of the
Securities under this Agreement, the Company will reimburse such Purchaser for
its reasonable legal and other expenses (including the cost of any investigation
preparation and travel in connection therewith) incurred in connection
therewith, as such expenses are incurred. The reimbursement
obligations of the Company under this paragraph shall be in addition to any
liability which the Company may otherwise have, shall extend upon the same terms
and conditions to any Affiliates of the Purchasers who are actually named in
such action, proceeding or investigation, and partners, directors, agents,
employees and controlling persons (if any), as the case may be, of the
Purchasers and any such Affiliate, and shall be binding upon and inure to the
benefit of any successors, assigns, heirs and personal representatives of the
Company, the Purchasers and any such Affiliate and any such
Person. The Company also agrees that neither the Purchasers nor any
such Affiliates, partners, directors, agents, employees or controlling persons
shall have any liability to the Company or any Person asserting claims on behalf
of or in right of the Company solely as a result of acquiring the Securities
under this Agreement, except to the extent that such claims are based on a
breach of any representations and warranties or covenants made by the Purchasers
in Transaction Documents.
Section 4.9
Indemnification
of Purchasers
. Subject to the provisions of this Section 4.9,
the Company will indemnify and hold the Purchasers and their directors,
officers, stockholders, members, partners, employees and agents (each, a “
Purchaser
Party
”) harmless from any and all losses, liabilities, obligations,
claims, contingencies, damages, costs and expenses, including all judgments,
amounts paid in settlements, court costs and reasonable attorneys’ fees and
costs of investigation that any such Purchaser Party may suffer or incur as a
result of or relating to (a) any breach of any of the representations,
warranties, covenants or agreements made by the Company in this Agreement or in
the other Transaction Documents or (b) any action instituted against a
Purchaser, or any of them or their respective Affiliates, by any stockholder of
the Company who is not an Affiliate of such Purchaser, with respect to any of
the transactions contemplated by the Transaction Documents (unless such action
is based upon a breach of such Purchaser’s representations, warranties or
covenants under the Transaction Documents or any agreements or understandings
such Purchaser may have with any such stockholder or any violations by the
Purchaser of state or federal securities laws or any conduct by such Purchaser
which constitutes fraud, gross negligence, willful misconduct or
malfeasance). If any action shall be brought against any Purchaser
Party in respect of which indemnity may be sought pursuant to this Agreement,
such Purchaser Party shall promptly notify the Company in writing, and the
Company shall have the right to assume the defense thereof with counsel of its
own choosing. Any Purchaser Party shall have the right to employ
separate counsel in any such action and participate in the defense thereof, but
the fees and expenses of such counsel shall be at the expense of such Purchaser
Party except to the extent that (i) the employment thereof has been specifically
authorized by the Company in writing, (ii) the Company has failed after a
reasonable period of time to assume such defense and to employ counsel or (iii)
in such action there is, in the reasonable opinion of such separate counsel, a
material conflict on any material issue between the position of the Company and
the position of such Purchaser Party. The Company will not be liable
to any Purchaser Party under this Agreement (i) for any settlement by a
Purchaser Party effected without the Company’s prior written consent, which
shall not be unreasonably withheld or delayed; or (ii) to the extent, but only
to the extent that a loss, claim, damage or liability is attributable to any
Purchaser Party’s breach of any of the representations, warranties, covenants or
agreements made by the Purchasers in this Agreement or in the other Transaction
Documents.
Section 4.10
Reservation
of Common Stock
. As of the date hereof, the Company has
reserved and the Company shall continue to reserve and keep available at all
times, free of preemptive rights, a sufficient number of shares of Common Stock
for the purpose of enabling the Company to issue Shares pursuant to this
Agreement and Warrant Shares pursuant to any exercise of the
Warrants.
Section 4.11
Listing
of Common Stock
. The Company hereby agrees to use best efforts
to maintain the listing of the Common Stock on a Trading Market, and as soon as
reasonably practicable following the Closing (but not later than the earlier of
the Effective Date and the first anniversary of the Closing Date) to list all of
the Shares and Warrant Shares on such Trading Market. The Company
further agrees, if the Company applies to have the Common Stock traded on any
other Trading Market, it will include in such application all of the Shares and
Warrant Shares, and will take such other action as is necessary to cause all of
the Shares and Warrant Shares to be listed on such other Trading Market as
promptly as possible. The Company will take all action reasonably
necessary to continue the listing and trading of its Common Stock on a Trading
Market and will comply in all material respects with the Company’s reporting,
filing and other obligations under the bylaws or rules of the Trading
Market.
Section 4.12
Equal
Treatment of Purchasers
. No consideration shall be offered or
paid to any person to amend or consent to a waiver or modification of any
provision of any of the Transaction Documents unless the same consideration is
also offered to all of the parties to the Transaction Documents. For
clarification purposes, this provision constitutes a separate right granted to
each Purchaser by the Company and negotiated separately by each Purchaser, and
is intended to treat for the Company the Purchasers as a class and shall not in
any way be construed as the Purchasers acting in concert or as a group with
respect to the purchase, disposition or voting of Securities or
otherwise.
Section 4.13
Subsequent
Equity Sales
.
(a) From
the date hereof until the earlier of one year from the date hereof or 90 days
after the Effective Date, neither the Company nor any Subsidiary shall issue
shares of Common Stock or Common Stock Equivalents;
provided
,
however
, the period
set forth in this Section 4.13 shall be extended for the number of Trading Days
during such period in which (i) trading in the Common Stock is suspended by any
Trading Market, or (ii) following the Effective Date, unless such Shares and
Warrant Shares may be sold pursuant to Rule 144 without volume restrictions, the
Registration Statement is not effective or the prospectus included in the
Registration Statement may not be used by the Purchasers for the resale of the
Shares and Warrant Shares;
provided
,
further
, that such
issuance shares must be registered after the registration of the
Securities.
(b) From
the date hereof until all the Securities become eligible for resale under the
Rule 144 without volume restrictions, the Company shall be prohibited from
effecting or entering into an agreement to effect any subsequent financing
involving a Variable Rate Transaction. The term “
Variable Rate
Transaction
” shall mean a transaction in which the Company issues or
sells (i) any debt or equity securities that are convertible into, exchangeable
or exercisable for, or include the right to receive additional shares of Common
Stock either (A) at a conversion, exercise or exchange rate or other price that
is based upon and/or varies with the trading prices of or quotations for the
shares of Common Stock at any time after the initial issuance of such debt or
equity securities, or (B) with a conversion, exercise or exchange price that is
subject to being reset at some future date after the initial issuance of such
debt or equity security or upon the occurrence of specified or contingent events
directly or indirectly related to the business of the Company or the market for
the Common Stock or (ii) enters into any agreement, including, but not limited
to, an equity line of credit, whereby the Company may sell securities at a
future determined price. Any Purchaser shall be entitled to obtain
injunctive relief against the Company to preclude any such issuance, which
remedy shall be in addition to any right to collect damages.
(c) Notwithstanding
the foregoing, this Section 4.13 shall not apply in respect of an Exempt
Issuance, except that no Variable Rate Transaction shall be an Exempt
Issuance.
Section 4.14
Short
Sales and Confidentiality After The Date Hereof
. Such Such
Purchaser has not directly or indirectly, nor has any Person acting on behalf of
or pursuant to any understanding with such Purchaser, engaged in any
transactions in the securities of the Company (including, without limitations,
any Short Sales involving the Company’s securities) since the time that such
Purchaser was contacted in February 2008 by the Company or any other Person
regarding an investment in the Company. Such Purchaser has maintained, and
covenants that until such time as the transactions contemplated by this
Agreement are publicly disclosed by the Company such Purchaser will maintain,
the confidentiality of all disclosures made to it in connection with this
transaction (including the existence and terms of this
transaction).
Section 4.15
Delivery
of Securities After Closing
. The Company shall deliver, or
cause to be delivered, the respective Securities purchased by each Purchaser to
such Purchaser within three (3) Trading Days of the Closing Date.
Section 4.16
Right of
Purchaser to Participate in Future Transactions
. Purchaser
will have a right to participate, on the terms and conditions set forth in this
Section 4.16, in all sales by the Company of any of Common Stock or Common Stock
Equivalents in each capital raising transaction, if any, that occurs at any time
when the Warrant, or any instrument issued upon transfer or split up thereof,
remains outstanding (in whole or in part), other than any such sale that is a
public offering underwritten on a firm commitment basis and registered with the
Commission under the Securities Act and other than a Exempt Issuance;
provided
,
however
, that if
under legal requirements applicable to a particular transaction the only Persons
eligible to purchase securities in such transaction are “accredited investors,”
within the meaning of Rule 501 under the Securities Act, then the Purchaser must
be an accredited investor in order to purchase securities in such
transaction. For any such transaction during such period, the Company
shall give at least four Business Days advance written notice to the Purchaser
prior to any offer or sale of any of the Company’s securities in such
transaction by providing to the Purchaser a term sheet which (i) contains
all significant business terms of such proposed transaction, (ii) is
sufficiently detailed so as to reasonably permit the Purchaser the opportunity
to determine whether or not to exercise its rights under this Section 4.16 and
(iii) is at least as detailed as the term sheet or summary of such transaction
as the Company shall furnish to any offeree or broker in such
transaction. The Purchaser shall have the right to participate in
such proposed transaction and to purchase its Pro Rata Share
of such securities which
are the subject of such proposed transaction for the same consideration and on
the same terms and conditions as contemplated for sales to third parties in such
transaction (or such lesser portion thereof as specified by the
Purchaser). If the Purchaser elects to exercise its rights hereunder
for a particular transaction, it shall deliver written notice to the Company
within four Business Days following receipt from the Company of the notice and
term sheet meeting the requirements of this Section 4.16, which notice from the
Purchaser shall be conditional upon (i) the Purchaser’s receipt of satisfactory
definitive documents for such transaction from the Company if the Company has
not furnished final, definitive documents for such transaction to the Purchaser
at or before the time the Company gives such notice of such transaction to the
Purchaser, and (ii) the satisfaction of the other conditions precedent to the
obligations of purchasers generally in such transaction to complete such
transaction. If, subsequent to the Company giving notice to the
Purchaser hereunder but prior to any of (i) the Purchaser exercising its right
to participate, (ii) the expiration of the four Business Day period without
response from the Purchaser or (iii) the rejection of such offer for such
financing by the Purchaser, the terms and conditions of the proposed sale to
third parties in such transaction are changed from those disclosed in the term
sheet provided to the Purchaser, the Company shall be required to provide a new
notice and term sheet meeting the requirements of this Section 4.16, reflecting
such revised terms, to the Purchaser hereunder and the Purchaser shall have the
right, which must be exercised within four Business Days of the date the
Purchaser receives such new notice and such revised term sheet, to exercise its
rights to purchase the securities on such changed terms and conditions and
otherwise as provided hereunder. If the Purchaser does not exercise
its rights hereunder with respect to a proposed transaction within the period or
periods provided, or affirmatively declines to engage in such proposed
transaction with the Company, then the Company may proceed with such proposed
transaction on the same terms and conditions as noticed to the Purchaser
(assuming the Purchaser has consented to the transaction, if required, pursuant
to this Agreement and such transaction does not violate any other term or
provision of the Transaction Documents),
provided
that if such
proposed transaction is not consummated within 75 days following the Company’s
notice hereunder, then the rights hereunder shall again be afforded to the
Purchaser for such proposed transaction. The rights and obligations
of this Section 4.16 shall in no way limit or restrict the other rights of the
Purchaser pursuant to this Agreement. Notwithstanding anything herein
to the contrary, failure of the Purchaser to affirmatively elect in writing to
participate in any proposed transaction within the required time frames shall be
deemed to be the equivalent of Purchaser’s decision not to participate in such
proposed transaction. Notwithstanding the foregoing, this Section
4.16 shall not apply in respect of an Exempt Issuance. The rights of
the Purchaser under this Section 4.16 shall apply to all capital raising
transactions described in Section 4.16 that occur during the period specified in
this Section 4.16.
Section 4.17
Limitation
on Certain Transactions
. From the date of this Agreement until
after the date all the Securities become eligible for resale under Rule 144
without volume restrictions or the Effective Date, without the prior written
consent of the Purchaser (which consent may be withheld in the Purchaser’s sole
discretion), the Company shall not issue or sell or agree to issue or sell any
securities in a capital raising transaction, unless such securities will not be,
and are not, registered for sale or resale under the Securities Act until on or
after such Effective Date;
provided
,
however
, that the
limitation of this Section 4.17 shall not apply to Exempt
Issuances.
ARTICLE
V
MISCELLANEOUS
Section 5.1
Termination
. This
Agreement may be terminated by any Purchaser, as to such Purchaser’s obligations
hereunder only and without any effect whatsoever on the obligations between the
Company and the other Purchasers, by written notice to the other parties, if the
Closing has not been consummated on or before April 7, 2008;
provided
,
however
, that no such
termination will affect the right of any party to sue for any breach by the
other party (or parties).
Section 5.2
Fees and
Expenses
. At the Closing, the Company has agreed to reimburse
the following Purchasers the following amounts for the legal fees and expenses
of its counsel: Stillwater LLC for $30,000; Kettle Hill Partners,
LP for $2,300; Kettle Hill Partners II, LP for $4,100; and Kettle Hill
Offshore, Ltd. for $3,600. Accordingly, in lieu of the foregoing
payments, the Subscription Amount that each of the foregoing Purchasers is to
pay at the Closing shall be reduced by the amount of such reimbursement in lieu
thereof. The Company shall deliver, prior to the Closing, a completed
and executed copy of the Closing Statement, attached hereto as Annex
A. Except as expressly set forth in the Transaction Documents to the
contrary, each party shall pay the fees and expenses of its advisers, counsel,
accountants and other experts, if any, and all other expenses incurred by such
party incident to the negotiation, preparation, execution, delivery and
performance of this Agreement. The Company shall pay all transfer
agent fees, stamp taxes and other taxes and duties levied in connection with the
delivery of any Securities.
Section 5.3
Entire
Agreement
. The Transaction Documents, together with the
exhibits and schedules thereto, contain the entire understanding of the parties
with respect to the subject matter hereof and supersede all prior agreements and
understandings, oral or written, with respect to such matters, which the parties
acknowledge have been merged into such documents, exhibits and
schedules.
Section 5.4
Notices
. Any
and all notices or other communications or deliveries required or permitted to
be provided hereunder shall be in writing and shall be deemed given and
effective on the earliest of (a) the date of transmission, if such notice or
communication is delivered via facsimile at the facsimile number set forth on
the signature pages attached hereto prior to 5:30 p.m. (Eastern Time) on a
Trading Day, (b) the next Trading Day after the date of transmission, if
such notice or communication is delivered via facsimile at the facsimile number
set forth on the signature pages attached hereto on a day that is not a Trading
Day or later than 5:30 p.m. (Eastern Time) on any Trading Day, (c) the 2
nd
Trading
Day following the date of mailing, if sent by U.S. nationally recognized
overnight courier service, or (d) upon actual receipt by the party to whom such
notice is required to be given. The address for such notices and
communications shall be as set forth on the signature pages attached hereto
until changed by notice given in accordance with this Section.
Section 5.5
Amendments;
Waivers
. No provision of this Agreement may be waived or
amended except in a written instrument signed, in the case of an amendment, by
the Company and each Purchaser or, in the case of a waiver, by the party against
whom enforcement of any such waiver is sought. No waiver of any
default with respect to any provision, condition or requirement of this
Agreement shall be deemed to be a continuing waiver in the future or a waiver of
any subsequent default or a waiver of any other provision, condition or
requirement hereof, nor shall any delay or omission of either party to exercise
any right hereunder in any manner impair the exercise of any such
right.
Section 5.6
Headings
. The
headings herein are for convenience only, do not constitute a part of this
Agreement and shall not be deemed to limit or affect any of the provisions
hereof. The language used in this Agreement will be deemed to be the language
chosen by the parties to express their mutual intent, and no rules of strict
construction will be applied against any party.
Section 5.7
Successors
and Assigns
. This Agreement shall be binding upon and inure to
the benefit of the parties and their successors and permitted
assigns. The Company may not assign this Agreement or any rights or
obligations hereunder without the prior written consent of each
Purchaser. Any Purchaser may assign any or all of its rights under
this Agreement to any Person to whom such Purchaser assigns or transfers any
Securities,
provided
such
transferee agrees in writing to be bound, with respect to the transferred
Securities, by the provisions hereof that apply to the
“Purchasers”.
Section 5.8
No
Third-Party Beneficiaries
. This Agreement is intended for the
benefit of the parties hereto and their respective successors and permitted
assigns and is not for the benefit of, nor may any provision hereof be enforced
by, any other Person, except as otherwise set forth in Section 4.9.
Section 5.9
Governing
Law
. All questions concerning the construction, validity,
enforcement and interpretation of the Transaction Documents shall be governed by
and construed and enforced in accordance with the internal laws of the State of
New York, without regard to the principles of choice of law and conflicts of law
thereof. Each party agrees that all legal proceedings concerning the
interpretations, enforcement and defense of the transactions contemplated by
this Agreement and any other Transaction Documents (whether brought against a
party hereto or its respective affiliates, directors, officers, stockholders,
employees or agents) shall be commenced exclusively in the state and federal
courts sitting in the City of New York. Each party hereto hereby
irrevocably submits to the exclusive jurisdiction of the state and federal
courts sitting in the City of New York, borough of Manhattan for the
adjudication of any dispute hereunder or in connection herewith or with any
transaction contemplated hereby or discussed herein (including with respect to
the enforcement of any of the Transaction Documents), and hereby irrevocably
waives, and agrees not to assert in any suit, action or proceeding, any claim
that it is not personally subject to the jurisdiction of any such court, that
such suit, action or proceeding has been commenced in an improper or
inconvenient venue for such proceeding. Each party hereto hereby
irrevocably waives personal service of process and consents to process being
served in any such suit, action or proceeding by mailing a copy thereof via
registered or certified mail or overnight delivery (with evidence of delivery)
to such party at the address in effect for notices to it under this Agreement
and agrees that such service shall constitute good and sufficient service of
process and notice thereof. Nothing contained herein shall be deemed to limit in
any way any right to serve process in any manner permitted by
law. Each party hereto hereby irrevocably waives, to the fullest
extent permitted by applicable law, any and all right to trial by jury in any
legal proceeding arising out of or relating to this Agreement or the
transactions contemplated hereby. If either party shall commence an
action or proceeding to enforce any provisions of the Transaction Documents,
then the prevailing party in such action or proceeding shall be reimbursed by
the other party for its reasonable attorneys’ fees and other costs and expenses
incurred with the investigation, preparation and prosecution of such action or
proceeding.
Section 5.10
Survival
. The
representations, warranties, agreements and covenants contained herein shall
survive the Closing and the delivery of the Shares and Warrant
Shares.
Section 5.11
Execution
. This
Agreement may be executed in two or more counterparts, all of which when taken
together shall be considered one and the same agreement and shall become
effective when counterparts have been signed by each party and delivered to the
other party, it being understood that both parties need not sign the same
counterpart. In the event that any signature is delivered by
electronic or facsimile transmission, such signature shall create a valid and
binding obligation of the party executing (or on whose behalf such signature is
executed) with the same force and effect as if such signature page were an
original thereof.
Section 5.12
Severability
. If
any provision of this Agreement is held to be invalid or unenforceable in any
respect, the validity and enforceability of the remaining terms and provisions
of this Agreement shall not in any way be affected or impaired thereby and the
parties will attempt to agree upon a valid and enforceable provision that is a
reasonable substitute therefor, and upon so agreeing, shall incorporate such
substitute provision in this Agreement.
Section 5.13
Rescission
and Withdrawal Right
. Notwithstanding anything to the contrary
contained in (and without limiting any similar provisions of) the Transaction
Documents, whenever any Purchaser exercises a right, election, demand or option
under a Transaction Document and the Company does not timely perform its related
obligations within the periods therein provided, then such Purchaser may rescind
or withdraw, in its sole discretion from time to time upon written notice to the
Company, such demand or election in whole or in part without prejudice to its
future actions and rights.
Section 5.14
Replacement
of Securities
. If any certificate or instrument evidencing any
Securities is mutilated, lost, stolen or destroyed, the Company shall issue or
cause to be issued in exchange and substitution for and upon cancellation
thereof, or in lieu of and substitution therefor, a new certificate or
instrument, but only upon receipt of evidence reasonably satisfactory to the
Company of such loss, theft or destruction and customary and reasonable
indemnity, if requested. The applicants for a new certificate or
instrument under such circumstances shall also pay any reasonable third-party
costs associated with the issuance of such replacement Securities. If
a replacement certificate or instrument evidencing any Securities is requested
due to a mutilation thereof, the Company may require delivery of such mutilated
certificate or instrument as a condition precedent to any issuance of a
replacement.
Section 5.15
Remedies
. In
addition to being entitled to exercise all rights provided herein or granted by
law, including recovery of damages, each of the Purchasers and the Company will
be entitled to specific performance under the Transaction
Documents. The parties agree that monetary damages may not be
adequate compensation for any loss incurred by reason of any breach of
obligations described in the foregoing sentence and hereby agrees to waive in
any action for specific performance of any such obligation the defense that a
remedy at law would be adequate.
Section 5.16
Payment
Set Aside
. To the extent that the Company makes a payment or
payments to any Purchaser pursuant to any Transaction Document or a Purchaser
enforces or exercises its rights thereunder, and such payment or payments or the
proceeds of such enforcement or exercise or any part thereof are subsequently
invalidated, declared to be fraudulent or preferential, set aside, recovered
from, disgorged by or are required to be refunded, repaid or otherwise restored
to the Company, a trustee, receiver or any other person under any law
(including, without limitation, any bankruptcy law, state or federal law, common
law or equitable cause of action), then to the extent of any such restoration
the obligation or part thereof originally intended to be satisfied shall be
revived and continued in full force and effect as if such payment had not been
made or such enforcement or setoff had not occurred.
Section 5.17
Independent
Nature of Purchasers’ Obligations and Rights
. The obligations
of each Purchaser under any Transaction Document are several and not joint with
the obligations of any other Purchaser, and no Purchaser shall be responsible in
any way for the performance of the obligations of any other Purchaser under any
Transaction Document. Nothing contained herein or in any Transaction
Document, and no action taken by any Purchaser pursuant thereto, shall be deemed
to constitute the Purchasers as a partnership, an association, a joint venture
or any other kind of entity, or create a presumption that the Purchasers are in
any way acting in concert or as a group with respect to such obligations or the
transactions contemplated by the Transaction Documents. Each
Purchaser shall be entitled to independently protect and enforce its rights,
including without limitation, the rights arising out of this Agreement or out of
the other Transaction Documents, and it shall not be necessary for any other
Purchaser to be joined as an additional party in any proceeding for such
purpose. Each Purchaser has been represented by its own separate
legal counsel in their review and negotiation of the Transaction
Documents. The Company has elected to provide all Purchasers with the
same terms and Transaction Documents for the convenience of the Company and not
because it was required or requested to do so by the Purchasers.
Section 5.18
Liquidated
Damages
. The Company’s obligations to pay any partial
liquidated damages or other amounts owing under the Transaction Documents is a
continuing obligation of the Company and shall not terminate until all unpaid
partial liquidated damages and other amounts have been paid notwithstanding the
fact that the instrument or security pursuant to which such partial liquidated
damages or other amounts are due and payable shall have been
canceled.
Section 5.19
Construction
. The
parties agree that each of them and/or their respective counsel has reviewed and
had an opportunity to revise the Transaction Documents and, therefore, the
normal rule of construction to the effect that any ambiguities are to be
resolved against the drafting party shall not be employed in the interpretation
of the Transaction Documents or any amendments hereto.
(Signature
Pages Follow)
IN
WITNESS WHEREOF, the parties hereto have caused this Securities Purchase
Agreement to be duly executed by their respective authorized signatories as of
the date first indicated above.
|
eMAGIN
CORPORATION
|
|
|
|
|
|
|
By:
|
/s/
Michael D.
Fowler
|
|
|
|
Michael
D. Fowler
|
|
|
|
Interim
Chief Financial Officer
|
|
Address
for Notice:
2070
Route 52
Hopewell
Junction, New York 12533
With a
copy to:
Richard
Friedman, Esq.
Sichenzia
Ross Friedman Ference LLP
61
Broadway
New York,
New York 10006
(212)
930-9700 telephone
(212)
930-9725 fax
1065
Avenue of the Americas, 21st Floor
New York,
New York 10018
Attn:
Richard A. Friedman
[REMAINDER
OF PAGE INTENTIONALLY LEFT BLANK
SIGNATURE
PAGE FOR PURCHASER FOLLOWS]
[PURCHASER
SIGNATURE PAGE TO SECURITIES PURCHASE AGREEMENT]
IN
WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement
to be duly executed by their respective authorized signatories as of the date
first indicated above.
[Name of
Purchaser]
____________________________________
[By:]
[Title:]
Address
for Notice of Purchaser:
Address
for Delivery of Securities for Purchaser (if not same as above):
Subscription
Amount:
Shares:
Warrant
Shares:
EIN
Number:
ANNEX
A
CLOSING
STATEMENT
Pursuant
to the attached Securities Purchase Agreement, dated as of the date hereto, the
purchasers shall purchase up to $___________ of Common Stock and Warrants from
eMagin Corporation, a Delaware corporation (the “
Company
”).
All funds will be wired into a trust account maintained by ____________, counsel
to the Company. All funds will be disbursed in accordance with this Closing
Statement.
Disbursement
Date:
________ ___, 2008
I.
PURCHASE
PRICE
|
|
Gross
Proceeds to be Received in Trust
|
$
|
|
|
II.
DISBURSEMENTS
|
|
|
$
|
|
$
|
|
$
|
|
$
|
|
|
Total
Amount Disbursed:
|
$
|
|
|
|
|
|
|
WIRE INSTRUCTIONS
:
|
|
To:
_____________________________________
|
|
To:
_____________________________________
|
|
Schedule
B
April 2,
2008
To the
Investors listed on
Schedule
A attached hereto
Re:
eMagin Corporation Legal
Opinion
Ladies
and Gentlemen:
We have
acted as counsel to eMagin Corporation, a Delaware corporation (the “
Company
”),
in connection with the Securities Purchase Agreement, dated as of April 2, 2008,
between you and the Company (the “
Purchase
Agreement
”) and the transactions contemplated
therein. Capitalized terms used herein and not otherwise defined
herein shall have the respective meanings assigned to such terms in the Purchase
Agreement. The Purchase Agreement, the Registration Rights Agreement
and the Warrants are hereinafter referred to collectively as the “
Transaction
Documents
.” As to other questions of fact relevant to our opinion, we
have made no independent verification of the facts and we have relied upon
statements or certificates of public officials and officers of the
Company.
In
connection with this opinion, we have examined originals or photostatic or
certified copies of (i) the Transaction Documents, (ii) the Company’s Articles
of Incorporation, as amended and restated, as in effect on the date hereof (the
“
Articles
of Incorporation
”), and (iii) the Company’s Bylaws, as in effect on the
date hereof (the “
Bylaws
”),
and we have examined and considered such corporate records, certificates and
matters of law as we have deemed appropriate as a basis for our opinions set
forth below.
In
rendering the opinions set forth in this opinion letter, we assume the
following:
(a)
the legal
capacity of each natural person;
(b)
the legal
existence of all parties to the transactions referred to in the Transaction
Documents;
(c)
the power
and authority of each person other than the Company or person(s) acting on
behalf of the Company to execute, deliver and perform each document executed and
delivered and to do each other act done or to be done by such
person;
(d)
the
authorization, execution and delivery by each person other than the Company or
person(s) acting on behalf of the Company of each document executed and
delivered or to be executed and delivered by such person;
(e)
the
legality, validity, binding effect and enforceability as to each person other
than the Company or person(s) acting on behalf of the Company of each document
executed and delivered or to be executed or delivered and of each other act done
or to be done by such person;
(f)
the
transactions referred to in the Transaction Documents have been
consummated;
(g)
the
payment of all the required documentary stamps taxes and fees imposed upon the
execution, filing or recording of the Transaction Documents;
(h)
that
there have been no undisclosed modifications of any provision of any document
reviewed by us in connection with the rendering of the opinions set forth in
this opinion letter and no undisclosed prior waiver of any right or remedy
contained in the Transaction Documents;
(i)
the
genuineness of each signature (other than the signatures of the officers of the
Company), the completeness of each document submitted to us other than the
Transaction Documents, the authenticity of each document reviewed by us as an
original, the conformity to the original of each document reviewed by us as a
copy and the authenticity of the original of each document received by us as a
copy;
(j)
the
truthfulness of each statement as to all factual matters otherwise not known to
us to be untruthful contained in any document encompassed within the due
diligence review undertaken by us;
(k)
the
accuracy on the date of this letter as well as on the date stated in all
governmental certifications of each statement as to each factual matter
contained in such governmental certifications;
(l)
that the
addressee has acted in good faith, without notice of adverse claims, and has
complied with all laws applicable to it that affect the transactions referred to
in the Transaction Documents;
(m)
that the
transactions referred to in the Transaction Documents comply with all tests of
good faith, fairness and conscionability required by law;
(n)
that
routine procedural matters such as service of process or qualification to do
business in the relevant jurisdictions will be satisfied by the parties seeking
to enforce the Transaction Documents;
(o)
that all
statutes, judicial and administrative decisions, and rules and regulations of
governmental agencies constituting the law for which we are assuming
responsibility are published (e.g., reported court decisions and the specialized
reporting services of bna, cch and prentice-hall) or otherwise generally
accessible (e.g., lexis or westlaw) in each case in a manner generally available
(i.e., in terms of access and distribution following publication) to lawyers
practicing in our judicial circuit;
(p)
that
agreements other than the Transaction Documents that are related to the
transactions referred to in the Transaction Documents will be enforced as
written;
(q)
that no
action, discretionary or otherwise will be taken by or on behalf of the Company
in the future that might result in a violation of law;
(r)
that
there are no other agreements or understandings among the parties that would
modify the terms of the Transaction Documents or the respective rights or
obligations of the parties to the Transaction Documents;
(s)
that with
respect to the Transaction Documents and to the transactions referred to
therein, there has been no mutual mistake of fact and there exists no fraud or
duress; and
(t)
the
constitutionality and validity of all relevant laws, regulations and agency
actions unless a reported case has otherwise held or widespread concern has been
expressed by commentators as reflected in materials which lawyers routinely
consult.
Whenever
a statement herein is qualified by “to our knowledge” or similar phrase, it
means that, during the course of our representation of the Company for the
purposes of this opinion letter, (a) no information that would give those
lawyers who participated in the representation of the Company in connection with
the Transaction Documents (collectively, the “
Transaction
Participants
”) current actual knowledge of the inaccuracy of such
statement has come to their attention; (b) we have not undertaken any
independent investigation or inquiry to determine the accuracy of such
statement; (c) any limited investigation or inquiry otherwise undertaken by
the Transaction Participants during the preparation of this opinion letter
should not be regarded as such an investigation or inquiry; and (d) no inference
as to our knowledge of any matters bearing on the accuracy of any such statement
should be drawn from the fact of our representation of the
Company. We also call to your attention to the fact that we are not
general counsel to the Company and we are not familiar with all aspects of
either the business affairs of the Company. We have not conducted an
independent audit of the Company or its files. As to certain
questions of fact material to this opinion, we have relied upon statements or
certificates from the Company or person(s) acting on behalf of the
Company.
The
validity, binding effect and enforceability of the Transaction Documents may be
limited or otherwise affected by (a) bankruptcy, moratorium, fraudulent
conveyance or other similar statutes, rules, regulations or other laws affecting
the enforcement of creditors’ rights and remedies generally and (b) the
unavailability of, or limitation on the availability of, a particular right or
remedy (whether in a proceeding in equity or at law) because of an equitable
principle or a requirement as to commercial reasonableness, conscionability or
good faith. In addition, certain remedies, waivers and other
provisions contained in the Transaction Documents might not be enforceable;
nevertheless, such unenforceability will not render such agreements invalid as a
whole or preclude the practical realization of the benefits to the Purchasers
thereunder.
We are
counsel admitted to practice in the State of New York and we do not express any
opinion with respect to the effect or applicability of the laws of any
jurisdiction, other than the laws of the State of New York, the corporate laws
of the State of Delaware and the federal laws of the United States of
America. In furnishing the opinion regarding the valid existence and
good standing of the Company, we have relied solely upon a good standing of the
Company from the Secretary of State of Delaware dated March 7,
2008.
Based on
the foregoing, and subject to the assumptions, qualifications, limitations and
exceptions stated in this letter, we are of the opinion that as of the date
hereof:
1.
The
Company is a corporation duly authorized, validly existing, and in good standing
in Delaware, its state of incorporation. The Company has all
requisite corporate power and authority to (i) conduct its business as presently
conducted as described in the Company’s Annual Report on Form 10-K for the year
ended December 31, 2006, as filed with the Securities and Exchange Commission on
April 2, 2007; (ii) own and operate its property; and (iii) lease the property
its leases.
2.
The
Company has the requisite corporate power and authority to enter into and to
consummate the transactions contemplated by each of the Transaction Documents
and otherwise to carry out its obligations thereunder. The execution
and delivery of each of the Transaction Documents by the Company and the
consummation by it of the transactions contemplated thereby have been duly
authorized by its Board of Directors and no further consent or authorization of
the Company’s Board of Directors or its stockholders are
required. Each of the Transaction Documents has been duly executed
and delivered by the Company and constitutes the legal, valid and binding
obligation of the Company enforceable against the Company in accordance with its
terms.
3.
To our
knowledge, except as specifically disclosed in the Purchase Agreement or the SEC
Reports, no shares of Common Stock are entitled to preemptive or similar
rights. To our knowledge, except as specifically disclosed in the
Purchase Agreement or the SEC Reports or as a result of the purchase and sale of
the Securities, there are no outstanding options, warrants, script rights to
subscribe to, calls or commitments of any character whatsoever relating to,
securities, rights or obligations convertible into or exchangeable for, or
giving any person any right to subscribe for or acquire any shares of Common
Stock, or contracts, commitments, understandings, or arrangements by which the
Company or any Subsidiary is or may become bound to issue additional shares of
Common Stock, or securities or rights convertible or exchangeable into shares of
Common Stock.
4.
The
Shares have been duly authorized and, when paid for and issued in accordance
with the terms of the Purchase Agreement shall have been validly issued, fully
paid and nonassessable. When issued by the Company in accordance with
the terms of the Purchase Agreement and the Warrants, the Warrant Shares will be
validly issued, fully paid and nonassessable.
5.
The
execution, delivery and performance of the Transaction Documents by the Company
and the consummation by the Company of the transactions contemplated by such
agreements do not and will not (i) conflict with or violate any provision of its
Articles of Incorporation or Bylaws, (ii) conflict with, or constitute a default
(or an event which with notice or lapse of time or both would become a default)
under, or give to others any rights of termination, amendment, acceleration or
cancellation of any agreement, indenture or other written instrument of the
Company or a Subsidiary thereof or other written agreement or understanding to
which the Company or a Subsidiary thereof is a party, and which is attached as
an exhibit to the SEC Reports, (iii) result in a violation of any law, rule or
regulation of any governmental authority, regulatory body, stock market or
trading facility to which the Company is subject, or by which any property or
asset of the Company is bound or affected, or (iv) result in any violation of
any order, judgment, injunction, decree or other restriction of any court or
governmental authority of which we have knowledge.
6.
To the
best of our knowledge, other than the declaration of effectiveness by the
Securities and Exchange Commission of the registration statement to be filed
pursuant to the Transaction Documents, no authorization, approval or consent of
any court, governmental body, regulatory agency, self-regulatory organization or
stock exchange or market, or the stockholders of the Company or any third party
is required to be obtained by the Company other than as provided in Sections
5(m) and 8(a)(2) of the Note Purchase Agreement, dated July 21, 2006, as amended
by the Amendment Agreement, dated July 23, 2007; Section 12(d)(11) of the
Certificate of Designations; or Section 3.12 of the Amended and Restated 8%
Senior Secured Convertible Notes Due 2008, in connection with the execution,
delivery and performance by the Company of the Transaction Documents or the
consummation of the other transactions contemplated thereby.
7.
To the
best of our knowledge, there is no action, suit, proceeding, inquiry or
investigation before or by any court, public board or body or any governmental
agency or self-regulatory organization pending or threatened against or
affecting the Company, wherein an unfavorable decision, ruling or finding would
have a Material Adverse Effect or which would adversely affect the validity or
enforceability of or the authority or ability of the Company to perform its
respective obligations under the Transaction Documents.
8.
The
Company is not, and as a result of and immediately upon Closing will not be, an
“investment company” or a company “controlled” by an “investment company,”
within the meaning of the Investment Company Act of 1940, as
amended.
9.
Assuming
the accuracy of the representations and warranties of the Company set forth in
Section 3.1 of the Purchase Agreement and of the Investors set forth in
Section 3.2(b)-(e) of the Purchase Agreement, the offer, issuance and sale
of the Shares and Warrants and the offer, sale and issuance of the Warrant
Shares to the Investors pursuant to the applicable Transaction Documents are
exempt from the registration requirements of the Securities Act.
This
opinion is furnished pursuant to the request of the addressees hereof and is
rendered by us solely for the benefit of the addressees hereof in connection
with the Transaction Documents. We are not hereby assuming any
professional responsibilities to any other person whatsoever. This
opinion may be relied upon only in connection with the Transaction
Documents. This opinion may not be used, disseminated, circulated,
quoted referred to or relied upon by any other person or for any other purpose
without our prior written consent. This opinion is rendered as of the
date set forth above, and we express no opinion as to circumstances or events
that may occur subsequent to such date. We assume no duty to update
or supplement this opinion to reflect any fact or circumstances that may
hereafter come to our attention or reflect any changes in any law that may
hereafter occur or become effective.
|
|
|
|
|
Sincerely,
|
|
|
|
|
|
|
|
|
|
|
|
Sichenzia
Ross Friedman Ference LLP
|
|
SCHEDULE
A
INVESTOR
|
Stillwater
LLC
|
Ginola
Limited
|
Crestflower
Corporation
|
Kettle
Hill Partners, LP
|
Kettle
Hill Partners II, LP
|
Kettle
Hill Offshore, Ltd.
|
Iroquois
Master Fund Ltd.
|
Total
|
Schedule
D
April 2,
2008
To the
Investors listed on
Schedule
A attached hereto
Re:
eMagin
Corporation Lockup Agreement
Ladies
and Gentlemen:
The
undersigned is an owner of record or a beneficial owner of shares of common
stock (the “
Common
Stock
”) of eMagin Corporation, a Delaware corporation (the “
Company
”)
or securities convertible into or exchangeable or exercisable for shares of
Common Stock. The Company proposes to carry out a transaction
involving the sale of shares of Common Stock and/or securities convertible into
or exchangeable or exercisable for Common Stock (the “
Transaction
”). The
undersigned recognizes that the Transaction will be of benefit to the
undersigned and will benefit the Company by, among other things, raising
additional capital for its operations. The undersigned acknowledges
that the investors in the Transaction (the “
Investors
”)
are or will be relying on the representations and agreements of the undersigned
contained in this letter agreement (the “
Letter
Agreement
”) in carrying out the Transaction and in entering into
agreements with the Company.
To induce
the Investors to continue their efforts in connection with the Transaction, the
undersigned hereby agrees that, without the prior written consent of the
majority of the Investors (as computed by the amount invested in this
Transaction, the “
Majority
Investors
”), which consent may be withheld in their sole discretion, the
undersigned will not (and will cause the undersigned’s spouse, and the immediate
family of such spouse or the undersigned living in the undersigned’s household,
not to), during the period commencing on the date hereof and ending 210 days
after the date hereof (such period, the “
Restricted
Period
”), (1) offer, pledge, sell, contract to sell, sell any option or
contract to purchase, purchase any option or contract to sell, grant any option,
right or warrant to purchase, or otherwise transfer or dispose of, directly or
indirectly, any shares of Common Stock or any securities convertible into or
exchangeable or exercisable for any shares of Common Stock (whether such shares
or any such securities are now owned or are hereafter acquired by the
undersigned, or the undersigned’s spouse or family member), or (2) enter into
any swap or other arrangement that transfers to another, in whole or in part,
any of the economic consequences of ownership of the Common Stock, whether any
such transaction described in clause (1) or (2) above is to be settled by
delivery of Common Stock or such other securities, in cash or
otherwise. The undersigned further agrees not to announce an
intention to do any of the foregoing during the Restricted Period. If
(i) during the last 17 days of the Restricted Period, the Company issues an
earnings release or discloses material news or a material event relating to the
Company occurs or (ii) prior to the expiration of the Restricted Period, the
Company announces that it will release earnings results during the 16-day period
beginning on the last day of the Restricted Period, the restrictions imposed by
this Letter Agreement shall continue to apply until the expiration of the 18-day
period beginning on the issuance of the earnings release or the occurrence of
the material news or material event.
Notwithstanding
anything else herein, the restrictions contained in the foregoing paragraphs
shall not apply to any of the following: (a) transfers of shares of Common Stock
or any security convertible into or exchangeable or exercisable for Common Stock
as a bona fide gift or gifts, by will or intestacy or to any trust for the
direct or indirect benefit of the undersigned or the immediate family of the
undersigned, or (b) distributions by a trust to its beneficiaries of shares of
Common Stock or any security convertible into or exchangeable or exercisable for
Common Stock, or (c) the securities sold or issued in the Transaction; provided
that in the case of any transfer or distribution pursuant to clauses (a) or (b),
each donee, distributee, trustee or beneficiary shall sign and deliver a lock-up
agreement in favor of the Investors substantially in the form of this Letter
Agreement.
In
addition, with respect to the Transaction only (and any registration statement
to be filed in connection therewith), the undersigned waives any rights,
including any and all notice rights and requirements, relating to registration
under the Securities Act of 1933, as amended (the “
Securities
Act
”), of any shares of Common Stock (or any security convertible into or
exchangeable or exercisable for Common Stock) owned either of record or
beneficially by the undersigned. The undersigned further agrees that,
without the prior written consent of the Majority Investors, the undersigned
will not, during the Restricted Period, make any demand for or exercise any
right with respect to the registration under the Securities Act of any shares of
Common Stock or any security convertible into or exchangeable or exercisable for
Common Stock. Notwithstanding anything to the contrary herein, the undersigned
may be included as a selling shareholder in any registration statement filed by
the Company on Form S-8.
During
the Restricted Period only, the undersigned agrees and consents to the entry of
stop transfer instructions with the Company’s transfer agent and registrar
against the transfer (except those in compliance with the restrictions set forth
in this Letter Agreement) of shares of Common Stock or securities convertible
into or exchangeable or exercisable for Common Stock held by the undersigned,
provided such instructions specifically state that they are null and void after
210 days from the date hereof. This Letter Agreement is irrevocable
and will be binding on the undersigned and the successors, heirs, personal
representatives and assigns of the undersigned.
This
letter shall be null and void on the sooner of 210 days from the date hereof of
the date on which the Investors no longer beneficially own any Shares
or Warrant Shares (as defined in the Securities Purchase Agreement between the
Company and the Investors dated the date hereof).
In
witness whereof, the undersigned has executed and delivered this Letter
Agreement to be effective as of the date first set forth above.
|
Very
truly yours,
|
|
|
|
|
|
|
|
|
|
|
|
(Printed Name
of Holder)
|
|
|
|
|
|
|
|
|
|
|
By:
|
|
|
|
|
(Signature)
|
|
|
|
(If
signing on behalf of an entity, print name of person signing and indicate
title or capacity, including as a custodian or trustee.)
|
|
|
|
|
|
SCHEDULE
A
INVESTOR
|
Stillwater
LLC
|
Ginola
Limited
|
Crestflower
Corporation
|
Kettle
Hill Partners, LP
|
Kettle
Hill Partners II, LP
|
Kettle
Hill Offshore, Ltd.
|
Iroquois
Master Fund Ltd.
|
Total
|
SCHEDULE
2.2(a)
List of Lockup Agreement
Signatories
Name
|
|
|
|
Capacity
|
Thomas
Paulsen
|
|
|
|
Interim
Chief Executive Officer, Director
|
Michael
D. Fowler
|
|
|
|
Interim
Chief Financial Officer
|
Claude
Charles
|
|
|
|
Director
|
Paul
Cronson
|
|
|
|
Director
|
Irwin
Engelman
|
|
|
|
Director
|
Jacob
Goldman
|
|
|
|
Director
|
Stephen
Seay
|
|
|
|
Director
|
SCHEDULE
3.1(a)
eMagin Corporation Direct
and Indirect Subsidiaries
eMagin
Corporation has one direct subsidiary and no indirect subsidiaries as indicated
below:
Direct
Subsidiaries
Virtual
Vision,
Inc. A
dormant subsidiary incorporated in the State of Delaware
Indirect
Subsidiaries
None
SCHEDULE
3.1(g)
Capitalization
Summary
Common
shares issued and outstanding
|
|
12,620,900
shares
|
Shares
issuable upon option exercise
|
|
879,323
shares (1)
|
Shares
issuable upon warrant exercise
|
|
9,340,509
shares (2), (4)
|
Shares
issuable upon conversion of debt
|
|
8,330,689
shares (3), (5),
(6)
|
Total
shares outstanding and issuable
|
|
31,171,421
shares
|
Note: Closing
price of eMagin’s common stock as of March 10, 2008 was $0.96 per
share.
1.
The
Company has a total of 879,323 options outstanding of which approximately
640,746 of these options have an exercise price of $2.60 per share or
greater.
2.
The
Company has a total of 9,340,509 warrants outstanding with an average strike
price of $2.65 per share. Approximately 1,107,052 of these warrants
are in the money with a strike price of $0.48 per share or less.
3.
The
Company has convertible debt with an aggregate principal balance of $5,962,309
outstanding that is convertible into 8,330,689 shares of common
stock.
4.
Pursuant
to anti-dilution provisions contained in warrant agreements the Company has
previously issued, the purchase price associated with those warrants is be
adjusted when common stock or common stock equivalents are issued at a price per
share that is less than the purchase price contained in respective
warrants.
5.
Pursuant
to Section 6.3 of the Amended and Restated 8% Senior Secured Convertible Notes
Due 2008, anti-dilutive adjustments to the conversion price per share can occur
in the event the Company sells common shares or issues common stock equivalents
at a price per share that is less than the $0.75 per share note conversion price
that is currently available to such note holders.
6.
8% Senior
Secured Convertible Note holders have a right of in financings of the
Company. Notice of the proposed financing was provided to all such
note holders on February 29, 2008. With the exception of one note
holder (in addition to Stillwater LLC) no notification of participation was
received by the Company or its counsel within the prescribed four trading day
period for such notification, which expired March 6, 2008.
SCHEDULE
3.1(r)
Sarbanes-Oxley: Internal
Accounting Controls
In
connection with Company management’s annual report on internal control over
financial reporting now in preparation, the Company anticipates that it will
disclose certain “material weaknesses” and/or “significant deficiencies”, as
such terms are defined under standards established by the Public Company
Accounting Oversight Board, with respect to its compliance with Section 404 of
the Sarbanes-Oxley Act. Concurrently with identification of any items
of this nature, the Company expects to present detailed plans for remediating
any such weaknesses or deficiencies with a timetable for
completion.
SCHEDULE
3.1(v)
Registration
Rights
Pursuant
to Section 8 of the Note Purchase Agreement dated July 21, 2006 and amended July
23, 2007 with respect to the 8% Senior Secured Convertible Notes and related
warrants, the Company is obligated to file a registration statement with respect
to 6,908,864 note conversion shares and 4,831,859 warrant shares.
Pursuant
to the Warrant Issuance Agreement dated January 30, 2008 as amended February 28,
2008 between the Company and Moriah Capital, L.P., the Company is obligated to
file a registration statement with respect to 1,000,000 warrant shares and
162,500 common shares no later than April 29, 2008.
42
Exhibit
10.61
LOAN
AND SECURITY AGREEMENT
by and
between
MORIAH
CAPITAL, L.P.,
as
Lender,
and
EMAGIN
CORPORATION,
as
Borrower
Dated:
August 7, 2007
LOAN AND SECURITY
AGREEMENT
THIS LOAN AND SECURITY AGREEMENT
dated this 7th day of August 2007 by and between
EMAGIN CORPORATION,
a Delaware
corporation, with its principal place of business located at 10500 N.E. 8
th
Street,
Suite 1400, Bellevue, Washington 98004 (the
"Borrower"
), and
MORIAH CAPITAL, L.P.,
a
Delaware limited partnership with offices at 685 Fifth Avenue, New York, New
York 10022 (as further defined below, the
"Lender"
).
R E C I T A L
S
:
WHEREAS
, Borrower desires to
enter into an accounts receivable and inventory-based revolving loan credit
facility with Lender pursuant to which Lender may make loans to Borrower;
and
WHEREAS
, Lender is willing to
make such loans on the terms and conditions hereinafter set forth;
and
WHEREAS
, Borrower is willing
to agree to the terms and conditions hereinafter set forth;
NOW, THEREFORE,
in
consideration of the foregoing, the mutual covenants and agreements herein
contained and other good and valuable consideration, Lender and Borrower
mutually covenant, warrant and agree as follows:
SECTION 1.
DEFINITIONS AND RULES OF
INTERPRETATION AND CONSTRUCTION
Specific Terms
Defined
. The following terms (including both the singular and
plurals thereof) shall have the following meanings unless the context indicates
otherwise:
1.1
"Account Debtor"
or
"account debtor"
shall have
the meaning ascribed to such term in the UCC and shall also include a Person
obligated for payment of an Account.
1.2
"Accounts"
shall mean all
"accounts" as defined in the UCC, and, in addition, any and all obligations of
any kind at any time due and/or owing to Borrower, whether now existing or
hereafter arising, and all rights of Borrower to receive payment or any other
consideration (whether classified under the UCC of the State of New York
or any other state as
accounts, accounts receivable, contract rights, chattel paper, general
intangibles or otherwise) including, without limitation, invoices, contract
rights, accounts receivable, general intangibles, choses-in-action, notes,
drafts, acceptances, instruments and all other debts, obligations and
liabilities in whatever form owing to Borrower from any person, firm,
governmental authority, corporation or any other entity, all security therefor,
and all Borrower's rights to goods sold (whether delivered, undelivered, in
transit or returned), which may be represented thereby, or with respect thereto,
including, but not limited to, all rights as an unpaid vendor (including
stoppage in transit, replevin or reclamation), all additional amounts due from
any Account Debtor together with all Proceeds and products of any and all of the
foregoing.
1.3
“Advance”
shall have the
meaning as set forth in
Section 2.2
hereof.
1.4
"Affiliate"
shall mean, means,
with respect to any Person, (a) any other Person that, directly or indirectly,
is in control of, is controlled by, or is under common control with such Person
or (b) any other Person who is a director or officer (i) of such Person, (ii) of
any Subsidiary of such Person or (iii) of any Person described in clause (a)
above. For the purposes of this definition, control of a Person shall
mean the power (direct or indirect) to direct or cause the direction of the
management or the policies of such Person whether through the ownership of any
class of stock or equity of such person or by contract or
otherwise.
1.5
"Agreement"
shall mean this
Loan and Security Agreement (including all Exhibits annexed hereto and the
Borrower’s Disclosure Schedule) as originally executed or, if amended, modified,
supplemented, renewed or extended from time to time, as so amended, modified,
supplemented, renewed or extended.
1.6
“Base Rate”
shall have the
meaning as set forth in Section 3.1 hereof.
1.7
"Borrower"
shall mean eMagin
Corporation and its successors.
1.8
“Borrower’s Disclosure
Schedule
” means the Disclosure Schedule prepared by Borrower that is
being delivered to Lender concurrently herewith.
1.9
“
Borrowing Base
” shall be
calculated at any time as the sum of (i) the product obtained by
multiplying the outstanding amount of Eligible Accounts, net of all taxes,
discounts, allowances and credits given or claimed, by 90%,
plus
(ii) the
lesser of (A) Six Hundred Thousand Dollars ($600,000) or (B) the product(s)
obtained by multiplying 50% by the values of Eligible Inventory as determined by
Lender in good faith in its reasonably commercial judgment, based on the lower
of cost or market.
1.10
“Borrowing Certificate”
shall
have the meaning as set forth in Section 2.1 hereof.
1.11
"Business Day"
shall mean any
day other than a Saturday, Sunday or any other day on which banks located in the
State of New York are authorized or required to close under applicable banking
laws.
1.12
"Capital Assets"
shall mean,
in accordance with GAAP, fixed assets, both tangible (such as land, buildings,
fixtures, machinery and equipment) and intangible (such as patents, copyrights,
trademarks, franchises and goodwill);
provided
, that
Capital Assets shall not include any item depreciated or amortized over a useful
life of twelve (12) months or less.
1.13
“Chattel Paper
” shall mean all
“chattel paper,” as such term is defined in the UCC, including electronic
chattel paper
1.14
"Collateral"
shall have the
meaning as set forth in Section 5.1 hereof.
1.15
“Closing Date”
shall mean the
date of this Agreement.
1.16
“
Common Stock
” shall mean the
Common Stock, par value $.001 per share, of the Borrower.
1.17
“Convertible Noteholders
”
shall mean the holders of Convertible Notes.
1.18
“Convertible Notes”
shall mean the Company’s 6% Senior Secured Convertible Notes due
2007-2008 issued by the Borrower to the Convertible Noteholders.
1.19
“Convertible Notes
Documentation
” shall mean all agreements and instruments entered into by
the Borrower in connection with the issuance of the Convertible
Notes.
1.20
“Default Rate”
shall have the
meaning as set forth in Section 3.1 hereof.
1.21
“
Deposit Accounts
” means all
“deposit accounts” as such term is defined in the UCC.
1.22
“
Eligible Accounts”
are
accounts created by Borrower in the ordinary course of its business which
satisfy the following criteria:
(1) such
accounts arise from bona fide completed transactions and have not remained
unpaid for more than ninety (90) days after the invoice date
thereof;
(2)
the amounts of the accounts reported to Lender are absolutely owing to Borrower
and do not arise from sales on consignment, guaranteed sales or other terms
under which payment by the account debtors may be conditional or
contingent;
(3) the
account debtor’s chief executive office or principal place of business is
located in the United States, unless payment of any such account debtor’s
accounts is backed by a letter of credit or credit insurance acceptable to, and
approved by, Lender in its sole discretion);
(4) such
accounts do not arise from any unearned portions of fees derived from progress
billings, as determined by Lender in its sole and absolute discretion, or from
any retainages or bill and hold sales;
(5)
there are no contra relationships, setoffs, counterclaims or disputes existing
with respect thereto;
(6) the
goods giving rise thereto were not at the time of the sale subject to any Liens
except for Permitted Encumbrances, and such accounts are free and clear of all
Liens except for Permitted Encumbrances;
(7) such
accounts are not accounts with respect to which the account debtor or any
officer or employee thereof is an officer, employee or agent of or is affiliated
with Borrower, directly or indirectly, whether by virtue of family membership,
ownership, control, management or otherwise;
(8) such
accounts are not accounts with respect to which the account debtor is the United
States or any state or political subdivision thereof or any department, agency
or instrumentality of the United States, any state or political subdivision,
unless there has been compliance with the Assignment of Claims Act or any
similar state or local law, if applicable;
(9) Borrower
has delivered to Lender or Lender’s representative such documents as Lender may
have requested in connection with such accounts and Lender shall have received a
verification of such account, satisfactory to it, if sent to the account debtor
or any other obligor or any bailee;
(10) there
are no facts existing or threatened which might result in any material adverse
change in the account debtor’s financial condition, except for the state of
facts in existence on March 27, 2007 that caused Borrower’s accountants, Eisner
LLP, to issue a “going concern” qualification in their opinion of that date to
Borrower, as set forth in Borrower’s Annual Report on Form 10-K for the year
ended December 31, 2006;
(11) such
accounts owed by a single account debtor or its affiliates do not represent more
than
thirty percent
(30%) of all otherwise Eligible Accounts (accounts excluded from Eligible
Accounts solely by reason of this subsection (11) shall nevertheless be
considered Eligible Accounts to the extent of the amount of such accounts which
does not exceed such percentage of all otherwise Eligible Accounts);
and
(12) such
accounts are not owed by an account debtor who is or whose affiliates are past
due upon other accounts owed to Borrower comprising more than fifty percent
(50%) of the accounts of such account debtor or its affiliates owed to
Borrower.
1.23
“Eligible Inventory”
shall mean all Inventory of the Borrower, excluding any Inventory having
any of the following characteristics:
(i) Inventory
that is: in-transit; located at any warehouse or other premises not approved by
Lender in writing or as to which Lender has not received a landlord or mortgagee
waiver in form and substance acceptable to Lender; not subject to a duly
perfected first priority security interest in Lender's favor; subject to any
lien or encumbrance that is not subordinate to Lender's first priority security
interest; covered by any negotiable or non-negotiable warehouse receipt, bill of
lading or other document of title; on consignment from any Person; on
consignment to any Person or subject to any bailment unless such consignee or
bailee has executed an agreement with Lender;
(ii) Work-in-process
Inventory;
(iii) Inventory
that is damaged, defective, obsolete, discontinued, tainted, slow moving or not
currently saleable in the normal course of the Borrower's operations, or the
amount of such Inventory that has been reduced by shrinkage;
(iv) Inventory
that the Borrower has returned, has attempted to return, is in the process of
returning or intends to return to the vendor thereof;
(v) Inventory
manufactured by the Borrower pursuant to a license unless the applicable
licensor has rights adverse to Lender that would interfere
with Lender’s exercise of its rights and remedies against
such Inventory;
(vi) Inventory
that is subject to a Lien in favor of any Person other than Lender;
(vii) Inventory
stored at locations holding less than ten (10%) of the aggregate value of
Borrower’s Inventory; and
(viii) Inventory
not covered by a casualty insurance policy acceptable to Lender and under which
Lender has been named as a loss payee and additional insured.
1.24
"
Environment
" means all air,
surface water, groundwater or land, including, without limitation, land surface
or subsurface, including, without limitation, all fish, wildlife, biota and all
other natural resources.
1.25
"Environmental Law"
or
"Environmental Laws"
shall
mean all federal, state and local laws, statutes, ordinances and regulations now
or hereafter in effect, and in each case as amended or supplemented from time to
time, and any judicial or administrative interpretation thereof, including any
judicial or administrative order, consent decree or judgment relating to the
regulation and protection of human health, safety, the environment and natural
resources (including ambient air, surface water, groundwater, wetlands, land
surface or subsurface strata, wildlife, aquatic species and
vegetation).
1.26
"Environmental Liabilities and
Costs"
shall mean, as to any Person, all liabilities, obligations,
responsibilities, remedial actions, losses, damages, punitive damages,
consequential damages, treble damages, costs and expenses (including all fees,
disbursements and expenses of counsel, experts and consultants and costs of
investigation and feasibility studies), fines, penalties, sanctions and interest
incurred as a result of any claim or demand by any other Person, whether based
in contract, tort, implied or express warranty, strict liability, criminal or
civil statute, including any Environmental Law, permit, order or agreement with
any Governmental Authority or other Person, and which arise from any
environmental, health or safety conditions, or a Release or conditions that are
reasonably likely to result in a Release, and result from the past, present or
future operations of such Person or any of its Affiliates.
1.27
"Environmental Lien"
shall
mean any Lien in favor of any Governmental Authority for Environmental
Liabilities and Costs.
1.28
"ERISA"
shall mean the
Employee Retirement Income Security Act of 1974, as the same now exists or may
from time to time hereafter be amended, modified, recodified or supplemented,
together with all rules, regulations and interpretations thereunder or related
thereto.
1.29
"Equipment"
shall mean
"equipment", as such term is defined in the UCC, now owned or hereafter acquired
by Borrower and, wherever located, and shall include, without limitation, all
equipment, machinery, furniture, fixtures, computer equipment, telephone
equipment, molds, tools, dies, partitions, tooling, transportation equipment,
all other tangible assets used in connection with the manufacture, sale or lease
of goods or rendition of services, and Borrower's interests in any leased
equipment, and all repairs, modifications, alterations, additions, controls and
operating accessories thereof or thereto, and all substitutions and replacements
therefor.
1.30
"Event of Default"
shall mean
the occurrence or existence of any event or condition described in Section 11 of
this Agreement which is not remedied within any applicable grace or cure
period.
1.31
“Financial Statements”
shall
have the meaning as set forth in Section 8.9 hereof.
1.32
"Financing Statements"
shall
mean the Uniform Commercial Code UCC-1 Financing Statements to be filed with
applicable Governmental Authorities of each State or Commonwealth or political
subdivisions thereof pursuant to which Lender shall perfect its security
interest in the Collateral.
1.33
"Fiscal Year"
shall mean that
twelve (12) month period commencing on January 1 and ending on December
31.
1.34
“GAAP”
means generally
accepted accounting principles in effect in the United States of America at the
time of any determination, and which are applied on a consistent
basis. All accounting terms used in this Agreement which are not
expressly defined in this Agreement shall have the meanings given to those terms
by GAAP, unless the context of this Agreement otherwise requires.
1.35
"Governmental Authority"
or
"Governmental
Authorities"
shall mean any federal, state, county or municipal
governmental agency, board, commission, officer, official or entity exercising
executive, legislative, judicial, regulatory or administrative functions of or
pertaining to government.
1.36
“Indebtedness"
shall mean,
with respect to any Person, all of the obligations of such Person which, in
accordance with GAAP, should be classified upon such Person’s balance sheet as
liabilities, or to which reference should be made by footnotes thereto,
including without limitation, with respect to Borrower, in any event and whether
or not so classified:
(a) all
debt and similar monetary obligations of Borrower, whether direct or indirect,
including, without limitation, Subordinated Debt;
(b) all
obligations of Borrower arising or incurred under or in respect of any
guaranties (whether direct or indirect) by Borrower of the indebtedness,
obligations or liabilities of any other Person; and
(c) all
obligations of Borrower arising or incurred under or in respect of any Lien upon
or in any property owned by such Person, even though such Person has not assumed
or become liable for the payment of such obligations.
1.37
“
Intellectual Property
” shall
mean all franchises, patents, trademarks, service marks, trade names (whether
registered or unregistered), copyrights, corporate names, licenses, trade
secrets, proprietary software or hardware, proprietary technology, technical
information, discoveries, designs and other proprietary rights, whether or not
patentable, and confidential information (including, without limitation,
know-how, processes and technology) used in the conduct of the business of the
Borrower or any Subsidiary.
1.38
“Intercreditor Agreement"
shall mean the Intercreditor Agreement, dated of even date herewith,
among the Lender, Alexandra Global Master Fund Ltd., in its capacity as
Collateral Agent for the Convertible Noteholders, and Borrower, in the form
annexed hereto as
Exhibit
[_]
.
1.39
"Inventory"
shall mean any
"inventory," as such term is defined in the UCC, now owned or hereafter acquired
by Borrower, wherever located, and, in any event, shall include, without
limitation, all raw materials, work-in-process, finished and semi-finished
Inventory including, without limitation, all materials, parts, components and
supplies relating to the manufacture or assembly thereof, packaging and shipping
supplies relating thereto, and all other inventory, merchandise, goods and other
personal property now or hereafter owned by Borrower, which are held for sale,
exchange or lease or are furnished or are to be furnished under a contract of
service or an exchange arrangement or which constitute raw materials,
work-in-process or materials used or consumed or to be used or consumed in
Borrower's business, or the processing, packaging, delivery or shipping of the
same, and all finished goods and the products of the foregoing, whatever form
and wherever located; and all names or marks affixed to or to be affixed thereto
for purposes of selling same by the seller, manufacturer, lessor or licensor
thereof and all right, title and interest of Borrower therein and
thereto.
1.40
“Interest”
shall have the
meaning as set forth in Section 3.1 hereof.
1.41
“
Investment Property
” means all
“investment property”, as such term is defined in the UCC, now owned or
hereafter acquired by any Person, wherever located.
1.42
“Landlord Agreements”
shall
mean
(i) the
agreement, of even date herewith, between Capgemeni U.S. LLC, as
sublandlord, Lender and the Borrower, as tenant, as consented to by Bellevue
Place Office Building Limited Partnership, with respect to the leased premises
at 10500 N.E. 8
th
Street,
Bellevue, Washington 98004, in the form of
Exhibit
F-1
annexed hereto, and (ii) the agreement, of even date herewith, among
International Business Machines Corporation, as landlord, Lender and the
Borrower, as tenant, with respect to the leased premises at 2070 Route 52,
Hopewell Junction, NY 12533, in the form of
Exhibit
F-2
annexed hereto .
1.43
“
Letter-of-Credit Rights
” means
“letter-of-credit rights” as such term is defined in the UCC, now owned or
hereafter acquired by any Person, including rights to payment or performance
under a letter of credit, whether or not such Person, as beneficiary, has
demanded or is entitled to demand payment or performance.
1.44
"Lien"
or
"lien"
shall mean any
mortgage, deed of trust, pledge, security interest, hypothecation, assignment,
lien (statutory or other), charge, or other encumbrance of any kind or nature
whatsoever (including, without limitation, pursuant to any conditional sale or
other title retention agreement, any financing lease having substantially the
same economic effect as any of the foregoing, and the filing of any financing
statement under the UCC or comparable law of any jurisdiction to evidence any of
the foregoing) on personal or real property or fixtures.
1.45
"Loan"
and
“Loans”
shall respectively
mean the principal amounts outstanding from time to time respecting any and all
Advances.
1.46
"Loan Documents"
shall mean
this Agreement and any and all other agreements, notes, documents, mortgages,
financing statements, guaranties, intercreditor agreements, subordination
agreements, certificates and instruments executed and/or delivered by
Borrower or any other Person to Lender pursuant to and in connection with the
Loan and this Agreement, including, without limitation the Note, the
Intercreditor Agreement, the Securities Issuance Agreement, the Lockbox
Agreement, the Landlord Agreements, the Note Conversion Agreement and the
Registration Rights Agreement.
1.47
“
Lockbox
” shall have the
meaning assigned to such term in the Lockbox Agreement.
1.48
“
Lockbox Agent”
means the
person serving from time to time as the Lockbox Agent under the Lockbox
Agreement.
1.49
“
Lockbox Agreement
” means that
certain Lockbox Agreement dated as of the date hereof, among Lender, the
Borrower and the Lockbox Agent.
1.50
"
Material Adverse Effect
" means
a materially adverse effect on (a) the business, assets, liabilities,
financial condition, results of operations or business prospects of the
Borrower, (b) the ability of the Borrower to perform its obligations under
any Loan Document to which it is a party, (c) the value of the Collateral
or the rights of Lender therein, (d) the validity or enforceability of any of
the Loan Documents, (e) the rights and remedies of Lender under any of such
Loan Documents or (f) the timely payment of the principal of or interest on
the Loans or other amounts payable in connection therewith. Except
with respect to representations made or deemed made by Borrower in any of the
other Loan Documents to which it is a party, all determinations of materiality
shall be made by the Lender in its reasonable judgment unless expressly provided
otherwise.
1.51
"
Material Contract
" means any
contract or other arrangement (other than Loan Documents), whether written or
oral, to which the Borrower is a party as to which the breach, nonperformance,
cancellation or failure to renew by any party thereto could have a Material
Adverse Effect.
1.52
“Maturity Date”
shall mean
August 7, 2008, or such earlier date by which the maturity of the Obligations
shall have been accelerated pursuant to the terms hereof;
provided
,
however
, that the
Maturity Date may be extended by the Lender in its sole and absolute discretion
for one (1) additional year to August 7, 2009 in accordance with Section 4.1
hereof.
1.53
"Maximum Credit"
shall mean
the amount of Two Million Five Hundred Thousand Dollars
($2,500,000.00.)
1.54
“1934 Act”
shall mean the
Securities Exchange Act of 1934, as amended.
1.55
“Note”
shall have the meaning
as set forth in Section 2.1.
1.56
“Note Conversion Agreement”
shall mean the Note Conversion Agreement, of even date herewith, between Lender
and Borrower with respect to the terms of conversion of the Note.
1.57
"Obligations"
shall mean any
and all Loans and all other obligations, liabilities and indebtedness of every
kind, nature and description owing by Borrower to Lender and/or its Affiliates,
including, without limitation, principal, interest, repurchase obligations,
charges, fees, costs and expenses, however evidenced, whether as principal,
surety, endorser, guarantor or otherwise, whether arising under this Agreement,
the other Loan Documents or otherwise, whether now existing or hereafter
arising, whether arising before, during or after the initial or any renewal term
of this Agreement or after the commencement of any case with respect to Borrower
under the United States Bankruptcy Code or any similar statute (including,
without limitation, the payment of interest and other amounts which would accrue
and become due but for the commencement of such case), whether direct or
indirect, absolute or contingent, joint or several, due or not due, primary or
secondary, liquidated or unliquidated, secured or unsecured, and however
acquired by Lender.
1.58
"Permitted Encumbrances"
shall
mean the following: (a) security interests and Liens granted to
Lender or its Affiliates; (b) purchase money security interests in favor of
equipment vendors upon any Capital Assets hereafter acquired (including, without
limitation, capitalized or finance leases);
provided
that
, (i) no such
purchase money or other mortgage, Lien or security interest (or capitalized or
finance lease, as the case may be) with respect to specific future Capital
Assets or as refinanced shall extend to or cover any other property, other than
the specific Capital Assets so acquired, and the proceeds thereof, (ii) such
mortgage, Lien or security interest only secures the cost or obligation to pay
the purchase price of such specific Capital Assets only (or the obligations
under the capitalized or finance lease) and (iii) the principal amount secured
thereby shall not exceed one hundred (100%) percent of the lesser of the cost or
the fair market value (at the time of the acquisition of the Capital Assets) of
the Capital Assets so acquired; (c) Liens of carriers, warehousemen, artisans,
bailees, mechanics and materialmen incurred in the ordinary course of business
securing sums not overdue; (d) Liens incurred in the ordinary course of business
in connection with worker’s compensation, unemployment insurance or other forms
of governmental insurance or benefits, relating to employees, securing sums (i)
not overdue or (ii) being diligently contested in good faith provided that
adequate reserves with respect thereto are maintained on the books of the
Borrower in conformity with GAAP; (e) Liens for taxes (i) not yet due or (ii)
being diligently contested in good faith by appropriate proceedings, provided
that adequate reserves with respect thereto are maintained on the books of the
Borrower in conformity with GAAP; and which have no effect on the priority of
Liens in favor of Lender or the value of the assets in which Lender has a
Lien; (f) subject to the terms of the
Intercreditor Agreement,
the Liens in favor of the Convertible Noteholders described
therein and (g) such other Liens as are set forth on
Exhibit
A
annexed hereto and made a part hereof.
1.59
"Person"
or
"person"
shall mean, as
applicable, any individual, sole proprietorship, partnership, corporation,
limited liability company, limited liability partnership, business trust,
unincorporated association, joint stock corporation, trust, joint venture or
other entity or any government or any agency or instrumentality or political
subdivision thereof.
1.60
"Proceeds"
shall have the
meaning ascribed to such term in the UCC and shall also include, but not be
limited to, (a) any and all proceeds of any and all insurance (including,
without limitation, life insurance, business interruption insurance and credit
insurance), indemnity, warranty or guaranty payable to Borrower from time to
time with respect to any of the Collateral or otherwise, (b) any and all
payments (in any form whatsoever) made or due and payable to Borrower from time
to time in connection with any requisition, confiscation, condemnation, seizure
or forfeiture of all or any part of the Collateral by any governmental body,
authority, bureau or agency or any other Person (whether or not acting under
color of Governmental Authority) and (c) any and all other amounts from time to
time paid or payable under or in connection with any of the
Collateral.
1.61
“Registration Rights Agreement”
shall mean the Registration Rights Agreement, of even date herewith,
between Borrower and Lender, in the form of
Exhibit
H
annexed hereto.
1.62
"
Release
" means any spilling,
leaking, pumping, pouring, emitting, emptying, discharging, injecting, escaping,
leaching, dumping, or disposing of a Hazardous Substance into the
Environment.
1.63
"Reserves"
shall mean, as of
any date of determination, such amounts as Lender may from time to time
establish and revise in good faith reducing the amount of the Maximum Credit
which would otherwise be available to Borrower (a) to reflect events,
conditions, contingencies or risks which, as determined by Lender in good faith,
do or may adversely affect either (i) the Collateral or any other property which
is security for the Obligations or its value, (ii) the assets, business or
prospects of Borrower or any Obligor or (iii) the security interests and other
rights of Lender in the Collateral (including the enforceability, perfection and
priority thereof); or (b) in respect of any state of facts which Lender
determines in good faith constitutes an Event of Default or may, with notice or
passage of time or both, constitute an Event of Default.
1.64
“Responsible Officer”
shall
mean the Chief Executive Officer or the Chief Financial Officer of the
Borrower.
1.65
“Revolving Loan Commitment”
shall mean the commitment to make Revolving Loans to Borrower in the
aggregate principal amount outstanding not to exceed the lesser of (a) the
Maximum Credit or (b) the Borrowing Base, as such Revolving Loan Commitment may
be adjusted pursuant to the terms of this Agreement.
1.66
“Revolving Loans”
shall have
the meaning as set forth in Section 2.1 hereof.
1.67
“SEC”
shall mean the United
States Securities and Exchange Commission.
1.68
“
SEC Reports
” shall mean the
Borrower’s (1) Annual Report on Form 10-K for the year ended December 31, 2006,
(2) Quarterly Report on Form 10-Q for the quarter ended March 31, 2007,
and (3) all other
periodic and other reports filed by the Borrower with the SEC pursuant to the
1934 Act subsequent to December 31, 2006, and prior to the date hereof, in each
case as filed with the SEC and including the information and documents (other
than exhibits) incorporated therein by reference.
1.69
“Securities Issuance
Agreement”
shall have the meaning set forth in Section 6.9.
1.70
“Servicing Fee”
shall have the
meaning as set forth in Section 3.2 hereof.
1.71
"Subordinated Debt"
shall
mean, at any particular time, Indebtedness of Borrower that shall be expressly
subordinated upon written terms and conditions, satisfactory to Lender, in right
of payment to the prior payment in full of all of the Obligations.
1.72
"Subsidiary"
shall mean, as to
any Person, a corporation, limited liability company or other entity with
respect to which more than fifty (50%) percent of the outstanding equity
interests of each class having voting power is at the time owned by such Person
or by one or more Subsidiaries of such Person or by such Person.
1.73
"Term"
shall have the meaning
set forth in Section 4.1.
1.74
"UCC"
shall mean the Uniform
Commercial Code as presently enacted in
New York (or any
successor legislation thereto), and as the same may be amended from time to
time, and the state counterparts thereof as may be enacted in such states or
jurisdictions where any of the Collateral is located or held.
1.75
Rules of Interpretation and
Construction.
In this Agreement unless the context otherwise
requires:
(a) All
terms used herein which are defined in the UCC (as presently in effect in the
State of New York) shall have the meanings given therein unless otherwise
defined in this Agreement;
(b) Sections
mentioned by number only are the respective Sections of this Agreement as so
numbered;
(c) Words
importing a particular gender shall mean and include the other gender and words
importing the singular number mean and include the plural number and vice
versa;
(d) Words
importing persons shall mean and include firms, associations, partnerships
(including limited partnerships), societies, trusts, corporations or other legal
entities, including public or governmental bodies, as well as natural
persons;
(e) Each
reference in this Agreement to a particular person shall be deemed to include a
reference to such person's successors and permitted assigns;
(f) Any
headings preceding the texts of any Section of this Agreement, and any table of
contents or marginal notes appended to copies hereof are intended, solely for
convenience of reference and shall not constitute a part of this Agreement, nor
shall they affect its meaning, construction or effect;
(g) If
any clause, provision or section of this Agreement shall be ruled invalid or
unenforceable by any court of competent jurisdiction, such holding shall not
invalidate or render unenforceable any of the remaining provisions
thereof;
(h) The
terms "herein", "hereunder", "hereby", "hereto", and any similar terms as used
in this Agreement refer to this Agreement; the term "heretofore: means before
the date of execution of this Agreement; and the term "hereafter" shall mean
after the date of execution of this Agreement;
(i) If
any clause, provision or section of this Agreement shall be determined to be
apparently contrary to or conflicting with any other clause, provision or
section of this Agreement, then the clause, provision or section containing the
more specific provisions shall control and govern with respect to such apparent
conflict;
(j) Unless
otherwise specified, (i) all accounting terms used herein or in any Loan
Document shall be interpreted in accordance with GAAP, (ii) all accounting
determinations and computations hereunder or thereunder shall be made in
accordance with GAAP, and (iii) all financial statements required to be
delivered hereunder or thereunder shall be prepared in accordance with
GAAP;
(k) An
Event of Default that occurs shall exist or continue or be continuing unless
such Event of Default is waived by Lender in accordance with the terms of this
Agreement; and
(l) The
word "and" when used from time to time herein shall mean "or" or "and/or" if
such meaning is expansive of the rights or interests of Lender in the given
context.
SECTION 2.
REVOLVING LOANS
2.1
Revolving Loans
.
(a) Lender
shall, subject to the terms and conditions contained herein and the satisfaction
of the closing and funding conditions set forth herein, make revolving loans to
Borrower (“
Revolving
Loans
”) during the Term in amounts requested by Borrower from time to
time,
provided
that the requested Revolving Loan would not cause the outstanding Revolving
Loans to exceed the lesser of the Maximum Credit or the Borrower
Base existing immediately prior to the making of the requested
Revolving Loan. Subject to the terms and conditions hereof, Borrower
may borrow, repay and reborrow Revolving Loans, as set forth in this
Agreement.
b) Revolving
Loans may be drawn in tranches of not less than Twenty-Five Thousand Dollars
($25,000) no more than 5 (five) times each month (each drawing, an
“
Advance
” and
collectively, the “
Advances
”). The obligation of
Borrower to repay the Advances shall be evidenced by a note (the "
Note
") in the form of
Exhibit
B
hereto and
dated the date hereof.
(c) Subject to mandatory payment of Advances as set
forth in Section 2.1(d) below, the principal amount of the Revolving
Loans shall be payable on the Maturity Date.
(d) Notwithstanding any provision herein to the contrary,
Borrower shall repay the Advances immediately at any time and from time to time
in an amount by which the outstanding principal balance of the Advances exceeds
the Maximum Credit, as determined by Lender, based on the most recent monthly
Inventory reconciliation report delivered by Borrower to Lender in accordance
with Section 9.5 hereof.
(e) Whenever Borrower desires an Advance, but no more
frequently than five (5) times every thirty (30) days, Borrower will
notify Lender by delivery of a borrowing certificate certified by a Responsible
Officer (“
Borrowing
Certificate
”) setting forth in reasonable detail a schedule of Eligible
Accounts and Eligible Inventory, and the calculation of the Advance requested in
connection therewith, which shall in all respects be subject to Lender’s review
and approval. Lender shall be entitled to rely on any facsimile transmission of
a Borrowing Certificate given by a person who Lender reasonably believes to be a
Responsible Officer, and Borrower shall indemnify and hold Lender harmless for
any damages or loss suffered by Lender as a result of such reliance. The funding
of each Advance shall be made in accordance with the applicable Borrowing
Certificate as approved by Lender.
(f) Until the Revolving Loans have been
repaid and this Agreement has been terminated, remittances and all other
proceeds of Borrower’s accounts receivable shall be sent to a lockbox
designated by and/or maintained in the name of Lender, and deposited into a bank
account now or hereafter selected by Lender and maintained in the name of Lender
under arrangements with the depository bank under which all funds deposited to
such bank account are required to be transferred solely to
Lender. Once instituted, such lockbox system shall remain in effect
until the sooner of the termination of this Agreement or such time as Lender
directs otherwise. Borrower shall bear all risk of loss of any funds
deposited into such account except to the extent such loss is covered by the
gross negligence or the willful misconduct of Lender. In connection
therewith, Borrower shall execute such lockbox and bank account agreements as
Lender shall reasonably specify to effect the transactions contemplated hereby,
including the Lockbox Agreement. Until this Agreement is terminated,
any collections or other proceeds received by Borrower from sales of Eligible
Inventory and the proceeds from the receipt of the Borrower’s accounts
receivables shall be held in trust for Lender and immediately remitted to Lender
in kind.
2.2
Maximum Credit.
The
aggregate principal amount of the Revolving Loans shall not exceed the Maximum
Credit.
2.3
Reserves.
Without
limiting any other rights and remedies of Lender hereunder or under the other
Loan Documents, the Maximum Credit shall be subject to Lender's continuing
right, in its sole discretion, to withhold a Reserve from Borrower's
availability under the Maximum Credit.
2.4
Use of
Proceeds.
Borrower shall use the proceeds of each Advance
solely for working capital purposes and such other purposes as are set forth
in Section 2.4 of the Borrower’s Disclosure Schedule, or as otherwise
agreed in writing by Lender prior to the release of such Advance under Section
2.1 hereunder.
2.5
Repayment
. Except as
otherwise set forth herein, Borrower shall repay the aggregate outstanding
principal amount of the Loans and all accrued and unpaid Interest, as calculated
in Section 3.1, on or prior to the Maturity Date.
SECTION 3.
INTEREST, FEES AND
CHARGES
3.1
Interest.
(a) Interest
(
“Interest”
) on all
Loans shall be computed on the basis of the actual number of days elapsed and a
year of 360 days. Interest shall accrue at a rate per annum equal to the greater
of (i) the sum of (A) the Base Rate plus (B) Two Percent (2.0%), or (ii) Ten
Percent (10%), and shall be payable by Borrower in arrears (x) prior to the
Maturity Date, on the first Business Day of each calendar month, (y) in full on
the Maturity Date and (z) on demand after the Maturity Date. Should Borrower
fail to fully repay the Loans and/or all accrued Interest on the Maturity Date,
then interest on all outstanding Loans, including principal and Interest, shall
accrue at the Default Rate, compounded quarterly.
(b) For
the purposes of this Section 3.1,
(i)
“Base Rate”
means a rate per
annum equal to the “Prime Rate” as reported in the “Money Rates”
column of
The Wall
Street Journal
, adjusted as and when such Prime Rate
changes.
(ii)
“Default Rate”
means a rate
per annum equal to fifteen percent (15%).
3.2
Servicing
Fee.
Borrower shall pay Moriah Capital Partners LLC a
servicing fee (
“Servicing
Fee”
) of $82,500.00 on the date hereof. Such fee shall be deemed fully
earned on the date hereof and shall not be subject to rebate or proration for
any reason.
3.3
Late Charges
. If the
payment of any Obligation due hereunder is more than fifteen
(15) days overdue, then, in addition to any interest charges payable
by Borrower in connection therewith, Lender may charge Borrow a late
fee of two and one-half percent (2.5%) of such overdue
payment.
3.4
Fees and
Expenses
. Borrower shall pay, on Lender's demand, all costs,
expenses, filing fees and taxes payable in connection with the preparation,
execution, delivery, recording, administration, collection, liquidation,
enforcement and defense of the Obligations, Lender's rights in the Collateral,
this Agreement, the other Loan Documents, and all other existing and future
agreements or documents contemplated herein or related hereto, including any
amendments, waivers, supplements or consents which may now or hereafter be made
or entered into in respect hereof, or in any way involving claims or defenses
asserted by Lender or claims or defenses against Lender asserted by Borrower or
any third party directly or indirectly arising out of or related to the
relationship between Borrower and Lender, including, but not limited to the
following, whether incurred before, during or after the Term or after the
commencement of any case with respect to Borrower under the United States
Bankruptcy Code or any similar or successor statute: (a) all costs and expenses
of filing or recording (including UCC Financing Statement and mortgage filing
fees; (b) all title insurance and other insurance premiums, appraisal fees, fees
incurred in connection with any environmental report and audit, survey and
search fees and charges; (c) all fees relating to lockbox charges and fees, the
wire transfer of loan proceeds and other funds and fees for returned checks; ;
and (d) all costs, fees and disbursements of counsel to Lender; provided,
however, and notwithstanding anything to the contrary herein, with respect to
any due diligence conducted by the Lender in connection with the transactions
contemplated by this Agreement, Borrower shall pay the Lender up to $15,000, of
which $10,000 has already been paid, and with respect to any legal fees incurred
by the Lender in connection with this Agreement as of the date hereof, the
Borrower shall pay up to $20,000 of Lender’s actual legal fees. If any fees,
costs or charges payable to Lender hereunder are not paid when due, Borrower
shall thereby be deemed to have requested, and Lender is hereby authorized at
its discretion to make and charge to Borrower’s account, a Loan as of such date
in an amount equal to such unpaid fees, costs or charges. For the avoidance of
doubt, Borrower shall not be obligated to pay Lender more than $35,000 pursuant
to this Section for pre-closing due diligence of Lender and pre-closing legal
fees, excluding filing and recording fees and
expenses. Notwithstanding anything to the contrary herein, unless an
Event of Default shall have occurred and is continuing, Borrower shall not pay
(i) any out-of-pocket expenses and costs hereinafter incurred by Lender during
the course of its periodic field examinations of the Collateral and Borrower’s
operations and (ii) any out-of-pocket expenses of any appraiser appointed by
Lender to value the Inventory.
3.5
Savings Clause
. The
Note and the obligations of Borrower hereunder are subject to the express
condition that at no time shall Borrower be obligated or required to pay
interest on the principal balance due hereunder at a rate which could subject
Lender to either civil or criminal liability as a result of being in excess of
the maximum interest rate which Borrower is permitted by applicable law to
contract or agree to pay. If by the terms hereof, Borrower is at any
time required or obligated to pay interest on the principal balance due
hereunder at a rate in excess of such maximum rate, the Interest Rate or the
Default Rate, as the case may be, shall be deemed to be immediately reduced to
such maximum rate and all previous payments in excess of the maximum rate shall
be deemed to have been payments in reduction of principal and not on account of
the interest due hereunder. All sums paid or agreed to be paid to
Lender for the use or forbearance of the Loans, shall, to the extent permitted
by applicable law, be amortized, prorated, allocated, and spread throughout the
full stated term of the Note until payment in full so that the rate or amount of
interest on account of the Loans does not exceed the maximum lawful rate of
interest from time to time in effect and applicable to the Loans for so long as
any Loan is outstanding.
SECTION 4.
TERM.
4.1
Term
.
(a) This
Agreement shall continue in full force and effect for a term ( as the same may
hereafter be extended, the
“Term”
) from the Closing Date
through and until August 7, 2008 (the “
Initial Term
”), or such
earlier date by which the maturity of the Obligations shall have been
accelerated pursuant to the terms hereof;
provided
,
however
, that upon
the satisfaction of the conditions set forth in Section 4.1(b) below, the Term
may be extended by Borrower for one (1) additional year to August 7, 2009 (the
“
Term Extension
”) by
written notice delivered to Lender no earlier than May 7, 2008 and no later than
June 7, 2008, with time being of the essence with respect thereto (the date of
delivery of such notice referred to as the “
Extension Notice
Date
”).
(b) Notwithstanding
the foregoing, the Term Extension shall be subject to Borrower’s satisfaction
of, and compliance with, all of the following conditions, as determined by
Lender (collectively, the “
Extension
Conditions
”):
(i)
Representations and
Warranties
. Each of the representations and warranties made by
or on behalf of Borrower to Lender in this Agreement or in other Loan Documents
shall be true and correct in all material respects when made at all times during
the period from the Extension Notice Date through the expiration of the Initial
Term (provided that any such representation or warranty that is qualified as to
materiality shall be true and correct in all respects), and Lender shall have
received a certification from a Responsible Officer with respect to the
foregoing in form and substance satisfactory to Lender.
(ii)
Performance,
etc
. Borrower shall have duly and properly performed, complied
with and observed each of its covenants, agreements and obligations contained in
this Agreement, and shall have duly and properly performed, complied with and
observed in all respects its covenants, agreements and obligations in all other
articles of this Agreement and any of the Loan Documents to which it is a party
or by which it is bound, as of the Extension Notice Date through the expiration
of the Initial Term, and Lender shall have received a certification from a
Responsible Officer with respect to the foregoing in form and
substance satisfactory to Lender.
(iii)
No Default
. No event shall
have occurred on or prior to the Notice Extension Date or at any time thereafter
and be continuing as of the Notice Extension Date through the expiration of the
Initial Term, and no condition shall exist on the Notice Extension Date or at
any time thereafter and be continuing as of the Notice Extension Date through
the expiration of the Initial Term, which constitutes an Event of Default or
which would, with notice or the lapse of time, or both, constitute an Event of
Default under this Agreement or any of the Loan Documents, and Lender shall have
received a certification from a Responsible Officer with respect to the
foregoing in form and substance satisfactory to Lender.
(iv)
Share Issuance.
Borrower shall
have issued to Lender additional shares of Common Stock valued at $195,000, in
accordance with the terms of the Securities Issuance Agreement, all of which
shares shall be registered in accordance with the terms of the Registration
Rights Agreement.
(v)
Financial
Condition
. Borrower shall have had positive earnings before
interest, taxes, depreciation and amortization for the three months ended June
30, 2008, and Lender shall have received a certification from a Responsible
Officer with respect to the foregoing in form and substance satisfactory to
Lender.
(c) In
the event that the Extension Conditions are not satisfied, then this
Agreement shall terminate upon the expiration of the Initial Term, or such
earlier date by which the maturity of the Obligations shall have been
accelerated pursuant to the terms hereof.
4.2
Early
Termination.
(a) Lender
shall have the right to terminate this Agreement at any time upon or after the
occurrence of an Event of Default.
(b) This
Agreement shall not be terminable by Borrower without Lender’s prior written
consent, which consent may be withheld by Lender in its sole
discretion.
Notwithstanding
the foregoing, if Lender accelerates the Loans due to an Event of Default,
Borrower shall pay to Lender an early payment fee in an amount equal to (i) two
percent (2%) of the Maximum Credit if such acceleration occurs prior
to the first anniversary of the Closing Date, and (ii) one percent (1%) of the
Maximum Credit if such acceleration occurs on or after the first anniversary of
the Closing Date; such fee being intended to compensate Lender for its costs and
expenses incurred in initially approving this Agreement or extending same. Such
early payment fee shall be due and payable by Borrower to Lender upon
termination by acceleration of this Agreement by Lender due to the occurrence
and continuance of an Event of Default.
4.3
Effect of
Termination.
Upon termination of this Agreement by Lender upon
or after the occurrence of an Event of Default, in addition to payment of all
Obligations which are not contingent, Borrower shall deposit such amount of cash
collateral as Lender determines is reasonably necessary to secure Lender from
loss, cost, damage or expense in connection with any remittance items or other
payments provisionally credited to the Obligations and/or to which Lender has
not yet received final and indefeasible payment.
SECTION 5.
COLLATERAL.
5.1
Security Interests in Borrower's
Assets
. As collateral security for the payment and performance
of the Obligations, subject to the last paragraph of this Section 5.1, Borrower
hereby grants and conveys to Lender a first priority continuing security
interest in and Lien upon all now owned and hereafter acquired property
(including, without limitation, real property) and assets of Borrower and the
Proceeds and products thereof (which property, assets together with all other
collateral security for the Obligations now or hereafter granted to or otherwise
acquired by Lender, are referred to herein collectively as the
"Collateral"
), including,
without limitation, all property of Borrower now or hereafter held or possessed
by Lender and including the following:
(a) All
now owned and hereafter acquired: Accounts; contract rights; chattel
paper (including, but not limited to, rentals and other amounts payable under
leases of equipment to customers pursuant to which Borrower is the lessor or
assignee of any lessor); general intangibles (including, but not limited to, tax
and duty refunds, patents, patent applications, trademarks, trademark
applications, tradenames and tradestyles, copyrights, copyright applications,
trade rights (whether or not registered), discoveries, improvements, processes,
know-how, formulas, trade secrets, service marks, other rights in intellectual
property (whether patentable or not), goodwill, customer and mailing lists, life
insurance policies, licenses (whether as licensor or licensee), franchises and
permits); documents (including, without limitation, all warehouse receipts);
instruments; all guaranties, letters of credit, steamship guaranties, airway
releases or other similar guaranties, agreements or property securing or
relating to any of the items referred to above (including, but not limited to,
purchase money security interests granted by Account Debtors in connection with
installment sales); all cash monies, investment properties, deposits,
securities, bank accounts, deposit accounts, credits and other property now or
hereafter held in any capacity by Lender;
(b) Inventory;
(c) Equipment
and fixtures;
(d) All
now owned and hereafter acquired right, title and interests of Borrower in, to
and in respect of any real or other personal property in or upon which Lender
has or may hereafter have a security interest, Lien or right of
setoff;
(e) All
of Borrower's existing and future leasehold interests in premises or facilities
leased from third parties by Borrower;
(f) All
present and future books and records relating to any of the above including,
without limitation, all present and future books of account of every kind or
nature, purchase and sale agreements, invoices, ledger cards, bills of lading
and other shipping evidence, statements, correspondence, memoranda, credit files
and other data relating to the Collateral or any account debtor, together with
the tapes, disks, diskettes and other data and software storage media and
devices, file cabinets or containers in or on which the foregoing are stored
(including any rights of Borrower with respect to any of the foregoing
maintained with or by any other Person); and
(g) Any
and all products and Proceeds of the foregoing in any form including, without
limitation, all insurance claims, warranty claims and proceeds and claims
against third parties for loss or destruction of or damage to any or the
foregoing.
Notwithstanding
the foregoing, Lender’s Lien upon Borrower’s Collateral other than Accounts and
Inventory shall be subject to the prior Lien of the Convertible Noteholders in
accordance with the terms of, and subject to the conditions set forth in, the
Intercreditor Agreement.
5.2
Financing
Statements
. Borrower hereby authorizes Lender to file
Financing Statements with respect to the Collateral in form acceptable to Lender
and its counsel, and hereby ratifies any actions taken by Lender prior to the
date hereof to file such Financing Statements. Borrower shall, at all
times, do, make, execute, deliver and record, register or file all Financing
Statements and other instruments, acts, pledges, leasehold or other mortgages,
amendments, modifications, assignments and transfers (or cause the same to be
done), and will deliver to Lender such instruments and/or documentation
evidencing items of Collateral, as may be requested by Lender to better secure
or perfect Lender's security interest in the Collateral or any security
interest, mortgage or Lien with respect thereto.
Borrower acknowledges
that it is not authorized to file any financing statement or amendment or
termination statement with respect to any Financing Statement without the prior
written consent of Lender and agrees that it will not do so without the prior
written consent of Lender, subject to Borrower’s rights under Section
9-509(d)(2) of the UCC.
SECTION 6.
CONDITIONS TO EXTENSION OF
CREDIT
The
obligation of Lender to make the initial Loans under this Agreement shall be
subject to the satisfaction or waiver by Lender, prior thereto or concurrently
therewith, of each of the following conditions precedent:
6.1
Loan
Documents
. Each of the Loan Documents shall have been duly and
properly authorized, executed and delivered by Borrower and the other parties
thereto and shall be in full force and effect as of the date hereof and on the
date of the initial Loans.
6.2
Representations and
Warranties
. Each of the representations and warranties made by
or on behalf of Borrower to Lender in this Agreement or in other Loan Documents
shall be true and correct in all material respects as of the date hereof and on
the date of the initial Loans, provided that any such representation or warranty
that is qualified by materiality shall be true and correct in all respects as of
the date hereof and on the date of the initial Loans.
6.3
Certified Copies of Corporate
Documents
. Lender shall have received from Borrower, certified
by a duly authorized officer to be true and complete on and as of a date which
is not more than ten (10) Business Days prior to the date hereof, a copy of each
of (a) the certificate of incorporation or such other formation documents of
Borrower in effect on such date of certification, and (b) the by-laws of
Borrower in effect on such date.
6.4
Proof of Corporate
Action
. Lender shall have received from Borrower a copy,
certified by a duly authorized officer to be true and complete on and as of the
date which is not more than ten (10) Business Days prior to the date hereof, of
the records of all corporate action taken by Borrower to authorize (a) its
execution and delivery of each of the Loan Documents to which it is or is to
become a party as contemplated or required by this Agreement, (b) its
performance of all of its agreements and obligations under each of such
documents, and (c) the incurring of the Obligations contemplated by this
Agreement.
6.5
Legal
Opinion
. Lender shall have received a written legal opinion,
addressed to Lender, dated the date hereof, from counsel for
Borrower. Such legal opinion shall be acceptable to Lender and its
counsel.
6.6
Collateral
.
(a) All
of the Obligations of Borrower to Lender under or in respect of this Agreement
shall be entitled to all of the benefits of and be secured by this Agreement and
the Loan Documents, and Lender shall have obtained a first, perfected security
interest in the Collateral of Borrower, subject only to the Permitted
Encumbrances.
(b) The
Loan Documents and all other documents in respect thereto, which shall create
and maintain a first perfected security interest in favor of Lender and the
appropriate Financing Statements in respect thereto and necessary to enable
Lender to perfect its security interests thereunder, shall have been duly
executed and delivered by Borrower to Lender.
6.7
Insurance
. Lender
shall have received evidence of insurance, additional insured and loss payee
endorsements required hereunder and under the other Loan Documents, in form and
substance satisfactory to Lender, and certificates of insurance policies and/or
endorsements naming Lender as loss payee as required hereunder.
6.8
Intercreditor
Agreement.
Lender shall have received the Intercreditor
Agreement
,
duly executed
by or on behalf of the Convertible Noteholders.
6.9
Equity Grant.
The
Borrower shall have issued to Lender Common Stock of the Borrower valued at
$195,000, on the terms set forth in the Securities Issuance Agreement, of even
date herewith, between the Borrower and Lender (the
“Securities Issuance
Agreement”
) in substantially the form annexed hereto as
Exhibit
D
.
6.10
Pay Proceeds Letter
. Borrower
shall have delivered to Lender a pay proceeds letter with respect to the
disbursement of the proceeds of the initial Loans in form and substance
satisfactory to Lender, which letter shall provide for, among other things, the
payment or reimbursement of all costs and expenses incurred by Lender in
connection with this Agreement and the other Loan Documents.
SECTION 7.
CONDITIONS TO MAKING FURTHER
LOANS.
The
obligations of Lender to make further Loans to Borrower shall be subject to the
satisfaction or waiver by Lender, prior thereto or concurrently therewith, of
each of the following conditions precedent:
7.1
Applications and
Compliance
. The application for such Loans shall have been
made by Borrower to Lender in accordance with the applicable provisions of this
Agreement and in compliance with all provisions of this Agreement.
7.2
Representations and
Warranties
. Each of the representations and warranties made by
or on behalf of Borrower to Lender in this Agreement or in other Loan Documents
shall have been true and correct in all material respects when made (provided
that any such representation or warranty that is qualified as to materiality
shall be true and correct in all respects), shall, for all purposes of this
Agreement, be deemed to be repeated on and as of the date of each Loan by Lender
hereunder and shall be true and correct in all respects on and as of each such
date, except to the extent that any of such representations and warranties
relate, by the express terms thereof, solely to a date prior to the date of each
Loan by Lender hereunder, and Lender shall have received a certification from a
Responsible Officer with respect to the foregoing in form and
substance satisfactory to Lender.
7.3
Performance,
etc
. Borrower shall have duly and properly performed, complied
with and observed each of its covenants, agreements and obligations contained in
this Agreement, and shall have duly and properly performed, complied with and
observed in all respects its covenants, agreements and obligations in all other
articles of this Agreement and any of the Loan Documents to which it is a party
or by which it is bound on the date of each Loan by Lender hereunder, and Lender
shall have received a certification from a Responsible Officer with respect to
the foregoing in form and substance satisfactory to
Lender. No event shall have occurred on or prior to the date of each
Loan by Lender hereunder and be continuing on the date of each Loan by Lender
hereunder, and no condition shall exist on the date of each Loan by Lender
hereunder, which constitutes an Event of Default or which would, with notice or
the lapse of time, or both, constitute an Event of Default under this Agreement
or any of the Loan Documents, and Lender shall have received a certification
from a Responsible Officer with respect to the foregoing in form and
substance satisfactory to Lender.
SECTION 8.
REPRESENTATIONS AND
WARRANTIES.
Borrower
hereby represents and warrants to Lender, knowing and intending that Lender
shall rely thereon in making the Loan contemplated hereby (each of which
representations and warranties shall be continuing unless expressly made in
relation only to a specific date), that:
8.1
Corporate Existence; Good
Standing
.
(a) Borrower
(i) is a corporation duly organized, validly existing and in good standing under
the laws of the jurisdiction of its organization, (ii) is in good standing in
all other jurisdictions in which it is required to be qualified to do business
as a foreign corporation, and (iii) has all requisite corporate power and
authority and full legal right to own or to hold under lease its properties and
to carry on the business as presently engaged. Borrower has no Subsidiaries that
contain assets or conduct operations.
(b) Borrower
has corporate power and authority and has full legal rights to enter into each
of the Loan Documents to which it is a party, to perform, observe and comply
with all of its agreements and obligations under each of such documents, and to
obtain all of the Loans contemplated by this Agreement.
8.2
Corporate Authority,
etc
. The execution and delivery by Borrower of the Loan
Documents to which it is a party, the performance by Borrower of all of its
agreements and obligations under each of such documents, and the incurring by
Borrower of all of the Obligations contemplated by this Agreement, have been
duly authorized by all necessary corporate actions on the part of Borrower and,
if required, its shareholders, and do not and will not (a) contravene
any provision of Borrower's charter, bylaws or other governing documents or this
Agreement (each as from time to time in effect), (b) conflict with, or result in
a breach of the terms, conditions, or provisions of, or constitute a default
under, or result in the creation of any mortgage, Lien, pledge, charge, security
interest or other encumbrance upon any of the property of Borrower under, any
agreement, mortgage or other instrument to which Borrower is or may become a
party, including, without limitation, the Convertible Notes; (c) violate or
contravene any provision of any law, regulation, order, ruling or interpretation
thereunder or any decree, order or judgment or any court or governmental or
regulatory authority, bureau, agency or official (all as from time to time in
effect and applicable to such entity), (d) other than waivers required from the
Borrower’s landlords and the consents required from the Convertible Noteholders,
require any waivers, consents or approvals by any of third party, including any
creditors or trustees for creditors of Borrower, or (e) require any approval,
consent, order, authorization, or license by, or giving notice to, or taking any
other action with respect to, any Governmental Authority.
8.3
Binding Effect of Documents,
etc
. Borrower and each shareholder of Borrower has duly
executed and delivered each of the Loan Documents to which it is a party, and
each of the Loan Documents is valid, binding and in full force and effect. The
agreements and obligations of Borrower and each shareholder of Borrower as
contained in each of the Loan Documents constitutes, or upon execution and
delivery thereof will constitute, legal, valid and binding obligations of
Borrower or the shareholders of Borrower, as the case may be, enforceable
against Borrower or the shareholders of Borrower, as the case may be, in
accordance with their respective terms, subject, as to the enforcement of
remedies only, to limitations imposed by federal and state laws regarding
bankruptcy, insolvency, reorganization, moratorium and other laws affecting
creditors' rights and remedies generally, and by general principles of law and
equity.
8.4
No Events of
Default
.
(a) No
Event of Default has occurred and is continuing and no event has occurred and is
continuing and no condition exists that would, with notice or the lapse of time,
or both, constitute an Event of Default.
(b) Borrower
is not in default under any material contract, agreement or instrument to which
Borrower is a party or by which Borrower or any of property of Borrower is
bound.
(c) The
execution, delivery and performance of and compliance with this Agreement and
the other Loan Documents will not, with or without the passage of
time or giving of notice, result in any such material violation, or be in
conflict with or constitute a default under any such term or provision, or
result in the creation of any Lien upon any of Borrower’s properties
or assets or the suspension, revocation, impairment, forfeiture or nonrenewal of
any permit, license, authorization or approval applicable to Borrower, or any of
its businesses or operations or any of its assets or properties.
8.5
No Governmental Consent
Necessary
. No consent or approval of, giving of notice to,
registration with or taking of any other action in respect of, any Governmental
Authority is required with respect to the execution, delivery and performance by
Borrower of this Agreement and the other Loan Documents to which it is a
party.
8.6
No
Proceedings
. There are no actions, suits, or proceedings
pending or, to the best of Borrower's knowledge, threatened against or affecting
Borrower in any court or before any Governmental Authority which, if adversely
determined, would have an adverse effect on the ability of Borrower to perform
its obligations under this Agreement or the other Loan Documents to which it is
a party.
8.7
No Violations of
Laws
. Borrower has conducted, and is conducting, its business,
so as to comply in all respects with all applicable federal, state, county and
municipal statutes and regulations. Borrower or any officer, director
or shareholder of Borrower is not charged with, or so far as is known by
Borrower, is not under investigation with respect to, any violation of any such
statutes, regulations or orders, which could have a Material Adverse
Effect.
8.8
Use of Proceeds of the
Loan
. Proceeds from the Loan shall be used only for those
purposes set forth in this Agreement. No part of the proceeds of the
Loan shall be used, directly or indirectly, for the purpose of purchasing or
carrying any margin stock or for the purpose of purchasing or carrying or
trading in any stock under such circumstances as to involve Borrower in a
violation of any statute or regulation. In particular, without
limitation of the foregoing, no part of the proceeds from the Loans are intended
to be used to acquire any publicly-held stock of any kind.
8.9
Financial
Statements
.
(a) The
audited and unaudited financial statements contained in the SEC Reports
(collectively, the
“Financial
Statements”
) (x) fairly present as of the respective dates
thereof the financial position of the Borrower and the results of its
operations, cash flows and stockholders’ equity for each of the periods then
ended in all material aspects; and (y) except for the fact that the unaudited
financial statements omit notes to such statements and year-end adjustments
thereto, have been prepared in accordance with GAAP in conformity with the rules
and regulations of the SEC.
(b) Except
as shown on the most recent Financial Statements, (i) Borrower has no other
Indebtedness as of the date hereof which would adversely affect the financial
condition of Borrower or the Collateral, and (ii) neither the Borrower nor any
Subsidiary has any liabilities, contingent or otherwise, except those which
individually or in the aggregate are not material to the financial condition or
operating results of the Borrower and the Subsidiaries, taken as a
whole.
8.10
Changes in Financial
Condition
. Except as disclosed in the SEC Reports, since June 15, 2007,
there has been no material adverse change and no material adverse development in
the business, properties, operations, condition (financial or otherwise),
results of operations or prospects of the Borrower. Except as
disclosed in the SEC Reports, since December 31, 2006, neither the Borrower nor
any Subsidiary has (i) declared or paid any dividends, (ii) sold any assets,
individually or in the aggregate, outside of the ordinary course of business,
(iii) had capital expenditures outside of the ordinary course of business, (iv)
engaged in any transaction with any Affiliate except as set forth in the SEC
Reports or (v) engaged in any other transaction outside of the ordinary course
of business.
8.11
Inventory
. Borrower's
Inventory, as of the date hereof, consists of items of quality and quantity
suitable for sale, lease or use in the ordinary course of its business, subject
to the following sentence. The value of obsolete items, items below
standard quality and items in the process of repair have been written down to
realizable market value, or adequate reserves have been provided therefore, and
the values carried on Borrower's most recent balance sheet contained in the
Financial Statements are set at the lower of cost or market, in accordance with
GAAP.
8.12
Equipment
. Borrower
shall keep its Equipment in good order and repair, and in running and marketable
condition, ordinary wear and tear excepted.
8.13
Taxes and
Assessments
.
(a)
Borrower has paid and discharged when due all taxes, assessments and other
governmental charges which may lawfully be levied or assessed upon its income
and profits, or upon all or any portion of any property belonging to it, whether
real, personal or mixed, to the extent that such taxes, assessment and other
charges have become due. Borrower has filed all tax returns, federal,
state and local, and all related information, required to be filed by
it.
(b) Borrower
shall make all payments to be made by it hereunder without any Tax Deduction,
unless a Tax Deduction (as defined below) is required by law. If Borrower is
aware that Borrower must make a Tax Deduction
(or
that there is a change in the rate or the basis of a Tax Deduction), it must
promptly notify Lender. If a Tax Deduction is required by law to be
made by Borrower, the amount of the payment due from Borrower will be increased
to an amount which (after making the Tax Deduction) leaves an amount equal to
the payment which would have been due if no Tax Deduction had been required. If
Borrower is required to make a Tax Deduction, that Borrower must make the
minimum Tax Deduction allowed by law and must make any payment required in
connection with that Tax Deduction within the time allowed by law. Within 30
days of making either a Tax Deduction or a payment required in connection with a
Tax Deduction, Borrower making that Tax Deduction must deliver to Lender
evidence satisfactory to Lender that the Tax Deduction has been made or (as
applicable) the appropriate payment has been paid to the relevant taxing
authority.
(c)
“Tax Deduction”
means a
deduction or withholding for or on account of Tax from a payment under a Loan
Document.
“Tax”
means
any tax, levy, impost, duty or other charge or withholding of a similar nature,
including any income, franchise, stamp, documentary, excise or property tax,
charge or levy (in each case, including any related penalty or
interest).
8.14
ERISA
. Borrower is in
compliance in all material respects with the applicable provisions of ERISA and
all regulations issued thereunder by the United States Treasury Department, the
Department of Labor and the Pension Benefit Guaranty Corporation.
8.15
Environmental
Matters
.
(a) Borrower
has duly complied with, and its facilities, business assets, property,
leaseholds and equipment are in compliance in all respects with, the provisions
of all laws, regulations and orders of all Governmental
Authorities.
(b) Borrower
has been issued all required federal, state and local licenses, certificates or
permits relating to the operation of its business; and Borrower and its
facilities, business, assets, property and equipment are in compliance in all
material respects with all applicable federal, state and local laws, rules and
regulations relating to air emissions, water discharge, noise emissions, solid
or liquid waste disposal, hazardous waste or materials, or other environmental,
health or safety matters.
8.16
United States Anti-Terrorism
Laws
(a) In
this Section 8.16:
“
Anti-Terrorism Law
” means each
of: (i) Executive Order No. 13224 of September 23,
2001 Blocking Property and Prohibiting Transactions With Persons Who
Commit, Threaten To Commit, or Support Terrorism (the
“Executive Order”
); (ii) the
Uniting and Strengthening America by Providing Appropriate Tools Required to
Intercept and Obstruct Terrorism Act of 2001, Public Law 107-56 (commonly known
as the USA Patriot Act); (iii) the Money Laundering Control Act of 1986, Public
Law 99-570; and (iv) any similar law enacted in the United States of America
subsequent to December 31, 2004.
“
holding company
” has the
meaning given to it in the United States Public Utility Holding Company Act of
1935, and any successor legislation and rules and regulations promulgated
thereunder.
“
investment company
” has the
meaning given to it in the United States Investment Company Act of
1940.
“
public utility
” has the
meaning given to it in the United States Federal Power Act of 1920.
“
Restricted Party
” means any
person listed: (i) in the Annex to the Executive Order; (ii) on the Specially
Designated Nationals and Blocked Persons list maintained by the Office of
Foreign Assets Control of the United States Department of the Treasury; or (iii)
in any successor list to either of the foregoing.
(b) Borrower
is not (i) a holding company or subject to regulation under the United States
Public Utility Holding Company Act of 1935; (ii) public utility or subject to
regulation under the United States Federal Power Act of 1920; (iii) required to
be registered as an investment company or subject to regulation under the United
States Investment Company Act of 1940; or (iv) subject to regulation under any
United States Federal or State law or regulation that limits his/its ability to
incur or guarantee indebtedness.
(c) To
the best of Borrower's knowledge, Borrower (i) is not, and is not controlled by,
a Restricted Party; (ii) has not received funds or other property from a
Restricted Party; and (iii) is not in breach of and is not the subject of any
action or investigation under any Anti-Terrorism Law.
(d) Borrower
has taken reasonable measures to ensure compliance with the Anti-Terrorism
Laws.
8.17
Location of
Collateral
. As of the date hereof, none of the Collateral is
or will be located in or on any property other than those set forth in Section
8.17 of the Borrower’s Disclosure Schedule.
8.18
Customers and
Vendors
. Section 8.18. of the Borrower’s Disclosure Schedule
sets forth a complete list of all customers, suppliers, manufacturers, vendors
and independent contractors of the Company and its Subsidiaries. Any
contracts or agreements with any such parties are in full force and
effect. There are no current or anticipated disputes among or between
any such parties and the Company or the Subsidiaries.
8.19
Other
Liens
. Borrower has good and marketable title to and owns all
of the Collateral free and clear of any and all Liens except the Permitted
Encumbrances and in favor of Lender. None of the Collateral, except
such Collateral as is pledged to the Convertible Noteholders, is
subject to any prohibition against encumbering, pledging, hypothecating or
assigning the same or requires notice or consent to Borrower's doing of the
same.
8.20
Books and
Records
. Borrower maintains its chief executive office and its
books and records related to its Accounts, Inventory and all other Collateral at
its address set forth in
Exhibit
E
of this Agreement.
8.21
Location of
Offices
.
Exhibit
E
hereto sets forth Borrower's chief executive office, and further sets
forth a complete and accurate list of all offices and locations at or out of
which Borrower conducts any of its business or operations.
8.22
SEC Reports.
The SEC
Reports do not contain any untrue statement of a material fact or omit to state
any material fact necessary in order to make the statements therein, in the
light of the circumstances under which they are made, not
misleading.
8.23
Representations and Warranties: True,
Accurate and Complete
.
(a) None
of the representations, certificates, reports, warranties or statements now or
hereafter made or delivered to Lender pursuant hereto or in connection with this
Agreement or any other Loan Document or the transactions contemplated hereby
contains or will contain any untrue statement of a fact, or omits or will omit
to state a fact necessary in order to make the statements contained herein and
therein, in light of the circumstances in which they are made, not
misleading.
(b) All
warranties and representations made herein or in any the Loan Documents by
Borrower will be true and accurate at the time Borrower requests Lender to make
a Loan to Borrower hereunder.
8.24
Intellectual Property
. Except
for Permitted Encumbrances, (1) the Borrower and each Subsidiary
holds all Intellectual Property that it owns free and clear of all Liens and
restrictions on use or transfer, whether or not recorded, and has sole title to
and ownership of or has the full, exclusive (subject to the rights of its
licensees) right to use in its field of business such Intellectual Property; and
the Borrower and each Subsidiary holds all Intellectual Property that it uses
but does not own under valid licenses or sub-licenses from others; (2) the use
of the Intellectual Property by the Borrower or any Subsidiary does not, to the
knowledge of the Borrower, violate or infringe on the rights of any other
Person; (3) neither the Borrower nor any Subsidiary has received any notice of
any conflict between the asserted rights of others and the Borrower or any
Subsidiary with respect to any Intellectual Property; (4) the Borrower and each
Subsidiary has used its commercially reasonable best efforts to protect its
rights in and to all Intellectual Property; (5) the Borrower and each Subsidiary
are in compliance with all material terms and conditions of its agreements
relating to the Intellectual Property; (6) neither the Borrower nor any
Subsidiary is, or since December 31, 2006 has been, a defendant in any action,
suit, investigation or proceeding relating to infringement or misappropriation
by the Borrower or any Subsidiary of any Intellectual Property nor has the
Borrower or any Subsidiary been notified of any alleged claim of infringement or
misappropriation by the Borrower or any Subsidiary of any Intellectual Property;
(7) to the knowledge of the Borrower, none of the products or services the
Borrower or any Subsidiary are researching, developing, propose to research and
develop, make, have made, use, or sell, infringes or misappropriates any
Intellectual Property right of any third party; (8) none of the trademarks and
service marks used by the Borrower or any Subsidiary, to the knowledge of the
Borrower, infringes the trademark or service mark rights of any third party; and
(9) to the Borrower’s knowledge, none of the material processes and formulae,
research and development results and other know-how relating to the Borrower's
or its Subsidiaries' respective businesses, the value of which to the Borrower
or any Subsidiary is contingent upon maintenance of the confidentiality thereof,
has been disclosed to any Person other than Persons bound by written
confidentiality agreements.
8.25
Employees
.
Neither the
Borrower nor any of its Subsidiaries has any collective bargaining agreements
with any of its employees. There is no labor union organizing
activity pending or, to the Borrower’s knowledge, threatened with respect to the
Borrower or any of its Subsidiaries. Except as disclosed in the SEC
Reports, neither the Borrower nor any of its Subsidiaries is a party to or bound
by any currently effective employment contract, deferred compensation
arrangement, bonus plan, incentive plan, profit sharing plan, retirement
agreement or other employee compensation plan or agreement. To the
Borrower’s knowledge, no employee of the Borrower or any of its Subsidiaries,
nor any consultant with whom the Borrower or any of its Subsidiaries has
contracted, is in violation of any material term of any employment contract or
any other contract relating to the right of any such individual to be employed
by, or to contract with, the Borrower or any of its Subsidiaries or to receive
any benefits; and, to the Borrower’s knowledge, the continued employment by the
Borrower or any of its Subsidiaries of its present employees, and the
performance of the Borrower’s and its Subsidiaries’ contracts with its
independent contractors, will not result in any such
violation. Except for employees who have a current effective
employment agreement with the Borrower or any of its Subsidiaries, no employee
of the Borrower or any of its Subsidiaries has been granted the right to
continued employment by the Borrower or any of its Subsidiaries or to any
material compensation following termination of employment with the Borrower or
any of its Subsidiaries. The Borrower is not aware that any officer,
director, manager, partner, key employee or group of employees intends to
terminate his, her or their employment with the Borrower or any of its
Subsidiaries, nor does the Borrower or any of its Subsidiaries have a present
intention to terminate any of the same.
8.26
Tax Status
. The
Borrower and each Subsidiary (i) has made or filed all federal and state income
and all other tax returns, reports and declarations required by any jurisdiction
to which it is subject, (ii) has paid all taxes and other governmental
assessments and charges that are shown or determined to be due on such returns,
reports and declarations, except those being contested in good faith and for
which it has set aside on its books a provision in the amount of such taxes
being contested in good faith and (iii) has set aside on its books provisions
reasonably adequate for the payment of all taxes for periods subsequent to the
periods to which such returns, reports or declarations apply. There
are no unpaid taxes claimed to be due by the taxing authority of any
jurisdiction, and the officers of the Borrower know of no basis for any such
claim.
8.27
Internal Accounting
Controls
.
The
Borrower maintains disclosure controls and procedures (as such term is defined
in Rule 13a-15 under the 1934 Act) that are effective in ensuring that
information required to be disclosed by the Borrower in the reports that it
files or submits under the 1934 Act is recorded, processed, summarized and
reported, within the time periods specified in the rules and forms of the SEC,
including, without limitation, controls and procedures designed to ensure that
information required to be disclosed by the Borrower in the reports that it
files or submits under the 1934 Act is accumulated and communicated to the
Borrower's management, including its principal executive officer or officers and
its principal financial officer or officers, as appropriate, to allow timely
decisions regarding required disclosure.
8.28
Sarbanes-Oxley
Act
.
The
Borrower is in compliance with any and all applicable requirements of the
Sarbanes-Oxley Act of 2002 that are effective as of the date hereof, and any and
all applicable rules and regulations promulgated by the SEC thereunder that are
effective as of the date hereof.
8.29
Indebtedness
. Attached
hereto as
Schedule 8.29
is a schedule of all Indebtedness of the Borrower, setting forth the principal
amount thereof, the interest rate, the maturity date and the security
therefor.
SECTION 9.
AFFIRMATIVE
COVENANTS.
Until
payment and satisfaction in full of all Obligations and the termination of this
Agreement, Borrower hereby covenants and agrees as follows:
9.1
Notify
Lender
. Borrower shall promptly, and in any event within three
(3) Business Days, inform Lender (a) if any one or more of the
representations and warranties made by Borrower in this Agreement or in any
document related hereto shall no longer be entirely true, accurate and complete
in any respect, (b) of any event or circumstance that, to its knowledge, would
cause Lender to consider any then existing Inventory as no longer constituting
Eligible Inventory; (c) of all material adverse information relating to the
financial condition of Borrower; (d) of any material return of goods; and (e) of
any loss, damage or destruction of any of the Collateral.
9.2
Pay Taxes and Liabilities; Comply
with Agreement
. Borrower shall promptly pay, when due, or
otherwise discharge, all indebtedness, sums and liabilities of any kind now or
hereafter owing by Borrower to any party however created, incurred, evidenced,
acquired, arising or payable, including without limitation the Obligations,
income taxes, excise taxes, sales and use taxes, license fees, and all other
taxes with respect to any of the Collateral, or any wages or salaries paid by
Borrower or otherwise, unless the validity of which are being contested in good
faith by Borrower by appropriate proceedings, provided that Borrower shall have
maintained reasonably adequate reserves and accrued the estimated liability on
Borrower's balance sheet for the payment of same.
9.3
Observe Covenants,
etc
. Borrower shall observe, perform and comply with the
covenants, terms and conditions of this Agreement, the Loan Documents and any
other agreement or document entered into between Borrower and
Lender.
9.4
Maintain Corporate Existence and
Qualifications
. Borrower shall maintain and preserve in full
force and effect, its corporate existence and rights, franchises, licenses and
qualifications necessary to continue its business, and comply with all
applicable statutes, rules and regulations pertaining to the operation, conduct
and maintenance of its existence and business including, without limitation, all
federal, state and local laws relating to benefit plans, environmental safety,
or health matters, and hazardous or liquid waste or chemicals or other liquids
(including use, sale, transport and disposal thereof).
9.5
Information and Documents to be
Furnished to Lender
. Borrower shall deliver or cause to be
delivered to Lender:
(a)
Annual Financial Statements
and
Projections.
Annual audited Financial Statements of the
Borrower within ninety (90) days after the end of Borrower’s Fiscal Year (which
period will be extended to one hundred five (105) days in the event that the
Borrower timely and properly files for an extension with the SEC in connection
with the filing of its Annual Report on From 10-K or 10-KSB) during the
Term. Such financial statements will (x) fairly present the financial
position of the Borrower as of the dates thereof and the results of its
operations, cash flows and stockholders’ equity for each of the periods then
ended in all material aspects; and (y) be prepared in accordance with
GAAP.
(b)
Quarterly Financial
Statements
. Quarterly Financial Statements of the Borrower no
later than forty-five (45) days after the close of each calendar quarter(which
period will be extended to fifty (50) days in the event that the Borrower timely
and properly files for an extension with the SEC in connection with the filing
of its Quarterly Report on From 10-Q or 10-QSB), the unaudited balance sheet and
the related statement of income of the Borrower, prepared in accordance with
GAAP, subject to year-end audit adjustments, together with such other
information with respect to the business of Borrower as Lender may
request.
(c)
Bi-Monthly Inventory Reconciliation
Report and Accounts Receivable Aging Report.
Not later than the 15
th
day and
the last day of each month of each calendar month, an Inventory reconciliation
report and accounts receivable aging report, each in form and substance
satisfactory to Lender.
(d)
Notice of Judgments, Environmental,
Health or Safety Complaints
.
(i) Within
ten (10) days thereafter, written notice to Lender of the entry of any judgment
or the institution of any lawsuit or of other legal or equitable proceedings or
the assertion of any crossclaim or counterclaim seeking monetary damages from
Borrower in an amount exceeding $25,000; and
(ii) Within
ten (10) days thereafter, notice or copies if written of all claims, complaints,
orders, citations or notices, whether formal or informal, written or oral, from
a governmental body or private person or entity, relating to air emissions,
water discharge, noise emission, solid or liquid waste disposal, hazardous waste
or materials, or any other environmental, health or safety matter, which
adversely effect Borrower. Such notices shall include, among other
information, the name of the party who filed the claim, the potential amount of
the claim, and the nature of the claim.
(e)
Other
Information
. Promptly upon demand therefor,
(i) Certificates
of insurance for all policies of insurance to be maintained by Borrower pursuant
hereto;
(ii) An
estoppel certificate executed by an authorized officer of Borrower indicating
that there then exists no Event of Default and no event which, with the giving
of notice or lapse of time, or both, would constitute an Event of
Default;
(iii) All
information received by Borrower affecting the financial status or condition of
any account debtor or the payment of any Account, including but not limited to,
invoices, original orders, shipping and delivery receipts; and
(iv) Assignments,
in form a
cceptable
to Lender, of all Accounts, and of the monies due or to become due on specific
contracts relating to the same.
(f)
Additional
Information
. From time to time, such other information as
Lender may reasonably request, including financial projections and cash flow
analysis.
Lender
acknowledges that Borrower is a publicly traded company. As such,
Lender agrees that it will not engage in the purchase or sale of the securities
of Borrower while in possession of material non-public information about the
Borrower.
9.6
Access to Records and
Property
. At any time and from time to time, upon reasonable
notice and during normal business hours, Borrower shall give any representatives
or designees of Lender reasonable access to its properties, and permit any of
them to, examine, audit, copy or make extracts from, any and all books, records
and documents in the possession of Borrower or any independent contractor
relating to Borrower's affairs and the Collateral, and to inspect any of its
properties wherever located, all at Borrower's expense. Notwithstanding the
foregoing, no such prior notice shall be required to be given in the event
Lender believes such access is necessary to preserve or protect the Collateral,
or following the occurrence and during the continuance of an Event of
Default.
9.7
Comply with
Laws
. Borrower shall comply with the requirements of all
applicable laws, rules, regulations and orders of any Governmental Authority,
compliance with which is necessary to maintain its corporate existence or the
conduct of its business or non-compliance with which would adversely affect in
any respect its ability to perform its obligations or any security given to
secure its obligations.
9.8
Insurance
Required
.
(g) Borrower
shall cause to be maintained, in full force and effect on all property of
Borrower including, without limitation, all Inventory and Equipment, insurance
in such amounts against such risks as is satisfactory to Lender, including, but
without limitation, business interruption, fire, boiler, theft, burglary,
pilferage, vandalism, malicious mischief, loss in transit, and hazard insurance
and, if as of the date hereof, any of the real property of Borrower
is in an area that has been identified by the Secretary of Housing and Urban
Development as having special flood or mudslide hazards, and on which the sale
of flood insurance has been made available under the National Flood Insurance
Act of 1968, then Borrower shall maintain flood insurance.
Said policy or policies
shall:
(i) Be
in a form and with insurers which are satisfactory to Lender;
(ii) Be
for such risks, and for such insured values as Lender or its assigns may require
in order to replace the property in the event of actual or constructive total
loss;
(iii) Designate
Lender and its assignees as additional insureds and loss payees as their
interests may from time to time appear;
(iv) Contain
a "breach of warranty clause" whereby the insurer agrees that a breach of the
insuring conditions or any negligence by Borrower or any other person shall not
invalidate the insurance as to Lender and its assignee;
(v) Provide
that they may not be canceled or altered without thirty (30) days prior written
notice to Lender and its assigns; and
(vi) Upon
demand, be delivered to Lender.
(h) Borrower
shall obtain such additional insurance as Lender may reasonably
require.
(i) Borrower
shall, in the event of loss or damage, forthwith notify Lender and file proofs
of loss with the appropriate insurer. Borrower hereby authorizes
Lender to endorse any checks or drafts constituting insurance
proceeds.
(j)
Borrower shall
forthwith upon receipt of insurance proceeds endorse and deliver the same to
Lender.
(k) In
no event shall Lender be required either to (i) ascertain the existence of or
examine any insurance policy or (iiii) advise Borrower in the event such
insurance coverage shall not comply with the requirements of this
Agreement.
9.9
Condition of Collateral; No
Liens
. Borrower shall maintain all Collateral in good
condition and repair at all times, and preserve it against any loss, damage, or
destruction of any nature whatsoever relating to said Collateral or its use, and
keep said Collateral free and clear of any Liens, except for the Permitted
Encumbrances.
9.10
Payment of
Proceeds
. Borrower shall forthwith upon receipt of all
proceeds of Collateral, pay such proceeds (insurance or otherwise) over to
Lender for application against the Obligations in such order and manner as
Lender may elect.
9.11
Records
. Borrower
shall at all times keep accurate and complete records of its operations, of the
Collateral and the status of each Account, which records shall be maintained at
its executive offices as set forth on
Exhibit
E
.
9.12
Equipment
. Borrower shall
maintain is Equipment in good operating condition, subject to ordinary wear and
tear, and shall not permit such Equipment to become a fixture to real estate or
accessions to other personal property.
9.13
Delivery of
Documents
. If any proceeds of Accounts shall include, or any
of the Accounts shall be evidenced by, notes, trade acceptances or instruments
or documents, or if any Inventory is covered by documents of title or chattel
paper, whether or not negotiable, then Borrower waives protest regardless of the
form of the endorsement. If Borrower fails to endorse any instrument
or document, Lender is authorized to endorse it on Borrower's
behalf.
9.14
United States
Contracts
. If any of the Accounts arise out of contracts with
the United States or any of its departments, agencies or instrumentalities,
Borrower will notify Lender, if requested by Lender, and execute any necessary
instruments in order that all monies due or to become due under such contract
shall be assigned to Lender and proper notice of the assignment given under the
Federal Assignment of Claims Act.
9.15
Name Changes; Location
Changes
.
(a) Borrower
shall promptly notify Lender if Borrower is known by or conducting business
under any names other than those set forth in this Agreement; and
(b) Borrower
shall deliver not less than thirty (30) Business Days prior written notice to
Lender if Borrower intends to conduct any of its business or operations at or
out of offices or locations other than those set forth in this Agreement, or if
it changes the location of its chief executive office or the address at which it
maintains its books and records or the location of any of the
Collateral.
9.16
Further
Assurances
. Borrower shall at any time or from time to time
upon request of Lender take such steps and execute and deliver such Financing
Statements and other documents all in the form of substance satisfactory to
Lender relating to the creation, validity or perfection of the security
interests provided for herein, under the UCC or other laws of the State of New
York
or of another
state or states in which the Collateral is located or which are reasonably
necessary to effectuate the purposes and provisions of this Agreement.
Borrower shall defend the right, title and interest of Lender in and
to the Collateral against the claims and demands of all Persons whomsoever, and
take such actions, including (i) all actions necessary to grant Lender “control”
of any Investment Property, Deposit Accounts, Letter-of-Credit Rights or
electronic Chattel Paper owned by it, with any agreements establishing control
to be in form and substance satisfactory to Lender, (ii) the prompt (but in no
event later than five (5) Business Days following Lender’s request therefor)
delivery to Lender of all original Instruments, Chattel Paper, negotiable
Documents and certificated securities owned by it (in each case, accompanied by
stock powers, allonges or other instruments of transfer executed in blank),
(iii) notification of Lender’s interest in Collateral at Lender’s request, and
(iv) the institution of litigation against third parties as shall be prudent in
order to protect and preserve its and/or Lender’s respective and several
interests in the Collateral.
9.17
SEC Reporting
Status.
Borrower shall timely file all reports required to be
filed with the SEC pursuant to Section 13 or 15(d) of the 1934 Act, and the
Borrower shall not terminate its status as an issuer required to file reports
under the 1934 Act even if the 1934 Act or the rules and regulations thereunder
would permit such termination.
9.18
Indemnification
. Borrower
shall indemnify, protect, defend and save harmless Lender, as well as Lender's
directors, officers, trustees, employees, agents, attorneys, members and
shareholders (hereinafter referred to collectively as the "
Indemnified Parties
" and
individually as an
"Indemnified
Party"
) from and against any and all losses, damages, expenses or
liabilities of any kind or nature (collectively, “
Damages
”) and from any suits,
claims or demands, by third parties, including reasonable counsel fees incurred
in investigating or defending such claim, suffered by any of them and caused by,
relating to, arising out of, resulting from, or in any way connected with the
Loans and the transactions contemplated herein,
provided
,
however
, the Borrower
shall not be liable to the Lender to the extent that any
such Damages arise out of or are based on the gross negligence of the
Lender.. In case any action shall be brought against an Indemnified Party based
upon any of the above and in respect to which indemnity may be sought against
Borrower, the Indemnified Party against whom such action was brought shall
promptly notify Borrower in writing, and Borrower shall assume the defense
thereof, including the employment of counsel selected by Borrower and reasonably
satisfactory to the Indemnified Party, the payment of all costs and expenses and
the right to negotiate and consent to settlement. Upon reasonable
determination made by the Indemnified Party, the Indemnified Party shall have
the right to employ separate counsel in any such action and to participate in
the defense thereof; provided, however that the Indemnified Party shall pay the
costs and expenses incurred in connection with the employment of separate
counsel. Borrower shall not be liable for any settlement of any such
action effected without its consent, but if settled with Borrower's consent, or
if there be a final judgment for the claimant in any such action, Borrower
agrees to indemnify and save harmless said Indemnified Party against whom such
action was brought from and against any loss or liability by reason of such
settlement or judgment, except as otherwise provided above. The provisions of
this Section shall survive the termination of this Agreement and the final
repayment of the Obligations.
SECTION 10.
NEGATIVE
COVENANTS.
Until
payment and satisfaction in full of all Obligations and the termination of this
Agreement, Borrower hereby covenants and agrees as follows:
10.1
Fundamental Transactions; No Creation
of Subsidiaries
.
(a)
Borrower will not engage in or be a party to a Fundamental Transaction (as
defined below) unless all of the following conditions are met:
(i)
Lender shall have been afforded the opportunity, if Lender so elects, to convert
all outstanding Indebtedness of Borrower hereunder into Common Stock of Borrower
prior to, or at the closing of (such conversion date to be selected by Lender),
the Fundamental Transaction in accordance with the terms of the Note Conversion
Agreement; and
(ii)
Lender shall have received payment in full of all outstanding Obligations no
later than the date of the closing of the Fundamental Transaction, to the extent
not converted into Common Stock, together with such releases and related
documentation as Lender shall reasonably request.
“Fundamental
Transaction” means
(i) Any
consolidation or merger of the Borrower with or into another entity where the
stockholders of the Borrower immediately prior to such transaction do not
collectively own at least 51% of the outstanding voting securities of the
surviving corporation of such consolidation or merger immediately following such
transaction; or the sale of all or substantially all of the assets of the
Borrower in a single transaction or a series of related transactions;
or
(ii) The
occurrence of any transaction or event in connection with which all or
substantially all the Common Stock shall be exchanged for, converted into,
acquired for or constitute the right to receive consideration (whether by means
of an exchange offer, liquidation, tender offer, consolidation, merger,
combination, reclassification, recapitalization or otherwise) which is not all
or substantially all common stock which is (or will, upon consummation of or
immediately following such transaction or event, will be) listed on a national
securities exchange or approved for quotation on Nasdaq or any similar United
States system of automated dissemination of transaction reporting of securities
prices, including the OTC Bulletin Board; or
(iii) The
acquisition by a Person or entity or group of Persons or entities acting in
concert as a partnership, limited partnership, syndicate or group, as a result
of a tender or exchange offer, open market purchases, privately negotiated
purchases or otherwise, of beneficial ownership of securities of the Borrower
representing 50% or more of the combined voting power of the
outstanding voting securities of the Borrower ordinarily (and apart from rights
accruing in special circumstances) having the right to vote in the election of
directors.
(b)
Borrower will not create or permit to exist any Subsidiary, other than Virtual
Vision, Inc., which Subsidiary is dormant, unless such new Subsidiary is a
wholly-owned Subsidiary and is designated by Lender as either a co-borrower or
guarantor hereunder and such Subsidiary shall have entered into all such
documentation required by Lender, including, without limitation, to grant to
Lender a first priority perfected security interest in substantially all of such
Subsidiary’s assets to secure the Obligations.
10.2
Disposition of Assets or
Collateral
. Borrower will not sell, lease, transfer, convey,
or otherwise dispose of any or all of its assets or Collateral, other than (a)
the sale of Inventory in the ordinary course of business, and (b) the
disposition or transfer in the ordinary course of business during any fiscal
year of obsolete and worn-out Equipment having an aggregate fair market value of
not more than $25,000 and only to the extent that the proceeds of any such
disposition are used to acquire replacement Equipment which is subject to
Lender’s first priority security interest or are used to repay Loans.
Notwithstanding the foregoing, Borrower shall be permitted to dispose
of assets other than Accounts and Inventory in a transaction that
does not constitute a Fundamental Transaction under Section 10.1 hereof,
provided that all of the following conditions are met: (i) Borrower
shall have provided Lender with not less than fifteen (15) days’
prior written notice of such proposed asset sale, describing in reasonable
detail the assets to be sold and the consideration to be received therefor, (ii)
the net proceeds of such transaction are used to redeem Indebtedness represented
by any outstanding and unpaid Loans, and (iii) Lender shall have determined, in
its reasonable commercial judgment, that such asset sale will not impair
Lender’s rights in its remaining Collateral or its prospect of repayment
hereunder.
10.3
Other
Liens
. Borrower will not incur, create or permit to exist any
Lien on any of its property or assets, whether now owned or hereafter acquired,
except (a) those Liens in favor of Lender created by this Agreement and the
other Loan Documents; and (b) for the Permitted Encumbrances.
10.4
Other
Liabilities
. Borrower will not incur, create, assume, or
permit to exist, any Indebtedness or liability on account of either borrowed
money or the deferred purchase price of property, except (a) Obligations to
Lender, (b) the Convertible Notes or (c) Indebtedness constituting Subordinated
Debt or incurred in connection with any of the Permitted
Encumbrances.
10.5
Loans
. Borrower
will not make any loans to any Person, other than advances to employees of
Borrower in the ordinary course of business, with outstanding advances to any
employee not to exceed $2,500 at any time.
10.6
Guaranties
. Borrower
will not assume, guaranty, endorse, contingently agree to purchase or otherwise
become liable upon the obligation of any Person, except by the endorsement of
negotiable instruments for deposit or collection or similar transactions in the
ordinary course of business.
10.7
Remove
Property
. Borrower will not remove, or cause or permit to be
removed, without Lender's prior written consent, any of its Collateral or assets
from those locations set forth on
Exhibit
E
annexed hereto, except for sales of Inventory in the ordinary course of
Borrower's business.
10.8
Transfers of Notes or
Accounts
. Borrower will not sell, assign, transfer, discount
or otherwise dispose of any Accounts or any promissory note payable to it, with
or without recourse, except for the Lien of Lender therein.
10.9
Dividends
. Borrower
will not declare or pay any cash dividend, make any distribution on, redeem,
retire or otherwise acquire directly or indirectly, any shares of its stock or
other equity interests without the prior written consent of Lender, except as
set forth in
Section
10.9
of Borrower’s Disclosure Schedule.
10.10
Payments to Affiliates
. Except
as set forth in
Section
10.10
of the Borrower’s Disclosure Schedule, or as otherwise
approved by Lender in writing in advance, Borrower shall not make any payments
of cash or other property to any Affiliate.
10.11
Modification of
Documents
. Borrower will not change, alter or modify, or
permit any change, alteration or modification of its certificate of
incorporation, by-laws or other governing documents without Lender's prior
written consent.
10.12
Change Business or
Name
. Borrower will not change or alter the nature of its
business, or change its name as it appears in the official filings of its state
of organization.
10.13
Settlements
. Other
than in the ordinary course of its business, Borrower will not comprise, settle
or adjust any claims in any amount relating to any of the Collateral, without
the prior written consent of Lender.
10.14
Bank
Accounts
. Section 10.14 of the Borrower’s Disclosure Schedule
lists all banks and other financial institutions at which Borrower maintains
deposits and/or other accounts, and correctly identifies the name, address and
telephone number of each such depository, the name in which the account is held,
a description of the purpose of the account, and the complete account
number. Borrower shall not establish any depository or other bank
account with any financial institution (other than the accounts set forth in
Section 10.14 of the Borrower’s Disclosure Schedule) without Lender’s prior
written consent.
10.15
Convertible Note
Documentation. W
ithout the prior written consent of Lender,
Borrower shall not (a) amend, modify or in any way alter the terms of any of the
Convertible Note Documentation, other than with respect to changes or
corrections solely of a ministerial nature that have no adverse effect on
Lender’s rights or obligations hereunder and no adverse effect on the status or
priority of lender’s Lien hereunder, or (b) make any payments in respect of the
indebtedness evidenced by the Convertible Note Documentation.
SECTION 11.
EVENTS OF
DEFAULT.
The
occurrence of any of the following shall constitute an event of default
(hereinafter referred to as an
"Event of
Default"
):
11.1
Failure to Pay
. The
failure by Borrower to pay, when due, (a) any payment of principal, interest or
other charges due and owing to Lender pursuant to any obligations of Borrower to
Lender including, without limitation, those Obligations arising pursuant to this
Agreement or any Loan Document, or under any other agreement for the payment of
monies then due and payable to Lender, or (b) any taxes due to any Governmental
Authority.
11.2
Failure of
Insurance
. Failure of one or more of the insurance policies
required hereunder to remain in full force and effect; failure on the part of
Borrower to pay or cause to be paid all premiums when due on the insurance
policies pursuant to this Agreement; failure on the part of Borrower to take
such other action as may be requested by Lender in order to keep said policies
of insurance in full force and effect until the entire indebtedness represented
by the Loan Documents, and interest thereon, has been paid in full; and failure
on the part of Borrower to execute any and all documentation required by the
insurance companies issuing said policies to effectuate said
assignments.
11.3
Failure to
Perform
. Borrower's failure to perform or observe any
covenant, term or condition of Section 9 of this Agreement (Affirmative
Covenants) to be performed or observed by Borrower, and such failure shall
continue unremedied for a period of ten (10) Business Days from the date of such
failure (irrespective of whether Lender delivers written notice thereof to
Borrower),
provided
,
however
, that such
cure period shall not apply to a breach which is incapable of cure within said
10-Business Day period; and
provided
further
, that such
cure period shall be five (5) Business Days for a breach of Section 9.5(c)
(Monthly Inventory Reconciliation Report); and
provided
further
, that such
cure period shall not apply to any payment of principal, interest or other
charges due and owing to Lender.
11.4
Cross Default
. The occurrence
of any Event of Default on any of the Obligations or an Event of Default under
any Loan Document, or an event of default under the Convertible Notes which has
not been waived or cured.
11.5
False Representation or
Warranty
. Borrower shall have made any statement,
representation or warranty in this Agreement or in any of the other Loan
Documents to which it is a party or in a certificate executed by Borrower
incident to this Agreement, which is at any time found to have been false in any
respect at the time such representation or warranty was made.
11.6
Liquidation, Voluntary Bankruptcy,
Dissolution, Assignment to Creditors
. Any resolution shall be
passed or any action (including a meeting of creditors) shall be taken by
Borrower for the termination, winding up, liquidation or dissolution of
Borrower, or Borrower shall make an assignment for the benefit of creditors,
become insolvent or be unable to pay its debts as they mature, or Borrower shall
file a petition in voluntary liquidation or bankruptcy, or Borrower shall file a
petition or answer or consent seeking, or consenting to, the reorganization of
Borrower or the readjustment of any of the indebtedness of Borrower under any
applicable insolvency or bankruptcy laws now or hereafter existing (including
the United States Bankruptcy Code), or Borrower shall consent to the appointment
of any receiver, administrator, liquidator, custodian or trustee of all or any
part of the property or assets of Borrower or any corporate action shall be
taken by Borrower for the purposes of effecting any of the
foregoing.
11.7
Involuntary Petition Against Borrower
. Any petition or application for any relief is filed against
Borrower under applicable insolvency or bankruptcy laws now or hereafter
existing (including the United States Bankruptcy Code) or under any insolvency,
reorganization, receivership, readjustment of debt, dissolution or liquidation
law or statute of any jurisdiction now or hereafter in effect (whether at law or
in equity), and is not discharged or stayed within thirty (30) days of the
filing thereof.
11.8
Judgments;
Levies
. Any judgment or judgments aggregating in excess of
$25,000 or any injunction or attachment is obtained against Borrower which
remains unstayed or unsatisfied for a period of fifteen
(15) days or is enforced.
11.9
Change in
Condition
. There occurs any event or a change in the condition
or affairs, financial or otherwise, of Borrower which, in the reasonable opinion
of Lender, impairs Lender's security or ability of Borrower to discharge its
obligations hereunder or which impairs the rights of Lender in such
Collateral.
11.10
[RESERVED]
11.11
Failure to
Notify
. If at any time Borrower fails to provide Lender
immediately with notice or copies, if written, of all complaints, orders,
citations or notices with respect to environmental, health or safety
complaints.
11.12
Failure to Deliver
Documentation
. Borrower shall fail to obtain and deliver to
Lender any other documentation required to be signed or obtained as part of this
Agreement, or shall have failed to take any reasonable action requested by
Lender to perfect, protect, preserve and maintain the security interests and
Lien on the Collateral provided for herein.
11.13
Non-Payment of
Debts
. Any default by Borrower under any agreement, document
or instrument relating to any indebtedness for borrowed money owing to any
person other than Lender, or any capitalized lease obligations, contingent
indebtedness in connection with any guarantee, letter of credit, indemnity or
similar type of instrument in favor of any person other than Lender, in any case
in an amount in excess of $50,000, which default continues unwaived for more
than the applicable cure period, if any, with respect thereto, or any default by
Borrower under any contract, lease, license or other obligation to any Person
other than Lender, which affects its business or the Collateral or other
property which is security for the Obligations and which default continues for
more than the applicable cure period, if any, with respect thereto.
11.14
Dissolution; Maintenance of
Existence
. Borrower is dissolved, or Borrower fails to
maintain its corporate existence in good standing, or the usual business of
Borrower ceases or is suspended in any respect.
11.15
Indictment
. The
indictment of Borrower or any director or Responsible Officer of Borrower under
any criminal statute, or commencement of criminal or civil proceedings against
Borrower, pursuant to which statute or proceedings the penalties or remedies
sought or available include forfeiture of any portion of the property of
Borrower.
11.16
Tax Liens
. The
filing of a Lien for any unpaid taxes filed by any Governmental Authority
against Borrower or any of its assets.
11.17
Challenge to Validity of Loan
Documents
. Borrower attempts to terminate, challenges the
validity of, or its liability under this Agreement or any other Loan Document,
or any proceeding shall be brought to challenge the validity, binding effect of
Loan Document, or any Loan Document ceases to be a valid, binding and
enforceable obligation of the Borrower (to the extent such Person is a party
thereto).
11.18
Trading of Common
Stock
.
(a) Sales
of Common Stock owned by Lender cannot be made pursuant to the Borrower’s
Registration Statement of Form S-1, to be filed with the SEC by reason of a stop
order, any untrue statement of a material fact or omission of a material fact in
such Registration Statement, or the Borrower’s failure to update such
Registration Statement, or otherwise on account of Borrower’s noncompliance with
the terms of the Registration Rights Agreement, unless such Common Stock may be
publicly resold by Lender without restriction under Rule 144 promulgated under
the Securities Act of 1933, as amended, and Lender shall have received an
opinion of counsel to Borrower as may be necessary or requested by Lender to
allow such resales, provided the Borrower and its counsel receive reasonably
requested representations from Lender and its broker, if any; or
(b) The
Common Stock ceases to be included for quotation on the OTC Bulletin
Board.
SECTION 12.
REMEDIES.
12.1
Acceleration; Other
Remedies
. Upon the occurrence of an Event of Default and at
any time thereafter:
(a) Lender
shall have all rights and remedies provided in this Agreement, any of the other
Loan Documents, the UCC or other applicable law, all of which rights and
remedies may be exercised without notice to Borrower, all such notices being
hereby waived, except such notice as is expressly provided for hereunder or is
not waivable under applicable law. All rights and remedies of Lender
are cumulative and not exclusive and are enforceable, in Lender's discretion,
alternatively, successively, or concurrently on any one or more occasions and in
any order Lender may determine. Without limiting the foregoing,
Lender may (i) accelerate the payment of all Obligations and demand immediate
payment thereof to Lender, (ii) with or without judicial process or the aid or
assistance of others, enter upon any premises on or in which any of the
Collateral may be located and take possession of the Collateral or complete
processing, manufacturing and repair of all or any portion of the Collateral,
(iii) require Borrower, at Borrower's expense, to assemble and make
available to Lender any part or all of the Collateral at any place and time
designated by Lender, (iv) collect, foreclose, receive, appropriate, setoff and
realize upon any and all Collateral, subject to the rights of the Convertible
Noteholders in accordance with the terms of the Intercreditor Agreement, (v)
extend the time of payment of, compromise or settle for cash, credit, return of
merchandise, and upon any terms or conditions, any and all Accounts or other
Collateral which includes a monetary obligation and discharge or release the
account debtor or other obligor, without affecting any of the Obligations, (vi)
sell, lease, transfer, assign, deliver or otherwise dispose of any and all
Collateral (including, without limitation, entering into contracts with respect
thereto, by public or private sales at any exchange, broker's board, any office
of Lender or elsewhere) at such prices or terms as Lender may deem reasonable,
for cash, upon credit or for future delivery, with Lender having the right to
purchase the whole or any part of the Collateral at any such public sale, all of
the foregoing being free from any right or equity of redemption of Borrower,
which right or equity of redemption is hereby expressly waived and released by
Borrower. If any of the Collateral or other security the Obligations
is sold or leased by Lender upon credit terms or for future delivery, the
Obligations shall not be reduced as a result thereof until payment therefor is
finally collected by Lender. If notice of disposition of Collateral
is required by law, ten (10) days prior notice by Lender to Borrower designating
the time and place of any public sale or the time after which any private sale
or other intended disposition of Collateral is to be made, shall be deemed to be
reasonable notice thereof and Borrower waives any other notice. In
the event Lender institutes an action to recover any Collateral or seeks
recovery of any Collateral by way of prejudgment remedy, Borrower waives the
posting of any bond which might otherwise be required.
(b) Lender
may apply the cash proceeds of Collateral or other security for the Obligations
actually received by Lender from any sale, lease, foreclosure or other
disposition of the Collateral to payment of any of the Obligations, in whole or
in part (including attorneys' fees and legal expenses incurred by Lender with
respect thereto or otherwise chargeable to Borrower) and in such order as Lender
may elect, whether or not then due. Borrower shall remain liable to
Lender for the payment on demand of any deficiency together with interest at the
highest rate provided for herein and all costs and expenses of collection or
enforcement, including reasonable attorneys' fees and legal
expenses.
(c) If
Borrower shall default in the performance of any of the provisions of this
Agreement or any other Loan Document to which it is a party, Lender may (but
without any obligation to do so) perform same for Borrower's account and any
monies expended in doing so shall be chargeable with interest to Borrower,
repayable by Borrower on demand and added to the Obligations.
(d) Lender
may, at its option, cure any default by Borrower under any agreement with a
third party or pay or bond on appeal any judgment entered against Borrower,
discharge taxes, Liens at any time levied on or existing with respect to the
Collateral and pay any amount, incur any expense or perform any act which, in
Lender's sole judgment, is necessary or appropriate to preserve, protect,
insure, maintain, or realize upon the Collateral. Lender may charge
Borrower's loan account for any amounts so expended, such amounts to be
repayable by Borrower on demand. Lender shall be under no obligation
to effect such cure, payment, bonding or discharge, and shall not, by doing so,
be deemed to have assumed any obligation or liability of Borrower.
(e) Borrower
hereby grants to Lender an irrevocable, non-exclusive license, to the extent not
prohibited by Convertible Notes Documentation and subject to the rights of the
Convertible Noteholders in accordance with the terms of the Intercreditor
Agreement, exercisable due to an occurrence and during the continuance of an
Event of Default without payment of royalty or other compensation to Borrower,
to use, transfer, license or sublicense any Intellectual Property now owned,
licensed to, or hereafter acquired by Borrower, and wherever the same may be
located, and including in such license access to all media in which any of the
licensed items may be recorded or stored and to all computer and automatic
machinery software and programs used for the compilation or printout thereof,
and represents, promises and agrees that any such license or sublicense is not
and will not be in conflict with the contractual or commercial rights of any
third Person; provided, that such license will terminate upon the payment in
full of all Obligations.
12.2
Set-off
. Lender
shall have the right, immediately and without notice of other action, to set-off
against any of Borrower's liabilities to Lender any money or other liability
owed by Lender or any Affiliate of Lender (and such Affiliate of Lender is
hereby authorized to effect such set-off) in any capacity to Borrower, whether
or not due, and Lender or such Affiliate shall be deemed to have exercised such
right of set-off and to have made a charge against any such money or other
liability immediately upon the occurrence of such Event of Default even though
the actual book entries may be made at a time subsequent thereto. The
right of set-off granted hereunder shall be effective irrespective of whether
Lender shall have made demand under or in connection with the
Loan. Lender is hereby granted a security interest in all money and
property of Borrower being held by it or any Affiliate of Lender, which security
interest shall be a first priority perfected security interest in favor of
Lender as a result of Lender's or Affiliates of Lender's possession
thereof. None of the rights of Lender described in this Section 12.2
are intended to diminish or limit in any way Lender's or Affiliates of Lender's
common-law set-off rights.
12.3
Costs and
Expenses
. Borrower shall be liable for all reasonable costs,
charges and expenses, including attorney's fees and disbursements, incurred by
Lender by reason of the occurrence of any Event of Default or the exercise of
Lender's remedies with respect thereto, each of which shall be repayable by
Borrower on demand with interest, and added to the Obligations.
12.4
No
Marshalling
. Lender shall be under no obligation whatsoever to
proceed first against any of the Collateral or other property which is security
for the Obligations before proceeding against any other of the
Collateral. It is expressly understood and agreed that all of the
Collateral or other property which is security for the Obligations stands as
equal security for all Obligations, and that Lender shall have the right to
proceed against any or all of the Collateral or other property which is security
for the Obligations in any order, or simultaneously, as in its sole and absolute
discretion it shall determine. It is further understood and agreed
that Lender shall have the right, as it in its sole and absolute discretion
shall determine, to sell any or all of the Collateral or other property which is
security for the Obligations in any order or simultaneously, as Lender shall
determine in its sole and absolute discretion.
12.5
No Implied Waivers; Rights
Cumulative
. No delay on the part of Lender in exercising any
right, remedy, power or privilege hereunder or under any of the Loan Documents
or provided by statute or at law or in equity or otherwise shall impair,
prejudice or constitute a waiver of any such right, remedy, power or privilege
or be construed as a waiver of any Event of Default or as an acquiescence
therein. No right, remedy, power or privilege conferred on or
reserved to Lender hereunder or under any of the Loan Documents or otherwise is
intended to be exclusive of any other right, remedy, power or
privilege. Each and every right, remedy, power or privilege conferred
on or reserved to Lender under this Agreement or under any of the other Loan
Documents or otherwise shall be cumulative and in addition to each and every
other right, remedy, power or privilege so conferred on or reserved to Lender
and may be exercised by Lender at such time or times and in such order and
manner as Lender shall (in its sole and complete discretion) deem
expedient.
SECTION 13.
OTHER RIGHTS OF
LENDER.
13.1
Collections
.
Subject to the rights of
the Convertible Noteholders under the Intercreditor Agreement, Borrower is
authorized to collect the Accounts and any other monetary obligations included
in, or proceeds of, the Collateral on behalf of and in trust for Lender, at
Borrower's expense, but such authority shall, at Lender's option, automatically
terminate upon the occurrence of an Event of Default. Lender may
modify or terminate such authority at any time whether or not an Event of
Default has occurred and directly collect the Accounts and other monetary
obligations included in the Collateral. Borrower shall, at Borrower's
expense and in the manner requested by Lender from time to time, direct that
remittances and all other proceeds of accounts and other Collateral shall be (a)
remitted in kind to Lender, (b) sent to a post office box designated
by and/or in the name of Lender, or in the name of Borrower, but as to which
access is limited to Lender and/or (c) deposited into a bank account
maintained in the name of Lender and/or a blocked bank account under
arrangements with the depository bank under which all funds deposited to such
blocked bank account are required to be transferred solely to
Lender. In connection therewith, Borrower shall execute such post
office box and/or blocked bank account agreements as Lender shall
specify.
13.2
Repayment of
Obligations
. All Obligations shall be payable at Lender's
office set forth below or at a bank or such other place as Lender may expressly
designate from time to time for purposes of this Section. Lender
shall apply all proceeds of Accounts or other Collateral received by Lender and
all other payments in respect of the Obligations to the Loans whether or not
then due or to any other Obligations then due, in whatever order or manner
Lender shall determine.
13.3
Lender Appointed
Attorney-in-Fact
.
(a) Borrower
hereby irrevocably constitutes and appoints Lender, with full power of
substitution, as its true and lawful attorney-in-fact, with full irrevocable
power and authority in its place and stead and in its name or otherwise, from
time to time in Lender's discretion, at Borrower's sole cost and expense, to
take any and all appropriate action and to execute and deliver any and all
documents and instruments which Lender may deem reasonably necessary or
advisable to accomplish the purposes of this Agreement, including, without
limiting the generality of the foregoing, (i) at any time any of the Obligations
are outstanding, (A) to transmit to account debtors, other obligors or any
bailees notice of the interest of Lender in the Collateral or request from
account debtors or such other obligors or bailees at any time, in the name of
Borrower or Lender or any designee of Lender, information concerning the
Collateral and any amounts owing with respect thereto; (B) to execute in the
name of Borrower and file against Borrower in favor of Lender Financing
Statements or amendments with respect to the Collateral, or record a copy or an
excerpt hereof in the United States Copyright Office or the United States Patent
and Trademark Office and to take all other steps as are necessary in the
reasonable opinion of Lender under applicable law to perfect the security
interests granted herein; (C) to obtain and adjust insurance required pursuant
to this Agreement and to pay all or any part of the premiums therefor and the
costs thereof, and (D) to pay or discharge taxes, Liens, security interests or
other encumbrances levied or placed on or threatened against the Collateral;
(ii) after and during the continuation of an Event of Default, (A) to receive,
take, endorse, assign, deliver, accept and deposit, in the name of Lender or
Borrower, any and all cash, checks, commercial paper, drafts, remittances and
other instruments and documents relating to the Collateral or the proceeds
thereof, (B) to notify account debtors or other obligors to make payment
directly to Lender, or notify bailees as to the disposition of Collateral, (C)
to change the address for delivery of mail to Borrower and to receive and open
mail addressed to Borrower, (D) take or bring, in the name of Lender or
Borrower, all steps, actions, suits or proceedings deemed by Lender necessary or
desirable to effect collection of or other realization upon the Collateral; and
(E) to extend the time of payment of, compromise or settle for cash, credit,
return of merchandise, and upon any terms or conditions, any and all accounts or
other Collateral which includes a monetary obligation and discharge or release
the account debtor or other obligor, without affecting any of the
Obligations.
(b) Borrower
hereby ratifies, to the extent permitted by law, all that Lender shall lawfully
and in good faith do or cause to be done by virtue of and in compliance with
this Agreement. The powers of attorney granted pursuant to this
Agreement are each a power coupled with an interest and shall be irrevocable
until the Obligations are paid indefeasibly in fully.
13.4
Release of
Lender
. In no event will Lender have any liability
to Borrower for lost profits or other special or consequential
damages.
13.5
Uniform Commercial
Code
. At all times prior and subsequent to an Event of Default
hereinafter, Lender shall be entitled to all the rights and remedies of a
secured party under the UCC with respect to all Collateral.
13.6
Preservation of
Collateral
. At all times prior and subsequent to an Event of
Default hereinafter, Lender may (but without any obligation to do so) take any
and all action which in its sole and absolute discretion is necessary and proper
to preserve its interest in the Collateral, including without limitation the
payment of debts of Borrower which might, in Lender's sole and absolute
discretion, impair the Collateral or Lender's security interest therein,
purchasing insurance on the Collateral, repairing the Collateral, or paying
taxes or assessments thereon, and the sums so expended by Lender shall be
secured by the Collateral, shall be added to the amount of the Obligations due
Lender and shall be payable on demand with interest at the rate set forth in
Section 3.1 hereof from the date expended by Lender until repaid by
Borrower. After written notice by Lender to Borrower and
automatically, without notice, after an Event of Default, Borrower shall not,
without the prior written consent of Lender in each instance, (a) grant any
extension of time of payment of any of the accounts or any other Collateral
which includes a monetary obligation, (b) compromise or settle any of the
accounts or any such other Collateral for less than the full amount thereof, (c)
release in whole or in part any account debtor or other person liable for the
payment of any of the accounts or any such other Collateral, or (d) grant
any credits, discounts, allowances, deductions, return authorizations or the
like with respect to any of the accounts or any such other
Collateral.
13.7
Lender's Right to
Cure
. In the event Borrower shall fail to perform any of its
Obligations hereunder or under any of the Loan Documents, then Lender, in
addition to all of its rights and remedies hereunder, may perform the same, but
shall not be obligated to do so, at the cost and expense of
Borrower. In any such event, Borrower shall promptly reimburse Lender
together with interest at the rate set forth in
Section 3.1 hereof from the date such sums are expended until
repaid by Borrower.
13.8
Inspection of
Collateral
. From time to time as requested by Lender, at the
sole expense of Borrower in accordance with Section 3.4, Lender or its designee
shall have access, prior to an Event of Default during reasonable business hours
and on or after an Event of Default at any time, to all of the premises where
Collateral is located for the purposes of inspecting, disposing and realizing
upon the Collateral, and all Borrower's books and records, and Borrower shall
permit Lender or its designee to make such copies of such books and records or
extracts therefrom as Lender may request. Without expense to Lender,
Lender may use such of Borrower's personnel, equipment, including computer
equipment, programs, printed output and computer readable media, supplies and
premises for the collection of Accounts and realization on other Collateral as
Lender, in its sole discretion, deems appropriate. Borrower hereby
irrevocably authorizes all accountants and third parties to disclose and deliver
to Lender at Borrower's expense all financial information, books and records,
work papers, management reports and other information in their possession
regarding Borrower.
SECTION 14.
PROVISIONS OF GENERAL
APPLICATION.
14.1
Waivers
. Borrower
waives demand, presentment, notice of dishonor protest and notice of
protest of any instrument either of Borrower or others which may be included in
the Collateral.
14.2
Survival
. All
covenants, agreements, representations and warranties made by Borrower herein or
in any of the Loan Documents or in any certificate, report or instrument
contemplated hereby shall survive any independent investigation made by Lender
and the execution and delivery of this Agreement, and such certificates, reports
or instruments and shall continue so long as any Obligations are outstanding and
unsatisfied, applicable statutes of limitations to the contrary
notwithstanding.
14.3
Notices
. All
notices, requests and demands to or upon the respective parties hereto shall be
given in writing and shall be deemed to have been duly given or made upon
receipt by the receiving party. All notices, requests and demands are
to be given or made to the respective parties at the following addresses (or to
such other addresses as either party may designate by notice in accordance with
the provisions of this paragraph):
|
If
to Borrower:
|
eMagin
Corporation.
|
|
|
10500
N.E. 8
th
Street
|
|
|
Suite
1400
|
|
|
Bellevue,
Washington 12533
|
|
|
Attention:
John Atherly
|
|
|
|
|
With
a copy to:
|
Sichenzia
Ross Friedman Ference LLP
|
|
|
61
Broadway
|
|
|
New
York, New York 10006
|
|
|
Attention: Richard
A. Friedman, Esq.
|
|
|
|
|
If
to Lender:
|
Moriah
Capital, L.P.
|
|
|
685
Fifth Avenue
|
|
|
New
York, New York 10022
|
|
|
Attention:
Greg Zilberstein
|
|
|
|
|
|
|
|
With
a copy to:
|
Cohen
Tauber Spievack & Wagner LLP
|
|
|
420
Lexington Avenue, Suite 2400
|
|
|
New
York, New York 10170
|
|
|
Attention: Adam
Stein, Esq.
|
Notwithstanding
the foregoing, that parties expressly acknowledge and agree that foregoing
provisions of notice by Lender to Borrower’s counsel is an
accommodation only, and that Lender shall have fulfilled its notice
obligation hereunder if notice shall have been received by Borrower
at its address set forth above, irrespective of whether such notice is received
by Borrower’s counsel.
14.4
Amendments; Waiver of
Defaults
. The terms of this Agreement shall not be amended,
waived, altered, modified, supplemented or terminated in any manner whatsoever
except by a written instrument signed by Lender and Borrower. Any
default or Event of Default by a party hereto may only be waived by a written
instrument specifically describing such default or Event of Default and signed
by the other party hereto.
14.5
Binding on
Successors
.
(a) This
Agreement shall be binding upon and inure to the benefit of the parties hereto
and their respective successors and assigns,
except
that
, Borrower may
not assign any of its rights under this Agreement or the other Loan Documents to
any Person without the prior written consent of Lender.
(b) Lender
may assign any or all of the Obligations together with any or all of the
security therefor to any Person and any such assignee shall succeed to all of
Lender’s rights with respect thereto. Upon such assignment, Lender
shall be released from all responsibility for the Collateral to the extent same
is assigned to any transferee. Lender may from time to time sell or
otherwise grant participations in any of the Obligations and the holder of any
such participation shall, subject to the terms of any agreement between Lender
and such holder, be entitled to the same benefits as Lender with respect to any
security for the Obligations in which such holder is a
participant. Borrower agrees that each such holder may exercise any
and all rights of set-off and counterclaim with respect to its participation in
the Obligations as fully as though Borrower were directly indebted to such
holder in the amount of such participation.
14.6
Invalidity
. Any
provision of this Agreement which may be determined by competent authority to be
prohibited or unenforceable in any jurisdiction shall, as to such jurisdiction,
be ineffective to the extent of such prohibition or unenforceability without
invalidating the remaining provisions hereof, and any such prohibition or
unenforceability in any jurisdiction shall not invalidate or render
unenforceable such provision in any other jurisdiction.
14.7
Publicity.
Borrower
hereby consents to the issuance by Lender of (a) a public announcement or press
release relating to the financial arrangement entered into between the Borrower
and Lender in substantially the form annexed hereto as
Exhibit G
, as well as (b)
other announcements which are commonly known as tombstones, in such publications
and to such selected parties as Lender shall in its sole and absolute discretion
deem appropriate, or as required by applicable law.
14.8
Section or Paragraph Headings
.
Section and paragraph headings are for convenience only and shall not be
construed as part of this Agreement.
14.9
Governing Law
. This
Agreement shall be construed in accordance with, and shall be governed by, the
laws of the State of New York including, without limitation, Section 5-1401 of
the New York General Obligations Law (without giving effect to conflict of law
rules).
14.10
Waiver of Jury
Trial
. THE PARTIES HERETO HEREBY WAIVE ANY AND ALL RIGHTS THAT
THEY MAY NOW OR HEREAFTER HAVE UNDER THE LAWS OF THE UNITED STATES OF AMERICA OR
ANY STATE TO A TRIAL BY JURY OF ANY AND ALL ISSUES ARISING EITHER DIRECTLY OR
INDIRECTLY IN ANY ACTION OR PROCEEDING BETWEEN BORROWER, LENDER OR ITS
SUCCESSORS AND ASSIGNS, OUT OF OR IN ANY WAY CONNECTED WITH THIS AGREEMENT, THE
OTHER LOAN DOCUMENTS, THE OBLIGATIONS AND/OR THE COLLATERAL. IT IS
INTENDED THAT SAID WAIVER SHALL APPLY TO ANY AND ALL DEFENSES, RIGHTS, AND/OR
COUNTERCLAIMS IN ANY ACTION OR PROCEEDINGS BETWEEN BORROWER AND
LENDER. BORROWER WAIVES ALL RIGHTS TO INTERPOSE ANY CLAIMS,
DEDUCTIONS, SETOFFS OR COUNTERCLAIMS OF ANY KIND, NATURE OR DESCRIPTION IN ANY
ACTION OR PROCEEDING INSTITUTED BY LENDER WITH RESPECT TO THIS AGREEMENT, THE
OTHER LOAN DOCUMENTS, THE OBLIGATIONS, THE COLLATERAL OR ANY MATTER ARISING
THEREFROM OR RELATING THERETO, EXCEPT COMPULSORY COUNTERCLAIMS.
14.11
Consent to
Jurisdiction
. Borrower and Lender each hereby
(a) irrevocably submits and consents to the exclusive jurisdiction of the
Supreme Court for New York County, State of New York, and the United State
District Court for the Southern District of New York with respect to any action
or proceeding arising out of this Agreement, the Note, the other Obligations,
the other Loan Documents, the Collateral or any matter arising therefrom or
relating thereto and (b) waives any objection based on venue or
forum
non
conveniens
with
respect thereto. In any such action or proceeding, Borrower waives
personal service of the summons and complaint or other process and papers
therein and agrees that the service thereof may be made by certified mail,
return receipt requested, directed to Borrower at its chief executive office set
forth herein or other address thereof of which Lender has received notice as
provided herein, service to be deemed complete as permitted under the rules of
either of said Courts. Any such action or proceeding commenced by
Borrower against Lender will be litigated only in the New York Supreme Court for
New York County, State of New York, and the United States District Court for the
Southern District of New York.
14.12
Entire
Agreement
. This Agreement, the other Loan Documents, any
supplements or amendments hereto or thereto, and any instruments or documents
delivered or to be delivered in connection herewith or therewith represents the
entire agreement and understanding concerning the subject matter hereof and
thereof between the parties hereto, and supersede all other prior agreements,
understandings, negotiations and discussions, representations, warranties,
commitments, proposals, offers and contracts concerning the subject matter
hereof, whether oral or written. In the event of any inconsistency
between the terms of this Agreement and any schedule or exhibit hereto, the
terms of this Agreement shall govern.
14.13
Counterparts
. This
Agreement may be executed in counterparts, each of which when so executed, shall
be deemed an original, but all of which shall constitute but one and the same
instrument.
[REMAINDER
OF PAGE INTENTIONALLY LEFT BLANK]
IN WITNESS WHEREOF,
this
Agreement has been duly executed as of the day and year first above
written.
|
EMAGIN
CORPORATION
|
|
|
|
|
|
|
By:
|
/s/
|
|
|
|
Name
|
|
|
|
Title
|
|
|
|
|
|
|
MORIAH
CAPITAL L.P.
|
|
|
|
|
|
|
By:
|
Moriah
Capital Management, L.P., General Partner
|
|
|
By:
|
Moriah
Capital Management, GP, LLC, General Partner
|
|
|
|
|
|
|
|
|
|
[SIGNATURE
PAGE OF LOAN AND SECURITY AGREEMENT]
SCHEDULE
2.4
TO
LOAN
AND SECURITY AGREEMENT
The
Company shall use the loans for working capital purposes and not to redeem any
Common Stock or Common Stock Equivalents or to settle any outstanding
litigation.
SCHEDULE
8.17
TO
LOAN
AND SECURITY AGREEMENT
LOCATION
OF COLLATERAL
eMagin
Corporation
2070
Route 52
Hopewell
Junction, NY 12533
eMagin
Corporation
10500
N.E. 8
th
Street
Suite
1400
Bellevue,
WA 98004
ASTERIA
MANUFACTURING SDN BHD
WISMA AIC
LOT 3
SELANGOR
DARU EHASN
MALAYSIA
SCHEDULE
8.18
TO
LOAN
AND SECURITY AGREEMENT
CUSTOMERS
AND VENDORS
SCHEDULE
8.29
TO
LOAN
AND SECURITY AGREEMENT
INDEBTEDNESS
Great
Plains
|
|
$
|
(15,340
|
)
|
|
|
|
|
|
6%
Debentures
|
|
|
(6,020,000
|
)
|
|
|
|
|
|
Empire
State (NY Urban Development)
|
|
|
(115,717
|
)
|
|
|
|
|
|
|
|
$
|
(6,151,057
|
)
|
SCHEDULE
10.9
TO
LOAN
AND SECURITY AGREEMENT
DIVIDENDS
Holders
of $6.02 million of convertible notes have the option to convert 50% of their
notes into Series A Preferred Stock. Notes converted into Series A
Preferred Stock would be paid an annual dividend of 8%.
SCHEDULE
10.10
TO
LOAN
AND SECURITY AGREEMENT
PAYMENTS
TO AFFILIATES
Paul
Cronson, a member of eMagin’s Board of Directors, is the Managing Director of
Larkspur Capital. Larkspur has been engaged to represent the Company
if approached by a third party interested in merging or acquiring the
Company. His firm would be entitled to fees if a transaction were
completed that resulted in a merger, acquisition or sale of eMagin’s
assets. Larkspur would also be entitled to fees if capital were
raised from a firm introduced by them to the Company and to compensation fo
expenses incurred.
Paul
Cronson (Director) is a representative of Navicorp III a holder of $200,000 of
our convertible notes.
John
Atherly (Officer) is a holder of $40,000 of our convertible notes.
Olivier
Prache (VP) is a holder of $10,000 of our convertible notes.
SCHEDULE
10.14
TO
LOAN
AND SECURITY AGREEMENT
BANK
ACCOUNTS
EXHIBIT
A
TO
LOAN
AND SECURITY AGREEMENT
Permitted
Encumbrances
None
other than the convertible notes due December 21, 2008
EXHIBIT
B
TO
LOAN
AND SECURITY AGREEMENT
Form of Revolving Loan
Note
SECURED
CONVERTIBLE REVOLVING LOAN NOTE
Up to
$2,500,000
Dated:
August 7, 2007
FOR VALUE RECEIVED, the undersigned,
EMAGIN CORPORATION
, a
Delaware corporation, with its principal place of business located at 10500 N.E.
8
th
Street, Suite 1400 Bellevue, Washington 12533 (“
eMagin
” and “
Borrower
”) promises to pay to
the order of
MORIAH CAPITAL,
L.P.,
a Delaware limited partnership with offices at 685 Fifth Avenue,
New York, New York 10022, and its successors and assigns (“
Lender
”), on or before the
Maturity Date, the principal sum of up to Two Million Five Hundred Thousand
Dollars ($2,500,000) in accordance with the Loan and Security Agreement, of even
date herewith, entered into by and between Borrower and Lender (as amended from
time to time, the “
Agreement
”). Capitalized
terms used herein and not defined herein shall have their respective meanings as
set forth in the Agreement.
INTEREST; DUE
DATE
: Interest shall be due and payable as provided in the
Agreement. The Loan and all other Indebtedness evidenced hereby not
paid before the Maturity Date shall be due and payable on the Maturity
Date.
MAXIMUM RATE OF
INTEREST
: It is intended that the rate of interest herein
shall never exceed the maximum rate, if any, which may be legally charged on the
Loans evidenced by this Note (the “
Maximum Rate
”), and if the
provisions for interest contained in this Note would result in a rate higher
than the Maximum Rate, interest shall nevertheless be limited to the Maximum
Rate, and any amounts which may be paid toward interest in excess of the Maximum
Rate shall be applied to the reduction of principal, or, at the option of
Lender, returned to Borrower.
PLACE OF
PAYMENT
: All payments hereon shall be made, and all notices to
Lender required or authorized hereby shall be given, at the office of Lender at
the address designated in the Agreement, or to such other place as Lender may
from time to time direct by written notice to Borrower.
APPLICATION OF
PAYMENTS
: All payments received hereunder shall be applied in
accordance with the provisions of the Agreement.
PAYMENT AND
COLLECTION
: All amounts payable hereunder are payable by check
or wire transfer in immediately available funds to the account number specified
by Lender, in lawful money of the United States. Borrower agrees to
perform and comply with each of the covenants, conditions, provisions and
agreements contained in every instrument now evidencing or securing said
Indebtedness.
SECURITY
: This
Note is issued pursuant to the Agreement and is secured by a pledge of the
Collateral as described in the Loan Documents. Notwithstanding the
pledge of the Collateral described above, Borrower hereby acknowledges, admits
and agrees that Borrower’s obligations under this Note are recourse obligations
of Borrower to which Borrower pledges its full faith and credit.
DEFAULTS
: Upon
the happening of an Event of Default, Lender shall have all of the rights and
remedies set forth in the Agreement.
The
failure to exercise any of the rights and remedies set forth in the Agreement
shall not constitute a waiver of the right to exercise the same or any other
option at any subsequent time in respect of the same event or any other
event. The acceptance by Lender of any payment which is less than
payment in full of all amounts due and payable at the time of such payment shall
not constitute a waiver of the right to exercise any of the foregoing rights and
remedies at that time or at any subsequent time or nullify any prior exercise of
any such rights or remedies without the express consent of Lender, except as and
to the extent otherwise provided by law.
WAIVERS
: Borrower
waives diligence, presentment, protest and demand and also notice of protest,
demand, dishonor and nonpayment of this Note.
TERMINOLOGY
: Any
reference herein to Lender shall be deemed to include and apply to every
subsequent holder of this Note. Any reference herein to Borrower
shall mean eMagin and any of its Subsidiaries that may be bound under any of the
Loan Documents.
AGREEMENT
: Reference
is made to the Agreement for provisions as to the Loan, rates of interest,
Collateral, acceleration and release matters. If there is any
conflict between the terms of this Note and the terms of the Agreement, the
terms of the Agreement shall control.
APPLICABLE
LAW
: This Note shall be governed by and construed and
interpreted in accordance under the laws of the State of New York, the laws of
which Borrower hereby expressly elects to apply to this Note, without giving
effect to provisions for choice of law thereunder. Borrowers agree
that any action or proceeding brought to enforce or arising out of this Note
shall be commenced in accordance with the provisions of the
Agreement.
SIGNATURE
PAGE TO FOLLOW
IN WITNESS WHEREOF,
this
Secured Convertible Revolving Loan Note has been duly executed and delivered as
of the day and year first above written.
|
EMAGIN
CORPORATION
|
|
|
|
|
|
|
By:
|
/s/
|
|
|
|
Name
|
|
|
|
Title
|
|
|
|
|
|
EXHIBIT
C
TO
LOAN
AND SECURITY AGREEMENT
Form of Intercreditor
Agreement
EXHIBIT
C
INTERCREDITOR
AGREEMENT
INTERCREDITOR AGREEMENT,
dated August
7, 2007, by and among
MORIAH
CAPITAL, L.P.,
a Delaware limited partnership with offices at 685 Fifth
Avenue, New York, New York 10022 (
“Moriah”)
,
ALEXANDRA GLOBAL MASTER FUND
LTD.
, a British Virgin Islands international business company with the
offices of its investment advisor at 767 Third Avenue, 39
th
Floor,
New York, New York 10017 (
“Alexandra”
), in its capacity
as collateral agent pursuant to the Noteholder Agreements (such capitalized term
and all other capitalized terms used herein having the respective meanings
provided in this Agreement) acting for and on behalf of the holders of Notes (in
such capacity, the
“Notes
Collateral Agent”
as hereinafter further defined) and
EMAGIN CORPORATION
, a Delaware
corporation, with its principal place of business located at 10500 N.E. 8
th
Street,
Suite 1400, Bellevue, Washington 98004 (the
“Borrower”
).
R E C I T A L
S
:
A. The
Notes Collateral Agent is the collateral agent under the Pledge and Security
Agreement, dated as of July 21, 2006, made by the Borrower to the Notes
Collateral Agent, as amended by Amendment No. 1 to Pledge and Security
Agreement, dated as of July 23, 2007 by and between the Borrower and the Notes
Collateral Agent (the
“Note
Pledge Agreement”
) for the benefit of the holders (the
“Noteholders”
) from time to
time of the Amended and Restated 8% Senior Secured Convertible Notes Due 2008
issued by the Borrower (the
“Notes”
) pursuant to the
several Note Purchase Agreements, dated as of July 21, 2006, by and between the
Borrower and the several investors named therein, as amended by the several
Amendment Agreements, dated as of July 23, 2007, by and between the Borrower and
the several investors named therein (the
“Note Purchase Agreements”
)
and, to secure the Borrower’s obligations to the Noteholders, the Notes
Collateral Agent and the holders of Series A Senior Secured Convertible
Preferred Stock, par value $0.001 per share, of the Borrower issued or issuable
upon conversion of the Notes, the Borrower granted to the Notes Collateral Agent
a security interest in and to the property of the Borrower described on
Schedule 2
annexed
hereto (collectively, the
“Notes
Collateral”
).
B. Pursuant
to a Loan and Security Agreement, of even date herewith, between Moriah and
Borrower (as the same may hereafter be amended, the
“Moriah Loan Agreement;”
the
term
“Moriah Loan Agreements”
shall include all of the Loan Documents, as that term is defined in the
Moriah Loan Agreement), Moriah is providing an accounts receivable and inventory
based credit facility to Borrower that is secured by all now owned and hereafter
acquired property (including, without limitation, real property) and assets of
Borrower and the proceeds and products thereof, as more particularly described
in
Schedule 1
annexed hereto (collectively, the
“Moriah
Collateral”
).
C. It
is a condition to the consummation of the transactions contemplated by the
Moriah Loan Agreements that the Notes Collateral Agent subordinate its liens in
the Accounts and Inventory as the same may be included in the Notes Collateral
on terms satisfactory to Moriah.
D. The
Notes Collateral Agent and Moriah have each filed or may hereafter file
financing statements under the Uniform Commercial Code, as may be amended from
time to time (
“UCC”
)
with respect to the Notes Collateral and the Moriah Collateral, respectively, in
connection with the foregoing.
E. The
Notes Collateral Agent and Moriah desire to agree on the relative priority of
their respective security interests in, and liens on, their respective
collateral.
In
consideration of the foregoing, the mutual covenants and agreements herein
contained and other good and valuable consideration, the Notes Collateral Agent
and Moriah mutually covenant, warrant and agree as follows:
1.
Definitions
. All
the agreements or instruments herein defined shall mean such agreements or
instruments as the same may from time to time be supplemented or amended or the
terms thereof waived or modified to the extent permitted by, and in accordance
with the terms thereof. The following terms (including both the
singular and plurals thereof) shall have the following meanings unless the
context indicates otherwise:
1.1 “
Bankruptcy Cod
e” means the
United States Bankruptcy Code (11 U.S.C. §§101
et
seq
.).
1.2 “
Claim
” or “
Claims
” means, as applicable,
the Moriah Claim and/or the Noteholder Claim.
1.3 “
Collateral
” means all property
and interests in property now owned or hereafter acquired by any Loan Party in
or upon which a security interest or mortgage lien is granted to Moriah or the
Notes Collateral Agent under the Security Documents.
1.4 “
Creditors
” shall mean Moriah,
the Noteholders and the Notes Collateral Agent and their respective successors
and assigns.
1.5 “
Enforcement Action
” means with
respect to a Claim, the demand for payment or acceleration of such Claim, the
repossession of any Collateral, the commencement or prosecution of enforcement
of any of the rights and remedies under, as applicable, the Noteholder
Agreements, the Moriah Loan Agreements, or applicable law with respect to such
Claim, including, but not limited to, judicial or UCC foreclosure, provided that
Enforcement Action shall not include the filing of a claim in an Insolvency
Proceeding.
1.6 “
Enforcement Notice
” means a
written notice delivered by the Enforcing Party to the other Party stating that
an "Event of Default" (as defined in the Noteholder Agreements or the Moriah
Loan Agreements, respectively) has occurred and is continuing and that an
Enforcement Period has commenced.
1.7 “
Enforcement Period
”
means the period of time following the receipt by either the Notes Collateral
Agent or Moriah of an Enforcement Notice until (a) the Noteholder Claim is Paid
in Full (if the Notes Collateral Agent is the Enforcing Party) or the Moriah
Claim is Paid in Full (if Moriah is the Enforcing Party), or (b) the Creditors
agree in writing to terminate such Enforcement Period.
1.8 “
Enforcing Party
” means Moriah
in the case of an Enforcement Action with respect to the Moriah Claim, and the
Notes Collateral Agent in the case of an Enforcement Action with respect to the
Noteholder Claim.
1.9 “
Insolvency Proceeding
” means
any voluntary or involuntary insolvency, bankruptcy, receivership,
custodianship, liquidation, dissolution, reorganization, assignment for the
benefit of creditors, appointment of a custodian, receiver, trustee or other
officer with similar powers or any other proceeding for the liquidation,
dissolution or other winding up of any Loan Party.
1.10
“
Loan Party
”
means Borrower and each
subsidiary of Borrower which is now or may hereafter become a party to the
Noteholder Agreements or the Moriah Loan Agreements.
1.10A “
Lockbox Agreement
” means the
Lockbox Agreement, dated as of July 21, 2006, by and between the Borrower and
the Notes Collateral Agent, as amended by Amendment No. 1 to Lockbox Agreement,
dated as of July 23, 2007, by and between the Borrower and the Notes Collateral
Agent.
1.11 “
Maximum Moriah Debt
” means the
sum of (a) $2,500,000, plus (b) such other indebtedness that may be permitted to
be incurred from time to time on or after the date hereof under the terms of the
Notes as Permitted Indebtedness as such term is defined in the
Notes.
1.12
“
Moriah Claim
” means all
of the obligations of the Loan Parties to Moriah as set forth in the Moriah Loan
Agreements.
1.13 “
Moriah Senior Collateral
”
means the Collateral described in
Section 2.1(a)
in
which Moriah has a senior lien or security interest.
1.14 “
Noteholder Agreements
” means
the Note Purchase Agreements, the Notes, the Note Pledge Agreement, the Patent
and Trademark Security Agreement, dated as of July 21, 2006, by and between the
Borrower and the Notes Collateral Agent, as amended by Amendment No. 1 to Patent
and Trademark Security Agreement dated as of July 23, 2007, by and between the
Borrower and the Notes Collateral Agent, the Lockbox Agreement, the Certificate
of Designations of Series A Senior Secured Convertible Preferred Stock of the
Borrower, the Amended and Restated Common Stock Purchase Warrants issued by the
Borrower to the holders of Notes pursuant to the Note Purchase Agreements and
the other agreements, instruments and documents contemplated
thereby.
1.15
“
Noteholder Claim
” means
all obligations of the Loan Parties to the Notes Collateral Agent and the
Noteholders as set forth in the Noteholder Agreements.
1.16 “
Noteholder Senior Collateral
”
means the Collateral described in
Section 2.1(b)
in
which the Notes Collateral Agent has a senior lien or security
interest.
1.17 “
Notes Collateral Agent
” means
Alexandra in its capacity as collateral agent pursuant to the Note Pledge
Agreement and the other applicable Noteholder Agreements, and its successors and
assigns including any replacement or successor trustee or agent or any
additional trustee or agent.
1.18
“
Paid in Full
” means, in
the case of the Moriah Claim, the aggregate outstanding, unpaid amount of the
Moriah Claim has been paid in full in cash and all commitments to make loans or
extend other financial accommodations have terminated and, in the case of the
Noteholder Claim, the aggregate outstanding unpaid amount of the Noteholder
Claim has been paid in full in cash and all commitments to make loans or extend
other financial accommodations have terminated. If after receipt of
any payment of, or proceeds of collateral applied to the payment of, either any
Moriah Claim or Noteholder Claim, as the case may be, any of the Creditors is
required to surrender or return such payment or proceeds to any person for any
reason, then the Moriah Claim or Noteholder Claim as applicable, intended to be
satisfied by such payment or proceeds shall be reinstated and continue as if
such payment or proceeds had not been received by such Creditor, as the case may
be. Notwithstanding anything to the contrary contained herein, for
purposes of this definition, the Moriah Claim shall not include any amount of
the Moriah Claim in excess of the Maximum Moriah Debt.
1.19
“
Party
” means Moriah or
the Notes Collateral Agent.
1.20 “
Person
” or “
person
” means, as applicable,
any individual, sole proprietorship, partnership, corporation, limited liability
company, limited liability partnership, partnership, business trust,
unincorporated association, joint stock corporation, trust, joint venture or
other entity or any government or any agency or instrumentality or political
subdivision thereof.
1.21
“
Post-Petition Interest
”
means interest at the contract rate under the Moriah Loan Agreements or the
Noteholder Agreements, as applicable, accruing subsequent to the filing of any
Insolvency Proceeding as to any Loan Party whether or not such interest is an
allowable claim in any such Insolvency Proceeding.
1.22
“
Security Documents
”
means, collectively, the Noteholder Agreements and the Moriah Loan
Agreements.
2.
Intercreditor
Agreement
.
2.1.
Lien
Priorities
. Notwithstanding (a) the date, manner or order of
filing, recordation, or perfection of the security interests or liens granted in
favor of Moriah and the Notes Collateral Agent, (b) any provisions of the UCC,
or any applicable law or decision, (c) the provisions of the Moriah Loan
Agreements, Noteholder Agreements or any contract between any of the Creditors
on one hand, and the Borrower or any affiliate thereof, on the other hand, or
(d) whether either Moriah or the Notes Collateral Agent holds possession of all
or any part of the Collateral, the following, as between Moriah and the Notes
Collateral Agent, shall be the relative priority of the security interests and
liens of Moriah and the Notes Collateral Agent in the Collateral:
(a) Moriah
shall have a first and prior security interest to the extent set forth herein in
all Accounts and Inventory as defined in the Section 9-102 of the
UCC. The Notes Collateral Agent shall have a second and subordinate
security interest in the foregoing property and interests in such property;
provided, that,
any
amount of the Moriah Claim in excess of the Maximum Moriah Debt at any time
outstanding (together with the interest on such excess) shall not be entitled to
the benefit of the priority of the security interest of Moriah provided for in
this Section 2.1(a).
(b) The
Notes Collateral Agent shall have a first and prior security interest in the
remainder of the Collateral that is the subject of the Noteholder Agreements and
Moriah shall have a second and subordinate security interest in such Notes
Collateral whether now owned or hereafter created by any Loan
Party.
Neither
Moriah nor the Notes Collateral Agent shall contest the validity, perfection,
priority or enforceability of any lien or security interest heretofore granted
to the other Party or granted in connection herewith or contemplated
hereby. Notwithstanding any failure of a Party to perfect its
security interests in any Collateral or any other defect in any security
interests or obligations owing to such Party, the priority and rights as between
the parties hereto shall be as set forth herein.
2.2.
Distribution of Proceeds of
Collateral
.
(a)
No Enforcement
Period
: Except as provided in
Section 2.2(b)
below
(with respect to distribution of proceeds of Collateral during an Enforcement
Period):
(i) All
realizations upon and proceeds of Moriah Senior Collateral shall be paid to
Moriah for application to the Moriah Claim, with any residual proceeds after
satisfaction of the Moriah Claim being paid to the Notes Collateral Agent for
the benefit of the Noteholders.
(ii) All
realizations upon and proceeds of Noteholder Senior Collateral shall be paid to
the Notes Collateral Agent for application to the Noteholder Claim, with any
residual proceeds after satisfaction of the Noteholder Claim being paid to
Moriah.
(b)
During Enforcement
Period
: During any Enforcement Period, all proceeds of
Collateral shall be distributed in accordance with the following
procedure:
(i) All
realizations upon and proceeds of Moriah Senior Collateral shall be applied to
the Moriah Claim. After the Moriah Claim is Paid in Full and the
Moriah Loan Agreements are terminated and fully paid or otherwise satisfied, any
remaining proceeds of the Moriah Senior Collateral shall be applied to the
Noteholder Claim.
(ii) All
realizations upon and proceeds of Noteholder Senior Collateral shall be applied
to the Noteholder Claim. After the Noteholder Claim is Paid in Full
and the Noteholder Agreements are terminated and fully paid or otherwise
satisfied, any remaining proceeds of the Noteholder Senior Collateral shall be
applied to the Moriah Claim.
(iii) After
the Moriah Claim and the Noteholder Claim have been paid in full in cash and all
commitments to make loans or extend other financial accommodations have
terminated, the balance of the realizations upon and proceeds of the Collateral,
if any, shall be paid to the respective Loan Party or as otherwise required by
applicable law.
(c)
Payments Held in
Trust
. Should any payment or distribution be received by a
Party that is not permitted to receive and retain such payment or distribution
pursuant to the terms hereof, such Party shall receive and hold the same in
trust, as trustee, for the Party entitled to receive and retain such payment,
and shall forthwith deliver the same to such Party in precisely the form
received (except for endorsement or assignment where necessary), for application
to the Claim of such Party and, until so delivered, the recipient shall hold the
same in trust as the property of such Party entitled to the same. If
a Party obligated to make an endorsement or assignment pursuant to the
provisions of this Section fails to make any such endorsement or assignment, the
permitted recipient of such payment or distribution, or any of its officers or
employees, is hereby irrevocably authorized to make the same.
2.3.
Enforcement
Actions
. Each of Moriah and the Notes Collateral Agent agrees
not to commence or take any Enforcement Action until an Enforcement Notice has
been given by such Enforcing Party to the other Party. Subject to the
foregoing, Moriah and the Notes Collateral Agent agree that during an
Enforcement Period:
(a)
|
Moriah
may, at its option, take and continue any Enforcement Action with respect
to Moriah Senior Collateral and realize thereon, without the prior written
consent of the Notes Collateral Agent, provided that during any
Enforcement Period with respect to the Noteholder Senior Collateral,
Moriah shall not commence or take any Enforcement Action or realize upon
the Noteholder Senior Collateral without the Notes Collateral Agent's
prior written consent.
|
(b)
|
Subject
to the standstill period described in Section 2.3(e) below, the Notes
Collateral Agent may, at its option, take and continue any Enforcement
Action with respect to the Noteholder Senior Collateral and realize
thereon without the prior written consent of Moriah, provided that during
any Enforcement Period with respect to the Moriah Senior Collateral, the
Notes Collateral Agent shall not commence or take any Enforcement Action
or realize upon any of the Moriah Senior Collateral without Moriah's prior
written consent. In furtherance and not in limitation of the foregoing,
during an Enforcement Period, the Notes Collateral Agent shall not take
any action to enforce its rights under the Lockbox Agreement, whether
pursuant to Section 2 thereof or
otherwise.
|
(c)
|
If
both Moriah and the Notes Collateral Agent elect to proceed with
Enforcement Actions, then each shall proceed with the Enforcement Action
of any security interests in or liens on any Collateral in which it has a
senior lien or security interest, as described in and provided by
Section 2.1
,
without prejudice to the other Party to join in any
proceedings.
|
(d)
|
Each
Enforcing Party shall so notify the other Party at such time as the
Enforcing Party's Claim is Paid in
Full.
|
(e)
|
Notwithstanding
anything herein to the contrary, but subject to the proviso at the end of
this paragraph, the Notes Collateral Agent agrees that, during the first
five (5) days of an Enforcement Period (the “Standstill Period”), it shall
not take any action to realize on the Noteholder Senior Collateral, so as
not to impair the collection by Moriah of Borrower’s outstanding accounts
receivable during that period;
provided
,
however
, that
the Notes Collateral Agent shall be entitled to take such action as it
deems necessary in its sole discretion to (i) protect its secured position
during the Standstill Period, (ii) protect its interest from claims or
liens of third parties or governmental authorities, or (iii) preserve the
Noteholder Senior Collateral from deterioration or
diminishment.
|
2.4.
Accountings
. Each
of Moriah and the Notes Collateral Agent agree upon the occurrence of any
Enforcement Action, to render accountings to the other, upon reasonable request
of the other, giving effect to the application of realizations upon and proceeds
of Collateral as hereinbefore provided.
2.5.
Notices of
Defaults
. Moriah and the Notes Collateral Agent agree to give
to the other copies of any notice of the occurrence of an Event of Default,
respectively, simultaneously with the sending of such notice to the applicable
Loan Party, but the failure to give or forward any such notice shall not affect
the validity of such notice, create a cause of action against the Party failing
to give such notice, or create any claim or right on behalf of the other Party
or any third party. The sending or receipt of such notice shall not
obligate the recipient to cure such Event of Default.
2.6.
Agency for
Perfection
. Moriah and the Notes Collateral Agent each hereby
appoint each other as agent for purposes of perfecting their respective security
interests and liens in the Collateral. To the extent that either
Party obtains possession of Collateral in which the other Party has a senior
priority under the terms hereof, the Party having possession shall notify the
other Party of such fact and shall deliver such Collateral to the Party having
the senior priority upon request of such Party. Each Party shall be a
bailee for the other Party with respect to Collateral in such Party's
possession. If directed by a Loan Party, the bailee Party shall,
after the Claim of such bailee Party has been Paid in Full, deliver the
Collateral in its possession to the other Party.
2.7.
UCC Notices
. In the
event that Moriah or the Notes Collateral Agent shall be required by the UCC or
any other applicable law to give notice to the other of intended disposition of
Collateral, such notice shall be given in accordance with
Section 3.8
hereof,
and five (5) days' notice shall be deemed to be commercially
reasonable.
2.8.
Information Sharing
. Upon the
occurrence and continuance of an Enforcement Period, in the event that either
Moriah or the Notes Collateral Agent shall, in connection with any Enforcement
Action, receive possession or control of any books and records which contain
information identifying or pertaining to any of the property of any Loan Party
in which the other Party has been granted a lien, it shall notify the other
Party that it has received such books and records and shall, as promptly as
practicable thereafter, make available to the other Party duplicate copies of
such books and records in the same form as the original. All
reasonable expenses incurred by either Moriah or the Notes Collateral Agent in
performing its obligations under this paragraph shall be borne by the Loan
Parties and shall constitute indebtedness under the respective Party's
agreements with the Loan Parties. The failure of either Party to
share information shall not create a cause of action against the Party failing
to share information or create any claim on behalf of any Loan Party or any
third party.
2.9.
Obligations of the Loan Parties
Unconditional
. Nothing contained herein is intended to or
shall increase or impair the obligations, liabilities and indebtedness of the
Loan Parties to pay the Claims as and when the same shall become due and payable
in accordance with the terms of the Moriah Loan Agreements and the Noteholder
Agreements, as applicable, or to affect the relative rights of the Loan Parties
and creditors of the Loan Parties other than the Creditors.
2.10.
Continuing
Obligations
. This Agreement shall be irrevocable and shall
continue in effect until each Claim has been Paid In Full. This is a
continuing agreement and each Party may continue, at any time and without notice
to the other Party, to extend credit to or for the benefit of the Loan Parties
on the faith hereof.
2.11.
Certain Waivers
.
(a) The
Notes Collateral Agent acknowledges that Moriah has not made any warranties or
representations with respect to the due execution, legality, validity,
completeness or enforceability of the Moriah Loan Agreements or the
collectibility of the Moriah Claim.
(b) Each
of the Notes Collateral Agent and Moriah shall be entitled to manage and
supervise its financial arrangements with each Loan Party in accordance with its
usual practices, modified from time to time as it deems appropriate under the
circumstances, without affecting the validity or enforceability of this
Agreement.
(c) Moriah
shall have no liability to the Notes Collateral Agent for, and the Notes
Collateral Agent hereby waives any claim which the Notes Collateral Agent may
now or hereafter have against Moriah arising out of any and all actions which
Moriah, in good faith, takes or omits to take (including, without limitation,
actions with respect to the creation, perfection or continuation of liens or
security interests in any existing or future Collateral, actions with respect to
the occurrence of a default or event of default, actions with respect to the
foreclosure upon, sale, release, or depreciation of, or failure to realize upon,
any of the Collateral and actions with respect to the collection of any claim
for all or any part of the Noteholder Claim from any account debtor, guarantor
or any other person) with respect to and in accordance with any Moriah Loan
Agreements or any other agreement related thereto or to the collection of the
Moriah Claim or the valuation, use, protection or release of the Collateral, so
long as any such actions are taken in a manner consistent with the terms of this
Agreement or any election of the application of Section 1111(b)(2) of the
Bankruptcy Code.
(d) Moriah
acknowledges that the Notes Collateral Agent has made no warranties or
representations with respect to the due execution, legality, validity,
completeness or enforceability of the Noteholder Agreements or the
collectibility of the Noteholder Claim.
(e) The
Notes Collateral Agent shall have no liability to Moriah for, and Moriah hereby
waives any claim which Moriah may now or hereafter have against the Notes
Collateral Agent arising out of any and all actions which the Notes Collateral
Agent, in good faith, takes or omits to take (including, without limitation,
actions with respect to the creation, perfection or continuation of liens or
security interests in any existing or future Collateral, actions with respect to
the occurrence of a default or event of default, actions with respect to the
foreclosure upon, sale, release, or depreciation of, or failure to realize upon,
any of the Collateral and actions with respect to the collection of any claim
for all or any part of the Moriah Claim from any account debtor, guarantor or
any other person) with respect to and in accordance with the Noteholder
Agreements or any other agreement related thereto or to the
collection of the Noteholder Claim or the valuation, use, protection or release
of the Collateral, so long as any such actions are taken in a manner consistent
with the terms of this Agreement or any election of the application of Section
1111(b)(2) of the Bankruptcy Code.
2.12.
Modifications and
Waivers
. Any modification or waiver of any provision of this
Agreement, or any consent to any departure by either Party from the terms
hereof, shall not be effective in any event unless the same is in writing and
signed by Moriah and the Notes Collateral Agent, and then such modification,
waiver or consent shall be effective only in the specific instance and for the
specific purpose given. Any notice to or demand on any Party in any
event not specifically required hereunder shall not entitle the Party receiving
such notice or demand to any other or further notice or demand in the same,
similar or other circumstances unless specifically required
hereunder. Each Loan Party hereby acknowledges and agrees that this
Agreement may be amended or otherwise modified without notice to or consent by
any Loan Party.
2.13.
Insurance
. The
Party having a senior security interest or lien in the Collateral shall have,
subject to such Party’s rights under its agreements with the Loan Parties, the
sole and exclusive right, as against the other Party, to adjust settlement of
such insurance policy in the event of any loss.
2.14
Effect of
Bankruptcy
. This Agreement shall be and remain enforceable
notwithstanding any Insolvency Proceeding by or against the
Borrower.
3.
Miscellaneous
.
3.1.
Representations, Warranties and
Covenants
. Each Party represents, warrants and covenants to
the other that:
(a) except
as set forth herein, it has not subordinated, and agrees that it will not
subordinate at any time while this Agreement remain in effect, any right, claim
or interest of any kind in or to the Collateral as to which such Party has a
senior lien or security interest, and any subordination in violation of this
sub-paragraph shall be null and void;
(b) it
has not assigned or transferred any right, claim or interest of any kind in or
to its Claim; and
(c) the
execution, delivery and performance by or on behalf of such Party has been duly
authorized by all necessary action, corporate or otherwise, does not violate any
provision of law, governmental regulation, or any agreement or instrument by
which such Party is bound, and requires no governmental or other consent that
has not been obtained.
3.2.
No Benefit to Third
Parties
. The terms and provisions of this Agreement shall be
for the sole benefit of the Creditors and their respective successors and
assigns, and no other Person shall have any right, benefit, priority or interest
under or because of this Agreement.
3.3.
Independent Credit
Investigations
. Neither Party nor any of their respective
directors, officers, agents or employees shall be responsible to any other
person for the solvency, financial condition or ability of any Loan Party to
repay the Moriah Claim or the Noteholder Claim, or for statements of any Loan
Party, oral or written, or for the validity, sufficiency or enforceability of
the Moriah Claim or the Noteholder Claim, the Moriah Loan Agreements, the
Noteholder Agreements, or any liens or security interests granted by any Loan
Party in connection therewith. Each of the Creditors has entered into
its respective financing agreements with Loan Parties based upon its own
independent investigation and makes no warranty or representation to the other
Party with respect to matters identified or referred to in this
paragraph. If either Party, in its sole discretion, undertakes, at
any time or from time to time, to provide any such information to the other
Party, such information shall be given with no representation or warranty of any
kind from such Person and such Person shall be under no obligation (a) to
provide any such information to any other Person at that time or to any Person
on any subsequent occasion or (b) to undertake any investigation not a part of
its regular business routine.
3.4
Amendments to Financing Arrangements
or to this Agreement
. Moriah and the Notes Collateral Agent
shall each endeavor to notify the other Party of any material amendment or
modification of the Moriah Loan Agreement or the Noteholder Agreements,
respectively, but the failure to do so shall not create a cause of action
against the Party failing to give such notice or create any claim or right on
behalf of the other Party. Moriah and the Notes Collateral Agent
shall, upon request of the other Party, provide copies of all such modifications
or amendments and copies of all other documentation relevant to the
Collateral.
3.5.
Marshaling of
Assets
. The Notes Collateral Agent hereby waives any and all
rights to have the Moriah Senior Collateral, or any part thereof, marshaled upon
any foreclosure of any of Moriah's liens thereon or with respect to any other
Enforcement Action by Moriah. Moriah hereby waives any and all rights
to have the Noteholder Senior Collateral, or any part thereof, marshaled upon
any foreclosure of the Notes Collateral Agent's liens thereon or with respect to
any other Enforcement Action by the Notes Collateral Agent. If any
Claim is now or hereafter secured by collateral other than the Collateral
described hereunder, the Party holding such collateral shall have no obligation
to marshal such collateral before enforcing its rights in the Collateral
hereunder, and the other Party shall have no rights hereunder to share or
participate in any proceeds of such other collateral. Each Party
shall have the right, subject to
Section 2.3
, to take
Enforcement Action against Collateral in such order, or in whole or in part, and
subject to such conditions as such Enforcing Party determines in its sole
discretion.
3.6.
Successors and
Assigns.
This Agreement shall be binding upon and inure to the
benefit of the respective successors and assigns of each of the Parties, but
does not otherwise create, and shall not be construed as creating, any rights
enforceable by any Loan Party or any other person not a party to this
Agreement.
3.7.
Agreement
Absolute
. This Agreement shall be and remain absolute and
unconditional under any and all circumstances, and no act or omission on the
part of any Party to this Agreement shall affect or impair the agreement of the
other Party hereunder. Each of the Parties hereby authorizes the
other Party to (a) change any terms relating to such obligations of and Loan
Party to such Party or the loan agreements relating thereto as such other Party
in its discretion may deem advisable and with Borrower’s agreement; (b) grant
renewals, increases or extensions of the time for payment of the Claim of such
Party; (c) receive notes or other evidences of the obligations of the Loan
Parties to such other Party or renewals, increases or extensions thereof; and
(d) take or omit to take any action for the enforcement of, or waive any rights
with respect to, any obligation of the Loan Parties to such other Party without
invalidating or impairing any provision hereof. The Parties hereby
acknowledge and agree that this Agreement does not increase or expand the
obligations of Borrower under the respective Security Documents to which the
Parties are party. Further, the Parties acknowledge that if Borrower,
in good faith, shall make a payment of Claims in a manner that is inconsistent
with the terms hereof, it shall have no liability to either Party therefor as
long as Borrower cooperates with the Parties to rectify such
mistake.
3.8.
Notice.
All
notices, requests and demands to or upon the respective parties shall be given
in writing and shall be deemed to have been duly given or made upon receipt by
the receiving party. All notices, requests and demands are to be
given or made to the respective parties at the following addresses (or to such
other addresses as either party may designate by notice in accordance with the
provisions of this paragraph):
|
If
to Moriah:
|
Moriah
Capital, L.P.
|
|
|
685
Fifth Avenue
|
|
|
New
York, New York 10022
|
|
|
Attention:
Greg Zilberstein
|
|
With
a copy to:
|
|
|
|
Cohen
Tauber Spievack & Wagner LLP
|
|
|
420
Lexington Avenue
|
|
|
Suite
2400
|
|
|
New
York, New York 10170
|
|
|
Attention:
Adam Stein, Esq.
|
|
|
|
|
|
If
to the Notes
|
|
Collateral
Agent:
|
Alexandra
Global Master Fund Ltd.
|
|
|
c/o
Alexandra Investment Management, LLC
|
|
|
767
Third Avenue
|
|
|
39
th
Floor
|
|
|
New
York, New York 10017
|
|
|
Attention:
Chief Legal Officer
|
3.9.
Relationship of
Parties
. This Agreement is entered into solely for the
purposes set forth herein, and except as expressly provided herein, neither
Party assumes any other duties or responsibilities to the other regarding the
financial condition of the Borrower or any other Party, or regarding any
collateral, or regarding any other circumstance bearing upon the risk of
nonpayment of the obligations of the Borrower under any of the agreements
hereinabove referred to. Each Party shall be responsible for managing
its banking investments and/or business relationships with the Borrower, and
neither Party shall be deemed to be the agent of the other for any purpose
(except for the limited purpose set forth in Section 2.6) nor shall any party
hereto be deemed to be acting in concert with, or at the direction of, any other
party.
3.10.
Governing Law
. This
Agreement shall be construed in accordance with, and shall be governed by, the
laws of the State of New York (without giving effect to choice of law or
conflict of law rules).
3.11.
Consent to
Jurisdiction
. Each Party hereby (a) irrevocably submits
and consents to the exclusive jurisdiction of the Supreme Court for New York
County, State of New York, and the United State District Court for the Southern
District of New York with respect to any action or proceeding arising out of
this Agreement or any matter arising therefrom or relating thereto and (b)
waives any objection based on venue or
forum
non
conveniens
with
respect thereto.
3.12.
Counterparts
. This
Agreement may be executed in counterparts and by facsimile or other electronic
transmission, each of which when so executed, shall be deemed an original, but
all of which together shall constitute but one and the same
instrument.
3.13
Headings
. The
headings, captions and footers of this Agreement are for convenience of
reference and shall not form part of, or affect the interpretation of, this
Agreement.
3.14
Severability
. If
any provision of this Agreement shall be invalid or unenforceable in any
jurisdiction, such invalidity or unenforceability shall not affect the validity
or enforceability of the remainder of this Agreement or the validity or
enforceability of this Agreement in any other jurisdiction.
3.15
Entire Agreement;
Benefit
. This Agreement constitutes the entire agreement
between the parties hereto with respect to the subject matter
hereof. There are no restrictions, promises, warranties, or
undertakings, other than those set forth or referred to herein. This
Agreement supersedes all prior agreements and understandings, whether written or
oral, between the parties hereto with respect to the subject matter
hereof. This Agreement and the terms and provisions hereof are for
the sole benefit of only the Notes Collateral Agent, for the benefit of the
Noteholders, and Moriah and their respective successors and permitted
assigns.
3.16
Waiver
. Failure of
any party to exercise any right or remedy under this Agreement or otherwise, or
delay by a party in exercising such right or remedy, or any course of dealing
between the parties, shall not operate as a waiver thereof or an amendment
hereof, nor shall any single or partial exercise of any such right or power, or
any abandonment or discontinuance of steps to enforce such a right or power,
preclude any other or further exercise thereof or exercise of any other right or
power.
3.17
Construction
. The language
used in this Agreement will be deemed to be the language chosen by the parties
to express their mutual intent, and no rules of strict construction will be
applied against any party.
[Remainder
of this Page Intentionally Left Blank]
IN WITNESS WHEREOF,
this
Intercreditor Agreement has been duly executed as of the day and year first
above written.
|
ALEXANDRA GLOBAL MASTER FUND
LTD.,
|
|
|
As Notes Collateral
Agent
|
|
|
|
|
|
|
|
|
|
By:
|
ALEXANDRA
INVESTMENT
|
|
|
|
MANAGEMENT,
LLC,
|
|
|
|
As Investment
Advisor
|
|
|
|
|
|
|
MORIAH CAPITAL,
L.P.
|
|
|
|
|
|
|
By:
|
Moriah Capital Management,
L.P.,
|
|
|
|
General
Partner
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
By:
|
Moriah Capital Management, GP,
LLC,
|
|
|
|
General
Partner
|
|
|
|
|
|
|
|
|
|
|
Acknowledged
and agreed to by:
|
|
|
|
|
|
|
EMAGIN
CORPORATION
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ACKNOWLEDGMENT
The
undersigned hereby acknowledges and agrees to the foregoing terms and
provisions. By executing this Agreement, the undersigned agrees that
it will, together with its successors and assigns, be bound by the provisions
hereof as they relate to the relative rights of the Notes Collateral Agent and
Moriah as between them. The undersigned further agrees that: (i) the terms of
this Agreement shall not give the undersigned any substantive rights vis-a-vis
either the Notes Collateral Agent, the Noteholders or Moriah, (ii) it does not
and will not receive any right, benefit, priority or interest under or because
of the existence of this Agreement, (iii) it will execute and deliver such
additional documents and take such additional action as may be necessary or
desirable in the opinion of any Creditor to effectuate the provisions and
purposes of this Agreement and (iv) this Agreement may be amended or
supplemented from time to time without notice to, or the consent of, the
undersigned.
If either
Moriah or the Notes Collateral Agent shall enforce its rights or remedies in
violation of the terms of this Agreement, the undersigned agrees that it shall
not use such violation as a defense to any Enforcement Action by either Moriah
or the Notes Collateral Agent nor assert such violation as a counterclaim or
basis for set-off or recoupment against either Moriah, the Noteholders or the
Notes Collateral Agent.
|
EMAGIN
CORPORATION
|
|
|
|
|
|
August7,
2007
|
By:
|
/s/
|
|
|
|
Name
|
|
|
|
Title
|
|
|
|
|
|
Schedule
1
Moriah
Collateral
All now owned and hereafter acquired
property (including, without limitation, real property) and assets of Borrower
and the Proceeds and products thereof (which property, assets together with all
other collateral security for the Obligations now or hereafter granted to or
otherwise acquired by Lender, are referred to herein collectively as the "
Collateral
"),
including, without limitation, all property of Borrower now or hereafter held or
possessed by Lender and including the following (capitalized terms used but not
defined herein have the meanings given to them in the Moriah Loan
Agreement):
(a)
All now
owned and hereafter acquired: Accounts; contract rights; chattel
paper (including, but not limited to, rentals and other amounts payable under
leases of equipment to customers pursuant to which Borrower is the lessor or
assignee of any lessor); general intangibles (including, but not limited to, tax
and duty refunds, patents, patent applications, trademarks, trademark
applications, tradenames and tradestyles, copyrights, copyright applications,
trade rights (whether or not registered), discoveries, improvements, processes,
know-how, formulas, trade secrets, service marks, other rights in intellectual
property (whether patentable or not), goodwill, customer and mailing lists, life
insurance policies, licenses (whether as licensor or licensee), franchises and
permits); documents (including, without limitation, all warehouse receipts);
instruments; all guaranties, letters of credit, steamship guaranties, airway
releases or other similar guaranties, agreements or property securing or
relating to any of the items referred to above (including, but not limited to,
purchase money security interests granted by Account Debtors in connection with
installment sales); all cash monies, investment properties, deposits,
securities, bank accounts, deposit accounts, credits and other property now or
hereafter held in any capacity by Lender;
(b)
Inventory;
(c)
Equipment
and fixtures;
(d)
All now
owned and hereafter acquired right, title and interests of Borrower in, to and
in respect of any real or other personal property in or upon which Lender has or
may hereafter have a security interest, Lien or right of setoff;
(e)
All of
Borrower's existing and future leasehold interests in premises or facilities
leased from third parties by Borrower;
(f)
All
present and future books and records relating to any of the above including,
without limitation, all present and future books of account of every kind or
nature, purchase and sale agreements, invoices, ledger cards, bills of lading
and other shipping evidence, statements, correspondence, memoranda, credit files
and other data relating to the Collateral or any account debtor, together with
the tapes, disks, diskettes and other data and software storage media and
devices, file cabinets or containers in or on which the foregoing are stored
(including any rights of Borrower with respect to any of the foregoing
maintained with or by any other Person); and
(g)
Any and
all products and Proceeds of the foregoing in any form including, without
limitation, all insurance claims, warranty claims and proceeds and claims
against third parties for loss or destruction of or damage to any or the
foregoing.
Schedule
2
Notes
Collateral
The Notes Collateral includes each of
the following, whether now existing or hereafter arising:
(1) all
Accounts of eMagin Corporation, a Delaware Corporation, (the “Borrower”) and, if
the Collateral Agent exercises its rights under Section 3(b) of the Pledge and
Security Agreement, dated as of July 21, 2006, by the Borrower, to Alexandra
Global Master Fund Ltd., as Collateral Agent (the “Note Pledge Agreement”), the
Lockbox and each and every General Intangible relating thereto;
(2) all
Inventory of the Borrower;
(3) all
Equipment of the Borrower;
(4) all
Proprietary Information owned or licensed by the Borrower, whether existing on
the date hereof or developed or acquired hereafter;
(5) all
of the Borrower’s right, title and interest in and to all Contracts, Documents,
Chattel Paper, Instruments, Investment Property and General Intangibles, whether
existing on the date hereof or hereafter arising;
(6) all
cash, securities, rights and other property at any time and from time to time
received, receivable or otherwise distributed in respect of the Collateral,
including, without limitation in respect of the cash or other property held in
the Lockbox or the Collateral Account;
(7) all
Patents, Patent Licenses, Trademarks and Trademark Licenses;
(8) all
insurance policies to the extent they relate to items (1) through (7)
above;
(9) all
books, ledgers, books of account, records, writings, databases, information and
other property relating to, used or useful in connection with, evidencing,
embodying, incorporating, or referring to any of the foregoing; and
(10) to
the extent not otherwise included, all Proceeds, products, rents, issues,
profits and returns of and from any and all of the foregoing, which Proceeds may
be in the form of Accounts, Chattel Paper, Inventory or
otherwise; all as provided in the Note Pledge
Agreement. Capitalized terms used herein but not defined herein shall
have the meanings provided for such terms in the Note Pledge
Agreement.
EXHIBIT
D
TO
LOAN
AND SECURITY AGREEMENT
Form of Securities Issuance
Agreement
EXHIBIT D
SECURITIES
ISSUANCE AGREEMENT
THIS
SECURITIES ISSUANCE AGREEMENT (this “
Agreement
”) is made
and entered into as of August 7, 2007, by and between eMagin Corporation, a
Delaware corporation (the “
Company
”), and Moriah
Capital, L.P., a Delaware limited partnership (the “
Lender
”).
Capitalized
terms not otherwise defined herein have the meaning set forth in that certain
Loan and Security Agreement by and between Lender, as lender, and the Company,
as borrower, of even date herewith (the “
Loan
Agreement
”).
RECITALS
WHEREAS,
the Company has authorized the issuance to Lender on the date hereof of shares
of the Company’s common stock, $0.001 par value per share (“
Common Stock
”), with
an aggregate market value on the Closing Date of $195,000, based on the closing
price of the Common Stock on the OTC Bulletin Board on the Closing Date (the
“
Initial Issued
Shares
”);
WHEREAS,
the Company wishes to issue the Issued Shares (as defined below) to
Lender;
WHEREAS,
the Company has authorized the issuance to Lender, pursuant to the terms of the
Loan Agreement, on the effective date of extension of the initial term of the
Loan (if so extended), Common Stock with an aggregate market value of $195,000
based on the average closing price of the Common Stock on the OTC Bulletin Board
or such other trading market which such Common Stock is then listed or traded,
for the ten (10) trading days preceding such effective date(the “
Contingent Issued
Shares
”) (the Contingent Shares, together with the Initial Issued Shares,
are referred to herein as the “
Issued Shares
”);
and
WHEREAS,
the issuances and other obligations and transactions described and contemplated
hereby are in partial consideration for Lender agreeing to enter into, perform
or accept, as applicable, the Loan Agreement and the other Loan
Documents;
NOW,
THEREFORE, in consideration of the foregoing recitals and the mutual promises,
representations, warranties and covenants set forth herein, and for other good
and valuable consideration, the receipt and sufficiency of which are hereby
acknowledged, the parties hereto agree as follows:
1.
Issuance
.
1.1
|
On
the date of execution of this Agreement, also known as the Closing Date,
the Company agrees to issue to Lender, and Lender agrees to acquire from
the Company, the Initial Issued
Shares.
|
1.2
|
On
the date of extension of the initial term of the Loan, also known as the
Extension Date, the Company agrees to issue to Lender, and Lender agrees
to acquire from the Company, the Contingent Issued Shares, the certificate
for which shares shall be delivered to Lender within five (5) days of such
date.
|
2.
Closing;
Delivery
. (a)
Closing Obligations of
Company
. At the Closing Date, except as set forth below, the Company
shall have taken and shall take all actions necessary to issue the Issued Shares
to Lender and to consummate the transactions contemplated hereby, including,
without limitation, delivery or causing to be delivered to Lender the
following:
(a)
|
A
certificate for the Initial Issued Shares within five (5) days of the
Closing Date;
|
(b)
|
executed
originals, and delivery of, all of the Loan Documents;
and
|
(c)
|
such
other certificates, documents, receipts and instruments as Lender or its
legal counsel may request.
|
(b)
Closing Obligations of
Lender
. At the Closing Date, Lender shall have taken and shall
take all actions necessary for its acquisition of the Initial Issued Shares, and
to consummate the transactions contemplated hereby.
3.
Representations and
Warranties of the Company
. The Company hereby represents and
warrants to Lender as follows:
3.1
Organization, Good Standing
and Qualification
. Each of the Company and its Subsidiaries is
a corporation duly organized, validly existing and in good standing under the
laws of its jurisdiction of organization. Each of the Company and its
Subsidiaries has the corporate power and authority to own and operate its
properties and assets; to execute, deliver and perform or cause to be executed,
delivered and performed this Agreement ; and to carry on its business as
presently conducted.
3.2
|
Capitalization; Voting
Rights
.
|
(a)
The
authorized and issued capital stock of the Company as of the date hereof is as
disclosed in the Company’s filings that are required by the Securities Act of
1933, as amended (the “
Securities Act
”) and
the Securities Exchange Act of 1934, as amended (the “
Securities Exchange
Act
”) (the “
SEC
Reports
”) to be filed with the Securities and Exchange Commission (“
SEC
”).
(b)
Except as
disclosed in the SEC Reports, other than: (i) Common Stock reserved for issuance
under the Company’s stock option plans and (ii) the Issued Shares, there are no
outstanding options, warrants, rights (including, but not limited to, conversion
or preemptive rights and rights of first refusal), proxy or stockholder
agreements, or other arrangements or agreements of any kind for the purchase or
acquisition from the Company or its Subsidiaries, of any of their
securities. Neither the offer, issuance or sale of any of, or the
issuance of any of, the Issued Shares, nor the consummation of any transactions
contemplated hereby, will result in a change in the price or number of any
securities of the Company or its Subsidiaries authorized or issued.
(c)
All
issued and outstanding securities: (i) have been duly authorized and validly
issued and are fully paid and nonassessable and (ii) were issued in compliance
with all applicable state and federal laws.
(d)
The
Issued Shares have been duly and validly reserved for issuance. When
issued in compliance with the provisions of this Agreement, the Issued Shares
will be validly issued, fully paid and nonassessable, and will be free of any
liens, charges, encumbrances, options, rights of first refusal, security
interests, claims, mortgages, pledges, charges, easements, covenants,
restrictions, (except as contained herein) obligations, or any other
encumbrances (including, without limitation, any conditional sale or other title
retention agreement or any lease in the nature thereof and any agreement to
grant or to permit or suffer to exist any of the foregoing) or third party
rights or equitable interests of any nature whatsoever or any Liens all of the
above shall be referred to herein as a “Lien”.
3.3
Authorization; Binding
Obligations
. All corporate action on the part of the Company
necessary for the authorization of the Loan Documents, and the performance of
the same, has been taken or will be taken prior to the Closing
Date. The Loan Documents, when executed and delivered, will be valid
and binding obligations of the Company, enforceable against it in accordance
with their terms.
3.4
Title to Properties and
Assets; Liens, Etc
. Except for Permitted Encumbrances, each of
the Company and each of its Subsidiaries has good and marketable title to its
properties and assets, and good title to its leasehold estates, in each case not
subject to any Liens.
3.5
No
Conflicts
. Neither the Company nor any of its Subsidiaries is
in violation or default of (a) any term of its formation documents or by-laws or
(b) of any provision of any indebtedness for borrowed money, Contract any
mortgage, indenture, lease, license, agreement or contract (collectively, “
Contracts
”) or
judgment, order, writ, injunction, or decree (“
Orders
”). The
execution, delivery and performance of this Agreement and the Loan Documents
will not, with or without the passage of time or giving of notice, result in any
violation, or be in conflict with, or constitute a default under, any such term
or provision of indebtedness for borrowed money, Contract or Order, or result in
the creation of any Lien upon any of the securities, properties or assets of the
Company or any of its Subsidiaries, or the suspension, revocation, impairment,
forfeiture or nonrenewal of any licenses, permits, franchises, approvals,
consents, waiver, notices, authorizations, qualifications, concessions, or the
like.
3.6
Registration Rights and
Voting Rights
. Except as disclosed in the Registration Rights
Agreement, neither the Company nor any of its Subsidiaries is presently under
any obligation, and neither the Company nor any of its Subsidiaries has granted
any rights, to register any of the Company’s or its Subsidiaries’
securities. Except as disclosed in any SEC Reports, to the Company’s
best knowledge, no stockholder of the Company or any of its Subsidiaries has
entered into any agreement with respect to the voting of equity securities of
the Company or any of its Subsidiaries.
3.7
Valid
Offering
. Assuming the accuracy of the representations and
warranties of Lender contained in this Agreement, the offer, sale and issuance
of the Issued Shares will be exempt from the registration requirements of the
Securities Act, and will have been registered or qualified (or are exempt from
registration and qualification) under the registration, permit or qualification
requirements of all applicable state securities laws.
3.8
SEC
Reports
. The Company’s SEC Reports do not contain
any untrue statement of a material fact nor omit to state a material fact
necessary in order to make the statements contained herein or therein, in light
of the circumstances in which they are made, not misleading.
3.9
Fees; Brokers;
Finders
. There are no fees, commissions or other compensation
due to any third party in connection with the Loan Documents. All
negotiations relative to the Loan Documents, and the transactions contemplated
thereby, have been carried on by the Company with Lender and without the
intervention of any other person or entity acting on behalf of the Company, and
in such manner as not to give rise to any claim against the Company or Lender
for any finder's fee, brokerage commission or like payment, and if any such fee,
commission or payment is payable, it shall be the sole responsibility of the
Company and the Company shall pay, and indemnify Lender for, the
same.
4.
Representations and
Warranties of Lender
. The Lender hereby represents and
warrants to the Company that (a) the Lender has the power and authority to
execute, deliver and perform this Agreement, (b) all partnership or corporate
action on Lender’s part required for the execution, delivery and performance of
this Agreement has been or will be taken on or prior to the Closing Date, (c)
upon execution and delivery, this Agreement will be valid and binding
obligations of Lender, enforceable in accordance with its terms, and (d) the
Lender will not engage in “short sales” of the issued and outstanding Common
Stock during the Term.
5.
Covenants of the
Company
. The Company covenants and agrees with Lender as
follows:
5.1
Reporting
Requirements
. The Company and its Subsidiaries will timely
file with the SEC and state regulatory authorities all reports, documents,
information and other material required to be filed or disclosed
thereto.
5.2
Confidentiality
. The
Company agrees that it will not disclose, and will not include in any public
announcement, the name of Lender or the terms of this Agreement other than as
permitted under the Loan Agreement or as required by law.
5.3
SEC
Reporting.
The Company shall comply with all reporting
requirements under the Securities Exchange Act, including, but not limited to,
making available all required current information regarding the Company under
Rule 144(c) under the Securities Act, so as to enable Lender to effect resales
of the Issued Shares under Rule 144. The Company shall cooperate with
Lender in connection with all resales pursuant to Rule 144(d) and Rule 144(k)
and provide legal opinions necessary to allow such resales, provided the Company
and its counsel receive reasonably requested representations from Lender and
broker, if any.
5.4
Indemnification
. The
Company and its Subsidiaries agree, jointly and severally, to indemnify, hold
harmless, reimburse and defend Lender, and Lender’s partners, officers,
directors, agents, representatives, affiliates, members, managers, and
employees, against any claim, cost, expense, liability, obligation, loss or
damage (including, without limitations, reasonable legal fees) of any nature,
incurred by or imposed upon them which results, arises out of, or is based upon:
(a) any misrepresentation by the Company or any of its Subsidiaries, or breach
of any warranty by the Company or any of its Subsidiaries in this Agreement, or
in any exhibits or schedules attached hereto, and (b) any breach or default in
performance by Company or any of its Subsidiaries of the their obligations
hereunder.
6.
Put
Option
. The Company hereby grants to Lender an option (the
“
Put Option
”)
to sell all or any portion of the Issued Shares (the “
Put Shares
”) to the
Company for a total purchase price of $195,000, pro-rated for any portion
thereof (the “
Put
Price
”). The Put Option may be exercised with respect to any
amount that is equal to or less than the entire balance of the outstanding Put
Shares, at any time during the earlier to occur of the following Put Option
exercise periods (the “Put Period”): (a) the ten (10) Business Day period
commencing on the first anniversary hereof, or (b) the ten
(10) Business Day period commencing on the date which is nine (9) months after
the date that the registration statement for the registration of the Issued
Shares is declared effective by the SEC . If not exercised during the
Put Period, the Put Option shall terminate and shall be of no further force or
effect. The Put Option shall be exercisable by Lender’s delivery of
written notice to the Company (the “
Put
Notice
”). The Put Notice shall specify the date on which the
closing of the purchase of the Put Shares shall take place (the “
Put Closing Date
”),
which such date shall be no earlier than ten (10) days but no later than thirty
(30) days from the date of the Put Notice. On or before the Put
Closing Date, Lender will deliver to the Company the certificate(s) representing
the Put Shares (duly endorsed for transfer by Lender or accompanied by duly
executed stock powers in blank) and the Company shall tender to Lender the Put
Price in cash by wire transfer of immediately available funds to an account at a
bank designated by Lender. The Company and Lender acknowledge and
agree that the Company’s obligation to purchase the Issued Shares from Lender
pursuant to the Put Option is an Obligation secured by the Collateral and any
related guarantees under the Loan Documents, and for so long as the Put Option
is outstanding and, if exercised, the Put Price is not yet tendered, the
Lender’s right to receive the Put Price shall be secured by the
Collateral and any related guarantees under the Loan Documents.
Lender’s right to exercise the Put Option shall not be transferred or assigned
to any third party.
6.1 Notwithstanding
the foregoing, Lender shall have the right, but not the obligation, to
accelerate the exercise of the Put Option upon a Fundamental
Transaction (as defined in the Loan Agreement), as follows: The Company shall
send written notice of the proposed Fundamental Transaction (“Fundamental
Transaction Notice
”)
no later than thirty (30) days prior to the date of the proposed consummation of
the Fundamental Transaction, together with all relevant information relating
thereto, in form sufficient to enable Lender to make an informed decision as to
whether it should accelerate the Put Option. Within fifteen (15) days
of Lender’s receipt of the Fundamental Transaction Notice, Lender shall advise
the Company whether the Lender has elected to accelerate the exercise of the Put
Option. Lender’s failure to timely notify the Company of Lender’s
intention to accelerate the Put Option shall be deemed an intention to decline
to accelerate the Put Option.
6.2 In
addition, notwithstanding the foregoing, Lender shall have the right, but not
the obligation, to accelerate the exercise of the Put Option following an Event
of Default under the Loan Documents (which acceleration right shall not be
waived if not exercised following a prior Event of Default), in which event the
Put Price shall be added to the Obligations under the Loan Agreement and secured
by the Collateral thereunder, and shall be immediately due and payable to
Lender.
6.3 If
any portion of the Note is converted into Common Stock pursuant to the Loan
Documents, the Put Option set forth hereinabove, if not terminated by its terms
herein, shall terminate.
7.
Miscellaneous
.
7.1
Notices
. All
notices, requests and demands to or upon the respective parties hereto shall be
given in writing and shall be deemed to have been duly given or made upon
receipt by the receiving party. All notices, requests and demands are
to be given or made to the respective parties at the following addresses (or to
such other addresses as either party may designate by notice in accordance with
the provisions of this paragraph):
If to the Company:
10500
N.E. 8
th
Street
Suite
1400
Bellevue,
Washington 12533
Attention: John Atherly
With a copy to:
Sichenzia Ross Friedman Ference
LLP
61 Broadway
New York, New York 10006
Attention: Richard A.
Friedman, Esq.
If to Lender:
685 Fifth Avenue
New York, New York 10022
Attention: Greg
Zilberstein
With a copy to:
Cohen Tauber Spievack & Wagner
LLP
420 Lexington Avenue, Suite
2400
New York, New York 10170
Attention: Adam Stein,
Esq.
7.2
Amendment
. Any
modification or amendment shall be in writing and signed by the parties hereto,
and any waiver of, or consent to any departure from, any representation,
warranty, covenant or other term or provision shall be in writing and signed by
each affected party hereto or thereto, as applicable.
7.3
Construction
. No
provision of this Agreement shall be construed against or interpreted to the
disadvantage of any party hereto by reason of such party or its counsel having,
or being deemed to have, structured or drafted such provision.
7.4
Entire
Agreement
. This Agreement contains the entire agreement of the
parties with respect to the subject matter hereof and supersedes all other
negotiations, representations, warranties, agreements and understandings, oral
or otherwise, between the parties with respect to the matters contained
herein.
7.5
Headings
. Section
and paragraph headings are for convenience only and shall not be construed as
part of this Agreement.
7.6
Severability
. Every
provision of this Agreement is intended to be severable. If, in any
jurisdiction, any term or provision hereof is determined to be invalid or
unenforceable, (a) the remaining terms and provisions hereof shall be
unimpaired, (b) any such invalidity or unenforceability in any jurisdiction
shall not invalidate or render unenforceable such term or provision in any other
jurisdiction, and (c) the invalid or unenforceable term or provision shall, for
purposes of such jurisdiction, be deemed replaced by a term or provision that is
valid and enforceable and that comes closest to expressing the intention of the
invalid or unenforceable term or provision. If a court of competent
jurisdiction determines that any covenant or restriction, by the length of time
or any other restriction, or portion thereof, set forth in this Agreement is
unreasonable or unenforceable, the court shall reduce or modify such covenants
or restrictions to those which it deems reasonable and enforceable under the
circumstances and, as so reduced or modified, the parties hereto agree that such
covenants and restrictions shall remain in full force and effect as so
modified. In the event a court of competent jurisdiction determines
that any provision of this Agreement is invalid or against public policy and
cannot be so reduced or modified so as to be made enforceable, the remaining
provisions of this Agreement shall not be affected thereby, and shall remain in
full force and effect.
7.7
Successors
and
Assigns
. All covenants, promises and agreements by or on
behalf of the parties contained in this Agreement shall be binding upon and
shall inure to the benefit of the parties hereto and their respective successors
and permitted assigns;
provided
,
however
, that nothing
in this Agreement, express or implied, shall confer on the Company the right to
assign any of its rights or obligations hereunder at any time.
7.8
Survival
. All
covenants, agreements, representations and warranties made by the Company herein
or in any certificate, report or instrument contemplated hereby shall survive
any independent investigation made by Lender and the execution and delivery of
this Agreement, and such certificates, reports or instruments and shall continue
so long as any Obligations are outstanding and unsatisfied, applicable statutes
of limitations to the contrary notwithstanding.
7.9
No Waiver
; Rights and
Remedies
. A waiver of a breach of any term, covenant or
condition of this Agreement shall not operate or be construed as a continuing
waiver of such term, covenant or condition, or breach, or of any other term,
covenant or condition, or breach by such party. No failure to
exercise and no delay in exercising any right, remedy, or power hereunder shall
preclude any other or further exercise of any other right, remedy or power
provided herein or by law or in equity. Lender is entitled to
exercise all rights and remedies available to it at law or in equity in
connection with this Agreement. The rights and remedies of Lender
hereunder are several and cumulative at Lender’s discretion and may be exercised
at Lender’s discretion.
7.10
Governing Law;
Jurisdiction
. This Agreement shall be governed by and
construed in accordance with the applicable laws pertaining in the State of New
York (without giving effect to New York's principles of conflicts of
law). The parties hereby (a) irrevocably submit and consent to the
exclusive jurisdiction of the Supreme Court for New York County, State of New
York, and the United State District Court for the Southern District of New York
with respect to any action or proceeding arising out of this Agreement and (b)
waive any objection based on venue or
forum
non
conveniens
with
respect hereto. In any such action or proceeding, the Company waives
personal service of the summons and complaint or other process and papers
therein and agrees that the service thereof may be made by mail directed to the
Company at its office set forth herein or other address thereof of which Lender
has received notice as provided herein, service to be deemed complete as
permitted under the rules of either of said Courts. Any such action
or proceeding commenced by the Company against Lender will be litigated only in
the New York Supreme Court for New York County, State of New York, and the
United States District Court for the Southern District of New York.
7.11
Counterparts
. This
Agreement may be executed in counterparts and by facsimile or electronic
signature, each of which when so executed, shall be deemed an original, but all
of which shall constitute but one and the same instrument.
[SIGNATURE
PAGE FOLLOWS]
IN
WITNESS WHEREOF, the parties hereto have executed this Securities Issuance
Agreement as of the date set forth in the first paragraph hereof.
|
EMAGIN
CORPORATION
|
|
|
|
|
|
|
By:
|
/s/
|
|
|
|
Name
|
|
|
|
Title
|
|
|
|
|
|
|
MORIAH CAPITAL,
L.P.
|
|
|
|
|
|
|
By:
|
Moriah Capital Management,
L.P.,
|
|
|
|
General
Partner
|
|
|
|
|
|
|
|
|
|
|
|
|
|
By:
|
Moriah Capital Management, GP,
LLC,
|
|
|
|
General
Partner
|
|
|
|
|
|
|
|
|
|
EXHIBIT
E
TO
LOAN
AND SECURITY AGREEMENT
Chief Executive
Office
eMagin
Corporation
10500
N.E. 8
th
Street
Suite
1400
Bellevue,
WA 98004
Principal Place of
Business
eMagin
Corporation
10500
N.E. 8
th
Street
Suite
1400
Bellevue,
WA 98004
Locations of
Collateral
eMagin
Corporation
2070
Route 52
Hopewell
Junction, NY 12533
eMagin
Corporation
10500
N.E. 8
th
Street
Suite
1400
Bellevue,
WA 98004
ASTERIA
MANUFACTURING SDN BHD
WISMA AIC
LOT 3
SELANGOR
DARU EHASN
MALAYSIA
Locations of Books and
Records
eMagin
Corporation
10500
N.E. 8
th
Street
Suite
1400
Bellevue,
WA 98004
EXHIBIT
F
TO
LOAN
AND SECURITY AGREEMENT
Forms of Landlord
Agreements
SUBLEASE
AGREEMENT
This
Sublease Agreement (the
'Sublease")
is made
as of July , 2005 by and
between
CAPGEMINI U.S. LLC
,
a Delaware limited
liability company, (the
'Sublessor"),
and
EMAGIN
CORPORATION,
a Delaware corporation (the
'Sublessee").
RECITALS
A.
Bellevue
Place Office Building Limited Partnership, a Washington limited partnership (the
'Landlord")
and
Ernst & Young U.S. LLP, a Delaware limited liability partnership
("E&Y"), entered into that certain Bank of America Office Lease and First
Lease Addendum, both dated April 20, 2000 (the
Office Lease"),
for
certain space on the fourteenth (14
h
) floor
in the Bank of America Building at Bellevue Place, 10500 NE
gh
Street,
Bellevue, Washington (the
"Building"),
which
leased space is more specifically described in the Office Lease. The Office
Lease was subsequently assigned to Sublessor, formerly known as Cap Gemini Ernst
& Young U.S. LLC, pursuant to that certain Assignment of Lease dated
February 26, 2002 (the
"Assignment").
B.
The
Office Lease was further amended by that certain Second Lease Addendum dated
October 23, 2003 (the
'Second Addendum").
The Office Lease, as amended by the Second Addendum, is hereinafter
referred to as the
'Prime
Lease".
C.
Sublessor desires to sublet the Subleased Premises (as defined herein) located
in the Building to Sublessee, and Sublessee desires to sublease the Subleased
Premises from Sublessor, for the term and upon the conditions set forth
herein.
NOW,
THEREFORE, in consideration of the rent and other payments hereinafter set
forth, the covenants and agreements of the parties contained herein, and other
good and valuable consideration, the receipt and sufficiency of which is hereby
acknowledged, the parties hereby agree as follows:
1.
Demise.
Subject to
Section 23
hereof, Sub lessor does hereby agree to sublease the Subleased Premises
to Sublessee, and Sublessee does hereby accept and sublease the Subleased
Premises from Sublessor, for the term and upon the conditions set forth
herein.
2.
Term
Provided Landlord has consented
to this Sublease pursuant to
Section
23 the term
of the sublease of the Subleased Premises shall commence on July
1,
2005 (the
"Commencement Date").
This Sublease shall expire at 11:59 p.m. on August 31, 2009, but in no
event later than the expiration date of the Prime Lease, unless sooner
terminated in accordance with the provisions of this Sublease.
Notwithstanding
the foregoing, if the Landlord has not consented to this Sublease on or before
July 1, 2005, then Sublessor and Sublessee agree that the Commencement Date may
be moved forward for up to an additional 31 days
(i.e.
August 1, 2005)
in order to further pursue such request and to accommodate the Landlord's
requirements in connection with its review and approval thereof; whereupon the
Rent Commencenemt Date and the Base Rent adjustment dates referenced in Section
5 (a) below shall also be moved forward by the same number of days.
Sublessor
and Sublessee agree to use their best efforts to obtain the Landlord's consent
as soon as reasonably possible following the date of execution of this
Sublease.
Notwithstanding
the Commencement Date, upon execution of this Sublease, and Landlord's consent
to the Sublease, Sublessee shall have the right to access the Subleased Premises
prior to the Commencement Date, rent-free and without any other consideration to
Sublessor, for the purpose of installing Tenant's fixtures and
equipment.
3.
Subleased Premises.
The
'Subleased
Premises"
shall mean approximately -18;961 rentable square feet on the
14
1h
floor of the Building, as more specifically depicted on
Exhibit
A
attached hereto and made a part hereof. The Subleased Premises include
all of the Leased Premises identified in the Prime Lease.
4.
Use. The
Sublessee may use the Subleased Premises under the trade name "eMagin" solely
for general office purposes (including incidental light assembly of electronic
equipment, if and to the extent permitted in the Prime Lease or consented to by
the Landlord), in accordance with all applicable laws, ordinances and
regulations aid subject to the Incorporated Provisions (defined in Section 6
below) of the Prime Lease and this Sublease.
5.
Payment of
Rent.
(a) Beginning
on September 1, 2005 (the
"Rent Commencement
Date'),
Sublessee
shall pay base rent as follows (the
'Base
Rent"):
Dates
|
|
Montly Base
Rent
|
|
Annual Base Rent Per
RSF
|
Rent
Commencement Date — June 30, 2006
|
|
$
|
22,561.39
|
|
$14.28 /
RSF
|
July
1, 2006 — June 30, 2007
|
|
$
|
39,028.06
|
|
$24.70 /
RSF
|
July
1, 2007 — August 31, 2009
|
|
$
|
40,608.14
|
|
$25.70
/ RSF
|
|
|
|
|
|
|
Sublessor
hereby directs Sublessee, and Sublessee does hereby agree, that such payment of
Base Rent and payment of all other amounts due and payable to Sublessor under
this Sublease shall be made to (and to the order of) Capgemini U.S. LLC,
Corporate Real Estate Services, One Panorama Center, 7701 Las Colinas Ridge,
Suite 600, Irving, Texas 75063 (or at such other place as the Sublessor
subsequently shall designate in writing) and shall be paid in lawful money of
the United States of America without notice or demand, and without abatement,
deduction, counter-claim or setoff. Any installment of Base Rent that is
received by Sublessor after the fifth (5th) day of the calendar month shall, at
Sublessor's option, be subject to a late charge of ten percent (10%) of the
amount thereof and such charge shall be paid by Sublessee upon demand by
Sublessor, it being understood that the late fee described herein shall not be
deemed a liquidated damages calculation and shall not preclude any other remedy
of Sublessor under this Sublease or at law. To
he
extent that this Sublease shall commence on a day other than the first
day of any calendar
month, or
terminate on a day other than the last day of any calendar month, the Base Rent
under this Sublease shall be prorated on a per diem basis for that particular
month.
(b)
In
addition to payment of Base Rent as aforesaid, Sublessee shall pay to Sublessor
Operating Costs and Maintenance Expenses, as such term is defined in the Prime
Lease, with respect to the Subleased Premises, to the extent that such Operating
Costs and Maintenance Expenses exceed that which Sublessor must pay for the
calendar year 2005 (the "Base Year"). For example, if the Operating Costs and
Maintenance Expenses required to be paid by Sublessor for the Base Year are
determined to be $9.70 per foot (the "Base Year Rate"), and the Operating Costs
and Maintenance Expenses required to be paid by Sublessor for calendar year 2006
are estimated by the Landlord to be $10.70 per foot as determined pursuant to
the Prime Lease, then Sublessee shall pay said $1.00 increase in the Base Year
Rate to Sublessor as additional rent at the same times and in the same manner as
specified in the Prime Lease. Furthermore, to the extent that Landlord charges
Sublessor for any service, act or utility provided to the Subleased Premises
beyond the basic services, acts and utilities that are required to be supplied
by the Prime Lease without charge, including, without limitation, heating, air
conditioning, utilities and additional cleaning, Sublessee shall pay
for such charges as additional rent, immediately upon demand therefor to
the extent such charges relate to the Subleased Premises (the
"Additional
Rent").
(c)
All
payments referenced in this
Section 5,
including,
without limitation, Base Rent and Additional Rent are hereinafter referred to
collectively as
'Rent".
(d)
Notwithstanding the provisions of this Section 5 regarding Sublessee's,
obligation to pay Rent to Sublessor, Sublessor and Sublessee understand,
acknowledge and agree that the Base Rent and Additional Rent required to be paid
by Sublessor to Landlord under the Prime Lease is more than the Rent required to
be paid by Sublessee pursuant to this Sublease, and that Sublessor shall
continue to be obligated to pay such Base Rent and Additional Rent (except to
the extent that Sublessee is required to pay the excess Operating Costs and
Maintenance Expenses as provided in Section 5 (b) above) to the Landlord at the
times and in the manner specified in the Prime Lease.
6.
Certain Provisions of Lease
Incorporated.
The following provisions of the Prime Lease (the
'Incorporated
Provisions
") are explicitly incorporated herein by reference
and made a part hereof: Paragraphs 2.2, 6.5, Article 9, Paragraphs 10.2, 10.3,
11.2, 11.3, 12.1, 12.2, Article 13, Article 14, Article 15, Article 16, Article
19, Article 21, Article 22, Article 23, Article 26, Paragraph 34.2, Article 37
(excluding Paragraphs 37.7 and 37.14). No consent, waiver, amendment, or other
change by Landlord as permitted under the Prime Lease of Sublessor's obligations
and liabilities as tenant under the Prime Lease shall reduce or limit
Sublessee's obligations and liabilities to Sublessor hereunder unless Sublessor
shall have agreed in writing that such consent, waiver, amendment or change
shall be effective hereunder. Unless the context requires otherwise, for the
period during the term of this Sublease only, (i) references in the Incorporated
Provisions to Landlord shall refer to Sublessor (subject to the provisions of
this Sublease which relieve Sublessor of any obligation or responsibility for
the performance of the obligations of Landlord under the Prime Lease), (ii)
references in such provisions to Tenant shall refer to Sublessee, and (iii)
references in such provisions to the Premises shall refer to the Subleased
Premises
hereunder. Sublessee expressly assumes toward Sublessor and agrees to perform
all of the obligations, responsibilities and covenants that Sublessor has
assumed as Tenant under the Incorporated Provisions
in
respect of the Subleased
Premises. Sublessee acknowledges that it has received a copy of the Prime Lease,
and agrees not to do, or cause to be done, any act (whether of omission or
commission) which would result in a default under or breach of any term,
covenant, provision or condition of the Prime Lease. Sublessee shall not have
any expansion, contraction or similar rights (including without limitation any
rights of first offer or rights of first refusal) under the Prime Lease, or any
rights to cancel, terminate, extend or renew the term of the Prime
Lease.
Notwithstanding
the incorporation herein of the Incorporated Provisions or anything otherwise
contained in this Sublease to the contrary,
(a)
Sublessor
shall not be obligated to render or provide any of the services required to be
provided by Landlord under the Prime Lease or the Incorporated Provisions,
respectively, and Sublessor shall not be obligated to satisfy any obligations of
the Landlord thereunder; and
(b)
Sublessor
shall not have any responsibility or liability to Sublessee (i) on account of
any act or omission of Landlord, any default by Landlord, or breach by Landlord
of any term, covenant or condition of the Prime Lease, or any failure by
Landlord to perform any of its obligations under the Prime Lease, or (ii) by
reason of any condition of or in the Building or the Subleased Premises now or
hereafter existing;
provided,
however, that Sublessor shall, at Sublessee's request and expense, take all such
reasonable actions as Sublessee shall direct to enforce Sublessor's rights and
remedies under the Prime Lease with respect to the Subleased Premises or, at
Sublessor's option, authorize Sublessee to enforce the same in Sublessor's name.
Sublessee shall indemnify and hold harmless Sublessor against any loss,
liability, claim, cost or expense arising out of or in connection with any
actions taken pursuant to the preceding sentence, and Sublessee shall be
entitled to receive and retain any recovery allocable to the Subleased Premises
during the term of this Sublease resulting from such actions, after recovery by
Sublessor of all loss, liability, claim, cost and expense due to Sublessor by
Sublessee hereunder.
7. Net
Return
The payments
of Sublessee hereunder to Sublessor are intended to constitute an absolutely net
return to Sublessor with respect to the Subleased Premises, and except to the
extent of (i) the difference between the Base Rent payable hereunder and the
Base Rent payable under the Prime Lease, and (ii) excluding the cost of
Operating Costs and Maintenance Expenses to be paid by Sublessor for the
Subleased Premises, all costs of any kind relating to the Incorporated
Provisions (with respect to the Subleased Premises), this Sublease, or the use
and operation of the Subleased Premises shall be the responsibility of the
Sublessee. Without limiting the generality of the foregoing, (i) whenever
Sublessee requires Landlord to furnish any service or perform any act for which
Landlord is entitled to make a separate charge under the Prime Lease, including,
without limitation, heating, air conditioning and utilities, Sublessee shall pay
the same, and (ii) Sublessee shall pay to Sublessor any charges billed to
Sublessor from time to time, to the extent any such charges are allocable, as
determined by Sublessor, for services provided to the Subleased
Premises.
8.
Property Located in or about
the Subleased Premises.
All improvements, fixtures, equipment and
personal property in or about the Subleased Premises shall be in or about the
Subleased Premises at the sole risk of Sublessee. The improvements, fixtures,
equipment and personal property in or about the Subleased Premises as of the
Commencement Date (as more particularly described on
Exhibit B
attached hereto and made a
part hereof, the
"Sublessor's
Property"),
other
than the equipment, trade fixtures and personal property of Sublessee or anyone
claiming by, through or under Sublessee shall be and remain the property of
Sublessor and shall be kept by Sublessee in good condition and repair (subject
to normal wear and tear) and shall not be removed from the Subleased Premises.
Sublessor makes no warranties of any kind or nature, `Whether express or implied
(including without limitation warranties of merchantability or fitness for a
particular purpose), with respect to the Sublessor's Property, and Sublessee
accepts the Sublessor's Property for use during the term hereof in its "as is"
and "where is" condition. Sublessee shall insure the Sublessor's Property in the
name of Sublessor as part of the property insurance required hereunder.
Sublessor shall have the right to enter the Subleased Premises at all reasonable
times and after giving Sublessee reasonable notice, for the purpose of, among
other things, inspecting the Subleased Premises and the Sublessor's Property. In
consideration of the Rent payable to Sublessor, and provided that Sublessee
shall not then be in default under this Sublease, upon the end of the term of
this Sublease (or if, this Sublease is terminated by Landlord on account of
Sublessor's default of its obligations under the Prime Lease excluding any such
termination on account of Sublessee's default of its obligations under this
Sublease) Sublessor shall transfer the Sublessor's Property to Sublessee in its
"as is" and "where is" condition, with all representations and warranties
(including without limitation warranties of merchantability or fitness for a
particular purpose) hereby waived by Sublessee. Any applicable sales, use or
similar tax or charge which may be imposed or due by reason of such use or
transfer of Sublessor's Property shall be the sole responsibility of Sublessee,
and Sublessee agrees to pay such taxes or charges to Sublessor at any, time upon
demand (including after the termination or expiration of this Sublease).
Sublessee hereby acknowledges that it has inspected the Sublessor's Property and
waives any and all claims against Sublessor arising out of any damage, defect or
condition relating to the Sublessor's Property.
9.
Surrender.
At the
termination of this Sublease, by lapse of time or otherwise, Sublessee shall
surrender possession of the Subleased Premises to Sublessor and deliver all keys
to the Subleased Premises and all locks therein to Sublessor and make known to
Sublessor the combination of all combination locks in the Subleased Premises and
shall return the Subleased Premises and the Sublessor's Property (to the extent
the Sublessor's Property has not been transferred to Sublessee pursuant to the
terms of
Section 8
of this Sublease) to Sublessor in broom clean condition and in as good
condition as Sublessee originally took possession, normal wear and tear
excepted, failing which Sublessor may restore the Subleased Premises and the
Sublessor's Property to such condition and the Sublessee shall pay the cost
thereof to Sublessor on demand. Upon or prior to such termination of this
Sublease, Sublessee shall remove all of Sublessee's personal property (but not
Landlord's personal property) and only those improvements, alterations and
additions, which as a condition to Sublessor's or Landlord's consent to the
installation thereof, are required to be removed and restored upon termination
hereof.
10.
Assignment and Subletting.
Sublessee shall have no right to sublet the Subleased Premises or any
portion thereof or assign or otherwise transfer its interest in this Sublease,
whether expressly or by operation of law, without the prior written consent of
Sublessor and all other consents and approvals that may be required under the
Prime Lease.
11.
Representations and
Warranties of Sublessor.
As of the date hereof, Sublessor represents and
warrants to Sublessee, and agrees, as follows: (i) the Prime Lease which is
identified by the documents referenced above in Recital Paragraphs A and B
represents a true, correct and complete copy of the Prime Lease; (ii) the Prime
Lease has not been modified or amended except as set forth in the documents
referenced above in Rectal Paragraphs A and B; (iii) Sublessor has received no
written notice from Landbrd of default still outstanding; (iv) Sublessor will
not, from the date hereof through the date of termination of this Sublease,
trigger an Event of Default (as defined in the Prime Lease) (excluding those
caused by breach of this Sublease by Sublessee or any acts or omissions of
Sublessee) which results in Landlord rightfully terminating "and retaking
possession of the Subleased Premises from Sublessee prior to the end of the term
of this Sublease; (v) no liens exist, nor will be permitted by Sublessor to
exist, against the Subleased Premises in violation of Section 22 of the Prime
Lease for work performed, materials furnished, equipment supplied or obligations
incurred by or on behalf of Sublessor; (vi) if any rent is abated pursuant to
paragraph 16 of the Prime Lease, the Rent owed by Sublessee pursuant to this
Sublease shall also be abated proportionately and for the same time, and (vi)
any award which may be sought by Sublessor pursuant to Section 28.4 of the Prime
Lease will be prorated between Sublessor and Sublessee based upon their
respective interests in the Subleased Premises..
12.
Indemnification By
Sublessee.
Sublessee agrees, to the extent not expressly prohibited by
law, to pay, and to protect, defend, indemnify and save harmless Sublessor and
Landlord and their respective past, present and future employees, officers and
agents (each an
"Indemnified Party"
and collectively, the
Indemnified Parties"),
from and against any liabilities, losses, damages, costs or expenses
(including, but not limited to, attorneys' fees and expenses) of any nature
whatsoever which may be imposed upon, incurred by, or asserted against any
Indemnified Party by reason of or in connection with (i) any accident, injury
to, or death of any person or any damage to property or any other events
occurring on or about the Subleased Premises, or (ii) any breach by Sublessee
(excluding any breach caused by Sublessor) of any term or condition of the
Incorporated Provisions or the Prime Lease, with respect to the Subleased
Premises, or this Sublease or any failure by Sublessee to perform or comply with
(x) any of the terms of the Incorporated Provisions, with respect to the
Subleased Premises or (y) this Sublease, or (z) any restrictions, statutes,
laws, ordinances or regulations affecting the Subleased Premises or any part
thereof or Sublessee's use of the Subleased Premises.
13.
Indemnification by
Sublessor.
Subject to the limitations on Sublessor's liabilities as
specified in Section 24 below, Sublessor agrees, to the extent not expressly
prohibited by law, to pay, and to protect, defend, indemnify and save harmless
Sublessee and Sublessee's past, present and future employees, officers and
agents (each an
"Indemnified Party"
and collectively, the
"Indemnified Parties"),
from and against any liabilities, losses, damages, costs or expenses
(including, but not limited to, attorneys' fees and expenses) of any nature
whatsoever which may be imposed upon, incurred by, or asserted against any
Indemnified Party which result from Sublessor's breach of the Prime Lease
(except to the extent such breach arises out of Sublessee's breach of this
Sublease).
14.
Insurance.
As
pursuant to the Incorporated Provisions, Sublessee shall obtain all insurance
policies (and in such amounts) required under the Prime Lease, including, but
not limited to, personal property insurance covering the Sublessee's personal
property. Sublessee shall include Sublessor and Landlord as additional insureds
under all liability-related insurance
policies
required under the terms of the Prime Lease and under all liability related
insurance policies which Sublessee may carry with respect to the Subleased
Premises, any property located thereon, or with respect to any claim or accident
arising on or about the Subleased Premises. Prior to the commencement of the
term of this Sublease or any occupancy of or access to the Subleased Premises by
Sublessee, Sublessee shall deliver to Sublessor certificates of insurance
showing such policies to be valid and in effect. Any rights of settlement
allocated to Sublessor as Tenant under the Prime Lease shall continue to be the
rights of Sublessor hereunder.
Sublessee
hereby releases Sublessor and Landlord; and their respective officers,
-employees, agents and representatives, from any and all claims or demands of
damage, liability, loss, expense or injury to the Subleased Premises or to the
furnishings, fixtures, equipment, inventory or other property of Sublessee in,
about or upon the Subleased Premises, which is caused by or results from perils,
events or happenings which are the subject of insurance carried by Sublessee
which is required under this Sublease or otherwise in force at the time of any
such loss, whether or not due to the negligence of Sublessor or Landlord or
their respective officers, employees, agents and representatives, and regardless
of cause or origin. Any insurance carried by Sublessee with respect to the
Buildings or the Subleased Premises (or property therein or occurrences thereon)
shall include a clause or endorsement denying to the insurer rights of
subrogation against Sublessor and Landlord and their respective officers,
employees, agents and representatives.
15.
Defaults.
It shall be
an Event of Default hereunder
(a)
Sublessee
shall fail to pay Rent when due; or
(b)
Sublessee
shall fail to pay when due any payments required to be made by Sublessee as
described in this Sublease other than Rent (after, in the case of the first such
failure, ten (10) business days' written notice from Sublessor, and thereafter
without requirement of such notice and grace period; or
(c)
Sublessee
shall fail to keep or perform any one or more of the other terms, conditions,
covenants or agreements of this Sublease or the Incorporated Provisions, and
such failure shall continue for ten (10) days after notice of such failure to
Sublessee; or
(d)
Sublessee
shall cause or permit to occur a default under the Incorporated Provisions which
is not cured prior to five (5) days before the expiration of any cure period
applicable thereto pursuant to the Incorporated Provisions or the Prime
Lease.
16.
Remedies.
In the
event of an Event of Default by Sublessee hereunder, Sublessor may exercise any
remedies available to Landlord under the Incorporated Provisions, and, in
addition to or, at its option, in lieu of, any or all other remedies provided
for herein or in the Incorporated Provisions or available to Sublessor at law or
in equity, Sublessor shall be entitled to enjoin such breach or a threatened
breach, or to perform such obligation or cure such breach an behalf of Sublessee
and recover the cost of such performance or cure from Sublessee upon demand.
Notwithstanding anything to the contrary contained in the Prime Lease, Sublessor
shall have the right to terminate this Sublease immediately upon an Event of
Default by Sublessee and, at
Sublessor's
sole option, Sublessor shall have the right to retain all equipment and fixtures
located on the Subleased Premises as security for the outstanding obligations of
Sublessee.
17.
Tenant Improvements.
Sublessor has not made any warranty or representation as to the condition
of the Subleased Premises or any agreement or promise to decorate, alter, repair
or improve the Subleased Premises and Sublessee hereby waives any and all rights
it may have, express or implied, against Sublessor in connection therewith. The
Subleased Premises are to be leased to Sublessee in "as-is"
condition.
18.
Alterations.
Sublessee shall make no alterations or improvements to the Subleased
Premises except in accordance with the requirements of the Prime Lease and with
the prior written consent of Sublessor which consent shall not be unreasonably
withheld or delayed, and, to the extent such consent is required under the Prime
Lease, the prior written consent of Landlord. Such alteration shall be completed
in accordance with a schedule and plans and specifications submitted to and
approved by the Landlord and Sublessor. Sublessee hereby indemnifies and holds
harmless Sublessor against any loss, liability, cost, damage or claim arising
out of or elating to any alteration or improvements made by or on behalf of
Sublessee to the Subleased Premises, whether or not approved by
Sublessor.
19.
Notices.
All notices
and demands hereunder shall be in writing and shall be served in person, by
prepaid certified United States Mail, return receipt requested, or by nationally
recognized overnight courier, as follows:
If to
Sublessor:
Corporate
Real Estate Services
Capgemini
U.S. LLC
One
Panorama Center
7701 Las
Colinas Ridge, Suite 600
Irving,
Texas 75063
With a
copy to:
Office of
the General Counsel
Capgemini
U.S. LLC
750
Seventh Avenue, 18
th
Floor
New York,
New York 10019
If to
Sublessee:
eMagin
Corporation Bellevue Place
10500 NE
8
th
Street, 14
th
Floor
Bellevue,
Washington
Tel:
(425) 882-7878
Fax:
(425) 882-7373
Attn:
John Atherly
Such
notices shall be deemed served when delivered, if served in person, or by
certified mail, or on the next business day after delivery to a nationally
recognized overnight courier service. Any party may change the address for
notices to it by a notice given as described herein.
20.
Brokers.
Sublessor
and Sublessee represent and warrant that they have not dealt with any brokers in
connection with the sublease of the Subleased Premises other than Trammell Crow
Company and Washington Partners Corporate Real Estate. Sublessor and Sublessee
do hereby indemnify, defend and agree to hold each other harmless from and
against any and all loss, cost, liability or obligations (including reasonable
attorneys' fees) related to any fees or commissions claimed by any parties, to
the extent such claims are based on the acts or agreements of the indemnifying
party.
21.
Security Deposit.
In
order to secure Sublessee's performance hereunder, Sublessee hereby agrees that
within three days of the Sublease Approval date, it shall deposit with Sublessor
a security deposit in the amount of EIGHTY-ONE THOUSAND TWO HUNDRED SIXTEEN
Dollars and 00/100 Dollars ($81,216.00) (the
"Security Deposit").
Such Security Deposit shall be held by Sublessor, without interest, and
upon the occurrence of any default of the Sublessee's obligations hereunder, may
be applied or retained for the payment or performance of such obligations. The
use, application or retention of the Security Deposit, or any portion thereof,
by Sublessor shall not prevent Sublessor from exercising any other right or
remedy provided by this Sublease or by law (it being intended that Sublessor
shall not first be required to proceed against the Security Deposit) and shall
not operate as a limitation on any recovery to which Sublessor may otherwise be
entitled. If any portion of the Security Deposit is used, applied or retained by
Sublessor for the purposes set forth above, Sublessee agrees, within ten (10)
days after the written demand therefor is made by Sublessor, to deposit cash
with the Sublessor in an amount sufficient to restore the Security Deposit to
its original amount. Notwithstanding the foregoing, provided no Sublessee
default has occurred, Sublessor will apply two (2) months of such deposit toward
Sublessee's Base Rent otherwise due for the last two months of the Sublease
Term.
22.
Miscellaneous.
(a)
Sublessor
and Landlord and their agents shall have the right of access to the Subleased
Premises at all reasonable times on reasonable notice to Sublessee (except in
the event of an emergency, in which case no notice is necessary) in order to
inspect or exhibit the Subleased Premises.
(b)
This
Sublease contains the entire agreement between the parties hereto, and shall not
be modified in any manner except by a writing signed by the party against which
such modification is sought to be enforced.
(c) The
agreements, terms, covenants, and conditions herein shall bind and inure to the
benefit of Sublessor and Sublessee and their respective heirs, personal
representatives, successors, and permitted assigns.
(d)
Each of
the indemnifications contained in this Sublease shall survive the expiration or
earlier termination of this Sublease. . In addition,
Section
24
shall survive the expiration or earlier termination of this
Sublease.
(e)
The
Recitals to this Agreement are incorporated herein by this reference as if set
forth in full including, but not limited to, the terms, conditions and
provisions of the Office Lease and the Prime Lease as described in Recital
Paragraphs A and B.
23.
Landlord's Consent.
Sublessor and Sublessee acknowledge that this Sublease is subject to
Sublessor's receipt of the written approval of and consent by the Landlord to
the sublease transaction described herein.
24.
Limitation on Liability of
Sublessor.
In no event will Sublessor be liable for consequential,
incidental, indirect, punitive or special damages (including loss of profits or
business) regardless of whether such liability is based on breach of contract,
tort, strict liability, breach of warranties, failure of essential purpose or
otherwise, and even if advised of the likelihood of such damages.
25.
Security.
Sublessee
shall contract directly with security providers for any services it deems
reasonably appropriate, and Sublessee acknowledges
•
that
Sublessor shall have no liability or responsibility for security of the
Subleased Premises.
26.
Parkin.
Subject to the terms of the Prime Sublease, Sublessor hereby assigns to
Sublessee effective upon the Commencement Date any and all rights which the
Sublessor has under the Prime Lease to the number of parking spaces in the
parking lot(s) in or adjacent to the Building equal to the ratio allocated to
Sublessor under the Prime Lease, provided that (i) Sublessor shall not be a
party to any lease of parking spaces by Sublessee, as any lease shall be solely
between Sublessee and Landlord (or its parking garage operators), and Sublessor
shall not have any responsibility (or make any warranty) to Sublessee with
respect to such spaces, (ii) any such lease of parking spaces shall be at
Sublessee's sole cost and expense, which shall be paid in accordance with the
prevailing parking rates charged by the Landlord (or its parking garage
operators), and (iii) this assignment of rights to any parking spaces shall be
conditioned on Sublessee's agreement to lease such spaces from Landlord (or its
parking garage operators), and (iv) Sublessor shall not be required to assign
any parking spaces to the extent Sublessor would continue to have any payment or
other obligations to the Landlord (or its parking garage operators) relating to
any such spaces.). Sublessee agrees to indemnify and save harmless Sublessor
from and against any liabilities, losses, damages, costs or expenses (including,
but not limited to, attorneys' fees and expenses) of any nature whatsoever which
may be imposed upon, incurred by, or asserted against Sublessor by reason of or
in connection with Sublessee's use of the parking garage or such parking
spaces.
27.
Subordination and
Attornment.
This Sublease shall be subject and subordinate to the Prime
Lease and all mortgages, deeds of trust, ground leases and security agreements
now or hereafter encumbering the Building. In the event of termination of the
Prime Lease for any reason, or in the event of any reentry or repossession of
the Subleased Premises by Landlord, Landlord may at its option, either (i)
terminate this Sublease, or (ii) take over all of the right, title and interests
of Sublessor under this Sublease, in which case the Sublessee will attom to
Landlord, but nevertheless Landlord will not (1) be liable for any previous act
or omission of
Sublessor
under this Sublease, (2) be subject to any defense or offset previously accrued
in favor of the Sublessee against Sublessor, or (3) be bound by any previous
modification of this Sublease made without Landlord's written consent, or by any
previous prepayment by Sublessee of more than one month's rent.
28.
No Presumption Against
Draftor.
Sublessor and Sublessee acknowledge that both parties have been
represented by counsel and are fully aware of the contents of this Sublease.
Therefore, Sublessee hereby waives any presumption that may exist under law or
equity against the Sublessor by virtue of Sublessor creating the initial draft
of this Sublease.
IN
WITNESS WHEREOF, the parties have executed this Sublease as of the day and year
first above written.
SUBLESSOR:
|
|
|
SUBLESSEE:
|
|
|
|
|
|
|
CAPGEMINI
U.S. LLC, a
|
|
|
EMAGIN
CORPORATION, a
|
|
Delaware
limited liability company
|
|
|
Delaware
corporation
|
|
|
|
|
|
|
By
|
|
|
By
|
|
Its
|
|
|
Its
|
|
|
|
|
|
|
STATE
OF
|
|
)
|
|
|
) ss
)
|
COUNTY
OF
|
|
)
|
|
|
|
|
|
|
I certify
that I know or have satisfactory evidence
that_______________________________ is
the
person who appeared before me, and said person acknowledged that he signed this
instrument,
on oath statedthat he was authorized to execute the instrument as the
_____________________________________
on behalf
of
Capgemini
U.S. LLC, a
Delaware limited liability
company,
pursuant to the provisions of the Limited Liability Company Agreement of said
company, and acknowledged it to be the free and voluntary act of said company
for the uses and purposes mentioned in the instrument.
|
|
DATED:
|
|
|
|
|
|
|
|
|
|
|
|
NAME:
|
|
|
|
|
(Print
Name)
|
|
|
|
|
|
|
|
|
|
|
Notary
Public in and for the State of___________
Commission
Expires: ______________________
|
STATE OF
WASHINGTON
|
)
|
|
|
|
)
SS
|
|
|
COUNTY OF
KING
|
)
|
|
|
I certify
that I know or have satisfactory evidence that John Atherly is the person who
appeared before me, and said person acknowledged that he signed this instrument,
and acknowledged it as the Chief Financial Officer of
eMagin Corporation,
a
Washington
corporation to be the free and voluntary act of such entity
for the uses and purposes mentioned in the instrument.
|
|
DATED:
|
|
|
|
|
|
|
|
|
|
|
|
NAME:
|
|
|
|
|
(Print
Name)
|
|
|
|
|
|
|
|
|
|
|
Notary
Public in and for the State of___________
Commission
Expires: ______________________
|
EXHIBIT A
SUBLEASED PREMISES
EXHIBIT B
SUBLESSOR'S PROPERTY
Exhibit
B
|
SubIessors
Property
|
|
(to
best of our
knowledge)
|
(to
best of our knowledge)
|
AssetGroup
|
Category
|
Count
|
Brand
|
Model
|
Accessory
|
Coat
Rack
|
4
|
|
Unknown
|
Appliance
|
Dishwasher
|
1
|
Whirlpool
|
Quiet
Wash/DU912DFGGO
|
Appliance
|
Ice
Machine
|
1
|
Whir]pool
|
Gold/GI1500XHWO
|
Appliance
|
Microwave
|
I
|
Sanyo
|
Unknown
Sanyo
|
Appliance
|
Microwave
|
1
|
General
Electric
|
Spacemaker
II JEM25WYOOI
|
Appliance
|
Refrigerator
|
1
|
General
Electric
|
TAX65NXARWH
|
Appliance
|
Refrigerator
|
1
|
A-U
LINE
|
ULN-75RB-OO
|
Appliance
|
Refrigerator
|
1
|
General
Electric
|
TBXI8JJCARWW
|
Art
|
Artwork
|
19
|
|
Untitled
|
AV
Equipment
|
Camera
|
2
|
Toshiba
Security
|
Cybershot
|
AV
Equipment
|
Other
|
2
|
AMX
|
<T-MCA
0897
|
AV
Equipment
|
Projector
|
1
|
Barco
Graphics
|
Unknown
lnFocus
|
AV
Equipment
|
VCR
|
2
|
Samsung-including
1 Sony
|
SV-300W
|
Chairs
|
Chair
- Aeron
|
94
|
Herman
Miller
|
Aeron
|
Chairs
|
Chair
- Guest
|
8
|
Alexzandria
Designs
|
Unknown
Alexzandria Designs
|
Chairs
|
Chair-
Lounge
|
6
|
Haworth
|
WR9376777RC8944
|
Chairs
|
Chair
- Stacking
|
71
|
Steelcase
|
4754
12M
|
Chairs
|
Chair
- Task
|
39
|
Haworth
|
MHP
152031
|
Chairs
|
Chair
|
2
|
|
|
Filing
Cabinets
|
File
Cabinet - 2 Drawer Lateral
|
1
|
Artelite
|
Unknown
Artelite
|
Filing
Cabinets
|
File
Cabinet -2 Drawer Lateral
|
11
|
|
|
Filing
Cabinets
|
File
Cabinet - 2 Drawer Vertical
|
62
|
Hawoith
|
Unknown
Haworth
|
Filing
Cabinets
|
File
Cabinet - 3 Drawer Lateral
|
26
|
Meridian
|
Unknown
Meridian
|
Filing
Cabinets
|
File
Cabinet - 4 Drawer Lateral
|
1
|
|
Unknown
|
Filing
Cabinets
|
File
Cabinet - 5 Drawer Vertical
|
4
|
Meridian
|
Unknown
Meridian
|
Filing
Cabinets
|
File
Cabinet - 5 Drawer
'/ortical
Lateral
|
2
|
8
in conference rooms
|
Unknown
|
Furniture
|
Bookcase
- Wood
|
7
|
|
Unknown
|
Exhibit
B
|
S u
blessor's Property
|
|
(to
best of our knowledge)
|
(to
best of our knowledge)
|
AssetGroup
-
|
Category
|
Count
|
Brand
|
Model
|
Furniture
|
Bookcase
- Misc.
|
3
|
|
Unknown
|
Furniture
|
Desk
|
4
|
Artelite
|
Unknown
Artelite
|
Furniture
|
Mailroom
- Mail Slots
|
I
|
Hamilton
|
FSM481676-L
|
Furniture
|
Miscellaneous
Workstations
|
68
|
Haworth
|
Unknown
Haworth
|
Furniture
|
Sofa
|
3
|
Brattrud
|
Unknown
Branching Out
|
Furniture
|
Sofa
|
I
|
|
|
Furniture
|
Special
Cabinet
|
I
|
Quartet
Ovonics
|
Unknown
Quaret Ovonics
|
Tables
|
Table
- Boomerang
|
69
|
Knoll
|
Boomerang
Knoll
|
Tables
|
Table
- Conference Room
|
I
|
Haworth.
|
Unknown
Haworth
|
Tables
|
Table
- Conference Room
|
8
|
Vecta
|
Unknown
Vecta
|
Tables
|
Table
- Conference Room
|
5
|
Versteel
|
Unknown
Versteel
|
Tables
|
Table
- Conference Room
|
27
|
Versteel
|
Unknown
Versteel
|
Tables
|
Table
- Conference Room
|
4
|
Round-small
|
Unknown
|
Tables
|
Table
- Elliptical
|
4
|
Artelite
|
Unknown
Artelite
|
Tables
|
Table
- Reception Area
|
I
|
Fleischmanri
|
A21-MAM9
|
Tables
|
Table
- Reception Area
|
4
|
Ivan
Allen
|
Unknown
Ivan Allen
|
Television
|
TV
Monitors
|
3
|
Mitsubishi
|
Mitsubishi
AM2752A
|
Whiteboards
|
Whiteboard
- Electronic
|
3
|
Steelase
Microfield
|
Egan
Team Board/203
|
Whiteboards
|
Whiteboard
- Free Standing
|
13
|
Bretford
|
Unknown
Bretford
|
Whiteboards
|
Whiteboard
- Mobile (Large Curved)
|
4
|
KnowWhere
|
Unknown
KnowWhere
|
Whiteboards
|
Whiteboard
- Wall Mounted with
|
17
|
|
Unknown
|
Whiteboards
|
Whitebcard
- Workstation
|
68
|
Haworth
|
Unknown
Haworth
|
Chairs
|
Leather
|
12
|
Haworth
Boardroom
|
|
|
|
|
|
|
Phone
Room
|
Equipment
Racks
|
8
|
|
|
Phone
Room
|
Metal
Storage Units wlDoors
|
I
|
|
|
Phone
Room
|
Metal
Storage Shelf
|
1
|
|
|
AV
Equipment
|
Projector
|
1
|
Proxima
|
|
AV
Equipment
|
Projector
|
1
|
Sanyo
|
|
Computer
Room
|
Server
Racks
|
6
|
Compaq
(empty)
|
|
Computer
Room
|
Server
Racks
|
2
|
|
|
Exhibit
B
|
Sub
lessor's Property
|
|
(to
best of our knowledge)
|
(to
best of our knowledge)
|
AssetGroup.
|
Category
|
Count
|
Brand
|
Model
|
Storage
Rooms in Common Corridor
|
|
|
|
|
|
Metai
Storage Sheff
|
5
|
|
|
|
Wood
Storage Shelf
|
2
|
|
|
|
4-Drawer
Vertical
|
3
|
|
|
Sublessor
makes no warranties of any kind or nature, whether express or implied (including
without limitation warranties of merchantability or fitness for a particular
purpose), with respect to the Sublessor's Property, and Sublessee accepts the
Sublessor's Property for use during the term hereof in its "as is" and "where
is" condition.
International
Business Machines Corporation
|
|
2070 Route
52
|
|
|
|
Hopewell
Junction, NY 12533
|
|
|
|
|
|
November 29, 2004
Mr. Gary W. Jones
President/ CEO
eMagin Corporation
2070 Route 52
Hopewell
Junction, NY 12533
Subject:
Lease dated
May
28, 1999, as
amended by First Amendment to Lease dated July 09, 1999, Second Amendment
to
Lease
dated January 29, 2001, Third Amendment to Lease dated May 28, 2002
between International Business Machines Corporation, as Landlord, and eMagin
Corporation, as Tenant,
(collectively,
the
"Lease") for the premises located at the Hudson Valley Research Park,
2070 Route 52, Hopewell Junction, NY 12533, as such premises are more
particularly described in the Lease.
Fourth
Amendment to Lease effective as of June 1, 2004 Dear Mr. Jones,
The
letter, upon your signed acceptance, amends the above referenced Lease between
IBM and eMagin Corporation for the Premises located at the Hudson Valley
Research Park in Hopewell Junction, NY. The Lease shall be amended as follows ("
Amendment 4") and shall be effective as of June 1, 2004:
Replace
"Exhibit Al" dated 6-01-02 in its entirety with "Exhibit Al".
Replace
"Exhibit A2" dated 6-01-02 in its entirety with "Exhibit A2".
Replace
"Exhibit A3" dated 6-01-02 in its entirety with "Exhibit A3".
Replace
"Exhibit
Er
dated 9-15-99
in its entirety with "Exhibit
Replace
"Schedule A" dated 6-01-02 in its entirety with "Schedule A".
Replace
"Schedule B" dated 6-01-02 in its entirety with "Schedule B".
Replace
"Schedule D" dated 6-01-99 in its entirety with "Schedule D".
Paragraph
4(a): Shall be amended by changing the expiration date from May 31, 2004 to May
31, 2009. The term of this Lease
(herein
called the "Term") shall be for a period of five (5) years, to commence on June
1, 2004 (the "Commencement Date"), and shall expire on May 31, 2009 unless
sooner terminated as hereinafter provided.
Paragraph 4(c): The first
sentence shall be deleted in its entirety and replaced with "After May 31,
2007 the Landlord at its sole discretion may grant the Tenant an option to
extend the Term for all or any part of the Premises
for one
(1),
two
(2)
year period subject to and upon the provisions set forth in this
subparagraph and subject to a Rent to be determined by the Landlord in its sole
discretion
.
Paragraph 28 (a): The
first sentence shall be deleted in it entirety and replaced with
"Commencing as of June 1, 2004 and continuing thereafter throughout the
Term the landlord shall provide the tenant with 3 (three) received parking
spaces and unreserved parking (the "Tenants Parking Spaces" )as outlined on
EXHIBIT B.
Paragraph
35, Security Deposit shall be added to the Lease as follows:
(a) The
Tenant has deposited with the Landlord the sum of One Hundred Fifty Thousand and
00/100 Dollars ($150,000.00) as security for the faithful performance and
observance by the Tendant of the provisions of this Lease on its part to be
per
formed.
If the Tenant defaults in
respect
of any of these provisions
, including the payment of rent, the Landlord
may use,
apply or
retain the whole or any part of the security so deposited to the extent required
for the payment of any rent for which the Tenant is in default or for any sum
which the Landlord may expend or may be required to expend by reason of the
Tenant's default in respect of any of these provisions, includ
ing any
damages or deficiency in the reletting of the Premises, whether such damages or
deficiency accrued before or after summary proceedings or other reentry by the
Landlord. If the Tendant shall fully and faithfully comply with all provisions
of
this
Lease on the Tenant's part to be performed, the security shall be credited
toward the payment of rent as described in paragraph (b) hereof.If the Landlord
sells or leases the
Building,
the Landlord shall have the right to transfer the security to the vendee or
lessee and the Landlord shall thereupon be released by the Tenant from all
liability for the return of such security. The Tenant agrees to look solely to
the new landlord for the return of said security. It is agreed that the
provisions hereof shall apply to every transfer or assign
ment made
of the security to a new landlord_The Tenant fur
ther
covenants that it will not assign, pledge or encumber or attempt to assign,
pledge or encumber the monies deposited herein as security and that neither the
Landlord nor its successors or assigns shall be bound by any such assignment,
pledge or encumbrance, or attempted assignment, attempted pledge or attempted
encumbrance.
(b) If
Tenant is not in Default on March 31, 2009 the security
deposit
will be credited toward the April 1, 2009 and May 1, 2009 rent payments as shown
in Schedule A, Table 1.
Paragraph
36, Use of Rec Center shall be added to the Lease as follows:
A maximum
of four (4) of Tenant's employees will be authorized access to the Landlord's
Rec Center located on Schenandoah Road, Hopewell Junction, NY, for the sole
purpose of use of the parking, locker rooms, exercise rooms, running track,
basketball, tennis courts and common areas. Tenant's employees are not
authorized to participate in any other activities or sports organized by the
Landlord or its employees, guests or invitees.
Please
indicate eMagin's acceptance of this Fourth Amendment to Lease by having an
authorized representative sign four (4) copies of this letter on behalf of
eMagin and return two (2) copies to IBM, Route
100,
Somers, NY 10589,
Attention: Program Manager, Real
Estate
Services.
Except as
amended herein of this Fourth Amendment to Lease, all the terms and conditions
of the Lease shall remain in full force and effect.
Persons
signing below certify that they are authorized representatives of their company
and empowered to execute this document on behalf of their company.
Very
truly yours,
INTERNATIONAL BUSINESS
MACHINES CORPORATION
/s/ David
W. Pfirman
David W.
Pfirman
Senior
Program Manager, Real Estate Operations
Accepted
and Agreed to:
eMagin
Corporation
/s/ Gary
W. Jones
Gary W.
Jones
President/
CEO
CC:
Mr. Sujit
Ramchand, IBM Area Counsel
Ms.
Maureen Duffy, IBM General Counsel, Real Estate
Services
Ms.
Debra Durstewitz, Site Operations, East Fishkill
File
SCHEDULE
A
eMagin
CORPORATION
BASE
RENT
COMPUTATION SCHEDULE-- AMEND. 4
Effective Date
06/01/2004
Effective
Date
|
|
Amend. 3
|
Amend. 4
|
Rate/SF
|
Annual Rent
|
Monthly
Rent
|
B310
|
Storage
|
10,352
|
56881
|
$7.00
|
$39,816.00
|
$3,318.00
|
B334
|
Office
|
8,604
|
8,
604
|
$17.00
|
$146,268.00
|
$12,189.00
|
B3300
|
Office
|
608
|
608
|
$17.00
|
$10,336.00
|
$861.33
|
|
Dry
|
7,691
|
7,691
|
$18.00
|
$138,438.00
|
$11,536.50
|
|
Clean
|
16,316
|
16,316
|
$35.00
|
$571,060.00
|
$47,588.33
|
|
1Storage
|
4.376
|
4.376
|
$7.00
|
$30.632.00
|
$2,552.67
|
Total
|
47,947
|
43,283
|
|
$936,550.00
|
$78,045.83
|
Average
Rent/NPSF
|
|
|
|
$21.64
|
|
Average
Rent/NRSF
|
|
|
|
$15.45
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 1,
2004
|
|
|
|
|
|
B310
|
Storage
|
|
0
|
$7.00
|
$0.00
|
$0.00
|
6334
|
Office
|
|
6,554
|
$17.00
|
$111,418.00
|
$9,284.83
|
B3300
|
Office
|
|
1,606
|
$17.00
|
$27,302.00
|
$2,275.17
|
|
Dry
|
|
5,850
|
$18.00
|
$105,300.00
|
$8,775.00
|
|
Clean
|
|
16,3161
|
$35.00
|
$571,060.00
|
$47,588.33
|
|
Storge
|
|
6,524
|
$7.00
|
$45,668.00
|
$3,805.67
|
Total
|
|
36,850
|
|
$860,748.00
|
$71,729.00
|
Average
Rent/NPSF
|
|
|
|
$23.36
|
$1.03
|
Average
Rent/NRSF
|
|
|
|
$16.30
|
$0.23
|
|
|
|
|
|
|
Deriving
Net Rentable Basis
|
Building Number
|
|
|
|
Net Productive
Sq. Ft.
June
1, 2004
|
|
|
|
|
|
|
|
June
1,
04
|
|
|
Net
Productive
Sq.
Ft.
Dec
1, 2004
|
|
|
|
Net
Rentable
Sq.
Ft.
Dec
1, 04
|
|
|
310
|
|
|
|
5,688
|
|
|
|
1.26
|
|
|
|
7,167
|
|
|
|
|
|
|
0
|
|
|
330
|
|
|
|
8,604
|
|
|
1.26
|
|
|
|
10,841
|
|
|
|
6,554
|
|
|
|
8,258
|
|
|
334
|
|
|
|
28,991
|
|
|
|
1.47
|
|
|
|
42,617
|
|
|
|
30,296
|
|
|
|
44,535
|
|
Total
|
|
|
|
43,283
|
|
|
|
|
|
|
|
60,625
|
|
|
36,850
|
|
|
|
52,793
|
|
BOMA Formula
for Net Productive to Net Rentable
|
|
|
|
|
|
|
|
Building
Rentable
|
= Building Net
Rentable
|
Example
|
475000
+1.55
|
Building NET
Productive
|
|
|
306,300
|
SCHEDULE
B
eMagin
CORPORATION
BASE RENT COMPUTATION SCHEDULE—
AMEND.
|
|
Effective
Date
|
Lease End
Date
|
|
|
06/01/2004
|
May 31,
2009
|
Table
1
|
2004
|
2005
|
2006
|
2007
|
2008
|
2009
|
January
|
$73,914.15
|
$71,729.00
|
$73,880.87
|
$76,097.30
|
$78,380.21
|
$80,731.62
|
February
|
$73,914.15
|
$71,729.00
|
$73,880.87
|
$76,097.30
|
$78,380.21
|
$80,731.62
|
March
|
$73,914.15
|
$71,729.00
|
$73,880.87
|
$76,097.30
|
$78,380.21
|
$80,731.62
|
April
|
$0.00
|
$71,729.00
|
$73,880.87
|
$76,097.30
|
$78,380.21
|
$11,463.24
|
May
|
$0.00
|
$71,729.00
|
$73,880.87
|
$76,097.30
|
$78,380.21
|
$0.00
|
June
4
|
$78,045.831
|
$73,880.871
|
$76,097.30
|
$78,380.211
|
$80,731.62
|
|
July
|
$78,045.83!
|
$73,880.871
|
$76,097.30
|
$78,380.21
|
$80,731.62
|
|
Aug
|
$78,045.83
|
$73,880.871
|
$76,097.30
|
$78,380.21
|
$80,731.62
|
|
September
|
$75,860.681
|
$73,880.87
|
$76,097.30
|
$78,380.21
|
$80,731.62
|
|
October
|
$75,860.68
|
$73,880.87
|
$76,097.30
|
$78,380.21
|
$80,731.62
|
|
November
|
$69,987.15
|
$73,880.87
|
$76,097.30
|
$78,380.21
|
$80,731.62
|
|
December
|
$71,729.00
|
$73,880.87
|
$76,097.30
|
$78,380.21
|
$80,731.62
|
|
Total
|
$749,317.47
|
$875,811.09
|
$902,085.42
|
$929,147.99
|
$957,022.421
|
$253,658.10
|
Notes:
Amendments
1
May 1999 $8,525.67 Per Mo. credit for 6,254 S/F in 6/310, under construction
& unavailable
2
June 2001 Reclassified office and lab (5,000 s.f.) to storage
space
3
May 2002 Space Givebacks in Bldgs. 310, 3300
4
June 2004
Space
Givebacks in Bldgs. 310, 330C and B334, 5 year renewal with initial increase
3%
per year thereafter effective June 1.
At
IBM's sole discretion two, (2) year renewal options will be offered after the
3rd year.
at
the same terms
2004
Payment Reconcilliation
Table
2
|
|
|
2004
Base
Rent
|
|
|
|
Loan
Amoritization
|
|
|
|
Total Rent
Due
|
|
|
|
Total
Payments
|
|
|
|
Delta
(due
IBM) due eMagin
|
|
January
|
|
$
|
69,978.171
|
|
|
$
|
3,935.98
|
|
|
$
|
73,914.15
|
|
|
$
|
73,914.15
|
|
|
$
|
0.00
|
|
February
|
|
$
|
69,978.17
|
|
|
$
|
3,935.98
|
|
|
$
|
73,914.15
|
|
|
$
|
73,914.15
|
|
|
$
|
0.00
|
|
March
|
|
$
|
69,978.17
|
|
|
$
|
0.00
|
|
|
$
|
69,978.17
|
|
|
$
|
73,914.151
|
|
|
$
|
3,935.98
|
|
April
|
|
$
|
0.00
|
|
|
$
|
0.00
;
|
|
|
$
|
0.001
|
|
|
$
|
73,914.151
|
|
|
$
|
73,914.15
|
|
May
|
|
$
|
0.00
|
|
|
$0.00'
|
|
|
$0.00
|
|
|
$
|
73,914.15
|
|
|
$
|
73,914.15
|
|
June
|
|
$
|
78,045.83
|
|
|
$
|
0.001
|
|
|
$
|
78,045.83
|
|
|
$
|
73,914.151
|
|
|
$
|
(4,131.69
|
)
|
July
|
|
$
|
78,045.83
|
|
|
$
|
0.001
|
|
|
$
|
78,045.83
|
|
|
$
|
73,914.151
|
|
|
$
|
(4,131.69
|
)
|
Aug
|
|
$
|
78,045.83
|
|
|
$
|
0.00
|
|
|
$
|
78,045.83
|
|
|
$
|
73,914.15
|
|
|
$
|
(4,131.69
|
)
|
September
|
|
$
|
78,045.83
|
|
|
$
|
0.00
|
|
|
$
|
78,045.83
|
|
|
$
|
71,729.00
|
|
|
$
|
(6,316.84
|
)
|
October
|
|
$
|
78,045.83
;
|
|
|
$
|
0.00
|
|
|
$
|
78,045.83
|
|
|
$
|
71,729.00
|
|
|
$
|
(6,316.84
|
)
|
November
|
|
$
|
78,045.831
|
|
|
$
|
0.00
|
|
|
$
|
78,045.83
|
|
|
$
|
69,978.15
|
|
|
$
|
(8,067.68
|
)
|
Subtotal
due
Magin
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$118,667.86
:
|
|
Security
Dlepoit
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
(150,000.00
|
)
|
December
|
|
$
|
71,729.001
|
|
|
$
|
0.00
|
|
|
$
|
71,729.00
|
|
|
$
|
103,061.14
|
|
|
$
|
(31,332.14
|
)
|
Total
|
|
$
|
749,843.83;
|
|
|
$
|
7,871.96
|
|
|
$
|
757,715.79
|
|
|
$
|
757,715.80
|
|
|
$
|
0.00
|
|
SCHEDULE
D
Computed
Utilities Schedule
eMagin
CORPORATION
Effective
Date 6/1/04
Maximum Available
Capacities
|
|
|
|
|
Utilities
|
|
Peak Allowable
Usage
|
|
Total Annual
Allowable
|
|
|
|
|
|
Electricity
|
|
|
N/A
|
|
|
Chilled
Water
|
|
350 Tons
|
|
1,401,600
Ton-Hrs
|
Low Temp
Chilled Wate
|
|
130 Tons
|
|
569,400
Ton-Hrs
|
High Temp Hot
Water
|
|
5 MBH
|
|
19,251 M
MBTU
|
Deionized
Water
|
|
30 gpm
|
|
13,220 1K
Gal
|
Compressed
Air
|
|
10 scfm
|
|
550,000
SCF
|
UHP
Nitrogen
|
|
scfm
|
|
6,000,000 SCF
|
Std.
Oxygen
|
|
scfm
|
|
100,000
SCF
|
Std.
Argon
|
|
scfm
|
|
100,000
SCF
|
Std. Forming
Gas
|
|
15 scfm
|
|
150,000
SCF
|
|
|
|
|
|
|
SCHEDULE
D
Computed
Utilities Schedule
eMagin
CORPORATION
Effective Date
6/1/04
Maximum Available
Capacities
|
|
|
|
|
Utilities
|
|
Peak Allowable
Usage
|
|
Total Annual
Allowable
|
|
|
|
|
|
Electricity
|
|
|
N/A
|
|
|
Chilled
Water
|
|
350 Tons
|
|
1,401,600
Ton-Hrs
|
Low Temp
Chilled Wate
|
|
130 Tons
|
|
569,400
Ton-Hrs
|
High Temp Hot
Water
|
|
5 MBH
|
|
19,251 M
MBTU
|
Deionized
Water
|
|
30 gpm
|
|
13,220 1K
Gal
|
Compressed
Air
|
|
10 scfm
|
|
550,000
SCF
|
UHP
Nitrogen
|
|
scfm
|
|
6,000,000 SCF
|
Std.
Oxygen
|
|
scfm
|
|
100,000
SCF
|
Std.
Argon
|
|
scfm
|
|
100,000
SCF
|
Std. Forming
Gas
|
|
15 scfm
|
|
150,000
SCF
|
|
|
|
|
|
|
EXHIBIT
G
TO
LOAN
AND SECURITY AGREEMENT
Form
of Press Release
eMagin
Corporation (the “Company”) has entered into agreements, effective as of August
7, 2007 (the “Closing Date”), with Moriah Capital, L.P. (“Moriah”), pursuant to
which the Company may borrow an amount not to exceed $2,500,000. Such
funds may be drawn down by the Company in tranches of at least $25,000 up to
five times each month. In connection with the transaction, the Company issued,
executed and delivered to Moriah the following:
·
|
A
Loan and Security Agreement;
|
·
|
A
Secured Convertible Revolving Loan Note with a principal amount not to
exceed $2,500,000;
|
·
|
A
Loan Conversion Agreement;
|
·
|
A
Securities Issuance Agreement pursuant to which the Company issued 162,500
shares of its common stock, which shares have an aggregate market value on
the Closing Date of $195,000;
|
·
|
A
Registration Rights Agreement;
|
·
|
An
Intercreditor
Agreement; and
|
·
|
A
Post-Closing Agreement.
|
Pursuant
to the Loan and Security Agreement, the Company is permitted to borrow an amount
not to exceed 90% of its eligible accounts (as defined in the agreements), net
of all taxes, discounts, allowances and credits given or claimed, plus 50% of
its eligible inventory capped at $600,000. As of August 9,
2007, pursuant to the Loan and Security Agreement, the Company has
borrowed $607,500. The Company's obligations under the loans are secured by all
of the assets of the Company, including but not limited to inventory and
accounts receivable; provided, however, that Moriah’s lien on the collateral
other than Accounts and Inventory (as such terms are defined in the agreements)
are subject to the prior lien of the holders of the Company’s outstanding
Amended and Restated 8% Senior Secured Convertible Notes Due 2008 in accordance
with the terms of, and subject to the conditions set forth in the Intercreditor
Agreement.
The Loan
and Security Agreement expires on August 7, 2008, but may be extended at
the Company’s option for an additional one year period with the Company issuing
additional shares of common stock to Moriah having an aggregate market value of
$195,000 based on the average closing price of the Common Stock on the OTC
Bulletin Board or such other trading market which such common stock is then
listed or traded for the ten (10) trading days preceding the effective date of
the extension of the initial term of the loan. Annual interest on the
loans is equal to the greater of (i) the sum of (A) the Prime Rate as
reported in the “Money Rates” column of The Wall Street Journal, adjusted as and
when such Prime Rate changes plus (B) 2% or (ii) 10%, and shall be payable
in arrears prior to the Maturity Date, on the first Business Day of each
calendar month, and in full on the Maturity Date.
As part
of the transaction, up to $2,000,000 of the amount of the loan that the Company
actually borrows may be converted to shares of the Company's common stock
pursuant to the terms of the Loan Conversion Agreement. The conversion price is
$1.50, subject to adjustment as provided in the Conversion
Agreement.
Notwithstanding
the foregoing, Moriah has contractually agreed to restrict its ability to
convert the convertible notes evidencing the loans made to the
Company pursuant to the Loan Agreement if such conversion would result in
Moriah’s share ownership exceeding the difference between 4.99% of the
outstanding shares of common stock of the Company and the number of shares of
common stock beneficially owned by Moriah.
The
Company has also agreed to file a registration statement to register the resale
of shares of the Company's common stock issuable under the Securities Issuance
Agreement and the shares issuable upon conversion of the convertible note,
although the Company is not subject to penalties for failure to register such
shares.
In the
event that Moriah accelerates the Loans due to an event of default, the Company
shall pay to Moriah an early payment fee in an amount equal to (i) two percent
(2%) of the maximum credit if such acceleration occurs prior to the first
anniversary of the Closing Date, and (ii) one percent (1%) of the maximum credit
if such acceleration occurs on or after the first anniversary of the Closing
Date.
As part
of the transaction, the Company is paying Moriah a servicing fee of
$82,500.
The
Company has also granted Moriah a put option pursuant to the Securities Issuance
Agreement pursuant to which Moriah can sell the shares issued to Moriah under
the Securities Issuance Agreement back to the Company for $195,000 at any time
during the earlier to occur of the following Put Option exercise periods (the
“Put Period”): (a) the ten (10) Business Day period commencing on the first
anniversary of the Closing Date, or (b) the ten (10)
Business Day period commencing on the date which is nine (9) months after the
date that the registration statement for the registration of the Issued Shares
is declared effective by the Securities and Exchange Commission.
In
addition to the foregoing, as part of the transaction, the Intercreditor
Agreement was entered into between Moriah and Alexandra Global Master Fund
Ltd.
In
connection with the transaction, the parties executed a Post-Closing Agreement
pursuant to which the parties agreed to enter into certain agreements and
exchange certain documents after the closing for the
transaction. Pursuant to the Post-Closing Agreement, the Company
shall (i) provide to Moriah certain landlord consents, (ii) execute patent and
trademark security and pledge agreements in form and substance not inconsistent
with the existing security and pledge agreements executed by the Company in
favor of Alexandra Global Master Fund Ltd. (with the sole exception that such
agreements shall be subordinate to the existing pledge and security agreements
executed by the Company in favor of Alexandra Global Master Fund Ltd.) and (iii)
execute a Depository Account Agreement (“Lockbox Agreement.) Pursuant to the
Lockbox Agreement, until the revolving loan is repaid and the Loan and Security
Agreement is terminated, remittances and all other proceeds of the Company’s
accounts receivables shall be deposited into a bank account controlled by
Moriah.
EXHIBIT
H
TO
LOAN
AND SECURITY AGREEMENT
Form of Registration Rights
Agreement
EXHIBIT H
REGISTRATION
RIGHTS AGREEMENT
This
Registration Rights Agreement (this “
Agreement
”) is made
and entered into as of August 7, 2007, by and between eMagin Corporation, a
Delaware corporation (the “
Company
”), and Moriah
Capital, L.P. (the “
Lender
”).
This
Agreement is made pursuant to the Securities Issuance Agreement, dated as of the
date hereof, by and between the Lender and the Company (as amended, modified or
supplemented from time to time, the “
Securities Issuance
Agreement
”), and pursuant to the Loan and Security Agreement (the “
Loan Agreement
”)
referred to therein.
The
Company and the Lender hereby agree as follows:
1.
Definitions
. Capitalized
terms used and not otherwise defined herein that are defined in the Securities
Issuance Agreement, shall have the meanings given such terms in the Securities
Issuance Agreement. Capitalized terms not defined herein or in the
Securities Issuance Agreement shall have the meaning set forth in the Loan
Agreement. As used in this Agreement, the following terms shall have
the following meanings:
“
Commission
” means the
Securities and Exchange Commission.
“
Common Stock
” means
shares of the Company’s common stock, par value $0.001 per share.
“
Effectiveness Date
”
means, with respect to the Registration Statement required to be filed
hereunder, a date no later than one hundred and twenty (120) days following the
date hereof.
“
Effectiveness Period
”
shall have the meaning set forth in
Section
2(a)
.
“
Exchange Act
” means
the Securities Exchange Act of 1934, as amended, and any successor
statute.
“
Filing Date
” means
with respect to the Registration Statement required to be filed hereunder, a
date no later than thirty (30) days following the date hereof.
“
Holder
” or “
Holders
” means the
Lender or any of its affiliates or transferees to the extent any of them hold
Registrable Securities.
“
Indemnified Party
”
shall have the meaning set forth in
Section
5(c)
.
“
Indemnifying
Part
y
” shall
have the meaning set forth in
Section
5(c)
.
“
Note
” shall have the
meaning set forth in the Securities Issuance Agreement.
“
Proceeding
” means an
action, claim, suit, investigation or proceeding (including, without limitation,
an investigation or partial proceeding, such as a deposition), whether commenced
or threatened.
“
Prospectus
” means the
prospectus included in the Registration Statement (including, without
limitation, a prospectus that includes any information previously omitted from a
prospectus filed as part of an effective registration statement in reliance upon
Rule 430A promulgated under the Securities Act), as amended or supplemented by
any prospectus supplement, with respect to the terms of the offering of any
portion of the Registrable Securities covered by the Registration Statement, and
all amendments and supplements to the Prospectus, including post-effective
amendments, and all material incorporated by reference or deemed to be
incorporated by reference in such Prospectus.
“
Registrable
Securities
” means the shares of Common Stock (i) issued to the Lender
pursuant to the Stock Issuance Agreement
(
including shares to be
issued to the Lender on the date hereof and shares to be issued to the Lender
upon an extension of the original term of the Loan Agreement, if so extended),
and (ii) issuable upon the conversion of the Note.
“
Registration
Statement
” means each registration statement required to be filed
hereunder, including the Prospectus, amendments and supplements to such
registration statement or Prospectus, including pre- and post-effective
amendments, all exhibits thereto, and all material incorporated by reference or
deemed to be incorporated by reference in such registration
statement.
“
Rule 144
” means Rule
144 promulgated by the Commission pursuant to the Securities Act, as such Rule
may be amended from time to time, or any similar rule or regulation hereafter
adopted by the Commission having substantially the same effect as such
Rule.
“
Rule 415
” means Rule
415 promulgated by the Commission pursuant to the Securities Act, as such Rule
may be amended from time to time, or any similar rule or regulation hereafter
adopted by the Commission having substantially the same effect as such
Rule.
“
Securities Act
” means
the Securities Act of 1933, as amended, and any successor statute.
“
Securities Issuance
Agreement
” shall have the meaning provided above.
“
Trading Market
” means
any of the OTC Bulletin Board, NASDAQ Capital Market, the Nasdaq National
Market, the American Stock Exchange or the New York Stock Exchange.
2.
Registration
.
(a)
On or
prior to the applicable Filing Date, the Company shall prepare and file with the
Commission a Registration Statement covering the Registrable
Securities for an offering to be made on a continuous basis pursuant
to Rule 415. The Company shall use good faith efforts to include the
Registrable Securities in the Company’s Registration Statement on Form S-1 as
filed with the Commission on July 25, 2007. If such inclusion is not permitted
by the selling security holders thereunder, or is otherwise impractical, then
the Registrable Securities shall be included in the Company’s next succeeding
registration statement. The Registration Statement shall be on
Form S-1 or SB-2. The Company shall cause such Registration Statement
to become effective and remain effective as provided herein. The
Company shall use its reasonable commercial efforts to cause such Registration
Statement to be declared effective under the Securities Act as promptly as
possible after the filing thereof
,
but in any event no later
than the Effectiveness Date. The Company shall use its reasonable
commercial efforts to keep such Registration Statement continuously effective
under the Securities Act until the date which is the earlier date of when (i)
all Registrable Securities have been sold or (ii) all Registrable Securities may
be sold immediately without registration under the Securities Act and without
volume restrictions pursuant to Rule 144(k), as determined by the counsel to the
Company pursuant to a written opinion letter to such effect, addressed and
acceptable to the Company’s transfer agent and the affected Holders
(the “
Effectiveness
Period
”). Notwithstanding anything contained herein to the
contrary, in the event that the Commission limits the amount of Registrable
Securities that may be sold by selling security holders in a particular
Registration Statement, or the Commission takes the position that the all or a
portion of the Registrable Securities cannot be registered, the Company may
exclude from such registration statement the minimum number of Registrable
Securities on behalf of the Lender as is necessary to comply with such
limitation by the Commission. In such event the Company shall give the Lender
prompt notice of the number of the Registrable Securities so
excluded. Further, and in addition to the foregoing, the Company will not
be liable for payment of any damages or penalties for any delay in registration
of the Registrable Securities in the event that such delay is due to the fact
that the SEC has limited the amount of Registrable Securities that may be
included and sold by selling security holders in the Registration Statement
pursuant to Rule 415 promulgated under the 1933 Act or any other
basis.
(c) Within
3 business days of the Effectiveness Date, the Company shall cause its counsel
to issue a blanket opinion in the form attached hereto as
Exhibit A
, to the
transfer agent stating that the shares are subject to an effective registration
statement and can be reissued free of restrictive legend upon notice of a sale
by the Lender and confirmation by the Lender that it has complied with the
prospectus delivery requirements, provided that the Company has not advised the
transfer agent orally or in writing that the opinion has been withdrawn. Copies
of the blanket opinion required by this
Section 2(c)
shall be
delivered to the Lender within the time frame set forth above.
3.
Registration
Procedures
. If and whenever the Company is required by the
provisions hereof to effect the registration of any Registrable Securities under
the Securities Act, the Company will, as expeditiously as possible:
(a)
prepare
and file with the Commission the Registration Statement with respect to such
Registrable Securities, respond as promptly as possible to any comments received
from the Commission, and use its best efforts to cause the Registration
Statement to become and remain effective for the Effectiveness Period with
respect thereto, and promptly provide to the Lender copies of all filings and
correspondence relating thereto;
(b)
prepare
and file with the Commission such amendments and supplements to the Registration
Statement and the Prospectus used in connection therewith as may be necessary to
comply with the provisions of the Securities Act with respect to the disposition
of all Registrable Securities covered by the Registration Statement and to keep
such Registration Statement effective until the expiration of the Effectiveness
Period;
(c)
furnish
to the Lender such number of copies of the Registration Statement and the
Prospectus included therein (including each preliminary Prospectus) as the
Lender may reasonably request to facilitate the public sale or disposition of
the Registrable Securities covered by the Registration Statement;
(d)
use its
commercially reasonable efforts to register or qualify the Lender’s Registrable
Securities covered by the Registration Statement under the securities or “blue
sky” laws of such jurisdictions within the United States as the Lender may
reasonably request, provided, however, that the Company shall not for any such
purpose be required to qualify generally to transact business as a foreign
corporation in any jurisdiction where it is not so qualified or to consent to
general service of process in any such jurisdiction;
(e)
list the
Registrable Securities covered by the Registration Statement with any securities
exchange/Trading Market on which the Common Stock of the Company is then
listed;
(f)
immediately
notify the Lender, at any time when a Prospectus relating thereto is required to
be delivered under the Securities Act, of the happening of any event of which
the Company has knowledge, or has reason to know, as a result of which the
Prospectus contained in such Registration Statement, as then in effect, includes
an untrue statement of a material fact or omits to state a material fact
required to be stated therein or necessary to make the statements therein not
misleading in light of the circumstances then existing; and
(g)
make
available for inspection by the Lender and any attorney, accountant or other
representative retained by the Lender, all publicly available, non-confidential
financial and other records, pertinent corporate documents and properties of the
Company, and cause the Company’s officers, directors and employees to supply all
publicly available, non-confidential information reasonably requested by the
attorney, accountant or representative of the Lender.
4.
Registration
Expenses
. All expenses relating to the Company’s compliance
with
Sections 2 and
3
hereof, including, without limitation, all registration and filing
fees, printing expenses, counsel fees and disbursements and independent public
accountants for the Company, fees and expenses incurred in connection with
complying with state securities or “blue sky” laws, fees of any Trading Market,
transfer taxes, fees of transfer agents and registrars, fees of, and
disbursements incurred by, one counsel for the Holders to the extent such
counsel is required due to Company’s failure to meet any of its obligations
hereunder, are called “
Registration
Expenses
.” All selling commissions applicable to the sale of Registrable
Securities, including, without limitation, any fees and disbursements of any
special counsel to the Holders beyond those included in Registration Expenses,
are called “
Selling
Expenses
.” The Company shall only be responsible for all
Registration Expenses.
5.
Indemnification
.
(a)
In the
event of a registration of any Registrable Securities under the Securities Act
pursuant to this Agreement, the Company will indemnify and hold harmless the
Lender, and its officers, directors, partners, managers and members and each
other person or entity, if any, who controls the Lender within the meaning of
the Securities Act, against any losses, claims, damages or liabilities, joint or
several, to which the Lender, or such persons or entities may become subject
under the Securities Act or otherwise, insofar as such losses, claims, damages
or liabilities (or Proceedings in respect thereof) arising out of or are based
upon any Registration Statement under which such Registrable Securities were
registered under the Securities Act pursuant to this Agreement, any preliminary
Prospectus or final Prospectus contained therein, or any amendment or supplement
thereof, or arise out of or are based upon any document, information or material
in connection therewith, and will reimburse the Lender, and each such person or
entity for any and all reasonable legal or other expenses incurred by them in
connection with investigating or defending any such loss, claim, damage,
liability or proceedings; provided, however, that the Company will not be liable
in any such case if and to the extent that any such loss, claim, damage or
liability arises out of or is based upon an untrue statement or alleged untrue
statement or omission or alleged omission so made in conformity with information
furnished by or on behalf of the Lender or any such person or entity in writing
specifically for use in any such document.
(b)
In the
event of a registration of the Registrable Securities under the Securities Act
pursuant to this Agreement, the Lender will indemnify and hold harmless the
Company, and its officers, directors and each other person, if any, who controls
the Company within the meaning of the Securities Act, against all losses,
claims, damages or liabilities, joint or several, to which the Company or such
persons may become subject under the Securities Act or otherwise, insofar as
such losses, claims, damages or liabilities (or actions in respect thereof)
arise out of or are based upon any untrue statement or alleged untrue statement
of any material fact which was furnished in writing by the Lender to the Company
expressly for use in (and such information is contained in) the Registration
Statement under which such Registrable Securities were registered under the
Securities Act pursuant to this Agreement, any preliminary Prospectus or final
Prospectus contained therein, or any amendment or supplement thereof, or arise
out of or are based upon the omission or alleged omission to state therein a
material fact required to be stated therein or necessary to make the statements
therein not misleading, and will reimburse the Company and each such person for
any reasonable legal or other expenses incurred by them in connection with
investigating or defending any such loss, claim, damage, liability or action,
provided, however, that the Lender will be liable in any such case if and only
to the extent that any such loss, claim, damage or liability arises out of or is
based upon an untrue statement or alleged untrue statement or omission or
alleged omission so made in conformity with information furnished in writing to
the Company by or on behalf of the Lender specifically for use in any such
document. Notwithstanding the provisions of this paragraph, the
Lender shall not be required to indemnify any person or entity in excess of the
amount of the aggregate net proceeds received by the Lender in respect of
Registrable Securities in connection with any such registration under the
Securities Act.
(c)
Promptly
after receipt by a party entitled to claim indemnification hereunder (an “
Indemnified Party
”)
of notice of the commencement of any Proceeding, such Indemnified Party shall,
if a claim for indemnification in respect thereof is to be made against a party
hereto obligated to indemnify such Indemnified Party (an “
Indemnifying Party
”),
notify the Indemnifying Party in writing thereof, but the omission so to notify
the Indemnifying Party shall not relieve it from any liability which it may have
to such Indemnified Party other than under this Section and shall only relieve
it from any liability which it may have to such Indemnified Party under this
Section if and to the extent the Indemnifying Party is prejudiced by such
omission. In case any such action shall be brought against any Indemnified Party
and it shall notify the Indemnifying Party of the commencement thereof, the
Indemnifying Party shall be entitled to participate in and, to the extent it
shall wish, to assume and undertake the defense thereof with counsel
satisfactory to such Indemnified Party, and, after notice from the Indemnifying
Party to such Indemnified Party of its election so to assume and undertake the
defense thereof, the Indemnifying Party shall not be liable to such Indemnified
Party under this Section for any legal expenses subsequently incurred by such
Indemnified Party in connection with the defense thereof; if the Indemnified
Party retains its own counsel, then the Indemnified Party shall pay all
reasonable fees, costs and expenses of such counsel, provided, however, that, if
the defendants in any such action include both the Indemnified Party and the
Indemnifying Party and the Indemnified Party shall have reasonably concluded
that there may be reasonable defenses available to it which are different from
or additional to those available to the Indemnifying Party or if the interests
of the Indemnified Party reasonably may be deemed to conflict with the interests
of the Indemnifying Party, the Indemnified Party shall have the right to select
one separate counsel and to assume such legal defenses and otherwise to
participate in the defense of such action, with the reasonable expenses and fees
of such separate counsel and other expenses related to such participation to be
reimbursed by the Indemnifying Party as incurred.
(d)
In order
to provide for just and equitable contribution in the event of joint liability
under the Securities Act in any case in which either (i) the Lender, or any
officer, director, partner, member, manager or controlling person or entity of
the Lender, makes a claim for indemnification pursuant to this Section but it is
judicially determined (by the entry of a final judgment or decree by a court of
competent jurisdiction and the expiration of time to appeal or the denial of the
last right of appeal) that such indemnification may not be enforced in such case
notwithstanding the fact that this Section provides for indemnification in such
case, or (ii) contribution under the Securities Act may be required on the part
of the Lender or such officer, director, partner, member, manager or controlling
person or entity of the Lender in circumstances for which indemnification is
provided under this Section; then, and in each such case, the Company and the
Lender will contribute to the aggregate losses, claims, damages or liabilities
to which they may be subject (after contribution from others) in such proportion
so that the Lender is responsible only for the portion represented by the
percentage that the public offering price of its securities offered by the
Registration Statement bears to the public offering price of all securities
offered by such Registration Statement, provided, however, that, in any such
case, (A) the Lender will not be required to contribute any amount in excess of
the public offering price of all such securities offered by it pursuant to such
Registration Statement and (B) no person or entity guilty of fraudulent
misrepresentation (within the meaning of Section 10(f) of the Act) will be
entitled to contribution from any person or entity who was not guilty of such
fraudulent misrepresentation.
6.
Representations and
Warranties
.
(a)
The
Common Stock is registered pursuant to Section 12(b) or 12(g) of the Exchange
Act and, except with respect to certain matters which the Company has disclosed
to the Loan Agreement or the Securities Issuance Agreement, the Company has
timely filed all proxy statements, reports, schedules, forms, statements and
other documents required to be filed by it under the Exchange
Act. Each Financial Statement was, at the time of its filing, in
compliance with the requirements of its respective form and none of the
Financial Statements, nor the financial statements (and the notes thereto)
included in the Financial Statements, as of their respective filing dates,
contained any untrue statement of a material fact or omitted to state a material
fact required to be stated therein or necessary to make the statements therein,
in light of the circumstances under which they were made, not
misleading. The financial statements of the Company included in the
Financial Statements comply as to form in all material respects with applicable
accounting requirements and the published rules and regulations of the
Commission or other applicable rules and regulations with respect
thereto. Such financial statements have been prepared in accordance
with U.S. generally accepted accounting principles (“
GAAP
”) applied on a
consistent basis during the periods involved (except (i) as may be otherwise
indicated in such financial statements or the notes thereto or (ii) in the case
of unaudited interim statements, to the extent they may not include footnotes or
may be condensed) and fairly present in all material respects the financial
condition, the results of operations and the cash flows of the Company and its
subsidiaries, on a consolidated basis, as of, and for, the periods presented in
each such Financial Statements.
(b)
The
Common Stock is listed for trading on the OTC Bulletin Board
and satisfies all
requirements for the continuation of such listing. The Company has
not received any notice that its Common Stock will be delisted from the OTC
Bulletin Board (except for prior notices which have been fully remedied) or that
the Common Stock does not meet all requirements for the continuation of such
listing.
(c)
Neither
the Company, nor any of its affiliates, nor any person or entity acting on its
or their behalf, has directly or indirectly made any offers or sales of any
security or solicited any offers to buy any security under circumstances that
would cause the offering of the Securities pursuant to the Securities Issuance
Agreement and the Loan Documents to be integrated with prior offerings by the
Company for purposes of the Securities Act which would prevent the Company from
selling the Common Stock pursuant to Rule 506 under the Securities Act, or any
applicable exchange-related stockholder approval provisions, nor will the
Company or any of its affiliates take any action or steps that would cause the
offering of such Securities to be integrated with other offerings.
(d)
The Notes
and the shares of Common Stock which the Lender may acquire pursuant to the
Notes are all restricted securities under the Securities Act as of the date of
this Agreement. The Company will not issue any stop transfer order or
other order impeding the sale and delivery of any of the Registrable Securities
at such time as such Registrable Securities are registered for public sale or an
exemption from registration is available, except as required by federal or state
securities laws.
(e)
The
Company understands the nature of the Registrable Securities issuable upon the
conversion of the Notes and recognizes that the issuance of such Registrable
Securities may have a potential dilutive effect. The Company
specifically acknowledges that its obligation to issue the Registrable
Securities is binding upon the Company and enforceable regardless of the
dilution such issuance may have on the ownership interests of other shareholders
of the Company.
(f) Except
for agreements made in the ordinary course of business, there is no agreement
that has not been filed with the Commission as an exhibit to a registration
statement or to a form required to be filed by the Company under the Exchange
Act, the breach of which could reasonably be expected to have a material and
adverse effect on the Company or subsidiaries, or would prohibit or otherwise
interfere with the ability of the Company to enter into and perform any of its
obligations under this Agreement in any material respect.
(g) The
Company will at all times have authorized and reserved a sufficient number of
shares of Common Stock for the full conversion of the Notes.
7.
Miscellaneous
.
(a)
Remedies
. In
the event of a breach by the Company of any of its obligations under this
Agreement, each Holder will be entitled to specific performance of its rights
under this Agreement.
(b)
Existing Registration
Rights
. Except as and to the extent specified in
Schedule 7(b)
hereto,
the Company has not previously entered into any agreement granting any
registration rights with respect to any of its securities to any Person that
have not been fully satisfied.
(c)
Compliance
. Each
Holder covenants and agrees that it will comply with the prospectus delivery
requirements of the Securities Act as applicable to it in connection with sales
of Registrable Securities pursuant to the Registration Statement.
(d)
Discontinued
Disposition
. Each Holder agrees by its acquisition of such
Registrable Securities that, upon receipt of a notice from the Company of the
occurrence of a Discontinuation Event (as defined below), such Holder will
forthwith discontinue disposition of such Registrable Securities under the
applicable Registration Statement until such Holder’s receipt of the copies of
the supplemented Prospectus and/or amended Registration Statement or until it is
advised in writing (the “
Advice
”) by the
Company that the use of the applicable Prospectus may be resumed, and, in either
case, has received copies of any additional or supplemental filings that are
incorporated or deemed to be incorporated by reference in such Prospectus or
Registration Statement. The Company may provide appropriate stop orders to
enforce the provisions of this paragraph. For purposes of this
Section, a “
Discontinuation
Event
” shall mean (i) when the Commission notifies the Company whether
there will be a “review” of such Registration Statement and whenever the
Commission comments in writing on such Registration Statement (the Company shall
provide true and complete copies thereof and all written responses thereto to
each of the Holders); (ii) any request by the Commission or any other
Governmental Authority for amendments or supplements to such Registration
Statement or Prospectus or for additional information; (iii) the issuance by the
Commission of any stop order suspending the effectiveness of such Registration
Statement covering any or all of the Registrable Securities or the initiation of
any Proceedings for that purpose; (iv) the receipt by the Company of any
notification with respect to the suspension of the qualification or exemption
from qualification of any of the Registrable Securities for sale in any
jurisdiction, or the initiation or threatening of any Proceeding for such
purpose; and/or (v) the occurrence of any event or passage of time that makes
the financial statements included in such Registration Statement ineligible for
inclusion therein or any statement made in such Registration Statement or
Prospectus or any document incorporated or deemed to be incorporated therein by
reference untrue in any material respect or that requires any revisions to such
Registration Statement, Prospectus or other documents so that, in the case of
such Registration Statement or Prospectus, as the case may be, it will not
contain any untrue statement of a material fact or omit to state any material
fact required to be stated therein or necessary to make the statements therein,
in light of the circumstances under which they were made, not
misleading.
(e)
Piggy-Back
Registrations
. If at any time during the Effectiveness Period
there is not an effective Registration Statement covering all of the Registrable
Securities and the Company shall determine to prepare and file with the
Commission a registration statement relating to an offering for its own account
or the account of others under the Securities Act of any of its equity
securities, other than on Form S-4 or Form S-8 (each as promulgated under the
Securities Act) or their then equivalents relating to equity securities to be
issued solely in connection with any acquisition of any entity or business or
equity securities issuable in connection with stock option or other employee
benefit plans, then the Company shall send to each Holder written notice of such
determination and, if within 15 days after receipt of such notice, any such
Holder shall so request in writing, the Company shall use its best efforts to
include in such registration statement all or any part of such Registrable
Securities such holder requests to be registered to the extent the Company may
do so without violating registration rights of others which exist as of the date
of this Agreement, subject to customary underwriter cutbacks applicable to all
holders of registration rights and subject to obtaining any required the consent
of any selling stockholder(s) to such inclusion under such registration
statement.
(f)
Amendments and
Waivers
. The provisions of this Agreement, including the
provisions of this sentence, may not be amended, modified or supplemented unless
the same shall be in writing and signed by the Company and the Holders of the
then outstanding Registrable Securities. Notwithstanding the foregoing, a waiver
or consent to depart from the provisions hereof with respect to a matter that
relates exclusively to the rights of certain Holders and that does not directly
or indirectly affect the rights of other Holders may be given by Holders of at
least a majority of the Registrable Securities to which such waiver or consent
relates; provided, however, that the provisions of this sentence may not be
amended, modified, or supplemented except in accordance with the provisions of
the immediately preceding sentence.
(g)
Notices
. Any
notice or request hereunder may be given to the Company or the Lender at the
respective addresses set forth below or as may hereafter be specified in a
notice designated as a change of address under this Section. Any
notice or request hereunder shall be given by registered or certified mail,
return receipt requested, hand delivery, overnight mail, Federal Express or
other national overnight next day carrier (collectively, “
Courier
”). Notices
and requests shall be deemed delivered upon receipt. The address for
such notices and communications shall be as follows:
If
to the Company:
|
10500
N.E. 8
th
Street
Suite
1400
Bellevue,
Washington 12533
Attention: John
Atherly
|
|
|
with
a copy to:
|
|
|
Sichenzia
Ross Friedman Ference LLP
61
Broadway
New
York, New York 10006
Attention: Richard
A. Friedman, Esq.
|
|
|
If
to Lender:
|
685
Fifth Avenue
New
York, New York 10022
Attention:
Greg Zilberstein
|
|
|
with
a copy to:
|
|
|
Cohen
Tauber Spievack & Wagner LLP
420
Lexington Avenue
Suite
2400
New
York, New York 10170
Attention:
Adam Stein, Esq.
|
If
to any other Person who is then the registered Holder:
|
To
the address of such Holder as it appears in the stock transfer books of
the Company
|
or such
other address as may be designated in writing hereafter in accordance with this
Section by such Person.
(h)
Successors and
Assigns
. This Agreement shall inure to the benefit of and be
binding upon the successors and permitted assigns of each of the parties and
shall inure to the benefit of each Holder. The Company may not assign its rights
or obligations hereunder without the prior written consent of each
Holder. Each Holder may assign their respective rights hereunder in
the manner and to Persons as permitted under the Loan Documents.
(i)
Execution and
Counterparts
. This Agreement may be executed in any number of
counterparts, each of which when so executed shall be deemed to be an original
and, all of which taken together shall constitute one and the same Agreement. In
the event that any signature is delivered by facsimile or electronic
transmission, such signature shall create a valid binding obligation of the
party executing (or on whose behalf such signature is executed) the same with
the same force and effect as if such facsimile or electronic signature were the
original thereof.
(j)
Governing
Law
. All questions concerning the construction, validity,
enforcement and interpretation of this Agreement shall be governed by and
construed and enforced in accordance with the internal laws of the State of New
York, without regard to the principles of conflicts of law thereof. Each party
agrees that all Proceedings concerning the interpretations, enforcement and
defense of the transactions contemplated by this Agreement shall be commenced
exclusively in the state and federal courts sitting in the City of New York,
Borough of Manhattan. Each party hereto hereby irrevocably submits to the
exclusive jurisdiction of the state and federal courts sitting in the City of
New York, Borough of Manhattan for the adjudication of any dispute hereunder or
in connection herewith or with any transaction contemplated hereby or discussed
herein, and hereby irrevocably waives, and agrees not to assert in any
Proceeding, any claim that it is not personally subject to the jurisdiction of
any such court, that such Proceeding is improper. Each party hereto
hereby irrevocably waives personal service of process and consents to process
being served in any such Proceeding by mailing a copy thereof via registered or
certified mail or overnight delivery (with evidence of delivery) to such party
at the address in effect for notices to it under this Agreement and agrees that
such service shall constitute good and sufficient service of process and notice
thereof. Nothing contained herein shall be deemed to limit in any way
any right to serve process in any manner permitted by law. Each party
hereto hereby irrevocably waives, to the fullest extent permitted by applicable
law, any and all right to trial by jury in any legal proceeding arising out of
or relating to this Agreement or the transactions contemplated
hereby. (k)
Cumulative
Remedies
. The remedies provided herein are cumulative and not
exclusive of any remedies provided by law or in equity.
(l)
Severability
. If
any term, provision, covenant or restriction of this Agreement is held by a
court of competent jurisdiction to be invalid, illegal, void or unenforceable,
the remainder of the terms, provisions, covenants and restrictions set forth
herein shall remain in full force and effect and shall in no way be affected,
impaired or invalidated, and the parties hereto shall use their reasonable
efforts to find and employ an alternative means to achieve the same or
substantially the same result as that contemplated by such term, provision,
covenant or restriction. It is hereby stipulated and declared to be the
intention of the parties that they would have executed the remaining terms,
provisions, covenants and restrictions without including any of such that may be
hereafter declared invalid, illegal, void or unenforceable.
(j)
Headings
. The
headings in this Agreement are for convenience of reference only and shall not
limit or otherwise affect the meaning hereof.
IN
WITNESS WHEREOF, the parties have executed this Registration Rights Agreement as
of the date first written above.
|
EMAGIN
CORPORATION
|
|
|
|
|
|
|
By:
|
/s/
|
|
|
|
Name
|
|
|
|
Title
|
|
|
|
|
|
|
MORIAH CAPITAL,
L.P.
|
|
|
|
|
|
|
By:
|
Moriah Capital Management,
L.P.,
|
|
|
|
General
Partner
|
|
|
|
|
|
|
|
|
|
|
|
|
|
By:
|
Moriah Capital Management, GP,
LLC,
|
|
|
|
General
Partner
|
|
|
|
|
|
|
|
|
|
EXHIBIT
A
[DATE]
[ADDRESS]
Attn:
[
_________________]
A
Registration Statement on Form [___] under the Securities Act of 1933, as
amended (the “
Act
”), with respect
to the resale of the Shares was declared effective by the Securities and
Exchange Commission on
[DATE]
. Enclosed is the Prospectus dated
[DATE]
. We
understand that the Shares are to be offered and sold in the manner described in
the Prospectus.
Based
upon the foregoing, upon request by the Selling Stockholder at any time while
the registration statement remains effective, it is our opinion that the Shares
have been registered for resale under the Act and new certificates evidencing
the Shares upon their transfer or re-registration by the Selling Stockholder may
be issued without restrictive legend. We will advise you if the
registration statement is not available or effective at any point in the
future.
Very
truly yours,
[COMPANY
COUNSEL]
SCHEDULE
7(B)
Pursuant
to Section 8 of the Note Purchase Agreement dated July 21, 2006 and amended July
23, 2007 with respect to the 8% Senior Secured Notes and related warrants, the
Company is obligated to file a registration statement with respect to 6,908,864
note conversion shares and 4,831,859 warrant
shares.
EXHIBIT
I
TO
LOAN
AND SECURITY AGREEMENT
Form of Conversion
Agreement
EXHIBIT
I
LOAN CONVERSION
AGREEMENT
LOAN CONVERSION AGREEMENT,
dated as of August 7, 2007 (this “
Agreement
”), between
eMagin Corporation, a Delaware corporation (the “
Compan
y”), and Moriah
Capital, L.P., a Delaware limited partnership (together with its successors and
any assignees, “
Lender
”).
WHEREAS,
Lender has contemporaneously entered into a Loan and Security Agreement, dated
as of the date hereof (as the same may be amended, the “
Loan Agreement
”),
between Lender, as lender, and the Company, as borrower;
WHEREAS,
pursuant to the Loan Agreement, the outstanding principal and accrued and unpaid
interest due to Lender (“
Loan Indebtedness
”)
under the Note is convertible into such number of fully paid and nonassessable
shares (as may be adjusted pursuant to
Section 4
hereof, the
“
Shares
”) of
Common Stock, par value $0.001 per share (“
Common Stock
”), of
the Company, as equals (i) that portion of the Loan Indebtedness under the Loan
Agreement that Lender elects to convert into Common Stock divided by (ii) the
Conversion Price (as defined below);
NOW,
THEREFORE, the parties agree as follows:
1.
Conversion
Right; Term
. Subject to
the terms hereof, commencing on the date hereof and until
the first to
occur of (a) the date that the Loan Indebtedness is repaid in full in
accordance with the terms of the Loan Agreement or (b) the date that the
Loan Indebtedness is converted into Common Stock upon a Mandatory Conversion (as
defined in
Section
12
below)
(the “
Expiration
Date
”)
, Lender shall
have the right, at any time and from time to time, to convert (the “
Conversion Right
”)
any amount of the Loan Indebtedness into such number of shares of Common Stock
that shall be obtained by dividing the then-outstanding Loan Indebtedness by the
Conversion Price; provided, however, the total Loan Indebtedness that is
convertible hereunder shall not exceed Two Million Dollars ($2,000,000.00) (the
“Conversion Limit”).
To the extent not
exercised by 5:00 P.M., New York City time, on the Expiration Date, this
Agreement shall completely and automatically terminate and expire, and
thereafter it shall be of no force or effect whatsoever.
1A.
Conversion
Limitations
. Notwithstanding anything contained herein to the
contrary, Lender shall not be entitled to convert pursuant to the hereof an
amount that would be convertible into that number of shares of Common Stock that
would exceed the difference between 4.99% of the issued and outstanding shares
of Common Stock and the number of shares of Common Stock beneficially owned by
Lender (the “
4.99%
Limitation
”). For the purposes of the immediately preceding
sentence, beneficial ownership shall be determined in accordance with Section
13(d) of the Securities Exchange Act of 1934, as amended, and Regulation 13d-3
thereunder. Lender may void the 4.99% Limitation upon 75 days prior notice to
the Company or without any notice requirement upon an Event of
Default.
In the
event that Lender voids the 4.99% Limitation, Lender shall not be entitled to
convert pursuant to the hereof an amount that would be convertible into that
number of shares of Common Stock that would exceed the difference between 9.99%
of the issued and outstanding shares of Common Stock and the number of shares of
Common Stock beneficially owned by Lender (the “9
.99%
Limitation
”). For the purposes of the immediately preceding
sentence, beneficial ownership shall be determined in accordance with Section
13(d) of the Securities Exchange Act of 1934, as amended, and Regulation 13d-3
thereunder. Lender may void the 9.99% Limitation upon 75 days prior notice to
the Company or without any notice requirement upon an Event of
Default.
2.
Certain
Definitions
. The terms set forth below shall have the
following meanings. Capitalized terms used but not defined herein have the
meanings given to them in the Loan Agreement.
“
Conversion
Price
” means
an amount per share of Common Stock equal to $1.50, which Conversion
Price shall be subject to adjustment as provided herein.
“
Common Stock
Equivalent
” means any warrant, option, subscription or purchase right
with respect to shares of Common Stock, any security or property rights
convertible into, exchangeable for, or otherwise entitling the holder thereof to
acquire, shares of Common Stock or any warrant, option, subscription or purchase
right with respect to any such convertible, exchangeable or other
security.
“
Current Fair Market
Value
” when used with respect to the Common Stock as of a specified date
means, with respect to a share of Common Stock, the average of the closing
prices of the Common Stock sold on all securities exchanges including the NASD
OTCBB, NASDAQ Capital Market, the Nasdaq National Market, the American Stock
Exchange or the New York Stock Exchange (each a “
Trading Market
”) on
which the Common Stock may at the time be listed, or, if there have been no
sales on any such exchange on such day, the average of the highest bid and
lowest asked prices on all such exchanges at the end of regular trading such
day, or, if on such day the Common Stock is not so listed, the average of the
representative bid and asked prices quoted in the NASDAQ System as of 4:00 p.m.,
New York City time, or, if on such day the Common Stock is not quoted in the
NASDAQ System, the average of the highest bid and lowest asked price on such day
in the domestic over-the-counter market as reported by the Pink Sheets, LLC, or
any similar successor organization, in each such case averaged over a period of
five Trading Days consisting of the day as of which the Current Fair Market
Value of Common Stock is being determined (or if such day is not a Trading Day,
the Trading Day next preceding such day) and the
four consecutive
Trading Days prior to such day. If on the date for which Current Fair
Market Value is to be determined the Common Stock is not listed on any
securities exchange or quoted in the NASDAQ System or the over-the-counter
market, the Current Fair Market Value of Common Stock shall be the highest price
per share of Common Stock at which the Company has sold shares of Common Stock
or Common Stock Equivalents to one or more unaffiliated third parties in a bona
fide financing round during the 365 days prior to the date of such
determination. If no such sales were made during the 365 days prior
to the date of such determination, the Current Fair Market Value of
Common Stock shall be the price per share which the Company could then obtain
from a willing buyer on an arms’-length basis (not an affiliate, employee or
director of the Company at the time of determination) for shares of Common Stock
sold by the Company, from authorized but unissued shares, as determined in by an
independent appraiser mutually acceptable to, and unaffiliated with, the Company
and Lender, whose appraisal costs shall be paid by the Company.
“
Trading Day
” means at
any time a day on which the Trading Market on which the Common Stock may be
listed is open for general trading of securities.
3.
Deficiency in Shares
Available for Issuance
. If at any time the Conversion Right is exercised
the Company does not have available for issuance upon such conversion as
authorized and unissued shares or in its treasury at least the number of shares
of Common Stock required to be issued pursuant hereto, then, at the election of
Lender made by notice from Lender to the Company, the Conversion Right, to the
extent that sufficient shares of Common Stock are not then available for
issuance upon conversion, shall be converted into the right to receive from the
Company, in lieu of the shares of Common Stock which the Company is unable to
issue, payment in an amount equal to the product obtained by multiplying
(a) the number of shares of Common Stock which the Company is unable to
issue times
(b) the Current
Market Value of the Common Stock as of the Conversion Date. Such amount shall
further be deemed to be an Obligation under the Loan Agreement secured by the
Collateral thereunder. Any payment of such amount shall be deemed to be a
payment of principal plus a premium equal to the total amount payable less the
principal portion of the Loan converted as to which such payment is required to
be made because shares of Common Stock are not then available for issuance upon
such conversion.
4.
Conversion
Procedure
.
(a) In
order to exercise the conversion privilege hereunder, Lender shall give a
Conversion Notice in the form of
Annex A
(or such
other notice which is acceptable to the Company) to the Company.
(b) As
promptly as practicable, but in no event later than three (3) Business Days
after a Conversion Notice is given, the Company shall issue and shall deliver to
Lender the number of full shares of Common Stock issuable upon such
conversion.
(c) (1) If
Lender shall have given a Conversion Notice in accordance with the terms hereof,
the Company's obligation to issue and deliver the shares of Common Stock upon
such conversion shall be absolute and unconditional up to the amount of the
outstanding Loan Indebtedness (but not to exceed the Conversion Limit),
irrespective of any action or inaction by Lender to enforce the same, any waiver
or consent with respect to any provision hereof or of the Loan Agreement, the
recovery of any judgment against any person or any action to enforce the same,
any failure or delay in the enforcement of any other obligation of the Company
to Lender, or any setoff, counterclaim, recoupment, limitation or termination,
or any breach or alleged breach by Lender or any other person or entity of any
obligation to the Company or any violation or alleged violation of law by Lender
or any other person or entity, and irrespective of any other circumstance which
might otherwise limit such obligation of the Company to Lender in connection
with such conversion;
provided
,
however,
that nothing herein
shall limit or prejudice the right of the Company to pursue any such claim in
any other manner permitted by applicable law.
(2) If
in any case the Company shall fail to issue and deliver the shares of Common
Stock to Lender upon Lender’s exercise of the Conversion Right in accordance
with the terms of this Agreement and the Loan Agreement within five (5) Business
Days after Lender gives the Conversion Notice, in addition to any other
liabilities the Company may have hereunder and under applicable law (A) the
Company shall pay or reimburse Lender on demand for all out-of-pocket expenses,
including, without limitation, reasonable fees and expenses of legal counsel,
incurred by Lender as a result of such failure, (B) if as a result of such
failure Lender shall suffer any damages or liabilities (including, without
limitation, margin interest and the cost of purchasing securities to cover a
sale (whether by Lender or Lender's securities broker) or borrowing of shares of
Common Stock by Lender for purposes of settling any trade involving a sale of
shares of Common Stock made by Lender, then the Company shall upon demand of
Lender pay to Lender an amount equal to the damages and liabilities suffered by
Lender by reason thereof which Lender documents to the reasonable satisfaction
of the Company, and (C) Lender may by written notice given at any time prior to
delivery to Lender of the shares of Common Stock issuable in connection with
such exercise of Lender's Conversion Right, rescind such exercise and the
Conversion Notice relating thereto.
5.
Notices of Certain Company
Actions
.
In case
on or after the date of this Agreement:
(a) the
Company shall declare a dividend (or any other distribution) on its Common Stock
(other than in cash out of retained earnings); or
(b) the
Company shall authorize the granting to the holders of its Common Stock of
rights or warrants to subscribe for or purchase any share of any class or any
other rights or warrants;
the
Company shall give Lender, as promptly as possible but in any event at least ten
(10) Business Days prior to the applicable date hereinafter specified, a notice
stating the date on which a record is to be taken for the purpose of such
dividend, distribution or rights or warrants, or, if a record is not to be
taken, the date as of which the holders of Common Stock of record to be entitled
to such dividend, distribution or rights are to be determined. Such notice shall
not include any information which would be material non-public information for
purposes of the Securities Exchange Act of 1934, as amended. Failure to give
such notice, or any defect therein, shall not affect the legality or validity of
such dividend, distribution, reclassification, consolidation, merger, sale,
transfer, dissolution, liquidation or winding-up. In the case of any such action
of which the Company gives such notice to Lender or is required to give such
notice to Lender, Lender shall be entitled to give a Conversion Notice which is
contingent on the completion of such action.
6.
Stock Fully Paid,
Reservation of Shares
. All Shares that may be issued upon the
exercise of the rights represented by this Agreement will, upon issuance, be
duly authorized, fully paid and nonassessable, and will be free from all Liens
with respect to the issue thereof. During the period within which the
Conversion Right may be exercised, the Company will at all times have
authorized, and reserved for the exercise of the Conversion Right a sufficient
number of shares of its Common Stock to enable the Company to fulfill its
obligation hereunder.
7.
Adjustment of Conversion
Price and Number of Shares
. The number and kind of securities
purchasable upon conversion, and the Conversion Price, shall be subject to the
adjustment from time to time upon the occurrence of certain events, as
follows:
(a)
Adjustment for Common Stock
Dividends and Distributions
. If the Company makes, or fixes a
record date for the determination of holders of Common Stock entitled to
receive, a dividend or other distribution payable in additional shares of Common
Stock or Common Stock Equivalents, in each such event the
Conversion Price that is then in effect shall be decreased as of the
time of such issuance or, in the event such record date is fixed, as of
the close of business on such record date
, by
multiplying the
Conversion Price then in
effect by a fraction
(i)
the
numerator of which is the total number of shares of Common Stock and Common
Stock Equivalents issued and outstanding immediately prior to the time of such
issuance or
the close of business on such record date
, and
(ii)
the
denominator of which is the total number of shares of Common Stock and Common
Stock Equivalents issued and outstanding immediately prior to the time of such
issuance or
the close of business on such record date
plus the number of shares of Common Stock or Common Stock
Equivalents issuable in payment of such dividend or distribution;
provided
,
however
, that if such
record date is fixed and such dividend is not fully paid or if such distribution
is not fully made on the date fixed therefor, the
Conversion
Price shall be recomputed accordingly as of
the close of
business on such record date
and thereafter the
Conversion Price shall be adjusted pursuant to this
Section 4(a) to reflect the actual payment of such dividend or
distribution.
(c)
Adjustments for
Reclassification, Reorganization and Consolidation
. In case of
(1)
any reclassification, reorganization,
change or conversion of securities of the Common Stock (other than a change in
par value) into other shares or securities of the Company,
(2)
any merger or consolidation of the
Company with or into another entity (other than a merger or consolidation with
another entity in which the Company is the acquiring and the surviving entity
and that does not result in any reclassification or change of the Common
Stock
), or
(3)
any
sale of all or substantially all the assets of the Company,
Lender shall have the right to receive, in lieu of the shares of
Common Stock
into which the Loan Indebtedness is convertible, the
kind and amount of shares of stock and other securities, money and property
receivable upon such reclassification, reorganization, change, merger or
consolidation or sale upon conversion by Lender of the maximum number of shares
of Common Stock into which the Loan Indebtedness
could have
been converted
immediately prior to such
reclassification, reorganization, change, merger or consolidation or
sale, all subject to further adjustment as provided herein or with respect to
such other securities or property by the terms thereof. The
provisions of this
Section
shall similarly
attach to successive reclassifications, reorganizations, changes, mergers or
consolidations.
(e)
No
Impairment
. The Company shall not, by amendment of its
Certificate of Incorporation or bylaws, or through any reorganization,
recapitalization, transfer of assets, consolidation, merger, dissolution, issue
or sale of securities or any other voluntary action, avoid or seek to avoid the
observance or performance of any of the terms to be observed or performed
hereunder by the Company, but will at all times in good faith assist in the
carrying out of all the provisions of this Agreement and in the taking of all
such actions as may be necessary or appropriate in order to protect the rights
of Lender against impairment.
(f)
Notice of
Adjustments
. Whenever the consideration issuable upon a
conversion hereunder shall be changed pursuant to this Agreement, the Company
shall prepare a certificate setting forth, in reasonable detail, the event
requiring the change and the kind and amount of shares of stock and other
securities, money and property subsequently issuable upon a conversion
hereof. Such certificate shall be signed by its chief financial
officer and shall be delivered to Lender or such other person as Lender or any
successor notice recipient may designate.
(g)
Fractional
Shares
. No fractional shares of Common Stock will be issued in
connection with any exercise hereunder, but in lieu of such fractional shares
the Company shall round up the number of shares issuable in connection with such
exercise to the next whole share.
(h)
Mandatory Conversion
.
If the following conditions are met, then the Company may, on not less
than fifteen (15) days prior written notice (“
Mandatory Conversion
Notice
”) to Lender (“
Mandatory Conversion Notice
Date
”), demand that all, but not less than all, of the outstanding Loan
Indebtedness be converted into Common Stock on the terms set forth herein (a
“
Mandatory
Conversion
”):
(1) The
Company’s Common Stock, trading on any Trading Market, has a Current Market
Value equal to $3.50 (as adjusted in accordance with the terms hereof) or more
for ten (10) consecutive Trading Days (the “Mandatory Conversion Measurement
Period”).
(2) All
of the shares of Common Stock into which the Loan Indebtedness is convertible
are then freely tradable under an effective registration statement filed with
the Securities and Exchange Commission or pursuant to Rule 144 of the Rules and
Regulations promulgated under the Securities Act of 1933, as amended, and Lender
shall have received an opinion of counsel to the Company as may be necessary or
requested by Lender to allow such resales, provided the Company and its counsel
receive reasonably requested representations from Lender and its broker, if
any.
(3) Each
of the representations and warranties made by or on behalf of the Company to
Lender in this Agreement and in other Loan Documents shall be true and correct
in all material respects as of the Mandatory Conversion Notice Date (provided
that any such representation or warranty that is qualified as to materiality
shall be true and correct in all respects), and Lender shall have received a
certification from a Responsible Officer with respect to the
foregoing in form and substance satisfactory to Lender.
(4) The
Company shall have duly and properly performed, complied with and observed each
of its covenants, agreements and obligations contained in this Agreement and the
other Loan Documents as of the Mandatory Conversion Notice Date, and Lender
shall have received a certification from a Responsible Officer with respect to
the foregoing in form and substance satisfactory to
Lender.
(5) No
event shall have occurred on or prior to the Mandatory Conversion Notice Date or
at any time thereafter and be continuing as of the date of the Mandatory
Conversion, and no condition shall exist on the Mandatory Conversion Notice Date
or at any time thereafter and be continuing as of the date of the Mandatory
Conversion, which constitutes an Event of Default or which would, with notice or
the lapse of time, or both, constitute an Event of Default under this Agreement
or any of the other Loan Documents, and Lender shall have received a
certification from a Responsible Officer with respect to the
foregoing in form and substance satisfactory to Lender.
The
Mandatory Conversion Notice shall be accompanied by a certificate of the Company
setting forth, in reasonable detail, the calculation of the Current Fair Market
Value of the Common Stock and the number of Shares issuable upon the Mandatory
Conversion. Such certificate shall be signed by the Company’s chief financial
officer and shall be delivered to Lender or such other person as Lender or any
successor notice recipient may designate.
Notwithstanding
the foregoing, the Company may not effect a Mandatory Conversion in the event
that the number of shares of Common Stock issuable upon such Mandatory
Conversion would exceed the number of shares of Common Stock that could be sold
over a period of twenty (20) Trading Days based on twenty five percent (25%) of
the average daily trading volume of the Common Stock on the Trading Market
during the Mandatory Conversion Measurement Period.
8.
Compliance with Securities
Act; Disposition of Shares of Stock
. The Company is obligated
to register the shares to be issued upon conversion under the Securities Act of
1933, as amended, pursuant to the Registration Rights Agreement. Until such
shares are duly registered, Lender will not offer, sell or otherwise dispose of
any such Shares except under circumstances which will not result in a violation
of applicable securities laws.
9.
Rights as
Shareholder
. Lender shall not be entitled to vote or, subject
to
Section
4(a)
, receive dividends with respect to, or be deemed the holder of,
Shares issuable on the exercise hereof for any purpose, nor shall anything
contained herein be construed to confer upon Lender, as such, any right to vote
for the election of directors or upon any matter submitted to shareholders at
any meeting thereof, or to receive notice of meetings, or to receive dividends
or subscription rights or otherwise, until
the Conversion Right shall
have been exercised and the Shares purchasable upon the exercise hereof shall
have become deliverable, as provided herein.
10.
Representations and
Warranties of Company
. The Company represents and warrants to
Lender as follows:
(a) This
Agreement has been duly authorized and executed by the Company and is a valid
and binding obligation of the Company enforceable in accordance with its
terms.
(b) The
Shares have been duly authorized and reserved for issuance by the Company and,
when issued in accordance with the terms hereof, will be validly issued, fully
paid and nonassessable.
(c) The
execution and delivery of this Agreement are not, and the issuance of the Shares
upon conversion under this Agreement in accordance with the terms hereof will
not be, inconsistent with the Company’s charter or bylaws, as amended, and do
not and will not constitute a default under, any indenture, mortgage, contract
or other agreement or instrument of which the Company is a party or by which it
is otherwise bound.
11.
Miscellaneous.
(a)
Notices
. All
notices, requests and demands to or upon the respective parties hereto shall be
given in writing and shall be deemed to have been duly given or made upon
receipt by the receiving party. All notices, requests and demands are
to be given or made to the respective parties at the following addresses (or to
such other addresses as either party may designate by notice in accordance with
the provisions of this paragraph):
If
to the Company:
|
10500
N.E. 8
th
Street
|
|
Suite
1400
|
|
Bellevue,
Washington 12533
|
|
Attention:
John Atherly
|
|
|
With
a copy to:
|
Sichenzia
Ross Friedman Ference LLP
|
|
61
Broadway
|
|
New
York, New York 10006
|
|
Attention: Richard
A. Friedman, Esq.
|
|
|
If
to Lender:
|
Moriah
Capital, L.P.
|
|
685
Fifth Avenue
|
|
New
York, New York 10022
|
|
Attention:
Greg Zilberstein
|
|
|
|
|
With
a copy to:
|
Cohen
Tauber Spievack & Wagner LLP
|
|
420
Lexington Avenue, Suite 2400
|
|
New
York, New York 10170
|
|
Attention: Adam
Stein, Esq.
|
(b)
Amendments
. The
terms of this Agreement shall not be amended, altered, modified, supplemented or
terminated in any manner whatsoever except by a written instrument signed by the
parties hereto. The terms of this Agreement shall not be waived
except by a written instrument signed by the party to be charged with such
waiver.
(c)
Binding on
Successors
. This Agreement shall be binding upon and inure to
the benefit of the parties hereto and their respective successors and permitted
assigns in accordance with, and subject to, the terms of the Loan
Agreement.
(d)
Invalidity
. Any
provision of this Agreement which may be determined by competent authority to be
prohibited or unenforceable in any jurisdiction shall, as to such jurisdiction,
be ineffective to the extent of such prohibition or unenforceability without
invalidating the remaining provisions hereof, and any such prohibition or
unenforceability in any jurisdiction shall not invalidate or render
unenforceable such provision in any other jurisdiction.
(d)
Section or Paragraph
Headings
. Section and paragraph headings are for convenience
only and shall not be construed as part of this Agreement.
(e)
Governing
Law
. This Agreement shall be construed in accordance with, and
shall be governed by, the laws of the State of New York (without giving effect
to conflict of law rules.
(f)
Counterparts
. This
Agreement may be executed in counterparts and by facsimile or electronic
signature, each of which when so executed, shall be deemed an original, but all
of which shall constitute but one and the same instrument.
[SIGNATURE
PAGE FOLLOWS]
IN WITNESS WHEREOF
, the
parties have executed this Loan Conversion Agreement as of the date set forth
below.
|
EMAGIN
CORPORATION
|
|
|
|
|
|
|
By:
|
/s/
|
|
|
|
Name
|
|
|
|
Title
|
|
|
|
|
|
|
MORIAH CAPITAL,
L.P.
|
|
|
|
|
|
|
By:
|
Moriah Capital Management,
L.P.,
|
|
|
|
General
Partner
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
By:
|
Moriah Capital Management, GP,
LLC,
|
|
|
|
General
Partner
|
|
|
|
|
|
|
|
|
|
Annex
A
NOTICE OF
CONVERSION
To: eMagin
Corporation
1. The
undersigned hereby elects to purchase _____ shares of Common Stock of eMagin
Corporation in accordance with the terms of the attached Agreement, and tenders
herewith a certificate of an executive officer of Moriah Capital, L.P. setting
forth the amount of Loan Indebtedness to be cancelled, which amount is equal to
the then applicable Conversion Price per share multiplied by the number of
Shares being purchased, which represents full payment of the purchase price of
such shares.
2. Please
issue a certificate or certificates representing said shares in the name of the
undersigned or in such other name or names as are specified below:
Name:
Address:
3. The
undersigned represents that the aforesaid shares are being acquired for the
account of the undersigned for investment and not with a view to, or for resale
in connection with, the distribution thereof and that the undersigned has no
present intention of distributing or reselling such shares.
Signature:__________________________
Name:_____________________________
Address:___________________________
_________________________________
_________________________________
Social
Security or Taxpayer Identification No.:
EXHIBIT
J
TO
LOAN
AND SECURITY AGREEMENT
POST-CLOSING
AGREEMENT
POST-CLOSING AGREEMENT
("
Agreement"
) dated
this 7
th
day of
August, 2007, with respect to the Loan and Security Agreement, dated this 7th
day of August, 2007 ("
Loan Agreement"
) by
and between
EMAGIN
CORPORATION
,
a Delaware corporation,
with its principal place of business located at 10500 N.E. 8
th
Street,
Suite 1400, Bellevue, Washington 98004 (
"Borrower"
), and
MORIAH CAPITAL, L.P.,
a
Delaware limited partnership with offices at 685 Fifth Avenue, New York, New
York 10022 (
"Lender"
). Capitalized
terms used but not defined herein have the meanings given to them in the Loan
Agreement.
R E C I T A L
S:
WHEREAS, the parties have entered
into the Loan Agreement on the date hereof, and
WHEREAS, to facilitate the closing of
the transactions contemplated by the Loan Agreement, Lender has entered into the
Loan Agreement in reliance on Borrower�s undertaking to satisfy the conditions
set forth herein; and
WHEREAS, Borrower has agreed to
satisfy the conditions set forth herein within the time periods set forth
herein;
NOW, THEREFORE, the parties agree as
follows:
1)
Landlord
Agreements
. Within thirty (30) days of the date hereof,
Borrower shall provide Lender with (a) that certain landlord agreement in the
form attached hereto executed by Borrower, CapGemeni U.S. LLC, and Bellevue
Place Office Building Limited Partnership and (b) that certain landlord
agreement in the form attached hereto executed by Borrower and International
Business Machines Corporation.
2)
Intellectual Property
Security and Pledge Agreements
Within ten (10) Business Days
of being provided with patent and trademark security and pledge agreements in
form and substance not inconsistent with the existing security and pledge
agreements executed by Borrower in favor of Alexandra Global Master Fund Ltd.
(with the sole exception that such agreements shall be subordinate to the
existing assignment agreements executed by Borrower in favor of Alexandra Global
Master Fund Ltd.), Borrower shall execute and deliver such agreements to
Lender.
3)
Lockbox
Agreement
. Within thirty (30) days of the date hereof,
Borrower shall provide Lender with that certain lockbox agreement substantially
in the form attached hereto executed by Borrower and HSBC Bank USA, National
Association.
4)
Event of Default; No Other
Waiver; Counterparts
. Borrower's failure to timely comply with
any of the foregoing covenants shall constitute an Event of Default under the
Loan Agreement. Except as expressly set forth herein, nothing
contained herein shall act as a waiver or excuse of performance of any
Obligations. This Agreement may be executed in counterparts,
including facsimile or electronic signature, each of which when so executed,
shall be deemed an original, but all of which shall constitute but one and the
same instrument.
IN WITNESS WHEREOF,
this
Post-Closing Agreement has been duly executed as of the day and year first above
written.
|
EMAGIN
CORPORATION
|
|
|
|
|
|
|
By:
|
/s/
|
|
|
|
Name
|
|
|
|
Title
|
|
|
|
|
|
|
MORIAH CAPITAL
L.P.
|
|
|
|
|
|
|
By:
|
Moriah Capital Management,
L.P.,
|
|
|
|
General
Partner
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
By:
|
Moriah Capital Management, GP,
LLC,
|
|
|
|
General
Partner
|
|
|
|
|
|